PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smith, JR; de Billy, E; Hobbs, S; Powers, M; Prodromou, C; Pearl, L; Clarke, PA; Worknnan, P				Smith, J. R.; de Billy, E.; Hobbs, S.; Powers, M.; Prodromou, C.; Pearl, L.; Clarke, P. A.; Worknnan, P.			Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins	ONCOGENE			English	Article						CDC37; HSP90; client; kinase; chaperone	MOLECULAR CHAPERONE; CO-CHAPERONE; CYCLIN D1; PHOSPHORYLATION; P50(CDC37); COMPLEX; DEGRADATION; INHIBITORS; STABILITY; ONCOGENE	The HSP90 molecular chaperone plays a key role in the maturation, stability and activation of its clients, including many oncogenic proteins. Kinases are a substantial and important subset of clients requiring the key cochaperone CDC37. We sought an improved understanding of protein kinase chaperoning by CDC37 in cancer cells. CDC37 overexpression in human colon cancer cells increased CDK4 protein levels, which was negated upon CDC37 knockdown. Overexpressing CDC37 increased CDK4 protein half-life and enhanced binding of HSP90 to CDK4, consistent with CDC37 promoting kinase loading onto chaperone complexes. Against expectation, expression of C-terminus-truncated CDC37 (Delta C-CDC37) that lacks HSP90 binding capacity did not affect kinase client expression or activity; moreover, as with wild-type CDC37 overexpression, it augmented CDK4-HSP90 complex formation. However, although truncation blocked binding to HSP90 in cells, Delta C-CDC37 also showed diminished client protein binding and was relatively unstable. CDC37 mutants with single and double point mutations at residues M164 and L205 showed greatly reduced binding to HSP90, but retained association with client kinases. Surprisingly, these mutants phenocopied wild-type CDC37 overexpression by increasing CDK4-HSP90 association and CDK4 protein levels in cells. Furthermore, expression of the mutants was sufficient to protect kinase clients CDK4, CDK6, CRAF and ERBB2 from depletion induced by silencing endogenous CDC37, indicating that CDC37's client stabilising function cannot be inactivated by substantially reducing its direct interaction with HSP90. However, CDC37 could not compensate for loss of HSP90 function, showing that CDC37 and HSP90 have their own distinct and non-redundant roles in maintaining kinase clients. Our data substantiate the important function of CDC37 in chaperoning protein kinases. Furthermore, we demonstrate that CDC37 can stabilise kinase clients by a mechanism that is not dependent on a substantial direct interaction between CDC37 and HSP90, but nevertheless requires HSP90 activity. These results have significant implications for therapeutic targeting of CDC37.	[Smith, J. R.; de Billy, E.; Hobbs, S.; Powers, M.; Clarke, P. A.; Worknnan, P.] Haddow Labs, Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Surrey SM2 5NG, England; [Prodromou, C.; Pearl, L.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Clarke, PA (corresponding author), Haddow Labs, Canc Res UK Ctr Canc Therapeut, Inst Canc Res, Div Canc Therapeut, 15 Cotswold Rd, Surrey SM2 5NG, England.	paul.clarke@icr.ac.uk; paul.workman@icr.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021; de billy, emmanuel/AAA-6095-2020	Prodromou, Chrisostomos/0000-0003-4320-1147; de Crespin de Billy, emmanuel/0000-0002-3610-7083; Clarke, Paul/0000-0001-9342-1290; Pearl, Laurence/0000-0002-6910-1809	Cancer Research UK Programme [C3091A8274, C309/A11566]; Cancer Research UK [11566] Funding Source: researchfish	Cancer Research UK Programme(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank our colleagues in the Signal Transduction and Molecular Pharmacology Team and Chaperone Project Team for helpful discussions and Craig McAndrew for valuable assistance with gel filtration. The authors' work is supported by Cancer Research UK Programme grant number C3091A8274 and C309/A11566. PW is a Cancer Research UK Life Fellow.	Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray J, 2007, DANCING TIMES, V97, P67; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Karnitz LM, 2007, SCI STKE, V2007, pe22; Katayama Y, 2004, INT J ONCOL, V25, P579; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Marino-Enriiquez A, 2014, ONCOGENE, V33, P1872, DOI 10.1038/onc.2013.127; Miyata Y, 2004, ANN NY ACAD SCI, V1030, P150, DOI 10.1196/annals.1329.019; Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rao J, 2001, J BIOL CHEM, V276, P5814, DOI 10.1074/jbc.M007385200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Turnbull EL, 2005, FEBS J, V272, P4129, DOI 10.1111/j.1742-4658.2005.04825.x; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	50	32	32	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					15	26		10.1038/onc.2013.519	http://dx.doi.org/10.1038/onc.2013.519			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24292678	Green Accepted			2022-12-25	WOS:000349740100002
J	Newbold, A; Salmon, JM; Martin, BP; Stanley, K; Johnstone, RW				Newbold, A.; Salmon, J. M.; Martin, B. P.; Stanley, K.; Johnstone, R. W.			The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the E mu-myc model of B-cell lymphoma	ONCOGENE			English	Article						histone deacetylase inhibitors; CDKN1A; tumor-suppressor protein; cell cycle arrest	HISTONE-DEACETYLASE INHIBITORS; THERAPEUTIC ACTIVITIES; CANCER CELLS; APOPTOSIS; GROWTH; GENE; DIFFERENTIATION; P21(CIP1/WAF1); VORINOSTAT; BUTYRATE	Following the establishment of histone deacetylases (HDACs) as promising therapeutic targets for the reversal of aberrant epigenetic states associated with cancer, the development of HDAC inhibitors (HDACi) and their underlying mechanisms of action has been a significant area of scientific interest. HDACi induce diverse biological responses including the inhibition of cell proliferation by blocking progression through the G1 or G2/M phases of the cell cycle. As a putative tumor-suppressor protein, p21(waf1)/(cip1) influences cell proliferation by inhibiting the activity of cyclin-cyclin-dependent kinase (CDK) complexes at the G1/S and G2/M cell cycle checkpoints. HDACi transcriptionally activate CDKN1A, and it has been proposed that induction of p21waf1/cip1 can determine if a cell undergoes apoptosis or cell cycle arrest following HDACi treatment. In the E mu-myc transgenic mouse model of B-cell lymphoma, knockout of cdkn1a had no effect on disease latency, indicating that p21waf1/cip1 did not function as a tumor suppressor in this system. Although HDACi robustly induced expression of p21waf1/cip1 in wild-type Em-myc lymphomas, deletion of cdkn1a did not sensitize the lymphoma cells to HDACi-induced apoptosis and HDACi-induced cell cycle arrest still occurred. However, knockdown of cdkn1b in cdkn1a knockout lymphomas resulted in defective vorinostat-mediated arrest at G1/S indicating an essential role of p27(Kip1) in mediating this biological response to vorinostat. These data demonstrate that induction of cdkn1a does not regulate HDACi-mediated tumor cell apoptosis and refute the notion that p21(waf1)/(cip1) is an obligate mediator of HDACi-induced cell cycle arrest.	[Newbold, A.; Salmon, J. M.; Martin, B. P.; Stanley, K.; Johnstone, R. W.] Peter MacCallum Canc Ctr, Gene Regulat Lab, Canc Therapeut Program, East Melbourne, Vic 3002, Australia; [Johnstone, R. W.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Johnstone, RW (corresponding author), Peter MacCallum Canc Ctr, Gene Regulat Lab, Canc Therapeut Program, St Andrews Pl, East Melbourne, Vic 3002, Australia.	ricky.johnstone@petermac.org	Johnstone, Ricky w/H-3748-2014	Johnstone, Ricky w/0000-0001-7053-9237	NHMRC Program; Cancer Council Victoria; Leukemia Foundation of Australia; Victorian Cancer Agency; Victorian Breast Cancer Research Consortium	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia; Victorian Cancer Agency; Victorian Breast Cancer Research Consortium	RWJ is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and supported by NHMRC Program and Project Grants, the Cancer Council Victoria, The Leukemia Foundation of Australia, the Victorian Cancer Agency and Victorian Breast Cancer Research Consortium.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Burgess AJ, 2001, MOL PHARMACOL, V60, P828; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Ellis L, 2009, BLOOD, V114, P380, DOI 10.1182/blood-2008-10-182758; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hitomi T, 2003, FEBS LETT, V554, P347, DOI 10.1016/S0014-5793(03)01186-4; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Newbold A, 2013, MOL CANC TH IN PRESS; Newbold A, 2008, MOL CANCER THER, V7, P1066, DOI 10.1158/1535-7163.MCT-07-2256; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Peart MJ, 2003, CANCER RES, V63, P4460; Pitts TM, 2009, MOL CANCER THER, V8, P342, DOI 10.1158/1535-7163.MCT-08-0534; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Rosato RR, 2004, MOL PHARMACOL, V65, P571, DOI 10.1124/mol.65.3.571; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Svechnikova I, 2007, BIOCHEM BIOPH RES CO, V354, P466, DOI 10.1016/j.bbrc.2006.12.222; Uehara N, 2012, ONCOL REP, V28, P105, DOI 10.3892/or.2012.1758	27	39	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5415	5423		10.1038/onc.2013.482	http://dx.doi.org/10.1038/onc.2013.482			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24292681				2022-12-25	WOS:000345120700003
J	Hasim, S; Hussin, NA; Alomar, F; Bidasee, KR; Nickerson, KW; Wilson, MA				Hasim, Sahar; Hussin, Nur Ahmad; Alomar, Fadhel; Bidasee, Keshore R.; Nickerson, Kenneth W.; Wilson, Mark A.			A Glutathione-independent Glyoxalase of the DJ-1 Superfamily Plays an Important Role in Managing Metabolically Generated Methylglyoxal in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; DJ-1; Glycolysis; Structural Biology; X-ray Crystallography; Hsp31; Glyoxalase; Methylglyoxal	RESOLUTION CRYSTAL-STRUCTURE; YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI HSP31; I ENZYME; PROTEIN; CHAPERONE; MODEL; MEMBER; ACID; IDENTIFICATION	Background: Glyoxalases are a varied group of enzymes that detoxify methylglyoxal by converting it to d-lactate. Results: The Candida albicans glyoxalase Glx3 is important for yeast growth, especially in glycerol. Conclusion: Many yeasts contain a novel group of glyoxalases that are not redundant with previously characterized enzymes. Significance: This is the first demonstration of physiologically relevant glutathione-independent glyoxalases in fungi. Methylglyoxal is a cytotoxic reactive carbonyl compound produced by central metabolism. Dedicated glyoxalases convert methylglyoxal to d-lactate using multiple catalytic strategies. In this study, the DJ-1 superfamily member ORF 19.251/GLX3 from Candida albicans is shown to possess glyoxalase activity, making this the first demonstrated glutathione-independent glyoxalase in fungi. The crystal structure of Glx3p indicates that the protein is a monomer containing the catalytic triad Cys(136)-His(137)-Glu(168). Purified Glx3p has an in vitro methylglyoxalase activity (K-m = 5.5 mm and k(cat) = 7.8 s(-1)) that is significantly greater than that of more distantly related members of the DJ-1 superfamily. A close Glx3p homolog from Saccharomyces cerevisiae (YDR533C/Hsp31) also has glyoxalase activity, suggesting that fungal members of the Hsp31 clade of the DJ-1 superfamily are all probable glutathione-independent glyoxalases. A homozygous glx3 null mutant in C. albicans strain SC5314 displays greater sensitivity to millimolar levels of exogenous methylglyoxal, elevated levels of intracellular methylglyoxal, and carbon source-dependent growth defects, especially when grown on glycerol. These phenotypic defects are complemented by restoration of the wild-type GLX3 locus. The growth defect of Glx3-deficient cells in glycerol is also partially complemented by added inorganic phosphate, which is not observed for wild-type or glucose-grown cells. Therefore, C. albicans Glx3 and its fungal homologs are physiologically relevant glutathione-independent glyoxalases that are not redundant with the previously characterized glutathione-dependent GLO1/GLO2 system. In addition to its role in detoxifying glyoxals, Glx3 and its close homologs may have other important roles in stress response.	[Hasim, Sahar; Hussin, Nur Ahmad; Nickerson, Kenneth W.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Alomar, Fadhel; Bidasee, Keshore R.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Alomar, Fadhel; Bidasee, Keshore R.] Univ Nebraska Med Ctr, Redox Biol Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Nickerson, KW (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	knickerson1@unl.edu; mwilson13@unl.edu	Nickerson, Kenneth/V-9979-2019	Alomar, Fadhel Ahmed/0000-0003-0788-6919	Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999, P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Audrey Atkins (University of Nebraska-Lincoln), Wayne Riekhof (University of Nebraska-Lincoln), and Todd Holyoak (University of Waterloo) for useful discussions. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health Grant P41GM103393 from NIGMS.	AHMED MU, 1986, J BIOL CHEM, V261, P4889; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Bucala R, 1992, Adv Pharmacol, V23, P1; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; CASAZZA JP, 1984, J BIOL CHEM, V259, P231; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chen XJ, 2000, INT REV CYTOL, V194, P197; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Cooper R A, 1975, Methods Enzymol, V41, P502; COOPER RA, 1970, FEBS LETT, V11, P273, DOI 10.1016/0014-5793(70)80546-4; Dakin HD, 1913, J BIOL CHEM, V14, P423; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fioravanti E, 2008, BIOCHEMISTRY-US, V47, P11581, DOI 10.1021/bi800882v; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; GREEN ML, 1968, BIOCHEM J, V106, P267, DOI 10.1042/bj1060267; Guo PC, 2010, ACTA CRYSTALLOGR F, V66, P1557, DOI 10.1107/S1744309110039965; HALL SS, 1978, J AM CHEM SOC, V100, P5934, DOI 10.1021/ja00486a054; HALL SS, 1976, J AM CHEM SOC, V98, P7460, DOI 10.1021/ja00439a077; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon K, 2013, FEBS J, V280, P3328, DOI 10.1111/febs.12321; Lages NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032749; Lakshminarasimhan M, 2010, J BIOL CHEM, V285, P29651, DOI 10.1074/jbc.M110.147934; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Madzelan P, 2012, FEBS J, V279, P4111, DOI 10.1111/febs.12004; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Meyerhof O, 1934, BIOCHEM Z, V271, P89; MISRA K, 1995, BIOCHEM J, V305, P999, DOI 10.1042/bj3050999; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickerson KW, 2006, APPL ENVIRON MICROB, V72, P3805, DOI 10.1128/AEM.02765-05; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENNINCKX MJ, 1983, J BIOL CHEM, V258, P6030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Premkumar L, 2011, J STRUCT BIOL, V176, P414, DOI 10.1016/j.jsb.2011.08.011; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Sastry MSR, 2009, PROTEIN SCI, V18, P1439, DOI 10.1002/pro.158; Sastry MSR, 2004, P NATL ACAD SCI USA, V101, P8587, DOI 10.1073/pnas.0403033101; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Scheijen J. L., 2013, CLIN CHEM LAB MED, V10; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Synnott JM, 2010, EUKARYOT CELL, V9, P1734, DOI 10.1128/EC.00159-10; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; VANDERJAGT DL, 1993, BIOCHEM SOC T, V21, P522, DOI 10.1042/bst0210522; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Zhao YH, 2003, PROTEIN SCI, V12, P2303, DOI 10.1110/ps.03121403	65	61	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1662	1674		10.1074/jbc.M113.505784	http://dx.doi.org/10.1074/jbc.M113.505784			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302734	Green Published, hybrid			2022-12-25	WOS:000332401700039
J	Farris, SP; Miles, MF				Farris, Sean P.; Miles, Michael F.			Fyn-Dependent Gene Networks in Acute Ethanol Sensitivity	PLOS ONE			English	Article							ACUTE FUNCTIONAL TOLERANCE; LONG-TERM POTENTIATION; TYROSINE KINASE; NUCLEUS-ACCUMBENS; BEHAVIORAL-RESPONSES; ALCOHOL DEPENDENCE; GABA(A) RECEPTOR; NMDA RECEPTORS; EXPRESSION; BRAIN	Studies in humans and animal models document that acute behavioral responses to ethanol are predisposing factor for the risk of long-term drinking behavior. Prior microarray data from our laboratory document strain-and brain region-specific variation in gene expression profile responses to acute ethanol that may be underlying regulators of ethanol behavioral phenotypes. The non-receptor tyrosine kinase Fyn has previously been mechanistically implicated in the sedative-hypnotic response to acute ethanol. To further understand how Fyn may modulate ethanol behaviors, we used whole-genome expression profiling. We characterized basal and acute ethanol-evoked (3 g/kg) gene expression patterns in nucleus accumbens (NAC), prefrontal cortex (PFC), and ventral midbrain (VMB) of control and Fyn knockout mice. Bioinformatics analysis identified a set of Fyn-related gene networks differently regulated by acute ethanol across the three brain regions. In particular, our analysis suggested a coordinate basal decrease in myelin-associated gene expression within NAC and PFC as an underlying factor in sensitivity of Fyn null animals to ethanol sedation. An in silico analysis across the BXD recombinant inbred (RI) strains of mice identified a significant correlation between Fyn expression and a previously published ethanol loss-of-righting-reflex (LORR) phenotype. By combining PFC gene expression correlates to Fyn and LORR across multiple genomic datasets, we identified robust Fyn-centric gene networks related to LORR. Our results thus suggest that multiple system-wide changes exist within specific brain regions of Fyn knockout mice, and that distinct Fyn-dependent expression networks within PFC may be important determinates of the LORR due to acute ethanol. These results add to the interpretation of acute ethanol behavioral sensitivity in Fyn kinase null animals, and identify Fyn-centric gene networks influencing variance in ethanol LORR. Such networks may also inform future design of pharmacotherapies for the treatment and prevention of alcohol use disorders.	[Farris, Sean P.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Miles, MF (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	mfmiles@vcu.edu		Farris, Sean/0000-0002-9158-1984	National Institute of Alcohol Abuse and Alcoholism [F31AA0018615, U01AA016667, P20AA017828, R01AA014717]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017828, F31AA018615, R01AA014717, U01AA016667] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute of Alcohol Abuse and Alcoholism by support through grants F31AA0018615 to SPF; U01AA016667, P20AA017828, and R01AA014717 to MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett B, 2007, ALCOHOL CLIN EXP RES, V31, P200, DOI 10.1111/j.1530-0277.2006.00296.x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; Bice PJ, 2006, BEHAV GENET, V36, P248, DOI 10.1007/s10519-005-9019-6; Blednov YA, 2011, J PHARMACOL EXP THER, V336, P145, DOI 10.1124/jpet.110.171645; Boehm SL, 2004, NEUROSCI LETT, V372, P6, DOI 10.1016/j.neulet.2004.08.028; Boehm SL, 2004, J PHARMACOL EXP THER, V309, P1154, DOI 10.1124/jpet.103.064444; Boehm SL, 2003, ALCOHOL CLIN EXP RES, V27, P1033, DOI 10.1097/01.ALC.0000075822.80583.71; Bowers BJ, 2006, ALCOHOL, V40, P19, DOI 10.1016/j.alcohol.2006.09.004; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dick DM, 2002, ALCOHOL CLIN EXP RES, V26, P1453, DOI 10.1097/01.ALC.0000034037.10333.FD; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Ehlers CL, 2010, ADDICT BIOL, V15, P185, DOI 10.1111/j.1369-1600.2009.00195.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Goto J, 2004, CELL MOL NEUROBIOL, V24, P149, DOI 10.1023/B:CEMN.0000012720.71630.14; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Haughey HM, 2008, GENES BRAIN BEHAV, V7, P447, DOI 10.1111/j.1601-183X.2007.00369.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hill SY, 2004, AM J MED GENET B, V128B, P102, DOI 10.1002/ajmg.b.30013; Hu W, 2008, J PHARMACOL EXP THER, V326, P792, DOI 10.1124/jpet.108.137521; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kareken DA, 2010, ALCOHOL CLIN EXP RES, V34, P2169, DOI 10.1111/j.1530-0277.2010.01293.x; KEIR WJ, 1990, J PHARMACOL EXP THER, V254, P831; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lewohl Joanne M, 2005, Alcohol Clin Exp Res, V29, P1698, DOI 10.1097/01.alc.0000179406.98868.59; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Logrip ML, 2009, J NEUROCHEM, V109, P1459, DOI 10.1111/j.1471-4159.2009.06073.x; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Metten P, 1998, MAMM GENOME, V9, P983, DOI 10.1007/s003359900911; MIYAKAWA T, 1994, MOL BRAIN RES, V27, P179, DOI 10.1016/0169-328X(94)90201-1; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Morozova TV, 2011, GENETICS, V187, P1193, DOI 10.1534/genetics.110.125229; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakanishi H, 2007, P NATL ACAD SCI USA, V104, P14442, DOI 10.1073/pnas.0703211104; Neasta J, 2011, BIOL PSYCHIAT, V70, P575, DOI 10.1016/j.biopsych.2011.03.019; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Ponomarev I, 2004, ALCOHOL CLIN EXP RES, V28, P991, DOI 10.1097/01.ALC.0000131978.79857.5E; Quinn PD, 2011, ALCOHOL CLIN EXP RES, V35, P1759, DOI 10.1111/j.1530-0277.2011.01521.x; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Repunte-Canonigo V, 2010, BRAIN RES, V1339, P1, DOI 10.1016/j.brainres.2010.03.063; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schumann G, 2003, BIOL PSYCHIAT, V54, P1422, DOI 10.1016/S0006-3223(03)00635-8; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; Setlow B, 1997, J NEUROSCI RES, V49, P515; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Suvarna N, 2005, J BIOL CHEM, V280, P31450, DOI 10.1074/jbc.M504120200; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Trepanier CH, 2012, FEBS J, V279, P12, DOI 10.1111/j.1742-4658.2011.08391.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350	80	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82435	10.1371/journal.pone.0082435	http://dx.doi.org/10.1371/journal.pone.0082435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312422	Green Published, gold			2022-12-25	WOS:000327670300080
J	Girona, J; Rosales, R; Plana, N; Saavedra, P; Masana, L; Vallve, JC				Girona, Josefa; Rosales, Roser; Plana, Nuria; Saavedra, Paula; Masana, Lluis; Vallve, Joan-Carles			FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ADIPOSE-TISSUE DEPOTS; METABOLIC SYNDROME; PLASMA FATTY-ACID-BINDING-PROTEIN-4; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL-CELLS; HEART-DISEASE; IN-VITRO; EXPRESSION; PATHOGENESIS	Purpose: The migration and proliferation of vascular smooth muscle cells play crucial roles in the development of atherosclerotic lesions. This study examined the effects of fatty acid binding protein 4 (FABP4), an adipokine that is associated with cardiovascular risk, endothelial dysfunction and proinflammatory effects, on the migration and proliferation of human coronary artery smooth muscle cells (HCASMCs). Methods and Results: A DNA 5-bromo-2'-deoxy-uridine (BrdU) incorporation assay indicated that FABP4 significantly induced the dose-dependent proliferation of HCASMCs with a maximum stimulatory effect at 120 ng/ml (13% vs. unstimulated cells, p<0.05). An anti-FABP4 antibody (40 ng/ml) significantly inhibited the induced cell proliferation, demonstrating the specificity of the FABP4 proliferative effect. FABP4 significantly induced HCASMC migration in a dose-dependent manner with an initial effect at 60 ng/ml (12% vs. unstimulated cells, p<0.05). Time-course studies demonstrated that FABP4 significantly increased cell migration compared with unstimulated cells from 4 h (23% vs. 17%, p<0.05) to 12 h (74% vs. 59%, p<0.05). Pretreatment with LY-294002 (5 mu M) and PD98059 (10 mu M) blocked the FABP4-induced proliferation and migration of HCASMCs, suggesting the activation of a kinase pathway. On a molecular level, we observed an up-regulation of the MAPK pathway without activation of Akt. We found that FABP4 induced the active forms of the nuclear transcription factors c-jun and c-myc, which are regulated by MAPK cascades, and increased the expression of the downstream genes cyclin D1 and MMP2, CCL2, and fibulin 4 and 5, which are involved in cell cycle regulation and cell migration. Conclusions: These findings indicate a direct effect of FABP4 on the migration and proliferation of HCASMCs, suggesting a role for this adipokine in vascular remodelling. Taken together, these results demonstrate that the FABP4-induced DNA synthesis and cell migration are mediated primarily through a MAPK-dependent pathway that activates the transcription factors c-jun and c-myc in HCASMCs.	[Girona, Josefa; Rosales, Roser; Plana, Nuria; Saavedra, Paula; Masana, Lluis; Vallve, Joan-Carles] Univ Rovira & Virgili, Sant Joan Univ Hosp, IISPV,Res Unit Lipids & Atherosclerosis, Spanish Biomed Res Ctr Diabet & Associated Metab, E-43201 Reus, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Vallve, JC (corresponding author), Univ Rovira & Virgili, Sant Joan Univ Hosp, IISPV,Res Unit Lipids & Atherosclerosis, Spanish Biomed Res Ctr Diabet & Associated Metab, C St Llorenc 21, E-43201 Reus, Spain.	jc.vallve@urv.cat	Girona, Josefa/U-3489-2018; MASANA, LUIS/M-7002-2019; Rosales, Roser/AAF-9511-2021; Vallvé, Joan-Carles/T-6742-2019	Girona, Josefa/0000-0002-6267-8779; MASANA, LUIS/0000-0002-0789-4954; Rosales, Roser/0000-0002-9386-7169; Vallvé, Joan-Carles/0000-0001-8711-9618; Saavedra, Paula/0000-0002-9907-475X; Plana, Nuria/0000-0002-4231-7618	ISCIII, Madrid, Spain [PI 10/02547]; CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion), Spain	ISCIII, Madrid, Spain(Instituto de Salud Carlos III); CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion), Spain	This work was supported by grants from the ISCIII, Madrid, Spain (PI 10/02547) and CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Aragones G, 2012, EUR J CLIN INVEST, V42, P34, DOI 10.1111/j.1365-2362.2011.02553.x; Aragones G, 2010, ATHEROSCLEROSIS, V213, P329, DOI 10.1016/j.atherosclerosis.2010.07.026; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Cabre A, 2007, Atherosclerosis, V195, pe150; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Cabre A, 2010, J LIPID RES, V51, P1173, DOI 10.1194/jlr.M900066; Coll B, 2008, ATHEROSCLEROSIS, V199, P147, DOI 10.1016/j.atherosclerosis.2007.09.032; Doi M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-44; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Fisher RM, 2002, MOL CELL BIOCHEM, V239, P95, DOI 10.1023/A:1020532823751; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Lee K, 2013, ATHEROSCLEROSIS, V226, P74, DOI 10.1016/j.atherosclerosis.2012.09.037; Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu L, 2013, ARTERIOSCL THROM VAS, V33, P572, DOI 10.1161/ATVBAHA.112.301016; Peeters W, 2011, EUR HEART J, V32, P1758, DOI 10.1093/eurheartj/ehq387; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	37	46	51	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81914	10.1371/journal.pone.0081914	http://dx.doi.org/10.1371/journal.pone.0081914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312381	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300057
J	Jiang, ZB; Chen, YC; Yao, F; Chen, WZ; Zhong, SP; Zheng, FC; Shi, GG				Jiang, Zebin; Chen, Yicun; Yao, Fen; Chen, Weizhou; Zhong, Shuping; Zheng, Fuchun; Shi, Ganggang			Antioxidant, Antibacterial and Antischistosomal Activities of Extracts from Grateloupia livida (Harv). Yamada	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; IN-VITRO; FATTY-ACIDS; SEAWEEDS; FRACTIONS; REDUCTASE; OIL	The present study was designated to evaluate the antioxidant, antibacterial and antischistosomal activities of Grateloupia livida (GL) extracts in vitro. A GL Ethanol extract (EE) was separated into petroleum ether (PE), ethyl acetate (EA), n-butyl alcohol (BuOH) and aqueous (AQ) fractions to fractionate the polar and non-polar compounds in the EE. Extracts antioxidant activities were evaluated in vitro by DPPH radical-scavenging, deoxyribose radical scavenging, and beta-carotene bleaching assays, all using butylated hydroxytoluene (BHT) as the reference antioxidant compound. The most effective antioxidant properties were observed in the PE fraction in all three assays. Antimicrobial testing showed that the PE fraction exhibited broad-spectrum antimicrobial activity, with the PE fraction also exhibiting strong activity against the human pathogenic trematode S. japonicum adult worm. In order to investigate the relationships between bioactivity and chemical composition, the chemical composition of the PE fraction was analyzed by gas chromatography-mass spectrometry (GC-MS). In total, 25 components were identified in the PE fraction, most of which have known antioxidant and antimicrobial activities. However, none of the compounds have reported activity against Schistosoma, suggesting that the schistosomicidal activity of the PE fraction may be related to minor constituents present in the extract, or governed by more intricate synergistic or additive relationships. Finally, fractions with the greatest biological activity displayed neither cellular cytotoxicity, at concentrations up to 100 ug/ml, or acute oral toxicity in mice, at doses up to 2000 mg/kg. Based on antioxidant, antimicrobial, antischistosomal activities, and low toxicity, the PE fraction possesses properties useful for food preservation and overall improvement of human health.	[Jiang, Zebin; Zheng, Fuchun] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Pharm, Shantou, Peoples R China; [Jiang, Zebin; Chen, Yicun; Yao, Fen; Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Peoples R China; [Shi, Ganggang] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Cardiovasc Dis, Shantou, Peoples R China; [Chen, Weizhou] Shantou Univ, Inst Marine Biol, Shantou, Peoples R China; [Zhong, Shuping] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	Shantou University; Shantou University; Shantou University; Shantou University; University of Southern California	Zheng, FC (corresponding author), Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Pharm, Shantou, Peoples R China.	zhengfuchunsh@yahoo.com.cn; ggshi@stu.edu.cn			Guangdong Natural Science Foundation [9351503102000001]; Guangdong Province Administration of Traditional Chinese Medicine [2010408]; Doctoral Fund of Ministry of Education of China [20104402120006]; 211 project of Guangdong province; central government special funds supporting the development of local colleges and universities	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Administration of Traditional Chinese Medicine; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); 211 project of Guangdong province(Guangdong University of Technology); central government special funds supporting the development of local colleges and universities	This study was undertaken and supported within the teamwork projects funded by the Guangdong Natural Science Foundation (9351503102000001), Guangdong Province Administration of Traditional Chinese Medicine (No. 2010408), Doctoral Fund of Ministry of Education of China (No. 20104402120006), the 211 project of Guangdong province and the central government special funds supporting the development of local colleges and universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149; [Anonymous], 2001, GUID DOC AC OR TOX T; Athukorala Y, 2003, J FOOD LIPIDS, V10, P251, DOI 10.1111/j.1745-4522.2003.tb00019.x; Banday MR, 2010, EUR J MED CHEM, V45, P1459, DOI 10.1016/j.ejmech.2009.12.052; Bangmei X, 2004, FLORA ALGARUM MARINA; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Blois M.S., 1958, ANTIOXIDANT DETERMIN; Chandini SK, 2008, FOOD CHEM, V107, P707, DOI 10.1016/j.foodchem.2007.08.081; Cho ML, 2011, FOOD CHEM, V127, P999, DOI 10.1016/j.foodchem.2011.01.072; Cho M, 2010, J MED FOOD, V13, P1232, DOI 10.1089/jmf.2010.1124; COOPPAN RM, 1986, AM J TROP MED HYG, V35, P765, DOI 10.4269/ajtmh.1986.35.765; de Melo NI, 2011, MOLECULES, V16, P762, DOI 10.3390/molecules16010762; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Han N, 2012, AFRICAN J BIOTECHNOL, V11; Hashem FA, 1999, PHYTOTHER RES, V13, P329, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;329::AID-PTR458&gt;3.0.CO;2-U; Kumar P. P., 2010, African Journal of Biochemistry Research, V4, P191; Kumaran A, 2006, FOOD CHEM, V97, P109, DOI 10.1016/j.foodchem.2005.03.032; LAMELA M, 1989, J ETHNOPHARMACOL, V27, P35, DOI 10.1016/0378-8741(89)90075-5; Lecanu L, 2004, STEROIDS, V69, P1, DOI 10.1016/j.steroids.2003.09.007; Liu F, 2010, J EXP MAR BIOL ECOL, V382, P82, DOI 10.1016/j.jembe.2009.11.005; Liu M, 2011, J BIOCHEM, V149, P27, DOI 10.1093/jb/mvq110; MACDONALD MJ, 1988, DIABETES, V37, P997, DOI 10.2337/diabetes.37.7.997; Magalhaes LG, 2010, PARASITOL RES, V106, P395, DOI 10.1007/s00436-009-1674-8; Mariod AA, 2009, FOOD CHEM, V116, P306, DOI 10.1016/j.foodchem.2009.02.051; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; O'Sullivan AM, 2011, FOOD CHEM, V126, P1064, DOI 10.1016/j.foodchem.2010.11.127; OECD, 2002, GUID DOC REC ASS US; Preethi R., 2010, ADV BIOL RES, V4, P122; Rios AD, 2009, FOOD CHEM, V113, P1113, DOI 10.1016/j.foodchem.2008.08.084; Shao SQ, 2010, J AGR FOOD CHEM, V58, P11616, DOI 10.1021/jf102285b; Shon MY, 2003, FOOD CHEM, V82, P593, DOI 10.1016/S0308-8146(03)00015-3; Singh G, 2006, FOOD CONTROL, V17, P745, DOI 10.1016/j.foodcont.2005.03.010; Skrivanova E, 2005, LETT APPL MICROBIOL, V41, P77, DOI 10.1111/j.1472-765X.2005.01709.x; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Song LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031456; Wang SC, 2007, INT J BIOL MACROMOL, V41, P369, DOI 10.1016/j.ijbiomac.2007.05.008; Xiao SH, 2009, PARASITOL RES, V106, P237, DOI 10.1007/s00436-009-1656-x; Yan XJ, 1998, PLANT FOOD HUM NUTR, V52, P253, DOI 10.1023/A:1008007014659; Ye H, 2009, EUR FOOD RES TECHNOL, V230, P101, DOI 10.1007/s00217-009-1147-4; Yesilada E, 2000, J ETHNOPHARMACOL, V73, P471, DOI 10.1016/S0378-8741(00)00327-5; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735; Zhang L., 2000, J JIMEI U NATURAL SC, V5, P35	44	18	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80413	10.1371/journal.pone.0080413	http://dx.doi.org/10.1371/journal.pone.0080413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312216	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300012
J	Nantanda, R; Tumwine, JK; Ndeezi, G; Ostergaard, MS				Nantanda, Rebecca; Tumwine, James K.; Ndeezi, Grace; Ostergaard, Marianne S.			Asthma and Pneumonia among Children Less Than Five Years with Acute Respiratory Symptoms in Mulago Hospital, Uganda: Evidence of Under-Diagnosis of Asthma	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; VIRAL PNEUMONIA; ETIOLOGY; MANAGEMENT; MALARIA; BRONCHIOLITIS; EPIDEMIOLOGY; RISK; MULTICENTER; INFECTIONS	Background: Pneumonia is considered the major cause of mortality among children with acute respiratory disease in low-income countries but may be over-diagnosed at the cost of under-diagnosing asthma. We report the magnitude of asthma and pneumonia among "under-fives" with cough and difficulty breathing, based on stringent clinical criteria. We also describe the treatment for children with acute respiratory symptoms in Mulago Hospital. Methods: We enrolled 614 children aged 2-59 months with cough and difficulty breathing. Interviews, physical examination, blood and radiological investigations were done. We defined asthma according to Global Initiative for Asthma guidelines. Pneumonia was defined according to World Health Organization guidelines, which were modified by including fever and white cell count, C-reactive protein, blood culture and chest x-ray. Children with asthma or bronchiolitis were collectively referred to as "asthma syndrome" due to challenges of differentiating the two conditions in young children. Three pediatricians reviewed each participant's case report post hoc and made a diagnosis according to the study criteria. Results: Of the 614 children, 41.2% (95% CI: 37.3-45.2) had asthma syndrome, 27.2% (95% CI: 23.7-30.9) had bacterial pneumonia, 26.5% (95% CI: 23.1-30.2) had viral pneumonia, while 5.1% (95% CI: 3.5-7.1) had other diagnoses including tuberculosis. Only 9.5% of the children with asthma syndrome had been previously diagnosed as asthma. Of the 253 children with asthma syndrome, 95.3% (95% CI: 91.9-97.5) had a prescription for antibiotics, 87.7% (95% CI: 83.1-91.5) for bronchodilators and 43.1% (95% CI: 36.9-49.4) for steroids. Conclusion: Although reports indicate that acute respiratory symptoms in children are predominantly due to pneumonia, asthma syndrome contributes a significant proportion. Antibiotics are used irrationally due to misdiagnosis of asthma as pneumonia. There is need for better diagnostic tools for childhood asthma and pneumonia in Uganda.	[Nantanda, Rebecca] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Tumwine, James K.; Ndeezi, Grace] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Ostergaard, Marianne S.] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Ostergaard, Marianne S.] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	Makerere University; Makerere University; University of Copenhagen; University of Copenhagen	Nantanda, R (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	rnantanda@gmail.com			Danish Ministry of Foreign Affairs (DANIDA) through a project called "Quality Medicine Use for Children in Uganda" (Childmed project) [09-100KU]	Danish Ministry of Foreign Affairs (DANIDA) through a project called "Quality Medicine Use for Children in Uganda" (Childmed project)	The study was funded by Danish Ministry of Foreign Affairs (DANIDA) through a project called "Quality Medicine Use for Children in Uganda" (Childmed project). Project number:09-100KU. website: http://childmed.ku.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2007, ALLERGY, V62, P247, DOI 10.1111/j.1398-9995.2007.01325.x; [Anonymous], 2011, DEMOGRAPHIC HLTH SUR; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; CHRISTENSEN KK, 2010, CHILDHOOD PNEUMONIA; Erdem G, 2010, PEDIATR RADIOL, V40, P1768, DOI 10.1007/s00247-010-1680-0; Fernandes RM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-112; Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN; Global Initiative for Asthma, 2005, POCK GUID ASTHM MAN; Green RJ, 2010, SAMJ S AFR MED J, V100, P320, DOI 10.7196/SAMJ.4016; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hazir T, 2004, ARCH DIS CHILD, V89, P1049, DOI 10.1136/adc.2003.035741; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Johnson AWBR, 2008, J NATL MED ASSOC, V100, P370, DOI 10.1016/S0027-9684(15)31269-4; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; da Cunha AJLA, 2009, J TROP PEDIATRICS, V55, P198, DOI 10.1093/tropej/fmn105; Madhi SA, 2007, VACCINE, V25, P2413, DOI 10.1016/j.vaccine.2006.09.010; Mansbach JM, 2009, CLIN LAB MED, V29, P741, DOI 10.1016/j.cll.2009.07.011; Mansbach JM, 2009, PEDIATRICS, V123, pE573, DOI 10.1542/peds.2008-1675; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MCCONNOCHIE KM, 1986, AM J DIS CHILD, V140, P806, DOI 10.1001/archpedi.1986.02140220088039; *MIN HLTH UG, 2010, UG CLIN GUID; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Nantanda R, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-141; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Ostergaard MS, 2012, PRIM CARE RESP J, V21, P214, DOI 10.4104/pcrj.2012.00038; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Phankingthongkum S, 2002, PEDIAT ALLERG IMM-UK, V13, P119, DOI 10.1034/j.1399-3038.2002.01025.x; Quanjer PH, 1997, EUR RESPIR J, V10, pS2; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sachdev H P, 1994, Indian Pediatr, V31, P1251; Sachdev H P, 2001, Indian Pediatr, V38, P827; Shah D, 1999, Indian Pediatr, V36, P767; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; *UG NAT EXP PROGR, 2003, MULT PLAN 2010 2014; Ukwaja KN, 2011, J INFECT DEV COUNTR, V5, P199, DOI 10.3855/jidc.945; UNICEF, 2011, LEV TRENDS CHILD MOR; [UNICEF WHO], 2006, PNEUM FORG KILL CHIL; *UNICEF WHO, 2008, HDB INT MAN CHILDH I; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; Winter MA, 2011, J FAM PSYCHOL, V25, P857, DOI 10.1037/a0026191; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; World Health Organization, 2005, EM TRIAG ASS TREATM; World Health Organization, 2003, PREV ALL ALL ASTHM; World Health Organization, 2012, CHRON RESP DIS; World Health Organization, 2001, STAND INT CHEST RAD; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	55	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81562	10.1371/journal.pone.0081562	http://dx.doi.org/10.1371/journal.pone.0081562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312321	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300037
J	Pinto, AD; Gournis, E; Al-Bargash, D; Shahin, R				Pinto, Andrew D.; Gournis, Effie; Al-Bargash, Dana; Shahin, Rita			Impact of a Labour Disruption Affecting Local Public Health on the Incidence of Chlamydia Infections in Toronto	PLOS ONE			English	Article							NOSOCOMIAL INFECTION; PARTNER NOTIFICATION; DOCTORS STRIKE; MORTALITY; EMERGENCY; DISEASES; SYSTEMS; RISK	Introduction: Labour disruptions that interrupt services can be a natural experiment to examine the effect of halting a program. A five-week municipal labour disruption in Toronto during the summer of 2009 provided an opportunity to investigate the impact of reduced sexual health services. Methods: We examined the incidence of reported chlamydia in Toronto during the five years (2004-2008) preceding the labour disruption and during the periods just before, during, and after the labour disruption. Comparisons of actual reports for 2009 were made to immediately adjacent periods around the labour disruption, to historical trends and to forecasted rates. Interrupted time series analysis was used to test for significant differences in the trend of reported chlamydia incidence. Results: There was no significant difference in the trend of reported chlamydia incidence around the time of the strike. However, there was a small but significant increase in the incidence of reported chlamydia, particularly among females under 25 years old immediately following the labour disruption. The reported incidence for this group was higher than would be expected based on annual increases and projected seasonal trends. Conclusions: There was a small increase in incidence of reported cases of chlamydia for certain groups that went beyond what is expected during the time immediately following the labour disruption. While causation cannot be implied from our ecological study, public health services may play a role in the control of sexually transmitted infections, even in the short-term. This underscores the need for future work to understand whether the changes observed can be attributed to the absence of these services.	[Pinto, Andrew D.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Pinto, Andrew D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Gournis, Effie; Shahin, Rita] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gournis, Effie; Al-Bargash, Dana; Shahin, Rita] Toronto Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Pinto, AD (corresponding author), St Michaels Hosp, Dept Family & Community Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	andrew.pinto@utoronto.ca		Pinto, Andrew/0000-0003-1841-9347	Ontario Ministry of Health and Long-Term Care; Canadian Institutes for Health Research	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Andrew D. Pinto receives funding from the Ontario Ministry of Health and Long-Term Care and the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELKADER M, 1990, SOC PSYCH PSYCH EPID, V25, P154, DOI 10.1007/BF00782745; Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Al-Bargash D, 2012, COMMUNICATION; ALLEBECK P, 1985, PUBLIC HEALTH, V99, P10, DOI 10.1016/S0033-3506(85)80121-9; Aral SO, 2002, SEX TRANSM INFECT, V78, pI3, DOI 10.1136/sti.78.suppl_1.i3; BELMIN J, 1992, AM J MED, V93, P151, DOI 10.1016/0002-9343(92)90044-C; Canadian Union of Public Employees, 2009, TOR CIT WORK STRIK S; CP24, 2009, CP24            0727; Cunningham SA, 2008, SOC SCI MED, V67, P1784, DOI 10.1016/j.socscimed.2008.09.044; DELGADORODRIGUEZ M, 1993, INFECT CONT HOSP EP, V14, P706; Dierssen T, 1997, J HOSP INFECT, V36, P241, DOI 10.1016/S0195-6701(97)90200-0; Erceg M, 2007, COLLEGIUM ANTROPOL, V31, P891; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014; Leonard A, 2010, COMMUNICATION; Macke BA, 1999, AM J PREV MED, V17, P230, DOI 10.1016/S0749-3797(99)00076-8; Mann Janice, 2007, Can Commun Dis Rep, V33 Suppl 1, P2; MATHEWS C, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002843; McKeown D, 2011, COMMUNICABLE DIS TOR; Ministry of Health and Long-Term Care, 2008, SEX HLTH SEX TRANSM; Ministry of Health and Long-term Care, 2008, ONT PUBL HLTH STAND; Ministry of Health and Long-Term Care Ontario, 2009, INF DIS PROT APP B P; MUSTARD CA, 1995, AM J OBSTET GYNECOL, V172, P631, DOI 10.1016/0002-9378(95)90584-7; OXMAN AD, 1994, CAN J PUBLIC HEALTH, V85, pS41; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; *PUBL HLTH AG CAN, 2006, CAN GUID SEX TRANSM; Rekart ML, 2008, SEX TRANSM INFECT, V84, P87, DOI 10.1136/sti.2007.027938; Rekart ML, 2012, J INFECT DIS; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Siegel-Itzkovich J, 2000, BRIT MED J, V320, P1292, DOI 10.1136/bmj.320.7245.1292; Slater P E, 1984, J Emerg Med, V2, P111, DOI 10.1016/0736-4679(84)90330-5; SLATER PE, 1984, AM J EMERG MED, V2, P486, DOI 10.1016/0735-6757(84)90069-X; SLATER PE, 1983, LANCET, V2, P1306; Sondorp E, 2005, B WORLD HEALTH ORGAN, V83, P163; Tuite AR, 2012, SEX TRANSM DIS, V39, P260, DOI 10.1097/OLQ.0b013e31824717ae; Walsh B, 2006, ACAD EMERG MED, V13, P1242, DOI 10.1197/j.aem.2005.12.024	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e79375	10.1371/journal.pone.0079375	http://dx.doi.org/10.1371/journal.pone.0079375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261MX	24312180	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300006
J	Rittenour, WR; Harris, SD				Rittenour, William R.; Harris, Steven D.			Glycosylphosphatidylinositol-Anchored Proteins in Fusarium graminearum: Inventory, Variability, and Virulence	PLOS ONE			English	Article							CELL-WALL; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; WHEAT SPIKES; GENOME-WIDE; GPI ANCHOR; FLIP-FLOP; ADHESION; GENE; CONIDIA	The contribution of cell surface proteins to plant pathogenicity of fungi is not well understood. As such, the objective of this study was to investigate the functions and importance of glycosylphosphatidylinositol-anchored proteins (GPI-APs) in the wheat pathogen F. graminearum. GPI-APs are surface proteins that are attached to either the membrane or cell wall. In order to simultaneously disrupt several GPI-APs, a phosphoethanolamine transferase-encoding gene gpi7 was deleted and the resultant mutant characterized in terms of growth, development, and virulence. The Delta gpi7 mutants exhibited slower radial growth rates and aberrantly shaped macroconidia. Furthermore, virulence tests and microscopic analyses indicated that Gpi7 is required for ramification of the fungus throughout the rachis of wheat heads. In parallel, bioinformatics tools were utilized to predict and inventory GPI-APs within the proteome of F. graminearum. Two of the genes identified in this screen (FGSG_01588 and FGSG_08844) displayed isolate-specific length variability as observed for other fungal cell wall adhesion genes. Nevertheless, deletion of these genes failed to reveal obvious defects in growth, development, or virulence. This research demonstrates the global importance of GPI-APs to in planta proliferation in F. graminearum, and also highlights the potential of individual GPI-APs as diagnostic markers.	[Rittenour, William R.; Harris, Steven D.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Rittenour, William R.; Harris, Steven D.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68583 USA; [Rittenour, William R.] Chestnut Brew Works LLC, Morgantown, WV USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Harris, SD (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	sharris2@unl.edu			National Science Foundation [BES-0519080]; Nebraska Research Foundation	National Science Foundation(National Science Foundation (NSF)); Nebraska Research Foundation	This research was supported by the National Science Foundation (BES-0519080) and the Nebraska Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn N, 2004, MOL CELLS, V17, P166; Apoga D, 2001, MYCOL RES, V105, P1251, DOI 10.1016/S0953-7562(08)61997-8; BARBOSA IP, 1993, EXP MYCOL, V17, P274, DOI 10.1006/emyc.1993.1026; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; DOSS RP, 1993, APPL ENVIRON MICROB, V59, P1786, DOI 10.1128/AEM.59.6.1786-1791.1993; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fujita M, 2004, J BIOL CHEM, V279, P51869, DOI 10.1074/jbc.M405232200; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; GHANNOUM MA, 1995, INFECT IMMUN, V63, P4528, DOI 10.1128/IAI.63.11.4528-4530.1995; Goodman CS, 1997, COLD SPRING HARB SYM, V62, P479; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hughes HB, 1999, MICROBIOL-UK, V145, P1927, DOI 10.1099/13500872-145-8-1927; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Leidich SD, 1998, J BIOL CHEM, V273, P26078, DOI 10.1074/jbc.273.40.26078; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Li H, 2007, MOL MICROBIOL, V64, P1014, DOI 10.1111/j.1365-2958.2007.05709.x; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Linder T, 2008, FUNGAL GENET BIOL, V45, P485, DOI 10.1016/j.fgb.2007.08.002; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Narasimhan ML, 2003, PLANT J, V36, P390, DOI 10.1046/j.1365-313X.2003.01886.x; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Richard M, 2002, MICROBIOL-SGM, V148, P2125, DOI 10.1099/00221287-148-7-2125; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Rittenour WR, 2008, FUNGAL GENET BIOL, V45, P933, DOI 10.1016/j.fgb.2008.01.007; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Schumacher CFA, 2008, PHYTOPATHOLOGY, V98, P760, DOI 10.1094/PHYTO-98-7-0760; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; Vishwakarma RA, 2005, ORG BIOMOL CHEM, V3, P1275, DOI 10.1039/b500300h; Zacks MA, 2006, MOL MEMBR BIOL, V23, P209, DOI 10.1080/09687860600601494; Zelinger E, 2006, PHYSIOL MOL PLANT P, V68, P209, DOI 10.1016/j.pmpp.2006.11.002; Zhang NX, 2003, GENOME RES, V13, P2005, DOI 10.1101/gr.1024903	51	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81603	10.1371/journal.pone.0081603	http://dx.doi.org/10.1371/journal.pone.0081603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312325	Green Published, gold			2022-12-25	WOS:000327670300039
J	Kravitz, E; Gaisler-Salomon, I; Biegon, A				Kravitz, Efrat; Gaisler-Salomon, Inna; Biegon, Anat			Hippocampal Glutamate NMDA Receptor Loss Tracks Progression in Alzheimer's Disease: Quantitative Autoradiography in Postmortem Human Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PERIPHERAL BENZODIAZEPINE-RECEPTORS; AMYLOID-DEPOSITION; BINDING-SITES; NEUROINFLAMMATION; MEMORY; PREVALENCE; EXPRESSION; PERSISTENT; MICROGLIA	Early Alzheimer's disease (AD) is characterized by memory loss and hippocampal atrophy with relative sparing of basal ganglia. Activation of glutamate NMDA receptors in the hippocampus is an important step in memory formation. We measured the density of NMDA receptors in samples of hippocampus, entorhinal cortex and basal ganglia obtained from subjects who died with pathologically confirmed AD and age-and sex-matched non-demented controls. We found significant decreases in NMDA receptor density in the hippocampus and entorhinal cortex but not in the basal ganglia. Loss of NMDA receptors was significantly correlated with neuropathological progression as assessed by Braak staging postmortem. The same samples were probed for neuroinflammation by measuring the density and gene expression of translocator protein 18kDA (TSPO), an established marker of microglial activation. Unlike NMDA receptor loss, increased densities of TSPO were found in all of the brain regions sampled. However hippocampal, but not striatal TSPO density and gene expression were inversely correlated with NMDA receptor density and positively correlated with Braak stage, suggesting NMDA receptors exacerbate neuroniflammatory damage. The high correlation between hippocampal NMDA receptor loss and disease progression supports the use of non invasive imaging with NMDA receptor tracers and positron emission tomography as a superior method for diagnosis, staging and treatment monitoring of AD in vivo.	[Kravitz, Efrat] Sheba Med Ctr, J Sagol Neurosci Ctr, Ramat Gan, Israel; [Gaisler-Salomon, Inna] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Biegon, Anat] SUNY Stony Brook, Sch Med, Dept Neurol, Stony Brook, NY 11794 USA	Chaim Sheba Medical Center; University of Haifa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Biegon, A (corresponding author), SUNY Stony Brook, Sch Med, Dept Neurol, Stony Brook, NY 11794 USA.	biegon@bnl.gov		Gaisler-Salomon, Inna/0000-0002-5082-0686				Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; Biegon A, 2007, SYNAPSE, V61, P577, DOI 10.1002/syn.20400; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Castellano C, 2001, CURR DRUG TARGETS, V2, P273, DOI 10.2174/1389450013348515; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; DIORIO D, 1991, NEUROBIOL AGING, V12, P255, DOI 10.1016/0197-4580(91)90106-T; Duvernoy H. M., 1988, HUMAN HIPPOCAMPUS AT; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathis CA, 2013, ANN NEUROL, V73, P751, DOI 10.1002/ana.23797; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; YOUNG AB, 1987, J NEURAL TRANSM, P147	34	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81244	10.1371/journal.pone.0081244	http://dx.doi.org/10.1371/journal.pone.0081244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312282	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900026
J	Tsirimonaki, E; Fedonidis, C; Pneumaticos, SG; Tragas, AA; Michalopoulos, I; Mangoura, D				Tsirimonaki, Emmanouella; Fedonidis, Constantinos; Pneumaticos, Spiros G.; Tragas, Adamantios A.; Michalopoulos, Ioannis; Mangoura, Dimitra			PKC epsilon Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC DEGENERATION; NF-KAPPA-B; GROWTH-PLATE CHONDROCYTES; FACTOR-BINDING SITES; ARTICULAR CHONDROCYTES; TRANSCRIPTION FACTOR; IN-VITRO; DIFFERENTIAL EXPRESSION	The protein kinase C (PKC) signaling, a major regulator of chondrocytic differentiation, has been also implicated in pathological extracellular matrix remodeling, and here we investigate the mechanism of PKC epsilon-dependent regulation of the chondrocytic phenotype in human nucleus pulposus (NP) cells derived from herniated disks. NP cells from each donor were successfully propagated for 25+ culture passages, with remarkable tolerance to repeated freeze-and-thaw cycles throughout long-term culturing. More specifically, after an initial downregulation of COL2A1, a stable chondrocytic phenotype was attested by the levels of mRNA expression for aggrecan, biglycan, fibromodulin, and lumican, while higher expression of SOX-trio and Patched-1 witnessed further differentiation potential. NP cells in culture also exhibited a stable molecular profile of PKC isoforms: throughout patient samples and passages, mRNAs for PKC alpha, delta, epsilon, zeta, eta, iota, and mu were steadily detected, whereas beta, gamma, and theta were not. Focusing on the signalling of PKC epsilon, an isoform that may confer protection against degeneration, we found that activation with the PKC epsilon-specific activator small peptide psi epsilon RACK led sequentially to a prolonged activation of ERK1/2, increased abundance of the early gene products ATF, CREB1, and Fos with concurrent silencing of transcription for Ki67, and increases in mRNA expression for aggrecan. More importantly, psi epsilon RACK induced upregulation of hsa-miR-377 expression, coupled to decreases in ADAMTS5 and cleaved aggrecan. Therefore, PKCe activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKC epsilon/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs. Moreover, this pathway should be considered as a target for understanding the molecular mechanism of IVD degeneration and for therapeutic restoration of degenerated disks.	[Tsirimonaki, Emmanouella; Fedonidis, Constantinos; Pneumaticos, Spiros G.; Tragas, Adamantios A.; Michalopoulos, Ioannis; Mangoura, Dimitra] Acad Athens, Biomed Res Fdn, Athens, Greece; [Pneumaticos, Spiros G.] Univ Athens, Athens Med Sch, Dept Orthoped, Athens, Greece	Academy of Athens; National & Kapodistrian University of Athens	Mangoura, D (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	mangoura@bioacademy.gr	, 0000-0001-8991-8712/S-4398-2016	, 0000-0001-8991-8712/0000-0001-8991-8712	Hellenic Society of Surgical Orthopedics and Trauma (EEXOT); Biomedical Research Foundation (BRFAA) of the Academy of Athens	Hellenic Society of Surgical Orthopedics and Trauma (EEXOT); Biomedical Research Foundation (BRFAA) of the Academy of Athens	Supported by the Hellenic Society of Surgical Orthopedics and Trauma (EEXOT; www.eexot.gr) to DM and SP and Biomedical Research Foundation (BRFAA) of the Academy of Athens (www.bioacademy.gr) internal funds to ET, IM, and DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Andreas K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2605; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Arai F, 2012, J ORTHOP RES, V30, P1478, DOI 10.1002/jor.22095; Artmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038365; Asimaki O, 2011, NEUROCHEM INT, V58, P135, DOI 10.1016/j.neuint.2010.11.002; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Bright R, 2008, NEUROSCI LETT, V441, P120, DOI 10.1016/j.neulet.2008.05.080; Broos S, 2011, NUCLEIC ACIDS RES, V39, pW74, DOI 10.1093/nar/gkr355; Campo GM, 2009, BBA-GEN SUBJECTS, V1790, P1353, DOI 10.1016/j.bbagen.2009.07.003; Cheng Y, 2000, J BIOL CHEM, V275, P23326, DOI 10.1074/jbc.M001837200; Chockalingam PS, 2007, ARTHRITIS RHEUM, V56, P4074, DOI 10.1002/art.23043; Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005; Ding L, 2009, OSTEOARTHR CARTILAGE, V17, P1385, DOI 10.1016/j.joca.2009.03.024; Domowicz MS, 2003, DEV BRAIN RES, V143, P207, DOI 10.1016/S0165-3806(03)00133-0; Feng G, 2013, OSTEOARTHR CARTILAGE, V21, P582, DOI 10.1016/j.joca.2013.01.001; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gan JC, 2003, CLIN ORTHOP RELAT R, P315, DOI 10.1097/01.blo.0000063797.98363.d3; Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; Groma G, 2011, MATRIX BIOL, V30, P275, DOI 10.1016/j.matbio.2011.04.002; HENNIG AK, 1993, DEV BRAIN RES, V73, P261, DOI 10.1016/0165-3806(93)90146-2; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368; Hurst-Kennedy J, 2009, BBA-MOL CELL RES, V1793, P836, DOI 10.1016/j.bbamcr.2009.01.020; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Iwashina T, 2006, SPINE, V31, P1177, DOI 10.1097/01.brs.0000217687.36874.c4; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kawata K, 2010, J CELL PHYSIOL, V222, P138, DOI 10.1002/jcp.21930; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim KW, 2009, SPINE J, V9, P323, DOI 10.1016/j.spinee.2008.05.003; Kim MK, 2005, BIOCHEM PHARMACOL, V70, P1764, DOI 10.1016/j.bcp.2005.09.015; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V303, P206, DOI 10.1016/S0006-291X(03)00305-X; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Lee VA, 2007, MOL CELLS, V24, P9; Leondaritis G, 2011, NEUROBLASTOMA, P85; Leondaritis G, 2009, J NEUROCHEM, V109, P573, DOI 10.1111/j.1471-4159.2009.05975.x; Liang WG, 2012, J CELL BIOCHEM, V113, P2112, DOI 10.1002/jcb.24082; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Logotheti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041957; Mangoura D, 2000, INT J DEV NEUROSCI, V18, P693, DOI 10.1016/S0736-5748(00)00031-9; Mangoura D, 2006, ONCOGENE, V25, P735, DOI 10.1038/sj.onc.1209113; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McLaughlin D, 2006, J NEUROSCI RES, V83, P1190, DOI 10.1002/jnr.20828; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Miyamoto T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3182; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Oshevski S, 1999, BIOCHEM BIOPH RES CO, V263, P603, DOI 10.1006/bbrc.1999.1425; Peng H, 2010, INFLAMM RES, V59, P519, DOI 10.1007/s00011-010-0156-x; Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Preradovic A, 2005, CELL TISSUE RES, V321, P459, DOI 10.1007/s00441-005-1116-6; Qvit Nir, 2010, Drug Discov Today Dis Mech, V7, pe87, DOI 10.1016/j.ddmec.2010.07.001; Rastogi A, 2009, J CELL PHYSIOL, V220, P698, DOI 10.1002/jcp.21816; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; SHAPIRO IM, 1991, AM J CLIN NUTR, V54, pS1209, DOI 10.1093/ajcn/54.6.1209s; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59; Struglics A, 2012, ARTHRITIS RHEUM-US, V64, P4151, DOI 10.1002/art.34665; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Watanabe T, 2010, J ORTHOP RES, V28, P623, DOI 10.1002/jor.21036; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Xia MS, 2011, J ORTHOP RES, V29, P556, DOI 10.1002/jor.21273; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang SH, 2008, SPINE, V33, P1951, DOI 10.1097/BRS.0b013e31817e6974; Yoon YM, 2000, J BONE MINER RES, V15, P2197, DOI 10.1359/jbmr.2000.15.11.2197; Yoon YM, 2000, J BIOL CHEM, V275, P12353, DOI 10.1074/jbc.275.16.12353; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Yosimichi G, 2006, BONE, V38, P853, DOI 10.1016/j.bone.2005.11.016; Zisopoulou S, 2013, BEHAV BRAIN RES, V253, P280, DOI 10.1016/j.bbr.2013.07.036	88	30	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82045	10.1371/journal.pone.0082045	http://dx.doi.org/10.1371/journal.pone.0082045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312401	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900067
J	Green, DS; Rupasinghe, C; Warburton, R; Wilson, JL; Sallum, CO; Taylor, L; Yatawara, A; Mierke, D; Polgar, P; Hill, N				Green, Daniel S.; Rupasinghe, Chamila; Warburton, Rod; Wilson, Jamie L.; Sallum, Christine O.; Taylor, Linda; Yatawara, Achani; Mierke, Dale; Polgar, Peter; Hill, Nicholas			A Cell Permeable Peptide Targeting the Intracellular Loop 2 of Endothelin B Receptor Reduces Pulmonary Hypertension in a Hypoxic Rat Model	PLOS ONE			English	Article							ET(B) RECEPTORS; ETB RECEPTORS; ACTIVATION; TRANSDUCTION; EXPRESSION; MIMICKING; KINASE; ET(A)	Cell permeable peptides (CPP) aid cellular uptake of targeted cargo across the hydrophobic plasma membrane. CPP-mediated cargo delivery of receptor signaling motifs provides an opportunity to regulate specific receptor initiated signaling cascades. Both endothelin-1 receptors, ETA and ETB, have been targets of antagonist therapies for individuals with pulmonary arterial hypertension (PAH). These therapies have had success but have been accompanied by adverse reactions. Also, unlike the CPP which target specific signaling cascades, the antagonists target the entire function of the receptor. Using the CPP strategy of biased antagonism of the ETB receptor's intracellular loop 2 (ICB2), we demonstrate blunting of hypoxic pulmonary hypertension (HPH) in the rat, including indices of pulmonary arterial pressure, right ventricular hypertrophy and pulmonary vascular remodeling. Further, ex vivo analysis of the pulmonary artery treated with the IC2B peptide upon injection manifests marked reductions in Akt and ERK activation. Both kinases have been intimately related to cell proliferation and vascular contraction, the hallmarks of PAH. These observations in sum illustrate an involvement of the ETB receptor in HPH and furthermore provide a basis for a novel, CPP-based, strategy in the treatment of PAH, ultimately able to target not only ET-1, but also other factors involved in the development of PAH.	[Green, Daniel S.; Wilson, Jamie L.; Sallum, Christine O.; Taylor, Linda; Polgar, Peter] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Rupasinghe, Chamila; Yatawara, Achani; Mierke, Dale] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Warburton, Rod; Hill, Nicholas] Tufts Sch Med, Div Pulm Med, Boston, MA 02111 USA	Boston University; Dartmouth College	Hill, N (corresponding author), Tufts Sch Med, Div Pulm Med, Boston, MA 02111 USA.	nhill@tuftsmedicalcenter.org	Wilson, Jamie/J-5913-2019		NIH [HL025776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025776] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by NIH Grant number HL025776 to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Fisher Kimberly A., 2008, P145, DOI 10.1007/978-1-60327-075-5_8; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Hoeper MM, 2009, EUR RESPIR J, V34, P529, DOI 10.1183/09031936.00094409; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Ivy DD, 2002, AM J PHYSIOL-LUNG C, V282, pL703, DOI 10.1152/ajplung.00272.2001; Kelland NF, 2010, J VASC RES, V47, P16, DOI 10.1159/000231717; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; McNamara PJ, 2008, AM J PHYSIOL-LUNG C, V294, pL205, DOI 10.1152/ajplung.00234.2007; Nishida M, 2004, EUR J PHARMACOL, V496, P159, DOI 10.1016/j.ejphar.2004.06.028; Pei YZ, 2011, EUR J PHARMACOL, V666, P165, DOI 10.1016/j.ejphar.2011.05.035; Rousselle C, 2001, J PHARMACOL EXP THER, V296, P124; Sallum CO, 2012, CHEM BIOL DRUG DES, V80, P374, DOI 10.1111/j.1747-0285.2012.01405.x; SATO K, 1995, AM J PHYSIOL-LUNG C, V269, pL668, DOI 10.1152/ajplung.1995.269.5.L668; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Tykocki NR, 2009, J PHARMACOL EXP THER, V329, P875, DOI 10.1124/jpet.108.145953; Wagstaff KM, 2006, CURR MED CHEM, V13, P1371, DOI 10.2174/092986706776872871; Wilson JL, 2012, EXP CELL RES, V318, P1125, DOI 10.1016/j.yexcr.2012.03.029; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yu J, 2010, CHEM BIOL DRUG DES, V76, P70, DOI 10.1111/j.1747-0285.2010.00985.x; Zrelli H, 2011, PLANTA MED, V77, P1680, DOI 10.1055/s-0030-1271073	30	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81309	10.1371/journal.pone.0081309	http://dx.doi.org/10.1371/journal.pone.0081309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312288	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100072
J	Sherman, D; Oram, T; Deutsch, D; Gordon, G; Ahissar, E; Harel, D				Sherman, Dana; Oram, Tess; Deutsch, Dudi; Gordon, Goren; Ahissar, Ehud; Harel, David			Tactile Modulation of Whisking via the Brainstem Loop: Statechart Modeling and Experimental Validation	PLOS ONE			English	Article							RHYTHMIC WHISKING; FUNCTIONAL PLASTICITY; OBJECT LOCALIZATION; RODENT WHISKING; BEHAVING MONKEY; EYE-MOVEMENTS; RAT; CORTEX; NEURONS; NUCLEUS	Rats repeatedly sweep their facial whiskers back and forth in order to explore their environment. Such explorative whisking appears to be driven by central pattern generators (CPGs) that operate independently of direct sensory feedback. Nevertheless, whisking can be modulated by sensory feedback, and it has been hypothesized that some of this modulation already occurs within the brainstem. However, the interaction between sensory feedback and CPG activity is poorly understood. Using the visual language of statecharts, a dynamic, bottom-up computerized model of the brainstem loop of the whisking system was built in order to investigate the interaction between sensory feedback and CPG activity during whisking behavior. As a benchmark, we used a previously quantified closed-loop phenomenon of the whisking system, touched-induced pump (TIP), which is thought to be mediated by the brainstem loop. First, we showed that TIPs depend on sensory feedback, by comparing TIP occurrence in intact rats with that in rats whose sensory nerve was experimentally cut. We then inspected several possible feedback mechanisms of TIPs using our model. The model ruled out all hypothesized mechanisms but one, which adequately simulated the corresponding motion observed in the rat. Results of the simulations suggest that TIPs are generated via sensory feedback that activates extrinsic retractor muscles in the mystacial pad. The model further predicted that in addition to the touching whisker, all whiskers found on the same side of the snout should exhibit a TIP. We present experimental results that confirm the predicted movements in behaving rats, establishing the validity of the hypothesized interaction between sensory feedback and CPG activity we suggest here for the generation of TIPs in the whisking system.	[Sherman, Dana; Oram, Tess; Deutsch, Dudi; Gordon, Goren; Ahissar, Ehud] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sherman, Dana; Harel, David] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il	Gordon, Goren/ABB-8100-2021	Gordon, Goren/0000-0002-8351-7034	Israel Science Foundation [749/10]; United States-Israel Binational Science Foundation (BSF) [2011243]; Estate of Irving and Toby Bieber and Lord David Alliance, CBE; Minerva Foundation; Federal German Ministry for Education and Research; FP7 BIOTACT project [ICT 215910]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Estate of Irving and Toby Bieber and Lord David Alliance, CBE; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); FP7 BIOTACT project	This work was supported by the Israel Science Foundation grant #749/10, the United States-Israel Binational Science Foundation (BSF) grant 2011243, the Estate of Irving and Toby Bieber and Lord David Alliance, CBE, and by Minerva Foundation funded by the Federal German Ministry for Education and Research. E.A. holds the Helen Diller Family Professorial Chair of Neurobiology. Video analysis was performed using the BIOTACT Whisker Tracking Tool, which was jointly created by the International School of Advanced Studies in Trieste, the University of Sheffield, and the Weizmann Institute in Rehovot, under the auspices of the FP7 BIOTACT project (ICT 215910). The authors are particularly grateful for the contributions of Igor Perkon and Goren Gordon to programming parts of the tracking tool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN A, 1991, J HIRNFORSCH, V32, P735; Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Ahissar Ehud, 1994, Current Opinion in Neurobiology, V4, P580, DOI 10.1016/0959-4388(94)90060-4; Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Deutsch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044272; Diamond ME, 2008, PLOS BIOL, V6, P1627, DOI 10.1371/journal.pbio.0060220; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Fisher J, 2011, COMMUN ACM, V54, P72, DOI 10.1145/2001269.2001289; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Haidarliu S, 2012, ANAT REC, V295, P1181, DOI 10.1002/ar.22501; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; HALPERN BP, 1983, AM J OTOLARYNG, V4, P246, DOI 10.1016/S0196-0709(83)80066-0; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Harel D, 1997, COMPUTER, V30, P31, DOI 10.1109/2.596624; Harel D., 2003, Bulletin of the European Association for Theoretical Computer Science, P226; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; KLEIN BG, 1985, J COMP NEUROL, V232, P55, DOI 10.1002/cne.902320106; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; LOVICK TA, 1972, J PHYSIOL-LONDON, V226, pP4; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Moore JD, COMMON BRAI IN PRESS; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Perkon I, 2011, J NEUROPHYSIOL, V105, P1950, DOI 10.1152/jn.00764.2010; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Solomon E, 1990, HUMAN ANATOMY PHYSL; Swerdlin N, 2008, P IEEE, V96, P1421, DOI 10.1109/JPROC.2008.925435; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WISE SP, 1977, J COMP NEUROL, V175, P129, DOI 10.1002/cne.901750202; WOOLSTON DC, 1983, NEUROSCI LETT, V36, P43, DOI 10.1016/0304-3940(83)90483-4; Xiao B, 2012, FAST MOTOR PATHWAY P; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	56	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79831	10.1371/journal.pone.0079831	http://dx.doi.org/10.1371/journal.pone.0079831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312186	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100015
J	Yang, HY; Hsu, YF; Chiu, PT; Ho, SJ; Wang, CH; Chi, CC; Huang, YH; Lee, CF; Li, YS; Ou, G; Hsu, MJ				Yang, Hung-Yu; Hsu, Ya-Fen; Chiu, Pei-Ting; Ho, Shiau-Jing; Wang, Chi-Han; Chi, Chih-Chin; Huang, Yu-Han; Lee, Cheng-Feng; Li, Ying-Shiuan; Ou, George; Hsu, Ming-Jen			Anti-Cancer Activity of an Osthole Derivative, NBM-T-BMX-OS01: Targeting Vascular Endothelial Growth Factor Receptor Signaling and Angiogenesis	PLOS ONE			English	Article							CANCER CELLS; BREAST-CANCER; TUMOR-GROWTH; IN-VITRO; VEGF; SURVIVIN; APOPTOSIS; THERAPY; MECHANISMS; INHIBITION	Angiogenesis occurs during tissue growth, development and wound healing. It is also required for tumor progression and represents a rational target for therapeutic intervention. NBM-T-BMX-OS01 (BMX), derived from the semisynthesis of osthole, an active ingredient isolated from Chinese herb Cnidium monnieri (L.) Cuss., was recently shown to enhance learning and memory in rats. In this study, we characterized the anti-angionenic activities of NBM-T-BMX-OS01 (BMX) in an effort to develop novel inhibitors to suppress angiogenesis and tumor growth. BMX inhibited vascular endothelial growth actor (VEGF)-induced proliferation, migration and endothelial tube formation in human umbilical endothelial cell (HUVECs). BMX also attenuated VEGF-incluced microvessel sprouting from aortic rings ex vivo and reduced HCT116 colorectal cancer cells-induced angiogenesis in vivo. Moreover, BMX inhibited the phosphorylation of VEGFR2, FAK, Akt and ERK in HUVECs exposed to VEGF. BMX was also shown to inhibit HCT116 cell proliferation and to suppress the growth of subcutaneous xenografts of HCT116 cells in vivo. Taken together, this study provides evidence that BMX modulates vascul endothelial cell remodeling and leads to the inhibition of tumor angiogenesis. These results also support the role of BMX as a potential drug candidate and warrant the clinical development in the treatment of cancer.	[Yang, Hung-Yu] Taipei Med Univ, Wan Fang Hosp, Div Cardiol, Taipei, Taiwan; [Hsu, Ya-Fen] Landseed Hosp, Dept Surg, Div Gen Surg, Tao Yuan, Taiwan; [Chiu, Pei-Ting; Huang, Yu-Han; Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ho, Shiau-Jing; Wang, Chi-Han; Chi, Chih-Chin; Lee, Cheng-Feng; Li, Ying-Shiuan] NatureWise Biotech & Med Corp, Taipei, Taiwan; [Ou, George; Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Hsu, MJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	aspirin@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	National Science Council of Taiwan [NSC98-2320-B-038-007]; Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan [99TMU-WFH-02-4]; Landseed Hospital, Taoyuan, Taiwan [LSH-2012-04]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan; Landseed Hospital, Taoyuan, Taiwan	This work was supported by grant from the National Science Council of Taiwan (NSC98-2320-B-038-007]; grant [99TMU-WFH-02-4] from the Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan; and grant [LSH-2012-04] from the Landseed Hospital, Taoyuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Argyriou AA, 2009, ONCOLOGY-BASEL, V77, P1, DOI 10.1159/000218165; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Hsu MJ, 2000, BRIT J PHARMACOL, V131, P1285, DOI 10.1038/sj.bjp.0703559; Hsu YF, 2012, BBA-GEN SUBJECTS, V1820, P104, DOI 10.1016/j.bbagen.2011.11.011; Huang SW, 2012, CARCINOGENESIS, V33, P1022, DOI 10.1093/carcin/bgs127; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kao SJ, 2012, TOXICOL APPL PHARM, V261, P105, DOI 10.1016/j.taap.2012.03.020; Kappert K, 2005, CARDIOVASC RES, V65, P587, DOI 10.1016/j.cardiores.2004.08.016; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Liang HJ, 2009, CHEM-BIOL INTERACT, V181, P309, DOI 10.1016/j.cbi.2009.08.003; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mehrotra S, CANC CELL, V17, P53; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Sugano M, 2007, ATHEROSCLEROSIS, V191, P33, DOI 10.1016/j.atherosclerosis.2006.04.021; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Thairu N, 2011, ANGIOGENESIS, V14, P223, DOI 10.1007/s10456-011-9208-2; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; Wedge SR, 2002, CANCER RES, V62, P4645; Won MS, 2009, BIOCHEM BIOPH RES CO, V385, P16, DOI 10.1016/j.bbrc.2009.05.022; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xu XM, 2012, MOL MED REP, V6, P1018, DOI 10.3892/mmr.2012.1044; Xu XM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-33; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang YC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/514908; Yuan L, 2003, ANN NY ACAD SCI, V1010, P347, DOI 10.1196/annals.1299.063; Zetter BR, 2008, NAT REV CANCER, V8, P647, DOI 10.1038/nrc2458; Zhang JJ, 2011, PHYTOTHER RES, V25, P638, DOI 10.1002/ptr.3315; Zhang LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037865	58	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81592	10.1371/journal.pone.0081592	http://dx.doi.org/10.1371/journal.pone.0081592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312323	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100088
J	Castanera, D; Pascual, C; Razzolini, NL; Vila, B; Barco, JL; Canudo, JI				Castanera, Diego; Pascual, Carlos; Razzolini, Novella L.; Vila, Bernat; Barco, Jose L.; Canudo, Jose I.			Discriminating between Medium-Sized Tridactyl Trackmakers: Tracking Ornithopod Tracks in the Base of the Cretaceous (Berriasian, Spain)	PLOS ONE			English	Article							DINOSAUR FOOTPRINTS; ICHNOLOGICAL EVIDENCE; EVOLUTION	Background: Recent work on the Jurassic-Cretaceous transition of the Iberian Range (Spain) has opened a new window onto the interpretation of the trackmakers of some medium-sized tridactyl tracks. The ichnotaxon Therangospodus oncalensis has been described in the Huerteles Formation (Berriasian) and is one of the classical tracks from the area assigned to medium-sized theropods. Methodology/Principal Findings: A review of the type locality of Therangospodus oncalensis (Fuentesalvo tracksite) and other tracksites from the Huerteles Formation (Berriasian) has yielded new information on the morphology, gait and trackmaker identity of the aforementioned ichnospecies. The new data suggest that the trackmaker is an ornithopod rather than a theropod on the basis of the length/width ratio, the anterior triangle length-width ratio, the short steps, the round to quadrangular heel pad impression and the probable manus impressions. Conclusions/Significance: T. oncalensis shows similarities with various tracks from the Berriasian of Europe assigned to Iguanodontipus. The ichnotaxonomical status of this ichnospecies is here considered as Iguanodontipus? oncalensis due to the current state of knowledge of the ichnotaxonomy of medium-sized ornithopod tracks. This reassessment of I? oncalensis also has two significant implications for the palaeoecology of the faunas during the deposition of the Huerteles Formation: 1- the high number and percentage of theropod tracks would be lower than previous papers have suggested. 2- the gregarious behaviour described in the type locality (Fuentesalvo) would be among ornithopods instead of theropods.	[Castanera, Diego; Vila, Bernat; Canudo, Jose I.] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Razzolini, Novella L.] Inst Catala Paleontol Miquel Crusafont, Sabadell, Barcelona, Spain; [Barco, Jose L.] Paleoymas Poligono INBISA Empresarium, Zaragoza, Spain	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP)	Castanera, D (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	dcastanera@unizar.es	CASTANERA, DIEGO/AAH-5598-2019; VILA, BERNAT/AAA-7367-2021	CASTANERA, DIEGO/0000-0003-3950-1630; VILA, BERNAT/0000-0002-5935-1732; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Ministerio de Ciencia e Innovacion of Spain [CGL2011-30069-C02-01, CGL2010-16447]; European Regional Development Fund; Government of Aragon ("Grupos Consolidados"); Ministry of Education [AP2008-01340]; Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC))	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados")(Gobierno de Aragon); Ministry of Education; Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC))	This paper is a contribution to the projects CGL2011-30069-C02-01 and CGL2010-16447, subsidized by the Ministerio de Ciencia e Innovacion of Spain, the European Regional Development Fund, the Government of Aragon ("Grupos Consolidados"). DC is the beneficiary of a grant from the Ministry of Education (AP2008-01340). BV acknowledges support from the Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC) 2011). NLR is the beneficiary of a grant from the project CGL2011-30069-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRREZABALA L M, 1983, Munibe, V35, P1; Aguirrezabala L.M., 1980, Munibe, V32, P257; Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Canudo J.I., 2005, Geogaceta, V38, P39; Gomez-Fernandez JC, 1994, J PALEOLIMNOL, V11, P91, DOI 10.1007/BF00683272; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Cobos A, 2011, THESIS U PAIS VASCO; Cobos Alberto, 2012, Geogaceta, V52, P185; Conti MA, 2005, PALAIOS, V20, P534, DOI 10.2110/palo.2003.p03-99; Dall Vecchia Fabio M., 2000, Memorie di Scienze Geologiche, V52, P227; Diaz-Martinez I, 2012, FUNDAMENTAL, V20, P63; Diedrich Cajus, 2004, Ichnos, V11, P215, DOI 10.1080/10420940490444924; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Fanti F, 2013, ICHNOS, V20, P54, DOI 10.1080/10420940.2013.778845; FUENTES VIDARTE C., 2005, CELTIBERIA, V99, P367; Fuentes Vidarte C, 2002, HUELLAS DINOSAURIOS, P360; Gierlinski GD, 2009, ACT 4 JORN INT PAL D, P75; Goldring R, 2005, CRETACEOUS RES, V26, P665, DOI 10.1016/j.cretres.2005.03.001; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HernuYndez Medrano N., 2008, ZUBIA, V23-24, P79, DOI DOI 10.1093/JISESA/IEU138; Herrero-Gascon Jesus, 2013, Geogaceta, V53, P21; Hornung JJ, 2012, PALAEONTOL Z, V86, P231, DOI 10.1007/s12542-012-0131-7; Jackson SJ, 2009, PALAIOS, V24, P222, DOI 10.2110/palo.2007.p07-070r; Kim JY, 2009, CRETACEOUS RES, V30, P1387, DOI 10.1016/j.cretres.2009.08.003; Lockley M.G., 1987, Mountain Geologist, V24, P107; LOCKLEY M. G., 1998, GAIA ASPECTS THERPRO, V15, P312; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin, 1998, Modern Geology, V23, P317; Lockley Martin G., 2001, P428; Lockley MG, 2012, ICHNOS, V19, P93, DOI 10.1080/10420940.2011.625726; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P133; Lockley MG, 1998, ASPECTS THEROPOD PAL, V15, P339; Lockley MG, 2009, ACT 4 JORN INT PAL D, P121; Lockley MG, 2004, ICHNOS, V11, P262, DOI [DOI 10.1080/10420940490428805, 10.1080/10420940490428805]; Maidment SCR, ACTA PALEON IN PRESS; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; MARTIN-CLOSAS C., 1998, REV SOC GEOLOGICA ES, V11, P253; MARTY D., 2008, GEOFOCUS, V21, P1; Mas R., 2004, GEOLOG A ESPA A, P503; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Meyer Christian A., 2003, Ichnos, V10, P221, DOI 10.1080/10420940390256186; Mickelson Debra L., 2004, Ichnos, V11, P125, DOI 10.1080/10420940490445437; Milan J, 2008, ICHNOS, V15, P19, DOI 10.1080/10420940600864712; Moratalla Garcia JJ, 1993, THESIS U COMPLUTENSE; Moratalla J.J., 1992, Journal of Vertebrate Paleontology, V12, P150; Moratalla JJ, 2010, PALAEOGEOGR PALAEOCL, V295, P116, DOI 10.1016/j.palaeo.2010.05.027; MORATALLA JJ, 1988, GEOBIOS-LYON, V21, P395, DOI 10.1016/S0016-6995(88)80042-1; Moratalla Jose J., 2009, Revista Espanola de Paleontologia, V24, P59; Moratalla Jose J., 1994, Ichnos, V3, P89; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; Pascual-Arribas C, 2000, ESTUD GEOL, V56, P41, DOI [10.3989/egeol.00561-2155, DOI 10.3989/EGE01.00561-2155]; Pascual-Arribas Carlos, 2009, Studia Geologica Salmanticensia, V45, P105; Paul G., 1991, MODERN GEOLOGY; Pazos PJ, 2012, GONDWANA RES, V22, P1125, DOI 10.1016/j.gr.2012.02.003; Quijada I, 2010, GEOGACETA, V49, P15; Quijada I, 2012, TIDALITES 2012, P103; Romilio A, 2011, CRETACEOUS RES, V32, P135, DOI 10.1016/j.cretres.2010.11.003; Salas R, 2001, MEM MUS NAT HIST NAT, V186, P145; Santos VF, 2012, CRETACEOUS RES, P1; Sarjeant William A.S., 1998, Ichnos, V6, P183; Schudack U, 2009, J IBER GEOL, V35, P141; Thulborn T., 1990, DINOSAUR TRACKS; Wings O, 2005, KAUPIA DARMSTADTER B, V14, P105; Woodhams KE, 1989, DINOSAUR TRACKS TRAC, P299; Wright JL, 1999, SP PALAEONT, P209; Wright Joanna L., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P143; Xing Li-Da, 2011, Vertebrata Palasiatica, V49, P423	70	52	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81830	10.1371/journal.pone.0081830	http://dx.doi.org/10.1371/journal.pone.0081830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303075	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400091
J	Lu, ZL; Wang, LG; Zhou, R; Qiu, Y; Yang, LN; Zhang, CY; Cai, M; Mi, MT; Xu, HX				Lu, Zongliang; Wang, Leiguang; Zhou, Rui; Qiu, Yi; Yang, Liuna; Zhang, Chanyu; Cai, Min; Mi, Mantian; Xu, Hongxia			Evaluation of the Spermicidal and Contraceptive Activity of Platycodin D, a Saponin from Platycodon grandiflorum	PLOS ONE			English	Article							IN-VITRO DETERMINATION; VAGINAL SPERMICIDES; MEMBRANE; EXTRACT; NONOXYNOL-9; CHOLESTEROL; INHIBITION; ACTIVATION; INTEGRITY; INCREASE	Background: The extract of Platycodon grandiflorum has been reported to have effective spermicidal activity. This study was designed to evaluate the spermicidal and contraceptive activity, as well as the safety, of Platycodin D (PD), a major saponin in Platycodon grandiflorum. Methods: Using the computer-aided sperm analysis (CASA) test criteria, the sperm-immobilizing activity of PD was studied using highly motile human sperm. The sperm viability was assessed by fluorescent staining using SYBR-14 (living sperm) and propidium iodide (dead sperm). The sperm membrane integrity was assessed by evaluating the hypo-osmotic swelling (HOS) and examinations by transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The in vivo contraceptive efficacy was evaluated in rats using post-intrauterine PD application. The comet assay was employed to determine whether PD caused DNA damage in the sperm. Vaginal biopsies were also performed to determine whether the PD gel induced vaginal inflammation. Results: A dose-dependent effect of PD on the sperm motility and viability was observed. The maximum spermicidal effect was observed with a 0.25 mM concentration of PD. More than 70% of the PD-treated sperm lost their HOS responsiveness at a concentration of 0.20 mM PD, indicating that PD caused injury to the sperm plasma membrane. TEM and SEM revealed significant damage to both the head and tail membranes of the sperm. PD decreased the fertility to zero in rats, was non-DNA damaging and was not harmful to the vaginal tissue in the rats. Conclusion: PD has significant spermicidal activity that should be explored in further studies.	[Lu, Zongliang; Zhou, Rui; Yang, Liuna; Xu, Hongxia] Third Mil Med Univ, Daping Hosp, Dept Nutr, Chongqing, Peoples R China; [Wang, Leiguang; Qiu, Yi] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Wang, Leiguang; Qiu, Yi] Shandong Prov Family Planning Inst Sci & Technol, Jinan, Peoples R China; [Lu, Zongliang; Zhou, Rui; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing, Peoples R China; [Zhang, Chanyu] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Cai, Min] Inst Chongqing Natl Populat & Family Planning Sci, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Chongqing Medical University	Xu, HX (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Nutr, Chongqing, Peoples R China.	clara.red9@gmail.com	Xu, Hongxia/AAN-8608-2021	xu, hongxia/0000-0001-5215-734X	Shandong Provincial Key Laboratory for Improving Birth Outcome Technique grant [2012kf01]	Shandong Provincial Key Laboratory for Improving Birth Outcome Technique grant	This work was supported by the Shandong Provincial Key Laboratory for Improving Birth Outcome Technique grant (No. 2012kf01, to HX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2005, LIFE SCI, V76, P2315, DOI 10.1016/j.lfs.2004.10.042; Armah CN, 1999, BIOPHYS J, V76, P281, DOI 10.1016/S0006-3495(99)77196-1; Chaudhury K, 2004, HUM REPROD, V19, P1826, DOI 10.1093/humrep/deh332; D'Cruz OJ, 2001, CONTRACEPTION, V64, P113, DOI 10.1016/S0010-7824(01)00233-5; Das N, 2011, CONTRACEPTION, V83, P167, DOI 10.1016/j.contraception.2010.05.009; Farnsworth N R, 1982, Res Front Fertil Regul, V2, P1; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; FUJITA T, 1970, Z ZELLFORSCH MIK ANA, V105, P483, DOI 10.1007/BF00335423; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; *GB T, 2005, 102005ISO1099310; GEE JM, 1988, J NUTR, V118, P1391, DOI 10.1093/jn/118.11.1391; Hughes CM, 1996, MOL HUM REPROD, V2, P613, DOI 10.1093/molehr/2.8.613; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Kim MO, 2008, INT J CANCER, V122, P2674, DOI 10.1002/ijc.23442; Kumar S, 2007, CONTRACEPTION, V75, P71, DOI 10.1016/j.contraception.2006.07.015; Lakshmi V, 2008, ARCH MED RES, V39, P631, DOI 10.1016/j.arcmed.2008.06.007; Lambert PC, 2004, J REPROD MED, V49, P817; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; LUKE S, 2013, SPERMATOGENESIS METH, V927, P137; Mkrtchyan A, 2005, PHYTOMEDICINE, V12, P403, DOI 10.1016/j.phymed.2004.10.004; Morroni C, 2006, SAMJ S AFR MED J, V96, P620; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; PAKRASHI A, 1991, CONTRACEPTION, V43, P475, DOI 10.1016/0010-7824(91)90137-5; Pal D, 2009, REPRODUCTION, V138, P453, DOI 10.1530/REP-09-0034; Paul D, 2006, CONTRACEPTION, V73, P284, DOI 10.1016/j.contraception.2005.07.014; Paul S, 2011, NEW BIOTECHNOL, V28, P684, DOI 10.1016/j.nbt.2011.02.008; PRIMORAC M, 1985, PHARMAZIE, V40, P585; QIU Y, 2008, ZHONGGUO JI HUA SHEN, V4, P222; QIU Y, 2010, ZHONGHUA YI XUE ZA Z, V44, P3107; Qiu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P448, DOI 10.1631/jzus.B1000347; Saha P, 2010, REPROD SCI, V17, P454, DOI 10.1177/1933719110361378; Shin CY, 2002, PLANTA MED, V68, P221, DOI 10.1055/s-2002-23130; Singh KK, 2012, CONTRACEPTION, V85, P122, DOI 10.1016/j.contraception.2011.04.013; Singh NP, 1998, MUTAGENESIS, V13, P75, DOI 10.1093/mutage/13.1.75; Souad K, 2007, CONTRACEPTION, V75, P152, DOI 10.1016/j.contraception.2006.10.006; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; STORY JA, 1984, AM J CLIN NUTR, V39, P917, DOI 10.1093/ajcn/39.6.917; Vis EH, 2005, NUTR CANCER, V51, P37, DOI 10.1207/s15327914nc5101_6; *WHO, 1997, AB TAB AV DAT FREQ M; World Health Organization, 1999, WHO LAB MAN EX HUM S	40	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82068	10.1371/journal.pone.0082068	http://dx.doi.org/10.1371/journal.pone.0082068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303079	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400096
J	Tan, LQ; Wang, LY; Wei, K; Zhang, CC; Wu, LY; Qi, GN; Cheng, H; Zhang, Q; Cui, QM; Liang, JB				Tan, Li-Qiang; Wang, Li-Yuan; Wei, Kang; Zhang, Cheng-Cai; Wu, Li-Yun; Qi, Gui-Nian; Cheng, Hao; Zhang, Qiang; Cui, Qing-Mei; Liang, Jin-Bo			Floral Transcriptome Sequencing for SSR Marker Development and Linkage Map Construction in the Tea Plant (Camellia sinensis)	PLOS ONE			English	Article							DE-NOVO CHARACTERIZATION; MICROSATELLITE MARKERS; SEGREGATION DISTORTION; TAGS ESTS; IDENTIFICATION; TOOL; AMPLIFICATION; GENERATION; SELECTION; CHINA	Despite the worldwide consumption and high economic importance of tea, the plant (Camellia sinensis) is not well studied in molecular biology. Under the few circumstances in which the plant is studied, C. sinensis flowers, which are important for reproduction and cross-breeding, receive less emphasis than investigation of its leaves or roots. Using high-throughput Illumina RNA sequencing, we analyzed a C. sinensis floral transcriptome, and 26.9 million clean reads were assembled into 75,531 unigenes averaging 402 bp. Among them, 50,792 (67.2%) unigenes were annotated with a BLAST search against the NCBI Non-Redundant (NR) database and 10,290 (16.67%) were detected that contained one or more simple sequence repeats (SSRs). From these SSR-containing sequences, 2,439 candidate SSR markers were developed and 720 were experimentally tested, validating 431 (59.9%) novel polymorphic SSR markers for C. sinensis. Then, a consensus SSR-based linkage map was constructed that covered 1,156.9 cM with 237 SSR markers distributed in 15 linkage groups. Both transcriptome information and the genetic map of C. sinensis presented here offer a valuable foundation for molecular biology investigations such as functional gene isolation, quantitative trait loci mapping, and marker-assisted selection breeding in this important species.	[Tan, Li-Qiang; Wang, Li-Yuan; Wei, Kang; Zhang, Cheng-Cai; Wu, Li-Yun; Cheng, Hao] Chinese Acad Agr Sci TRICAAS, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou, Zhejiang, Peoples R China; [Tan, Li-Qiang; Qi, Gui-Nian] Sichuan Agr Univ, Coll Hort, Yaan, Peoples R China; [Zhang, Qiang; Cui, Qing-Mei; Liang, Jin-Bo] Enshi Acad Agr Sci, Tea Res Inst, Enshi, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Sichuan Agricultural University	Wang, LY (corresponding author), Chinese Acad Agr Sci TRICAAS, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou, Zhejiang, Peoples R China.	wangly@mail.tricaas.com; guinian5612@163.com; chenghao@mail.tricaas.com			earmarked fund for Modern Agro-industry Technology Research System [nycytx-23]; Zhejiang Provincial Natural Science Foundation of China [LY13C160004]	earmarked fund for Modern Agro-industry Technology Research System; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System (nycytx-23) and Zhejiang Provincial Natural Science Foundation of China (LY13C160004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fang W, 2012, PLANT SYST EVOL, V298, P469, DOI 10.1007/s00606-011-0559-3; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Folta KM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-12; Freeman S, 2004, MOL ECOL NOTES, V4, P324, DOI 10.1111/j.1471-8286.2004.00682.x; Hackett CA, 2000, HEREDITY, V85, P346, DOI 10.1046/j.1365-2540.2000.00769.x; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hu CY, 2013, EUPHYTICA, V191, P141, DOI 10.1007/s10681-013-0908-0; Huang FuPing, 2006, Journal of Tea Science, V26, P171; Huang JianAn, 2005, Journal of Tea Science, V25, P7; Hung CY, 2008, CONSERV GENET, V9, P779, DOI 10.1007/s10592-007-9391-2; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kamunya SM, 2010, TREE GENET GENOMES, V6, P915, DOI 10.1007/s11295-010-0301-2; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liebhard R, 2003, THEOR APPL GENET, V106, P1497, DOI 10.1007/s00122-003-1209-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma JQ, 2012, SCI HORTIC-AMSTERDAM, V134, P167, DOI 10.1016/j.scienta.2011.10.029; Ma JQ, 2010, AM J BOT, V97, pE153, DOI 10.3732/ajb.1000376; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Rozen S, 2000, Methods Mol Biol, V132, P365; Sharma H, 2011, AM J BOT, V98, pE133, DOI 10.3732/ajb.1000525; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; TAKEDA Y, 1990, JARQ-JPN AGR RES Q, V24, P111; Taniguchi F, 2012, BREEDING SCI, V62, P263, DOI 10.1270/jsbbs.62.263; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YX, 2010, EUPHYTICA, V173, P193, DOI 10.1007/s10681-009-0085-3; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Yao MZ, 2012, TREE GENET GENOMES, V8, P205, DOI 10.1007/s11295-011-0433-z; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhao LP, 2008, CONSERV GENET, V9, P1327, DOI 10.1007/s10592-007-9476-y; [赵思东 Zhao Sidong], 2003, [中南林学院学报, Journal of Central South Forestry University], V23, P58	50	64	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81611	10.1371/journal.pone.0081611	http://dx.doi.org/10.1371/journal.pone.0081611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303059	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400075
J	Xu, Y; Ohms, SJ; Li, Z; Wang, Q; Gong, GM; Hu, YQ; Mao, ZY; Shannon, MF; Fan, JY				Xu, Yan; Ohms, Stephen J.; Li, Zhen; Wang, Qiao; Gong, Guangming; Hu, Yiqiao; Mao, Zhiyong; Shannon, M. Frances; Fan, Jun Y.			Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance	PLOS ONE			English	Article							BREAST-CANCER CELLS; LOOP RT-PCR; GENOMIC ORGANIZATION; IN-VITRO; MICRORNAS; RNA; QUANTIFICATION; TRANSPORTERS; VIVO	Multidrug resistance (MDR) frequently develops in cancer patients exposed to chemotherapeutic agents and is usually brought about by over-expression of P-glycoprotein (P-gp) which acts as a drug efflux pump to reduce the intracellular concentration of the drug(s). Thus, inhibiting P-gp expression might assist in overcoming MDR in cancer chemotherapy. MiRNAome profiling using next-generation sequencing identified differentially expressed microRNAs (miRs) between parental K562 cells and MDR K562 cells (K562/ADM) induced by adriamycin treatment. Two miRs, miR-381 and miR-495, that were strongly down-regulated in K562/ADM cells, are validated to target the 3'-UTR of the MDR1 gene. These miRs are located within a miR cluster located at chromosome region 14q32.31, and all miRs in this cluster appear to be down-regulated in K562/ADM cells. Functional analysis indicated that restoring expression of miR-381 or miR-495 in K562/ADM cells was correlated with reduced expression of the MDR1 gene and its protein product, P-gp, and increased drug uptake by the cells. Thus, we have demonstrated that changing the levels of certain miR species modulates the MDR phenotype in leukemia cells, and propose further exploration of the use of miR-based therapies to overcome MDR.	[Xu, Yan; Li, Zhen; Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Xu, Yan; Shannon, M. Frances; Fan, Jun Y.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Biol, Canberra, ACT 2601, Australia; [Xu, Yan; Gong, Guangming; Hu, Yiqiao] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Ohms, Stephen J.] Australian Natl Univ, John Curtin Sch Med Res, Australian Canc Res Fdn, Biomol Resource Facil, Canberra, ACT 2601, Australia; [Wang, Qiao] Univ Melbourne, Natl Informat & Commun Technol Australia, Victoria Res Lab, Melbourne, Vic, Australia; [Shannon, M. Frances] Univ Canberra, Canberra, ACT 2601, Australia	Tongji University; Australian National University; John Curtin School of Medical Research; Nanjing University; Australian National University; John Curtin School of Medical Research; University of Melbourne; University of Canberra	Mao, ZY (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	zhiyong_mao@tongji.edu.cn; Frances.Shannon@canberra.edu.au; jun.fan@anu.edu.au		Mao, Zhiyong/0000-0002-5298-1918	Bioplatforms Australia; China Postdoctoral Science Foundation [2013M53126]; Tongji University; Lianyungang Municipal Science and Technology Bureau [NY1007]	Bioplatforms Australia; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tongji University; Lianyungang Municipal Science and Technology Bureau	This work was supported by an Epigenomics Capacity Development grant from Bioplatforms Australia (http://www.bioplatforms.com.au/) and a financial grant awarded to YX. from the China Postdoctoral Science Foundation (2013M53126). The authors acknowledge the Startup grant from Tongji University to ZM and the agricultural research project of Lianyungang Municipal Science and Technology Bureau (NY1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ando T, 2000, LEUKEMIA, V14, P1915, DOI 10.1038/sj.leu.2401914; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; KAMADA N, 1992, CANCER RES, V52, P1481; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Liu Y, 2010, CANCER CHEMOTH PHARM, V66, P433, DOI 10.1007/s00280-009-1177-4; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Maden BEH, 1997, CHROMOSOMA, V105, P391, DOI 10.1007/s004120050200; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Mutoh K, 2006, MOL CANCER THER, V5, P877, DOI 10.1158/1535-7163.MCT-05-0240; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Perloff MD, 2003, PHARMACEUT RES, V20, P1177, DOI 10.1023/A:1025092829696; Petriz J, 1997, LEUKEMIA, V11, P1124, DOI 10.1038/sj.leu.2400659; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Su XY, 2006, BLOOD, V108, P4198, DOI 10.1182/blood-2006-07-032953; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; TSURUO T, 1981, CANCER RES, V41, P1967; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Velingkar V., 2010, INT J PHARM SCI RES, V1, P104; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Xu Y, 2012, BIOSCIENCE REP, V32, P559, DOI 10.1042/BSR20120020; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	47	67	74	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82062	10.1371/journal.pone.0082062	http://dx.doi.org/10.1371/journal.pone.0082062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303078	Green Published, gold			2022-12-25	WOS:000327546400095
J	Padler-Karavani, V; Hurtado-Ziola, N; Chang, YC; Sonnenburg, JL; Ronaghy, A; Yu, H; Verhagen, A; Nizet, V; Chen, X; Varki, N; Varki, A; Angata, T				Padler-Karavani, Vered; Hurtado-Ziola, Nancy; Chang, Yung-Chi; Sonnenburg, Justin L.; Ronaghy, Arash; Yu, Hai; Verhagen, Andrea; Nizet, Victor; Chen, Xi; Varki, Nissi; Varki, Ajit; Angata, Takashi			Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates	FASEB JOURNAL			English	Article						sialic acids; N-acetylneuraminic acid; N-glycolylneuraminic acid; innate immunity	SIALIC ACIDS; INNATE IMMUNITY; RECEPTOR; GANGLIOSIDES; MACROPHAGES; DIVERSITY; INTERACT; PATHOGEN; REVEALS; CLONING	Siglecs are sialic acid-binding Ig-like lectins that recognize sialoglycans via amino-terminal V-set domains. CD33-related Siglecs (CD33rSiglecs) on innate immune cells recognize endogenous sialoglycans as self-associated molecular patterns (SAMPs), dampening immune responses via cytosolic immunoreceptor tyrosine-based inhibition motifs that recruit tyrosine phosphatases. However, sialic acid-expressing pathogens subvert this mechanism through molecular mimicry. Meanwhile, endogenous host SAMPs must continually evolve to evade other pathogens that exploit sialic acids as invasion targets. We hypothesized that these opposing selection forces have accelerated CD33rSiglec evolution. We address this by comparative analysis of major CD33rSiglec (Siglec-3, Siglec-5, and Siglec-9) orthologs in humans, chimpanzees, and baboons. Recombinant soluble molecules displaying ligand-binding domains show marked quantitative and qualitative interspecies differences in interactions with strains of the sialylated pathogen, group B Streptococcus, and with sialoglycans presented as gangliosides or in the form of sialoglycan microarrays, including variations such as N-glycolyl and O-acetyl groups. Primate Siglecs also show quantitative and qualitative intra- and interspecies variations in expression patterns on leukocytes, both in circulation and in tissues. Taken together our data explain why the CD33rSiglec-encoding gene cluster is undergoing rapid evolution via multiple mechanisms, driven by the need to maintain self-recognition by innate immune cells, while escaping 2 distinct mechanisms of pathogen subversion.Padler-Karavani, V., Hurtado-Ziola, N., Chang, Y.-C., Sonnenburg, J. L., Ronaghy, A., Yu, H., Verhagen, A., Nizet, V., Chen, X., Varki, N., Varki, A., Angata, T. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.	[Padler-Karavani, Vered; Hurtado-Ziola, Nancy; Sonnenburg, Justin L.; Verhagen, Andrea; Varki, Ajit; Angata, Takashi] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Padler-Karavani, Vered; Hurtado-Ziola, Nancy; Sonnenburg, Justin L.; Verhagen, Andrea; Varki, Ajit; Angata, Takashi] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chang, Yung-Chi; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ronaghy, Arash; Varki, Nissi] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Chen, Xi/H-1811-2018; Nizet, Victor/AAF-3190-2019; PADLER-KARAVANI, VERED/AAC-6055-2022	Chen, Xi/0000-0002-3160-614X; PADLER-KARAVANI, VERED/0000-0002-4761-3571; Nizet, Victor/0000-0003-3847-0422	University of California at San Diego Program of Excellence in Glycosciences (U.S. National Institutes of Health) [P01HL107150]; Mathers Foundation of New York; International Sepharadic Education Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	University of California at San Diego Program of Excellence in Glycosciences (U.S. National Institutes of Health); Mathers Foundation of New York; International Sepharadic Education Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Yerkes Primate Research Center (Atlanta, GA, USA), Zoo Atlanta (Atlanta, GA, USA), the San Diego Zoo (San Diego, CA, USA), the Lincoln Park Zoo (Chicago, IL, USA), the Primate Foundation of Arizona (Mesa, AZ), and the Southwest Primate Research Center (San Antonio, TX, USA), for providing nonhuman primate blood samples. The laboratories of A.V. and V.N. are supported by the University of California at San Diego Program of Excellence in Glycosciences (U.S. National Institutes of Health grant P01HL107150). A.V. is also supported by the Mathers Foundation of New York. V.P.-K. was partially supported by an International Sepharadic Education Foundation postdoctoral fellowship. The authors declare no conflicts of interest.	Altevogt BM, 2011, CHIMPANZEES IN BIOMEDICAL AND BEHAVIORAL RESEARCH: ASSESSING THE NECESSITY, P1; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Baker CJ, 2013, VACCINE, V31, pD3, DOI 10.1016/j.vaccine.2013.02.030; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Cao H, 2008, EUR J IMMUNOL, V38, P2303, DOI 10.1002/eji.200738078; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; Esko JD, 2009, ESSENTIALS GLYCOBIOL, P489; Ghaderi D, 2011, P NATL ACAD SCI USA, V108, P17743, DOI 10.1073/pnas.1102302108; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Khatua B, 2012, J LEUKOCYTE BIOL, V91, P641, DOI 10.1189/jlb.0511260; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Liu Y, 2009, TRENDS IMMUNOL, V30, P557, DOI 10.1016/j.it.2009.09.006; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SJOBERG ER, 1995, J BIOL CHEM, V270, P2921, DOI 10.1074/jbc.270.7.2921; SONG Y, 1995, GLYCOBIOLOGY, V5, P207, DOI 10.1093/glycob/5.2.207; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki A, 2009, P NATL ACAD SCI USA, V106, P14739, DOI 10.1073/pnas.0908196106; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Wang XX, 2012, P NATL ACAD SCI USA, V109, P9935, DOI 10.1073/pnas.1119459109; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483	46	53	54	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1280	1293		10.1096/fj.13-241497	http://dx.doi.org/10.1096/fj.13-241497			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308974	Green Published			2022-12-25	WOS:000335324800021
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Residues in the Polar Loop of Subunit c in Escherichia coli ATP Synthase Function in Gating Proton Transport to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP Synthase; F1F0-ATPase; Membrane Energetics; Membrane Transport; Proton Transport; Chemical Modifications Inhibiting Function; Cysteine Substitution Mutagenesis; Loops of Transmembrane Proteins; Subunit c	AQUEOUS ACCESS PATHWAYS; ROTOR RING; H+-ATPASE; EPSILON-SUBUNIT; CROSS-LINKING; ROTARY MOTOR; F1; BINDING; F-0; HELICES	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occur in the middle of the membrane at Asp-61 on the second transmembrane helix (TMH) of subunit c, which folds in a hairpin-like structure with two TMHs. Previously, the aqueous accessibility of Cys substitutions in the transmembrane regions of subunit c was probed by testing the inhibitory effects of Ag+ or Cd2+ on function, which revealed extensive aqueous access in the region around Asp-61 and on the half of TMH2 extending to the cytoplasm. In the current study, we surveyed the Ag+ and Cd2+ sensitivity of Cys substitutions in the loop of the helical hairpin and used a variety of assays to categorize the mechanisms by which Ag+ or Cd2+ chelation with the Cys thiolates caused inhibition. We identified two distinct metal-sensitive regions in the cytoplasmic loop where function was inhibited by different mechanisms. Metal binding to Cys substitutions in the N-terminal half of the loop resulted in an uncoupling of F-1 from F-0 with release of F-1 from the membrane. In contrast, substitutions in the C-terminal half of the loop retained membrane-bound F-1 after metal treatment. In several of these cases, inhibition was shown to be due to blockage of passive H+ translocation through F-0 as assayed with F-0 reconstituted into liposomes. The results suggest that the C-terminal domain of the cytoplasmic loop may function in gating H+ translocation to the cytoplasm.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	National Institutes of Health from the United States Public Health Service [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023105, R01GM023105] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105 from the United States Public Health Service.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AGGELER R, 1995, BBA-BIOENERGETICS, V1230, P62, DOI 10.1016/0005-2728(95)00040-P; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Dmitriev OY, 2007, PROTEIN SCI, V16, P2118, DOI 10.1110/ps.072776307; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; FRAGA D, 1991, J BACTERIOL, V173, P2639, DOI 10.1128/jb.173.8.2639-2643.1991; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P7532; HATCH L, 1993, BIOCHIM BIOPHYS ACTA, V1141, P183, DOI 10.1016/0005-2728(93)90041-D; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P11355, DOI 10.1074/jbc.275.15.11355; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; MILLER MJ, 1989, J BIOL CHEM, V264, P305; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Reed P W, 1979, Methods Enzymol, V55, P435; Saroussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043045; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Steed P. R., 2010, THESIS U WISCONSIN M; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	65	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2127	2138		10.1074/jbc.M113.527879	http://dx.doi.org/10.1074/jbc.M113.527879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297166	Green Published, hybrid			2022-12-25	WOS:000331130200021
J	Chandel, K; Mendki, MJ; Parikh, RY; Kulkarni, G; Tikar, SN; Sukumaran, D; Prakash, S; Parashar, BD; Shouche, YS; Veer, V				Chandel, Kshitij; Mendki, Murlidhar J.; Parikh, Rasesh Y.; Kulkarni, Girish; Tikar, Sachin N.; Sukumaran, Devanathan; Prakash, Shri; Parashar, Brahma D.; Shouche, Yogesh S.; Veer, Vijay			Midgut Microbial Community of Culex quinquefasciatus Mosquito Populations from India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; BACTERIA; ADULT; IDENTIFICATION; DIPTERA; CULICIDAE; FLORA; GUT	The mosquito Culex quinquefasciatus is a ubiquitous species that serves as a major vector for west nile virus and lymphatic filariasis. Ingestion of bloodmeal by females triggers a series of physiological processes in the midgut and also exposes them to infection by these pathogens. The bacteria normally harbored in the midgut are known to influence physiology and can also alter the response to various pathogens. The midgut bacteria in female Cx. quinquefasciatus mosquitoes collected over a large geographical area from India was studied. Examination of 16S ribosomal DNA amplicons from culturable microflora revealed the presence of 83 bacterial species belonging to 31 bacterial genera. All of these species belong to three phyla i.e. Proteobacteria, Firmicutes and Actinobacteria. Phylum Proteobacteria was the most dominant phylum (37 species), followed by Firmicutes (33 species) and Actinobacteria (13 species). Phylum Proteobacteria, was dominated by members of gamma-proteobacteria class. The genus Staphylococcus was the largest genus represented by 11 species whereas Enterobacter was the most prevalent genus and recovered from all the field stations except Leh. Highest bacterial prevalence was observed from Bhuj (22 species) followed by Nagrota (18 species), Masimpur (18 species) and Hathigarh (16 species). Whereas, least species were observed from Leh (8 species). It has been observed that individual mosquito harbor extremely diverse gut bacteria and have very small overlap bacterial taxa in their gut. This variation in midgut microbiota may be one of the factors responsible for variation in disease transmission rates or vector competence within mosquito population. The present data strongly encourage further investigations to verify the potential role of the detected bacteria in mosquito for the transmission of lymphatic filariasis and west nile virus. To the best of our knowledge this is the first study on midgut microbiota of wild Cx. quinquefasciatus from over a large geographical area.	[Chandel, Kshitij; Mendki, Murlidhar J.; Tikar, Sachin N.; Sukumaran, Devanathan; Prakash, Shri; Parashar, Brahma D.; Veer, Vijay] Def Res & Dev Estab, Vector Management Div, Gwalior 474002, India; [Parikh, Rasesh Y.; Kulkarni, Girish; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Chandel, K (corresponding author), Def Res & Dev Estab, Vector Management Div, Jhansi Rd, Gwalior 474002, India.	chandelkc@gmail.com	SUKUMARAN, DEVANATHAN/L-6343-2019; Chandel, Kshitij/P-2075-2017	Chandel, Kshitij/0000-0003-0906-6367	Director, Defence Research and Development Establishment, Gwalior under auspicious of Defence Research and Development Organization, Ministry of Defence, Govt. of India, India	Director, Defence Research and Development Establishment, Gwalior under auspicious of Defence Research and Development Organization, Ministry of Defence, Govt. of India, India	This project was funded by Director, Defence Research and Development Establishment, Gwalior under auspicious of Defence Research and Development Organization, Ministry of Defence, Govt. of India, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V K, 2006, Med J Armed Forces India, V62, P359, DOI 10.1016/S0377-1237(06)80109-7; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Clarke K. R., 2001, CHANGES MARINE COMMU; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Ignatova E. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P12; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Jadin J, 1965, Bull Acad Natl Med, V149, P470; Kaya, 1993, INSECT PATHOLOGY; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Mourya DT, 2002, ACTA VIROL, V46, P257; MOURYA DT, 1989, T ROY SOC TROP MED H, V83, P550, DOI 10.1016/0035-9203(89)90288-5; Noden BH, 2011, PARASITOL INT, V60, P440, DOI 10.1016/j.parint.2011.07.007; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Sambrook J, 2001, MOL CLONING LAB MANU; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sorensen T, 1948, BIOLOGISKE SKRIFTER, V5, P1; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Tajedin L, 2009, IRAN J ARTHROPOD-BOR, V3, P36; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767	37	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80453	10.1371/journal.pone.0080453	http://dx.doi.org/10.1371/journal.pone.0080453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312223	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300013
J	Huang, YY; Khan, M; Mandoiu, II				Huang, Yanyan; Khan, Mazhar; Mandoiu, Ion I.			Neuraminidase Subtyping of Avian Influenza Viruses with PrimerHunter-Designed Primers and Quadruplicate Primer Pools	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; A VIRUSES; ASSAY; IDENTIFICATION; HEMAGGLUTININ; GENES; BIRDS; H5N1	We have previously developed a software package called PrimerHunter to design primers for PCR-based virus subtyping. In this study, 9 pairs of primers were designed with PrimerHunter and successfully used to differentiate the 9 neuraminidase (NA) genes of avian influenza viruses (AIVs) in multiple PCR-based assays. Furthermore, primer pools were designed and successfully used to decrease the number of reactions needed for NA subtyping from 9 to 4. The quadruplicate primer-pool method is cost-saving, and was shown to be suitable for the NA subtyping of both cultured AIVs and uncultured AIV swab samples. The primers selected for this study showed excellent sensitivity and specificity in NA subtyping by RT-PCR, SYBR green-based Real-time PCR and Real-time RT-PCR methods. AIV RNA of 2 to 200 copies (varied by NA subtypes) could be detected by these reactions. No unspecific amplification was displayed when detecting RNAs of other avian infectious viruses such as Infectious bronchitis virus, Infectious bursal disease virus and Newcastle disease virus. In summary, this study introduced several sensitive and specific PCR-based assays for NA subtyping of AIVs and also validated again the effectiveness of the PrimerHunter tool for the design of subtyping primers.	[Huang, Yanyan; Khan, Mazhar] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT 06269 USA; [Huang, Yanyan] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Mandoiu, Ion I.] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA	University of Connecticut; Memorial University Newfoundland; University of Connecticut	Khan, M (corresponding author), Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT 06269 USA.	mazhar.khan@uconn.edu; ion@engr.uconn.edu	huang, yan/GWM-4747-2022	Mandoiu, Ion/0000-0002-4818-0237	National Science Foundation (NSF) [IIS-0546457, DBI-0543365]	National Science Foundation (NSF)(National Science Foundation (NSF))	Study was funded by National Science Foundation (NSF) awards IIS-0546457 and DBI-0543365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-77; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Duitama J, 2009, NUCLEIC ACIDS RES, V37, P2483, DOI 10.1093/nar/gkp073; Ewens WJ, 2006, STAT METHODS BIOINFO; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Gall A, 2009, J CLIN MICROBIOL, V47, P2985, DOI 10.1128/JCM.00850-09; Gusfield D., 2002, P 6 ANN INT C COMP B, P254, DOI DOI 10.1145/565196.565229; Huang YY, 2010, VIRUS RES, V151, P26, DOI 10.1016/j.virusres.2010.03.010; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ong WT, 2007, J VIROL METHODS, V144, P57, DOI 10.1016/j.jviromet.2007.03.019; Parmley J, 2009, INTEGR ZOOL, V4, P409, DOI 10.1111/j.1749-4877.2009.00177.x; Pedersen Janice C., 2008, V436, P67, DOI 10.1007/978-1-59745-279-3_9; Pryor Robert J., 2006, V336, P19; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2007, AVIAN DIS, V51, P201, DOI 10.1637/7732-101006-REGR.1; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsukamoto K, 2012, J CLIN MICROBIOL, V50, P37, DOI 10.1128/JCM.01195-11; Tsukamoto K, 2009, J CLIN MICROBIOL, V47, P2301, DOI 10.1128/JCM.02366-08; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wei HL, 2006, VIRUS GENES, V32, P261, DOI 10.1007/s11262-005-6910-4	27	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81842	10.1371/journal.pone.0081842	http://dx.doi.org/10.1371/journal.pone.0081842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312367	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300054
J	Goovaerts, O; Jennes, W; Massinga-Loembe, M; Ceulemans, A; Worodria, W; Mayanja-Kizza, H; Colebunders, R; Kestens, L				Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Worodria, William; Mayanja-Kizza, Harriet; Colebunders, Robert; Kestens, Luc		TB-IRIS Study Grp	LPS-Binding Protein and IL-6 Mark Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome in HIV Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; LIPOPOLYSACCHARIDE; INFECTION; LIPOARABINOMANNAN; ACTIVATION; MORTALITY; RESPONSES; DISEASE	Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) remains a poorly understood complication in HIV-TB co-infected patients initiating antiretroviral therapy (ART). The role of the innate immune system in TB-IRIS is becoming increasingly apparent, however the potential involvement in TB-IRIS of a leaky gut and proteins that interfere with TLR stimulation by binding PAMPs has not been investigated before. Here we aimed to investigate the innate nature of the cytokine response in TB-IRIS and to identify novel potential biomarkers. Methods: From a large prospective cohort of HIV-TB co-infected patients receiving TB treatment, we compared 40 patients who developed TB-IRIS during the first month of ART with 40 patients matched for age, sex and baseline CD4 count who did not. We analyzed plasma levels of lipopolysaccharide (LPS)-binding protein (LBP), LPS, sCD14, endotoxin-core antibody, intestinal fatty acid-binding protein (I-FABP) and 18 pro-and anti-inflammatory cytokines before and during ART. Results: We observed lower baseline levels of IL-6 (p = 0.041), GCSF (p = 0.036) and LBP (p = 0.016) in TB-IRIS patients. At IRIS event, we detected higher levels of LBP, IL-1RA, IL-4, IL-6, IL-7, IL-8, G-CSF (p <= 0.032) and lower I-FABP levels (p = 0.013) compared to HIV-TB co-infected controls. Only IL-6 showed an independent effect in multivariate models containing significant cytokines from pre-ART (p = 0.039) and during TB-IRIS (p = 0.034). Conclusion: We report pre-ART IL-6 and LBP levels as well as IL-6, LBP and I-FABP levels during IRIS-event as potential biomarkers in TB-IRIS. Our results show no evidence of the possible contribution of a leaky gut to TB-IRIS and indicate that IL-6 holds a distinct role in the disturbed innate cytokine profile before and during TB-IRIS. Future clinical studies should investigate the importance and clinical relevance of these markers for the diagnosis and treatment of TB-IRIS.	[Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Goovaerts, Odin; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Massinga-Loembe, Marguerite] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Massinga-Loembe, Marguerite] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Worodria, William; Mayanja-Kizza, Harriet] Mulago Hosp, Dept Med, Kampala, Uganda; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Worodria, William] Infect Dis Network Treatment & Res Africa INTERCT, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; Eberhard Karls University of Tubingen; Mulago National Referral Hospital; Makerere University; Institute of Tropical Medicine (ITM); University of Antwerp	Goovaerts, O (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	ogoovaerts@itg.be	Jennes, Wim/M-2523-2013; Locht, Camille/L-3516-2018; Mayanja-Kizza, Harriet/AAM-5372-2020	Jennes, Wim/0000-0002-3125-6389; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Massinga Loembe, Marguerite/0000-0002-7822-566X; Van den Bergh, Rafael/0000-0001-6277-8713; Locht, Camille/0000-0001-7295-7336; Cobelens, Frank/0000-0002-4367-1133	EC [LSHP-CT-2007-037659-]; Belgian Institute for Science and Technology (IWT)	EC(European CommissionEuropean Commission Joint Research Centre); Belgian Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The TB-IRIS project was funded by EC FP6 Specific Targeted Research Project (STREP) grant LSHP-CT-2007-037659-. O. Goovaerts holds a PhD student scholarship from the Belgian Institute for Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Bukh AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021275; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Conesa-Botella A, 2012, CLIN INFECT DIS; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; DENTENER MA, 1993, J IMMUNOL, V151, P4258; Elsing C, 2011, INFECTION, V39, P327, DOI 10.1007/s15010-011-0117-5; French Martyn A, 2007, Curr HIV/AIDS Rep, V4, P16, DOI 10.1007/s11904-007-0003-z; Grant P, 2012, CULT DIALECTICS, P1; Haddow LJ, 2011, AIDS, V25, P1163, DOI 10.1097/QAD.0b013e3283477d67; Hallatschek W, 2004, EUR J IMMUNOL, V34, P1441, DOI 10.1002/eji.200324874; Juffermans NP, 1998, J INFECT DIS, V178, P1839, DOI 10.1086/314492; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Narendran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063541; Natarajan K, 2011, TUBERCULOSIS, V91, P427, DOI 10.1016/j.tube.2011.04.003; Oliver BG, 2010, J INFECT DIS, V202, P1728, DOI 10.1086/657082; Porter BO, 2010, CLIN IMMUNOL, V136, P42, DOI 10.1016/j.clim.2010.02.010; Ruhwald M, 2007, AIDS, V21, P882, DOI 10.1097/QAD.0b013e3280b079c8; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Skinner NA, 2005, CLIN EXP IMMUNOL, V141, P270, DOI 10.1111/j.1365-2249.2005.02839.x; Stone S F, 2002, HIV Med, V3, P21, DOI 10.1046/j.1464-2662.2001.00096.x; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Van den Bergh R, 2006, LANCET INFECT DIS, V6, P2, DOI 10.1016/S1473-3099(05)70302-9; (WHO) WHO, 2012, IMPR DIAGN TREATM SM; World Health Organisation (WHO), 2011, TB HIV FACTS; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Worodria William, 2009, Expert Rev Respir Med, V3, P147, DOI 10.1586/ers.09.8; Yu WM, 1998, J IMMUNOL, V161, P4244	40	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81856	10.1371/journal.pone.0081856	http://dx.doi.org/10.1371/journal.pone.0081856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312369	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900056
J	Tsioras, K; Papastefanaki, F; Politis, PK; Matsas, R; Gaitanou, M				Tsioras, Konstantinos; Papastefanaki, Florentia; Politis, Panagiotis K.; Matsas, Rebecca; Gaitanou, Maria			Functional Interactions between BM88/Cend1, Ran-Binding Protein M and Dyrk1B Kinase Affect Cyclin D1 Levels and Cell Cycle Progression/Exit in Mouse Neuroblastoma Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; SCAFFOLDING PROTEIN; JOUBERT SYNDROME; CEREBELLAR DEVELOPMENT; EXPRESSION PATTERN; GROWTH ARREST; BM88 ANTIGEN; EXIT; AHI1; PROLIFERATION	BM88/Cend1 is a neuronal-lineage specific modulator with a pivotal role in coordination of cell cycle exit and differentiation of neuronal precursors. In the current study we identified the signal transduction scaffolding protein Ran-binding protein M (RanBPM) as a BM88/Cend1 binding partner and showed that BM88/Cend1, RanBPM and the dual specificity tyrosine-phosphorylation regulated kinase 1B (Dyrk1B) are expressed in mouse brain as well as in cultured embryonic cortical neurons while RanBPM can form complexes with either of the two other proteins. To elucidate a potential mechanism involving BM88/Cend1, RanBPM and Dyrk1B in cell cycle progression/exit, we transiently co-expressed these proteins in mouse neuroblastoma Neuro 2a cells. We found that the BM88/Cend1dependent or Dyrk1B-dependent down-regulation of cyclin D1 is reversed following their functional interaction with RanBPM. More specifically, functional interaction of RanBPM with either BM88/Cend1 or Dyrk1B stabilizes cyclin D1 in the nucleus and promotes 5-bromo-2'-deoxyuridine (BrdU) incorporation as a measure of enhanced cell proliferation. However, the RanBPM-dependent Dyrk1B cytosolic retention and degradation is reverted in the presence of Cend1 resulting in cyclin D1 destabilization. Co-expression of RanBPM with either BM88/Cend1 or Dyrk1B also had a negative effect on Neuro 2a cell differentiation. Our results suggest that functional interactions between BM88/Cend1, RanBPM and Dyrk1B affect the balance between cellular proliferation and differentiation in Neuro 2a cells and indicate that a potentially similar mechanism may influence cell cycle progression/exit and differentiation of neuronal precursors.	[Tsioras, Konstantinos; Papastefanaki, Florentia; Matsas, Rebecca; Gaitanou, Maria] Hellenic Pasteur Inst, Lab Cellular & Mol Neurobiol, Athens, Greece; [Politis, Panagiotis K.] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Athens, Greece	Academy of Athens	Matsas, R (corresponding author), Hellenic Pasteur Inst, Lab Cellular & Mol Neurobiol, Athens, Greece.	rmatsa@pasteur.gr; mgaitanou@pasteur.gr	Politis, Panagiotis/AAO-2423-2020	Politis, Panagiotis/0000-0002-2556-2857	European Regional Development Fund; FP7 REGPOT Project Neurosign [264083]; Fondation BNP Paribas; Greek General Secretariat for Research and Technology SYNERGASIA Project NOISEPLUS [09SYN-21-969]	European Regional Development Fund(European Commission); FP7 REGPOT Project Neurosign; Fondation BNP Paribas; Greek General Secretariat for Research and Technology SYNERGASIA Project NOISEPLUS	This work was part of the project entitled "Infectious and neurodegenerative diseases in the 21st century: study of basic mechanisms for the development of the translational research and cutting edge technologies aiming to effective diagnosis prevention and therapy" which was co-funded by the European Regional Development Fund and national resources, in the framework of the Action: "KRIPIS: Development proposals of Research Institutions". This work was further supported by FP7 REGPOT Project Neurosign 264083, Fondation BNP Paribas and the Greek General Secretariat for Research and Technology SYNERGASIA Project NOISEPLUS 09SYN-21-969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAO JP, 2007, MOL CANCER, DOI DOI 10.1158/1535-7163.MCT-06-0443.PUBMED:17407548; Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Cesi V, 2002, CELL DEATH DIFFER, V9, P1232, DOI 10.1038/sj.cdd.4401103; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Foskolou IP, 2013, ONCOGENE, V32, P947, DOI 10.1038/onc.2012.129; Frost D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019264; Gaitanou M, 2001, BIOCHEM J, V355, P715, DOI 10.1042/bj3550715; Gaitanou M, 1997, J NEUROSCI RES, V48, P507, DOI 10.1002/(SICI)1097-4547(19970615)48:6<507::AID-JNR3>3.3.CO;2-2; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gitten J, 1998, J CHILD NEUROL, V13, P391, DOI 10.1177/088307389801300806; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; HOLROYD S, 1991, BIOL PSYCHIAT, V29, P287, DOI 10.1016/0006-3223(91)91291-X; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Jin K, 2009, J BIOL CHEM, V284, P22916, DOI 10.1074/jbc.M109.035519; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; Koshy B, 2010, J TROP PEDIATRICS, V56, P209, DOI 10.1093/tropej/fmp084; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Makri G, 2010, STEM CELLS, V28, P127, DOI 10.1002/stem.258; MAMALAKI A, 1995, J BIOL CHEM, V270, P14201, DOI 10.1074/jbc.270.23.14201; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; PATSAVOUDI E, 1995, J NEUROSCI RES, V40, P506, DOI 10.1002/jnr.490400410; Pitto L, 2010, CELL CYCLE, V9, P434, DOI 10.4161/cc.9.3.10762; POIRIER Y, 1989, J VIROL, V63, P2088, DOI 10.1128/JVI.63.5.2088-2098.1989; Politis PK, 2008, FEBS LETT, V582, P741, DOI 10.1016/j.febslet.2008.01.052; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Politis PK, 2007, GENE EXPR PATTERNS, V7, P165, DOI 10.1016/j.modgep.2006.06.007; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Sergaki MC, 2010, MOL CELL NEUROSCI, V44, P15, DOI 10.1016/j.mcn.2010.01.011; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Suresh B, 2010, J BIOL CHEM, V285, P35340, DOI 10.1074/jbc.M110.156836; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Torri F, 2010, FASEB J, V24, P3066, DOI 10.1096/fj.09-152611; Wakabayashi T, 2010, J NEUROCHEM, V112, P1235, DOI 10.1111/j.1471-4159.2009.06536.x; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Weng L, 2013, J NEUROSCI, V33, P8172, DOI 10.1523/JNEUROSCI.0119-13.2013; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	58	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82172	10.1371/journal.pone.0082172	http://dx.doi.org/10.1371/journal.pone.0082172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312406	Green Submitted, gold, Green Published			2022-12-25	WOS:000327657900068
J	Zheng, CJ; Sohn, MJ; Lee, S; Kim, WG				Zheng, Chang Ji; Sohn, Mi-Jin; Lee, Sangku; Kim, Won-Gon			Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; FATTY-ACID SYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; TRICLOSAN RESISTANCE; FUNGAL PRODUCTS; ANTIBACTERIAL; TARGET; DISCOVERY; CHALLENGES	Bacterial enoyl-acyl carrier protein reductase (FabI) is a promising novel antibacterial target. We isolated a new class of FabI inhibitor from Penicillium chrysogenum, which produces various antibiotics, the mechanisms of some of them are unknown. The isolated FabI inhibitor was determined to be meleagrin by mass spectroscopy and nuclear magnetic resonance spectral analyses, and its more active and inactive derivatives were chemically prepared. Consistent with their selective inhibition of Staphylococcus aureus FabI, meleagrin and its more active derivatives directly bound to S. aureus FabI in a fluorescence quenching assay, inhibited intracellular fatty acid biosynthesis and growth of S. aureus, and increased the minimum inhibitory concentration for fabI-overexpressing S. aureus. The compounds that were not effective against the FabK isoform, however, inhibited the growth of Streptococcus pneumoniae that contained only the FabK isoform. Additionally no resistant mutant to the compounds was obtained. Importantly, fabK-overexpressing Escherichia coli was not resistant to these compounds, but was resistant to triclosan. These results demonstrate that the compounds inhibited another target in addition to FabI. Thus, meleagrin is a new class of FabI inhibitor with at least one additional mode of action that could have potential for treating multidrug-resistant bacteria.	[Zheng, Chang Ji; Sohn, Mi-Jin; Lee, Sangku; Kim, Won-Gon] Korea Res Inst Biosci & Biotechnol, Superbacteria Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, WG (corresponding author), Korea Res Inst Biosci & Biotechnol, Superbacteria Res Ctr, Taejon, South Korea.	wgkim@kribb.re.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A2A2A01014821, 2011-0031944]; Intelligent Synthetic Biology Center of Global Frontier Project	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Intelligent Synthetic Biology Center of Global Frontier Project	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A2A2A01014821) and the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringmann G, 2005, TETRAHEDRON, V61, P7252, DOI 10.1016/j.tet.2005.05.026; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Chen YG, 2009, J MED MICROBIOL, V58, P1086, DOI 10.1099/jmm.0.008524-0; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; KAWAI K, 1984, CHEM PHARM BULL, V32, P94; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Mattheus W, 2010, CHEM BIOL, V17, P1067, DOI 10.1016/j.chembiol.2010.07.015; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Moir Donald T., 2005, Current Drug Targets - Infectious Disorders, V5, P297; NOZAWA K, 1979, J NAT PROD, V42, P374, DOI 10.1021/np50004a004; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Singh M P, 2000, Curr Opin Drug Discov Devel, V3, P167; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; Slater-Radosti C, 2001, J ANTIMICROB CHEMOTH, V48, P1, DOI 10.1093/jac/48.1.1; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zheng CJ, 2007, BIOCHEM BIOPH RES CO, V362, P1107, DOI 10.1016/j.bbrc.2007.08.144; Zheng CJ, 2009, J ANTIMICROB CHEMOTH, V63, P949, DOI 10.1093/jac/dkp058; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	31	31	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e78922	10.1371/journal.pone.0078922	http://dx.doi.org/10.1371/journal.pone.0078922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312171	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900002
J	Liu, L; Xu, ZB; Zhong, L; Wang, H; Jiang, S; Long, QL; Xu, JJ; Guo, JM				Liu, Li; Xu, Zhibing; Zhong, Lei; Wang, Hang; Jiang, Shuai; Long, Qilai; Xu, Jiejie; Guo, Jianming			Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; CANCER; GENE; LYSINE-27; PROSTATE; MEMORY	Increased expression of EZH2 correlates with aggressive clinical behavior in various malignancies. In this study, aim to investigate the clinical and prognostic values of EZH2 expression and activity in tumor tissues and improve the risk stratification in patients with renal cell carcinoma after surgery. We analyzed EZH2 expression and its activity as indicated by H3K27me3 levels comprising 373 patients with renal cell carcinoma in our institute. Outcome was assessed as overall survival and disease free survival using Kaplan-Meier analysis. Prognostic values of EZH2 and H3K27me3 expression for clinical outcomes were evaluated by Cox regression analysis. We used receiver operating characteristic to calculate diagnostic accuracy. High EZH2 expression correlates with poor overall survival in all patients, especially in advanced RCC, which is an independent prognostic factor in disease free survival and overall survival. Compared with EZH2, H3K27me3 expression is not an independent prognostic factor. The expressions of H3K27me3 and EZH2 are not completely consistent, which might be due to complicated interaction of Polycomb Repressor Complex 2. A combination of EZH2 expression and TNM stage could have better prognostic value than do TNM stage or EZH2 expression alone in both sets for disease free survival and overall survival. These results imply hat evaluating intratumoral EZH2 density might improve prognostic value to the TNM staging system and inform treatment decisions for patients with late-stage renal cell carcinoma	[Liu, Li; Xu, Zhibing; Zhong, Lei; Wang, Hang; Jiang, Shuai; Long, Qilai; Guo, Jianming] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Xu, Jiejie] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, JJ (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	jjxufdu@fudan.edu.cn; guo.jianming@zs-hospital.sh.cn			Shanghai Health and Family Planning Commission [20114214]; National Natural Science Foundation of China [31100629, 31270863]; Shanghai Rising-Star Program [13QA1400300]	Shanghai Health and Family Planning Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by grants from Shanghai Health and Family Planning Commission (20114214, http://wsj.sh.gov.cn/website/b/65167.shtml), National Natural Science Foundation of China (Nos. 31100629 and 31270863, http://www.nsfc.gov.cn/Portal0/default152.htm), and Shanghai Rising-Star Program (No. 13QA1400300, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Dalkilic E, 2013, IRAN J KIDNEY DIS, V7, P198; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Eble JN, 2004, PATHOLOGY GENETICS T; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Ficarra V, 2007, LANCET ONCOL, V8, P554, DOI 10.1016/S1470-2045(07)70173-0; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Furge KA, 2010, LANCET ONCOL, V11, P571, DOI 10.1016/S1470-2045(09)70380-8; Hinz S, 2009, J UROLOGY, V182, P2920, DOI 10.1016/j.juro.2009.08.014; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Jacobs JJL, 1999, SEMIN CELL DEV BIOL, V10, P227, DOI 10.1006/scdb.1999.0304; Jonasch E, 2012, MOL CANCER RES, V10, P859, DOI 10.1158/1541-7786.MCR-12-0117; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Meskawi M, 2012, EUR UROL, V62, P303, DOI 10.1016/j.eururo.2012.04.049; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruutu M, 2008, EUR UROL SUPPL, V7, P436, DOI 10.1016/j.eursup.2008.01.005; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4	30	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81484	10.1371/journal.pone.0081484	http://dx.doi.org/10.1371/journal.pone.0081484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312307	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100083
J	Mutter, M; Munch, TA				Mutter, Marion; Muench, Thomas A.			Strategies for Expanding the Operational Range of Channelrhodopsin in Optogenetic Vision	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; BIPOLAR CELLS; HALORHODOPSIN; PHOTOCYCLES; ACTIVATION; MICE	Some hereditary diseases, such as retinitis pigmentosa, lead to blindness due to the death of photoreceptors, though the rest of the visual system might be only slightly affected. Optogenetics is a promising tool for restoring vision after retinal degeneration. In optogenetics, light-sensitive ion channels ("channelrhodopsins") are expressed in neurons so that the neurons can be activated by light. Currently existing variants of channelrhodopsin - engineered for use in neurophysiological research - do not necessarily support the goal of vision restoration optimally, due to two factors: First, the nature of the light stimulus is fundamentally different in "optogenetic vision" compared to "optogenetic neuroscience". Second, the retinal target neurons have specific properties that need to be accounted for, e.g. most retinal neurons are non-spiking. In this study, by using a computational model, we investigate properties of channelrhodopsin that might improve successful vision restoration. We pay particular attention to the operational brightness range and suggest strategies that would allow optogenetic vision over a wider intensity range than currently possible, spanning the brightest 5 orders of naturally occurring luminance. We also discuss the biophysical limitations of channelrhodopsin, and of the expressing cells, that prevent further expansion of this operational range, and we suggest design strategies for optogenetic tools which might help overcoming these limitations. Furthermore, the computational model used for this study is provided as an interactive tool for the research community.	[Muench, Thomas A.] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; Univ Tubingen, Bernstein Ctr Computat Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Munch, TA (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.	thomas.muench@cin.uni-tuebingen.de		Munch, Thomas/0000-0002-8884-6961	Deutsche Forschungsgemeinschaft [DFG EXC 307]; Tubingen University; German Ministry of Education, Science, Research and Technology [BMBF FKZ 01GQ1002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University; German Ministry of Education, Science, Research and Technology	This study was supported by funds from the Deutsche Forschungsgemeinschaft to the Werner Reichardt Centre for Integrative Neuroscience Tubingen (DFG EXC 307) and to the Open Access Publishing Fund of Tubingen University, and the German Ministry of Education, Science, Research and Technology to the Bernstein Center for Computational Neuroscience Tubingen (BMBF FKZ 01GQ1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Berndt A., 2011, THESIS HUMBOLDT U BE; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; DUSCHL A, 1990, J BIOL CHEM, V265, P1261; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Kleinlogel S, 2011, NAT METHODS, V8, P1083, DOI [10.1038/NMETH.1766, 10.1038/nmeth.1766]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Land MF, 2008, ANIMAL EYES; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Oltedal L, 2009, J PHYSIOL-LONDON, V587, P829, DOI 10.1113/jphysiol.2008.165415; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	29	2	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81278	10.1371/journal.pone.0081278	http://dx.doi.org/10.1371/journal.pone.0081278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312285	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100069
J	Sove, RJ; Ghonaim, N; Goldman, D; Ellis, CG				Sove, Richard J.; Ghonaim, Nour; Goldman, Daniel; Ellis, Christopher Gerald			A Computational Model of a Microfluidic Device to Measure the Dynamics of Oxygen-Dependent ATP Release from Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; FLOW; RESPONSES; TUBE; TONE	Erythrocytes are proposed to be involved in blood flow regulation through both shear- and oxygen-dependent mechanisms for the release of adenosine triphosphate (ATP), a potent vasodilator. In a recent study, the dynamics of shear-dependent ATP release from erythrocytes was measured using a microfluidic device with a constriction in the channel to increase shear stress. The brief period of increased shear stress resulted in ATP release within 25 to 75 milliseconds downstream of the constriction. The long-term goal of our research is to apply a similar approach to determine the dynamics of oxygen-dependent ATP release. In the place of the constriction, an oxygen permeable membrane would be used to decrease the hemoglobin oxygen saturation of erythrocytes flowing through the channel This paper describes the first stage in achieving that goal, the development of a computational model of the proposed experimental system to determine the feasibility of altering oxygen saturation rapidly enough to measure ATP release dynamics. The computational model was constructed based on hemodynamics, molecular transport of oxygen and ATP, kinetics of luciferin/luciferase reaction for reporting ATP concentrations, light absorption by hemoglobin, and sensor characteristics. A linear model of oxygen saturation-dependent ATP release with variable time delay was used in this study. The computational results demonstrate that a microfluidic device with a 100 gm deep channel will cause a rapid decrease in oxygen saturation over the oxygen permeable membrane that yields a measurable light intensity profile for a change in rate of ATP release from erythrocytes on a timescale as short as 25 milliseconds. The simulation also demonstrates that the complex dynamics of ATP release from erythrocytes combined with the consumption by luciferin/luciferase in a flowing system results in light intensity values that do not simply correlate with ATP concentrations. A computational model is required for proper interpretation of experimental data.	[Sove, Richard J.; Goldman, Daniel; Ellis, Christopher Gerald] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Ghonaim, Nour; Goldman, Daniel; Ellis, Christopher Gerald] Univ Western Ontario, Biomed Engn Grad Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Ellis, CG (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	cgellis@uwo.ca	Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013; Goldman, Daniel/CAF-8020-2022	Ellis, Christopher G/0000-0002-7760-1846; Goldman, Daniel/0000-0002-8707-5536	Canadian Institute of Health Research [MOP102504]; National Institute of Health [HL089125]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089125] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by the Canadian Institute of Health Research (MOP102504) and the National Institute of Health (HL089125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2008, AM J PHYSIOL-HEART C, V295, pH1562, DOI 10.1152/ajpheart.00261.2008; DELUCA M, 1974, BIOCHEMISTRY-US, V13, P921, DOI 10.1021/bi00702a015; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; ELLSWORTH ML, 1987, AM J PHYSIOL, V252, pH1031, DOI 10.1152/ajpheart.1987.252.5.H1031; Ellsworth ML, 2000, ACTA PHYSIOL SCAND, V168, P551, DOI 10.1046/j.1365-201x.2000.00708.x; Ghonaim NW, 2011, MICROCIRCULATION, V18, P646, DOI 10.1111/j.1549-8719.2011.00132.x; Goldman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00246; Hubley MJ, 1996, BBA-GEN SUBJECTS, V1291, P115, DOI 10.1016/0304-4165(96)00053-0; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Moyers-Gonzalez MA, 2010, BIORHEOLOGY, V47, P39, DOI 10.3233/BIR-2010-0558; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Salama K, 2004, BIOSENS BIOELECTRON, V19, P1377, DOI 10.1016/j.bios.2003.12.031; Sprague RS, 2011, AM J PHYSIOL-HEART C, V301, pH2466, DOI 10.1152/ajpheart.00729.2011; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Zhang W, 1996, J PHYS CHEM-US, V100, P9462, DOI 10.1021/jp960027y	16	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81537	10.1371/journal.pone.0081537	http://dx.doi.org/10.1371/journal.pone.0081537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312316	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100085
J	Medina-Rodriguez, EM; Arenzana, FJ; Bribian, A; de Castro, F				Maria Medina-Rodriguez, Eva; Javier Arenzana, Francisco; Bribian, Ana; de Castro, Fernando			Protocol to Isolate a Large Amount of Functional Oligodendrocyte Precursor Cells from the Cerebral Cortex of Adult Mice and Humans	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; GLIAL-CELLS; PROGENITOR CELLS; OPTIC-NERVE; ENSHEATHING CELLS; EMBRYONIC BRAIN; OLFACTORY-BULB; STEM-CELLS; DIFFERENTIATION	During development, oligodendrocytes are generated from oligodendrocyte precursor cells (OPCs), a cell type that is a significant proportion of the total cells (3-8%) in the adult central nervous system (CNS) of both rodents and humans. Adult OPCs are responsible for the spontaneous remyelination that occurs in demyelinating diseases like Multiple Sclerosis (MS) and they constitute an interesting source of cells for regenerative therapy in such conditions. However, there is little data regarding the neurobiology of adult OPCs isolated from mice since an efficient method to isolate them has yet to be established. We have designed a protocol to obtain viable adult OPCs from the cerebral cortex of different mouse strains and we have compared its efficiency with other well-known methods. In addition, we show that this protocol is also useful to isolate functional OPCs from human brain biopsies. Using this method we can isolate primary cortical OPCs in sufficient quantities so as to be able to study their survival, maturation and function, and to facilitate an evaluation of their utility in myelin repair.	[Maria Medina-Rodriguez, Eva; Javier Arenzana, Francisco; Bribian, Ana; de Castro, Fernando] Hosp Nacl Paraplejicos, Grp Neurobiol Desarrollo GNDe, Toledo, Spain	Hospital Nacional de Paraplejicos	de Castro, F (corresponding author), Hosp Nacl Paraplejicos, Grp Neurobiol Desarrollo GNDe, Toledo, Spain.	fdec@sescam.jccm.es	de Castro, Fernando/Q-8624-2018; Bribian, Ana/M-2978-2014	de Castro, Fernando/0000-0002-7018-8032; Medina-Rodriguez, Eva Maria/0000-0002-4893-1547	Spanish Ministerio de Economia y Competitividad-MINECO [SAF2009-07842, SAF2012-40023 ADE10-0010, RD07-0060-2007, RD12-0032-12]; F.E.D.E.R.-European Union "Una manera de hacer Europa"; MINECO FPI program [SAF2009-07842];  [ADE10-0010]	Spanish Ministerio de Economia y Competitividad-MINECO(Spanish Government); F.E.D.E.R.-European Union "Una manera de hacer Europa"; MINECO FPI program(Spanish Government); 	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad-MINECO (SAF2009-07842, SAF2012-40023 ADE10-0010, RD07-0060-2007, RD12-0032-12 -partially supported by F.E.D.E.R.-European Union "Una manera de hacer Europa" and the Fundacion Eugenio Rodriguez Pascual (Spain) to F.d.C. E.M.M.-R. is a recipient of a predoctoral fellowship from the MINECO FPI program (associated to SAF2009-07842). A. B. is hired by the ADE10-0010 grant and F.J.A by the SAF2009-07842 grant. F.d.C. is on contract to SESCAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2013, DRUGS, V73, P625, DOI 10.1007/s40265-013-0030-6; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Carpentier PA, 2008, VIROLOGY, V375, P24, DOI 10.1016/j.virol.2008.01.024; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Clemente D, 2011, J NEUROSCI, V31, P14899, DOI 10.1523/JNEUROSCI.1158-11.2011; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; de Castro F, 2013, CELL MOL LIFE SCI, V70, P4355, DOI 10.1007/s00018-013-1365-6; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dincman TA, 2012, J NEUROSCI METH, V209, P219, DOI 10.1016/j.jneumeth.2012.06.017; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Dubois-Dalcq M, 2008, BRAIN, V131, P1686, DOI 10.1093/brain/awn076; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Duncan ID, 2005, J INHERIT METAB DIS, V28, P357, DOI 10.1007/s10545-005-7058-z; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gonzalez-Amaro R, 2002, REV NEUROLOGIA, V35, P985, DOI 10.33588/rn.3510.2002379; Gruen L, 2006, STEM CELLS, V24, P2162, DOI 10.1634/stemcells.2006-0105; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lambertsen KL, 2002, J CEREBR BLOOD F MET, V22, P785, DOI 10.1097/00004647-200207000-00004; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Le Bras B, 2005, INT J DEV BIOL, V49, P209, DOI 10.1387/ijdb.041963bl; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Lubetzki C, 2005, CURR OPIN NEUROL, V18, P237, DOI 10.1097/01.wco.0000169739.83793.e0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Medina-Rodriguez EM, 2013, CELL MOL LIFE SCI, V70, P3449, DOI 10.1007/s00018-013-1340-2; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Noble M, 2013, CELL STEM CELL, V12, P503, DOI 10.1016/j.stem.2013.04.021; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; Qi YC, 2002, TRENDS NEUROSCI, V25, P223, DOI 10.1016/S0166-2236(02)02145-8; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; SATOH J, 1995, DEV NEUROSCI-BASEL, V17, P137, DOI 10.1159/000111282; Schauwecker PE, 2006, BRAIN RES, V1120, P83, DOI 10.1016/j.brainres.2006.08.086; Shi JY, 1998, J NEUROSCI, V18, P4627; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Spassky N, 2001, DEVELOPMENT, V128, P4993; Spassky N, 1998, J NEUROSCI, V18, P8331; Stangel M, 2002, PROG NEUROBIOL, V68, P361, DOI 10.1016/S0301-0082(02)00105-3; Staugaitis SM, 2009, NEURON GLIA BIOL, V5, P35, DOI 10.1017/S1740925X09990342; Sundberg M, 2010, STEM CELL RES, V5, P91, DOI 10.1016/j.scr.2010.04.005; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Targett MP, 1996, NEUROPATH APPL NEURO, V22, P199; Wang B, 2006, NEUROSCI LETT, V401, P65, DOI 10.1016/j.neulet.2006.02.085; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593	68	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81620	10.1371/journal.pone.0081620	http://dx.doi.org/10.1371/journal.pone.0081620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303061	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400077
J	Qiao, LY; Yu, SJ; Kay, JC; Xia, CM				Qiao, Li-Ya; Yu, Sharon J.; Kay, Jarren C.; Xia, Chun-Mei			In Vivo Regulation of Brain-Derived Neurotrophic Factor in Dorsal Root Ganglia Is Mediated by Nerve Growth Factor-Triggered Akt Activation during Cystitis	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; CHRONIC BLADDER INFLAMMATION; RAT MICTURITION PATHWAYS; FACTOR MESSENGER-RNA; PROTEIN-KINASE 5; UP-REGULATION; URINARY-BLADDER; SPINAL-CORD; PHOSPHATIDYLINOSITOL 3-KINASE	The role of brain-derived neurotrophic factor (BDNF) in sensory hypersensitivity has been suggested; however the molecular mechanisms and signal transduction that regulate BDNF expression in primary afferent neurons during visceral inflammation are not clear. Here we used a rat model of cystitis and found that the mRNA and protein levels of BDNF were increased in the L6 dorsal root ganglia (DRG) in response to bladder inflammation. BDNF up-regulation in the L6 DRG was triggered by endogenous nerve growth factor (NGF) because neutralization of NGF with a specific NGF antibody reduced BDNF levels during cystitis. The neutralizing NGF antibody also subsequently reduced cystitis-induced up-regulation of the serine/threonine kinase Akt activity in L6 DRG. To examine whether the NGF-induced Akt activation led to BDNF up-regulation in DRG in cystitis, we found that in cystitis the phospho-Akt immunoreactivity was co-localized with BDNF in L6 DRG, and prevention of the endogenous Akt activity in the L6 DRG by inhibition of phosphoinositide 3-kinase (PI3K) with a potent inhibitor LY294002 reversed cystitis-induced BDNF up-regulation. Further study showed that application of NGF to the nerve terminals of the ganglion-nerve two-compartmented preparation enhanced BDNF expression in the DRG neuronal soma; which was reduced by pretreatment of the ganglia with the PI3K inhibitor LY294002 and wortmannin. These in vivo and in vitro experiments indicated that NGF played an important role in the activation of Akt and subsequent up-regulation of BDNF in the sensory neurons in visceral inflammation such as cystitis.	[Qiao, Li-Ya; Yu, Sharon J.; Kay, Jarren C.; Xia, Chun-Mei] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA	Virginia Commonwealth University	Qiao, LY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lqiao2@vcu.edu			National Institutes of Health (NIH) [DK077917]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health (NIH) DK077917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Antunes-Lopes T, 2013, J UROLOGY, V189, P359, DOI 10.1016/j.juro.2012.08.187; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; Arms L, 2011, AM J PHYSIOL-RENAL, V301, pF252, DOI 10.1152/ajprenal.00556.2010; Berger RE, 2010, J UROLOGY, V183, P1404; Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Cao XH, 2012, J NEUROCHEM, V121, P944, DOI 10.1111/j.1471-4159.2012.07736.x; Chaban VV, 2008, ETHNIC DIS, V18; Chen J, 2013, NEUROSCIENCE, V248, P469, DOI 10.1016/j.neuroscience.2013.06.024; Chen XW, 2010, J NEUROSCI, V30, P2365, DOI 10.1523/JNEUROSCI.5462-09.2010; Chung CW, 2010, J BIOL CHEM, V285, P4206, DOI 10.1074/jbc.M109.040444; Cruz CD, 2005, EUR J NEUROSCI, V21, P773, DOI 10.1111/j.1460-9568.2005.03893.x; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Frias B, 2013, NEUROSCIENCE, V234, P88, DOI 10.1016/j.neuroscience.2012.12.044; Groth R, 2002, PAIN, V100, P171, DOI 10.1016/S0304-3959(02)00264-6; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Jacobs BL, 2010, CAN J UROL, V17, P4989; Kashiba H, 1997, NEUROREPORT, V8, P1229, DOI 10.1097/00001756-199703240-00034; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Lamb K, 2004, J PAIN, V5, P150, DOI 10.1016/j.jpain.2004.01.001; Li WP, 1999, NEUROSCI LETT, V260, P49, DOI 10.1016/S0304-3940(98)00958-6; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Matayoshi S, 2005, J PHYSIOL-LONDON, V569, P685, DOI 10.1113/jphysiol.2005.095331; Matsuoka Y, 2007, BIOCHEM BIOPH RES CO, V362, P682, DOI 10.1016/j.bbrc.2007.08.022; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-12; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Michael GJ, 1997, J NEUROSCI, V17, P8476; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Obata K, 2004, NEUROSCIENCE, V126, P1011, DOI 10.1016/j.neuroscience.2004.04.036; Obrietan K, 2002, J NEUROPHYSIOL, V88, P1005, DOI 10.1152/jn.2002.88.2.1005; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pezet S, 2008, J NEUROSCI, V28, P4261, DOI 10.1523/JNEUROSCI.5392-07.2008; Qiao LY, 2008, NEUROGASTROENT MOTIL, V20, P928, DOI 10.1111/j.1365-2982.2008.01119.x; Qiao LY, 2007, AM J PHYSIOL-REG I, V292, pR1368, DOI 10.1152/ajpregu.00570.2006; Qiao LY, 2010, PAIN, V151, P117, DOI 10.1016/j.pain.2010.06.029; Qiao LY, 2002, J COMP NEUROL, V454, P200, DOI 10.1002/cne.10447; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; Saini Rajiv, 2008, Curr Urol Rep, V9, P314, DOI 10.1007/s11934-008-0054-8; Salh B, 1998, J IMMUNOL, V161, P6947; Schuligoi R, 1998, BRIT J PHARMACOL, V125, P388, DOI 10.1038/sj.bjp.0702079; Seth JH, 2013, BJU INT, V111, P372, DOI 10.1111/j.1464-410X.2012.11672.x; Singer W, 2008, MOL PHARMACOL, V73, P1085, DOI 10.1124/mol.107.041814; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Theiss AL, 2004, INFLAMM BOWEL DIS, V10, P871, DOI 10.1097/00054725-200411000-00021; Uchida H, 2013, NEUROSCIENCE, V240, P147, DOI 10.1016/j.neuroscience.2013.02.053; Vizzard MA, 2001, J CHEM NEUROANAT, V21, P125, DOI 10.1016/S0891-0618(00)00115-0; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang LN, 2012, J NEUROSCI RES, V90, P1249, DOI 10.1002/jnr.22815; Watson FL, 2002, NAT NEUROSCI, V5, P1017, DOI 10.1038/nn1002-1017c; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Yang J, 2010, EUR J PAIN, V14, P574, DOI 10.1016/j.ejpain.2009.10.007; Yu SJ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-48; Yu SJ, 2012, EXP NEUROL, V238, P209, DOI 10.1016/j.expneurol.2012.08.007; Zhang QL, 2012, REGUL PEPTIDES, V177, P73, DOI 10.1016/j.regpep.2012.05.088; Zhou J, 2005, NEUROENDOCRINOLOGY, V81, P294, DOI 10.1159/000088448; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	68	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81547	10.1371/journal.pone.0081547	http://dx.doi.org/10.1371/journal.pone.0081547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303055	Green Published, gold			2022-12-25	WOS:000327546400071
J	Picatoste, B; Ramirez, E; Caro-Vadillo, A; Iborra, C; Egido, J; Tunon, J; Lorenzo, O				Picatoste, Belen; Ramirez, Elisa; Caro-Vadillo, Alicia; Iborra, Cristian; Egido, Jesus; Tunon, Jose; Lorenzo, Oscar			Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MYOCARDIAL-INFARCTION; DPP-4 INHIBITION; GENE-EXPRESSION; ACTIVATION; RECEPTOR; CELLS; IMPROVES; HEART; RAT	Background: Myocardial fibrosis is a key process in diabetic cardiomyopathy. However, their underlying mechanisms have not been elucidated, leading to a lack of therapy. The glucagon-like peptide-1 (GLP-1) enhancer, sitagliptin, reduces hyperglycemia but may also trigger direct effects on the heart. Methods: Goto-Kakizaki (GK) rats developed type-II diabetes and received sitagliptin, an anti-hyperglycemic drug (metformin) or vehicle (n=10, each). After cardiac structure and function assessment, plasma and left ventricles were isolated for biochemical studies. Cultured cardiomyocytes and fibroblasts were used for in vitro assays. Results: Untreated GK rats exhibited hyperglycemia, hyperlipidemia, plasma GLP-1 decrease, and cardiac cell-death, hypertrophy, fibrosis and prolonged deceleration time. Moreover, cardiac pro-apoptotic/necrotic, hypertrophic and fibrotic factors were up-regulated. Importantly, both sitagliptin and metformin lessened all these parameters. In cultured cardiomyocytes and cardiac fibroblasts, high-concentration of palmitate or glucose induced cell-death, hypertrophy and fibrosis. Interestingly, GLP-1 and its insulinotropic-inactive metabolite, GLP-1(9-36), alleviated these responses. In addition, despite a specific GLP-1 receptor was only detected in cardiomyocytes, GLP-1 isoforms attenuated the pro-fibrotic expression in cardiomyocytes and fibroblasts. In addition, GLP-1 receptor signalling may be linked to PPAR delta activation, and metformin may also exhibit anti-apoptotic/necrotic and anti-fibrotic direct effects in cardiac cells. Conclusions: Sitagliptin, via GLP-1 stabilization, promoted cardioprotection in type-II diabetic hearts primarily by limiting hyperglycemia e hyperlipidemia. However, GLP-1 and GLP-1(9-36) promoted survival and anti-hypertrophic/fibrotic effects on cultured cardiac cells, suggesting cell-autonomous cardioprotective actions.	[Picatoste, Belen; Ramirez, Elisa; Iborra, Cristian; Egido, Jesus; Tunon, Jose; Lorenzo, Oscar] Fdn Jimenez Diaz, Inst Invest Sanitarias, E-28040 Madrid, Spain; [Caro-Vadillo, Alicia] Univ Complutense Madrid, Sch Vet, Madrid, Spain	Fundacion Jimenez Diaz; Complutense University of Madrid	Lorenzo, O (corresponding author), Fdn Jimenez Diaz, Inst Invest Sanitarias, E-28040 Madrid, Spain.	olorenzo@fjd.es	Tuñón, José L/R-3037-2016; Lorenzo, Oscar/L-2526-2013; Tunon, Jose/ABA-8847-2020	Tuñón, José L/0000-0003-2220-180X; Lorenzo, Oscar/0000-0001-5515-6078; Tunon, Jose/0000-0002-1373-0999; Picatoste Botija, Maria Belen/0000-0001-5752-2051	Ministerio de Educacion y Ciencia [SAF2009-08367]; Comunidad de Madrid [CCG10-UAM/BIO-5289]; Merck/MSD	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Merck/MSD(Merck & Company)	This work was supported by national funding from Ministerio de Educacion y Ciencia (SAF2009-08367), Comunidad de Madrid (CCG10-UAM/BIO-5289), and a unrestricted grant from by Merck/MSD. These grants were used to provide consumables and animals required. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Ares-Carrasco S, 2012, J PROTEOMICS, V75, P1816, DOI 10.1016/j.jprot.2011.12.023; Ares-Carrasco S, 2009, AM J PHYSIOL-HEART C, V297, pH2109, DOI 10.1152/ajpheart.00157.2009; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chen S, 2000, J MOL CELL CARDIOL, V32, P1621, DOI 10.1006/jmcc.2000.1197; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cobble M, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-8; D'Souza A, 2011, EXP PHYSIOL, V96, P875, DOI 10.1113/expphysiol.2011.058271; Dhillon S, 2010, DRUGS, V70, P489, DOI 10.2165/11203790-000000000-00000; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Escudero Eduardo Manuel, 2004, Eur J Echocardiogr, V5, P169, DOI 10.1016/j.euje.2003.11.004; Fan SC, 2010, HORM METAB RES, V42, P637, DOI 10.1055/s-0030-1253373; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Hickson-Bick DLM, 2002, AM J PHYSIOL-HEART C, V282, pH656, DOI 10.1152/ajpheart.00726.2001; Hui HX, 2010, PANCREAS, V39, P315, DOI 10.1097/MPA.0b013e3181bc30dd; Ishibashi Y, 2011, HORM METAB RES, V43, P731, DOI 10.1055/s-0031-1284383; Ishibashi Y, 2012, MICROVASC RES, V84, P395, DOI 10.1016/j.mvr.2012.06.008; Kim HJ, 2009, CIRC RES, V105, P16, DOI 10.1161/CIRCRESAHA.108.189159; Lenski M, 2011, J MOL CELL CARDIOL, V51, P906, DOI 10.1016/j.yjmcc.2011.08.001; Lorell BH, 2000, CIRCULATION, V102, P470; Martin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041545; Mellitzer G, 2011, CURR OPIN LIPIDOL, V22, P171, DOI 10.1097/MOL.0b013e32834622a2; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Mizushige K, 2000, CIRCULATION, V101, P899, DOI 10.1161/01.CIR.101.8.899; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Mudaliar S, 2012, DIABETOLOGIA, V55, P1865, DOI 10.1007/s00125-012-2561-x; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okerson T, 2010, CARDIOVASC THER; ORSKOV C, 1987, SCAND J CLIN LAB INV, V47, P165; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Ravassa S, 2011, AM J PHYSIOL-HEART C, V300, pH1361, DOI 10.1152/ajpheart.00885.2010; Read PA, 2010, CIRC-CARDIOVASC IMAG, V3, P195, DOI 10.1161/CIRCIMAGING.109.899377; REGAN TJ, 1983, ANNU REV MED, V34, P161, DOI 10.1146/annurev.me.34.020183.001113; Rendell M, 2012, EXPERT OPIN PHARMACO, V13, P553, DOI 10.1517/14656566.2012.656088; Rosenstock J, 2008, DIABETES OBES METAB, V10, P376, DOI 10.1111/j.1463-1326.2008.00876.x; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tahara A, 2009, PHARMACOL REP, V61, P899, DOI 10.1016/S1734-1140(09)70147-1; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang XF, 2011, CHINESE MED J-PEKING, V124, P1876, DOI 10.3760/cma.j.issn.0366-6999.2011.12.020; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Ye YM, 2010, AM J PHYSIOL-HEART C, V298, pH1454, DOI 10.1152/ajpheart.00867.2009; Zhang HJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P25, DOI 10.1016/j.abb.2007.01.028	55	71	75	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78330	10.1371/journal.pone.0078330	http://dx.doi.org/10.1371/journal.pone.0078330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24302978	gold, Green Published			2022-12-25	WOS:000326032600096
J	Kang, Z; Yu, Y; Zhu, YJ; Davis, S; Walker, R; Meltzer, PS; Helman, LJ; Cao, L				Kang, Z.; Yu, Y.; Zhu, Y. J.; Davis, S.; Walker, R.; Meltzer, P. S.; Helman, L. J.; Cao, L.			Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma	ONCOGENE			English	Article						IGF1R; IGFBP2; rhabdomyosarcoma; antibody therapy; drug resistance; drug combination	GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-2; FACTOR RECEPTOR INHIBITORS; CHILDRENS ONCOLOGY GROUP; PHASE-II; CANDIDATE BIOMARKER; MONOCLONAL-ANTIBODY; PROSTATE-CANCER; INSULIN; TARGET	Agents targeting the insulin-like growth factor-1 receptor (IGF1R) are in clinical development, but, despite some initial success of single agents in sarcoma, response rates are low with brief durations. Thus, it is important to identify markers predictive of response, to understand mechanisms of resistance, and to explore combination therapies. In this study, we found that, although associated with PAX3-FKHR translocation, increased IGF1R level is an independent prognostic marker for worse overall survival, particularly in patients with PAX3-FKHR-positive rhabdomyosarcoma (RMS). IGF1R antibody-resistant RMS cells were generated using an in vivo model. Expression analysis indicated that IGFBP2 is both the most affected gene in the insulin-like growth factor (IGF) signaling pathway and the most significantly downregulated gene in the resistant lines, indicating that there is a strong selection to repress IGFBP2 expression in tumor cells resistant to IGF1R antibody. IGFBP2 is inhibitory to IGF1R phosphorylation and its signaling. Similar to antibodies to IGF1/2 or IGF2, the addition of exogenous IGFBP2 potentiates the activity of IGF1R antibody against the RMS cells, and it reverses the resistance to IGF1R antibody. In contrast to IGF1R, lower expression of IGFBP2 is associated with poorer overall survival, consistent with its inhibitory activity found in this study. Finally, blocking downstream Protein kinase B (AKT) activation with Phosphatidylinositide 3-kinases (PI3K)- or mammalian target of rapamycin (mTOR)-specific inhibitors significantly sensitized the resistant cells to the IGF1R antibody. These findings show that constitutive IGFBP2 downregulation may represent a novel mechanism for acquired resistance to IGF1R therapeutic antibody in vivo and suggest various drug combinations to enhance antibody activity and to overcome resistance.	[Kang, Z.; Yu, Y.; Zhu, Y. J.; Davis, S.; Walker, R.; Meltzer, P. S.; Cao, L.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kang, Z.] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick, MD USA; [Helman, L. J.] NCI, Ctr Canc Res, Pediatr Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cao, L (corresponding author), NCI, Genet Branch, 37 Convent Dr,MSC 4265, Bethesda, MD 20892 USA.	caoli@mail.nih.gov	Davis, Sean/AAD-1801-2021; Cao, Liang/K-7806-2017	Davis, Sean/0000-0002-8991-6458; Kang, zhigang/0000-0003-3444-4315; Walker, Robert/0000-0001-8235-4686; Cao, Liang/0000-0001-7293-8338	Intramural Research Program of the US National Cancer Institute (NCI); NCI; NIH [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZICBC011048] Funding Source: NIH RePORTER	Intramural Research Program of the US National Cancer Institute (NCI); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Cancer Institute (NCI). This project was also funded in part with federal funds from the NCI, NIH, under contract N01-CO-12400.	Arai T, 1996, ENDOCRINOLOGY, V137, P4571, DOI 10.1210/en.137.11.4571; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Bhat RV, 1997, J PHARMACOL EXP THER, V281, P522; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Crist WM, 2001, J CLIN ONCOL, V19, P3091, DOI 10.1200/JCO.2001.19.12.3091; Davicioni E, 2010, J CLIN ONCOL, V28, P1240, DOI 10.1200/JCO.2008.21.1268; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hendrickson AW, 2009, CURR OPIN INVEST DR, V10, P1032; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Hoeflich A, 2001, CANCER RES, V61, P8601; Hoflich A, 1998, FEBS LETT, V434, P329, DOI 10.1016/S0014-5793(98)01011-4; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Martin JL, 2007, ENDOCRINOLOGY, V148, P2532, DOI 10.1210/en.2006-1335; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; Mayeenuddin LH, 2010, ONCOGENE, V29, P6367, DOI 10.1038/onc.2010.364; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Moore LM, 2009, P NATL ACAD SCI USA, V106, P16675, DOI 10.1073/pnas.0900807106; Olmos D, 2010, MOL CANCER THER, V9, P2447, DOI 10.1158/1535-7163.MCT-10-0719; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Reidy DL, 2010, J CLIN ONCOL, V28, P4240, DOI 10.1200/JCO.2010.30.4154; Shariat SF, 2002, J CLIN ONCOL, V20, P833, DOI 10.1200/JCO.20.3.833; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	43	18	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5697	5705		10.1038/onc.2013.509	http://dx.doi.org/10.1038/onc.2013.509			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24292683	Green Accepted			2022-12-25	WOS:000346089300005
J	Chandrashekran, A; Sarkar, R; Thrasher, A; Fraser, SE; Dibb, N; Casimir, C; Winston, R; Readhead, C				Chandrashekran, Anil; Sarkar, Rupa; Thrasher, Adrian; Fraser, Scott E.; Dibb, Nicholas; Casimir, Colin; Winston, Robert; Readhead, Carol			Efficient generation of transgenic mice by lentivirus-mediated modification of spermatozoa	FASEB JOURNAL			English	Article						lentiviral vectors; transgenesis; male germ cells; in vitro fertilization	C-KIT RECEPTOR; RETROVIRAL TRANSDUCTION; STEM-CELLS; GENE-TRANSFER; VECTORS; TRANSMISSION; EXPRESSION; INTEGRATION; PROTEINS; HIV-1	Transgenic technologies conventionally rely on the oocyte as a substrate for genetic modification. Owing to their accessibility, however, male germ cells, including mature sperm, have material advantages for use in transgenesis. Here we have exploited lentiviruses to generate transgenic animals via the male germline. When pseudotyped lentiviral vectors encoding green fluorescent protein (GFP) were incubated with mouse spermatozoa, these sperm were highly successful in producing transgenics. Lentivirally transduced mouse spermatozoa were used in in vitro fertilization (IVF) studies, and when followed by embryo transfer, 42% of founders were found to be transgenic for GFP. Inverse PCR strategy for integration site analysis demonstrated integration of at least 1 or 2 copies of GFP in the transgenics, mapping to different chromosomes. GFP expression was detected in a wide range of murine tissues, including testis and the transgene was stably transmitted to a third generation of transgenic animals. This relatively simple, yet highly efficient, technique for generating transgenic animals by transducing spermatozoa with lentiviral vectors in vitro is a powerful tool for the study of fertilization/preimplantation development, vertical viral gene transmission, gene function and regulation, and epigenetic inheritance.Chandrashekran, A., Sarkar, R., Thrasher, A., Fraser, S. E., Dibb, N., Casimir, C., Readhead, C., Winston, R. Efficient generation of transgenic mice by lentivirus-mediated modification of spermatozoa.	[Chandrashekran, Anil; Sarkar, Rupa; Dibb, Nicholas; Winston, Robert] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Dept Surg & Canc, Div Canc, London, England; [Thrasher, Adrian] UCL, Inst Child Hlth, Mol Immunol Unit, London, England; [Fraser, Scott E.; Readhead, Carol] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Casimir, Colin] Middlesex Univ, Sch Sci & Technol, Dept Nat Sci, London N17 8HR, England	Imperial College London; University of London; University College London; California Institute of Technology; Middlesex University	Chandrashekran, A (corresponding author), Royal Vet Coll, Dept Vet Clin Sci, Hawkshead Ln, N Mymms AL9 7TA, England.	achandrashekran@rvc.ac.uk	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Sarkar, Rupa/0000-0003-0014-2239; Chandrashekran, Anil/0000-0002-7037-7693	Institute of Obstetrics and Gynaecology Trust; London, UK; Atazoa Ltd. (London, UK); Genesis Research Trust; UK Biotechnology and Biological Resources Research Council	Institute of Obstetrics and Gynaecology Trust; London, UK; Atazoa Ltd. (London, UK); Genesis Research Trust; UK Biotechnology and Biological Resources Research Council	The authors thank Malcolm Parker and Ilpo Huhtaniemi (Imperial College London) for critically reading the manuscript. The authors also thank Aura Keeter, Natasha Bouey, and Joaquin Gutierrez (California Institute of Technology), and Ihsan Isa (Imperial College London), for their dedicated technical assistance; and Naveenan Navaratnam and Geok Chin Tan (Imperial College London) for helpful discussion and support. The authors thank Amy Cutler and Zoe Webster (Transgenic and Embryonic Stem Cell Laboratory, Medical Research Council-Clinical Sciences Centre, London, UK) for assistance with IVF followed by embryo transfer to obtain transgenic animals, and their maintenance and welfare. The authors thank Luigi Naldini [San Raffaele Telethon Institute for Gene Therapy (TIGET), San Raffaele Scientific Institute, Milan, Italy] for providing the PGK-GFP encoded lentiviral vector and Rusty Landsford (California Institute of Technology, Pasadena, CA, USA) for the vectors containing H2Bcherry reporters. This work was supported by Atazoa Ltd. (London, UK) and by the Genesis Research Trust (previously known as the Institute of Obstetrics and Gynaecology Trust; London, UK). R.S. was supported by a Case Ph. D. studentship from the UK Biotechnology and Biological Resources Research Council. Author contributions: A. C. and C. R. designed and performed experiments and analyzed the data; R. S. performed experiments; C. C., S.E.F., A.T., N.D., and R.W. contributed reagents, lent support and advice on experiments, and contributed to the writing and editing of the manuscript; A.C. and C.R. wrote the manuscript. R.W. and C.R. are joint senior authors. Conflicts of interest: C.R., N.D., and R. W. are directors of a commercial enterprise, Atazoa Ltd., which hopes to exploit novel techniques for animal transgenesis. A.C. is a former employee of Atazoa Ltd.	Baccetti B, 1999, J ACQ IMMUN DEF SYND, V21, P355; Baup D, 2010, TRANSGENIC RES, V19, P399, DOI 10.1007/s11248-009-9318-4; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Chandrashekran A, 2004, J GENE MED, V6, P1189, DOI 10.1002/jgm.625; Chandrashekran A, 2004, BLOOD, V104, P2697, DOI 10.1182/blood-2003-10-3717; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; Dufait I., 2012, SCIENTIFICA CAIRO, V2012, DOI 10.6064/2012/694137; Emeagi PU, 2013, CURR MOL MED, V13, P602; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Feng HL, 1998, MOL REPROD DEV, V49, P317, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;317::AID-MRD12&gt;3.0.CO;2-T; Galimi F, 2002, CURR TOP MICROBIOL, V261, P245; GORDON JW, 1983, METHOD ENZYMOL, V101, P411; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Hiripi L, 2010, TRANSGENIC RES, V19, P799, DOI 10.1007/s11248-009-9356-y; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Honaramooz A, 2008, FASEB J, V22, P374, DOI 10.1096/fj.07-8935com; Howe Steven J, 2012, Methods Mol Biol, V891, P85, DOI 10.1007/978-1-61779-873-3_5; Kanatsu-Shinohara M, 2004, BIOL REPROD, V71, P1202, DOI 10.1095/biolreprod.104.031294; Landazuri N, 2006, BIOTECHNOL BIOENG, V93, P146, DOI 10.1002/bit.20697; Li C, 2010, BIOL REPROD, V82, P331, DOI 10.1095/biolreprod.109.078501; Liechtenstein T, 2013, VIRUS RES, V176, P1, DOI 10.1016/j.virusres.2013.05.007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Michalkiewicz M, 2007, AM J PHYSIOL-HEART C, V293, pH881, DOI 10.1152/ajpheart.00060.2007; Monne M, 2011, BIOL REPROD, V85, P661, DOI 10.1095/biolreprod.111.092098; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Prather RS, 2007, ADV EXP MED BIOL, V591, P1; Sandlow JI, 1997, UROLOGY, V49, P494, DOI 10.1016/S0090-4295(96)00494-3; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sato Y., 2010, PLOS ONE, V5; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sehgal L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021975; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Smolenski RT, 2007, CARDIOVASC RES, V73, P143, DOI 10.1016/j.cardiores.2006.10.027; Watson Deborah J, 2004, Methods Mol Biol, V246, P413; Zhang Y., 2012, PLOS ONE, V7; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	39	14	14	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					569	576		10.1096/fj.13-233999	http://dx.doi.org/10.1096/fj.13-233999			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24297703				2022-12-25	WOS:000331072200005
J	Esquivies, L; Blackler, A; Peran, M; Rodriguez-Esteban, C; Izpisua Belmonte, JC; Booker, E; Gray, PC; Ahn, C; Kwiatkowski, W; Choe, S				Esquivies, Luis; Blackler, Alissa; Peran, Macarena; Rodriguez-Esteban, Concepcion; Izpisua Belmonte, Juan Carlos; Booker, Evan; Gray, Peter C.; Ahn, Chihoon; Kwiatkowski, Witek; Choe, Senyon			Designer Nodal/BMP2 Chimeras Mimic Nodal Signaling, Promote Chondrogenesis, and Reveal a BMP2-like Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Cartilage Biology; Chondrogenesis; Protein Chimeras; Protein Structure; Nodal	STEM-CELLS; ACTIVIN-A; CRIPTO; BONE; DIFFERENTIATION; BETA	Background: Nodal is a TGF- superfamily member that plays important roles in development and diseases but is difficult to produce for biochemical studies. Results: Nodal promotes chondrogenesis, and Nodal/bone morphogenetic protein 2 chimeras function indistinguishably from Nodal but have BMP2-like structure. Conclusion: Nodal/BMP2 chimeras can substitute for Nodal in functional and structural studies. Significance: Nodal/BMP2 chimeras have therapeutic potential. Nodal, a member of the TGF- superfamily, plays an important role in vertebrate and invertebrate early development. The biochemical study of Nodal and its signaling pathway has been a challenge, mainly because of difficulties in producing the protein in sufficient quantities. We have developed a library of stable, chemically refoldable Nodal/BMP2 chimeric ligands (NB2 library). Three chimeras, named NB250, NB260, and NB264, show Nodal-like signaling properties including dependence on the co-receptor Cripto and activation of the Smad2 pathway. NB250, like Nodal, alters heart looping during the establishment of embryonic left-right asymmetry, and both NB250 and NB260, as well as Nodal, induce chondrogenic differentiation of human adipose-derived stem cells. This Nodal-induced differentiation is shown to be more efficient than BPM2-induced differentiation. Interestingly, the crystal structure of NB250 shows a backbone scaffold similar to that of BMP2. Our results show that these chimeric ligands may have therapeutic implications in cartilage injuries.	[Esquivies, Luis; Kwiatkowski, Witek; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Blackler, Alissa; Booker, Evan; Gray, Peter C.; Choe, Senyon] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Peran, Macarena; Rodriguez-Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Peran, Macarena] Univ Jaen, Dept Hlth Sci, Jaen 23071, Spain; [Ahn, Chihoon] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 350333, South Korea; [Ahn, Chihoon; Choe, Senyon] Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Res Inst, Inchon 406840, South Korea	Salk Institute; Salk Institute; Salk Institute; Universidad de Jaen; Gachon University	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	choe@salk.edu	Peran, Macarena/I-5225-2016	Peran, Macarena/0000-0001-7562-2347	Jesse and Caryl Phillips Foundation Graduate Student Endowment; Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i); Clayton Medical Research Foundation, Inc.; Cancer Center [P30 CA014195-38]; World Class University [R32-10215]; Incheon Free Economy Zone of Korea; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Jesse and Caryl Phillips Foundation Graduate Student Endowment; Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i); Clayton Medical Research Foundation, Inc.; Cancer Center; World Class University; Incheon Free Economy Zone of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Jesse and Caryl Phillips Foundation Graduate Student Endowment.; Supported first by the Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i) and continued with a grant from Jaen University.; Supported by the Clayton Medical Research Foundation, Inc. and Cancer Center Core Grant P30 CA014195-38.; Supported by World Class University Program Grant R32-10215 and the Incheon Free Economy Zone of Korea (joint Center for Biosciences).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Allendorph GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026402; Calvanese L, 2010, BIOPOLYMERS, V93, P1011, DOI 10.1002/bip.21517; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; JIANG TX, 1993, DEV BIOL, V155, P545, DOI 10.1006/dbio.1993.1051; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Merino R, 1999, DEVELOPMENT, V126, P2161; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Peran M, 2013, STEM CELL RES, V10, P464, DOI 10.1016/j.scr.2013.02.002; RIVIER C, 1991, ENDOCRINOLOGY, V129, P2463, DOI 10.1210/endo-129-5-2463; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	27	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1788	1797		10.1074/jbc.M113.529180	http://dx.doi.org/10.1074/jbc.M113.529180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24311780	hybrid, Green Published			2022-12-25	WOS:000332401700049
J	Guo, L; Ding, JJ; Guo, R; Hou, YJ; Wang, DC; Huang, L				Guo, Li; Ding, Jingjin; Guo, Rong; Hou, Yanjie; Wang, Da-Cheng; Huang, Li			Biochemical and Structural Insights into RNA Binding by Ssh10b, a Member of the Highly Conserved Sac10b Protein Family in Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Crystal Structure; RNA-binding Protein; RNA Structure; RNA-Protein Interaction; Sac10b Family; Ssh10b; Sulfolobus shibatae	INITIATION-FACTOR 3; TRANSLATION INITIATION; CHROMATIN PROTEIN; MESSENGER-RNAS; CRYSTAL-STRUCTURE; DNA; ALBA; LEADERLESS; SIR2; S1	Background: Proteins of the Sac10b family are widespread in Archaea. Results: Ssh10b, a member of the Sac10b family from Sulfolobus shibatae, disrupts base pairing in structured RNA through interactions between adjacently bound protein dimers. Conclusion: Binding by Ssh10b destabilizes RNA secondary structure. Significance: Proteins of the Sac10b family may play a role in RNA transactions requiring destabilization of RNA secondary structure. Proteins of the Sac10b family are highly conserved in Archaea. Ssh10b, a member of the Sac10b family from the hyperthermophilic crenarchaeon Sulfolobus shibatae, binds to RNA in vivo. Here we show that binding by Ssh10b destabilizes RNA secondary structure. Structural analysis of Ssh10b in complex with a 25-bp RNA duplex containing local distortions reveals that Ssh10b binds the two RNA strands symmetrically as a tetramer with each dimer bound asymmetrically to a single RNA strand. Amino acid residues involved in double-stranded RNA binding are similar, but non-identical, to those in dsDNA binding. The dimer-dimer interaction mediated by the intermolecular -sheet appears to facilitate the destabilization of base pairing in the secondary structure of RNA. Our results suggest that proteins of the Sac10b family may play important roles in RNA transactions requiring destabilization of RNA secondary structure in Sulfolobus.	[Guo, Li; Guo, Rong; Huang, Li] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Ding, Jingjin; Hou, Yanjie; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, DC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn; huangl@sun.im.ac.cn		Ding, Jingjin/0000-0001-9941-7997	Photon Factory (High Energy Accelerator Research Organization, Tsukuba, Japan) [2011G044]	Photon Factory (High Energy Accelerator Research Organization, Tsukuba, Japan)	We thank the staff at beamline 17A of the Photon Factory (Grant 2011G044, High Energy Accelerator Research Organization, Tsukuba, Japan) for technical assistance during data collection.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Benelli D, 2003, MOL MICROBIOL, V50, P635, DOI 10.1046/j.1365-2958.2003.03721.x; Bini E, 2002, RNA, V8, P1129, DOI 10.1017/S1355838202021052; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; FORTERRE P, 1995, CR ACAD SCI III-VIE, V318, P415; Gissot M, 2013, J MOL BIOL, V425, P1287, DOI 10.1016/j.jmb.2013.01.039; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Heinicke I, 2004, MOL GENET GENOMICS, V272, P76, DOI 10.1007/s00438-004-1033-5; HILBERS CW, 1985, BIOCHIMIE, V67, P685, DOI 10.1016/S0300-9084(85)80156-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; KOLB A, 1977, P NATL ACAD SCI USA, V74, P2379, DOI 10.1073/pnas.74.6.2379; KUCHINO Y, 1989, METHOD ENZYMOL, V180, P154; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Liu Y., 2011, PLOS ONE, V6; Liu Y, 2009, J BACTERIOL, V191, P2315, DOI 10.1128/JB.01534-08; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Mani J, 2011, PLOS ONE, V6; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Moll I, 1998, FEBS LETT, V436, P213, DOI 10.1016/S0014-5793(98)01131-4; Petrelli D, 2003, J MOL BIOL, V331, P541, DOI 10.1016/S0022-2836(03)00731-9; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Tanaka T, 2012, J BIOL CHEM, V287, P10394, DOI 10.1074/jbc.M112.343210; Tedin K, 1997, MOL MICROBIOL, V25, P189, DOI 10.1046/j.1365-2958.1997.4421810.x; Tedin K, 1999, MOL MICROBIOL, V31, P67, DOI 10.1046/j.1365-2958.1999.01147.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6; Wilce J, 2012, ADV EXP MED BIOL, V747, P91, DOI 10.1007/978-1-4614-3229-6_6; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	54	16	17	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1478	1490		10.1074/jbc.M113.521351	http://dx.doi.org/10.1074/jbc.M113.521351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307170	Green Published, hybrid			2022-12-25	WOS:000332401700024
J	Neacsu, CD; Ko, YP; Tagariello, A; Karlsen, KR; Neiss, WF; Paulsson, M; Wagener, R				Neacsu, Cristian Dan; Ko, Ya-Ping; Tagariello, Andreas; Karlsen, Kristina Rokenes; Neiss, Wolfram Friedrich; Paulsson, Mats; Wagener, Raimund			Matrilin-1 Is Essential for Zebrafish Development by Facilitating Collagen II Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Collagen; Extracellular Matrix Proteins; Secretion; Zebrafish; Collagen II; Matrilin-1	EXTRACELLULAR-MATRIX PROTEINS; MICE LACKING; CHONDROCYTE MATURATION; CHONDROITIN SULFATE; AMINO-PROPEPTIDE; SITE-1 PROTEASE; IX COLLAGEN; CARTILAGE; PROCOLLAGEN; EXPRESSION	Background: Matrilin-1 is an abundant cartilage extracellular matrix protein. Results: Morpholino knockdown of matrilin-1 in zebrafish results in growth defects, disturbed craniofacial cartilage formation, and decreased collagen II deposition. Conclusion: Matrilin-1 is indispensible for zebrafish development, presumably by facilitating secretion of collagen II. Significance: These results challenge the concept that matrilins only function as extracellular adaptor proteins. Matrilin-1 is the prototypical member of the matrilin protein family and is highly expressed in cartilage. However, gene targeting of matrilin-1 in mouse did not lead to pronounced phenotypes. Here we used the zebrafish as an alternative model to study matrilin function in vivo. Matrilin-1 displays a multiphasic expression during zebrafish development. In an early phase, with peak expression at about 15 h post-fertilization, matrilin-1 is present throughout the zebrafish embryo with exception of the notochord. Later, when the skeleton develops, matrilin-1 is expressed mainly in cartilage. Morpholino knockdown of matrilin-1 results both in overall growth defects and in disturbances in the formation of the craniofacial cartilage, most prominently loss of collagen II deposition. In fish with mild phenotypes, certain cartilage extracellular matrix components were present, but the tissue did not show features characteristic for cartilage. The cells showed endoplasmic reticulum aberrations but no activation of XBP-1, a marker for endoplasmic reticulum stress. In severe phenotypes nearly all chondrocytes died. During the early expression phase the matrilin-1 knockdown had no effects on cell morphology, but increased cell death was observed. In addition, the broad deposition of collagen II was largely abolished. Interestingly, the early phenotype could be rescued by the co-injection of mRNA coding for the von Willebrand factor C domain of collagen II1a, indicating that the functional loss of this domain occurs as a consequence of matrilin-1 deficiency. The results show that matrilin-1 is indispensible for zebrafish cartilage formation and plays a role in the early collagen II-dependent developmental events.	[Neacsu, Cristian Dan; Ko, Ya-Ping; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Tagariello, Andreas] Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [Karlsen, Kristina Rokenes; Neiss, Wolfram Friedrich] Univ Cologne, Dept Anat 1, D-50924 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Erlangen Nuremberg; University of Cologne	Wagener, R (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de			Deutsche Forschungsgemeinschaft [WA1338/2-6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant WA1338/2-6 (to R. W. and M. P.).	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Baas D, 2009, MATRIX BIOL, V28, P490, DOI 10.1016/j.matbio.2009.07.004; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; FRENCH SW, 1972, EXP MOL PATHOL, V16, P16, DOI 10.1016/0014-4800(72)90017-2; Fresquet M, 2010, J BIOL CHEM, V285, P34048, DOI 10.1074/jbc.M110.154443; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Huang CC, 2009, DEV BIOL, V332, P360, DOI 10.1016/j.ydbio.2009.06.003; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; IRWIN MH, 1985, J CELL BIOL, V101, P814, DOI 10.1083/jcb.101.3.814; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Ko YP, 2004, MOL CELL BIOL, V24, P1691, DOI 10.1128/MCB.24.4.1691-1699.2004; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lele Z, 1997, MECH DEVELOP, V61, P89, DOI 10.1016/S0925-4773(96)00626-0; Leung AWL, 2010, DEV DYNAM, V239, P2319, DOI 10.1002/dvdy.22366; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; Mates L, 2004, MATRIX BIOL, V23, P195, DOI 10.1016/j.matbio.2004.05.003; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Weston J A, 1970, Adv Morphog, V8, P41; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	58	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1505	1518		10.1074/jbc.M113.529933	http://dx.doi.org/10.1074/jbc.M113.529933			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293366	Green Published, hybrid			2022-12-25	WOS:000332401700026
J	Cenit, MC; Marquez, A; Cordero-Coma, M; Gorrono-Echebarria, MB; Fonollose, A; Adan, A; Martinez-Berriotxoa, A; Valle, DD; Pato, E; Blanco, R; Canal, J; Diaz-Llopis, M; Serrano, JLG; de Ramon, E; del Rio, MJ; Martin-Villa, JM; Molins, B; Ortego-Centeno, N; Martin, J				Carmen Cenit, Maria; Marquez, Ana; Cordero-Coma, Miguel; Begona Gorrono-Echebarria, Marina; Fonollose, Alejandro; Adan, Alfredo; Martinez-Berriotxoa, Agustin; Diaz Valle, David; Pato, Esperanza; Blanco, Ricardo; Canal, Joaquin; Diaz-Llopis, Manuel; Garcia Serrano, Jose Luis; de Ramon, Enrique; Jose del Rio, Maria; Martin-Villa, Jose Manuel; Molins, Blanca; Ortego-Centeno, Norberto; Martin, Javier			No Evidence of Association between Common Autoimmunity STAT4 and IL23R Risk Polymorphisms and Non-Anterior Uveitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHINESE HAN POPULATION; BEHCETS-DISEASE; SUSCEPTIBILITY LOCI; RHEUMATOID-ARTHRITIS; T-CELLS; GENE; IL23R-IL12RB2; VARIANTS	Objective: STAT4 and IL23R loci represent common susceptibility genetic factors in autoimmunity. We decided to investigate for the first time the possible role of different STAT4/IL23R autoimmune disease-associated polymorphisms on the susceptibility to develop non-anterior uveitis and its main clinical phenotypes. Methods: Four functional polymorphisms (rs3821236, rs7574865, rs7574070, and rs897200) located within STAT4 gene as well as three independent polymorphisms (rs7517847, rs11209026, and rs1495965) located within IL23R were genotyped using TaqMan (R) allelic discrimination in a total of 206 patients with non-anterior uveitis and 1553 healthy controls from Spain. Results: No statistically significant differences were found when allele and genotype distributions were compared between non-anterior uveitis patients and controls for any STAT4 (rs3821236: P=0.39, OR=1.12, CI 95%=0.87-1.43; rs7574865: P=0.59 OR=1.07, CI 95%=0.84-1.37; rs7574070: P=0.26, OR=0.89, CI 95%=0.72-1.10; rs897200: P=0.22, OR=0.88, CI 95%=0.71-1.08;) or IL23R polymorphisms (rs7517847: P=0.49, OR=1.08, CI 95%=0.87-1.33; rs11209026: P=0.26, OR=0.78, CI 95%=0.51-1.21; rs1495965: P=0.51, OR=0.93, CI 95%=0.76-1.15). Conclusion: Our results do not support a relevant role, similar to that described for other autoimmune diseases, of IL23R and STAT4 polymorphisms in the non-anterior uveitis genetic predisposition. Further studies are needed to discard a possible weak effect of the studied variant.	[Carmen Cenit, Maria; Marquez, Ana; Martin, Javier] CSIC, IPBLN, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Cordero-Coma, Miguel] Hosp Leon, Dept Ophthalmol, Leon, Spain; [Begona Gorrono-Echebarria, Marina] Hosp Univ Principe Asturias, Dept Ophthalmol, Alcala De Henares, Spain; [Fonollose, Alejandro; Martinez-Berriotxoa, Agustin] Hosp Cruces, Dept Internal Med, Bilbao, Spain; [Adan, Alfredo; Molins, Blanca] Hosp Clin Barcelona, Dept Ophthalmol, Barcelona, Spain; [Diaz Valle, David] Hosp Clin San Carlos, Dept Ophthalmol, Madrid, Spain; [Pato, Esperanza] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Blanco, Ricardo] Hosp Marques Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Canal, Joaquin] Hosp Marques Valdecilla, Dept Ophthalmol, Santander, Spain; [Diaz-Llopis, Manuel] Hosp Univ La Fe, Dept Ophthalmol, Valencia, Spain; [Garcia Serrano, Jose Luis] Hosp Clin San Cecilio, Dept Ophthalmol, Granada, Spain; [de Ramon, Enrique] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Jose del Rio, Maria] Hosp Carlos Haya, Dept Ophthalmol, Malaga, Spain; [Martin-Villa, Jose Manuel] Univ Complutense Madrid, Fac Med, Dept Immunol, Madrid, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universidad de Leon; Hospital de Leon; Prince of Asturias University Hospital; Hospital Universitario Cruces; University of Barcelona; Hospital Clinic de Barcelona; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitari i Politecnic La Fe; Hospital Universitario San Cecilio; Hospital Carlos Haya; Hospital Carlos Haya; Complutense University of Madrid; Hospital Universitario San Cecilio	Marquez, A (corresponding author), CSIC, IPBLN, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	anamaort@ipb.csic.es	Martín, Javier/AAV-5209-2021; Martín, María/HDL-9512-2022; Centeno, Norberto Ortego/C-4793-2019; Martin-Villa, Jose M./K-2522-2019; Martin-Villa, Jose M. M/F-9234-2013; Martin, Javier/B-8141-2008; blanco, ricardo/AAA-1248-2020; Cenit, Maria Carmen MC/E-9538-2017	Centeno, Norberto Ortego/0000-0003-2325-0937; Martin-Villa, Jose M./0000-0002-2436-8585; Martin-Villa, Jose M. M/0000-0002-2436-8585; Martin, Javier/0000-0002-2202-0622; blanco, ricardo/0000-0003-2344-2285; Cenit, Maria Carmen MC/0000-0001-8667-5313; Gorrono Echebarria, Marina Begona/0000-0003-2805-9664; Adan, Alfredo/0000-0002-0849-8814; Marquez, Ana/0000-0001-9913-7688; DIAZ VALLE, DAVID/0000-0003-4450-7471				Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94; Atan D, 2010, INVEST OPHTH VIS SCI, V51, P4133, DOI 10.1167/iovs.09-4583; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen Y, 2004, TISSUE ANTIGENS, V63, P41, DOI 10.1111/j.1399-0039.2004.00150.x; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Deschenes J, 2008, OCUL IMMUNOL INFLAMM, V16, P1, DOI 10.1080/09273940801899822; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Kim HS, 2011, DIS MARKERS, V31, P17, DOI [10.1155/2011/185106, 10.3233/DMA-2011-0796]; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; LEHOANG P, 1992, AM J OPHTHALMOL, V113, P33, DOI 10.1016/S0002-9394(14)75749-6; Levy RA, 2011, CLIN REV ALLERG IMMU, V41, P214, DOI 10.1007/s12016-011-8267-x; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mattapallil MJ, 2008, J IMMUNOL, V180, P6751, DOI 10.4049/jimmunol.180.10.6751; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Oruc S, 2001, AM J OPHTHALMOL, V131, P657, DOI 10.1016/S0002-9394(00)00863-1; Palomino-Morales RJ, 2010, J RHEUMATOL, V37, P1016, DOI 10.3899/jrheum.091007; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; SHINDO Y, 1994, HUM IMMUNOL, V39, P169, DOI 10.1016/0198-8859(94)90257-7; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Wallace GR, 2007, HUM IMMUNOL, V68, P122, DOI 10.1016/j.humimm.2006.11.010; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Xu H, 1997, CELL IMMUNOL, V178, P69, DOI 10.1006/cimm.1997.1121; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	45	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e72892	10.1371/journal.pone.0072892	http://dx.doi.org/10.1371/journal.pone.0072892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312163	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300001
J	Deschaght, P; Schelstraete, P; Van Simaey, L; Vanderkercken, M; Raman, A; Mahieu, L; Van daele, S; De Baets, F; Vaneechoutte, M				Deschaght, Pieter; Schelstraete, Petra; Van Simaey, Leen; Vanderkercken, Marleen; Raman, Ann; Mahieu, Linda; Van daele, Sabine; De Baets, Frans; Vaneechoutte, Mario			Is the Improvement of CF Patients, Hospitalized for Pulmonary Exacerbation, Correlated to a Decrease in Bacterial Load?	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ACUTE RESPIRATORY EXACERBATIONS; ONCE-DAILY TOBRAMYCIN; PSEUDOMONAS-AERUGINOSA; BRONCHOPULMONARY INFECTION; MULTIRESISTANT BACTERIA; DOUBLE-BLIND; CHILDREN; THERAPY; CARBENICILLIN	Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aeruginosa. In case eradication fails after antibiotic treatment, patients become chronically colonized with P. aeruginosa, with recurrent pulmonary exacerbation, for which patients typically are hospitalized for 2 weeks and receive intravenous antibiotic treatment. Normally, improvement of the patients' health is established. Aim: Determination of the correspondence between patient improvement and changes of the P. aeruginosa and total bacterial load in the sputum. Methods: Eighteen CF patients with exacerbation were included for a total of 27 hospitalization episodes. At day 1, 8 and 15, inflammation and lung function parameters were determined, together with the P. aeruginosa load in the sputum using culture, quantitative PCR (qPCR) and propidium monoazide qPCR. Results: Patients improved during hospitalization (decrease in levels of C-reactive protein, white blood cell counts and erythrocyte sedimentation rate, increase of FEV1), reaching normal values already after one week. Also the P. aeruginosa load and the total bacterial load decreased during the first week of antibiotic treatment (p < 0.05), except for patients with a low lung function (FEV1 <= 39.4%), for whom no significant decrease of P. aeruginosa was established. Comparison of culture-based and propidium monoazide qPCR-based quantification of P. aeruginosa showed that at the end of the treatment on average 62% of the P. aeruginosa cells are not cultivable, indicating that many cells are alive but dormant, or dead but still structurally intact. Conclusion: Improvement of the clinical status is accompanied with a decrease of the P. aeruginosa load, whereby both occur mainly during the first week of antibiotic treatment. However, for patients with a low lung function, no decrease of the P. aeruginosa load is observed. Comparison of detection techniques shows that a large amount of noncultivable or dead bacteria are present in the samples.	[Deschaght, Pieter; Van Simaey, Leen; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, LBR, Ghent, Belgium; [Schelstraete, Petra; Vanderkercken, Marleen; Raman, Ann; Mahieu, Linda; Van daele, Sabine; De Baets, Frans] Ghent Univ Hosp UZ Gent, MucoCtr Ghent, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Vaneechoutte, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, LBR, Ghent, Belgium.	Mario.Vaneechoutte@ugent.be	Vaneechoutte, Mario/A-6189-2009	Vaneechoutte, Mario/0000-0002-4586-203X; Van daele, Sabine/0000-0002-6632-1240	Belgium Cystic Fibrosis Association (MucoVereniging)	Belgium Cystic Fibrosis Association (MucoVereniging)	This study was funded by the Belgium Cystic Fibrosis Association (MucoVereniging) (www.muco.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2005, LANCET, V366, P463, DOI 10.1016/S0140-6736(05)67060-2; Baele M, 2003, INT J SYST EVOL MICR, V53, P143, DOI 10.1099/ijs.0.02246-0; BEAUDRY PH, 1980, J PEDIATR-US, V97, P144, DOI 10.1016/S0022-3476(80)80155-7; Belgisch Mucoviscidose Register, 2008, BELGISCH MUCOVISCIDO; Block JK, 2006, THORAX, V61, P969, DOI 10.1136/thx.2006.061366; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Burkhardt O, 2006, J ANTIMICROB CHEMOTH, V58, P822, DOI 10.1093/jac/dkl328; de Boer K, 2011, THORAX, V66, P680, DOI 10.1136/thx.2011.161117; Deschaght P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-245; Deschaght P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-244; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; HYATT AC, 1981, J PEDIATR-US, V99, P307, DOI 10.1016/S0022-3476(81)80486-6; Kim J, 2009, J ANTIMICROB CHEMOTH, V63, P129, DOI 10.1093/jac/dkn462; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Master V, 2001, PEDIATR PULM, V31, P367, DOI 10.1002/ppul.1060; MCLAUGHLIN FJ, 1983, J INFECT DIS, V147, P559, DOI 10.1093/infdis/147.3.559; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; PENKETH A, 1984, THORAX, V39, P299, DOI 10.1136/thx.39.4.299; PENKETH ARL, 1983, BRIT J DIS CHEST, V77, P179, DOI 10.1016/0007-0971(83)90025-6; Plummer A, 2011, COCHRANE DB SYST REV, V1; Puspita ID, 2012, MICROBES ENVIRON, V27, P356, DOI 10.1264/jsme2.ME12092; Rogers GB, 2010, CLIN MICROBIOL INFEC, V16, P1656, DOI 10.1111/j.1469-0691.2010.03189.x; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Schelstraete P, 2010, J CYST FIBROS, V9, P99, DOI 10.1016/j.jcf.2009.11.006; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; UK Cystic Fibrosis Trust Antibiotic Group, 2002, ANT TREATM CYST FIBR; Vic P, 1998, ARCH DIS CHILD, V78, P536, DOI 10.1136/adc.78.6.536; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]	36	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e79010	10.1371/journal.pone.0079010	http://dx.doi.org/10.1371/journal.pone.0079010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312174	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300005
J	Omri, S; Behar-Cohen, F; Rothschild, PR; Gelize, E; Jonet, L; Jeanny, JC; Omri, B; Crisanti, P				Omri, Samy; Behar-Cohen, Francine; Rothschild, Pierre-Raphael; Gelize, Emmanuelle; Jonet, Laurent; Jeanny, Jean Claude; Omri, Boubaker; Crisanti, Patricia			PKC zeta Mediates Breakdown of Outer Blood-Retinal Barriers in Diabetic Retinopathy	PLOS ONE			English	Article							KINASE-C-ZETA; CELL POLARITY; SIGNAL-TRANSDUCTION; ARACHIDONIC-ACID; TNF-ALPHA; KAPPA-B; COMPLEX; CERAMIDE; PERMEABILITY; INFLAMMATION	Aims/hypothesis: Diabetic macular edema represents the main cause of visual loss in diabetic retinopathy. Besides inner blood retinal barrier breakdown, the role of the outer blood retinal barrier breakdown has been poorly analyzed. We characterized the structural and molecular alterations of the outer blood retinal barrier during the time course of diabetes, focusing on PKC zeta a critical protein for tight junction assembly, known to be overactivated by hyperglycemia. Methods: Studies were conducted on a type2 diabetes Goto-Kakizaki rat model. PKC zeta level and subcellular localization were assessed by immunoblotting and immunohistochemistry. Cell death was detected by TUNEL assays. PKC zeta level on specific layers was assessed by laser microdissection followed by Western blotting. The functional role of PKC zeta was then evaluated in vivo, using intraocular administration of its specific inhibitor. Results: PKC zeta was localized in tight junction protein complexes of the retinal pigment epithelium and in photoreceptors inner segments. Strikingly, in outer segment PKC zeta staining was restricted to cone photoreceptors. Short-term hyperglycemia induced activation and delocalization of PKC zeta from both retinal pigment epithelium junctions and cone outer segment. Outer blood retinal barrier disruption and photoreceptor cone degeneration characterized long-term hyperglycemia. In vivo, reduction of PKC zeta overactivation using a specific inhibitor, restored its tight-junction localization and not only improved the outer blood retinal barrier, but also reduced photoreceptor cell-death. Conclusions: In the retina, hyperglycemia induced overactivation of PKC zeta is associated with outer blood retinal barrier breakdown and photoreceptor degeneration. In vivo, short-term inhibition of PKC zeta restores the outer barrier structure and reduces photoreceptor cell death, identifying PKC zeta as a potential target for early and underestimated diabetes-induced retinal pathology.	[Omri, Samy; Behar-Cohen, Francine; Rothschild, Pierre-Raphael; Gelize, Emmanuelle; Jonet, Laurent; Jeanny, Jean Claude; Omri, Boubaker; Crisanti, Patricia] Inst Natl Sante & Rech Med, U872, Paris, France; [Omri, Samy; Behar-Cohen, Francine; Rothschild, Pierre-Raphael; Gelize, Emmanuelle; Jonet, Laurent; Jeanny, Jean Claude; Omri, Boubaker; Crisanti, Patricia] Univ Paris 05, UMRS 872, Paris, France; [Omri, Samy; Behar-Cohen, Francine; Rothschild, Pierre-Raphael; Gelize, Emmanuelle; Jonet, Laurent; Jeanny, Jean Claude; Omri, Boubaker; Crisanti, Patricia] Univ Paris 06, Ctr Rech Cordeliers, UMRS 872, Paris, France; [Behar-Cohen, Francine; Rothschild, Pierre-Raphael; Gelize, Emmanuelle] Hop Hotel Dieu, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Crisanti, P (corresponding author), Inst Natl Sante & Rech Med, U872, Paris, France.	lassiaz@idf.inserm.fr	Rothschild, Pierre-Raphael/GZM-2621-2022	Omri, Samy/0000-0002-2054-8298				ADAMS AJ, 1987, APPL OPTICS, V26, P1455, DOI 10.1364/AO.26.001455; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bieberich E, 2008, FUTURE LIPIDOL, V3, P273, DOI 10.2217/17460875.3.3.273; Burbach GJ, 2004, J NEUROSCI METH, V138, P141, DOI 10.1016/j.jneumeth.2004.03.022; Cho NC, 2000, ARCH OPHTHALMOL-CHIC, V118, P1393; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Crisanti P, 2006, APOPTOSIS, V11, P983, DOI 10.1007/s10495-006-6750-2; de Kozak Y, 2007, AM J PATHOL, V170, P1241, DOI 10.2353/ajpath.2007.060236; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gardner TW, 2008, CURR DIABETES REP, V8, P263, DOI 10.1007/s11892-008-0047-5; GHALAYINI AJ, 1994, CURR EYE RES, V13, P145, DOI 10.3109/02713689409042409; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hurd TW, 2005, NAT CELL BIOL, V7, P205, DOI 10.1038/ncb0305-205; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Lee A, 2007, J NEUROSCI, V27, P12743, DOI 10.1523/JNEUROSCI.4264-07.2007; Liang H, 2007, J NEUROIMMUNOL, V183, P104, DOI 10.1016/j.jneuroim.2006.11.028; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macdonald NJ, 1999, J NEUROSCI RES, V57, P219, DOI 10.1002/(SICI)1097-4547(19990715)57:2<219::AID-JNR7>3.0.CO;2-C; Miyamoto N, 2008, OPHTHALMIC RES, V40, P203, DOI 10.1159/000119877; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Sato T, 1999, J BIOCHEM, V125, P96, DOI 10.1093/oxfordjournals.jbchem.a022275; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Titchenell PM, 2012, BIOCHEM J, V446, P455, DOI 10.1042/BJ20111961; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; Willis CL, 2010, J CEREBR BLOOD F MET, V30, P1847, DOI 10.1038/jcbfm.2010.119; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Xu Hui-Zhuo, 2011, J Ocul Biol Dis Infor, V4, P83, DOI 10.1007/s12177-011-9068-4; Xu HZ, 2011, INVEST OPHTH VIS SCI, V52, P2160, DOI 10.1167/iovs.10-6518; Yamamoto S, 1996, BRIT J OPHTHALMOL, V80, P973, DOI 10.1136/bjo.80.11.973	39	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81600	10.1371/journal.pone.0081600	http://dx.doi.org/10.1371/journal.pone.0081600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312324	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300038
J	McLinden, RJ; LaBranche, CC; Chenine, AL; Polonis, VR; Eller, MA; Wieczorek, L; Ochsenbauer, C; Kappes, JC; Perfetto, S; Montefiori, DC; Michael, NL; Kim, JH				McLinden, Robert J.; LaBranche, Celia C.; Chenine, Agnes-Laurence; Polonis, Victoria R.; Eller, Michael A.; Wieczorek, Lindsay; Ochsenbauer, Christina; Kappes, John C.; Perfetto, Stephen; Montefiori, David C.; Michael, Nelson L.; Kim, Jerome H.			Detection of HIV-1 Neutralizing Antibodies in a Human CD4(+)/CXCR4(+)/CCR5(+) T-Lymphoblastoid Cell Assay System	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; INFECTIOUS MOLECULAR CLONES; PROXIMAL EXTERNAL REGION; BLOOD MONONUCLEAR-CELLS; FUSION INHIBITOR T-20; SUBTYPE-B; V3 LOOP; INTEGRIN ALPHA(4)BETA(7)	Sensitive assays are needed to meaningfully assess low levels of neutralizing antibodies (NAbs) that may be important for protection against the acquisition of HIV-1 infection in vaccine recipients. The current assay of choice uses a non-lymphoid cell line (TZM-bl) that may lack sensitivity owing to over expression of CD4 and CCR5. We used transfection of a human CD4+/CXCR4+/alpha(4)beta(7)+ T-lymphoblastoid cell line (A3.01) with a CMV IE promoter-driven CCR5neo vector to stably express CCR5. The resulting line, designated A3R5, is permissive to a wide range of CCR5-tropic circulating strains of HIV-1, including HIV-1 molecular clones containing a Tat-inducible Renilla luciferase reporter gene and expressing multiple Env subtypes. Flow cytometric analysis found CCR5 surface expression on A3R5 cells to be markedly less than TZM-bl but similar to CD3.8 stimulated PBMC. More importantly, neutralization mediated by a diverse panel of monoclonal antibodies, HIV-1 positive polyclonal sera and sCD4 was consistently greater in A3R5 compared to TZM-bl cells. The A3R5 cell line provides a novel approach to guide the development and qualification of promising new HIV-1 vaccine immunogens.	[McLinden, Robert J.; Chenine, Agnes-Laurence; Polonis, Victoria R.; Eller, Michael A.; Wieczorek, Lindsay; Michael, Nelson L.; Kim, Jerome H.] WRAIR, Mil HIV Res Program, Silver Spring, MD USA; [LaBranche, Celia C.; Montefiori, David C.] Duke U Med Ctr, Dept Surg, Durham, NC USA; [Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Birmingham Vet Affairs Med Ctr, Res Serv, Birmingham, AL USA; [Perfetto, Stephen] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	Walter Reed Army Institute of Research (WRAIR); University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; National Institutes of Health (NIH) - USA	McLinden, RJ (corresponding author), WRAIR, Mil HIV Res Program, Silver Spring, MD USA.	rmclinden@hivresearch.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877	U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institute of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA-VIMC) [38619, 1032144]; NIH Center for HIV/AIDS Vaccine Immunology (CHAVI) [UO1-AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, N01AI002642, P30AI027767] Funding Source: NIH RePORTER	U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA-VIMC); NIH Center for HIV/AIDS Vaccine Immunology (CHAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by an Interagency Agreement (Y1-AI-2642-12) between U.S. Army Medical Research and Material Command (USAMRMC) and the National Institute of Allergy and Infectious Diseases. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The contribution of DCM was supported by the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA-VIMC), grant numbers 38619 and 1032144. The contribution of CO and JCK was supported by NIH Center for HIV/AIDS Vaccine Immunology (CHAVI) grant, UO1-AI067854; the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA-VIMC), grant numbers 38619 and 1032144; and facilities of the Virology and Genetic Sequencing cores of the UAB Center for AIDS Research (P30-AI-27767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; Bihl FK, 2005, J TRANSL MED, V3; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BINLEY JM, 2008, J VIROL; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Brown BK, 2007, J VIROL, V81, P2087, DOI 10.1128/JVI.02011-06; BURES R, 2000, IMMUNIZATION R UNPUB; BUTTKE TM, 1992, J BIOL CHEM, V267, P8819; CHENINE AL, 2013, PLOS ONE; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Darden JM, 2000, CYTOMETRY, V40, P141, DOI 10.1002/(SICI)1097-0320(20000601)40:2<141::AID-CYTO8>3.3.CO;2-6; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gilbert P, 2010, J INFECT DIS, V202, P595, DOI 10.1086/654816; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Kim JH, 2003, AIDS RES HUM RETROV, V19, P807, DOI 10.1089/088922203769232601; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Louder MK, 2005, VIROLOGY, V339, P226, DOI 10.1016/j.virol.2005.06.003; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; Mascola JR, 1997, J VIROL, V71, P7198, DOI 10.1128/JVI.71.10.7198-7206.1997; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola Jr, 1999, METH MOLEC MED, V17, P309, DOI 10.1385/0-89603-369-4:309; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moody MA, 2010, J EXP MED, V207, P763, DOI 10.1084/jem.20091281; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Ott DE, 2002, REV MED VIROL, V12, P359, DOI 10.1002/rmv.367; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Peachman KK, 2010, VIRAL IMMUNOL, V23, P627, DOI 10.1089/vim.2010.0061; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Perfetto SP, 1998, CYTOMETRY, V33, P133, DOI 10.1002/(SICI)1097-0320(19981001)33:2<133::AID-CYTO7>3.0.CO;2-K; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Polonis VR, 2001, AIDS RES HUM RETROV, V17, P69, DOI 10.1089/088922201750056807; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Rusert P, 2009, AIDS, V23, P1319, DOI 10.1097/QAD.0b013e32832d92c2; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Spenlehauer C, 2001, VIROLOGY, V280, P292, DOI 10.1006/viro.2000.0780; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Thongcharoen P, 2007, JAIDS-J ACQ IMM DEF, V46, P48; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WRIN T, 1994, AIDS, V8, P1622, DOI 10.1097/00002030-199411000-00017; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2008, J VIROL, V82, P6869, DOI 10.1128/JVI.00033-08; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	103	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e77756	10.1371/journal.pone.0077756	http://dx.doi.org/10.1371/journal.pone.0077756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312168	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900001
J	Hanson, N; Thompson, D; Duck, C; Moss, S; Lonergan, M				Hanson, Nora; Thompson, Dave; Duck, Callan; Moss, Simon; Lonergan, Mike			Pup Mortality in a Rapidly Declining Harbour Seal (Phoca vitulina) Population	PLOS ONE			English	Article							SURVIVAL; MODEL; MASS; TAGS	The harbour seal population in Orkney, off the north coast of Scotland, has reduced by 65% between 2001 and 2010. The cause(s) of this decline are unknown but must affect the demographic parameters of the population. Here, satellite telemetry data were used to test the hypothesis that increased pup mortality could be a primary driver of the decline in Orkney. Pup mortality and tag failure parameters were estimated from the duration of operation of satellite tags deployed on harbour seal pups from the Orkney population (n = 24) and from another population on the west coast of Scotland (n = 24) where abundance was stable. Survival probabilities from both populations were best represented by a common gamma distribution and were not different from one another, suggesting that increased pup mortality is unlikely to be the primary agent in the Orkney population decline. The estimated probability of surviving to 6 months was 0.390 (95% CI 0.297 - 0.648) and tag failure was represented by a Gaussian distribution, with estimated mean 270 (95% CI = 198 - 288) and s.d. 21 (95% CI = 1 - 66) days. These results suggest that adult survival is the most likely proximate cause of the decline. They also demonstrate a novel technique for attaining age-specific mortality rates from telemetry data.	[Hanson, Nora; Thompson, Dave; Duck, Callan; Moss, Simon; Lonergan, Mike] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Hanson, N (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 9AJ, Fife, Scotland.	nnh@st-andrews.ac.uk		Thompson, David/0000-0003-1546-2876; Hanson, Nora/0000-0002-0017-8963	Scottish Government; Scottish Natural Heritage; Natural Environment Research Council; Natural Environment Research Council [smru10001] Funding Source: researchfish	Scottish Government; Scottish Natural Heritage; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Scottish Government (www.scotland.gov.uk), Scottish Natural Heritage (www.snh.gov.uk) and the Natural Environment Research Council (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Bowen WD, 2003, J ZOOL, V261, P155, DOI 10.1017/S0952836903004047; Bowen WD, 2001, FUNCT ECOL, V15, P325, DOI 10.1046/j.1365-2435.2001.00530.x; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Colchero F, 2012, J ANIM ECOL, V81, P139, DOI 10.1111/j.1365-2656.2011.01898.x; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cunningham L, 2009, AQUAT CONSERV, V19, P398, DOI 10.1002/aqc.983; Dietz R., 2012, J MARINE SCI, V69, P1; Dube Y, 2003, CAN J ZOOL, V81, P188, DOI 10.1139/Z02-231; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Fieberg J, 2011, ENVIRON ECOL STAT, V18, P209, DOI 10.1007/s10651-009-0128-x; Greaves DK, 2005, PHYSIOL BIOCHEM ZOOL, V78, P9, DOI 10.1086/425201; Harding KC, 2005, FUNCT ECOL, V19, P129, DOI 10.1111/j.0269-8463.2005.00945.x; HARKONEN T, 1990, OPHELIA, V32, P211; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harkonen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000887; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; HINDELL MA, 1991, J ANIM ECOL, V60, P119, DOI 10.2307/5449; Holbrook CM, 2013, ENVIRON BIOL FISH, V96, P165, DOI 10.1007/s10641-012-0016-3; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jorgensen C, 2001, J EXP BIOL, V204, P3993; Le Boeuf Burney J., 1994, P121; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lonergan M, 2013, AQUAT CONSERV, V23, P135, DOI 10.1002/aqc.2277; Lonergan M, 2011, MAR POLICY, V35, P584, DOI 10.1016/j.marpol.2011.01.020; Mackey BL, 2008, J ZOOL, V274, P18, DOI 10.1111/j.1469-7998.2007.00352.x; Murray DL, 2006, J WILDLIFE MANAGE, V70, P1530, DOI 10.2193/0022-541X(2006)70[1530:OITSE]2.0.CO;2; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; OSPAR, 2009, OSPAR SYST EC QUAL O; Prewitt JS, 2010, J COMP PHYSIOL B, V180, P757, DOI 10.1007/s00360-010-0448-z; R Core Development Team, 2011, R LANG ENV STAT COMP; SCOS, 2011, SCI ADV MATT REL MAN; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; Thompson Dave, 2010, NAMMCO Scientific Publications, V8, P117	37	10	10	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80727	10.1371/journal.pone.0080727	http://dx.doi.org/10.1371/journal.pone.0080727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312239	Green Published, gold			2022-12-25	WOS:000327652100051
J	Nozawa, Y; Lin, CH; Chung, AC				Nozawa, Yoko; Lin, Che-Hung; Chung, Ai-Chi			Bathymetric Variation in Recruitment and Relative Importance of Pre- and Post-Settlement Processes in Coral Assemblages at Lyudao (Green Island), Taiwan	PLOS ONE			English	Article							SCLERACTINIAN CORAL; DEPTH; SETTLEMENT; PATTERNS; REEFS; IDENTIFICATION; CONSEQUENCES; SURVIVORSHIP; COMMUNITIES; MORTALITY	Studieson coral communities have typically been conducted in shallow waters (similar to 5 m). However, in the face of climate change, and as shallow coral communities become degraded, a greater understanding of deeper coral communities is needed as hey become the main reef remnants, playing a central role in the future of coral reefs. To understand the dynamics of deeper coral assemblages, he recruitment and taxonomic composition of different life-stages at 5 and depths were compared at three locations in Lyudao, southeastern Taiwan in 2010. Coral recruits (<1 cm diameter, <4 months old) were examined using settlement plates. Juvenile corals cm, several year old were examined quadrats, and adult corals (>5 cm, several years to decades old) were examined using transect lines. Pocilloporid and poritid corals had similar and highers number of recruits at 5 m compared to 15 m, whereas acroporid recruits were more abundant at 15 m. The primary cause for the former may be larval behavior, such that they position themselves in shallow ate while that for he latter may be the dominance of brooding acroporid species (Isopora spp.) at 15 m. The taxonomic especially between recruits and juveniles/adults, was more similar at 15 m than at 5 m. These results suggest a relative importance of pre- and post-settlement processes in assemblage determinants with depth habitats (more disturbed) are more influenced by post-settlement processes (mortality even hose in deeper habitat ore protected) are more influenced by pre-settlement processes (larval supply)	[Nozawa, Yoko; Lin, Che-Hung; Chung, Ai-Chi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan	Nozawa, Y (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	nozaway@gate.sinica.edu.tw			Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This study was supported by a research grant of Academia Sinica to YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Babcock RC, 2003, ZOOL STUD, V42, P211; Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; BAK RPM, 1995, B MAR SCI, V56, P609; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Birkeland C., 1982, Proceedings of the International Coral Reef Symposium, P339; Birkeland C., 1977, Proceedings int Coral Reef Symp, V3, P15; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Carlon DB, 2001, B MAR SCI, V68, P525; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Dai C-F, 2009, SCLERACTINIA FAUNA T, P162; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; Edmunds PJ, 2004, MAR ECOL PROG SER, V278, P115, DOI 10.3354/meps278115; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Harriott VJ, 1985, P 5 INT COR REEF S, V4, P367; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUSTON M, 1985, CORAL REEFS, V4, P19, DOI 10.1007/BF00302200; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Kawaguti S., 1941, Palao Tropical Biological Station Studies, V2, P319; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Kuo CY, 2011, ZOOL STUD, V50, P85; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Liang WD, 2003, DEEP-SEA RES PT II, V50, P1085, DOI 10.1016/S0967-0645(03)00011-0; Mason B, 2011, CORAL REEFS, V30, P667, DOI 10.1007/s00338-011-0739-1; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; Mundy C, 2000, MAR ECOL PROG SER, V198, P109, DOI 10.3354/meps198109; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Nozawa Y, 2008, MAR ECOL PROG SER, V358, P151, DOI 10.3354/meps07342; Nozawa Y, 2012, J EXP MAR BIOL ECOL, V413, P145, DOI 10.1016/j.jembe.2011.12.008; Nozawa Yoko, 2010, Galaxea - Tokyo, V12, P31; Nozawa Y, 2011, ZOOL STUD, V50, P53; Nozawa Y, 2008, J EXP MAR BIOL ECOL, V367, P127, DOI 10.1016/j.jembe.2008.09.004; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; ROGERS CS, 1984, CORAL REEFS, V3, P69, DOI 10.1007/BF00263756; SAMMARCO PW, 1991, LIMNOL OCEANOGR, V36, P496, DOI 10.4319/lo.1991.36.3.0496; Sinniger F, 2013, CORAL REEFS, V32, P153, DOI 10.1007/s00338-012-0973-1; Smith SR, 1997, P 8 INT COR REEF S, V2, P1197; Soong K, 2003, CORAL REEFS, V22, P224, DOI 10.1007/s00338-003-0311-8; Suzuki G, 2012, CORAL REEFS, V31, P535, DOI 10.1007/s00338-011-0865-9; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; Suzuki G, 2011, MAR POLLUT BULL, V62, P2803, DOI 10.1016/j.marpolbul.2011.08.050; Suzuki Go, 2009, Galaxea - Tokyo, V11, P13; Suzuki G, 2011, J MAR BIOL ASSOC UK, V91, P677, DOI 10.1017/S0025315410000573; Szmant AM, 2010, P 10 INT COR REEF S, V1, P431; Tioho H, 2001, MAR ECOL PROG SER, V213, P79, DOI 10.3354/meps213079; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Vermeij MJA, 2003, B MAR SCI, V73, P725; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Wilkinson C, 2008, STATUS CORAL REEFS W; Wu CC, 1999, B AM METEOROL SOC, V80, P67, DOI 10.1175/1520-0477(1999)080<0067:TATCUA>2.0.CO;2	59	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81474	10.1371/journal.pone.0081474	http://dx.doi.org/10.1371/journal.pone.0081474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312304	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100082
J	Groenewoud, MJ; Goorden, SMI; Kassies, J; Pellis-van Berkel, W; Lamb, RF; Elgersma, Y; Zwartkruis, FJT				Groenewoud, Marlous J.; Goorden, Susan M. I.; Kassies, Jorien; Pellis-van Berkel, Wendy; Lamb, Richard F.; Elgersma, Ype; Zwartkruis, Fried J. T.			Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							TUBEROUS-SCLEROSIS; CELL-GROWTH; PHOSPHOLIPASE-D; AMINO-ACIDS; S6 KINASE; INSULIN; RHEB; RAPTOR; ACTIVATION; PHOSPHORYLATION	The Ras-like GTPase Rheb has been identified as a crucial activator of mTORC1. Activation most likely requires a direct interaction between Rheb and mTOR, but the exact mechanism remains unclear. Using a panel of Rheb-deficient mouse embryonic fibroblasts (MEFs), we show that Rheb is indeed essential for the rapid increase of mTORC1 activity following stimulation with insulin or amino acids. However, mTORC1 activity is less severely reduced in Rheb-deficient MEFs in the continuous presence of serum or upon stimulation with serum. This remaining mTORC1 activity is blocked by depleting the cells for amino acids or imposing energy stress. In addition, MEK inhibitors and the RSK-inhibitor BI-D1870 interfere in mTORC1 activity, suggesting that RSK acts as a bypass for Rheb in activating mTORC1. Finally, we show that this rapamycin-sensitive, Rheb-independent mTORC1 activity is important for cell cycle progression. In conclusion, whereas rapid adaptation in mTORC1 activity requires Rheb, a second Rheb-independent activation mechanism exists that contributes to cell cycle progression.	[Groenewoud, Marlous J.; Kassies, Jorien; Pellis-van Berkel, Wendy; Zwartkruis, Fried J. T.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Utrecht, Netherlands; [Groenewoud, Marlous J.; Kassies, Jorien; Pellis-van Berkel, Wendy; Zwartkruis, Fried J. T.] Univ Med Ctr Utrecht, Canc Genom Ctr, Utrecht, Netherlands; [Goorden, Susan M. I.; Elgersma, Ype] Erasmus MC Univ, Med Ctr, ENCORE Expertise Ctr Neurodev Disorders, Dept Neurosci, Rotterdam, Netherlands; [Lamb, Richard F.] Univ Liverpool, Dept Mol & Clin Canc Med, Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Cancer Research UK; University of Liverpool	Zwartkruis, FJT (corresponding author), Univ Med Ctr Utrecht, Ctr Biomed Genet, Utrecht, Netherlands.	G.J.T.Zwartkruis@umcutrecht.nl	Elgersma, Ype/F-5164-2013	Elgersma, Ype/0000-0002-3758-1297	Dutch Cancer Society KWF [UU2005-3404]; Centre for Biomedical Genetics; Netherlands Organization for Scientific Research (NOW-ZoNMW)	Dutch Cancer Society KWF(KWF Kankerbestrijding); Centre for Biomedical Genetics; Netherlands Organization for Scientific Research (NOW-ZoNMW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Cancer Society KWF UU2005-3404 (URL: http://www.kwfkankerbestrijding.nl/Pages/Home.aspx) (to MJG), the Centre for Biomedical Genetics (URL: http://www.biomedicalgenetics.nl/) (to FJTZ), the Netherlands Organization for Scientific Research (NOW-ZoNMW; VICI-grant to YE and TopTalent grant to SMIG), (URL: http://www.zonmw.nl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abs E, 2013, ANN NEUROL; Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jaber N, 2012, AUTOPHAGY, V8, P707, DOI 10.4161/auto.19627; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	61	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81649	10.1371/journal.pone.0081649	http://dx.doi.org/10.1371/journal.pone.0081649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303063	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400079
J	Huang, J; Wang, JL; Gu, LJ; Bao, JF; Yin, J; Tang, ZH; Wang, L; Yuan, WJ				Huang, Juan; Wang, Jialin; Gu, Lijie; Bao, Jinfang; Yin, Jun; Tang, Zhihuan; Wang, Ling; Yuan, Weijie			Effect of a Low-Protein Diet Supplemented with Ketoacids on Skeletal Muscle Atrophy and Autophagy in Rats with Type 2 Diabetic Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; CHRONIC DIALYSIS PATIENTS; HEMODIALYSIS-PATIENTS; MELLITUS PATIENTS; AMINO-ACIDS; YOUNG MEN; LEUCINE; RESTRICTION; DEGRADATION	A low-protein diet supplemented with ketoacids maintains nutritional status in patients with diabetic nephropathy. The activation of autophagy has been shown in the skeletal muscle of diabetic and uremic rats. This study aimed to determine whether a low-protein diet supplemented with ketoacids improves muscle atrophy and decreases the increased autophagy observed in rats with type 2 diabetic nephropathy. In this study, 24-week-old Goto-Kakizaki male rats were randomly divided into groups that received either a normal protein diet (NPD group), a low-protein diet (LPD group) or a low-protein diet supplemented with ketoacids (LPD+KA group) for 24 weeks. Age-and weight-matched Wistar rats served as control animals and received a normal protein diet (control group). We found that protein restriction attenuated proteinuria and decreased blood urea nitrogen and serum creatinine levels. Compared with the NPD and LPD groups, the LPD+KA group showed a delay in body weight loss, an attenuation in soleus muscle mass loss and a decrease of the mean cross-sectional area of soleus muscle fibers. The mRNA and protein expression of autophagy-related genes, such as Beclin-1, LC3B, Bnip3, p62 and Cathepsin L, were increased in the soleus muscle of GK rats fed with NPD compared to Wistar rats. Importantly, LPD resulted in a slight reduction in the expression of autophagy-related genes; however, these differences were not statistically significant. In addition, LPD+KA abolished the upregulation of autophagy-related gene expression. Furthermore, the activation of autophagy in the NPD and LPD groups was confirmed by the appearance of autophagosomes or autolysosomes using electron microscopy, when compared with the Control and LPD+KA groups. Our results showed that LPD+KA abolished the activation of autophagy in skeletal muscle and decreased muscle loss in rats with type 2 diabetic nephropathy.	[Huang, Juan; Wang, Jialin; Gu, Lijie; Bao, Jinfang; Yin, Jun; Tang, Zhihuan; Wang, Ling; Yuan, Weijie] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yuan, WJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China.	ywj4169@163.com		yuan, wei jie/0000-0002-6395-9994; gu, li jie/0000-0002-4351-7582				Anthony JC, 2000, J NUTR, V130, P2413; Aparicio M, 2000, J AM SOC NEPHROL, V11, P708, DOI 10.1681/ASN.V114708; Aparicio M, 2012, J RENAL NUTR, V22, pS1, DOI 10.1053/j.jrn.2011.09.005; Aparicio M, 2012, J RENAL NUTR, V22, pS22, DOI 10.1053/j.jrn.2011.09.006; Aparicio M, 2009, J RENAL NUTR, V19, pS5, DOI 10.1053/j.jrn.2009.06.017; BARSOTTI G, 1988, CLIN NEPHROL, V29, P280; Barsotti G, 1987, Infusionsther Klin Ernahr, V14 Suppl 5, P12; Bernhard J, 2001, J AM SOC NEPHROL, V12, P1249, DOI 10.1681/ASN.V1261249; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; BRODSKY IG, 1992, J CLIN ENDOCR METAB, V75, P351, DOI 10.1210/jc.75.2.351; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Chang JH, 2009, NEPHROLOGY, V14, P750, DOI 10.1111/j.1440-1797.2009.01115.x; Chauveau P, 1999, AM J KIDNEY DIS, V34, P500, DOI 10.1016/S0272-6386(99)70078-8; Cianciaruso B, 2008, NEPHROL DIAL TRANSPL, V23, P636, DOI 10.1093/ndt/gfm576; Ciarambino T, 2011, NUTRITION, V27, P46, DOI 10.1016/j.nut.2009.10.017; de Mutsert R, 2008, NEPHROL DIAL TRANSPL, V23, P2957, DOI 10.1093/ndt/gfn167; De Santo Natale Gaspare, 2011, Front Biosci (Schol Ed), V3, P1432; Di Iorio BR, 2003, KIDNEY INT, V64, P1822, DOI 10.1046/j.1523-1755.2003.00282.x; DIAZ M, 1975, KIDNEY INT, V8, P349, DOI 10.1038/ki.1975.126; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dussol B, 2005, J RENAL NUTR, V15, P398, DOI 10.1053/j.jrn.2005.07.003; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Fanzani A, 2011, TOXICOL APPL PHARM, V250, P312, DOI 10.1016/j.taap.2010.11.003; FOLLMANN P, 1993, DOC OPHTHALMOL, V83, P55, DOI 10.1007/BF01203570; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; Glynn EL, 2010, J NUTR, V140, P1970, DOI 10.3945/jn.110.127647; GOODSHIP THJ, 1990, J AM SOC NEPHROL, V1, P66; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Hansen HP, 2002, KIDNEY INT, V62, P220, DOI 10.1046/j.1523-1755.2002.00421.x; Janssen U, 2004, J NEPHROL, V17, P769; Janssen U, 2003, KIDNEY INT, V63, P2162, DOI 10.1046/j.1523-1755.2003.00007.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kalantar-Zadeh K, 2011, NAT REV NEPHROL, V7, P369, DOI 10.1038/nrneph.2011.60; Koya D, 2009, DIABETOLOGIA, V52, P2037, DOI 10.1007/s00125-009-1467-8; Lopez LV, 2008, NUTR HOSP, V23, P141; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsuda Sanae, 2004, Clin Exp Nephrol, V8, P322; Meloni C, 2004, J RENAL NUTR, V14, P208, DOI 10.1053/j.jm.2004.07.011; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; MOTIL KJ, 1981, AM J PHYSIOL, V240, pE712, DOI 10.1152/ajpendo.1981.240.6.E712; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Pupim LB, 2005, KIDNEY INT, V68, P1857, DOI 10.1111/j.1523-1755.2005.00605.x; Robertson L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002181.pub2; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Sugawara T, 2009, AMINO ACIDS, V37, P609, DOI 10.1007/s00726-008-0180-0; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Walser M, 1975, Clin Nephrol, V3, P180; WALSER M, 1975, LIFE SCI, V17, P1011, DOI 10.1016/0024-3205(75)90320-3; Wang JL, 2012, NEPHRON CLIN PRACT, V121, pC102, DOI 10.1159/000345159; Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; ZATZ R, 1985, P NATL ACAD SCI USA, V82, P5963, DOI 10.1073/pnas.82.17.5963; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	62	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81464	10.1371/journal.pone.0081464	http://dx.doi.org/10.1371/journal.pone.0081464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303049	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400065
J	Kaman, WE; El Arkoubi-El Arkoubi, N; Roffel, S; Endtz, HP; van Belkum, A; Bikker, FJ; Hays, JP				Kaman, Wendy E.; El Arkoubi-El Arkoubi, Nora; Roffel, Sanne; Endtz, Hubert P.; van Belkum, Alex; Bikker, Floris J.; Hays, John P.			Evaluation of a FRET-Peptide Substrate to Predict Virulence in Pseudomonas aeruginosa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OUTER-MEMBRANE; PROTEASE; AZITHROMYCIN; LASA; EXPRESSION; INFECTION; SYSTEMS; AIRWAY; GENES	Pseudomonas aeruginosa produces a number of proteases that are associated with virulence and disease progression. A substrate able to detect P. aeruginosa-specific proteolytic activity could help to rapidly alert clinicians to the virulence potential of individual P. aeruginosa strains. For this purpose we designed a set of P. aeruginosa-specific fluorogenic substrates, comprising fluorescence resonance energy transfer (FRET)-labeled peptides, and evaluated their applicability to P. aeruginosa virulence in a range of clinical isolates. A FRET-peptide comprising three glycines (3xGly) was found to be specific for the detection of P. aeruginosa proteases. Further screening of 97 P. aeruginosa clinical isolates showed a wide variation in 3xGly cleavage activity. The absence of 3xGly degradation by a lasI knock out strain indicated that 3xGly cleavage by P. aeruginosa could be quorum sensing (QS)-related, a hypothesis strengthened by the observation of a strong correlation between 3xGly cleavage, LasA staphylolytic activity and pyocyanin production. Additionally, isolates able to cleave 3xGly were more susceptible to the QS inhibiting antibiotic azithromycin (AZM). In conclusion, we designed and evaluated a 3xGly substrate possibly useful as a simple tool to predict virulence and AZM susceptibility.	[Kaman, Wendy E.; El Arkoubi-El Arkoubi, Nora; Endtz, Hubert P.; van Belkum, Alex; Hays, John P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Kaman, Wendy E.; Roffel, Sanne; Bikker, Floris J.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands; [Kaman, Wendy E.; Roffel, Sanne; Bikker, Floris J.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van Belkum, Alex] BioMerieux, Res & Dev Microbiol, La Balme Les Grottes, France	Erasmus University Rotterdam; Erasmus MC; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; bioMerieux	Kaman, WE (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	w.kaman@erasmusmc.nl	Bikker, Floris/R-1941-2019; Kaman, Wendy/B-2976-2012; Hays, J/I-9007-2017; Bikker, Floris/B-1187-2012	Bikker, Floris/0000-0002-9453-4630; Hays, J/0000-0001-9183-4497; 	European Community [241742]; STW Valorisation Grant, TNO SBIR: Bacalyzer [16-001]	European Community(European Commission); STW Valorisation Grant, TNO SBIR: Bacalyzer	This research was funded by the European Community's Seventh Framework Programme FP7/2007-2013, TEMPOtest-QC, under grant agreement no. 241742 and an STW Valorisation Grant, TNO SBIR: Bacalyzer no. 16-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BODEY GP, 1983, REV INFECT DIS, V5, P279; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buyck JM, 2012, CLIN INFECT DIS, V55, P534, DOI 10.1093/cid/cis473; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Cugini C, 2010, MICROBIOL-SGM, V156, P3096, DOI 10.1099/mic.0.037911-0; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Elston C, 2007, ANAL BIOCHEM, V368, P87, DOI 10.1016/j.ab.2007.04.041; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Girard G, 2008, FUTURE MICROBIOL, V3, P97, DOI 10.2217/17460913.3.1.97; Hodgkinson JT, 2012, ORG BIOMOL CHEM, V10, P6032, DOI 10.1039/c2ob25198a; Imamura Y, 2005, ANTIMICROB AGENTS CH, V49, P1377, DOI 10.1128/AAC.49.4.1377-1380.2005; Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kaman WE, 2012, J CLIN MICROBIOL, V50, P104, DOI 10.1128/JCM.05313-11; Karatuna O, 2010, CLIN MICROBIOL INFEC, V16, P1770, DOI 10.1111/j.1469-0691.2010.03177.x; KESSLER E, 1993, J BIOL CHEM, V268, P7503; KESSLER E, 1995, METHOD ENZYMOL, V248, P740; Kohler T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000883; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rada B, 2009, IMMUNOL RES, V43, P198, DOI 10.1007/s12026-008-8071-8; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; van Delden C, 2012, INTENS CARE MED, V38, P1118, DOI 10.1007/s00134-012-2559-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; Wildeboer D, 2012, EUR J CLIN MICROBIOL, V31, P2183, DOI 10.1007/s10096-012-1553-6; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Xu NX, 1997, ANAL BIOCHEM, V248, P7, DOI 10.1006/abio.1997.2073	31	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81428	10.1371/journal.pone.0081428	http://dx.doi.org/10.1371/journal.pone.0081428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303047	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400063
J	Markussen, T; Sindre, H; Jonassen, CM; Tengs, T; Kristoffersen, AB; Ramsell, J; Numanovic, S; Hjortaas, MJ; Christiansen, DH; Dale, OB; Falk, K				Markussen, Turhan; Sindre, Hilde; Jonassen, Christine Monceyron; Tengs, Torstein; Kristoffersen, Anja B.; Ramsell, Jon; Numanovic, Sanela; Hjortaas, Monika J.; Christiansen, Debes H.; Dale, Ole Bendik; Falk, Knut			Ultra-Deep Pyrosequencing of Partial Surface Protein Genes from Infectious Salmon Anaemia Virus (ISAV) Suggest Novel Mechanisms Involved in Transition to Virulence	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; FARMED ATLANTIC SALMON; HEMAGGLUTININ GENE; A VIRUS; NEURAMINIDASE ACTIVITIES; RNA RECOMBINATION; FUSION PROTEIN; CLEAVAGE SITE; NORTH-AMERICA; VIRAL-RNA	Uncultivable HPR0 strains of infectious salmon anaemia viruses (ISAVs) infecting gills are non-virulent putative precursors of virulent ISAVs (vISAVs) causing systemic disease in farmed Atlantic salmon (Salmo salar). The transition to virulence involves two molecular events, a deletion in the highly polymorphic region (HPR) of the hemagglutinin-esterase (HE) gene and a Q(266)-> L-266 substitution or insertion next to the putative cleavage site (R-267) in the fusion protein (F). We have performed ultra-deep pyrosequencing (UDPS) of these gene regions from healthy fish positive for HPR0 virus carrying full-length HPR sampled in a screening program, and a vISAV strain from an ISA outbreak at the same farming site three weeks later, and compared the mutant spectra. As the UDPS data shows the presence of both HE genotypes at both sampling times, and the outbreak strain was unlikely to be directly related to the HPR0 strain, this is the first report of a double infection with HPR0s and vISAVs. For F amplicon reads, mutation frequencies generating L-266 codons in screening samples and Q(266) codons in outbreak samples were not higher than at any random site. We suggest quasispecies heterogeneity as well as RNA structural properties are linked to transition to virulence. More specifically, a mechanism where selected single point mutations in the full-length HPR alter the RNA structure facilitating single- or sequential deletions in this region is proposed. The data provides stronger support for the deletion hypothesis, as opposed to recombination, as the responsible mechanism for generating the sequence deletions in HE.	[Markussen, Turhan; Sindre, Hilde; Jonassen, Christine Monceyron; Tengs, Torstein; Ramsell, Jon; Numanovic, Sanela; Hjortaas, Monika J.; Dale, Ole Bendik] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway; [Kristoffersen, Anja B.; Falk, Knut] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway; [Christiansen, Debes H.] Natl Reference Lab Fish Dis Food & Vet Author, Torshavn, Faroe Islands, Denmark	Norwegian Veterinary Institute; Norwegian Veterinary Institute	Markussen, T (corresponding author), Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway.	turhan.markussen@vetinst.no	Falk, Knut/D-2952-2012; Dale, Ole Bendik/ABB-6276-2021	Falk, Knut/0000-0002-9830-3493; Sindre, Hilde/0000-0001-8668-1529	Norwegian Research Council [207024/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by The Norwegian Research Council (project no. 207024/E40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Andreoni M, 2004, MICROBIOLOGICA, V27, P71; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Borno G, 2010, FISKEHELSERAPPORTEN, P1; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Cook-Versloot M, 2004, B EUR ASSOC FISH PAT, V24, P203; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; Deng YM, 2011, ANTIVIR RES, V90, P87, DOI 10.1016/j.antiviral.2011.02.014; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Deyde VM, 2009, EXPERT REV MOL DIAGN, V9, P493, DOI 10.1586/ERM.09.21; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; FIELDS S, 1982, CELL, V28, P303, DOI 10.1016/0092-8674(82)90348-8; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Gorzer I, 2010, J VIROL METHODS, V169, P248, DOI 10.1016/j.jviromet.2010.07.040; Goic B, 2008, VIROLOGY, V379, P55, DOI 10.1016/j.virol.2008.05.036; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Ko SY, 2012, CLIN MICROBIOL INFEC, V18, pE404, DOI 10.1111/j.1469-0691.2012.03951.x; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; Kulshreshtha V, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-338; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Li JL, 2010, AVIAN DIS, V54, P586, DOI 10.1637/8806-040109-ResNote.1; Lovely JE, 1999, DIS AQUAT ORGAN, V35, P145, DOI 10.3354/dao035145; Lyngoy C., 2003, INT RESPONSE INFECT, P97; Lyngstad TM, 2008, PREV VET MED, V84, P213, DOI 10.1016/j.prevetmed.2007.12.008; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Lyngstad TM, 2012, DIS AQUAT ORGAN, V101, P197, DOI 10.3354/dao02520; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; Menendez-Arias L, 2002, PROG NUCLEIC ACID RE, V71, P91, DOI 10.1016/S0079-6603(02)71042-8; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Mullins J.E., 1998, Bulletin of the European Association of Fish Pathologists, V18, P110; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; Newman RM, 2013, J INFECT DIS, V208, P17, DOI 10.1093/infdis/jis679; Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052; Ojosnegros S, 2011, VIRUS RES, V162, P203, DOI 10.1016/j.virusres.2011.09.018; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pingen M, 2012, ANTIVIR THER, V17, P1621, DOI 10.3851/IMP2267; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rodger HD, 1998, VET REC, V142, P538, DOI 10.1136/vr.142.20.538; Rowley HM, 1999, J FISH DIS, V22, P483, DOI 10.1046/j.1365-2761.1999.00190.x; Sanjuan R, 2011, MOL BIOL EVOL, V28, P1333, DOI 10.1093/molbev/msq329; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shtyrya Y, 2009, GLYCOCONJUGATE J, V26, P99, DOI 10.1007/s10719-008-9169-x; Sorrell EM, 2010, J VIROL, V84, P11831, DOI 10.1128/JVI.01460-10; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	73	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81571	10.1371/journal.pone.0081571	http://dx.doi.org/10.1371/journal.pone.0081571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303056	Green Published, gold			2022-12-25	WOS:000327546400072
J	Tareen, AM; Luder, CGK; Zautner, AE; Gross, U; Heimesaat, MM; Bereswill, S; Lugert, R				Tareen, A. Malik; Lueder, Carsten G. K.; Zautner, Andreas E.; Gross, Uwe; Heimesaat, Markus M.; Bereswill, Stefan; Lugert, Raimond			The Campylobacter jejuni Cj0268c Protein Is Required for Adhesion and Invasion In Vitro	PLOS ONE			English	Article							EPITHELIAL-CELLS; BINDING PROTEIN; IDENTIFICATION; COLONIZATION; FIBRONECTIN; GENE; ASSOCIATION; EVOLUTION; SYSTEM; JLPA	Adherence of Campylobacter jejuni to its particular host cells is mediated by several pathogen proteins. We screened a transposon-based mutant library of C. jejuni in order to identify clones with an invasion deficient phenotype towards Caco2 cells and detected a mutant with the transposon insertion in gene cj0268c. In vitro characterization of a generated non-random mutant, the mutant complemented with an intact copy of cj0268c and parental strain NCTC 11168 confirmed the relevance of Cj0268c in the invasion process, in particular regarding adherence to host cells. Whereas Cj0268c does not impact autoagglutination or motility of C. jejuni, heterologous expression in E. coli strain DH5 alpha enhanced the potential of the complemented E. coli strain to adhere to Caco2 cells significantly and, thus, indicates that Cj0268c does not need to interact with other C. jejuni proteins to develop its adherence-mediating phenotype. Flow cytometric measurements of E. coli expressing Cj0268c indicate a localization of the protein in the periplasmic space with no access of its C-terminus to the bacterial surface. Since a respective knockout mutant possesses clearly reduced resistance to Triton X-100 treatment, Cj0268c contributes to the stability of the bacterial cell wall. Finally, we could show that the presence of cj0268c seems to be ubiquitous in isolates of C. jejuni and does not correlate with specific clonal groups regarding pathogenicity or pathogen metabolism.	[Tareen, A. Malik; Lueder, Carsten G. K.; Zautner, Andreas E.; Gross, Uwe; Lugert, Raimond] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Zautner, Andreas E.] Univ Med Ctr Gottingen, Dept Clin Chem, Cent Lab, Gottingen, Germany; [Heimesaat, Markus M.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany	University of Gottingen; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lugert, R (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	rlugert@gwdg.de	Zautner, Andreas Erich/AAE-7425-2019; Zautner, Andreas Erich/ABA-9655-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Heimesaat, Markus/0000-0001-6399-651X	Deutsche Forschungsgemeinschaft [GR 906/13-1]; German Academic Exchange Service (DAAD); DFG [SFB633, TP A7, TP B6]; German Federal Ministery of Education and Research (BMBF) [TP 1.1, TP 8.2]; German Research Foundation; Open Access Publication Funds of the G?ttingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the G?ttingen University	This work was supported by the Deutsche Forschungsgemeinschaft (grant number GR 906/13-1). A. Malik Tareen was funded by a grant from the German Academic Exchange Service (DAAD). Stefan Bereswill and Markus M. Heimesaat are supported by DFG (SFB633, TP A7) (SFB633, TP B6) and by the German Federal Ministery of Education and Research (BMBF) ("Lab in a hanky'' projects TP 1.1 and TP 8.2). Furthermore, the authors acknowledge the support by the German Research Foundation and the Open Access Publication Funds of the G?ttingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Boehm M, 2013, EUR J MICROBIOL IMMU, V3, P163, DOI 10.1556/EuJMI.3.2013.3.3; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Dasti JI, 2007, J MED MICROBIOL, V56, P833, DOI 10.1099/jmm.0.47103-0; Eucker TP, 2012, CELL MICROBIOL, V14, P226, DOI 10.1111/j.1462-5822.2011.01714.x; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Friedman C.R., 2000, CAMPYLOBACTER, P121; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; Holden KM, 2012, MICROB PATHOGENESIS, V52, P344, DOI 10.1016/j.micpath.2012.03.004; Javed MA, 2012, INFECT IMMUN, V80, P2361, DOI 10.1128/IAI.00151-12; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Kanipes MI, 2004, INFECT IMMUN, V72, P2452, DOI 10.1128/IAI.72.4.2452-2455.2004; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Lertpiriyapong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042842; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2006, J ANTIMICROB CHEMOTH, V58, P966, DOI 10.1093/jac/dkl374; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Oakland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020084; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Schmidt-Ott R, 2005, J INFECTION, V50, P12, DOI 10.1016/j.jinf.2004.02.013; Schmidt-Ott R, 2006, CLIN VACCINE IMMUNOL, V13, P779, DOI 10.1128/CVI.00065-06; Tareen AM, 2011, MICROBIOL-SGM, V157, P1776, DOI 10.1099/mic.0.045567-0; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; Zautner AE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-171; Zautner AE, 2011, APPL ENVIRON MICROB, V77, P2359, DOI 10.1128/AEM.02403-10	41	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81069	10.1371/journal.pone.0081069	http://dx.doi.org/10.1371/journal.pone.0081069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303031	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400048
J	Wang, TG; Choi, E; Monaco, MCG; Campanac, E; Medynets, M; Do, T; Rao, P; Johnson, KR; Elkahloun, AG; Von Geldern, G; Johnson, T; Subramaniam, S; Hoffman, D; Major, E; Nath, A				Wang, Tongguang; Choi, Elliot; Monaco, Maria Chiara G.; Campanac, Emilie; Medynets, Marie; Thao Do; Rao, Prashant; Johnson, Kory R.; Elkahloun, Abdel G.; Von Geldern, Gloria; Johnson, Tory; Subramaniam, Sriram; Hoffman, Dax; Major, Eugene; Nath, Avindra			Derivation of Neural Stem Cells from Human Adult Peripheral CD34+Cells for an Autologous Model of Neuroinflammation	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; MULTIPLE-SCLEROSIS; DIRECT CONVERSION; PRECURSOR CELLS; ADIPOSE-TISSUE; IPS CELLS; T-CELLS; DIFFERENTIATION; INDUCTION	Proinflammatory factors from activated T cells inhibit neurogenesis in adult animal brain and cultured human fetal neural stem cells (NSC). However, the role of inhibition of neurogenesis in human neuroinflammatory diseases is still uncertain because of the difficulty in obtaining adult NSC from patients. Recent developments in cell reprogramming suggest that NSC may be derived directly from adult fibroblasts. We generated NSC from adult human peripheral CD34+ cells by transfecting the cells with Sendai virus constructs containing Sox2, Oct3/4, c-Myc and Klf4. The derived NSC could be differentiated to glial cells and action potential firing neurons. Co-culturing NSC with activated autologous T cells or treatment with recombinant granzyme B caused inhibition of neurogenesis as indicated by decreased NSC proliferation and neuronal differentiation. Thus, we have established a unique autologous in vitro model to study the pathophysiology of neuroinflammatory diseases that has potential for usage in personalized medicine.	[Wang, Tongguang; Choi, Elliot; Medynets, Marie] NINDS, Translat Neurosci Ctr, NIH, Bethesda, MD 20892 USA; [Choi, Elliot; Von Geldern, Gloria; Johnson, Tory; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bethesda, MD 20892 USA; [Monaco, Maria Chiara G.; Major, Eugene] NINDS, Lab Mol Med & Neurosci, NIH, Bethesda, MD 20892 USA; [Campanac, Emilie; Hoffman, Dax] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Unit, NIH, Bethesda, MD USA; [Thao Do; Rao, Prashant; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Johnson, Tory] NINDS, Bioinformat Sect, NIH, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Wang, TG (corresponding author), NINDS, Translat Neurosci Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	david.wang@nih.gov	Hoffman, Dax A/E-5155-2011	Hoffman, Dax A/0000-0001-6999-2157; Subramaniam, Sriram/0000-0003-4231-4115	NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by intramural funds from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2003, J NEUROSCI, V23, P8513; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Almeida-Porada G, 2005, BRIT J HAEMATOL, V130, P276, DOI 10.1111/j.1365-2141.2005.05588.x; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; AZARI H, 2011, JOVE-J VIS EXP, P3640, DOI DOI 10.3791/2639; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Belicchi M, 2004, J NEUROSCI RES, V77, P475, DOI 10.1002/jnr.20151; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Fischedick G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034645; Giannakopoulou A, 2011, NEUROREPORT, V22, P68, DOI 10.1097/WNR.0b013e32834272eb; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Haile Y, 2011, J IMMUNOL, V187, P4861, DOI 10.4049/jimmunol.1100943; Hao HN, 2003, J HEMATOTH STEM CELL, V12, P23, DOI 10.1089/152581603321210109; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Ideguchi M, 2008, J NEUROSCI RES, V86, P1936, DOI 10.1002/jnr.21652; Jin CH, 2003, GENE THER, V10, P272, DOI 10.1038/sj.gt.3301877; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Lee DY, 2012, CANCER CELL, V22, P131, DOI 10.1016/j.ccr.2012.05.036; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021801; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Lujan E, 2012, CURR OPIN GENET DEV, V22, P517, DOI 10.1016/j.gde.2012.07.002; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Luo HL, 2012, BIOMATERIALS, V33, P4277, DOI 10.1016/j.biomaterials.2012.02.042; Malfuson JV, 2013, LEUKEMIA; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Matsui T, 2012, NEURAL STEM CELLS DI; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Padovan CS, 2003, CELL TRANSPLANT, V12, P839, DOI 10.3727/000000003771000183; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; Reali C, 2006, EXP NEUROL, V197, P399, DOI 10.1016/j.expneurol.2005.10.004; Schneider R, 2011, J IMMUNOL, V187, P4119, DOI 10.4049/jimmunol.1100885; Schwartz L, 2006, CURR HIV RES, V4, P319, DOI 10.2174/157016206777709438; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Shi HY, 2013, NEUROSCI LETT, V532, P70, DOI 10.1016/j.neulet.2012.10.042; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Song B, 2012, STEM CELL RES, V8, P259, DOI 10.1016/j.scr.2011.12.001; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Stevens HE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00059; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zangiacomi V, 2008, STEM CELLS DEV, V17, P1005, DOI 10.1089/scd.2007.0248; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang N., 2010, PLOS CURRENTS, V2; Zhang YG, 2012, STEM CELLS, V30, P510, DOI 10.1002/stem.1006; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhen H-Y, BIOCH BIOPHYSICAL RE	64	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81720	10.1371/journal.pone.0081720	http://dx.doi.org/10.1371/journal.pone.0081720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303066	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400082
J	Wexler-Cohen, Y; Stevens, GC; Barnoy, E; van der Bliek, AM; Johnson, PJ				Wexler-Cohen, Yael; Stevens, Grant C.; Barnoy, Eran; van der Bliek, Alexander M.; Johnson, Patricia J.			A dynamin-related protein contributes to Trichomonas vaginalis hydrogenosomal fission	FASEB JOURNAL			English	Article						organelle division; evolution; parasitology	SINGLE DYNAMIN; GENOME SEQUENCE; MITOCHONDRIAL; MEMBRANE; ENDOCYTOSIS; TINIDAZOLE; ORGANELLES; EVOLUTION; DIVISION; VESICLE	Trichomonas vaginalis is a highly divergent, unicellular eukaryote of the phylum Metamonada, class Parabasalia, and the source of a common sexually transmitted infection. This parasite lacks mitochondria, but harbors an evolutionarily related organelle, the hydrogenosome. We explored the role of dynamin-related proteins (DRPs) in the division of the hydrogenosome. Eight DRP homologues [T. vaginalis DRPs (TvDRPs)], which can be grouped into 3 subclasses, are present in T. vaginalis. We examined 5 TvDRPs that are representative of each subclass, by introducing dominant negative mutations analogous to those known to interfere with mitochondrial division in yeast, worms, and mammals. Microscopic and cell fractionation analyses of parasites expressing one of the mutated TvDRPs (TVAG_350040) demonstrated that this protein localizes to hydrogenosomes. Moreover, these organelles were found to be increased in size and reduced in number in cells expressing this dominant negative protein, relative to parasites expressing the corresponding wild-type TvDRP, the other 4 mutant TvDRPs, or an empty vector control. Our data indicate a role for a TvDRP in the fission of T. vaginalis hydrogenosomes, similar to that described for peroxisomes and mitochondria. These findings reveal a conservation of core components involved in the division of diverse eukaryotic organelles across broad phylogenetic distances.Wexler-Cohen, Y. Stevens, G. C., Barnoy, E. van der Bliek, A. M., Johnson, P. J. A dynamin-related protein contributes to Trichomonas vaginalis hydrogenosomal fission.	[Wexler-Cohen, Yael; Stevens, Grant C.; Johnson, Patricia J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [van der Bliek, Alexander M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA; [Barnoy, Eran] Univ Calif Los Angeles, Dept Biol Stat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Johnson, PJ (corresponding author), Univ Calif Los Angeles, 609 Charles E Young Dr E,1602 Mol Sci Bldg, Los Angeles, CA 90024 USA.	johnsonp@ucla.edu			U.S. National Institutes of Health [AI27857, GM051866]; Long-Term European Molecular Biology Organization (EMBO) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027857, R29AI027857, R01AI027857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051866] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Long-Term European Molecular Biology Organization (EMBO) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Sirus Kohan for assistance with electron microscopic analyses performed at the Electron Microscopy Services Center of the University of California-Los Angeles Brain Research Institute and their colleagues, Dr. Gil Lustig, Angelica Riestra, Olivia Twu, Dr. Clea Mantini, and Dr. Brian Janssen for assistance, support, and insightful comments. This work was funded by U.S. National Institutes of Health grants AI27857 (to P.J.J.) and GM051866 (to A.M.V.) and a Long-Term European Molecular Biology Organization (EMBO) fellowship (to Y.W.-C.).	Benchimol M, 2008, CURR PHARM DESIGN, V14, P872, DOI 10.2174/138161208784041114; Benchimol M, 2008, TISSUE CELL, V40, P61, DOI 10.1016/j.tice.2007.09.006; Benchimol M, 2009, TISSUE CELL, V41, P151, DOI 10.1016/j.tice.2009.01.001; Bui HT, 2012, J CELL BIOL, V199, P613, DOI 10.1083/jcb.201207079; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Delgadillo MG, 1997, P NATL ACAD SCI USA, V94, P4716, DOI 10.1073/pnas.94.9.4716; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Fung HB, 2005, CLIN THER, V27, P1859, DOI 10.1016/j.clinthera.2005.12.012; Gaechter V, 2008, TRAFFIC, V9, P57, DOI 10.1111/j.1600-0854.2007.00657.x; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Hirt RP, 2011, ADV PARASIT, V77, P87, DOI 10.1016/B978-0-12-391429-3.00006-X; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; Narcisi EM, 1996, ANTIMICROB AGENTS CH, V40, P1121, DOI 10.1128/AAC.40.5.1121; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Rahaman A, 2008, CURR BIOL, V18, P1227, DOI 10.1016/j.cub.2008.07.042; Ryan CM, 2011, ESSAYS BIOCHEM, V51, P161, DOI [10.1042/BSE0510161, 10.1042/bse0510161]; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shiflett AM, 2010, ANNU REV MICROBIOL, V64, P409, DOI 10.1146/annurev.micro.62.081307.162826; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065	36	14	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1113	1121		10.1096/fj.13-235473	http://dx.doi.org/10.1096/fj.13-235473			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297697	Green Published			2022-12-25	WOS:000335324800008
J	Niedzielska, M; Bodendorfer, B; Munch, S; Eichner, A; Derigs, M; da Costa, O; Schweizer, A; Neff, F; Nitschke, L; Sparwasser, T; Keyse, SM; Lang, R				Niedzielska, Magdalena; Bodendorfer, Barbara; Muench, Sandra; Eichner, Alexander; Derigs, Marcus; da Costa, Olivia; Schweizer, Astrid; Neff, Frauke; Nitschke, Lars; Sparwasser, Tim; Keyse, Stephen M.; Lang, Roland			Gene Trap Mice Reveal an Essential Function of Dual Specificity Phosphatase Dusp16/MKP-7 in Perinatal Survival and Regulation of Toll-like Receptor (TLR)-induced Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokines; Interferon; Dendritic Cells; Endotoxin; Gene Knock-out; Innate Immunity; Macrophages; MAP Kinases (MAPKs); Dual Specificity Phosphatase; Gene Trap; Perinatal Lethality	PROTEIN-KINASE PHOSPHATASE; MAP KINASE; INTERLEUKIN-12 P40; IMMUNE-RESPONSES; INFLAMMATORY RESPONSES; ACTIVATION; INNATE; MKP-7; IL-12; ERK	MAPK activity is negatively regulated by members of the dual specificity phosphatase (Dusp) family, which differ in expression, substrate specificity, and subcellular localization. Here, we investigated the function of Dusp16/MKP-7 in the innate immune system. The Dusp16 isoforms A1 and B1 were inducibly expressed in macrophages and dendritic cells following Toll-like receptor stimulation. A gene trap approach was used to generate Dusp16-deficient mice. Homozygous Dusp16tp/tp mice developed without gross abnormalities but died perinatally. Fetal liver cells from Dusp16tp/tp embryos efficiently reconstituted the lymphoid and myeloid compartments with Dusp16-deficient hematopoietic cells. However, GM-CSF-induced proliferation of bone marrow progenitors in vitro was impaired in the absence of Dusp16. In vivo challenge with Escherichia coli LPS triggered higher production of IL-12p40 in mice with a Dusp16-deficient immune system. In vitro, Dusp16-deficient macrophages, but not dendritic cells, selectively overexpressed a subset of TLR-induced genes, including the cytokine IL-12. Dusp16-deficient fibroblasts showed enhanced activation of p38 and JNK MAPKs. In macrophages, pharmacological inhibition and siRNA knockdown of JNK1/2 normalized IL-12p40 secretion. Production of IL-10 and its inhibitory effect on IL-12 production were unaltered in Dusp16tp/tp macrophages. Altogether, the Dusp16 gene trap mouse model identifies an essential role in perinatal survival and reveals selective control of differentiation and cytokine production of myeloid cells by the MAPK phosphatase Dusp16.	[Niedzielska, Magdalena; Bodendorfer, Barbara; Derigs, Marcus; Lang, Roland] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Eichner, Alexander; da Costa, Olivia; Sparwasser, Tim] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Schweizer, Astrid; Nitschke, Lars] Univ Erlangen Nurnberg, Dept Biol, Chair Genet, D-91058 Erlangen, Germany; [Neff, Frauke] Helmholtz Ctr Munich, Inst Pathol, D-85764 Neuherberg, Germany; [Muench, Sandra; Keyse, Stephen M.] Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Med Res Inst, Div Canc Res,Canc Res UK Stress Response Lab, Dundee DD1 9SY, Scotland	University of Erlangen Nuremberg; Technical University of Munich; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee	Lang, R (corresponding author), Inst Clin Microbiol Immunol & Hyg, Wasserturmstr 3-5, D-91054 Erlangen, Germany.	roland.lang@uk-erlangen.de	Sparwasser, Tim/AAF-7085-2019; Keyse, Stephen M./B-9575-2009; Sparwasser, Tim D/AAA-4306-2022	Sparwasser, Tim/0000-0001-5645-902X; Keyse, Stephen M./0000-0002-5150-8221; Lang, Roland/0000-0003-0502-3677; Derigs, Marcus/0000-0002-2904-3894	Deutsche Forschungsgemeinschaft [SFB 643, TP A10]; Bayerische Forschungsstiftung; Cancer Research UK Program Grant CR-UK Stress Response Laboratory [C8227/A12053]; Cancer Research UK [12053] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerische Forschungsstiftung; Cancer Research UK Program Grant CR-UK Stress Response Laboratory; Cancer Research UK(Cancer Research UK)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 643, TP A10 (to R. L.) and a Bayerische Forschungsstiftung fellowship (to M. N.). Work in the Keyse laboratory was supported by Cancer Research UK Program Grant CR-UK Stress Response Laboratory C8227/A12053.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Huang J, 2011, J CHEMOTHERAPY, V23, P221, DOI 10.1179/joc.2011.23.4.221; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Musikacharoen T, 2011, J BIOL CHEM, V286, P24896, DOI 10.1074/jbc.M111.245019; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rodriguez N, 2010, J LEUKOCYTE BIOL, V88, P579, DOI 10.1189/jlb.0210083; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wiese M, 2010, J IMMUNOL METHODS, V353, P102, DOI 10.1016/j.jim.2009.12.002; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001; Zhang W, 2013, EUR J IMMUNOL, V43, P258, DOI 10.1002/eji.201242697; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	45	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2112	2126		10.1074/jbc.M113.535245	http://dx.doi.org/10.1074/jbc.M113.535245			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311790	Green Published, hybrid			2022-12-25	WOS:000331130200020
J	Baile, MG; Sathappa, M; Lu, YW; Pryce, E; Whited, K; McCaffery, JM; Han, XL; Alder, NN; Claypool, SM				Baile, Matthew G.; Sathappa, Murugappan; Lu, Ya-Wen; Pryce, Erin; Whited, Kevin; McCaffery, J. Michael; Han, Xianlin; Alder, Nathan N.; Claypool, Steven M.			Unremodeled and Remodeled Cardiolipin Are Functionally Indistinguishable in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Cardiolipin; Membrane Biogenesis; Membrane Lipids; Mitochondria; Mitochondrial Diseases; Phospholipid; Yeast	CYTOCHROME-C-OXIDASE; MULTIDIMENSIONAL MASS-SPECTROMETRY; BARTH-SYNDROME; MITOCHONDRIAL DYSFUNCTION; INTERMEMBRANE SPACE; PHOSPHOLIPASE A(2); RESPIRATORY-CHAIN; OXIDATIVE STRESS; ATP SYNTHASE; MEMBRANE	Background: The phospholipid cardiolipin undergoes acyl chain remodeling after biosynthesis, which has been hypothesized to optimize mitochondrial function. Results: cld1 yeast, containing unremodeled cardiolipin, have no mitochondrial morphology or oxidative phosphorylation defects. Conclusion: Cardiolipin remodeling is not required for optimal mitochondrial bioenergetic function in yeast. Significance: Cardiolipin remodeling may be important for presently unknown mitochondrial processes and/or have unappreciated physiological functions. After biosynthesis, an evolutionarily conserved acyl chain remodeling process generates a final highly homogeneous and yet tissue-specific molecular form of the mitochondrial lipid cardiolipin. Hence, cardiolipin molecules in different organisms, and even different tissues within the same organism, contain a distinct collection of attached acyl chains. This observation is the basis for the widely accepted paradigm that the acyl chain composition of cardiolipin is matched to the unique mitochondrial demands of a tissue. For this hypothesis to be correct, cardiolipin molecules with different acyl chain compositions should have distinct functional capacities, and cardiolipin that has been remodeled should promote cardiolipin-dependent mitochondrial processes better than its unremodeled form. However, functional disparities between different molecular forms of cardiolipin have never been established. Here, we interrogate this simple but crucial prediction utilizing the best available model to do so, Saccharomyces cerevisiae. Specifically, we compare the ability of unremodeled and remodeled cardiolipin, which differ markedly in their acyl chain composition, to support mitochondrial activities known to require cardiolipin. Surprisingly, defined changes in the acyl chain composition of cardiolipin do not alter either mitochondrial morphology or oxidative phosphorylation. Importantly, preventing cardiolipin remodeling initiation in yeast lacking TAZ1, an ortholog of the causative gene in Barth syndrome, ameliorates mitochondrial dysfunction. Thus, our data do not support the prevailing hypothesis that unremodeled cardiolipin is functionally distinct from remodeled cardiolipin, at least for the functions examined, suggesting alternative physiological roles for this conserved pathway.	[Baile, Matthew G.; Lu, Ya-Wen; Whited, Kevin; Claypool, Steven M.] Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Sathappa, Murugappan; Alder, Nathan N.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Pryce, Erin; McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Dept Biol, Baltimore, MD 21218 USA; [Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Connecticut; Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute	Claypool, SM (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	sclaypo1@jhmi.edu	Lu, Ya-Wen/A-7813-2016; Sathappa, Murugappan/AAD-6709-2019	Lu, Ya-Wen/0000-0003-0479-1471; Sathappa, Murugappan/0000-0003-2146-1917; Baile, Matthew/0000-0002-2680-1178; Alder, Nathan/0000-0003-4474-7803; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [R00HL089185, 1R01HL108882]; NCRR [SRR022588A]; National Science Foundation [MCB-1024908]; intramural institutional research funds; Div Of Molecular and Cellular Bioscience [1330695] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108882, R00HL089185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); intramural institutional research funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL089185 and 1R01HL108882 (to S. M. C.) and Grant SRR022588A from NCRR (to J. M. M.). This work was also supported by National Science Foundation Grant MCB-1024908 (to N. N. A.) and intramural institutional research funds (to X. H.).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; [Anonymous], 2010, LIPID ANAL ISOLATION; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; DAUM G, 1982, J BIOL CHEM, V257, P3028; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; EBLE KS, 1990, J BIOL CHEM, V265, P19434; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jarosch E, 1996, J BIOL CHEM, V271, P17219, DOI 10.1074/jbc.271.29.17219; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521; Kim J, 2011, J LIPID RES, V52, P125, DOI 10.1194/jlr.M010520; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Marom M, 2009, BIOCHEMISTRY-US, V48, P11185, DOI 10.1021/bi900998v; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Musatov A, 2006, FREE RADICAL BIO MED, V41, P238, DOI 10.1016/j.freeradbiomed.2006.03.018; OHASHI A, 1982, J BIOL CHEM, V257, P3042; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Panneels V, 2003, BIOCHEM BIOPH RES CO, V300, P65, DOI 10.1016/S0006-291X(02)02795-X; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; POYTON RO, 1975, J BIOL CHEM, V250, P762; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2012, CHEM PHYS LIPIDS, V165, P512, DOI 10.1016/j.chemphyslip.2012.03.001; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Thorsness Mary K, 2002, Methods Mol Biol, V197, P177, DOI 10.1385/1-59259-284-8:177; TZAGOLOFF A, 1975, J BACTERIOL, V122, P826, DOI 10.1128/JB.122.3.826-831.1975; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	78	82	83	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1768	1778		10.1074/jbc.M113.525733	http://dx.doi.org/10.1074/jbc.M113.525733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285538	Green Published, hybrid			2022-12-25	WOS:000332401700047
J	Cramer, JM; Scarsdale, JN; Walavalkar, NM; Buchwald, WA; Ginder, GD; Williams, DC				Cramer, Jason M.; Scarsdale, J. Neel; Walavalkar, Ninad M.; Buchwald, William A.; Ginder, Gordon D.; Williams, David C., Jr.			Probing the Dynamic Distribution of Bound States for Methylcytosine-binding Domains on DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; DNA Binding Protein; DNA Methylation; Nuclear Magnetic Resonance; Protein Dynamics; MBD2; MBD3; Hydroxymethylated DNA; Residual Dipolar Couplings	PRIMARY ERYTHROID-CELLS; METHYL-CPG; CHEMICAL-SHIFTS; COMPLEX; NMR; PROTEINS; MBD2; TRANSCRIPTION; EXPRESSION; MBD3/NURD	Background: Although highly homologous to MBD2, the functional role of MBD3 remains in question. Results: MBD3 preferentially localizes to methylated and, to a lesser degree, unmethylated CpG dinucleotides. Conclusion: Dynamic distribution between methylated and unmethylated sites modifies the genomic localization of MBD3. Significance: Changes in the dynamic distribution on DNA dictate functional differences between MBD proteins. Although highly homologous to other methylcytosine-binding domain (MBD) proteins, MBD3 does not selectively bind methylated DNA, and thus the functional role of MBD3 remains in question. To explore the structural basis of its binding properties and potential function, we characterized the solution structure and binding distribution of the MBD3 MBD on hydroxymethylated, methylated, and unmethylated DNA. The overall fold of this domain is very similar to other MBDs, yet a key loop involved in DNA binding is more disordered than previously observed. Specific recognition of methylated DNA constrains the structure of this loop and results in large chemical shift changes in NMR spectra. Based on these spectral changes, we show that MBD3 preferentially localizes to methylated and, to a lesser degree, unmethylated cytosine-guanosine dinucleotides (CpGs), yet does not distinguish between hydroxymethylated and unmethylated sites. Measuring residual dipolar couplings for the different bound states clearly shows that the MBD3 structure does not change between methylation-specific and nonspecific binding modes. Furthermore, residual dipolar couplings measured for MBD3 bound to methylated DNA can be described by a linear combination of those for the methylation and nonspecific binding modes, confirming the preferential localization to methylated sites. The highly homologous MBD2 protein shows similar but much stronger localization to methylated as well as unmethylated CpGs. Together, these data establish the structural basis for the relative distribution of MBD2 and MBD3 on genomic DNA and their observed occupancy at active and inactive CpG-rich promoters.	[Cramer, Jason M.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Scarsdale, J. Neel] Virginia Commonwealth Univ, Ctr Study Biol Complex, Inst Struct Biol & Drug Design, Richmond, VA 23298 USA; [Scarsdale, J. Neel; Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Buchwald, William A.; Ginder, Gordon D.; Williams, David C., Jr.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Williams, DC (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	david_willjr@med.unc.edu			National Institutes of Health [R01 GM098624, R01 DK029902]; NCI Cancer Center Core Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098624 (to D. C. W.) and R01 DK029902 (to G. D. G.). NMR data were acquired using NMR instrumentation in the Virginia Commonwealth University Massey Cancer Center Structural Biology Core, and surface plasmon resonance data were acquired in the Virginia Commonwealth University Massey Cancer Center Flow Cytometry Core, both of which are supported, in part, by NCI Cancer Center Core Support Grant P30 CA016059.	Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Feng Q, 2001, GENE DEV, V15, P827; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Kransdorf EP, 2006, BLOOD, V108, P2836, DOI 10.1182/blood-2006-04-016394; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Matsumoto M, 2008, GENE, V420, P125, DOI 10.1016/j.gene.2008.05.007; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singal R, 2002, J BIOL CHEM, V277, P1897, DOI 10.1074/jbc.M105580200; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	30	41	44	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1294	1302		10.1074/jbc.M113.512236	http://dx.doi.org/10.1074/jbc.M113.512236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307175	hybrid, Green Published			2022-12-25	WOS:000332401700009
J	Naito-Matsui, Y; Takada, S; Kano, Y; Iyoda, T; Sugai, M; Shimizu, A; Inaba, K; Nitschke, L; Tsubata, T; Oka, S; Kozutsumi, Y; Takematsu, H				Naito-Matsui, Yuko; Takada, Shuhei; Kano, Yoshinobu; Iyoda, Tomonori; Sugai, Manabu; Shimizu, Akira; Inaba, Kayo; Nitschke, Lars; Tsubata, Takeshi; Oka, Shogo; Kozutsumi, Yasunori; Takematsu, Hiromu			Functional Evaluation of Activation-dependent Alterations in the Sialoglycan Composition of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycobiology; Glycoconjugate; Lectin; Sialic Acid; T Cell; Germinal Center; Sialic Acid Modification; Siglec	N-GLYCOLYLNEURAMINIC ACID; B-CELL; PEANUT AGGLUTININ; ACETYLNEURAMINIC ACID; CD169(+) MACROPHAGES; BINDING-RECEPTOR; CUTTING EDGE; DYING CELLS; SIALOADHESIN; EXPRESSION	Background: Sialic acids play key roles in molecular recognition. Results: T-cell activation alters the principal sialic acid species profile, regulating expression of siglec ligands, T-cell activation per se, and T cell-B cell interactions. Conclusion: This activation-dependent change in the sialoglycan profile modulates immune responses. Significance: Pronounced changes in the sialoglycan profile not only serve as cellular markers but also reflect cellular functionality. Sialic acids (Sias) are often conjugated to the termini of cellular glycans and are key mediators of cellular recognition. Sias are nine-carbon acidic sugars, and, in vertebrates, the major species are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), differing in structure at the C5 position. Previously, we described a positive feedback loop involving regulation of Neu5Gc expression in mouse B cells. In this context, Neu5Gc negatively regulated B-cell proliferation, and Neu5Gc expression was suppressed upon activation. Similarly, resting mouse T cells expressed principally Neu5Gc, and Neu5Ac was induced upon activation. In the present work, we used various probes to examine sialoglycan expression by activated T cells in terms of the Sia species expressed and the linkages of Sias to glycans. Upon T-cell activation, sialoglycan expression shifted from Neu5Gc to Neu5Ac, and the linkage shifted from 2,6 to 2,3. These changes altered the expression levels of sialic acid-binding immunoglobulin-like lectin (siglec) ligands. Expression of sialoadhesin and Siglec-F ligands increased, and that of CD22 ligands decreased. Neu5Gc exerted a negative effect on T-cell activation, both in terms of the proliferative response and in the context of activation marker expression. Suppression of Neu5Gc expression in mouse T and B cells prevented the development of nonspecific CD22-mediated T cell-B cell interactions. Our results suggest that an activation-dependent shift from Neu5Gc to Neu5Ac and replacement of 2,6 by 2,3 linkages may regulate immune cell interactions at several levels.	[Naito-Matsui, Yuko; Takada, Shuhei; Kano, Yoshinobu; Kozutsumi, Yasunori; Takematsu, Hiromu] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan; [Iyoda, Tomonori; Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Immunol Lab, Sakyo Ku, Kyoto 6068501, Japan; [Sugai, Manabu; Shimizu, Akira] Kyoto Univ Hosp, Dept Expt Therapeut, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Nitschke, Lars] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany; [Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Oka, Shogo; Takematsu, Hiromu] Kyoto Univ, Dept Biol Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; University of Erlangen Nuremberg; Tokyo Medical & Dental University (TMDU); Kyoto University	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 53 Shogoin Kawahara, Tokyo 6068507, Japan.	htakema@pharm.kyoto-u.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258; Sugai, Manabu/0000-0003-1668-7647; Takematsu, Hiromu/0000-0003-1689-9500	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Suzuken Memorial Foundation; CREST, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25293069, 24659148, 24390073] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Uehara Memorial Foundation; the Suzuken Memorial Foundation; and CREST, Japan Science and Technology Agency.	Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Baum LG, 2009, IMMUNOL REV, V230, P5, DOI 10.1111/j.1600-065X.2009.00800.x; Bi SG, 2009, BBA-GEN SUBJECTS, V1790, P1599, DOI 10.1016/j.bbagen.2009.07.027; Buchlis G, 2013, J IMMUNOL, V191, P228, DOI 10.4049/jimmunol.1202905; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Grabie N, 2002, EUR J IMMUNOL, V32, P2766, DOI 10.1002/1521-4141(2002010)32:10<2766::AID-IMMU2766>3.0.CO;2-0; Gray E. E., 2012, PLOS ONE, V7; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; HATHCOCK KS, 1995, J IMMUNOL, V155, P4575; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kidder D, 2013, J IMMUNOL, V190, P2593, DOI 10.4049/jimmunol.1201172; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koyama S, 1996, GLYCOCONJUGATE J, V13, P353, DOI 10.1007/BF00731467; LASZLO G, 1993, J IMMUNOL, V150, P5252; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; LONDON J, 1978, J IMMUNOL, V121, P438; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Muerkoster S, 1999, BLOOD, V93, P4375, DOI 10.1182/blood.V93.12.4375.412k32_4375_4386; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Redelinghuys P, 2011, J BIOL CHEM, V286, P34522, DOI 10.1074/jbc.M111.243410; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SCHAUER R, 1983, BIOCHEM SOC T, V11, P270, DOI 10.1042/bst0110270; SCHWARTZALBIEZ R, 1990, INT IMMUNOL, V2, P929, DOI 10.1093/intimm/2.10.929; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Soto PC, 2010, J IMMUNOL, V184, P4185, DOI 10.4049/jimmunol.0903420; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	59	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1564	1579		10.1074/jbc.M113.523753	http://dx.doi.org/10.1074/jbc.M113.523753			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297165	Green Published, hybrid			2022-12-25	WOS:000332401700031
J	Berlinguer-Palmini, R; Masi, A; Narducci, R; Cavone, L; Maratea, D; Cozzi, A; Sili, M; Moroni, F; Mannaioni, G				Berlinguer-Palmini, Rolando; Masi, Alessio; Narducci, Roberto; Cavone, Leonardo; Maratea, Dario; Cozzi, Andrea; Sili, Maria; Moroni, Flavio; Mannaioni, Guido			GPR35 Activation Reduces Ca2+ Transients and Contributes to the Kynurenic Acid-Dependent Reduction of Synaptic Activity at CA3-CA1 Synapses	PLOS ONE			English	Article							COUPLED RECEPTOR GPR35; TRANSMITTER RELEASE; ORPHAN RECEPTOR; CYCLIC-AMP; RAT-BRAIN; GLUTAMATE; INHIBITORS; HYDROXYLASE; PATHWAY; TRANSMISSION	Limited information is available on the brain expression and role of GPR35, a Gi/o coupled receptor activated by kynurenic acid (KYNA). In mouse cultured astrocytes, we detected GPR35 transcript using RT-PCR and we found that KYNA (0.1 to 100 mu M) decreased forskolin (FRSK)-induced cAMP production (p<0.05). Both CID2745687 (3 mu M, CID), a recently described GPR35 antagonist, and GPR35 gene silencing significantly prevented the action of KYNA on FRSK-induced cAMP production. In these cultures, we then evaluated whether GPR35 activation was able to modulate intracellular Ca2+ concentration ([Ca2+]i) and [Ca2+]i fluxes. We found that both KYNA and zaprinast, a phosphodiesterase (PDE) inhibitor and GPR35 agonist, did not modify either basal or peaks of [Ca2+]i induced by challenging the cells with ATP (30 mu M). However, the [Ca2+]i plateau phase following peak was significantly attenuated by these compounds in a store-operated Ca2+ channel (SOC)-independent manner. The activation of GPR35 by KYNA and zaprinast was also studied at the CA3-CA1 synapse in the rat hippocampus. Evoked excitatory post synaptic currents (eEPSCs) were recorded from CA1 pyramidal neurons in acute brain slices. The action of KYNA on GPR35 was pharmacologically isolated by using NMDA and alpha 7 nicotinic receptor blockers and resulted in a significant reduction of eEPSC amplitude. This effect was prevented in the presence of CID. Moreover, zaprinast reduced eEPSC amplitude in a PDE5- and cGMP-independent mechanism, thus suggesting that glutamatergic transmission in this area is modulated by GPR35. In conclusion, GPR35 is expressed in cultured astrocytes and its activation modulates cAMP production and [Ca2+]i. GPR35 activation may contribute to KYNA effects on the previously reported decrease of brain extracellular glutamate levels and reduction of excitatory transmission.	[Berlinguer-Palmini, Rolando; Masi, Alessio; Narducci, Roberto; Maratea, Dario; Cozzi, Andrea; Sili, Maria; Moroni, Flavio; Mannaioni, Guido] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Pharmacol & Toxicol, Florence, Italy; [Cavone, Leonardo] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy	University of Florence; University of Florence	Mannaioni, G (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Pharmacol & Toxicol, Florence, Italy.	guido.mannaioni@unifi.it	Palmini, Rolando Berlinguer/K-8764-2013; Masi, Alessio/AAB-4884-2022	Palmini, Rolando Berlinguer/0000-0002-1786-496X; Masi, Alessio/0000-0002-0361-0950; mannaioni, guido/0000-0002-8273-7377	Ente Cassa di Risparmio di Firenze; PRIN Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (Guido Mannaioni)	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); PRIN Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (Guido Mannaioni)(Ministry of Education, Universities and Research (MIUR))	The work was supported by Grant by Ente Cassa di Risparmio di Firenze and by PRIN Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (Guido Mannaioni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2012, BIOCHEM PHARMACOL, V84, P1078, DOI 10.1016/j.bcp.2012.07.030; BOULTON CL, 1994, EUR J NEUROSCI, V6, P1528, DOI 10.1111/j.1460-9568.1994.tb00543.x; BROOME MR, 1994, NEUROPHARMACOLOGY, V33, P1511, DOI 10.1016/0028-3908(94)90056-6; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carpenedo R, 2002, J NEUROCHEM, V82, P1465, DOI 10.1046/j.1471-4159.2002.01090.x; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; CARPENEDO R, 1994, NEUROSCIENCE, V61, P237, DOI 10.1016/0306-4522(94)90227-5; Chiarugi A, 1996, J NEUROCHEM, V67, P692; Cosi C, 2011, NEUROPHARMACOLOGY, V60, P1227, DOI 10.1016/j.neuropharm.2010.11.014; Cozzi A, 1997, EUR J NEUROSCI, V9, P1350, DOI 10.1111/j.1460-9568.1997.tb01489.x; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Deng HY, 2011, J MED CHEM, V54, P7385, DOI 10.1021/jm200999f; Deng HY, 2011, FEBS LETT, V585, P1957, DOI 10.1016/j.febslet.2011.05.026; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Guidetti P, 2007, GLIA, V55, P78, DOI 10.1002/glia.20432; Guo JA, 2008, J PHARMACOL EXP THER, V324, P342, DOI 10.1124/jpet.107.127266; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; LOMBARDI G, 1993, BRIT J PHARMACOL, V110, P1407, DOI 10.1111/j.1476-5381.1993.tb13977.x; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Masi A, 2013, BR J PHARM; Mok MHS, 2009, NEUROPHARMACOLOGY, V57, P242, DOI 10.1016/j.neuropharm.2009.06.003; MORONI F, 1991, J NEUROCHEM, V57, P1630, DOI 10.1111/j.1471-4159.1991.tb06361.x; Moroni F, 2012, J NEURAL TRANSM, V119, P133, DOI 10.1007/s00702-011-0763-x; Nemeth H, 2004, NEUROPHARMACOLOGY, V47, P916, DOI 10.1016/j.neuropharm.2004.06.007; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Ohshiro H, 2008, BIOCHEM BIOPH RES CO, V365, P344, DOI 10.1016/j.bbrc.2007.10.197; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; STONE TW, 1993, PHARMACOL REV, V45, P309; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; VECSEI L, 1991, EUR J PHARMACOL, V196, P239, DOI 10.1016/0014-2999(91)90436-T; Vellani V, 2004, J PHYSIOL-LONDON, V560, P391, DOI 10.1113/jphysiol.2004.067462; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Willoughby D, 2012, BIOCHEM SOC T, V40, P246, DOI 10.1042/BST20110613; Wu ML, 1999, J NEUROCHEM, V73, P1318; Yang YH, 2010, PHARMACOLOGY, V86, P1, DOI 10.1159/000314164; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	52	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82180	10.1371/journal.pone.0082180	http://dx.doi.org/10.1371/journal.pone.0082180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312407	Green Published, gold			2022-12-25	WOS:000327670300075
J	Fukumoto, I; Tamura, A; Matsumura, M; Miura, H; Yui, N				Fukumoto, Izumi; Tamura, Atsushi; Matsumura, Mitsuaki; Miura, Hiroyuki; Yui, Nobuhiko			Sensitization Potential of Dental Resins: 2-Hydroxyethyl Methacrylate and Its Water-Soluble Oligomers Have Immunostimulatory Effects	PLOS ONE			English	Article							HUMAN CELL-LINE; TEST H-CLAT; SKIN SENSITIZATION; IN-VITRO; CONTACT ALLERGY; ROS PRODUCTION; METAL ALLERGY; ACTIVATION; HEMA; EXPRESSION	The immunostimulatory effects of the representative dental resin monomer 2-hydroxyethyl methacrylate (HEMA), a HEMA derivative that does not contain a double bond (2-hydroxyethyl isobutyrate, HEIB), and polymerized water-soluble oligomers of HEMA (PHEMA) were investigated. It is known that expression levels of either or both of CD54 and CD86 in THP-1 cells are increased by exposure to sensitizing substances. In this study, the expression levels of CD54 and CD86, the production of reactive oxygen species (ROS), and the viability of the cells were measured after 24 h of incubation with these materials at different concentrations. The concentrations of the materials that induced the expression of both CD54 and CD86 were low in the following order: NiSO4, HEMA, and methyl methacrylate (MMA). These results indicate that these dental resin monomers have lower sensitizing potentials than NiSO4. Although HEIB, which lacks a double bond, resulted in negligible ROS production and reduced cytotoxicity than HEMA, it induced the expression of CD54 and CD86. Comparison of the results for HEMA and HEIB indicates that dental resin monomer-induced sensitization may be related not only to the oxidative stress related to the methacryloyl group but also to the structures of these compounds. Of particular interest is the result that a water-soluble PHEMA oligomer with a relatively high-molecular weight also exhibited negligible cytotoxicity, whereas the expression level of CD54 increased after exposure to PHEMA at a high concentration. This result serves as a warning that polymerized substances also have the potential to induce sensitization. This study provides insight into the nature of allergic responses to dental resin materials in clinical use and may facilitate the development of more biocompatible restorative materials in the future.	[Fukumoto, Izumi; Matsumura, Mitsuaki; Miura, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Restorat Sci, Tokyo, Japan; [Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tamura, A (corresponding author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo, Japan.	tamura.org@tmd.ac.jp		Tamura, Atsushi/0000-0003-0235-7364	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23107004, 2306]; Torii Pharmaceutical Co. (Tokyo, Japan)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Torii Pharmaceutical Co. (Tokyo, Japan)	This work was financially supported by a Grant-in-Aid for Scientific Research (No. 23107004) on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. Part of this work was financially supported by a Torii Pharmaceutical Co. (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto-Korte K, 2007, CONTACT DERMATITIS, V57, P324, DOI 10.1111/j.1600-0536.2007.01237.x; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275, DOI 10.1177/026119291003800403; Chang CW, 2009, CHEM COMMUN, P3580, DOI 10.1039/b904456f; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Durner J, 2010, DENT MATER, V26, P91, DOI 10.1016/j.dental.2009.08.014; FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x; Fujisawa S, 2001, ARTIF CELL BLOOD SUB, V29, P245, DOI 10.1081/BIO-100103048; Garner Lisa A, 2004, Dermatol Ther, V17, P321, DOI 10.1111/j.1396-0296.2004.04034.x; Goldberg M, 2008, CLIN ORAL INVEST, V12, P1, DOI 10.1007/s00784-007-0162-8; Goon ATJ, 2006, CONTACT DERMATITIS, V55, P219, DOI 10.1111/j.1600-0536.2006.00922.x; Goon ATJ, 2005, CONTACT DERMATITIS, V52, P130, DOI 10.1111/j.0105-1873.2005.00518.x; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; JONTELL M, 1995, J DENT RES, V74, P1162, DOI 10.1177/00220345950740050401; Katsuno K, 1998, J ORAL REHABIL, V25, P180; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Lee J, 2002, J POLYM SCI POL CHEM, V40, P1858, DOI 10.1002/pola.10252; Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50, DOI 10.14573/altex.2011.1.050; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Moad G, 2005, AUST J CHEM, V58, P379, DOI 10.1071/CH05072; Nocca G, 2011, DENT MATER, V27, pE87, DOI 10.1016/j.dental.2011.01.002; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Roth PJ, 2011, MACROMOL RAPID COMM, V32, P1123, DOI 10.1002/marc.201100127; Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014; Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9; Schafer T, 2001, ALLERGY, V56, P1192, DOI 10.1034/j.1398-9995.2001.00086.x; Schram SE, 2010, INT J DERMATOL, V49, P115, DOI 10.1111/j.1365-4632.2009.04307.x; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Vamnes JS, 2004, COMMUNITY DENT ORAL, V32, P150, DOI 10.1111/j.0301-5661.2004.00148.x; Washizaki K, 2002, ENV DERMATOL, V9, P128; Weaver JVM, 2004, MACROMOLECULES, V37, P2395, DOI 10.1021/ma0356358; Yoshida Y, 2003, TOXICOL IN VITRO, V17, P221, DOI 10.1016/S0887-2333(03)00006-7	41	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82540	10.1371/journal.pone.0082540	http://dx.doi.org/10.1371/journal.pone.0082540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312427	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300082
J	Couture, O; Lombardi, E; Davis, K; Hays, E; Chandar, N				Couture, Oliver; Lombardi, Eric; Davis, Kendra; Hays, Emily; Chandar, Nalini			Gene Expression Profiles Resulting from Stable Loss of p53 Mirrors Its Role in Tissue Differentiation	PLOS ONE			English	Article							MYOGENIC DIFFERENTIATION; VITAMIN-D; NOTCH; PROTEIN; IDENTIFICATION; TARGET; TRANSCRIPTION; CASPASE-3; ELEMENT; NUMB	The tumor suppressor gene p53 is involved in a variety of cellular activities such as cellular stress responses, cell cycle regulation and differentiation. In our previous studies we have shown p53's transcription activating role to be important in osteoblast differentiation. There is still a debate in the literature as to whether p53 inhibits or promotes differentiation. We have found p53 heterozygous mice to show a p53 dependency on some bone marker gene expression that is absent in knockout mice. Mice heterozygous for p53 also show a higher incidence of osteosarcomas than p53 knockout mice. This suggests that p53 is able to modify the environment within osteoblasts. In this study we compare changes in gene expression resulting after either a transient or stable reduction in p53. Accordingly we reduced p53 levels transiently and stably in C2C12 cells, which are capable of both myoblast and osteoblast differentiation, and compared the changes in gene expression of candidate genes regulated by the p53 pathway. Using a PCR array to assay for p53 target genes, we have found different expression profiles when comparing stable versus transient knockdown of p53. As expected, several genes with profound changes after transient p53 loss were related to apoptosis and cell cycle regulation. In contrast, stable p53 loss produced a greater change in MyoD and other transcription factors with tissue specific roles, suggesting that long term loss of p53 affects tissue homeostasis to a greater degree than changes resulting from acute loss of p53. These differences in gene expression were validated by measuring promoter activity of different pathway specific genes involved in differentiation. These studies suggest that an important role for p53 is context dependent, with a stable reduction in p53 expression affecting normal tissue physiology more than acute loss of p53.	[Couture, Oliver; Lombardi, Eric; Davis, Kendra; Hays, Emily; Chandar, Nalini] Midwestern Univ, Chicago Coll Osteopath Med, Dept Biochem, Downers Grove, IL 60515 USA	Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine	Chandar, N (corresponding author), Midwestern Univ, Chicago Coll Osteopath Med, Dept Biochem, Downers Grove, IL 60515 USA.	nchand@midwestern.edu			National Institutes of Health [R15 AR055362]; Midwestern University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR055362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwestern University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the National Institutes of Health grant R15 AR055362 to Nalini Chandar and funds from Midwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroszkiewicz J, 2010, ADV MED SCI-POLAND, V55, P266, DOI 10.2478/v10039-010-0043-2; BAI L, 2006, J CANC MOL, V53, P12; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Ceglia L, 2008, MOL ASPECTS MED, V29, P407, DOI 10.1016/j.mam.2008.07.002; CHANDAR N, 1992, BRIT J CANCER, V65, P208, DOI 10.1038/bjc.1992.43; CHANDAR N, 1993, MOL CARCINOGEN, V8, P299, DOI 10.1002/mc.2940080413; Chandar N, 2000, ANTICANCER RES, V20, P2553; Chandar N, 2005, J ORTHOP RES, V23, P1345, DOI 10.1016/j.orthres.2005.04.010; Chen H, 2011, CALCIFIED TISSUE INT, V89, P411, DOI 10.1007/s00223-011-9533-x; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engin F, 2010, BONE, V46, P274, DOI 10.1016/j.bone.2009.05.027; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katoh M, 2006, INT J MOL MED, V18, P517; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Kommagani R, 2010, CELL DEATH DIFFER, V17, P398, DOI 10.1038/cdd.2009.135; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LIAN JB, 1993, J ORAL IMPLANTOL, V19, P105; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Menendez S, 2010, CELL CYCLE, V9, P3887, DOI 10.4161/cc.9.19.13301; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Morimoto I, 2002, GENE CHROMOSOME CANC, V33, P270, DOI 10.1002/gcc.10020; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; Mourikis P, 2012, DEVELOPMENT, V139, P4536, DOI 10.1242/dev.084756; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Roemer K, 2012, ADV EXP MED BIOL, V727, P223, DOI 10.1007/978-1-4614-0899-4_17; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Smith ND, 2003, J UROLOGY, V169, P1219, DOI 10.1097/01.ju.0000056085.58221.80; Sola S, 2013, BBA-GEN SUBJECTS, V1830, P2160, DOI 10.1016/j.bbagen.2012.09.021; Solozobova Valeriya, 2011, World J Biol Chem, V2, P202, DOI 10.4331/wjbc.v2.i9.202; Tamir Y, 1998, ONCOGENE, V17, P347, DOI 10.1038/sj.onc.1201929; TANAKA M, 2013, MUSCLE NERVE, P73355; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2	50	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82494	10.1371/journal.pone.0082494	http://dx.doi.org/10.1371/journal.pone.0082494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312426	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900072
J	Shen, HY; Canas, PM; Garcia-Sanz, P; Lan, JQ; Boison, D; Moratalla, R; Cunha, RA; Chen, JF				Shen, Hai-Ying; Canas, Paula M.; Garcia-Sanz, Patricia; Lan, Jing-Quan; Boison, Detlev; Moratalla, Rosario; Cunha, Rodrigo A.; Chen, Jiang-Fan			Adenosine A(2A) Receptors in Striatal Glutamatergic Terminals and GABAergic Neurons Oppositely Modulate Psychostimulant Action and DARPP-32 Phosphorylation	PLOS ONE			English	Article							CAMP-REGULATED PHOSPHOPROTEIN; MEDIUM SPINY NEURONS; DOPAMINE D-1; SYNAPTIC-TRANSMISSION; RESTRICTED EXPRESSION; MEDIATED INHIBITION; OPTOGENETIC CONTROL; CHRONIC COCAINE; NMDA RECEPTORS; 32 KDA	Adenosine A(2A) receptors (A(2A)R) are located postsynaptically in striatopallidal GABAergic neurons, antagonizing dopamine D-2 receptor functions, and are also located presynaptically at corticostriatal terminals, facilitating glutamate release. To address the hypothesis that these two A(2A)R populations differently control the action of psychostimulants, we characterized A(2A)R modulation of cocaine-induced effects at the level of DARPP-32 phosphorylation at Thr-34 and Thr-75, c-Fos expression, and psychomotor activity using two lines of cell-type selective A(2A)R knockout (KO) mice with selective A(2A)R deletion in GABAergic neurons (striatum-A(2A)R-KO mice), or with A(2A)R deletion in both striatal GABAergic neurons and projecting cortical glutamatergic neurons (forebrain-A(2A)R-KO mice). We demonstrated that striatum-A(2A)R KO mice lacked A(2A)Rs exclusively in striatal GABAergic terminals whereas forebrain-A(2A)R KO mice lacked A(2A)Rs in both striatal GABAergic and glutamatergic terminals leading to a blunted A(2A)R-mediated facilitation of synaptosomal glutamate release. The inactivation of A(2A)Rs in GABAergic neurons reduced striatal DARPP-32 phosphorylation at Thr-34 and increased its phosphorylation at Thr-75. Conversely, the additional deletion of corticostriatal glutamatergic A(2A)Rs produced opposite effects on DARPP-32 phosphorylation at Thr-34 and Thr-75. This distinct modulation of DARPP-32 phosphorylation was associated with opposite responses to cocaine-induced striatal c-Fos expression and psychomotor activity in striatum-A(2A)R KO (enhanced) and forebrain-A(2A)R KO mice (reduced). Thus, A(2A)Rs in glutamatergic corticostriatal terminals and in GABAergic striatal neurons modulate the action of psychostimulants and DARPP-32 phosphorylation in opposite ways. We conclude that A(2A)Rs in glutamatergic terminals prominently control the action of psychostimulants and define a novel mechanism by which A(2A)Rs fine-tune striatal activity by integrating GABAergic, dopaminergic and glutamatergic signaling.	[Shen, Hai-Ying; Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Mol Neuropharmacol Lab, Boston, MA 02118 USA; [Canas, Paula M.; Cunha, Rodrigo A.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Garcia-Sanz, Patricia; Moratalla, Rosario] Inst Salud Carlos III, Inst Cajal, Consejo Super Investigac Cientificas, Madrid, Spain; [Garcia-Sanz, Patricia; Moratalla, Rosario] Inst Salud Carlos III, Ctr Investigac Biomed Red, Madrid, Spain; [Lan, Jing-Quan; Boison, Detlev] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR USA; [Cunha, Rodrigo A.] Univ Coimbra, Fac Med, Coimbra, Portugal	Boston University; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Instituto de Salud Carlos III; Instituto de Salud Carlos III; Universidade de Coimbra	Chen, JF (corresponding author), Boston Univ, Sch Med, Dept Neurol, Mol Neuropharmacol Lab, Boston, MA 02118 USA.	chenjf@bu.edu	Cunha, Rodrigo A/E-7475-2015; Garcia-Sanz, Patricia/H-9814-2015; Boison, Detlev/ABE-6302-2020; Canas, Paula M/Q-2101-2015; Moratalla, Rosario V/H-9280-2015	Cunha, Rodrigo A/0000-0003-2550-6422; Garcia-Sanz, Patricia/0000-0002-8745-4675; Canas, Paula M/0000-0002-4091-6406; Moratalla, Rosario V/0000-0002-7623-8010; Chen, Jiang-Fan/0000-0002-0446-3956; Shen, Hai-Ying/0000-0001-8430-2978; Boison, Detlev/0000-0002-7740-5781	National Institutes of Health (NIH) [NS048995, NS41083-05, NS41083-07]; United States Department of Defense [W81XWH-07-1-0012]; Spanish Ministrie de Ciencia e Innovacion [ISCIII: BFU2010-20664]; Spanish Ministrie de Sanidad y Politica Social [ISCIII: BFU2010-20664]; PNSD; RedRTA [RD06/0001/1011]; CIBERNED; National Institute of Mental Health (NIMH) [R01MH083973]; NIH [R01NS073947];  [PTDC/SAU-NEU/108668/2008];  [DARPA-BAA-09-68]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947, R01NS048995, R01NS041083] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Spanish Ministrie de Ciencia e Innovacion; Spanish Ministrie de Sanidad y Politica Social; PNSD; RedRTA; CIBERNED(Instituto de Salud Carlos III); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) grants NS048995, NS41083-05 and NS41083-07, and United States Department of Defense grant W81XWH-07-1-0012 to JFC, grants of PTDC/SAU-NEU/108668/2008 and DARPA-BAA-09-68 to RAC; grants from the Spanish Ministries de Ciencia e Innovacion and Sanidad y Politica Social, ISCIII: BFU2010-20664, PNSD, RedRTA (RD06/0001/1011) and CIBERNED to RM; National Institute of Mental Health (NIMH) grant R01MH083973 to DB, and a NIH grant R01NS073947. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2005, J NEUROSCI, V25, P8432, DOI 10.1523/JNEUROSCI.1289-05.2005; Bastia E, 2005, NEUROPSYCHOPHARMACOL, V30, P891, DOI 10.1038/sj.npp.1300630; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bonci A, 1996, NEURON, V16, P631, DOI 10.1016/S0896-6273(00)80082-3; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BULFONE A, 1993, J NEUROSCI, V13, P3155; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Cunha RA, 1998, J NEUROSCI, V18, P1987; Cunha RA, 2008, CURR PHARM DESIGN, V14, P1512, DOI 10.2174/138161208784480090; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Fiorillo CD, 2000, J NEUROPHYSIOL, V83, P1307, DOI 10.1152/jn.2000.83.3.1307; Fredduzzi S, 2002, J NEUROSCI, V22, P1054, DOI 10.1523/JNEUROSCI.22-03-01054.2002; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Hack Stephen P., 2003, Critical Reviews in Neurobiology, V15, P235; Harvey J, 1997, J NEUROSCI, V17, P5271; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lindskog M, 1999, NEUROSCIENCE, V88, P1005, DOI 10.1016/S0306-4522(98)00411-4; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Manzoni O, 1998, J NEUROSCI, V18, P7996; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Martire A, 2011, J NEUROCHEM, V116, P273, DOI 10.1111/j.1471-4159.2010.07101.x; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; MORELLI M, 1994, EUR J PHARMACOL, V251, P21, DOI 10.1016/0014-2999(94)90438-3; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088; Pennartz CMA, 2009, CONSCIOUS COGN, V18, P718, DOI 10.1016/j.concog.2009.03.003; POLLACK AE, 1995, NEUROSCIENCE, V68, P721, DOI 10.1016/0306-4522(95)00168-I; Pollack AE, 1996, BRAIN RES, V743, P124, DOI 10.1016/S0006-8993(96)01036-0; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; Quiroz C, 2009, THESCIENTIFICWORLDJO, V9, P1321, DOI 10.1100/tsw.2009.143; Rodrigues RJ, 2008, NEUROBIOL AGING, V29, P1597, DOI 10.1016/j.neurobiolaging.2007.03.025; Rodrigues RJ, 2005, J NEUROCHEM, V92, P433, DOI 10.1111/j.1471-4159.2004.02887.x; Rosin Diane L., 2003, Neurology, V61, pS12; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Sebastiao AM, 2000, TRENDS PHARMACOL SCI, V21, P341, DOI 10.1016/S0165-6147(00)01517-0; Shen HY, 2008, J NEUROSCI, V28, P2970, DOI 10.1523/JNEUROSCI.5255-07.2008; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tozzi A, 2007, NEUROPHARMACOLOGY, V53, P783, DOI 10.1016/j.neuropharm.2007.08.006; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Xiao DQ, 2006, J NEUROSCI, V26, P13548, DOI 10.1523/JNEUROSCI.3554-06.2006; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009; Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313	53	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80902	10.1371/journal.pone.0080902	http://dx.doi.org/10.1371/journal.pone.0080902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312250	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900015
J	Vural, A; McQuiston, TJ; Blumer, JB; Park, C; Hwang, IY; Williams-Bey, Y; Shi, CS; Ma, DZ; Kehrl, JH				Vural, Ali; McQuiston, Travis J.; Blumer, Joe B.; Park, Chung; Hwang, Il-Young; Williams-Bey, Yolanda; Shi, Chong-Shan; Ma, Dzwokai Zach; Kehrl, John H.			Normal Autophagic Activity in Macrophages from Mice Lacking G alpha(i3), AGS3, or RGS19	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ALPHA-INTERACTING PROTEIN; SIGNALING COMPLEX; REGULATOR AGS3; ACTIVATOR; INSULIN; INNATE; G(I3); GAIP; MACROAUTOPHAGY	In macrophages autophagy assists antigen presentation, affects cytokine release, and promotes intracellular pathogen elimination. In some cells autophagy is modulated by a signaling pathway that employs G alpha(i3), Activator of G-protein Signaling-3 (AGS3/GPSM1), and Regulator of G-protein Signaling 19 (RGS19). As macrophages express each of these proteins, we tested their importance in regulating macrophage autophagy. We assessed LC3 processing and the formation of LC3 puncta in bone marrow derived macrophages prepared from wild type, Gnai3(-/-), Gpsm1(-/-), or Rgs19(-/-) mice following amino acid starvation or Nigericin treatment. In addition, we evaluated rapamycin-induced autophagic proteolysis rates by long-lived protein degradation assays and anti-autophagic action after rapamycin induction in wild type, Gnai3(-/-), and Gpsm1(-/-) macrophages. In similar assays we compared macrophages treated or not with pertussis toxin, an inhibitor of GPCR (G-protein couple receptor) triggered G alpha(i) nucleotide exchange. Despite previous findings, the level of basal autophagy, autophagic induction, autophagic flux, autophagic degradation and the anti-autophagic action in macrophages that lacked G alpha(i3), AGS3, or RGS19; or had been treated with pertussis toxin, were similar to controls. These results indicate that while Gai signaling may impact autophagy in some cell types it does not in macrophages.	[Vural, Ali; Park, Chung; Hwang, Il-Young; Williams-Bey, Yolanda; Shi, Chong-Shan; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [McQuiston, Travis J.] NIAID, Translat Mycol Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Ma, Dzwokai Zach] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Medical University of South Carolina; University of California System; University of California Santa Barbara	Kehrl, JH (corresponding author), NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Blumer, Joe/0000-0002-0020-3815; Kehrl, John/0000-0002-6526-159X	National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the intramural program of the National Institutes of Allergy and Infectious Diseases. There was no other source of external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Gohla A, 2007, AUTOPHAGY, V3, P393, DOI 10.4161/auto.4256; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARRIS J, 2009, CURR PROTOC IMMUNOL, pCH14; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lim J, 2012, J BIOL CHEM, V287, P23271, DOI 10.1074/jbc.M112.364281; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mihalache CC, 2012, EXP CELL RES, V318, P1187, DOI 10.1016/j.yexcr.2011.12.021; Mintern JD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00060; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; OgierDenis E, 1997, J BIOL CHEM, V272, P24599, DOI 10.1074/jbc.272.39.24599; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Oner SS, 2013, J BIOL CHEM, V288, P24091, DOI 10.1074/jbc.M112.444505; Oner SS, 2013, J BIOL CHEM, V288, P3003, DOI 10.1074/jbc.M112.418467; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Roberts Esteban A., 2008, V445, P111, DOI 10.1007/978-1-59745-157-4_6; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Swanson MS, 2009, METHOD ENZYMOL, V452, P383, DOI 10.1016/S0076-6879(08)03623-9; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Xu Yi, 2010, Proc Am Thorac Soc, V7, P22, DOI 10.1513/pats.200909-103JS	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81886	10.1371/journal.pone.0081886	http://dx.doi.org/10.1371/journal.pone.0081886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312373	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900058
J	Canene-Adams, K; Sfanos, KS; Liang, CT; Yegnasubramanian, S; Nelson, WG; Brayton, C; De Marzo, AM				Canene-Adams, Kirstie; Sfanos, Karen S.; Liang, Chung-Tiang; Yegnasubramanian, Srinivasan; Nelson, William G.; Brayton, Cory; De Marzo, Angelo M.			Dietary Chemoprevention of PhIP Induced Carcinogenesis in Male Fischer 344 Rats with Tomato and Broccoli	PLOS ONE			English	Article							PROSTATE-CANCER; MEAT MUTAGENS; HETEROCYCLIC AMINES; COLON-CANCER; PREVENTION; RISK; EXPRESSION; VEGETABLES; CONSUMPTION; LYCOPENE	The heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-B] pyridine (PhIP), found in meats cooked at high temperatures, has been implicated in epidemiological and rodent studies for causing breast, prostate, and colorectal cancers. A previous animal study using a xenograft model has shown that whole tomato and broccoli, when eaten in combination, exhibit a marked effect on tumor reduction compared to when eaten alone. Our aim was to determine if PhIP-induced carcinogenesis can be prevented by dietary consumption of whole tomato + broccoli powders. Male Fischer 344 rats (n = 45) were randomized into the following treatment groups: control (AIN93G diet), PhIP (200 ppm in AIN93G diet for the first 20 weeks of the study), or tomato + broccoli + PhIP (mixed in AIN93G diet at 10% each and fed with PhIP for 20 weeks, and then without PhIP for 32 weeks). Study animals were monitored for 52 weeks and were euthanized as necessary based on a set of criteria for health status and tumor burden. Although there appeared to be some hepatic and intestinal toxicity due to the combination of PhIP and tomato + broccoli, these rodents had improved survival and reduced incidence and/or severity of PhIP-induced neoplastic lesions compared to the PhIP-alone treated group. Rats eating tomato + broccoli exhibited a marked decrease in the number and size of cribiform prostatic intraepitheilial neoplasia/carcinoma in situ (cribiform PIN/CIS) lesions and in the incidence of invasive intestinal adenocarcinomas and skin carcinomas. Although the apparent toxic effects of combined PhIP and tomato + broccoli need additional study, the results of this study support the hypothesis that a diet rich in tomato and broccoli can reduce or prevent dietary carcinogen-induced cancers.	[Canene-Adams, Kirstie; Sfanos, Karen S.; De Marzo, Angelo M.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Liang, Chung-Tiang; Brayton, Cory] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Yegnasubramanian, Srinivasan; Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Canene-Adams, K (corresponding author), Texas State Univ, Sch Family & Consumer Sci, Nutr & Foods Program, San Marcos, TX 78666 USA.	ka26@txstate.edu	Brayton, Cory/AAW-4681-2021	Brayton, Cory/0000-0002-6666-6548; Canene-Adams, Kirstie/0000-0003-4617-448X	Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [T32 CA067751]; Prevent Cancer Foundation; Chris and Felicia Evensen Prostate Cancer Foundation Young Investigator [CB RR 007002-34]; Maryland Cigarette Restitution Fund at Johns Hopkins; NATIONAL CANCER INSTITUTE [T32CA067751] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prevent Cancer Foundation; Chris and Felicia Evensen Prostate Cancer Foundation Young Investigator; Maryland Cigarette Restitution Fund at Johns Hopkins; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KCA was funded by a Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32 CA067751). KSS was funded by a Postdoctoral Fellowship Award from the Prevent Cancer Foundation and is currently supported as the Chris and Felicia Evensen Prostate Cancer Foundation Young Investigator (CB RR 007002-34). Support was also provided by the Maryland Cigarette Restitution Fund at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Bogen KT, 2007, PROSTATE CANC PROSTA; Borowsky AD, 2006, NEOPLASIA, V8, P708, DOI 10.1593/neo.06373; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Cerhan JR, 2004, CANCER EPIDEM BIOMAR, V13, P1114; Cross AJ, 2005, CANCER RES, V65, P11779, DOI 10.1158/0008-5472.CAN-05-2191; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Di Paolo OA, 2005, INT J CANCER, V117, P8, DOI 10.1002/ijc.21152; Divisi Duilio, 2006, Acta Biomed, V77, P118; El-Zein R, 2006, MUTAT RES-FUND MOL M, V601, P1, DOI 10.1016/j.mrfmmm.2006.05.023; Enokida H, 2005, INT J CANCER, V116, P174, DOI 10.1002/ijc.21017; Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340; Giovannucci E, 1998, P SOC EXP BIOL MED, V218, P129, DOI 10.3181/00379727-218-44277; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P1403; Giovannucci E, 2002, JNCI-J NATL CANCER I, V94, P391, DOI 10.1093/jnci/94.5.391; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; Gooderham NJ, 2002, MUTAT RES-FUND MOL M, V506, P91, DOI 10.1016/S0027-5107(02)00155-0; Harnack L, 2002, AM J CLIN NUTR, V76, P889, DOI 10.1093/ajcn/76.4.889; HASEGAWA R, 1993, CARCINOGENESIS, V14, P2553, DOI 10.1093/carcin/14.12.2553; Hikosaka A, 2004, CARCINOGENESIS, V25, P381, DOI 10.1093/carcin/bgh031; Hirose M, 2000, CANCER LETT, V155, P79, DOI 10.1016/S0304-3835(00)00411-0; Ikeda Y, 2005, CANCER LETT, V224, P23, DOI 10.1016/j.canlet.2004.10.040; Inaguma S, 2003, CANCER SCI, V94, P974, DOI 10.1111/j.1349-7006.2003.tb01387.x; John EM, 2011, NUTR CANCER, V63, P525, DOI 10.1080/01635581.2011.539311; Keating GA, 2004, J CHROMATOGR B, V802, P127, DOI 10.1016/j.jchromb.2003.10.047; Koh WP, 2005, EUR J CLIN NUTR, V59, P16, DOI 10.1038/sj.ejcn.1602027; Kristal AR, 2002, NUTR CANCER, V42, P1, DOI 10.1207/S15327914NC421_1; Lee Joanne, 2007, Cancer Control, V14, P78; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Li GX, 2012, CANCER PREV RES, V5, P963, DOI 10.1158/1940-6207.CAPR-12-0023; Lin XH, 2001, AM J PATHOL, V159, P1815, DOI 10.1016/S0002-9440(10)63028-3; Mandimika T, 2012, FOOD CHEM, V131, P1272, DOI 10.1016/j.foodchem.2011.09.117; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Nakagama H, 2005, CANCER SCI, V96, P627, DOI 10.1111/j.1349-7006.2005.00107.x; Nakai Y, 2007, CANCER RES, V67, P1378, DOI 10.1158/0008-5472.CAN-06-1336; Nelson CP, 2001, CANCER RES, V61, P103; Oba S, 2006, CANCER LETT, V244, P260, DOI 10.1016/j.canlet.2005.12.037; Panel WCRF, 1997, FOOD NUTR PREV CANC; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Parsons JK, 2001, PROSTATE, V49, P30, DOI 10.1002/pros.1115; Rautalahti M, 1997, CANCER LETT, V114, P235, DOI 10.1016/S0304-3835(97)04672-7; Rodriguez C, 2006, CANCER EPIDEM BIOMAR, V15, P211, DOI 10.1158/1055-9965.EPI-05-0614; Shirai T, 2002, MUTAT RES-FUND MOL M, V506, P129, DOI 10.1016/S0027-5107(02)00159-8; Shirai T, 1997, CANCER RES, V57, P195; Shirai T, 1999, CANCER LETT, V143, P217, DOI 10.1016/S0304-3835(99)00128-7; Smigel K, 1996, J NATL CANCER I, V88, P145, DOI 10.1093/jnci/88.3-4.145; Sonoda T, 2004, CANCER SCI, V95, P238, DOI 10.1111/j.1349-7006.2004.tb02209.x; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Stuart GR, 2000, CANCER RES, V60, P266; Tewari A, 2005, BJU INT, V96, P1247, DOI 10.1111/j.1464-410X.2005.05824.x; Van Horn L, 2010, J AM DIET ASSOC, V110, P1638, DOI 10.1016/j.jada.2010.08.018; Vaughn MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025707; Wang R, 2008, CARCINOGENESIS, V29, P834, DOI 10.1093/carcin/bgn051; Wiseman MJ, 2005, J NUTR, V135, p3037S; Wong KY, 2005, NUTR CANCER, V52, P147, DOI 10.1207/s15327914nc5202_5; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P1120, DOI 10.1158/1055-9965.EPI-05-0782	57	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79842	10.1371/journal.pone.0079842	http://dx.doi.org/10.1371/journal.pone.0079842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312188	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100016
J	Imperiale, A; Moussallieh, FM; Sebag, F; Brunaud, L; Barlier, A; Elbayed, K; Bachellier, P; Goichot, B; Pacak, K; Namer, IJ; Taieb, D				Imperiale, Alessio; Moussallieh, Francois-Marie; Sebag, Frederic; Brunaud, Laurent; Barlier, Anne; Elbayed, Karim; Bachellier, Philippe; Goichot, Bernard; Pacak, Karel; Namer, Izzie-Jacques; Taieb, David			A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; CROSS-VALIDATION; GENE-MUTATIONS; PHEOCHROMOCYTOMA; SPECTROSCOPY; PHENOTYPES; FUMARATE; DATABASE; DISEASE; KREBS	Paragangliomas (PGLs) are frequently associated with germline mutations in genes involved in energy metabolism. The purpose of the present study was to assess whether the tumor metabolomic profile of patients with hereditary and apparently sporadic PGLs enables the distinction of different subtypes of tumors. Twenty-eight unrelated patients with a histological diagnosis of PGLs were included in the present study. Twelve had germline mutations in SDHx genes (5 SDHB, 7 SDHD), 6 VHL, and 10 were apparently sporadic. Intact tumor samples from these patients (one per patient) were evaluated with H-1 high-resolution magic angle spinning (HRMAS) NMR spectroscopy. SDHx-related tumors were characterized by an increase in succinate levels in comparison to other tumor subtypes (p = 0.0001 vs VHL and p = 0.000003 vs apparently sporadic). Furthermore, we found significantly lower values of glutamate in SDHx-related tumors compared to other subtypes (p = 0.0007 vs VHL and p = 0.003 vs apparently sporadic). Moreover, SDHx-tumors also exhibited lower values of ATP/ADP/AMP (p = 0.01) compared to VHL. VHL tumors were found to have the highest values of glutathione (GSH) compared to other tumors. Based on 4 metabolites (succinate, glutamate, GSH, and ATP/ADP/AMP), tumors were accurately distinguished from the other ones on both 3- and 2-class PLS-DA models. The present study shows that HRMAS NMR spectroscopy is a very promising method for investigating the metabolomic profile of various PGLs. The present data suggest the existence of a specific succinate-glutamate hallmark of SDHx PGLs. The relevance of such a metabolomic hallmark is expected to be very useful in designing novel treatment options as well as improving the diagnosis and follow-up of these tumors, including metastatic ones.	[Imperiale, Alessio; Moussallieh, Francois-Marie; Namer, Izzie-Jacques] Univ Hosp Strasbourg, Dept Biophys & Nucl Med, Strasbourg, France; [Imperiale, Alessio; Moussallieh, Francois-Marie; Elbayed, Karim; Namer, Izzie-Jacques] Univ Strasbourg, ICube, UMR 7357, CNRS, Strasbourg, France; [Imperiale, Alessio; Moussallieh, Francois-Marie; Elbayed, Karim; Namer, Izzie-Jacques] Fac Med Strasbourg, FMTS, Strasbourg, France; [Sebag, Frederic] Aix Marseille Univ, La Timone Univ Hosp, Dept Endocrine Surg, Marseille, France; [Brunaud, Laurent] Brabois Univ Hosp, Dept Digest Hepatobiliary & Endocrine Surg, Nancy, France; [Barlier, Anne] Aix Marseille Univ, Concept Hosp, Lab Biochem & Mol Biol, Marseille, France; [Bachellier, Philippe] Univ Hosp Strasbourg, Dept Visceral Surg & Transplantat, Strasbourg, France; [Goichot, Bernard] Univ Hosp Strasbourg, Dept Internal Med Diabet & Metab Disorders, Strasbourg, France; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Taieb, David] Aix Marseille Univ, Dept Biophys & Nucl Med, La Timone Univ Hosp, European Ctr Res Med Imaging, Marseille, France	CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Nancy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; CHU Strasbourg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Imperiale, A (corresponding author), Univ Hosp Strasbourg, Dept Biophys & Nucl Med, Strasbourg, France.	alessio.imperiale@chru-strasbourg.fr	Taieb, Pr. David/M-5219-2017; Brunaud, Laurent/AAW-9384-2020; NAMER, Izzie-Jacques/AAS-7224-2020; Imperiale, Alessio/AAP-7968-2020	Brunaud, Laurent/0000-0001-5182-6660; NAMER, Izzie-Jacques/0000-0003-1822-7759; Goichot, Bernard/0000-0001-7794-1683; Barlier, Anne/0000-0002-3740-6173	Region Alsace; Oseo; Communaute Urbaine de Strasbourg; Conseil Departemental du Bas-Rhin; Bruker BioSpin; University of Strasbourg; Strasbourg University Hospital	Region Alsace(Region Grand-Est); Oseo; Communaute Urbaine de Strasbourg; Conseil Departemental du Bas-Rhin; Bruker BioSpin; University of Strasbourg; Strasbourg University Hospital	This work is part of the CARMeN project and was supported by grants from Region Alsace, Oseo, Communaute Urbaine de Strasbourg, Conseil Departemental du Bas-Rhin, Bruker BioSpin, University of Strasbourg and Strasbourg University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Burgess DJ, 2013, NAT REV CANCER, V13, P437, DOI 10.1038/nrc3551; Burnichon N, 2012, CLIN CANCER RES, V18, P2828, DOI 10.1158/1078-0432.CCR-12-0160; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Ebbels TMD, 2009, PROG NUCL MAG RES SP, V55, P361, DOI 10.1016/j.pnmrs.2009.07.003; Eisenhofer G, 1999, NEW ENGL J MED, V340, P1872, DOI 10.1056/NEJM199906173402404; Eisenhofer G, 2001, J CLIN ENDOCR METAB, V86, P1999, DOI 10.1210/jc.86.5.1999; Eisenhofer G, 2011, ENDOCR-RELAT CANCER, V18, P97, DOI 10.1677/ERC-10-0211; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Feichtinger Rene G, 2011, Front Biosci (Elite Ed), V3, P194, DOI 10.2741/e233; Gill AJ, 2010, HUM PATHOL, V41, P805, DOI 10.1016/j.humpath.2009.12.005; Huang H, 2008, CANCER-AM CANCER SOC, V113, P2020, DOI 10.1002/cncr.23812; Imperiale A, 2013, ENDOCR-RELAT CANCER, V20, P705, DOI 10.1530/ERC-13-0232; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jafri M, 2013, CLIN ENDOCRINOL, V78, P898, DOI 10.1111/cen.12074; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Korpershoek E, 2011, J CLIN ENDOCR METAB, V96, pE1472, DOI 10.1210/jc.2011-1043; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Martinez-Bisbal MC, 2004, NMR BIOMED, V17, P191, DOI 10.1002/nbm.888; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Piccini V, 2012, ENDOCR-RELAT CANCER, V19, P149, DOI 10.1530/ERC-11-0369; Piotto M, 2013, REPRODUCIBLE SAMPLE; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; Rao JU, 2013, CLIN CANCER RES, V19, P3787, DOI 10.1158/1078-0432.CCR-12-3922; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Wishart D.S., 2013, EXPLORING HUMAN META; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2; Yang M, 2013, CANCER CELL, V23, P709, DOI 10.1016/j.ccr.2013.05.015	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80539	10.1371/journal.pone.0080539	http://dx.doi.org/10.1371/journal.pone.0080539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312232	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100047
J	Laddha, NC; Dwivedi, M; Gani, AR; Mansuri, MS; Begum, R				Laddha, Naresh C.; Dwivedi, Mitesh; Gani, Amina R.; Mansuri, Mohmmad Shoab; Begum, Rasheedunnisa			Tumor Necrosis Factor B (TNFB) Genetic Variants and Its Increased Expression Are Associated with Vitiligo Susceptibility	PLOS ONE			English	Article							LYMPHOTOXIN-ALPHA-GENE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MHC CLASS-II; INTERCELLULAR-ADHESION MOLECULE-1; DEPENDENT DIABETES-MELLITUS; MESSENGER-RNA EXPRESSION; GENERALIZED VITILIGO; PROMOTER POLYMORPHISM; AUTOIMMUNE-DISEASES; MYOCARDIAL-INFARCTION	Genetic polymorphisms in TNFB are involved in the regulation of its expression and are found to be associated with various autoimmune diseases. The aim of the present study was to determine whether TNFB +252A/G (rs909253) and exon 3 C/A (rs1041981) polymorphisms are associated with vitiligo susceptibility, and expression of TNFB and ICAM1 affects the disease and progression. We have earlier reported the role of TNFA in autoimmune pathogenesis of vitiligo and we now show involvement of TNFB in vitiligo pathogenesis. The two polymorphisms investigated in the TNFB were in strong link disequilibrium and significantly associated with vitiligo. TNFB and ICAM1 transcripts were significantly increased in compared to controls. Active vitiligo patients showed significant increase in TNFB transcripts compared to stable The genotype-phenotype analysis revealed that TNFB expression levels were higher in patients with GG and AA genotypes as compared to controls. Patients with the early age of onset and female patients showed higher TNFB and ICAM1 expression. Overall, our findings suggest that the increased TNFB transcript levels in vitiligo patients could result, at leat in part, from variations at the genetic level which in turn leads to increased ICAM1 expression. For the first time, we show that TNFB +252A/G and exon 3 C/A polymorphisms are associated with vitiligo susceptibility and influence the TNFB and ICAM1 TNFB +252A/G and exon 3 C/A polymorphisms are associated with vitiligo susceptibility and influence the TNFB and ICAM1 expession. Moreover, the study also emphasizes influence of TNFB and ICAM1 on the disease progression, onset and gender bias for developing vitiligo.	[Laddha, Naresh C.; Dwivedi, Mitesh; Gani, Amina R.; Mansuri, Mohmmad Shoab; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, India.	rasheedunnisab@yahoo.co.in	Dwivedi, Mitesh/Q-1276-2019; Begum, Rasheedunnisa/AAF-2981-2020	Dwivedi, Mitesh/0000-0001-8497-0765; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980	ICMR, New Delhi, India [BMS/Adhoc/122/11-2012]; GSBTM, Gandhinagar, Gujarat, India [GSBTM/MD/PROJECTS/SSA/453/2010-2011]; DBT, New Delhi, India [BT/PR9024/MED/12/332/2007]	ICMR, New Delhi, India(Indian Council of Medical Research (ICMR)); GSBTM, Gandhinagar, Gujarat, India; DBT, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by grants to RB (BMS/Adhoc/122/11-2012) ICMR, New Delhi, India; (GSBTM/MD/PROJECTS/SSA/453/2010-2011), GSBTM, Gandhinagar, Gujarat, India and (BT/PR9024/MED/12/332/2007) DBT, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Ahn Sung Ku, 1994, Yonsei Medical Journal, V35, P404; ALBADRI AMT, 1993, J PATHOL, V169, P203, DOI 10.1002/path.1711690205; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; BETTINOTTI MP, 1993, IMMUNOGENETICS, V37, P449; Beutler B, 1998, BLOOD CELL MOL DIS, V24, P216, DOI 10.1006/bcmd.1998.0187; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Candore G, 2003, BIOMED PHARMACOTHER, V57, P274, DOI 10.1016/S0753-3322(03)00079-9; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; CUI J, 1995, ARCH DERMATOL, V131, P314, DOI 10.1001/archderm.131.3.314; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; DAWKINS RL, 1989, HUM IMMUNOL, V26, P91, DOI 10.1016/0198-8859(89)90094-3; Dwivedi M, 2013, BRIT J DERMATOL, V169, P1114, DOI 10.1111/bjd.12467; Dwivedi M, 2009, BRIT J DERMATOL, V161, P63, DOI 10.1111/j.1365-2133.2009.09140.x; Dwivedi M, 2008, PIGM CELL MELANOMA R, V21, P407, DOI 10.1111/j.1755-148X.2008.00462.x; Dwivedi M, 2013, J INTERF CYTOK RES, V33, P646, DOI 10.1089/jir.2012.0171; Dwivedi M, 2013, J DERMATOL SCI, V71, P195, DOI 10.1016/j.jdermsci.2013.04.026; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; Em S, 2007, PIGM CELL RES, V20, P405, DOI 10.1111/j.1600-0749.2007.00406.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; FUNAHASHI I, 1991, J IMMUNOTHER, V10, P28, DOI 10.1097/00002371-199102000-00005; Gonzalez S, 2003, AM J GASTROENTEROL, V98, P1101, DOI 10.1016/S0002-9270(03)00134-5; Gottenberg JE, 2004, ARTHRITIS RHEUM-US, V50, P570, DOI 10.1002/art.20060; Grimes PE, 2004, J AM ACAD DERMATOL, V51, P52, DOI 10.1016/j.jaad.2003.12.031; Hamid YH, 2005, DIABETOLOGIA, V48, P445, DOI 10.1007/s00125-004-1659-1; HARNING R, 1991, J INVEST DERMATOL, V97, P1078, DOI 10.1111/1523-1747.ep12492607; Hasegawa M, 1997, J RHEUMATOL, V24, P663; Hedley SJ, 1998, BRIT J DERMATOL, V139, P965; Huang Carol L, 2002, Am J Clin Dermatol, V3, P301, DOI 10.2165/00128071-200203050-00001; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Kemp E H, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003362; Kemp EH, 1997, J INVEST DERMATOL, V109, P69, DOI 10.1111/1523-1747.ep12276556; Kim TG, 1996, HUM IMMUNOL, V46, P10, DOI 10.1016/0198-8859(95)00170-0; KOBAYASHI Y, 1986, J BIOCHEM-TOKYO, V100, P727, DOI 10.1093/oxfordjournals.jbchem.a121765; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Laddha NC, 2008, J DERMATOL SCI, V49, P260, DOI 10.1016/j.jdermsci.2007.10.002; Laddha NC, 2013, FREE RADICAL BIO MED, V65, P1110, DOI 10.1016/j.freeradbiomed.2013.08.189; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; Le Gal FA, 2001, J INVEST DERMATOL, V117, P1464, DOI 10.1046/j.0022-202x.2001.01605.x; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Lee SH, 1997, LUPUS, V6, P603, DOI 10.1177/096120339700600708; Lucas R, 1997, J LEUKOCYTE BIOL, V61, P551, DOI 10.1002/jlb.61.5.551; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; Mandelcorn-Monson RL, 2003, J INVEST DERMATOL, V121, P550, DOI 10.1046/j.1523-1747.2003.12413.x; MARKLUND SL, 1992, J BIOL CHEM, V267, P6696; Martinez-Esparza M, 1998, EUR J BIOCHEM, V255, P139, DOI 10.1046/j.1432-1327.1998.2550139.x; McHugh NJ, 2006, ANN RHEUM DIS, V65, P488, DOI 10.1136/ard.2005.039842; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; MORELLI JG, 1993, J INVEST DERMATOL, V100, pS191; Moretti S, 2002, ARCH DERMATOL, V138, P273, DOI 10.1001/archderm.138.2.273; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; NATH SK, 1994, AM J HUM GENET, V55, P981; ORTONNE JP, 1993, PIGM CELL RES, V6, P61, DOI 10.1111/j.1600-0749.1993.tb00584.x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; POCIOT F, 1993, EUR J IMMUNOL, V23, P224, DOI 10.1002/eji.1830230135; Reimann E, 2012, HUM IMMUNOL, V73, P393, DOI 10.1016/j.humimm.2012.01.011; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; Shajil E. M., 2006, Indian Journal of Dermatology, V51, P100; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Smerdel-Ramoya A, 2005, RHEUMATOLOGY, V44, P1368, DOI 10.1093/rheumatology/kei015; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; STEINMAN L, 1995, CELL, V80, P7, DOI 10.1016/0092-8674(95)90443-3; Sun XK, 2006, INT J DERMATOL, V45, P1176, DOI 10.1111/j.1365-4632.2006.02907.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Whichelow CE, 1996, EUR J IMMUNOGENET, V23, P425, DOI 10.1111/j.1744-313X.1996.tb00133.x; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yagi H, 1997, EUR J DERMATOL, V7, P19; Yamada A, 2004, J MOL MED, V82, P477, DOI 10.1007/s00109-004-0556-x; YOHN JJ, 1990, J INVEST DERMATOL, V95, P233, DOI 10.1111/1523-1747.ep12478093; Zeff RA, 1997, J AM ACAD DERMATOL, V37, P620, DOI 10.1016/S0190-9622(97)70181-6; Zhang J, 1997, Chin Med Sci J, V12, P107; Zhang XJ, 2005, J DERMATOL SCI, V39, P137, DOI 10.1016/j.jdermsci.2005.06.004	86	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81736	10.1371/journal.pone.0081736	http://dx.doi.org/10.1371/journal.pone.0081736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312346	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100095
J	Macias, D; Garcia-Gorriz, E; Stips, A				Macias, Diego; Garcia-Gorriz, Elisa; Stips, Adolf			Understanding the Causes of Recent Warming of Mediterranean Waters. How Much Could Be Attributed to Climate Change?	PLOS ONE			English	Article							SEA; VARIABILITY; TRENDS	During the decades, Mediterranean waters have been warming at a rather high rate resulting in scientific and end is observed in satellite data, field data and model simulations, and affects both surface Mediterranean basin. However, the warming rate is regionally different and seems to question of what causes underlie the observed trends. Here, we analyze available on on sea surface temperature (SST) from he last 25 years using spectral techniques and find that more warming tendency during this period is due to a non-linear, wave-like tendency. Using a state of the a hydrodynamic model, we perform a hindcast simulation and obtain the simulated SST evolution of h Mediterranean basin or the last 52 years. These SST results show a clear sinusoidal tendency that follows the Atlantic Multidecadal Oscillation (AMO) during the simulation period. Our results reveal that 58% of recent warming in Mediterranean waters could be attributed to this AMO-like oscillation, being anthropogenic-induced climate change only responsible for 42% of total trend The observed acceleration of water warming during the 1990s therefore appears to be caused by a superimposition of anthropogenic-induced warming with the positive phase of he AMO, while the recent slowdown of this tendency is likely due to a shift in the AMO phase. It has been proposed that hi change in the AMO phase will mask the effect of warming in the forthcoming decades, and our results indicate that he same could also be applicable to the Mediterranean Henceforth, natural multidecadal temperature oscillations should be taken into account to avoid underestimation of anthropogenic-induced warming of the Mediterranean basin in the future.	[Macias, Diego; Garcia-Gorriz, Elisa; Stips, Adolf] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Res Unit, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Macias, D (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Res Unit, I-21020 Ispra, Italy.	diego.macias-moy@jrc.ec.europa.eu	Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X				Bethoux JP, 1996, J MARINE SYST, V7, P383, DOI 10.1016/0924-7963(95)00008-9; Burchard H., 2002, TECHNICAL REPORT; de Madron XD, 2011, PROG OCEANOGR, V91, P97, DOI 10.1016/j.pocean.2011.02.003; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Ghil M, 2000, REV GEOPHYS, V40, P1; Herrmann M, 2008, CONT SHELF RES, V28, P2092, DOI 10.1016/j.csr.2008.03.003; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knudsen MF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1186; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Macias D, 2007, J MAR RES, V65, P523, DOI 10.1357/002224007782689085; Macias D, 2014, J MARINE SYST, V135, P150, DOI 10.1016/j.jmarsys.2013.04.014; Macias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030436; Marullo S, 2007, OCEAN SCI, V3, P299, DOI 10.5194/os-3-299-2007; Marullo S, 2011, J CLIMATE, V24, P4385, DOI 10.1175/2011JCLI3884.1; Nye JA, 2014, J MARINE SYST, V133, P103, DOI 10.1016/j.jmarsys.2013.02.006; Nykjaer L, 2009, CLIM RES, V39, P11, DOI 10.3354/cr00794; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Stips A, 2004, OCEAN DYNAM, V54, P266, DOI 10.1007/s10236-003-0077-0; Vargas-Yanez M, 2008, GLOBAL PLANET CHANGE, V63, P177, DOI 10.1016/j.gloplacha.2007.09.001; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; Zhou JS, 2013, J ATMOS SCI, V70, P3, DOI 10.1175/JAS-D-12-0208.1; [No title captured]	26	60	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81591	10.1371/journal.pone.0081591	http://dx.doi.org/10.1371/journal.pone.0081591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312322	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100087
J	Negrao, AB; Pereira, AC; Guindalini, C; Santos, HC; Messas, GP; Laranjeira, R; Vallada, H				Negrao, Andre Brooking; Pereira, Alexandre Costa; Guindalini, Camila; Santos, Hadassa Campos; Messas, Guilherme Peres; Laranjeira, Ronaldo; Vallada, Homero			Butyrylcholinesterase Genetic Variants: Association with Cocaine Dependence and Related Phenotypes	PLOS ONE			English	Article							K-VARIANT; BCHE GENE; RISK; DRD2; POLYMORPHISMS; ABUSE; CHOLINESTERASE; HAPLOTYPE; GENOTYPES; MUTATION	Objective: The search for genetic vulnerability factors in cocaine dependence has focused on the role that neuroplasticity plays in addiction. However, like many other drugs, the ability of an individual to metabolize cocaine can also influence susceptibility to dependence. Butyrylcholinesterase (BChE) metabolizes cocaine, and genetic variants of the BChE gene (BCHE) alter its catalytic activity. Therefore, we hypothesize that cocaine users with polymorphisms in BCHE can show diverse addictive behaviors due to differences in effective plasma concentrations of cocaine. Those polymorphisms might also influence users to prefer one of the two main preparations (crack or powder cocaine), despite having equal access to both. The present work investigates polymorphisms in BCHE and if those genetic variants constitute risk factors for cocaine dependence and for crack cocaine use. Methods: A total of 1,436 individuals (698 cocaine-dependent patients and 738 controls) were genotyped for three single nucleotide polymorphisms (SNPs) in BCHE: rs1803274, rs4263329, and rs4680662. Results: For rs4263329, a nominal difference was found between cases and controls. For rs1803274 (the functional SNP), a statistically significant difference was found between patients who used crack cocaine exclusively and those who used only powder cocaine (P = 0.027; OR = 4.36; 95% CI = 1.18-16.04). Allele frequencies and genotypes related to other markers did not differ between cases and controls or between the two cocaine subgroups. Conclusions: Our findings suggest that the AA genotype of rs1803274 is a risk factor for crack cocaine use, which is more addictive than powder cocaine use. Further studies are needed in order to confirm this preliminary result and clarify the role of BCHE and its variants in cocaine dependence.	[Negrao, Andre Brooking; Vallada, Homero] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat LIM 23, Sao Paulo, Brazil; [Negrao, Andre Brooking; Pereira, Alexandre Costa; Santos, Hadassa Campos] Univ Sao Paulo, Sch Med, Lab Genet & Mol Cardiol LIM 13, Heart Inst InCor, Sao Paulo, Brazil; [Guindalini, Camila] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Guindalini, Camila] Univ Fed Sao Paulo, Dept Psychiat, Clin Neurosci Lab, Sao Paulo, Brazil; [Messas, Guilherme Peres] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil; [Laranjeira, Ronaldo] Univ Fed Sao Paulo, Natl Inst Alcohol & Drug Policies, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Negrao, AB (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat LIM 23, Sao Paulo, Brazil.	negrao@me.com	Pereira, Alexandre/HHN-1038-2022; Vallada, Homero/D-1333-2014; MESSAS, GUILHERME P/B-8916-2014; Negrao, Andre Brooking/C-9526-2014	Vallada, Homero/0000-0001-5123-8295; Guindalini, Camila/0000-0002-6278-5881; Negrao, Andre Brooking/0000-0002-8133-6723	CNPq - Brazilian Foundation for Scientific and Technological Development [141762/2008-0]	CNPq - Brazilian Foundation for Scientific and Technological Development	The first author was partially support by CNPq - Brazilian Foundation for Scientific and Technological Development (Grant 141762/2008-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALLDERDICE PW, 1991, GENOMICS, V11, P452, DOI 10.1016/0888-7543(91)90154-7; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; Ballon N, 2007, AM J MED GENET B, V144B, P1034, DOI 10.1002/ajmg.b.30540; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Blaho K, 2000, AM J EMERG MED, V18, P593, DOI 10.1053/ajem.2000.9282; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Chen CY, 2004, PSYCHOPHARMACOLOGY, V172, P78, DOI 10.1007/s00213-003-1624-6; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107; Dunn John, 2000, Revista Brasileira de Psiquiatria, V22, P11, DOI 10.1590/S1516-44462000000100004; Farrer LA, 2009, ARCH GEN PSYCHIAT, V66, P267, DOI 10.1001/archgenpsychiatry.2008.538; Fernandez-Castillo N, 2010, PSYCHIAT GENET, V20, P317, DOI 10.1097/YPG.0b013e32833b6320; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gelernter J, 2005, AM J MED GENET B, V136B, P45, DOI 10.1002/ajmg.b.30189; Genro JP, 2008, AM J MED GENET B, V147B, P1568, DOI 10.1002/ajmg.b.30863; Goodall R, 2004, ANN CLIN BIOCHEM, V41, P98, DOI 10.1258/000456304322879971; GOSSOP M, 1994, BRIT J PSYCHIAT, V164, P660, DOI 10.1192/bjp.164.5.660; Guindalini C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-10; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Howard TD, 2010, ENVIRON HEALTH PERSP, V118, P1395, DOI 10.1289/ehp.0901764; Kamendulis LM, 1996, J PHARMACOL EXP THER, V279, P713; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P1313, DOI 10.1001/archpsyc.64.11.1313; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Lohoff FW, 2010, NEUROSCI LETT, V473, P87, DOI 10.1016/j.neulet.2010.02.021; Magura S, 1996, SUBST USE MISUSE, V31, P1131, DOI 10.3109/10826089609063969; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; Mikami LR, 2008, PHARMACOGENET GENOM, V18, P213, DOI 10.1097/FPC.0b013e3282f5107e; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raygani AV, 2004, NEUROSCI LETT, V371, P142, DOI 10.1016/j.neulet.2004.08.057; Stapleton JA, 2007, ADDICT BIOL, V12, P221, DOI 10.1111/j.1369-1600.2007.00058.x; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Vaisi-Raygani A, 2010, MOL BIOL REP, V37, P2083, DOI 10.1007/s11033-009-9666-4; Volkow ND, 2000, LIFE SCI, V67, pPL1507	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80505	10.1371/journal.pone.0080505	http://dx.doi.org/10.1371/journal.pone.0080505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312228	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100044
J	Rawal, S; Atia, M; Nisenbaum, R; Pare, DE; Joorden, S; Hwang, SW				Rawal, Shail; Atia, Mina; Nisenbaum, Rosane; Pare, Dwayne E.; Joorden, Steve; Hwang, Stephen W.			Is "Appearing Chronically Ill" a Sign of Poor Health? A Study of Diagnostic Accuracy	PLOS ONE			English	Article								Objective: To determine the sensitivity and specificity of a physician's assessment that a patient "appears chronically ill" for the detection of poor health status. Methods: The health status of 126 adult outpatients was determined using the 12-Item Short Form Health Survey (SF-12). Physician participants (n = 111 residents and faculty) viewed photographs of each patient participant and assessed whether or not the patient appeared chronically ill. For the entire group of physicians, the median sensitivity and specificity of "appearing chronically ill" for the detection of poor health status (defined as SF-12 physical health score below age group norms by at least 1 SD) were calculated. The study took place from February 2009 to January 2011. Results: Forty-two participants (33%) had an SF-12 physical health score >= 1 SD below age group norms, and 22 (18%) had a score >= 2 SD below age group norms. When poor health status was defined as an SF-12 physical score >= 1 SD below age group norms, the median sensitivity was 38.1% (IQR 28.6-47.6%), specificity 78.6% (IQR 69.0-84.0%), positive likelihood ratio 1.64 (IQR 1.42-2.15), and negative likelihood ratio 0.82 (IQR 0.74-0.87). For an SF-12 physical score >= 2 SD below age group norms, the median sensitivity was 45.5% (IQR 36.4-54.5%), specificity 76.9% (IQR 66.3-83.7%), positive likelihood ratio 1.77 (IQR 1.49-2.25), and negative likelihood ratio 0.75 (IQR 0.66-0.86). Conclusions: Our study suggests that a physician's assessment that a patient "appears chronically ill'' has poor sensitivity and modest specificity for the detection of poor health status in adult outpatients. The associated likelihood ratios indicate that this assessment may have limited diagnostic value.	[Rawal, Shail] Univ Toronto, Dept Med, Toronto, ON, Canada; [Atia, Mina; Nisenbaum, Rosane; Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Pare, Dwayne E.; Joorden, Steve] Univ Toronto Scarborough, Dept Psychol, Ctr Computat Cognit Neurosci, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Scarborough	Hwang, SW (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	hwangs@smh.ca	Hwang, Stephen W./GVR-7773-2022		Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	The Centre for Research on Inner City Health gratefully acknowledges the support of the Ontario Ministry of Health and Long-Term Care. The views expressed in this publication are the views of the authors and do not necessarily reflect the views of the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickely LS, 2007, BATES GUIDE PHYS EXA; Desai NR, 2009, NEW ENGL J MED, V360, P1016, DOI 10.1056/NEJMcps0805508; GJORUP T, 1982, ACTA MED SCAND, V212, P325; GJORUP T, 1989, J INTERN MED, V226, P123, DOI 10.1111/j.1365-2796.1989.tb01366.x; Hwang SW, 2011, J GEN INTERN MED, V26, P136, DOI 10.1007/s11606-010-1537-0; Kay J, 2008, NEW ENGL J MED, V358, P827, DOI 10.1056/NEJMcpc0708697; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Meyer GS, 2007, NEW ENGL J MED, V357, P807, DOI 10.1056/NEJMcpc079020; Swartz MH, 2002, TXB PHYS DIAGNOSIS H	9	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79934	10.1371/journal.pone.0079934	http://dx.doi.org/10.1371/journal.pone.0079934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312192	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100020
J	Yi, HS; Hallowell, N; Griffiths, S; Leung, TY				Yi, Huso; Hallowell, Nina; Griffiths, Sian; Leung, Tak Yeung			Motivations for Undertaking DNA Sequencing-Based Non-invasive Prenatal Testing for Fetal Aneuploidy: A Qualitative Study with Early Adopter Patients in Hong Kong	PLOS ONE			English	Article							MATERNAL PLASMA; DOWN-SYNDROME; ETHICAL CONSIDERATIONS; HEALTH-PROFESSIONALS; DIAGNOSIS; TRISOMY-21; ATTITUDES; MEDICINE; BLOOD; SERUM	Background: A newly introduced cell-free fetal DNA sequencing based non-invasive prenatal testing (DNA-NIPT) detects Down syndrome with sensitivity of 99% at early gestational stage without risk of miscarriage. Attention has been given to its public health implications; little is known from consumer perspectives. This qualitative study aimed to explore women's motivations for using, and perceptions of, DNA-NIPT in Hong Kong. Methods and Findings: In-depth interviews were conducted with 45 women who had undertaken DNA-NIPT recruited by purposive sampling based on socio-demographic and clinical characteristics. The sample included 31 women identified as high-risk from serum and ultrasound based Down syndrome screening (SU-DSS). Thematic narrative analysis examined informed-decision making of the test and identified the benefits and needs. Women outlined a number of reasons for accessing DNA-NIPT: reducing the uncertainty associated with risk probability-based results from SU-DSS, undertaking DNA-NIPT as a comprehensive measure to counteract risk from childbearing especially at advanced age, perceived predictive accuracy and absence of risk of harm to fetus. Accounts of women deemed high-risk or not high-risk are distinctive in a number of respects. High-risk women accessed DNA-NIPT to get a clearer idea of their risk. This group perceived SU-DSS as an unnecessary and confusing procedure because of its varying, protocol-dependent detection rates. Those women not deemed high-risk, in contrast, undertook DNA-NIPT for psychological assurance and to reduce anxiety even after receiving the negative result from SU-DSS. Conclusions: DNA-NIPT was regarded positively by women who chose this method of screening over the routine, less expensive testing options. Given its perceived utility, health providers need to consider whether DNA-NIPT should be offered as part of universal routine care to women at high-risk for fetal aneuploidy. If this is the case, then further development of guidelines and quality assurance will be needed to provide a service suited to patients' needs.	[Yi, Huso; Griffiths, Sian] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Global Hlth, Hlth Eth & Med Humanities Unit, Shatin, Hong Kong, Peoples R China; [Hallowell, Nina] PHG Fdn, Cambridge, England; [Leung, Tak Yeung] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yi, HS (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Global Hlth, Hlth Eth & Med Humanities Unit, Shatin, Hong Kong, Peoples R China.	husoyi@cuhk.edu.hk	Yi, Huso/X-8902-2018	Yi, Huso/0000-0003-4724-5235	University Grants Committee (UGC) of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]	University Grants Committee (UGC) of the Government of the Hong Kong Special Administrative Region, China	The study was supported by the University Grants Committee (UGC) of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). The study sponsor had no role in the study design; collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; [Anonymous], 2012, OBSTET GYNECOL, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ashworth P., 2008, QUALITATIVE PSYCHOL; BAKER C, 1992, J ADV NURS, V17, P1355, DOI 10.1111/j.1365-2648.1992.tb01859.x; Benn P, 2012, ULTRASOUND OBST GYN, V39, P127, DOI 10.1002/uog.11083; Benn P, 2011, PRENATAL DIAG, V31, P519, DOI 10.1002/pd.2730; Benn PA, 2010, CURR OPIN OBSTET GYN, V22, P128, DOI 10.1097/GCO.0b013e3283372352; Benn PA, 2009, JAMA-J AM MED ASSOC, V301, P2154, DOI 10.1001/jama.2009.707; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bindra R, 2002, ULTRASOUND OBST GYN, V20, P219, DOI 10.1046/j.1469-0705.2002.00808.x; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Deans Z, 2012, J MED ETHICS, V38, P614, DOI 10.1136/medethics-2011-100180; Deans Z, 2011, HEALTH CARE ANAL, V19, P122, DOI 10.1007/s10728-010-0146-8; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Glaser B, 1978, DISCOV GROUNDED THEO; Glaser B.G, 1978, THEORETICAL SENSITIV; Greenhalgh T, 1999, BRIT MED J, V318, P48; Hill M, 2012, GENET MED, V14, P905, DOI 10.1038/gim.2012.68; Hong Kong Demographic Statistics Section, 2011, AG SPEC FERT RAT HON; International Society for Prenatal Diagnosis, 2011, PREN DET DOWN SYNDR; Kagan KO, 2010, ULTRASOUND OBST GYN, V36, P542, DOI 10.1002/uog.7663; Kelly SE, 2012, PUBLIC HEALTH GENOM, V15, P73, DOI 10.1159/000331254; Kent A, 2008, SEMIN FETAL NEONAT M, V13, P109, DOI 10.1016/j.siny.2007.12.009; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P2616, DOI 10.3109/14767058.2012.712569; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Milligan E, 2011, ETHICS CONSENT CHOIC; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Newson AJ, 2008, SEMIN FETAL NEONAT M, V13, P103, DOI 10.1016/j.siny.2007.12.004; Nicolaides K H, 2002, J Matern Fetal Neonatal Med, V12, P9; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Priest Helena, 2003, Nurse Res, V10, P50; Public NSGCPolicy Committee, 2012, NON PREN TEST NON PR; QSR International Ltd, 2012, NVIVO QUAL DAT AN SO; Sahota DS, 2013, HONG KONG MED J, V19, P101; Sayres LC, 2011, PRENATAL DIAG, V31, P1070, DOI 10.1002/pd.2835; Sayres LC, 2011, OBSTET GYNECOL SURV, V66, P431, DOI 10.1097/OGX.0b013e31822dfbe2; Schmitz D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2690; Schmitz D, 2009, NAT REV GENET, V10, P515, DOI 10.1038/nrg2631; Skirton H, 2013, PRENATAL DIAG, V33, P532, DOI 10.1002/pd.4094; Smith RP, 2006, PRENATAL DIAG, V26, P631, DOI 10.1002/pd.1476; Spencer K, 2001, BRIT J OBSTET GYNAEC, V108, P1043; van den Heuvel A, 2010, PATIENT EDUC COUNS, V78, P24, DOI 10.1016/j.pec.2009.05.014; Verweij EJ, 2012, FETAL DIAGN THER, V31, P81, DOI 10.1159/000333060; Wright CF, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2451; Yotsumoto J, 2012, PRENATAL DIAG, V32, P674, DOI 10.1002/pd.3886; [No title captured]	50	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81794	10.1371/journal.pone.0081794	http://dx.doi.org/10.1371/journal.pone.0081794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312358	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100099
J	Yue-Chun, L; Cheng, Z; Jun, H; Jun-Hua, C; Jing-Lin, Z; Jia-Feng, L				Yue-Chun, Li; Cheng, Zheng; Jun, Hong; Jun-Hua, Cheng; Jing-Lin, Zhao; Jia-Feng, Lin			Catheter Ablation of Idiopathic Premature Ventricular Contractions and Ventricular Tachycardias Originating from the Vicinity of Endocardial and Epicardial Mitral Annulus	PLOS ONE			English	Article							OUTFLOW TRACT TACHYCARDIA; ARRHYTHMIAS	Background: Several previous reports have revealed that idiopathic ventricular arrhythmias (VAs), including premature ventricular contractions (PVCs) and ventricular tachycardias (IVTs), can originate from endocardial mitral annulus (ENDO MA). However, these data are limited to ENDO MA VAs, and little is known about the electrocardiographic (ECG) characteristics and the efficacy of radiofrequency catheter ablation (RFCA) via the coronary venous system for the VAs arising from the epicardial MA (EPI MA). Methodology/Principal Findings: Characteristics of body surface electrocardiogram and electrophysiologic recordings were analyzed in 21 patients with symptomatic PVCs/IVTs originating from the vicinity of MA. Among 597 patients with PVCs/IVTs, the incidence of VAs originating from the ENDO and EPI MA was 3.52% (21 cases). Eleven (52%) from the ENDO MA, and 10 (48%) from the EPI MA. There were different characteristics of ECG of PVCs/VT originating from the ENDO and EPI MA. The prolonged pseudodelta wave time and intrinsicoid deflection time in lead V2 and the precordial maximum deflection index reliably differentiated EPI MA VAs from ENDO MA VAs with high sensitivity and specificity. Successful RFCA in 18 patients could be achieved (85.7% acute procedural success). Conclusions/Significance: ECG characteristics of PVCs/VTs originating from the different portions of the MA are different, and can help regionalize the origin of these arrhythmias. RFCA within the coronary venous system was relatively effective and safe for the PVCs/IVTs and should be seen as an alternative approach, when the MA PVCs/IVTs could not be eliminated by RFCA from the endocardium.	[Yue-Chun, Li; Cheng, Zheng; Jun, Hong; Jun-Hua, Cheng; Jing-Lin, Zhao; Jia-Feng, Lin] Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China	Wenzhou Medical University	Jia-Feng, L (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China.	linjiafeng_wzmcfey@163.com			Wenzhou Municipal Science and Technology Commission [Y2008086]; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China [2011ZYC-A27]	Wenzhou Municipal Science and Technology Commission; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China	This study is supported by Wenzhou Municipal Science and Technology Commission (Grant No. Y2008086) and Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association (Grant No. 2011ZYC-A27), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baman TS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P274, DOI 10.1161/CIRCEP.109.910802; Berruezo A, 2004, CIRCULATION, V109, P1842, DOI 10.1161/01.CIR.0000125525.04081.4B; Chen J, 2012, EUROPACE, V14, P388, DOI 10.1093/europace/eur318; COGGINS DL, 1994, J AM COLL CARDIOL, V23, P1333, DOI 10.1016/0735-1097(94)90375-1; Daniels DV, 2006, CIRCULATION, V113, P1659, DOI 10.1161/CIRCULATIONAHA.105.611640; Ito S, 2003, J CARDIOVASC ELECTR, V14, P1280, DOI 10.1046/j.1540-8167.2003.03211.x; Kumagai K, 2005, J CARDIOVASC ELECTR, V16, P1029, DOI 10.1111/j.1540-8167.2005.40749.x; Li YC, 2012, INT J CARDIOL, DOI [10.1016/j.ijcard.2012.06.119, DOI 10.1016/J.IJ-CARD.2012.06.119]; Obel OA, 2006, J AM COLL CARDIOL, V48, P1813, DOI 10.1016/j.jacc.2006.06.006; Sosa E, 1996, J CARDIOVASC ELECTR, V7, P531, DOI 10.1111/j.1540-8167.1996.tb00559.x; Tada H, 2005, J AM COLL CARDIOL, V45, P877, DOI 10.1016/j.jacc.2004.12.025; Yamada T, 2008, J AM COLL CARDIOL, V52, P139, DOI 10.1016/j.jacc.2008.03.040; Yamada T, 2008, CIRC-ARRHYTHMIA ELEC, V1, P396, DOI 10.1161/CIRCEP.108.795948	13	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80777	10.1371/journal.pone.0080777	http://dx.doi.org/10.1371/journal.pone.0080777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312241	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100053
J	Ahmed, S; Rekha, RS; Bin Ahsan, K; Doi, M; Grander, M; Roy, AK; Ekstrom, EC; Wagatsuma, Y; Vahter, M; Raqib, R				Ahmed, Sultan; Rekha, Rokeya Sultana; Bin Ahsan, Khalid; Doi, Mariko; Grander, Margaretha; Roy, Anjan Kumar; Ekstrom, Eva-Charlotte; Wagatsuma, Yukiko; Vahter, Marie; Raqib, Rubhana			Arsenic Exposure Affects Plasma Insulin-Like Growth Factor 1 (IGF-1) in Children in Rural Bangladesh	PLOS ONE			English	Article							FACTOR-I; DRINKING-WATER; OXIDATIVE STRESS; INFANT-MORTALITY; PREGNANCY; BIRTH; COHORT; SIZE; EXPRESSION; PROTEIN	Background: Exposure to inorganic arsenic (As) through drinking water during pregnancy is associated with lower birth size and child growth. The aim of the study was to assess the effects of As exposure on child growth parameters to evaluate causal associations. Methodology/Findings: Children born in a longitudinal mother-child cohort in rural Bangladesh were studied at 4.5 years (n=640) as well as at birth (n=134). Exposure to arsenic was assessed by concurrent and prenatal (maternal) urinary concentrations of arsenic metabolites (U-As). Associations with plasma concentrations of insulin-like growth factor 1 (IGF-1), calcium (Ca), vitamin D (Vit-D), bone-specific alkaline phosphatase (B-ALP), intact parathyroid hormone (iPTH), and phosphate (PO4) were evaluated by linear regression analysis, adjusted for socioeconomic factor, parity and child sex. Child U-As (per 10 mu g/L) was significantly inversely associated with concurrent plasma IGF-1 (beta=-0.27; 95% confidence interval: -0.50, -0.0042) at 4.5 years. The effect was more obvious in girls (beta=-0.29; -0.59, 0.021) than in boys, and particularly in girls with adequate height (beta=-0.491; -0.97, -0.02) or weight (beta=-0.47; 0.97, 0.01). Maternal U-As was inversely associated with child IGF-1 at birth (r=-0.254, P=0.003), but not at 4.5 years. There was a tendency of positive association between U-As and plasma PO4 in stunted boys (beta=0.27; 0.089, 0.46). When stratified by % monomethylarsonic acid (MMA, arsenic metabolite) (median split at 9.7%), a much stronger inverse association between U-As and IGF-1 in the girls (beta=-0.41; -0.77, -0.03) was obtained above the median split. Conclusion: The results suggest that As-related growth impairment in children is mediated, at least partly, through suppressed IGF-1 levels.	[Ahmed, Sultan; Rekha, Rokeya Sultana; Bin Ahsan, Khalid; Roy, Anjan Kumar; Raqib, Rubhana] Int Ctr Diarrhoeal Dis Res, Ctr Vaccine Sci, Dhaka, Bangladesh; [Ahmed, Sultan; Grander, Margaretha; Vahter, Marie] Karolinska Inst, Inst Environm Med IMM, Stockholm, Sweden; [Doi, Mariko; Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; University of Tsukuba; Uppsala University	Raqib, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Vaccine Sci, Dhaka, Bangladesh.	rubhana@icddrb.org	Vahter, Marie/HGB-1674-2022; Wagatsuma, Yukiko/AAE-5881-2020	Wagatsuma, Yukiko/0000-0002-8056-9998; Raqib, Rubhana/0000-0002-8116-4511	Swedish Agency for Research Cooperation [GR00599]; Japan Society for the Promotion of Science [18256005]; icddr,b	Swedish Agency for Research Cooperation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); icddr,b	The study was supported by the Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC Agreement support; grant GR00599); Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (18256005) and icddr,b. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Arena JMD, 1986, POISONING; Odstrcil ADA, 2010, EXP TOXICOL PATHOL, V62, P243, DOI 10.1016/j.etp.2009.04.001; Casazza K, 2008, J CLIN ENDOCR METAB, V93, P4917, DOI 10.1210/jc.2008-0999; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Courtland HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014762; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DOYLE JJ, 1979, J ANIM SCI, V49, P482, DOI 10.2527/jas1979.492482x; Ellenhorn MJ, 1988, ARSENIC MED TOXICOLO; Fall C. H. D., 1995, Archives of Disease in Childhood, V73, P287; Fangstrom B, 2009, TOXICOL APPL PHARM, V239, P208, DOI 10.1016/j.taap.2008.12.019; Gardner R, 2011, AM J PUBLIC HEALTH, V101, pS333, DOI 10.2105/AJPH.2010.300025; Gardner RM, 2013, AM J EPIDEM IN PRESS; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Hong GM, 2012, TOXICOL APPL PHARM, V260, P250, DOI 10.1016/j.taap.2012.03.002; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Hopenhayn-Rich C, 2000, ENVIRON HEALTH PERSP, V108, P667, DOI 10.2307/3434889; Hyun SE, 2012, CLIN BIOCHEM, V45, P16, DOI 10.1016/j.clinbiochem.2011.10.003; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; Kippler M, 2012, REPROD TOXICOL, V34, P504, DOI 10.1016/j.reprotox.2012.08.002; Lammon CA, 2004, BIRTH DEFECTS RES B, V71, P124, DOI 10.1002/bdrb.20006; LINDGREN A, 1984, ACTA PHARMACOL TOX, V54, P311; LINDGREN A, 1982, ACTA PHARMACOL TOX, V51, P253; Milton AH, 2005, EPIDEMIOLOGY, V16, P82, DOI 10.1097/01.ede.0000147105.94041.e6; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Odstrcil AA, 2007, TOXIC EFFECT ARSENIC; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Puzik A, 2012, CYTOKINE, V60, P369, DOI 10.1016/j.cyto.2012.07.025; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Saha KK, 2012, ENVIRON HEALTH PERSP, V120, P1208, DOI 10.1289/ehp.1003378; Scarth JP, 2006, XENOBIOTICA, V36, P119, DOI 10.1080/00498250600621627; Tirapegui J, 1996, NUTR RES, V16, P869, DOI 10.1016/0271-5317(96)00080-2; Vahter ME, 2006, J HEALTH POPUL NUTR, V24, P236; WALKER BE, 1979, J CLIN PATHOL, V32, P488, DOI 10.1136/jcp.32.5.488; WILLHITE CC, 1981, EXP MOL PATHOL, V34, P145, DOI 10.1016/0014-4800(81)90071-X; Yang CY, 2003, ENVIRON RES, V91, P29, DOI 10.1016/S0013-9351(02)00015-4; Yuksel B, 2011, J CLIN RES PEDIATR E, V3, P84, DOI 10.4274/jcrpe.v3i2.17; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81530	10.1371/journal.pone.0081530	http://dx.doi.org/10.1371/journal.pone.0081530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303053	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400069
J	Chen, Y; Zhou, Y; Yin, TF; Liu, CX; Luo, FL				Chen, Yue; Zhou, Ya; Yin, Tan-Feng; Liu, Chun-Xiang; Luo, Fang-Li			The Invasive Wetland Plant Alternanthera philoxeroides Shows a Higher Tolerance to Waterlogging than Its Native Congener Alternanthera sessilis	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; PERFORMANCE COMPARISONS; PHENOTYPIC PLASTICITY; TRAITS; SUBMERGENCE; GROWTH; SIZE; TIME; AVAILABILITY; CONSERVATION	Plant invasion is one of the major threats to natural ecosystems. Phenotypic plasticity is considered to be important for promoting plant invasiveness. High tolerance of stress can also increase survival of invasive plants in adverse habitats. Limited growth and conservation of carbohydrate are considered to increase tolerance of flooding in plants. However, few studies have examined whether invasive species shows a higher phenotypic plasticity in response to waterlogging or a higher tolerance of waterlogging (lower plasticity) than native species. We conducted a greenhouse experiment to compare the growth and morphological and physiological responses to waterlogging of the invasive, clonal, wetland species Alternanthera philoxeroides with those of its co-occurring, native, congeneric, clonal species Alternanthera sessilis. Plants of A. philoxeroides and A. sessilis were subjected to three treatments (control, 0 and 60 cm waterlogging). Both A. philoxeroides and A. sessilis survived all treatments. Overall growth was lower in A. philoxeroides than in A. sessilis, but waterlogging negatively affected the growth of A. philoxeroides less strongly than that of A. sessilis. Alternanthera philoxeroides thus showed less sensitivity of growth traits (lower plasticity) and higher waterlogging tolerance. Moreover, the photosynthetic capacity of A. philoxeroides was higher than that of A. sessilis during waterlogging. Alternanthera philoxeroides also had higher total non-structural and non-soluble carbohydrate concentrations than A. sessilis at the end of treatments. Our results suggest that higher tolerance to waterlogging and higher photosynthetic capacity may partly explain the invasion success of A. philoxeroides in wetlands.	[Chen, Yue; Zhou, Ya; Yin, Tan-Feng; Liu, Chun-Xiang; Luo, Fang-Li] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Luo, FL (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	ecoluofangli@163.com			Beijing Forestry University Young Scientist Fund [BLX2011023]; Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; Program for New Century Excellent Talents in University [NECT-10-0234]; National Science Foundation of China [31200314, 41071329]	Beijing Forestry University Young Scientist Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Beijing Forestry University Young Scientist Fund (BLX2011023), the Fundamental Research Funds for the Central Universities (TD-JC-2013-1), the Program for New Century Excellent Talents in University (NECT-10-0234), and the National Science Foundation of China (31200314, 41071329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2000, PERSPECT PLANT ECOL, V3, P52, DOI DOI 10.1078/1433-8319-00004; Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Fan SF, 2013, HYDROBIOLOGIA, V711, P129, DOI 10.1007/s10750-013-1471-3; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Geng YP, 2006, ACTA OECOL, V30, P380, DOI 10.1016/j.actao.2006.07.002; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; He WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035681; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Kettenring KM, 2012, BIOL INVASIONS, V14, P2489, DOI 10.1007/s10530-012-0246-5; Kolb A, 2003, BIOL INVASIONS, V5, P229, DOI 10.1023/A:1026185503777; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025629; Mahelka V, 2006, WEED RES, V46, P82, DOI 10.1111/j.1365-3180.2006.00490.x; Matzek V, 2011, BIOL INVASIONS, V13, P3005, DOI 10.1007/s10530-011-9985-y; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mommer L, 2005, NEW PHYTOL, V167, P197, DOI 10.1111/j.1469-8137.2005.01404.x; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Panda D, 2008, AQUAT BOT, V88, P127, DOI 10.1016/j.aquabot.2007.08.012; Parolin P, 2009, ANN BOT-LONDON, V103, P359, DOI 10.1093/aob/mcn216; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Pysek Petr, 2007, V193, P97; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Radford IJ, 2007, AUSTRAL ECOL, V32, P338, DOI 10.1111/j.1442-9993.2007.01700.x; Sarkar RK, 2006, CURR SCI INDIA, V91, P899; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Sun Y, 2010, WEED RES, V50, P527, DOI 10.1111/j.1365-3180.2010.00822.x; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Kleunen M, 2007, PROG PHYS GEOG, V31, P447, DOI 10.1177/0309133307081295; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Willis AJ, 2000, ECOL LETT, V3, P275, DOI 10.1046/j.1461-0248.2000.00149.x; Xiao Y, 2010, AQUAT BOT, V92, P9, DOI 10.1016/j.aquabot.2009.09.001; Xie D, 2011, HYDROBIOLOGIA, V658, P221, DOI 10.1007/s10750-010-0475-5; Xu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035873; Yu LF, 2010, FLORA, V205, P449, DOI 10.1016/j.flora.2009.12.016	46	32	39	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81456	10.1371/journal.pone.0081456	http://dx.doi.org/10.1371/journal.pone.0081456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303048	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400064
J	Lee, YK; Lin, TH; Chang, CF; Lo, YL				Lee, Yung-Kuo; Lin, Tsung-Hsien; Chang, Chuan-Fa; Lo, Yu-Li			Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via beta-Catenin/GSK-3 beta Modulation in Colorectal Carcinoma	PLOS ONE			English	Article							CANCER DRUG-RESISTANCE; CYCLIN D1 EXPRESSION; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; BETA-CATENIN; DECREASED EXPRESSION; COLON-CARCINOMA; GENE-EXPRESSION; CELL-SURVIVAL; CACO-2 CELLS	Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer drugs, involves the upregulation of ATP binding cassette (ABC) transporters and induction of galectin-3 signaling. Galectin-3 plays an anti-apoptotic role in many cancer cells and regulates various pathways to activate MDR. Thus, the inhibition of galectin-3 has the potential to enhance the efficacy of the anticancer drug epirubicin. In this study, we examined the effects and mechanisms of silencing galectin-3 via RNA interference (RNAi) on the beta-catenin/GSK-3 beta pathway in human colon adenocarcinoma Caco-2 cells. Galectin-3 knockdown increased the intracellular accumulation of epirubicin in Caco-2 cells; suppressed the mRNA expression of galectin-3, beta-catenin, cyclin D1, c-myc, P-glycoprotein (P-gp), MDR-associated protein (MRP) 1, and MRP2; and downregulated the protein expression of P-gp, cyclin D1, galectin-3, beta-catenin, c-Myc, and Bcl-2. Moreover, galectin-3 RNAi treatment significantly increased the mRNA level of GSK-3 beta, Bax, caspase-3, and caspase-9; remarkably increased the Bax-to-Bcl-2 ratio; and upregulated the GSK-3 beta and Bax protein expressions. Apoptosis was induced by galectin-3 RNAi and/or epirubicin as demonstrated by chromatin condensation, a higher sub-G1 phase proportion, and increased caspase-3 and caspase-9 activity, indicating an intrinsic/mitochondrial apoptosis pathway. Epirubicin-mediated resistance was effectively inhibited via galectin-3 RNAi treatment. However, these phenomena could be rescued after galectin-3 overexpression. We show for the first time that the silencing of galectin-3 sensitizes MDR cells to epirubicin by inhibiting ABC transporters and activating the mitochondrial pathway of apoptosis through modulation of the beta-catenin/GSK-3 beta pathway in human colon cancer cells.	[Lee, Yung-Kuo; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Lee, Yung-Kuo; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Tsung-Hsien; Lo, Yu-Li] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan; [Lo, Yu-Li] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National University Tainan; National Taiwan University	Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	affa@mail.ncku.edu.tw; yulilo@mail.nutn.edu.tw	Chang, Chuan-Fa/F-8660-2011	Chang, Chuan-Fa/0000-0003-2404-1248; Lo, Yu-Li/0000-0002-6548-3280	National University of Tainan, Taiwan [AB100-318, AB101-316]; National Science Council, Taiwan [NSC 101-2321-B-006-008, NSC 102-2321-B-006-006, NSC 102-2320-B-024-002]	National University of Tainan, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants AB100-318 and AB101-316 from the National University of Tainan, Taiwan and NSC 101-2321-B-006-008, NSC 102-2321-B-006-006 and NSC 102-2320-B-024-002 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2008, CANCER EPIDEM BIOMAR, V17, P2128, DOI 10.1158/1055-9965.EPI-08-0182; Aleman C, 2003, CANCER RES, V63, P3084; CASTRONOVO V, 1992, JNCI-J NATL CANCER I, V84, P1161, DOI 10.1093/jnci/84.15.1161; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cheng YL, 2011, BIOCHEM BIOPH RES CO, V412, P334, DOI 10.1016/j.bbrc.2011.07.099; Cheong TC, 2010, CANCER SCI, V101, P94, DOI 10.1111/j.1349-7006.2009.01364.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Endo K, 2005, ANTICANCER RES, V25, P3117; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Greco C, 2004, GLYCOBIOLOGY, V14, P783, DOI 10.1093/glycob/cwh092; Gutmann H, 1999, PHARM RES-DORDR, V16, P402, DOI 10.1023/A:1018825819249; Huang WC, 2011, FASEB J, V25, P3661, DOI 10.1096/fj.10-180190; Iacovazzi PA, 2010, IMMUNOPHARM IMMUNOT, V32, P160, DOI [10.3109/08923970902936880, 10.1080/08923970902936880]; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Kornmann M, 1999, CANCER RES, V59, P3505; Lee WK, 2013, INT J CANCER, V133, P556, DOI 10.1002/ijc.28060; Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x; Lin CI, 2009, BIOCHEM BIOPH RES CO, V379, P626, DOI 10.1016/j.bbrc.2008.12.153; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Lo YL, 2008, EUR J PHARM SCI, V35, P52, DOI 10.1016/j.ejps.2008.06.003; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI [10.1016/j.tox. 2012.08.003, DOI 10.1016/J.T0X.2012.08.003.PUBMED:22914566]; Lo YL, 2013, INT J MOL SCI, V14, P158, DOI 10.3390/ijms14010158; LOTZ MM, 1993, P NATL ACAD SCI USA, V90, P3466, DOI 10.1073/pnas.90.8.3466; Mao YL, 2011, INT J COLORECTAL DIS, V26, P29, DOI 10.1007/s00384-010-1090-7; Marbeuf-Gueye C, 2000, EUR J PHARMACOL, V391, P207, DOI 10.1016/S0014-2999(00)00047-9; Nakahara S, 2007, CANCER METAST REV, V26, P605, DOI 10.1007/s10555-007-9095-6; Nakamura M, 1999, INT J ONCOL, V15, P143; Nakamura Y, 2006, INT J CANCER, V118, P2448, DOI 10.1002/ijc.21691; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Seo SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-199; Shi YH, 2007, INT J CANCER, V121, P1175, DOI 10.1002/ijc.22848; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Wang XF, 2007, LEUKEMIA RES, V31, P989, DOI 10.1016/j.leukres.2006.09.001; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Xia ZS, 2009, MOL MED REP, V2, P579, DOI 10.3892/mmr_00000140; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027; Yamada T, 2000, CANCER RES, V60, P4761; Yamamoto-Sugitani M, 2011, P NATL ACAD SCI USA, V108, P17468, DOI 10.1073/pnas.1111138108; Zaia Povegliano L, 2011, J GASTROINTEST CANC, V42, P217, DOI DOI 10.1007/S12029-010-9189-1.PUBMED:20635166	43	28	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82478	10.1371/journal.pone.0082478	http://dx.doi.org/10.1371/journal.pone.0082478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303084	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400102
J	Li, XR; He, MA; Zhu, J; Yao, P; Li, XL; Yuan, J; Min, XW; Lang, MJ; Yang, HD; Hu, FB; Wu, TC; Wei, S				Li, Xiaorong; He, Meian; Zhu, Jiang; Yao, Ping; Li, Xiulou; Yuan, Jing; Min, Xinwen; Lang, Mingjian; Yang, Handong; Hu, Frank B.; Wu, Tangchun; Wei, Sheng			Higher Carbohydrate Antigen 125 Levels Are Associated with Increased Risk of Coronary Heart Disease in Elderly Chinese: A Population-Based Case-Control Study	PLOS ONE			English	Article							SERUM CA-125 LEVELS; CLINICAL SEVERITY; AORTIC-STENOSIS; OVARIAN-CANCER; TUMOR-MARKERS; CA125 LEVELS; FAILURE; INFLAMMATION; ATHEROSCLEROSIS; ACTIVATION	Background: High carbohydrate antigen 125 (CA-125) level was reported to be associated with some cardiac dysfunctions, such as chronic heart failure, but the relationship between CA-125 level and coronary heart disease (CHD) risk remains unclear. The aim of this study was to explore the potential association in a Chinese older population. Methods: In a population-based case-control study conducted in a Chinese older population, serum CA-125 levels were measured in 1177 diagnosed CHD patients and 3531 age and sex matched control subjects without CHD. Results: Serum CA-125 level was significantly higher in CHD patients than controls (P < 0.001) with adjustment for age, gender, smoking, drinking, BMI, physical activity, hypertension, dyslipidemia, diabetes mellitus, medication history and family history of CHD and myocardial infarction. CHD risk was doubled (OR: 2.10, 95% CI: 1.69-2.60) among subjects in the highest quartile compared to those in the lowest quartile of CA-125 level (P-trend < 0.001). Furthermore, CA-125 levels were associated with CHD risks in subjects with age over 60 years (OR: 2.19, 95% CI: 1.75-2.73), current smokers (OR: 2.29, 95% CI: 1.50-3.49), current drinkers (OR: 2.35, 95% CI: 1.57-3.53) and subjects with hypertension (OR: 2.04, 95% CI: 1.71-2.43). Conclusions: Elevated serum CA-125 level might be associated with increased risk of coronary heart disease in the Chinese older population. Further investigations are needed to identify the possible biological role of CA-125 in CHD development in the future.	[Li, Xiaorong; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Li, Xiaorong; He, Meian; Yao, Ping; Yuan, Jing; Wu, Tangchun; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhu, Jiang; Li, Xiulou; Min, Xinwen; Lang, Mingjian; Yang, Handong] Dongfeng Motor Corp, Dongfeng Cent Hosp, Shiyan, Hubei, Peoples R China; [Zhu, Jiang; Li, Xiulou; Min, Xinwen; Lang, Mingjian; Yang, Handong] Hubei Univ Med, Shiyan, Hubei, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Dongfeng Motor; Hubei University of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wei, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	ws2008cn@gmail.com		Min, Xinwen/0000-0002-8429-6560	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program [2011CB503800]; Natural Scientific Foundation of China [NSFC-81172751]; Dongfeng Motor Corporation (DMC)	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Dongfeng Motor Corporation (DMC)	The study is funded by the Huazhong University of Science and Technology Foundation for Educational Development and Research; the National Basic Research Program grant 2011CB503800, the Natural Scientific Foundation of China (NSFC-81172751), and the Dongfeng Motor Corporation (DMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Antonini-Canterin F, 2008, INT J CARDIOL, V128, P406, DOI 10.1016/j.ijcard.2007.05.039; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Chelbi F, 2002, PRESSE MED, V31, P1366; Csordas A, 2008, BIOMARK INSIGHTS, V3, P127; D'Aloia A, 2003, J AM COLL CARDIOL, V41, P1805, DOI 10.1016/S0735-1097(03)00311-5; De Gennaro L, 2012, EUR J CLIN INVEST, V42, P371, DOI 10.1111/j.1365-2362.2011.02592.x; De Gennaro L, 2009, CORONARY ARTERY DIS, V20, P274, DOI 10.1097/MCA.0b013e3283229d82; Duman C, 2003, CARDIOLOGY, V100, P7, DOI 10.1159/000072385; El-Mesallamy HO, 2012, ANGIOLOGY, V63, P96, DOI 10.1177/0003319711408587; Epiney M, 2000, HUM REPROD, V15, P1261, DOI 10.1093/humrep/15.6.1261; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; HUANG F, 2012, MED HYPOTHESES, V26, P26; Johnson CC, 2008, GYNECOL ONCOL, V110, P383, DOI 10.1016/j.ygyno.2008.05.006; Joo NS, 2011, J KOREAN MED SCI, V26, P1328, DOI 10.3346/jkms.2011.26.10.1328; KABAWAT SE, 1983, INT J GYNECOL PATHOL, V2, P275, DOI 10.1097/00004347-198303000-00005; KENEMANS P, 1993, EUR J OBSTET GYN R B, V49, P115, DOI 10.1016/0028-2243(93)90135-Y; Kosar F, 2006, EUR J HEART FAIL, V8, P270, DOI 10.1016/j.ejheart.2005.09.002; Kouris NT, 2005, EUR J HEART FAIL, V7, P199, DOI 10.1016/j.ejheart.2004.07.015; Leard LE, 2004, RESPIROLOGY, V9, P292, DOI 10.1111/j.1440-1843.2004.00602.x; LEARD LE, 2002, RESPIROLOGY, V7, P171, DOI DOI 10.1046/J.1440-1843.2002.00404.X; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ozeren A, 2003, MEDIAT INFLAMM, V12, P361, DOI 10.1080/09629350310001633360; Ragni Temistocle, 2003, Ital Heart J Suppl, V4, P340; Righi L, 2010, ENDOCR-RELAT CANCER, V17, P977, DOI 10.1677/ERC-10-0157; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rostoff P, 2008, INT J CARDIOL, V130, pE114, DOI 10.1016/j.ijcard.2007.07.018; Saygili U, 2002, INT J GYNECOL CANCER, V12, P438, DOI 10.1046/j.1525-1438.2002.01171.x; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Sikaris KA, 2011, HEART LUNG CIRC, V20, P634, DOI 10.1016/j.hlc.2010.08.001; Sugishita H, 2005, GEN THORAC CARDIOVAS, V53, P486, DOI 10.1007/s11748-005-0092-9; Topalak O, 2002, GYNECOL ONCOL, V85, P108, DOI 10.1006/gyno.2001.6575; Turgut O, 2011, INT J CARDIOL, V146, P99, DOI 10.1016/j.ijcard.2010.05.077; Turk HM, 2003, TUMOR BIOL, V24, P172, DOI 10.1159/000074425; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Varol E, 2005, EUR J HEART FAIL, V7, P840, DOI 10.1016/j.ejheart.2004.12.008; Varol E, 2007, HEART VESSELS, V22, P30, DOI 10.1007/s00380-006-0938-9; Varol E, 2012, TURK KARDIYOL DERN A, V40, P309, DOI 10.5543/tkda.2012.87894; Vizzardi E, 2008, ECHOCARDIOGR-J CARD, V25, P955, DOI 10.1111/j.1540-8175.2008.00714.x; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120; Yalta K, 2006, ADV THER, V23, P1052, DOI 10.1007/BF02850225; Yanada M, 2007, Kyobu Geka, V60, P1148; ZEILLEMAKER AM, 1994, J CLIN PATHOL, V47, P263, DOI 10.1136/jcp.47.3.263	49	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81328	10.1371/journal.pone.0081328	http://dx.doi.org/10.1371/journal.pone.0081328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303042	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400059
J	Lorenzi, L; Tabellini, G; Vermi, W; Moratto, D; Porta, F; Notarangelo, LD; Patrizi, O; Sozzani, S; de St Basile, G; Latour, S; Pace, D; Lonardi, S; Facchetti, F; Badolato, R; Parolini, S				Lorenzi, Luisa; Tabellini, Giovanna; Vermi, William; Moratto, Daniele; Porta, Fulvio; Notarangelo, Lucia D.; Patrizi, Ornella; Sozzani, Silvano; de St Basile, Genevieve; Latour, Sylvain; Pace, David; Lonardi, Silvia; Facchetti, Fabio; Badolato, Raffaele; Parolini, Silvia			Occurrence of Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Hermansky-Pudlak Type 2 Syndrome Is Associated to Natural Killer and Natural Killer T Cell Defects	PLOS ONE			English	Article							NK CELLS; CYTOTOXICITY RECEPTORS; IFN-GAMMA; EXPRESSION; MUTATIONS; IMMUNITY; INNATE; DIFFERENTIATION; TRANSPORT; DISEASES	Hermansky Pudlak type 2 syndrome (HPS2) is a rare autosomal recessive primary immune deficiency caused by mutations on beta 3A gene (AP3B1 gene). The defect results in the impairment of the adaptor protein 3 (AP-3) complex, responsible for protein sorting to secretory lysosomes leading to oculo-cutaneous albinism, bleeding disorders and immunodeficiency. We have studied peripheral blood and lymph node biopsies from two siblings affected by HPS2. Lymph node histology showed a nodular lymphocyte predominance type Hodgkin lymphoma (NLPHL) in both HPS2 siblings. By immunohistochemistry, CD8 T-cells from HPS2 NLPHL contained an increased amount of perforin (Prf) + suggesting a defect in the release of this granules-associated protein. By analyzing peripheral blood immune cells we found a significant reduction of circulating NKT cells and of CD56(bright) CD16(-) Natural Killer (NK) cells subset. Functionally, NK cells were defective in their cytotoxic activity against tumor cell lines including Hodgkin Lymphoma as well as in IFN-gamma production. This defect was associated with increased baseline level of CD107a and CD63 at the surface level of unstimulated and IL-2-activated NK cells. In summary, these results suggest that a combined and profound defect of innate and adaptive effector cells might explain the susceptibility to infections and lymphoma in these HPS2 patients.	[Lorenzi, Luisa; Vermi, William; Lonardi, Silvia; Facchetti, Fabio] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy; [Tabellini, Giovanna; Patrizi, Ornella; Sozzani, Silvano; Parolini, Silvia] Univ Brescia, Dept Mol & Translat Med, Sect Expt Oncol & Immunol, Brescia, Italy; [Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Moratto, Daniele; Badolato, Raffaele] Univ Brescia, Inst Mol Med Angelo Nocivelli, Dept Clin & Expt Sci, Brescia, Italy; [Porta, Fulvio; Notarangelo, Lucia D.] Spedali Civil Brescia, Osped Bambini, Oncol Haematol & BMT Unit, I-25125 Brescia, Italy; [de St Basile, Genevieve; Latour, Sylvain] INSERM, U768, F-75654 Paris 13, France; [de St Basile, Genevieve; Latour, Sylvain] Univ Paris 04, F-75230 Paris 05, France; [de St Basile, Genevieve; Latour, Sylvain] Necker Enfants Malad Hosp, AP HP, Ctr Etud Deficits Immunitaires, Paris, France; [Pace, David] Mater Dei Hosp, Dept Pediat, Msida, Malta	University of Brescia; University of Brescia; Washington University (WUSTL); University of Brescia; Hospital Spedali Civili Brescia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Badolato, R (corresponding author), Univ Brescia, Inst Mol Med Angelo Nocivelli, Dept Clin & Expt Sci, Brescia, Italy.	badolato@med.unibs.it	Badolato, Raffaele/A-8081-2010; Lorenzi, Luisa/Q-1355-2015; Facchetti, Fabio/E-7190-2010; Patrizi, Ornella/ABC-5102-2020; LORENZI, Luisa/T-9207-2019; Pace, David/AAO-8928-2021; Latour, Sylvain/H-3652-2017; Sozzani, Silvano/C-1447-2009; de Saint Basile, Genevieve/G-9731-2017	Badolato, Raffaele/0000-0001-7375-5410; Lorenzi, Luisa/0000-0003-2483-2955; Facchetti, Fabio/0000-0003-4975-2388; LORENZI, Luisa/0000-0003-2483-2955; Pace, David/0000-0002-3275-1189; Latour, Sylvain/0000-0001-8238-4391; Sozzani, Silvano/0000-0002-3144-8743; de Saint Basile, Genevieve/0000-0002-1913-5269; PAROLINI, Silvia/0000-0003-1968-7765; VERMI, WILLIAM/0000-0002-2291-2997	EU; Ministero dell'Istruzione dell'Universita e della Ricerca; Ministero dell'Istruzione dell'Universita e della Ricerca [PRIN 2009 CKARAL_002, PRIN 2008 B5CN7S_005, PRIN 2008 PTB3HC_002]; Centro di Studio e Ricerca	EU(European Commission); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Centro di Studio e Ricerca	This work was funded by EU Grant FP7 (HLH-cure) and Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2009) to RB. WV is supported by Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2009 CKARAL_002). FF is supported by Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008 B5CN7S_005). SP and GT are supported by Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008 PTB3HC_002) and by Centro di Studio e Ricerca "Quality and Technology Assessment, Governance and Communication Strategies in Health Systems.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azakami K, 2009, BLOOD, V114, P3208, DOI 10.1182/blood-2009-02-203042; Bauduer F, 2005, BRIT J HAEMATOL, V130, P648, DOI 10.1111/j.1365-2141.2005.05672.x; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Boaru DA, 2006, TOXICOLOGY, V218, P134, DOI 10.1016/j.tox.2005.10.005; Campbell GNS, 2004, LEUKEMIA LYMPHOMA, V45, P609, DOI 10.1080/10428190310001602354; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; ElenitobaJohnson KSJ, 1997, SEMIN DIAGN PATHOL, V14, P35; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; Fais F, 2004, INT J CANCER, V109, P402, DOI 10.1002/ijc.11723; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Knebel FH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/509089; Li TK, 2003, CANCER RES, V63, P8400; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Marcenaro E, 2011, IMMUNOTHERAPY-UK, V3, P1075, DOI [10.2217/IMT.11.99, 10.2217/imt.11.99]; MINGARI MC, 1991, J EXP MED, V174, P21, DOI 10.1084/jem.174.1.21; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; MORETTA A, 1990, J EXP MED, V171, P695, DOI 10.1084/jem.171.3.695; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Poppema S, 2004, LEUKEMIA LYMPHOMA, V45, P423, DOI 10.1080/10428190310001593166; PURTILO DT, 1982, AM J MED, V73, P49, DOI 10.1016/0002-9343(82)90923-8; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Saarinen S, 2011, BRIT J HAEMATOL, V154, P413, DOI 10.1111/j.1365-2141.2010.08528.x; Said JW, 2007, ADV ANAT PATHOL, V14, P189, DOI 10.1097/PAP.0b013e31805048fc; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Schmid JP, 2009, EMBO MOL MED, V1, P112, DOI 10.1002/emmm.200900009; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tran H, 2008, BLOOD REV, V22, P261, DOI 10.1016/j.blre.2008.03.009; Unal A, 2005, LEUKEMIA LYMPHOMA, V46, P1613, DOI 10.1080/10428190500236502; van den Berg A, 2002, BLOOD, V99, P1492, DOI 10.1182/blood.V99.4.1492; van Krieken Joannes H, 2004, Am J Clin Pathol, V122 Suppl, pS122; Vermi W, 2009, IMMUNOBIOLOGY, V214, P877, DOI 10.1016/j.imbio.2009.06.013; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vitale C, 2004, EUR J IMMUNOL, V34, P455, DOI 10.1002/eji.200324668; Wenham M, 2010, HAEMATOL-HEMATOL J, V95, P333, DOI 10.3324/haematol.2009.012286; Xu CH, 2010, AM J HEMATOL, V85, P539, DOI 10.1002/ajh.21743; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711	48	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80131	10.1371/journal.pone.0080131	http://dx.doi.org/10.1371/journal.pone.0080131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302998	Green Published, gold			2022-12-25	WOS:000327546400014
J	Pereira-Carvalho, R; Mendes-Aguiar, CO; Oliveira-Neto, MP; Covas, CJF; Bertho, AL; Da-Cruz, AM; Gomes-Silva, A				Pereira-Carvalho, Regina; Mendes-Aguiar, Carolina O.; Oliveira-Neto, Manoel P.; Covas, Claudia J. F.; Bertho, Alvaro L.; Da-Cruz, Alda M.; Gomes-Silva, Adriano			Leishmania braziliensis-Reactive T Cells Are Down-Regulated in Long-Term Cured Cutaneous Leishmaniasis, but the Renewal Capacity of T Effector Memory Compartments Is Preserved	PLOS ONE			English	Article							ANTIGEN-INDEPENDENT ACTIVATION; MUCOSAL LEISHMANIASIS; RESPONSES; LESIONS; SKIN; PERSISTENCE; PARASITES; SCARS; VACCINATION; EXPRESSION	Leishmania (Viannia) braziliensis control and tissue damage relate to the effector immune response, which in turn affects clinical outcome. Leishmania reactive CD4(+) and CD8(+) T cells are expanded in long-term healed cutaneous leishmaniasis (hCL) patients but their functional characteristics remain to be determined. This study investigates antigen-specific recall in long-term healed CL caused by L. braziliensis infection. Healed CL subjects were grouped according to the time elapsed since the end of therapy: less than two years and two to five years. Activation phenotype (CD69(+) or CD25(+)) and subpopulations of memory T cell phenotypes [central memory (TCM): CD45RO(+) CCR7(+) or effector memory (Tem): CD45RO(+) CCR7(-)] were quantified in ex vivo blood mononuclear cells and after Leishmania antigens stimuli. A reduction in the percentage of activated Leishmania-responder CD4(+) and CD8(+) T cells in hCL was associated with the time elapsed since clinical cure. Percentage of CD69(+) in TCD4(+) and TCD8(+) cells were negatively correlated with IL-10 levels. Ex vivo analyses showed contracted Tem CD4(+) and Tem CD8(+) compartments from hCL with long time elapsed since clinical cure, although renewal of these compartments was observed following in vitro exposure to leishmanial stimuli. Our results show that healed L. braziliensis infected patients exhibit a recall response to Leishmania antigens with evident expansion of effector memory T cells. Regulated leishmanial-specific response seems to emerge only about two years after initial contact with the parasite antigens.	[Pereira-Carvalho, Regina; Mendes-Aguiar, Carolina O.; Covas, Claudia J. F.; Da-Cruz, Alda M.; Gomes-Silva, Adriano] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil; [Oliveira-Neto, Manoel P.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas IPEC, BR-21045900 Rio De Janeiro, Brazil; [Bertho, Alvaro L.] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Gomes-Silva, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil.	gomesas@ioc.fiocruz.br	Da-Cruz, Alda Maria/J-2152-2012; Covas, Claudia/G-6971-2017	Covas, Claudia/0000-0001-7304-6278	IOC/FIOCRUZ internal funds; PAPESIV/VPPDT/FIOCRUZ; FAPERJ APQ-1 [E-26/170.844/2003]; CNPq; CAPES/FAPERJ [PAPDRJ - E-26/102.457/2010]; FAPERJ (JCNE)	IOC/FIOCRUZ internal funds; PAPESIV/VPPDT/FIOCRUZ; FAPERJ APQ-1(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/FAPERJ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ (JCNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by IOC/FIOCRUZ internal funds, PAPESIV/VPPDT/FIOCRUZ (www.ioc.fiocruz.br), and by FAPERJ APQ-1 (grant number E-26/170.844/2003) (www.faperj.br). AG-S is a PhD student sponsored by CNPq (www.cnpq.br). COM-A received a postdoctoral scholarship from CAPES/FAPERJ (PAPDRJ - E-26/102.457/2010). AMD-C is a CNPq and FAPERJ (JCNE) fellowship researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral VF, 2000, MEM I OSWALDO CRUZ, V95, P209, DOI 10.1590/S0074-02762000000200012; Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bittar RC, 2007, MEM I OSWALDO CRUZ, V102, P625, DOI 10.1590/S0074-02762007005000069; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Bomfim G, 2007, AM J TROP MED HYG, V77, P854, DOI 10.4269/ajtmh.2007.77.854; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; Camera PD, 2006, T ROY SOC TROP MED H, V100, P1112, DOI 10.1016/j.trstmh.2006.02.014; Campanelli AP, 2006, J INFECT DIS, V193, P1313, DOI 10.1086/502980; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; Carvalho LP, 2007, PARASITE IMMUNOL, V29, P251, DOI 10.1111/j.1365-3024.2007.00940.x; CONCEICAOSILVA F, 1990, CLIN EXP IMMUNOL, V79, P221, DOI 10.1111/j.1365-2249.1990.tb05182.x; Da-Cruz AM, 2010, J INVEST DERMATOL, V130, P1329, DOI 10.1038/jid.2009.428; Da-Cruz AM, 2002, CLIN DIAGN LAB IMMUN, V9, P251, DOI 10.1128/CDLI.9.2.251-256.2002; DaCruz AM, 1996, MEM I OSWALDO CRUZ, V91, P225, DOI 10.1590/S0074-02761996000200019; de Oliveira M R, 1995, Rev Soc Bras Med Trop, V28, P325, DOI 10.1590/S0037-86821995000400004; De-Campos SN, 2010, VET IMMUNOL IMMUNOP, V137, P149, DOI 10.1016/j.vetimm.2010.04.009; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; Gollob KJ, 2005, TRENDS PARASITOL, V21, P347, DOI 10.1016/j.pt.2005.06.007; Gomes-Silva A, 2007, CLIN EXP IMMUNOL, V149, P440, DOI 10.1111/j.1365-2249.2007.03436.x; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Khamesipour A, 2012, MICROBES INFECT, V14, P702, DOI 10.1016/j.micinf.2012.02.006; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Mendes-Aguiar CD, 2009, CLIN EXP IMMUNOL, V157, P377, DOI 10.1111/j.1365-2249.2009.03970.x; Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135; MENDONCA SC, 1986, CLIN EXP IMMUNOL, V64, P269; Morgado FN, 2010, PARASITE IMMUNOL, V32, P285, DOI 10.1111/j.1365-3024.2009.01188.x; Munitic I, 2009, J VIROL, V83, P11795, DOI 10.1128/JVI.01402-09; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Okwor I, 2008, IMMUNOL RES, V41, P123, DOI 10.1007/s12026-008-8016-2; Ramanathan S, 2009, CRIT REV IMMUNOL, V29, P219, DOI 10.1615/CritRevImmunol.v29.i3.30; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Salhi A, 2008, J IMMUNOL, V180, P6139, DOI 10.4049/jimmunol.180.9.6139; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; SARAVIA NG, 1989, J INFECT DIS, V159, P725, DOI 10.1093/infdis/159.4.725; Schubach A, 1998, AM J TROP MED HYG, V58, P824, DOI 10.4269/ajtmh.1998.58.824; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Steel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019197; Toledo VPCP, 2001, MEM I OSWALDO CRUZ, V96, P89, DOI 10.1590/S0074-02762001000100010; Tuon FF, 2008, CLIN IMMUNOL, V128, P442, DOI 10.1016/j.clim.2008.05.007; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; *WHO, 2010, WHO TECH REP SER, V949, P85694; ZAJTCHUK JT, 1989, LARYNGOSCOPE, V99, P925, DOI 10.1288/00005537-198909000-00006; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029	50	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81529	10.1371/journal.pone.0081529	http://dx.doi.org/10.1371/journal.pone.0081529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303052	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400068
J	Qin, W; Chi, BL; Oenema, O				Qin, Wei; Chi, Baoliang; Oenema, Oene			Long-Term Monitoring of Rainfed Wheat Yield and Soil Water at the Loess Plateau Reveals Low Water Use Efficiency	PLOS ONE			English	Article							FAO CROP MODEL; TRITICUM-AESTIVUM L.; WINTER-WHEAT; AQUACROP MODEL; IRRIGATED MAIZE; DEFICIT IRRIGATION; SEMIARID AREAS; CLIMATE-CHANGE; SIMULATION; TRANSPIRATION	Increasing crop yield and water use efficiency (WUE) in dryland farming requires a quantitative understanding of relationships between crop yield and the water balance over many years. Here, we report on a long-term dryland monitoring site at the Loess Plateau, Shanxi, China, where winter wheat was grown for 30 consecutive years and soil water content (0-200 cm) was measured every 10 days. The monitoring data were used to calibrate the AquaCrop model and then to analyse the components of the water balance. There was a strong positive relationship between total available water and mean cereal yield. However, only one-third of the available water was actually used by the winter wheat for crop transpiration. The remaining two-thirds were lost by soil evaporation, of which 40 and 60% was lost during the growing and fallow seasons, respectively. Wheat yields ranged from 0.6 to 3.9 ton/ha and WUE from 0.3 to 0.9 kg/m(3). Results of model experiments suggest that minimizing soil evaporation via straw mulch or plastic film covers could potentially double wheat yields and WUE. We conclude that the relatively low wheat yields and low WUE were mainly related to (i) limited rainfall, (ii) low soil water storage during fallow season due to large soil evaporation, and (iii) poor synchronisation of the wheat growing season to the rain season. The model experiments suggest significant potential for increased yields and WUE.	[Qin, Wei; Chi, Baoliang] Shanxi Acad Agr Sci, Dryland Agr Res Ctr, Taiyuan, Shanxi, Peoples R China; [Qin, Wei; Oenema, Oene] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Shanxi Agricultural University; Wageningen University & Research	Chi, BL (corresponding author), Shanxi Acad Agr Sci, Dryland Agr Res Ctr, Taiyuan, Shanxi, Peoples R China.	Baoliangchi@hotmail.com; Oene.Oenema@wur.nl	Qin, Wei/F-1044-2010	Qin, Wei/0000-0002-0860-121X				Abedinpour M, 2012, AGR WATER MANAGE, V110, P55, DOI 10.1016/j.agwat.2012.04.001; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andarzian B, 2011, AGR WATER MANAGE, V100, P1, DOI 10.1016/j.agwat.2011.08.023; Araya A, 2010, AGR WATER MANAGE, V97, P1838, DOI 10.1016/j.agwat.2010.06.021; Araya A, 2010, FIELD CROP RES, V116, P196, DOI 10.1016/j.fcr.2009.12.010; Chakraborty D, 2010, AGR WATER MANAGE, V97, P738, DOI 10.1016/j.agwat.2010.01.006; Chakraboyty D, 2008, AGR WATER MANAGE, V95, P1323, DOI 10.1016/j.agwat.2008.06.001; De Wit C.T., 1958, TRANSPIRATION CROP Y; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; DEWIT CT, 1987, GEODERMA, V40, P253, DOI 10.1016/0016-7061(87)90036-X; Dominguez A, 2011, AGR WATER MANAGE, V98, P1451, DOI 10.1016/j.agwat.2011.04.015; Farahani HJ, 2009, AGRON J, V101, P469, DOI 10.2134/agronj2008.0182s; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Geerts S, 2009, AGR WATER MANAGE, V96, P1652, DOI 10.1016/j.agwat.2009.06.020; Geerts S, 2009, AGRON J, V101, P499, DOI 10.2134/agronj2008.0137s; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hanjra MA, 2010, FOOD POLICY, V35, P365, DOI 10.1016/j.foodpol.2010.05.006; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hou XQ, 2012, FIELD CROP RES, V129, P7, DOI 10.1016/j.fcr.2011.12.021; Hsiao TC, 2009, AGRON J, V101, P448, DOI 10.2134/agronj2008.0218s; Hu KL, 2008, AGR WATER MANAGE, V95, P1180, DOI 10.1016/j.agwat.2008.05.001; Hu KL, 2010, J ENVIRON QUAL, V39, P667, DOI 10.2134/jeq2009.0204; Huang MB, 2004, IRRIGATION SCI, V23, P47, DOI 10.1007/s00271-004-0092-z; IPCC, 2007, CONTRIBUTION WORKING; IUSS Working Group WRB, 2006, WORLD SOIL RES REP, V103; Kang SZ, 2003, AGR SYST, V78, P355, DOI 10.1016/S0308-521X(03)00037-4; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Marris E, 2008, NATURE, V452, P273, DOI 10.1038/452273a; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Mkhabela MS, 2012, AGR WATER MANAGE, V110, P16, DOI 10.1016/j.agwat.2012.03.009; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Raes D, 2009, AGRON J, V101, P438, DOI 10.2134/agronj2008.0140s; Robert PC, 2002, PLANT SOIL, V247, P143, DOI 10.1023/A:1021171514148; Rockstrom J, 2010, AGR WATER MANAGE, V97, P543, DOI 10.1016/j.agwat.2009.09.009; Sachs Jeffrey D., 2008, COMMON WEALTH EC CRO; Salemi H, 2011, AFR J AGR RES, V6, P2204; Siahpoosh MR, 2012, AGRON J, V104, P1238, DOI 10.2134/agronj2011.0320; Smil V., 2000, FEEDING WORLD CHALLE; Steduto P, 2009, AGRON J, V101, P426, DOI 10.2134/agronj2008.0139s; Steduto Pasquale, 2012, IRRIGATION DRAINAGE; Stricevic R, 2011, AGR WATER MANAGE, V98, P1615, DOI 10.1016/j.agwat.2011.05.011; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Todorovic M, 2009, AGRON J, V101, P509, DOI 10.2134/agronj2008.0166s; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang P, 2012, AGR WATER MANAGE, V105, P32, DOI 10.1016/j.agwat.2011.12.024; Wang XB, 2007, SOIL TILL RES, V93, P239, DOI 10.1016/j.still.2006.05.005; Wang XB, 2012, FIELD CROP RES, V132, P106, DOI 10.1016/j.fcr.2011.09.012; WHISLER FD, 1986, ADV AGRON, V40, P141, DOI DOI 10.1016/S0065-2113(08)60282-5; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; World Water Assessment Programme, 2009, 3 UN WORLD WAT DEV R; Xie WY, 2011, J SHANXI AGR SCI; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang HP, 1999, AGR WATER MANAGE, V38, P195, DOI 10.1016/S0378-3774(98)00069-9; Zhang XY, 2006, AGRON J, V98, P1620, DOI 10.2134/agronj2005.0358; Zhang XY, 2010, AGR WATER MANAGE, V97, P1117, DOI 10.1016/j.agwat.2009.06.003; Zwart SJ, 2010, AGR WATER MANAGE, V97, P1617, DOI 10.1016/j.agwat.2010.05.018	60	40	42	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e78828	10.1371/journal.pone.0078828	http://dx.doi.org/10.1371/journal.pone.0078828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302987	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400004
J	Kim, YK; Kim, S; Shin, YJ; Hur, YS; Kim, WY; Lee, MS; Cheon, CI; Verma, DPS				Kim, Yun-Kyoung; Kim, Sunghan; Shin, Yun-jeong; Hur, Yoon-Sun; Kim, Woo-Young; Lee, Myung-Sok; Cheon, Choong-Ill; Verma, Desh Pal S.			Ribosomal Protein S6, a Target of Rapamycin, Is Involved in the Regulation of rRNA Genes by Possible Epigenetic Changes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Histone Deacetylase; Ribosomal RNA (rRNA); Stress Response; TOR	POLYMERASE-I; HISTONE DEACETYLASES; NUCLEOLAR DOMINANCE; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; KINASE; RDNA; LOCALIZATION; ASSOCIATION	The target of rapamycin (TOR) kinase pathway regulates various biological processes, including translation, synthesis of ribosomal proteins, and transcription of rRNA. The ribosomal protein S6 (RPS6) is one of the well known downstream components of the TOR pathway. Ribosomal proteins have been known to have diverse functions in regulating cellular metabolism as well as protein synthesis. So far, however, little is known about other possible role(s) of RPS6 in plants, besides being a component of the 40 S ribosomal subunit and acting as a target of TOR. Here, we report that RPS6 may have a novel function via interaction with histone deacetylase 2B (AtHD2B) that belongs to the plant-specific histone deacetylase HD2 family. RPS6 and AtHD2B were localized to the nucleolus. Co-expression of RPS6 and AtHD2B caused a change in the location of both RPS6 and AtHD2B to one or several nucleolar spots. ChIP analysis suggests that RPS6 directly interacts with the rRNA gene promoter. Protoplasts overexpressing both AtHD2B and RPS6 exhibited down-regulation of pre-18 S rRNA synthesis with a concomitant decrease in transcription of some of the ribosomal proteins, suggesting their direct role in ribosome biogenesis and plant development. This is consistent with the mutation in rps6b that results in reduction in 18 S rRNA transcription and decreased root growth. We propose that the interaction between RPS6 and AtHD2B brings about a change in the chromatin structure of rDNA and thus plays an important role in linking TOR signaling to rDNA transcription and ribosome biogenesis in plants.	[Kim, Yun-Kyoung; Shin, Yun-jeong; Hur, Yoon-Sun; Lee, Myung-Sok; Cheon, Choong-Ill] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea; [Kim, Sunghan] Seoul Natl Univ, Dept Plant Sci, Seoul 151742, South Korea; [Kim, Sunghan; Verma, Desh Pal S.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Kim, Sunghan; Verma, Desh Pal S.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA	Sookmyung Women's University; Sookmyung Women's University; Seoul National University (SNU); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cheon, CI (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Hyochangwon Gil 52, Seoul 140742, South Korea.	ccheon@sookmyung.ac.kr; verma.1@osu.edu	Kim, Sunghan/ABH-3874-2020	Kim, Sunghan/0000-0002-4955-8780	National Science Foundation [0726284]; National Research Foundation of Korea [201100300074, 2010-A0604-C00031]; Korean Government; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation Grant 0726284 (to D. P. S. V.), National Research Foundation of Korea Grant 201100300074 funded by the Korean Government (to Sookmyung MRC Center and C. I. C.), and National Research Foundation of Korea Grant 2010-A0604-C00031 (to S. K.).	Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creff A, 2010, PLANT MOL BIOL, V73, P533, DOI 10.1007/s11103-010-9639-y; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLEISCHER S, 1983, EMBO J, V2, P2319, DOI 10.1002/j.1460-2075.1983.tb01740.x; FRANCO R, 1990, J BIOL CHEM, V265, P4321; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Saez-Vasquez J, 2004, MOL CELL BIOL, V24, P7284, DOI 10.1128/MCB.24.16.7284-7297.2004; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; SUZUKI H, 1991, PLANT PHYSIOL, V95, P384, DOI 10.1104/pp.95.2.384; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x	45	49	50	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3901	3912		10.1074/jbc.M113.515015	http://dx.doi.org/10.1074/jbc.M113.515015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24302738	Green Published, hybrid			2022-12-25	WOS:000331403800007
J	Vitaloni, M; Pulecio, J; Bilic, J; Kuebler, B; Laricchia-Robbio, L; Belmonte, JC				Vitaloni, Marianna; Pulecio, Julian; Bilic, Josipa; Kuebler, Bernd; Laricchia-Robbio, Leopoldo; Izpisua Belmonte, Juan Carlos			MicroRNAs Contribute to Induced Pluripotent Stem Cell Somatic Donor Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computational Biology; Differentiation; Induced Pluripotent Stem (iPS) Cell; Induced Pluripotent Stem Cells; MicroRNA; Hematopoietic Progenitor Cell	EPIGENETIC MEMORY; HUMAN FIBROBLASTS; GENERATION; EXPRESSION; DIFFERENTIATION; MOUSE; EFFICIENT; IDENTIFICATION; PROGENITORS; DISCOVERY	Induced pluripotent stem cells (iPSCs) maintain during the first few culture passages a set of epigenetic marks and metabolites characteristic of their somatic cell of origin, a concept defined as epigenetic donor memory. These residual somatic features are lost over time after extensive culture passaging. Therefore, epigenetic donor memory may be responsible for the higher differentiation efficiency toward the tissue of origin observed in low passage iPSCs versus high passage iPSC or iPSCs derived from a different tissue source. Remarkably, there are no studies on the relevance of microRNA (miRNA) memory following reprogramming, despite the established role of these molecules in the context of pluripotency and differentiation. Using hematopoietic progenitors cells as a model, we demonstrated that miRNAs play a central role in somatic memory retention in iPSCs. Moreover, the comparison of the miRNA expression profiles among iPSCs from different sources allowed for the detection of a set of candidate miRNAs responsible for the higher differentiation efficiency rates toward blood progenitors observed in low passage iPSCs. Combining bioinformatic predictive algorithms with biological target validation, we identified miR-155 as a key player for the in vitro differentiation of iPSC toward hematopoietic progenitors. In summary, this study reveals that during the initial passages following reprogramming, iPSCs maintained the expression of a miRNA set exclusive to the original somatic population. Hence the use of these miRNAs might hold a direct application toward our understanding of the differentiation process of iPSCs toward hematopoietic progenitor cells.	[Vitaloni, Marianna; Pulecio, Julian; Bilic, Josipa; Kuebler, Bernd; Laricchia-Robbio, Leopoldo; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JC (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Kuebler, Bernd/K-2823-2017	Kuebler, Bernd/0000-0002-4472-871X; Vitaloni, Marianna/0000-0002-4250-3525; Bilic Zimmermann, Josipa/0000-0001-9642-6265; Pulecio, Julian/0000-0002-4455-8095	Fundacion Cellex; TERCEL-ISCIII-MINECO; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; California Institute for Regenerative Medicine	Fundacion Cellex; TERCEL-ISCIII-MINECO; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by grants from Fundacion Cellex, TERCEL-ISCIII-MINECO, the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, and the California Institute for Regenerative Medicine (to the Izpisua Belmonte laboratory).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee SB, 2012, STEM CELLS, V30, P997, DOI 10.1002/stem.1074; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nishishita Naoki, 2011, J Stem Cells, V6, P101; O'Connell RM, 2012, CURR TOP DEV BIOL, V99, P145, DOI 10.1016/B978-0-12-387038-4.00006-9; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Rizzi R, 2012, CELL DEATH DIFFER, V19, P1162, DOI 10.1038/cdd.2011.205; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Zheng W, 2011, MOL BIOTECHNOL, V47, P200, DOI 10.1007/s12033-010-9329-7	51	30	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2084	2098		10.1074/jbc.M113.538702	http://dx.doi.org/10.1074/jbc.M113.538702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311783	hybrid, Green Published			2022-12-25	WOS:000331130200018
J	Adler, L; Chen, CH; Koutalos, Y				Adler, Leopold; Chen, Chunhe; Koutalos, Yiannis			Mitochondria Contribute to NADPH Generation in Mouse Rod Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Metabolism; Mitochondria; Photoreceptors; Retinoid; NADPH	MONOCARBOXYLATE TRANSPORT INHIBITION; RETINAL FUNCTION; OUTER SEGMENTS; AEROBIC GLYCOLYSIS; MAMMALIAN RETINA; LACTATE; CELLS; METABOLISM; GLUCOSE; EXPRESSION	Background: The major source of NADPH is considered to be the pentose phosphate pathway. Results: In isolated mouse rod photoreceptors, blocking metabolite entry into mitochondria substantially reduces NADPH generation. Mitochondrial metabolic substrates support NADPH generation. Conclusion: Mitochondria-linked pathways contribute substantially to NADPH generation in mouse rod photoreceptors. Significance: A wide range of photoreceptor cell functions depend on adequate NADPH supply. NADPH is the primary source of reducing equivalents in the cytosol. Its major source is considered to be the pentose phosphate pathway, but cytosolic NADP(+)-dependent dehydrogenases using intermediates of mitochondrial pathways for substrates have been known to contribute. Photoreceptors, a nonproliferating cell type, provide a unique model for measuring the functional utilization of NADPH at the single cell level. In these cells, NADPH availability can be monitored from the reduction of the all-trans-retinal generated by light to all-trans-retinol using single cell fluorescence imaging. We have used mouse rod photoreceptors to investigate the generation of NADPH by different metabolic pathways. In the absence of extracellular metabolic substrates, NADPH generation was severely compromised. Extracellular glutamine supported NADPH generation to levels comparable to those of glucose, but pyruvate and lactate were relatively ineffective. At low extracellular substrate concentrations, partial inhibition of ATP synthesis lowered, whereas suppression of ATP consumption augmented NADPH availability. Blocking pyruvate transport into mitochondria decreased NADPH availability, and addition of glutamine restored it. Our findings demonstrate that in a nonproliferating cell type, mitochondria-linked pathways can generate substantial amounts of NADPH and do so even when the pentose phosphate pathway is operational. Competing demands for ATP and NADPH at low metabolic substrate concentrations indicate a vulnerability to nutrient shortages. By supporting substantial NADPH generation, mitochondria provide alternative metabolic pathways that may support cell function and maintain viability under transient nutrient shortages. Such pathways may play an important role in protecting against retinal degeneration.	[Adler, Leopold; Chen, Chunhe; Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Koutalos, Yiannis] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu			National Institutes of Health [R01-EY014850]; Research to Prevent Blindness (New York); National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY014850. This work was also supported by an unrestricted grant to the Department of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness (New York). This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Archibald RM, 1944, J BIOL CHEM, V154, P643; Bergersen L, 1999, NEUROSCIENCE, V90, P319, DOI 10.1016/S0306-4522(98)00427-8; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; BLISS AF, 1951, ARCH BIOCHEM BIOPHYS, V31, P197, DOI 10.1016/0003-9861(51)90206-8; Bui BV, 2004, EUR J NEUROSCI, V20, P1525, DOI 10.1111/j.1460-9568.2004.03601.x; Bui BV, 2004, INVEST OPHTH VIS SCI, V45, P584, DOI 10.1167/iovs.03-0695; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chen CH, 2002, BIOPHYS J, V83, P1403, DOI 10.1016/S0006-3495(02)73911-8; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DEMONTIS GC, 1995, BIOPHYS J, V69, P439, DOI 10.1016/S0006-3495(95)79917-9; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HSU SC, 1994, J BIOL CHEM, V269, P17954; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; KAGAWA Y, 1966, J BIOL CHEM, V241, P2461; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Martin PM, 2007, INVEST OPHTH VIS SCI, V48, P3356, DOI 10.1167/iovs.06-0888; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NELSON DL, 2000, LEHNINGER PRINCIPLES, P558; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Poitry S, 2000, J NEUROSCI, V20, P1809; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; STEIN WH, 1954, J BIOL CHEM, V211, P915; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Wada M, 2006, BRAIN RES, V1081, P92, DOI 10.1016/j.brainres.2006.01.084; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P1569; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P766; Winkler BS, 2004, NEUROCHEM INT, V45, P311, DOI 10.1016/j.neuint.2003.08.017; Winkler BS, 2003, EXP EYE RES, V77, P327, DOI 10.1016/S0014-4835(03)00147-7; Winkler BS, 2003, EXP EYE RES, V76, P715, DOI 10.1016/S0014-4835(03)00052-6; WINKLER BS, 1986, EXP EYE RES, V42, P585, DOI 10.1016/0014-4835(86)90048-5; WINKLER BS, 1983, EXP EYE RES, V36, P581, DOI 10.1016/0014-4835(83)90052-0; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x	52	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1519	1528		10.1074/jbc.M113.511295	http://dx.doi.org/10.1074/jbc.M113.511295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297174	hybrid, Green Published			2022-12-25	WOS:000332401700027
J	Yun, B; Lee, H; Ghosh, M; Cravatt, BF; Hsu, KL; Bonventre, JV; Ewing, H; Gelb, MH; Leslie, CC				Yun, Bogeon; Lee, HeeJung; Ghosh, Moumita; Cravatt, Benjamin F.; Hsu, Ku-Lung; Bonventre, Joseph V.; Ewing, Heather; Gelb, Michael H.; Leslie, Christina C.			Serine Hydrolase Inhibitors Block Necrotic Cell Death by Preventing Calcium Overload of the Mitochondria and Permeability Transition Pore Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Calcium; CaMKII; Fatty Acid; Mitochondria; Mitochondrial Permeability Transition; Phospholipase A; Cyclosporin A; Pyrrophenone; Serine Hydrolase	CYTOSOLIC PHOSPHOLIPASE A(2); PROTEIN-KINASE-C; REPERFUSION INJURY; CYCLOSPORINE-A; OXIDATIVE STRESS; LUNG FIBROBLASTS; CA2+ UPTAKE; NECROSIS; MECHANISMS; UNIPORTER	Background: Mitochondrial calcium overload triggers permeability transition pore formation, fatty acid release, and necrotic cell death. Results: Pyrrophenone and KT195 inhibit cell death by blocking mitochondrial calcium uptake. Conclusion: Serine hydrolase inhibitors block mitochondrial calcium uptake but do not directly inhibit the enzyme releasing fatty acids during pore formation. Significance: Serine hydrolase inhibitors have potential to block necrotic cell death associated with disease. Perturbation of calcium signaling that occurs during cell injury and disease, promotes cell death. In mouse lung fibroblasts A23187 triggered mitochondrial permeability transition pore (MPTP) formation, lactate dehydrogenase (LDH) release, and necrotic cell death that were blocked by cyclosporin A (CsA) and EGTA. LDH release temporally correlated with arachidonic acid release but did not involve cytosolic phospholipase A(2) (cPLA(2)) or calcium-independent PLA(2). Surprisingly, release of arachidonic acid and LDH from cPLA(2)-deficient fibroblasts was inhibited by the cPLA(2) inhibitor pyrrophenone, and another serine hydrolase inhibitor KT195, by preventing mitochondrial calcium uptake. Inhibitors of calcium/calmodulin-dependent protein kinase II, a mitochondrial Ca2+ uniporter (MCU) regulator, also prevented MPTP formation and arachidonic acid release induced by A23187 and H2O2. Pyrrophenone blocked MCU-mediated mitochondrial calcium uptake in permeabilized fibroblasts but not in isolated mitochondria. Unlike pyrrophenone, the diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol and CsA blocked cell death and arachidonic acid release not by preventing mitochondrial calcium uptake but by inhibiting MPTP formation. In fibroblasts stimulated with thapsigargin, which induces MPTP formation by a direct effect on mitochondria, LDH and arachidonic acid release were blocked by CsA and 1-oleoyl-2-acetyl-sn-glycerol but not by pyrrophenone or EGTA. Therefore serine hydrolase inhibitors prevent necrotic cell death by blocking mitochondrial calcium uptake but not the enzyme releasing fatty acids that occurs by a novel pathway during MPTP formation. This work reveals the potential for development of small molecule cell-permeable serine hydrolase inhibitors that block MCU-mediated mitochondrial calcium overload, MPTP formation, and necrotic cell death.	[Yun, Bogeon; Lee, HeeJung; Ghosh, Moumita; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Cravatt, Benjamin F.; Hsu, Ku-Lung] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.; Hsu, Ku-Lung] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Ewing, Heather; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Scripps Research Institute; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	Hsu, Ku-Lung/L-6256-2019; Hsu, Ku-Lung/J-2885-2014	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972; gelb, michael/0000-0001-7000-5219	National Institutes of Health [HL61378, HL34303, HL50040, DA009789, DA033760, MH084512]; Hewitt Foundation Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061378, R01HL050040, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA033760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewitt Foundation Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL61378, HL34303, HL50040, DA009789, DA033760, and MH084512 and a Hewitt Foundation Postdoctoral Fellowship.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Baines CP, 2011, PEDIATR CARDIOL, V32, P258, DOI 10.1007/s00246-010-9880-9; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barbayianni E, 2009, BIOORGAN MED CHEM, V17, P4833, DOI 10.1016/j.bmc.2009.03.069; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Broekemeier KM, 2002, BIOCHEMISTRY-US, V41, P7771, DOI 10.1021/bi020157z; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Chinopoulos C, 2005, J BIOENERG BIOMEMBR, V37, P237, DOI 10.1007/s10863-005-6634-0; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; CROMPTON M, 1988, BIOCHEM J, V255, P357; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; GELB MH, 1985, BIOCHEMISTRY-US, V24, P1813, DOI 10.1021/bi00329a001; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; Knox CD, 2004, AM J PHYSIOL-GASTR L, V287, pG533, DOI 10.1152/ajpgi.00050.2004; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Lemasters JJ, 1999, CARDIOVASC RES, V44, P470, DOI 10.1016/S0008-6363(99)00368-5; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Mcgee AM, 2011, BIOCHEM J, V433, P119, DOI 10.1042/BJ20101431; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	68	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1491	1504		10.1074/jbc.M113.497651	http://dx.doi.org/10.1074/jbc.M113.497651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297180	Green Published, hybrid			2022-12-25	WOS:000332401700025
J	Zhou, FJ; Walker, SE; Mitchell, SF; Lorsch, JR; Hinnebusch, AG				Zhou, Fujun; Walker, Sarah E.; Mitchell, Sarah F.; Lorsch, Jon R.; Hinnebusch, Alan G.			Identification and Characterization of Functionally Critical, Conserved Motifs in the Internal Repeats and N-terminal Domain of Yeast Translation Initiation Factor 4B (yeIF4B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Ribosomes; Translation Initiation Factors; Translation Regulation; Yeast; eIF4A; eIF4B; Translation Initiation; Yeast Translation	RNA RECOGNITION MOTIF; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; HELICASE ACTIVITY; SHUTTLE VECTORS; IN-VIVO; EIF4B; COMPLEX; PROTEIN; SELECTION	Background: The internal repeats and NTD of yeIF4B stimulate translation initiation. Results: The minimal number of repeats and conserved motifs in the repeat and NTD necessary for yeIF4B function was determined. Conclusion: Two repeats provide appreciable function, except when the NTD is missing or eIF4F function is limiting or compromised. Significance: The results provide a comprehensive description of functionally critical sequence elements in yeIF4B. eIF4B has been implicated in attachment of the 43 S preinitiation complex (PIC) to mRNAs and scanning to the start codon. We recently determined that the internal seven repeats (of approximate to 26 amino acids each) of Saccharomyces cerevisiae eIF4B (yeIF4B) compose the region most critically required to enhance mRNA recruitment by 43 S PICs in vitro and stimulate general translation initiation in yeast. Moreover, although the N-terminal domain (NTD) of yeIF4B contributes to these activities, the RNA recognition motif is dispensable. We have now determined that only two of the seven internal repeats are sufficient for wild-type (WT) yeIF4B function in vivo when all other domains are intact. However, three or more repeats are needed in the absence of the NTD or when the functions of eIF4F components are compromised. We corroborated these observations in the reconstituted system by demonstrating that yeIF4B variants with only one or two repeats display substantial activity in promoting mRNA recruitment by the PIC, whereas additional repeats are required at lower levels of eIF4A or when the NTD is missing. These findings indicate functional overlap among the 7-repeats and NTD domains of yeIF4B and eIF4A in mRNA recruitment. Interestingly, only three highly conserved positions in the 26-amino acid repeat are essential for function in vitro and in vivo. Finally, we identified conserved motifs in the NTD and demonstrate functional overlap of two such motifs. These results provide a comprehensive description of the critical sequence elements in yeIF4B that support eIF4F function in mRNA recruitment by the PIC.	[Zhou, Fujun; Hinnebusch, Alan G.] Eunice Kennedy Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Walker, Sarah E.; Mitchell, Sarah F.; Lorsch, Jon R.] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Lorsch, JR (corresponding author), Eunice Kennedy Shriver NICHD, Lab Mech & Regulat Prot Synth, NIH, Bldg 45,Rm 3AN44, Bethesda, MD 20892 USA.	jon.lorsch@nih.gov; ahinnebusch@nih.gov	Walker, Sarah/U-1609-2019	Walker, Sarah/0000-0002-9983-2485; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health; American Heart Association;  [GM62128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant (to A. G. H. and F. Z.) and Grant GM62128 (to J. R. L.). This work was also supported by an American Heart Association postdoctoral fellowship (to S. E. W.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Andreou A. Z., 2013, J MOL BIOL, DOI 10.1016/j.jmb.2013.09.027; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; CIGAN AM, 1993, P NATL ACAD SCI USA, V90, P5350, DOI 10.1073/pnas.90.11.5350; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Niederberger N, 1998, RNA, V4, P1259, DOI 10.1017/S1355838298980487; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; oze A. R., 2011, J MOL BIOL, V412, P674; Park EH, 2013, J BIOL CHEM, V288, P2340, DOI 10.1074/jbc.M112.398537; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Rajagopal V, 2012, J BIOL CHEM, V287, P20301, DOI 10.1074/jbc.M112.347278; REID GA, 1982, J BIOL CHEM, V257, P3062; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P803, DOI 10.1093/nar/26.3.803; SIKORSKI RS, 1989, GENETICS, V122, P19; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Walker SE, 2013, RNA, V19, P191, DOI 10.1261/rna.035881.112	37	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1704	1722		10.1074/jbc.M113.529370	http://dx.doi.org/10.1074/jbc.M113.529370			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285537	Green Published, hybrid			2022-12-25	WOS:000332401700042
J	Barnabe, C; Buitrago, R; Bremond, P; Aliaga, C; Salas, R; Vidaurre, P; Herrera, C; Cerqueira, F; Bosseno, MF; Waleckx, E; Breniere, SF				Barnabe, Christian; Buitrago, Rosio; Bremond, Philippe; Aliaga, Claudia; Salas, Renata; Vidaurre, Pablo; Herrera, Claudia; Cerqueira, Frederique; Bosseno, Marie-France; Waleckx, Etienne; Frederique Breniere, Simone			Putative Panmixia in Restricted Populations of Trypanosoma cruzi Isolated from Wild Triatoma infestans in Bolivia	PLOS ONE			English	Article							GENETIC EXCHANGE; NUCLEOTIDE-SEQUENCES; NATURAL-POPULATIONS; CLONAL EVOLUTION; F-STATISTICS; DIVERSITY; IMPACT; RECOMBINATION; MICROORGANISMS; IDENTIFICATION	Trypanosoma cruzi, the causative agent of Chagas disease, is subdivided into six discrete typing units (DTUs; TcI-TcVI) of which TcI is ubiquitous and genetically highly variable. While clonality is the dominant mode of propagation, recombinant events play a significant evolutive role. Recently, foci of wild Triatoma infestans have been described in Bolivia, mainly infected by TcI. Hence, for the first time, we evaluated the level of genetic exchange within TcI natural potentially panmictic populations (single DTU, host, area and sampling time). Seventy-nine TcI stocks from wild T. infestans, belonging to six populations were characterized at eight microsatellite loci. For each population, Hardy-Weinberg equilibrium (HWE), linkage disequilibrium (LD), and presence of repeated multilocus genotypes (MLG) were analyzed by using a total of seven statistics, to test the null hypothesis of panmixia (H-0). For three populations, none of the seven statistics allowed to rejecting H-0; for another one the low size did not allow us to conclude, and for the two others the tests have given contradictory results. Interestingly, apparent panmixia was only observed in very restricted areas, and was not observed when grouping populations distant of only two kilometers or more. Nevertheless it is worth stressing that for the statistic tests of "HWE", in order to minimize the type I error (i.e. incorrect rejection of a true H-0), we used the Bonferroni correction (BC) known to considerably increase the type II error (i.e. failure to reject a false H-0). For the other tests (LD and MLG), we did not use BC and the risk of type II error in these cases was acceptable. Thus, these results should be considered as a good indicator of the existence of panmixia in wild environment but this must be confirmed on larger samples to reduce the risk of type II error.	[Barnabe, Christian; Buitrago, Rosio; Bremond, Philippe; Aliaga, Claudia; Salas, Renata; Bosseno, Marie-France; Waleckx, Etienne; Frederique Breniere, Simone] Univ Montpellier I, IRD, CNRS 5290, IRD 224, La Paz, Bolivia; [Barnabe, Christian; Buitrago, Rosio; Bremond, Philippe; Aliaga, Claudia; Salas, Renata; Bosseno, Marie-France; Waleckx, Etienne; Frederique Breniere, Simone] Univ Montpellier 2, IRD, CNRS 5290, IRD 224, La Paz, Bolivia; [Barnabe, Christian; Buitrago, Rosio; Aliaga, Claudia; Salas, Renata; Bosseno, Marie-France; Waleckx, Etienne; Frederique Breniere, Simone] Inst Nacl Labs Salud INLASA, Dept Entomol, La Paz, Bolivia; [Vidaurre, Pablo] Serv Dept Salud SEDES La Paz, La Paz, Bolivia; [Herrera, Claudia] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA; [Cerqueira, Frederique] Univ Montpellier 2, Plateforme Genom Environm Labex Ctr Mediterrance, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Tulane University; Universite de Montpellier	Barnabe, C (corresponding author), Univ Montpellier I, IRD, CNRS 5290, IRD 224, La Paz, Bolivia.	christian.barnabe@ird.fr	Waleckx, Etienne/GOG-9370-2022; Barnabé, Christian/R-2904-2016; Waleckx, Etienne/G-2439-2017; Breniere, Simone Frederique/J-9214-2016	Barnabé, Christian/0000-0003-1857-0741; Waleckx, Etienne/0000-0002-3270-6476; Breniere, Simone Frederique/0000-0003-4385-3989	IRD; National Agency for Research (ANR, France) [3624]; European Commission [223034]	IRD; National Agency for Research (ANR, France)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the IRD, the National Agency for Research (ANR No 3624, France) and the European Commission Framework Program Project "Comparative epidemiology of genetic lineages of Trypanosoma cruzi" ChagasEpiNet, Contract No. 223034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Balloux F, 2003, GENETICS, V164, P1635; Barnabe C, 2012, INFECT GENET EVOL, V12, P1879, DOI 10.1016/j.meegid.2012.08.018; Barnabe C, 2011, INFECT GENET EVOL, V11, P1752, DOI 10.1016/j.meegid.2011.07.011; Bogliolo AR, 1996, ACTA TROP, V61, P31, DOI 10.1016/0001-706X(95)00138-5; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; BROWN AHD, 1980, GENETICS, V96, P523; Buitrago R, 2010, AM J TROP MED HYG, V82, P574, DOI 10.4269/ajtmh.2010.09-0325; Carrasco HJ, 1996, AM J TROP MED HYG, V54, P418, DOI 10.4269/ajtmh.1996.54.418; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; de Meeus T, 2004, INFECT GENET EVOL, V4, P345, DOI 10.1016/j.meegid.2004.05.002; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Ferreira RC, 2012, INFECT GENET EVOL, V12, P1064, DOI 10.1016/j.meegid.2012.03.010; Breniere SF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001650; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Higo H, 2007, PARASITOL RES, V100, P1023, DOI 10.1007/s00436-006-0376-8; Judson OP, 1996, TRENDS ECOL EVOL, V11, pA41; Laurent JP, 1997, PARASITOLOGY, V114, P213, DOI 10.1017/S0031182096008414; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2010, HEREDITY, V104, P135, DOI 10.1038/hdy.2009.128; R Core Team, 2022, R LANG ENV STAT COMP; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Rougeron V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001004; Sterkers Y, 2012, MOL MICROBIOL, V86, P15, DOI 10.1111/j.1365-2958.2012.08185.x; Sturm NR, 2003, INT J PARASITOL, V33, P269, DOI 10.1016/S0020-7519(02)00264-3; Teriokhin AT, 2007, ZH OBSHCH BIOL, V68, P332; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; Tibayrenc M, 1999, MICROBES INFECT, V1, P465, DOI 10.1016/S1286-4579(99)80050-1; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; TIBAYRENC M, 1991, PARASITOL TODAY, V7, P228, DOI 10.1016/0169-4758(91)90234-F; Tibayrenc M, 2012, P NATL ACAD SCI USA; Tibayrenc M, 2010, ELSEV INSIGHT, P475, DOI 10.1016/B978-0-12-384876-5.00019-8; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	59	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82269	10.1371/journal.pone.0082269	http://dx.doi.org/10.1371/journal.pone.0082269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312410	Green Submitted, gold, Green Published			2022-12-25	WOS:000327670300077
J	Sarkinen, T; George, M				Saerkinen, Tiina; George, Morvah			Plastid Marker Variation: Can Complete Plastid Genomes from Closely Related Species Help?	PLOS ONE			English	Article							COPY NUCLEAR GENES; PHYLOGENETIC UTILITY; MOLECULAR PHYLOGENY; NONCODING REGIONS; DNA BARCODES; CHLOROPLAST; SEQUENCES; IDENTIFICATION; HARE; TORTOISE	Rapidly evolving non-coding plastid on NCP are currently widely used in evolutionary biology especially in plant systematic studies where NCPs have become one of the most commonly used tools in clarifying species relationships. Currently, the generally small amount of sequence variation provided by NCPs compared to nuclear regions makes plastid phylogeny reconstruction challenging at the species-level, especially so in species rich clades such as Solanum with c 1,200 species. Previous studies have established that the set of most highly variable NCPs vary between major plant families, here we explore whether this variation extends beyond family level to genera and major clades within genera. Using full plastome data, we identify the most highly variable plastid markers in the Potato clade of Solanum. We then compare sequence variation between the Potato and the closely related Morelloid clade. Results show that whilst narrow set of NCPs show consistently high variation, levels of sequence variation in most NCPs differ greatly between closely related clades. The high variation detected between closely related groups implies that repeated screening studies will be needed for individual projects despite the potential availability of results from closely related taxa, and indicates a narrower applicability of family-specific screening studies than previously thought.	[Saerkinen, Tiina] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Saerkinen, Tiina] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [George, Morvah] Royal Bot Gardens, Millenium Seed Bank, Richmond, Surrey, England	Natural History Museum London; Royal Botanic Gardens, Kew	Sarkinen, T (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	t.sarkinen@rbge.ac.uk			National Science Foundation (NSF) [DEB-0316614]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) grant 'PBI Solanum - a world treatment' DEB-0316614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Chung SM, 2007, GENOME, V50, P215, DOI 10.1139/G07-003; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Curto MA, 2012, MOL PHYLOGENET EVOL, V63, P758, DOI 10.1016/j.ympev.2012.02.010; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feleke Y, 2006, PLANT SYST EVOL, V262, P75, DOI 10.1007/s00606-006-0475-0; Fortune PM, 2008, AM J BOT, V95, P454, DOI 10.3732/ajb.95.4.454; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Hughes CE, 2006, PHILOS T R SOC B, V361, P211, DOI 10.1098/rstb.2005.1735; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Hung KH, 2009, TAXON, V58, P1216, DOI 10.1002/tax.584013; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Levin RA, 2009, MOL PHYLOGENET EVOL, V53, P881, DOI 10.1016/j.ympev.2009.08.016; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Motta-Aldana JR, 2010, CROP SCI, V50, P1773, DOI 10.2135/cropsci2009.12.0706; Naumann J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-357; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; PALMER J D, 1987, American Naturalist, V130, pS6, DOI 10.1086/284689; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sarkinen T, 2012, J BIOGEOGR, V39, P884, DOI 10.1111/j.1365-2699.2011.02644.x; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Valcarcel V, 2008, MOL PHYLLOGENET EVOL, V27, P1; von Crautlein M, 2011, BIODIVERS CONSERV, V20, P373, DOI 10.1007/s10531-010-9964-0; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Wills DM, 2006, J HERED, V97, P403, DOI 10.1093/jhered/esl001; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Zhang YJ., 2011, PLOS ONE, V6, DOI [DOI 10.1371/journal.pone.0020596, 10.1371/journal.pone.0020596]	57	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82266	10.1371/journal.pone.0082266	http://dx.doi.org/10.1371/journal.pone.0082266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312409	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300076
J	Chen, WR; Chen, XY; Hu, ZM; Lin, HT; Zhou, FQ; Luo, LX; Zhang, XY; Zhong, XJ; Yang, Y; Wu, CR; Lin, ZL; Ye, SB; Liu, YZ				Chen, Weirong; Chen, Xiaoyun; Hu, Zhengmao; Lin, Haotian; Zhou, Fengqi; Luo, Lixia; Zhang, Xinyu; Zhong, Xiaojian; Yang, Ye; Wu, Changrui; Lin, Zhuoling; Ye, Shaobi; Liu, Yizhi		Study Grp CCPMOH	A Missense Mutation in CRYBB2 Leads to Progressive Congenital Membranous Cataract by Impacting the Solubility and Function of beta B2-Crystallin	PLOS ONE			English	Article							CRYSTALLIN GENE-MUTATIONS; HUMAN LENS; INHERITED CATARACT; CHINESE FAMILY; PEDIATRIC CATARACT; INDIAN FAMILIES; IDENTIFICATION; PROTEIN; ALLELE	Congenital cataract is a major cause of visual impairment and childhood blindness. The solubility and stability of crystallin proteins play critical roles in maintaining the optical transparency of the lens during the life span. Previous studies have shown that approximately 8.3%similar to 25% of congenital cataracts are inherited, and mutations in crystallins are the most common. In this study, we attempted to identify the genetic defect in a four-generation family affected with congenital cataracts. The congenital cataract phenotype of this four-generation family was identified as membranous cataract by slit-lamp photography. Mutation screening of the candidate genes detected a heterozygous c.465G -> C change in the exon6 of the beta B2-crystallin gene (CRYBB2) in all family members affected with cataracts, resulting in the substitution of a highly conserved Tryptophan to Cystine (p.W151C). The mutation was confirmed by restriction fragment length polymorphism (RFLP) analysis and found that the transition resulted in the absence of a BslI restriction site in the affected members of the pedigree. The outcome of PolyPhen-2 and SIFT analysis predicted that this W151C mutation would probably damage to the structure and function of beta B2-crystallin. Wild type (wt) and W151C mutant beta B2-crystallin were expressed in human lens epithelial cells (HLECs), and the fluorescence results showed that Wt-beta B2-crystallin was evenly distributed throughout the cells, whereas approximately 34.7% of cells transfected with the W151C mutant beta B2-crystallin formed intracellular aggregates. Taken together, these data suggest that the missense mutation in CRYBB2 gene leads to progressive congenital membranous cataract by impacting the solubility and function of beta B2-crystallin.	[Chen, Weirong; Chen, Xiaoyun; Lin, Haotian; Luo, Lixia; Zhang, Xinyu; Zhong, Xiaojian; Yang, Ye; Wu, Changrui; Lin, Zhuoling; Ye, Shaobi; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Zhengmao] Cent S Univ, Xiangya Med Coll, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zhou, Fengqi] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Central South University; Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	Zhong, Xiaojian/J-9727-2016; liu, yi/GXE-9662-2022; Chen, Wei/GZK-7348-2022	Zhong, Xiaojian/0000-0002-4201-0747; 	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China	This study was funded by the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010-2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of Ministry of Health). The sponsor of the study had no role in the design of the original study protocol, data collection, data analysis, data interpretation, writing of the report, or decision to submit the manuscript for publication.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; CARVER JA, 1994, BBA-PROTEIN STRUCT M, V1204, P195, DOI 10.1016/0167-4838(94)90009-4; Devi RR, 2008, MOL VIS, V14, P1157; Feng JH, 2000, J BIOL CHEM, V275, P11585, DOI 10.1074/jbc.275.16.11585; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; INANA G, 1983, NATURE, V302, P310, DOI 10.1038/302310a0; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Liu BF, 2005, MOL VIS, V11, P321; Lou D, 2009, EYE, V23, P1213, DOI 10.1038/eye.2008.222; Maeda YY, 2001, MAMM GENOME, V12, P278, DOI 10.1007/s003350010281; Mothobi ME, 2009, MOL VIS, V15, P1470; Pauli S, 2007, MOL VIS, V13, P962; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Reddy MA, 2004, HUM MOL GENET, V13, P945, DOI 10.1093/hmg/ddh110; Santhiya ST, 2010, MOL VIS, V16, P1837; Santhiya ST, 2004, INVEST OPHTH VIS SCI, V45, P3599, DOI 10.1167/iovs.04-0207; Vanita, 2001, J MED GENET, V38, P392, DOI 10.1136/jmg.38.6.392; Wang KJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P337, DOI 10.1001/archophthalmol.2011.11; Wang L, 2009, OPHTHALMIC RES, V41, P148, DOI 10.1159/000209668; Weisschuh N, 2012, MOL VIS, V18, P174; Yao K, 2005, MOL VIS, V11, P758; Yao K, 2011, MOL VIS, V17, P144	26	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81290	10.1371/journal.pone.0081290	http://dx.doi.org/10.1371/journal.pone.0081290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312286	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900027
J	Ruhi, A; Boix, D; Gascon, S; Sala, J; Batzer, DP				Ruhi, Albert; Boix, Dani; Gascon, Stephanie; Sala, Jordi; Batzer, Darold P.			Functional and Phylogenetic Relatedness in Temporary Wetland Invertebrates: Current Macroecological Patterns and Implications for Future Climatic Change Scenarios	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; MACROINVERTEBRATE ASSEMBLAGES; FOOD-WEB; COMMUNITIES; DIVERSITY; HISTORY; TRAITS; TEMPERATE; HETEROGENEITY	In freshwater ecosystems, species compositions are known to be determined hierarchically by large to small-scale environmental factors, based on the biological traits of the organisms. However, in ephemeral habitats this heuristic framework remains largely untested. Although temporary wetland faunas are constrained by a local filter (i.e., desiccation), we propose its magnitude may still depend on large-scale climate characteristics. If this is true, climate should be related to the degree of functional and taxonomic relatedness of invertebrate communities inhabiting seasonal wetlands. We tested this hypothesis in two ways. First, based on 52 biological traits for invertebrates, we conducted a case study to explore functional trends among temperate seasonal wetlands differing in the harshness (i.e., dryness) of their dry season. After finding evidence of trait filtering, we addressed whether it could be generalized across a broader climatic scale. To this end, a meta-analysis (225 seasonal wetlands spread across broad climatic categories: Arid, Temperate, and Cold) allowed us to identify whether an equivalent climate-dependent pattern of trait richness was consistent between the Nearctic and the Western Palearctic. Functional overlap of invertebrates increased from mild (i.e., Temperate) to harsher climates (i.e., Arid and Cold), and phylogenetic clustering (using taxonomy as a surrogate) was highest in Arid and lowest in Temperate wetlands. We show that, (i) as has been described in streams, higher relatedness than would be expected by chance is generally observed in seasonal wetland invertebrate communities; and (ii) this relatedness is not constant but climate-dependent, with the climate under which a given seasonal wetland is located determining the functional overlap and the phylogenetic clustering of the community. Finally, using a space-for-time substitution approach we suggest our results may anticipate how the invertebrate biodiversity embedded in these vulnerable and often overlooked ecosystems will be affected by long-term climate change.	[Ruhi, Albert; Boix, Dani; Gascon, Stephanie; Sala, Jordi] Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain; [Ruhi, Albert] Catalan Inst Water Res, Girona, Catalonia, Spain; [Batzer, Darold P.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Universitat de Girona; Institut Catala de Recerca de l'Aigua (ICRA); University System of Georgia; University of Georgia	Ruhi, A (corresponding author), Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain.	aruhi@icra.cat	Boix, Dani/L-5190-2014; Gascón, Stéphanie/L-7471-2014; Sala, Jordi/L-8234-2014	Boix, Dani/0000-0001-5468-2236; Gascón, Stéphanie/0000-0003-1951-9083; Sala, Jordi/0000-0002-1227-8566	Ministerio de Ciencia y Tecnologia of the Spanish Government [CGL2011-23907]; Autonomous Region of Sardinia, Italy [CRP-24943]	Ministerio de Ciencia y Tecnologia of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Region of Sardinia, Italy(Regione Sardegna)	This work was supported by a Scientific Research grant (CGL2011-23907) from the Ministerio de Ciencia y Tecnologia of the Spanish Government (http://www.idi.mineco.gob.es/portal/site/MICINN/) and by a Scientific Research grant (CRP-24943) from the Autonomous Region of Sardinia, Italy (https://www.regione.sardegna.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2012, J ECOL, V100, P478, DOI 10.1111/j.1365-2745.2011.01930.x; Batzer DP, 2013, FRESHWATER BIOL, V58, P1647, DOI 10.1111/fwb.12156; Batzer DP, 1996, ANNU REV ENTOMOL, V41, P75, DOI 10.1146/annurev.en.41.010196.000451; Beche LA, 2006, FRESHWATER BIOL, V51, P56, DOI 10.1111/j.1365-2427.2005.01473.x; Beche LA, 2009, BIODIVERS CONSERV, V18, P3909, DOI 10.1007/s10531-009-9688-1; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Brucet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030877; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Carranza A, 2011, DIVERS DISTRIB, V17, P25, DOI 10.1111/j.1472-4642.2010.00720.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cereghino R, 2012, HYDROBIOLOGIA, V689, P51, DOI 10.1007/s10750-011-0744-y; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Dehling DM, 2010, J BIOGEOGR, V37, P1919, DOI 10.1111/j.1365-2699.2010.02347.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; *EPA US, 2012, FRESHW BIOL TRAITS D; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jeffries M, 2008, ECOGRAPHY, V31, P765, DOI 10.1111/j.0906-7590.2008.05487.x; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Koppen W., 1931, GRUNDRISS KLIMAKUNDE; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Layer K, 2011, ADV ECOL RES, V44, P69, DOI 10.1016/B978-0-12-374794-5.00002-X; Layer K, 2010, GLOBAL CHANGE BIOL, V16, P3133, DOI 10.1111/j.1365-2486.2010.02195.x; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; PICKETT S T A, 1989, P110; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Ruhi A, 2009, HYDROBIOLOGIA, V634, P137, DOI 10.1007/s10750-009-9896-4; Ruhi A, 2014, HYDROBIOLOGIA, V723, P25, DOI 10.1007/s10750-013-1514-9; Ruhi A, 2013, OECOLOGIA, V171, P545, DOI 10.1007/s00442-012-2440-7; Ruhi A, 2012, LIMNOLOGICA, V42, P328, DOI 10.1016/j.limno.2012.07.005; Ruhi A, 2012, ANN LIMNOL-INT J LIM, V48, P81, DOI 10.1051/limn/2011059; Ruhi A, 2012, FRESHW SCI, V31, P22, DOI 10.1899/11-018.1; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Somerfield PJ, 2008, ICES J MAR SCI, V65, P1462, DOI 10.1093/icesjms/fsn118; Statzner B, 2004, ECOGRAPHY, V27, P470, DOI 10.1111/j.0906-7590.2004.03836.x; Statzner B, 2001, ANNU REV ENTOMOL, V46, P291, DOI 10.1146/annurev.ento.46.1.291; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Tachet H., 2002, INVERTEBRES EAU DOUC; Teixeira-de Mello F, 2009, FRESHWATER BIOL, V54, P1202, DOI 10.1111/j.1365-2427.2009.02167.x; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Verberk WCEP, 2008, FRESHWATER BIOL, V53, P1722, DOI 10.1111/j.1365-2427.2008.02035.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WIGGINS G B, 1980, Archiv fuer Hydrobiologie Supplement, V58, P97; Williams DD., 2006, BIOL TEMPORARY WATER; Wissinger SA, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P1043; Woodward G, 2010, GLOBAL CHANGE BIOL, V16, P1979, DOI 10.1111/j.1365-2486.2009.02052.x	63	33	33	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81739	10.1371/journal.pone.0081739	http://dx.doi.org/10.1371/journal.pone.0081739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312347	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900047
J	Sang, HQ; Li, TT; Li, HY; Liu, JG				Sang, Haiquan; Li, Tingting; Li, Hangyu; Liu, Jingang			Down-Regulation of Gab1 Inhibits Cell Proliferation and Migration in Hilar Cholangiocarcinoma	PLOS ONE			English	Article							ACTIVATED AKT EXPRESSION; LYMPH-NODE METASTASIS; DOCKING PROTEIN GAB1; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; PHOSPHATIDYLINOSITOL 3-KINASE; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TUMOR PROGRESSION; PHOSPHO-AKT	Hilar cholangiocarcinoma is a highly aggressive malignancy originating from the hilar biliary duct epithelium. Due to few effective comprehensive treatments, the prognosis of hilar cholangiocarcinoma is poor. In this study, immunohistochemistry was first used to detect and analyze the expression of Gab1, VEGFR-2, and MMP-9 in hilar cholangiocarcinoma solid tumors and the relationships to the clinical pathological features. Furthermore, Gab1 and VEGFR-2 siRNA were used to interfere the hilar cholangiocarcinoma cell line ICBD-1 and then detect the PI3K/Akt signaling pathway, MMP-9 levels and malignant biological behaviors of tumor cells. The data showed that 1. Gab1, VEGFR-2, and MMP-9 were highly expressed and positively correlated with each other in hilar cholangiocarcinoma tissues, which were related to lymph node metastasis and differentiation. 2. After Gab1 or VEGFR-2 siRNA interference, PI3K/Akt pathway activity and MMP-9 levels were decreased in ICBD-1 cells. At the same time, cell proliferation decreased, cell cycle arrested in G1 phase, apoptosis increased and invasion decreased. These results suggest that the expression of Gab1, VEGFR-2, and MMP-9 are significantly related to the malignant biological behavior of hilar cholangiocarcinoma. Gab1 regulates growth, apoptosis and invasion through the VEGFR-2/Gab1/PI3K/Akt signaling pathway in hilar cholangiocarcinoma cells and influences the invasion of tumor cells via MMP-9.	[Sang, Haiquan] China Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shenyang, Liaoning, Peoples R China; [Li, Tingting] China Med Univ, Shengjing Hosp, Dept Clin Genet, Shenyang, Liaoning, Peoples R China; [Li, Tingting] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA; [Li, Tingting] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Li, Hangyu; Liu, Jingang] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; University of Rochester; University of Rochester; China Medical University	Liu, JG (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Liaoning, Peoples R China.	liujg51347@hotmail.com		Li, Hangyu/0000-0002-2570-1642	National Natural Science Foundation of China [81001091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (project no. 81001091) to Tingting Li. The funder had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Duff SE, 2006, EUR J CANCER, V42, P112, DOI 10.1016/j.ejca.2005.09.018; Felici A, 2010, J CELL BIOCHEM, V111, P310, DOI 10.1002/jcb.22695; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Figueras J, 2000, LIVER TRANSPLANT, V6, P786, DOI 10.1053/jlts.2000.18507; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Ito F, 2008, ANN SURG, V248, P273, DOI 10.1097/SLA.0b013e31817f2bfd; Kabashima A, 2000, CLIN CANCER RES, V6, P3581; Kermorgant S, 2001, AM J PHYSIOL-GASTR L, V281, pG1068, DOI 10.1152/ajpgi.2001.281.4.G1068; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Khan SA, 2002, GUT, V51, P1; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kitagawa Y, 2001, ANN SURG, V233, P385, DOI 10.1097/00000658-200103000-00013; Lamothe B, 2004, MOL CELL BIOL, V24, P5657, DOI 10.1128/MCB.24.13.5657-5666.2004; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Leelawat K, 2007, WORLD J GASTROENTERO, V13, P1561, DOI 10.3748/wjg.v13.i10.1561; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; Murakami Y, 2011, ANN SURG ONCOL, V18, P651, DOI 10.1245/s10434-010-1325-4; Murakawa K, 2004, J SURG RES, V122, P184, DOI 10.1016/j.jss.2004.06.003; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Oka M, 2008, J INVEST DERMATOL, V128, P188, DOI 10.1038/sj.jid.5700961; Onodera M, 2009, LAB INVEST, V89, P1261, DOI 10.1038/labinvest.2009.89; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Rea DJ, 2004, ARCH SURG-CHICAGO, V139, P514, DOI 10.1001/archsurg.139.5.514; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Seiden-Long I, 2008, CARCINOGENESIS, V29, P647, DOI 10.1093/carcin/bgn009; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Takada T, 2002, CANCER, V95, P1685, DOI 10.1002/cncr.10831; Tanno S, 2004, CANCER RES, V64, P3486, DOI 10.1158/0008-5472.CAN-03-1788; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.21358; Vern-Gross TZ, 2011, INT J RADIAT ONCOL, V81, P189, DOI 10.1016/j.ijrobp.2010.05.001; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yonemori A, 2009, BRIT J SURG, V96, P509, DOI 10.1002/bjs.6585; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	51	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81347	10.1371/journal.pone.0081347	http://dx.doi.org/10.1371/journal.pone.0081347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312291	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900028
J	Chen, ZZ; Jia, S; Li, DH; Cai, JY; Tu, J; Geng, B; Guan, YF; Cui, QH; Yang, JC				Chen, Zhenzhen; Jia, Shi; Li, Danhua; Cai, Junyan; Tu, Jian; Geng, Bin; Guan, Youfei; Cui, Qinghua; Yang, Jichun			Silencing of Long Noncoding RNA AK139328 Attenuates Ischemia/Reperfusion Injury in Mouse Livers	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACTIVATED-RECEPTOR-GAMMA; MOLECULAR-MECHANISMS; EXPRESSION; PROTECTS; AKT; INHIBITION; EVOLUTION; MICRORNA; INSIGHTS	Recently, increasing evidences had suggested that long noncoding RNAs (LncRNAs) are involved in a wide range of physiological and pathophysiological processes. Here we determined the LncRNA expression profile using microarray technology in mouse livers after ischemia/reperfusion treatment. Seventy one LncRNAs were upregulated, and 27 LncRNAs were downregulated in ischemia/reperfusion-treated mouse livers. Eleven of the most significantly deregulated LncRNAs were further validated by quantitative PCR assays. Among the upregulated LncRNAs confirmed by quantitative PCR assays, AK139328 exhibited the highest expression level in normal mouse livers. siRNA-mediated knockdown of hepatic AK139328 decreased plasma aminotransferase activities, and reduced necrosis area in the livers with a decrease in caspase-3 activation after ischemia/reperfusion treatment. In ischemia/reperfusion liver, knockdown of AK139328 increased survival signaling proteins including phosphorylated Akt (pAkt), glycogen synthase kinase 3 (pGSK3) and endothelial nitric oxide synthase (peNOS). Furthermore, knockdown of AK139328 also reduced macrophage infitration and inhibited NF-kappa B activity and inflammatory cytokines expression. In conclusion, these findings revealed that deregulated LncRNAs are involved in liver ischemia/reperfusion injury. Silencing of AK139328 ameliorated ischemia/reperfusion injury in the liver with the activation of Akt signaling pathway and inhibition of NF-kappa B activity. LncRNA AK139328 might be a novel target for diagnosis and treatment of liver surgery or transplantation.	[Chen, Zhenzhen; Jia, Shi; Li, Danhua; Cai, Junyan; Tu, Jian; Geng, Bin; Guan, Youfei; Cui, Qinghua; Yang, Jichun] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China; [Cui, Qinghua] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China; [Chen, Zhenzhen; Jia, Shi; Li, Danhua; Cai, Junyan; Tu, Jian; Geng, Bin; Guan, Youfei; Cui, Qinghua; Yang, Jichun] Peking Univ, MOE Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangj@hsc.pku.edu.cn	jia, shi/HHS-4172-2022; Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710; guan, youfei/0000-0002-5231-0209; Chen, Zhenzhen/0000-0001-9919-3997	Ministry of Science and Technology [2012CB517504, 2012CB517806]; Natural Science Foundation of China [81170791]; "New Century Excellent Talents in Universities" Program from the Ministry of Education of China; Beijing Natural Science Foundation [7122107]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "New Century Excellent Talents in Universities" Program from the Ministry of Education of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from by the Ministry of Science and Technology (2012CB517504 and 2012CB517806), and the Natural Science Foundation of China (81170791). This study was also supported by "New Century Excellent Talents in Universities" Program from the Ministry of Education of China (to Cui Q) and by a grant from Beijing Natural Science Foundation (7122107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Carini R, 2004, GASTROENTEROLOGY, V127, P914, DOI 10.1053/j.gastro.2004.06.018; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Dal Ponte C, 2011, LIVER TRANSPLANT, V17, P474, DOI 10.1002/lt.22256; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dorn C, 2013, EXP MOL PATHOL, V94, P10, DOI 10.1016/j.yexmp.2012.05.003; Elrod JW, 2006, CIRC RES, V99, P78, DOI 10.1161/01.RES.0000231306.03510.77; Fu HL, 2012, MOL MED, V18, P1128, DOI 10.2119/molmed.2012.00088; Gu TT, 2011, J MOL HISTOL, V42, P105, DOI 10.1007/s10735-011-9312-z; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Han ZB, 2013, MOL CELLS, V35, P285, DOI 10.1007/s10059-013-2275-z; Huang JF, 2012, HEPATOLOGY; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Li J, 2011, HEPATOLOGY, V53, P1906, DOI 10.1002/hep.24295; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Qiu CX, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-90; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Sakai N, 2012, HEPATOLOGY, V56, P1468, DOI 10.1002/hep.25768; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Suetsugu H, 2005, GUT, V54, P835, DOI 10.1136/gut.2004.043034; Taki-Eldin A, 2012, J SURG RES, V178, P646, DOI 10.1016/j.jss.2012.05.069; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang R, 2010, BIOCHEM J, V430, P245, DOI 10.1042/BJ20100701; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Xu D, 2013, HEPATOLOGY; Yang C, 2012, GENE, V496, P8, DOI 10.1016/j.gene.2012.01.012; Yang JC, 2009, FEBS LETT, V583, P3009, DOI 10.1016/j.febslet.2009.08.008; Yang XH, 2012, J SURG RES, V178, P996, DOI 10.1016/j.jss.2012.07.007; Yu J, 2011, J HEPATOL, V55, P328, DOI 10.1016/j.jhep.2010.11.029; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zeng TB, 2013, GENES GENET SYST, V88, P127, DOI 10.1266/ggs.88.127; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225; Zhu S, 2011, ARTERIOSCL THROM VAS, V31, P1739, DOI 10.1161/ATVBAHA.111.226142; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	51	47	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80817	10.1371/journal.pone.0080817	http://dx.doi.org/10.1371/journal.pone.0080817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312245	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100054
J	Ellegaard, KM; Klasson, L; Andersson, SGE				Ellegaard, Kirsten Maren; Klasson, Lisa; Andersson, Siv G. E.			Testing the Reproducibility of Multiple Displacement Amplification on Genomes of Clonal Endosymbiont Populations	PLOS ONE			English	Article							INTRACELLULAR BACTERIAL SYMBIONTS; SINGLE-CELL GENOMICS; SEQUENCING LIBRARIES; DNA AMPLIFICATION; CLINICAL-SAMPLES; COPY NUMBER; HOST; POLYMERASE; SOFTWARE; PCR	The multiple displacement amplification method has revolutionized genomic studies of uncultured bacteria, where the extraction of pure DNA in sufficient quantity for next-generation sequencing is challenging. However, the method is problematic in that it amplifies the target DNA unevenly, induces the formation of chimeric reads and also amplifies contaminating DNA. Here, we have tested the reproducibility of the multiple displacement amplification method using serial dilutions of extracted genomic DNA and intact cells from the cultured endosymbiont Bartonella australis. The amplified DNA was sequenced with the Illumina sequencing technology, and the results were compared to sequence data obtained from unamplified DNA in this study as well as from a previously published genome project. We show that artifacts such as the extent of the amplification bias, the percentage of chimeric reads and the relative fraction of contaminating DNA increase dramatically for the smallest amounts of template DNA. The pattern of read coverage was reproducibly obtained for samples with higher amounts of template DNA, suggesting that the bias is non-random and genome-specific. A re-analysis of previously published sequence data obtained after amplification from clonal endosymbiont populations confirmed these predictions. We conclude that many of the artifacts associated with the use of the multiple displacement amplification method can be alleviated or much reduced by using multiple cells as the template for the amplification. These findings should be particularly useful for researchers studying the genomes of endosymbionts and other uncultured bacteria, for which a small clonal population of cells can be isolated.	[Ellegaard, Kirsten Maren; Klasson, Lisa; Andersson, Siv G. E.] Uppsala Univ, Biomed Ctr, Sci Life Lab, Dept Mol Evolut Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Biomed Ctr, Sci Life Lab, Dept Mol Evolut Cell & Mol Biol, Uppsala, Sweden.	siv.andersson@icm.uu.se		Klasson, Lisa/0000-0002-5874-7153; Ellegaard, Kirsten/0000-0003-1093-1645	Swedish Research Council for Agricultural Sciences; European Union; Swedish Research Council; Knut and Alice Wallenberg Foundation; Science for Life Laboratory	Swedish Research Council for Agricultural Sciences; European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Science for Life Laboratory	The authors have been supported by grants to LK from the Swedish Research Council for Agricultural Sciences, to SGEA from the European Union, the Swedish Research Council and the Knut and Alice Wallenberg Foundation and to LK and SGEA from the Science for Life Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Ellegaard KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003381; Epis S, 2010, ANN MICROBIOL, V60, P455, DOI 10.1007/s13213-010-0063-y; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Groathouse NA, 2006, J CLIN MICROBIOL, V44, P1502, DOI 10.1128/JCM.44.4.1502-1508.2006; Guy L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003393; Harrington ED, 2010, BIOINFORMATICS, V26, P2979, DOI 10.1093/bioinformatics/btq564; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Jeyaprakash A, 2004, J INVERTEBR PATHOL, V86, P111, DOI 10.1016/j.jip.2004.05.005; Jose Lopez-Sanchez M, 2008, ENVIRON MICROBIOL, V10, P3417, DOI 10.1111/j.1462-2920.2008.01776.x; Kamke J, 2012, BIOL BULL-US, V223, P30, DOI 10.1086/BBLv223n1p30; Kendall M, 1975, MULTIVARIATE ANAL; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Komaki K, 2000, INSECT BIOCHEM MOLEC, V30, P253, DOI 10.1016/S0965-1748(99)00125-3; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Penz T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003012; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10; Wolschin F, 2004, APPL ENVIRON MICROB, V70, P4096, DOI 10.1128/AEM.70.7.4096-4102.2004; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	58	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82319	10.1371/journal.pone.0082319	http://dx.doi.org/10.1371/journal.pone.0082319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312412	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100111
J	Fadhlaoui-Zid, K; Haber, M; Martinez-Cruz, B; Zalloua, P; Elgaaied, AB; Comas, D				Fadhlaoui-Zid, Karima; Haber, Marc; Martinez-Cruz, Begona; Zalloua, Pierre; Elgaaied, Amel Benammar; Comas, David			Genome-Wide and Paternal Diversity Reveal a Recent Origin of Human Populations in North Africa	PLOS ONE			English	Article							ALU INSERTION POLYMORPHISMS; MITOCHONDRIAL-DNA; IBERIAN PENINSULA; GENETIC DIVERSITY; MEDITERRANEAN AREA; SOUTHERN TUNISIA; MIGRATORY EVENTS; JERBA ISLAND; SUB-SAHARAN; WEST AFRICA	The geostrategic location of North Africa as a crossroad between three continents and as a stepping-stone outside Africa has evoked anthropological and genetic interest in this region. Numerous studies have described the genetic landscape of the human population in North Africa employing paternal, maternal, and biparental molecular markers. However, information from these markers which have different inheritance patterns has been mostly assessed independently, resulting in an incomplete description of the region. In this study, we analyze uniparental and genome-wide markers examining similarities or contrasts in the results and consequently provide a comprehensive description of the evolutionary history of North Africa populations. Our results show that both males and females in North Africa underwent a similar admixture history with slight differences in the proportions of admixture components. Consequently, genome-wide diversity show similar patterns with admixture tests suggesting North Africans are a mixture of ancestral populations related to current Africans and Eurasians with more affinity towards the out-of-Africa populations than to sub-Saharan Africans. We estimate from the paternal lineages that most North Africans emerged,15,000 years ago during the last glacial warming and that population splits started after the desiccation of the Sahara. Although most North Africans share a common admixture history, the Tunisian Berbers show long periods of genetic isolation and appear to have diverged from surrounding populations without subsequent mixture. On the other hand, continuous gene flow from the Middle East made Egyptians genetically closer to Eurasians than to other North Africans. We show that genetic diversity of today's North Africans mostly captures patterns from migrations post Last Glacial Maximum and therefore may be insufficient to inform on the initial population of the region during the Middle Paleolithic period.	[Fadhlaoui-Zid, Karima; Haber, Marc; Martinez-Cruz, Begona; Comas, David] Univ Pompeu Fabra, Consejo Super Invest Cient, Inst Biol Evolut, Dept Ciencies Expt & Salut, Barcelona, Spain; [Fadhlaoui-Zid, Karima; Elgaaied, Amel Benammar] Univ El Manar, Fac Sci Tunis, Lab Genet Immunol & Pathol Humaines, Tunis, Tunisia; [Haber, Marc; Zalloua, Pierre] Lebanese Amer Univ, Beirut, Lebanon	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Lebanese American University	Comas, D (corresponding author), Univ Pompeu Fabra, Consejo Super Invest Cient, Inst Biol Evolut, Dept Ciencies Expt & Salut, Barcelona, Spain.	david.comas@upf.edu	Haber, Marc/Y-5090-2019; Elgaaied, Amel Ben Ammar/AAL-1183-2020; Haber, Marc/D-2553-2012; Fadhlaoui-Zid, Karima/AAC-6973-2021; Comas, David/D-5382-2014	Haber, Marc/0000-0003-1000-1448; Haber, Marc/0000-0003-1000-1448; Comas, David/0000-0002-5075-0956; zalloua, pierre/0000-0002-8494-5081; Martinez-Cruz, Begona/0000-0003-1268-6620; Fadhlaoui, karima/0000-0002-8980-9716	Spanish Government MCINN [CGL2010-14944/BOS]; Programa de Cooperacion Interuniversitaria e Investigacion Cientifica, Spanish Ministry of Foreign Affairs and Cooperation [A75180/06, A/8394/07, B/018514/08, A1/040218/11]	Spanish Government MCINN(Spanish Government); Programa de Cooperacion Interuniversitaria e Investigacion Cientifica, Spanish Ministry of Foreign Affairs and Cooperation	This study was supported in parts by Spanish Government MCINN grant CGL2010-14944/BOS and Programa de Cooperacion Interuniversitaria e Investigacion Cientifica, Spanish Ministry of Foreign Affairs and Cooperation grants A75180/06, A/8394/07, B/018514/08, A1/040218/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Badro DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054616; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Yosef O., 1987, AFR ARCHAEOL REV, V5, P29; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; Barton RNE, 2009, QUATERNARY SCI REV, V28; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 1997, HUM BIOL, V69, P295; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Botigue LR, 2013, P NATL ACAD IN PRESS; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Camps G., 1982, CAMBRIDGE HIST AFRIC, P548; Camps G., 1974, CIVILISATIONS PREHIS; CHAABANI H, 1984, J IMMUNOGENET, V11, P107; Cherni L, 2005, FORENSIC SCI INT, V147, P101, DOI 10.1016/j.forsciint.2004.04.009; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Coudray C, 2007, FORENSIC SCI INT, V168, pE21, DOI 10.1016/j.forsciint.2007.01.016; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Debenath A, 2000, ANTHROPOLOGIE, V104, P131; Ennafaa H, 2006, ANN HUM BIOL, V33, P634, DOI 10.1080/03014460600931087; Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2004, HUM BIOL, V76, P559, DOI 10.1353/hub.2004.0054; Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x; Fadhlaoui-Zid K, 2010, TISSUE ANTIGENS, V76, P416, DOI 10.1111/j.1399-0039.2010.01534.x; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; Felsenstein J, 1989, CLADISTICS, V5; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Flores C, 2000, ANN HUM GENET, V64, P321, DOI 10.1046/j.1469-1809.2000.6440321.x; Frigi S, 2011, ANN HUM BIOL, V38, P53, DOI 10.3109/03014460.2010.490241; Garcea E., 2010, S E MED PEOPLES 130, P192; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Gonzalez-Perez E, 2003, COLLEGIUM ANTROPOL, V27, P491; Guenounou BA, 2006, INT J IMMUNOGENET, V33, P93, DOI 10.1111/j.1744-313X.2006.00577.x; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hiernaux J., 1975, PEOPLE AFRICA; Jolliffe I, 1986, PRINCIPAL COPONENTS; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Khodjet-El-Khil H, 2008, HUM BIOL, V80, P435, DOI 10.3378/1534-6617-80.4.435; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loveslati BY, 2001, EUR J IMMUNOGENET, V28, P531; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Ottoni C, 2011, AM J PHYS ANTHROPOL, V145, P118, DOI 10.1002/ajpa.21473; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebala K, 2012, EUR J HUM GENET; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Wilson IJ, 2003, J ROYAL STAT SOC A, V166; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020	67	32	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80293	10.1371/journal.pone.0080293	http://dx.doi.org/10.1371/journal.pone.0080293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312208	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100033
J	Lecarpentier, E; Cordier, AG; Proulx, F; Fouron, JC; Gitz, L; Grange, G; Benachi, A; Tsatsaris, V				Lecarpentier, Edouard; Cordier, Anne Gaelle; Proulx, Francine; Fouron, Jean Claude; Gitz, Laurence; Grange, Gilles; Benachi, Alexandra; Tsatsaris, Vassilis			Hemodynamic Impact of Absent or Reverse End-Diastolic Flow in the Two Umbilical Arteries in Growth-Restricted Fetuses	PLOS ONE			English	Article							LONGITUDINAL REFERENCE RANGES; FETAL AORTIC ISTHMUS; BLOOD-FLOW; PULSATILITY INDEX; DOPPLER INDEXES; REFERENCE VALUES; DUCTUS VENOSUS; PLACENTAL ENDS; BIRTH-WEIGHT; WAVE	Objective: To determine if bilateral absent or reverse end-diastolic (ARED) flow in the two umbilical arteries (UAs) at the perivesical (PVC) segment represents a more severe degree of hemodynamic compromise than unilateral ARED flow at the PVC segment in singleton pregnancies complicated by intrauterine growth restriction (IUGR). Methods: This was a prospective observational study. One hundred nine fetuses with IUGR underwent a total of 225 ultrasound (US) examinations. We measured the pulsatility index (PI) from the two UAs at the PVC segment, UA in the free floating cord (FFC), middle cerebral artery (MCA), ductus venosus (DV) and the aortic isthmus blood flow index (IFI). Three groups were classified according to bilateral positive end-diastolic (PED) flow, unilateral ARED flow or bilateral ARED flow in the UAs at the PVC segment. Results: The proportions of US examinations with PED flow, unilateral ARED flow and bilateral ARED flow in the UAs were 54.7%, 20.4%, and 24.9%, respectively. At the last US examination, the IFI z-scores were significantly lower in the bilateral ARED group (-6.28 +/- 4.30) compared to the unilateral ARED group (-1.72 +/- 3.18, p<0.05) and the bilateral PED group (-0.83 +/- 2.36, p<0.05), the DV-PI z-scores were significantly higher in the bilateral ARED group (2.15 +/- 3.79) compared to the bilateral PED group (0.64 +/- 1.50, p<0.05). Before 32 weeks of gestation, the interval between US examination and delivery was significantly shorter in the bilateral ARED group (8.9 days +/- 8.2) than the unilateral ARED group (15.9 days +/- 13.4, p<0.05) and the bilateral PED group (30.3 days +/- 25.7, p<0.05). Conclusion: There are significant differences in fetal blood fluxes between left and right UA. Doppler examination at the PVC segment significantly improves the comparability of UA-PI between two successive US examinations and allows a longitudinal and independent hemodynamic investigation of each UA. Examination of a single UA in free floating cord may miss a large fraction of unilateral ARED flow. In singleton IUGR fetuses, a bilateral ARED flow in the UAs at the PVC segment indicates more severe hemodynamic compromise and worse fetal conditions than unilateral ARED flow.	[Lecarpentier, Edouard; Proulx, Francine; Grange, Gilles; Tsatsaris, Vassilis] Paris Descartes Univ, APHP, Obstet & Gynecol Unit, Maternite Port Royal, Paris, France; [Cordier, Anne Gaelle; Proulx, Francine; Gitz, Laurence; Benachi, Alexandra] Univ Paris 11, Hop Antoine Beclere, AP HP, Dept Obstet & Gynecol, Paris, France; [Benachi, Alexandra; Tsatsaris, Vassilis] Fdn Prevent Prematurite & Protect Nouveau Ne Prem, Premup Fdn, Paris, France; [Fouron, Jean Claude] Univ Montreal, Fetal Cardiol Unit, Ctr Hosp Univ CHU St Justine, Pediat Cardiol Serv,Dept Pediat, Montreal, PQ, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Tsatsaris, V (corresponding author), Paris Descartes Univ, APHP, Obstet & Gynecol Unit, Maternite Port Royal, Paris, France.	vassilis.tsatsaris@cch.aphp.fr	Lecarpentier, Edouard/Q-4557-2018					Acharya G, 2005, ULTRASOUND OBST GYN, V26, P162, DOI 10.1002/uog.1902; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; ALFIREVIC Z, 2010, COCHRANE DB SYST REV, P7529; Balbis S, 2007, ULTRASOUND MED BIOL, V33, P1895, DOI 10.1016/j.ultrasmedbio.2007.06.009; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; BONNIN P, 1992, ULTRASOUND OBST GYN, V2, P18, DOI 10.1046/j.1469-0705.1992.02010018.x; BONNIN P, 1993, CIRCULATION, V88, P216, DOI 10.1161/01.CIR.88.1.216; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; Figueras F, 2006, J PERINAT MED, V34, P409, DOI 10.1515/JPM.2006.081; FOROUZAN I, 1991, OBSTET GYNECOL, V77, P209, DOI 10.1097/00006250-199102000-00009; HECHER K, 1995, CIRCULATION, V91, P129, DOI 10.1161/01.CIR.91.1.129; Janeczek S, 2012, J ULTRAS MED, V31, P679; Kessler J, 2006, ULTRASOUND OBST GYN, V28, P890, DOI 10.1002/uog.3857; Khare M, 2006, ACTA OBSTET GYN SCAN, V85, P922, DOI 10.1080/00016340600604757; Kiserud T, 2005, SEMIN FETAL NEONAT M, V10, P493, DOI 10.1016/j.siny.2005.08.007; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; MEHALEK KE, 1989, J ULTRAS MED, V8, P171; Predanic M, 1998, OBSTET GYNECOL, V91, P757, DOI 10.1016/S0029-7844(98)00059-3; Rizzo G, 1996, ULTRASOUND OBST GYN, V7, P401, DOI 10.1046/j.1469-0705.1996.07060401.x; Ruskamp J, 2003, ULTRASOUND OBST GYN, V21, P441, DOI 10.1002/uog.105; SONESSON SE, 1993, J CLIN ULTRASOUND, V21, P317, DOI 10.1002/jcu.1870210505; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; Spinillo A, 2012, PRENATAL DIAG, V32, P1263, DOI 10.1002/pd.3988; THOMAS RL, 1991, J ULTRAS MED, V10, P201; Ullberg U, 2003, ACTA OBSTET GYN SCAN, V82, P716, DOI 10.1034/j.1600-0412.2003.00161.x; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; VIEYRES P, 1991, J ULTRAS MED, V10, P671, DOI 10.7863/jum.1991.10.12.671	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81160	10.1371/journal.pone.0081160	http://dx.doi.org/10.1371/journal.pone.0081160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312271	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100062
J	Pirog, KA; Katakura, Y; Mironov, A; Briggs, MD				Pirog, Katarzyna A.; Katakura, Yoshihisa; Mironov, Aleksandr; Briggs, Michael D.			Mild Myopathy Is Associated with COMP but Not MATN3 Mutations in Mouse Models of Genetic Skeletal Diseases	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; EXTRACELLULAR-MATRIX; IX COLLAGEN; A-DOMAIN; MURINE MODEL; CARTILAGE; PSEUDOACHONDROPLASIA; MUSCLE; TENDON	Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are skeletal disorders resulting from mutations in COMP, matrilin-3 or collagen IX and are characterised by short-limbed dwarfism and premature osteoarthritis. Interestingly, recent reports suggest patients can also manifest with muscle weakness. Here we present a detailed analysis of two mouse models of the PSACH/MED disease spectrum; Delta D469 T3-COMP (PSACH) and V194D matrilin-3 (MED). In grip test experiments T3-COMP mice were weaker than wild-type littermates, whereas V194D mice behaved as controls, confirming that short-limbed dwarfism alone does not contribute to PSACH/MED-related muscle weakness. Muscles from T3-COMP mice showed an increase in centronuclear fibers at the myotendinous junction. T3-COMP tendons became more lax in cyclic testing and showed thicker collagen fibers when compared with wild-type tissue; matrilin-3 mutant tissues were indistinguishable from controls. This comprehensive study of the myopathy associated with PSACH/MED mutations enables a better understanding of the disease progression, confirms that it is genotype specific and that the limb weakness originates from muscle and tendon pathology rather than short-limbed dwarfism itself. Since some patients are primarily diagnosed with neuromuscular symptoms, this study will facilitate better awareness of the differential diagnoses that might be associated with the PSACH/MED spectrum and subsequent care of PSACH/MED patients.	[Pirog, Katarzyna A.; Briggs, Michael D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Katakura, Yoshihisa] Manchester Metropolitan Univ, Div Mech Engn, Sch Engn, Manchester M15 6BH, Lancs, England; [Mironov, Aleksandr] Fac Life Sci, Electron Microscopy Core Facil, Manchester, Lancs, England; [Mironov, Aleksandr] Univ Manchester, Manchester, Lancs, England	Newcastle University - UK; Manchester Metropolitan University; University of Manchester; University of Manchester; University of Manchester	Pirog, KA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	katarzyna.pirog@ncl.ac.uk	Pirog, Katarzyna/AAD-6682-2021	Pirog, Katarzyna/0000-0003-0736-3296; Mironov, Aleksandr/0000-0002-1497-328X	Wellcome Trust [084353/Z/07/Z, 088785/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors gratefully acknowledge the support of the Wellcome Trust (MDB is the recipient of a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science; Grant 084353/Z/07/Z). The research was undertaken in the Wellcome Trust Centre for Cell-Matrix Research (Grant 088785/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk C, 2008, J ANAT, V212, P645, DOI 10.1111/j.1469-7580.2008.00887.x; Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Benjamin M., 1996, Man Ther, V1, P186, DOI 10.1054/math.1996.0267; BODENSTEINER JB, 1994, MUSCLE NERVE, V17, P131, DOI 10.1002/mus.880170202; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chapman KL, 2003, PEDIATR PATHOL MOL M, V22, P53, DOI 10.1080/15227950307699; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Ernst L., 2011, COLOR ATLAS FETAL NE, V2011th; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; Fricke O, 2007, GROWTH HORM IGF RES, V17, P1, DOI 10.1016/j.ghir.2006.10.004; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; GARFIN SR, 1981, J APPL PHYSIOL, V51, P317, DOI 10.1152/jappl.1981.51.2.317; Goh KL, 2012, J APPL PHYSIOL, V113, P878, DOI 10.1152/japplphysiol.00258.2012; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; Jackson GC, 2010, AM J MED GENET A, V152A, P863, DOI 10.1002/ajmg.a.33240; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Jakkula E, 2003, J MED GENET, V40, P942, DOI 10.1136/jmg.40.12.942; Kardon G, 2011, DEVELOPMENT, V138, P2855, DOI 10.1242/dev.067181; Kennedy Jason, 2005, Hum Mutat, V25, P593, DOI 10.1002/humu.9342; Ker RF, 2007, INT J FATIGUE, V29, P1001, DOI 10.1016/j.ijfatigue.2006.09.020; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Klatt AR, 2002, MATRIX BIOL, V21, P289, DOI 10.1016/S0945-053X(02)00006-9; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Pirog KA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/686457; Pirog KA, 2010, HUM MOL GENET, V19, P52, DOI 10.1093/hmg/ddp466; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Poole CA, 1997, OSTEOARTHR CARTILAGE, V5, P191, DOI 10.1016/S1063-4584(97)80014-3; Provenzano PP, 2001, CONNECT TISSUE RES, V42, P123, DOI 10.3109/03008200109014254; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P194; Rittweger J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P174; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; Schoenau E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P232; Segat D, 2000, MATRIX BIOL, V19, P649, DOI 10.1016/S0945-053X(00)00112-8; Smith RKW, 2002, EQUINE VET J, V34, P726, DOI 10.2746/042516402776250423; Sodersten F, 2005, MATRIX BIOL, V24, P376, DOI 10.1016/j.matbio.2005.06.003; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; Staheli L. T., 2007, FUNDAMENTALS PEDIAT; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; TIDBALL JG, 1991, J BIOMECH, V24, P43, DOI 10.1016/0021-9290(91)90376-X; Unger S, 2001, AM J MED GENET, V106, P244, DOI 10.1002/ajmg.10234; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wright M J, 2000, J Med Genet, V37, pE25, DOI 10.1136/jmg.37.9.e25; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	65	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82412	10.1371/journal.pone.0082412	http://dx.doi.org/10.1371/journal.pone.0082412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312420	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100116
J	ten Broek, CMA; Bots, J; Varela-Lasheras, I; Bugiani, M; Galis, F; Van Dongen, S				ten Broek, Clara Mariquita Antoinette; Bots, Jessica; Varela-Lasheras, Irma; Bugiani, Marianna; Galis, Frietson; Van Dongen, Stefan			Amniotic Fluid Deficiency and Congenital Abnormalities both Influence Fluctuating Asymmetry in Developing Limbs of Human Deceased Fetuses	PLOS ONE			English	Article							DEVELOPMENTAL INSTABILITY; DIRECTIONAL ASYMMETRY; PULMONARY HYPOPLASIA; OLIGOHYDRAMNIOS; CANALIZATION; COMPRESSION; HYDRAMNIOS; DISORDERS; STABILITY; DEFECTS	Fluctuating asymmetry (FA), as an indirect measure of developmental instability (DI), has been intensively studied for associations with stress and fitness. Patterns, however, appear heterogeneous and the underlying causes remain largely unknown. One aspect that has received relatively little attention in the literature is the consequence of direct mechanical effects on asymmetries. The crucial prerequisite for FA to reflect DI is that environmental conditions on both sides should be identical. This condition may be violated during early human development if amniotic fluid volume is deficient, as the resulting mechanical pressures may increase asymmetries. Indeed, we showed that limb bones of deceased human fetuses exhibited increased asymmetry, when there was not sufficient amniotic fluid (and, thus, space) in the uterine cavity. As amniotic fluid deficiency is known to cause substantial asymmetries and abnormal limb development, these subtle asymmetries are probably at least in part caused by the mechanical pressures. On the other hand, deficiencies in amniotic fluid volume are known to be associated with other congenital abnormalities that may disturb DI. More specifically, urogenital abnormalities can directly affect/reduce amniotic fluid volume. We disentangled the direct mechanical effects on FA from the indirect effects of urogenital abnormalities, the latter presumably representing DI. We discovered that both factors contributed significantly to the increase in FA. However, the direct mechanical effect of uterine pressure, albeit statistically significant, appeared less important than the effects of urogenital abnormalities, with an effect size only two-third as large. We, thus, conclude that correcting for the relevant direct factors allowed for a representative test of the association between DI and stress, and confirmed that fetuses form a suitable model system to increase our understanding in patterns of FA and symmetry development.	[ten Broek, Clara Mariquita Antoinette; Bots, Jessica; Van Dongen, Stefan] Univ Antwerp, Grp Evolutionary Ecol, B-2020 Antwerp, Belgium; [Varela-Lasheras, Irma] Gulbenkian Inst Sci, Dept Patterning & Morphogenesis, Oeiros, Portugal; [Bugiani, Marianna] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [ten Broek, Clara Mariquita Antoinette; Galis, Frietson] Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands	University of Antwerp; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Naturalis Biodiversity Center	ten Broek, CMA (corresponding author), Univ Antwerp, Grp Evolutionary Ecol, B-2020 Antwerp, Belgium.	claartje.tenbroek@uantwerpen.be		Galis, Frietson/0000-0003-3659-0965; varela lasheras, irma/0000-0002-0419-1938	University of Antwerp; Research Foundation - Flanders (FWO)	University of Antwerp; Research Foundation - Flanders (FWO)(FWO)	We gratefully acknowledge support of the Research Fund of the University of Antwerp. This work was also supported by a mobility grant from the Research Foundation - Flanders (FWO); www.ua.ac.be; www.fwo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele H, 2012, FETAL DIAGN THER, V32, P251, DOI 10.1159/000338659; Bagnall K, 2005, ANAT REC, V203, P293; Bates D, 2013, IME4 LINEAR MIXED EF; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Broek ten CMA, 2012, EVOLUTIONARY BIOL, V12, P1; Dashe JS, 2002, OBSTET GYNECOL, V100, P134, DOI 10.1016/S0029-7844(02)02013-6; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Gawlikowska A, 2007, MED SCI MONITOR, V13, pBR131; GRAHAM JM, 1980, J PEDIATR-US, V96, P1052, DOI 10.1016/S0022-3476(80)80640-8; Greenacre M. J., 2010, CA SIMPLE MULTIPLE J; Hallgrimsson B, 2003, J EXP ZOOL PART B, V296B, P40, DOI 10.1002/jez.b.00015; Klingenberg Christian Peter, 2003, P14; Kobyliansky E, 1990, INT J ANTHR, V5, P17, DOI [10.1007/BF02442368, DOI 10.1007/BF02442368]; Magann EF, 2007, OBSTET GYNECOL SURV, V62, P795, DOI 10.1097/01.ogx.0000290349.58707.e0; Martinez-Frias M L, 1999, J Perinatol, V19, P514; MILLER ME, 1979, J PEDIATR-US, V94, P387, DOI 10.1016/S0022-3476(79)80577-6; MILLER ME, 1981, J PEDIATR-US, V98, P292, DOI 10.1016/S0022-3476(81)80664-6; Moh W, 2012, J PREGNANCY, V2012, P2012; Moore TR, 1997, CLIN OBSTET GYNECOL, V40, P303, DOI 10.1097/00003081-199706000-00007; Ostergard D R, 1970, Obstet Gynecol Surv, V25, P297, DOI 10.1097/00006254-197004000-00001; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; PANDE BS, 1971, J ANAT, V109, P457; Peipert J F, 1991, Obstet Gynecol Surv, V46, P325, DOI 10.1097/00006254-199106000-00002; PERLMAN M, 1974, AM J OBSTET GYNECOL, V118, P1119, DOI 10.1016/0002-9378(74)90692-9; Polak M., 2003, CAUSES CONSEQUENCES; POTTER EL, 1946, J PEDIATR, V29, P68, DOI 10.1016/S0022-3476(46)80241-5; Schultz AH, 1926, Q REV BIOL, V1, P465, DOI 10.1086/394257; SELBY GW, 1956, J PEDIATR-US, V48, P70, DOI 10.1016/S0022-3476(56)80120-0; Shimada K, 1994, Nihon Hinyokika Gakkai Zasshi, V85, P990; Team R.C., 2012, COMPUTING, V1, P12; THOMAS IT, 1974, J PEDIATR-US, V84, P811, DOI 10.1016/S0022-3476(74)80753-5; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P1695, DOI 10.1111/j.1420-9101.2009.01780.x; Van Dongen S, 2011, ANN HUM BIOL, V38, P317, DOI 10.3109/03014460.2010.544676; Van Dongen S, 2010, ANIM BIOL, V60, P169, DOI 10.1163/157075610X491716; Van Dongen S, 2009, EVOLUTION, V63, P1832, DOI 10.1111/j.1558-5646.2009.00675.x; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WEAVER DD, 1988, CLIN OBSTET GYNECOL, V31, P253, DOI 10.1097/00003081-198806000-00005; WEBSTER WS, 1987, TERATOLOGY, V35, P253, DOI 10.1002/tera.1420350212	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81824	10.1371/journal.pone.0081824	http://dx.doi.org/10.1371/journal.pone.0081824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312362	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327652100102
J	Alawi, F; Lin, P				Alawi, Faizan; Lin, Ping			Dyskerin Localizes to the Mitotic Apparatus and Is Required for Orderly Mitosis in Human Cells	PLOS ONE			English	Article							DYSKERATOSIS-CONGENITA; RIBOSOMAL-RNA; CHROMOSOME CONGRESSION; IN-VIVO; CANCER; SPINDLE; MICRONUCLEUS; ASSOCIATION; BIOGENESIS; TELOMERASE	Dyskerin is a highly conserved, nucleolar RNA-binding protein with established roles in small nuclear ribonucleoprotein biogenesis, telomerase and telomere maintenance and precursor rRNA processing. Telomerase is functional during S phase and the bulk of rRNA maturation occurs during G(1) and S phases; both processes are inactivated during mitosis. Yet, we show that during the course of cell cycle progression, human dyskerin expression peaks during G(2)/M in parallel with the upregulation of pro-mitotic factors. Dyskerin redistributed from the nucleolus in interphase cells to the perichromosomal region during prometaphase, metaphase and anaphase. With continued anaphase progression, dyskerin also localized to the cytoplasm within the mid-pole region. Loss of dyskerin function via siRNA-mediated depletion promoted G(2)/M accumulation and this was accompanied by an increased mitotic index and activation of the spindle assembly checkpoint. Live cell imaging further revealed an array of mitotic defects including delayed prometaphase progression, a significantly increased incidence of multi-polar spindles, and anaphase bridges culminating in micronucleus formation. Together, these findings suggest that dyskerin is a highly dynamic protein throughout the cell cycle and increases the repertoire of fundamental cellular processes that are disrupted by absence of its normal function.	[Alawi, Faizan; Lin, Ping] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Alawi, F (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	falawi@upenn.edu			National Institutes of Health [DE018416, DE021428]; Skin Disease Research Center of the University of Pennsylvania [P30-AR057217]; Abramson Cancer Center Pilot Projects Program [P30-CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE021428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin Disease Research Center of the University of Pennsylvania; Abramson Cancer Center Pilot Projects Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work described in the paper was supported by funds from National Institutes of Health grants DE018416 and DE021428, the Skin Disease Research Center of the University of Pennsylvania (P30-AR057217) and the Abramson Cancer Center Pilot Projects Program (P30-CA016520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2007, BIOCHEM BIOPH RES CO, V362, P893, DOI 10.1016/j.bbrc.2007.08.071; Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Andreassi MG, 2011, MUTAGENESIS, V26, P77, DOI 10.1093/mutage/geq077; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bonassi S, 2011, MUTAT RES-REV MUTAT, V728, P88, DOI 10.1016/j.mrrev.2011.06.005; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; de la Fuente J, 2007, PEDIATR TRANSPLANT, V11, P584, DOI 10.1111/j.1399-3046.2007.00721.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DOKAL I, 1992, BLOOD, V80, P3090; Dundr M, 1998, MOL BIOL CELL, V9, P2407, DOI 10.1091/mbc.9.9.2407; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V659, P274, DOI 10.1016/j.mrrev.2008.05.006; Jady BE, 2012, GENE DEV, V26, P1897, DOI 10.1101/gad.197467.112; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; KEHRER H, 1992, CLIN GENET, V41, P129; Killian A, 2004, ONCOGENE, V23, P8597, DOI 10.1038/sj.onc.1207845; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Meier UT, 2006, TRENDS BIOCHEM SCI, V31, P311, DOI 10.1016/j.tibs.2006.04.002; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2010, J PATHOL, V222, P345, DOI 10.1002/path.2777; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Sirri V, 2000, J CELL BIOL, V148, P259, DOI 10.1083/jcb.148.2.259; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; ten Hoopen R, 2000, CHROMOSOMA, V109, P482, DOI 10.1007/s004120000109; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yokoyama H, 2008, J CELL BIOL, V180, P867, DOI 10.1083/jcb.200706189; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	47	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80805	10.1371/journal.pone.0080805	http://dx.doi.org/10.1371/journal.pone.0080805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303026	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400042
J	Fornari, M; Calvenzani, V; Masiero, S; Tonelli, C; Petroni, K				Fornari, Monica; Calvenzani, Valentina; Masiero, Simona; Tonelli, Chiara; Petroni, Katia			The Arabidopsis NF-YA3 and NF-YA8 Genes Are Functionally Redundant and Are Required in Early Embryogenesis	PLOS ONE			English	Article							Y TRANSCRIPTION FACTORS; CCAAT-BINDING COMPLEX; APICAL-BASAL AXIS; EMBRYO DEVELOPMENT; DIFFERENTIAL EXPRESSION; NUCLEAR TRANSLOCATION; AUXIN TRANSPORT; SUBUNITS; THALIANA; PROTEIN	Nuclear factor Y (NF-Y) is a trimeric transcription factor composed of three distinct subunits called NF-YA, NF-YB and NF-YC. In Arabidopsis thaliana, NF-Y subunits are known to play roles in many processes, such as gametogenesis, embryogenesis, seed development, drought resistance, ABA signaling, flowering time, primary root elongation, Endoplasmic Reticulum (ER) stress response and blue light responses. Here, we report that the closely related NF-YA3 and NF-YA8 genes control early embryogenesis. Detailed GUS and in situ analyses showed that NF-YA3 and NF-YA8 are expressed in vegetative and reproductive tissues with the highest expression being during embryo development from the globular to the torpedo embryo stage. Plants from the nf-ya3 and nf-ya8 single mutants do not display any obvious phenotypic alteration, whereas nf-ya3 nf-ya8 double mutants are embryo lethal. Morphological analyses showed that the nf-ya3 nf-ya8 embryos fail to undergo to the heart stage and develop into abnormal globular embryos with both proembryo and suspensor characterized by a disordered cell cluster with an irregular shape, suggesting defects in embryo development. The suppression of both NF-YA3 and NF-YA8 gene expression by RNAi experiments resulted in defective embryos that phenocopied the nf-ya3 nf-ya8 double mutants, whereas complementation experiments partially rescued the abnormal globular nf-ya3 nf-ya8 embryos, confirming that NF-YA3 and NF-YA8 are required in early embryogenesis. Finally, the lack of GFP expression of the auxin responsive DR5rev::GFP marker line in double mutant embryos suggested that mutations in both NF-YA3 and NF-YA8 affect auxin response in early developing embryos. Our findings indicate that NF-YA3 and NF-YA8 are functionally redundant genes required in early embryogenesis of Arabidopsis thaliana.	[Fornari, Monica; Calvenzani, Valentina; Masiero, Simona; Tonelli, Chiara; Petroni, Katia] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milan	Petroni, K (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	katia.petroni@unimi.it	Petroni, Katia/K-1159-2018; Masiero, Simona/J-2898-2013; Tonelli, Chiara/F-7969-2015	Petroni, Katia/0000-0003-3318-0442; Tonelli, Chiara/0000-0002-9505-3118; masiero, simona/0000-0002-7563-7634	MIUR FIRB ERA-PG CisCode project [RBER062B5L]	MIUR FIRB ERA-PG CisCode project	This work was supported by MIUR FIRB ERA-PG CisCode project (RBER062B5L) to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 1999, PLANT J, V17, P169, DOI 10.1046/j.1365-313X.1999.00361.x; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Calvenzani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042902; CANAS LA, 1994, PLANT J, V6, P597, DOI 10.1046/j.1365-313X.1994.6040597.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Smet I, 2007, CURR OPIN GENET DEV, V17, P337, DOI 10.1016/j.gde.2007.04.012; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Frontini M, 2004, CELL CYCLE, V3, P217; Goda H, 2005, ARCH MICROBIOL, V184, P93, DOI 10.1007/s00203-005-0014-3; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Hackenberg D, 2012, INT J MOL SCI, V13, P3458, DOI 10.3390/ijms13033458; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim HU, 2004, PLANT PHYSIOL, V134, P1206, DOI 10.1104/pp.103.035832; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANSFIELD SG, 1991, CAN J BOT, V69, P447, DOI 10.1139/b91-062; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; ODELL JT, 1994, PLANT PHYSIOL, V106, P447, DOI 10.1104/pp.106.2.447; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Procissi A, 1997, PLANT CELL, V9, P1547, DOI 10.1105/tpc.9.9.1547; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Rubery PH, 1974, CARRIER MEDIATED AUX, P101; Schade B, 1997, J PEPT RES, V49, P363; SCOFIELD SR, 1993, CELL, V75, P507, DOI 10.1016/0092-8674(93)90385-4; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Tuncher A, 2005, J MOL BIOL, V352, P517, DOI 10.1016/j.jmb.2005.06.068; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; VANTUNEN AJ, 1988, EMBO J, V7, P1257, DOI 10.1002/j.1460-2075.1988.tb02939.x; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637; Weijers D, 2001, DEVELOPMENT, V128, P4289; WEST MAL, 1993, PLANT CELL, V5, P1361, DOI 10.1105/tpc.5.10.1361; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Wu X, 2007, DEV BIOL, V309, P306, DOI 10.1016/j.ydbio.2007.07.019; Xiang DQ, 2011, PLANT CELL, V23, P4348, DOI 10.1105/tpc.111.091777; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x	68	29	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82043	10.1371/journal.pone.0082043	http://dx.doi.org/10.1371/journal.pone.0082043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303077	Green Published, gold			2022-12-25	WOS:000327546400094
J	Ma, ZM; Kong, J; Gordon, D; Gurevitz, M; Kallen, RG				Ma, Zhongming; Kong, Jun; Gordon, Dalia; Gurevitz, Michael; Kallen, Roland G.			Direct Evidence that Scorpion alpha-Toxins (Site-3) Modulate Sodium Channel Inactivation by Hindrance of Voltage-Sensor Movements	PLOS ONE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; TRANSFECTED CELLS; LINING RESIDUES; MOLECULAR-BASIS; RECEPTOR-SITE; K+ CHANNEL; DOMAIN IV; S4; IDENTIFICATION	The position of the voltage-sensing transmembrane segment, S4, in voltage-gated ion channels as a function of voltage remains incompletely elucidated. Site-3 toxins bind primarily to the extracellular loops connecting transmembrane helical segments S1-S2 and S3-S4 in Domain 4 (D4) and S5-S6 in Domain 1 (D1) and slow fast-inactivation of voltage-gated sodium channels. As S4 of the human skeletal muscle voltage-gated sodium channel, hNa(v)1.4, moves in response to depolarization from the resting to the inactivated state, two D4S4 reporters (R2C and R3C, Arg1451Cys and Arg1454Cys, respectively) move from internal to external positions as deduced by reactivity to internally or externally applied sulfhydryl group reagents, methane thiosulfonates (MTS). The changes in reporter reactivity, when cycling rapidly between hyperpolarized and depolarized voltages, enabled determination of the positions of the D4 voltage-sensor and of its rate of movement. Scorpion a-toxin binding impedes D4S4 segment movement during inactivation since the modification rates of R3C in hNav1.4 with methanethiosulfonate (CH3SO2SCH2CH2R, where R = -N(CH3)(3)(+) trimethylammonium, MTSET) and benzophenone-4-carboxamidocysteine methanethiosulfonate (BPMTS) were slowed similar to 10-fold in toxin-modified channels. Based upon the different size, hydrophobicity and charge of the two reagents it is unlikely that the change in reactivity is due to direct or indirect blockage of access of this site to reagent in the presence of toxin (Tx), but rather is the result of inability of this segment to move outward to the normal extent and at the normal rate in the toxin-modified channel. Measurements of availability of R3C to internally applied reagent show decreased access (slower rates of thiol reaction) providing further evidence for encumbered D4S4 movement in the presence of toxins consistent with the assignment of at least part of the toxin binding site to the region of D4S4 region of the voltage-sensor module.	[Ma, Zhongming; Kong, Jun; Kallen, Roland G.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kallen, Roland G.] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA USA; [Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, Ramat Aviv, Israel	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tel Aviv University	Kallen, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	rgk@mail.med.upenn.edu			BARD; United States-Israel Binational Agricultural Research & Development Fund [IS-2901-97C]; American Heart Association; Muscular Dystrophy Association; NIH [AR 41,762, P01 08075]	BARD; United States-Israel Binational Agricultural Research & Development Fund; American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by grants from: BARD, The United States-Israel Binational Agricultural Research & Development Fund (IS-2901-97C), American Heart Association, Muscular Dystrophy Association, and the NIH (AR 41,762 and P01 08075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Benzinger GR, 1998, J BIOL CHEM, V273, P80, DOI 10.1074/jbc.273.1.80; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2004, BRIT J PHARMACOL, V142, P1115, DOI 10.1038/sj.bjp.0705793; Catterall W A, 1992, Bull Soc Pathol Exot, V85, P481; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen LQ, 1996, J GEN PHYSIOL, V108, P549, DOI 10.1085/jgp.108.6.549; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Groome JR, 1999, J PHYSIOL-LONDON, V516, P687, DOI 10.1111/j.1469-7793.1999.0687u.x; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horn R, 1998, METHOD ENZYMOL, V293, P145; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Kontis KJ, 1997, J GEN PHYSIOL, V110, P403, DOI 10.1085/jgp.110.4.403; Krimm I, 1999, J MOL BIOL, V285, P1749, DOI 10.1006/jmbi.1998.2418; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MOZHAYEVA GN, 1980, BIOCHIM BIOPHYS ACTA, V597, P587, DOI 10.1016/0005-2736(80)90230-8; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; SHEETS MF, 1995, J GEN PHYSIOL, V106, P617, DOI 10.1085/jgp.106.4.617; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; STRICHARTZ G, 1987, ANNU REV NEUROSCI, V10, P237; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; WANG GK, 1985, J GEN PHYSIOL, V86, P739, DOI 10.1085/jgp.86.5.739; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang YC, 2003, J NEUROSCI, V23, P4922; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	48	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e77758	10.1371/journal.pone.0077758	http://dx.doi.org/10.1371/journal.pone.0077758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302985	Green Submitted, gold, Green Published			2022-12-25	WOS:000327546400003
J	Matsuo, M; Shimodaira, T; Kasama, T; Hata, Y; Echigo, A; Okabe, M; Arai, K; Makino, Y; Niwa, SI; Saya, H; Kishimoto, T				Matsuo, Moe; Shimodaira, Tetsuhiro; Kasama, Takashi; Hata, Yukie; Echigo, Ayumi; Okabe, Masaki; Arai, Kazuya; Makino, Yasutaka; Niwa, Shin-Ichiro; Saya, Hideyuki; Kishimoto, Toshihiko			Katanin p60 Contributes to Microtubule Instability around the Midbody and Facilitates Cytokinesis in Rat Cells	PLOS ONE			English	Article							MITOTIC SPINDLE; SEVERING ACTIVITY; TUMOR-SUPPRESSOR; ELEGANS MEIOSIS; GAMMA-TUBULIN; P80 KATANIN; ESCRT-III; PROTEIN; CENTROSOME; GENERATION	The completion of cytokinesis is crucial for mitotic cell division. Cleavage furrow ingression is followed by the breaking and resealing of the intercellular bridge, but the detailed mechanism underlying this phenomenon remains unknown. Katanin is a microtubule-severing protein comprised of an AAA ATPase subunit and an accessory subunit designated as p60 and p80, respectively. Localization of katanin p60 was observed at the midzone to midbody from anaphase to cytokinesis in rat cells, and showed a ring-shaped distribution in the gap between the inside of the contractile ring and the central spindle bundle in telophase. Katanin p60 did not bind with p80 at the midzone or midbody, and localization was shown to be dependent on microtubules. At the central spindle and the midbody, no microtubule growth plus termini were seen with katanin p60, and microtubule density was inversely correlated with katanin p60 density in the region of katanin p60 localization that seemed to lead to microtubule destabilization at the midbody. Inhibition of katanin p60 resulted in incomplete cytokinesis by regression and thus caused the appearance of binucleate cells. These results suggest that katanin p60 contributes to microtubule instability at the midzone and midbody and facilitates cytokinesis in rat cells.	[Matsuo, Moe; Shimodaira, Tetsuhiro; Echigo, Ayumi; Okabe, Masaki; Kishimoto, Toshihiko] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan; [Kasama, Takashi; Hata, Yukie; Arai, Kazuya; Makino, Yasutaka; Niwa, Shin-Ichiro] Link Genom Co Ltd, Tokyo, Japan; [Hata, Yukie; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Kishimoto, Toshihiko] Toho Univ, Fac Sci, Proteome Anal Ctr, Funabashi, Chiba 274, Japan	Toho University; Keio University; Toho University	Kishimoto, T (corresponding author), Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan.	kisimoto@biomol.sci.toho-u.ac.jp	Saya, Hideyuki/J-4325-2013	Saya, Hideyuki/0000-0001-6610-1902	Link Genomics, Inc.; Grants-in-Aid for Scientific Research [24550195] Funding Source: KAKEN	Link Genomics, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is partly supported by funding from Link Genomics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030367; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally FJ, 1996, J CELL SCI, V109, P561; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; NISLOW C, 1990, J CELL BIOL, V111, P511, DOI 10.1083/jcb.111.2.511; Panteris E, 2011, CYTOSKELETON, V68, P401, DOI 10.1002/cm.20522; Quarmby L, 2000, J CELL SCI, V113, P2821; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Srayko M, 2000, GENE DEV, V14, P1072; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	46	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80392	10.1371/journal.pone.0080392	http://dx.doi.org/10.1371/journal.pone.0080392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303010	gold, Green Submitted, Green Published			2022-12-25	WOS:000327546400026
J	Milferstedt, K; Santa-Catalina, G; Godon, JJ; Escudie, R; Bernet, N				Milferstedt, Kim; Santa-Catalina, Gaelle; Godon, Jean-Jacques; Escudie, Renaud; Bernet, Nicolas			Disturbance Frequency Determines Morphology and Community Development in Multi-Species Biofilm at the Landscape Scale	PLOS ONE			English	Article							WATER BIOFILMS; BIOCIDE ACTION; SUCCESSION; DIVERSITY; ALPHA	Many natural and engineered biofilm systems periodically face disturbances. Here we present how the recovery time of a biofilm between disturbances (expressed as disturbance frequency) shapes the development of morphology and community structure in a multi-species biofilm at the landscape scale. It was hypothesized that a high disturbance frequency favors the development of a stable adapted biofilm system while a low disturbance frequency promotes a dynamic biofilm response. Biofilms were grown in laboratory-scale reactors over a period of 55-70 days and exposed to the biocide monochloramine at two frequencies: daily or weekly pulse injections. One untreated reactor served as control. Biofilm morphology and community structure were followed on comparably large biofilm areas at the landscape scale using automated image analysis (spatial gray level dependence matrices) and community fingerprinting (single-strand conformation polymorphisms). We demonstrated that a weekly disturbed biofilm developed a resilient morphology and community structure. Immediately after the disturbance, the biofilm simplified but recovered its initial complex morphology and community structure between two biocide pulses. In the daily treated reactor, one organism largely dominated a morphologically simple and stable biofilm. Disturbances primarily affected the abundance distribution of already present bacterial taxa but did not promote growth of previously undetected organisms. Our work indicates that disturbances can be used as lever to engineer biofilms by maintaining a biofilm between two developmental states.	[Milferstedt, Kim; Santa-Catalina, Gaelle; Godon, Jean-Jacques; Escudie, Renaud; Bernet, Nicolas] INRA UR0050, Lab Biotechnol Environn, Narbonne, France	INRAE	Milferstedt, K (corresponding author), INRA UR0050, Lab Biotechnol Environn, Narbonne, France.	kim.milferstedt@supagro.inra.fr	BERNET, Nicolas/B-7333-2011	BERNET, Nicolas/0000-0003-2710-3547; Escudie, Renaud/0000-0003-0736-0327	Agence Nationale de la Recherche (ANR) [ANR-08-PRECODD-00]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	The authors are thankful for financial support in part from Agence Nationale de la Recherche (ANR, http://www.agence-nationale-recherche.fr/) under grant No. ANR-08-PRECODD-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARAK A, 2006, Patent No. 7052614; BARAK A, 1999, Patent No. 5976386; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x; DAVIS CK, 2002, NOVEL BIOCIDE PROVID; Domingo JWS, 2003, WATER SCI TECHNOL, V47, P149, DOI 10.2166/wst.2003.0305; FISHER SG, 1990, ENVIRON MANAGE, V14, P725, DOI 10.1007/BF02394721; FLEMMING HC, 2008, MARINE IND BIOFOULIN, P103; Foissner W, 1996, FRESHWATER BIOL, V35, P375; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Lee WH, 2011, ENVIRON SCI TECHNOL, V45, P1412, DOI 10.1021/es1035305; Lewandowski Z, 2004, WATER SCI TECHNOL, V49, P359, DOI 10.2166/wst.2004.0880; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Milferstedt K, 2006, BIOTECHNOL BIOENG, V94, P773, DOI 10.1002/bit.20893; Milferstedt K, 2009, BIOTECHNOL BIOENG, V102, P368, DOI 10.1002/bit.22075; Morgenroth E., 2009, Reviews in Environmental Science and Bio/Technology, V8, P203, DOI 10.1007/s11157-009-9163-1; Morgenroth E, 1999, WATER SCI TECHNOL, V39, P33, DOI 10.2166/wst.1999.0321; Oksanen, 2010, MULTIVARIATE ANAL EC; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Picioreanu C, 2000, BIOTECHNOL BIOENG, V68, P355, DOI 10.1002/(SICI)1097-0290(20000520)68:4<355::AID-BIT1>3.0.CO;2-A; R Development Core Team, 2009, R FDN STAT COMP; Remmert H, 1991, MOSAIC CYCLE CONCEPT; Rochex A, 2008, WATER RES, V42, P4915, DOI 10.1016/j.watres.2008.09.015; Roeder RS, 2010, INT J HYG ENVIR HEAL, V213, P183, DOI 10.1016/j.ijheh.2010.04.007; Sanderson SS, 1997, BIOTECHNOL BIOENG, V56, P201, DOI 10.1002/(SICI)1097-0290(19971020)56:2<201::AID-BIT9>3.0.CO;2-T; SRINIVASAN R, 1995, BIOTECHNOL BIOENG, V46, P553, DOI 10.1002/bit.260460608; Stewart PS, 1996, BIOTECHNOL BIOENG, V49, P445, DOI 10.1002/(SICI)1097-0290(19960220)49:4&lt;445::AID-BIT12&gt;3.0.CO;2-9; Stoodley P, 1998, BIOTECHNOL BIOENG, V57, P536, DOI 10.1002/(SICI)1097-0290(19980305)57:5<536::AID-BIT5>3.0.CO;2-H; Szomolay B, 2005, ENVIRON MICROBIOL, V7, P1186, DOI 10.1111/j.1462-2920.2005.00797.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams MM, 2005, BIOFOULING, V21, P279, DOI 10.1080/08927010500452695	39	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80692	10.1371/journal.pone.0080692	http://dx.doi.org/10.1371/journal.pone.0080692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303024	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400040
J	Ganin, IP; Shishkin, SL; Kaplan, AY				Ganin, Ilya P.; Shishkin, Sergei L.; Kaplan, Alexander Y.			A P300-based Brain-Computer Interface with Stimuli on Moving Objects: Four-Session Single-Trial and Triple-Trial Tests with a Game-Like Task Design	PLOS ONE			English	Article							SMOOTH-PURSUIT; P300 SPELLER; EVOKED-POTENTIALS; BCI; ATTENTION; PERFORMANCE; ALLOCATION; PARADIGM; WHEELCHAIR; AMPLITUDE	Brain-computer interfaces (BCIs) are tools for controlling computers and other devices without using muscular activity, employing user-controlled variations in signals recorded from the user's brain. One of the most efficient noninvasive BCIs is based on the P300 wave of the brain's response to stimuli and is therefore referred to as the P300 BCI. Many modifications of this BCI have been proposed to further improve the BCI's characteristics or to better adapt the BCI to various applications. However, in the original P300 BCI and in all of its modifications, the spatial positions of stimuli were fixed relative to each other, which can impose constraints on designing applications controlled by this BCI. We designed and tested a P300 BCI with stimuli presented on objects that were freely moving on a screen at a speed of 5.4 degrees/s. Healthy participants practiced a game-like task with this BCI in either single-trial or triple-trial mode within four sessions. At each step, the participants were required to select one of nine moving objects. The mean online accuracy of BCI-based selection was 81% in the triple-trial mode and 65% in the single-trial mode. A relatively high P300 amplitude was observed in response to targets in most participants. Self-rated interest in the task was high and stable over the four sessions (the medians in the 1st/4th sessions were 79/84% and 76/71% in the groups practicing in the single-trial and triple-trial modes, respectively). We conclude that the movement of stimulus positions relative to each other may not prevent the efficient use of the P300 BCI by people controlling their gaze, e. g., in robotic devices and in video games.	[Ganin, Ilya P.; Shishkin, Sergei L.; Kaplan, Alexander Y.] Moscow MV Lomonosov State Univ, Fac Biol, Lab Neurophysiol & Neurocomp Interfaces, Moscow, Russia; [Shishkin, Sergei L.] Natl Res Ctr, Ctr Converging Nano Bio Informat Cognit & Social, Lab Neuroergon & Brain Comp Interfaces, NBICS Ctr,Kurchatov Inst, Moscow, Russia	Lomonosov Moscow State University; National Research Centre - Kurchatov Institute	Kaplan, AY (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Lab Neurophysiol & Neurocomp Interfaces, Moscow, Russia.	akaplan@mail.ru	Shishkin, Sergei L./A-3461-2013; Ganin, Ilya P/D-6923-2018; Kaplan, Alexander/L-5832-2017	Shishkin, Sergei L./0000-0002-3257-1022; Kaplan, Alexander/0000-0002-3912-4639	Skolkovo Foundation [1110034]	Skolkovo Foundation	This study was supported by funding from the Skolkovo Foundation (project #1110034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2011, P 5 INT BCI C 2011 2, P236; Allison BZ, 2006, INT J PSYCHOPHYSIOL, V59, P127, DOI 10.1016/j.ijpsycho.2005.02.007; Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Aloise F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025025; Arico P, 2011, P 5 INT BCI C 22 24, P240; Bayliss JD, 2003, IEEE T NEUR SYS REH, V11, P113, DOI 10.1109/TNSRE.2003.814438; Bayliss JD, 2000, IEEE T REHABIL ENG, V8, P188, DOI 10.1109/86.847811; Beer AL, 2004, COGNITIVE BRAIN RES, V18, P205, DOI 10.1016/j.cogbrainres.2003.10.004; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Bensch Michael, 2007, Comput Intell Neurosci, P71863, DOI 10.1155/2007/71863; Bianchi L, 2010, BRAIN TOPOGR, V23, P180, DOI 10.1007/s10548-010-0143-0; Bieger J, 2010, TN201000315 KON PHIL, P1; Bos DPO, 2010, HUM-COMPUT INT-SPRIN, P149, DOI 10.1007/978-1-84996-272-8_10; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cinel C., 2004, BIOMED TECH, V49, P39; Citi L, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056006; Congedo M., 2011, P 5 INT BRAIN COMP I, P280; Datta A, 2007, COMPUT INTEL NEUROSC, P93968, DOI DOI 10.1155/2007/93968; DONCHIN E, 1967, ELECTROEN CLIN NEURO, V22, P537, DOI 10.1016/0013-4694(67)90061-2; Donnerer M, 2010, PRESENCE-TELEOP VIRT, V19, P12, DOI 10.1162/pres.19.1.12; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Escolano C, 2012, IEEE T SYST MAN CY B, V42, P793, DOI 10.1109/TSMCB.2011.2177968; Eskandari P, 2008, IEEE ENG MED BIO, P662, DOI 10.1109/IEMBS.2008.4649239; Fard MM, 2009, ADV NEURAL INF PROCE, V21, p[665, 1065]; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Fazel-Rezai R, 2009, CAN J ELECT COMPUT E, V34, P81, DOI 10.1109/CJECE.2009.5443854; Finke A, 2011, P 2011 INT UKIERI WO, P16; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Frenzel S, 2010, ARXIV10063688V1; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; Frye GE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025024; Ganin I. P., 2012, Human Physiology, V38, P121, DOI 10.1134/S0362119712020041; Ganin I. P., 2011, P 5 INT BCI C 2011, P308; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Groenegress C, 2010, PRESENCE-TELEOP VIRT, V19, P1, DOI 10.1162/pres.19.1.1; Guan C., 2004, P IEEE INT WORKSH BI; Guan JN, 2005, 2005 FIRST INTERNATIONAL CONFERENCE ON NEURAL INTERFACE AND CONTROL PROCEEDINGS, P45; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Hakvoort G, 2011, THESIS U TWENTE; Hawkins GE, 2013, BEHAV RES METHODS, V45, P301, DOI 10.3758/s13428-012-0264-3; Heinen SJ, 2011, J VISION, V11, DOI 10.1167/11.2.9; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Jin J, 2012, J NEUROSCI METH, V205, P265, DOI 10.1016/j.jneumeth.2012.01.004; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Kaplan A. J., 2009, RU Patent, Patent No. [2406554, 2406554 C1]; Kaplan AY, 2013, IEEE T COMP INTEL AI, V5, P141, DOI 10.1109/TCIAIG.2012.2237517; Kaplan AY, 2005, INT J NEUROSCI, V115, P781, DOI 10.1080/00207450590881975; Khan AZ, 2010, J VISION, V10, DOI 10.1167/10.13.7; KHURANA B, 1987, VISION RES, V27, P1603, DOI 10.1016/0042-6989(87)90168-4; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER AF, 1983, HUM FACTORS, V25, P597, DOI 10.1177/001872088302500601; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Lakey CE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025019; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Liu T, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036003; Long JY, 2012, IEEE T NEUR SYS REH, V20, P720, DOI 10.1109/TNSRE.2012.2197221; Lovejoy LP, 2009, VISION RES, V49, P1275, DOI 10.1016/j.visres.2009.01.011; Luck S.J., 2005, INTRO EVENT RELATED; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; Michalski A, 1999, ACTA NEUROBIOL EXP, V59, P123; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Muhl C, 2009, 5 INT SUMM WORKSH MU, P41; Nijholt A, 2009, ENTERTAIN COMPUT, V1, P85, DOI 10.1016/j.entcom.2009.09.007; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Onose G, 2012, SPINAL CORD, V50, P599, DOI 10.1038/sc.2012.14; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Pires G, 2012, CLIN NEUROPHYSIOL, V123, P1168, DOI 10.1016/j.clinph.2011.10.040; Pires G, 2008, IEEE ENG MED BIO, P658, DOI 10.1109/IEMBS.2008.4649238; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; ROGER M, 1981, PSYCHOPHYSIOLOGY, V18, P477, DOI 10.1111/j.1469-8986.1981.tb02485.x; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Shishkin SL, 2011, NEUROSCI LETT, V496, P95, DOI 10.1016/j.neulet.2011.03.089; Shishkin SL, 2009, J INTEGR NEUROSCI, V8, P471, DOI 10.1142/S0219635209002320; Silvoni S, 2011, P 5 INT BCI C AUSTR, P324; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; SOMMER W, 1992, BIOL PSYCHOL, V33, P37, DOI 10.1016/0301-0511(92)90004-E; Suchow JW, 2011, CURR BIOL, V21, P140, DOI 10.1016/j.cub.2010.12.019; Tonin L., 2009, INT J BIOELECTROMAGN, V11, P97; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Townsend G, 2012, NEUROSCI LETT, V531, P63, DOI 10.1016/j.neulet.2012.08.041; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yu TY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036012; Yuksel B, 2010, P SIGCHI C HUM FACT, P855; Yuksel BF, 2011, P 5 INT BCI C 2011 2, P288; Zhang D, 2013, NEUROIMAGE, V71, P30, DOI 10.1016/j.neuroimage.2012.12.069; Zhang HH, 2008, IEEE T BIO-MED ENG, V55, P1754, DOI 10.1109/TBME.2008.919128	104	21	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77755	10.1371/journal.pone.0077755	http://dx.doi.org/10.1371/journal.pone.0077755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24302977	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800007
J	Landry, MC; Champagne, C; Boulanger, MC; Jette, A; Fuchs, M; Dziengelewski, C; Lavoie, JN				Landry, Marie-Claude; Champagne, Claudia; Boulanger, Marie-Chloe; Jette, Alexandra; Fuchs, Margit; Dziengelewski, Claire; Lavoie, Josee N.			A Functional Interplay between the Small GTPase Rab11a and Mitochondria-shaping Proteins Regulates Mitochondrial Positioning and Polarization of the Actin Cytoskeleton Downstream of Src Family Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cytoskeleton; Mitochondria; Rab; Src; Trafficking; Viral Protein; Ad E4orf4; Drp1; Rab11-FIP; Podosome	ADENOVIRUS E4ORF4 PROTEIN; DYNAMIN-RELATED PROTEIN-1; TRANS-GOLGI NETWORK; CELL-DEATH PATHWAYS; MAMMALIAN-CELLS; MEDIATED PHOSPHORYLATION; RECYCLING ENDOSOME; P53-INDEPENDENT APOPTOSIS; ENDOPLASMIC-RETICULUM; ENDOCYTIC TRANSPORT	It is believed that mitochondrial dynamics is coordinated with endosomal traffic rates during cytoskeletal remodeling, but the mechanisms involved are largely unknown. The adenovirus early region 4 ORF4 protein (E4orf4) subverts signaling by Src family kinases (SFK) to perturb cellular morphology, membrane traffic, and organellar dynamics and to trigger cell death. Using E4orf4 as a model, we uncovered a functional connection between mitochondria-shaping proteins and the small GTPase Rab11a, a key regulator of polarized transport via recycling endosomes. We found that E4orf4 induced dramatic changes in the morphology of mitochondria along with their mobilization at the vicinity of a polarized actin network typifying E4orf4 action, in a manner controlled by SFK and Rab11a. Mitochondrial remodeling was associated with increased proximity between Rab11a and mitochondrial membranes, changes in fusion-fission dynamics, and mitochondrial relocalization of the fission factor dynamin-related protein 1 (Drp1), which was regulated by the Rab11a effector protein FIP1/RCP. Knockdown of FIP1/RCP or inhibition of Drp1 markedly impaired mitochondrial remodeling and actin assembly, involving Rab11a-mediated mitochondrial dynamics in E4orf4-induced signaling. A similar mobilization of mitochondria near actin-rich structures was mediated by Rab11 and Drp1 in viral Src-transformed cells and contributed to the biogenesis of podosome rosettes. These findings suggest a role for Rab11a in the trafficking of Drp1 to mitochondria upon SFK activation and unravel a novel functional interplay between Rab11a and mitochondria during reshaping of the cell cytoskeleton, which would facilitate mitochondria redistribution near energy-requiring actin-rich structures.	[Landry, Marie-Claude; Champagne, Claudia; Boulanger, Marie-Chloe; Jette, Alexandra; Fuchs, Margit; Dziengelewski, Claire; Lavoie, Josee N.] Univ Laval, Ctr Rech Canc, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ G1R 3S3, Canada; [Lavoie, Josee N.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University	Lavoie, JN (corresponding author), Univ Laval, Ctr Rech Canc, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ G1R 3S3, Canada.	josee.lavoie@crhdq.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research [MOP-49450]; Natural Sciences and Engineering Research Council [RF:RGPIN371663]; Fond de la Recherche en Sante du Quebec; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Operating Grant MOP-49450 (to J. N. L.) and by the Natural Sciences and Engineering Research Council Grant RF:RGPIN371663 (to J. N. L.).; Supported by a Studentship from the Fond de la Recherche en Sante du Quebec. Present address: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Ontario M5G 1X5, Canada.; Supported by a summer studentship from the Natural Sciences and Engineering Research Council.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bilodeau N, 2010, J PROTEOME RES, V9, P708, DOI 10.1021/pr900481b; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonekamp NA, 2010, EXP CELL RES, V316, P3454, DOI 10.1016/j.yexcr.2010.07.020; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Gould GW, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002186; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Green DR, 2011, CELL, V147, DOI 10.1016/j.cell.2011.10.036; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hebert-Chatelain E, 2013, INT J BIOCHEM CELL B, V45, P90, DOI 10.1016/j.biocel.2012.08.014; Hebert-Chatelain E, 2012, BBA-BIOENERGETICS, V1817, P718, DOI 10.1016/j.bbabio.2012.01.014; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Imoto M, 1998, J CELL SCI, V111, P1341; Jing JA, 2010, MOL BIOL CELL, V21, P3041, DOI 10.1091/mbc.E10-04-0313; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Landry MC, 2006, B CANCER, V93, P921; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Lavoie JN, 2010, CELL SIGNAL, V22, P1604, DOI 10.1016/j.cellsig.2010.04.007; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Mitra K, 2012, J CELL BIOL, V197, P487, DOI 10.1083/jcb.201110058; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; MORRIS RL, 1993, J CELL SCI, V104, P917; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; Pechkovsky A, 2013, P NATL ACAD SCI USA, V110, pE1724, DOI 10.1073/pnas.1220282110; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Sanchez-Madrid F, 2007, TRENDS IMMUNOL, V28, P193, DOI 10.1016/j.it.2007.03.007; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Santel A, 2001, J CELL SCI, V114, P867; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Schiel JA, 2013, TRENDS CELL BIOL, V23, P319, DOI 10.1016/j.tcb.2013.02.003; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Sharp TM, 2010, CURR OPIN INFECT DIS, V23, P464, DOI 10.1097/QCO.0b013e32833dcebd; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Smadja-Lamere N, 2008, J BIOL CHEM, V283, P34352, DOI 10.1074/jbc.M803364200; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	110	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2230	2249		10.1074/jbc.M113.516351	http://dx.doi.org/10.1074/jbc.M113.516351			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302731	Green Published, hybrid			2022-12-25	WOS:000331130200030
J	Lauer, JL; Bhowmick, M; Tokmina-Roszyk, D; Lin, Y; Van Doren, SR; Fields, GB				Lauer, Janelle L.; Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Lin, Yan; Van Doren, Steven R.; Fields, Gregg B.			The Role of Collagen Charge Clusters in the Modulation of Matrix Metalloproteinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix Proteins; Matrix Metalloproteinase (MMP); Protease; Protein Folding; Charge Clusters; Collagenolysis Mechanism; Triple Helix	TRIPLE-HELICAL COLLAGEN; I COLLAGEN; MODEL PEPTIDES; CLEAVAGE SITE; ELECTROSTATIC INTERACTIONS; FLUOROGENIC SUBSTRATE; STRUCTURAL INSIGHTS; SEQUENCE DEPENDENCE; THERMAL-STABILITY; DOMAIN RESIDUES	Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. Several substrate structural features that direct MMP collagenolysis have been identified. The present study evaluated the role of charged residue clusters in the regulation of MMP collagenolysis. A series of 10 triple-helical peptide (THP) substrates were constructed in which either Lys-Gly-Asp or Gly-Asp-Lys motifs replaced Gly-Pro-Hyp (where Hyp is 4-hydroxy-l-proline) repeats. The stabilities of THPs containing the two different motifs were analyzed, and kinetic parameters for substrate hydrolysis by six MMPs were determined. A general trend for virtually all enzymes was that, as Gly-Asp-Lys motifs were moved from the extreme N and C termini to the interior next to the cleavage site sequence, k(cat)/K-m values increased. Additionally, all Gly-Asp-Lys THPs were as good or better substrates than the parent THP in which Gly-Asp-Lys was not present. In turn, the Lys-Gly-Asp THPs were also always better substrates than the parent THP, but the magnitude of the difference was considerably less compared with the Gly-Asp-Lys series. Of the MMPs tested, MMP-2 and MMP-9 most greatly favored the presence of charged residues with preference for the Gly-Asp-Lys series. Lys-Gly-(Asp/Glu) motifs are more commonly found near potential MMP cleavage sites than Gly-(Asp/Glu)-Lys motifs. As Lys-Gly-Asp is not as favored by MMPs as Gly-Asp-Lys, the Lys-Gly-Asp motif appears advantageous over the Gly-Asp-Lys motif by preventing unwanted MMP hydrolysis. More specifically, the lack of Gly-Asp-Lys clusters may diminish potential MMP-2 and MMP-9 collagenolytic activity. The present study indicates that MMPs have interactions spanning the P-23-P-23 subsites of collagenous substrates.	[Lauer, Janelle L.; Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Lauer, Janelle L.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Texas System; University of Texas Health San Antonio; Max Planck Society; Torrey Pines Institute for Molecular Studies, Florida; University of Missouri System; University of Missouri Columbia	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org		Van Doren, Steven/0000-0003-2838-4598	National Institutes of Health [CA98799]; NHLBI [268201000036C]; NIDCR Craniofacial Oral Biology Student Training in Academic Research Program [DE14318]; Multiple Sclerosis National Research Institute; Robert A. Welch Foundation; Texas Higher Education Science and Technology Acquisition and Retention Program; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR Craniofacial Oral Biology Student Training in Academic Research Program; Multiple Sclerosis National Research Institute; Robert A. Welch Foundation(The Welch Foundation); Texas Higher Education Science and Technology Acquisition and Retention Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799 (to G. B. F.), Contract 268201000036C from the NHLBI (to G. B. F.), and Grant DE14318 from the NIDCR Craniofacial Oral Biology Student Training in Academic Research Program (to J. L. L.). This work was also supported by the Multiple Sclerosis National Research Institute, the Robert A. Welch Foundation, and the Texas Higher Education Science and Technology Acquisition and Retention Program (all to G. B. F.).	Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Akers WJ, 2012, BIOCONJUGATE CHEM, V23, P656, DOI 10.1021/bc300027y; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; BIRKEDALHANSEN H, 1985, J BIOL CHEM, V260, P6411; Cerofolini L, 2013, J BIOL CHEM, V288, P30659, DOI 10.1074/jbc.M113.477240; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Falconi M, 2003, J COMPUT AID MOL DES, V17, P837, DOI 10.1023/B:JCAM.0000021883.44532.75; Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields GB, 2010, METHODS MOL BIOL, V622, P393, DOI 10.1007/978-1-60327-299-5_24; Fields Gregg B., 2008, P827, DOI 10.1007/978-0-387-69057-5_39; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GROSS J, 1980, COLLAGENASE NORMAL P, P11; HASTY KA, 1993, MATRIX, V13, P181, DOI 10.1016/S0934-8832(11)80001-6; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jaisson S, 2007, MATRIX BIOL, V26, P190, DOI 10.1016/j.matbio.2006.10.008; Jalan AA, 2013, BIOMACROMOLECULES, V14, P179, DOI 10.1021/bm3015818; Knapinska A, 2012, CHEMBIOCHEM, V13, P2002, DOI 10.1002/cbic.201200298; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Li YJ, 2005, J AM CHEM SOC, V127, P10490, DOI 10.1021/ja052801d; Liu XY, 1996, BIOCHEMISTRY-US, V35, P4306, DOI 10.1021/bi952270d; Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mikhailova M, 2012, MATRIX BIOL, V31, P380, DOI 10.1016/j.matbio.2012.10.001; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Ravikumar KM, 2008, PROTEINS, V72, P1320, DOI 10.1002/prot.22026; Ravikumar KM, 2007, J MECH MATER STRUCT, V2, P999, DOI 10.2140/jomms.2007.2.999; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	82	8	8	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1981	1992		10.1074/jbc.M113.513408	http://dx.doi.org/10.1074/jbc.M113.513408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297171	hybrid, Green Published			2022-12-25	WOS:000331130200010
J	Ableser, MJ; Penuela, S; Lee, J; Shao, Q; Laird, DW				Ableser, Mark J.; Penuela, Silvia; Lee, Jack; Shao, Qing; Laird, Dale W.			Connexin43 Reduces Melanoma Growth within a Keratinocyte Microenvironment and during Tumorigenesis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Connexin; Gap Junctions; Keratinocytes; Melanoma; Tumor Suppressor Gene	JUNCTIONAL INTERCELLULAR COMMUNICATION; C6 GLIOMA-CELLS; GAP-JUNCTION; SUPPRESSIVE FUNCTION; ENDOTHELIAL-CELLS; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; LIVER-TUMORS; E-CADHERIN; EXPRESSION	Background: Cx43 is a gap junction protein that is highly expressed in the epidermis. Results: Ectopic expression of Cx43 in gap junctional intercellular communication-deficient melanomas reduces growth in keratinocyte co-cultures and tumorigenicity assays. Conclusion: Cx43 acts as a tumor suppressor during melanoma tumorigenesis. Significance: Cx43 may serve as a potential therapeutic target for melanomas. Connexins (Cx) have been identified as tumor suppressors or enhancers, a distinction that appears to be dependent on the type and stage of disease. However, the role of connexins in melanoma tumorigenesis and their status during cancer onset and progression remain controversial and unclear. Here, we show that the aggressive B16-BL6 mouse melanoma cell line expresses low basal levels of Cx26 and Cx43, rendering them gap junctional intercellular communication-deficient as elucidated by immunofluorescence, Western blotting, and dye transfer studies. Following ectopic expression of green fluorescent protein-tagged Cx26 and Cx43 in these connexin-deficient melanomas, punctate gap junction-like plaques were evident at sites of cell-cell apposition, and the incidence of dye transfer was significantly increased similar to connexin-rich keratinocytes. We found that the expression of Cx43, but not Cx26, significantly reduced cellular proliferation and anchorage-independent growth from control melanomas, whereas migration was unaffected. Additionally, melanomas expressing Cx43 displayed significantly reduced growth within the in situ-like microenvironment of keratinocytes, despite a lack of heterocellular gap junctional intercellular communication between the two cell types. Furthermore, when grown in vivo in the chicken chorioallantoic membrane, primary tumors derived from Cx43-expressing melanomas were significantly smaller than controls, whereas Cx26-expressing melanomas produced tumors similar to controls. Collectively, these results suggest that Cx43, and not Cx26, can act as a tumor suppressor during melanoma tumorigenesis.	[Ableser, Mark J.; Penuela, Silvia; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Lee, Jack; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg 00077, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canadian Institutes of Health Research (to D. W. L.).	Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; EGHBALI B, 1991, P NATL ACAD SCI USA, V88, P10701, DOI 10.1073/pnas.88.23.10701; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Falk MM, 2000, J CELL SCI, V113, P4109; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Girolamo F, 2006, MED SCI MONITOR, V12, pBR21; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Haass NK, 2004, J MOL HISTOL, V35, P309; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Huang RP, 1998, CANCER RES, V58, P5089; Ionta M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-22; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kalra J, 2006, CARCINOGENESIS, V27, P2528, DOI 10.1093/carcin/bgl110; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; KRUTOVSKIKH V, 1994, INT J CANCER, V56, P87; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Langlois S, 2010, CANCER RES, V70, P4222, DOI 10.1158/0008-5472.CAN-09-3281; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Masuda M, 2001, ANAT RECORD, V262, P137, DOI 10.1002/1097-0185(20010201)262:2<137::AID-AR1018>3.0.CO;2-2; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Omori Y, 1999, CARCINOGENESIS, V20, P1913, DOI 10.1093/carcin/20.10.1913; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; Princen F, 2001, CARCINOGENESIS, V22, P507, DOI 10.1093/carcin/22.3.507; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Richard G, 2000, EXP DERMATOL, V9, P77, DOI 10.1034/j.1600-0625.2000.009002077.x; Saito-Katsuragi M, 2007, CANCER, V110, P1162, DOI 10.1002/cncr.22894; Sato H, 2007, J MEMBRANE BIOL, V216, P17, DOI 10.1007/s00232-007-9020-5; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; SHIH IM, 1994, AM J PATHOL, V145, P837; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Stoletov K, 2013, J CELL SCI, V126, P904, DOI 10.1242/jcs.112748; Su YA, 2000, MOL CARCINOGEN, V28, P119, DOI 10.1002/1098-2744(200006)28:2<119::AID-MC8>3.0.CO;2-N; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thomas T, 2004, J BIOL CHEM, V279, P19157, DOI 10.1074/jbc.M314117200; VALYINAGY IT, 1993, LAB INVEST, V69, P152; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; YAMAOKA K, 1995, J HEPATOL, V22, P536, DOI 10.1016/0168-8278(95)80447-1; Zhang YW, 2003, CANCER RES, V63, P1623; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883; Zucker SN, 2013, J CELL PHYSIOL, V228, P853, DOI 10.1002/jcp.24235	55	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1592	1603		10.1074/jbc.M113.507228	http://dx.doi.org/10.1074/jbc.M113.507228			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297173	hybrid, Green Published			2022-12-25	WOS:000332401700033
J	Aoki, R; Hiraide, Y; Yamakawa, H; Fujita, Y				Aoki, Rina; Hiraide, Yuto; Yamakawa, Hisanori; Fujita, Yuichi			A Novel "Oxygen-induced" Greening Process in a Cyanobacterial Mutant Lacking the Transcriptional Activator ChlR Involved in Low-oxygen Adaptation of Tetrapyrrole Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Hypoxia; Photosynthesis; Photosynthetic Pigments; Photosystem II; Chlorophyll; Greening; Transcriptional Regulator	PHOTOSYSTEM-II COMPLEX; CHLOROPHYLL BIOSYNTHESIS; PROTOCHLOROPHYLLIDE REDUCTION; DIFFERENTIAL OPERATION; EXPRESSION; ENZYME; GENES; STOICHIOMETRY; ARABIDOPSIS; REGULATOR	Background: ChlR activates the transcription of genes encoding low-oxygen-type enzymes in response to hypoxia in cyanobacteria. Results: The chlR-lacking mutant showed a novel oxygen-induced greening process upon exposure to air. Conclusion: The contents of photosystems were correlated well with the chlorophyll contents in the greening process. Significance: Oxygen-induced greening provides a promising alternative system to investigate the biogenesis of photosystems. ChlR activates the transcription of the chlA(II)-ho2-hemN operon in response to low-oxygen conditions in the cyanobacterium Synechocystis sp. PCC 6803. Three genes in the operon encode low-oxygen-type enzymes to bypass three oxygen-dependent reactions in tetrapyrrole biosynthesis. A chlR-lacking mutant, chlR, shows poor photoautotrophic growth due to low chlorophyll (Chl) content under low-oxygen conditions, which is caused by no induction of the operon. Here, we characterized the processes of etiolation of chlR cells in low-oxygen conditions and the subsequent regreening of the etiolated cells upon exposure to oxygen, by HPLC, Western blotting, and low-temperature fluorescence spectra. The Chl content of the etiolated chlR cells incubated under low-oxygen conditions for 7 days was only 10% of that of the wild-type with accumulation of almost all intermediates of the magnesium branch of Chl biosynthesis. Both photosystem I (PSI) and photosystem II (PSII) were significantly decreased, accompanied by a preferential decrease of antenna Chl in PSI. Upon exposure to oxygen, the etiolated chlR cells resumed to produce Chl after a short lag (approximate to 2 h), and the level at 72 h was 80% of that of the wild-type. During this novel oxygen-induced greening process, the PSI and PSII contents were largely increased in parallel with the increase in Chl contents. After 72 h, the PSI content reached approximate to 50% of the wild-type level in contrast to the full recovery of PSII. chlR provides a promising alternative system to investigate the biogenesis of PSI and PSII.	[Aoki, Rina; Hiraide, Yuto; Yamakawa, Hisanori; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp	Fujita, Yuichi/G-8908-2013		Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency; Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists;  [19570036];  [20200063];  [23370020];  [12J00105]	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency; Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported by Grants-in-aid for Scientific Research 19570036, 20200063, and 23370020 (to Y. F.) and 12J00105 (to R. A.) and the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency.; Supported by a fellowship from the Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists.	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; Boehm M, 2011, J BIOL CHEM, V286, P14812, DOI 10.1074/jbc.M110.207944; Cahoon AB, 2000, PLANT CELL, V12, P559, DOI 10.1105/tpc.12.4.559; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; FUJITA Y, 1990, PLANT CELL PHYSIOL, V31, P145; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GOLDBERG I, 1970, Journal of Cell Biology, V44, P563, DOI 10.1083/jcb.44.3.563; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; HOOBER JK, 1976, J CELL BIOL, V70, P326, DOI 10.1083/jcb.70.2.326; Kada S, 2003, PLANT MOL BIOL, V51, P225, DOI 10.1023/A:1021195226978; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kopecna J, 2013, PLANTA, V237, P497, DOI 10.1007/s00425-012-1761-4; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; MELIS A, 1980, P NATL ACAD SCI-BIOL, V77, P4712, DOI 10.1073/pnas.77.8.4712; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Ohad I, 1974, Methods Enzymol, V32, P865; Ohnishi N, 2008, PHOTOSYNTH RES, V98, P315, DOI 10.1007/s11120-008-9344-8; PONTOPPIDAN B, 1994, EUR J BIOCHEM, V225, P529, DOI 10.1111/j.1432-1033.1994.00529.x; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Rudiger W, 2012, ADV PHOTOSYNTH RESP, V34, P175, DOI 10.1007/978-94-007-1579-0_8; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Vothknecht UC, 1996, P NATL ACAD SCI USA, V93, P9287, DOI 10.1073/pnas.93.17.9287; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	38	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1841	1851		10.1074/jbc.M113.495358	http://dx.doi.org/10.1074/jbc.M113.495358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297184	Green Published, hybrid			2022-12-25	WOS:000332401700053
J	Bondar, A; Lazar, J				Bondar, Alexey; Lazar, Josef			Dissociated G alpha(GTP) and G beta gamma Protein Subunits Are the Major Activated Form of Heterotrimeric Gi/o Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Cell Signaling; Heterotrimeric G Proteins; Membrane Proteins; Microscopic Imaging; Plasma Membrane; Potassium Channels; Two-photon Polarization Microscopy	STRUCTURAL BASIS; RECEPTOR; ALPHA; GTP; COMPLEX; CONFORMATIONS; TRANSLOCATION; EFFECTOR; CELLS	Background: The nature of the activated form of heterotrimeric Gi/o proteins is unclear. Results: Non-modified Gi/o heterotrimers dissociate upon activation, whereas fluorescently labeled Gi/o heterotrimers dissociate or rearrange depending on fluorescent protein localization. Conclusion: Dissociated G(GTP) and G subunits represent the major activated form of Gi/o proteins. Significance: The identification of the Gi/o protein activated form is crucial for the elucidation of signaling mechanisms and rational drug design. Although most heterotrimeric G proteins are thought to dissociate into G and G subunits upon activation, the evidence in the Gi/o family has long been inconsistent and contradictory. The Gi/o protein family mediates inhibition of cAMP production and regulates the activity of ion channels. On the basis of experimental evidence, both heterotrimer dissociation and rearrangement have been postulated as crucial steps of Gi/o protein activation and signal transduction. We have now investigated the process of Gi/o activation in living cells directly by two-photon polarization microscopy and indirectly by observations of G protein-coupled receptor kinase-derived polypeptides. Our observations of existing fluorescently labeled and non-modified Gi/o constructs indicate that the molecular mechanism of Gi/o activation is affected by the presence and localization of the fluorescent label. All investigated non-labeled, non-modified Gi/o complexes dissociate extensively upon activation. The dissociated subunits can activate downstream effectors and are thus likely to be the major activated Gi/o form. Constructs of Gi/o subunits fluorescently labeled at the N terminus (GAP43-CFP-Gi/o) seem to faithfully reproduce the behavior of the non-modified Gi/o subunits. Gi constructs labeled within the helical domain (Gi-L91-YFP) largely do not dissociate upon activation, yet still activate downstream effectors, suggesting that the dissociation seen in non-modified Gi/o proteins is not required for downstream signaling. Our results appear to reconcile disparate published data and settle a long running dispute.	[Bondar, Alexey; Lazar, Josef] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Inst Nanobiol, Nove Hrady 37333, Czech Republic; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Struct Biol Global Change Res Ctr, Nove Hrady 37333, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Czech Academy of Sciences	Bondar, A (corresponding author), Univ South Bohemia, Zamek 136, Nove Hrady 37333, Czech Republic.	bondar@nh.cas.cz	Lazar, Josef/AAI-7246-2020; Bondar, Alexey/G-9459-2014; Lazar, Josef/H-7487-2014; Lazar, Josef/D-8523-2012	Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-6285-3995; Lazar, Josef/0000-0002-8579-8589	European Commission [PIRG-GA-2007-209789]; Czech Government [AVOZ60870520]; University of South Bohemia Grant Agency [141/2013/P]; University of South Bohemia fellowship; Industrial Property Office of the Czech Republic;  [P205/13-10799S]	European Commission(European CommissionEuropean Commission Joint Research Centre); Czech Government; University of South Bohemia Grant Agency; University of South Bohemia fellowship; Industrial Property Office of the Czech Republic; 	This work was supported by European Commission FP7 Marie Curie International Reintegration Grant PIRG-GA-2007-209789 "MemSensors" (to J. L.), by Czech Government Institutional Grant AVOZ60870520 (to J. L.), by Grant P205/13-10799S (to J. L.), by University of South Bohemia Grant Agency Grant 141/2013/P (to A. B.), and by a University of South Bohemia fellowship (to A. B.). Patent 302233, covering the method of 2PPM, device and applications, has been awarded by the Industrial Property Office of the Czech Republic (to J. L.). A Patent Cooperation Treaty (PCT) application has been filed (by J. L.). J. L. is a founder and owner of Innovative Bioimaging, LLC.	Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Berlin S, 2011, J BIOL CHEM, V286, P33223, DOI 10.1074/jbc.M111.271056; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Digby GJ, 2008, J PHYSIOL-LONDON, V586, P3325, DOI 10.1113/jphysiol.2008.153965; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hommers LG, 2010, J BIOL CHEM, V285, P8227, DOI 10.1074/jbc.M109.015388; KATADA T, 1984, J BIOL CHEM, V259, P3578; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	34	16	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1271	1281		10.1074/jbc.M113.493643	http://dx.doi.org/10.1074/jbc.M113.493643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307173	Green Published, hybrid			2022-12-25	WOS:000332401700007
J	Lee, CF; Lai, HL; Lee, YC; Chien, CL; Chern, Y				Lee, Chien-fei; Lai, Hsin-Lin; Lee, Yi-Chao; Chien, Chen-Li; Chern, Yijuang			The A(2A) Adenosine Receptor Is a Dual Coding Gene A NOVEL MECHANISM OF GENE USAGE AND SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosine Receptor; AP1 Transcription Factor; Gene Regulation; Hypoxia; Protein Kinase A (PKA); A2A Adenosine Receptor; Alternative Reading Frame; Dual Coding Gene; Overlapping Reading Frame	NERVE GROWTH-FACTOR; OVERLAPPING READING FRAME; NF-KAPPA-B; MESSENGER-RNA; HUNTINGTONS-DISEASE; ALTERNATIVE USAGE; INITIATION CODONS; PC12 CELLS; TRANSLATION; PROTEIN	Background:Adora2a encodes A(2A) adenosine receptor (A(2A)R) and a new protein (uORF5) translated from an out-of-frame AUG. Results: uORF5 exists in tissues where the Adora2a transcript is detected and is up-regulated by A(2A)R activation. uORF5 suppresses AP1-mediated transcription. Conclusion:Adora2a encodes two distinct proteins (A(2A)R and uORF5) in an A(2A)R-dependent manner. Significance: uORF5 may participate in the functions of A(2A)R during pathophysiological conditions. The A(2A) adenosine receptor (A(2A)R) is a G protein-coupled receptor and a major target of caffeine. The A(2A)R gene encodes alternative transcripts that are initiated from at least two independent promoters. The different transcripts of the A(2A)R gene contain the same coding region and 3-untranslated region and different 5-untranslated regions that are highly conserved among species. We report here that in addition to the production of the A(2A)R protein, translation from an upstream, out-of-frame AUG of the rat A(2A)R gene produces a 134-amino acid protein (designated uORF5). An anti-uORF5 antibody recognized a protein of the predicted size of uORF5 in PC12 cells and rat brains. Up-regulation of A(2A)R transcripts by hypoxia led to increased levels of both the A(2A)R and uORF5 proteins. Moreover, stimulation of A(2A)R increased the level of the uORF5 protein via post-transcriptional regulation. Expression of the uORF5 protein suppressed the AP1-mediated transcription promoted by nerve growth factor and modulated the expression of several proteins that were implicated in the MAPK pathway. Taken together, our results show that the rat A(2A)R gene encodes two distinct proteins (A(2A)R and uORF5) in an A(2A)R-dependent manner. Our study reveals a new example of the complexity of the mammalian genome and provides novel insights into the function of A(2A)R.	[Lee, Chien-fei; Chien, Chen-Li; Chern, Yijuang] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan; [Lee, Chien-fei; Lai, Hsin-Lin; Lee, Yi-Chao; Chien, Chen-Li; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Div Neurosci, Taipei 115, Taiwan; [Chern, Yijuang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Ph D Program Neural Regenerat Med, Taipei 110, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chern, Y (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	bmychern@ibms.sinica.edu.tw	chern, yijuang/S-7013-2018	chern, yijuang/0000-0002-5842-5429; Lee, Yi-Chao/0000-0003-3451-183X	National Science Council [NSC96-2321-B-001-015, NSC97-2321-B-001-012, 100-2320-B-001-0110MY3]; Institute of Biomedical Sciences of Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences of Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2321-B-001-015, NSC97-2321-B-001-012, and 100-2320-B-001-0110MY3 and the Institute of Biomedical Sciences of Academia Sinica.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chen WS, 2001, MOL CELL BIOL, V21, P4636, DOI 10.1128/MCB.21.14.4636-4646.2001; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; CHERN YJ, 1993, MOL PHARMACOL, V44, P950; Chiang MC, 2009, HUM MOL GENET, V18, P2929, DOI 10.1093/hmg/ddp230; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Emanuel RL, 1998, ENDOCRINOLOGY, V139, P2831, DOI 10.1210/en.139.6.2831; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Grummt M. V. K. M., 2006, THESIS U HEIDELBERG; Harlow E., 1988, ANTIBODIES LAB MANUA, P59; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jagadish N, 2005, BIOCHEM J, V389, P73, DOI 10.1042/BJ20041577; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kobayashi S, 1999, J BIOL CHEM, V274, P20358, DOI 10.1074/jbc.274.29.20358; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Koizumi S, 2009, J GASTROENTEROL, V44, P419, DOI 10.1007/s00535-009-0028-8; Konrad FM, 2013, FASEB J, V27, P3524, DOI 10.1096/fj.13-228122; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kulisevsky J, 2012, EUR NEUROL, V67, P4, DOI 10.1159/000331768; Lambrecht N, 2000, J BIOL CHEM, V275, P4041, DOI 10.1074/jbc.275.6.4041; Lee J, 2002, NUCLEIC ACIDS RES, V30, P5110, DOI 10.1093/nar/gkf664; Lee YC, 1999, J NEUROCHEM, V73, P1790, DOI 10.1046/j.1471-4159.1999.0731790.x; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Liang H, 2006, GENOME RES, V16, P190, DOI 10.1101/gr.4246506; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Moore CC, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-141; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Noto S, 1998, FEBS LETT, V441, P127, DOI 10.1016/S0014-5793(98)01530-0; Okazaki S, 1998, BIOCHEM BIOPH RES CO, V250, P347, DOI 10.1006/bbrc.1998.9331; OPPENHEIM DS, 1980, GENETICS, V95, P785; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pinna A, 1997, BRAIN RES, V759, P41, DOI 10.1016/S0006-8993(97)00214-X; Ribrioux S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-122; Satoh S, 1999, EUR J NEUROSCI, V11, P1587, DOI 10.1046/j.1460-9568.1999.00569.x; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SHAW DC, 1978, NATURE, V272, P510, DOI 10.1038/272510a0; Sun WC, 2010, VET IMMUNOL IMMUNOP, V135, P289, DOI 10.1016/j.vetimm.2009.12.001; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Tong L, 1996, J NEUROSCI RES, V45, P1, DOI 10.1002/(SICI)1097-4547(19960701)45:1<1::AID-JNR1>3.0.CO;2-I; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; WEAVER DR, 1993, MOL BRAIN RES, V20, P313, DOI 10.1016/0169-328X(93)90058-W; WEAVER DR, 1992, AM J PHYSIOL, V263, pF991, DOI 10.1152/ajprenal.1992.263.6.F991; Xu H, 2010, CELL RES, V20, P445, DOI 10.1038/cr.2010.25	66	21	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1257	1270		10.1074/jbc.M113.509059	http://dx.doi.org/10.1074/jbc.M113.509059			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293369	Green Published, hybrid			2022-12-25	WOS:000332401700006
J	Ramadoss, P; Abraham, BJ; Tsai, L; Zhou, YM; Costa-e-Sousa, RH; Ye, FL; Bilban, M; Zhao, KJ; Hollenberg, AN				Ramadoss, Preeti; Abraham, Brian J.; Tsai, Linus; Zhou, Yiming; Costa-e-Sousa, Ricardo H.; Ye, Felix; Bilban, Martin; Zhao, Keji; Hollenberg, Anthony N.			Novel Mechanism of Positive versus Negative Regulation by Thyroid Hormone Receptor beta 1 (TR beta 1) Identified by Genome-wide Profiling of Binding Sites in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); Nuclear Receptors; Thyroid Hormone; Transcription Regulation; Transcription Target Genes; ChIP-seq; TRb1; Thyroid Hormone Receptor; gpd2; thrsp	RETINOID-X-RECEPTOR; GENE-EXPRESSION; NUCLEAR RECEPTOR; IN-VIVO; RESPONSE ELEMENT; TRANSCRIPTION FACTOR; ACID; PROTEIN; BIOTINYLATION; ACTIVATION	Background: Examining the TR1 cistrome in mouse liver is critical to understanding thyroid hormone signaling. Results: Novel mechanisms of positive versus negative regulation by biotinylated TR1 were identified. Conclusion: TR1 regulates transcription by changes in relative binding and use of preferred binding motifs. Significance: This study demonstrates that a mechanism other than differential co-regulator recruitment is involved in transcriptional regulation by TR1 Triiodothyronine (T3) regulates key metabolic processes in the liver through the thyroid hormone receptor, TR1. However, the number of known target genes directly regulated by TR1 is limited, and the mechanisms by which positive and especially negative transcriptional regulation occur are not well understood. To characterize the TR1 cistrome in vivo, we expressed a biotinylated TR1 in hypo- and hyperthyroid mouse livers, used ChIP-seq to identify genomic TR1 targets, and correlated these data with gene expression changes. As with other nuclear receptors, the majority of TR1 binding sites were not in proximal promoters but in the gene body of known genes. Remarkably, T3 can dictate changes in TR1 binding, with strong correlation to T3-induced gene expression changes, suggesting that differential TR1 binding regulates transcriptional outcome. Additionally, DR-4 and DR-0 motifs were significantly enriched at binding sites where T3 induced an increase or decrease in TR1 binding, respectively, leading to either positive or negative regulation by T3. Taken together, the results of this study provide new insights into the mechanisms of transcriptional regulation by TR1 in vivo.	[Ramadoss, Preeti; Tsai, Linus; Zhou, Yiming; Costa-e-Sousa, Ricardo H.; Ye, Felix; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Abraham, Brian J.; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Core Facil, Core Facil Genom, A-1090 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University of Vienna; Medical University of Vienna	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02115 USA.	thollenb@bidmc.harvard.edu	Abraham, Brian/C-2230-2019	Abraham, Brian/0000-0001-8085-3027; Bilban, Martin/0000-0001-7043-7142; Tsai, Linus/0000-0002-0134-6949; Costa e Sousa, Ricardo Henrique/0000-0002-0443-6392	National Institutes of Health [DK-091941, DK-056123]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, R21DK091941, R56DK056123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-091941 and DK-056123 (to A. N. H.).	ADAN RAH, 1992, J BIOL CHEM, V267, P3771; Alonso M, 2009, ENDOCRINOLOGY, V150, P3927, DOI 10.1210/en.2009-0093; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Machado DS, 2009, P NATL ACAD SCI USA, V106, P9441, DOI 10.1073/pnas.0903227106; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Paquette MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-634; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	57	71	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1313	1328		10.1074/jbc.M113.521450	http://dx.doi.org/10.1074/jbc.M113.521450			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24288132	hybrid, Green Published			2022-12-25	WOS:000332401700011
J	You, JS; Lincoln, HC; Kim, CR; Frey, JW; Goodman, CA; Zhong, XP; Hornberger, TA				You, Jae-Sung; Lincoln, Hannah C.; Kim, Chan-Ran; Frey, John W.; Goodman, Craig A.; Zhong, Xiao-Ping; Hornberger, Troy A.			The Role of Diacylglycerol Kinase zeta and Phosphatidic Acid in the Mechanical Activation of Mammalian Target of Rapamycin (mTOR) Signaling and Skeletal Muscle Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mechanotransduction; mTOR; Phosphatidic Acid; Phospholipase D; Skeletal Muscle; Diacylglycerol Kinase; Hypertrophy	PHOSPHOLIPASE-D; PHOSPHOINOSITIDE 3-KINASE; PROTEIN; COMPLEX; PHOSPHORYLATION; LOCALIZATION; DIFFERENTIATION; IDENTIFICATION; RESISTANCE; INHIBITOR	Background: Diacylglycerol kinases (DGKs) synthesize phosphatidic acid (PA), and PA can activate growth-regulatory mTOR signaling. Results: The isoform of DGK is necessary for a mechanically induced increase in PA-mTOR signaling, and overexpression of DGK induces skeletal muscle hypertrophy. Conclusion: PA synthesized by DGK regulates the mechanical activation of mTOR signaling and hypertrophy. Significance: DGK is a potential target for treating muscle atrophy/wasting. The activation of mTOR signaling is essential for mechanically induced changes in skeletal muscle mass, and previous studies have suggested that mechanical stimuli activate mTOR (mammalian target of rapamycin) signaling through a phospholipase D (PLD)-dependent increase in the concentration of phosphatidic acid (PA). Consistent with this conclusion, we obtained evidence which further suggests that mechanical stimuli utilize PA as a direct upstream activator of mTOR signaling. Unexpectedly though, we found that the activation of PLD is not necessary for the mechanically induced increases in PA or mTOR signaling. Motivated by this observation, we performed experiments that were aimed at identifying the enzyme(s) that promotes the increase in PA. These experiments revealed that mechanical stimulation increases the concentration of diacylglycerol (DAG) and the activity of DAG kinases (DGKs) in membranous structures. Furthermore, using knock-out mice, we determined that the isoform of DGK (DGK) is necessary for the mechanically induced increase in PA. We also determined that DGK significantly contributes to the mechanical activation of mTOR signaling, and this is likely driven by an enhanced binding of PA to mTOR. Last, we found that the overexpression of DGK is sufficient to induce muscle fiber hypertrophy through an mTOR-dependent mechanism, and this event requires DGK kinase activity (i.e. the synthesis of PA). Combined, these results indicate that DGK, but not PLD, plays an important role in mechanically induced increases in PA and mTOR signaling. Furthermore, this study suggests that DGK could be a fundamental component of the mechanism(s) through which mechanical stimuli regulate skeletal muscle mass.	[You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Program Cellular & Mol Biol, Madison, WI 53706 USA; [You, Jae-Sung; Lincoln, Hannah C.; Kim, Chan-Ran; Frey, John W.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Dept Comparat Biosci, Sch Vet Med, Madison, WI 53706 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Div Allergy & Immunol, Dept Pediat, Durham, NC 27710 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Hornberger, TA (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	You, Jae-Sung/ABF-6763-2020; Goodman, Craig/H-8085-2019	You, Jae-Sung/0000-0001-7791-8563; Goodman, Craig/0000-0002-5874-7743; Hornberger, Troy/0000-0002-2349-1899	National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079088, R01AI076357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR057347 (to T. A. H.).	Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Baldanzi G, 2010, CELL DEATH DIFFER, V17, P1059, DOI 10.1038/cdd.2009.210; Ballou LM, 2003, FEBS LETT, V550, P51, DOI 10.1016/S0014-5793(03)00816-0; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; CLELAND PJF, 1989, J BIOL CHEM, V264, P17704; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; ElBawab S, 1996, J LIPID RES, V37, P2098; Evangelisti C, 2006, J CELL PHYSIOL, V209, P370, DOI 10.1002/jcp.20744; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2013, MOL ENDOCRINOL, V27, P1946, DOI 10.1210/me.2013-1194; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hornberger TA, 2006, J CELL BIOCHEM, V97, P1207, DOI 10.1002/jcb.20671; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Jaafar R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-55; Jacobs B. L., 2013, J MUSCLE RES CELL MO, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mendoza GJA, 2001, MOL THER, V3, P565, DOI 10.1006/mthe.2001.0292; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato T, 2013, MOL CELL BIOL, V33, P136, DOI 10.1128/MCB.00869-12; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; You JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047258; Zhao K, 2012, J LIPID RES, V53, P2102, DOI 10.1194/jlr.M027557; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	97	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1551	1563		10.1074/jbc.M113.531392	http://dx.doi.org/10.1074/jbc.M113.531392			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302719	hybrid, Green Published			2022-12-25	WOS:000332401700030
J	Osaki, Y; Yokohama, A; Saito, A; Tahara, K; Yanagisawa, K; Ogawa, Y; Ishizaki, T; Mitsui, T; Koiso, H; Takizawa, M; Uchiumi, H; Saitoh, T; Handa, H; Murakami, H; Tsukamoto, N; Nojima, Y				Osaki, Yohei; Yokohama, Akihiko; Saito, Akio; Tahara, Kenichi; Yanagisawa, Kunio; Ogawa, Yoshiyuki; Ishizaki, Takuma; Mitsui, Takeki; Koiso, Hiromi; Takizawa, Makiko; Uchiumi, Hideki; Saitoh, Takayuki; Handa, Hiroshi; Murakami, Hirokazu; Tsukamoto, Norifumi; Nojima, Yoshihisa			Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?	PLOS ONE			English	Article							IDENTIFICATION; DISTINCT; PROGENITORS; EXPRESSION; GENERATION; LEUKEMIA; SUBSETS; MARKERS; PU.1; ETS	Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy. Plasmacytoid DCs (pDCs), which are defined as lineage marker (Lin)(-)HLA-DR(+)CD56(-)CD123(+)CD11c(-)cells, are considered to be the normal counterpart of BPDCNs. However, BPDCN can be distinguished from pDCs by uniform expression of CD56. In this study, to identify a normal counterpart of BPDCN, we searched for a Lin(-)HLA(-)DR(+)CD56(+) population and focused on a minor subpopulation of Lin-DR(+)CD56(+)CD123(+)CD11c(-)cells that we designated as pDC-like cells (pDLCs). pDLC constituted 0.03% of peripheral blood mononuclear cells (PBMCs), and the pDLC/pDC ratio was higher in bone marrow cells than in PBMCs. pDLC clearly expressed BDCA2, BDCA4, and myeloid antigens, which are frequently expressed by BPDCN. pDLCs exhibited modest expression of Toll-like receptors and produced less interferon-a after CpG stimulation, but presented very low endocytic ability unlike mDCs. These functional differences were attributed to the expression profile of transcriptional factors. After in vitro culture with Flt3-ligand and GM-CSF, pDLCs expressed CD11c and BDCA1. These data suggested that pDLCs are a distinct subpopulation, with an immunophenotype similar to BPDCNs. Moreover, our results indicate that pDLCs might be immature DCs and might contribute to the immunophenotypical diversity of BPDCNs.	[Osaki, Yohei; Saito, Akio; Tahara, Kenichi; Yanagisawa, Kunio; Ogawa, Yoshiyuki; Ishizaki, Takuma; Mitsui, Takeki; Uchiumi, Hideki; Handa, Hiroshi; Nojima, Yoshihisa] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Maebashi, Gunma, Japan; [Yokohama, Akihiko; Takizawa, Makiko] Gunma Univ Hosp, Fac Med, Div Blood Transfus Serv, Maebashi, Gunma, Japan; [Koiso, Hiromi; Tsukamoto, Norifumi] Gunma Univ Hosp, Ctr Oncol, Maebashi, Gunma, Japan; [Saitoh, Takayuki; Murakami, Hirokazu] Gunma Univ, Fac Med, Gunma Univ Sch Hlth Sci, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University; Gunma University	Yokohama, A (corresponding author), Gunma Univ Hosp, Fac Med, Div Blood Transfus Serv, Maebashi, Gunma, Japan.	ayoko@gunma-u.ac.jp	Saitoh, Takayuki/AAR-5529-2021		National Cancer Center Research and Development Fund [23-A-17]	National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-17). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chaperot L, 2001, BLOOD, V97, P3210, DOI 10.1182/blood.V97.10.3210; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Comeau MR, 2002, J IMMUNOL, V169, P75, DOI 10.4049/jimmunol.169.1.75; Dargent JL, 2011, J CUTAN PATHOL, V38, P893, DOI 10.1111/j.1600-0560.2011.01777.x; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Gruenbacher G, 2010, CANCER RES, V70, P9611, DOI 10.1158/0008-5472.CAN-10-1968; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Inoue D, 2011, ACTA HAEMATOL-BASEL, V126, P122, DOI 10.1159/000328180; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Marafioti T, 2008, BLOOD, V111, P3778, DOI 10.1182/blood-2007-10-117531; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Narita M, 2008, ACTA HAEMATOL-BASEL, V120, P91, DOI 10.1159/000165510; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pulendran B, 2000, J IMMUNOL, V165, P566, DOI 10.4049/jimmunol.165.1.566; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Saito A, 2012, EUR J HAEMATOL, V88, P340, DOI 10.1111/j.1600-0609.2011.01745.x; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Shi J, 2008, CANCER LETT, V270, P19, DOI 10.1016/j.canlet.2008.04.048; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tel J, 2012, BLOOD, V120, P3936, DOI 10.1182/blood-2012-06-435941; Watanabe N, 2010, LEUKEMIA RES, V34, P1517, DOI 10.1016/j.leukres.2010.03.002; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81722	10.1371/journal.pone.0081722	http://dx.doi.org/10.1371/journal.pone.0081722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312342	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300045
J	Tang, J; Luo, JM; Ma, J				Tang, Jun; Luo, Jin-Ming; Ma, Jun			Information Transmission in a Neuron-Astrocyte Coupled Model	PLOS ONE			English	Article							ASTROGLIAL NETWORKS; GLUTAMATE RELEASE; ATP; SYNCHRONIZATION; INHIBITION; STEP; GLIA	A coupled model containing two neurons and one astrocyte is constructed by integrating Hodgkin-Huxley neuronal model i ncl Li-Rinzel calcium m model. Based on this hybrid model, information transmission between neurons s studied numerically. Our results show that when the successive spikes are produced in neuron 1 (Ni), the bursting-like spikes (BLSs) occur in neurons simultaneously during the spikes being transferred to neuron 2 (N2). The existence of the astrocyte and a high expression level of mGluRs facilitate the occurrence of BLSs but the rate of occurrence is not sensitive to the parameter Furthermore, time delay r occurs during the information transmission, and r is almost independent the effect of the astrocyte. Additionally, we found that low coupling strength may result in the distortion of h distortion is also proven to be almost independent of the astrocyte. info	[Tang, Jun; Luo, Jin-Ming] China Univ Min & Technol, Coll Sci, Xuzhou, Peoples R China; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China	China University of Mining & Technology; Lanzhou University of Technology	Tang, J (corresponding author), China Univ Min & Technol, Coll Sci, Xuzhou, Peoples R China.	tjuns1979@126.com	Ma, Jun/G-2376-2010; Tang, Jun/H-5964-2011; Tang, Jun/C-6958-2015	Ma, Jun/0000-0002-6127-000X; Tang, Jun/0000-0001-5942-9248	National Nature Science of Foundation of China [11105219]	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Nature Science of Foundation of China under the Grant No. 11105219 (JT) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini P, 2009, J BIOL PHYS, V35, P413, DOI 10.1007/s10867-009-9166-8; Amiri M, 2013, J COMPUT NEUROSCI, V34, P489, DOI 10.1007/s10827-012-0432-6; Amiri M, 2012, J COMPUT NEUROSCI, V33, P285, DOI 10.1007/s10827-012-0386-8; Amiri M, 2012, NEUROSCI RES, V72, P172, DOI 10.1016/j.neures.2011.11.006; Amiri M, 2012, J THEOR BIOL, V292, P60, DOI 10.1016/j.jtbi.2011.09.013; Amiri M, 2011, BIOL CYBERN, V105, P153, DOI 10.1007/s00422-011-0455-5; Amiri M, 2011, NEURAL COMPUT APPL, V20, P1131, DOI 10.1007/s00521-010-0479-0; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Di Garbo A, 2007, BIOSYSTEMS, V89, P74, DOI 10.1016/j.biosystems.2006.05.013; Di Garbo A, 2009, J BIOL PHYS, V35, P361, DOI 10.1007/s10867-009-9143-2; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; FELLIN T, 2006, J PHYSL, V21, P208, DOI DOI 10.1152/PHYSIOL.00161.2005; Gao Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051914; Gerstner W, 1996, PHYS REV LETT, V76, P1755, DOI 10.1103/PhysRevLett.76.1755; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kandel E.R., 1991, PRINC NEUROSCI; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Nadkarni S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.268101; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Perc M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026229; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pereira A, 2009, J BIOL PHYS, V35, P465, DOI 10.1007/s10867-009-9147-y; Postnov DE, 2007, BIOSYSTEMS, V89, P84, DOI 10.1016/j.biosystems.2006.04.012; Postnov DE, 2009, J BIOL PHYS, V35, P425, DOI 10.1007/s10867-009-9156-x; Postnov DE, 2008, J BIOL PHYS, V34, P441, DOI 10.1007/s10867-008-9070-7; Silchenko AN, 2008, BIOL CYBERN, V98, P61, DOI 10.1007/s00422-007-0196-7; Stamatakis M, 2006, J THEOR BIOL, V241, P649, DOI 10.1016/j.jtbi.2006.01.002; Tang J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046207; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Volman V, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00058; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	48	31	32	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80324	10.1371/journal.pone.0080324	http://dx.doi.org/10.1371/journal.pone.0080324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312211	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300010
J	Yang, YH; Zhao, J; Liu, P; Xing, HJ; Li, CC; Wei, GR; Kang, ZS				Yang, Yuheng; Zhao, Jing; Liu, Peng; Xing, Huijun; Li, Chaochao; Wei, Guorong; Kang, Zhensheng			Glycerol-3-Phosphate Metabolism in Wheat Contributes to Systemic Acquired Resistance against Puccinia striiformis f. sp tritici	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SALICYLIC-ACID; PLANT; RNAI; ACCUMULATION; PHOSPHATE; IMMUNITY; GENES; NHO1	Glycerol-3-phosphate (G3P) is a proposed regulator of plant defense signaling in basal resistance and systemic acquired resistance (SAR). The GLY1-encoded glycerol-3-phosphate dehydrogenase (G3PDH) and GLI1-encoded glycerol kinase (GK) are two key enzymes involved in the G3P biosynthesis in plants. However, their physiological importance in wheat defense against pathogens remains unclear. In this study, quantification analysis revealed that G3P levels were significantly induced in wheat leaves challenged by the avirulent Puccinia striiformis f. sp. tritici (Pst) race CYR23. The transcriptional levels of TaGLY1 and TaGLI1 were likewise significantly induced by avirulent Pst infection. Furthermore, knocking down TaGLY1 and TaGLI1 individually or simultaneously with barley stripe mosaic virus-induced gene silencing (BSMV-VIGS) inhibited G3P accumulation and compromised the resistance in the wheat cultivar Suwon 11, whereas the accumulation of salicylic acid (SA) and the expression of the SA-induced marker gene TaPR1 in plant leaves were altered significantly after gene silencing. These results suggested that G3P contributes to wheat systemic acquired resistance (SAR) against stripe rust, and provided evidence that the G3P function as a signaling molecule is conserved in dicots and monocots. Meanwhile, the simultaneous co-silencing of multiple genes by the VIGS system proved to be a powerful tool for multi-gene functional analysis in plants.	[Yang, Yuheng; Zhao, Jing; Liu, Peng; Xing, Huijun; Li, Chaochao; Wei, Guorong; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Yang, Yuheng; Zhao, Jing; Liu, Peng; Xing, Huijun; Li, Chaochao; Wei, Guorong; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Kang, ZS (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	kangzs@nwsuaf.edu.cn	Yang, Yuheng/J-9450-2019	Yang, Yuheng/0000-0003-2613-7091; Kang, Zhensheng/0000-0001-5575-0122	National Key Basic Research Program of China [2013CB127700]; Modern Agro-industry Technology Research System in China; National Natural Science Foundation of China [30930064]; 111 Project from the Ministry of Education of China [B07049]	National Key Basic Research Program of China(National Basic Research Program of China); Modern Agro-industry Technology Research System in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from the Ministry of Education of China(Ministry of Education, China - 111 Project)	This study was supported by the National Key Basic Research Program of China (2013CB127700), Modern Agro-industry Technology Research System in China, the National Natural Science Foundation of China (No. 30930064) and the 111 Project from the Ministry of Education of China (B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Chandra-Shekara AC, 2007, P NATL ACAD SCI USA, V104, P7277, DOI 10.1073/pnas.0609259104; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gust AA, 2012, NATURE, V486, P198, DOI 10.1038/486198a; Hammerschmidt R, 2009, ADV BOT RES, V51, P173, DOI 10.1016/S0065-2296(09)51005-1; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kang Z, 1984, ACTA CLLEGII SEPTENT, V4, P18; Li JR, 2012, PLANT BIOTECHNOL REP, V6, P183, DOI 10.1007/s11816-011-0213-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Schmid A, 2002, TRENDS NEUROSCI, V25, P71, DOI 10.1016/S0166-2236(02)02034-9; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; SHAH J, 2013, FRONT PLANT SCI, V4; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Venugopal SC, 2009, PLANT SIGNAL BEHAV, V4, P746, DOI 10.4161/psb.4.8.9111; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006	36	31	34	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81756	10.1371/journal.pone.0081756	http://dx.doi.org/10.1371/journal.pone.0081756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312351	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300049
J	Nakamura, M; Nishida, S; Hayashida, K; Ueki, Y; Dauvilliers, Y; Inoue, Y				Nakamura, Masaki; Nishida, Shingo; Hayashida, Kenichi; Ueki, Yoichiro; Dauvilliers, Yves; Inoue, Yuichi			Differences in Brain Morphological Findings between Narcolepsy with and without Cataplexy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SLEEP LATENCY TEST; GRAY-MATTER; HYPOTHALAMUS; AMYGDALA; NEURONS; CORTEX; WHITE	Objective: Maps of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) obtained by diffusion tensor imaging (DTI) can detect microscopic axonal changes by estimating the diffusivity of water molecules using magnetic resonance imaging (MRI). We applied an MRI voxel-based statistical approach to FA and ADC maps to evaluate microstructural abnormalities in the brain in narcolepsy and to investigate differences between patients having narcolepsy with and without cataplexy. Methods: Twelve patients with drug-naive narcolepsy with cataplexy (NA/CA), 12 with drug-naive narcolepsy without cataplexy (NA w/o CA) and 12 age-matched healthy normal controls (NC) were enrolled. FA and ADC maps for these 3 groups were statistically compared by using voxel-based one-way ANOVA. In addition, we investigated the correlation between FA and ADC values and clinical variables in the patient groups. Results: Compared to the NC group, the NA/CA group showed higher ADC values in the left inferior frontal gyrus and left amygdala, and a lower ADC value in the left postcentral gyrus. The ADC value in the right inferior frontal gyrus and FA value in the right precuneus were higher for NA/CA group than for the NA w/o CA group. However, no significant differences were observed in FA and ADC values between the NA w/o CA and NC groups in any of the areas investigated. In addition, no correlation was found between the clinical variables and ADC and FA values of any brain areas in these patient groups. Conclusions: Several microstructural changes were noted in the inferior frontal gyrus and amygdala in the NA/CA but not in the NA w/o CA group. These findings suggest that these 2 narcolepsy conditions have different pathological mechanisms: narcolepsy without cataplexy form appears to be a potentially broader condition without any significant brain imaging differences from normal controls.	[Nakamura, Masaki; Nishida, Shingo; Hayashida, Kenichi; Ueki, Yoichiro; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Nakamura, Masaki; Nishida, Shingo; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Dauvilliers, Yves] Hop Gui De Chauliac, Natl Reference Network Narcolepsy, Inserm U1061, Dept Neurol,UM1,Sleep Disorders Ctr, Montpellier, France	Tokyo Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Nakamura, M (corresponding author), Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan.	nakamura@somnology.com		Dauvilliers, yves/0000-0003-0683-6506	Japan Society for the Promotion of Science (JSPS) KAKENHI [21791161]; Grants-in-Aid for Scientific Research [23591739] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 21791161, Grant-in-Aid for Young Scientists (B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.jsps.go.jp/english/index.html	Alicata D, 2009, PSYCHIAT RES-NEUROIM, V174, P1, DOI 10.1016/j.pscychresns.2009.03.011; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; ASENBAUM S, 1995, J NUCL MED, V36, P1150; Bayard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033525; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Desseilles M, 2008, SLEEP, V31, P777, DOI 10.1093/sleep/31.6.777; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Gulyani S, 2002, NEUROSCIENCE, V112, P355, DOI 10.1016/S0306-4522(02)00089-1; Hagen T, 2007, NEURORADIOLOGY, V49, P921, DOI 10.1007/s00234-007-0272-7; Joo EY, 2005, NEUROIMAGE, V28, P410, DOI 10.1016/j.neuroimage.2005.06.019; Joo EY, 2004, ANN NEUROL, V56, P437, DOI 10.1002/ana.20212; Kaufmann C, 2002, NEUROLOGY, V58, P1852, DOI 10.1212/WNL.58.12.1852; Krumbholz K, 2009, HUM BRAIN MAPP, V30, P1457, DOI 10.1002/hbm.20615; Levens SM, 2011, NEUROPSYCHOLOGIA, V49, P3201, DOI 10.1016/j.neuropsychologia.2011.07.021; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Lodi R, 2004, NEUROLOGY, V63, P1513; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Marti I, 2009, SLEEP MED, V10, P1146, DOI 10.1016/j.sleep.2009.03.008; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2006, BRAIN, V129, P1609, DOI 10.1093/brain/awl079; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura M, 2011, J SLEEP RES, V20, P45, DOI 10.1111/j.1365-2869.2010.00870.x; Overeem S, 2003, SLEEP, V26, P44; Peyron C, 1998, J NEUROSCI, V18, P9996; Poryazova R, 2009, SLEEP, V32, P607, DOI 10.1093/sleep/32.5.607; Sasai T, 2009, SLEEP MED, V10, P961, DOI 10.1016/j.sleep.2008.12.007; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Scherfler C, 2012, SLEEP, V35, P345, DOI 10.5665/sleep.1692; Schwartz S, 2008, BRAIN, V131, P514, DOI 10.1093/brain/awm292; Sener RN, 2003, AM J NEURORADIOL, V24, P965; Siegel JM, 1999, J NEUROSCI, V19, P248, DOI 10.1523/JNEUROSCI.19-01-00248.1999; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Takei Y, 2011, CLIN NEUROPHYSIOL; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993	40	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81059	10.1371/journal.pone.0081059	http://dx.doi.org/10.1371/journal.pone.0081059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312261	gold, Green Submitted, Green Published			2022-12-25	WOS:000327657900021
J	Stout, RF; Grubisic, V; Parpura, V				Stout, Randy F., Jr.; Grubisic, Vladimir; Parpura, Vladimir			A Caenorhabditis elegans Locomotion Phenotype Caused by Transgenic Repeats of the hlh-17 Promoter Sequence	PLOS ONE			English	Article							C. ELEGANS; GLIAL-CELLS; GENE; PROTEIN; TRANSFORMATION; INTEGRATION; EXPRESSION; INDUCTION; MUTATION; NEURONS	Transgene technology is one of the most heavily relied upon tools in modern biological research. Expression of an exogenous gene within cells, for research and therapeutic applications, nearly always includes promoters and other regulatory sequences. We found that repeats of a non-protein coding transgenic sequence produced profound changes to the behavior of the nematode Caenorhabditis elegans. These changes were produced by a glial promoter sequence but, unexpectedly, major deficits were observed specifically in backward locomotion, a neuron-driven behavior. We also present evidence that this behavioral phenotype is transpromoter copy number-dependent and manifests early in development and is maintained into adulthood of the worm.	[Stout, Randy F., Jr.; Grubisic, Vladimir; Parpura, Vladimir] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Atom Force Microscopy & Nanot, Ctr Glial Biol Med,Dept Neurobiol, Birmingham, AL 35294 USA; [Parpura, Vladimir] Univ Rijeka, Dept Biotechnol, Rijeka, Croatia	University of Alabama System; University of Alabama Birmingham; University of Rijeka	Parpura, V (corresponding author), Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Atom Force Microscopy & Nanot, Ctr Glial Biol Med,Dept Neurobiol, Birmingham, AL 35294 USA.	vlad@uab.edu		Stout, Randy/0000-0003-2725-306X; Grubisic, Vladimir/0000-0003-1429-2844	National Science Foundation [CBET 0943343]	National Science Foundation(National Science Foundation (NSF))	Funding provided by National Science Foundation (CBET 0943343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Felton CM, 2011, J NEUROSCI RES, V89, P1627, DOI 10.1002/jnr.22694; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Kage-Nakadai E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-1; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kuroyanagi H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003337; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MADURO M, 1995, GENETICS, V141, P977; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; McMiller TL, 2005, GENE, V356, P1, DOI 10.1016/j.gene.2005.05.003; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; MILLER DM, 1993, GENETICS, V135, P741; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Praitis V, 2001, GENETICS, V157, P1217; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robert VJ, 2010, GENETICA, V138, P541, DOI 10.1007/s10709-009-9362-2; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Sekar RB, 2007, AM J PHYSIOL-HEART C, V293, pH2757, DOI 10.1152/ajpheart.00477.2007; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Sicot G, 2013, BBA-MOL BASIS DIS, V1832, P1390, DOI 10.1016/j.bbadis.2013.03.002; Spilker KA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-7; Stout RF, 2012, METHODS MOL BIOL, V814, P153, DOI 10.1007/978-1-61779-452-0_12; Stout RF, 2011, CELL CALCIUM, V50, P98, DOI 10.1016/j.ceca.2011.05.016; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; WALTHALL WW, 1995, J NEUROSCI, V15, P1035; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	41	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81771	10.1371/journal.pone.0081771	http://dx.doi.org/10.1371/journal.pone.0081771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312354	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900051
J	Sugihara, H; Ishimoto, T; Watanabe, M; Sawayama, H; Iwatsuki, M; Baba, Y; Komohara, Y; Takeya, M; Baba, H				Sugihara, Hidetaka; Ishimoto, Takatsugu; Watanabe, Masayuki; Sawayama, Hiroshi; Iwatsuki, Masaaki; Baba, Yoshifumi; Komohara, Yoshihiro; Takeya, Motohiro; Baba, Hideo			Identification of miR-30e*Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer	PLOS ONE			English	Article							CELL SELF-RENEWAL; COLORECTAL-CANCER; ACTIVATED MACROPHAGES; STEM-CELLS; PROGRESSION; MICRORNAS; PROLIFERATION; MARKER; INK4A	Bmi1 is overexpressed in a variety of human cancers including gastrointestinal cancer. The high expression level of Bmi1 protein is associated with poor prognosis of gastrointestinal cancer patients. On the other hand, tumor-associated macrophages (TAMs) contribute to tumor growth, invasion, and metastasis by producing various mediators in the tumor microenvironment. The aim of this study was to investigate TAM-mediated regulation of Bmi1 expression in gastrointestinal cancer. The relationship between TAMs and Bmi1 expression was analyzed by immunohistochemistry and quantitative real-time PCR (qRT-PCR), and results showed a positive correlation with tumor-infiltrating macrophages (CD68 and CD163) and Bmi1 expression in cancer cells. Co-culture with TAMs triggered Bmi1 expression in cancer cell lines and enhanced sphere formation ability. miRNA microarray analysis of a gastric cancer cell line co-cultured with macrophages was conducted, and using in silico methods to analyze the results, we identified miR-30e* as a potential regulator of Bmi1 expression. Luciferase assays using miR-30e* mimic revealed that Bmi1 was a direct target for miR-30e* by interactions with the putative miR-30e* binding sites in the Bmi1 3' untranslated region. qRT-PCR analysis of resected cancer specimens showed that miR-30e* expression was downregulated in tumor regions compared with non-tumor regions, and Bmi1 expression was inversely correlated with miR-30e* expression in gastric cancer tissues, but not in colon cancer tissues. Our findings suggest that TAMs may cause increased Bmi1 expression through miR-30e* suppression, leading to tumor progression. The suppression of Bmi1 expression mediated by TAMs may thus represent a possible strategy as the treatment of gastrointestinal cancer.	[Sugihara, Hidetaka; Ishimoto, Takatsugu; Watanabe, Masayuki; Sawayama, Hiroshi; Iwatsuki, Masaaki; Baba, Yoshifumi; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan	Kumamoto University; Kumamoto University	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp	Ishimoto, Takatsugu/AAP-1356-2020	Ishimoto, Takatsugu/0000-0003-1852-1835	Okukubo Memorial Fund for Medical Research at Kumamoto University School of Medicine; Japan Medical Association; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [26293290] Funding Source: KAKEN	Okukubo Memorial Fund for Medical Research at Kumamoto University School of Medicine; Japan Medical Association; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Okukubo Memorial Fund for Medical Research at Kumamoto University School of Medicine, Medical Research Encouragement Prize of the Japan Medical Association and a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (to TI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; HAUPT Y, 1993, ONCOGENE, V8, P3161; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepeler T, 2012, ONCOGENE, V31, P2750, DOI 10.1038/onc.2011.453; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	35	48	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81839	10.1371/journal.pone.0081839	http://dx.doi.org/10.1371/journal.pone.0081839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312366	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900054
J	Ushinsky, A; Reinhardt, LE; Simmons, AN; Strigo, IA				Ushinsky, Alexander; Reinhardt, Lindsay E.; Simmons, Alan N.; Strigo, Irina A.			Further Evidence of Emotional Allodynia in Unmedicated Young Adults with Major Depressive Disorder	PLOS ONE			English	Article							PAIN PERCEPTION; THERMAL GRILL; INDUCED MOOD; MECHANISMS; RESPONSES; KETAMINE; ILLUSION; STIMULI; VALENCE	Background: Recent evidence suggests that sensitivity to the emotional sequela of experimental thermal pain(measured by emotional unpleasantness) is heightened in individuals with major depressive disorder(MDD), a phenomenon we termed "emotional allodynia". The aim of this study was to examine whether acute happy and sad mood induction alters emotional allodynia in MDD. We hypothesized that emotional allodynia will be a robust characteristic of individuals with MDD compared to healthy controls. Thus, it would remain following acute mood induction, independent of valence. Methods: Twenty-one subjects with current MDD and 21 well-matched healthy subjects(HC) received graded brief temperature stimuli following happy and sad mood inductions procedures(MIP). All subjects rated the intensity and affect(pleasantness/unpleasantness) of each stimulus. Sensory(pain intensity) and affective(pain unpleasantness) thresholds were determined by methods of constant stimuli. Results: The MIPs reliably induced happy and sad mood and the resulting induced mood and subjective arousal were not different between the groups at the time of temperature stimulation. Compared to HC, MDD individuals demonstrated emotional allodynia. We found significantly decreased affective pain thresholds whereby significantly lower temperatures became unpleasant in the MDD compared to the HC group. This was not observed for the sensory pain thresholds. Within the MDD, the affective pain thresholds were significantly lower than the corresponding pain intensity thresholds, whereby non-painful temperatures were already unpleasant for the MDD irrespective of the induced mood. This was not observed for the HC groups where the affective and pain intensity thresholds were comparable. Conclusions: These findings suggest that emotional allodynia may be a chronic characteristic of current MDD. Future studies should determine if emotional allodynia persists after psychological or pharmacological interventions. Finally, longitudinal work should examine whether emotional allodynia is a result of or vulnerability for depression and the role it plays in the increased susceptibility for pain complaints in this disorder.	[Ushinsky, Alexander; Simmons, Alan N.; Strigo, Irina A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Reinhardt, Lindsay E.; Simmons, Alan N.; Strigo, Irina A.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Strigo, Irina A.] BCI, La Jolla, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strigo, IA (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	istrigo@ucsd.edu	strigo, irina A/L-9882-2016; Simmons, Alan/A-9815-2008	strigo, irina A/0000-0002-8799-716X; Simmons, Alan/0000-0003-3963-2112	National Institutes of Health (NIH) [MH080003]; Veterans Administration via Center of Excellence in Stress and Mental Health; CS RD Merit Grant [1I01CX000292-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080003, R00MH080003] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration via Center of Excellence in Stress and Mental Health; CS RD Merit Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a National Institutes of Health (NIH) grant [MH080003] to IAS, Veterans Administration via Center of Excellence in Stress and Mental Health to ANS and IAS and CS R&D Merit Grant [1I01CX000292-01A1] to ANS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER G, 1993, BIOL PSYCHIAT, V34, P687, DOI 10.1016/0006-3223(93)90041-B; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bar KJ, 2005, PAIN, V117, P97, DOI 10.1016/j.pain.2005.05.016; Bar KJ, 2003, J PSYCHIATR RES, V37, P345, DOI 10.1016/S0022-3956(03)00051-7; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014; Boettger MK, 2013, PSYCHOSOM MED; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Craig ADB, 2004, PROG PAIN RES MANAG, V30, P311; DAVIS GC, 1979, AM J PSYCHIAT, V136, P1148; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; First M. B., 1997, STRUCTURED CLIN INTE; Gormsen L, 2004, EUR J PAIN, V8, P487, DOI 10.1016/j.ejpain.2003.11.015; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Klauenberg S, 2008, PAIN, V140, P332, DOI 10.1016/j.pain.2008.09.003; LAUTENBACHER S, 1994, J PSYCHIAT RES, V28, P109, DOI 10.1016/0022-3956(94)90023-X; Lautenbacher S, 1999, PSYCHOSOM MED, V61, P822, DOI 10.1097/00006842-199911000-00015; Lepine JP, 2004, HUM PSYCHOPHARM CLIN, V19, pS3, DOI 10.1002/hup.618; Loggia ML, 2008, J PAIN, V9, P784, DOI 10.1016/j.jpain.2008.03.014; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; MELZACK R, 1968, P423; MERSKEY H, 1965, J PSYCHOSOM RES, V8, P405, DOI 10.1016/0022-3999(65)90083-8; Merskey H., 1994, IASP TERMINOLOGY IAS; Naisberg Y, 1996, MED HYPOTHESES, V47, P415, DOI 10.1016/S0306-9877(96)90152-8; Pinerua-Shuhaibar L, 1999, J AFFECT DISORDERS, V56, P119, DOI 10.1016/S0165-0327(99)00051-8; Pinerua-Shuhaibar L, 2011, J PAIN, V12, P360, DOI 10.1016/j.jpain.2010.08.002; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Rhudy JL, 2008, PAIN, V136, P250, DOI 10.1016/j.pain.2007.06.031; SNAITH P, 1993, PSYCHOL MED, V23, P957, DOI 10.1017/S0033291700026428; Strigo IA, 2002, PAIN, V97, P235, DOI 10.1016/S0304-3959(02)00023-4; Strigo IA, 2005, PAIN, V113, P255, DOI 10.1016/j.pain.2004.10.023; Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.0b013e3181656a48; Suarez-Roca H, 2003, J PSYCHOSOM RES, V55, P253, DOI 10.1016/S0022-3999(02)00498-1; Terhaar J, 2009, EUR J PAIN, V14, P4; VONKNORRING L, 1978, BIOL PSYCHOL, V6, P27, DOI 10.1016/0301-0511(78)90004-2; Wagner G, 2009, NEUROPSYCHOLOGIA, V47, P980, DOI 10.1016/j.neuropsychologia.2008.10.021; Walsh T. M., 1998, PAIN RES MANAG, V3, P135; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Zautra AJ, 2010, PAIN, V149, P12, DOI 10.1016/j.pain.2009.10.001; ZELMAN DC, 1991, PAIN, V46, P105, DOI 10.1016/0304-3959(91)90040-5	47	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80507	10.1371/journal.pone.0080507	http://dx.doi.org/10.1371/journal.pone.0080507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261IJ	24312229	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900011
J	de Matos, AL; McFadden, G; Esteves, PJ				de Matos, Ana Lemos; McFadden, Grant; Esteves, Pedro J.			Positive Evolutionary Selection On the RIG-I-Like Receptor Genes in Mammals	PLOS ONE			English	Article							AMINO-ACID SITES; INNATE IMMUNE RECOGNITION; DOUBLE-STRANDED-RNA; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; HELICASE; MDA5; INTERFERON; VIRUS; LGP2	The mammalian RIG-I-like receptors, RIG-I, MDA5 and LGP2, are a family of DExD/H box RNA helicases responsible for the cytoplasmic detection of viral RNA. These receptors detect a variety of RNA viruses, or DNA viruses that express unusual RNA species, many of which are responsible for a great number of severe and lethal diseases. Host innate sentinel proteins involved in pathogen recognition must rapidly evolve in a dynamic arms race with pathogens, and thus are subjected to long-term positive selection pressures to avoid potential infections. Using six codon-based Maximum Likelihood methods, we were able to identify specific codons under positive selection in each of these three genes. The highest number of positively selected codons was detected in MDA5, but a great percentage of these codons were located outside of the currently defined protein domains for MDA5, which likely reflects the imposition of both functional and structural constraints. Additionally, our results support LGP2 as being the least prone to evolutionary change, since the lowest number of codons under selection was observed for this gene. On the other hand, the preponderance of positively selected codons for RIG-I were detected in known protein functional domains, suggesting that pressure has been imposed by the vast number of viruses that are recognized by this RNA helicase. Furthermore, the RIG-I repressor domain, the region responsible for recognizing and binding to its RNA substrates, exhibited the strongest evidence of selective pressures. Branch-site analyses were performed and several species branches on the three receptor gene trees showed evidence of episodic positive selection. In conclusion, by looking for evidence of positive evolutionary selection on mammalian RIG-I-like receptor genes, we propose that a multitude of viruses have crafted the receptors biological function in host defense, specifically for the RIG-I gene, contributing to the innate species-specific resistance/susceptibility to diverse viral pathogens.	[de Matos, Ana Lemos; Esteves, Pedro J.] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [de Matos, Ana Lemos] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Porto, Portugal; [de Matos, Ana Lemos; McFadden, Grant] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Esteves, Pedro J.] Inst Invest & Formacao Avancada Ciencias & Tecnol, CESPU, Gandra, Portugal	Universidade do Porto; Universidade do Porto; State University System of Florida; University of Florida	Esteves, PJ (corresponding author), Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	pjesteves@cibio.up.pt	Esteves, Pedro J/A-7537-2010	Esteves, Pedro J/0000-0002-6055-8298; McFadden, Grant/0000-0002-2556-3526	Portuguese Foundation for Science and Technology [PTDC/BIA-BEC/103158/2008, FCT-ANR/BIA-BIC/0043/2012]; ALM [SFRH/BD/48566/2008]; "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme 2007/2013 (ON. 2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ALM; "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme 2007/2013 (ON. 2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF)	The Portuguese Foundation for Science and Technology supported the doctoral fellowship of ALM (SFRH/BD/48566/2008). Two research projects from the Portuguese Foundation for Science and Technology (PTDC/BIA-BEC/103158/2008 and FCT-ANR/BIA-BIC/0043/2012) also funded the study. "Genomics Applied To Genetic Resources" cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON. 2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berke IC, 2013, CELL MICROBIOL, V15, P386, DOI 10.1111/cmi.12061; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; de Matos AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-121; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Grayson Phil, 2012, Int J Evol Biol, V2012, P958164, DOI 10.1155/2012/958164; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jann OC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-288; Jiggins FM, 2003, J MOL EVOL, V57, P598, DOI 10.1007/s00239-003-2506-6; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Machado JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-342; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nakajima T, 2008, IMMUNOGENETICS, V60, P727, DOI 10.1007/s00251-008-0332-0; NEVES F, INNATE IMMUN; Nielsen R, 1998, GENETICS, V148, P929; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; PINHEIRO A, 2013, PLOS ONE IN PRESS; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scheffler K, 2005, MOL BIOL EVOL, V22, P2531, DOI 10.1093/molbev/msi250; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2012, EUR J CELL BIOL, V91, P78, DOI 10.1016/j.ejcb.2011.01.015; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Smith JM, 1996, GENETICS, V142, P1033; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Vasseur E, 2011, HUM MOL GENET, V20, P4462, DOI 10.1093/hmg/ddr377; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Wlasiuk G, 2009, MOL BIOL EVOL, V26, P937, DOI 10.1093/molbev/msp018; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zwickl D., 2006, GARLI GENETIC ALGORI	88	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81864	10.1371/journal.pone.0081864	http://dx.doi.org/10.1371/journal.pone.0081864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312370	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100103
J	Gupta, S; Hau, AM; Beach, JR; Harwalker, J; Mantuano, E; Gonias, SL; Egelhoff, TT; Hansel, DE				Gupta, Sounak; Hau, Andrew M.; Beach, Jordan R.; Harwalker, Jyoti; Mantuano, Elisabetta; Gonias, Steven L.; Egelhoff, Thomas T.; Hansel, Donna E.			Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL MOTILITY; ACTIVATION; GROWTH; RHOA; CYTOSKELETON; METASTASIS; ADHESION; PATHWAY; RICTOR	Bladder cancer is the fourth most common cause of cancer in males in the United States. Invasive behavior is a major determinant of prognosis. In this study, we identified mammalian target of rapamycin complex 2 (mTORC2) as a central regulator of bladder cancer cell migration and invasion. mTORC2 activity was assessed by the extent of phosphorylation of Ser473 in AKT and determined to be approximately 5-fold higher in specimens of invasive human bladder cancer as opposed to non-invasive human bladder cancer. The immortalized malignant bladder cell lines, UMUC-3, J82 and T24 demonstrated higher baseline mTORC2 activity relative to the benign bladder papilloma-derived cell line RT4 and the normal urothelial cell line HU1. The malignant bladder cancer cells also demonstrated increased migration in transwell and denudation assays, increased invasion of matrigel, and increased capacity to invade human bladder specimens. Gene silencing of rictor, a critical component of mTORC2, substantially inhibited bladder cancer cell migration and invasion. This was accompanied by a significant decrease in Rac1 activation and paxillin phosphorylation. These studies identify mTORC2 as a major target for neutralizing bladder cancer invasion.	[Gupta, Sounak; Hau, Andrew M.; Mantuano, Elisabetta; Gonias, Steven L.; Hansel, Donna E.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Beach, Jordan R.; Egelhoff, Thomas T.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Harwalker, Jyoti] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA	University of California System; University of California San Diego; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hansel, DE (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dhansel@ucsd.edu	Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261; Beach, Jordan/0000-0003-0633-4928	Case Western Reserve University/Cleveland Clinic CTSA from the National Cancer Institute [UL1 RR024989]; KL2 career development award [RR024990]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050009] Funding Source: NIH RePORTER	Case Western Reserve University/Cleveland Clinic CTSA from the National Cancer Institute; KL2 career development award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Case Western Reserve University/Cleveland Clinic CTSA Grant Number UL1 RR024989 from the National Cancer Institute, and a KL2 career development award (RR024990) to D.E. Hansel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hussain TO, 2013, ADV ANAT PATHOL, V20, P53, DOI 10.1097/PAP.0b013e31827bd0ec; American Cancer Society, 2013, CANC FACTS FIG 2013; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Cheng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057284; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Eble J.N, 2004, PATHOLOGY GENETICS T; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hansel DE, 2010, AM J PATHOL, V176, P3062, DOI 10.2353/ajpath.2010.090872; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamat AM, 2011, ONCOLOGY-NY, V25, P951; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Koromilas AE, 2011, FUTURE ONCOL, V7, P845, DOI [10.2217/FON.11.59, 10.2217/fon.11.59]; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Li HY, 2012, BREAST CANCER RES TR, V134, P1057, DOI 10.1007/s10549-012-2036-2; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; Watts KE, 2012, UROLOGY, V80, P361, DOI 10.1016/j.urology.2012.04.010; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yu L, 2013, ONCOGENE; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhu ZH, 2013, INT J ONCOL, V42, P1271, DOI 10.3892/ijo.2013.1807; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	38	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81081	10.1371/journal.pone.0081081	http://dx.doi.org/10.1371/journal.pone.0081081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312263	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100059
J	Hosek, J; Vanco, J; Starha, P; Parakova, L; Travnicek, Z				Hosek, Jan; Vanco, Jan; Starha, Pavel; Parakova, Lenka; Travnicek, Zdenek			Effect of 2-Chloro-Substitution of Adenine Moiety in Mixed-Ligand Gold(I) Triphenylphosphine Complexes on Anti-Inflammatory Activity: The Discrepancy between the In Vivo and In Vitro Models	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITIES; ANTICANCER THERAPEUTICS; CRYSTAL-STRUCTURES; X-RAY; AURANOFIN; PHOSPHINE; MECHANISM; COMPOUND; CELLS; CYTOTOXICITY	A series of gold(I) triphenylphosphine (PPh3) complexes (1-9) involving 2-chloro-N6-(substituted-benzyl) adenine derivatives as N-donor ligands was synthesized and thoroughly characterized by relevant methods, including electrospray-ionization (ESI) mass spectrometry and multinuclear NMR spectroscopy. The anti-inflammatory and antiedematous effects of three representatives 1, 5 and 9 were evaluated by means of in vitro model based on the expression of pro-and anti-inflammatory cytokines and influence of the complexes on selected forms of matrix metalloproteinases secreted by LPS-activated THP-1 monocytes and in vivo model evaluating the antiedematous effect of the complexes in the carrageenan-induced rat hind-paw edema model. In addition to the pharmacological observations, the affected hind paws were post mortem subjected to histological and immunohistochemical evaluations. The results of both in vivo and ex vivo methods revealed low antiedematous and anti-inflammatory effects of the complexes, even though the in vitro model identified them as promising anti-inflammatory acting compounds. The reason for this discrepancy lies probably in low stability of the studied complexes in biological environment, as demonstrated by the solution interaction studies with sulfur-containing biomolecules (cysteine and reduced glutathione) using the ESI mass spectrometry.	[Hosek, Jan; Vanco, Jan; Starha, Pavel; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Parakova, Lenka] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic	Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Parakova, Lenka/AGZ-4403-2022; Vanco, Jan/H-2705-2013; Starha, Pavel/H-3902-2016; Hosek, Jan/B-6274-2009	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Starha, Pavel/0000-0003-0422-045X; Travnicek, Zdenek/0000-0002-5890-7874	Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0017]; Palacky University [PrF_2013_015]	Operational Program Research and Development for Innovations - European Regional Development Fund; Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Palacky University	The authors would like to thank the Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), the Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0017)and Palacky University (Student project PrF_2013_015) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro E, 2008, INORG CHEM, V47, P6262, DOI 10.1021/ic800314p; Bruce MI, 1996, J ORGANOMET CHEM, V518, P121, DOI 10.1016/0022-328X(96)06195-5; BRUCE MI, 1989, INORG SYN, V26, P324, DOI 10.1002/9780470132579.ch59; Buac D, 2012, MINI-REV MED CHEM, V12, P1193, DOI 10.2174/138955712802762040; Cajan M, 2011, J MOL STRUCT, V994, P350, DOI 10.1016/j.molstruc.2011.03.049; Cao ZY, 2013, J AM CHEM SOC, V135, P8197, DOI 10.1021/ja4040895; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Coppi G, 1989, Boll Chim Farm, V128, P22; Demirovic D, 2013, EXP GERONTOL, V48, P94, DOI 10.1016/j.exger.2012.02.005; Gandin V, 2010, BIOCHEM PHARMACOL, V79, P90, DOI 10.1016/j.bcp.2009.07.023; GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0; GIRARD GR, 1989, INORG CHIM ACTA, V166, P141, DOI 10.1016/S0020-1693(00)80799-9; Hedstrom E, 2009, CELL CYCLE, V8, P3584, DOI 10.4161/cc.8.21.9977; HOKE GD, 1991, MOL PHARMACOL, V39, P90; HOKE GD, 1989, TOXICOL APPL PHARM, V99, P50, DOI 10.1016/0041-008X(89)90110-5; HOKE GD, 1988, J BIOL CHEM, V263, P11203; Iqbal MS, 2009, BIOL TRACE ELEM RES, V130, P204, DOI 10.1007/s12011-009-8330-0; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Kiernan J, 2008, HISTOLOGICAL HISTOCH; Kim NH, 2007, IMMUNOLOGY, V122, P607, DOI 10.1111/j.1365-2567.2007.02679.x; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Kostova Irena, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P19, DOI 10.2174/187152006774755500; Lee M T, 1989, J Enzyme Inhib, V3, P35, DOI 10.3109/14756368909030362; Lemoine P, 2004, J INORG BIOCHEM, V98, P1734, DOI 10.1016/j.jinorgbio.2004.07.010; LEWIS D, 1983, ANN RHEUM DIS, V42, P566, DOI 10.1136/ard.42.5.566; Lima JC, 2011, ANTI-CANCER AGENT ME, V11, P921; Liu B, 2013, J AM CHEM SOC, V135, P3323, DOI 10.1021/ja3110472; Mackowiak M, 2005, PHARMACOL REP, V57, P845; Mann FG, 1937, J CHEM SOC, P1828, DOI 10.1039/jr9370001828; Navarro M, 2009, COORDIN CHEM REV, V253, P1619, DOI 10.1016/j.ccr.2008.12.003; Nomiya K, 2000, J INORG BIOCHEM, V78, P363, DOI 10.1016/S0162-0134(00)00065-9; Nomiya K, 2003, J INORG BIOCHEM, V95, P208, DOI 10.1016/S0162-0134(03)00125-9; Oh CH, 1999, ARCH PHARM, V332, P187, DOI 10.1002/(SICI)1521-4184(19996)332:6<187::AID-ARDP187>3.0.CO;2-D; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Ott I, 2009, J MED CHEM, V52, P763, DOI 10.1021/jm8012135; Pencikova K, 2012, PHYTOMEDICINE, V19, P890, DOI 10.1016/j.phymed.2012.04.001; Pouchert C., 1981, ALDRICH LIB INFRARED; Pradal A, 2011, SYNTHESIS-STUTTGART, P1501, DOI 10.1055/s-0030-1258465; Rackham O, 2007, BIOCHEM PHARMACOL, V74, P992, DOI 10.1016/j.bcp.2007.07.022; Saccoccia F, 2012, J INORG BIOCHEM, V108, P105, DOI 10.1016/j.jinorgbio.2011.11.005; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Schoniger W., 1956, MIKROCHIM ACTA, V44, P869, DOI [DOI 10.1007/BF01262130, 10.1007/BF01262130]; Seitz M, 2003, J CLIN IMMUNOL, V23, P477, DOI 10.1023/B:JOCI.0000010424.41475.17; SHAW CF, 1988, J AM CHEM SOC, V110, P729, DOI 10.1021/ja00211a011; SMITH PF, 1989, J PHARMACOL EXP THER, V249, P944; SORENSON JRJ, 1976, J MED CHEM, V19, P135, DOI 10.1021/jm00223a024; TALHOUK RS, 1991, DEVELOPMENT, V112, P439; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Travnicek Z, 2012, J MED CHEM, V55, P4568, DOI 10.1021/jm201416p; Vergara E, 2010, CHEMMEDCHEM, V5, P96, DOI 10.1002/cmdc.200900370; VONNAGELI CW, 1893, UEBER OLIGODYNAMISCH, P51; WILLIAMS HJ, 1992, ARTHRITIS RHEUM, V35, P259, DOI 10.1002/art.1780350304; Youn HS, 2006, BIOCHEM BIOPH RES CO, V350, P866, DOI 10.1016/j.bbrc.2006.09.097; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	55	9	9	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82441	10.1371/journal.pone.0082441	http://dx.doi.org/10.1371/journal.pone.0082441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312423	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100117
J	Morchikh, M; Naughtin, M; Di Nunzio, F; Xavier, J; Charneau, P; Jacob, Y; Lavigne, M				Morchikh, Mehdi; Naughtin, Monica; Di Nunzio, Francesca; Xavier, Johan; Charneau, Pierre; Jacob, Yves; Lavigne, Marc			TOX4 and NOVA1 Proteins Are Partners of the LEDGF PWWP Domain and Affect HIV-1 Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRE-MESSENGER-RNA; TRANSCRIPTIONAL COACTIVATOR P75; SMALL-MOLECULE INHIBITORS; HOST MITOTIC CHROMOSOMES; INTEGRATION IN-VITRO; STRESS-RELATED GENES; DNA INTEGRATION; GROWTH-FACTOR; BINDING PROTEIN	PWWP domains are involved in the chromatin attachment of several proteins. They bind to both DNA and proteins and their interaction with specific histone methylation marks define them as a new class of histone code readers. The lens epithelium derived growth factor (LEDGF/p75) contains an N-terminal PWWP domain necessary for its interaction with chromatin but also a C-terminal domain which interacts with several proteins, such as lentiviral integrases. These two domains confer a chromatin-tethering function to LEDGF/p75 and in the case of lentiviral integrases, this tethering participates in the efficiency and site selectivity of integration. Although proteins interacting with LEDGF/p75 C-terminal domain have been extensively studied, no data exist about partners of its PWWP domain regulating its interaction with chromatin. In this study, we report the identification by yeast-two-hybrid of thirteen potential partners of the LEDGF PWWP domain. Five of these interactions were confirmed in mammalian cells, using both a protein complementation assay and co-immunoprecipitation approaches. Three of these partners interact with full length LEDGF/p75, they are specific for PWWP domains of the HDGF family and they require PWWP amino acids essential for the interaction with chromatin. Among them, the transcription activator TOX4 and the splicing cofactor NOVA1 were selected for a more extensive study. These two proteins or their PWWP interacting regions (PIR) colocalize with LEDGF/p75 in Hela cells and interact in vitro in the presence of DNA. Finally, single round VSV-G pseudotyped HIV-1 but not MLV infection is inhibited in cells overexpressing these two PIRs. The observed inhibition of infection can be attributed to a defect in the integration step. Our data suggest that a regulation of LEDGF interaction with chromatin by cellular partners of its PWWP domain could be involved in several processes linked to LEDGF tethering properties, such as lentiviral integration, DNA repair or transcriptional regulation.	[Morchikh, Mehdi; Naughtin, Monica; Xavier, Johan; Lavigne, Marc] Ecole Normale Super Lyon, CNRS, Lab Joliot Curie, F-69364 Lyon, France; [Morchikh, Mehdi; Lavigne, Marc] Inst Pasteur, CNRS, Unite Virol Struct, Unite Rech Associee, Paris, France; [Morchikh, Mehdi] Univ Paris 06, Paris, France; [Di Nunzio, Francesca; Charneau, Pierre] Inst Pasteur, Unite Virol Mol & Vaccinol, CNRS, Paris, France; [Jacob, Yves] Inst Pasteur, Unite Genet Mol Virus ARN, CNRS, Paris, France; [Jacob, Yves] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Jacob, Yves] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Lavigne, M (corresponding author), Ecole Normale Super Lyon, CNRS, Lab Joliot Curie, F-69364 Lyon, France.	marc.lavigne@ens-lyon.fr	CHARNEAU, Pierre/M-1565-2017; Di Nunzio, Francesca/A-6153-2014	CHARNEAU, Pierre/0000-0003-1184-5773; Di Nunzio, Francesca/0000-0003-2879-3164; LAVIGNE, Marc/0000-0002-3131-2539; Jacob, Yves/0000-0001-9125-2374	Agence Nationale de la Recherche sur le SIDA et les hepatites [AO 2011-1]; Centre National de la Recherche Scientifique (CNRS, Missions Interdisciplinaires); Ecole Normale Superieure de Lyon (ENS); Ministere de la recherche et de l'enseignement superieur; Pierre Berge fundation; Pasteur Weizman fundation; CNRS; SIDACTION; ANRS	Agence Nationale de la Recherche sur le SIDA et les hepatites(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS, Missions Interdisciplinaires); Ecole Normale Superieure de Lyon (ENS); Ministere de la recherche et de l'enseignement superieur; Pierre Berge fundation; Pasteur Weizman fundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); SIDACTION; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the Agence Nationale de la Recherche sur le SIDA et les hepatites (AO 2011-1), Centre National de la Recherche Scientifique (CNRS, Missions Interdisciplinaires) and Ecole Normale Superieure de Lyon (ENS). MM was funded by the Ministere de la recherche et de l'enseignement superieur, Pierre Berge and Pasteur Weizman fundations. MN was funded by the CNRS and ENS and FDN by SIDACTION. JX is funded by the ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, J VIROL, V70, P3571, DOI 10.1128/JVI.70.6.3571-3580.1996; Aliahmad P, 2012, CURR OPIN IMMUNOL, V24, P173, DOI 10.1016/j.coi.2011.12.001; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; BORMAN AM, 1995, J VIROL, V69, P2058, DOI 10.1128/JVI.69.4.2058-2067.1995; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Brown SJ, 2012, HUM MOL GENET, V21, pR90, DOI 10.1093/hmg/dds353; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Desfarges S, 2010, VIRUSES-BASEL, V2, P111, DOI 10.3390/v2010111; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Fromont-Racine M, 2002, METHOD ENZYMOL, V350, P513, DOI 10.1016/S0076-6879(02)50982-4; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Gunderson FQ, 2011, P NATL ACAD SCI USA, V108, P2004, DOI 10.1073/pnas.1011982108; Hayouka Z, 2010, BIOORGAN MED CHEM, V18, P8388, DOI 10.1016/j.bmc.2010.09.046; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hindmarsh P, 1999, J VIROL, V73, P2994, DOI 10.1128/JVI.73.4.2994-3003.1999; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Joshi SR, 2012, NUCLEIC ACIDS RES, V40, P10161, DOI 10.1093/nar/gks815; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Lee SJ, 2009, EXP MOL MED, V41, P189, DOI 10.3858/emm.2009.41.3.022; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Llano M, 2006, J MOL BIOL; Llano M, 2006, SCIENCE; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Maltby VE, 2012, MOL CELL BIOL, V32, P3479, DOI 10.1128/MCB.00389-12; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522; Moisy D, 2012, J VIROL, V86, P9122, DOI 10.1128/JVI.00789-12; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Musunuru K, 2004, NUCLEIC ACIDS RES, V32, P4852, DOI 10.1093/nar/gkh799; Nameki N, 2005, PROTEIN SCI, V14, P756, DOI 10.1110/ps.04975305; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Park E, 2011, J BIOL CHEM, V286, P25301, DOI 10.1074/jbc.M110.206540; Park E, 2009, J BIOL CHEM, V284, P12792, DOI 10.1074/jbc.M807386200; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Qiu Y, 2012, BIOCHEM J, V442, P527, DOI 10.1042/BJ20111885; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Rowell JP, 2012, STRUCTURE, V20, P2014, DOI 10.1016/j.str.2012.09.004; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Sue SC, 2004, J MOL BIOL, V343, P1365, DOI 10.1016/j.jmb.2004.09.014; Sue SC, 2007, J MOL BIOL, V367, P456, DOI 10.1016/j.jmb.2007.01.010; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Sy SMH, 2010, NUCLEUS-AUSTIN, V1, P472, DOI 10.4161/nucl.1.6.13059; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Velasco G, 2006, J BIOL CHEM, V281, P16546, DOI 10.1074/jbc.M600573200; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang LL, 2012, CANCER BIOTHER RADIO, V27, P329, DOI 10.1089/cbr.2012.1199; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06	121	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81217	10.1371/journal.pone.0081217	http://dx.doi.org/10.1371/journal.pone.0081217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312278	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100065
J	Nielsen, NO; Strom, M; Boyd, HA; Andersen, EW; Wohlfahrt, J; Lundqvist, M; Cohen, A; Hougaard, DM; Melbye, M				Nielsen, Nina O.; Strom, Marin; Boyd, Heather A.; Andersen, Elisabeth W.; Wohlfahrt, Jan; Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.; Melbye, Mads			Vitamin D Status during Pregnancy and the Risk of Subsequent Postpartum Depression: A Case-Control Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D DEFICIENCY; D-RECEPTOR; SYMPTOMS; ASSOCIATION; MORTALITY; COHORT; WOMEN; TIME	Epidemiological studies have provided evidence of an association between vitamin D insufficiency and depression and other mood disorders, and a role for vitamin D in various brain functions has been suggested. We hypothesized that low vitamin D status during pregnancy might increase the risk of postpartum depression (PPD). The objective of the study was thus to determine whether low vitamin D status during pregnancy was associated with postpartum depression. In a case-control study nested in the Danish National Birth Cohort, we measured late pregnancy serum concentrations of 25[OH]D3 in 605 women with PPD and 875 controls. Odds ratios [OR) for PPD were calculated for six levels of 25[OH]D3. Overall, we found no association between vitamin D concentrations and risk of PPD (p = 0.08). Compared with women with vitamin D concentrations between 50 and 79 nmol/L, the adjusted odds ratios for PPD were 1.35 (95% CI: 0.64; 2.85), 0.83 (CI: 0.50; 1.39) and 1.13 (CI: 0.84; 1.51) among women with vitamin D concentrations < 15 nmol/L, 1524 nmol/L and 2549 nmol/L, respectively, and 1.53 (CI: 1.04; 2.26) and 1.89 (CI: 1.06; 3.37) among women with vitamin D concentrations of 8099 nmol/L and = 100 nmol/L, respectively. In an additional analysis among women with sufficient vitamin D (= 50 nmol/L), we observed a significant positive association between vitamin D concentrations and PPD. Our results did not support an association between low maternal vitamin D concentrations during pregnancy and risk of PPD. Instead, an increased risk of PPD was found among women with the highest vitamin D concentrations	[Nielsen, Nina O.; Strom, Marin; Boyd, Heather A.; Andersen, Elisabeth W.; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Nielsen, Nina O.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	Statens Serum Institut; University of Southern Denmark; Statens Serum Institut	Nielsen, NO (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	noni@niph.dk	Hougaard, David/AAD-6368-2019	Boyd, Heather/0000-0001-6849-9985; Nielsen, Nina Odgaard/0000-0001-6127-5970; Strom, Marin/0000-0003-1926-6610; melbye, mads/0000-0001-8264-6785	Danish Research Council for Health and Disease [10-094025]; Lundbeck Foundation [R67-A6489]	Danish Research Council for Health and Disease; Lundbeck Foundation(Lundbeckfonden)	The Danish National Birth Cohort was established by the Danish Epidemiology Science Centre, Department of Epidemiology, Institute of Public Health, University of Aarhus, Denmark, and funded by Danish National Research Foundation, Danish Pharmaceutical Association, Ministry of Health, National Board of Health, Statens Serum Institut, BIOMED, March of Dimes Birth Defects Foundation, Danish Heart Association, Danish Medical Research Council, Egmont Foundation, Augustinus Foundation, the Health Foundation and the European Union (QLK1-2000-00 083). The present study was funded by a 1-year research grant from the Danish Research Council for Health and Disease (10-094025) and the Lundbeck Foundation (R67-A6489). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; Beck CT, 1995, NURS RES, V44, P298, DOI 10.1097/00006199-199509000-00007; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Chun RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030773; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; EMERSON DL, 1983, AM J REPROD IMMUNOL, V4, P185, DOI 10.1111/j.1600-0897.1983.tb00276.x; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Glade MJ, 2012, NUTRITION, V28, P344, DOI 10.1016/j.nut.2011.11.006; Heaney RP, 2008, NUTR REV, V66, pS178, DOI 10.1111/j.1753-4887.2008.00102.x; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Lansdowne ATG, 1998, PSYCHOPHARMACOLOGY, V135, P319, DOI 10.1007/s002130050517; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Miller GJ, 1995, CLIN CANCER RES, V1, P997; Murphy Pamela K, 2010, J Am Psychiatr Nurses Assoc, V16, P170, DOI 10.1177/1078390310370476; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Penckofer Sue, 2010, Issues Ment Health Nurs, V31, P385, DOI 10.3109/01612840903437657; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544; Shipowick CD, 2009, APPL NURS RES, V22, P221, DOI 10.1016/j.apnr.2007.08.001; Sit D, 2011, DEPRESS ANXIETY, V28, P400, DOI 10.1002/da.20807; Strom M, 2009, J CLIN PSYCHIAT, V70, P1707, DOI 10.4088/JCP.09m05012blu; Sylven SM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.022; Tatano C, 2008, MCN-AM J MATERN-CHIL, V33, P121, DOI 10.1097/01.NMC.0000313421.97236.cf; Thielen K, 2009, ACTA PSYCHIAT SCAND, V119, P312, DOI 10.1111/j.1600-0447.2008.01282.x; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8; Villegas L, 2011, J RURAL HEALTH, V27, P278, DOI 10.1111/j.1748-0361.2010.00339.x; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c	43	46	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80686	10.1371/journal.pone.0080686	http://dx.doi.org/10.1371/journal.pone.0080686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312237	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100050
J	O'Leary, C; Cole, SJ; Langford, M; Hewage, J; White, A; Cooper, HM				O'Leary, Conor; Cole, Stacey J.; Langford, Michael; Hewage, Jayani; White, Amanda; Cooper, Helen M.			RGMa Regulates Cortical Interneuron Migration and Differentiation	PLOS ONE			English	Article							REPULSIVE GUIDANCE MOLECULE; MEDIAL GANGLIONIC EMINENCE; NEURAL-TUBE CLOSURE; RECEPTOR NEOGENIN; AXON GUIDANCE; GABAERGIC INTERNEURONS; CELL-MIGRATION; GROWTH CONE; MOUSE; DCC	The etiology of neuropsychiatric disorders, including schizophrenia and autism, has been linked to a failure to establish the intricate neural network comprising excitatory pyramidal and inhibitory interneurons during neocortex development. A large proportion of cortical inhibitory interneurons originate in the medial ganglionic eminence (MGE) of the ventral telencephalon and then migrate through the ventral subventricular zone, across the corticostriatal junction, into the embryonic cortex. Successful navigation of newborn interneurons through the complex environment of the ventral telencephalon is governed by spatiotemporally restricted deployment of both chemorepulsive and chemoattractive guidance cues which work in concert to create a migratory corridor. Despite the expanding list of interneuron guidance cues, cues responsible for preventing interneurons from re-entering the ventricular zone of the ganglionic eminences have not been well characterized. Here we provide evidence that the chemorepulsive axon guidance cue, RGMa (Repulsive Guidance Molecule a), may fulfill this function. The ventricular zone restricted expression of RGMa in the ganglionic eminences and the presence of its receptor, Neogenin, in the ventricular zone and on newborn and maturing MGE-derived interneurons implicates RGMa-Neogenin interactions in interneuron differentiation and migration. Using an in vitro approach, we show that RGMa promotes interneuron differentiation by potentiating neurite outgrowth. In addition, using in vitro explant and migration assays, we provide evidence that RGMa is a repulsive guidance cue for newborn interneurons migrating out of the ganglionic eminence ventricular zone. Intriguingly, the alternative Neogenin ligand, Netrin-1, had no effect on migration. However, we observed complete abrogation of RGMa-induced chemorepulsion when newborn interneurons were simultaneously exposed to RGMa and Netrin-1 gradients, suggesting a novel mechanism for the tight regulation of RGMa-guided interneuron migration. We propose that during peak neurogenesis, repulsive RGMa-Neogenin interactions drive interneurons into the migratory corridor and prevent re-entry into the ventricular zone of the ganglionic eminences.	[O'Leary, Conor; Cole, Stacey J.; Langford, Michael; Hewage, Jayani; White, Amanda; Cooper, Helen M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Cooper, HM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	h.cooper@uq.edu.au	Cooper, Helen M/AAA-2182-2019; Cooper, Helen/G-3505-2010; White, Amanda/K-8753-2017	Cooper, Helen M/0000-0001-9838-5743; White, Amanda/0000-0001-5078-2248; O'Leary, Conor/0000-0003-0536-5191	National Health and Medical Research Council of Australia Project Grant [569638]; Australian Government Australian Postgraduate Award; Queensland State Government Smart Futures Fellowship	National Health and Medical Research Council of Australia Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Australian Postgraduate Award(Australian Government); Queensland State Government Smart Futures Fellowship	i) National Health and Medical Research Council of Australia Project Grant (569638). ii) Australian Government Australian Postgraduate Award iii) Queensland State Government Smart Futures Fellowship The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2001, DEVELOPMENT, V128, P353; Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Avila A, 2013, CELL REP, V4, P738, DOI 10.1016/j.celrep.2013.07.016; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Bennett KL, 1997, J BIOL CHEM, V272, P26940, DOI 10.1074/jbc.272.43.26940; Bradford D, 2010, J COMP NEUROL, V518, P3237, DOI 10.1002/cne.22397; Bradford D, 2009, INT J BIOCHEM CELL B, V41, P487, DOI 10.1016/j.biocel.2008.03.014; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2007, J NEUROSCI, V27, P11847, DOI 10.1523/JNEUROSCI.3525-07.2007; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Capelli LP, 2012, EUR J MED GENET, V55, P132, DOI 10.1016/j.ejmg.2011.10.004; Ciceri G, 2013, NAT NEUROSCI, V16, P1199, DOI 10.1038/nn.3485; Clark CEJ, 2012, NEUROSIGNALS, V20, P202, DOI 10.1159/000332153; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Dehmelt L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-100; Faux C, 2012, NEUROSIGNALS, V20, P168, DOI 10.1159/000334489; Feng JZ, 2012, EXP NEUROL, V238, P235, DOI 10.1016/j.expneurol.2012.08.014; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hernandez-Miranda LR, 2011, J NEUROSCI, V31, P6174, DOI 10.1523/JNEUROSCI.5464-10.2011; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kee N, 2013, DEV NEUROBIOL, V73, P176, DOI 10.1002/dneu.22051; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kyoto A, 2007, BRAIN RES, V1186, P74, DOI 10.1016/j.brainres.2007.10.038; Lah GJ, 2012, MOL CELL BIOL, V32, P968, DOI 10.1128/MCB.06128-11; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3147pt2; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Mirakaj V, 2012, FASEB J, V26, P1549, DOI 10.1096/fj.11-200063; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rudolph J, 2010, CELL ADHES MIGR, V4, P400, DOI 10.4161/cam.4.3.11640; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Suda M, 2008, BIOCHEM BIOPH RES CO, V371, P501, DOI 10.1016/j.bbrc.2008.04.114; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tassew NG, 2012, DEV CELL, V22, P391, DOI 10.1016/j.devcel.2011.11.022; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; Zimmer G, 2008, EUR J NEUROSCI, V28, P62, DOI 10.1111/j.1460-9568.2008.06320.x	77	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81711	10.1371/journal.pone.0081711	http://dx.doi.org/10.1371/journal.pone.0081711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312340	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100093
J	Reisser, J; Shaw, J; Wilcox, C; Hardesty, BD; Proietti, M; Thums, M; Pattiaratchi, C				Reisser, Julia; Shaw, Jeremy; Wilcox, Chris; Hardesty, Britta Denise; Proietti, Maira; Thums, Michele; Pattiaratchi, Charitha			Marine Plastic Pollution in Waters around Australia: Characteristics, Concentrations, and Pathways	PLOS ONE			English	Article							COASTAL WATERS; CURRENT SYSTEM; DEBRIS; MICROPLASTICS; INGESTION; ACCUMULATION; ENVIRONMENT; TRANSPORT; SEA; CONNECTIVITY	Plastics represent the vast majority of human-made debris present in the oceans. However, their characteristics, accumulation zones, and transport pathways remain poorly assessed. We characterised and estimated the concentration of marine plastics in waters around Australia using surface net tows, and inferred their potential pathways using particle-tracking models and real drifter trajectories. The 839 marine plastics recorded were predominantly small fragments (microplastics, median length = 2.8 mm, mean length = 4.9 mm) resulting from the breakdown of larger objects made of polyethylene and polypropylene (e.g. packaging and fishing items). Mean sea surface plastic concentration was 4256.4 pieces km-2, and after incorporating the effect of vertical wind mixing, this value increased to 8966.3 pieces km-2. These plastics appear to be associated with a wide range of ocean currents that connect the sampled sites to their international and domestic sources, including populated areas of Australia's east coast. This study shows that plastic contamination levels in surface waters of Australia are similar to those in the Caribbean Sea and Gulf of Maine, but considerably lower than those found in the subtropical gyres and Mediterranean Sea. Microplastics such as the ones described here have the potential to affect organisms ranging from megafauna to small fish and zooplankton.	[Reisser, Julia; Thums, Michele; Pattiaratchi, Charitha] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Reisser, Julia; Thums, Michele; Pattiaratchi, Charitha] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Reisser, Julia; Wilcox, Chris; Hardesty, Britta Denise] Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Floreat, WA, Australia; [Shaw, Jeremy] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Wilcox, Chris; Hardesty, Britta Denise] Commonwealth Sci & Ind Res Org, Marine & Atmospher Res, Hobart, Tas, Australia; [Proietti, Maira] Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Rio Grande Do S, Brazil; [Thums, Michele] Australian Inst Marine Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Federal do Rio Grande; Australian Institute of Marine Science	Reisser, J (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	jureisser@gmail.com	Pattiaratchi, Charitha/E-6916-2011; Hardesty, Britta Denise/A-3189-2011; Thums, Michele/A-3850-2013; Shaw, Jeremy A/B-4156-2011; Reisser, Julia/K-2065-2013	Pattiaratchi, Charitha/0000-0003-2229-6183; Hardesty, Britta Denise/0000-0003-1948-5098; Thums, Michele/0000-0002-8669-8440; Shaw, Jeremy A/0000-0002-5140-457X; Proietti, Maira/0000-0002-5504-5770; Reisser, Julia/0000-0002-1785-1042	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility, Austral Fisheries, Australian Institute of Marine Science, CSIRO's Flagship postgraduate scholarship	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility, Austral Fisheries, Australian Institute of Marine Science, CSIRO's Flagship postgraduate scholarship	This project was funded by University of Western Australia (http://www.uwa.edu.au) and Commonwealth Scientific and Industrial Research (http://www.csiro.au). It has also been supported by Australia's Marine National Facility, Austral Fisheries, Australian Institute of Marine Science, CSIRO's Flagship postgraduate scholarship (JR), and the Shell social investment program (BDH and CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Basheer C, 2004, MAR POLLUT BULL, V48, P1161, DOI 10.1016/j.marpolbul.2004.04.009; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; BOWMAKER JK, 1980, TRENDS NEUROSCI, V3, P196, DOI 10.1016/0166-2236(80)90072-7; Browne MA, 2010, ENVIRON SCI TECHNOL, V44, P3404, DOI 10.1021/es903784e; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Carey MJ, 2011, EMU, V111, P229, DOI 10.1071/MU10085; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Commonwealth of Australia, 2009, BACKGR PAP THREAT AB; Condie SA, 2008, CONT SHELF RES, V28, P1724, DOI 10.1016/j.csr.2008.04.003; Condie SA, 2005, ENVIRON MODELL SOFTW, V20, P1149, DOI 10.1016/j.envsoft.2004.07.005; Davidson TM, 2012, MAR POLLUT BULL, V64, P1821, DOI 10.1016/j.marpolbul.2012.06.005; de Stephanis R, 2013, MAR POLLUT BULL, V69, P206, DOI 10.1016/j.marpolbul.2013.01.033; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Edyvane KS, 2004, MAR POLLUT BULL, V48, P1060, DOI 10.1016/j.marpolbul.2003.12.012; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Eriksson C, 2003, AMBIO, V32, P380, DOI 10.1639/0044-7447(2003)032[0380:OABAOS]2.0.CO;2; Fendall LS, 2009, MAR POLLUT BULL, V58, P1225, DOI 10.1016/j.marpolbul.2009.04.025; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Frost A, 1997, MAR POLLUT BULL, V34, P348, DOI 10.1016/S0025-326X(96)00149-X; Gassel M, 2013, MARINE POLLUTION B, V64, P2374; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Harrison JP, 2012, SCI TOTAL ENVIRON, V416, P455, DOI 10.1016/j.scitotenv.2011.11.078; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Hoornweg D., 2012, WHAT WASTE GLOBAL RE; JONES MM, 1995, MAR POLLUT BULL, V30, P25, DOI 10.1016/0025-326X(94)00108-L; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; Ohlmann JC, 2005, J ATMOS OCEAN TECH, V22, P1381, DOI 10.1175/JTECH1786.1; PACIA, 2011, NAT PLAST REC SURV 2; Pattiaratchi C., 2009, Journal of the Royal Society of Western Australia, V92, P221; PlasticsEurope, 2012, PLAST FACTS 2012 AN; Rakestraw A., 2012, HASTINGS INT COMP LA, V35, P383; Ridgway KR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001921; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Schiller A, 2008, PROG OCEANOGR, V76, P334, DOI 10.1016/j.pocean.2008.01.003; Schuyler Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040884; SONG Y, 1991, MAR POLLUT BULL, V22, P608; TALLEY L., 2011, DESCRIPTIVE PHYS OCE; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thiel M, 2013, MAR POLLUT BULL, V71, P307, DOI 10.1016/j.marpolbul.2013.01.005; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Verlis KM, 2013, MAR POLLUT BULL, V72, P244, DOI 10.1016/j.marpolbul.2013.03.017; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Webb DJ, 2000, J PHYS OCEANOGR, V30, P706, DOI 10.1175/1520-0485(2000)030<0706:EFSZJI>2.0.CO;2; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Yamashita R, 2007, MAR POLLUT BULL, V54, P485, DOI 10.1016/j.marpolbul.2006.11.012; Young JW, 1997, ENVIRON BIOL FISH, V50, P275, DOI 10.1023/A:1007326120380	63	263	273	7	258	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80466	10.1371/journal.pone.0080466	http://dx.doi.org/10.1371/journal.pone.0080466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312224	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100041
J	Ataka, K; Asakawa, A; Nagaishi, K; Kaimoto, K; Sawada, A; Hayakawa, Y; Tatezawa, R; Inui, A; Fujimiya, M				Ataka, Koji; Asakawa, Akihiro; Nagaishi, Kanna; Kaimoto, Kaori; Sawada, Atsushi; Hayakawa, Yuko; Tatezawa, Ryota; Inui, Akio; Fujimiya, Mineko			Bone Marrow-Derived Microglia Infiltrate into the Paraventricular Nucleus of Chronic Psychological Stress-Loaded Mice	PLOS ONE			English	Article							INTERLEUKIN-1-BETA; NEURODEGENERATION; DEPRESSION; MONOCYTES; DISEASE; CELLS; ACTIVATION; MOTILITY; ANXIETY; MODELS	Background: Microglia of the central nervous system act as sentinels and rapidly react to infection or inflammation. The pathophysiological role of bone marrow-derived microglia is of particular interest because they affect neurodegenerative disorders and neuropathic pain. The hypothesis of the current study is that chronic psychological stress (chronic PS) induces the infiltration of bone marrow-derived microglia into hypothalamus by means of chemokine axes in brain and bone marrow. Methods and Findings: Here we show that bone marrow-derived microglia specifically infiltrate the paraventricular nucleus (PVN) of mice that received chronic PS. Bone marrow derived-microglia are CX(3)CR1(low)CCR2(+)CXCR4(high), as distinct from CX(3)CR1(high)CCR2-CXCR4(low) resident microglia, and express higher levels of interleukin-1 beta (IL-1 beta) but lower levels of tumor necrosis factor-alpha (TNF-alpha). Chronic PS stimulates the expression of monocyte chemotactic protein-1 (MCP-1) in PVN neurons, reduces stromal cell-derived factor-1 (SDF-1) in the bone marrow and increases the frequency of CXCR4(+) monocytes in peripheral circulation. And then a chemokine (C-C motif) receptor 2 (CCR2) or a beta(3)-adrenoceptor blockade prevents infiltration of bone marrow-derived microglia in the PVN. Conclusion: Chronic PS induces the infiltration of bone marrow-derived microglia into PVN, and it is conceivable that the MCP-1/CCR2 axis in PVN and the SDF-1/CXCR4 axis in bone marrow are involved in this mechanism.	[Ataka, Koji; Nagaishi, Kanna; Hayakawa, Yuko; Tatezawa, Ryota; Fujimiya, Mineko] Sapporo Med Univ, Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Asakawa, Akihiro; Kaimoto, Kaori; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Sawada, Atsushi] Sapporo Med Univ, Sch Med, Dept Anesthesiol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Kagoshima University; Sapporo Medical University	Fujimiya, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Anat, Sapporo, Hokkaido, Japan.	fujimiya@sapmed.ac.jp		Ataka, Koji/0000-0002-2572-5572	Japan Society for the Promotion of Science [22590661]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (#22590661 to KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Ataka K, 2012, AM J PHYSIOL-GASTR L, V303, pG519, DOI 10.1152/ajpgi.00390.2011; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bradesi S, 2010, NEUROGASTROENT MOTIL, V22, P499, DOI 10.1111/j.1365-2982.2010.01491.x; Brevet M, 2010, J NEUROSCI RES, V88, P1890, DOI 10.1002/jnr.22362; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; CLAUSEN BH, 2008, J NEUROINFLAMM, V23, P5; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kosloski LM, 2010, J NEUROCHEM, V114, P1261, DOI 10.1111/j.1471-4159.2010.06834.x; Kovacs K.J, 2005, TEC BEHAV N 1, V15, P775; Kuriyama H, 2004, NEUROSCIENCE, V124, P459, DOI 10.1016/j.neuroscience.2003.12.012; Lilly AJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/274564; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Monnikes H, 2001, DIGEST DIS, V19, P201, DOI 10.1159/000050681; Nadal R., 2006, TASKS TECHNIQUES SAM, P25; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; OGAWA N, 1993, JPN J PHARMACOL, V61, P115, DOI 10.1254/jjp.61.115; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Viviani B, 2003, J NEUROSCI, V23, P8692; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018	41	62	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81744	10.1371/journal.pone.0081744	http://dx.doi.org/10.1371/journal.pone.0081744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303068	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400084
J	Berisha, A; Mukherjee, K; Vilcinskas, A; Spengler, B; Rompp, A				Berisha, Arton; Mukherjee, Krishnendu; Vilcinskas, Andreas; Spengler, Bernhard; Roempp, Andreas			High-Resolution Mass Spectrometry Driven Discovery of Peptidic Danger Signals in Insect Immunity	PLOS ONE			English	Article							GALLERIA-MELLONELLA; ACCURATE MASS; MICROBIAL METALLOPROTEINASES; PROTEIN IDENTIFICATION; MODEL; RECOGNITION; INHIBITORS; FAMILY	The 'danger model' is an alternative concept for immune response postulating that the immune system reacts to entities that do damage (danger associated molecular patterns, DAMP) and not only to entities that are foreign (pathogen-associated molecular patterns, PAMP) as proposed by classical immunology concepts. In this study we used Galleria mellonella to validate the danger model in insects. Hemolymph of G. mellonella was digested with thermolysin (as a representative for virulence-associated metalloproteinases produced by humanpathogens) followed by chromatographic fractionation. Immune-stimulatory activity was tested by measuring lysozyme activity with the lytic zone assays against Micrococcus luteus cell wall components. Peptides were analyzed by nano-scale liquid chromatography coupled to high-resolution Fourier transform mass spectrometers. Addressing the lack of a genome sequence we complemented the rudimentary NCBI protein database with a recently established transcriptome and de novo sequencing methods for peptide identification. This approach led to identification of 127 peptides, 9 of which were identified in bioactive fractions. Detailed MS/MS experiments in comparison with synthetic analogues confirmed the amino acid sequence of all 9 peptides. To test the potential of these putative danger signals to induce immune responses we injected the synthetic analogues into G. mellonella and monitored the anti-bacterial activity against living Micrococcus luteus. Six out of 9 peptides identified in the bioactive fractions exhibited immune-stimulatory activity when injected. Hence, we provide evidence that small peptides resulting from thermolysin-mediated digestion of hemolymph proteins function as endogenous danger signals which can set the immune system into alarm. Consequently, our study indicates that the danger model also plays a role in insect immunity.	[Berisha, Arton; Spengler, Bernhard; Roempp, Andreas] Univ Giessen, Inst Inorgan & Analyt Chem, D-35390 Giessen, Germany; [Mukherjee, Krishnendu; Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Rompp, A (corresponding author), Univ Giessen, Inst Inorgan & Analyt Chem, D-35390 Giessen, Germany.	andreas.roempp@anorg.chemie.uni-giessen.de	Spengler, Bernhard/A-9497-2012; Mukherjee, Krishnendu/A-8186-2011; Mukherjee, Krishnendu/U-7159-2017; Roempp, Andreas/C-3922-2011	Mukherjee, Krishnendu/0000-0003-3470-9117; Spengler, Bernhard/0000-0003-0179-5653	Hessian ministry of Science and Arts (HMWK) through LOEWE focus "Ambiprobe"; Hessian ministry of Science and Arts (HMWK) through LOEWE focus "Insect biotechnology"; Deutsche Forschungsgemeinschaft DFG [Sp314/13-1]; European Research Council ERC-STG [210356]	Hessian ministry of Science and Arts (HMWK) through LOEWE focus "Ambiprobe"; Hessian ministry of Science and Arts (HMWK) through LOEWE focus "Insect biotechnology"; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); European Research Council ERC-STG(European Research Council (ERC))	This work was supported by the Hessian ministry of Science and Arts (HMWK) through LOEWE focus "Ambiprobe" and LOEWE focus "Insect biotechnology", by the Deutsche Forschungsgemeinschaft DFG through project Sp314/13-1, and by the European Research Council ERC-STG 210356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekoya OA, 2009, CHEM BIOL DRUG DES, V73, P7, DOI 10.1111/j.1747-0285.2008.00757.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Altincicek B, 2006, DEV COMP IMMUNOL, V30, P1108, DOI 10.1016/j.dci.2006.03.002; Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128; Amiteye S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-500; Clermont A, 2004, BIOCHEM J, V382, P315, DOI 10.1042/BJ20031923; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Griesch J, 2000, INSECT BIOCHEM MOLEC, V30, P461, DOI 10.1016/S0965-1748(00)00010-2; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Langsdorf M, 2010, RAPID COMMUN MASS SP, V24, P2885, DOI 10.1002/rcm.4717; Lazzaro BP, 2011, SCIENCE, V332, P43, DOI 10.1126/science.1200486; Marshall AG, 2002, INT J MASS SPECTROM, V215, P59, DOI 10.1016/S1387-3806(01)00588-7; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; Rompp A, 2007, PROTEOMICS, V7, P474, DOI 10.1002/pmic.200600719; Rompp A, 2005, EUR J MASS SPECTROM, V11, P443, DOI 10.1255/ejms.732; Schober Y, 2011, RAPID COMMUN MASS SP, V25, P2475, DOI 10.1002/rcm.5135; Scigelova M, 2006, PROTEOMICS, P16, DOI 10.1002/pmic.200600528; Spengler B, 2007, EUR J MASS SPECTROM, V13, P83, DOI 10.1255/ejms.840; Spengler B, 2004, J AM SOC MASS SPECTR, V15, P703, DOI 10.1016/j.jasms.2004.01.007; Vilcinskas A, 1997, EUR J ENTOMOL, V94, P461; Vilcinskas A, 2002, IUBMB LIFE, V54, P339, DOI 10.1080/15216540216040; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Vilcinskas A, 2011, CURR PHARM DESIGN, V17, P1240, DOI 10.2174/138161211795703799; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wedde M, 2007, BIOL CHEM, V388, P119, DOI 10.1515/BC.2007.013; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983	33	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80406	10.1371/journal.pone.0080406	http://dx.doi.org/10.1371/journal.pone.0080406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303012	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400028
J	Ghabooli, S; Shiganova, TA; Briski, E; Piraino, S; Fuentes, V; Thibault-Botha, D; Angel, DL; Cristescu, ME; MacIsaac, HJ				Ghabooli, Sara; Shiganova, Tamara A.; Briski, Elizabeta; Piraino, Stefano; Fuentes, Veronica; Thibault-Botha, Delphine; Angel, Dror L.; Cristescu, Melania E.; MacIsaac, Hugh J.			Invasion Pathway of the Ctenophore Mnemiopsis leidyi in the Mediterranean Sea	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; POPULATION-GENETICS; MARINE COMMUNITIES; FRAMEWORK; SOFTWARE; BIOINVASION; DIVERSITY; TRANSPORT; DYNAMICS; PLANKTON	Gelatinous zooplankton outbreaks have increased globally owing to a number of human-mediated factors, including food web alterations and species introductions. The invasive ctenophore Mnemiopsis leidyi entered the Black Sea in the early 1980s. The invasion was followed by the Azov, Caspian, Baltic and North Seas, and, most recently, the Mediterranean Sea. Previous studies identified two distinct invasion pathways of M. leidyi from its native range in the western Atlantic Ocean to Eurasia. However, the source of newly established populations in the Mediterranean Sea remains unclear. Here we build upon our previous study and investigate sequence variation in both mitochondrial (Cytochrome c Oxidase subunit I) and nuclear (Internal Transcribed Spacer) markers in M. leidyi, encompassing five native and 11 introduced populations, including four from the Mediterranean Sea. Extant genetic diversity in Mediterranean populations (n=8, N-a=10) preclude the occurrence of a severe genetic bottleneck or founder effects in the initial colonizing population. Our mitochondrial and nuclear marker surveys revealed two possible pathways of introduction into Mediterranean Sea. In total, 17 haplotypes and 18 alleles were recovered from all surveyed populations. Haplotype and allelic diversity of Mediterranean populations were comparable to populations from which they were likely drawn. The distribution of genetic diversity and pattern of genetic differentiation suggest initial colonization of the Mediterranean from the Black-Azov Seas (pairwise F-ST=0.001-0.028). However, some haplotypes and alleles from the Mediterranean Sea were not detected from the well-sampled Black Sea, although they were found in Gulf of Mexico populations that were also genetically similar to those in the Mediterranean Sea (pairwise F-ST=0.010-0.032), raising the possibility of multiple invasion sources. Multiple introductions from a combination of Black Sea and native region sources could be facilitated by intense local and transcontinental shipping activity, respectively.	[Ghabooli, Sara; Cristescu, Melania E.; MacIsaac, Hugh J.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Shiganova, Tamara A.] Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow, Russia; [Briski, Elizabeta] Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, Burlington, ON, Canada; [Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Fuentes, Veronica] Inst Ciencias Mar, Dept Biol Marina & Oceanog, E-08039 Barcelona, Catalunya, Spain; [Thibault-Botha, Delphine] Aix Marseille Univ, Mediterranean Inst Oceanog, Marseille, France; [Angel, Dror L.] Univ Haifa, Charney Sch Marine Sci, Recanati Inst Maritime Studies, IL-31999 Haifa, Israel; [Angel, Dror L.] Univ Haifa, Charney Sch Marine Sci, Dept Maritime Civilizat, IL-31999 Haifa, Israel; [Cristescu, Melania E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; Russian Academy of Sciences; Shirshov Institute of Oceanology; Fisheries & Oceans Canada; University of Salento; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Aix-Marseille Universite; University of Haifa; University of Haifa; McGill University	Ghabooli, S (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	ghabool@uwindsor.ca	Briski, Elizabeta/A-7910-2015; Shiganova, Tamara A./J-7430-2018; Briski, Elizabeta/P-4108-2019; Thibault, Delphine/AAR-4300-2020; Piraino, Stefano/J-5234-2012; macisaac, hugh/AAE-3742-2020	Briski, Elizabeta/0000-0003-1896-3860; Piraino, Stefano/0000-0002-8752-9390; 	NSERC; DFO Invasive Species Research Chair; European Community; ENPI CBCMED EC Programme	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); DFO Invasive Species Research Chair; European Community(European Commission); ENPI CBCMED EC Programme	This study was supported financially by NSERC Discovery Grants to MEC and HJM, and by a DFO Invasive Species Research Chair to HJM. The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) for the VECTORS and COCONET projects, and the ENPI CBCMED EC Programme for the project MED-JELLYRISK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; Boero F, 1996, TRENDS ECOL EVOL, V11, P177, DOI 10.1016/0169-5347(96)20007-2; Boero Ferdinando, 2009, Aquatic Invasions, V4, P675, DOI 10.3391/ai.2009.4.4.13; Bolte S, 2013, MAR ECOL PROG SER, V485, P25, DOI 10.3354/meps10321; Briski E, 2013, LIMNOL OCEANOGR, V58, P1361, DOI 10.4319/lo.2013.58.4.1361; Chao A, 2003, USERS GUIDE PROGRAM; CHAO A, 2006, SPADE VERSION 3 1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Edelist D, 2013, DIVERS DISTRIB, V19, P69, DOI 10.1111/ddi.12002; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Fuentes Veronica L., 2009, Aquatic Invasions, V4, P671, DOI 10.3391/ai.2009.4.4.12; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Galil Bella S., 2009, Aquatic Invasions, V4, P357, DOI 10.3391/ai.2009.4.2.8; Galil BS, 2012, INTEGR ZOOL, V7, P299, DOI 10.1111/j.1749-4877.2012.00307.x; Ghabooli S, 2011, BIOL INVASIONS, V13, P679, DOI 10.1007/s10530-010-9859-8; Goldstien SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065656; Gotelli NJ, 2006, ECOSIM NULL MODELS S; HARBISON GR, 1986, MAR BIOL, V90, P413, DOI 10.1007/BF00428565; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ivanov Vladimir P., 2000, Biological Invasions, V2, P255, DOI 10.1023/A:1010098624728; KIDEYS AE, 1994, ICES J MAR SCI, V51, P423, DOI 10.1006/jmsc.1994.1043; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Link JS, 2006, MAR ECOL PROG SER, V320, P153, DOI 10.3354/meps320153; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Nei M, 1987, MOL EVOLUTIONARY GEN; Pang K, 2008, CSH PROTOC; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Piraino S, 2002, MAR BIOL, V140, P1067, DOI 10.1007/s00227-001-0769-2; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Reusch TBH, 2010, MOL ECOL, V19, P2690, DOI 10.1111/j.1365-294X.2010.04701.x; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruiz Gregory M., 2003, P459; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Shiganova TA, 2004, NATO SCI S SS IV EAR, V35, P71; Shiganova TA, 2001, MAR BIOL, V139, P431; Shiganova T, 2009, J PLANKTON RES, V31, P61, DOI 10.1093/plankt/fbn102; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas VG, 2009, AQUAT CONSERV, V19, P354, DOI 10.1002/aqc.1008; VINOGRADOV ME, 1989, OKEANOLOGIYA+, V29, P293; White T., 1990, PCR PROTOCOLS GUIDE, P315; Woods EC, 2012, ECOL MONOGR, V82, P149, DOI 10.1890/11-1446.1; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327	51	37	37	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81067	10.1371/journal.pone.0081067	http://dx.doi.org/10.1371/journal.pone.0081067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303030	Green Published, gold, Green Accepted			2022-12-25	WOS:000327546400047
J	Ghadim, EE; Manouchehri, F; Soleimani, G; Hosseini, H; Kimiagar, S; Nafisi, S				Ghadim, Ehsan Ezzatpour; Manouchehri, Firouzeh; Soleimani, Gholamreza; Hosseini, Hadi; Kimiagar, Salimeh; Nafisi, Shohreh			Adsorption Properties of Tetracycline onto Graphene Oxide: Equilibrium, Kinetic and Thermodynamic Studies	PLOS ONE			English	Article							AQUEOUS-SOLUTION; DRUG-DELIVERY; REMOVAL; ENERGY; NANOCOMPOSITE; HYDROCARBONS; COMPOSITES; MECHANISM; BIOMASS; IONS	Graphene oxide (GO) nanoparticle is a high potential effective absorbent. Tetracycline (TC) is a broad-spectrum antibiotic produced, indicated for use against many bacterial infections. In the present research, a systematic study of the adsorption and release process of tetracycline on GO was performed by varying pH, sorption time and temperature. The results of our studies showed that tetracycline strongly loads on the GO surface via pi-pi interaction and cation-pi bonding. Investigation of TC adsorption kinetics showed that the equilibrium was reached within 15 min following the pseudo-second-order model with observed rate constants of k(2) = 0.2742-0.5362 g/mg min (at different temperatures). The sorption data has interpreted by the Langmuir model with the maximum adsorption of 323 mg/g (298 K). The mean energy of adsorption was determined 1.83 kJ/mol (298 K) based on the Dubinin-Radushkevich (D-R) adsorption isotherm. Moreover, the thermodynamic parameters such as Delta H degrees, Delta S degrees and Delta G degrees values for the adsorption were estimated which indicated the endothermic and spontaneous nature of the sorption process. The electrochemistry approved an ideal reaction for the adsorption under electrodic process. Simulation of GO and TC was done by LAMMPS. Force studies in z direction showed that tetracycline comes close to GO sheet by C-8 direction. Then it goes far and turns and again comes close from amine group to the GO sheet.	[Ghadim, Ehsan Ezzatpour] Islamic Azad Univ IAUCTB, Young Researchers & Elite Club, Cent Tehran Branch, Tehran, Iran; [Manouchehri, Firouzeh; Nafisi, Shohreh] Islamic Azad Univ, Cent Tehran Branch IAUCTB, Dept Chem, Tehran, Iran; [Soleimani, Gholamreza; Kimiagar, Salimeh] Islamic Azad Univ, Cent Tehran Branch IAUCTB, Dept Phys, Tehran, Iran; [Hosseini, Hadi] Shahid Beheshti Univ, Dept Chem, Tehran, Iran	Islamic Azad University; Islamic Azad University; Islamic Azad University; Shahid Beheshti University	Nafisi, S (corresponding author), Islamic Azad Univ, Cent Tehran Branch IAUCTB, Dept Chem, Tehran, Iran.	drshnafisi@gmail.com	Soleimani, Gholamreza/A-6169-2018; Hosseini, Hadi/Q-9651-2019; Manouchehri, Firouzeh/AAV-6074-2021	Hosseini, Hadi/0000-0003-4297-632X; Soleimani Jafari, Gholamreza/0000-0001-6052-5421; soleimani, Gholamreza/0000-0001-5291-6019	Azad University, Central Tehran Branch (IAUCTB)	Azad University, Central Tehran Branch (IAUCTB)	This work is supported by Azad University, Central Tehran Branch (IAUCTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri A, 2012, BIOELECTROCHEMISTRY, V88, P164, DOI 10.1016/j.bioelechem.2012.03.007; Branham ML, 2013, EUR J PHARM BIOPHARM, V83, P184, DOI 10.1016/j.ejpb.2012.09.017; Brenner DW, 2002, J PHYS-CONDENS MAT, V14, P783, DOI 10.1088/0953-8984/14/4/312; Brigante M, 2011, J HAZARD MATER, V192, P1597, DOI 10.1016/j.jhazmat.2011.06.082; Caroni ALPF, 2012, COLLOID SURFACE B, V100, P222, DOI 10.1016/j.colsurfb.2012.05.024; Castillo C, 2007, DYES PIGMENTS, V72, P178, DOI 10.1016/j.dyepig.2005.08.025; Chang YP, 2012, APPL SURF SCI, V261, P504, DOI 10.1016/j.apsusc.2012.08.045; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Fan LL, 2013, COLLOID SURFACE B, V103, P523, DOI 10.1016/j.colsurfb.2012.11.006; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Islam MM, 2003, AM J PATHOL, V163, P1557, DOI 10.1016/S0002-9440(10)63512-2; Li JL, 2012, ANGEW CHEM INT EDIT, V51, P1830, DOI 10.1002/anie.201106102; Liu P, 2012, BIORESOURCE TECHNOL, V121, P235, DOI 10.1016/j.biortech.2012.06.085; Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Margine ER, 2008, NANO LETT, V8, P3315, DOI 10.1021/nl801718f; Namgung R, 2011, BIOMATERIALS, V32, P3042, DOI 10.1016/j.biomaterials.2010.12.018; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Petrou AL, 2012, CHEM GEOL, V308, P50, DOI 10.1016/j.chemgeo.2012.03.015; Ramesha GK, 2011, J COLLOID INTERF SCI, V361, P270, DOI 10.1016/j.jcis.2011.05.050; Schwaab M, 2008, CHEM ENG SCI, V63, P2895, DOI 10.1016/j.ces.2008.03.010; Shen JF, 2010, J COLLOID INTERF SCI, V348, P377, DOI 10.1016/j.jcis.2010.04.055; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Song LF, 2012, J CHEM THERMODYN, V46, P86, DOI 10.1016/j.jct.2011.06.022; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u; Wammer KH, 2011, CHEMOSPHERE, V85, P1505, DOI 10.1016/j.chemosphere.2011.08.051; Yang X, 2013, COLLOID SURFACE A, V422, P118, DOI 10.1016/j.colsurfa.2012.11.063; Yao YJ, 2012, CHEM ENG J, V184, P326, DOI 10.1016/j.cej.2011.12.017; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhang L, 2011, CHEM ENG J, V178, P26, DOI 10.1016/j.cej.2011.09.127; Zhang PK, 2010, SEP PURIF TECHNOL, V70, P367, DOI 10.1016/j.seppur.2009.10.007; Zhao YP, 2012, GEODERMA, V183, P12, DOI 10.1016/j.geoderma.2012.03.004	36	135	139	6	222	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e79254	10.1371/journal.pone.0079254	http://dx.doi.org/10.1371/journal.pone.0079254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302989	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400005
J	Hofmann, H; Peeters, F				Hofmann, Hilmar; Peeters, Frank			In-Situ Optical and Acoustical Measurements of the Buoyant Cyanobacterium P. Rubescens: Spatial and Temporal Distribution Patterns	PLOS ONE			English	Article							DOPPLER CURRENT PROFILER; HIGH-RESOLUTION MEASUREMENTS; FRESH-WATER ZOOPLANKTON; PLANKTOTHRIX-RUBESCENS; LAKE ZURICH; VERTICAL MIGRATION; DAPHNIA; BLOOMS; DEPTH; MICROCYSTIS	Optical (fluorescence) and acoustic in-situ techniques were tested in their ability to measure the spatial and temporal distribution of plankton in freshwater ecosystems with special emphasis on the harmful and buoyant cyanobacterium P. rubescens. Fluorescence was measured with the multi-spectral FluoroProbe (Moldaenke FluoroProbe, MFP) and a Seapoint Chlorophyll Fluorometer (SCF). In-situ measurements of the acoustic backscatter strength (ABS) were conducted with three different acoustic devices covering multiple acoustic frequencies (614 kHz ADCP, 2 MHz ADP, and 6 MHz ADV). The MFP provides a fast and reliable technique to measure fluorescence at different wavelengths in situ, which allows discriminating between P. rubescens and other phytoplankton species. All three acoustic devices are sensitive to P. rubescens even if other scatterers, e. g., zooplankton or suspended sediment, are present in the water column, because P. rubescens containing gas vesicles has a strong density difference and hence acoustic contrast to the ambient water and other scatterers. After calibration, the combination of optical and acoustical measurements not only allows qualitative and quantitative observation of P. rubescens, but also distinction between P. rubescens, other phytoplankton, and zooplankton. As the measuring devices can sample in situ at high rates they enable assessment of plankton distributions at high temporal (minutes) and spatial (decimeters) resolution or covering large temporal (seasonal) and spatial (basin scale) scales.	[Hofmann, Hilmar; Peeters, Frank] Univ Konstanz, Limnol Inst, Constance, Germany	University of Konstanz	Hofmann, H (corresponding author), Univ Konstanz, Limnol Inst, Constance, Germany.	hilmar.hofmann@uni-konstanz.de	Hofmann, Hilmar/G-8445-2011		German Research Foundation (DFG) [HO 4536/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (DFG) - grant HO 4536/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barans CA, 1997, ESTUARIES, V20, P467, DOI 10.2307/1352607; Baumann HI, 2008, LIMNOLOGICA, V38, P350, DOI 10.1016/j.limno.2008.05.010; Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Carraro E, 2012, HYDROBIOLOGIA, V698, P77, DOI 10.1007/s10750-012-1096-y; Clay C.S., 1977, ACOUSTICAL OCEANOGRA; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Ernst B, 2006, HARMFUL ALGAE, V5, P281, DOI 10.1016/j.hal.2005.08.003; Ernst B, 2009, HARMFUL ALGAE, V8, P329, DOI 10.1016/j.hal.2008.07.006; FLAGG CN, 1989, DEEP-SEA RES, V36, P455, DOI 10.1016/0198-0149(89)90047-2; Giller PS, 1992, AQUATIC ECOLOGY SCAL, P649; Gons HJ, 2008, REMOTE SENS ENVIRON, V112, P4098, DOI 10.1016/j.rse.2007.06.029; Hembre LK, 2003, LIMNOL OCEANOGR, V48, P2221, DOI 10.4319/lo.2003.48.6.2221; Huber AMR, 2011, LIMNOL OCEANOGR, V56, P695, DOI 10.4319/lo.2011.56.2.0695; Hunter PD, 2008, LIMNOL OCEANOGR, V53, P2391, DOI 10.4319/lo.2008.53.6.2391; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Kucklentz V, 2001, ANTWORT BAYERISCHER; Kurmayer R, 1999, J PLANKTON RES, V21, P659, DOI 10.1093/plankt/21.4.659; Leboulanger C, 2002, AQUAT MICROB ECOL, V30, P83, DOI 10.3354/ame030083; LOHRMANN A, 1990, J ATMOS OCEAN TECH, V7, P19, DOI 10.1175/1520-0426(1990)007<0019:HRMOTV>2.0.CO;2; Lohrmann A., 2006, SAMPLING PING RATE; Lorke A, 2005, J ATMOS OCEAN TECH, V22, P1821, DOI 10.1175/JTECH1813.1; Lorke A, 2004, FRESHWATER BIOL, V49, P1280, DOI 10.1111/j.1365-2427.2004.01267.x; Lorke A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034607; Lu YY, 1999, J ATMOS OCEAN TECH, V16, P1556, DOI 10.1175/1520-0426(1999)016<1556:UABAIA>2.0.CO;2; Miller GS, 2003, J GREAT LAKES RES, V29, P427, DOI 10.1016/S0380-1330(03)70448-1; Oberhaus L, 2007, J PLANKTON RES, V29, P827, DOI 10.1093/plankt/fbm062; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; PINELALLOUL B, 1988, ECOLOGY, V69, P1393, DOI 10.2307/1941636; PINELALLOUL B, 1995, ECOSCIENCE, V2, P1; Record NR, 2006, CAN J FISH AQUAT SCI, V63, P2708, DOI 10.1139/F06-157; Rohrlack T, 2005, ENVIRON MICROBIOL, V7, P1667, DOI 10.1111/j.1462-2920.2005.00877.x; Sotton B, 2011, HARMFUL ALGAE, V10, P749, DOI 10.1016/j.hal.2011.06.006; Stramma L, 2005, DEEP-SEA RES PT I, V52, P221, DOI 10.1016/j.dsr.2004.07.021; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Van den Wyngaert S, 2011, LIMNOL OCEANOGR, V56, P97, DOI 10.4319/lo.2011.56.1.0097; Visser PM, 2005, AQUAT ECOL SER, V3, P109; Walsby AE, 2006, NEW PHYTOL, V169, P109, DOI 10.1111/j.1469-8137.2005.01567.x; Walsby AE, 2004, NEW PHYTOL, V162, P133, DOI 10.1111/j.1469-8137.2004.01020.x; Walsby AE, 2002, NEW PHYTOL, V154, P671, DOI 10.1046/j.1469-8137.2002.00401.x; Walsby AE, 2001, AQUAT SCI, V63, P326, DOI 10.1007/PL00001358; Wiebe PH, 1997, IEEE J OCEANIC ENG, V22, P445, DOI 10.1109/48.611135	41	13	14	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80913	10.1371/journal.pone.0080913	http://dx.doi.org/10.1371/journal.pone.0080913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303028	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400044
J	Jeffreys, RM; Burke, C; Jamieson, AJ; Narayanaswamy, BE; Ruhl, HA; Smith, KL; Witte, U				Jeffreys, Rachel M.; Burke, Ciara; Jamieson, Alan J.; Narayanaswamy, Bhavani E.; Ruhl, Henry A.; Smith, Kenneth L., Jr.; Witte, Ursula			Feeding Preferences of Abyssal Macrofauna Inferred from In Situ Pulse Chase Experiments	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; DEEP-SEA NEMATODES; PARTICULATE ORGANIC-CARBON; ANTARCTIC PENINSULA SHELF; BENTHIC BOUNDARY-LAYER; EASTERN NORTH PACIFIC; TIME-SERIES STATION; FOOD-WEB STRUCTURE; NE PACIFIC; STABLE-ISOTOPES	Climatic fluctuations may significantly alter the taxonomic and biochemical composition of phytoplankton blooms and subsequently phytodetritus, the food source for the majority of deep-sea communities. To examine the response of abyssal benthic communities to different food resources we simulated a food sedimentation event containing diatoms and coccolithophorids at Station M in the NE Pacific. In one set of experiments we measured incorporation of C-diatom and N-cocco into the macrofauna using isotopically enriched C-13-diatoms and N-15-coccolithophores. In a second experiment we measured incorporation of C and N from dual-labelled (C-13 and N-15) diatoms. The second experiment was repeated 2 months later to assess the effect of seasonality. The simulated food pulses represented additions of 650 - 800 mg C m(-2) and 120 mg N m(-2) to the seafloor. In all cases rapid incorporation of tracer was observed within 4 days, with between 20% and 52% of the macrofauna displaying evidence of enrichment. However, incorporation levels of both C-diatom and N-cocco were low (<0.05% and 0.005% of the added C and N). Incorporation of labelled diatoms was similar during both June and September suggesting that the community was not food limited during either period. We found no evidence for selective ingestion of the different food types in the metazoan fauna suggesting that macrofauna do not have strong preferences for diatom vs. coccolithophore dominated phytodetrital pulses. C: N ratios from both experiments suggest that the metazoan macrofauna community appear to have higher C demands and/or assimilation efficiencies compared to N. Concomitantly, the foraminifera preferentially selected for N-diatom over N-cocco, and we suggest that this may be related to foraminiferal requirements for intracellular nitrate. These experiments provide evidence that abyssal faunal feeding strategies are in part driven by an organism's internal stoichiometric budgets and biochemical requirements.	[Jeffreys, Rachel M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Burke, Ciara; Jamieson, Alan J.; Witte, Ursula] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland; [Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland; [Ruhl, Henry A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Smith, Kenneth L., Jr.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	University of Liverpool; University of Aberdeen; UHI Millennium Institute; NERC National Oceanography Centre; University of Southampton; Monterey Bay Aquarium Research Institute	Jeffreys, RM (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	rachel.jeffreys@liv.ac.uk	Jeffreys, Rachel/J-5645-2013	Jeffreys, Rachel/0000-0001-6114-2334; Narayanaswamy, Bhavani/0000-0002-5810-9127; Jamieson, Alan/0000-0001-9835-2909	Natural Environment Research Council Grant (UK); National Science Foundation (US); David and Lucile Packard Foundation; NERC [NE/E006426/1, noc010009] Funding Source: UKRI; Natural Environment Research Council [NE/E006426/1, noc010009] Funding Source: researchfish; Directorate For Geosciences [1026607] Funding Source: National Science Foundation	Natural Environment Research Council Grant (UK); National Science Foundation (US)(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by Natural Environment Research Council Grant (UK) awarded to UW and the National Science Foundation (US) and the David and Lucile Packard Foundation awarded to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; Anderson M.J., 2005, PERMUTATIONAL MULTIV; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; Beaulieu SE, 2002, OCEANOGR MAR BIOL, V40, P171; Beaulieu SE, 1998, DEEP-SEA RES PT II, V45, P781, DOI 10.1016/S0967-0645(98)00003-4; Bernhard JM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001949; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Blair NE, 1996, LIMNOL OCEANOGR, V41, P1208, DOI 10.4319/lo.1996.41.6.1208; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Canuel EA, 2007, LIMNOL OCEANOGR, V52, P590, DOI 10.4319/lo.2007.52.2.0590; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; Doi H, 2007, RAPID COMMUN MASS SP, V21, P997, DOI 10.1002/rcm.2925; Drazen JC, 1998, DEEP-SEA RES PT II, V45, P893, DOI 10.1016/S0967-0645(98)00007-1; Druffel ERM, 1998, DEEP-SEA RES PT II, V45, P667, DOI 10.1016/S0967-0645(98)00002-2; Enge AJ, 2013, BIOGEOSCI DISC, V10, P15305, DOI [10.5194/bgd-10-15305-2013., DOI 10.5194/BGD-10-15305-2013]; Enge AJ, 2011, MAR ECOL PROG SER, V438, P129, DOI 10.3354/meps09298; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Fonseca G, 2008, CAH BIOL MAR, V49, P295; Fornes WL, 1999, J MAR RES, V57, P335, DOI 10.1357/002224099321618245; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Frost PC, 2002, J N AM BENTHOL SOC, V21, P515, DOI 10.2307/1468427; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gontikaki E, 2011, DEEP-SEA RES PT I, V58, P160, DOI 10.1016/j.dsr.2010.11.011; Gooday AJ, 2002, MAR MICROPALEONTOL, V46, P83, DOI 10.1016/S0377-8398(02)00050-6; GOODAY AJ, 1988, NATURE, V332, P70, DOI 10.1038/332070a0; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Grasshoff K., 1999, METHODS SEAWATER ANA; Graves GR, 2012, CAN J ZOOL, V90, P787, DOI 10.1139/Z2012-047; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hunter W, 2012, ISME J, DOI [10.1038/ismej.2012.244, DOI 10.1038/ISMEJ.2012.244]; Hunter WR, 2013, BIOGEOSCIENCES, V10, P67, DOI 10.5194/bg-10-67-2013; Hunter WR, 2012, BIOGEOSCIENCES, V9, P993, DOI 10.5194/bg-9-993-2012; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Ingels J, 2011, J EXP MAR BIOL ECOL, V396, P185, DOI 10.1016/j.jembe.2010.10.018; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Jeffreys RM, 2012, MAR ECOL PROG SER, V470, P79, DOI 10.3354/meps10019; Koho KA, 2008, DEEP-SEA RES PT I, V55, P696, DOI 10.1016/j.dsr.2008.02.003; Koho KA, 2011, FEMS MICROBIOL ECOL, V75, P273, DOI 10.1111/j.1574-6941.2010.01010.x; Laguionie-Marchais C, 2013, DEEP-SEA RES PT I, V75, P175, DOI 10.1016/j.dsr.2012.12.007; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Levin LA, 1999, MAR ECOL PROG SER, V182, P37, DOI 10.3354/meps182037; MACKO SA, 1987, CHEM GEOL, V65, P79, DOI 10.1016/0168-9622(87)90064-9; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McGoldrick DJ, 2008, CAN J FISH AQUAT SCI, V65, P1983, DOI 10.1139/F08-109; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Mincks SL, 2008, DEEP-SEA RES PT II, V55, P2502, DOI 10.1016/j.dsr2.2008.06.009; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Nomaki H, 2008, MAR ECOL PROG SER, V357, P153, DOI 10.3354/meps07309; Nomaki H, 2006, MAR ECOL PROG SER, V310, P95, DOI 10.3354/meps310095; Nomaki H, 2009, DEEP-SEA RES PT I, V56, P1488, DOI 10.1016/j.dsr.2009.04.013; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Prokopenko MG, 2011, GEOCHIM COSMOCHIM AC, V75, P7180, DOI 10.1016/j.gca.2011.09.023; Raubenheimer D, 2004, ECOLOGY, V85, P1203, DOI 10.1890/02-0248; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR, V48, P93; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; SMITH CR, 1987, TRENDS ECOL EVOL, V2, P359, DOI 10.1016/0169-5347(87)90136-4; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith KL, 2008, LIMNOL OCEANOGR, V53, P2655, DOI 10.4319/lo.2008.53.6.2655; Smith KL, 2006, LIMNOL OCEANOGR, V51, P166, DOI 10.4319/lo.2006.51.1.0166; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; Smith KL, 1998, DEEP-SEA RES PT II, V45, P573, DOI 10.1016/S0967-0645(97)00094-5; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; Smith KL, 1998, DEEP-SEA RES PT II, V45, P843, DOI 10.1016/S0967-0645(98)00005-8; Suhr SB, 2003, MAR ECOL PROG SER, V262, P153, DOI 10.3354/meps262153; Sun MY, 2009, J EXP MAR BIOL ECOL, V376, P110, DOI 10.1016/j.jembe.2009.06.018; Sun MY, 1999, J MAR RES, V57, P775, DOI 10.1357/002224099321560573; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; Sweetman AK, 2009, J FORAMIN RES, V39, P15, DOI 10.2113/gsjfr.39.1.15; Tanaka Y, 2006, J EXP MAR BIOL ECOL, V336, P110, DOI 10.1016/j.jembe.2006.04.011; Thomas CJ, 2002, J MAR RES, V60, P517, DOI 10.1357/002224002762231205; Van Der Meer MTJ, 1998, ORG GEOCHEM, V28, P527, DOI 10.1016/S0146-6380(98)00024-2; van Oevelen D, 2012, LIMNOL OCEANOGR, V57, P645, DOI 10.4319/lo.2012.57.2.0645; Vardaro MF, 2009, LIMNOL OCEANOGR, V54, P2081, DOI 10.4319/lo.2009.54.6.2081; Venrick EL, 1998, MAR ECOL PROG SER, V167, P73, DOI 10.3354/meps167073; Williams TJ, 2006, APPL ENVIRON MICROB, V72, P1322, DOI 10.1128/AEM.72.2.1322-1329.2006; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Wolgast DM, 1998, DEEP-SEA RES PT II, V45, P881, DOI 10.1016/S0967-0645(98)00006-X; Woulds C, 2009, DEEP-SEA RES PT II, V56, P393, DOI 10.1016/j.dsr2.2008.10.008; Woulds C, 2007, LIMNOL OCEANOGR, V52, P1698, DOI 10.4319/lo.2007.52.4.1698; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P153, DOI 10.1016/j.dsr2.2010.10.014	92	24	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80510	10.1371/journal.pone.0080510	http://dx.doi.org/10.1371/journal.pone.0080510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303022	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000327546400038
J	Latus, H; Gummel, K; Diederichs, T; Bauer, A; Rupp, S; Kerst, G; Jux, C; Akintuerk, H; Schranz, D; Apitz, C				Latus, Heiner; Gummel, Kerstin; Diederichs, Tristan; Bauer, Anna; Rupp, Stefan; Kerst, Gunter; Jux, Christian; Akintuerk, Hakan; Schranz, Dietmar; Apitz, Christian			Aortopulmonary Collateral Flow Is Related to Pulmonary Artery Size and Affects Ventricular Dimensions in Patients after the Fontan Procedure	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; BLOOD-FLOW; RISK-FACTORS; COMPLETION; PHYSIOLOGY; OPERATION; CHILDREN; OUTCOMES	Background: Aortopulmonary collaterals (APCs) are frequently found in patients with a single-ventricle (SV) circulation. However, knowledge about the clinical significance of the systemic-to-pulmonary shunt flow in patients after the modified Fontan procedure and its potential causes is limited. Accordingly, the aim of our study was to detect and quantify APC flow using cardiovascular magnetic resonance (CMR) and assess its impact on SV volume and function as well as to evaluate the role of the size of the pulmonary arteries in regard to the development of APCs. Methods: 60 patients (mean age 13.3 +/- 6.8 years) after the Fontan procedure without patent tunnel fenestration underwent CMR as part of their routine clinical assessment that included ventricular functional analysis and flow measurements in the inferior vena cava (IVC), superior vena cava (SVC) and ascending aorta (Ao). APC flow was quantified using the systemic flow estimator: (Ao) - (IVC + SVC). Pulmonary artery index (Nakata index) was calculated as RPA + LPA area/body surface area using contrast enhanced MR angiography. The patient cohort was divided into two groups according to the median APC flow: group 1 < 0.495 l/min/m(2) and group 2 > 0.495 l/min/m(2). Results: Group 1 patients had significant smaller SV enddiastolic (71 +/- 16 vs 87 +/- 25 ml/m(2); p=0.004) and endsystolic volumes (29 +/- 11 vs 40 +/- 21 ml/m(2); p=0.02) whereas ejection fraction (59 +/- 9 vs 56 +/- 13%; p=0.38) differed not significantly. Interestingly, pulmonary artery size showed a significant inverse correlation with APC flow (r=-0.50, p=0.002). Conclusions: Volume load due to APC flow in Fontan patients affected SV dimensions, but did not result in an impairment of SV function. APC flow was related to small pulmonary artery size, suggesting that small pulmonary arteries represent a potential stimulus for the development of APCs.	[Latus, Heiner; Gummel, Kerstin; Diederichs, Tristan; Bauer, Anna; Rupp, Stefan; Kerst, Gunter; Akintuerk, Hakan; Schranz, Dietmar; Apitz, Christian] Justus Liebig Univ Clin, Pediat Heart Ctr, Giessen, Germany; [Jux, Christian] Univ Childrens Hosp Muenster, Dept Pediat Cardiol, Munster, Germany	Justus Liebig University Giessen; University of Munster	Latus, H (corresponding author), Justus Liebig Univ Clin, Pediat Heart Ctr, Giessen, Germany.	heiner.latus@googlemail.com	Rupp, Stefan/AGW-9352-2022; Schranz, Dietmar/AAU-3268-2021		Willy Robert Pitzer Stiftung, Bad Nauheim, Germany	Willy Robert Pitzer Stiftung, Bad Nauheim, Germany	This study was supported by the Willy Robert Pitzer Stiftung, Bad Nauheim, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascuitto RJ, 2004, PEDIATR CARDIOL, V25, P472, DOI 10.1007/s00246-004-0580-1; Atz AM, 2011, CONGENIT HEART DIS, V6, P313, DOI 10.1111/j.1747-0803.2011.00496.x; Baba K, 2012, CIRCULATION, V126, pS123, DOI 10.1161/CIRCULATIONAHA.111.084616; Banka P, 2011, AM HEART J, V162, P125, DOI 10.1016/j.ahj.2011.03.021; Berdat PA, 2005, ANN THORAC SURG, V79, P29, DOI 10.1016/j.athoracsur.2004.06.002; Biglino G, 2012, J THORAC CARDIOV SUR, V144, P1307, DOI 10.1016/j.jtcvs.2012.08.028; Dori Y, 2013, CIRC-CARDIOVASC INTE, V6, P101, DOI 10.1161/CIRCINTERVENTIONS.112.972265; Gerelli S, 2012, EUR J CARDIO-THORAC, V42, P513, DOI 10.1093/ejcts/ezs053; Glatz AC, 2012, CIRC-CARDIOVASC IMAG, V5, P218, DOI 10.1161/CIRCIMAGING.111.966986; Grosse-Wortmann L, 2012, J THORAC CARDIOV SUR, V144, P1329, DOI 10.1016/j.jtcvs.2012.03.032; Grosse-Wortmann L, 2009, CIRC-CARDIOVASC IMAG, V2, P219, DOI 10.1161/CIRCIMAGING.108.834192; Koch AME, 2008, EUR J HEART FAIL, V10, P60, DOI 10.1016/j.ejheart.2007.11.001; Lechner E, 2008, PEDIATR CARDIOL, V29, P901, DOI 10.1007/s00246-008-9225-0; McCrindle BW, 2010, CIRCULATION, V121, P34, DOI 10.1161/CIRCULATIONAHA.109.869396; NAKATA S, 1984, J THORAC CARDIOV SUR, V88, P610; Odenwald T, 2012, HEART, V98, P934, DOI 10.1136/heartjnl-2011-301599; Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51; Ovroutski S, 2012, CLIN RES CARDIOL, V101, P133, DOI 10.1007/s00392-011-0374-4; Prakash A, 2013, AM J CARDIOL, V112, P400, DOI 10.1016/j.amjcard.2013.03.043; Prakash A, 2012, AM J CARDIOL, V109, P1038, DOI 10.1016/j.amjcard.2011.11.040; Robbers-Visser D, 2009, J THORAC CARDIOV SUR, V138, P89, DOI 10.1016/j.jtcvs.2008.12.027; Schmitt B, 2010, CIRC-CARDIOVASC IMAG, V3, P623, DOI 10.1161/CIRCIMAGING.109.931592; SCHULZENEICK I, 2011, PEDIAT PULMONARY HYP; Szabo G, 2003, J THORAC CARDIOV SUR, V125, P1061, DOI 10.1067/mtc.2003.405; TRIEDMAN JK, 1993, J AM COLL CARDIOL, V22, P207, DOI 10.1016/0735-1097(93)90836-P; Valverde I, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-25; Voges I, 2010, CIRCULATION, V122, P1068, DOI 10.1161/CIRCULATIONAHA.109.889733; Wang RP, 2012, EUR J CARDIO-THORAC, V41, pe146, DOI 10.1093/ejcts/ezs189; Whitehead KK, 2009, CIRC-CARDIOVASC IMAG, V2, P405, DOI 10.1161/CIRCIMAGING.108.832113; Whitehead KK, 2009, J THORAC CARDIOV SUR, V138, P96, DOI 10.1016/j.jtcvs.2008.11.062	30	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81684	10.1371/journal.pone.0081684	http://dx.doi.org/10.1371/journal.pone.0081684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303064	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400080
J	Wang, TT; Cao, QH; Chen, MY; Xia, Q; Fan, XJ; Ma, XK; Lin, Q; Jia, CC; Dong, M; Ruan, DY; Lin, ZX; Wen, JY; Wei, L; Li, X; Chen, ZH; Wang, L; Wu, XY; Wan, XB				Wang, Tian-Tian; Cao, Qing-Hua; Chen, Ming-Yuan; Xia, Qing; Fan, Xin-Juan; Ma, Xiao-Kun; Lin, Qu; Jia, Chang-Chang; Dong, Min; Ruan, Dan-Yun; Lin, Ze-Xiao; Wen, Jing-Yun; Wei, Li; Li, Xing; Chen, Zhan-Hong; Wang, Lei; Wu, Xiang-Yuan; Wan, Xiang-Bo			Beclin 1 Deficiency Correlated with Lymph Node Metastasis, Predicts a Distinct Outcome in Intrahepatic and Extrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; REGULATES AUTOPHAGY; POOR-PROGNOSIS; CHROMOSOME 17Q; EXPRESSION; CANCER; PROTEIN; PROGRESSION; ACTIVATION; CARCINOMA	Autophagy can be tumor suppressive as well as promotive in regulation of tumorigenesis and disease progression. Accordingly, the prognostic significance of autophagy key regulator Beclin 1 was varied among different tumors. Here, we detected the clinicopathological and prognostic effect of Beclin 1 in the subtypes of intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC). Beclin 1 expression level was detected by immunohistochemistry staining in 106 ICC and 74 ECC patients. We found that Beclin 1 was lowly expressed in 126 (70%) cholangiocarcinoma patients, consist of 72 ICC and 54 ECC. Moreover, the cholangiocarcinoma patients with lymph node metastasis (N1) had a lower Beclin 1 level than that of N0 subgroup (P=0.012). However, we did not detect any correlations between Beclin 1 and other clinicopathological features, including tumor subtypes, vascular invasion, HBV infection, liver cirrhosis, cholecystolithiasis and TNM stage. Survival analysis showed that, compared with the high expression subset, Beclin 1 low expression was correlated with a poorer 3-year progression-free survival (PFS, 69.1% VS 46.8%, P=041) for cholangiocarcinoma. Importantly, our stratified univariate and multivariate analysis confirmed that Beclin 1 lowly expressed ICC had an inferior PFS as well as overall survival than ECC, particularly than that of Beclin 1 highly expressed ECC patients. Thus, our study demonstrated that Beclin 1low expression, correlated with lymph node metastasis, and might be a negative prognostic biomarker for cholangiocarcinoma. Combined Beclin 1 level with the anatomical location might lead to refined prognosis for the subtypes of ICC and ECC.	[Wang, Tian-Tian; Ma, Xiao-Kun; Lin, Qu; Dong, Min; Ruan, Dan-Yun; Lin, Ze-Xiao; Wen, Jing-Yun; Wei, Li; Li, Xing; Chen, Zhan-Hong; Wu, Xiang-Yuan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Qing-Hua; Fan, Xin-Juan; Wang, Lei; Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Gastrointestinal Inst, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Qing-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Ming-Yuan; Xia, Qing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Qing] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Jia, Chang-Chang] Sun Yat Sen Univ, Guangdong Prov Key Lab Liver Dis Res, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Shanghai Jiao Tong University; Sun Yat Sen University	Wu, XY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	wuxiangy@mail.sysu.edu.cn; wanxbo@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022; wen, jing/HDM-2205-2022		National Natural Science Foundation of China [81000934, 81370060, 81372566, 81372374]; Natural Science Foundation of Guangdong Province [10251008901000008]; Foundation for Distinguished Young Scholars of Sun Yat-sen University [13ykzd20]; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou [2013030]; Science and Technology Foundation of Guangdong Province [2011B03180076]; Ministry of Education & Guangdong Province [2012B091100460]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Scholars of Sun Yat-sen University; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou; Science and Technology Foundation of Guangdong Province; Ministry of Education & Guangdong Province	This work was supported by National Natural Science Foundation of China (No. 81000934 & No. 81370060 to X. B. Wan, No. 81372566 to L. Wang, and No. 81372374 to X.Y. Wu); Natural Science Foundation of Guangdong Province (No. 10251008901000008 to L. Wang); Foundation for Distinguished Young Scholars of Sun Yat-sen University (No. 13ykzd20 to X. B. Wan); Foundation for Pearl River Science & Technology Young Scholars of Guangzhou (No. 2013030 to X. B. Wan); Science and Technology Foundation of Guangdong Province (2011B03180076 to Q. Lin); and Combination Project of Production, Education and Research from Ministry of Education & Guangdong Province (2012B091100460 to X.Y. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Cai X, 2012, HEPATOLOGY, V56, P1804, DOI 10.1002/hep.25874; Chen YB, 2012, J SURG ONCOL, V105, P542, DOI 10.1002/jso.22151; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Cheng HY, 2012, EUR J GYNAECOL ONCOL, V33, P15; CLIBY W, 1993, CANCER RES, V53, P2393; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Edge SB, 2010, AJCC CANC STAGING MA; Fan LN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-320; Fan XJ, 2012, BRIT J CANCER, V106, P1735, DOI 10.1038/bjc.2012.82; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; GAO X, 1995, CANCER RES, V55, P1002; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Gores GJ, 2004, NAT CLIN PRACT GASTR, V1, P4, DOI 10.1038/ncpgasthep0008; Gruenberger B, 2010, LANCET ONCOL, V11, P1142, DOI 10.1016/S1470-2045(10)70247-3; Hashimoto N, 2009, ANN SURG ONCOL, V16, P395, DOI 10.1245/s10434-008-0236-0; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Huang S, 2012, AUTOPHAGY, V9; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim HJ, 2007, ANN ONCOL, V18, P892, DOI 10.1093/annonc/mdm006; Kim HS, 2011, PATHOL RES PRACT, V207, P247, DOI 10.1016/j.prp.2011.02.007; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; Koukourakis MI, 2010, BRIT J CANCER, V103, P1209, DOI 10.1038/sj.bjc.6605904; Lee SJ, 2011, AUTOPHAGY, V7, P829, DOI 10.4161/auto.7.8.15598; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liu B, 2013, CHIN J CANCER, V32, P113, DOI 10.5732/cjc.012.10010; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; SAITO H, 1993, CANCER RES, V53, P3382; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Wan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031989; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wu XY, 2013, TUMOR BIOL, V34, P713, DOI 10.1007/s13277-012-0599-5; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641	49	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80317	10.1371/journal.pone.0080317	http://dx.doi.org/10.1371/journal.pone.0080317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303007	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400023
J	You, QS; Peng, XY; Chen, CX; Xu, L; Jonas, JB				You, Qi Sheng; Peng, Xiao Yan; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.			Peripapillary Intrachoroidal Cavitations. The Beijing Eye Study	PLOS ONE			English	Article							OPTIC DISC; DETACHMENT; DEPTH; MYOPIA	Purpose: To assess prevalence, size and location of peripapillary intrachoroidal cavitations (PICCs) and their associations in a population-based sample.. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination included enhanced depth imaging of the choroid by spectral-domain optical coherence tomography and fundus photography. PICCs were defined as triangular thickening of the choroid with the base at the optic disc border and a distance between Bruch's membrane and sclera of >= 200 mu m. Parapapillary large choroidal vessels were excluded. Results: Out of 94 subjects with high myopia (refractive error <-6.0 diopters or axial length >26.5mm in right eyes), OCT images were available for 89 (94.7%) participants. A PICC was detected in 15 out of these 89 highly myopic subjects (prevalence: 16.9 +/- 4.0%) and in none of hyperopic, emmetropic or medium myopic subgroups each consisting of 100 randomly selected subjects. Mean PICC width was 4.2 +/- 2.3 hours (30 degrees) of disc circumference and mean length was 1363 +/- 384 mu m. PICCs were located most frequently (40%) at the inferior disc border. On fundus photos, a typical yellow-orange lesion was found in 8 (53%) eyes with PICCs. In binary regression analysis, presence of PICCs was significantly associated with optic disc tilting (P=0.04) and presence of posterior staphylomata (P=0.046). Conclusions: Prevalence of PICCs in the adult Chinese population was 16.9 +/- 4.0% in the highly myopic group, with no PICCs detected in non-highly myopic eyes. PICCs were located most frequently at the inferior optic disc border. Only half of the PICCs detected on OCT images showed a yellow-orange lesion on fundus photos. Presence of PICC was significantly associated only with an increased optic disc tilting and presence of posterior staphylomata, while it was not associated with axial length, refractive error or other ocular or systemic parameters.	[You, Qi Sheng; Peng, Xiao Yan; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/A-3619-2014; You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320	state natural sciences fund [81170890]; Beijing Nova Program [2010B032]; Beijing Beijing Ophthalmology and Visual Science Key Lab Fund [201210]; National Key Technology R&D Program of the Ministry of Science and Technology [2011BAH15B08, 2012BAH05F05]	state natural sciences fund(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Beijing Ophthalmology and Visual Science Key Lab Fund; National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	Supported by state natural sciences fund (81170890); Beijing Nova Program (2010B032), Beijing 2013 Beijing Ophthalmology and Visual Science Key Lab Fund (No. 201210) and National Key Technology R&D Program of the Ministry of Science and Technology (No. 2011BAH15B08 and 2012BAH05F05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Forte R, 2008, EYE, V22, P158, DOI 10.1038/sj.eye.6702666; Freund KB, 2011, ARCH OPHTHALMOL-CHIC, V129, P1096, DOI 10.1001/archophthalmol.2011.208; Freund KB, 2003, ARCH OPHTHALMOL-CHIC, V121, P197; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Ohno-Matsui K, 2013, EYE, V27, P630, DOI 10.1038/eye.2013.16; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Panda-Jonas S, 2013, ACTA OPHTHALMOL, DOI [10.1111/j. 1755-3768.2012.02570.x, DOI 10.1111/J.1755-3768.2012.02570.X.[]; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Shimada N, 2006, ARCH OPHTHALMOL-CHIC, V124, P46, DOI 10.1001/archopht.124.1.46; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Toranzo J, 2005, AM J OPHTHALMOL, V140, P731, DOI 10.1016/j.ajo.2005.03.063; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wei YH, 2009, EYE, V23, P141, DOI 10.1038/sj.eye.6702961; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yeh SI, 2013, OPHTHALMOLOGY, V120, P544, DOI 10.1016/j.ophtha.2012.08.028; You QS, 2013, OPHTHALMOLOGY, V120, P2013, DOI [10.1016/j.ophtha.2013.06.013, DOI 10.1016/J.0PHTHA.2013.06.013.PUBMED:23706949.[]	21	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78743	10.1371/journal.pone.0078743	http://dx.doi.org/10.1371/journal.pone.0078743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302981	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300081
J	Robinson, JLL; Hickey, TE; Warren, AY; Vowler, SL; Carroll, T; Lamb, AD; Papoutsoglou, N; Neal, DE; Tilley, WD; Carroll, JS				Robinson, J. L. L.; Hickey, T. E.; Warren, A. Y.; Vowler, S. L.; Carroll, T.; Lamb, A. D.; Papoutsoglou, N.; Neal, D. E.; Tilley, W. D.; Carroll, J. S.			Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype	ONCOGENE			English	Article						androgen receptor; FOXA1; prostate cancer; CRPC; genomics	RESISTANT PROSTATE-CANCER; FORKHEAD-BOX A1; ESTROGEN-RECEPTOR; BREAST-CANCER; INCREASED SURVIVAL; TRANSCRIPTION; PROGRESSION; GENOME; COREGULATORS; EXPRESSION	Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional activity is important for developing new AR-targeted therapies. FOXA1 is a key component of the AR transcriptional complex yet its role in prostate cancer progression and the relationship between AR and FOXA1 are not completely resolved. It is well established that FOXA1 levels are elevated in advanced prostate cancer and metastases. We mimicked these conditions by overexpressing FOXA1 in the androgen-responsive LNCaP prostate cancer cell line and observed a significant increase in AR genomic binding at novel regions that possess increased chromatin accessibility. High levels of FOXA1 resulted in increased proliferation at both sub-optimal and high 5 alpha-dihydrotestosterone (DHT) concentrations. Immunohistochemical staining for FOXA1 in a clinical prostate cancer cohort revealed that high FOXA1 expression is associated with shorter time to biochemical recurrence after radical prostatectomy (hazard ratio (HR) 5.0, 95% confidence interval (CI) 1.2-21.1, P = 0.028), positive surgical margins and higher stage disease at diagnosis. The gene expression program that results from FOXA1 overexpression is enriched for PTEN, Wnt and other pathways typically represented in CRPC gene signatures. Together, these results suggest that in an androgen-depleted state, elevated levels of FOXA1 enhance AR binding at genomic regions not normally occupied by AR, which in turn facilitates prostate cancer cell growth.	[Robinson, J. L. L.; Vowler, S. L.; Carroll, T.; Lamb, A. D.; Neal, D. E.; Carroll, J. S.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Robinson, J. L. L.; Vowler, S. L.; Carroll, T.; Lamb, A. D.; Neal, D. E.; Carroll, J. S.] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Hickey, T. E.; Neal, D. E.; Tilley, W. D.] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia; [Hickey, T. E.; Neal, D. E.; Tilley, W. D.] Univ Adelaide, Sch Med, Adelaide Prostate Canc Res Ctr, Adelaide, SA, Australia; [Warren, A. Y.] Cambridge Univ Hosp NHS Foundat Trust, Dept Histopathol, Cambridge, England; [Lamb, A. D.; Papoutsoglou, N.] Cambridge Univ Hosp NHS Foundat Trust, Dept Urol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Adelaide; University of Adelaide	Carroll, JS (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	jason.carroll@cruk.cam.ac.uk	Lamb, Alastair/AAD-6375-2019	Neal, David/0000-0002-6033-5086; Tilley, Wayne/0000-0003-1893-2626; Hickey, Theresa/0000-0002-2752-730X; Carroll, Jason/0000-0003-3643-0080	University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; National Health and Medical Research Council of Australia [627185]; Cancer Australia [627229]; Prostate Cancer Foundation of Australia; US Department of Defense Breast Cancer Research Program (BCRP) [W81XWH-11-1-0592]; ERC starting grant; EMBO Young Investigator Award; Cancer Research UK [15602, 22310] Funding Source: researchfish; National Institute for Health Research [CL-2012-14-003] Funding Source: researchfish	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Prostate Cancer Foundation of Australia; US Department of Defense Breast Cancer Research Program (BCRP)(United States Department of Defense); ERC starting grant(European Research Council (ERC)); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank the members of the genomic, proteomic and histopathology core facilities at Cancer Research UK. We would like to acknowledge the support of The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. We are grateful to study volunteers for their participation and staff at the Welcome Trust Clinical Research Facility, Addenbrooke's Clinical Research Centre, Cambridge. WDT is supported by grants from the National Health and Medical Research Council of Australia (ID 627185), Cancer Australia (ID 627229) and the Prostate Cancer Foundation of Australia. TEH holds a Postdoctoral Fellowship Award from the US Department of Defense Breast Cancer Research Program (BCRP; #W81XWH-11-1-0592). JSC is supported by an ERC starting grant and an EMBO Young Investigator Award.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Deutsch L, 2012, GENE CHROMOSOME CANC, V51, P618, DOI 10.1002/gcc.21950; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Imamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042456; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; Lin L, 2002, CANCER RES, V62, P5273; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang L, 2013, J CLIN NEUROSCI, V20, P654, DOI 10.1016/j.jocn.2012.03.055; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Whitaker HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013363; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882	54	57	58	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5666	5674		10.1038/onc.2013.508	http://dx.doi.org/10.1038/onc.2013.508			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24292680	Green Accepted, Green Submitted			2022-12-25	WOS:000346089300002
J	Matthews, LA; Selvaratnam, R; Jones, DR; Akimoto, M; McConkey, BJ; Melacini, G; Duncker, BP; Guarne, A				Matthews, Lindsay A.; Selvaratnam, Rajeevan; Jones, Darryl R.; Akimoto, Madoka; McConkey, Brendan J.; Melacini, Giuseppe; Duncker, Bernard P.; Guarne, Alba			A Novel Non-canonical Forkhead-associated (FHA) Domain-binding Interface Mediates the Interaction between Rad53 and Dbf4 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Checkpoint Control; DNA Damage Response; DNA Replication; NMR; Protein Domains; Protein-Protein Interactions; Yeast Genetics	DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; KINASE; PHOSPHORYLATION; COMPLEX; RECOGNITION; SPECIFICITY; RESISTANCE; SLD3; GENE	Background: The interaction between the checkpoint kinase Rad53 and Dbf4 is critical to suppress late origin firing and to stabilize stalled forks during replication stress. Results: The FHA1 domain of Rad53 interacts with the BRCT domain of Dbf4 through a novel non-canonical interface. Conclusion: FHA domains gain specificity by engaging multiple binding interfaces. Significance: Understanding how FHA domains interact with their binding partners is key to elucidate how they relay information along signaling pathways. Forkhead-associated (FHA) and BRCA1 C-terminal (BRCT) domains are overrepresented in DNA damage and replication stress response proteins. They function primarily as phosphoepitope recognition modules but can also mediate non-canonical interactions. The latter are rare, and only a few have been studied at a molecular level. We have identified a crucial non-canonical interaction between the N-terminal FHA1 domain of the checkpoint effector kinase Rad53 and the BRCT domain of the regulatory subunit of the Dbf4-dependent kinase that is critical to suppress late origin firing and to stabilize stalled forks during replication stress. The Rad53-Dbf4 interaction is phosphorylation-independent and involves a novel non-canonical interface on the FHA1 domain. Mutations within this surface result in hypersensitivity to genotoxic stress. Importantly, this surface is not conserved in the FHA2 domain of Rad53, suggesting that the FHA domains of Rad53 gain specificity by engaging additional interaction interfaces beyond their phosphoepitope-binding site. In general, our results point to FHA domains functioning as complex logic gates rather than mere phosphoepitope-targeting modules.	[Matthews, Lindsay A.; Melacini, Giuseppe; Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Selvaratnam, Rajeevan; Akimoto, Madoka; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4K1, Canada; [Jones, Darryl R.; McConkey, Brendan J.; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3H1, Canada	McMaster University; McMaster University; University of Waterloo	Guarne, A (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	guarnea@mcmaster.ca		Selvaratnam, Rajeevan/0000-0003-4457-616X; Duncker, Bernard/0000-0002-6055-9522	Canadian Institutes of Health Research [MOP-67189, MOP-68897]; Natural Sciences and Engineering Research Council [RGPIN 238392]; McMaster-Waterloo Bioinformatics Program; Canadian Institutes of Health Research; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster-Waterloo Bioinformatics Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Grants MOP-67189 (to A. G.) and MOP-68897 (to G. M.), Natural Sciences and Engineering Research Council Grant RGPIN 238392 (to B. P. D.), the McMaster-Waterloo Bioinformatics Program (to B. P. D., B. J. M., and A. G.), a Canadian Institutes of Health Research doctoral scholarship (to L. A. M.), and Ontario Graduate Scholarship doctoral awards (to D. R. J. and R. S.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aucher W, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003319; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Chen YC, 2013, GENETICS, V194, P389, DOI 10.1534/genetics.113.149740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P7925, DOI 10.1074/jbc.M412422200; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Goddard T. D., 2008, SPARKY 3; Gunasekara N, 2012, BIOCHEM BIOPH RES CO, V421, P832, DOI 10.1016/j.bbrc.2012.04.098; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; KITADA K, 1992, GENETICS, V131, P21; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Li XX, 2012, J BIOL CHEM, V287, P9137, DOI 10.1074/jbc.M111.311860; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Matthews LA, 2013, CELL CYCLE, V12, P1180, DOI 10.4161/cc.24416; Matthews LA, 2012, J BIOL CHEM, V287, P2378, DOI 10.1074/jbc.M111.233973; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Stead BE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-36; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Tong YF, 2010, P NATL ACAD SCI USA, V107, P20346, DOI 10.1073/pnas.1009008107; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yongkiettrakul S, 2004, BIOCHEMISTRY-US, V43, P3862, DOI 10.1021/bi036195f; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhang W, 2008, MOL CELL, V31, P1, DOI 10.1016/j.molcel.2008.06.009	42	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2589	2599		10.1074/jbc.M113.517060	http://dx.doi.org/10.1074/jbc.M113.517060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24285546	Green Published, hybrid			2022-12-25	WOS:000333403000010
J	Gutekunst, K; Chen, X; Schreiber, K; Kaspar, U; Makam, S; Appel, J				Gutekunst, Kirstin; Chen, Xi; Schreiber, Karoline; Kaspar, Ursula; Makam, Srinivas; Appel, Jens			The Bidirectional NiFe-hydrogenase in Synechocystis sp PCC 6803 Is Reduced by Flavodoxin and Ferredoxin and Is Essential under Mixotrophic, Nitrate-limiting Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Cyanobacteria; Hydrogenase; Photosynthesis; Physiology; Redox	PHOTOSYNTHETIC MICROBIAL MATS; CATALYTIC-PROPERTIES; PHYTOPLANKTON; CYANOBACTERIA; EVOLUTION; SUBUNIT; PROCHLOROCOCCUS; LOCALIZATION; RESPIRATION; NITROGEN	Cyanobacteria are able to use solar energy for the production of hydrogen. It is generally accepted that cyanobacterial NiFe-hydrogenases are reduced by NAD(P)H. This is in conflict with thermodynamic considerations, as the midpoint potentials of NAD(P)H do not suffice to support the measured hydrogen production under physiological conditions. We show that flavodoxin and ferredoxin directly reduce the bidirectional NiFe-hydrogenase of Synechocystis sp. PCC 6803 in vitro. A merodiploid ferredoxin-NADP reductase mutant produced correspondingly more photohydrogen. We furthermore found that the hydrogenase receives its electrons via pyruvate:flavodoxin/ferredoxin oxidoreductase (PFOR)-flavodoxin/ferredoxin under fermentative conditions, enabling the cells to gain ATP. These results strongly support that the bidirectional NiFe-hydrogenases in cyanobacteria function as electron sinks for low potential electrons from photosystem I and as a redox balancing device under fermentative conditions. However, the selective advantage of this enzyme is not known. No strong phenotype of mutants lacking the hydrogenase has been found. Because bidirectional hydrogenases are widespread in aquatic nutrient-rich environments that are capable of triggering phytoplankton blooms, we mimicked those conditions by growing cells in the presence of increased amounts of dissolved organic carbon and dissolved organic nitrogen. Under these conditions the hydrogenase was found to be essential. As these conditions close the two most important sinks for reduced flavodoxin/ferredoxin (CO2-fixation and nitrate reduction), this discovery further substantiates the connection between flavodoxin/ferredoxin and the NiFe-hydrogenase.	[Gutekunst, Kirstin; Chen, Xi; Schreiber, Karoline; Kaspar, Ursula; Appel, Jens] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Makam, Srinivas] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University of Kiel; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Gutekunst, K (corresponding author), Univ Kiel, Inst Bot, Bot Garten 5, D-24118 Kiel, Germany.	kgutekunst@bot.uni-kiel.de		Gutekunst, Kirstin/0000-0003-4366-423X; Appel, Jens/0000-0002-0658-7899	Airbus; Faculty of Mathematics of the University of Kiel; Cluster of Excellence "The Future Ocean"; FAZIT-Stiftung; Deutsche Bundesstiftung Umwelt; Brian and Kelly Swette Foundation; Faculty of Natural Sciences of the University of Kiel	Airbus; Faculty of Mathematics of the University of Kiel; Cluster of Excellence "The Future Ocean"; FAZIT-Stiftung; Deutsche Bundesstiftung Umwelt; Brian and Kelly Swette Foundation; Faculty of Natural Sciences of the University of Kiel	This work was supported by Airbus, the Faculty of Mathematics and Natural Sciences of the University of Kiel for the support of female scientists, the Cluster of Excellence "The Future Ocean," FAZIT-Stiftung, Deutsche Bundesstiftung Umwelt, and the Brian and Kelly Swette Foundation.	Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BIGGINS J, 1969, J BACTERIOL, V99, P570, DOI 10.1128/JB.99.2.570-575.1969; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Burow LC, 2013, ISME J, V7, P817, DOI 10.1038/ismej.2012.150; Burow LC, 2012, ISME J, V6, P863, DOI 10.1038/ismej.2011.142; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Munoz-Marin MD, 2013, P NATL ACAD SCI USA, V110, P8597, DOI 10.1073/pnas.1221775110; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; FUJITA Y, 1965, ARCH BIOCHEM BIOPHYS, V111, P619, DOI 10.1016/0003-9861(65)90243-2; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; HOUCHINS JP, 1981, J BACTERIOL, V146, P215, DOI 10.1128/JB.146.1.215-221.1981; KENTEMICH T, 1989, Z NATURFORSCH C, V44, P384; Kothari A, 2012, J BIOTECHNOL, V162, P105, DOI 10.1016/j.jbiotec.2012.04.017; Llama MJ, 1978, BIOCHEM SOC T, V6, P1337, DOI 10.1042/bst0061337; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; McNeely K, 2011, APPL ENVIRON MICROB, V77, P2435, DOI 10.1128/AEM.02792-10; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Montesinos ML, 1997, J BACTERIOL, V179, P853, DOI 10.1128/jb.179.3.853-862.1997; Moore LR, 2013, P NATL ACAD SCI USA, V110, P8323, DOI 10.1073/pnas.1305998110; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; NEUER G, 1982, BIOCHIM BIOPHYS ACTA, V716, P358, DOI 10.1016/0304-4165(82)90028-9; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Oesterhelt C, 2007, PLANT J, V51, P500, DOI 10.1111/j.1365-313X.2007.03159.x; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; Schmitz O, 1996, FEMS MICROBIOL LETT, V135, P97; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tittel J, 2003, P NATL ACAD SCI USA, V100, P12776, DOI 10.1073/pnas.2130696100; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wetz MS, 2004, MAR ECOL PROG SER, V272, P49, DOI 10.3354/meps272049; Wetz MS, 2003, LIMNOL OCEANOGR, V48, P1808, DOI 10.4319/lo.2003.48.5.1808; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	52	77	83	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1930	1937		10.1074/jbc.M113.526376	http://dx.doi.org/10.1074/jbc.M113.526376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311779	Green Published, hybrid			2022-12-25	WOS:000331130200005
J	Zhang, Q; Liu, B; Cheng, Y; Meng, QS; Xia, TT; Jiang, L; Chen, SH; Liu, Y; Guo, FF				Zhang, Qian; Liu, Bin; Cheng, Ying; Meng, Qingshu; Xia, Tingting; Jiang, Lei; Chen, Shanghai; Liu, Yong; Guo, Feifan			Leptin Signaling Is Required for Leucine Deprivation-enhanced Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Hypothalamus; Leptin; STAT3; Uncoupling Proteins; Fat Loss; Leucine Deprivation	RECEPTOR MESSENGER-RNA; DIET-INDUCED OBESITY; HIGH-FAT; PLASMA LEPTIN; FOOD-INTAKE; LONG FORM; GLUCOSE-TOLERANCE; NERVOUS-SYSTEM; AMINO-ACID; L-ARGININE	Background: Leucine deprivation decreases fat mass via enhancing energy expenditure; the involvement of leptin signaling is unknown. Results: Leucine deprivation promoted leptin signaling, and the increased energy expenditure was blocked in leptin signaling-disrupted mice. Conclusion: Leptin signaling is required for leucine deprivation-increased energy expenditure. Significance: Our studies reveal a physiological mechanism linking leptin signaling with leucine deprivation-enhanced energy expenditure. Leptin signaling in the hypothalamus is crucial in energy homeostasis. We have previously shown that dietary deprivation of the essential amino acid leucine in mice stimulates fat loss by increasing energy expenditure. The involvement of leptin signaling in this regulation, however, has not been reported. Here, we show that leucine deprivation promotes leptin signaling in mice maintained on an otherwise normal diet and restores leptin responses in mice maintained on a high fat diet, a regimen known to induce leptin resistance. In addition, we found that leucine deprivation stimulated energy expenditure, and fat loss was largely blocked in db/db mice homozygous for a mutation in leptin receptor and a knock-in mouse line Y3F with abrogation of leptin receptor Tyr(1138)-mediated signal transducer and activator transcript 3 signaling. Overall, our studies describe a novel link between hypothalamic leptin signaling and stimulation of energy expenditure under leucine deprivation.	[Zhang, Qian; Liu, Bin; Cheng, Ying; Meng, Qingshu; Xia, Tingting; Jiang, Lei; Chen, Shanghai; Liu, Yong; Guo, Feifan] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Liu, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	luiy@sibs.ac.cn; ffguo@sibs.ac.cn	Zhang, Qian/B-5047-2019; Xia, Tingting/K-9894-2016	Zhang, Qian/0000-0003-3032-9088; LIU, YONG/0000-0001-7771-4181	Ministry of Science and Technology of China 973 Program [2010CB912502, 2009CB919001]; National Natural Science Foundation [81130076, 31271269, 81100615]; Key Program of Shanghai Scientific and Technological Innovation Action Plan [13JC1409000]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-R-09]; Chinese Academy of Sciences [2011KIP307]	Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Program of Shanghai Scientific and Technological Innovation Action Plan; Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the Ministry of Science and Technology of China 973 Program 2010CB912502 and 2009CB919001, National Natural Science Foundation Grants 81130076, 31271269, and 81100615, Key Program of Shanghai Scientific and Technological Innovation Action Plan Grant 13JC1409000, Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-R-09, Chinese Academy of Sciences Project 2011KIP307.	Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Cheng Y, 2011, MOL ENDOCRINOL, V25, P1624, DOI 10.1210/me.2011-0028; Cheng Y, 2010, DIABETES, V59, P17, DOI 10.2337/db09-0929; Chuang SM, 2011, INT UROGYNECOL J, V22, P1381, DOI 10.1007/s00192-011-1468-2; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Du FY, 2000, J NUTR, V130, P514, DOI 10.1093/jn/130.3.514; Dube MG, 2002, DIABETES, V51, P1729, DOI 10.2337/diabetes.51.6.1729; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Fukuda M, 2011, CELL METAB, V13, P331, DOI 10.1016/j.cmet.2011.01.016; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; Huang H, 2013, ENDOCRINOLOGY, V154, P3660, DOI 10.1210/en.2013-1343; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Kasaoka S, 2004, NUTRITION, V20, P991, DOI 10.1016/j.nut.2004.08.006; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kim YW, 2006, DIABETES, V55, P716, DOI 10.2337/diabetes.55.03.06.db05-0917; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee YC, 2006, LIFE SCI, V78, P1155, DOI 10.1016/j.lfs.2005.06.009; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Mao XB, 2011, MOL BIOL REP, V38, P3201, DOI 10.1007/s11033-010-9992-6; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Shapiro A, 2011, BRIT J NUTR, V106, P390, DOI 10.1017/S000711451100033X; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Winnicki M, 2002, CIRCULATION, V106, P289, DOI 10.1161/01.CIR.0000025241.01418.4D; Xia TT, 2012, DIABETES, V61, P2461, DOI 10.2337/db11-1278; You J, 2010, MOL CELL BIOL, V30, P1650, DOI 10.1128/MCB.01307-09; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	52	17	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1779	1787		10.1074/jbc.M113.528943	http://dx.doi.org/10.1074/jbc.M113.528943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302741	Green Published, hybrid			2022-12-25	WOS:000332401700048
J	Chen, YJ; Lam, J; Gregory, CR; Schrepfer, S; Wulff, H				Chen, Yi-Je; Lam, Jenny; Gregory, Clare R.; Schrepfer, Sonja; Wulff, Heike			The Ca2+-Activated K+ Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ACTIVATED POTASSIUM CHANNEL; MEMORY T-CELLS; MOLECULE KV1.3 BLOCKER; THERAPEUTIC TARGET; CHRONIC REJECTION; CORONARY ARTERIOSCLEROSIS; UP-REGULATION; RAT MODEL; K(CA)3.1	Allograft vasculopathy (AV) remains one of the major challenges to the long-term functioning of solid organ transplants. Although its exact pathogenesis remains unclear, AV is characterized by both fibromuscular proliferation and infiltration of CD4(+) memory T cells. We here tested whether two experimental immunosuppressants targeting K+ channels might be useful for preventing AV. PAP-1 inhibits the voltage-gated Kv1.3 channel, which is overexpressed on CCR7(-) memory T cells and we therefore hypothesize that it should suppress the memory T cell component of AV. Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia. Using immunohistochemistry we demonstrated the presence of Kv1.3 on infiltrating T cells and of KCa3.1 on lymphocytes as well as on proliferating neointimal smooth muscle cells in human vasculopathy samples and in a rat aorta transplant model developing chronic AV. Treatment of PVG rats receiving orthotopically transplanted aortas from ACI rats with TRAM-34 dose-dependently reduced aortic luminal occlusion, intimal hyperplasia, mononuclear cell infiltration and collagen deposition 120 days after transplantation. The Kv1.3 blocker PAP-1 in contrast did not reduce intima hyperplasia despite drastically reducing plasma IFN-gamma levels and inhibiting lymphocyte infiltration. Our findings suggest that KCa3.1 channels play an important role in the pathogenesis of chronic AV and constitute an attractive target for the prevention of arteriopathy.	[Chen, Yi-Je; Lam, Jenny; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Gregory, Clare R.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Schrepfer, Sonja] Univ Heart Ctr Hamburg, Transplant & Stem Cell Immunobiol Lab, Hamburg, Germany; [Schrepfer, Sonja] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University	Wulff, H (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	hwulff@ucdavis.edu	wulff, Heike/Z-2056-2019		National Institutes of Health [RO1 GM076063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health RO1 GM076063 to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Ataga KI, 2006, PHARMACOTHERAPY, V26, P1557, DOI 10.1592/phco.26.11.1557; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bi D, 2013, J BIOL CHEM, V288, P15843, DOI 10.1074/jbc.M112.427187; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chen YJ, 2011, J CEREBR BLOOD F MET, V31, P2363, DOI 10.1038/jcbfm.2011.101; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Cheong A, 2011, CARDIOVASC RES, V89, P282, DOI 10.1093/cvr/cvq305; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Deuse T, 2004, TRANSPLANTATION, V77, P509, DOI 10.1097/01.TP.0000113443.70993.8C; Deuse T, 2003, TRANSPLANTATION, V76, P1627, DOI 10.1097/01.TP.0000092006.43818.B0; Deuse T, 2008, TRANSPLANTATION, V85, P870, DOI 10.1097/TP.0b013e3181673608; Deuse T, 2012, TRANSPLANTATION, V94, P695, DOI 10.1097/TP.0b013e3182660496; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Furukawa Y, 2002, AM J PATHOL, V160, P1077, DOI 10.1016/S0002-9440(10)64928-0; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Girodet PO, 2013, AM J RESP CELL MOL, V48, P212, DOI 10.1165/rcmb.2012-0103OC; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hua XQ, 2013, TRANSPLANTATION, V95, P285, DOI 10.1097/TP.0b013e318275a2f4; Jackson WF, 2005, CIRC RES, V97, P1211, DOI 10.1161/01.RES.0000196742.65848.56; Jackson WF, 2010, ARTERIOSCL THROM VAS, V30, P1073, DOI 10.1161/ATVBAHA.110.206565; Kenyon NJ, 2003, TOXICOL APPL PHARM, V186, P90, DOI 10.1016/S0041-008X(02)00025-X; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; LIBBY P, 1994, CLIN TRANSPLANT, V8, P313; Lu WH, 2011, J HEART LUNG TRANSPL, V30, P1044, DOI 10.1016/j.healun.2011.04.008; MENNANDER A, 1991, ARTERIOSCLER THROMB, V11, P671, DOI 10.1161/01.ATV.11.3.671; Mitchell RN, 2007, CIRC RES, V100, P967, DOI 10.1161/01.RES.0000261982.76892.09; Nagano H, 1998, AM J PATHOL, V152, P1187; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Pena TL, 2000, J BIOL CHEM, V275, P13677, DOI 10.1074/jbc.275.18.13677; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; SCHMID C, 1994, MICROSURG, V15, P279, DOI 10.1002/micr.1920150412; Schmid C, 1997, TRANSPLANTATION, V64, P222, DOI 10.1097/00007890-199707270-00007; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Strobaek D, 2013, BRIT J PHARMACOL, V168, P432, DOI 10.1111/j.1476-5381.2012.02143.x; Tarcha EJ, 2012, J PHARM EXP THER; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xu RD, 2012, CLIN IMMUNOL, V142, P209, DOI 10.1016/j.clim.2011.10.009	51	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81006	10.1371/journal.pone.0081006	http://dx.doi.org/10.1371/journal.pone.0081006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312257	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300021
J	Savary-Auzeloux, I; Magne, H; Migne, C; Oberli, M; Breuille, D; Faure, M; Vidal, K; Perrot, M; Remond, D; Combaret, L; Dardevet, D				Savary-Auzeloux, Isabelle; Magne, Hugues; Migne, Carole; Oberli, Marion; Breuille, Denis; Faure, Magali; Vidal, Karine; Perrot, Marie; Remond, Didier; Combaret, Lydie; Dardevet, Dominique			A Dietary Supplementation with Leucine and Antioxidants Is Capable to Accelerate Muscle Mass Recovery after Immobilization in Adult Rats	PLOS ONE			English	Article							TERM BED REST; PROTEASOME-DEPENDENT PROTEOLYSIS; STIMULATES PROTEIN-SYNTHESIS; AMINO-ACID SUPPLEMENTATION; SKELETAL-MUSCLE; OXIDATIVE STRESS; DISUSE ATROPHY; UBIQUITIN-PROTEASOME; RESISTANCE EXERCISE; PHYSICAL INACTIVITY	Prolonged inactivity induces muscle loss due to an activation of proteolysis and decreased protein synthesis; the latter is also involved in the recovery of muscle mass. The aim of the present work was to explore the evolution of muscle mass and protein metabolism during immobilization and recovery and assess the effect of a nutritional strategy for counteracting muscle loss and facilitating recovery. Adult rats (6-8 months) were subjected to unilateral hindlimb casting for 8 days (10-18) and then permitted to recover for 10 to 40 days (R10-R40). They were fed a Control or Experimental diet supplemented with antioxidants/polyphenols (AOX) (10 to 18), AOX and leucine (AOX + LEU) (18 to R15) and LEU alone (R15 to R40). Muscle mass, absolute protein synthesis rate and proteasome activities were measured in gastrocnemius muscle in casted and non-casted legs in post prandial (PP) and post absorptive (PA) states at each time point. Immobilized gastrocnemius protein content was similarly reduced (-37%) in both diets compared to the non-casted leg. Muscle mass recovery was accelerated by the AOX and LEU supplementation (+6% AOX+LEU vs. Control, P<0.05 at R40) due to a higher protein synthesis both in PA and PP states (+23% and 31% respectively, Experimental vs. Control diets, P<0.05, R40) without difference in trypsin-and chymotrypsin-like activities between diets. Thus, this nutritional supplementation accelerated the recovery of muscle mass via a stimulation of protein synthesis throughout the entire day (in the PP and PA states) and could be a promising strategy to be tested during recovery from bed rest in humans.	[Savary-Auzeloux, Isabelle; Magne, Hugues; Migne, Carole; Oberli, Marion; Remond, Didier; Combaret, Lydie; Dardevet, Dominique] Univ Clermont Ferrand 2, Univ Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [Savary-Auzeloux, Isabelle; Magne, Hugues; Migne, Carole; Oberli, Marion; Remond, Didier; Combaret, Lydie; Dardevet, Dominique] INRA, CRNH Auvergne, UNH, UMR 1019, Clermont Ferrand, France; [Breuille, Denis; Faure, Magali; Vidal, Karine; Perrot, Marie] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	Universite Clermont Auvergne (UCA); INRAE; Nestle SA	Savary-Auzeloux, I (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, Unite Nutr Humaine, BP 10448, Clermont Ferrand, France.	isabelle.savary@clermont.inra.fr		Remond, Didier/0000-0003-4430-0067; Savary-Auzeloux, Isabelle/0000-0002-3298-9787; Chen, Lu/0000-0002-9580-8576; Dardevet, Dominique/0000-0001-7320-9970; Combaret, Lydie/0000-0001-6550-8700	INRA; Nestle [1: 1]	INRA; Nestle(Nestle SA)	This work was supported by a research contract from INRA and Nestle (1: 1). Both contributors had a role in the decision to publish this manuscript.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Andrianjafiniony T, 2010, AM J PHYSIOL-CELL PH, V299, pC307, DOI 10.1152/ajpcell.00069.2010; Anthony JC, 2000, J NUTR, V130, P2413; Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Antonione R, 2008, J NUTR, V138, P2212, DOI 10.3945/jn.108.086462; Appell HJ, 1997, INT J SPORTS MED, V18, P157; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Barker T, 2007, J PHYSIOL-LONDON, V583, P421, DOI 10.1113/jphysiol.2007.139378; Biolo G, 2004, FASEB J, V18, pA757; Biolo G, 2004, J PHYSIOL-LONDON, V558, P381, DOI 10.1113/jphysiol.2004.066365; BOOTH FW, 1979, J APPL PHYSIOL, V47, P974, DOI 10.1152/jappl.1979.47.5.974; Brooks N, 2008, J APPL PHYSIOL, V105, P241, DOI 10.1152/japplphysiol.01346.2007; Brooks NE, 2010, MUSCLE NERVE, V42, P927, DOI 10.1002/mus.21780; Busquets S, 2002, J CELL PHYSIOL, V191, P283, DOI 10.1002/jcp.10097; Combaret L, 2005, J PHYSIOL-LONDON, V569, P489, DOI 10.1113/jphysiol.2005.098004; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Diamond-Stanic MK, 2011, BIOCHEM BIOPH RES CO, V405, P439, DOI 10.1016/j.bbrc.2011.01.049; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; Drummond MJ, 2012, J AGING RES, V2012; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Ferrando AA, 1997, J APPL PHYSIOL, V82, P807, DOI 10.1152/jappl.1997.82.3.807; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; FRYBURG DA, 1995, J CLIN INVEST, V96, P1722, DOI 10.1172/JCI118217; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2010, CURR OPIN CLIN NUTR, V13, P630, DOI 10.1097/MCO.0b013e32833f1ae5; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Glynn EL, 2010, J NUTR, V140, P1970, DOI 10.3945/jn.110.127647; GOLDSPINK DF, 1977, J PHYSIOL-LONDON, V269, pP87; GOLDSPINK DF, 1977, J PHYSIOL-LONDON, V264, P283, DOI 10.1113/jphysiol.1977.sp011668; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Ikemoto Madoka, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P257, DOI 10.2114/jpa.21.257; Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kimball SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1080, DOI 10.1152/ajpendo.2000.279.5.E1080; Koesterer TJ, 2002, J APPL PHYSIOL, V93, P1959, DOI 10.1152/japplphysiol.00511.2002; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Malmezat T, 1998, J NUTR, V128, P97, DOI 10.1093/jn/128.1.97; Margaritis I, 2009, CLIN BIOCHEM, V42, P371, DOI 10.1016/j.clinbiochem.2008.10.026; Marzani B, 2008, J NUTR, V138, P2205, DOI 10.3945/jn.108.094029; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mayot G, 2007, EXP GERONTOL, V42, P498, DOI 10.1016/j.exger.2007.01.003; Mazzucco S, 2010, CLIN NUTR, V29, P386, DOI 10.1016/j.clnu.2009.09.006; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; MOSONI L, 1993, AM J PHYSIOL, V264, pE614, DOI 10.1152/ajpendo.1993.264.4.E614; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; Paddon-Jones D, 2005, J NUTR, V135, p1809S, DOI 10.1093/jn/135.7.1809S; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Paddon-Jones D, 2006, J NUTR, V136, P2123, DOI 10.1093/jn/136.8.2123; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Rieu I, 2004, EXP GERONTOL, V39, P1315, DOI 10.1016/j.exger.2004.06.005; Rieu I, 2003, J NUTR, V133, P1198, DOI 10.1093/jn/133.4.1198; Servais S, 2007, FREE RADICAL BIO MED, V42, P627, DOI 10.1016/j.freeradbiomed.2006.12.001; Slimani L, 2012, AM J PHYSL ENDOCRINO; Stein TP, 2011, CRIT REV FOOD SCI, V51, P828, DOI 10.1080/10408398.2010.482679; Stein TP, 2003, J APPL PHYSIOL, V94, P1345; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Svanberg E, 1996, AM J PHYSIOL-ENDOC M, V271, pE718, DOI 10.1152/ajpendo.1996.271.4.E718; Symons TB, 2009, J APPL PHYSIOL, V107, P34, DOI 10.1152/japplphysiol.91137.2008; Taillandier D, 1996, J NUTR, V126, P266, DOI 10.1093/jn/126.1.266; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Vazeille E, 2012, J NUTR BIOCHEM, V23, P245, DOI 10.1016/j.jnutbio.2010.11.021; Volpi E, 1996, DIABETES, V45, P1245, DOI 10.2337/diabetes.45.9.1245; Zarzhevsky N, 2001, ANN NY ACAD SCI, V928, P212	79	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81495	10.1371/journal.pone.0081495	http://dx.doi.org/10.1371/journal.pone.0081495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312309	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300033
J	Wang, HH; Kung, NY; Grant, WE; Scanlan, JC; Field, HE				Wang, Hsiao-Hsuan; Kung, Nina Y.; Grant, William E.; Scanlan, Joe C.; Field, Hume E.			Recrudescent Infection Supports Hendra Virus Persistence in Australian Flying-Fox Populations	PLOS ONE			English	Article							PTEROPUS-POLIOCEPHALUS; BATS; HETEROGENEITY; REPRODUCTION; MOVEMENTS; RESERVOIR; DISEASE; ALECTO; HORSES	Zoonoses from wildlife threaten global public health. Hendra virus is one of several zoonotic viral diseases that have recently emerged from Pteropus species fruit-bats (flying-foxes). Most hypotheses regarding persistence of Hendra virus within flying-fox populations emphasize horizontal transmission within local populations (colonies) via urine and other secretions, and transmission among colonies via migration. As an alternative hypothesis, we explore the role of recrudescence in persistence of Hendra virus in flying-fox populations via computer simulation using a model that integrates published information on the ecology of flying-foxes, and the ecology and epidemiology of Hendra virus. Simulated infection patterns agree with infection patterns observed in the field and suggest that Hendra virus could be maintained in an isolated flying-fox population indefinitely via periodic recrudescence in a manner indistinguishable from maintenance via periodic immigration of infected individuals. Further, post-recrudescence pulses of infectious flying-foxes provide a plausible basis for the observed seasonal clustering of equine cases. Correct understanding of the infection dynamics of Hendra virus in flying-foxes is fundamental to effectively managing risk of infection in horses and humans. Given the lack of clear empirical evidence on how the virus is maintained within populations, the role of recrudescence merits increased attention.	[Wang, Hsiao-Hsuan; Grant, William E.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Kung, Nina Y.; Field, Hume E.] Queensland Ctr Emerging Infect Dis, Dept Agr Fisheries & Forestry, Archerfield Bc, Qld, Australia; [Scanlan, Joe C.] Dept Agr Fisheries & Forestry, Toowoomba, Qld, Australia; [Field, Hume E.] EcoHealth Alliance, New York, NY USA	Texas A&M University System; Texas A&M University College Station; Queensland Department of Agriculture & Fisheries; Queensland Department of Agriculture & Fisheries	Wang, HH (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	hsuan006@tamu.edu	Wang, Hsiao-Hsuan/AAE-7933-2020; Kung, Nina Y/H-1260-2012	Wang, Hsiao-Hsuan/0000-0002-7850-0406; 	Queensland Government	Queensland Government	Sources of funding: Queensland Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bartlett MS, 1956, DETERMINISTIC STOCHA, P81; Biosecurity Queensland, 2011, GUID VET HANDL POT H, P45; Breed AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028816; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Divljan Anja, 2011, Australian Zoologist, V35, P698; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H., 2005, ECOLOGY HENDRA VIRUS; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2011, CURR OPIN VIROL, V1, P658, DOI 10.1016/j.coviro.2011.10.025; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Glass K, 2004, EPIDEMIOL INFECT, V132, P675, DOI 10.1017/S0950268804002080; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; HALL L, 2000, AUSTR NATURAL HIST S, P62; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lenth R., 2019, Journal of Statistical Software, V60, P1; Mackenzie JS, 2003, J APPL MICROBIOL, V94, p59S; Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Martin S.W., 1987, VET EPIDEMIOLOGY PRI; McIlwee A. P., 2002, Australian Zoologist, V32, P76; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; NELSON J. E., 1965, AUSTRALIAN J ZOOL, V13, P53, DOI 10.1071/ZO9650053; PARRYJONES KA, 1992, WILDLIFE RES, V19, P331, DOI 10.1071/WR9920331; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Saltelli A., 2000, SENSITIVITY ANAL; Vardon MJ, 1998, AUST J ZOOL, V46, P329, DOI 10.1071/ZO98023; Wilensky U, 1999, NETLOGO	40	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80430	10.1371/journal.pone.0080430	http://dx.doi.org/10.1371/journal.pone.0080430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312221	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900008
J	Cai, GH; Leadbetter, CW; Muehlbauer, MF; Molnar, TJ; Hillman, BI				Cai, Guohong; Leadbetter, Clayton W.; Muehlbauer, Megan F.; Molnar, Thomas J.; Hillman, Bradley I.			Genome-Wide Microsatellite Identification in the Fungus Anisogramma anomala Using Illumina Sequencing and Genome Assembly	PLOS ONE			English	Article							EASTERN FILBERT BLIGHT; HAZELNUT; RESISTANCE; MARKERS	High-throughput sequencing has been dramatically accelerating the discovery of microsatellite markers (also known as Simple Sequence Repeats). Both 454 and Illumina reads have been used directly in microsatellite discovery and primer design (the "Seq-to-SSR" approach). However, constraints of this approach include: 1) many microsatellite-containing reads do not have sufficient flanking sequences to allow primer design, and 2) difficulties in removing microsatellite loci residing in longer, repetitive regions. In the current study, we applied the novel "Seq-Assembly-SSR" approach to overcome these constraints in Anisogramma anomala. In our approach, Illumina reads were first assembled into a draft genome, and the latter was then used in microsatellite discovery. A. anomala is an obligate biotrophic ascomycete that causes eastern filbert blight disease of commercial European hazelnut. Little is known about its population structure or diversity. Approximately 26 M 146 bp Illumina reads were generated from a paired-end library of a fungal strain from Oregon. The reads were assembled into a draft genome of 333 Mb (excluding gaps), with contig N-50 of 10,384 bp and scaffold N-50 of 32,987 bp. A bioinformatics pipeline identified 46,677 microsatellite motifs at 44,247 loci, including 2,430 compound loci. Primers were successfully designed for 42,923 loci (97%). After removing 2,886 loci close to assembly gaps and 676 loci in repetitive regions, a genome-wide microsatellite database of 39,361 loci was generated for the fungus. In experimental screening of 236 loci using four geographically representative strains, 228 (96.6%) were successfully amplified and 214 (90.7%) produced single PCR products. Twenty-three (9.7%) were found to be perfect polymorphic loci. A small-scale population study using 11 polymorphic loci revealed considerable gene diversity. Clustering analysis grouped isolates of this fungus into two clades in accordance with their geographic origins. Thus, the "Seq-Assembly-SSR" approach has proven to be a successful one for microsatellite discovery.	[Cai, Guohong; Leadbetter, Clayton W.; Muehlbauer, Megan F.; Molnar, Thomas J.; Hillman, Bradley I.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Cai, GH (corresponding author), ARS, USDA, Ames, IA USA.	cai@aesop.rutgers.edu; hillman@aesop.rutgers.edu	Cai, Guohong/N-1274-2013; Molnar, Thomas/AAC-1429-2021	Cai, Guohong/0000-0002-7700-6019; Molnar, Thomas/0000-0001-6099-4244; Hillman, Bradley/0000-0002-2552-5087	New Jersey Agricultural Experiment Station; Rutgers Center for Turfgrass Science; USDA-NIFA; USDA-NIFA Specialty Crops Research Initiative Competitive [2009-51181-06028]	New Jersey Agricultural Experiment Station; Rutgers Center for Turfgrass Science; USDA-NIFA(United States Department of Agriculture (USDA)); USDA-NIFA Specialty Crops Research Initiative Competitive	Funding was provided by the New Jersey Agricultural Experiment Station, the Rutgers Center for Turfgrass Science, Hatch funds provided by USDA-NIFA, and the USDA-NIFA Specialty Crops Research Initiative Competitive Grant 2009-51181-06028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Barss H.P., 1930, CALIF AGR DEP B, V19, P489; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Capik JM, 2012, J AM SOC HORTIC SCI, V137, P157, DOI 10.21273/JASHS.137.3.157; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; DAVISON AD, 1973, PLANT DIS REP, V57, P522; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; GOTTWALD TR, 1980, PHYTOPATHOLOGY, V70, P1087, DOI 10.1094/Phyto-70-1087; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Halsted B.D., 1892, NEW JERSEY AGR EXPT, V13, P287; Humphrey JE, 1893, MASSACHUSETTS STATE, V10, P242; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Johnson KB, 1996, PLANT DIS, V80, P1308, DOI 10.1094/PD-80-1308; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Mehlenbacher S.A., 1991, GENETIC RESOURCES TE, P789; MEHLENBACHER SA, 1991, HORTSCIENCE, V26, P410, DOI 10.21273/HORTSCI.26.4.410; Mehlenbacher SA, 2004, HORTSCIENCE, V39, P1498, DOI 10.21273/HORTSCI.39.6.1498; MEHLENBACHER SA, 1991, HORTSCIENCE, V26, P442, DOI 10.21273/HORTSCI.26.4.442; Mehlenbacher SA, 2007, HORTSCIENCE, V42, P715, DOI 10.21273/HORTSCI.42.3.715; Mehlenbacher SA, 2012, HORTSCIENCE, V47, P1180, DOI 10.21273/HORTSCI.47.8.1180; Mehlenbacher SA, 2009, HORTSCIENCE, V44, P845, DOI 10.21273/HORTSCI.44.3.845; Molnar T. J., 2012, Acta Horticulturae, P57; Molnar TJ, 2010, HORTSCIENCE, V45, P832, DOI 10.21273/HORTSCI.45.5.832; Morris R.T., 1920, AM NUT J, V11, P57; Peck CH, 1875, ANN REPORT NEW YORK, V28, P31; PINKERTON JN, 1992, PLANT DIS, V76, P1179, DOI 10.1094/PD-76-1179; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; STONE JK, 1994, MYCOLOGIA, V86, P674, DOI 10.2307/3760539; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang J., 2009, GENOME RES; Weir B. S., 1996, GENETIC DATA ANAL; YAMAOKA Y, 1984, T MYCOL SOC JPN, V25, P435; Yu JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026933	39	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82408	10.1371/journal.pone.0082408	http://dx.doi.org/10.1371/journal.pone.0082408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312419	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100115
J	Vayssier-Taussat, M; Moutailler, S; Michelet, L; Devillers, E; Bonnet, S; Cheval, J; Hebert, C; Eloit, M				Vayssier-Taussat, Muriel; Moutailler, Sara; Michelet, Lorraine; Devillers, Elodie; Bonnet, Sarah; Cheval, Justine; Hebert, Charles; Eloit, Marc			Next Generation Sequencing Uncovers Unexpected Bacterial Pathogens in Ticks in Western Europe	PLOS ONE			English	Article							CANDIDATUS NEOEHRLICHIA MIKURENSIS; MIYAMOTOI SP-NOV; BORRELIA-MIYAMOTOI; IXODES-RICINUS; CLINICAL PRESENTATION; BARTONELLA-HENSELAE; LYME-DISEASE; BANK VOLES; VECTOR; TRANSMISSION	Background and Aims: Ticks are highly susceptible to global environmental and socio-economical changes. Several tick-borne pathogens have been reported in new geographical regions while new species, strains or genetic variants of tick-borne microorganisms are continually being detected. However, tick-borne pathogens are still poorly understood, and it is estimated that half of all human tick-borne disease has an unknown origin. Therefore in order to prevent these diseases, more effort is required to identify unknown or unexpected tick-borne pathogens. lxodes ricinus is the vector for a broad range of bacterial pathogens and the most prevalent tick in Europe. The aim of the present study was to evaluate the capability of Next Generation Sequencing (NGS) to extend the inventory of pathogenic bacteria carried by this species of tick in France. Methods: RNA and DNA were extracted from 1450 ricinus questing nymphs collected by flagging in Alsace, France. RNA was pooled and used for NGS. Following de novo assembly, bacterial contigs were assigned to the closest known taxonomy. DNA was used for real time PCR to confirm taxonomic species assignment of NGS-derived contigs for the doubtful cases, and for determination of prevalence. Results: We have generated a global in-depth picture of tick-borne bacteria. We identified RNA from the main pathogenic bacterial species known to be transmitted by I. ricinus. In addition we also identified unanticipated bacterial species for which we have estimated the prevalence within those ticks inhabiting the studied areas. Conclusions: The data obtained from this study has proven that NGS has an enormous potential to detect the unexpected and provides the means to monitor pathogen occurrence.	[Vayssier-Taussat, Muriel; Moutailler, Sara; Michelet, Lorraine; Devillers, Elodie; Bonnet, Sarah] Anses, USC Bipar, INRA, Maisons Alfort, France; [Cheval, Justine; Hebert, Charles; Eloit, Marc] PathoQuest SAS, Paris, France; [Eloit, Marc] ANSES, INRA, Ecole Natl Vet Alfort, UMR Virol ENVA 1161, Maisons Alfort, France; [Eloit, Marc] Inst Pasteur, Lab Pathogen Discovery, Paris, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eloit, M (corresponding author), PathoQuest SAS, Paris, France.	marc.eloit@pasteur.fr	Bonnet, Sarah I/AAD-4191-2020; Sara, Moutailler/J-9633-2019; Michelet, Lorraine/AAR-3577-2021	Bonnet, Sarah I/0000-0002-6365-6117; Sara, Moutailler/0000-0003-3010-6968; Michelet, Lorraine/0000-0003-2991-1660	EU [FP7-261504 EDENext]	EU(European Commission)	This study was partially funded by the EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext 181 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2011, EMERG INFECT DIS, V17, P1716, DOI 10.3201/eid1709.101058; Brouqui P, 2007, FEMS IMMUNOL MED MIC, V49, P2, DOI 10.1111/j.1574-695X.2006.00138.x; Buckwalter MR, 2011, J VIROL, V85, P6893, DOI 10.1128/JVI.00274-11; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Cotte V, 2008, EMERG INFECT DIS, V14, P1074, DOI 10.3201/eid1407.071110; Cowling DW, 1999, PREV VET MED, V39, P211, DOI 10.1016/S0167-5877(98)00131-7; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dietrich F, 2010, APPL ENVIRON MICROB, V76, P1395, DOI 10.1128/AEM.02788-09; Doyle CK, 2005, J MOL DIAGN, V7, P504, DOI 10.1016/S1525-1578(10)60581-8; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; FUKUNAGA M, 1995, FEMS MICROBIOL LETT, V134, P255, DOI 10.1111/j.1574-6968.1995.tb07947.x; Geller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051914; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Haselbarth K, 2007, INT J MED MICROBIOL, V297, P197, DOI 10.1016/j.ijmm.2007.01.002; Hauck Walter W., 1991, Annals of Epidemiology, V1, P277; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; Janecek E, 2012, EMERG INFECT DIS, V18, P1689, DOI 10.3201/eid1810.120390; Kik M, 2011, EMERG INFECT DIS, V17, P936, DOI 10.3201/eid1705.101834; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Li H, 2013, APPL ENVIRON MICROB, V79, P1024, DOI 10.1128/AEM.02917-12; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Logares R, 2013, ENV MICROBIOL; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Mayne PJ, 2011, INT J GEN MED, V4, P845, DOI 10.2147/IJGM.S27336; MCKIEL JA, 1967, CAN J MICROBIOL, V13, P503, DOI 10.1139/m67-065; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Reis C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001186; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Richter D, 2003, EMERG INFECT DIS, V9, P697; Sarksyan DS, 2012, TERAPEVT ARKH, V84, P34; Sauvage V, 2011, J VIROL; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Socolovschi C, 2009, PARASITE, V16, P259, DOI 10.1051/parasite/2009164259; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; Vayssier-Taussat M, 2012, EMERG INFECT DIS, V18, P2063, DOI 10.3201/eid1812.120846; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09	49	104	107	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81439	10.1371/journal.pone.0081439	http://dx.doi.org/10.1371/journal.pone.0081439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312301	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100080
J	Barrufol, M; Schmid, B; Bruelheide, H; Chi, XL; Hector, A; Ma, KP; Michalski, S; Tang, ZY; Niklaus, PA				Barrufol, Martin; Schmid, Bernhard; Bruelheide, Helge; Chi, Xiulian; Hector, Andrew; Ma, Keping; Michalski, Stefan; Tang, Zhiyao; Niklaus, Pascal A.			Biodiversity Promotes Tree Growth during Succession in Subtropical Forest	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; CLIMATE-CHANGE; PRODUCTIVITY; DEFORESTATION; EVENNESS; POOLS; BACK	Losses of plant species diversity can affect ecosystem functioning, with decreased primary productivity being the most frequently reported effect in experimental plant assemblages, including tree plantations. Less is known about the role of biodiversity in natural ecosystems, including forests, despite their importance for global biogeochemical cycling and climate. In general, experimental manipulations of tree diversity will take decades to yield final results. To date, biodiversity effects in natural forests therefore have only been reported from sample surveys or meta-analyses with plots not initially selected for diversity. We studied biomass and growth of subtropical forests stands in southeastern China. Taking advantage of variation in species recruitment during secondary succession, we adopted a comparative study design selecting forest plots to span a gradient in species richness. We repeatedly censored the stem diameter of two tree size cohorts, comprising 93 species belonging to 57 genera and 33 families. Tree size and growth were analyzed in dependence of species richness, the functional diversity of growth-related traits, and phylogenetic diversity, using both general linear and structural equation modeling. Successional age covaried with diversity, but differently so in the two size cohorts. Plot-level stem basal area and growth were positively related with species richness, while growth was negatively related to successional age. The productivity increase in species-rich, functionally and phylogenetically diverse plots was driven by both larger mean sizes and larger numbers of trees. The biodiversity effects we report exceed those from experimental studies, sample surveys and meta-analyses, suggesting that subtropical tree diversity is an important driver of forest productivity and re-growth after disturbance that supports the provision of ecological services by these ecosystems.	[Barrufol, Martin; Schmid, Bernhard; Hector, Andrew; Niklaus, Pascal A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bruelheide, Helge] Univ Halle Wittenberg, Geobot & Bot Garden, Inst Biol, D-06108 Halle, Saale, Germany; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Ma, Keping] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Michalski, Stefan] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany	University of Zurich; Martin Luther University Halle Wittenberg; Peking University; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Niklaus, PA (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	pascal.niklaus@ieu.uzh.ch	Chi, Xiulian/A-8898-2015; Baruffol, Martin/A-2406-2014; Schmid, Bernhard/C-8625-2009; Niklaus, Pascal A/G-5786-2010; Tang, Zhiyao/B-8795-2008; Hector, Andrew/H-4199-2011; Michalski, Stefan G/O-5774-2015; Bruelheide, Helge/G-3907-2013	Baruffol, Martin/0000-0001-9358-5885; Schmid, Bernhard/0000-0002-8430-3214; Niklaus, Pascal A/0000-0002-2360-1357; Hector, Andrew/0000-0002-1309-7716; Michalski, Stefan G/0000-0002-8969-7355; Bruelheide, Helge/0000-0003-3135-0356; Tang, Zhiyao/0000-0003-0154-6403	German Science Foundation [DFG FOR 891/1]; Sino-German Centre for Research Promotion [GZ 524, 592, 698, 699]; National Science Foundation of China [NSFC 31021001]; National Basic Research Program of China on Global Change [2010CB50600]	German Science Foundation(German Research Foundation (DFG)); Sino-German Centre for Research Promotion; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China on Global Change(National Basic Research Program of China)	Funding was provided by the German Science Foundation (http://www.dfg.de; DFG FOR 891/1), the Sino-German Centre for Research Promotion (http://www.sinogermanscience.org.cn; GZ 524, 592, 698 and 699), the National Science Foundation of China (http://www.nsfc.gov.cn; NSFC 31021001), and the National Basic Research Program of China on Global Change (http://www.973.gov.cn/Default_3.aspx; #2010CB50600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bohnke M, 2012, TREES-STRUCT FUNCT, V26, P641, DOI 10.1007/s00468-011-0632-0; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Durieux L, 2003, REMOTE SENS ENVIRON, V86, P132, DOI 10.1016/S0034-4257(03)00095-6; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Piotto D, 2008, FOREST ECOL MANAG, V255, P781, DOI 10.1016/j.foreco.2007.09.065; Safford HD, 2001, OIKOS, V95, P282, DOI 10.1034/j.1600-0706.2001.950210.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Schmitz M, FOLIA GEOBO IN PRESS; Shevliakova E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003176; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Snedecor G.W., 1989, AMES IOWA STATE U PR; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	36	97	102	12	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81246	10.1371/journal.pone.0081246	http://dx.doi.org/10.1371/journal.pone.0081246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303037	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000327546400054
J	Chiang, SC; Han, CL; Yu, KH; Chen, YJ; Wu, KP				Chiang, Su-Chien; Han, Chia-Li; Yu, Kun-Hsing; Chen, Yu-Ju; Wu, Kun-Pin			Prioritization of Cancer Marker Candidates Based on the Immunohistochemistry Staining Images Deposited in the Human Protein Atlas	PLOS ONE			English	Article							DEFENSE PEPTIDE LL-37; ANTIBODY-BASED PROTEOMICS; CLEAR-CELL CARCINOMA; CARCINOEMBRYONIC ANTIGEN; GENE PRIORITIZATION; GASTRIC-CANCER; GROWTH-FACTOR; ANNEXIN-IV; BIOMARKERS; EXPRESSION	Cancer marker discovery is an emerging topic in high-throughput quantitative proteomics. However, the omics technology usually generates a long list of marker candidates that requires a labor-intensive filtering process in order to screen for potentially useful markers. Specifically, various parameters, such as the level of overexpression of the marker in the cancer type of interest, which is related to sensitivity, and the specificity of the marker among cancer groups, are the most critical considerations. Protein expression profiling on the basis of immunohistochemistry (IHC) staining images is a technique commonly used during such filtering procedures. To systematically investigate the protein expression in different cancer versus normal tissues and cell types, the Human Protein Atlas is a most comprehensive resource because it includes millions of high-resolution IHC images with expert-curated annotations. To facilitate the filtering of potential biomarker candidates from large-scale omics datasets, in this study we have proposed a scoring approach for quantifying IHC annotation of paired cancerous/normal tissues and cancerous/normal cell types. We have comprehensively calculated the scores of all the 17219 tested antibodies deposited in the Human Protein Atlas based on their accumulated IHC images and obtained 457110 scores covering 20 different types of cancers. Statistical tests demonstrate the ability of the proposed scoring approach to prioritize cancer-specific proteins. Top 100 potential marker candidates were prioritized for the 20 cancer types with statistical significance. In addition, a model study was carried out of 1482 membrane proteins identified from a quantitative comparison of paired cancerous and adjacent normal tissues from patients with colorectal cancer (CRC). The proposed scoring approach demonstrated successful prioritization and identified four CRC markers, including two of the most widely used, namely CEACAM5 and CEACAM6. These results demonstrate the potential of this scoring approach in terms of cancer marker discovery and development. All the calculated scores are available at http://bal.ym.edu.tw/hpa/.	[Chiang, Su-Chien; Wu, Kun-Pin] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Han, Chia-Li; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Yu, Kun-Hsing] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University	Wu, KP (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	kpwu@ym.edu.tw	Yu, Kun-Hsing/J-3300-2019; Chen, Yu-Ju/E-9481-2015	Yu, Kun-Hsing/0000-0001-9892-8218; Chen, Yu-Ju/0000-0002-3178-6697	Yang-Ming University; Academia Sinica (Research Project on Nanoscience and Technology); National Science Council of Taiwan	Yang-Ming University; Academia Sinica (Research Project on Nanoscience and Technology)(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Yang-Ming University, Academia Sinica (Research Project on Nanoscience and Technology), and National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; An LL, 2005, INT J HEMATOL, V81, P45, DOI 10.1532/IJH97.A10407; Batruch I, 2011, J PROTEOME RES, V10, P941, DOI 10.1021/pr100745u; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P825, DOI 10.1074/mcp.M700411-MCP200; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Chang YH, 2009, J PROTEOME RES, V8, P5465, DOI 10.1021/pr900454e; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Drake RR, 2010, J PROTEOME RES, V9, P2109, DOI 10.1021/pr1001498; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Falk R, 2007, BIOMOL ENG, V24, P155, DOI 10.1016/j.bioeng.2007.01.001; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Han CL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003087; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Hensel JA, 2011, PROSTATE, V71, P659, DOI 10.1002/pros.21282; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Leth-Larsen R, 2010, MOL CELL PROTEOMICS, V9, P1369, DOI 10.1074/mcp.R900006-MCP200; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Lin LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044615; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Minton O, 2010, PALLIATIVE MED, V24, P310, DOI 10.1177/0269216309360104; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Perkins GL, 2003, AM FAM PHYSICIAN, V68, P1075; Planque C, 2009, MOL CELL PROTEOMICS, V8, P2746, DOI 10.1074/mcp.M900134-MCP200; Ren SX, 2012, CANCER RES, V72, P6512, DOI 10.1158/0008-5472.CAN-12-2359; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Simpson RJ, 2008, CURR OPIN CHEM BIOL, V12, P72, DOI 10.1016/j.cbpa.2008.02.010; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; THOMSON DMP, 1969, P NATL ACAD SCI USA, V64, P161, DOI 10.1073/pnas.64.1.161; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Tranchevent LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/bib/bbq007; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Weber G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2221; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Wu WKK, 2010, J CELL PHYSIOL, V223, P178, DOI 10.1002/jcp.22026; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yang YH, 2003, LEUKEMIA RES, V27, P947, DOI 10.1016/S0145-2126(03)00020-1; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002; Zolg W, 2006, MOL CELL PROTEOMICS, V5, P1720, DOI 10.1074/mcp.R600001-MCP200	52	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81079	10.1371/journal.pone.0081079	http://dx.doi.org/10.1371/journal.pone.0081079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303032	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400049
J	Zhang, HY; Li, C; Miao, HM; Xiong, SJ				Zhang, Haiyang; Li, Chun; Miao, Hongmei; Xiong, Songjin			Insights from the Complete Chloroplast Genome into the Evolution of Sesamum indicum L.	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA; ORGANIZATION; IDENTIFICATION; REVEALS; REGIONS; PLANTS	Sesame (Sesamum indicum L.) is one of the oldest oilseed crops. In order to investigate the evolutionary characters according to the Sesame Genome Project, apart from sequencing its nuclear genome, we sequenced the complete chloroplast genome of S. indicum cv. Yuzhi 11 (white seeded) using Illumina and 454 sequencing. Comparisons of chloroplast genomes between S. indicum and the 18 other higher plants were then analyzed. The chloroplast genome of cv. Yuzhi 11 contains 153,338 bp and a total of 114 unique genes (KC569603). The number of chloroplast genes in sesame is the same as that in Nicotiana tabacum, Vitis vinifera and Platanus occidentalis. The variation in the length of the large single-copy (LSC) regions and inverted repeats (IR) in sesame compared to 18 other higher plant species was the main contributor to size variation in the cp genome in these species. The 77 functional chloroplast genes, except for ycf1 and ycf2, were highly conserved. The deletion of the cp ycf1 gene sequence in cp genomes may be due either to its transfer to the nuclear genome, as has occurred in sesame, or direct deletion, as has occurred in Panax ginseng and Cucumis sativus. The sesame ycf2 gene is only 5,721 bp in length and has lost about 1,179 bp. Nucleotides 1-585 of ycf2 when queried in BLAST had hits in the sesame draft genome. Five repeats (R10, R12, R13, R14 and R17) were unique to the sesame chloroplast genome. We also found that IR contraction/expansion in the cp genome alters its rate of evolution. Chloroplast genes and repeats display the signature of convergent evolution in sesame and other species. These findings provide a foundation for further investigation of cp genome evolution in Sesamum and other higher plants.	[Zhang, Haiyang; Li, Chun; Miao, Hongmei] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Peoples R China; [Xiong, Songjin] Nankai Univ, TEDA, Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China	Henan Academy of Agricultural Sciences; Nankai University	Zhang, HY (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Peoples R China.	zhy@hnagri.org.cn	Miao, Hongmei/AAQ-7525-2021	Li, Chun/0000-0002-9370-1775	Earmarked Fund for the China Agriculture Research System [CARS-15]; China National '973' Project [2011CB109304]	Earmarked Fund for the China Agriculture Research System; China National '973' Project(National Basic Research Program of China)	This work was financially supported by the Earmarked Fund for the China Agriculture Research System (Grant No. CARS-15) and China National '973' Project (2011CB109304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilakumar Kandangath Raghavan, 2010, Agriculturae Conspectus Scientificus, V75, P159; Arslan C, 2007, J AM OIL CHEM SOC, V84, P917, DOI 10.1007/s11746-007-1125-6; Ashri A, 1998, PLANT BREEDING REV, P179, DOI 10.1002/9780470650110.ch5; BEDIGIAN D, 1986, ECON BOT, V40, P137, DOI 10.1007/BF02859136; Bungard RA, 2004, BIOESSAYS, V26, P235, DOI 10.1002/bies.10405; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; GAUT BS, 1993, MOL PHYLOGENET EVOL, V2, P89, DOI 10.1006/mpev.1993.1009; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Jarvie T, 2008, NAT METHODS, V5, P1; Khan A, 2010, AFR J BIOTECHNOL, V9, P3494; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin CP, 2012, GENOME BIOL EVOL, V4, P374, DOI 10.1093/gbe/evs021; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; McInerney JO, 2006, TRENDS ECOL EVOL, V21, P230, DOI 10.1016/j.tree.2006.03.008; NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043; Nimmakayala P, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - OILSEEDS, P261, DOI 10.1007/978-3-642-14871-2_16; OHARAMAYS EP, 1993, MICROCHEM J, V47, P245, DOI 10.1006/mchj.1993.1039; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Parks MB, 2011, THESIS OREGON STATE; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Sall T, 2003, J EVOLUTION BIOL, V16, P1019, DOI 10.1046/j.1420-9101.2003.00554.x; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stoebe B, 1998, PLANT MOL BIOL REP, V16, P243, DOI 10.1023/A:1007568326120; Sugiura M, 2003, PHOTOSYNTH RES, V76, P371, DOI 10.1023/A:1024913304263; SUGIURA M, 1989, ANNU REV CELL BIOL, V5, P51, DOI 10.1146/annurev.cb.05.110189.000411; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiong AS, 2009, BIOTECHNOL ADV, V27, P340, DOI 10.1016/j.biotechadv.2009.01.012; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Yue WenDi, 2012, Acta Agronomica Sinica, V38, P2286; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; [张海洋 Zhang Haiyang], 2012, [植物学报, Chinese Bulletin of Botany], V47, P602; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang T, 2003, CHINESE AGR SCI B, V19, P44; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	56	36	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80508	10.1371/journal.pone.0080508	http://dx.doi.org/10.1371/journal.pone.0080508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303020	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400036
J	Effenberger, KA; Anderson, DD; Bray, WM; Prichard, BE; Ma, NC; Adams, MS; Ghosh, AK; Jurica, MS				Effenberger, Kerstin A.; Anderson, David D.; Bray, Walter M.; Prichard, Beth E.; Ma, Nianchun; Adams, Matthew S.; Ghosh, Arun K.; Jurica, Melissa S.			Coherence between Cellular Responses and in Vitro Splicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Drug Action; Enzyme Inhibitors; Nucleus; RNA Splicing	SF3B; SPLICEOSTATIN; SUBSTANCES; MUTATIONS; DISCOVERY; CULTURE; TARGET; E7107	Pladienolide B (PB) is a potent cancer cell growth inhibitor that targets the SF3B1 subunit of the spliceosome. There is considerable interest in the compound as a potential chemotherapeutic, as well as a tool to study SF3B1 function in splicing and cancer development. The molecular structure of PB, a bacterial natural product, contains a 12-member macrolide ring with an extended epoxide-containing side chain. Using a novel concise enantioselective synthesis, we created a series of PB structural analogs and the structurally related compound herboxidiene. We show that two methyl groups in the PB side chain, as well as a feature of the macrolide ring shared with herboxidiene, are required for splicing inhibition in vitro. Unexpectedly, we find that the epoxy group contributes only modestly to PB potency and is not absolutely necessary for activity. The orientations of at least two chiral centers off the macrolide ring have no effect on PB activity. Importantly, the ability of analogs to inhibit splicing in vitro directly correlated with their effects in a series of cellular assays. Those effects likely arise from inhibition of some, but not all, endogenous splicing events in cells, as previously reported for the structurally distinct SF3B1 inhibitor spliceostatin A. Together, our data support the idea that the impact of PB on cells is derived from its ability to impair the function of SF3B1 in splicing and also demonstrate that simplification of the PB scaffold is feasible.	[Effenberger, Kerstin A.; Prichard, Beth E.; Adams, Matthew S.; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Effenberger, Kerstin A.; Prichard, Beth E.; Adams, Matthew S.; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Bray, Walter M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Anderson, David D.; Ma, Nianchun; Ghosh, Arun K.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Anderson, David D.; Ma, Nianchun; Ghosh, Arun K.] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jurica, MS (corresponding author), Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	mjurica@ucsc.edu			National Institutes of Health [R01CA136762, 1S10RR022455]; University of California Cancer Research Coordinating Committee; California Institute for Quantitative Biosciences (QB3); United States Department of State; American Chemical Society Division of Medicinal Chemistry; American Foundation for Pharmaceutical Education; NATIONAL CANCER INSTITUTE [R01CA136762] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); California Institute for Quantitative Biosciences (QB3); United States Department of State; American Chemical Society Division of Medicinal Chemistry(American Chemical Society); American Foundation for Pharmaceutical Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA136762 (to M. S. J.) and 1S10RR022455. This work was also supported by the University of California Cancer Research Coordinating Committee, the California Institute for Quantitative Biosciences (QB3), and the United States Department of State.; Supported by predoctoral fellowships from the American Chemical Society Division of Medicinal Chemistry and the American Foundation for Pharmaceutical Education.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; Gao Y, 2013, CHEMBIOCHEM, V14, P49, DOI 10.1002/cbic.201200558; Ghosh AK, 2012, ORG LETT, V14, P4730, DOI 10.1021/ol301886g; Ghosh AK, 2011, ORG LETT, V13, P66, DOI 10.1021/ol102549a; Gundluru MK, 2011, MEDCHEMCOMM, V2, P904, DOI 10.1039/c1md00040c; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hong D. S., 2013, INVEST NEW DRUGS, DOI 10. 1007/s10637-013-0046-5; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lagisetti C, 2009, J MED CHEM, V52, P6979, DOI 10.1021/jm901215m; Lamond AI, 2011, COLD SPRING HARB PER, V3; Liu X., 2013, J NANOMATER, V2013, DOI DOI 10.1155/2013/902538; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Muller S, 2011, ORG LETT, V13, P3940, DOI 10.1021/ol201464m; Nakajima H, 1996, J ANTIBIOT, V49, P1204; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Sakai T, 2004, J ANTIBIOT, V57, P173, DOI 10.7164/antibiotics.57.173; Sakai Y, 2002, J ANTIBIOT, V55, P863, DOI 10.7164/antibiotics.55.863; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; SEKIASANO M, 1994, J ANTIBIOT, V47, P1395, DOI 10.7164/antibiotics.47.1395; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Villa R, 2013, J MED CHEM, V56, P6576, DOI 10.1021/jm400861t; Villa R, 2012, ORG LETT, V14, P5396, DOI 10.1021/ol3023006; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	39	54	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1938	1947		10.1074/jbc.M113.515536	http://dx.doi.org/10.1074/jbc.M113.515536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302718	Green Published, hybrid			2022-12-25	WOS:000331130200006
J	Campbell, DJ; Somaratne, JB; Prior, DL; Yii, M; Kenny, JF; Newcomb, AE; Kelly, DJ; Black, MJ				Campbell, Duncan J.; Somaratne, Jithendra B.; Prior, David L.; Yii, Michael; Kenny, James F.; Newcomb, Andrew E.; Kelly, Darren J.; Black, Mary Jane			Obesity Is Associated with Lower Coronary Microvascular Density	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; INSULIN-RESISTANCE; WAIST CIRCUMFERENCE; HEART; RISK; IMPACT; WEIGHT; ANGIOGENESIS; HYPERTENSION	Background: Obesity is associated with diastolic dysfunction, lower maximal myocardial blood flow, impaired myocardial metabolism and increased risk of heart failure. We examined the association between obesity, left ventricular filling pressure and myocardial structure. Methods: We performed histological analysis of non-ischemic myocardium from 57 patients (46 men and 11 women) undergoing coronary artery bypass graft surgery who did not have previous cardiac surgery, myocardial infarction, heart failure, atrial fibrillation or loop diuretic therapy. Results: Non-obese (body mass index, BMI, <= 30 kg/m(2), n=33) and obese patients (BMI >30 kg/m(2), n=24) did not differ with respect to myocardial total, interstitial or perivascular fibrosis, arteriolar dimensions, or cardiomyocyte width. Obese patients had lower capillary length density (1145 +/- 239, mean +/- SD, vs. 1371 +/- 333 mm/mm(3), P=0.007) and higher diffusion radius (16.9 +/- 1.5 vs. 15.6 +/- 2.0 mu m, P=0.012), in comparison with non-obese patients. However, the diffusion radius/cardiomyocyte width ratio of obese patients (0.73 +/- 0.11 mu m/mu m) was not significantly different from that of non-obese patients (0.71 +/- 0.11 mu m/mu m), suggesting that differences in cardiomyocyte width explained in part the differences in capillary length density and diffusion radius between non-obese and obese patients. Increased BMI was associated with increased pulmonary capillary wedge pressure (PCWP, P<0.0001), and lower capillary length density was associated with both increased BMI (P=0.043) and increased PCWP (P=0.016). Conclusions: Obesity and its accompanying increase in left ventricular filling pressure were associated with lower coronary microvascular density, which may contribute to the lower maximal myocardial	[Campbell, Duncan J.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Campbell, Duncan J.; Prior, David L.; Kelly, Darren J.] Univ Melbourne, St Vincents Hlth, Dept Med, Fitzroy, Vic 3065, Australia; [Somaratne, Jithendra B.; Prior, David L.] St Vincents Hlth, Dept Cardiol, Fitzroy, Vic, Australia; [Yii, Michael; Newcomb, Andrew E.] Univ Melbourne, St Vincents Hlth, Dept Surg, Fitzroy, Vic 3065, Australia; [Yii, Michael; Kenny, James F.; Newcomb, Andrew E.] St Vincents Hlth, Dept Cardiothorac Surg, Fitzroy, Vic, Australia; [Black, Mary Jane] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Monash University	Campbell, DJ (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	dcampbell@svi.edu.au	Newcomb, Andrew/ABD-9220-2021	Newcomb, Andrew/0000-0002-0465-3602; Somaratne, Jithendra/0000-0002-5165-4077; Kelly, Darren/0000-0003-4850-3929; Black, Mary Jane/0000-0002-9253-3773	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia [395508, 566867]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grants from the National Health and Medical Research Council of Australia and from the National Heart Foundation of Australia. Duncan Campbell (Grant ID 395508) and Darren Kelly (Grant ID 566867) are recipients of Senior Research Fellowships from the National Health and Medical Research Council of Australia. St Vincent's Institute of Medical Research is supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, J AM COLL CARDIOL, V57, P586, DOI 10.1016/j.jacc.2010.09.039; Aellen J, 2012, MICROCIRCULATION, V19, P554, DOI 10.1111/j.1549-8719.2012.00188.x; Ahmed Q, 1997, HUM PATHOL, V28, P264, DOI 10.1016/S0046-8177(97)90122-2; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ANVERSA P, 1990, PROG CARDIOVASC DIS, V33, P49, DOI 10.1016/0033-0620(90)90039-5; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Burla AK, 2013, INT J CARDIOL, V165, P483, DOI 10.1016/j.ijcard.2011.09.012; Campbell DJ, 2013, INT J CARDIOL, V167, P1027, DOI 10.1016/j.ijcard.2012.03.075; Campbell DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049813; Campbell DJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-80; Campbell DJ, 2011, HYPERTENSION, V57, P186, DOI 10.1161/HYPERTENSIONAHA.110.165043; Cil H, 2012, ECHOCARDIOGR-J CARD, V29, P647, DOI 10.1111/j.1540-8175.2012.01688.x; De Ciuceis C, 2013, BLOOD PRESSURE, V22, P165, DOI 10.3109/08037051.2012.749584; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gruber C, 2012, CARDIOVASC PATHOL, V21, P346, DOI 10.1016/j.carpath.2011.11.003; Horwich TB, 2010, J AM COLL CARDIOL, V55, P283, DOI 10.1016/j.jacc.2009.07.029; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Johnson BL, 2013, J AM COLL SURGEONS, V216, P545, DOI 10.1016/j.jamcollsurg.2012.12.019; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Kosmala W, 2012, CIRC-CARDIOVASC IMAG, V5, P349, DOI 10.1161/CIRCIMAGING.111.969956; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li ZL, 2012, ARTERIOSCL THROM VAS, V32, P1132, DOI 10.1161/ATVBAHA.111.244061; MESSER JV, 1962, J CLIN INVEST, V41, P725, DOI 10.1172/JCI104531; Niemann B, 2011, J AM COLL CARDIOL, V57, P577, DOI 10.1016/j.jacc.2010.09.040; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Quercioli A, 2012, JACC-CARDIOVASC IMAG, V5, P805, DOI 10.1016/j.jcmg.2012.01.020; RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rider OJ, 2013, INT J OBESITY, V37, P972, DOI 10.1038/ijo.2012.170; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024; Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062; Sugawara T, 2003, MOL CELL BIOCHEM, V248, P165, DOI 10.1023/A:1024196504666; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Toblli JE, 2004, AM J HYPERTENS, V17, P172, DOI 10.1016/j.amjhyper.2003.10.006; TOMANEK RJ, 1992, CIRCULATION, V86, P320, DOI 10.1161/01.CIR.86.1.320; Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	46	34	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81798	10.1371/journal.pone.0081798	http://dx.doi.org/10.1371/journal.pone.0081798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312359	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300051
J	Ewing, L; Leach, K; Pellicano, E; Jeffery, L; Rhodes, G				Ewing, Louise; Leach, Katie; Pellicano, Elizabeth; Jeffery, Linda; Rhodes, Gillian			Reduced Face Aftereffects in Autism Are Not Due to Poor Attention	PLOS ONE			English	Article							IDENTITY RECOGNITION; SPECTRUM DISORDERS; VISUAL-ADAPTATION; FACIAL IDENTITY; SOCIAL-STIMULI; CHILDREN; MECHANISMS; INSIGHTS	This study aimed to determine why face identity aftereffects are diminished in children with autism, relative to typical children. To address the possibility that reduced face aftereffects might reflect reduced attention to adapting stimuli, we investigated the consequence of controlling attention to adapting faces during a face identity aftereffect task in children with autism and typical children. We also included a size-change between adaptation and test stimuli to determine whether the reduced aftereffects reflect atypical adaptation to low-or higher-level stimulus properties. Results indicated that when attention was controlled and directed towards adapting stimuli, face identity aftereffects in children with autism were significantly reduced relative to typical children. This finding challenges the notion that atypicalities in the quality and/or quantity of children's attention during adaptation might account for group differences previously observed in this paradigm. Additionally, evidence of diminished face identity aftereffects despite a stimulus size change supports an adaptive processing atypicality in autism that extends beyond low-level, retinotopically coded stimulus properties. These findings support the notion that diminished face aftereffects in autism reflect atypicalities in adaptive norm-based coding, which could also contribute to face processing difficulties in this group.	[Ewing, Louise; Leach, Katie; Pellicano, Elizabeth; Jeffery, Linda; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Australian Res Council, Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia; [Pellicano, Elizabeth] Univ London, Inst Educ, Ctr Res Autism & Educ, London WC1N 1AZ, England	University of Western Australia; University of London; University College London; UCL Institute of Education	Ewing, L (corresponding author), Univ Western Australia, Sch Psychol, Australian Res Council, Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	louise.ewing@uwa.edu.au	Pellicano, Liz/I-5749-2019; Ewing, Louise/H-9158-2014; Jeffery, Linda/H-5127-2014	Pellicano, Liz/0000-0002-7246-8003; Jeffery, Linda/0000-0002-3980-5864; Ewing, Louise/0000-0001-5263-1267; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council Centre of Excellence in Cognition and its Disorders [CE110001021]; Australian Research Council Professorial Fellowship [DP0877379]; Australian Research Council [DP0770923]; University of Western Australia; Australian Federation of University Women; Clothworkers' Foundation; Pears Foundation; Medical Research Council [MR/J013145/1] Funding Source: researchfish; MRC [MR/J013145/1] Funding Source: UKRI	Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council); Australian Research Council Professorial Fellowship(Australian Research Council); Australian Research Council(Australian Research Council); University of Western Australia; Australian Federation of University Women; Clothworkers' Foundation; Pears Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Australian Research Council Centre of Excellence in Cognition and its Disorders (project number CE110001021) and an Australian Research Council Professorial Fellowship to G. R (project number DP0877379). It was also supported by an Australian Research Council Discovery Grant (DP0770923) to LJ and GR, and awards to L. E. from the University of Western Australia and the Australian Federation of University Women. Research at the Centre for Research in Autism and Education (CRAE) is supported by The Clothworkers' Foundation and Pears Foundation (E.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Churches O, 2010, NEUROREPORT, V21, P399, DOI 10.1097/WNR.0b013e328334311b; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Constantino JN., 2002, SOCIAL RESPONSIVENES; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dennett HW, 2012, PSYCHOL SCI, V23, P1279, DOI 10.1177/0956797612446350; Ewing L, 2013, DEVELOPMENTAL SCI, V16, P116, DOI 10.1111/desc.12007; Fiorentini C, 2012, NEUROPSYCHOLOGIA, V50, P2926, DOI 10.1016/j.neuropsychologia.2012.08.019; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Glasson EJ, 2008, MED J AUSTRALIA, V188, P288, DOI 10.5694/j.1326-5377.2008.tb01623.x; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hedley D, 2011, AUTISM RES, V4, P449, DOI 10.1002/aur.214; Jeffery L, 2011, BRIT J PSYCHOL, V102, P799, DOI 10.1111/j.2044-8295.2011.02066.x; Jeffery L, 2010, J VISION, V10, DOI 10.1167/10.5.18; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; McKone E, 2012, COGN NEUROPSYCHOL, V29, P174, DOI 10.1080/02643294.2012.660138; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Murray JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045928; NISHIMURA M, 2010, NEUROPSYCHOLOGIA, V8, P1; Nishimura M, 2008, DEVELOPMENTAL SCI, V11, P620, DOI 10.1111/j.1467-7687.2008.00706.x; PELLICANO E, 2013, NEUROPSYCHOLOGIA; Pellicano E, 2007, CURR BIOL, V17, P1508, DOI 10.1016/j.cub.2007.07.065; Pimperton H, 2009, J EXP CHILD PSYCHOL, V104, P229, DOI 10.1016/j.jecp.2009.05.009; RHODES G, 2013, INDIVIDUAL DIF UNPUB; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; RHODES G, 2013, NEUROPSYCHOLOGIA; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; Rutter M., 2003, SOCIAL COMMUNICATION; Susilo T, 2010, J VISION, V10, DOI 10.1167/10.13.1; Webb S. J., 2011, OXFORD HDB FACE PERC, P839; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Wilson CE, 2010, J INTELL DISABIL RES, V54, P1104, DOI 10.1111/j.1365-2788.2010.01340.x; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24	43	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81353	10.1371/journal.pone.0081353	http://dx.doi.org/10.1371/journal.pone.0081353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261MX	24312293	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327670300031
J	Horie, M; Noguchi, S; Tanaka, W; Goto, Y; Yoshihara, H; Kawakami, M; Suzuki, M; Sakamoto, Y				Horie, Masafumi; Noguchi, Satoshi; Tanaka, Wakae; Goto, Yasushi; Yoshihara, Hisanao; Kawakami, Masaki; Suzuki, Masaru; Sakamoto, Yoshio			Relationships among Smoking Habits, Airflow Limitations, and Metabolic Abnormalities in School Workers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; NATIONAL-HEALTH; LUNG-FUNCTION; FUNCTION IMPAIRMENT; SEX-DIFFERENCES; UNITED-STATES; RISK	Background: Chronic obstructive pulmonary disease is caused mainly by habitual smoking and is common among elderly individuals. It involves not only airflow limitation but also metabolic disorders, leading to increased cardiovascular morbidity and mortality. Objective: We evaluated relationships among smoking habits, airflow limitation, and metabolic abnormalities. Methods: Between 2001 and 2008, 15,324 school workers (9700 males, 5624 females; age: >= 30 years) underwent medical checkups, including blood tests and spirometry. They also responded to a questionnaire on smoking habits and medical history. Results: Airflow limitation was more prevalent in current smokers than in ex-smokers and never-smokers in men and women. The frequency of hypertriglyceridemia was higher in current smokers in all age groups, and those of low high-density-lipoprotein cholesterolemia and diabetes mellitus were higher in current smokers in age groups >= 40 s in men, but not in women. There were significant differences in the frequencies of metabolic abnormalities between subjects with airflow limitations and those without in women, but not in men. Smoking index was an independent factor associated with increased frequencies of hypertriglyceridemia (OR 1.015; 95% CI: 1.012-1.018; p<0.0001) and low high-density-lipoprotein cholesterolemia (1.013; 1.010-1.016; p<0.0001) in men. Length of smoking cessation was an independent factor associated with a decreased frequency of hypertriglyceridemia (0.984; 0.975-0.994; p = 0.007). Conclusions: Habitual smoking causes high incidences of airflow limitation and metabolic abnormalities. Women, but not men, with airflow limitation had higher frequencies of metabolic abnormalities.	[Horie, Masafumi; Noguchi, Satoshi; Tanaka, Wakae; Goto, Yasushi] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Yoshihara, Hisanao] Teikyo Univ, Dept Allergy & Resp Med, Itabashi Ku, Tokyo 173, Japan; [Kawakami, Masaki; Suzuki, Masaru; Sakamoto, Yoshio] Kanto Cent Hosp, Dept Resp Med, Tokyo, Japan	University of Tokyo; Teikyo University	Horie, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	mhorie-tky@umin.ac.jp						Almagro P, 2010, RESP MED, V104, P253, DOI 10.1016/j.rmed.2009.09.019; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Basili S, 1999, ATHEROSCLEROSIS, V147, P249, DOI 10.1016/S0021-9150(99)00192-6; Ben-Zaken Cohen Sigal, 2007, Am J Respir Crit Care Med, V176, P113; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; BOLTON CH, 1989, J ROY SOC MED, V82, P91, DOI 10.1177/014107688908200212; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CHAJEKSHAUL T, 1990, EUR J CLIN INVEST, V20, P299, DOI 10.1111/j.1365-2362.1990.tb01859.x; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; FEKETE T, 1987, HORM METAB RES, V19, P661, DOI 10.1055/s-2007-1011903; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Ford ES, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-115; Freeman DJ, 1998, EUR J CLIN INVEST, V28, P584; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; GERACE TA, 1991, PREV MED, V20, P602, DOI 10.1016/0091-7435(91)90058-C; Global Initiative for Chronic Obstructive Lung Disease, UPD 2013 GLOB STRAT; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Hanson C, 2013, TRANSL RES; Kirkpatrick DP, 2009, CURR OPIN PULM MED, V15, P100, DOI 10.1097/MCP.0b013e3283232825; Kuzuya M, 2006, ATHEROSCLEROSIS, V185, P183, DOI 10.1016/j.atherosclerosis.2005.05.040; LANGE P, 1991, EUR RESPIR J, V4, P1080; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; National Institute of Health and Nutrition, 2007, NAT HLTH NUTR SURV J; Paek YJ, 2010, METABOLISM, V59, P1300, DOI 10.1016/j.metabol.2009.12.005; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Petty Thomas L, 2004, Respir Care, V49, P678; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; US Preventive Serv Task Force, 2008, ANN INTERN MED, V148, P529, DOI 10.7326/0003-4819-148-7-200804010-00212; Villablanca AC, 2000, CLIN CHEST MED, V21, P159, DOI 10.1016/S0272-5231(05)70015-0; Yeatts K, 2007, ENVIRON HEALTH PERSP, V115, P709, DOI 10.1289/ehp.9499	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81145	10.1371/journal.pone.0081145	http://dx.doi.org/10.1371/journal.pone.0081145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312268	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300025
J	Williams, PT				Williams, Paul T.			Dose-Response Relationship of Physical Activity to Premature and Total All-Cause and Cardiovascular Disease Mortality in Walkers	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DEATH CERTIFICATE COMPLETION; BODY-MASS INDEX; VIGOROUS EXERCISE; INCIDENT HYPERTENSION; AMERICAN-COLLEGE; WALKING DISTANCE; PUBLIC-HEALTH; WEIGHT-GAIN; RISK	Purpose: To assess the dose-response relationships between cause-specific mortality and exercise energy expenditure in a prospective epidemiological cohort of walkers. Methods: The sample consisted of the 8,436 male and 33,586 female participants of the National Walkers' Health Study. Walking energy expenditure was calculated in metabolic equivalents (METs, 1 MET = 3.5 ml O-2/kg/min), which were used to divide the cohort into four exercise categories: category 1 (<= 1.07 MET-hours/d), category 2 (1.07 to 1.8 MET-hours/d), category 3 (1.8 to 3.6 MET-hours/d), and category 4 (>= 3.6 MET-hours/d). Competing risk regression analyses were use to calculate the risk of mortality for categories 2, 3 and 4 relative to category 1. Results: 22.9% of the subjects were in category 1, 16.1% in category 2, 33.3% in category 3, and 27.7% in category 4. There were 2,448 deaths during the 9.6 average years of follow-up. Total mortality was 11.2% lower in category 2 (P = 0.04), 32.4% lower in category 3 (P < 10(-12)) and 32.9% lower in category 4 (P = 10(-11)) than in category 1. For underlying causes of death, the respective risk reductions for categories 2, 3 and 4 were 23.6% (P = 0.008), 35.2% (P < 10(-5)), and 34.9% (P = 0.0001) for cardiovascular disease mortality; 27.8% (P = 0.18), 20.6% (P = 0.07), and 31.4% (P = 0.009) for ischemic heart disease mortality; and 39.4% (P = 0.18), 63.8% (P = 0.005), and 90.6% (P = 0.002) for diabetes mortality when compared to category 1. For all related mortality (i.e., underlying and contributing causes of death combined), the respective risk reductions for categories 2, 3 and 4 were 18.7% (P = 0.22), 42.5% (P = 0.001), and 57.5% (P = 0.0001) for heart failure; 9.4% (P = 0.56), 44.3% (P = 0.0004), and 33.5% (P = 0.02) for hypertensive diseases; 11.5% (P = 0.38), 41.0% (P < 10(-4)), and 35.5% (P = 0.001) for dysrhythmias: and 23.2% (P = 0.13), 45.8% (P = 0.0002), and 41.1% (P = 0.005) for cerebrovascular diseases when compared to category 1. Conclusions: There are substantial health benefits to exceeding the current exercise guidelines.	Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Williams, PT (corresponding author), Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [HL094717]; Department of Energy [DE-AC03-76SF00098]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant HL094717 from the National Heart, Lung, and Blood Institute and was conducted at the Ernest Orlando Lawrence Berkeley National Laboratory (Department of Energy DE-AC03-76SF00098 to the University of California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2004, INSTR COMPL CAUS OF; DAVEY SG, 2000, PUBLIC HLTH, V114, P308; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fujita K, 2004, J EPIDEMIOL, V14, pS26, DOI 10.2188/jea.14.S26; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hsia J, 2005, AM J PREV MED, V28, P19, DOI 10.1016/j.amepre.2004.09.012; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; Lakkireddy DR, 2004, AM J MED, V117, P492, DOI 10.1016/j.amjmed.2004.04.018; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McEwen LN, 2006, DIABETES CARE, V29, P247, DOI 10.2337/diacare.29.02.06.dc05-0998; Messite J, 1996, JAMA-J AM MED ASSOC, V275, P794, DOI 10.1001/jama.275.10.794; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Noda H, 2005, J AM COLL CARDIOL, V46, P1761, DOI 10.1016/j.jacc.2005.07.038; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pA1, DOI DOI 10.1111/J.1753-4887.2008.00136.X; Smith TC, 2007, J CLIN EPIDEMIOL, V60, P309, DOI 10.1016/j.jclinepi.2006.06.013; Stessman J, 2000, J AM GERIATR SOC, V48, P499, DOI 10.1111/j.1532-5415.2000.tb04995.x; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; Williams PT, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041822; Williams PT, 2008, MED SCI SPORT EXER, V40, P998, DOI 10.1249/MSS.0b013e31816722a9; Williams PT, 2008, J HYPERTENS, V26, P1085, DOI 10.1097/HJH.0b013e3282fb81dc; Williams PT, 2008, MED SCI SPORT EXER, V40, P433, DOI 10.1249/MSS.0b013e31815f38f1; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, DIABETES CARE, V30, P2838, DOI 10.2337/dc07-1189; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2012, MED SCI SPORT EXER, V44, P1728, DOI 10.1249/MSS.0b013e318258af3f; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036360; Williams PT, 2010, ATHEROSCLEROSIS, V209, P524, DOI 10.1016/j.atherosclerosis.2009.09.018; Williams PT, 2009, STROKE, V40, P1921, DOI 10.1161/STROKEAHA.108.535427; Williams PT, 2009, MED SCI SPORT EXER, V41, P73, DOI 10.1249/MSS.0b013e3181831417; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; World Health Organization, 1992, INT STAT CLASS DIS R	46	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e78777	10.1371/journal.pone.0078777	http://dx.doi.org/10.1371/journal.pone.0078777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312170	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300004
J	Apinjohr, TO; Anchang-Kimbi, JK; Njua-Yafi, C; Mugri, RN; Ngwai, AN; Rockett, KA; Mbunwe, E; Besingi, RN; Clark, TG; Kwiatkowski, DP; Achidi, EA				Apinjohr, Tobias O.; Anchang-Kimbi, Judith K.; Njua-Yafi, Clarisse; Mugri, Regina N.; Ngwai, Andre N.; Rockett, Kirk A.; Mbunwe, Eric; Besingi, Richard N.; Clark, Taane G.; Kwiatkowski, Dominic P.; Achidi, Eric A.		MalariaGEN Consortium	Association of Cytokine and Toll-Like Receptor Gene Polymorphisms with Severe Malaria in Three Regions of Cameroon	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; IL-13 PROMOTER; INNATE IMMUNITY; ETHNIC-GROUPS; SUSCEPTIBILITY; VARIANTS; MUTATIONS	P. falciparum malaria is one of the most widespread and deadliest infectious diseases in children under five years in endemic areas. The disease has been a strong force for evolutionary selection in the human genome, and uncovering the critical human genetic factors that confer resistance to the disease would provide clues to the molecular basis of protective immunity that would be invaluable for vaccine development. We investigated the effect of single nucleotide polymorphisms (SNPs) on malaria pathology in a case- control study of 1862 individuals from two major ethnic groups in three regions with intense perennial P. falciparum transmission in Cameroon. Twenty nine polymorphisms in cytokine and toll-like receptor (TLR) genes as well as the sickle cell trait (HbS) were assayed on the Sequenom iPLEX platform. Our results confirm the known protective effect of HbS against severe malaria and also reveal a protective effect of SNPs in interleukin-10 (IL10) cerebral malaria and hyperpyrexia. Furthermore, IL17RE rs708567 GA and hHbS rs334 AT individuals were associated with protection from uncomplicated malaria and anaemia respectively in this study. Meanwhile, individuals with the hHbS rs334 TT, IL10 rs3024500 AA, and IL17RD rs6780995 GA genotypes were more susceptible to severe malarial anaemia, cerebral malaria, and hyperpyrexia respectively. Taken together, our results suggest that polymorphisms in some immune response genes may have important implications for the susceptibility to severe malaria in Cameroonians. Moreover using uncomplicated malaria may allow us to identify novel pathways in the early development of the disease.	[Apinjohr, Tobias O.; Besingi, Richard N.; Achidi, Eric A.] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon; [Anchang-Kimbi, Judith K.] Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon; [Njua-Yafi, Clarisse] Univ Yaounde I, Dept Anim Biol & Physiol, Yaounde, Cameroon; [Mugri, Regina N.; Ngwai, Andre N.; Mbunwe, Eric; Achidi, Eric A.] Univ Buea, Dept Med Lab Sci, Buea, Cameroon; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Mbunwe, Eric] Brussels Free Univ, Diabet Res Ctr, Brussels, Belgium; [Besingi, Richard N.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Clark, Taane G.] London Sch Hyg & Trop Med, London WC1, England	University of Yaounde I; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; State University System of Florida; University of Florida; University of London; London School of Hygiene & Tropical Medicine	Apinjohr, TO (corresponding author), Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.	apinjohtoby@yahoo.co.uk	Clark, Taane G./AAM-2570-2020; Anchang-Kimbi, Judith/AAE-9802-2020	Clark, Taane G./0000-0001-8985-9265; Apinjoh, Tobias/0000-0001-9889-7271; Kwiatkowski, Dominic/0000-0002-5023-0176	European Community [242095 -EVIMalaR]; Central Africa Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM); European and Developing Countries Clinical Trials Partnership (EDCTP); MalariaGEN; Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 087285, 096527, 075491/Z/04, 090532/Z/09/Z]; Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health of the Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; Wellcome Trust Sanger Institute [077012/Z/05/Z]; MRC [G0600718, G0600230] Funding Source: UKRI	European Community(European Commission); Central Africa Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM); European and Developing Countries Clinical Trials Partnership (EDCTP); MalariaGEN; Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health of the Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Sanger Institute(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 242095 -EVIMalaR and partial financial support from the Central Africa Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM), funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) as well as from MalariaGEN. The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and the Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health (566) as part of the Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230), the Wellcome Trust Biomedical ethics Enhancement Award (087285) and Strategic Award (096527). The Wellcome Trust also provided core awards to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achidi EA, 2008, ANN TROP MED PARASIT, V102, P103, DOI 10.1179/136485908X252287; Achidi EA, 2013, J TROP DIS, V1, P103, DOI DOI 10.4172/JTD.1000403; Achidi EA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-215; Ackerman HC, 2003, GENES IMMUN, V4, P476, DOI 10.1038/sj.gene.6364008; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Campino S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-44; Carpenter D, 2007, HUM IMMUNOL, V68, P165, DOI 10.1016/j.humimm.2006.12.002; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cramer JP, 2004, TROP MED INT HEALTH, V9, P1074, DOI 10.1111/j.1365-3156.2004.01312.x; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Genc MR, 2004, EUR J OBSTET GYN R B, V116, P152, DOI 10.1016/j.ejogrb.2004.02.010; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Griffith JW, 2007, J INFECT DIS, V196, P1553, DOI 10.1086/522865; Gyan BA, 2004, CLIN EXP IMMUNOL, V138, P145, DOI 10.1111/j.1365-2249.2004.02590.x; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Koch O, 2005, GENES IMMUN, V6, P312, DOI 10.1038/sj.gene.6364214; Kraan TCTMV, 2002, GENES IMMUN, V3, P436, DOI 10.1038/sj.gene.6363896; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kurtzhals JAL, 1999, J INFECT DIS, V180, P1753, DOI 10.1086/315077; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Mangano VD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004206; Manjurano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047463; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Ohashi J, 2003, GENES IMMUN, V4, P528, DOI 10.1038/sj.gene.6364010; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Ouma C, 2008, HUM GENET, V124, P515, DOI 10.1007/s00439-008-0578-5; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; ROOTH I, 1991, AM J TROP MED HYG, V45, P309, DOI 10.4269/ajtmh.1991.45.309; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Teo YY, 2007, ANN HUM GENET, V71, P701, DOI 10.1111/j.1469-1809.2007.00356.x; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Walley AJ, 2004, EUR J HUM GENET, V12, P132, DOI 10.1038/sj.ejhg.5201084; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zisman-Rozen S, 2007, ONCOGENE, V26, P6093, DOI 10.1038/sj.onc.1210424	64	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81071	10.1371/journal.pone.0081071	http://dx.doi.org/10.1371/journal.pone.0081071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312262	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100058
J	Luo, XC; Shi, QX; Gui, Y; Pan, J; Huai, MF; Liu, ML; Dong, ZQ; Zhang, MJ; Wang, LL; Gu, Y; Zhong, JL; Zhao, XL; Jenkins, EC; Brown, WT; Zhong, N				Luo, Xiucui; Shi, Qingxi; Gui, Yang; Pan, Jing; Huai, Maofang; Liu, Meilin; Dong, Ziqing; Zhang, Meijiao; Wang, Leilei; Gu, Ying; Zhong, Julia; Zhao, Xinliang; Jenkins, Edmund C.; Brown, W. Ted; Zhong, Nanbert			LncRNA Pathway Involved in Premature Preterm Rupture of Membrane (PPROM): An Epigenomic Approach to Study the Pathogenesis of Reproductive Disorders	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LONG NONCODING RNAS; FETAL MEMBRANES; POLYMORPHISM; GENE; ASSOCIATION; EXPRESSION; ANRIL; LOCUS; LABOR	Preterm birth (PTB) is a live birth delivered before 37 weeks of gestation (GW). About one-third of PTBs result from the preterm premature rupture of membranes (PPROM). Up to the present, the pathogenic mechanisms underlying PPROM are not clearly understood. Here, we investigated the differential expression of long chain non-coding RNAs (lncRNAs) in placentas of PTBs with PPROM, and their possible involvement in the pathogenic pathways leading to PPROM. A total number of 1954, 776, and 1050 lncRNAs were identified with a microarray from placentas of PPROM (group A), which were compared to full-term birth (FTB) (group B), PTB (group C), and premature rupture of membrane (PROM) (group D) at fullterm, respectively. Instead of investigating the individual pathogenic role of each lncRNA involved in the molecular mechanism underlying PPROM, we have focused on investigating the metabolic pathways and their functions to explore what is the likely association and how they are possibly involved in the development of PPROM. Six groups, including upregulation and down-regulation in the comparisons of A vs. B, A vs. C, and A vs. D, of pathways were analyzed. Our results showed that 22 pathways were characterized as up-regulated 7 down-regulated in A vs. C, 18 up-regulated and 15 down-regulated in A vs. D, and 33 up-regulated and 7 down-regulated in A vs. B. Functional analysis showed pathways of infection and inflammatory response, ECM-receptor interactions, apoptosis, actin cytoskeleton, and smooth muscle contraction are the major pathogenic mechanisms involved in the development of PPROM. Characterization of these pathways through identification of lncRNAs opened new avenues for further investigating the epigenomic mechanisms of lncRNAs in PPROM as well as PTB.	[Luo, Xiucui; Shi, Qingxi; Gui, Yang; Pan, Jing; Huai, Maofang; Liu, Meilin; Dong, Ziqing; Zhang, Meijiao; Wang, Leilei; Gu, Ying; Zhong, Nanbert] Lianyungang Maternal & Childrens Hosp, Ctr Translat Med Maternal & Childrens Hlth, Lianyungang, Jiangsu, Peoples R China; [Zhong, Julia] Hunter Coll High Sch, New York, NY USA; [Jenkins, Edmund C.; Brown, W. Ted; Zhong, Nanbert] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Zhao, Xinliang; Zhong, Nanbert] Peking Univ, Ctr Med Genet, Beijing 100871, Peoples R China; [Zhong, Nanbert] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Zhong, Nanbert] March Dimes Global Network Maternal & Infant Hlth, White Plains, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); Institute for Basic Research in Developmental Disabilities; Peking University; Shanghai Jiao Tong University	Zhong, N (corresponding author), Lianyungang Maternal & Childrens Hosp, Ctr Translat Med Maternal & Childrens Hlth, Lianyungang, Jiangsu, Peoples R China.	nanbert.zhong@opwdd.ny.gov	Brown, William/GXN-2777-2022		Lianyungang Maternal and Children's Hospital; March of Dimes Global Network for Maternal and Infant Health (MOD-GNMIH); Peking University Center of Medical Genetics (PUCMG); New York State Office for People with Developmental Disabilities (NYS OPWDD)	Lianyungang Maternal and Children's Hospital; March of Dimes Global Network for Maternal and Infant Health (MOD-GNMIH); Peking University Center of Medical Genetics (PUCMG); New York State Office for People with Developmental Disabilities (NYS OPWDD)	This project is granted by a special fund from Lianyungang Maternal and Children's Hospital, along with support from the March of Dimes Global Network for Maternal and Infant Health (MOD-GNMIH), Peking University Center of Medical Genetics (PUCMG), and New York State Office for People with Developmental Disabilities (NYS OPWDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annilo T, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-81; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Crosthwaite SK, 2004, FEBS LETT, V567, P49, DOI 10.1016/j.febslet.2004.04.073; DeFranco E, 2007, SEMIN REPROD MED, V25, P40, DOI 10.1055/s-2006-956774; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dreesen TD, 2006, PROSTAG LEUKOTR ESS, V75, P97, DOI 10.1016/j.plefa.2006.05.001; Erez O, 2009, J MATERN-FETAL NEO M, V22, P1103, DOI 10.3109/14767050902994796; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Castillo AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022822; Ferrand PE, 2002, MOL HUM REPROD, V8, P1031, DOI 10.1093/molehr/8.11.1031; Fortunato SJ, 2002, AM J OBSTET GYNECOL, V187, P1159, DOI 10.1067/mob.2002.127457; Fuks A, 2005, AM J OBSTET GYNECOL, V193, P1132, DOI 10.1016/j.ajog.2005.05.082; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gomez-Lopez N, 2010, BIOL REPROD, V82, P809, DOI 10.1095/biolreprod.109.080432; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Iacobucci I, 2011, LEUKEMIA RES, V35, P1052, DOI 10.1016/j.leukres.2011.02.020; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P1368, DOI 10.1016/j.ajog.2004.07.007; Kalish RB, 2006, J REPROD IMMUNOL, V70, P109, DOI 10.1016/j.jri.2005.12.002; Kamada S, 2005, MOL CELL BIOL, V25, P9469, DOI 10.1128/MCB.25.21.9469-9477.2005; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Lukaszewski T, 2009, GINEKOL POL, V80, P914; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pasmant E, 2011, J NATL CANCER I, V103, P1713, DOI 10.1093/jnci/djr416; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Roberts AK, 1999, AM J OBSTET GYNECOL, V180, P1297, DOI 10.1016/S0002-9378(99)70632-0; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P805, DOI 10.1016/0002-9378(93)90009-8; Romero R GF, 2010, INFLAMMATION INFECT; Romero R, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.026; Salminen A, 2009, ANN MED, V41, P629, DOI 10.1080/07853890903186176; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Shore AN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002840; Srinivas S K, 2005, Minerva Ginecol, V57, P389; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Valdez-Velazquez LL, 2007, J RENIN-ANGIO-ALDO S, V8, P160, DOI 10.3317/jraas.2007.026; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoshikawa H, 1999, ONCOGENE, V18, P3415, DOI 10.1038/sj.onc.1202677	69	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79897	10.1371/journal.pone.0079897	http://dx.doi.org/10.1371/journal.pone.0079897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312190	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100018
J	Wang, Y; Wei, BY; Tian, YX; Wang, Z; Tian, Y; Tan, SD; Dong, SZ; Song, QS				Wang, Yang; Wei, Baoyang; Tian, Yixing; Wang, Zhi; Tian, Yun; Tan, Shuduan; Dong, Shengzhang; Song, Qisheng			Evaluation of the Potential Effect of Transgenic Rice Expressing Cry1Ab on the Hematology and Enzyme Activity in Organs of Female Swiss Rats	PLOS ONE			English	Article							PREDATOR CYRTORHINUS-LIVIDIPENNIS; BACILLUS-THURINGIENSIS BERLINER; INDICA BASMATI RICE; BT RICE; GASTROINTESTINAL CONTENTS; FIELD-EVALUATION; STEM BORERS; WISTAR RATS; TOXIN; PROTEIN	To assess the safety of transgenic rice expressing Cry1Ab protein to vertebrates, the effect of Cry1Ab rice on broad health indicators in blood and various organs of Swiss rats were analyzed. The 30 and 90 day safety studies of Cry1Ab rice on female Swiss rats revealed that Cry1Ab rice had no significant effect on the several elements of blood lymph including hemogram, calcium ion concentration and apoptosis rate of lymphocytes, indicating that Cry1Ab protein could not affect the blood lymph of Swiss rat. Similarly, Cry1Ab rice had no effect on enzyme activities in a variety of organs of Swiss rat. However, Cry1Ab rice did have significant effects on the blood biochemistry indexes including urea, triglyceride (TG), glutamic oxalacetic transaminase (AST) and alkaline phosphatase (ALP) after the rats were fed with Cry1Ab rice for 30 days, but not after 90 days, indicating that Cry1Ab protein may influence blood metabolism for a short duration. Quantitative real-time PCR (qPCR) analysis of the 6 genes encoding enzymes responsible for the major detoxification functions of liver revealed that Cry1Ab rice exerted no influences on the levels of these transcripts in liver of Swiss rat, indicating that significant differences registered in part of the blood biochemical parameters in the 30 day study might result from other untested organs or tissues in response to the stress of exogenous Cry1Ab protein. The results suggest that Cry1Ab protein has no significant long-term (90 day) effects on female Swiss rat.	[Wang, Yang; Wei, Baoyang; Tian, Yixing; Wang, Zhi; Tian, Yun; Tan, Shuduan; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Dong, Shengzhang; Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@sina.com; SongQ@missouri.edu		Dong, Shengzhang/0000-0002-8218-4688	Natural Science Foundation of P. R. China [31071943, 31272339]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC))	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of our study has come from the Natural Science Foundation of P. R. China (No.31272339). Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. All programs and services of the U.S. Department of Agriculture are offered on a nondiscriminatory basis without regard to race, color, national origin, religion, sex, age, marital status, or handicap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aris A, 2011, REPROD TOXICOL, V31, P528, DOI 10.1016/j.reprotox.2011.02.004; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen M, 2006, ENVIRON ENTOMOL, V35, P127, DOI 10.1603/0046-225X-35.1.127; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P72; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; CHUBB IW, 1979, LANCET, V1, P688; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Livak KJ., 2001, METHODS, V25, P402; Mesnage R, 2013, J APPL TOXICOL, V33, P695, DOI 10.1002/jat.2712; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; OECD, 2004, CONSENSUS DOCUMENT C; POINAR GO, 1975, NEMATOLOGICA, V21, P463, DOI 10.1163/187529275X00239; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Walsh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036141; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wang ZH, 2002, J SCI FOOD AGR, V82, P738, DOI 10.1002/jsfa.1105; Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	33	7	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80424	10.1371/journal.pone.0080424	http://dx.doi.org/10.1371/journal.pone.0080424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312218	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100038
J	Xu, QF; Ni, HP; Chen, QQ; Sun, F; Zhou, T; Lan, Y; Zhou, YJ				Xu, Qiufang; Ni, Haiping; Chen, Qingqing; Sun, Feng; Zhou, Tong; Lan, Ying; Zhou, Yijun			Comparative Proteomic Analysis Reveals the Cross-Talk between the Responses Induced by H2O2 and by Long-Term Rice Black-Streaked Dwarf Virus Infection in Rice	PLOS ONE			English	Article							ANTIOXIDANT ENZYMES; OXIDATIVE STRESS; BINDING PROTEINS; DISEASE; EXPRESSION; NETWORK; LEAVES; PLANTS; BURST; MAIZE	Hydrogen peroxide (H2O2) could be produced during the plant-virus compatible interaction. However, the cell responses regulated by the enhanced H2O2 in virus infected plant are largely unknown. To make clear the influence of Rice black-streaked dwarf virus (RBSDV) infection on H2O2 accumulation, 2 2 we measured the content of H2O2 and found the H2O2 level was increased in rice seedlings inoculated with RBSDV. To reveal the responses initiated by the enhanced H2O2 during plant-virus interaction, the present study investigated the global piroteome changes of rice under long-term RBSDV infection. Approximately 1800 protein spots were detected on two-dimensional electrophoresis (2-DE) gels. Among them, 72 spots were found differently expressed, of which 69 spots were uccessfully identified by MALDI-TOF/TOF-MS. Furthermore, the differentially expressed proteins induced by RBSDV infection were compared to that induced by H2O2. 19 proteins corresponding to 37 spots which were differentially expressed under RBSDV infection, were observed differentially expressed under H2O2 stress as well. These overlapping responsive proteins are mainly related to photosynthesis, redox homeostasis, metabolism, energy pathway, and cell wall modification. The increased H2O2 in FZBSDV infected plant may produce an oxidative stress, impair photosynthesis, disturb the metabolism, and eventually result in abnormal growth. The data provide a new understanding of the pivotal role of H2O2 in rice-RBSDV compatible interaction.	[Xu, Qiufang; Ni, Haiping; Chen, Qingqing; Sun, Feng; Zhou, Tong; Lan, Ying; Zhou, Yijun] Jiangsu Acad Agr Sci, Jiangsu Tech Serv Ctr Diag & Detect Plant Virus D, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Xu, QF (corresponding author), Jiangsu Acad Agr Sci, Jiangsu Tech Serv Ctr Diag & Detect Plant Virus D, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	xuqiufang@jaas.ac.cn; yjzhou@jaas.ac.cn			Jiangsu Agriculture Science and Technology Innovation Fund [CX(13)5019]; National Natural Science Foundation of China [31000841, 31201484]; Special Fund for Agro-Scientific Research in the Public Interest of China [201003031]; National Key Basic Research and Development Program (973 Program) of China [2010CB126203]	Jiangsu Agriculture Science and Technology Innovation Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China)	This research was financially supported by grants from the Jiangsu Agriculture Science and Technology Innovation Fund (CX(13)5019), the National Natural Science Foundation of China (31000841, 31201484), the Special Fund for Agro-Scientific Research in the Public Interest of China (201003031), and National Key Basic Research and Development Program (973 Program) of China (2010CB126203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Avilan L, 2000, J BIOL CHEM, V275, P9447, DOI 10.1074/jbc.275.13.9447; Bai FW, 2002, VIRUS GENES, V25, P201, DOI 10.1023/A:1020170020581; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; De Cnodder T, 2005, NEW PHYTOL, V168, P541, DOI 10.1111/j.1469-8137.2005.01540.x; Diaz-Vivancos P, 2006, J EXP BOT, V57, P3813, DOI 10.1093/jxb/erl138; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Guo DP, 2005, PLANT SCI, V168, P57, DOI 10.1016/j.plantsci.2004.07.019; Hafez YM, 2012, PHYTOPATHOLOGY, V102, P848, DOI 10.1094/PHYTO-01-12-0012-R; Hao ZN, 2011, PLANT PHYSIOL BIOCH, V49, P744, DOI 10.1016/j.plaphy.2011.01.014; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; Ji Ying-hua, 2011, Zhongguo Shuidao Kexue, V25, P91, DOI 10.3969/j.issn.1001-7216.2011.01.014; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; KLECZKOWSKI LA, 1994, PHYTOCHEMISTRY, V37, P1507, DOI 10.1016/S0031-9422(00)89568-0; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li KP, 2011, GENE, V485, P106, DOI 10.1016/j.gene.2011.06.016; Li L, 2011, J PHYTOPATHOL, V159, P1, DOI 10.1111/j.1439-0434.2010.01713.x; Li ZhaoHui, 2002, Agricultural Sciences in China, V1, P531; LU Y, 2012, CHINESE J RICE SCI, V26, P34; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Meisrimler CN, 2011, J PROTEOMICS, V74, P1437, DOI 10.1016/j.jprot.2011.01.012; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Odanaka S, 2002, PLANT PHYSIOL, V129, P1119, DOI 10.1104/pp.000703; [任萍 REN Ping], 2009, [河北农业大学学报, Journal of Agricultural University of Hebei], V32, P89; Riedle-Bauer M, 2000, J PHYTOPATHOL, V148, P297, DOI 10.1046/j.1439-0434.2000.00503.x; Salvucci ME, 1996, PHOTOSYNTH RES, V47, P1, DOI 10.1007/BF00017748; SHIKATA E, 1977, VIROLOGY, V77, P826, DOI 10.1016/0042-6822(77)90502-5; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Synkova H, 2006, PLANT SCI, V171, P607, DOI 10.1016/j.plantsci.2006.06.002; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Umate P, 2010, PLANT SIGNAL BEHAV, V5, P1537, DOI 10.4161/psb.5.12.13410; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang HD, 2009, PLANT PATHOL, V58, P815, DOI 10.1111/j.1365-3059.2009.02091.x; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; [肖冬来 Xiao Donglai], 2010, [热带作物学报, Chinese Journal of Tropical Crops], V31, P435; Xu QF, 2012, J EXP BOT, V63, P2421, DOI 10.1093/jxb/err397; Yang DH, 2000, FEBS LETT, V466, P385, DOI 10.1016/S0014-5793(00)01107-8	52	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81640	10.1371/journal.pone.0081640	http://dx.doi.org/10.1371/journal.pone.0081640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312331	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100091
J	Alaggio, R; Turrini, R; Boldrin, D; Merlo, A; Gambini, C; Ferrari, A; Dall'Igna, P; Coffin, CM; Martines, A; Bonaldi, L; De Salvo, GL; Zanovello, P; Rosato, A				Alaggio, Rita; Turrini, Riccardo; Boldrin, Daniela; Merlo, Anna; Gambini, Claudio; Ferrari, Andrea; Dall'Igna, Patrizia; Coffin, Cheryl M.; Martines, Annalisa; Bonaldi, Laura; De Salvo, Gian Luca; Zanovello, Paola; Rosato, Antonio			Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1; ESOPHAGEAL CANCER; GENE; SARCOMA; TUMORIGENESIS; BIOMARKER; MARKER; CELLS	Malignant peripheral nerve sheath tumors (MPNST) are very aggressive malignancies comprising approximately 5-10% of all soft tissue sarcomas. In this study, we focused on pediatric MPNST arising in the first 2 decades of life, as they represent one the most frequent non-rhabdomyosarcomatous soft tissue sarcomas in children. In MPNST, several genetic alterations affect the chromosomal region 17q encompassing the BIRC5/SURVIVIN gene. As cancer-specific expression of survivin has been found to be an effective marker for cancer detection and outcome prediction, we analyzed survivin expression in 35 tumor samples derived from young patients affected by sporadic and neurofibromatosis type 1-associated MPNST. Survivin mRNA and protein expression were assessed by Real-Time PCR and immunohistochemical staining, respectively, while gene amplification was analyzed by FISH. Data were correlated with the clinicopathological characteristics of patients. Survivin mRNA was overexpressed in pediatric MPNST and associated to a copy number gain of BIRC5; furthermore, increased levels of transcripts correlated with a higher FNCLCC tumor grade (grade 1 and 2 vs. 3, p = 0.0067), and with a lower survival probability (Log-rank test, p = 0.0038). Overall, these data support the concept that survivin can be regarded as a useful prognostic marker for pediatric MPNST and a promising target for therapeutic interventions.	[Alaggio, Rita] Univ Padua, Dept Med, Padua, Italy; [Turrini, Riccardo; Boldrin, Daniela; Merlo, Anna; Martines, Annalisa; Bonaldi, Laura; De Salvo, Gian Luca; Zanovello, Paola; Rosato, Antonio] IRCCS, Veneto Inst Oncol IOV, Padua, Italy; [Gambini, Claudio] IRCCS, Ist Giannina Gaslini, Serv Anat & Istol Patol, Genoa, Italy; [Ferrari, Andrea] Fdn IRCCS, INT, Milan, Italy; [Dall'Igna, Patrizia] Univ Padua, Dept Pediat, Pediat Surg Sect, Padua, Italy; [Coffin, Cheryl M.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Rosato, Antonio] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Padua; Vanderbilt University; University of Padua	Rosato, A (corresponding author), IRCCS, Veneto Inst Oncol IOV, Padua, Italy.	antonio.rosato@unipd.it	Merlo, Anna/FCK-4327-2022; Rosato, Antonio/E-8626-2010; Martines, Annalisa/S-1181-2018; De Salvo, Gian Luca/Q-3964-2019; alaggio, rita/AAC-2348-2019; Ferrari, Andrea/R-1028-2016; De Salvo, Gian Luca/F-4909-2012	Merlo, Anna/0000-0002-2741-9624; Rosato, Antonio/0000-0002-5263-8386; Martines, Annalisa/0000-0002-4701-8457; De Salvo, Gian Luca/0000-0001-7451-8476; alaggio, rita/0000-0003-3915-3816; Ferrari, Andrea/0000-0002-4724-0517; De Salvo, Gian Luca/0000-0001-7451-8476; Zanovello, Paola/0000-0002-9996-2669; Dall'Igna, Patrizia/0000-0002-3822-3272; BONALDI, LAURA/0000-0001-7101-3093	Italian Association for Cancer Research (AIRC); Fondazione Berlucchi	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Berlucchi	This work was supported by funds from the Italian Association for Cancer Research (AIRC) and Fondazione Berlucchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baykara M, 2011, INT IMMUNOPHARMACOL, V11, P2227, DOI 10.1016/j.intimp.2011.10.005; Carli M, 2005, J CLIN ONCOL, V23, P8422, DOI 10.1200/JCO.2005.01.4886; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Carroll SL, 2012, ACTA NEUROPATHOL, V123, P321, DOI 10.1007/s00401-011-0928-6; Carter BZ, 2012, BLOOD, V120, P173, DOI 10.1182/blood-2012-02-409888; Cates JMM, 2012, PEDIATR DEVEL PATHOL, V15, P62, DOI 10.2350/11-03-1003-PB.1; Church DN, 2012, CURR ONCOL REP, V14, P120, DOI 10.1007/s11912-012-0215-2; Coindre JM, 2013, WHO CLASSIFICATION T, P17; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Ferrari A, 2007, CANCER-AM CANCER SOC, V109, P1406, DOI 10.1002/cncr.22533; Ghadimi MP, 2012, CLIN CANCER RES, V18, P2545, DOI 10.1158/1078-0432.CCR-11-2592; Gottfried ON, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09221; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hingorani P, 2013, PEDIATR BLOOD CANCER, V60, P35, DOI 10.1002/pbc.24290; Karube K, 2006, J CLIN PATHOL, V59, P160, DOI 10.1136/jcp.2004.023598; Kato J, 2001, INT J CANCER, V95, P92; Keizman D, 2009, J NEURO-ONCOL, V94, P383, DOI 10.1007/s11060-009-9862-z; Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; Krieg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065338; Lechler P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-120; Levy P, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-20; Li F, 2005, BRIT J CANCER, V92, P212, DOI 10.1038/sj.bjc.6602340; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margulis V, 2008, WORLD J UROL, V26, P59, DOI 10.1007/s00345-007-0219-y; MEIS JM, 1992, AM J SURG PATHOL, V16, P694, DOI 10.1097/00000478-199207000-00008; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Okuya M, 2010, J BIOL CHEM, V285, P1850, DOI 10.1074/jbc.M109.023762; Patel AV, 2012, CLIN CANCER RES, V18, P5020, DOI 10.1158/1078-0432.CCR-12-1072; Rodriguez FJ, 2012, ACTA NEUROPATHOL, V123, P295, DOI 10.1007/s00401-012-0954-z; Rosato A, 2006, INT J CANCER, V119, P1717, DOI 10.1002/ijc.21923; Rosato A, 2013, LUNG CANCER, V79, P180, DOI 10.1016/j.lungcan.2012.11.004; Storlazzi CT, 2006, J PATHOL, V209, P492, DOI 10.1002/path.1998; Taubert H, 2007, ONCOGENE, V26, P7170, DOI 10.1038/sj.onc.1210530; Upadhyaya M, 2008, HUM MUTAT, V29, P74, DOI [10.1002/humu.20601, 10.1002/humu.20793]; Upadhyaya M, 2011, FRONT BIOSCI-LANDMRK, V16, P937, DOI 10.2741/3727; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100	39	14	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80456	10.1371/journal.pone.0080456	http://dx.doi.org/10.1371/journal.pone.0080456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303016	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400032
J	Hiester, KG; Santy, LC				Hiester, Kevin G.; Santy, Lorraine C.			The Cytohesin Coiled-Coil Domain Interacts with Threonine 276 to Control Membrane Association	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLASMA-MEMBRANE; ARF6 ACTIVATION; CELL-MIGRATION; SEC7 DOMAIN; FACTOR ARNO; PH DOMAIN; PROTEIN; FAMILY; INHIBITION	Cell migration is regulated by a number of small GTPases, including members of the Arf family. Cytohesins, a family of Arf-activating proteins, have been extensively implicated in the regulation of Arfs during migration and cell shape change. Membrane association of both the Arf and its activating protein is a prerequisite for Arf activation. Therefore regulating the extent of cytohesin membrane association is a mechanism for controlling the initiation of cell movement. We have discovered a novel intramolecular interaction that controls the association of cytohesins with membranes. The presence of the coiled-coil domain reduces the association of cytohesin 2 with membranes. We demonstrate that this domain interacts with more C-terminal regions of the protein. This interaction is independent of another previously identified autoinhibitory conformation. A threonine residue (T276) in the cytohesin 2 PH domain is a target for phosphorylation by Akt. Mutation of this threonine to aspartic acid, to mimic phosphorylation, disrupts the binding of the coiled-coil domain to c-terminal regions and promotes membrane association of cytohesin 2. The presence of a second autoinhibitory interaction in the cytohesins suggests that these proteins can act a signal integrators that stimulate migration only after receive multiple pro-migratory signals.	[Hiester, Kevin G.; Santy, Lorraine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Santy, LC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	lcsanty@psu.edu		Santy, Lorraine/0000-0002-4795-0738	American Cancer Society [RSG-09-168-01-CSM]; National Institutes of Health [1 R01 DK093729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093729] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant number RSG-09-168-01-CSM from the American Cancer Society (www.cancer.org) and grant number 1 R01 DK093729 from the National Institutes of Health (www.nih.gov) to L. C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Attar MA, 2012, EXP CELL RES, V318, P228, DOI 10.1016/j.yexcr.2011.10.018; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hall B, 2008, ANAL BIOCHEM, V374, P243, DOI 10.1016/j.ab.2007.11.032; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Karihaloo A, 2005, NEPHRON EXP NEPHROL, V100, pE40, DOI 10.1159/000084111; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Li J, 2012, DEV CELL, V22, P1286, DOI 10.1016/j.devcel.2012.03.004; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	36	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82084	10.1371/journal.pone.0082084	http://dx.doi.org/10.1371/journal.pone.0082084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303080	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400097
J	Murugan, RN; Jacob, B; Ahn, M; Hwang, E; Sohn, H; Park, HN; Lee, E; Seo, JH; Cheong, C; Nam, KY; Hyun, JK; Jeong, KW; Kim, Y; Shin, SY; Bang, JK				Murugan, Ravichandran N.; Jacob, Binu; Ahn, Mija; Hwang, Eunha; Sohn, Hoik; Park, Hyo-Nam; Lee, Eunjung; Seo, Ji-Hyung; Cheong, Chaejoon; Nam, Ky-Youb; Hyun, Jae-Kyung; Jeong, Ki-Woong; Kim, Yangmee; Shin, Song Yub; Bang, Jeong Kyu			De Novo Design and Synthesis of Ultra-Short Peptidomimetic Antibiotics Having Dual Antimicrobial and Anti-Inflammatory Activities	PLOS ONE			English	Article							IN-VIVO ACTIVITY; ANTIBACTERIAL PROPERTIES; BETA-PEPTIDES; BUFORIN II; MODE; MECHANISM; MEMBRANE; LIPOPEPTIDES; STABILITY; FOLDAMERS	Background: Much attention has been focused on the design and synthesis of potent, cationic antimicrobial peptides (AMPs) that possess both antimicrobial and anti-inflammatory activities. However, their development into therapeutic agents has been limited mainly due to their large size (12 to 50 residues in length) and poor protease stability. Methodology/Principal Findings: In an attempt to overcome the issues described above, a set of ultra-short, His-derived antimicrobial peptides (HDAMPs) has been developed for the first time. Through systematic tuning of pendant hydrophobic alkyl tails at the N(pi)- and N(tau)-positions on His, and the positive charge of Arg, much higher prokaryotic selectivity was achieved, compared to human AMP LL-37. Additionally, the most potent HDAMPs showed promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and proteolytic resistance. Our results from transmission electron microscopy, membrane depolarization, confocal laser-scanning microscopy, and calcein-dye leakage experiments propose that HDAMP-1 kills microbial cells via dissipation of the membrane potential by forming pore/ion channels on bacterial cell membranes. Conclusion/Significance: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.	[Murugan, Ravichandran N.; Ahn, Mija; Hwang, Eunha; Seo, Ji-Hyung; Cheong, Chaejoon; Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chung Buk, South Korea; [Jacob, Binu; Shin, Song Yub] Chosun Univ, Grad Sch, Dept Biomat, Kwangju, South Korea; [Jacob, Binu; Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea; [Sohn, Hoik] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Park, Hyo-Nam; Hyun, Jae-Kyung] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea; [Lee, Eunjung; Jeong, Ki-Woong; Kim, Yangmee] Konkuk Univ, Inst SMART Biotechnol, Dept Biosci & Biotechnol, Seoul, South Korea; [Nam, Ky-Youb] Bioinformat & Mol Design Res Ctr, Seoul, South Korea	Korea Basic Science Institute (KBSI); Chosun University; Chosun University; University of Texas System; University of Texas Austin; Korea Basic Science Institute (KBSI); Konkuk University	Shin, SY (corresponding author), Chosun Univ, Grad Sch, Dept Biomat, Kwangju, South Korea.	syshin@chosun.ac.kr; bangjk@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022; Jacob, Binu/GQP-7954-2022; Hyun, Jaekyung/AAK-2521-2020; Jacob, Binu/K-7621-2016; Jacob, Binu/GQQ-3019-2022; Jacob, Binu/AAA-2737-2022	Hyun, Jaekyung/0000-0003-2914-537X; Jacob, Binu/0000-0002-2770-8741; Jacob, Binu/0000-0002-2770-8741; 	Korea Basic Science Institute [T33418, T33518]; Korea Research Foundation; Korean Government [KRF-2011-0009039]	Korea Basic Science Institute; Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported in part by the Korea Basic Science Institute's research program grants T33418 (J.K.B) and T33518 (J-k.H.), and the Korea Research Foundation, funded by the Korean Government (KRF-2011-0009039 to S.Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bremner JB, 2010, ANGEW CHEM INT EDIT, V49, P537, DOI 10.1002/anie.200904392; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Choi S, 2009, P NATL ACAD SCI USA, V106, P6968, DOI 10.1073/pnas.0811818106; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Chongsiriwatana NP, 2010, ANTIMICROB AGENTS CH, V55, P417; Claudon P, 2010, ANGEW CHEM INT EDIT, V49, P333, DOI 10.1002/anie.200905591; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; Gough M, 1996, INFECT IMMUN, V64, P4922, DOI 10.1128/IAI.64.12.4922-4927.1996; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hansen T, 2011, J MED CHEM, V54, P858, DOI 10.1021/jm101327d; Heller WT, 2000, BIOCHEMISTRY-US, V39, P139, DOI 10.1021/bi991892m; Himes RA, 2007, J AM CHEM SOC, V129, P5352, DOI 10.1021/ja0708013; Jahnsen RD, 2012, J MED CHEM, V55, P7253, DOI 10.1021/jm300820a; Kichler A, 2007, J MOL MED, V85, P191, DOI 10.1007/s00109-006-0119-4; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067597; Liu DH, 2001, J AM CHEM SOC, V123, P7553, DOI 10.1021/ja0107475; Liu ZG, 2007, ANTIMICROB AGENTS CH, V51, P597, DOI 10.1128/AAC.00828-06; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003; Nan YH, 2012, PEPTIDES, V35, P239, DOI 10.1016/j.peptides.2012.04.004; Navon-Venezia S, 2002, ANTIMICROB AGENTS CH, V46, P689, DOI 10.1128/AAC.46.3.689-694.2002; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; Niu YH, 2011, CHEM COMMUN, V47, P12197, DOI 10.1039/c1cc14476f; Oren Z, 1998, BIOPOLYMERS, V47, P451; Osapay G, 1997, J MED CHEM, V40, P2241, DOI 10.1021/jm960850i; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Porter EA, 2005, J AM CHEM SOC, V127, P11516, DOI 10.1021/ja0519785; Qian WJ, 2011, J ORG CHEM, V76, P8885, DOI 10.1021/jo201599c; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Rozek A, 2003, BIOCHEMISTRY-US, V42, P14130, DOI 10.1021/bi035643g; Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553; Sharma RK, 2009, J MED CHEM, V52, P7421, DOI 10.1021/jm900622d; Shuey SW, 2006, BIOORG MED CHEM LETT, V16, P1245, DOI 10.1016/j.bmcl.2005.11.075; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Zaknoon F, 2009, ANTIMICROB AGENTS CH, V53, P3422, DOI 10.1128/AAC.00010-09; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	24	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80025	10.1371/journal.pone.0080025	http://dx.doi.org/10.1371/journal.pone.0080025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302996	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400012
J	Armando, I; Villar, VM; Jones, JE; Lee, H; Wang, XY; Asico, LD; Yu, PY; Yang, J; Escano, CS; Pascua-Crusan, AM; Felder, RA; Jose, PA				Armando, Ines; Villar, Van Anthony M.; Jones, John E.; Lee, Hewang; Wang, Xiaoyan; Asico, Laureano D.; Yu, Peiying; Yang, Jian; Escano, Crisanto S., Jr.; Pascua-Crusan, Annabelle M.; Felder, Robin A.; Jose, Pedro A.			Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation	FASEB JOURNAL			English	Article						renal proximal tubule cells; kidney; blood pressure; C57Bl; 6 mice	NA+/H+ EXCHANGER NHE3; PROTEIN-COUPLED RECEPTOR; MEDIATED INHIBITION; ANGIOTENSIN-II; BLOOD-PRESSURE; HYPERTENSION; MECHANISMS; EXPRESSION; GENE; NATRIURESIS	The dopamine D-3 receptor (D3R) is crucial in the regulation of blood pressure and sodium balance, in that Drd3 gene ablation in mice results in hypertension and failure to excrete a dietary salt load. The mechanism responsible for the renal sodium retention in these mice is largely unknown. We now offer and describe a novel mechanism by which D3R decreases sodium transport in the long term by inhibiting the deubiquitinylating activity of ubiquitin-specific peptidase 48 (USP48), thereby promoting Na+-H+ exchanger (NHE)-3 degradation. We found that stimulation with the D3R-specific agonist PD128907 (1 M, 30 min) promoted the interaction and colocalization among D3R, NHE3, and USP48; inhibited USP48 activity (-35 +/- 6%, vs. vehicle), resulting in increased ubiquitinylated NHE3 (+140 +/- 10%); and decreased NHE3 expression (-50 +/- 9%) in human renal proximal tubule cells (hRPTCs). USP48 silencing decreased NHE3's half-life (USP48 siRNA t(1/2)=6.1 h vs. vehicle t(1/2)=12.9 h), whereas overexpression of USP48 increased NHE3 half-life (t(1/2)=21.8 h), indicating that USP48 protects NHE3 from degradation via deubiquitinylation. USP48 accounted for approximate to 30% of the total deubiquitinylating activity in these cells. Extending our studies in vivo, we found that pharmacologic blockade of D3R via the D3R-specific antagonist GR103691 (1 g/kg/min, 4 d) in C57Bl/6J mice increased renal NHE3 expression (+310 +/- 15%, vs. vehicle), whereas an innovative kidney-restricted Usp48 silencing via siRNA (3 g/d, 7 d) increased ubiquitinylated NHE3 (+250 +/- 30%, vs. controls), decreased total NHE3 (-23 +/- 2%), and lowered blood pressure (-24 +/- 2 mm Hg), compared with that in control mice that received either the vehicle or nonsilencing siRNA. Our data demonstrate a crucial role for the dynamic interaction between D3R and USP48 in the regulation of NHE3 expression and function.Armando, I., Villar, V. A. M., Jones J. E., Lee, H., Wang, X., Asico L. D., Yu, P., Yang, J., Escano, C. S. Jr., Pascua-Crusan, A. M., Felder, R. A., Jose, P. A. Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation.	[Armando, Ines; Villar, Van Anthony M.; Jones, John E.; Lee, Hewang; Wang, Xiaoyan; Asico, Laureano D.; Yu, Peiying; Yang, Jian; Escano, Crisanto S., Jr.; Pascua-Crusan, Annabelle M.; Jose, Pedro A.] Univ Maryland, Div Nephrol, Dept Med, Sch Med, Baltimore, MD 21201 USA; [Felder, Robin A.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University System of Maryland; University of Maryland Baltimore; University of Virginia	Villar, VM (corresponding author), Univ Maryland, Div Nephrol, Dept Med, Sch Med, 20 Penn St,HSF 2,Ste S003C, Baltimore, MD 21201 USA.	vvillar@medicine.umaryland.edu	Wang, Xiaoyan/GOK-1663-2022; Asico, Laureano/AAM-6321-2020	Wang, Xiaoyan/0000-0001-7406-5008; Lee, Hewang/0000-0003-1338-2573	U.S. National Institutes of Health [P01HL074940, P01HL068686, R01HL092196, R37HL023081, R01DK039308, R01DK090918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686, R01HL092196, P01HL074940, R01HL023081, R37HL023081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090918, R01DK039308] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health grants P01HL074940, P01HL068686, R01HL092196, R37HL023081, R01DK039308, and R01DK090918. The authors declare no conflicts of interest.	Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Brismar H, 2000, CLIN EXP HYPERTENS, V22, P303, DOI 10.1081/CEH-100100079; Carey RM, 2001, HYPERTENSION, V38, P297, DOI 10.1161/hy0901.096422; CHEN CJ, 1992, CLIN EXP HYPERTENS A, V14, P615, DOI 10.3109/10641969209036211; Cuevas S, 2012, HYPERTENSION, V59, P446, DOI 10.1161/HYPERTENSIONAHA.111.185744; Day CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034923; Di Sole F, 2011, KIDNEY INT, V80, P822, DOI 10.1038/ki.2011.229; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; FELDER RA, 1990, HYPERTENSION, V15, P560, DOI 10.1161/01.HYP.15.6.560; Felder RA, 2006, NAT CLIN PRACT NEPHR, V2, P637, DOI 10.1038/ncpneph0301; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Flegelova H, 2006, BBA-GEN SUBJECTS, V1760, P504, DOI 10.1016/j.bbagen.2006.01.014; Gomes P, 2002, AM J PHYSIOL-RENAL, V283, pF114, DOI 10.1152/ajprenal.00244.2001; Harris RC, 2012, CURR OPIN NEPHROL HY, V21, P61, DOI 10.1097/MNH.0b013e32834de2cb; Hu MC, 2013, AM J PHYSIOL-RENAL, V304, pF1169, DOI 10.1152/ajprenal.00630.2012; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Jose PA, 1998, PHARMACOL THERAPEUT, V80, P149, DOI 10.1016/S0163-7258(98)00027-8; KANEKO S, 1990, J AUTON PHARMACOL, V10, pS53, DOI 10.1111/j.1474-8673.1990.tb00228.x; KANEKO S, 1992, AM J PHYSIOL, V263, pR631, DOI 10.1152/ajpregu.1992.263.3.R631; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Klisic J, 2002, AM J PHYSIOL-RENAL, V283, pF532, DOI 10.1152/ajprenal.00365.2001; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Ladines CA, 2001, AM J PHYSIOL-REG I, V281, pR1071, DOI 10.1152/ajpregu.2001.281.4.R1071; Li HW, 2008, J CLIN INVEST, V118, P2180, DOI 10.1172/JCI33637; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lockhart PJ, 2004, DNA SEQUENCE, V15, P9, DOI 10.1080/10855660310001638197; Luippold G, 1998, N-S ARCH PHARMACOL, V358, P690, DOI 10.1007/PL00005314; Luippold G, 2001, J AM SOC NEPHROL, V12, P2272, DOI 10.1681/ASN.V12112272; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Mikhalyov I, 2011, BBA-BIOMEMBRANES, V1808, P1930, DOI 10.1016/j.bbamem.2011.04.002; Moe OW, 1997, CURR OPIN NEPHROL HY, V6, P440, DOI 10.1097/00041552-199709000-00006; Morales Patricio, 2007, Soc Reprod Fertil Suppl, V65, P269; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nogueira C, 2008, AM J PHYSIOL-RENAL, V294, pF1232, DOI 10.1152/ajprenal.00025.2007; Ortiz PA, 2001, HYPERTENSION, V38, P621, DOI 10.1161/hy09t1.093361; Pedrosa R, 2004, AM J PHYSIOL-RENAL, V287, pF1059, DOI 10.1152/ajprenal.00139.2004; Pedrosa R, 2004, BRIT J PHARMACOL, V142, P1343, DOI 10.1038/sj.bjp.0705893; Queiroz-Leite GD, 2011, BIOCHEM BIOPH RES CO, V409, P470, DOI 10.1016/j.bbrc.2011.05.028; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Ueda A, 2003, AM J HYPERTENS, V16, P853, DOI 10.1016/S0895-7061(03)01013-6; Villar VAM, 2013, FASEB J, V27, P1808, DOI 10.1096/fj.12-208439; Villar VM, 2013, J BIOL CHEM, V288, P152, DOI 10.1074/jbc.M112.428458; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yu Peiying, 2013, Methods Mol Biol, V964, P15, DOI 10.1007/978-1-62703-251-3_2; Zeng CY, 2008, KIDNEY INT, V74, P750, DOI 10.1038/ki.2008.247; Zeng CY, 2008, AM J PHYSIOL-HEART C, V294, pH551, DOI 10.1152/ajpheart.01036.2007; Zeng CY, 2006, CURR HYPERTENS REV, V2, P247, DOI 10.2174/157340206778132563; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038745	59	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1422	1434		10.1096/fj.13-243840	http://dx.doi.org/10.1096/fj.13-243840			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308971	Green Published			2022-12-25	WOS:000335324800033
J	Feng, B; Li, K; Zhong, HX; Ren, G; Wang, HF; Shang, YL; Bai, M; Liang, J; Wang, X; Fan, DM				Feng, Bin; Li, Kai; Zhong, Haixing; Ren, Gui; Wang, Hefei; Shang, Yulong; Bai, Ming; Liang, Jie; Wang, Xin; Fan, Daiming			RhoE Promotes Metastasis in Gastric Cancer through a Mechanism Dependent on Enhanced Expression of CXCR4	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; UP-REGULATION; PROTEIN; CELLS; INVASION; IDENTIFICATION; PROGRESSION; INHIBITION; MIGRATION; RECEPTOR	RhoE, a novel member of the Rho protein family, is a key regulator of the cytoskeleton and cell migration. Our group has previously shown that RhoE as a direct target for HIF-1 alpha and mediates hypoxia-induced epithelial to mesenchymal transition in gastric cancer cells. Therefore, we assumed that RhoE might play an important role in gastric cancer metastasis. In the present study, we have explored the role of RhoE expression in gastric cancer, cell invasion and metastasis, and the influence of RhoE on regulating the potential expression of down-stream genes. RhoE expression was elevated in gastric cancer tissues as compared with normal gastric tissues. We also found a close correlation between the histological grade and the diagnosis of the patient. Up-regulation of RhoE significantly enhanced the migratory and invasive abilities of gastric cancer cells both in vitro and in vivo. Moreover, down-regulation of RhoE diminished the metastatic potential of cancer cells. PCR array and subsequent transwell assay showed that the regulation of gastric cancer metastasis by RhoE was partially mediated by CXCR4. This observation suggested that CXCR4 might be a downstream effector for RhoE. In summary, our study identified RhoE as a novel prognostic biomarker and metastatic-promoting gene of gastric cancer.	[Feng, Bin; Li, Kai; Ren, Gui; Wang, Hefei; Shang, Yulong; Bai, Ming; Liang, Jie; Wang, Xin; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Feng, Bin; Li, Kai; Ren, Gui; Wang, Hefei; Shang, Yulong; Bai, Ming; Liang, Jie; Wang, Xin; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Zhong, Haixing] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liang, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	liangjie@fmmu.edu.cn; wangx6666@yahoo.com; daimingfan@fmmu.edu.cn			National Basic Research Program of China [2009CB521700]; National High Technology Research and Development Program of China [2006AA02A253]; National Science and Technology Supporting Program during the Eleventh Five-year Plan Period [2006BAI02A14]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science and Technology Supporting Program during the Eleventh Five-year Plan Period	This work was supported by the National Basic Research Program of China (No: 2009CB521700), the National High Technology Research and Development Program of China (No: 2006AA02A253) and the National Science and Technology Supporting Program during the Eleventh Five-year Plan Period (No: 2006BAI02A14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Foster R, 1996, MOL CELL BIOL, V16, P2689; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861; Jin HF, 2007, MOL CANCER RES, V5, P423, DOI 10.1158/1541-7786.MCR-06-0407; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Li K, 2009, BIOCHEM BIOPH RES CO, V379, P212, DOI 10.1016/j.bbrc.2008.12.044; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; Ma WL, 2012, HEPATOLOGY; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Ren G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-67; Riento K, 2006, METHOD ENZYMOL, V406, P533, DOI 10.1016/S0076-6879(06)06041-1; Song JG, 2006, NEOPLASIA, V8, P995, DOI 10.1593/neo.06592; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Zhang FM, 2009, CANCER LETT, V274, P250, DOI 10.1016/j.canlet.2008.09.031; Zhao H, 2012, TUMOR BIOL, V33, P1363, DOI 10.1007/s13277-012-0384-5; Zhou JF, 2013, ANN SURG ONCOL, V20, P175, DOI 10.1245/s10434-012-2472-6; Zhou JF, 2011, BIOCHEM BIOPH RES CO, V415, P348, DOI 10.1016/j.bbrc.2011.10.065	28	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81709	10.1371/journal.pone.0081709	http://dx.doi.org/10.1371/journal.pone.0081709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312338	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300043
J	Zhou, Y; Feng, X; Liu, YL; Ye, SC; Wang, H; Tan, WK; Tian, T; Qiu, YM; Luo, HS				Zhou, Yu; Feng, Xiao; Liu, Ya-ling; Ye, Shi-cai; Wang, Hao; Tan, Wen-kai; Tian, Ting; Qiu, Yu-mei; Luo, He-sheng			Down-Regulation of miR-126 Is Associated with Colorectal Cancer Cells Proliferation, Migration and Invasion by Targeting IRS-1 via the AKT and ERK1/2 Signaling Pathways	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MIR-200 FAMILY; GROWTH; MICRORNAS; ACTIVATION; SUPPRESSOR; EXPRESSION; PROGRESSION; METASTASIS; MECHANISM	Background: Colorectal carcinoma (CRC) is one of the leading causes of cancer-related mortality worldwide. MicroRNAs (miRNAs, miRs) play important roles in carcinogenesis. MiR-126 has been shown to be down-regulated in CRC. In this study, we identified the potential effects of miR-126 on some important biological properties of CRC cells and clarified the regulation of insulin receptor substrate 1 (IRS-1) and its possible signaling pathway by miR-126. Methods: The effect of miR-126 on IRS-1, AKT, and ERK1/2 expression was assessed in the CRC cell lines HT-29 and HCT-116 with a miR-126 mimic or inhibitor to increase or decrease miR-126 expression. Furthermore, the roles of miR-126 in regulation of the biological properties of CRC cells were analyzed with miR-126 mimic or inhibitor-transfected cells. The 39untranslated region (39-UTR) of IRS-1 regulated by miR-126 was analyzed by using a dual-luciferase reporter assay. Results: We found that IRS-1 is the functional downstream target of miR-126 by directly targeting the 39-UTR of IRS-1. Endogenous miR-126 and exogenous miR-126 mimic inhibited IRS-1 expression. Furthermore, gain-of-function or loss-offunction studies showed that over-expression of miR-126 down-regulated IRS-1, suppressed AKT and ERK1/2 activation, CRC cells proliferation, migration, invasion, and caused cell cycle arrest, but had no effect on cell apoptosis. Knockdown of miR126 promoted these processes in HCT-116 cells and promoted AKT and ERK1/2 activation by up-regulating the expression of the IRS-1 protein. Conclusions: MiR-126 may play roles in regulation of the biological behavior of CRC cells, at least in part, by targeting IRS-1 via AKT and ERK1/2 signaling pathways.	[Zhou, Yu; Liu, Ya-ling; Luo, He-sheng] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China; [Zhou, Yu; Feng, Xiao; Ye, Shi-cai; Wang, Hao; Tan, Wen-kai; Tian, Ting; Qiu, Yu-mei] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China	Wuhan University; Guangdong Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China.	luohesheng2013@126.com			Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [LYM11103]	Foundation for Distinguished Young Talents in Higher Education of Guangdong, China	This study was supported by Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (grant number LYM11103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chang Q, 2002, CANCER RES, V62, P6035; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Kim EJ, 2003, J NUTR, V133, P2675, DOI 10.1093/jn/133.8.2675; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Li N, 2013, MOL CELL BIOCHEM, V380, P107, DOI 10.1007/s11010-013-1664-0; Li XM, 2011, MED ONCOL, V28, P1054, DOI 10.1007/s12032-010-9637-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P1206; Strillacci A, 2013, J PATHOL, V229, P379, DOI 10.1002/path.4097; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Sun HZ, 2006, CANCER RES, V66, P11106, DOI 10.1158/0008-5472.CAN-06-2641; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang ZG, 2012, BIOCHEM BIOPH RES CO, V427, P444, DOI 10.1016/j.bbrc.2012.06.123; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Yang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042978; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yin Y, 2013, BBA-GENE REGUL MECH, V1829, P239, DOI 10.1016/j.bbagrm.2012.11.006; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	42	38	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81203	10.1371/journal.pone.0081203	http://dx.doi.org/10.1371/journal.pone.0081203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312276	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300028
J	Bermingham, EN; Kittelmann, S; Young, W; Kerr, KR; Swanson, KS; Roy, NC; Thomas, DG				Bermingham, Emma N.; Kittelmann, Sandra; Young, Wayne; Kerr, Katherine R.; Swanson, Kelly S.; Roy, Nicole C.; Thomas, David G.			Post-Weaning Diet Affects Faecal Microbial Composition but Not Selected Adipose Gene Expression in the Cat (Felis catus)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOME; DEVELOPMENTAL PLASTICITY; INTESTINAL MICROBIOTA; INDUCED OBESITY; BACTERIAL; DIVERSITY; EXPOSURE; FERMENTATION; INFLAMMATION	The effects of pre-(i.e., gestation and during lactation) and post-weaning diet on the composition of faecal bacterial communities and adipose expression of key genes in the glucose and insulin pathways were investigated in the cat. Queens were maintained on a moderate protein: fat: carbohydrate kibbled ("Diet A"; 35: 20: 28% DM; n = 4) or high protein: fat: carbohydrate canned ("Diet B"; 45: 37: 2% DM; n = 3) diet throughout pregnancy and lactation. Offspring were weaned onto these diets in a nested design (n = 5 per treatment). Faecal samples were collected at wk 8 and 17 of age. DNA was isolated from faeces and bacterial 16S rRNA gene amplicons were analysed by pyrosequencing. RNA was extracted from blood (wk 18) and adipose tissue and ovarian/testicular tissues (wk 24) and gene expression levels determined using RT-qPCR. Differences (P < 0.05) in composition of faecal bacteria were observed between pregnant queens fed Diet A or B. However, pre-weaning diet had little effect on faecal bacterial composition in weaned kittens. In contrast, post-weaning diet altered bacterial population profiles in the kittens. Increased (P < 0.05) abundance of Firmicutes (77% vs 52% of total reads) and Actinobacteria (0.8% vs 0.2% of total reads), and decreased (P < 0.05) abundance of Fusobacteria (1.6% vs 18.4% of total reads) were observed for kittens fed the Diet A compared to those fed Diet B post-weaning. Feeding Diet B pre-weaning increased (P < 0.05) the expression levels of INRS, LEPT, PAI-1 and tended to increase GLUT1, while the expression levels of IRS-1 in blood increased in kittens fed Diet A pre-weaning. Post-weaning diet had no effect on expression levels of target genes. Correlations between the expression levels of genes involved in glucose and insulin pathways and faecal Bacteriodetes and Firmicutes phyla were identified. The reasons for why post-weaning diet affects microbial populations and not gene expression levels are of interest.	[Bermingham, Emma N.; Young, Wayne; Roy, Nicole C.] AgRes Grasslands, Food Nutr & Hlth, Palmerston North, New Zealand; [Kittelmann, Sandra] AgRes Grasslands, Anim Nutr & Hlth, Palmerston North, New Zealand; [Kerr, Katherine R.; Swanson, Kelly S.] Univ Illinois, Div Nutrit Sci, Urbana, IL USA; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Roy, Nicole C.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Thomas, David G.] Massey Univ, Inst Food Nutr & Human Hlth, Ctr Feline Nutr, Palmerston North, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Massey University; Massey University	Bermingham, EN (corresponding author), AgRes Grasslands, Food Nutr & Hlth, Palmerston North, New Zealand.	emma.bermingham@agresearch.co.nz	Roy, Nicole C/AAP-5016-2020	roy, nicole clemence/0000-0002-6744-9705; Bermingham, Emma/0000-0003-0952-5260; Swanson, Kelly/0000-0001-5518-3076; Kittelmann, Sandra/0000-0002-6019-9854; Young, Wayne/0000-0003-0464-2062	Massey University Research Fund [09/0240]; AgResearch Capability Fund [A15120]; CORE Fund [A17976]; International Mobility Fund (NZ)	Massey University Research Fund; AgResearch Capability Fund; CORE Fund; International Mobility Fund (NZ)	This study was funded by the Massey University Research Fund (09/0240) and AgResearch Capability (A15120) and CORE (A17976) Funds. ENB received financial assistance from the International Mobility Fund (NZ) to visit KSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2011, NUTR REV, V69, P99, DOI 10.1111/j.1753-4887.2010.00365.x; Backus RC, 2010, J ANIM PHYSIOL AN N, V94, pE318, DOI 10.1111/j.1439-0396.2010.01014.x; Bedani R, 2010, J SCI FOOD AGR, V90, P233, DOI 10.1002/jsfa.3800; Beloshapka A. N. S. E., 2011, J ANIM SCI, V89, P284, DOI [10.2527/ asasann.2017.228., DOI 10.2527/ASASANN.2017.228]; Bermingham EN, 2013, MICROBIOLOGYOPEN, V2, P173, DOI 10.1002/mbo3.60; Bermingham EN, 2011, BRIT J NUTR, V106, pS49, DOI 10.1017/S0007114511000572; Brennan CL, 2004, DOMEST ANIM ENDOCRIN, V26, P291, DOI 10.1016/j.domaniend.2003.11.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; De Bandt JP, 2011, CURR OPIN CLIN NUTR, V14, P334, DOI 10.1097/MCO.0b013e328347924a; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fo Thomas, 2011, FRONTIERS MICROBIOLO, V2; Fujiwara R, 2010, BRIT J NUTR, V103, P530, DOI 10.1017/S000711450999198X; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hendriks WH, 1999, J ANIM PHYSIOL AN N, V82, P94, DOI 10.1111/j.1439-0396.1999.00214.x; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooda S, 2012, BRIT J NUTR; Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; LOESCHE WJ, 1968, ARCH ORAL BIOL, V13, P191, DOI 10.1016/0003-9969(68)90051-4; Low FM, 2011, EPIGENOMICS-UK, V3, P279, DOI [10.2217/EPI.11.17, 10.2217/epi.11.17]; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Mori A, 2009, VET RES COMMUN, V33, P315, DOI 10.1007/s11259-008-9179-y; Mori A, 2009, VET RES COMMUN, V33, P211, DOI 10.1007/s11259-008-9168-1; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Roseboom TJ, 2012, PLACENTA; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Sanz Y, 2011, AM J CLIN NUTR, V94, p2000S, DOI 10.3945/ajcn.110.001172; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Thum C, 2012, J NUTR, V142, P1921, DOI 10.3945/jn.112.166231; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2009, FRONT BIOSCI-LANDMRK, V14, P4673, DOI 10.2741/3559; Vester BM, 2009, BRIT J NUTR, V102, P1136, DOI 10.1017/S0007114509371652; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Young W, 2012, APPL ENVIRON MICROB, V78, P6656, DOI 10.1128/AEM.01536-12; Zini E, 2010, HORM METAB RES, V42, P340, DOI 10.1055/s-0030-1248251; Zini E, 2009, VET J, V180, P66, DOI 10.1016/j.tvjl.2007.10.022; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	52	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80992	10.1371/journal.pone.0080992	http://dx.doi.org/10.1371/journal.pone.0080992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312255	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900018
J	Chen, J; Qi, LH; Xia, Z; Shen, M; Shen, X; Mei, J; DeRiemer, K; Yuan, ZA				Chen, Jing; Qi, Lihong; Xia, Zhen; Shen, Mei; Shen, Xin; Mei, Jian; DeRiemer, Kathryn; Yuan, Zheng'an			Which Urban Migrants Default from Tuberculosis Treatment in Shanghai, China?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; TB PATIENTS; EPIDEMIOLOGY; BARRIERS; IMPACT; DOT	Background: Migration is a major challenge to tuberculosis (TB) control worldwide. TB treatment requires multiple drugs for at least six months. Some TB patients default before completing their treatment regimen, which can lead to ongoing infectiousness and drug resistance. Methods: We conducted a retrospective analysis of 29,943 active TB cases among urban migrants that were reported between 2000 to 2008 in Shanghai, China. We used logistic regression models to identify factors independently associated with treatment defaults in TB patients among urban migrants during 2005-2008. Results: Fifty-two percent of the total TB patients reported in Shanghai during the study period were among urban migrants. Three factors increased the odds of a treatment default: case management using self-administered therapy (OR, 5.84, 95% CI, 3.14-10.86, p<0.0005), being a retreatment case (OR, 1.47, 95% CI, 1.25-1.71, p<0.0005), and age >= 60 years old (OR, 1.33, 95% CI, 1.05-1.67, p=0.017). The presence of a cavity in the initial chest radiograph decreased the odds for a treatment default (OR, 0.87, 95% CI, 0.77-0.97, p=0.015), as did migration from central China (OR, 0.85, 95% CI, 0.73-0.99, p=0.042), case management by family members (OR, 0.73, 95% CI 0.66-0.81, p<0.0005), and the combination of case detection by a required physical exam and case management by health care staff (OR, 0.64, 95% CI, 0.45-0.93, p=0.019). Conclusion: Among TB patients who were urban migrants in Shanghai, case management using self-administered therapy was the strongest modifiable risk factor that was independently associated with treatment defaults. Interventions that target retreated TB cases could also reduce treatment defaults among urban migrants. Health departments should develop effective measures to prevent treatment defaults among urban migrants, to ensure completion of therapy among urban migrants who move between cities and provinces, and to improve reporting of treatment outcomes.	[Chen, Jing; Xia, Zhen; Shen, Mei; Shen, Xin; Mei, Jian; Yuan, Zheng'an] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [Qi, Lihong; DeRiemer, Kathryn] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA	Shanghai Center for Disease Control & Prevention; University of California System; University of California Davis	Yuan, ZA (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China.	zayuan@scdc.sh.cn	Qi, LI/AAF-3389-2019	DeRiemer, Kathryn/0000-0002-8375-7505	Key Project of Chinese National Programs [2013ZX10004903]; National Institutes of Health (NIH) [D43 TW007887]; Shanghai Public Health Key Discipline Construction Project [12GWZX0601]; FOGARTY INTERNATIONAL CENTER [D43TW007887] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006452] Funding Source: NIH RePORTER	Key Project of Chinese National Programs; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Public Health Key Discipline Construction Project; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was financially supported by the Key Project of Chinese National Programs (2013ZX10004903) and by National Institutes of Health (NIH) grant D43 TW007887. This work was also partly supported by the Shanghai Public Health Key Discipline Construction Project, 12GWZX0601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Department of Disease Contorl Ministry of Health, 2009, GUID IMPL NAT CONTR; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Kim J, 2008, INT J TUBERC LUNG D, V12, P1128; Kirwan DE, 2009, TROP MED INT HEALTH, V14, P1442, DOI 10.1111/j.1365-3156.2009.02405.x; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Ministry of Health of the Peoples Republic of China, REP INC MORT MAND RE; Shanghai Municipal Statistic Bureau, SHANGHAI STAT YB 208; Shanghai Municipal Statistic Bureau, SHANGH CHIN SHANG MU; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; The National Bureau of Statistics of China, 2010, RUR MIGR SURV REP 20; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wang Y, 2008, TROP MED INT HEALTH, V13, P927, DOI 10.1111/j.1365-3156.2008.02093.x; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; *WHO, PUBL WHO; World Health Organization, WHO PUBL; World Health Organization, 2012, WHO PUBL; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959	22	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81351	10.1371/journal.pone.0081351	http://dx.doi.org/10.1371/journal.pone.0081351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312292	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900029
J	Elfaitouri, A; Herrmann, B; Bolin-Wiener, A; Wang, YL; Gottfries, CG; Zachrisson, O; Pipkorn, R; Ronnblom, L; Blomberg, J				Elfaitouri, Amal; Herrmann, Bjorn; Bolin-Wiener, Agnes; Wang, Yilin; Gottfries, Carl-Gerhard; Zachrisson, Olof; Pipkorn, Ruediger; Ronnblom, Lars; Blomberg, Jonas			Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; EPSTEIN-BARR-VIRUS; HEAT-SHOCK-PROTEIN; CHLAMYDIA-PNEUMONIAE INFECTION; SERUM ANTIBODIES; MYCOPLASMA-FERMENTANS; HUMAN HERPESVIRUS-7; CRYSTAL-STRUCTURE; PEPTIDE THERAPY; BLOOD	Myalgic encephalomyelitis (ME, also called Chronic Fatigue Syndrome), a common disease with chronic fatigability, cognitive dysfunction and myalgia of unknown etiology, often starts with an infection. The chaperonin human heat shock protein 60 (HSP60) occurs in mitochondria and in bacteria, is highly conserved, antigenic and a major autoantigen. The anti-HSP60 humoral (IgG and IgM) immune response was studied in 69 ME patients and 76 blood donors (BD) (the Training set) with recombinant human and E coli HSP60, and 136 30-mer overlapping and targeted peptides from HSP60 of humans, Chlamydia, Mycoplasma and 26 other species in a multiplex suspension array. Peptides from HSP60 helix I had a chaperonin-like activity, but these and other HSP60 peptides also bound IgG and IgM with an ME preference, theoretically indicating a competition between HSP60 function and antibody binding. A HSP60-based panel of 25 antigens was selected. When evaluated with 61 other ME and 399 non-ME samples (331 BD, 20 Multiple Sclerosis and 48 Systemic Lupus Erythematosus patients), a peptide from Chlamydia pneumoniae HSP60 detected IgM in 15 of 61 (24%) of ME, and in 1 of 399 non-ME at a high cutoff (p<0.0001). IgM to specific cross-reactive epitopes of human and microbial HSP60 occurs in a subset of ME, compatible with infection-induced autoimmunity.	[Elfaitouri, Amal; Herrmann, Bjorn; Bolin-Wiener, Agnes; Wang, Yilin; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Clin Microbiol Sect, Uppsala, Sweden; [Gottfries, Carl-Gerhard; Zachrisson, Olof] Gottfries Clin AB, Molndal, Sweden; [Pipkorn, Ruediger] Deutsch Krebsforschungszentrum, Heidelberg, Germany; [Ronnblom, Lars] Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden	Uppsala University; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University	Blomberg, J (corresponding author), Uppsala Univ, Dept Med Sci, Clin Microbiol Sect, Uppsala, Sweden.	jonas.blomberg@medsci.uu.se	Wang, Yilin/P-8610-2017; Elfaitouri, Amal/GRO-7027-2022	Elfaitouri, Amal/0000-0002-0704-3252; Blomberg, Jonas/0000-0001-6492-2491	ME research UK [SC 036942]; Olle Engkvist Foundation	ME research UK; Olle Engkvist Foundation	Funded by ME research UK (charity no. SC 036942; http://www.meresearch.org.uk/) and the Olle Engkvist Foundation (http://www.engkviststiftelserna.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D V, 1991, Can Dis Wkly Rep, V17 Suppl 1E, P33; BLOMBERG J, 1983, J CLIN MICROBIOL, V17, P1081, DOI 10.1128/JCM.17.6.1081-1091.1983; Blomberg J, 2012, CLIN VACCINE IMMUNOL, V19, P1399, DOI 10.1128/CVI.00391-12; Blomberg J, 2011, ADV VIROL, V2011, DOI 10.1155/2011/341294; Booth NE, 2012, INT J CLIN EXP MED, V5, P208; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Cappello F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000552; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chia J, 2010, J CLIN PATHOL, V63, P165, DOI 10.1136/jcp.2009.070466; Chia JKS, 1999, CLIN INFECT DIS, V29, P452, DOI 10.1086/520239; Deshmukh US, 2003, ANN NY ACAD SCI, V987, P91, DOI 10.1111/j.1749-6632.2003.tb06036.x; Domeika M, 1998, J INFECT DIS, V177, P714, DOI 10.1086/514218; Drossman DA, 1999, GUT, V45, P1; Durai M, 2009, J AUTOIMMUN, V33, P208, DOI 10.1016/j.jaut.2009.09.007; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Elias D, 1999, INT IMMUNOL, V11, P957, DOI 10.1093/intimm/11.6.957; ELIAS D, 1995, EUR J IMMUNOL, V25, P2851, DOI 10.1002/eji.1830251021; ELIAS D, 1994, LANCET, V343, P704, DOI 10.1016/S0140-6736(94)91582-2; ELIAS D, 1994, DIABETES, V43, P992, DOI 10.2337/diabetes.43.8.992; Elias D, 1997, DIABETES, V46, P758, DOI 10.2337/diabetes.46.5.758; ELIAS D, 1995, DIABETES, V44, P1132, DOI 10.2337/diabetes.44.9.1132; Elias D, 1996, DIABETES, V45, P1168, DOI 10.2337/diabetes.45.9.1168; Endresen GKM, 2003, RHEUMATOL INT, V23, P211, DOI 10.1007/s00296-003-0355-7; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; Fluge O, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-28; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Harkonen T, 2000, J MED VIROL, V62, P383, DOI 10.1002/1096-9071(200011)62:3<383::AID-JMV11>3.0.CO;2-#; Hokama Y, 2009, J CLIN LAB ANAL, V23, P210, DOI 10.1002/jcla.20325; Horvath L, 2002, IMMUNOL LETT, V80, P155, DOI 10.1016/S0165-2478(01)00336-4; Ichiki Y, 2004, MITOCHONDRION, V4, P743, DOI 10.1016/j.mito.2004.07.024; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; JONES DB, 1993, IMMUNOL TODAY, V14, P115, DOI 10.1016/0167-5699(93)90210-C; Mansilla MJ, 2012, MOL MED, V18, P1018, DOI 10.2119/molmed.2012.00119; KAWAI K, 1992, INTERNAL MED, V31, P313, DOI 10.2169/internalmedicine.31.313; Kerr JR, 2008, J CLIN PATHOL, V61, P1, DOI 10.1136/jcp.2007.051342; Kerr JR, 2010, J GEN VIROL, V91, P893, DOI 10.1099/vir.0.017590-0; Kim HR, 2006, J IMMUNOL, V177, P6634, DOI 10.4049/jimmunol.177.10.6634; KOMAROFF AL, 1993, CLIN INFECT DIS, V17, P1074, DOI 10.1093/clinids/17.6.1074; KOMAROFF AL, 1992, J INFECT DIS, V165, P184, DOI 10.1093/infdis/165.1.184; Konstantinov K, 1996, J CLIN INVEST, V98, P1888, DOI 10.1172/JCI118990; Kozireva S, 2001, ANN HEMATOL, V80, P669, DOI 10.1007/s002770100359; LACHUMANAN R, 1993, INFECT IMMUN, V61, P4527, DOI 10.1128/IAI.61.10.4527-4531.1993; Lerner AM, 2007, IN VIVO, V21, P707; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Lerner AM, 2004, IN VIVO, V18, P101; Lerner AM, 2002, DRUG TODAY, V38, P549; Lin JS, 1996, INFECT IMMUN, V64, P4396, DOI 10.1128/IAI.64.10.4396-4400.1996; Lodi R, 1997, MUSCLE NERVE, V20, P765; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Lu Y, 2010, AUTOIMMUNITY, V43, P654, DOI 10.3109/08916931003674683; Maeda H, 2000, FEMS IMMUNOL MED MIC, V28, P219, DOI 10.1111/j.1574-695X.2000.tb01480.x; MAEDA H, 1994, FEMS MICROBIOL LETT, V119, P129, DOI 10.1016/0378-1097(94)90404-9; Maes M, 2007, J AFFECT DISORDERS, V99, P237, DOI 10.1016/j.jad.2006.08.021; Maes M, 2012, METAB BRAIN DIS, V27, P415, DOI 10.1007/s11011-012-9316-8; Metzler B, 1997, ARTERIOSCL THROM VAS, V17, P536, DOI 10.1161/01.ATV.17.3.536; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; Nasralla M, 1999, EUR J CLIN MICROBIOL, V18, P859, DOI 10.1007/s100960050420; NATELSON BH, 1994, J MED VIROL, V42, P42, DOI 10.1002/jmv.1890420109; Nijs J, 2002, FEMS IMMUNOL MED MIC, V34, P209, DOI 10.1111/j.1574-695X.2002.tb00626.x; Ortega-Hernandez OD, 2009, ANN NY ACAD SCI, V1173, P600, DOI 10.1111/j.1749-6632.2009.04799.x; Ortega-Hernandez OD, 2009, ANN NY ACAD SCI, V1173, P589, DOI 10.1111/j.1749-6632.2009.04802.x; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; Perschinka H, 2007, ATHEROSCLEROSIS, V194, P79, DOI 10.1016/j.atherosclerosis.2006.09.028; Petrov D, 2012, INDIAN J PEDIATR, V79, P52, DOI 10.1007/s12098-011-0463-4; PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P175, DOI 10.1159/000119233; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Ranford JC, 2002, J CLIN PATHOL-MOL PA, V55, P209, DOI 10.1136/mp.55.4.209; Sairenji T, 1995, INTERVIROLOGY, V38, P269, DOI 10.1159/000150450; Salinas GF, 2013, CLIN IMMUNOL, V146, P34, DOI 10.1016/j.clim.2012.10.005; SUMAYA CV, 1991, REV INFECT DIS, V13, pS19; SWANINK CMA, 1995, CLIN INFECT DIS, V20, P1390, DOI 10.1093/clinids/20.5.1390; Sziller I, 1998, HUM REPROD, V13, P1088, DOI 10.1093/humrep/13.4.1088; Thambirajah AA, 2008, CLIN INVEST MED, V31, pE319; Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027981; Uray K, 2003, INT IMMUNOL, V15, P1229, DOI 10.1093/intimm/dxg122; Van Noort JM, 1998, PROG BRAIN RES, V117, P435; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8; VanNess JM, 2003, MED SCI SPORT EXER, V35, P908, DOI 10.1249/01.MSS.0000069510.58763.E8; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; WHELTON CL, 1992, J RHEUMATOL, V19, P939; White AT, 2010, PSYCHOPHYSIOLOGY, V47, P615, DOI 10.1111/j.1469-8986.2010.00978.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wysocki J, 2002, CARDIOVASC PATHOL, V11, P238, DOI 10.1016/S1054-8807(02)00109-6; Xue Y, 2011, LANGMUIR, V27, P296, DOI 10.1021/la103800h; Yokota S, 2000, CELL STRESS CHAPERON, V5, P337, DOI 10.1379/1466-1268(2000)005<0337:AACCIH>2.0.CO;2; Zhang LH, 2010, J CLIN PATHOL, V63, P156, DOI 10.1136/jcp.2009.072561; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	93	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81155	10.1371/journal.pone.0081155	http://dx.doi.org/10.1371/journal.pone.0081155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312270	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900023
J	Pflieger, A; Teguo, PW; Papastamoulis, Y; Chaignepain, S; Subra, F; Munir, S; Delelis, O; Lesbats, P; Calmels, C; Andreola, ML; Merillon, JM; Auge-Gouillou, C; Parissi, V				Pflieger, Aude; Teguo, Pierre Waffo; Papastamoulis, Yorgos; Chaignepain, Stephane; Subra, Frederic; Munir, Soundasse; Delelis, Olivier; Lesbats, Paul; Calmels, Christina; Andreola, Marie-Line; Merillon, Jean-Michel; Auge-Gouillou, Corinne; Parissi, Vincent			Natural Stilbenoids Isolated from Grapevine Exhibiting Inhibitory Effects against HIV-1 Integrase and Eukaryote MOS1 Transposase In Vitro Activities	PLOS ONE			English	Article							CENTRIFUGAL PARTITION CHROMATOGRAPHY; DNA INTEGRATION; RESVERATROL; MECHANISMS; COMPLEX	Polynucleotidyl transferases are enzymes involved in several DNA mobility mechanisms in prokaryotes and eukaryotes. Some of them such as retroviral integrases are crucial for pathogenous processes and are therefore good candidates for therapeutic approaches. To identify new therapeutic compounds and new tools for investigating the common functional features of these proteins, we addressed the inhibition properties of natural stilbenoids deriving from resveratrol on two models: the HIV-1 integrase and the eukaryote MOS-1 transposase. Two resveratrol dimers, leachianol F and G, were isolated for the first time in Vitis along with fourteen known stilbenoids: E-resveratrol, E-piceid, E-pterostilbene, E-piceatannol, (+)-E-epsilon-viniferin, E-epsilon-viniferinglucoside, E-scirpusin A, quadragularin A, ampelopsin A, pallidol, E-miyabenol C, E-vitisin B, hopeaphenol, and isohopeaphenol and were purified from stalks of Vitis vinifera (Vitaceae), and moracin M from stem bark of Milliciaexelsa (Moraceae). These compounds were tested in in vitro and in vivo assays reproducing the activity of both enzymes. Several molecules presented significant inhibition on both systems. Some of the molecules were found to be active against both proteins while others were specific for one of the two models. Comparison of the differential effects of the molecules suggested that the compounds could target specific intermediate nucleocomplexes of the reactions. Additionally E-pterostilbene was found active on the early lentiviral replication steps in lentiviruses transduced cells. Consequently, in addition to representing new original lead compounds for further modelling of new active agents against HIV-1 integrase, these molecules could be good tools for identifying such reaction intermediates in DNA mobility processes.	[Pflieger, Aude; Lesbats, Paul; Auge-Gouillou, Corinne] Univ Tours, UFR Sci Pharmaceut, EA 6306, Tours, France; [Teguo, Pierre Waffo; Papastamoulis, Yorgos; Merillon, Jean-Michel] Univ Bordeaux Segalen, Grp Etude Subst Vegetales Activite Biol, ISVV, EA UFR Pharmacie 3675, Bordeaux, France; [Chaignepain, Stephane] Univ Bordeaux Segalen, Plateforme Prote Ctr Genom Fonct, CBMN, UMR 5248, Bordeaux, France; [Subra, Frederic; Munir, Soundasse; Delelis, Olivier] CNRS, LBPA, Ecole Normale Super Cachan, F-75700 Paris, France; [Lesbats, Paul] London Res Inst, Canc Res UK, Clare Hall Labs, Potters Bar, Herts, England; [Calmels, Christina; Andreola, Marie-Line; Parissi, Vincent] Univ Bordeaux Segalen, CNRS, Lab MFP, UMR 5234, Bordeaux, France	Universite de Tours; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Parissi, V (corresponding author), Univ Bordeaux Segalen, CNRS, Lab MFP, UMR 5234, Bordeaux, France.	vincent.parissi@reger.u-bordeaux2.fr	GOUILLOU, Corinne AUGE/T-2346-2018	GOUILLOU, Corinne AUGE/0000-0002-3340-5560; Lesbats, Paul/0000-0002-4623-0675	Universite Francois Rabelais (Tours); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Region Centre (InhDDE projet); GIS Mariner of the french CNRS	Universite Francois Rabelais (Tours); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Region Centre (InhDDE projet)(Region Centre-Val de Loire); GIS Mariner of the french CNRS	This research was supported by grants from the Universite Francois Rabelais (Tours), the Ministere de l'Education Nationale, de la Recherche et de la Technologie and from the Region Centre (InhDDE projet). It was also supported by the GIS Mariner of the french CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedoya LM, 2006, BIOORG MED CHEM LETT, V16, P4075, DOI 10.1016/j.bmcl.2006.04.087; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Cherepanov P, 2010, EMBO REP, V11, P328, DOI 10.1038/embor.2010.58; Chevolot L, 1998, J CHROMATOGR B, V706, P43, DOI 10.1016/S0378-4347(97)00448-9; Crenes G, 2009, MOSL GENETICA, V138, P509; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Germon S, 2009, GENETICA, V137, P265, DOI 10.1007/s10709-009-9375-x; Grandgenett D, 2010, VIRUSES-BASEL, V2, P1185, DOI 10.3390/v2051185; Hare S, 2010, NATURE; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Kapche G.D.M., 2007, ANAL SCI XRAY STRUCT, V23, P59; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Munir S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-87; Richard E, 2001, MOL THER, V4, P331, DOI 10.1006/mthe.2001.0467; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Williamson EA, 2012, CANCER RES, V72, P6200, DOI 10.1158/0008-5472.CAN-12-0313; Yamada M, 2006, CHEM PHARM BULL, V54, P354, DOI 10.1248/cpb.54.354; Zamborlini A, 2011, J BIOL CHEM, V286, P21013, DOI 10.1074/jbc.M110.189274; Zga N, 2009, J CHROMATOGR B, V877, P1000, DOI 10.1016/j.jchromb.2009.02.026	28	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81184	10.1371/journal.pone.0081184	http://dx.doi.org/10.1371/journal.pone.0081184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312275	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900025
J	Yuan, F; Tabor, DE; Nelson, RK; Yuan, HJ; Zhang, YJ; Nuxoll, J; Bynote, KK; Lele, SM; Wang, D; Gould, KA				Yuan, Fang; Tabor, Dana E.; Nelson, Richard K.; Yuan, Hongjiang; Zhang, Yijia; Nuxoll, Jenny; Bynote, Kimberly K.; Lele, Subodh M.; Wang, Dong; Gould, Karen A.			A Dexamethasone Prodrug Reduces the Renal Macrophage Response and Provides Enhanced Resolution of Established Murine Lupus Nephritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS; GLUCOCORTICOID TREATMENT; RHEUMATOID-ARTHRITIS; MICE; DISEASE; RECEPTOR; KIDNEY; GLOMERULONEPHRITIS; ERYTHEMATOSUS; PATHOGENESIS	We evaluated the ability of a macromolecular prodrug of dexamethasone (P-Dex) to treat lupus nephritis in (NZB x NZW)F1 mice. We also explored the mechanism underlying the anti-inflammatory effects of this prodrug. P-Dex eliminated albuminuria in most (NZB x NZW) F1 mice. Furthermore, P-Dex reduced the incidence of severe nephritis and extended lifespan in these mice. P-Dex treatment also prevented the development of lupus-associated hypertension and vasculitis. Although P-Dex did not reduce serum levels of anti-dsDNA antibodies or glomerular immune complexes, P-Dex reduced macrophage recruitment to the kidney and attenuated tubulointerstitial injury. In contrast to what was observed with free dexamethasone, P-Dex did not induce any deterioration of bone quality. However, P-Dex did lead to reduced peripheral white blood cell counts and adrenal gland atrophy. These results suggest that P-Dex is more effective and less toxic than free dexamethasone for the treatment of lupus nephritis in (NZB x NZW) F1 mice. Furthermore, the data suggest that P-Dex may treat nephritis by attenuating the renal inflammatory response to immune complexes, leading to decreased immune cell infiltration and diminished renal inflammation and injury.	[Yuan, Fang; Yuan, Hongjiang; Zhang, Yijia; Wang, Dong] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Tabor, Dana E.; Nelson, Richard K.; Nuxoll, Jenny; Bynote, Kimberly K.; Gould, Karen A.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Lele, Subodh M.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, D (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	dwang@unmc.edu; kagould@unmc.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103480]; NIH [R01 AR053325]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103480] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103480 (K.A.G. and D.W.). This study was also supported in part by NIH R01 AR053325 (http://www.nih.gov/) (D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Benigni A, 2007, ARTHRITIS RHEUM, V56, P1569, DOI 10.1002/art.22524; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; Bynote KK, 2008, GENES IMMUN, V9, P137, DOI 10.1038/sj.gene.6364458; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Ferraccioli G, 2008, LUPUS, V17, P533, DOI 10.1177/0961203307088002; Fu YY, 2006, J IMMUNOL, V176, P632, DOI 10.4049/jimmunol.176.1.632; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Howie J B, 1968, Adv Immunol, V9, P215, DOI 10.1016/S0065-2776(08)60444-7; Hsieh C, 2011, ARTHRIT CARE RES, V63, P865, DOI 10.1002/acr.20441; Kielian T, 2008, J IMMUNOL, V180, P5004, DOI 10.4049/jimmunol.180.7.5004; LAMBERT PH, 1968, J EXP MED, V127, P507, DOI 10.1084/jem.127.3.507; Liu XM, 2008, PHARM RES-DORDR, V25, P2910, DOI 10.1007/s11095-008-9683-3; Manolides AS, 2010, J BONE MINER METAB, V28, P532, DOI 10.1007/s00774-009-0156-5; Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P2154, DOI 10.1002/art.38006; Papadimitraki ED, 2009, LUPUS, V18, P831, DOI 10.1177/0961203309103054; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Pawar RD, 2012, ARTHRITIS RHEUM-US, V64, P1620, DOI 10.1002/art.33485; Ruiz-Irastorza G, 2012, RHEUMATOLOGY, V51, P1145, DOI 10.1093/rheumatology/ker410; Ryan MJ, 2007, AM J PHYSIOL-REG I, V292, pR736, DOI 10.1152/ajpregu.00168.2006; Ryan MJ, 2009, AM J PHYSIOL-REG I, V296, pR1258, DOI 10.1152/ajpregu.90864.2008; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; SETTIPANE GA, 1978, J ALLERGY CLIN IMMUN, V62, P162, DOI 10.1016/0091-6749(78)90101-X; SLACK JH, 1984, J IMMUNOL, V132, P1271; STEWARD MW, 1976, CLIN EXP IMMUNOL, V26, P363; SUGISAKI T, 1991, CLIN IMMUNOL IMMUNOP, V61, P296, DOI 10.1016/S0090-1229(05)80002-9; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Yu F, 2010, KIDNEY INT, V77, P820, DOI 10.1038/ki.2010.13; Yuan F, 2012, ARTHRITIS RHEUM	31	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81483	10.1371/journal.pone.0081483	http://dx.doi.org/10.1371/journal.pone.0081483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312306	Green Submitted, gold, Green Published			2022-12-25	WOS:000327657900034
J	Bomans, K; Lang, A; Roedl, V; Adolf, L; Kyriosoglou, K; Diepold, K; Eberl, G; Molhoj, M; Strauss, U; Schmalz, C; Vogel, R; Reusch, D; Wegele, H; Wiedmann, M; Bulau, P				Bomans, Katrin; Lang, Antje; Roedl, Veronika; Adolf, Lisa; Kyriosoglou, Kyrillos; Diepold, Katharina; Eberl, Gabriele; Molhoj, Michael; Strauss, Ulrike; Schmalz, Christian; Vogel, Rudolf; Reusch, Dietmar; Wegele, Harald; Wiedmann, Michael; Bulau, Patrick			Identification and Monitoring of Host Cell Proteins by Mass Spectrometry Combined with High Performance Immunochemistry Testing	PLOS ONE			English	Article							ESCHERICHIA-COLI; INCLUSION-BODIES; ALKALINE-PHOSPHATASE; ADENYLATE KINASE; GENOME SEQUENCE; PROTEOMICS; QUANTITATION; IMPURITIES; DNA	Biotherapetatics are often produced in non host cells like Escherichia coli, yeast, and various mammalian cell lines. A major focus of any therapeutic protein purification process is to reduce host cell proteins to an acceptable low level. In this study, various E. coli host cell proteins were identified at different purifications steps by HPLC fractionation, SDS-PAGE analysis, and tryptic peptide mapping combined with online liquid chromatography mass spectrometry (LC-MS). However, no host cell proteins could be verified by direct LC-MS analysis of final drug substance material. In contrast, the application of affinity enrichment chromatography prior to comprehensive LC-MS as adequate to identify several low abundant host cell proteins at the final drug substance level. Bacterial alkaline phospliatase (BAP) was identified as being the most abundant host cell protein at several purification steps. Thus, e firstly established two different assays for enzymatic and immunological BAP monitoring using the cobas (R) technology. By using this strategy we were able to demonstrate an almost complete removal of BAP enzymatic activity by the established therapeutic protein purification process. In summary, the impact of fermentation purification, and formulation conditions on host cell protein removal and biological activity can be conducted by monitoring process-specific host cell proteins in a GMP-compatible and high-throughput (> 1000 samples/day) manner.	[Bomans, Katrin; Adolf, Lisa; Kyriosoglou, Kyrillos; Diepold, Katharina; Molhoj, Michael; Reusch, Dietmar; Wegele, Harald; Wiedmann, Michael; Bulau, Patrick] Roche Diagnost GmbH, Pharma Dev, Penzberg, Germany; [Lang, Antje; Roedl, Veronika; Eberl, Gabriele; Strauss, Ulrike; Schmalz, Christian] Roche Diagnost GmbH, Pharma Biotech, Penzberg, Germany; [Vogel, Rudolf] Roche Diagnost GmbH, Profess Diagnost, Penzberg, Germany	Roche Holding; Roche Holding; Roche Holding	Bulau, P (corresponding author), Roche Diagnost GmbH, Pharma Dev, Penzberg, Germany.	patrick.bulau@roche.com		Bulau, Patrick/0000-0002-7121-2954				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRIGGS J, 1991, ANAL CHEM, V63, P850, DOI 10.1021/ac00009a003; BRUNE M, 1985, NUCLEIC ACIDS RES, V13, P7139, DOI 10.1093/nar/13.19.7139; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Doneanu CE, 2012, MABS-AUSTIN, V4, P24, DOI 10.4161/mabs.4.1.18748; EATON LC, 1995, J CHROMATOGR A, V705, P105, DOI 10.1016/0021-9673(94)01249-E; Gao SX, 2011, BIOTECHNOL BIOENG, V108, P977, DOI 10.1002/bit.22982; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; HART RA, 1990, J BIOL CHEM, V265, P12728; Hayduk EJ, 2004, ELECTROPHORESIS, V25, P2545, DOI 10.1002/elps.200406010; Hoffman K, 2000, BIOPHARM-APPL T BIO, V13, P38; ICH, 1999, GUID IND Q6B SPEC TE; Issaq HJ, 2005, J CHROMATOGR B, V817, P35, DOI 10.1016/j.jchromb.2004.07.042; JANEWAY CA, 2005, IMMUNOBIOLOGY IMMUNE, P90; Jin M, 2010, BIOTECHNOL BIOENG, V105, P306, DOI 10.1002/bit.22532; Kaltashov IA, 2012, BIOTECHNOL ADV, V30, P210, DOI 10.1016/j.biotechadv.2011.05.006; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Motoyama A, 2008, ANAL CHEM, V80, P7187, DOI 10.1021/ac8013669; Rathore AS, 2003, J PHARMACEUT BIOMED, V32, P1199, DOI 10.1016/S0731-7085(03)00157-2; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; RINAS U, 1992, APPL MICROBIOL BIOT, V37, P609; RINAS U, 1993, J BIOTECHNOL, V28, P313, DOI 10.1016/0168-1656(93)90179-Q; Savino E, 2011, BIOPROCESS INT, V9, P68; Schenauer MR, 2012, ANAL BIOCHEM, V428, P150, DOI 10.1016/j.ab.2012.05.018; SOWADSKI JM, 1985, J MOL BIOL, V186, P417, DOI 10.1016/0022-2836(85)90115-9; TALARICO TL, 1991, J BACTERIOL, V173, P7029, DOI 10.1128/jb.173.21.7029-7032.1991; VEERARAGAVAN K, 1989, FEMS MICROBIOL LETT, V61, P149, DOI 10.1016/0378-1097(89)90187-0; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang R, 2012, NAT BIOTECHNOL, V30, P135, DOI 10.1038/nbt.2112; Wang X, 2010, BIOPROCESS INT, V8, P18; Wang X, 2009, BIOTECHNOL BIOENG, V103, P446, DOI 10.1002/bit.22304; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190	39	18	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81639	10.1371/journal.pone.0081639	http://dx.doi.org/10.1371/journal.pone.0081639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312330	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100090
J	Medeiros, MM; da Silva, HB; Reis, AS; Barboza, R; Thompson, J; Lima, MRD; Marinho, CRF; Tadokoro, CE				Medeiros, Marcia M.; da Silva, Henrique B.; Reis, Aramys S.; Barboza, Renato; Thompson, Joanne; D'Imperio Lima, Maria Regina; Marinho, Claudio R. F.; Tadokoro, Carlos E.			Liver Accumulation of Plasmodium chabaudi-Infected Red Blood Cells and Modulation of Regulatory T Cell and Dendritic Cell Responses	PLOS ONE			English	Article							IN-VITRO; ENDOTHELIAL RECEPTOR; ADHESION MOLECULE-1; STAGE MALARIA; NITRIC-OXIDE; FALCIPARUM; CD36; CYTOADHERENCE; PROTECTION; IMMUNITY	It is postulated that accumulation of malaria-infected Red Blood Cells (iRBCs) in the liver be a Parasitic escape mechanism against full destruction by the host immune system. Therefore, we evaluated the in vivo mechanism of hi accumulation and it potential immunological consequences A massive liver accumulation of P. c. chabaudi AS-iRBCs Pc-iRBCs) was observed by intravital microscopy along with an over expression of ICAM-1 on day 7 of the infection, measured by qRT-PCR. Phenotypic changes were also observed in regulatory T cells (Tregs) and dendritic cells (DCs) that ere isolated from infected livers, which indicate a functional role for Tregs in the regulation of the liver inflammatory Line response. In fact, the suppressive function of liver-Tregs was in vitro tested, which demonstrated the capacity of cells to suppress naive T cell activation to the same extent as that observed for spleen-Tregs. On the other hand, it is already known that CD4+ T cells isolated from spleens of protozoan parasite-infected mice are refractory to proliferate in vivo. In our experiments, we observed a similar lack of in vitro proliferative capacity in liver CD4+ T cells that were isolated on day 7 of infection. it 15 also known that nitric oxide and IL-10 are partially involved in acute phase immunosuppression; we found high expression levels of IL-10 and iNOS mRNA in day 7-infected livers, which indicates a possible role for these molecules in the observed immune suppression. Taken together, these results indicate that malaria parasite accumulation within the liver could be an escape mechanism to avoid sterile immunity sponsored by a tolerogenic environment	[Medeiros, Marcia M.; da Silva, Henrique B.; Tadokoro, Carlos E.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [da Silva, Henrique B.; D'Imperio Lima, Maria Regina] Univ Sao Paulo, Inst Ciencias Biomed, Dept Immunol, BR-05508 Sao Paulo, Brazil; [Reis, Aramys S.; Barboza, Renato; Marinho, Claudio R. F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Thompson, Joanne] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Instituto Gulbenkian de Ciencia; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Edinburgh	Tadokoro, CE (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ctadokoro@igc.gulbenkian.pt	D'Império Lima, Maria Regina/I-4747-2012; Tadokoro, Carlos E/D-5111-2011; Reis, Aramys S/N-9170-2019; REIS, ARAMYS SILVA/G-4806-2012; Barboza, Renato/G-5833-2012; Marinho, Claudio Romero Farias/F-7507-2012; da Silva, Henrique/B-1266-2014	D'Império Lima, Maria Regina/0000-0002-4683-7709; Reis, Aramys S/0000-0003-4999-6382; REIS, ARAMYS SILVA/0000-0003-4999-6382; Barboza, Renato/0000-0002-6441-7513; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Melo Medeiros, Marcia/0000-0002-5364-9087; Tadokoro, Carlos Eduardo/0000-0002-7874-5657; , Henrique/0000-0002-5021-6200	CAPES-FCT [258/2010]; CAPES-IGC [04/2012]; Fundacao de Apoio a Pesquisa do Estado de Sao Paulo - FAPESP [2009/53.889-0]; FCT [PTDC/EBB-BIO/115514/2009]; Fundação para a Ciência e a Tecnologia [PTDC/EBB-BIO/115514/2009] Funding Source: FCT	CAPES-FCT(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Portuguese Foundation for Science and Technology); CAPES-IGC; Fundacao de Apoio a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	M.M.M.'s travel expenses and accommodation were supported by a CAPES-FCT travel grant # 258/2010. H.B.S. and M.R.D.L.'s travel expenses and accommodations were supported by a CAPES-IGC grant #04/2012. C.R.F.M.'s research was supported by a Fundacao de Apoio a Pesquisa do Estado de Sao Paulo - FAPESP grant # 2009/53.889-0 and CAPES-FCT grant #258/2010. C.E.T.'s research was supported by a FCT grant # PTDC/EBB-BIO/115514/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Bruna-Romero O, 2003, J IMMUNOL, V170, P3195, DOI 10.4049/jimmunol.170.6.3195; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; COX J, 1987, PARASITE IMMUNOL, V9, P543, DOI 10.1111/j.1365-3024.1987.tb00529.x; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Ebbinghaus P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-272; Feng H, 2012, SCAND J IMMUNOL, V75, P46, DOI 10.1111/j.1365-3083.2011.02622.x; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; GILKS CF, 1990, PARASITE IMMUNOL, V12, P45, DOI 10.1111/j.1365-3024.1990.tb00935.x; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; HOWARD RJ, 1989, BLOOD, V74, P2603; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mota MM, 2000, INFECT IMMUN, V68, P4135, DOI 10.1128/IAI.68.7.4135-4144.2000; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Ocana-Morgner C, 2007, EUR J IMMUNOL, V37, P1562, DOI 10.1002/eji.200737068; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Plebanski M, 2005, IMMUNOL CELL BIOL, V83, P307, DOI 10.1111/j.1440-1711.2005.01325.x; Pouniotis DS, 2004, INFECT IMMUN, V72, P5331, DOI 10.1128/IAI.72.9.5331-5339.2004; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Randall LM, 2008, INFECT IMMUN, V76, P3312, DOI 10.1128/IAI.01475-07; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Scholzen A, 2010, TRENDS PARASITOL, V26, P16, DOI 10.1016/j.pt.2009.10.004; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tartz S, 2006, INFECT IMMUN, V74, P2277, DOI 10.1128/IAI.74.4.2277-2285.2006; Taylor-Robinson AW, 1999, IMMUNOL LETT, V67, P1, DOI 10.1016/S0165-2478(98)00148-5; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Zago CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029894	56	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81409	10.1371/journal.pone.0081409	http://dx.doi.org/10.1371/journal.pone.0081409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312297	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100077
J	Wang, LN; Quan, CS; Liu, BQ; Wang, JF; Xiong, W; Zhao, PC; Fan, SD				Wang, Lina; Quan, Chunshan; Liu, Baoquan; Wang, Jianfeng; Xiong, Wen; Zhao, Pengchao; Fan, Shengdi			Functional Reconstitution of Staphylococcus aureus Truncated AgrC Histidine Kinase in a Model Membrane System	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; PROTEIN RECONSTITUTION; ESCHERICHIA-COLI; RECEPTOR; SENSOR; SOLUBILIZATION; DETERGENTS; TOPOLOGY; PROTEOLIPOSOMES; DETERMINANTS	The integral membrane protein AgrC is a histidine kinase whose sensor domains interact with an autoinducing peptide, resulting in a series of downstream responses. In this study, truncated AgrC(TM5-6C) and AgrC(TM5-6C)-GFP with GFP as a reporter gene were produced using a bacterial system. Purified AgrC(TM5-6C) and AgrC(TM5-6C)-GFP were reconstituted into liposomes by a detergent-mediated method. To achieve high-yield protein incorporation, we investigated the effect of different detergents on protein reconstitution efficiency. The highest incorporation was found with N, N-dimethyldode-cylamine Noxide during complete liposome solubilization, which resulted in a yield of 85 +/- 5%. The COOH-terminus of the protein AgrC(TM5-6C) was almost exclusively oriented towards the inside of the vesicles. AgrC(TM5-6C) in proteoliposomes exhibited approximately a 6-fold increase in constitutive activity compared with AgrC(TM5-6C) in detergent micelles. The reconstitution of AgrC(TM5-6C) or AgrC(TM5-6C)-GFP was characterized using dynamic light scattering, fluorescence microscopy, and transmission electron microscopy. Based on the results, the optimal conditions for protein incorporation were defined. These findings contribute to the study of membrane protein structure and function in vitro using a reconstitution system.	[Wang, Lina; Zhao, Pengchao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; [Quan, Chunshan; Liu, Baoquan; Wang, Jianfeng; Xiong, Wen; Fan, Shengdi] Dalian Nationalities Univ, Dept Life Sci, Dalian, Peoples R China; [Quan, Chunshan; Liu, Baoquan; Wang, Jianfeng; Xiong, Wen; Fan, Shengdi] State Ethn Affairs Commiss, Minist Educ, Dalian, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Minzu University	Quan, CS (corresponding author), Dalian Nationalities Univ, Dept Life Sci, Dalian, Peoples R China.	mikyeken@dlnu.edu.cn	Xiong, Wen/A-2492-2016	Xiong, Wen/0000-0002-2825-2061	National Natural Science Foundation of China [21272031, 21172028]; Special Fund of the central university [DC1210118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of the central university	This work was supported by the National Natural Science Foundation of China (No. 21272031 and No. 21172028) and Special Fund of the central university (No. DC1210118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bay DC, 2013, BBA-BIOMEMBRANES, V1828, P260, DOI 10.1016/j.bbamem.2012.09.003; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen LC, 2009, J MICROBIOL, V47, P572, DOI 10.1007/s12275-009-0004-2; Cisar EA, 2009, MOL MICROBIOL, V74, P44, DOI 10.1111/j.1365-2958.2009.06849.x; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Daghastanli KRP, 2004, COLLOID SURFACE B, V36, P127, DOI 10.1016/j.colsurfb.2004.03.015; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geisinger E, 2008, J BIOL CHEM, V283, P8930, DOI 10.1074/jbc.M710227200; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Groth G, 1996, BIOCHEM J, V318, P351, DOI 10.1042/bj3180351; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Heerklotz H, 2009, NAT PROTOC, V4, P686, DOI 10.1038/nprot.2009.35; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Jung K, 1997, J BIOL CHEM, V272, P10847; Jung K, 2001, J BIOL CHEM, V276, P40896, DOI 10.1074/jbc.M107871200; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lee KE, 2008, COLLOID SURFACE B, V62, P51, DOI 10.1016/j.colsurfb.2007.09.021; LEVY D, 1990, BIOCHEMISTRY-US, V29, P9480, DOI 10.1021/bi00492a022; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Lina G, 1998, MOL MICROBIOL, V28, P655, DOI 10.1046/j.1365-2958.1998.00830.x; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Ma PK, 2008, MOL MEMBR BIOL, V25, P449, DOI 10.1080/09687680802359885; Martin M, 2009, PROTEIN EXPRES PURIF, V66, P39, DOI 10.1016/j.pep.2009.02.006; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; UENO M, 1984, BIOCHEMISTRY-US, V23, P3070, DOI 10.1021/bi00308a034; Vecino AJ, 2010, BBA-BIOMEMBRANES, V1798, P2160, DOI 10.1016/j.bbamem.2010.07.005; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Williams Paul, 2002, Expert Opin Ther Targets, V6, P257, DOI 10.1517/14728222.6.3.257; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908	56	5	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80400	10.1371/journal.pone.0080400	http://dx.doi.org/10.1371/journal.pone.0080400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303011	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400027
J	Mason-Gamer, RJ				Mason-Gamer, Roberta J.			Phylogeny of a Genomically Diverse Group of Elymus (Poaceae) Allopolyploids Reveals Multiple Levels of Reticulation	PLOS ONE			English	Article							BOUND STARCH SYNTHASE; NORTH-AMERICAN ELYMUS; COPY NUCLEAR GENE; MAXIMUM-LIKELIHOOD-ESTIMATION; INTERNAL TRANSCRIBED SPACER; IN-SITU HYBRIDIZATION; PHOSPHOENOLPYRUVATE CARBOXYLASE; GENOME ANALYSIS; THINOPYRUM-INTERMEDIUM; AGROPYRON-REPENS	The grass tribe Triticeae (=Hordeeae) comprises only about 300 species, but it is well known for the economically important crop plants wheat, barley, and rye. The group is also recognized as a fascinating example of evolutionary complexity, with a history shaped by numerous events of auto-and allopolyploidy and apparent introgression involving diploids and polyploids. The genus Elymus comprises a heterogeneous collection of allopolyploid genome combinations, all of which include at least one set of homoeologs, designated St, derived from Pseudoroegneria. The current analysis includes a geographically and genomically diverse collection of 21 tetraploid Elymus species, and a single hexaploid species. Diploid and polyploid relationships were estimated using four molecular data sets, including one that combines two regions of the chloroplast genome, and three from unlinked nuclear genes: phosphoenolpyruvate carboxylase, beta-amylase, and granule-bound starch synthase I. Four gene trees were generated using maximum likelihood, and the phylogenetic placement of the polyploid sequences reveals extensive reticulation beyond allopolyploidy alone. The trees were interpreted with reference to numerous phenomena known to complicate allopolyploid phylogenies, and introgression was identified as a major factor in their history. The work illustrates the interpretation of complicated phylogenetic results through the sequential consideration of numerous possible explanations, and the results highlight the value of careful inspection of multiple independent molecular phylogenetic estimates, with particular focus on the differences among them.	Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mason-Gamer, RJ (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	robie@uic.edu			National Science Foundation [DEB-9974181]	National Science Foundation(National Science Foundation (NSF))	The work was supported by National Science Foundation DEB-9974181 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arft AM, 1998, AM J BOT, V85, P110, DOI 10.2307/2446560; Arterburn M, 2011, HEREDITAS, V148, P8, DOI 10.1111/j.1601-5223.2010.02084.x; ASSADI M, 1995, PLANT SYST EVOL, V194, P189, DOI 10.1007/BF00982855; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Barkworth M. E., 2000, Grasses: systematics and evolution., P110; Barkworth ME, 2011, TELOPEA, V13, P37; Barkworth ME, 2009, BREEDING SCI, V59, P561, DOI 10.1270/jsbbs.59.561; BATCHER MS, 2002, ELEMENT STEWARDSHIP; Bendiksby M, 2011, NEW PHYTOL, V191, P1150, DOI 10.1111/j.1469-8137.2011.03753.x; [卢宝荣 Lu Baorong], 2004, [生物多样性, Chinese Biodiversity], V12, P213; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; BREMER K, 1979, SYST ZOOL, V28, P624, DOI 10.2307/2412572; Brokaw JM, 2010, AM J BOT, V97, P1457, DOI 10.3732/ajb.0900388; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; CAUDERON Yvonne., 1958, Annales de l'Amelioration des Plantes, V8, P389; CAUDERON Y., 1961, Wheat Information Service, P13; Chapman MA, 2010, NEW PHYTOL, V186, P63, DOI 10.1111/j.1469-8137.2009.03091.x; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; CHURCH GL, 1958, AM J BOT, V45, P410, DOI 10.2307/2439642; Church SA, 2005, AM J BOT, V92, P1372, DOI 10.3732/ajb.92.8.1372; CLARK JR, 1991, PLANT MOL BIOL, V16, P1099, DOI 10.1007/BF00016086; Cook LM, 1998, MOL ECOL, V7, P1293, DOI 10.1046/j.1365-294x.1998.00453.x; CRETIN C, 1991, GENE, V99, P87, DOI 10.1016/0378-1119(91)90037-C; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; DEWEY D. R., 1967, American Journal of Botany, V54, P93, DOI 10.2307/2440890; DEWEY D R, 1984, P209; DEWEY DR, 1970, AM J BOT, V57, P861, DOI 10.2307/2441345; DEWEY DR, 1970, BOT GAZ, V131, P342, DOI 10.1086/336551; DEWEY DR, 1970, B TORREY BOT CLUB, V97, P315, DOI 10.2307/2483851; DEWEY DR, 1961, J HERED, V52, P13, DOI 10.1093/oxfordjournals.jhered.a107013; DEWEY DR, 1975, AM J BOT, V62, P524, DOI 10.2307/2441961; DEWEY DR, 1968, AM J BOT, V55, P1133, DOI 10.2307/2440735; DEWEY DR, 1983, BRITTONIA, V35, P30, DOI 10.2307/2806044; DEWEY DR, 1974, BOT GAZ, V135, P80, DOI 10.1086/336733; DEWEY DR, 1976, CROP SCI, V16, P175, DOI 10.2135/cropsci1976.0011183X001600020003x; DEWEY DR, 1982, GRASSES GRASSLANDS S, P51; Doyle JJ, 2004, NEW PHYTOL, V161, P121, DOI 10.1046/j.1469-8137.2003.00949.x; Emshwiller E, 2002, AM J BOT, V89, P1042, DOI 10.3732/ajb.89.7.1042; Essi L, 2008, MOL PHYLOGENET EVOL, V47, P1018, DOI 10.1016/j.ympev.2008.03.007; Fan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031122; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferguson D, 2001, P NATL ACAD SCI USA, V98, P3915, DOI 10.1073/pnas.061288698; *FLOR CHIN ED COMM, 2006, FLOR CHIN, V22; *FLOR N AM ED COMM, 2007, FLOR N AM, V24; Fortune PM, 2007, MOL PHYLOGENET EVOL, V43, P1040, DOI 10.1016/j.ympev.2006.11.018; Garcia-Jacas N, 2009, MOL PHYLOGENET EVOL, V52, P377, DOI 10.1016/j.ympev.2009.03.010; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Goh WL, 2013, PLANT SYST EVOL, V299, P239, DOI 10.1007/s00606-012-0718-1; Grover CE, 2012, PLANT SYST EVOL, V298, P1177, DOI 10.1007/s00606-012-0615-7; GU X, 1995, MOL BIOL EVOL, V12, P546; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HEDBERG O, 1995, TAXON, V44, P3, DOI 10.2307/1222672; Hedren M, 2011, BIOL J LINN SOC, V104, P107, DOI 10.1111/j.1095-8312.2011.01708.x; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Hughes CE, 2002, AM J BOT, V89, P1057, DOI 10.3732/ajb.89.7.1057; Hunt HV, 2013, MOL BIOL EVOL, V30, P109, DOI 10.1093/molbev/mss209; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; JENSEN KB, 1990, BOT GAZ, V151, P245, DOI 10.1086/337824; JENSEN KB, 1989, GENOME, V32, P468, DOI 10.1139/g89-470; JENSEN KB, 1989, BOT GAZ, V150, P84, DOI 10.1086/337752; Jensen KB, 1996, INT J PLANT SCI, V157, P136, DOI 10.1086/297330; JENSEN KB, 1993, GENOME, V36, P72, DOI 10.1139/g93-010; Johnson LA, 2012, BOT REV, V78, P288, DOI 10.1007/s12229-012-9101-8; Joly S, 2006, AM J BOT, V93, P412, DOI 10.3732/ajb.93.3.412; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kashkush K, 2002, GENETICS, V160, P1651; KELLOGG EA, 1989, AM J BOT, V76, P796, DOI 10.2307/2444536; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; Laureto PJ, 2011, SYST BOT, V36, P209, DOI 10.1600/036364411X553289; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; LEPINIEC L, 1994, PLANT SCI, V99, P111, DOI 10.1016/0168-9452(94)90168-6; LEPINIEC L, 1993, PLANT MOL BIOL, V21, P487, DOI 10.1007/BF00028806; Lihova J, 2006, AM J BOT, V93, P1206, DOI 10.3732/ajb.93.8.1206; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1994, PLANT SYST EVOL, V192, P165, DOI 10.1007/BF00986250; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; LIU ZW, 1993, GENOME, V36, P102, DOI 10.1139/g93-014; Love A., 1984, Feddes Repertorium, V95, P425; LU B, 1990, Acta Botanica Yunnanica, V12, P161; LU BR, 1993, PLANT SYST EVOL, V187, P191, DOI 10.1007/BF00994099; LU BR, 1990, HEREDITAS, V112, P109, DOI 10.1111/j.1601-5223.1990.tb00048.x; LU BR, 1992, HEREDITAS, V116, P121, DOI 10.1111/j.1601-5223.1992.tb00215.x; LU BR, 1993, PLANT SYST EVOL, V185, P35, DOI 10.1007/BF00937719; LU BR, 1991, HEREDITAS, V114, P117, DOI 10.1111/j.1601-5223.1991.tb00316.x; Ma JX, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-100; Mahelka V, 2007, ANN BOT-LONDON, V100, P249, DOI 10.1093/aob/mcm093; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; Marcussen T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-45; Martin AP, 2002, SYST BIOL, V51, P570, DOI 10.1080/10635150290069995; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2005, AM J BOT, V92, P1045, DOI 10.3732/ajb.92.6.1045; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; Mason-Gamer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010989; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; MCDADE LA, 1992, EVOLUTION, V46, P1329, DOI 10.1111/j.1558-5646.1992.tb01127.x; MINDELL DP, 1992, BIOSYSTEMS, V27, P53, DOI 10.1016/0303-2647(92)90046-2; MINDELL DP, 1991, MOL BIOL EVOL, V8, P897; NELSON G, 1980, SYST ZOOL, V29, P86, DOI 10.2307/2412630; Oberle B, 2012, BOT J LINN SOC, V168, P91, DOI 10.1111/j.1095-8339.2011.01191.x; Okito P, 2009, GENOME, V52, P391, DOI [10.1139/G09-015, 10.1139/g09-015]; Orgaard M, 2001, GENOME, V44, P275, DOI 10.1139/gen-44-2-275; Petersen G, 1997, MOL PHYLOGENET EVOL, V7, P217, DOI 10.1006/mpev.1996.0389; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Petersen G, 2011, PLANT SYST EVOL, V291, P197, DOI 10.1007/s00606-010-0381-3; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Redinbaugh MG, 2000, GENOME, V43, P846, DOI 10.1139/gen-43-5-846; Rodriguez F, 2009, SYST BOT, V34, P207, DOI 10.1600/036364409787602195; Roelofs D, 1997, MOL ECOL, V6, P641, DOI 10.1046/j.1365-294X.1997.00225.x; ROHDE W, 1988, NUCLEIC ACIDS RES, V16, P7185, DOI 10.1093/nar/16.14.7185; SALOMON B, 1994, PLANT SYST EVOL, V189, P1, DOI 10.1007/BF00937574; SALOMON B, 1993, GENOME, V36, P899, DOI 10.1139/g93-118; SALOMON B, 1992, PLANT SYST EVOL, V180, P1, DOI 10.1007/BF00940394; Sang T, 1999, SYST BOT, V24, P148, DOI 10.2307/2419546; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Sessa EB, 2012, MOL PHYLOGENET EVOL, V64, P563, DOI 10.1016/j.ympev.2012.05.009; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Smedmark JEE, 2005, ORG DIVERS EVOL, V5, P275, DOI 10.1016/j.ode.2004.12.003; Smedmark JEE, 2003, SYST BIOL, V52, P374, DOI 10.1080/10635150390197000; Smith JF, 2006, PLANT SYST EVOL, V261, P245, DOI 10.1007/s00606-006-0445-6; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Sosef MSM, 1997, TAXON, V46, P75, DOI 10.2307/1224293; STEBBINS GL, 1956, EVOLUTION, V10, P235, DOI 10.2307/2406009; Straub SCK, 2006, MOL PHYLOGENET EVOL, V39, P580, DOI 10.1016/j.ympev.2005.11.018; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2011, GENOME, V54, P655, DOI [10.1139/G11-036, 10.1139/g11-036]; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Sun G, 2009, BREEDING SCI, V59, P487, DOI 10.1270/jsbbs.59.487; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thorsson AET, 2010, J BIOGEOGR, V37, P2098, DOI 10.1111/j.1365-2699.2010.02353.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; TZVELEV NN, 1984, GRASSES SOVIET UNION; WADDELL PJ, 1996, HDB SYMBOLIC EVOLUTI, P53; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Webb DA., 1980, FLORA EUROPAEA, V5; Winkworth RC, 2004, MOL PHYLOGENET EVOL, V33, P109, DOI 10.1016/j.ympev.2004.05.006; Yan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026853; Yang HQ, 2007, TAXON, V56, P45, DOI 10.2307/25065734; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yen C, 2005, ACTA PHYTOTAXON SIN, V43, P82, DOI 10.1360/aps040073; Yen C, 2009, BREEDING SCI, V59, P513, DOI 10.1270/jsbbs.59.513; Zaveska Drabkova L, 2009, PLANT SYST EVOL, V278, P67, DOI 10.1007/s00606-008-0134-8; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Zhang YX, 2012, MOL PHYLOGENET EVOL, V63, P777, DOI 10.1016/j.ympev.2012.02.023; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	165	26	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78449	10.1371/journal.pone.0078449	http://dx.doi.org/10.1371/journal.pone.0078449			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24302986	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300029
J	Demajo, S; Uribesalgo, I; Gutierrez, A; Ballare, C; Capdevila, S; Roth, M; Zuber, J; Martin-Caballero, J; Di Croce, L				Demajo, S.; Uribesalgo, I.; Gutierrez, A.; Ballare, C.; Capdevila, S.; Roth, M.; Zuber, J.; Martin-Caballero, J.; Di Croce, L.			ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia	ONCOGENE			English	Article						acute myeloid leukemia; ZRF1; retinoic acid; transcription; differentiation	ACUTE PROMYELOCYTIC LEUKEMIA; TUMOR-ASSOCIATED ANTIGENS; RAR-ALPHA; DIFFERENTIATION; CANCER; CELLS; TRANSCRIPTION; EXPRESSION; RESPONSES; CHROMATIN	Acute myeloid leukemia (AML) is frequently linked to epigenetic abnormalities and deregulation of gene transcription, which lead to aberrant cell proliferation and accumulation of undifferentiated precursors. ZRF1, a recently characterized epigenetic factor involved in transcriptional regulation, is highly overexpressed in human AML, but it is not known whether it plays a role in leukemia progression. Here, we demonstrate that ZRF1 depletion decreases cell proliferation, induces apoptosis and enhances cell differentiation in human AML cells. Treatment with retinoic acid (RA), a differentiating agent currently used to treat certain AMLs, leads to a functional switch of ZRF1 from a negative regulator to an activator of differentiation. At the molecular level, ZRF1 controls the RA-regulated gene network through its interaction with the RA receptor alpha (RAR alpha) and its binding to RA target genes. Our genome-wide expression study reveals that ZRF1 regulates the transcription of nearly half of RA target genes. Consistent with our in vitro observations that ZRF1 regulates proliferation, apoptosis, and differentiation, ZRF1 depletion strongly inhibits leukemia progression in a xenograft mouse model. Finally, ZRF1 knockdown cooperates with RA treatment in leukemia suppression in vivo. Taken together, our data reveal that ZRF1 is a key transcriptional regulator in leukemia progression and suggest that ZRF1 inhibition could be a novel strategy to be explored for AML treatment.	[Demajo, S.; Uribesalgo, I.; Gutierrez, A.; Ballare, C.; Di Croce, L.] CRG, Barcelona, Spain; [Demajo, S.; Uribesalgo, I.; Gutierrez, A.; Ballare, C.; Di Croce, L.] UPF, Barcelona, Spain; [Capdevila, S.; Martin-Caballero, J.] PRBB, Unidad Anim Lab, Barcelona, Spain; [Roth, M.; Zuber, J.] Inst Mol Pathol, A-1030 Vienna, Austria; [Di Croce, L.] ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Pompeu Fabra University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); ICREA	Di Croce, L (corresponding author), ICREA, C Dr Aiguader 88, Barcelona 08003, Spain.	luciano.dicroce@crg.eu	Zuber, Johannes/E-7517-2011; Di Croce, Luciano/E-7759-2015; Gutierrez, Arantxa/K-8213-2015; Demajo, Santiago/AAB-1999-2021; Ballare, Cecilia/F-2593-2016	Zuber, Johannes/0000-0001-8810-6835; Di Croce, Luciano/0000-0003-3488-6228; Gutierrez, Arantxa/0000-0001-9033-3834; Ballare, Cecilia/0000-0002-9442-807X; Demajo Meseguer, Santiago/0000-0003-3998-8784; Uribesalgo, Iris/0000-0001-9492-1000	Spanish 'Ministerio de Educacion y Ciencia' [BFU2010-18692]; AGAUR; 'Fundacio La Marato and from by European Commission's 7th Framework Program 4DCellFate [277899]; PFIS fellowship of the 'Instituto de Salud Carlos III'; Worldwide Cancer Research [10-0177] Funding Source: researchfish; ICREA Funding Source: Custom	Spanish 'Ministerio de Educacion y Ciencia'(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); 'Fundacio La Marato and from by European Commission's 7th Framework Program 4DCellFate; PFIS fellowship of the 'Instituto de Salud Carlos III'; Worldwide Cancer Research; ICREA(ICREA)	We thank the members of the LDC laboratory for discussions, the CRG Genomic Unit, and VA Raker for help in preparing the manuscript. This work was supported by grants from the Spanish 'Ministerio de Educacion y Ciencia' (BFU2010-18692), from AGAUR, from 'Fundacio La Marato and from by European Commission's 7th Framework Program 4DCellFate grant number 277899 to LDC; SD was supported by a PFIS fellowship of the 'Instituto de Salud Carlos III'.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Berge T, 2007, BLOOD CELL MOL DIS, V39, P278, DOI 10.1016/j.bcmd.2007.05.007; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; DERMIME S, 1995, LEUKEMIA LYMPHOMA, V16, P289, DOI 10.3109/10428199509049768; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Giannopoulos K, 2006, INT J ONCOL, V29, P95; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Greiner J, 2004, INT J CANCER, V108, P704, DOI 10.1002/ijc.11623; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kastner P, 2001, ONCOGENE, V20, P7178, DOI 10.1038/sj.onc.1204757; Lehmann S, 2001, CLIN CANCER RES, V7, P367; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oren T, 2003, LEUKEMIA LYMPHOMA, V44, P1881, DOI 10.1080/1042819031000116661; Resto VA, 2000, CANCER RES, V60, P5529; Ribeiro JD, 2013, ONCOGENE, V32, P2161, DOI 10.1038/onc.2012.241; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Schmitt M, 2006, EXP HEMATOL, V34, P1709, DOI 10.1016/j.exphem.2006.07.009; SHOJI W, 1995, J BIOL CHEM, V270, P24818, DOI 10.1074/jbc.270.42.24818; Siegel S, 2012, ACTA HAEMATOL-BASEL, V127, P193, DOI 10.1159/000335133; Smith JC, 2007, J PROTEOME RES, V6, P3174, DOI 10.1021/pr070122r; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Uckun FM, 1996, BLOOD, V88, P1135, DOI 10.1182/blood.V88.4.1135.bloodjournal8841135; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Uribesalgo I, 2011, BRIEF FUNCT GENOMICS, V10, P18, DOI 10.1093/bfgp/elr002; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	36	17	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5501	5510		10.1038/onc.2013.501	http://dx.doi.org/10.1038/onc.2013.501			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24292673				2022-12-25	WOS:000346087900003
J	Su, B; Ji, YS; Sun, XL; Liu, XH; Chen, ZY				Su, Bo; Ji, Yun-Song; Sun, Xu-lu; Liu, Xiang-Hua; Chen, Zhe-Yu			Brain-derived Neurotrophic Factor (BDNF)-induced Mitochondrial Motility Arrest and Presynaptic Docking Contribute to BDNF-enhanced Synaptic Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Mitochondrial Transport; Signal Transduction; Synaptic Plasticity; TRP Channels	KINESIN HEAVY-CHAIN; HIPPOCAMPAL-NEURONS; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; AXONAL-TRANSPORT; CORTICAL-NEURONS; DENDRITIC GROWTH; TRPC CHANNELS; INCREASES; SYNAPTOSOMES	Background: Appropriate mitochondrial transport and localization are highly associated with neuronal activities. Results: BDNF induces mitochondrial motility arrest via Miro1 binding with Ca2+, which facilitates BDNF-enhanced neurotransmitter release. Conclusion: BDNF-regulated mitochondrial motility is essential for BDNF-enhanced synaptic transmission. Significance: These results provide novel insights into the mechanistic link between BDNF-dependent mitochondrial motility and BDNF-mediated synaptic transmission. Appropriate mitochondrial transport and distribution are essential for neurons because of the high energy and Ca2+ buffering requirements at synapses. Brain-derived neurotrophic factor (BDNF) plays an essential role in regulating synaptic transmission and plasticity. However, whether and how BDNF can regulate mitochondrial transport and distribution are still unclear. Here, we find that in cultured hippocampal neurons, application of BDNF for 15 min decreased the percentage of moving mitochondria in axons, a process dependent on the activation of the TrkB receptor and its downstream PI3K and phospholipase-C signaling pathways. Moreover, the BDNF-induced mitochondrial stopping requires the activation of transient receptor potential canonical 3 and 6 (TRPC3 and TRPC6) channels and elevated intracellular Ca2+ levels. The Ca2+ sensor Miro1 plays an important role in this process. Finally, the BDNF-induced mitochondrial stopping leads to the accumulation of more mitochondria at presynaptic sites. Mutant Miro1 lacking the ability to bind Ca2+ prevents BDNF-induced mitochondrial presynaptic accumulation and synaptic transmission, suggesting that Miro1-mediated mitochondrial motility is involved in BDNF-induced mitochondrial presynaptic docking and neurotransmission. Together, these data suggest that mitochondrial transport and distribution play essential roles in BDNF-mediated synaptic transmission.	[Su, Bo; Ji, Yun-Song; Sun, Xu-lu; Liu, Xiang-Hua; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National 973 Basic Research Program of China [2012CB911000]; National Natural Science Foundation of China [31130026, 31100968]; State Program of National Natural Science Foundation of China for Innovative Research Group [81321061]; China Postdoctoral Science Foundation [20110491590, 2012T50609]; Specialized Research Fund for the Doctoral Program of Higher Education [20100131120052]; Independent Innovation Foundation of Shandong University	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University	This work was supported by National 973 Basic Research Program of China Grant 2012CB911000, National Natural Science Foundation of China Grants 31130026 and 31100968, State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81321061, China Postdoctoral Science Foundation Grants 20110491590 and 2012T50609, Specialized Research Fund for the Doctoral Program of Higher Education 20100131120052, and the Independent Innovation Foundation of Shandong University.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Amaral MD, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/203536; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Billups B, 2002, J NEUROSCI, V22, P5840; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; He ZH, 2012, J NEUROSCI, V32, P9383, DOI 10.1523/JNEUROSCI.6363-11.2012; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shin HY, 2010, PLOS ONE, V5; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walsh B, 2001, J PHYSIOL-LONDON, V537, P971; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	52	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1213	1226		10.1074/jbc.M113.526129	http://dx.doi.org/10.1074/jbc.M113.526129			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302729	Green Published, hybrid			2022-12-25	WOS:000332401700003
J	Sun, F; Chen, HG; Li, W; Yang, X; Wang, X; Jiang, RC; Guo, ZY; Chen, HG; Huang, JT; Borowsky, AD; Qiu, Y				Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Chen, Hegang; Huang, Jiaoti; Borowsky, Alexander D.; Qiu, Yun			Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; EMT; Insulin-like Growth Factor (IGF); MicroRNA; Prostate Cancer; mir-29; Splicing Variant	TYROSINE KINASE ETK/BMX; GROWTH-FACTOR-I; INTRAEPITHELIAL NEOPLASIA; MICRORNA EXPRESSION; CELL SUBPOPULATION; GENE-EXPRESSION; FULL-LENGTH; STEM-CELLS; MURINE; DIFFERENTIATION	Background: AR splice variants may play a critical role in prostate cancer. Results: AR3 modulates expression of tumor-promoting growth factors and promotes epithelial-mesenchymal transition, leading to development of prostatic intraepithelial neoplasia. Conclusion: AR3 promotes prostate cancer by modulating multiple tumor-associated autocrine/paracrine factors. Significance: Our findings provide new insights into mechanisms by which AR3 contributes to prostate cancer despite its heterogeneous expression pattern. Deregulation of androgen receptor (AR) splice variants has been implicated to play a role in prostate cancer development and progression. To understand their functions in prostate, we established a transgenic mouse model (AR3Tg) with targeted expression of the constitutively active and androgen-independent AR splice variant AR3 (a.k.a. AR-V7) in prostate epithelium. We found that overexpression of AR3 modulates expression of a number of tumor-promoting autocrine/paracrine growth factors (including Tgf2 and Igf1) and expands prostatic progenitor cell population, leading to development of prostatic intraepithelial neoplasia. In addition, we showed that some epithelial-mesenchymal transition-associated genes are up-regulated in AR3Tg prostates, suggesting that AR3 may antagonize AR activity and halt the differentiation process driven by AR and androgen. This notion is supported by our observations that the number of Ck5(+)/Ck8(+) intermediate cells is increased in AR3Tg prostates after castration, and expression of AR3 transgene in these intermediate cells compromises prostate epithelium regeneration upon androgen replacement. Our results demonstrate that AR3 is a driver of prostate cancer, at least in part, through modulating multiple tumor-promoting autocrine/paracrine factors.	[Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Huang, Jiaoti] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Borowsky, Alexander D.] Univ Calif Davis, Ctr Comparat Med, Sacramento, CA 95817 USA; [Borowsky, Alexander D.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; University of California System; University of California Davis	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Borowsky, Alexander D/S-5404-2017; chen, hege/GYV-5810-2022	Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [CA106504]; Department of Defense [W81XWH-10-1-0309]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA106504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106504 (to Y. Q.). This work was also supported by Department of Defense Grant W81XWH-10-1-0309 (to Y. Q.).	Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chokkalingam AP, 2001, CANCER EPIDEM BIOMAR, V10, P421; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gregory CW, 2001, CANCER RES, V61, P2892; Guo S, 2011, PLOS ONE, V6; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Harman SM, 2000, J CLIN ENDOCR METAB, V85, P4258, DOI 10.1210/jc.85.11.4258; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin TH, 2013, J BIOL CHEM, V288, P19359, DOI 10.1074/jbc.M113.477216; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Tsai HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049887; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	61	64	65	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1529	1539		10.1074/jbc.M113.492140	http://dx.doi.org/10.1074/jbc.M113.492140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297183	Green Published, hybrid			2022-12-25	WOS:000332401700028
J	Xu, CS; Chen, HY; Wang, X; Gao, JD; Che, YQ; Li, Y; Ding, F; Luo, AP; Zhang, SG; Liu, ZH				Xu, Chengshan; Chen, Hongyan; Wang, Xiang; Gao, Jidong; Che, Yiqun; Li, Yi; Ding, Fang; Luo, Aiping; Zhang, Shuguang; Liu, Zhihua			S100A14, a Member of the EF-hand Calcium-binding Proteins, Is Overexpressed in Breast Cancer and Acts as a Modulator of HER2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; TUMOR-CELLS; RECEPTOR; EXPRESSION; SURVIVAL; TRASTUZUMAB; RESISTANCE; INVASION; FAMILY	HER2 is overexpressed in 20-25% of breast cancers. Overexpression of HER2 is an adverse prognostic factor and correlates with decreased patient survival. HER2 stimulates breast tumorigenesis via a number of intracellular signaling molecules, including PI3K/AKT and MAPK/ERK. S100A14, one member of the S100 protein family, is significantly associated without come of breast cancer patients. Here, for the first time, we show that S100A14 and HER2 are coexpressed in invasive breast cancer specimens, and there is a significant correlation between the expression levels of the two proteins by immunohistochemistry. S100A14 and HER2 are colocalized in plasma membrane of breast cancer tissue cells and breast cancer cell lines BT474 and SK-BR3. We demonstrate that S100A14 binds directly to HER2 by co-immunoprecipitation and pull-down assays. Further study shows that residues 956-1154 of the HER2 intracellular domain and residue 83 of S100A14 are essential for the two proteins binding. Moreover, we observe a decrease of HER2 phosphorylation, downstream signaling, and HER2-stimulated cell proliferation in S100A14-silenced MCF-7, BT474, and SK-BR3 cells. Our findings suggest that S100A14 functions as a modulator of HER2 signaling and provide mechanistic evidence for its role in breast cancer progression.	[Xu, Chengshan; Chen, Hongyan; Li, Yi; Ding, Fang; Luo, Aiping; Zhang, Shuguang; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Wang, Xiang; Gao, Jidong] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100021, Peoples R China; [Che, Yiqun] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Clin Lab, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, HY (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	chenhongyan@cicams.ac.cn; liuzh@cicams.ac.cn		Wang, Xiang/0000-0002-0913-0501	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81000954, 81130043]; Ministry of Education of China [20101106120012]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Basic Research Program of China Grant 2011CB504205, National Natural Science Foundation of China Grants 81000954 and 81130043, and Doctoral Fund of Ministry of Education of China Grant 20101106120012.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Anan K, 1998, EUR J SURG ONCOL, V24, P28, DOI 10.1016/S0748-7983(98)80121-2; Arisio R, 2000, J CLIN PATHOL, V53, P846, DOI 10.1136/jcp.53.11.846; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Bader AA, 2002, BREAST CANCER RES TR, V76, P11, DOI 10.1023/A:1020231300974; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen HY, 2012, J BIOL CHEM, V287, P17109, DOI 10.1074/jbc.M111.326975; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Fusun T, 2005, EXP ONCOL, V27, P145; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hernan R, 2003, CANCER RES, V63, P140; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; MITTRA I, 1995, J SURG ONCOL, V60, P106, DOI 10.1002/jso.2930600208; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schneider J, 2003, BRIT J CANCER, V88, P96, DOI 10.1038/sj.bjc.6600656; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sutterlin MW, 2000, ANTICANCER RES, V20, P5083; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Wang YY, 2010, ANN SURG ONCOL, V17, P89, DOI 10.1245/s10434-009-0722-z; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	43	42	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					827	837		10.1074/jbc.M113.469718	http://dx.doi.org/10.1074/jbc.M113.469718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24285542	Green Published, hybrid			2022-12-25	WOS:000330541200020
J	Chenine, AL; Wieczorek, L; Sanders-Buell, E; Wesberry, M; Towle, T; Pillis, DM; Molnar, S; McLinden, R; Edmonds, T; Hirsch, I; O'Connell, R; McCutchan, FE; Montefiori, DC; Ochsenbauer, C; Kappes, JC; Kim, JH; Polonis, VR; Tovanabutra, S				Chenine, Agnes-Laurence; Wieczorek, Lindsay; Sanders-Buell, Eric; Wesberry, Maggie; Towle, Teresa; Pillis, Devin M.; Molnar, Sebastian; McLinden, Robert; Edmonds, Tara; Hirsch, Ivan; O'Connell, Robert; McCutchan, Francine E.; Montefiori, David C.; Ochsenbauer, Christina; Kappes, John C.; Kim, Jerome H.; Polonis, Victoria R.; Tovanabutra, Sodsai			Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS MOLECULAR CLONES; ANTIBODY NEUTRALIZATION; CYTOPLASMIC DOMAIN; TERMINAL TAIL; ENV CLONES; VACCINE; EPITOPE; CONSTRUCTION; SEQUENCE	Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development of protective HIV-1 vaccines and drugs. These immune assays will be advanced by the development of standardized viral stocks, such as HIV-1 infectious molecular clones (IMC), that i) express a reporter gene, ii) are representative of globally diverse subtypes and iii) are engineered to easily exchange envelope (env) genes for expression of sequences of interest. Thus far, a subtype B IMC backbone expressing Renilla luciferase (LucR), and into which the ectodomain of heterologous env coding sequences can be expressed has been successfully developed but as execution of HIV-1 vaccine efficacy trials shifts increasingly to non-subtype B epidemics (Southern African and Southeast Asia), non-subtype B HIV-1 reagents are needed to support vaccine development. Here we describe two IMCs derived from subtypes C and CRF01_AE HIV-1 primary isolates expressing LucR (IMC. LucR) that were engineered to express heterologous gp160 Envs. 18 constructs expressing various subtypes C and CRF01_AE Envs, mostly acute, in subtype-matched and -unmatched HIV backbones were tested for functionality and neutralization sensitivity. Our results suggest a possible effect of non-env HIV-1 genes on the interaction of Env and neutralizing antibodies and highlight the need to generate a library of IMCs representative of the HIV-1 subtype spectrum to be used as standardized neutralization assay reagents for assessing HIV-1 vaccine efficacy.	[Chenine, Agnes-Laurence; Wieczorek, Lindsay; Sanders-Buell, Eric; Wesberry, Maggie; Towle, Teresa; Pillis, Devin M.; Molnar, Sebastian; McLinden, Robert; Tovanabutra, Sodsai] Henry M Jackson Fdn, Bethesda, MD 20817 USA; [Chenine, Agnes-Laurence; Wieczorek, Lindsay; Sanders-Buell, Eric; Wesberry, Maggie; Towle, Teresa; Pillis, Devin M.; Molnar, Sebastian; McLinden, Robert; O'Connell, Robert; Kim, Jerome H.; Polonis, Victoria R.; Tovanabutra, Sodsai] Mil HIV Res Program, Silver Spring, MD USA; [Edmonds, Tara; Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Birmingham, AL USA; [O'Connell, Robert; Kim, Jerome H.; Polonis, Victoria R.] Walter Reed Army Inst Res, Silver Spring, MD USA; [McCutchan, Francine E.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Montefiori, David C.] Duke Univ, Durham, NC USA; [Hirsch, Ivan] Ctr Rech Cancerol Marseille, Inserm UMR891, Marseille, France	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); University of Alabama System; University of Alabama Birmingham; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Bill & Melinda Gates Foundation; Duke University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Chenine, AL (corresponding author), Henry M Jackson Fdn, Bethesda, MD 20817 USA.	alchenine@hivresearch.org	molnar, sebastian/AAS-7925-2020; Molnar, Sebastian/AAS-6868-2020; Hirsch, Ivan/J-7726-2015	Hirsch, Ivan/0000-0003-1701-1438; Molnar, Sebastian/0000-0002-0171-8001	U.S. Army Medical Research and Material Command [DAMD17-93-V-3004]; Henry M. Jackson Foundation for the Advancement of Military Medicine, working with the Division of AIDS, National Institute of Allergy and Infectious Diseases National Institutes of Health; Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [38619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, working with the Division of AIDS, National Institute of Allergy and Infectious Diseases National Institutes of Health; Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Cooperative Agreement no. DAMD17-93-V-3004 between the U.S. Army Medical Research and Material Command; the Henry M. Jackson Foundation for the Advancement of Military Medicine, working with the Division of AIDS, National Institute of Allergy and Infectious Diseases National Institutes of Health; the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD), grant number 38619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BROWN B, 2012, DES ISSUES, V28, P1, DOI DOI 10.1371/J0URNAL.P0NE.0029454.PUBMED:22509241; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Buratti E, 1997, J VIROL, V71, P2457, DOI 10.1128/JVI.71.3.2457-2462.1997; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Cheung L, 2005, J GEN VIROL, V86, P131, DOI 10.1099/vir.0.80439-0; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; Cosset FL, 2011, ADV GENET, V73, P121, DOI 10.1016/B978-0-12-380860-8.00004-5; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; Fiorentini S, 2008, VACCINE, V26, P4758, DOI 10.1016/j.vaccine.2008.06.082; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GHOSH K, 1993, VIROLOGY, V194, P858, DOI 10.1006/viro.1993.1331; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Kageyama S, 1996, ACTA VIROL, V40, P195; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Levy JA, 1998, HIV PATHOGENESIS AID; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Louder MK, 2005, VIROLOGY, V339, P226, DOI 10.1016/j.virol.2005.06.003; Luciw PA, 2002, HUMAN IMMUNODEFICIEN, P1881; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Palma P, 2011, VACCINE, V29, P6810, DOI 10.1016/j.vaccine.2010.12.058; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peachman KK, 2010, VIROLOGY, V408, P213, DOI 10.1016/j.virol.2010.09.029; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Roodbari F, 2012, IRAN J IMMUNOL, V9, P86, DOI IJIv9i2A2; Rusert P, 2009, AIDS, V23, P1319, DOI 10.1097/QAD.0b013e32832d92c2; Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329; Salminen MO, 2000, VIROLOGY, V278, P103, DOI 10.1006/viro.2000.0640; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e76104	10.1371/journal.pone.0076104	http://dx.doi.org/10.1371/journal.pone.0076104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312165	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300002
J	He, QZ; Duan, ZG; Yu, Y; Liu, Z; Liu, ZH; Liang, SP				He, Quanze; Duan, Zhigui; Yu, Ying; Liu, Zhen; Liu, Zhonghua; Liang, Songping			The Venom Gland Transcriptome of Latrodectus tredecimguttatus Revealed by Deep Sequencing and cDNA Library Analysis	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEIN; ALPHA-LATROTOXIN; RNA-SEQ; CLONING; TOXIN; SCORPION; GENE; LATROINSECTOTOXIN; SUPERFAMILY; ANNOTATION	Latrodectus tredecimguttatus, commonly known as black widow spider, is well known for its dangerous bite. Although its venom has been characterized extensively, some fundamental questions about its molecular composition remain unanswered. The limited transcriptome and genome data available prevent further understanding of spider venom at the molecular level. In the present study, we combined next-generation sequencing and conventional DNA sequencing to construct a venom gland transcriptome of the spider L. tredecimguttatus, which resulted in the identification of 9,666 and 480 high-confidence proteins among 34,334 de novo sequences and 1,024 cDNA sequences, respectively, by assembly, translation, filtering, quantification and annotation. Extensive functional analyses of these proteins indicated that mRNAs involved in RNA transport and spliceosome, protein translation, processing and transport were highly enriched in the venom gland, which is consistent with the specific function of venom glands, namely the production of toxins. Furthermore, we identified 146 toxin-like proteins forming 12 families, including 6 new families in this spider in which alpha-LTX-Lt1a family2 is firstly identified as a subfamily of a-LTX-Lt1a family. The toxins were classified according to their bioactivities into five categories that functioned in a coordinate way. Few ion channels were expressed in venom gland cells, suggesting a possible mechanism of protection from the attack of their own toxins. The present study provides a gland transcriptome profile and extends our understanding of the toxinome of spiders and coordination mechanism for toxin production in protein expression quantity.	[He, Quanze; Duan, Zhigui; Liu, Zhen; Liu, Zhonghua; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Cooperat Innovat Ctr Engn & New Prod Dev Biol, Changsha, Hunan, Peoples R China; [Yu, Ying] Fudan Univ, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Hunan Normal University; Fudan University	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Cooperat Innovat Ctr Engn & New Prod Dev Biol, Changsha, Hunan, Peoples R China.	liuzh@hunnu.edu.cn; liangsp@hunnu.edu.cn			National Basic Research Program of China (973) [2010CB529800, 2012CB22305]	National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by grants from the National Basic Research Program of China (973): 2010CB529800 and 2012CB22305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton AC, 2000, BIOCHIMIE, V82, P453, DOI 10.1016/S0300-9084(00)00199-1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Danilevich VN, 1999, BIOORG KHIM+, V25, P537; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Dulubova IE, 1996, J BIOL CHEM, V271, P7535, DOI 10.1074/jbc.271.13.7535; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; GASPARINI S, 1994, J BIOL CHEM, V269, P19803; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; HE Q, 2010, TOXICON; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; JUNG EH, 2002, NUCLEOTIDE SEQUENCE; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; KIYATKIN N, 1992, TOXICON, V30, P771, DOI 10.1016/0041-0101(92)90012-T; KIYATKIN N, 1993, EUR J BIOCHEM, V213, P121, DOI 10.1111/j.1432-1033.1993.tb17741.x; KIYATKIN NI, 1990, FEBS LETT, V270, P127, DOI 10.1016/0014-5793(90)81250-R; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Legros C, 1998, J EXP BIOL, V201, P2625; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Luch A, 2010, EXPERIENTIA SUPPL, V100, P293; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulenga A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-217; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Orlova EV, 2000, NAT STRUCT BIOL, V7, P48, DOI 10.1038/71247; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; Richardson M, 2006, COMP BIOCHEM PHYS C, V142, P173, DOI 10.1016/j.cbpc.2005.09.010; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SEBASTIN PA, 2009, SPIDERS INDIA; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; VOLKOVA TM, 1995, TOXICON, V33, P483, DOI 10.1016/0041-0101(94)00166-6; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YM, 2001, BIOCHEM J, V354, P161, DOI 10.1042/0264-6021:3540161; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Yuan CH, 2007, TOXICON, V50, P646, DOI 10.1016/j.toxicon.2007.05.009; Yuan CH, 2007, BIOCHEM BIOPH RES CO, V352, P799, DOI 10.1016/j.bbrc.2006.11.086; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; ZHU S, 2007, NUCLEOTIDE SEQUENCE; Zuo XP, 2006, FEBS LETT, V580, P4508, DOI 10.1016/j.febslet.2006.07.024	60	45	47	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81357	10.1371/journal.pone.0081357	http://dx.doi.org/10.1371/journal.pone.0081357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312294	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900030
J	He, XJ; He, YY; Xi, BR; Zheng, JS; Zeng, X; Cai, QM; OuYang, Y; Wang, C; Zhou, XF; Huang, HY; Deng, W; Xin, SM; Huang, QX; Liu, H				He, Xiaoju; He, Yinyan; Xi, Binrong; Zheng, Jiusheng; Zeng, Xiaoming; Cai, Qinhua; OuYang, Yu; Wang, Chen; Zhou, Xiaofei; Huang, Huiying; Deng, Wei; Xin, Siming; Huang, Qixiang; Liu, Huai			LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis	PLOS ONE			English	Article							LONG NONCODING RNAS	Background: Long non-coding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of diseases. In this study, we aimed to investigate the lncRNA profiles in preeclampsia. Preeclampsia has been observed in patients with molar pregnancy where a fetus is absent, which demonstrate that the placenta is sufficient to cause this condition. Thus, we analyzed the lncRNA profiles in preeclampsia placentas. Methodology/Principal Findings: In this study, we described the lncRNA profiles in six preeclampsia placentas (T) and five normal pregnancy placentas (N) using microarray. With abundant and varied probes accounting for 33,045 LncRNAs in our microarray, 28,443 lncRNAs that were expressed at a specific level were detected. From the data, we found 738 lncRNAs that were differentially expressed (>= 1.5-fold-change) among preeclampsia placentas compared with controls. Coding-non-coding gene co-expression networks (CNC network) were constructed based on the correlation analysis between the differentially expressed lncRNAs and mRNAs. According to the CNC network and GO analysis of differentially expressed lncRNAs/mRNAs, we selected three lncRNAs to analyze the relationship between lncRNAs and preeclampsia. LOC391533, LOC284100, and CEACAMP8 were evaluated using qPCR in 40 preeclampsia placentas and 40 controls. These results revealed that three lncRNAs were aberrantly expressed in preeclampsia placentas compared with controls. Conclusions/Significance: Our study is the first study to determine the genome-wide lncRNAs expression patterns in preeclampsia placenta using microarray. These results revealed that clusters of lncRNAs were aberrantly expressed in preeclampsia placenta compared with controls, which indicated that lncRNAs differentially expressed in preeclampsia placenta might play a partial or key role in preeclampsia development. Misregulation of LOC391533, LOC284100, and CEACAMP8 might contribute to the mechanism underlying preeclampsia. Taken together, this study may provide potential targets for the future treatment of preeclampsia and novel insights into preeclampsia biology.	[He, Xiaoju; Xi, Binrong; Zheng, Jiusheng; Zeng, Xiaoming; Cai, Qinhua; OuYang, Yu; Wang, Chen; Zhou, Xiaofei; Huang, Huiying; Deng, Wei; Liu, Huai] Jiangxi Maternal & Child Hlth Hosp, Dept Obstet, Nanchang, Peoples R China; [He, Yinyan] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Xin, Siming; Huang, Qixiang] Nanchang Univ, Sch Med, Nanchang, Peoples R China	Shanghai Jiao Tong University; Nanchang University	He, XJ (corresponding author), Jiangxi Maternal & Child Hlth Hosp, Dept Obstet, Nanchang, Peoples R China.	hexiaoju21@163.com; lh8830@126.com			National Natural Science Foundation of China [81060054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81060054, http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Genest DS, 2012, HYPERTENSION, V60, P1104, DOI 10.1161/HYPERTENSIONAHA.112.194050; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Nejatizadeh A, 2008, BIOCHEM GENET, V46, P451, DOI 10.1007/s10528-008-9163-9; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Savaj S, 2012, IRAN J KIDNEY DIS, V6, P334; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Valenzuela FJ, 2012, J PREGNANCY, V2012, DOI [10.1155/2012/632732, DOI 10.1155/2012/632732]; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	16	82	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81437	10.1371/journal.pone.0081437	http://dx.doi.org/10.1371/journal.pone.0081437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312300	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900031
J	Bhallar, S; Evens, AM; Prachandl, S; Schumacker, PT; Gordon, LI				Bhallar, Savita; Evens, Andrew M.; Prachandl, Sheila; Schumacker, Paul T.; Gordon, Leo I.			Paradoxical Regulation of Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							FACTOR-I; CANCER-THERAPY; TUMOR ANGIOGENESIS; FACTOR 1-ALPHA; DEPENDENT INDUCTION; HDAC INHIBITORS; FACTOR (HIF)-1; AUTOPHAGY; HIF-1; PATHWAY	Hypoxia inducible factor (HIF) is important in cancer, as it regulates various oncogenic genes as well as genes involved in cell survival, proliferation, and migration. Elevated HIF-1 protein promotes a more aggressive tumor phenotype, and greater HIF-1 expression has been demonstrated to correlate with poorer prognosis, increased risk of metastasis and increased mortality. Recent reports suggest that HIF-1 activates autophagy, a lysosomal degradation pathway which may promote tumor cell survival. We show here that HIF-1 alpha expression is constitutively active in multiple diffuse large B cell lymphoma (DLBCL) cell lines under normoxia and it is regulated by the PI3K/AKT pathway. PCI-24781, a pan histone deacetylase inhibitor (HDACI), enhanced accumulation of HIF-1 alpha and induced autophagy initially, while extended incubation with the drug resulted in inhibition of HIF-1 alpha. We tested the hypothesis that PCI-24781- induced autophagy is mediated by HIF-1 alpha and that inhibition of HIF-1 alpha in these cells results in attenuation of autophagy and decreased survival. We also provide evidence that autophagy serves as a survival pathway in DLBCL cells treated with PCI-24781 which suggests that the use of autophagy inhibitors such as chloroquine or 3-methyl adenine in combination with PCI-24781 may enhance apoptosis in lymphoma cells.	[Bhallar, Savita; Prachandl, Sheila; Gordon, Leo I.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Bhallar, Savita; Prachandl, Sheila; Gordon, Leo I.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Evens, Andrew M.] Tufts Univ, Sch Med, Div Hematol Oncol, Boston, MA 02111 USA; [Evens, Andrew M.] Tufts Canc Ctr, Boston, MA USA; [Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Tufts University; Northwestern University; Feinberg School of Medicine	Bhallar, S (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.	s-bhalla@northwestern.edu		Evens, Andrew/0000-0002-6900-1824; Gordon, Leo/0000-0003-1666-7064; Schumacker, Paul T/0000-0001-9591-2034	T&C Schwartz Family Foundation	T&C Schwartz Family Foundation	The work was supported in part by funding from the T&C Schwartz Family Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual JE, 2013, BLOOD, V122, P2104, DOI 10.1182/blood-2013-02-485441; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Bhalla S, 2009, BLOOD, V114, P1062; Bhalla S, 2009, CLIN CANCER RES, V15, P3354, DOI 10.1158/1078-0432.CCR-08-2365; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Cardesa-Salzmann TM, 2011, HAEMATOL-HEMATOL J, V96, P996, DOI 10.3324/haematol.2010.037408; Chen SY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197946; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Evens AM, 2008, BRIT J HAEMATOL, V141, P676, DOI 10.1111/j.1365-2141.2008.07093.x; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; Ganjoo KN, 2008, J CANCER RES CLIN, V134, P381, DOI 10.1007/s00432-007-0294-x; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hu YL, 2012, CANCER RES, V72, P4294, DOI 10.1158/0008-5472.CAN-12-1076; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim MK, 2012, CANCER SCI, V103, P497, DOI 10.1111/j.1349-7006.2011.02168.x; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Larouche JF, 2010, J CLIN ONCOL, V28, P2094, DOI 10.1200/JCO.2009.24.5860; Lee K, 2011, ARCH PHARM RES, V34, P1583, DOI 10.1007/s12272-011-1021-3; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Paglin S, 2001, CANCER RES, V61, P439; Palayoor ST, 2008, INT J CANCER, V123, P2430, DOI 10.1002/ijc.23807; Paoluzzi L, 2010, CLIN CANCER RES, V16, P554, DOI 10.1158/1078-0432.CCR-09-1937; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Ruan J, 2011, CURR CANCER DRUG TAR, V11, P1030, DOI 10.2174/156800911798073014; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schumacker PT, 2011, CANCER CELL, V19, P299, DOI 10.1016/j.ccr.2011.03.001; Schwartz DL, 2009, MOL CANCER THER, V8, P947, DOI 10.1158/1535-7163.MCT-08-0981; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Nguyen T, 2011, CLIN CANCER RES, V17, P3219, DOI 10.1158/1078-0432.CCR-11-0234; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Welsh S, 2004, MOL CANCER THER, V3, P233; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	65	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81333	10.1371/journal.pone.0081333	http://dx.doi.org/10.1371/journal.pone.0081333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312289	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100073
J	Bryan, HM; Darimont, CT; Paquet, PC; Wynne-Edwards, KE; Smits, JEG				Bryan, Heather M.; Darimont, Chris T.; Paquet, Paul C.; Wynne-Edwards, Katherine E.; Smits, Judit E. G.			Stress and Reproductive Hormones in Grizzly Bears Reflect Nutritional Benefits and Social Consequences of a Salmon Foraging Niche	PLOS ONE			English	Article							LONG-TERM STRESS; HAIR CORTISOL CONCENTRATION; BLACK URSUS-AMERICANUS; PACIFIC SALMON; BROWN BEARS; SEASONAL DIFFERENCES; SPAWNING MIGRATION; BRITISH-COLUMBIA; BODY-SIZE; TESTOSTERONE	Physiological indicators of social and nutritional stress can provide insight into the responses of species to changes in food availability. In coastal British Columbia, Canada, grizzly bears evolved with spawning salmon as an abundant but spatially and temporally constrained food source. Recent and dramatic declines in salmon might have negative consequences on bear health and ultimately fitness. To examine broadly the chronic endocrine effects of a salmon niche, we compared cortisol, progesterone, and testosterone levels in hair from salmon-eating bears from coastal BC (n = 75) with the levels in a reference population from interior BC lacking access to salmon (n = 42). As predicted, testosterone was higher in coastal bears of both sexes relative to interior bears, possibly reflecting higher social density on the coast mediated by salmon availability. We also investigated associations between the amount of salmon individual bears consumed (as measured by stable isotope analysis) and cortisol and testosterone in hair. Also as predicted, cortisol decreased with increasing dietary salmon and was higher after a year of low dietary salmon than after a year of high dietary salmon. These findings at two spatial scales suggest that coastal bears might experience nutritional or social stress in response to on-going salmon declines, providing novel insights into the effects of resource availability on fitness-related physiology.	[Bryan, Heather M.; Wynne-Edwards, Katherine E.; Smits, Judit E. G.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Bryan, Heather M.; Darimont, Chris T.; Paquet, Paul C.] Raincoast Conservat Fdn, Bella Bella, BC, Canada; [Darimont, Chris T.] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Paquet, Paul C.] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Victoria; University of Calgary	Bryan, HM (corresponding author), Univ Victoria, Dept Geog, Victoria, BC, Canada.	heabry@gmail.com	Smits, Judit/E-8225-2012; Wynne-Edwards, Katherine/P-2326-2019	Wynne-Edwards, Katherine/0000-0002-2944-4516; Smits, Judit/0000-0001-5341-4088	Raincoast Conservation Foundation; Animal Welfare Institute; Blue Planet Links; Explorers Club; Habitat Conservation Trust Foundation; McLean Foundation; Moore Foundation; Norcross Foundation; Spirit Bear Research Foundation; Tides Canada; Willow Grove Foundation; Wilburforce; Foundations, Environment Canada Science Horizons; University of Calgary; National Science and Engineering Council (NSERC) [435683, RGPIN-106386-2008, RGPIN-22876-20]	Raincoast Conservation Foundation; Animal Welfare Institute; Blue Planet Links; Explorers Club; Habitat Conservation Trust Foundation; McLean Foundation; Moore Foundation(Gordon and Betty Moore Foundation); Norcross Foundation; Spirit Bear Research Foundation; Tides Canada; Willow Grove Foundation; Wilburforce; Foundations, Environment Canada Science Horizons; University of Calgary; National Science and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	For funding, the authors gratefully acknowledge support from Raincoast Conservation Foundation (www.raincoast.org), Animal Welfare Institute (www.awionline.org), Blue Planet Links (www.blueplanetlinks.com), Explorers Club (www.explorers.org), Habitat Conservation Trust Foundation (www.hctf.ca), McLean Foundation (www.mcleanfoundation.ca), Moore Foundation (www.moore.org), Norcross Foundation (www.norcrossws.org), Spirit Bear Research Foundation (www.spiritbearfoundation.com), Tides Canada (tidescanada.org), Willow Grove Foundation (www.willowgrovefoundation.com) and the Wilburforce (www.wilburforce.org) Foundations, Environment Canada Science Horizons (www.ec.gc.ca/sci_hor), the University of Calgary (www.ucalgary.ca), and National Science and Engineering Council (NSERC) (http://www.nserc-crsng.gc.ca) Discovery grants to CTD (435683), KEW (RGPIN-106386-2008) and JES (RGPIN-22876-20). HMB was supported by a National Science and Engineering Council (NSERC) postgraduate fellowship as well as by the University of Calgary. CTD recognizes support from the Tula Foundation (www.tula.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DJ, 1992, NEUROSCI BIOBEHAV R, V16, P177, DOI 10.1016/S0149-7634(05)80179-4; [Anonymous], CONNECTIVITY CONSERV; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; BCGOV, 2008, LANDSC UN BRIT COL; Bechshoft TO, 2012, ENVIRON RES, V116, P26, DOI 10.1016/j.envres.2012.04.010; Bechshoft TO, 2012, ENVIRON INT, V45, P15, DOI 10.1016/j.envint.2012.04.005; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Bryan HM, 2013, J AM ASSOC LAB ANIM, V52, P189; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Carroll C, 2004, CONSERV BIOL, V18, P1110, DOI 10.1111/j.1523-1739.2004.00083.x; Carruth LL, 2000, COMP BIOCHEM PHYS C, V127, P123, DOI 10.1016/S0742-8413(00)00140-7; Christensen JR, 2005, ENVIRON SCI TECHNOL, V39, P6952, DOI 10.1021/es050749f; Ciarniello LM, 2007, J WILDLIFE MANAGE, V71, P1446, DOI 10.2193/2006-229; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Darimont CT, 2010, CONSERV LETT, V3, P379, DOI 10.1111/j.1755-263X.2010.00145.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; Donahue SW, 2003, CLIN ORTHOP RELAT R, P295, DOI 10.1097/01.blo.0000038054.29678.6b; DYE HM, 1986, J FISH BIOL, V29, P167, DOI 10.1111/j.1095-8649.1986.tb04935.x; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Egbert AL, 1976, BEARS THEIR BIOL MAN, P41; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; GARSHELIS DL, 1994, J MAMMAL, V75, P175, DOI 10.2307/1382249; Gende SM, 2004, CAN J ZOOL, V82, P75, DOI 10.1139/Z03-226; Hamilton AN, 2012, BRIT COLUMBIA GRIZZL; Hamilton AN, 1987, THESIS U BRIT COLUMB; HARLOW HJ, 1990, CAN J ZOOL, V68, P183, DOI 10.1139/z90-025; HELLGREN EC, 1993, J MAMMAL, V74, P304, DOI 10.2307/1382385; Herrero S., 1983, BEARS THEIR BIOL MAN, V5, P54, DOI DOI 10.2307/3872520; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hilderbrand GV, 2000, J WILDLIFE MANAGE, V64, P178, DOI 10.2307/3802988; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Hofer H, 2012, NEW DIRECTIONS CONSE, P82; Jones ES, 2006, WILDLIFE SOC B, V34, P1320, DOI 10.2193/0091-7648(2006)34[1320:TVISCA]2.0.CO;2; Keckeis K, 2012, J COMP PHYSIOL B, V182, P985, DOI 10.1007/s00360-012-0674-7; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Koren L, 2006, HORM BEHAV, V49, P470, DOI 10.1016/j.yhbeh.2005.10.004; Koren L, 2002, ANIM BEHAV, V63, P403, DOI 10.1006/anbe.2001.1907; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Koren L, 2009, ANIM BEHAV, V77, P233, DOI 10.1016/j.anbehav.2008.09.031; Levi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001303; Lovari S, 2009, BEHAV PROCESS, V81, P20, DOI 10.1016/j.beproc.2008.12.008; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Macbeth B.J., 2013, THESIS U SASKATCHEWA; Macbeth BJ, 2012, WILDLIFE SOC B, V36, P747, DOI 10.1002/wsb.219; Malcolm KD, 2013, GEN COMP ENDOCR, V185, P97, DOI 10.1016/j.ygcen.2013.01.014; Martin JGA, 2008, BEHAV PROCESS, V77, P66, DOI 10.1016/j.beproc.2007.06.004; Mattson DJ, 2002, CONSERV BIOL, V16, P1123, DOI 10.1046/j.1523-1739.2002.00414.x; McCune B, 2002, ANAL ECOLOGICAL COMM; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; Meidinger D., 1991, ECOSYSTEMS BRIT COLU; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Milakovic B, 2012, J WILDLIFE MANAGE, V76, P170, DOI 10.1002/jwmg.235; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; Oliveira RF, 2004, ADV STUD BEHAV, V34, P165, DOI 10.1016/S0065-3454(04)34005-2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PALMER SS, 1988, BIOL REPROD, V38, P1044, DOI 10.1095/biolreprod38.5.1044; Peterman RM, 2012, CAN J FISH AQUAT SCI, V69, P1255, DOI 10.1139/F2012-063; Pfeffer K, 2002, ANIM BEHAV, V63, P687, DOI 10.1006/anbe.2001.1949; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Price MHH, 2008, CAN J FISH AQUAT SCI, V65, P2712, DOI 10.1139/F08-174; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Quinn TP, 2003, CAN J FISH AQUAT SCI, V60, P553, DOI 10.1139/F03-045; R Development Core Team, 2011, R LANG ENV STAT COMP; Reneerkens J, 2002, J EXP ZOOL, V293, P81, DOI 10.1002/jez.10113; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; ROHLF FJ, 1975, BIOMETRICS, V31, P93, DOI 10.2307/2529711; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM., 1993, PRIMATE SOCIAL CONFL, P171; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Seebacher F, 2012, PHILOS T R SOC B, V367, P1607, DOI 10.1098/rstb.2012.0036; Semmens B.X., 2008, MIXSIR BAYESIAN STAB; Slaney TL, 1996, FISHERIES, V21, P20, DOI 10.1577/1548-8446(1996)021<0020:SOASAT>2.0.CO;2; Stetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055967; TSUBOTA T, 1994, J REPROD FERTIL, V101, P557; Tsubota T, 1987, BEARS THEIR BIOL MAN, P355; Wasser SK, 1996, GEN COMP ENDOCR, V102, P255, DOI 10.1006/gcen.1996.0067; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; White D, 2005, URSUS, V16, P198, DOI 10.2192/1537-6176(2005)016[0198:SDISTM]2.0.CO;2; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zedrosser A, 2007, J ANIM ECOL, V76, P368, DOI 10.1111/j.1365-2656.2006.01203.x	105	69	70	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80537	10.1371/journal.pone.0080537	http://dx.doi.org/10.1371/journal.pone.0080537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312230	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100045
J	Nesbitt, RC; Lohela, TJ; Manu, A; Vesel, L; Okyere, E; Edmond, K; Owusu-Agyei, S; Kirkwood, BR; Gabrysch, S				Nesbitt, Robin C.; Lohela, Terhi J.; Manu, Alexander; Vesel, Linda; Okyere, Eunice; Edmond, Karen; Owusu-Agyei, Seth; Kirkwood, Betty R.; Gabrysch, Sabine			Quality along the Continuum: A Health Facility Assessment of Intrapartum and Postnatal Care in Ghana	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-A SUPPLEMENTATION; EMERGENCY OBSTETRIC CARE; MATERNAL SURVIVAL; SYSTEMATIC ANALYSIS; NEONATAL-MORTALITY; CHILD-MORTALITY; HOME-VISITS; OF-CARE; PROTOCOL	Objective: To evaluate quality of routine and emergency intrapartum and postnatal care using a health facility assessment, and to estimate "effective coverage" of skilled attendance in Brong Ahafo, Ghana. Methods: We conducted an assessment of all 86 health facilities in seven districts in Brong Ahafo. Using performance of key signal functions and the availability of relevant drugs, equipment and trained health professionals, we created composite quality categories in four dimensions: routine delivery care, emergency obstetric care (EmOC), emergency newborn care (EmNC) and non-medical quality. Linking the health facility assessment to surveillance data we estimated "effective coverage" of skilled attendance as the proportion of births in facilities of high quality. Findings: Delivery care was offered in 64/86 facilities; only 3-13% fulfilled our requirements for the highest quality category in any dimension. Quality was lowest in the emergency care dimensions, with 63% and 58% of facilities categorized as "low" or "substandard" for EmOC and EmNC, respectively. This implies performing less than four EmOC or three EmNC signal functions, and/or employing less than two skilled health professionals, and/or that no health professionals were present during our visit. Routine delivery care was "low" or "substandard" in 39% of facilities, meaning 25/64 facilities performed less than six routine signal functions and/or had less than two skilled health professionals and/or less than one midwife. While 68% of births were in health facilities, only 18% were in facilities with "high" or "highest" quality in all dimensions. Conclusion: Our comprehensive facility assessment showed that quality of routine and emergency intrapartum and postnatal care was generally low in the study region. While coverage with facility delivery was 68%, we estimated "effective coverage" of skilled attendance at 18%, thus revealing a large "quality gap." Effective coverage could be a meaningful indicator of progress towards reducing maternal and newborn mortality.	[Nesbitt, Robin C.; Gabrysch, Sabine] Heidelberg Univ, Inst Publ Hlth, Epidemiol & Biostat Unit, Heidelberg, Germany; [Lohela, Terhi J.] Helsinki Univ Hosp, Dept Anaesthesiol & Intens Care Med, Jorvi Hosp, Espoo, Finland; [Manu, Alexander; Okyere, Eunice; Owusu-Agyei, Seth] Ghana Hlth Serv, Kintampo Hlth Res Ctr, Kintampo, Ghana; [Manu, Alexander; Vesel, Linda; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Maternal & Child Hlth Intervent Res Grp, London WC1, England; [Edmond, Karen] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia	Ruprecht Karls University Heidelberg; University of Helsinki; Helsinki University Central Hospital; Ghana Health Service; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of Western Australia	Nesbitt, RC (corresponding author), Heidelberg Univ, Inst Publ Hlth, Epidemiol & Biostat Unit, Heidelberg, Germany.	robin.nesbitt@uni-heidelberg.de	Gabrysch, Sabine/A-3503-2013	Gabrysch, Sabine/0000-0002-7081-0506; Kirkwood, Betty/0000-0001-5274-6072; Okyere, Eunice/0000-0003-3566-7561; Owusu-Agyei, Seth/0000-0002-0807-1781; Lohela, Terhi/0000-0002-6596-1780	University of Heidelberg; European Social Fund; Ministry of Science, Research and the Arts Baden-Wurttemberg; Daimer and Benz Foundation; Baden-Wurttemberg Foundation; WHO; Bill and Melinda Gates Foundation; UK Department of International Development (DFID)	University of Heidelberg; European Social Fund(European Social Fund (ESF)); Ministry of Science, Research and the Arts Baden-Wurttemberg; Daimer and Benz Foundation; Baden-Wurttemberg Foundation; WHO(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department of International Development (DFID)	Sabine Gabrysch is paid by the University of Heidelberg through a Margarete von Wrangell Fellowship supported by the European Social Fund and by the Ministry of Science, Research and the Arts Baden-Wurttemberg. She is also supported by postdoctoral fellowships of the Daimer and Benz Foundation and the Baden-Wurttemberg Foundation. The latter funded part of the fieldwork and funds Robin Nesbitt who is employed as a doctoral student at the University of Heidelberg. The HFA was partly funded by WHO, Save the Children's Saving Newborn Lives (SNL) programme from the Bill and Melinda Gates Foundation, and the UK Department of International Development (DFID) for the benefit of developing countries; the views expressed are not necessarily those of DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averting Maternal Death and Disability Program (AMDD), 2003, US UN PROC IND EM OB; Bahl R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-22; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Edmond K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000658; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Ghana Statistical Service Research, 2008, GHAN DEM HLTH SURV 2; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Hozumi D, 2006, PROFILES HLTH FACILI; Keyes EB, 2011, INT J GYNECOL OBSTET, V115, P94, DOI 10.1016/j.ijgo.2011.07.009; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Levine AC, 2008, INT J EMERG MED, V1, P113, DOI 10.1007/s12245-008-0032-4; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Ministry of Health (MOH), 2011, NAT ASS EM OBST NEWB; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001; Pittrof R, 2002, ACTA OBSTET GYN SCAN, V81, P277, DOI 10.1034/j.1600-0412.2002.810401.x; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Vesel L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002326; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	35	82	82	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81089	10.1371/journal.pone.0081089	http://dx.doi.org/10.1371/journal.pone.0081089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312265	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000327652100060
J	Pai, NP; Behlim, T; Abrahams, L; Vadnais, C; Shivkumar, S; Pillay, S; Binder, A; Deli-Houssein, R; Engel, N; Josephs, L; Dheda, K				Pai, Nitika Pant; Behlim, Tarannum; Abrahams, Lameze; Vadnais, Caroline; Shivkumar, Sushmita; Pillay, Sabrina; Binder, Anke; Deli-Houssein, Roni; Engel, Nora; Josephs, Lawrence; Dheda, Keertan			Will an Unsupervised Self-Testing Strategy for HIV Work in Health Care Workers of South Africa? A Cross Sectional Pilot Feasibility Study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; PREVENTIVE BEHAVIOR; VAGINAL SWABS; METAANALYSIS; RISK	Background: In South Africa, stigma, discrimination, social visibility and fear of loss of confidentiality impede health facility-based HIV testing. With 50% of adults having ever tested for HIV in their lifetime, private, alternative testing options are urgently needed. Non-invasive, oral self-tests offer a potential for a confidential, unsupervised HIV self-testing option, but global data are limited. Methods: A pilot cross-sectional study was conducted from January to June 2012 in health care workers based at the University of Cape Town, South Africa. An innovative, unsupervised, self-testing strategy was evaluated for feasibility; defined as completion of self-testing process (i.e., self test conduct, interpretation and linkage). An oral point-of-care HIV test, an Internet and paper-based self-test HIV applications, and mobile phones were synergized to create an unsupervised strategy. Self-tests were additionally confirmed with rapid tests on site and laboratory tests. Of 270 health care workers (18 years and above, of unknown HIV status approached), 251 consented for participation. Findings: Overall, about 91% participants rated a positive experience with the strategy. Of 251 participants, 126 evaluated the Internet and 125 the paper-based application successfully; completion rate of 99.2%. All sero-positives were linked to treatment (completion rate: 100% (95% CI, 66.0-100). About half of sero-negatives were offered counselling on mobile phones; completion rate: 44.6% (95% CI, 38.0-51.0). A majority of participants (78.1%) were females, aged 18-24 years (61.4%). Nine participants were found sero-positive after confirmatory tests (prevalence 3.6% 95% CI, 1.8-6.9). Six of nine positive self-tests were accurately interpreted; sensitivity: 66.7% (95% CI, 30.9-91.0); specificity: 100% (95% CI, 98.1-100). Interpretation: Our unsupervised self-testing strategy was feasible to operationalize in health care workers in South Africa. Linkages were successfully operationalized with mobile phones in all sero-positives and about half of the sero-negatives sought post-test counselling. Controlled trials and implementation research studies are needed before a scale-up is considered.	[Pai, Nitika Pant] McGill Univ, Dept Med, Montreal, PQ, Canada; [Pai, Nitika Pant; Behlim, Tarannum; Vadnais, Caroline; Shivkumar, Sushmita; Pillay, Sabrina; Deli-Houssein, Roni] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Pai, Nitika Pant; Behlim, Tarannum; Vadnais, Caroline; Shivkumar, Sushmita; Pillay, Sabrina; Deli-Houssein, Roni] Ctr Hlth, Montreal, PQ, Canada; [Abrahams, Lameze; Binder, Anke; Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Abrahams, Lameze; Binder, Anke; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Abrahams, Lameze; Binder, Anke; Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Engel, Nora] Maastricht Univ, Dept Hlth Eth & Soc, Global Hlth, Maastricht, Netherlands; [Josephs, Lawrence] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; University of Cape Town; University of Cape Town; University of Cape Town; Maastricht University; McGill University	Pai, NP (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	nitika.pai@mcgill.ca	Josephs, Lawrence/H-7457-2019	Behlim, Tarannum/0000-0002-0881-2797; Engel, Nora/0000-0002-1823-3908; Pant Pai, Nitika/0000-0002-4672-0500	Grand Challenges Canada's Rising Stars in Global Health Award; CIHR; Bill Melinda Gates [OPP1061487]	Grand Challenges Canada's Rising Stars in Global Health Award; CIHR(Canadian Institutes of Health Research (CIHR)); Bill Melinda Gates(Bill & Melinda Gates Foundation)	The study was funded exclusively with grant support from Grand Challenges Canada's Rising Stars in Global Health Award 2011. NPP is additionally supported by a salary award from CIHR (CIHR New Investigator Award 2010, and by the Bill & Melinda Gates grant (OPP1061487). The funders had no role in study design, data collection, analyses, decision to publish, nor preparation of the manuscript.	Africa SS, 2012, MIDYEAR POPULATION E; Anderson JE, 2000, AM J PUBLIC HEALTH, V90, P1089, DOI 10.2105/AJPH.90.7.1089; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; de la Fuente L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046555; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; Gaydos CA, 2006, SEX TRANSM DIS, V33, P451, DOI 10.1097/01.olq.0000200497.14326.fb; Hottes TS, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1948; Kalibala S, 2011, KNOWING MYSELF 1 FEA; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; MacNeil JM, 1999, AIDS CARE, V11, P537, DOI 10.1080/09540129947695; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Mills EJ, 2012, AIDS, V26, P1425, DOI 10.1097/QAD.0b013e328354bf43; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Pai NP, 2012, CAN ASS HIV RES C MO; Richter M, 2010, S AFR MED J, V100; Schlumberger MG, 1999, EUR J EPIDEMIOL, V15, P207, DOI 10.1023/A:1007578402083; Spielberg F, 2007, COMPUTER COUNSELING; Technologies O, 2012, FINAL ADVISORY COMMI; UNAIDS, 2011, GLOB HIV AIDS RESP E; Van der Helm J., 2012, 19 INT AIDS C WASH D; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; WHO UNICEF UNAIDS, 2010, JUNPOHA UN ACC SCAL	25	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79772	10.1371/journal.pone.0079772	http://dx.doi.org/10.1371/journal.pone.0079772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312185	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100014
J	Pembrey, L; Raynor, P; Griffiths, P; Chaytor, S; Wright, J; Hall, AJ				Pembrey, Lucy; Raynor, Pauline; Griffiths, Paul; Chaytor, Shelley; Wright, John; Hall, Andrew J.			Seroprevalence of Cytomegalovirus, Epstein Barr Virus and Varicella Zoster Virus among Pregnant Women in Bradford: A Cohort Study	PLOS ONE			English	Article							GLYCOPROTEIN-B VACCINE; INFECTION; BORN; ACQUISITION; PROSPECTS; BIRTH	Objective: To estimate the seroprevalence of cytomegalovirus (CMV), Epstein Barr virus (EBV) and varicella zoster virus (VZV) among pregnant women in Bradford by ethnic group and country of birth. Methods: A stratified random sample of 949 pregnant women enrolled in the Born in Bradford birth cohort was selected to ensure sufficient numbers of White UK born women, Asian UK born women and Asian women born in Asia. Serum samples taken at 24-28 weeks' gestation were tested for CMV IgG, EBV IgG and VZV IgG. Each woman completed a questionnaire which included socio-demographic information. Results: CMV seroprevalence was 49% among the White British women, 89% among South Asian UK born women and 98% among South Asian women born in South Asia. These differences remained after adjusting for socio-demographic factors. In contrast, VZV seroprevalence was 95% among women born in the UK but significantly lower at 90% among South Asian women born in Asia. EBV seroprevalence was 94% overall and did not vary by ethnic group/country of birth. Conclusions: Although about half of White British women are at risk of primary CMV infection in pregnancy and the associated increased risk of congenital infection, most congenital CMV infections are likely to be in children born to South Asian women with non-primary infection during pregnancy. South Asian women born in South Asia are at risk of VZV infection during pregnancy which could produce congenital varicella syndrome or perinatal chickenpox. Differences in CMV and VZV seroprevalence by ethnic group and country of birth must be taken into account when universal immunisation against these viruses is contemplated.	[Pembrey, Lucy; Hall, Andrew J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [Raynor, Pauline; Wright, John] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Griffiths, Paul] UCL, Sch Med, Ctr Virol, London W1N 8AA, England; [Chaytor, Shelley] Royal Free Hosp, Dept Virol, London NW3 2QG, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Pembrey, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.	Lucy.Pembrey@lshtm.ac.uk	Wright, John/H-1624-2012	Wright, John/0000-0001-9572-7293	Wellcome Trust [083521/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by a project grant from the Wellcome Trust (www.wellcome.ac.uk), grant number: 083521/Z/07/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Daley AJ, 2008, AUST NZ J OBSTET GYN, V48, P26, DOI 10.1111/j.1479-828X.2007.00797.x; Gaytant MA, 2005, J MED VIROL, V76, P71, DOI 10.1002/jmv.20325; Gratacap-Cavallier B, 1998, EUR J EPIDEMIOL, V14, P147, DOI 10.1023/A:1007450729633; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0; Griffiths PD, 2001, VACCINE, V19, P1356, DOI 10.1016/S0264-410X(00)00377-7; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; Kharfan-Dabaja MA, 2012, LANCET INFECT DIS, V12, P290, DOI 10.1016/S1473-3099(11)70344-9; Lolekha S, 2001, AM J TROP MED HYG, V64, P131, DOI 10.4269/ajtmh.2001.64.131; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843; Morris MC, 2002, J MED VIROL, V67, P522, DOI 10.1002/jmv.10132; Nichols RA, 2011, EPIDEMICS-NETH, V3, P12, DOI 10.1016/j.epidem.2010.11.003; Pawelec G, 2012, CURR OPIN IMMUNOL, V24, P507, DOI 10.1016/j.coi.2012.04.002; Raynor P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-327; Ruiss R, 2011, J VIROL, V85, P13105, DOI 10.1128/JVI.05598-11; Sabbaj S, 2011, J INFECT DIS, V203, P1534, DOI 10.1093/infdis/jir138; Santorelli G, 2013, PAEDIATR PERINAT EP, V27, P388, DOI 10.1111/ppe.12052; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Steininger C, 2012, LANCET INFECT DIS, V12, P257, DOI 10.1016/S1473-3099(11)70367-X; Stronati M, 2007, J Chemother, V19 Suppl 2, P49; Talukder YS, 2007, EPIDEMIOL INFECT, V135, P1344, DOI 10.1017/S0950268807008497; TOOKEY PA, 1992, ARCH DIS CHILD-FETAL, V67, P779, DOI 10.1136/adc.67.7_Spec_No.779; Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018; Townsend CL, 2011, ARCH DIS CHILD-FETAL, V96, pF398, DOI 10.1136/adc.2010.199901; Traviss GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030707; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wright J, 2013, INT J EPIDEMIOL, V42, P978, DOI 10.1093/ije/dys112; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018	35	57	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81881	10.1371/journal.pone.0081881	http://dx.doi.org/10.1371/journal.pone.0081881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312372	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000327652100104
J	Rawlings, ND				Rawlings, Neil D.			Evolution of the Thermopsin Peptidase Family (A5)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ACID PROTEASE; SEQUENCE; ALIGNMENTS; GENOME	Thermopsin is a peptidase from Sulfolobus acidocaldarius that is active at low pH and high temperature. From reversible inhibition with pepstatin, thermopsin is thought to be an aspartic peptidase. It is a member of the only family of peptidases to be restricted entirely to the archaea, namely peptidase family A5. Evolution within this family has been mapped, using a taxonomic tree based on the known classification of archaea. Homologues are found only in archaeans that are both hyperthermophiles and acidophiles, and this implies lateral transfer of genes between archaea, because species with homologues are not necessarily closely related. Despite the remarkable stability and activity in extreme conditions, no tertiary structure has been solved for any member of the family, and the catalytic mechanism is unknown. Putative catalytic residues have been predicted here by examination of aligned sequences.	[Rawlings, Neil D.] Wellcome Trust Sanger Inst, Hinxton, Cambridgeshire, England; [Rawlings, Neil D.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, Cambridgeshire, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL)	Rawlings, ND (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambridgeshire, England.	ndr@sanger.ac.uk	Rawlings, Neil/M-5566-2013	Rawlings, Neil/0000-0001-5557-7665	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [grant number WT077044/Z/05/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AJ, 2007, BIOL CHEM, V388, P1151, DOI 10.1515/BC.2007.151; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; FUSEK M, 1990, J BIOL CHEM, V265, P1496; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Guagliardi A, 2002, BIOCHEM J, V368, P357, DOI 10.1042/BJ20021017; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kang MS, 2001, EMBO J, V20, P734, DOI 10.1093/emboj/20.4.734; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; Krupovic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049044; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN XL, 1990, J BIOL CHEM, V265, P1490; Podar M, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-9; Ponnuraj K, 2000, J MOL BIOL, V300, P1, DOI 10.1006/jmbi.2000.3849; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Tang J, 2012, HDB PROTEOLYTIC ENZY, V1, P299; TSURU D, 1986, J BIOCHEM-TOKYO, V99, P1537, DOI 10.1093/oxfordjournals.jbchem.a135624; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945	25	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e78998	10.1371/journal.pone.0078998	http://dx.doi.org/10.1371/journal.pone.0078998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312173	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100005
J	Garrido, JM; Vazquez, P; Molina, E; Plazaola, JM; Sevilla, IA; Geijo, MV; Alonso-Hearn, M; Juste, RA				Garrido, Joseba M.; Vazquez, Patricia; Molina, Elena; Plazaola, Jose M.; Sevilla, Iker A.; Geijo, Maria V.; Alonso-Hearn, Marta; Juste, Ramon A.			Paratuberculosis Vaccination Causes Only Limited Cross-Reactivity in the Skin Test for Diagnosis of Bovine Tuberculosis	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; MYCOBACTERIUM-BOVIS; MIXED INFECTION; JOHNES-DISEASE; DAIRY HERDS; CATTLE; IMMUNIZATION; GOATS; SPECIFICITY; CALVES	Although there is a wide consensus on the efficacy of paratuberculosis vaccination to limit economic losses, its use has been restricted because of its interference in the diagnosis of tuberculosis. Data from a vaccine clinical trial in the Basque Country (Spain) has been evaluated in relationship with bovine tuberculosis intradermal test results. The trial included two herds applying a Test and Culling strategy and five applying an inactivated vaccine. The vaccine was applied to animals of all ages present in each vaccinated herd when joining the trial, and then to all the replacers within their first three months of life. Yearly testing done with the comparative intradermal test (CIT) was applied to all animals older than 6 weeks. Between 2005 and 2011, the study generated 2,033 records from Vaccinated Herds (VH) and 2,252 from Test and Cull herds (TC). Pre-vaccination positive results rate was 2.40% among the 7 herds in the single bovine intradermal tuberculin test (BSIT). Two years later it rose to 20.42% in the VH and remained below at 0.75% in the TC. Applying the CIT reduced these rates to only 0.58% in the VH and to 0.25% in the TC ons. Regarding time since each animal joined the program, the proportion of positives to BSIT was variable and, in some cases, significantly different between time points. With regard to the age of vaccination, no significant differences were found between vaccination within the first year of life and afterwards. Vaccinated animals showed seventeen times more reactions than the non-vaccinated in the BSIT, but only four times more in the CIT. In conclusion, comparative intradermal test can be a useful tool to differentiate paratuberculosis vaccine cross-reactions from specific bovine tuberculosis reactions according to the European and Spanish legislation.	[Garrido, Joseba M.; Vazquez, Patricia; Molina, Elena; Sevilla, Iker A.; Geijo, Maria V.; Alonso-Hearn, Marta; Juste, Ramon A.] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Plazaola, Jose M.] Diputac Foral Gipuzkoa, Gipuzkoa, Spain		Juste, RA (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain.	rjuste@neiker.net	Juste, Ramon A./C-3570-2008; Sevilla, Iker A/O-6060-2014; Geijo, Maria V./K-6717-2014; GARRIDO, JOSEBA M/L-3202-2014; Geijo, Maria V./ABC-5808-2021; MOLINA, ELENA/L-1001-2014	Juste, Ramon A./0000-0001-6037-5873; Sevilla, Iker A/0000-0003-3968-3390; Geijo, Maria V./0000-0002-3120-1038; Geijo, Maria V./0000-0002-3120-1038; Vazquez, Patricia/0000-0002-4582-202X; Alonso-Hearn, Marta/0000-0001-5979-347X; MOLINA, ELENA/0000-0001-9630-740X; Joseba M., Garrido/0000-0002-7559-0653	Spanish Ministry of Economy and Competitiveness (MINECO) [RTA2005-0047, AGL-2008-05820]; MINECO	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); MINECO(Spanish Government)	This study was funded by a grant from the Spanish Ministry of Economy and Competitiveness (MINECO) (RTA2005-0047 and AGL-2008-05820). Patricia Vazquez had a pre-doctoral FPI fellowship from MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2010, PREV VET MED, V96, P161, DOI 10.1016/j.prevetmed.2010.06.007; Alonso-Hearn M, 2012, J DAIRY SCI, V95, P618, DOI 10.3168/jds.2009-2860; Alvarez J, 2008, VET MICROBIOL, V128, P72, DOI 10.1016/j.vetmic.2007.08.034; Alvarez J, 2009, VET MICROBIOL, V135, P389, DOI 10.1016/j.vetmic.2008.09.060; Aranaz A, 2006, VET RES, V37, P593, DOI 10.1051/vetres:2006021; Barry C, 2011, VET MED INT, V2011, DOI DOI 10.4061/2011/145092; Bastida Felix, 2011, J Immune Based Ther Vaccines, V9, P8, DOI 10.1186/1476-8518-9-8; BENEDICTUS G, 1988, SECOND INTERNATIONAL COLLOQUIUM ON PARATUBERCULOSIS, P136; Bezos J, 2012, RES VET SCI, V93, P636, DOI 10.1016/j.rvsc.2011.10.009; Chartier C, 2012, VET J, V191, P360, DOI 10.1016/j.tvjl.2011.03.009; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; Fridriksdottir V, 2000, VET MICROBIOL, V77, P263, DOI 10.1016/S0378-1135(00)00311-4; Gutierrez M, 1998, VET MICROBIOL, V62, P281, DOI 10.1016/S0378-1135(98)00217-X; JUSTE RA, 1993, PREV VET MED, V15, P101, DOI 10.1016/0167-5877(93)90106-4; Juste Ramon A, 2009, BMC Res Notes, V2, P233, DOI 10.1186/1756-0500-2-233; Klawonn W, 2002, DEUT TIERARZTL WOCH, V109, P510; Kohler H, 2001, J VET MED B, V48, P185, DOI 10.1046/j.1439-0450.2001.00443.x; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; de Val BP, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-191; Santema W, 2009, VACCINE, V27, P2312, DOI 10.1016/j.vaccine.2009.02.032; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P2079, DOI 10.1128/CVI.05421-11; Stott AW, 2005, VET REC, V156, P825, DOI 10.1136/vr.156.26.825; Stringer LA, 2011, NEW ZEAL VET J, V59, P218, DOI 10.1080/00480169.2011.596182; Sweeney RW, 2009, AM J VET RES, V70, P493, DOI 10.2460/ajvr.70.4.493; Thomsen VT, 2012, VET IMMUNOL IMMUNOP, V145, P316, DOI 10.1016/j.vetimm.2011.11.021	25	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80985	10.1371/journal.pone.0080985	http://dx.doi.org/10.1371/journal.pone.0080985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303029	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400045
J	Yeghiazarian, L; Cumberland, WG; Yang, OO				Yeghiazarian, Lilit; Cumberland, William G.; Yang, Otto O.			A Stochastic Multi-Scale Model of HIV-1 Transmission for Decision-Making: Application to a MSM Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; VIRAL LOAD; SENSITIVITY ANALYSIS; SEXUAL TRANSMISSION; PROTEASE INHIBITOR; SPREAD; MARKERS	Background: In the absence of an effective vaccine against HIV-1, the scientific community is presented with the challenge of developing alternative methods to curb its spread. Due to the complexity of the disease, however, our ability to predict the impact of various prevention and treatment strategies is limited. While ART has been widely accepted as the gold standard of modern care, its timing is debated. Objectives: To evaluate the impact of medical interventions at the level of individuals on the spread of infection across the whole population. Specifically, we investigate the impact of ART initiation timing on HIV-1 spread in an MSM (Men who have Sex with Men) population. Design and Methods: A stochastic multi-scale model of HIV-1 transmission that integrates within a single framework the in-host cellular dynamics and their outcomes, patient health states, and sexual contact networks. The model captures disease state and progression within individuals, and allows for simulation of therapeutic strategies. Results: Early ART initiation may substantially affect disease spread through a population. Conclusions: Our model provides a multi-scale, systems-based approach to evaluate the broader implications of therapeutic strategies.	[Yeghiazarian, Lilit] Univ Cincinnati, Dept Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA; [Cumberland, William G.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Microbiol, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Immunol, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA	University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yeghiazarian, L (corresponding author), Univ Cincinnati, Dept Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA.	yeghialt@ucmail.uc.edu			Ruth Kirchstein National Service Award (NIH); NIAID [AI043203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203, T32AI007370, P30AI028697] Funding Source: NIH RePORTER	Ruth Kirchstein National Service Award (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by the Ruth Kirchstein National Service Award (NIH) and the NIAID grant AI043203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Alvarez FP, 2007, METHOD INFORM MED, V46, P19; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; ARIAS E, 2007, US LIFE TABLES 2004; BAILEY, 1975, MATH THEORY INFECT D; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Breban R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046110; *CDC, 2011, NEW HOP STOPP HIV; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; CLARK SJ, 1994, J INFECT DIS, V170, P194, DOI 10.1093/infdis/170.1.194; De Cock KM, 2008, LANCET, V371, P2068, DOI 10.1016/S0140-6736(08)60732-1; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; FOUST E, 2001, MMWR-MORBID MORTAL W, V52, P1181; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Handcock MS, 2006, THEOR POPUL BIOL, V70, P125, DOI 10.1016/j.tpb.2006.02.004; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Hendriks JCM, 1996, AIDS, V10, P649, DOI 10.1097/00002030-199606000-00011; HETHCOTE HW, 1982, MATH BIOSCI, V58, P93, DOI 10.1016/0025-5564(82)90053-0; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kassutto S, 2006, CLIN INFECT DIS, V42, P1024, DOI 10.1086/500410; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lafeuillade A, 2003, J INFECT DIS, V188, P1426, DOI 10.1086/379251; LONGINI IM, 1980, MATH BIOSCI, V50, P85, DOI 10.1016/0025-5564(80)90123-6; Lori F, 1999, J INFECT DIS, V180, P1827, DOI 10.1086/315113; Losina E, 2004, CLIN INFECT DIS, V38, P1613, DOI 10.1086/420930; Louzoun Y, 2012, J THEOR BIOL, V310, P3, DOI 10.1016/j.jtbi.2012.06.020; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Newman M.E.J., 2002, PHYS REV E, V66; *OARAC, 2006, GUID US ANT AG HIV 1; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pincus JM, 2003, CLIN INFECT DIS, V37, P1699, DOI 10.1086/379772; Potterat JJ, 2002, SEX TRANSM INFECT, V78, pI159, DOI 10.1136/sti.78.suppl_1.i159; Riddler SA, 1997, AIDS, V11, pS141; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1999, NEW ENGL J MED, V340, P969, DOI 10.1056/NEJM199903253401217; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; Shirreff G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002185; Smith DE, 2004, AIDS, V18, P709, DOI 10.1097/00002030-200403260-00001; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Tattevin P, 2007, CLIN INFECT DIS, V44, pE28, DOI 10.1086/510683; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tuckwell HC, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041918; Tuckwell HC, 2007, BIOSYSTEMS, V90, P546, DOI 10.1016/j.biosystems.2006.12.006; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Yang OO, 2002, AIDS RES HUM RETROV, V18, P1051, DOI 10.1089/08892220260235416; Youm Y, 2002, SEX TRANSM DIS, V29, P689, DOI 10.1097/00007435-200211000-00012	88	7	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e70578	10.1371/journal.pone.0070578	http://dx.doi.org/10.1371/journal.pone.0070578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302983	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400001
J	Sacco, JJ; Yau, TY; Darling, S; Patel, V; Liu, H; Urbe, S; Clague, MJ; Coulson, JM				Sacco, J. J.; Yau, T. Y.; Darling, S.; Patel, V.; Liu, H.; Urbe, S.; Clague, M. J.; Coulson, J. M.			The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells	ONCOGENE			English	Article						deubiquitinase; ATXN3; phosphatase and tensin homolog; PTENP1; ceRNA; MJD	DEUBIQUITINATING ENZYME ATAXIN-3; TUMOR-SUPPRESSOR PTEN; PROTEIN STABILITY; PROSTATE-CANCER; DISEASE PROTEIN; MESSENGER-RNAS; IN-VIVO; UBIQUITINATION; EXPRESSION; MICE	The phosphatidylinositol-3-kinase (PI3K) pathway is commonly hyperactivated in cancer. One mechanism by which this occurs is by silencing of the phosphatase and tensin homolog (PTEN), a tumor suppressor and major antagonist of the pathway, through genetic, epigenetic or posttranscriptional mechanisms. Here, we used an unbiased siRNA screen in non-small-cell lung cancer cells to identify deubiquitylases (DUBs) that have an impact on PI3K signaling by regulating the abundance of PTEN. We found that PTEN expression was induced by depleting any of three members of the Josephin family DUBs: ataxin 3 (ATXN3), ataxin 3-like (ATXN3L) and Josephin domain containing 1 (JOSD1). However, this effect is not mediated through altered PTEN protein stability. Instead, depletion of each DUB increases expression of both the PTEN transcript and its competing endogenous RNA, PTENP1. In ATXN3-depleted cells, under conditions of transcriptional inhibition, PTEN and PTENP1 mRNAs rapidly decay, suggesting that ATXN3 acts primarily by repressing their transcription. Importantly, the PTEN induction observed in response to ATXN3 siRNA is sufficient to downregulate Akt phosphorylation and hence PI3K signaling. Histone deacetylase inhibitors (HDACi) have been suggested as potential mediators of PTEN transcriptional reactivation in non-small-cell lung cancer. Although PTEN exhibits a very limited response to the broad-spectrum HDACi Vorinostat (SAHA) in A549 cells, we find that combination with ATXN3 depletion enhances PTEN induction in an additive manner. Similarly, these interventions additively decrease cell viability. Thus, ATXN3 provides an autonomous, complementary therapeutic target in cancers with epigenetic downregulation of PTEN.	[Sacco, J. J.; Yau, T. Y.; Darling, S.; Patel, V.; Liu, H.; Urbe, S.; Clague, M. J.; Coulson, J. M.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Coulson, JM (corresponding author), Univ Liverpool, Inst Translat Med, Crown St, Liverpool L69 3BX, Merseyside, England.	j.m.coulson@liv.ac.uk	Urbe, Sylvie/S-1433-2018; Clague, Michael J/A-7199-2008	Urbe, Sylvie/0000-0003-4735-9814; Clague, Michael J/0000-0003-3355-9479; Liu, Han/0000-0002-0014-4675; Coulson, Judy/0000-0003-2191-2001	North-West Cancer Research; Clatterbridge Cancer Charity; Wellcome Trust	North-West Cancer Research; Clatterbridge Cancer Charity; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a project grant from Clatterbridge Cancer Research (now incorporated into North-West Cancer Research) and Clatterbridge Cancer Charity. Sarah Darling is supported by a Wellcome Trust Prize studentship. We thank Paul Todd for his input into initial phospho-Akt experiments.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Andersen CL, 2013, LEUKEMIA RES REPORTS, V2, P1; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Gan YH, 2009, ORAL ONCOL, V45, pE150, DOI 10.1016/j.oraloncology.2009.05.563; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Moss AC, 2009, CLIN CANCER RES, V15, P274, DOI 10.1158/1078-0432.CCR-08-1163; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Omerovic J, 2010, BIOCHEM J, V426, P65, DOI 10.1042/BJ20091413; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodriguez-Lebron E, 2013, MOL THER, V21, P1909, DOI 10.1038/mt.2013.152; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seki T, 2013, J BIOL CHEM, V288, P17145, DOI 10.1074/jbc.M113.463406; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang HL, 2013, NEUROPHARMACOLOGY, V70, P1, DOI 10.1016/j.neuropharm.2013.01.006; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yang Y, 2009, J CELL BIOCHEM, V106, P1102, DOI 10.1002/jcb.22100; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	55	44	48	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4265	4272		10.1038/onc.2013.512	http://dx.doi.org/10.1038/onc.2013.512			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24292675	Green Published, hybrid			2022-12-25	WOS:000341155800008
J	Brueggemann, LI; Mackie, AR; Cribbs, LL; Freda, J; Tripathi, A; Majetschak, M; Byron, KL				Brueggemann, Lioubov I.; Mackie, Alexander R.; Cribbs, Leanne L.; Freda, Jessica; Tripathi, Abhishek; Majetschak, Matthias; Byron, Kenneth L.			Differential Protein Kinase C-dependent Modulation of Kv7.4 and Kv7.5 Subunits of Vascular Kv7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Patch Clamp Electrophysiology; Potassium Channels; Protein Phosphorylation; Signal Transduction; Vascular Smooth Muscle Cells; KCNQ Channel; Mesenteric Artery; Vasopressin	KCNQ POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; K+ CHANNELS; SIGNALING PATHWAYS; PROXIMITY LIGATION; K(V)7 CHANNELS; IN-VIVO; VASOPRESSIN; EPILEPSY; HYPERTENSION	The Kv7 family (Kv7.1-7.5) of voltage-activated potassium channels contributes to the maintenance of resting membrane potential in excitable cells. Previously, we provided pharmacological and electrophysiological evidence that Kv7.4 and Kv7.5 form predominantly heteromeric channels and that Kv7 activity is regulated by protein kinase C (PKC) in response to vasoconstrictors in vascular smooth muscle cells. Direct evidence for Kv7.4/7.5 heteromer formation, however, is lacking. Furthermore, it remains to be determined whether both subunits are regulated by PKC. Utilizing proximity ligation assays to visualize single molecule interactions, we now show that Kv7.4/Kv.7.5 heteromers are endogenously expressed in vascular smooth muscle cells. Introduction of dominant-negative Kv7.4 and Kv7.5 subunits in mesenteric artery myocytes reduced endogenous Kv7 currents by 84 and 76%, respectively. Expression of an inducible protein kinase C (PKC) translocation system revealed that PKC activation is sufficient to suppress endogenous Kv7 currents in A7r5 rat aortic and mesenteric artery smooth muscle cells. Arginine vasopressin (100 and 500 pm) and the PKC activator phorbol 12-myristate 13-acetate (1 nm) each inhibited human (h) Kv7.5 and hKv7.4/7.5, but not hKv7.4 channels expressed in A7r5 cells. A decrease in hKv7.5 and hKv7.4/7.5 current densities was associated with an increase in PKC-dependent phosphorylation of the channel proteins. These findings provide further evidence for a differential regulation of Kv7.4 and Kv7.5 channel subunits by PKC-dependent phosphorylation and new mechanistic insights into the role of heteromeric subunit assembly for regulation of vascular Kv7 channels.	[Brueggemann, Lioubov I.; Mackie, Alexander R.; Freda, Jessica; Majetschak, Matthias; Byron, Kenneth L.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Cribbs, Leanne L.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Tripathi, Abhishek; Majetschak, Matthias; Byron, Kenneth L.] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Byron, KL (corresponding author), 2160 S First Ave, Maywood, IL 60153 USA.	kbyron@lumc.edu		Byron, Kenneth/0000-0002-3875-9667	National Institutes of Health [R01 HL089564]; American Heart Association [0715618Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089564 (to K. L. B.) and American Heart Association Pre-doctoral Fellowship 0715618Z (to A. R. M.).	Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Brueggemann LI, 2007, AM J PHYSIOL-HEART C, V292, pH1352, DOI 10.1152/ajpheart.00065.2006; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; BYRON KL, 1993, J BIOL CHEM, V268, P6945; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Fan JP, 2000, J PHYSIOL-LONDON, V524, P821, DOI 10.1111/j.1469-7793.2000.00821.x; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Gratton JP, 2003, NAT MED, V9, P357, DOI 10.1038/nm835; Henderson KK, 2007, J APPL PHYSIOL, V102, P1402, DOI 10.1152/japplphysiol.00825.2006; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; Khanamiri S, 2013, HYPERTENSION, V62, P1090, DOI 10.1161/HYPERTENSIONAHA.113.01244; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spitzmaul G, 2013, J BIOL CHEM, V288, P9334, DOI 10.1074/jbc.M112.433383; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	48	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2099	2111		10.1074/jbc.M113.527820	http://dx.doi.org/10.1074/jbc.M113.527820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297175	Green Published, hybrid			2022-12-25	WOS:000331130200019
J	Hanna, J; Waterman, D; Isasa, M; Elsasser, S; Shi, Y; Gygi, S; Finley, D				Hanna, John; Waterman, David; Isasa, Marta; Elsasser, Suzanne; Shi, Yuan; Gygi, Steven; Finley, Daniel			Cuz1/Ynl155w, a Zinc-dependent Ubiquitin-binding Protein, Protects Cells from Metalloid-induced Proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Degradation; Protein Misfolding; Stress Response; Ubiquitin	PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR; 26S PROTEASOME; EXPRESSION; RESISTANCE; CDC48; IDENTIFICATION; SYSTEM; RPN1; UBP6	Background: Protein misfolding, a universal threat to cells, is dealt with by the ubiquitin-proteasome system. Results: Ynl155w is a zinc-dependent ubiquitin-binding protein, interacts with proteasome and Cdc48, and is essential for surviving metalloids. Conclusion: Ynl155w may protect cells from metalloid-induced proteotoxicity by delivering ubiquitinated proteins to Cdc48 and proteasome. Significance: Ynl155w represents a novel stress response factor for misfolded proteins. Protein misfolding is a universal threat to cells. The ubiquitin-proteasome system mediates a cellular stress response capable of eliminating misfolded proteins. Here we identify Cuz1/Ynl155w as a component of the ubiquitin system, capable of interacting with both the proteasome and Cdc48. Cuz1/Ynl155w is regulated by the transcription factor Rpn4, and is required for cells to survive exposure to the trivalent metalloids arsenic and antimony. A related protein, Yor052c, shows similar phenotypes, suggesting a multicomponent stress response pathway. Cuz1/Ynl155w functions as a zinc-dependent ubiquitin-binding protein. Thus, Cuz1/Ynl155w is proposed to protect cells from metalloid-induced proteotoxicity by delivering ubiquitinated substrates to Cdc48 and the proteasome for destruction.	[Hanna, John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Waterman, David; Isasa, Marta; Elsasser, Suzanne; Shi, Yuan; Gygi, Steven; Finley, Daniel] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hanna, J (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jwhanna@partners.org			National Institutes of Health [GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R37GM043601, R01GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM043601 (to D. F.).	Barthelme D, 2013, P NATL ACAD SCI USA, V110, P3327, DOI 10.1073/pnas.1300408110; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Buchberger Alexander, 2013, Subcell Biochem, V66, P195, DOI 10.1007/978-94-007-5940-4_8; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hanna J, 2012, J BIOL CHEM, V287, P34400, DOI 10.1074/jbc.M112.390294; Hwang GW, 2006, FEBS LETT, V580, P6813, DOI 10.1016/j.febslet.2006.11.045; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sa-Moura B, 2013, J BIOL CHEM, V288, P33682, DOI 10.1074/jbc.M113.521088; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	33	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1876	1885		10.1074/jbc.M113.534032	http://dx.doi.org/10.1074/jbc.M113.534032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297164	hybrid, Green Published			2022-12-25	WOS:000332401700056
J	Li, QL; Eades, G; Yao, Y; Zhang, YS; Zhou, Q				Li, Qinglin; Eades, Gabriel; Yao, Yuan; Zhang, Yongshu; Zhou, Qun			Characterization of a Stem-like Subpopulation in Basal-like Ductal Carcinoma in Situ (DCIS) Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exosomes; MicroRNA; Breast Cancer; Cancer Stem Cells; Chemoprevention; Basal-like DCIS Stem Cell; Sulforaphane	INVASIVE BREAST-CANCER; CELLS; EXPRESSION; TRANSITION; EXOSOMES; WOMEN; SIDE	Background: Very little is known about cancer stem cells in ductal carcinoma in situ (DCIS). Results: Basal-like DCIS contain CD49f+/CD24- ALDH1+ stem-like subpopulations with enhanced migratory capacity, unique exosomal microRNA signature, and sulforaphane sensitivity. Conclusion: We characterized basal-like DCIS stem cells and demonstrate a potential chemopreventive strategy. Significance: DCIS stem cells are important therapeutic targets for preventing recurrence or progression to invasive disease. Previously, we found that basal-like ductal carcinoma in situ (DCIS) contains cancer stem-like cells. Here, we characterize stem-like subpopulations in a model of basal-like DCIS and identify subpopulations of CD49f+/CD24- stem-like cells that possess aldehyde dehydrogenase 1 activity. We found that these cells show enhanced migration potential compared with non-stem DCIS cells. We also found that the chemopreventive agent sulforaphane can target these DCIS stem-like cells, reduce aldehyde dehydrogenase 1 (ALDH1) expression, and decrease mammosphere and progenitor colony formation. Furthermore, we characterized exosomal trafficking of microRNAs in DCIS and found that several microRNAs (miRs) including miR-140, miR-29a, and miR-21 are differentially expressed in exosomes from DCIS stem-like cells. We found that SFN treatment could reprogram DCIS stem-like cells as evidenced by significant changes in exosomal secretion more closely resembling that of non-stem cancer cells. Finally, we demonstrated that exosomal secretion of miR-140 might impact signaling in nearby breast cancer cells.	[Li, Qinglin; Eades, Gabriel; Yao, Yuan; Zhang, Yongshu; Zhou, Qun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu	Li, Qinglin/K-2570-2015	Li, Qinglin/0000-0002-4125-1944	American Cancer Society; NCI, National Institutes of Health [R01 CA163820, R01 CA157779]; NATIONAL CANCER INSTITUTE [R01CA157779, P30CA134274, T32CA154274, R01CA163820] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from American Cancer Society and NCI, National Institutes of Health R01 CA163820 and R01 CA157779 (to Q. Z.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Espina V., 2010, PLOS ONE, V5; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fowble B, 1997, INT J RADIAT ONCOL, V38, P949, DOI 10.1016/S0360-3016(97)00153-3; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li Q., 2013, ONCOGENE, V10, DOI 1038/onc.2013.226; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Schnitt SJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2228; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130	22	60	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1303	1312		10.1074/jbc.M113.502278	http://dx.doi.org/10.1074/jbc.M113.502278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297178	hybrid, Green Published			2022-12-25	WOS:000332401700010
J	Vogel, CFA; Khan, EM; Leung, PSC; Gershwin, ME; Chang, WLW; Wu, DL; Haarmann-Stemmann, T; Hoffmann, A; Denison, MS				Vogel, Christoph F. A.; Khan, Elaine M.; Leung, Patrick S. C.; Gershwin, M. Eric; Chang, W. L. William; Wu, Dalei; Haarmann-Stemmann, Thomas; Hoffmann, Alexander; Denison, Michael S.			Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response A ROLE FOR NUCLEAR FACTOR-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aryl Hydrocarbon Receptor; Dendritic Cells; Gene Regulation; Inflammation; NF-Kappa B (NF-KB)	TRANSFORMING GROWTH FACTOR-BETA(1); T-CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; IMMUNE-SYSTEM; MOUSE EMBRYO; AHR GENE; EXPRESSION	Background: Aryl hydrocarbon receptor (AhR) is a protein regulating differentiation and function of immune cells. Results: NF-B activates transcription of AhR and enhances activity of AhR-regulated genes. Conclusion: Activation of NF-B involves RelA-mediated expression of AhR. Significance: Inflammatory stimuli and cytokines that regulate NF-B induce AhR expression during activation and differentiation of immune cells. The aryl hydrocarbon receptor (AhR) is involved in the regulation of immune responses, T-cell differentiation, and immunity. Here, we show that inflammatory stimuli such as LPS induce the expression of AhR in human dendritic cells (DC) associated with an AhR-dependent increase of CYP1A1 (cytochrome P4501A1). In vivo data confirmed the elevated expression of AhR by LPS and the LPS-enhanced 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated induction of CYP1A1 in thymus of B6 mice. Inhibition of nuclear factor-B (NF-B) repressed both normal and LPS-enhanced, TCDD-inducible, AhR-dependent gene expression and canonical pathway control of RelA-regulated AhR-responsive gene expression. LPS-mediated induction of AhR was NF-B-dependent, as shown in mouse embryonic fibroblasts (MEFs) derived from Rel null mice. AhR expression and TCDD-mediated induction of CYP1A1 was significantly reduced in RelA-deficient MEF compared with wild type MEF cells and ectopic expression of RelA restored the expression of AhR and induction of CYP1A1 in MEF RelA null cells. Promoter analysis of the human AhR gene identified three putative NF-B-binding elements upstream of the transcription start site. Mutation analysis of the AhR promoter identified one NF-B site as responsible for mediating the induction of AhR expression by LPS and electrophoretic shift assays demonstrated that this NF-B motif is recognized by the RelA/p50 heterodimer. Our results show for the first time that NF-B RelA is a critical component regulating the expression of AhR and the induction of AhR-dependent gene expression in immune cells illustrating the interaction of AhR and NF-B signaling.	[Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Vogel, Christoph F. A.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Chang, W. L. William] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Wu, Dalei] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA; [Haarmann-Stemmann, Thomas] Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Sanford Burnham Prebys Medical Discovery Institute; Leibniz Institut fur Umweltmedizinische Forschung (IUF); University of California System; University of California Los Angeles	Vogel, CFA (corresponding author), Univ Calif Davis, Dept Environm Toxicol, 1 Shields Ave, Davis, CA 95616 USA.	cfvogel@ucdavis.edu	Chang, W. L. William/AAX-1773-2021		NIEHS, National Institutes of Health [R01 ES019898-02, R01 ES007685]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, R01ES019898] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NIEHS, National Institutes of Health Grants R01 ES019898-02 (to C. F. A. V.) and R01 ES007685 (to M. S. D.).	ABBOTT BD, 1995, DEV DYNAM, V204, P144, DOI 10.1002/aja.1002040205; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allan LL, 2005, MOL PHARMACOL, V67, P1740, DOI 10.1124/mol.104.009100; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bankoti J, 2010, TOXICOL APPL PHARM, V246, P18, DOI 10.1016/j.taap.2010.03.013; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Crawford RB, 1997, MOL PHARMACOL, V52, P921, DOI 10.1124/mol.52.6.921; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FitzGerald CT, 1996, ARCH BIOCHEM BIOPHYS, V333, P170, DOI 10.1006/abbi.1996.0378; Fitzgerald CT, 1998, DNA CELL BIOL, V17, P811, DOI 10.1089/dna.1998.17.811; HAYASHI S, 1995, CARCINOGENESIS, V16, P1403, DOI 10.1093/carcin/16.6.1403; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Kenyon NJ, 2008, TOXICOL APPL PHARM, V230, P269, DOI 10.1016/j.taap.2008.03.004; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; Kostyuk VA, 2013, CURR MED CHEM, V20, P869; Lahoti TS, 2013, ANN RHEUM DIS, V72, P1708, DOI 10.1136/annrheumdis-2012-202639; Lawrence BP, 2012, NAT IMMUNOL, V13, P117, DOI 10.1038/ni.2213; Lawrence BP, 1996, TOXICOL APPL PHARM, V138, P275, DOI 10.1006/taap.1996.0126; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Luecke S, 2010, CHEM-BIOL INTERACT, V184, P466, DOI 10.1016/j.cbi.2010.01.038; LUSTER MI, 1988, J IMMUNOL, V140, P928; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; MORRIS DL, 1993, IMMUNOPHARMACOLOGY, V26, P105, DOI 10.1016/0162-3109(93)90002-8; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; SCHMIDT JV, 1993, J BIOL CHEM, V268, P22203; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Sulentic CEW, 2011, TOXICOL SCI, V120, pS171, DOI 10.1093/toxsci/kfq324; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tsuda M, 2011, HEPATOLOGY, V54, P1293, DOI 10.1002/hep.24526; TUCKER AN, 1986, MOL PHARMACOL, V29, P372; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VOGEL C, 1994, ARCH TOXICOL, V68, P303, DOI 10.1007/s002040050073; Vogel CFA, 2003, BIOCHEM PHARMACOL, V66, P1231, DOI 10.1016/S0006-2952(03)00404-0; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Wu DL, 2011, BIOCHEM BIOPH RES CO, V410, P358, DOI 10.1016/j.bbrc.2011.06.018	46	176	186	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1866	1875		10.1074/jbc.M113.505578	http://dx.doi.org/10.1074/jbc.M113.505578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302727	Green Published, hybrid			2022-12-25	WOS:000332401700055
J	Johansson, P; Almqvist, EG; Johansson, JO; Mattsson, N; Andreasson, U; Hansson, O; Wallin, A; Blennow, K; Zetterberg, H; Svensson, J				Johansson, Per; Almqvist, Erik G.; Johansson, Jan-Ove; Mattsson, Niklas; Andreasson, Ulf; Hansson, Oskar; Wallin, Anders; Blennow, Kaj; Zetterberg, Henrik; Svensson, Johan			Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease	PLOS ONE			English	Article							BUTYRYLCHOLINESTERASE K VARIANT; VITAMIN-D; SENILE-DEMENTIA; VASCULAR DEMENTIA; MESSENGER-RNA; CHOLINESTERASES; COGNITION; CRITERIA	Background: Little is known of vitamin D concentration in cerebrospinal fluid (CSF) in Alzheimer's disease (AD) and its relation with CSF acetylcholinesterase (AChE) activity, a marker of cholinergic function. Methods: A cross-sectional study of 52 consecutive patients under primary evaluation of cognitive impairment and 17 healthy controls. The patients had AD dementia or mild cognitive impairment (MCI) diagnosed with AD dementia upon follow-up (n = 28), other dementias (n = 12), and stable MCI (SMCI, n = 12). We determined serum and CSF concentrations of calcium, parathyroid hormone (PTH), 25-hydroxyvitamin D (25OHD), and CSF activities of AChE and butyrylcholinesterase (BuChE). Findings: CSF 25OHD level was reduced in AD patients (P < 0.05), and CSF AChE activity was decreased both in patients with AD (P < 0.05) and other dementias (P < 0.01) compared to healthy controls. None of the measured variables differed between BuChE K-variant genotypes whereas the participants that were homozygous in terms of the apolipoprotein E (APOE) E4 allele had decreased CSF AChE activity compared to subjects lacking the APOE E4 allele (P = 0.01). In AD patients (n=28), CSF AChE activity correlated positively with CSF levels of total tau (T-tau) (r = 0.44, P < 0.05) and phosphorylated tau protein (P-tau) (r = 0.50, P < 0.01), but CSF activities of AChE or BuChE did not correlate with serum or CSF levels of 25OHD. Conclusions: In this pilot study, both CSF 25OHD level and CSF AChE activity were reduced in AD patients. However, the lack of correlations between 25OHD levels and CSF activities of AChE or BuChE might suggest different mechanisms of action, which could have implications for treatment trials.	[Johansson, Per] Skaraborg Cent Hosp, Dept Neuropsychiat, Falkoping, Sweden; [Johansson, Per; Johansson, Jan-Ove; Svensson, Johan] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden; [Almqvist, Erik G.; Svensson, Johan] Skaraborg Cent Hosp, Dept Endocrinol, Skovde, Sweden; [Mattsson, Niklas; Andreasson, Ulf; Wallin, Anders; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Mattsson, Niklas] Univ Calif San Francisco, VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94143 USA; [Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England	University of Gothenburg; University of Gothenburg; University of California System; University of California San Francisco; Lund University; University of London; University College London	Svensson, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden.	johan.svensson@medic.gu.se	Johansson, Per M/K-3961-2012; Hansson, Oskar/A-7134-2013; Mattsson-Carlgren, Niklas/H-7597-2019	Johansson, Per M/0000-0003-0073-7654; Hansson, Oskar/0000-0001-8467-7286; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Svensson, Johan/0000-0002-4487-6405	Swedish Research Council [523-2007-7111]; ALF/LUA research grant in Gothenburg [ALFGBG-146841]; Swedish Foundation for Strategic Research; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Lundbeck Foundation; Sahlgrenska University Hospital; Sahlgrenska Academy; Stiftelsen Psykiatriska Forskningsfonden; Stiftelsen Gamla Tjanarinnor; Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning; Alzheimer Foundation, Sweden; Dementia Association, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF/LUA research grant in Gothenburg; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Lundbeck Foundation(Lundbeckfonden); Sahlgrenska University Hospital; Sahlgrenska Academy; Stiftelsen Psykiatriska Forskningsfonden; Stiftelsen Gamla Tjanarinnor; Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning; Alzheimer Foundation, Sweden; Dementia Association, Sweden	This work was supported by grants from the Swedish Research Council (523-2007-7111), the ALF/LUA research grant in Gothenburg (ALFGBG-146841), the Swedish Foundation for Strategic Research, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Lundbeck Foundation, Sahlgrenska University Hospital, Sahlgrenska Academy, Stiftelsen Psykiatriska Forskningsfonden, Stiftelsen Gamla Tjanarinnor, Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning, the Alzheimer Foundation, Sweden and the Dementia Association, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2012, EUR J NEUROL, V19, P1023, DOI 10.1111/j.1468-1331.2012.03675.x; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Annweiler C, 2012, COGN BEHAV NEUROL, V25, P121, DOI 10.1097/WNN.0b013e31826df647; Annweiler C, 2012, J AM GERIATR SOC, V60, P793, DOI 10.1111/j.1532-5415.2011.03877.x; APPLEYARD ME, 1987, BRAIN, V110, P1309, DOI 10.1093/brain/110.5.1309; Atack J, 1989, BIOL MARKERS ALZHEIM, P1; ATACK JR, 1988, ANN NEUROL, V23, P161, DOI 10.1002/ana.410230209; BALABANOVA S, 1984, KLIN WOCHENSCHR, V62, P1086, DOI 10.1007/BF01711378; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2000, J NEURAL TRANSM, V107, P1065, DOI 10.1007/s007020070052; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Chacon MA, 2003, J NEUROCHEM, V87, P195, DOI 10.1046/j.1471-4159.2003.01985.x; Darreh-Shori T, 2012, J ALZHEIMERS DIS, V28, P443, DOI 10.3233/JAD-2011-111088; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holmoy T, 2009, MULT SCLER, V15, P1280, DOI 10.1177/1352458509107008; Inestrosa NC, 2008, FEBS J, V275, P625, DOI 10.1111/j.1742-4658.2007.06238.x; Johansson P, 2011, J ALZHEIMERS DIS, V24, P537, DOI 10.3233/JAD-2011-101878; Kehoe PG, 1998, J MED GENET, V35, P1034, DOI 10.1136/jmg.35.12.1034; Khanh VQL, 2011, AM J ALZHEIMERS DIS, V26, P511, DOI 10.1177/1533317511429321; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; Lehmann DJ, 2011, NEUROSCI LETT, V504, P79, DOI 10.1016/j.neulet.2011.08.057; Masoumi A, 2009, J ALZHEIMERS DIS, V17, P703, DOI 10.3233/JAD-2009-1080; McIlroy SP, 2000, J MED GENET, V37, P182, DOI 10.1136/jmg.37.3.182; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Parnetti L, 2011, ACTA NEUROL SCAND, V124, P122, DOI 10.1111/j.1600-0404.2010.01435.x; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shah I, 2012, CURR ALZHEIMER RES, V9, P1069, DOI 10.2174/156720512803568975; Shetty PK, 2011, AGING DIS, V2, P196; SUTHERLAND MK, 1992, MOL BRAIN RES, V13, P239; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Wallin A, 2003, DEMENT GERIATR COGN, V16, P200, DOI 10.1159/000072803; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	44	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81989	10.1371/journal.pone.0081989	http://dx.doi.org/10.1371/journal.pone.0081989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312390	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300062
J	Yang, ZX; Wang, SW; Zhao, ML; Li, SC; Zhang, QY				Yang, Zhixin; Wang, Shaowei; Zhao, Moli; Li, Shucai; Zhang, Qiangyong			The Onset of Double Diffusive Convection in a Viscoelastic Fluid-Saturated Porous Layer with Non-Equilibrium Model	PLOS ONE			English	Article								The onset of double diffusive convection in a viscoelastic fluid-saturated porous layer is studied when the fluid and solid phase are not in local thermal equilibrium. The modified Darcy model is used for the momentum equation and a two-field model is used for energy equation each representing the fluid and solid phases separately. The effect of thermal non-equilibrium on the onset of double diffusive convection is discussed. The critical Rayleigh number and the corresponding wave number for the exchange of stability and over-stability are obtained, and the onset criterion for stationary and oscillatory convection is derived analytically and discussed numerically.	[Yang, Zhixin; Wang, Shaowei; Zhao, Moli] Shandong Univ, Sch Civil Engn, Dept Engn Mech, Jinan 250100, Peoples R China; [Wang, Shaowei; Zhao, Moli; Li, Shucai; Zhang, Qiangyong] Shandong Univ, Geotech & Struct Engn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Wang, SW (corresponding author), Shandong Univ, Sch Civil Engn, Dept Engn Mech, Jinan 250100, Peoples R China.	shaoweiwang@sdu.edu.cn	Wang, Shaowei/AAP-6629-2021	Wang, Shaowei/0000-0002-4346-7706	National Natural Science Foundation of China [11002083, 11002049, 51279093]; National Basic Research Program of China [2013CB036000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Nos. 11002083, 11002049, and 51279093) and the National Basic Research Program of China (2013CB036000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu N, 2002, INT J HEAT MASS TRAN, V45, P2221, DOI 10.1016/S0017-9310(01)00331-3; Chen X, 2011, INT J HEAT FLUID FL, V32, P78, DOI 10.1016/j.ijheatfluidflow.2010.06.003; Chhabra RP, 1999, NONNEWTONIAN FLOW PR, DOI 10.1016/b978-075063770-1/50009-9; Delenda N, 2012, J NON-NEWTON FLUID, V181, P11, DOI 10.1016/j.jnnfm.2012.06.006; HORTON CW, 1945, J APPL PHYS, V16, P367, DOI 10.1063/1.1707601; HUPPERT HE, 1981, J FLUID MECH, V106, P299, DOI 10.1017/S0022112081001614; Malashetty MS, 2012, ACTA MECH, V223, P967, DOI 10.1007/s00707-012-0616-1; Malashetty MS, 2009, PHYS LETT A, V373, P781, DOI 10.1016/j.physleta.2008.12.057; Malashetty MS, 2005, INT J HEAT MASS TRAN, V48, P1155, DOI 10.1016/j.ijheatmasstransfer.2004.09.027; Malshetty M.S., 2011, PHYS FLUIDS, V23, P1; Nield D, 1968, WATER RESOUR RES, V4, P553, DOI DOI 10.1029/WR004I003P00553; Nield D.A., 2006, CONVECTION POROUS ME; Platten J., 1984, CONVECTION LIQUIDS, DOI 10.1007/978-3-642-82095-3; Pritchard D, 2007, J FLUID MECH, V571, P59, DOI 10.1017/S0022112006003211; TAUNTON JW, 1972, PHYS FLUIDS, V15, P748, DOI 10.1063/1.1693979; Turner J. S., 1973, BUOYANCY EFFECTS FLU; TURNER JS, 1985, ANNU REV FLUID MECH, V17, P11, DOI 10.1146/annurev.fl.17.010185.000303; TURNER JS, 1974, ANNU REV FLUID MECH, V6, P37, DOI 10.1146/annurev.fl.06.010174.000345; Wang SW, 2008, PHYS LETT A, V372, P3046, DOI 10.1016/j.physleta.2008.01.024; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005	20	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e79956	10.1371/journal.pone.0079956	http://dx.doi.org/10.1371/journal.pone.0079956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312193	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900004
J	Aizpurua, O; Garin, I; Alberdi, A; Salsamendi, E; Baagoe, H; Aihartza, J				Aizpurua, Ostaizka; Garin, Inazio; Alberdi, Antton; Salsamendi, Egoitz; Baagoe, Hans; Aihartza, Joxerra			Fishing Long-Fingered Bats (Myotis capaccinii) Prey Regularly upon Exotic Fish	PLOS ONE			English	Article							FORAGING BEHAVIOR; NOCTILIO-LEPORINUS; GAMBUSIA-AFFINIS; SIZE-ESTIMATION; BULLDOG-BAT; EARED BAT; DIET; SELECTION; ECHOLOCATION; CHIROPTERA	The long-fingered bat Myotis capaccinii is a European trawling bat reported to feed on fish in several Mediterranean locations, but the ecological circumstances of this behavior have not yet been studied. To elucidate the importance of fishing in this bat's diet, we evaluated the frequency and seasonal variation of fish remains in 3,000 fecal pellets collected from M. capaccinii at a nursery roost in Denia (Eastern Iberian Peninsula) in 2008, 2009, and 2010. Fish consumption occurred evenly throughout the year. All otoliths found in feces were identified as belonging to the surface-feeding fish Gambusia holbrooki. Measuring otoliths, we estimated that the mean size of consumed fish was significantly smaller than the mean measured for available fish, suggesting that the long-fingered bat's relatively small body may constrain its handling of larger prey. Of note, one bat had eaten 15 fish, showing that fish may be a locally or seasonally important trophic resource for this species. By capturing 15 bats and radio-tracking the four with the most fish remains in their droppings, we also identified fishing areas, including a single fishing ground comprising several ponds within a golf course. Ponds hold a high density of G. holbrooki, suggesting that the amount of fish at the water surface may be the principal factor triggering fishing. The observed six-fold increase in percentage of consumed fish across the study period may be related to recent pond-building in the area. We discuss whether this quick behavioral response is a novel feature of M. capaccinii or an intrinsic feature that has erupted and faded locally along the species' history.	[Aizpurua, Ostaizka; Garin, Inazio; Alberdi, Antton; Salsamendi, Egoitz; Aihartza, Joxerra] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain; [Baagoe, Hans] Zool Museum, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	University of Basque Country	Garin, I (corresponding author), Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain.	inazio.garin@ehu.es	Alberdi, Antton/M-2423-2017; Aihartza, Joxerra/Z-3061-2019; Aihartza, Joxerra/GSO-2446-2022; Aizpurua, Ostaizka/V-9490-2019; Garin, Inazio/B-8115-2009	Alberdi, Antton/0000-0002-2875-6446; Aihartza, Joxerra/0000-0003-0882-8964; Aizpurua, Ostaizka/0000-0001-8053-3672; SALSAMENDI PAGOLA, EGOITZ/0000-0002-7138-0560	MICINN [CGL2009-12393]; Basque Government [BFI-2009-252, BFI-2010-190, IT385-07, IT301-10]; University of The Basque Country UPV/ EHU [INF09/15]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Basque Government(Basque Government); University of The Basque Country UPV/ EHU	This study was part of the MICINN project CGL2009-12393 coordinated by J. Aihartza, UPV/EHU. The Basque Government provided grant support to O. Aizpurua and A. Alberdi (BFI-2009-252 and BFI-2010-190). Support was also provided by the University of The Basque Country UPV/ EHU (INF09/15) and the Basque Government (IT385-07 and IT301-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was performed with the permission of the Valencian Government.	Aihartza J, 2008, ACTA CHIROPTEROL, V10, P287, DOI 10.3161/150811008X414863; Aihartza JR, 2003, ACTA CHIROPTEROL, V5, P193, DOI 10.3161/001.005.0204; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Almenar D, 2008, J ZOOL, V274, P340, DOI 10.1111/j.1469-7998.2007.00390.x; Almenar D, 2013, BEHAV ECOL SOCIOBIOL, V67, P311, DOI 10.1007/s00265-012-1451-z; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; ALTENBACH JS, 1989, J MAMMAL, V70, P421, DOI 10.2307/1381532; Altringham JD, 1996, BATS BIOL BEHAV; Amelon Sybill K., 2009, P57; Anderson RO, 1996, FISHERIES TECHNIQUES, P447; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; Barrientos JA, 1998, BASES CURSO PRACTICO; Battaglia P, 2010, SCI MAR, V74, P605, DOI 10.3989/scimar.2010.74n3605; BELWOOD JJ, 1984, CAN J ZOOL, V62, P2113, DOI 10.1139/z84-306; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; Blood Brad R., 1998, Mammalian Species, V588, P1; Bordignon MO, 2006, REV BRAS ZOOL, V23, P50, DOI 10.1590/S0101-81752006000100003; BROOKE AP, 1994, J MAMMAL, V75, P212, DOI 10.2307/1382253; Brosset A., 1966, Mammalia, V30, P247, DOI 10.1515/mamm.1966.30.2.247; Caiola N, 2005, J APPL ICHTHYOL, V21, P358, DOI 10.1111/j.1439-0426.2005.00684.x; Carss DN, 1996, J ZOOL, V238, P319, DOI 10.1111/j.1469-7998.1996.tb05397.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Duffy DC, 1986, COLON WATERBIRD, V9, P1; Dwyer P. D., 1970, Mammalia, V34, P76, DOI 10.1515/mamm.1970.34.1.76; ECHEVERRIA TW, 1987, FISH B-NOAA, V85, P383; Elvira B, 1998, DONANA ACTA VERTEBRA, V15, P177; FENTON MB, 1990, BIOTROPICA, V22, P2, DOI 10.2307/2388713; Francour P, 1996, BIRD STUDY, V43, P129, DOI 10.1080/00063659609461004; Freeman PW, 2007, J ZOOL, V271, P469, DOI 10.1111/j.1469-7998.2006.00231.x; FREEMAN PW, 1981, J MAMMAL, V62, P166, DOI 10.2307/1380489; Gagliardi A, 2007, HYDROBIOLOGIA, V583, P213, DOI 10.1007/s10750-006-0528-y; Granadeiro JP, 2000, CYBIUM, V24, P383; Gudger E. W., 1943, Journal of the Bombay Natural History Society, V43, P635; Harvey James T., 2000, NOAA Technical Report NMFS, V150, P1; Herling C, 2005, MAR BIOL, V147, P13, DOI 10.1007/s00227-004-1547-8; Hood C.S., 1984, Mammalian Species, P1, DOI 10.2307/3503809; HOOD C S, 1983, Mammalian Species, P1, DOI 10.2307/3503897; Hutson MA, 2008, MYOTIS CAPACCINII IU; Johnson JH, 2006, J GREAT LAKES RES, V32, P91, DOI 10.3394/0380-1330(2006)32[91:ETSOFC]2.0.CO;2; JONES G, 1990, J ANIM ECOL, V59, P587, DOI 10.2307/4882; Kalko EKV, 1998, BEHAV ECOL SOCIOBIOL, V42, P305, DOI 10.1007/s002650050443; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; Law Bradley, 2000, Australian Mammalogy, V22, P121; LEOPOLD M F, 1992, Aquatic Mammals, V18, P19; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; Lidster Wayne W., 1994, Journal of Northwest Atlantic Fishery Science, V16, P33; Lowe S, 2000, 10 WORLDS WORST INVS; Ma J, 2003, J ZOOL, V261, P245, DOI 10.1017/S095283690300414X; Ma J, 2005, CURR ZOOL, V51, P7; Martin-Vide J, 2006, INT J CLIMATOL, V26, P1455, DOI 10.1002/joc.1388; McAney CM, 1991, ANAL BAT DROPPINGS; MILTON DA, 1983, J FISH BIOL, V23, P23, DOI 10.1111/j.1095-8649.1983.tb02879.x; Neubaum DJ, 2005, J MAMMAL, V86, P95, DOI 10.1644/1545-1542(2005)086<0095:SACOBB>2.0.CO;2; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pierce G.J., 1993, Symposia of the Zoological Society of London, V66, P241; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Radhakrishnan KV, 2010, ENVIRON BIOL FISH, V89, P505, DOI 10.1007/s10641-010-9685-y; Reynolds SJ, 1996, BIRD STUDY, V43, P96, DOI 10.1080/00063659609460999; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; ROBSON S K, 1984, Australian Mammalogy, V7, P51; Salyer JC, 1946, T AM FISH SOC, V76, P97, DOI DOI 10.1577/1548-8659(1946)76[97:TEBKMA]2.0.CO;2; Sanchis-Moll EJ, 1988, GUIA NATURALEZA COMU; Schnitzler H-U, 1994, BAT RES NEWS, V35, P43; SHIEL CB, 1991, J ZOOL, V223, P299, DOI 10.1111/j.1469-7998.1991.tb04766.x; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Spitzenberger F, 2001, HDB SAUGETIERE EUROP, P281; Stearns CR, 2011, AM MIDL NAT, V166, P163, DOI 10.1674/0003-0031-166.1.163; SUTHERS RA, 1965, J EXP ZOOL, V158, P319, DOI 10.1002/jez.1401580307; Tarkan AS, 2007, FOLIA ZOOL, V56, P328; TREACY SD, 1981, J WILDLIFE MANAGE, V45, P990, DOI 10.2307/3808110; TUTTLE MD, 1974, J MAMMAL, V55, P475, DOI 10.2307/1379025; VELDKAMP R, 1995, ARDEA, V83, P143; Waessle JA, 2003, SCI MAR, V67, P233, DOI 10.3989/scimar.2003.67n2233; WHITAKER JO, 1980, J MAMMAL, V61, P540, DOI 10.2307/1379850; Williams C, 2011, HYSTRIX, V22, P159, DOI 10.4404/Hystrix-22.1-4498	78	18	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80163	10.1371/journal.pone.0080163	http://dx.doi.org/10.1371/journal.pone.0080163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312200	Green Published, gold			2022-12-25	WOS:000327652100025
J	Brotherton, MC; Bourassa, S; Leprohon, P; Legare, D; Poirier, GG; Droit, A; Ouellette, M				Brotherton, Marie-Christine; Bourassa, Sylvie; Leprohon, Philippe; Legare, Danielle; Poirier, Guy G.; Droit, Arnaud; Ouellette, Marc			Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; INCREASED TRYPANOTHIONE LEVELS; GENE-EXPRESSION ANALYSIS; ABC-TRANSPORTER MRPA; INDIAN KALA-AZAR; VISCERAL LEISHMANIASIS; DRUG-RESISTANCE; ORNITHINE-DECARBOXYLASE; SURFACE GLYCOPROTEIN; P-GLYCOPROTEIN	Background: Antimonials remain the primary antileishmanial drugs in most developing countries. However, drug resistance to these compounds is increasing and our understanding of resistance mechanisms is partial. Methods/Principal Findings: In the present study, quantitative proteomics using stable isotope labelling of amino acids in cell culture (SILAC) and genome next generation sequencing were used in order to better characterize in vitro generated Leishmania infantum antimony resistant mutant (Sb2000.1). Using the proteomic method, 58 proteins were found to be differentially regulated in Sb2000.1. The ABC transporter MRPA (ABCC3), a known marker of antimony resistance, was observed for the first time in a proteomic screen. Furthermore, transfection of its gene conferred antimony resistance in wild-type cells. Next generation sequencing revealed aneuploidy for 8 chromosomes in Sb2000.1. Moreover, specific amplified regions derived from chromosomes 17 and 23 were observed in Sb2000.1 and a single nucleotide polymorphism (SNP) was detected in a protein kinase (LinJ. 33.1810-E629K). Conclusion/Significance: Our results suggest that differentially expressed proteins, chromosome number variations (CNVs), specific gene amplification and SNPs are important features of antimony resistance in Leishmania.	[Brotherton, Marie-Christine; Leprohon, Philippe; Legare, Danielle; Ouellette, Marc] Univ Laval, CHU Quebec, Ctr Rech, Ctr Rech Infectiol, Quebec City, PQ G1K 7P4, Canada; [Brotherton, Marie-Christine; Leprohon, Philippe; Legare, Danielle; Ouellette, Marc] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Bourassa, Sylvie; Poirier, Guy G.; Droit, Arnaud] Univ Laval, CHU Quebec, Ctr Genom Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Ouellette, M (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Ctr Rech Infectiol, Pavillon CHUL, Quebec City, PQ G1K 7P4, Canada.	marc.ouellette@crchul.ulaval.ca	Droit, Arnaud/AGZ-6283-2022; Leprohon, Philippe/U-5474-2019; Ouellette, Marc/K-8694-2017	Droit, Arnaud/0000-0001-7922-790X; Ouellette, Marc/0000-0002-6743-9646; Brotherton, Marie-Christine/0000-0002-3439-5800; Poirier, Guy/0000-0002-4869-1424	Natural Sciences and Engineering Research Council of Canada (NSERC); Ministere du Developpement Economique, Innovation et Exportation (MDEIE); CIHR [MOP209278, MOP13233]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere du Developpement Economique, Innovation et Exportation (MDEIE); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and by the Ministere du Developpement Economique, Innovation et Exportation (MDEIE) grants to AD and by CIHR grants to GGP (MOP209278) and MO (MOP13233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Ashutosh, 2012, ANTIMICROB AGENTS CH, V56, P518, DOI 10.1128/AAC.00736-11; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004; Brochu C, 2004, CELL STRESS CHAPERON, V9, P294, DOI 10.1379/CSC-15R1.1; Brotherton MC, 2012, J PROTEOME RES, V11, P3974, DOI 10.1021/pr201248h; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Duesberg P, 2007, DRUG RESIST UPDATE, V10, P51, DOI 10.1016/j.drup.2007.02.003; El Fadili K, 2005, ANTIMICROB AGENTS CH, V49, P1988, DOI 10.1128/AAC.49.5.1988-1993.2005; El Fadili K, 2009, EXP PARASITOL, V123, P51, DOI 10.1016/j.exppara.2009.05.013; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Grondin K, 1997, EMBO J, V16, P3057, DOI 10.1093/emboj/16.11.3057; GRONDIN K, 1993, NUCLEIC ACIDS RES, V21, P1895, DOI 10.1093/nar/21.8.1895; Guimond C, 2003, NUCLEIC ACIDS RES, V31, P5886, DOI 10.1093/nar/gkg806; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Kazemi-Rad E, 2013, EXP PARASITOL, V135, P344, DOI 10.1016/j.exppara.2013.07.018; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; LAWRENCE F, 1985, P NATL ACAD SCI USA, V82, P4414, DOI 10.1073/pnas.82.13.4414; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; Leprohon P, 2009, ANTIMICROB AGENTS CH, V53, P2646, DOI 10.1128/AAC.01474-08; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Moreira W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.83; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee A, 2013, MOL MICROBIOL, V88, P189, DOI 10.1111/mmi.12178; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Olliaro P, 2009, TROP MED INT HEALTH, V14, P88, DOI 10.1111/j.1365-3156.2008.02195.x; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shaked-Mishan P, 2001, J BIOL CHEM, V276, P3971, DOI 10.1074/jbc.M005423200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Singh R, 2010, INT J ANTIMICROB AG, V36, P50, DOI 10.1016/j.ijantimicag.2010.03.012; SOTERIADOU KP, 1994, EUR J BIOCHEM, V223, P61, DOI 10.1111/j.1432-1033.1994.tb18966.x; Sterkers Y, 2012, MOL MICROBIOL, V86, P15, DOI 10.1111/j.1365-2958.2012.08185.x; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Thakur CP, 2001, T ROY SOC TROP MED H, V95, P187, DOI 10.1016/S0035-9203(01)90160-9; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Vergnes B, 2007, MOL CELL PROTEOMICS, V6, P88, DOI 10.1074/mcp.M600319-MCP200; Walker J, 2012, MOL BIOCHEM PARASIT, V183, P166, DOI 10.1016/j.molbiopara.2012.03.002; WILSON ME, 1990, J IMMUNOL, V144, P4825	66	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81899	10.1371/journal.pone.0081899	http://dx.doi.org/10.1371/journal.pone.0081899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312377	Green Submitted, gold, Green Published			2022-12-25	WOS:000327652100106
J	Haran, FJ; Alphonso, AL; Creason, A; Campbell, JS; Johnson, D; Young, E; Tsao, JW				Haran, F. J.; Alphonso, Aimee L.; Creason, Alia; Campbell, Justin S.; Johnson, Dagny; Young, Emily; Tsao, Jack W.			Analysis of Post-Deployment Cognitive Performance and Symptom Recovery in US Marines	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; REACTION-TIME; CONCUSSION; SEQUELAE; FREEDOM; UTILITY; HEALTH; ANAM; IRAQ	Background: Computerized neurocognitive testing (NCAT) has been proposed to be useful as a screening tool for post-deployment cognitive deficits in the setting of mild traumatic brain injury (mTBI). We assessed the clinical utility of post-injury/post-deployment Automated Neurocognitive Assessment Metric (ANAM) testing, using a longitudinal design to compare baseline ANAM tests with two post-deployment ANAM tests in a group of Marines who experienced combat during deployment. Methods and Findings: Post-deployment cognitive performance and symptom recovery were compared in a subsample of 1324 U.S. Marines with high rates of combat exposure during deployment. Of the sample, 169 Marines had available baseline and twice repeated post-deployment ANAM results. A retrospective analysis of the ANAM data, which consisted of a self-report questionnaire about deployment-related blast exposure, recent history of mTBI, current clinical symptoms, and cognitive performance. Self-reported concussion sustained anytime during deployment was associated with a decrease in cognitive performance measured between 2-8 weeks post-deployment. At the second post-deployment test conducted on average eight months later, performance on the second simple reaction time test, in particular, remained impaired and was the most consistent and sensitive indicator of the cognitive decrements. Additionally, post-concussive symptoms were shown to persist in injured Marines with a self-reported history of concussion for an additional five months after most cognitive deficits resolved. Results of this study showed a measurable deployment effect on cognitive performance, although this effect appears to resolve without lasting clinical sequelae in those without history of deployment-related concussion. Conclusions: These results highlight the need for a detailed clinical examination for service members with history of concussion and persistent clinical symptoms. Reliance solely upon computerized neurocognitive testing as a method for identifying service members requiring clinical follow-up post-concussion is not recommended, as cognitive functioning only slowly returned to baseline levels in the setting of persistent clinical symptoms.	[Haran, F. J.] Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA; [Alphonso, Aimee L.] Henry M Jackson Fdn Adv Mil Med, Arlington, VA USA; [Alphonso, Aimee L.] Walter Reed Natl Mil Med Ctr, Dept Orthoped & Rehabil, Bethesda, MD USA; [Creason, Alia] Univ Consulting Serv Inc, Arlington, VA USA; [Creason, Alia; Tsao, Jack W.] US Navy Bur Med & Surg BUMED, Traumat Brain Injury Programs, Wounded Ill & Injured Directorate, Arlington, VA USA; [Campbell, Justin S.] Naval Space & Warfare Syst Ctr Pacific, San Diego, CA USA; [Johnson, Dagny; Young, Emily] Eyak Corp, Arlington, VA USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed National Military Medical Center	Haran, FJ (corresponding author), Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA.	jay.haran@navy.mil		Campbell, Justin/0000-0002-3471-9430	Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA	Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA	This study was funded by the Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Bass E, 2012, VET HLTH ADM TREATME; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Center DaVBI, 2012, DOD TBI WORLDW 200 2; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johansson B, 2009, MENTAL FATIGUE IMPAI, P13; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thorne DR, 2006, BEHAV RES METHODS, V38, P569, DOI 10.3758/BF03193886; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79595	10.1371/journal.pone.0079595	http://dx.doi.org/10.1371/journal.pone.0079595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312183	Green Published, gold			2022-12-25	WOS:000327652100012
J	Menzies, AK; Timonin, ME; McGuire, LP; Willis, CKR				Menzies, Allyson K.; Timonin, Mary E.; McGuire, Liam P.; Willis, Craig K. R.			Personality Variation in Little Brown Bats	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; EXPLORATORY-BEHAVIOR; EASTERN CHIPMUNKS; METABOLIC-RATE; GREAT TITS; TEMPERAMENT; STRESS; CONSEQUENCES; POPULATIONS; MICE	Animal personality or temperament refers to individual differences in behaviour that are repeatable over time and across contexts. Personality has been linked to life-history traits, energetic traits and fitness, with implications for the evolution of behaviour. Personality has been quantified for a range of taxa (e. g., fish, songbirds, small mammals) but, so far, there has been little work on personality in bats, despite their diversity and potential as a model taxon for comparative studies. We used a novel environment test to quantify personality in little brown bats (Myotis lucifugus) and assess the short-term repeatability of a range of behaviours. We tested the hypothesis that development influences values of personality traits and predicted that trait values associated with activity would increase between newly volant, pre-weaning young-of-the-year (YOY) and more mature, self-sufficient YOY. We identified personality dimensions that were consistent with past studies of other taxa and found that these traits were repeatable over a 24-hour period. Consistent with our prediction, older YOY captured at a fall swarming site prior to hibernation had higher activity scores than younger YOY bats captured at a maternity colony, suggesting that personality traits vary as development progresses in YOY bats. Thus, we found evidence of short-term consistency of personality within individuals but with the potential for temporal flexibility of traits, depending on age.	[Menzies, Allyson K.] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; Univ Winnipeg, C FIR, Winnipeg, MB R3B 2E9, Canada	University of Winnipeg; University of Winnipeg	Menzies, AK (corresponding author), Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada.	allysonmenzies@gmail.com	McGuire, Liam/CAE-8434-2022	Willis, Craig/0000-0002-0985-8607	Natural Sciences and Engineering Research Council (NSERC) Canada Graduate Scholarship; NSERC; Canada Foundation for Innovation; Manitoba Research and Innovation Fund; Manitoba Hydro Forest Enhancement Program	Natural Sciences and Engineering Research Council (NSERC) Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Manitoba Research and Innovation Fund; Manitoba Hydro Forest Enhancement Program	Funding was provided by a Natural Sciences and Engineering Research Council (NSERC) Canada Graduate Scholarship to AKM and post-doctoral fellowship to LPM as well as grants to CKRW from NSERC, the Canada Foundation for Innovation, the Manitoba Research and Innovation Fund and Manitoba Hydro Forest Enhancement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony E.L.P., 1988, P47; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bergvall UA, 2011, ANIM BEHAV, V81, P101, DOI 10.1016/j.anbehav.2010.09.018; Blanco M, 2009, ANIMAL, V3, P108, DOI 10.1017/S1751731108002978; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Burggren Warren W., 1999, Zoology (Jena), V102, P148; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2011, J EVOLUTION BIOL, V24, P2153, DOI 10.1111/j.1420-9101.2011.02344.x; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Castillo-Guerrero JA, 2006, WILSON J ORNITHOL, V118, P527, DOI 10.1676/05-088.1; DEFANIS E, 1995, J ZOOL, V235, P85; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dohm MR, 2002, FUNCT ECOL, V16, P273; Edenbrow M, 2011, ANIM BEHAV, V82, P731, DOI 10.1016/j.anbehav.2011.07.003; Favre M, 2008, ANIM BEHAV, V76, P1373, DOI 10.1016/j.anbehav.2008.07.003; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Freeman HD, 2010, AM J PRIMATOL, V71, P1; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; FRIEDMAN WA, 1992, PHYSIOL BEHAV, V52, P97, DOI 10.1016/0031-9384(92)90438-8; GOULD E, 1981, DEV PSYCHOBIOL, V14, P41, DOI 10.1002/dev.420140106; Hayes JP, 1997, J MAMMAL, V78, P274, DOI 10.2307/1382882; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jung S, 2013, BEHAV PROCESS, V97, P90, DOI 10.1016/j.beproc.2012.11.016; KAISER HF, 1991, PSYCHOL REP, V68, P855, DOI 10.2466/pr0.1991.68.3.855; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kilgour RJ, 2013, ETHOLOGY, V119, P189, DOI 10.1111/eth.12052; Krackow S, 2003, ETHOLOGY, V109, P671, DOI 10.1046/j.1439-0310.2003.00913.x; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; Lahti K, 2002, FUNCT ECOL, V16, P167, DOI 10.1046/j.1365-2435.2002.00618.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MARCHETTI K, 1989, BIOL REV, V64, P51, DOI 10.1111/j.1469-185X.1989.tb00638.x; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Matheson AL, 2010, J EXP BIOL, V213, P2165, DOI 10.1242/jeb.040188; McRitchie WD, 2000, CAVES KARST MANITOBA, P73; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; NOLAN NA, 1973, PSYCHOPHARMACOLOGIA, V29, P277, DOI 10.1007/BF00414043; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; R Core Team, 2012, R LANG ENV STAT COMP; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Schjolden J, 2005, HORM BEHAV, V48, P537, DOI 10.1016/j.yhbeh.2005.04.008; Simmons NB, 2003, BAT ECOLOGY, P493; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Timonin ME, 2011, J ZOOL, V284, P198, DOI 10.1111/j.1469-7998.2011.00792.x; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Weiss A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2231; Wheelwright NT, 2003, CONDOR, V105, P279, DOI 10.1650/0010-5422(2003)105[0279:DOFSAT]2.0.CO;2; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; Yoshida M, 2005, FISHERIES SCI, V71, P314, DOI 10.1111/j.1444-2906.2005.00966.x	59	20	20	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80230	10.1371/journal.pone.0080230	http://dx.doi.org/10.1371/journal.pone.0080230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312205	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100030
J	Vesterinen, EJ; Lilley, T; Laine, VN; Wahlberg, N				Vesterinen, Eero J.; Lilley, Thomas; Laine, Veronika N.; Wahlberg, Niklas			Next Generation Sequencing of Fecal DNA Reveals the Dietary Diversity of the Widespread Insectivorous Predator Daubenton's Bat (Myotis daubentonii) in Southwestern Finland	PLOS ONE			English	Article							PREY DNA; VESPERTILIONIDAE; CHIROPTERA; BARCODE; NUMBER; DETECT	Understanding predator-prey dynamics is a fundamental task in the evaluation of the adaptive capacities of species. However, direct observations or morphological identification of fecal remains do not offer an effective way to study the dietary ecology of elusive species, such as nocturnal insectivorous bats. However, recent advances in molecular techniques have opened a new method for identifying prey species from fecal samples. In this study, we amplified species-specific mitochondrial COI fragments from fecal DNA extractions from 34 individual Daubenton's bats (Myotis daubentonii) collected between 2008 and 2010 from southwestern Finland. Altogether, 128 different species of prey were identified based on a comprehensive local DNA reference library. In our study area, Daubenton's bats feed most frequently on insects of the orders Diptera (found in the diet of 94% individuals), Trichoptera (69%) and Lepidoptera (63%). The most frequent dipteran family in the diet was Chironomidae, which was found in 31 of 34 individuals. Most common prey species were chironomids Microtendipes pedellus (found in 50% of bats), Glyptotendipes cauliginellus (44%), and Procladius ferrugineus (41%). For the first time, an accurate species level list of the diet of the insectivorous Daubenton's bat (Myotis daubentonii) in Finland is presented. We report a generally applicable method for describing the arthropod diet of vertebrate predators. We compare public databases to a national database to highlight the importance of a local reference database.	[Vesterinen, Eero J.; Lilley, Thomas; Laine, Veronika N.; Wahlberg, Niklas] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Turku	Vesterinen, EJ (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	ejvest@utu.fi	Wahlberg, Niklas/B-7765-2008; Vesterinen, Eero J./Q-9527-2019; Laine, Veronika N/B-7869-2014; Lilley, Thomas/F-2236-2015; Vesterinen, Eero/I-6638-2012	Wahlberg, Niklas/0000-0002-1259-3363; Vesterinen, Eero J./0000-0003-3665-5802; Laine, Veronika N/0000-0002-4516-7002; Lilley, Thomas/0000-0001-5864-4958; Vesterinen, Eero/0000-0003-3665-5802	Emil Aaltonen Foundation; Turku University Foundation; Maj and Tor Nessling Foundation; Kone Foundation	Emil Aaltonen Foundation; Turku University Foundation; Maj and Tor Nessling Foundation; Kone Foundation	Funding was provided by the Emil Aaltonen Foundation, Turku University Foundation, Maj and Tor Nessling Foundation, and Kone Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Alberdi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035692; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson G, 2005, NATIONALNYCKELN TILL; Beck Andres, 1995, Myotis, V32-33, P109; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Brosset A, 1966, MAMMALIA, V30; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2000, STAT SINICA, V10, P227; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Chinery M, 1994, EUROOPAN HYONTEISOPA, P320; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK., 2013, STAT ESTIMATION SPEC; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dietz C, 2009, BATS BRITAIN EUROPE; Dodd LE, 2012, J MAMMAL, V93, P1119, DOI 10.1644/11-MAMM-A-218.1; Encarnacao JA, 2004, MAMM BIOL, V69, P163, DOI 10.1078/1616-5047-00131; Flavin DA, 2001, ACTA THERIOL, V46, P43, DOI 10.1007/BF03192415; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graclik A, 2012, TURK J ZOOL, V36, P209, DOI 10.3906/zoo-1007-35; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill DA, 2005, MAMMAL REV, V35, P116, DOI 10.1111/j.1365-2907.2005.00058.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jumppanen K, 1994, DEV STATE ARCHIPELAG; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Koponen S, 1997, ENTOMOL FENNICA, V8, P177, DOI 10.33338/ef.83940; Kruger F, 2012, ACTA CHIROPTEROL, V14, P347, DOI 10.3161/150811012X661666; Kurskov AN, 1968, BELOVEZHSKAYA PUSHCH, V2, P147; Kurskov AN, 1981, RUKOKRYLYE BELORUSSI, P136; Laasonen EM, 1998, ENTOMOL FENNICA, V9, P115, DOI 10.33338/ef.83972; Lilley T, 2012, ECOTOXICOLOGY, DOI DOI 10.1007/S10646-012-0887-2.ACCESSED; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mikula Peter, 2012, Vespertilio, V16, P197; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Moorthie Sowmiya, 2011, Hugo J, V5, P1, DOI 10.1007/s11568-011-9156-3; Nissen H, 2013, FOLIA ZOOL, V62, P36; NYHOLM ERJK S., 1965, ANN ZOOL FENN, V2, P77; Paasivirta L, 2012, FINNISH CHIRONOMIDAE, P47; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pereira MJR, 2002, ACTA CHIROPTEROL, V4, P183, DOI 10.3161/001.004.0207; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Poulton EB, 1929, P ZOOL SOC LOND, V1929, P277; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Rydell J, 1997, P ROY SOC B-BIOL SCI, V264, P83, DOI 10.1098/rspb.1997.0012; Salmela J, ENTOMOLOGICA FENNICA, V22, P219; Santana SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028584, 10.1371/journal.pone.0025845]; SULLIVAN CM, 1993, J ZOOL, V231, P656, DOI 10.1111/j.1469-7998.1993.tb01947.x; Suominen T, 2010, MAR ENVIRON RES, V69, P216, DOI 10.1016/j.marenvres.2009.10.009; Svensson AM, 2002, HYDROBIOLOGIA, V489, P83, DOI 10.1023/A:1023254503466; SWIFT SM, 1983, J ZOOL, V200, P249, DOI 10.1111/j.1469-7998.1983.tb05787.x; Taake K-H, 1991, STRATEGIEN RESSOURCE; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Whitaker John O. Jr, 2009, P567; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	61	62	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82168	10.1371/journal.pone.0082168	http://dx.doi.org/10.1371/journal.pone.0082168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312405	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100109
J	Anne, SL; Govek, EE; Ayrault, O; Kim, JH; Zhu, XD; Murphy, DA; Van Aelst, L; Roussel, MF; Hatten, ME				Anne, Sandrine L.; Govek, Eve-Ellen; Ayrault, Olivier; Kim, Jee Hae; Zhu, Xiaodong; Murphy, David A.; Van Aelst, Linda; Roussel, Martine F.; Hatten, Mary E.			WNT3 Inhibits Cerebellar Granule Neuron Progenitor Proliferation and Medulloblastoma Formation via MAPK Activation	PLOS ONE			English	Article							BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; HUMAN HOMOLOG; BETA-CATENIN; SIGNALING PATHWAY; N-MYC; INT-1 PROTOONCOGENE; MOUSE FOREBRAIN; KINASE PATHWAY; PATCHED PTCH	During normal cerebellar development, the remarkable expansion of granule cell progenitors (GCPs) generates a population of granule neurons that outnumbers the total neuronal population of the cerebral cortex, and provides a model for identifying signaling pathways that may be defective in medulloblastoma. While many studies focus on identifying pathways that promote growth of GCPs, a critical unanswered question concerns the identification of signaling pathways that block mitogenic stimulation and induce early steps in differentiation. Here we identify WNT3 as a novel suppressor of GCP proliferation during cerebellar development and an inhibitor of medulloblastoma growth in mice. WNT3, produced in early postnatal cerebellum, inhibits GCP proliferation by down-regulating pro-proliferative target genes of the mitogen Sonic Hedgehog (SHH) and the bHLH transcription factor Atoh1. WNT3 suppresses GCP growth through a non-canonical Wnt signaling pathway, activating prototypic mitogen-activated protein kinases (MAPKs), the Ras-dependent extracellular-signal-regulated kinases 1/2 (ERK1/2) and ERK5, instead of the classical beta-catenin pathway. Inhibition of MAPK activity using a MAPK kinase (MEK) inhibitor reversed the inhibitory effect of WNT3 on GCP proliferation. Importantly, WNT3 inhibits proliferation of medulloblastoma tumor growth in mouse models by a similar mechanism. Thus, the present study suggests a novel role for WNT3 as a regulator of neurogenesis and repressor of neural tumors.	[Anne, Sandrine L.; Govek, Eve-Ellen; Kim, Jee Hae; Zhu, Xiaodong; Murphy, David A.; Hatten, Mary E.] Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; [Ayrault, Olivier; Roussel, Martine F.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Rockefeller University; St Jude Children's Research Hospital; Cold Spring Harbor Laboratory	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockefeller.edu	Roussel, Martine F/F-1469-2016	Roussel, Martine F/0000-0002-1740-8139	NIH [NS-051778, NS-067289, CA-096832, CA-021765]; Starr Cancer Consortium; American-Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; La Fondation pour la Recherche Medicale; Gephardt Endowed Fellowship of St Jude Children's Research Hospital;  [MH082808]; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289, R01NS051778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; American-Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Gephardt Endowed Fellowship of St Jude Children's Research Hospital; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS-051778 and NS-067289 (M. E. H.), the Starr Cancer Consortium (M. E. H. and L. V. A.), NIH grant CA-096832, Cancer Core Grant CA-021765, the American-Lebanese Syrian Associated Charities of St Jude Children's Research Hospital (M. F. R.), La Fondation pour la Recherche Medicale and the Gephardt Endowed Fellowship of St Jude Children's Research Hospital (O.A.), and MH082808 (L.V.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Baeza N, 2003, ONCOGENE, V22, P632, DOI 10.1038/sj.onc.1206156; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Browd SR, 2006, CANCER RES, V66, P2666, DOI 10.1158/0008-5472.CAN-05-2198; BULFONE A, 1993, J NEUROSCI, V13, P3155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Cheyette B.N., 2004, SCI STKE, V2004, P54, DOI [10.1126/stke.2632004pe54, DOI 10.1126/STKE.2632004PE54]; Chidambaram A, 1996, CANCER RES, V56, P4599; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; David MD, 2010, J NEUROSCI RES, V88, P3011, DOI 10.1002/jnr.22464; Dongkyun K, 2010, CELL BIOL INT, V34, P763, DOI 10.1042/CBI20090133; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee Y, 2003, CANCER RES, V63, P5428; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Nicot A, 2002, J NEUROSCI, V22, P9244; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; PARR BA, 1993, DEVELOPMENT, V119, P247; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Pietsch T, 1997, CANCER RES, V57, P2085; Polleux Franck, 2002, Sci STKE, V2002, ppl9, DOI 10.1126/stke.2002.136.pl9; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Raffel C, 1997, CANCER RES, V57, P842; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Robertson CP, 2004, DEV DYNAM, V229, P510, DOI 10.1002/dvdy.10501; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; SALINAS PC, 1992, MECH DEVELOP, V39, P151, DOI 10.1016/0925-4773(92)90042-I; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schneider S, 2011, CEREB CORTEX, V21, P134, DOI 10.1093/cercor/bhq070; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tada M, 2000, DEVELOPMENT, V127, P2227; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Unden AB, 1996, CANCER RES, V56, P4562; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weiner HL, 2002, CANCER RES, V62, P6385; Wetmore C, 2000, CANCER RES, V60, P2239; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zindy F, 2007, CANCER RES, V67, P2676, DOI 10.1158/0008-5472.CAN-06-3418; Zurawel RH, 1998, CANCER RES, V58, P896; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	111	54	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81769	10.1371/journal.pone.0081769	http://dx.doi.org/10.1371/journal.pone.0081769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303070	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000327546400086
J	Breckner, A; Ganz, M; Marcellin, D; Richter, J; Gerwin, N; Rausch, M				Breckner, Anke; Ganz, Magdalena; Marcellin, David; Richter, Jens; Gerwin, Nicole; Rausch, Martin			Effect of Calstabin1 Depletion on Calcium Transients and Energy Utilization in Muscle Fibers and Treatment Opportunities with RyR1 Stabilizers	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+; RYANODINE RECEPTOR; SKELETAL-MUSCLE; RELEASE; EXCITATION; K201; MECHANISM; CHANNELS; BINDING; JTV519	Depletion of calstabin1 (FKBP12) from the RyR1 channel and consequential calcium leakage from the sarcoplasmic reticulum (SR) is found in certain disease conditions such as dystrophy, aging or muscle overuse. Here, we first assessed the effect of calstabin1 depletion on resting Ca2+ levels and transients. We found that depletion of calstabin1 with the calstabin1-dissociation compound FK506 increased the release of calcium from the SR by 14 % during tetanic stimulation (50 Hz, 300 ms) and delayed cytosolic calcium removal. However, we did not find a significant increase in resting cytosolic Ca2+ levels. Therefore, we tested if increased SERCA activity could counterbalance calcium leakage. By measuring the energy utilization of muscle fibers with and without FK506 treatment, we observed that FK506-treatment increased oxygen consumption by 125% compared to baseline levels. Finally, we found that pretreatment of muscle fibers with the RyR1 stabilizer JTV-519 led to an almost complete normalization of calcium flux dynamics and energy utilization. We conclude that cytosolic calcium levels are mostly preserved in conditions with leaky RyR1 channels due to increased SERCA activity. Therefore, we suggest that RyR1 leakiness might lead to chronic metabolic stress, followed by cellular damage, and RyR1 stabilizers could potentially protect diseased muscle tissue.	[Breckner, Anke; Marcellin, David; Richter, Jens; Rausch, Martin] Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland; [Ganz, Magdalena] Univ Konstanz, Bioimaging Ctr, Constance, Germany; [Gerwin, Nicole] Novartis Inst BioMed Res, Musculoskeletal Dis Area, Basel, Switzerland	Novartis; University of Konstanz; Novartis	Rausch, M (corresponding author), Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland.	martin.rausch@novartis.com						Ahern GP, 1997, NEUROSCI LETT, V225, P81, DOI 10.1016/S0304-3940(97)00193-6; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blayney LM, 2010, CARDIOVASC RES, V85, P68, DOI 10.1093/cvr/cvp273; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Gilchrist JSC, 2003, CAN J PHYSIOL PHARM, V81, P220, DOI 10.1139/Y03-035; Hollingworth S, 1996, J GEN PHYSIOL, V108, P455, DOI 10.1085/jgp.108.5.455; Hollingworth S, 2009, BIOPHYS J, V97, P1864, DOI 10.1016/j.bpj.2009.07.021; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jiang Y, 1996, AM J PHYSIOL-CELL PH, V270, pC411; KANEKO N, 1994, DRUG DEVELOP RES, V33, P429, DOI 10.1002/ddr.430330406; Kimura J, 1999, JPN J PHARMACOL, V79, P275, DOI 10.1254/jjp.79.275; Kohno M, 2003, AM J PHYSIOL-HEART C, V284, pH1035, DOI 10.1152/ajpheart.00722.2002; Lamb GD, 1996, J PHYSIOL-LONDON, V494, P569, DOI 10.1113/jphysiol.1996.sp021514; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Loughrey CM, 2007, CARDIOVASC RES, V76, P236, DOI 10.1016/j.cardiores.2007.06.014; Norris SM, 2010, AM J PHYSIOL-CELL PH, V298, pC521, DOI 10.1152/ajpcell.00479.2009; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Rios E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.L110.107300; Russ DW, 2011, ACTA PHYSIOL, V201, P391, DOI 10.1111/j.1748-1716.2010.02191.x; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Ye YP, 2012, MOL PHARMACOL, V81, P53, DOI 10.1124/mol.111.074740	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81277	10.1371/journal.pone.0081277	http://dx.doi.org/10.1371/journal.pone.0081277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303040	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400057
J	Morales, SE; Holben, WE				Morales, Sergio E.; Holben, William E.			Functional Response of a Near-Surface Soil Microbial Community to a Simulated Underground CO2 Storage Leak	PLOS ONE			English	Article							BIOLOGICAL NITROGEN-FIXATION; ELEVATED CO2; N-2 FIXATION; MINERALIZATION; SEQUESTRATION; CARBON; IMPACTS; REVEALS; BOZEMAN; FLUXES	Understanding the impacts of leaks from geologic carbon sequestration, also known as carbon capture and storage, is key to developing effective strategies for carbon dioxide (CO2) emissions management and mitigation of potential negative effects. Here, we provide the first report on the potential effects of leaks from carbon capture and storage sites on microbial functional groups in surface and near-surface soils. Using a simulated subsurface CO2 storage leak scenario, we demonstrate how CO2 flow upward through the soil column altered both the abundance (DNA) and activity (mRNA) of microbial functional groups mediating carbon and nitrogen transformations. These microbial responses were found to be seasonally dependent and correlated to shifts in atmospheric conditions. While both DNA and mRNA levels were affected by elevated CO2, they did not react equally, suggesting two separate mechanisms for soil microbial community response to high CO2 levels. The results did not always agree with previous studies on elevated atmospheric (rather than subsurface) CO2 using FACE (Free-Air CO2 Enrichment) systems, suggesting that microbial community response to CO2 seepage from the subsurface might differ from its response to atmospheric CO2 increases.	[Morales, Sergio E.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Morales, Sergio E.; Holben, William E.] Univ Montana, Div Biol Sci, Cellular Mol & Microbial Biol Program, Missoula, MT 59812 USA; [Morales, Sergio E.; Holben, William E.] Univ Montana, Div Biol Sci, Syst Ecol Program, Missoula, MT 59812 USA; [Holben, William E.] Univ Montana, Montana Ecol Infect Dis Program, Missoula, MT 59812 USA	University of Otago; University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana	Morales, SE (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.	sergio.morales@otago.ac.nz	Morales, Sergio/O-5680-2019	Morales, Sergio/0000-0002-5862-0726	United States Department of Energy-Experimental Program to Stimulate Competitive Research (DOE-EPSCoR Implementation Grant) [DE-FG02-08ER46527]	United States Department of Energy-Experimental Program to Stimulate Competitive Research (DOE-EPSCoR Implementation Grant)	Funding for this project was provided by the United States Department of Energy-Experimental Program to Stimulate Competitive Research (DOE-EPSCoR Implementation Grant DE-FG02-08ER46527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWES G, 1991, PLANT CELL ENVIRON, V14, P795, DOI 10.1111/j.1365-3040.1991.tb01443.x; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cheng WG, 2001, BIOL FERT SOILS, V34, P7, DOI 10.1007/s003740100345; Edwards EJ, 2006, NEW PHYTOL, V169, P157, DOI 10.1111/j.1469-8137.2005.01568.x; FARRAR CD, 1995, NATURE, V376, P675, DOI 10.1038/376675a0; Farrar CD, 1999, MAGMATIC CARBON DIOX, P4217; Frerichs J, 2012, FEMS MICROBIOLOGY EC; Gouveia FJ, 2005, AEROMETRIC MEASUREME; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hungate BA, 1999, GLOBAL CHANGE BIOL, V5, P781, DOI 10.1046/j.1365-2486.1999.00275.x; IPCC, 2005, SPECIAL REPORT CARBO; Keith CJ, 2009, INT J GREENH GAS CON, V3, P626, DOI 10.1016/j.ijggc.2009.03.003; Lewicki JL, 2010, ENVIRON EARTH SCI, V60, P285, DOI 10.1007/s12665-009-0396-7; Lewicki JL, 2007, GEOPHYS RES LETT, V34; Little MG, 2010, ENVIRON SCI TECHNOL, V44, P9225, DOI 10.1021/es102235w; Male EJ, 2010, ENVIRON EARTH SCI, V60, P251, DOI 10.1007/s12665-009-0372-2; Marhan S, 2011, FEMS MICROBIOL ECOL, V76, P209, DOI 10.1111/j.1574-6941.2011.01048.x; Mayr C, 1999, J MICROBIOL METH, V36, P35, DOI 10.1016/S0167-7012(99)00009-3; Mikkelsen M, 2010, ENERG ENVIRON SCI, V3, P43, DOI 10.1039/b912904a; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; RICE CW, 1994, PLANT SOIL, V165, P67, DOI 10.1007/BF00009963; Ross DJ, 2004, PLANT SOIL, V260, P183, DOI 10.1023/B:PLSO.0000030188.77365.46; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soussana JE, 1996, PLANT SOIL, V187; Spangler LH, 2009, ENRGY PROCED, V1, P2143, DOI 10.1016/j.egypro.2009.01.279; Spangler LH, 2010, ENVIRON EARTH SCI, V60, P227, DOI 10.1007/s12665-009-0400-2; Stenhouse M, 2009, ENRGY PROCED, V1, P1895, DOI 10.1016/j.egypro.2009.01.247; Strazisar BR, 2009, INT J GREENH GAS CON, V3, P736, DOI 10.1016/j.ijggc.2009.07.005; Tissue DT, 1997, OECOLOGIA, V109, P28, DOI 10.1007/s004420050054; Torp TA, 2004, ENERGY, V29, P1361, DOI 10.1016/j.energy.2004.03.104; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; West JM, 2009, ENRGY PROCED, V1, P1863, DOI 10.1016/j.egypro.2009.01.243; White CM, 2003, J AIR WASTE MANAGE, V53, P645, DOI 10.1080/10473289.2003.10466206; Wielopolski L, 2011, INT J ENV RES PUB HE, V8, P818, DOI 10.3390/ijerph8030818; Zanetti S, 1996, PLANT PHYSIOL, V112, P575, DOI 10.1104/pp.112.2.575	39	24	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81742	10.1371/journal.pone.0081742	http://dx.doi.org/10.1371/journal.pone.0081742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303067	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400083
J	Walters, DM; White, KM; Patel, U; Davis, MJ; Veluci-Marlow, RM; Sunkesula, SRB; Bonner, JC; Martin, JR; Gladwell, W; Kleeberger, SR				Walters, Dianne M.; White, Kevin M.; Patel, Ushma; Davis, Martin J.; Veluci-Marlow, Roberta M.; Sunkesula, Solomon Raju Bhupanapadu; Bonner, James C.; Martin, Jessica R.; Gladwell, Wes; Kleeberger, Steven R.			Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5)	FASEB JOURNAL			English	Article						lung injury; inflammation; collagen; haplotype; mapping	MESSENGER-RNA EXPRESSION; HUMAN LUNG FIBROBLASTS; BRONCHOALVEOLAR LAVAGE; EOSINOPHIL ACTIVATION; GROWTH-FACTOR; RECEPTOR; INFLAMMATION; CANCER; INJURY; CELLS	Interstitial lung diseases (ILDs) are characterized by injury, inflammation, and scarring of alveoli, leading to impaired function. The etiology of idiopathic forms of ILD is not understood, making them particularly difficult to study due to the lack of appropriate animal models. Consequently, few effective therapies have emerged. We developed an inbred mouse model of ILD using vanadium pentoxide (V2O5), the most common form of a transition metal found in cigarette smoke, fuel ash, mineral ores, and steel alloys. Pulmonary responses to V2O5, including dose-dependent increases in lung permeability, inflammation, collagen content, and dysfunction, were significantly greater in DBA/2J mice compared to C57BL/6J mice. Inflammatory and fibrotic responses persisted for 4 mo in DBA/2J mice, while limited responses in C57BL/6J mice resolved. We investigated the genetic basis for differential responses through genetic mapping of V2O5-induced lung collagen content in BXD recombinant inbred (RI) strains and identified significant linkage on chromosome 4 with candidate genes that associate with V2O5-induced collagen content across the RI strains. Results suggest that V2O5 may induce pulmonary fibrosis through mechanisms distinct from those in other models of pulmonary fibrosis. These findings should further advance our understanding of mechanisms involved in ILD and thereby aid in identification of new therapeutic targets.Walters, D. M., White, K. M., Patel, U., Davis, M. J., Veluci-Marlow, R. M., Bhupanapadu Sunkesula, S. R., Bonner, J. C., Martin, J. R., Gladwell, W., Kleeberger, S. R. Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).	[Walters, Dianne M.; White, Kevin M.; Patel, Ushma; Davis, Martin J.; Veluci-Marlow, Roberta M.; Sunkesula, Solomon Raju Bhupanapadu] E Carolina Univ, Dept Physiol, Greenville, NC 27834 USA; [Bonner, James C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Martin, Jessica R.; Gladwell, Wes; Kleeberger, Steven R.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; East Carolina University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Walters, DM (corresponding author), E Carolina Univ, Brody Sch Med, Dept Physiol, 6N-98,600 Moye Blvd, Greenville, NC 27834 USA.	waltersd@ecu.edu	Kleeberger, Steven R/F-1807-2019	Kleeberger, Steven R/0000-0003-2948-8452	Intramural Research Program of the U.S. National Institutes of Health; NIEHS; East Carolina University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100512, ZIAES100513] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); East Carolina University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully acknowledge the U.S. National Institute of Environmental Health Sciences (NIEHS) Histology Core facility and Joani Zary Oswald (Brody School of Medicine Histology Core, East Carolina University) for histological services, and Dr. Paul Strausbauch for pathology advice. The authors also thank Dr. Jared M. Brown for use of laboratory equipment and technical advice, and M. Anthony Phipps for technical assistance. This research was supported (in part) by the Intramural Research Program of the U.S. National Institutes of Health, NIEHS, and East Carolina University. The authors declare no conflicts of interest.	Adachi A, 1998, B ENVIRON CONTAM TOX, V61, P276, DOI 10.1007/s001289900759; Alber A, 2012, INT J EXP PATHOL, V93, P243, DOI 10.1111/j.1365-2613.2012.00833.x; Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Antao-Menezes A, 2008, J IMMUNOL, V180, P4200, DOI 10.4049/jimmunol.180.6.4200; Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Bonner JC, 1998, AM J PHYSIOL-LUNG C, V274, pL72, DOI 10.1152/ajplung.1998.274.1.L72; Bonner JC, 2000, AM J PHYSIOL-LUNG C, V278, pL209, DOI 10.1152/ajplung.2000.278.1.L209; BOOMARS KA, 1995, THORAX, V50, P1087, DOI 10.1136/thx.50.10.1087; Brody AR, 2002, CHEST, V121, p31S, DOI 10.1378/chest.121.3_suppl.31S; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chong IW, 2000, INFLAMMATION, V24, P505, DOI 10.1023/A:1007021322323; Chung MP, 2003, AM J RESP CELL MOL, V29, P375, DOI 10.1165/rcmb.2003-0029OC; Cohen MD, 1996, FUND APPL TOXICOL, V33, P254, DOI 10.1006/faat.1996.0163; Cohen MD, 1997, J TOXICOL ENV HEALTH, V51, P591, DOI 10.1080/009841097159854; Cohen MD, 1996, TOXICOL APPL PHARM, V138, P110, DOI 10.1006/taap.1996.0104; Cohen Mitchell D, 2004, J Immunotoxicol, V1, P39, DOI 10.1080/15476910490438360; Costabel U, 2001, Curr Opin Pulm Med, V7, P255, DOI 10.1097/00063198-200109000-00002; Cottin V, 2009, CHEST, V136, P1, DOI 10.1378/chest.09-0538; Davis Gerald S., 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P81; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dreher K, 1996, CHEST, V109, pS33, DOI 10.1378/chest.109.3_Supplement.33S-a; Emad A, 2007, J CLIN IMMUNOL, V27, P605, DOI 10.1007/s10875-007-9114-y; FUJIMOTO K, 1995, CHEST, V108, P48, DOI 10.1378/chest.108.1.48; Fulkerson PC, 2006, AM J PATHOL, V169, P2117, DOI 10.2353/ajpath.2006.060617; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Grabowski GM, 1999, TOXICOL APPL PHARM, V156, P170, DOI 10.1006/taap.1999.8642; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P373; HAUSER R, 1995, AM J RESP CRIT CARE, V152, P1478, DOI 10.1164/ajrccm.152.5.7582280; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hirata H, 2008, RESPIROLOGY, V13, P788, DOI 10.1111/j.1440-1843.2008.01361.x; Howden R, 2008, AM J PHYSIOL-HEART C, V295, pH59, DOI 10.1152/ajpheart.00941.2007; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ingram JL, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-34; International Agency for Cancer Research (IARC), 2006, IARC MONOGR EVAL CAR, V86, P227; Irsigler GB, 1999, AM J IND MED, V35, P366, DOI 10.1002/(SICI)1097-0274(199904)35:4<366::AID-AJIM7>3.3.CO;2-E; Jakubzick C, 2004, IMMUNOL RES, V30, P339, DOI 10.1385/IR:30:3:339; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; KNECHT EA, 1992, J APPL TOXICOL, V12, P427, DOI 10.1002/jat.2550120611; Kodavanti UP, 1998, TOXICOL SCI, V43, P204, DOI 10.1093/toxsci/43.2.204; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Kuwano K, 1999, AM J RESP CELL MOL, V20, P53, DOI 10.1165/ajrcmb.20.1.2941; LEES REM, 1980, BRIT J IND MED, V37, P253; Loomis-King H., CURR OPIN PHARM, V13, P377; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Miyake Y, 2005, ANN OCCUP HYG, V49, P259, DOI 10.1093/annhyg/meh090; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; National Toxicology Program, 2002, Natl Toxicol Program Tech Rep Ser, P1; NEMERY B, 1990, EUR RESPIR J, V3, P202; Ohtsuka Y, 2006, EUR RESPIR J, V28, P1013, DOI 10.1183/09031936.06.00132505; Olsen AL, 2010, BREATHING AM, P99; Paun A, 2013, AM J RESP CELL MOL, V48, P330, DOI 10.1165/rcmb.2012-0078OC; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Pierce LM, 1996, TOXICOL APPL PHARM, V138, P1, DOI 10.1006/taap.1996.9999; Puxeddu I, 2006, J ALLERGY CLIN IMMUN, V117, P103, DOI 10.1016/j.jaci.2005.08.057; Rothenberg ME, 1996, MOL MED, V2, P334, DOI 10.1007/BF03401631; Schuler D, 2011, J TOXICOL PATHOL, V24, P149, DOI 10.1293/tox.24.149; SCHWARTZ DA, 1991, J APPL PHYSIOL, V71, P1688, DOI 10.1152/jappl.1991.71.5.1688; Shimizu Y, 2006, IMMUNOPHARM IMMUNOT, V28, P295, DOI 10.1080/08923970600809389; Shyur SD, 2008, EUR J HUM GENET, V16, P1283, DOI 10.1038/ejhg.2008.79; SJOBERG S G, 1955, AMA Arch Ind Health, V11, P505; Taskar V, 2008, SEMIN RESP CRIT CARE, V29, P670, DOI 10.1055/s-0028-1101277; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Walters Dianne M, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0546s40; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; WATERS MD, 1974, TOXICOL APPL PHARM, V28, P253, DOI 10.1016/0041-008X(74)90012-X; Woodin MA, 2000, AM J IND MED, V37, P353, DOI 10.1002/(SICI)1097-0274(200004)37:4<353::AID-AJIM5>3.3.CO;2-C; World Health Organization, 2002, AIR QUAL GUID, P162; Yu DF, 2011, AM J PHYSIOL-LUNG C, V301, pL31, DOI 10.1152/ajplung.00301.2010	72	11	11	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1098	1112		10.1096/fj.13-235044	http://dx.doi.org/10.1096/fj.13-235044			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24285090	Green Published			2022-12-25	WOS:000335324800007
J	Naydenov, NG; Feygin, A; Wang, LF; Ivanov, AI				Naydenov, Nayden G.; Feygin, Alex; Wang, Lifu; Ivanov, Andrei I.			N-Ethylmaleimide-sensitive Factor Attachment Protein alpha (alpha SNAP) Regulates Matrix Adhesion and Integrin Processing in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Migration; Cell Motility; Snare Proteins; Trafficking	MEMBRANE TRAFFICKING; ENDOPLASMIC-RETICULUM; MEDIATED TRAFFICKING; APICAL JUNCTIONS; EXCHANGE FACTOR; DISTINCT ROLES; CANCER-CELLS; SYNTAXIN 6; MIGRATION; FUSION	Integrin-based adhesion to the extracellular matrix (ECM) plays critical roles in controlling differentiation, survival, and motility of epithelial cells. Cells attach to the ECM via dynamic structures called focal adhesions (FA). FA undergo constant remodeling mediated by vesicle trafficking and fusion. A soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) is an essential mediator of membrane fusion; however, its roles in regulating ECM adhesion and cell motility remain unexplored. In this study, we found that siRNA-mediated knockdown of SNAP induced detachment of intestinal epithelial cells, whereas overexpression of SNAP increased ECM adhesion and inhibited cell invasion. Loss of SNAP impaired Golgi-dependent glycosylation and trafficking of 1 integrin and decreased phosphorylation of focal adhesion kinase (FAK) and paxillin resulting in FA disassembly. These effects of SNAP depletion on ECM adhesion were independent of apoptosis and NSF. In agreement with our previous reports that Golgi fragmentation mediates cellular effects of SNAP knockdown, we found that either pharmacologic or genetic disruption of the Golgi recapitulated all the effects of SNAP depletion on ECM adhesion. Furthermore, our data implicates 1 integrin, FAK, and paxillin in mediating the observed pro-adhesive effects of SNAP. These results reveal novel roles for SNAP in regulating ECM adhesion and motility of epithelial cells.	[Naydenov, Nayden G.; Feygin, Alex; Ivanov, Andrei I.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Virginia Inst Mol Med, Richmond, VA 23298 USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wang, Lifu] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia	Ivanov, AI (corresponding author), VCU Massey Canc Ctr, Goodwin Lab, Dept Human & Mol Genet, 401 Coll St,Rm 223, Richmond, VA 23298 USA.	aivanov2@vcu.edu	Ivanov, Andrei/V-1672-2019		National Institutes of Health [RO1 DK083968, R01 DK084953]; Crohn's and Colitis Foundation of America [254881]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084953, R01DK083968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083968 and R01 DK084953 (to A. I. I.) and Crohn's and Colitis Foundation of America Grant 254881 (to N. G. N.).	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Batiz LF, 2006, NEUROBIOL DIS, V23, P152, DOI 10.1016/j.nbd.2006.02.009; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; CHRISPEELS MJ, 1982, J CELL BIOL, V93, P5, DOI 10.1083/jcb.93.1.5; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Grabowski P, 2002, VIRCHOWS ARCH, V441, P256, DOI 10.1007/s00428-002-0650-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Huttenlocher A., 2011, COLD SPRING HARBOR P, V3; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Manabe R, 2002, J CELL SCI, V115, P1497; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Morrell CN, 2005, J PHARMACOL EXP THER, V314, P155, DOI 10.1124/jpet.104.082529; Morton AJ, 2001, BRAIN RES BULL, V56, P111, DOI 10.1016/S0361-9230(01)00611-6; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Nishiwaki Y, 2013, DEV CELL, V25, P374, DOI 10.1016/j.devcel.2013.04.015; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Parvani JG, 2013, MOL BIOL CELL, V24, P3449, DOI 10.1091/mbc.E12-10-0776; Peter F, 1998, J CELL SCI, V111, P2625; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Roales-Bujan R, 2012, ACTA NEUROPATHOL, V124, P531, DOI 10.1007/s00401-012-0992-6; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Skalski M, 2011, BBA-MOL CELL RES, V1813, P148, DOI 10.1016/j.bbamcr.2010.09.008; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Valdembri D, 2012, CURR OPIN CELL BIOL, V24, P582, DOI 10.1016/j.ceb.2012.08.004; VEIGA SS, 1995, INT J CANCER, V61, P420, DOI 10.1002/ijc.2910610324; Wang LF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2565; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Wu ZZ, 2011, BIOCHEM PHARMACOL, V82, P1860, DOI 10.1016/j.bcp.2011.09.010; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P827, DOI 10.1016/j.bcp.2010.05.026; Zebda N, 2012, MICROVASC RES, V83, P71, DOI 10.1016/j.mvr.2011.06.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	87	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2424	2439		10.1074/jbc.M113.498691	http://dx.doi.org/10.1074/jbc.M113.498691			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311785	Green Published, hybrid			2022-12-25	WOS:000331130200046
J	Byerly, MS; Swanson, RD; Wong, GW; Blackshaw, S				Byerly, Mardi S.; Swanson, Roy D.; Wong, G. William; Blackshaw, Seth			Stage-Specific Inhibition of TrkB Activity Leads to Long-Lasting and Sexually Dimorphic Effects on Body Weight and Hypothalamic Gene Expression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; ENERGY-BALANCE; ARCUATE NUCLEUS; ADULT MICE; FEEDING-BEHAVIOR; PRECURSOR CELLS; NEUROPEPTIDE-Y; PROTEIN-KINASE; FOOD-INTAKE; FAT DIET	During development, prenatal and postnatal factors program homeostatic set points to regulate food intake and body weight in the adult. Combinations of genetic and environmental factors contribute to the development of neural circuitry that regulates whole-body energy homeostasis. Brain-derived neurotrophic factor (Bdnf) and its receptor, Tyrosine kinase receptor B (TrkB), are strong candidates for mediating the reshaping of hypothalamic neural circuitry, given their well-characterized role in the central regulation of feeding and body weight. Here, we employ a chemical-genetic approach using the TrkB(F616A/F616A) knock-in mouse model to define the critical developmental period in which TrkB inhibition contributes to increased adult fat mass. Surprisingly, transient TrkB inhibition in embryos, preweaning pups, and adults all resulted in long-lasting increases in body weight and fat content. Moreover, sex-specific differences in the effects of TrkB inhibition on both body weight and hypothalamic gene expression were observed at multiple developmental stages. Our results highlight both the importance of the Bdnf/TrkB pathway in maintaining normal body weight throughout life and the role of sex-specific differences in the organization of hypothalamic neural circuitry that regulates body weight.	[Byerly, Mardi S.; Swanson, Roy D.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Byerly, Mardi S.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Byerly, Mardi S.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Technol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Byerly, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	mardibyerly@gmail.com		Wong, G. William/0000-0002-5286-6506	W.M. Keck Distinguished Young Scholar Award in Medical Research; American Heart Association [SDG2260721]; National Institutes of Health [DK084171]; National Institute of Diabetes and Digestive and Kidney Diseases training grant [T32DK007751]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007751, P30DK079637, R01DK084171] Funding Source: NIH RePORTER	W.M. Keck Distinguished Young Scholar Award in Medical Research; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases training grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a W.M. Keck Distinguished Young Scholar Award in Medical Research (to SB) and by grants from the American Heart Association (SDG2260721 to GWW), the National Institutes of Health (DK084171 to GWW), and the National Institute of Diabetes and Digestive and Kidney Diseases training grant (T32DK007751 to MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B. K., 1984, NUTR REV, V42, P354; Atlas, 2009, ALL MOUS BRAIN ATL; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Bouret SG, 2010, FORUM NUTR, V63, P84, DOI 10.1159/000264396; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Byerly Mardi S., 2013, BMC Physiology, V13, P10, DOI 10.1186/1472-6793-13-10; Byerly MS, 2009, WIRES SYST BIOL MED, V1, P380, DOI 10.1002/wsbm.22; Byerly MS, 2013, EUR J NEUROSCI; Byerly MS, 2013, AM J PHYSL REGUL INT; Caprio S, 1999, ENDOCRIN METAB CLIN, V28, P731, DOI 10.1016/S0889-8529(05)70099-2; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cheung CC, 2012, J COMP NEUROL; de Rijke CE, 2005, J MOL ENDOCRINOL, V35, P381, DOI 10.1677/jme.1.01808; Erickson JC, 1997, REGUL PEPTIDES, V70, P199, DOI 10.1016/S0167-0115(97)01007-0; Fox EA, 2004, AM J PHYSIOL-REG I, V286, pR994, DOI 10.1152/ajpregu.00727.2003; FRANKISH HM, 1995, PEPTIDES, V16, P757, DOI 10.1016/0196-9781(94)00200-P; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; HETHERINGTON AW, 1983, NUTR REV, V41, P124; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Hosomi S, 2003, BIOCHEM BIOPH RES CO, V301, P1011, DOI 10.1016/S0006-291X(03)00077-9; Ip FCF, 2001, NEUROSCI LETT, V301, P107, DOI 10.1016/S0304-3940(01)01603-2; Ishii Y, 2012, ENDOCRINOLOGY, V153, P3657, DOI 10.1210/en.2012-1328; Jebb SA, 2004, PUBLIC HEALTH NUTR, V7, P461, DOI 10.1079/PHN2003539; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Krieg WJS, 1932, J COMP NEUROL, V55, P19, DOI 10.1002/cne.900550104; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Levin BE, 2000, NUTRITION, V16, P909, DOI 10.1016/S0899-9007(00)00408-1; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Rinaman L, 2003, PHYSIOL BEHAV, V79, P65, DOI 10.1016/S0031-9384(03)00105-7; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Simerly RB, 2005, CURR OPIN NEUROBIOL, V15, P81, DOI 10.1016/j.conb.2005.01.013; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tran PV, 2006, J COMP NEUROL, V498, P637, DOI 10.1002/cne.21070; Tran PV, 2003, MOL CELL NEUROSCI, V22, P441, DOI 10.1016/S1044-7431(03)00027-7; Tremblay MS, 2002, INT J OBESITY, V26, P538, DOI 10.1038/sj.ijo.0801923; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Vink T, 2001, MOL PSYCHIATR, V6, P325, DOI 10.1038/sj.mp.4000854; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zeeni N, 2009, BRAIN RES, V1289, P49, DOI 10.1016/j.brainres.2009.06.076	71	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80781	10.1371/journal.pone.0080781	http://dx.doi.org/10.1371/journal.pone.0080781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312242	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300014
J	Eggs, B; Sanders, D				Eggs, Benjamin; Sanders, Dirk			Herbivory in Spiders: The Importance of Pollen for Orb-Weavers	PLOS ONE			English	Article							STABLE-ISOTOPES; DELTA-N-15; DELTA-C-13; PREDATORS; FIELD	Orb-weaving spiders (Araneidae) are commonly regarded as generalist insect predators but resources provided by plants such as pollen may be an important dietary supplementation. Their webs snare insect prey, but can also trap aerial plankton like pollen and fungal spores. When recycling their orb webs, the spiders may therefore also feed on adhering pollen grains or fungal spores via extraoral digestion. In this study we measured stable isotope ratios in the bodies of two araneid species (Aculepeira ceropegia and Araneus diadematus), their potential prey and pollen to determine the relative contribution of pollen to their diet. We found that about 25% of juvenile orb-weaving spiders' diet consisted of pollen, the other 75% of flying insects, mainly small dipterans and hymenopterans. The pollen grains in our study were too large to be taken up accidentally by the spiders and had first to be digested extraorally by enzymes in an active act of consumption. Therefore, pollen can be seen as a substantial component of the spiders' diet. This finding suggests that these spiders need to be classified as omnivores rather than pure carnivores.	[Eggs, Benjamin; Sanders, Dirk] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Sanders, Dirk] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Bern; University of Exeter	Eggs, B (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	benjamin.eggs@iee.unibe.ch	Eggs, Benjamin/AAB-8234-2020; Sanders, Dirk/B-4128-2013	Eggs, Benjamin/0000-0001-7618-4326; Sanders, Dirk/0000-0003-2383-8693	University of Bern	University of Bern	This work was supported by the University of Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Foelix R. F., 2011, BIOL SPIDERS; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Ludy C, 2006, ENTOMOL EXP APPL, V118, P145, DOI 10.1111/j.1570-7458.2006.00375.x; NYFFELER M, 1982, ANZ SCHADLINGSKD PFL, V55, P120, DOI 10.1007/BF01902580; NYFFELER M, 1981, ANZ SCHADLINGSKD PFL, V54, P33, DOI 10.1007/BF01905916; Nyffeler M, 1999, J ARACHNOL, V27, P317; Nyffeler M, 1983, MITTEILUNGEN SCHWEIZ, P200; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Parnell A., 2011, SIAR STABLE ISOTOPE; Peterson JA, 2010, ARTHROPOD-PLANT INTE, V4, P207, DOI 10.1007/s11829-010-9106-3; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riccardo G, 2007, B MICOLOGICO, V22, P47; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sanders D, 2013, HERBIVORY SPIDERS, P385; SMITH RB, 1984, SCIENCE, V226, P1330, DOI 10.1126/science.226.4680.1330; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Wise DH, 1993, SPIDERS ECOLOGICAL W	20	13	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82637	10.1371/journal.pone.0082637	http://dx.doi.org/10.1371/journal.pone.0082637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312430	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300083
J	Gu, M; Zhang, Y; Fan, SJ; Ding, XB; Ji, G; Huang, C				Gu, Ming; Zhang, Yu; Fan, Shengjie; Ding, Xiaobo; Ji, Guang; Huang, Cheng			Extracts of Rhizoma Polygonati Odorati Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; PPAR-ALPHA; INSULIN SENSITIVITY; UNCOUPLING PROTEIN-2; MESSENGER-RNA; TARGET GENES; GLUCOSE; LIVER; POLYSACCHARIDES	Polygonatum odoratum (Mill.) Druce belongs to the genus Polygonatum family of plants. In traditional Chinese medicine, the root of Polygonatum odoratum, Rhizoma Polygonati Odorati, is used both for food and medicine to prevent and treat metabolic disorders such as hyperlipidemia, hyperglycemia, obesity and cardiovascular disease. However, there is no solid experimental evidence to support these applications, and the underlying mechanism is also needed to be elucidated. Here, we examined the effect of the extract of Rhizoma Polygonati Odorati (ER) on metabolic disorders in diet-induced C57BL/6 obese mice. In the preventive experiment, the ER blocked body weight gain, and lowered serum total cholesterol (TC), triglyceride (TG) and fasting blood glucose, improved glucose tolerance test (GTT) and insulin tolerance test (ITT), reduced the levels of serum insulin and leptin, and increased serum adiponectin levels in mice fed with a high-fat diet significantly. In the therapeutic study, we induced obesity in the mice and treated the obese mice with ER for two weeks. We found that ER treatments reduced serum TG and fasting blood glucose, and improved glucose tolerance in the mice. Gene expression analysis showed that ER increased the mRNA levels of peroxisome proliferator-activated receptors (PPAR) c and a and their downstream target genes in mice livers, adipose tissues and HepG2 cells. Our data suggest that ER ameliorates metabolic disorders and enhances the mRNA expression of PPARs in obese C57BL/6 mice induced by high-fat diet.	[Gu, Ming; Zhang, Yu; Fan, Shengjie; Ding, Xiaobo; Huang, Cheng] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Ding, Xiaobo] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Ding, Xiaobo] Minist Educ, Key Lab Hort Sci Southern Mountainous Reg, Chongqing, Peoples R China; [Ji, Guang] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Southwest University - China; Shanghai University of Traditional Chinese Medicine	Ji, G (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China.	jiliver@vip.sina.com; chuang.shutcm@gmail.com						Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen HB, 2001, J ETHNOPHARMACOL, V74, P225, DOI 10.1016/S0378-8741(00)00359-7; Chen W, 2008, EXP CLIN ENDOCR DIAB, V116, P468, DOI 10.1055/s-2008-1058081; Choi SB, 2002, BIOSCI BIOTECH BIOCH, V66, P2036, DOI 10.1271/bbb.66.2036; Choudhary M, 2012, FUNCT FOODS HEALTH D, V2, P188, DOI 10.31989/ffhd.v2i6.90; Deng YF, 2012, J ETHNOPHARMACOL, V141, P228, DOI 10.1016/j.jep.2012.02.023; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Geloen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037633; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Guarner V, 2012, AGING DIS, V3, P269; Guo L, 2006, PHARMACOL THERAPEUT, V111, P145, DOI 10.1016/j.pharmthera.2005.10.009; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Huang HY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856381; Huang THW, 2005, BASIC CLIN PHARMACOL, V96, P3, DOI 10.1111/j.1742-7843.2005.pto960102.x; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Jin ML, 2013, INT J BIOL MACROMOL, V54, P16, DOI 10.1016/j.ijbiomac.2012.11.023; Kanagasabapathy G, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-261; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kumar V, 2012, CRIT REV FOOD SCI, V52, P899, DOI 10.1080/10408398.2010.512671; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Li HaiMing, 2010, Food and Drug, V12, P102; Li X., 2012, ISRN ENDOCRINOL, V2012; Lin E, 2007, DIABETES, V56, P735, DOI 10.2337/db06-1161; Lin H. W., 1994, Yaoxue Xuebao, V29, P215; Liu B, 2009, BBA-GEN SUBJECTS, V1790, P840, DOI 10.1016/j.bbagen.2009.04.020; Mezei O, 2003, J NUTR, V133, P1238; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Muhlhausler BS, 2009, ENDOCRINOLOGY, V150, P4287, DOI 10.1210/en.2009-0462; Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60; Oh KS, 2006, BIOCHEM BIOPH RES CO, V345, P1232, DOI 10.1016/j.bbrc.2006.04.182; Sahagun DO, 2012, PPAR RES, V2012, DOI 10.1155/2012/318613; Park MY, 2005, LIFE SCI, V77, P3344, DOI 10.1016/j.lfs.2005.05.043; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shu XS, 2009, J ETHNOPHARMACOL, V124, P539, DOI 10.1016/j.jep.2009.05.006; Sterchele PF, 1996, ARCH BIOCHEM BIOPHYS, V326, P281, DOI 10.1006/abbi.1996.0077; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tordjman K, 2002, J LIPID RES, V43, P936; Toth PP, 2009, CURR ATHEROSCLER REP, V11, P71, DOI 10.1007/s11883-009-0012-z; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang WJ, 2013, J INTEGR MED-JIM, V11, P153, DOI 10.3736/jintegrmed2013033; Wong CC, 2006, FOOD CHEM, V97, P705, DOI 10.1016/j.foodchem.2005.05.049; Xiao C, 2012, ARCH PHARM RES, V35, P1793, DOI 10.1007/s12272-012-1012-z; [徐光域 Xu Guangyu], 2005, [食品科学, Food Science], V26, P342; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yonezawa T, 2009, IUBMB LIFE, V61, P1123, DOI 10.1002/iub.264; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	66	21	24	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81724	10.1371/journal.pone.0081724	http://dx.doi.org/10.1371/journal.pone.0081724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312343	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300046
J	Smit, AN; Patton, DF; Michalik, M; Opiol, H; Mistlberger, RE				Smit, Andrea N.; Patton, Danica F.; Michalik, Mateusz; Opiol, Hanna; Mistlberger, Ralph E.			Dopaminergic Regulation of Circadian Food Anticipatory Activity Rhythms in the Rat	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; LOCOMOTOR-ACTIVITY; ENTRAINED RHYTHMS; REWARD; METHAMPHETAMINE; EXPRESSION; CLOCK; SCHEDULES; STRIATUM; SEEKING	Circadian activity rhythms are jointly controlled by a master pacemaker in the hypothalamic suprachiasmatic nuclei (SCN) and by food-entrainable circadian oscillators (FEOs) located elsewhere. The SCN mediates synchrony to daily light-dark cycles, whereas FEOs generate activity rhythms synchronized with regular daily mealtimes. The location of FEOs generating food anticipation rhythms, and the pathways that entrain these FEOs, remain to be clarified. To gain insight into entrainment pathways, we developed a protocol for measuring phase shifts of anticipatory activity rhythms in response to pharmacological probes. We used this protocol to examine a role for dopamine signaling in the timing of circadian food anticipation. To generate a stable food anticipation rhythm, rats were fed 3h/day beginning 6-h after lights-on or in constant light for at least 3 weeks. Rats then received the D2 agonist quinpirole (1 mg/kg IP) alone or after pretreatment with the dopamine synthesis inhibitor alpha-methylparatyrosine (AMPT). By comparison with vehicle injections, quinpirole administered i-h before lights-off (19h before mealtime) induced a phase delay of activity onset prior to the next meal. Delay shifts were larger in rats pretreated with AMPT, and smaller following quinpirole administered 4-h after lights-on. A significant shift was not observed in response to the D1 agonist SKF81297. These results provide evidence that signaling at D2 receptors is involved in phase control of FEOs responsible for circadian food anticipatory rhythms in rats.	[Smit, Andrea N.; Patton, Danica F.; Michalik, Mateusz; Opiol, Hanna; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN155172, F-RGPAS38028]; NSERC Post Graduate Scholarship; NSERC Undergraduate Research Scholarships	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Research Scholarships	This research was supported by operating grants RGPIN155172 and F-RGPAS38028 to REM from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). DFP was supported by an NSERC Post Graduate Scholarship. MM and HO were supported by NSERC Undergraduate Research Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1991, Bollettino Societa Italiana Biologia Sperimentale, V67, P213; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; Jansen HT, 2012, CHRONOBIOL INT, V29, P454, DOI 10.3109/07420528.2012.667467; Koeltzow TE, 2005, BEHAV BRAIN RES, V160, P250, DOI 10.1016/j.bbr.2004.12.005; Landry GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040895; Liu YY, 2012, J BIOL RHYTHM, V27, P398, DOI 10.1177/0748730412455913; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062463; Natsubori A, 2013, EUR J NEUROSCI, V37, P251, DOI 10.1111/ejn.12034; Pendergast JS, 2012, P NATL ACAD SCI USA, V109, P14218, DOI 10.1073/pnas.1206213109; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2012, J MOL NEUROSCI, V46, P258, DOI 10.1007/s12031-011-9529-z; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	37	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82381	10.1371/journal.pone.0082381	http://dx.doi.org/10.1371/journal.pone.0082381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312417	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300078
J	Luu, HN; Amirian, ES; Beasley, RP; Piller, L; Chan, WY; Scheurer, ME				Luu, Hung N.; Amirian, E. Susan; Beasley, R. Palmer; Piller, Linda; Chan, Wenyaw; Scheurer, Michael E.			Clinical Implications of the Cervical Papanicolaou Test Results in the Management of Anal Warts in HIV-Infected Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; NEGATIVE HOMOSEXUAL-MEN; POSITIVE WOMEN; GENITAL WARTS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; INTERAGENCY HIV; PREVALENCE	The Papanicolaou test (or Pap test) has long been used as a screening tool to detect cervical precancerous/cancerous lesions. However, studies on the use of this test to predict both the presence and change in size of genital warts are limited. We examined whether cervical Papanicolaou test results are associated with the size of the largest anal wart over time in HIV-infected women in an on-going cohort study in the US. A sample of 976 HIV-infected women included in a public dataset obtained from the Women's Interagency HIV Study (WIHS) was selected for analysis. A linear mixed model was performed to determine the relationship between the size of anal warts and cervical Pap test results. About 32% of participants had abnormal cervical Pap test results at baseline. In the adjusted model, a woman with a result of Atypia Squamous Cell Undetermined Significance/Low-grade Squamous Intraepithelial Lesion (ASCUS/LSIL) had an anal wart, on average, 12.81 mm(2) larger than a woman with normal cervical cytology. The growth rate of the largest anal wart after each visit in a woman with ASCUS/LSIL was 1.56 mm(2) slower than that of a woman with normal cervical results. However, they were not significant (P = 0.54 and P = 0.82, respectively). This is the first study to examine the relationship between cervical Pap test results and anal wart development in HIV-infected women. Even though no association between the size of anal wart and cervical Pap test results was found, a screening program using anal cytology testing in HIV-infected women should be considered. Further studies in cost-effectiveness and efficacy of an anal cytology test screening program are warranted.	[Luu, Hung N.; Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Luu, Hung N.; Beasley, R. Palmer; Piller, Linda] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chan, Wenyaw] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Luu, HN (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	hnluu@bcm.edu; scheurer@bcm.edu		Scheurer, Michael/0000-0002-8379-6088	Vietnam Education Foundation (VEF) under VEF Fellowship; National Institutes of Health/Fogarty Training Fellowship through the Center for International Training and Research (CITAR) [D43-TW007669]; School of Public Health, the University of Texas Health Science Center at Houston; University of Texas Health Science Center at Houston; UTHealth Innovation for Cancer Prevention Research; University of Texas School of Public Health-Cancer Prevention and Research Institute of Texas [RP101503]; Dan L. Duncan Cancer Center Scholar Award; FOGARTY INTERNATIONAL CENTER [D43TW007669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Vietnam Education Foundation (VEF) under VEF Fellowship; National Institutes of Health/Fogarty Training Fellowship through the Center for International Training and Research (CITAR); School of Public Health, the University of Texas Health Science Center at Houston; University of Texas Health Science Center at Houston; UTHealth Innovation for Cancer Prevention Research; University of Texas School of Public Health-Cancer Prevention and Research Institute of Texas; Dan L. Duncan Cancer Center Scholar Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work were supported by the Vietnam Education Foundation (VEF) under VEF Fellowship and National Institutes of Health/Fogarty Training Fellowship - D43-TW007669 through the Center for International Training and Research (CITAR), School of Public Health, the University of Texas Health Science Center at Houston, the University of Texas Health Science Center at Houston, and UTHealth Innovation for Cancer Prevention Research Pre- and Post-Doctoral Fellowship, The University of Texas School of Public Health-Cancer Prevention and Research Institute of Texas grant number RP101503 (to HNL) and in part by a Dan L. Duncan Cancer Center Scholar Award (to MES). The content is solely responsibility of the authors and does not necessarily represent official views of the Cancer Prevention and Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh-Grant L, 2004, JNCI-J NATL CANCER I, V96, P1070, DOI 10.1093/jnci/djh192; [Anonymous], 2000, SAS VERS 9 2; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Balding DJ, 2004, APPL LONGITUDINAL AN; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Beutner KR, 1998, CLIN INFECT DIS, V27, P796, DOI 10.1086/514964; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Chandler M G, 1996, Br J Nurs, V5, P174; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; FRISCH M, 1994, AM J EPIDEMIOL, V140, P12, DOI 10.1093/oxfordjournals.aje.a117154; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Goodman MT, 2010, J INFECT DIS, V201, P1331, DOI 10.1086/651620; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; Hernandez BY, 2005, CANCER EPIDEM BIOMAR, V14, P2550, DOI 10.1158/1055-9965.EPI-05-0460; Hessol NA, 2009, AIDS, V23, P59, DOI 10.1097/QAD.0b013e32831cc101; Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Kanno MB, 2005, INT J STD AIDS, V16, P549, DOI 10.1258/0956462054679160; KOUTSKY LA, 1988, EPIDEMIOL REV, V10, P122, DOI 10.1093/oxfordjournals.epirev.a036020; Lacey CJN, 2005, J CLIN VIROL, V32, pS82, DOI 10.1016/j.jcv.2004.10.020; Luu HN, 2012, J INFECT DIS, V205, P578, DOI 10.1093/infdis/jir813; Massad LS, 2008, OBSTET GYNECOL, V111, P1388, DOI 10.1097/AOG.0b013e3181744619; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; MELBYE M, 1991, LANCET, V338, P657, DOI 10.1016/0140-6736(91)91233-K; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; New York State Department of Health and AIDS Institute, 2007, UPD AN DYSPL CANC 20; Notermans DW, 2000, AIDS RES HUM RETROV, V16, P1507, DOI 10.1089/088922200750006038; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Palefsky JM, 1998, J ACQ IMMUN DEF SYND, V17, P314, DOI 10.1097/00042560-199804010-00004; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky Joel, 2002, AIDS Clin Care, V14, P44; RABKIN CS, 1992, AM J EPIDEMIOL, V136, P54, DOI 10.1093/oxfordjournals.aje.a116420; ROWEN D, 1991, GENITOURIN MED, V67, P460; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Vandepapeliere P, 2005, J INFECT DIS, V192, P2099, DOI 10.1086/498164; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 1993, ACTA CYTOL, V37, P115	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81751	10.1371/journal.pone.0081751	http://dx.doi.org/10.1371/journal.pone.0081751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312348	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900048
J	Otwombe, KN; Laher, F; Tutu-Gxashe, T; Gray, G; Mohapi, L				Otwombe, Kennedy N.; Laher, Fatima; Tutu-Gxashe, Thandeka; Gray, Glenda; Mohapi, Lerato			The Effect of a Maturing Antiretroviral Program on Early Mortality for Patients with Advanced Immune-Suppression in Soweto, South Africa	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; THERAPY; PREDICTORS; ADULTS; COUNT; START	Objective: We hypothesize that time to initiate care and maturity of a treatment program impact on outcome of severely immuno-compromised patients with higher risk of mortality. Design: We conducted a retrospective cohort analysis at the Perinatal HIV Research Unit Adult ART clinic, Soweto, South Africa. Methods: Eligibility criteria for this analysis were: attendance for minimum one visit between August 2004 and August 2010, age >= 18 years, CD4 count <= 50 cells/mm(3) and ART-naive at screening. We followed participants up to one year after ART initiation. We defined years 2004-2007 and 2008-2010 as the early and late eras respectively. Chi-square test and survival analysis methods were used for mortality comparisons between eras. Results: Of 2357 patients eligible for antiretroviral treatment, 395 (17%) had CD4 counts <= 50 cells/mm(3) and ART-naive at screening. Overall 261 (66%) were women. Patients had similar median age (35 vs. 33.5 years, p=0.08), time to HAART initiation (7 days, p=0.18) and baseline CD4 count (20 vs. 23 cells/mm3, p=0.5) between eras. Overall 63 (16%) patients died in their first year of treatment (2 per 100 person-months) and the main cause of death was tuberculosis (n=23, 37%). The proportion of deaths (52/262 vs. 11/133, p=0.003) and time to death from enrolment (logrank p=0.04) were significantly different between eras. Conclusion: Mortality decreased as the ART program matured in Soweto while time to initiation of treatment remained similar in both eras. Because ART guidelines were consistent during both eras, it is possible that with time, management of patients improved as expertise was gained.	[Otwombe, Kennedy N.; Laher, Fatima; Tutu-Gxashe, Thandeka; Gray, Glenda; Mohapi, Lerato] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, Gauteng, South Africa	University of Witwatersrand	Otwombe, KN (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, Gauteng, South Africa.	otwombek@phru.co.za			South African National Department of Health and USAID/PEPFAR; Canada-Africa Prevention Trials Network (CAPT)	South African National Department of Health and USAID/PEPFAR(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canada-Africa Prevention Trials Network (CAPT)	The authors gratefully acknowledge the South African National Department of Health and USAID/PEPFAR for funding the adult treatment clinic. The first author is a fellow of the Consortium for Advanced Research Training in Africa (CARTA) and has received funding support from the Canada-Africa Prevention Trials Network (CAPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; [Anonymous], GLOB HIV AIDS RESP; [Anonymous], 2011, WORLD AIDS DAY REP; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; DoH, 2010, S AFR ANT TREATM GUI; DoH, 2004, S AFR ANT TREATM GUI; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hoffmann CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P269, DOI 10.1097/QAI.0b013e31823219d1; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Jung AC, 1998, J GEN INTERN MED, V13, P131, DOI 10.1046/j.1525-1497.1998.00031.x; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kouanda S, 2012, AIDS CARE, V24, P478, DOI 10.1080/09540121.2011.630353; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Mujugira A, 2009, AIDS RES HUM RETROV, V25, P127, DOI 10.1089/aid.2008.0172; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Smit C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001949; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2010, REP GLOB AIDS EP; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81538	10.1371/journal.pone.0081538	http://dx.doi.org/10.1371/journal.pone.0081538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312317	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900039
J	Han, B; Li, J; Li, ZL; Guo, L; Wang, S; Liu, PS; Wu, YJ				Han, Bing; Li, Jing; Li, Zhilong; Guo, Ling; Wang, Shan; Liu, Peishu; Wu, Yaojiong			Trichostatin A Stabilizes the Expression of Pluripotent Genes in Human Mesenchymal Stem Cells during Ex Vivo Expansion	PLOS ONE			English	Article							STROMAL CELLS; DIFFERENTIATION	Background: Mesenchymal stem cells (MSCs) have been considered as ideal cells for the treatment of a variety of diseases. However, aging and spontaneous differentiation of MSCs during culture expansion dampen their effectiveness. Previous studies suggest that ex vivo aging of MSCs is largely caused by epigenetic changes particularly a decline of histone H3 acetylation levels in promoter regions of pluripotent genes due to inappropriate growth environment. Methodology/Principal Findings: In this study, we examined whether histone deacetylase inhibitor trichostatin A (TSA) could suppress the histone H3 deacetylation thus maintaining the primitive property of MSCs. We found that in regular adherent culture, human MSCs became flatter and larger upon successive passaging, while the expression of pluripotent genes such as Oct4, Sox2, Nanog, Rex-1, CD133 and TERT decreased markedly. Administration of low concentrations of TSA in culture significantly suppressed the morphological changes in MSCs otherwise occurred during culture expansion, increased their proliferation while retaining their cell contact growth inhibition property and multipotent differentiation ability. Moreover, TSA stabilized the expression of the above pluripotent genes and histone H3 acetylation levels in K9 and K14 in promoter regions of Oct4, Sox2 and TERT. Conclusions/Significance: Our results suggest that TSA may serve as an effective culture additive to maintain the primitive feature of MSCs during culture expansion.	[Han, Bing; Li, Jing; Liu, Peishu] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China; [Li, Jing; Li, Zhilong; Guo, Ling; Wang, Shan; Wu, Yaojiong] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Hlth Sci & Technol, Shenzhen 518057, Peoples R China; [Wang, Shan] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Shandong University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University	Wu, YJ (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Hlth Sci & Technol, Shenzhen 518057, Peoples R China.	wu.yaojiong@sz.tsinghua.edu.cn			Natural Science Foundation of China [30971496, U1032003]; "863 Projects" of Ministry of Science and Technology of PR China [2011AA020118]; Shenzhen Science and Technology Innovation Committee [JC201005280597A, GJHZ20120614194251967]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863 Projects" of Ministry of Science and Technology of PR China; Shenzhen Science and Technology Innovation Committee	This work was supported by grants from Natural Science Foundation of China (No. 30971496, U1032003), the "863 Projects" of Ministry of Science and Technology of PR China (No. 2011AA020118) and Shenzhen Science and Technology Innovation Committee (JC201005280597A, GJHZ20120614194251967) to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; Philippe B, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/503593; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Tan J, 2008, J GENET GENOMICS, V35, P585, DOI 10.1016/S1673-8527(08)60079-X; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yannarelli G, 2013, STEM CELLS, V31, P215, DOI 10.1002/stem.1262	23	20	22	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81781	10.1371/journal.pone.0081781	http://dx.doi.org/10.1371/journal.pone.0081781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312356	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100097
J	Hunt, T; Williams, MT; Olds, TS				Hunt, Toby; Williams, Marie T.; Olds, Tim S.			Reliability and Validity of the Multimedia Activity Recall in Children and Adults (MARCA) in People with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; SEDENTARY BEHAVIORS; INSULIN-RESISTANCE; ACTIVITY MONITORS; COMPUTERIZED USE; TIME RECALL; DAILY-LIFE; HEALTH; MODERATE	Objective: To determine the reliability and validity of the Multimedia Activity Recall for Children and Adults (MARCA) in people with chronic obstructive pulmonary disease (COPD). Design: People with COPD and their carers completed the Multimedia Activity Recall for Children and Adults (MARCA) for four, 24-hour periods (including test-retest of 2 days) while wearing a triaxial accelerometer (Actigraph GT3X+(R)), a multi-sensor armband (Sensewear Pro3 (R)) and a pedometer (New Lifestyles 1000 (R)). Setting: Self reported activity recalls (MARCA) and objective activity monitoring (Accelerometry) were recorded under free-living conditions. Participants: 24 couples were included in the analysis (COPD; age 74.4 +/- 7.9 yrs, FEV1 54 +/- 13% Carer; age 69.6 +/- 10.9 yrs, FEV1 99 +/- 24%). Interventions: Not applicable. Main Outcome Measure(s): Test-retest reliability was compared for MARCA activity domains and different energy expenditure zones. Validity was assessed between MARCA-derived physical activity level (in metabolic equivalent of task (MET) per minute), duration of moderate to vigorous physical activity (min) and related data from the objective measurement devices. Analysis included intra-class correlation coefficients (ICC), Bland-Altman analyses, paired t-tests (p) and Spearman's rank correlation coefficients (r(s)). Results: Reliability between occasions of recall for all activity domains was uniformly high, with test-retest correlations consistently >0.9. Validity correlations were moderate to strong (r(s) = 0.43-0.80) across all comparisons. The MARCA yields comparable PAL estimates and slightly higher moderate to vigorous physical activity (MVPA) estimates. Conclusion: In older adults with chronic illness, the MARCA is a valid and reliable tool for capturing not only the time and energy expenditure associated with physical and sedentary activities but also information on the types of activities.	[Hunt, Toby] Univ S Australia, Hlth & Use Time Grp, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Hunt, Toby] Repatriat Gen Hosp, Resp Clin Res Unit, Daw Pk, SA, Australia; [Williams, Marie T.] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Williams, Marie T.] Univ S Australia, Ctr Nutr Physiol, Adelaide, SA 5001, Australia	University of South Australia; University of South Australia; University of South Australia	Hunt, T (corresponding author), Univ S Australia, Hlth & Use Time Grp, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	toby.hunt@health.sa.gov.au	Williams, Marie T/C-8152-2009; Olds, Tim/A-1223-2008	Williams, Marie T/0000-0002-0473-5157; Olds, Tim/0000-0001-6894-5519	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Toby Hunt reports receiving honoraria for consultancy work and travel costs associated with Boehringer Ingelheim's clinical research programs. Other Authors: Marie Therese Williams reports receiving speaking fee honoraria and associated travel costs. Tim Olds reports receiving speaking fee honoraria and associated travel costs. These competing interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bassett DR, 2000, MED SCI SPORT EXER, V32, pS471, DOI 10.1097/00005768-200009001-00006; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Bossenbroek L, 2011, COPD, V8, P306, DOI 10.3109/15412555.2011.578601; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; Dinger MK, 2006, MED SCI SPORT EXER, V38, P774, DOI 10.1249/01.mss.0000210191.72081.43; Donaire-Gonzalez D, 2012, EUROPEAN RESP J; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Foley L, 2012, OBES REV, V13, P711, DOI 10.1111/j.1467-789X.2012.00993.x; Foley LS, 2013, METABOLISM, V62, P163, DOI 10.1016/j.metabol.2012.07.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gomersall SR, 2011, J SCI MED SPORT, V14, P143, DOI 10.1016/j.jsams.2010.08.006; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; Harvey SB, 2010, BRIT J PSYCHIAT, V197, P357, DOI 10.1192/bjp.bp.109.075176; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Joint FAO, 1985, EN PROT REQ REP JOIN; KLINK M, 1987, CHEST, V91, P540, DOI 10.1378/chest.91.4.540; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; Li YQ, 2006, SOC FORCES, V85, P497, DOI 10.1353/sof.2006.0132; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; McMinn D, 2010, MEAS PHYS EDUC EXERC, V14, P67, DOI 10.1080/10913671003715516; MOORE JA, 1988, CHEST, V94, P1260, DOI 10.1378/chest.94.6.1260; Olds TS, 2010, PEDIATR EXERC SCI, V22, P34, DOI 10.1123/pes.22.1.34; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2005, ARCH PHYS MED REHAB, V86, P1979, DOI 10.1016/j.apmr.2005.04.016; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ridley K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-10; Robinson J., 1999, TIME LIFE SURPRISING, V2nd; Schwarzer R., 1989, PSYCHOL HEALTH, V3, P1, DOI DOI 10.1080/08870448908400361; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; van Gestel AJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048081; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608	53	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81274	10.1371/journal.pone.0081274	http://dx.doi.org/10.1371/journal.pone.0081274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312284	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327652100068
J	Little, DP; Knopf, P; Schulz, C				Little, Damon P.; Knopf, Patrick; Schulz, Christian			DNA Barcode Identification of Podocarpaceae-The Second Largest Conifer Family	PLOS ONE			English	Article							CYTOTOXIC NORDITERPENE DILACTONES; CUTICLE MICROMORPHOLOGY; SEQUENCE QUALITY; LEAVES; PCR; MILANJIANUS; PARASITAXUS; ALGORITHMS; ALIGNMENT; AGENTS	We have generated matK, rbcL, and nrITS2 DNA barcodes for 320 specimens representing all 18 extant genera of the conifer family Podocarpaceae. The sample includes 145 of the 198 recognized species. Comparative analyses of sequence quality and species discrimination were conducted on the 159 individuals from which all three markers were recovered (representing 15 genera and 97 species). The vast majority of sequences were of high quality (B-30 = 0.596-0.989). Even the lowest quality sequences exceeded the minimum requirements of the BARCODE data standard. In the few instances that low quality sequences were generated, the responsible mechanism could not be discerned. There were no statistically significant differences in the discriminatory power of markers or marker combinations (p = 0.05). The discriminatory power of the barcode markers individually and in combination is low (56.7% of species at maximum). In some instances, species discrimination failed in spite of ostensibly useful variation being present (genotypes were shared among species), but in many cases there was simply an absence of sequence variation. Barcode gaps (maximum intraspecific p-distance > minimum interspecific p-distance) were observed in 50.5% of species when all three markers were considered simultaneously. The presence of a barcode gap was not predictive of discrimination success (p = 0.02) and there was no statistically significant difference in the frequency of barcode gaps among markers (p = 0.05). In addition, there was no correlation between number of individuals sampled per species and the presence of a barcode gap (p = 0.27).	[Little, Damon P.] New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA; [Knopf, Patrick; Schulz, Christian] Ruhr Univ Bochum, Lehrstuhl Evolut & Biodiversitat Pflanzen, Bochum, Nordrhein Westf, Germany	New York Botanical Garden; Ruhr University Bochum	Little, DP (corresponding author), New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA.	dlittle@nybg.org			Alfred P. Sloan Foundation [2010-6-02]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funding from the Alfred P. Sloan Foundation (http://www.sloan.org/; 2010-6-02) to DPL is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi HS, 2008, J ETHNOPHARMACOL, V119, P191, DOI 10.1016/j.jep.2008.06.023; Abdillahi HS, 2008, S AFR J BOT, V74, P359, DOI 10.1016/j.sajb.2008.01.024; Abdillahi HS, 2010, S AFR J BOT, V76, P1, DOI 10.1016/j.sajb.2009.09.002; Abdillahi HS, 2012, J ETHNOPHARMACOL, V139, P728, DOI 10.1016/j.jep.2011.11.044; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Baker DA, 2012, J AOAC INT, V95, P1023, DOI 10.5740/jaoacint.11-261; BAUCH J, 1977, HOLZFORSCHUNG, V31, P1, DOI 10.1515/hfsg.1977.31.1.1; Bergin DO, 2000, NEW ZEAL J BOT, V38, P343; Biffin Edward, 2011, Smithsonian Contributions to Botany, P1; Buchholz J. T., 1948, Journal of the Arnold Arboretum, V29, P123; Buchholz John T., 1948, JOUR ARNOLD ARBORETUM, V29, P64; Buchholz JT, 1948, J ARNOLD ARBORETUM, V29, P46; Cernusak Lucas A., 2011, Smithsonian Contributions to Botany, P189; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; CITES, 2012, CONV INT TRAD END SP; COCKAYNE L, 1919, NZ PLANTS THEIR STOR; Conran JG, 2000, AUST J BOT, V48, P715, DOI 10.1071/BT99062; DALLIMORE W, 1967, HDB CONIFERAE GINKGO; de Laubenfels D. J., 1988, FLORA MALESIANA, V10, P337; de Mendiburu F, 2012, AGRICOLAE VERSION 1; DELAUBEN.DJ, 1969, J ARNOLD ARBORETUM, V50, P315; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facciola S., 1990, CORNUCOPIA SOURCE BO; Farjon A, 2001, WORLD CHECKLIST BIBL; Farjon A, 2008, NATURAL HIST CONIFER; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARRIS JS, 1974, SYST ZOOL, V23, P548, DOI 10.2307/2412474; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fu L, 1994, FLORA CHINA, V4, P78; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gray N. E., 1951, Journal of the Arnold Arboretum, V32, P93; Gray N. E., 1960, Journal of the Arnold Arboretum, V41, P36; Gray N. E., 1962, Journal of the Arnold Arboretum, V43, P67; Gray N. E., 1948, Journal of the Arnold Arboretum, V29, P117; Gray N. E., 1953, Journal of the Arnold Arboretum, V34, P163; Gray N. E., 1953, Journal of the Arnold Arboretum, V34, P67; Gray N. E., 1958, Journal of the Arnold Arboretum, V39, P424; Gray N. E., 1956, Journal of the Arnold Arboretum, V37, P160; Gray N. E., 1955, Journal of the Arnold Arboretum, V36, P199; GRAY NETTA E., 1951, JOUR ARNOLD ARB, V32, P82; Hanner R, 2009, TECHNICAL REPORT; Harrell FE, 2012, HMISC PACKAGE VERSIO; HAYASHI Y, 1979, GANN, V70, P365; HEMBREE JA, 1980, EXPERIENTIA, V36, P28, DOI 10.1007/BF02003950; HEMBREE JA, 1979, PHYTOCHEMISTRY, V18, P1691, DOI 10.1016/0031-9422(79)80185-5; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; IUCN, 2019, INT UNION CONSERVATI; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Kelch DG, 2002, AUST SYST BOT, V15, P29, DOI 10.1071/SB01002; Knopf P., 2007, Feddes Repertorium, V118, P51, DOI 10.1002/fedr.200711126; KNOPF P, 2011, THESIS RUHR U BOCHUM; Knopf P, 2012, CLADISTICS, V28, P271, DOI 10.1111/j.1096-0031.2011.00381.x; KUBO I, 1984, J CHEM ECOL, V10, P547, DOI 10.1007/BF00994220; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li Y, 2011, J SYST EVOL, V49, P169, DOI 10.1111/j.1759-6831.2011.00128.x; LITTLE D, 2005, 2XREAD SIMPLE INDEL; Little D. P, 2012, BRONX BARCODE RECOGN; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Little DP, 2010, BIOINFORMATICS, V26, P2780, DOI 10.1093/bioinformatics/btq507; Little DP, 2004, SYST BOT, V29, P825, DOI 10.1600/0363644042451026; MCGUFFIN M, 2000, HERBS COMMERCE; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mill RR, 2009, BOT J LINN SOC, V159, P58, DOI 10.1111/j.1095-8339.2008.00901.x; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Paradis E., 2013, APE ANAL PHYLOGENETI; Park HS, 2004, HETEROCYCLES, V63, P347; Park HS, 2003, J NAT PROD, V66, P282, DOI 10.1021/np020334x; Pesole G, 1996, METHOD ENZYMOL, V266, P281; Phillips E. W. J., 1941, JOUR LINN SOC [LONDON] BOT, V52, P259; R Development Core Team, 2012, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizopoulos D, 2013, LATENT TRAIT MODELS; RUSSELL GB, 1972, AUST J BIOL SCI, V25, P1025, DOI 10.1071/BI9721025; SAEKI I, 1970, HOLZFORSCHUNG, V24, P83, DOI 10.1515/hfsg.1970.24.3.83; Salinas NR, 2013, 2MATRIX UTILITY INDE; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.2307/2333100; Schilling DMS, 2011, INT J PLANT SCI, V172, P601, DOI 10.1086/659460; SCHOONRAAD E, 1974, PHYTOMORPHOLOGY, V24, P75; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sinclair WT, 2002, PLANT SYST EVOL, V233, P79, DOI 10.1007/s00606-002-0199-8; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; STOCKEY RA, 1992, INT J PLANT SCI, V153, P589, DOI 10.1086/297082; Stockey RA, 1998, INT J PLANT SCI, V159, P923, DOI 10.1086/297613; Stockey RA, 1997, INT J PLANT SCI, V158, P198, DOI 10.1086/297431; STOCKEY RA, 1995, INT J PLANT SCI, V156, P723, DOI 10.1086/297294; STOCKEY RA, 1990, BOT GAZ, V151, P138, DOI 10.1086/337813; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Symonds EL, 2012, BR J NUTR, V15, P1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x	99	25	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81008	10.1371/journal.pone.0081008	http://dx.doi.org/10.1371/journal.pone.0081008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312258	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100057
J	Lu, JC; Yi, LP; Zhong, H; Wei, XF				Lu, Junchang; Yi, Laiping; Zhong, Hui; Wei, Xuefang			A New Oviraptorosaur (Dinosauria: Oviraptorosauria) from the Late Cretaceous of Southern China and Its Paleoecological Implications	PLOS ONE			English	Article							BAYAN MANDAHU; THEROPODA; CHIROSTENOTES; OSTEOLOGY; EGGS	A new oviraptorosaur Nankangia jiangxiensis gen. et sp. nov. is described on the basis of a partial postcranial skeleton with a partial lower jaw collected from the Upper Cretaceous Nanxiong Formation of Ganzhou, in Jiangxi Province of southern China. The new taxon is diagnosed by: (1) a mandibular symphysis that is not turned down; (2) neural spines of the cranial caudal vertebrae that are wider transversely than anteroposteriorly, forming a large posterior fossa with rugose central areas; (3) a femoral neck extending at an angle of about 90 to the shaft; and (4) a ratio of femur to tibia length of 0.95. Phylogenetic analysis recovers Nankangia as basal to the oviraptorid Yulong, but more derived than Caenagnathus, which also has a mandibular symphysis that is not turned down. The coexistence of Nankangia jiangxiensis, Ganzhousaurus nankangensis, Jiangxisaurus ganzhouensis, an unnamed oviraptorid from Nanxiong Basin and Banji long suggests that they occupied distinct ecological niches. Nankangia may have been more herbivorous than carnivorous.	[Lu, Junchang] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Yi, Laiping; Zhong, Hui] Ganzhou Museum Nat Hist, Ganzhou, Jiangxi, Peoples R China; [Wei, Xuefang] China Geol Survey, Cores & Samples Ctr Land & Resources, Sanhe, Hebei Province, Peoples R China	Chinese Academy of Geological Sciences; China Geological Survey	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.	Lujc2008@126.com			Natural Science Foundation of China [41272022]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	J. Lu was supported by Natural Science Foundation of China grants (41272022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, T JOINT SOVIET MONGO; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Barsbold R., 1983, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, P1; BARSBOLD R, 1976, DOKL AKAD NAUK SSSR+, V226, P685; Clark James M., 1999, American Museum Novitates, V3265, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; CRACRAFT J, 1971, Journal of Paleontology, V45, P805; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Gilmore C.W., 1924, GEOLOGICAL SURVEY CA, V38, p1e12; He Tao, 2008, Vertebrata Palasiatica, V46, P178; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; [Ji Qiang 季强], 2012, [地质通报, Geological Bulletin of China], V31, P2102; Jiangxi (Bureau of Geology and Mineral Resources of Jiangxi Province), 1984, REG GEOL JIANGX PROV; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu J. C., 2005, OVIRAPTORID DINOSAUR, P208; Lu JC, 2002, J VERTEBR PALEONTOL, V22, P871, DOI 10.1671/0272-4634(2002)022[0871:ANOTOF]2.0.CO;2; Lu Jun-Chang, 2005, Acta Palaeontologica Sinica, V44, P412; Lu Junchang, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P51; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lu JC, 2013, NATURWISSENSCHAFTEN, V100, P165, DOI 10.1007/s00114-012-1007-0; Lu Junchang, 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P43; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; OSMOLSKA H, 1976, NATURE, V262, P683, DOI 10.1038/262683a0; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Smith D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V186, P365; STERNBERG R. M., 1940, JOUR PALEONTOL, V14, P81; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Wang S, 2013, ZOOTAXA, V3640, P242, DOI 10.11646/zootaxa.3640.2.7; Wei XF, 2013, ACTA GEOL SIN-ENGL, V87, P899, DOI 10.1111/1755-6724.12098; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; [徐莉 Xu li], 2012, [地质论评, Geological Review], V58, P601; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2013, Vertebrata Palasiatica, V51, P85; Xu Xing, 2010, Vertebrata Palasiatica, V48, P11; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	45	24	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80557	10.1371/journal.pone.0080557	http://dx.doi.org/10.1371/journal.pone.0080557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312233	gold, Green Submitted, Green Published			2022-12-25	WOS:000327652100048
J	Rossi, F; Bernardo, ME; Bellini, G; Luongo, L; Conforti, A; Manzo, I; Guida, F; Cristino, L; Imperatore, R; Petrosino, S; Nobili, B; Di Marzo, V; Locatelli, F; Maione, S				Rossi, Francesca; Bernardo, Maria Ester; Bellini, Giulia; Luongo, Livio; Conforti, Antonella; Manzo, Iolanda; Guida, Francesca; Cristino, Luigia; Imperatore, Roberta; Petrosino, Stefania; Nobili, Bruno; Di Marzo, Vincenzo; Locatelli, Franco; Maione, Sabatino			The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties	PLOS ONE			English	Article							THERAPY POSITION STATEMENT; HUMAN BONE-MARROW; STEM-CELLS; INTERNATIONAL-SOCIETY; CB2 RECEPTORS; EXPRESSION; CYTOKINE; SYSTEM; ACTIVATION; DISEASES	Mesenchymal stromal cells are non-hematopoietic, multipotent progenitor cells producing cytokines, chemokines, and extracellular matrix proteins that support hematopoietic stem cell survival and engraftment, influence immune effector cell development, maturation, and function, and inhibit alloreactive T-cell responses. The immunosuppressive properties of human mesenchymal stromal cells have attracted much attention from immunologists, stem cell biologists and clinicians. Recently, the presence of the endocannabinoid system in hematopoietic and neural stem cells has been demonstrated. Endocannabinoids, mainly acting through the cannabinoid receptor subtype 2, are able to modulate cytokine release and to act as immunosuppressant when added to activated T lymphocytes. In the present study, we have investigated, through a multidisciplinary approach, the involvement of the endocannabinoids in migration, viability and cytokine release of human mesenchymal stromal cells. We show, for the first time, that cultures of human mesenchymal stromal cells express all of the components of the endocannabinoid system, suggesting a potential role for the cannabinoid CB2 receptor as a mediator of anti-inflammatory properties of human mesenchymal stromal cells, as well as of their survival pathways and their capability to home and migrate towards endocannabinoid sources.	[Rossi, Francesca; Manzo, Iolanda; Nobili, Bruno] Univ Naples 2, Dept Women Child & Gen & Specialist Surg, Naples, Italy; [Rossi, Francesca; Bernardo, Maria Ester; Conforti, Antonella; Nobili, Bruno; Locatelli, Franco] IRCCS Bambino Gesu Children Hosp, Dept Oncohaematol, Rome, Italy; [Bellini, Giulia; Luongo, Livio; Manzo, Iolanda; Guida, Francesca; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Luongo, Livio; Cristino, Luigia; Imperatore, Roberta; Petrosino, Stefania; Di Marzo, Vincenzo; Maione, Sabatino] Endocannabinoid Res Grp, Naples, Italy; [Cristino, Luigia] CNR, Inst Cybernet, I-80125 Naples, Italy; [Imperatore, Roberta; Petrosino, Stefania; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, I-80125 Naples, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	Universita della Campania Vanvitelli; IRCCS Bambino Gesu; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Pavia	Rossi, F (corresponding author), Univ Naples 2, Dept Women Child & Gen & Specialist Surg, Naples, Italy.	fra.rossi76@libero.it	Luongo, Livio/GXV-1993-2022; Conforti, Antonella/H-2209-2012; Cristino, Luigia/AAE-3934-2020; Di Marzo, Vincenzo/AAD-7742-2019	Conforti, Antonella/0000-0001-8524-5936; Cristino, Luigia/0000-0002-0182-4699; Di Marzo, Vincenzo/0000-0002-1490-3070; Luongo, Livio/0000-0002-1949-2039; IMPERATORE, Roberta/0000-0003-3609-2771; Maione, Sabatino/0000-0003-3850-6704; Rossi, Francesca/0000-0003-2879-6277				Bari M, 2011, STEM CELLS DEV, V20, P139, DOI 10.1089/scd.2009.0515; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Compagnucci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054271; Contartese A, 2012, PHARMACOL RES, V66, P555, DOI 10.1016/j.phrs.2012.08.003; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; De Miguel MP, 2012, CURR MOL MED, V12, P574; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Figueroa FE, 2012, BIOL RES, V45, P269, DOI 10.4067/S0716-97602012000300008; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Jiang SX, 2011, BLOOD, V117, P827, DOI 10.1182/blood-2010-01-265082; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004; Klein TW, 2000, P SOC EXP BIOL MED, V225, P1, DOI 10.1046/j.1525-1373.2000.22501.x; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Luongo L, 2010, NEUROBIOL DIS, V37, P177, DOI 10.1016/j.nbd.2009.09.021; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pistoia V, 2010, EXPERT REV CLIN IMMU, V6, P211, DOI 10.1586/ECI.09.86; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Rossi F, 2009, BONE, V44, P476, DOI 10.1016/j.bone.2008.10.056; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042259; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Rossi F, 2011, HAEMATOL-HEMATOL J, V96, P1883, DOI 10.3324/haematol.2011.045732; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Rossi F, 2011, BONE, V48, P997, DOI 10.1016/j.bone.2011.01.001; Scutt A, 2007, CALCIFIED TISSUE INT, V80, P50, DOI 10.1007/s00223-006-0171-7; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3	36	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80022	10.1371/journal.pone.0080022	http://dx.doi.org/10.1371/journal.pone.0080022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312195	Green Published, gold			2022-12-25	WOS:000327652100021
J	Schittenhelm, MM; Illing, B; Ahmut, F; Rasp, KH; Blumenstock, G; Dohner, K; Lopez, CD; Kampa-Schittenhelm, KM				Schittenhelm, Marcus M.; Illing, Barbara; Ahmut, Figen; Rasp, Katharina Henriette; Blumenstock, Gunnar; Doehner, Konstanze; Lopez, Charles D.; Kampa-Schittenhelm, Kerstin M.			Attenuated Expression of Apoptosis Stimulating Protein of p53-2 (ASPP2) in Human Acute Leukemia Is Associated with Therapy Failure	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR GENE; TP53 MUTATIONS; ASPP2/(53BP2L); ACTIVATION; COMPLEXITY; INHIBITOR; CELL; RAS	Inactivation of the p53 pathway is a universal event in human cancers and promotes tumorigenesis and resistance to chemotherapy. Inactivating p53 mutations are uncommon in non-complex karyotype leukemias, thus the p53-pathway must be inactivated by other mechanisms. The Apoptosis Stimulating Protein of p53-2 (ASPP2) is a damage-inducible p53-binding protein that enhances apoptosis at least in part through a p53-mediated pathway. We have previously shown, that ASPP2 is an independent haploinsufficient tumor suppressor in vivo. Now, we reveal that ASPP2 expression is significantly attenuated in acute myeloid and lymphoid leukemia - especially in patients with an unfavorable prognostic risk profile and patients who fail induction chemotherapy. In line, knock down of ASPP2 in expressing leukemia cell lines and native leukemic blasts attenuates damage-induced apoptosis. Furthermore, cultured blasts derived from high-risk leukemias fail to induce ASPP2 expression upon anthracycline treatment. The mechanisms of ASPP2 dysregulation are unknown. We provide evidence that attenuation of ASPP2 is caused by hypermethylation of the promoter and 5'UTR regions in native leukemia blasts. Together, our results suggest that ASPP2 contributes to the biology of leukemia and expression should be further explored as a potential prognostic and/or predictive biomarker to monitor therapy responses in acute leukemia.	[Schittenhelm, Marcus M.; Illing, Barbara; Ahmut, Figen; Rasp, Katharina Henriette; Kampa-Schittenhelm, Kerstin M.] Univ Tubingen Hosp, Dept Hematol Oncol Rheumatol Immunol & Pulmol, Tubingen, Germany; [Blumenstock, Gunnar] Univ Tubingen, Dept Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Doehner, Konstanze] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Lopez, Charles D.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Dept Med, Portland, OR 97201 USA; [Lopez, Charles D.] OHSU Knight Canc Inst, Portland, OR USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ulm University; Oregon Health & Science University; Oregon Health & Science University	Kampa-Schittenhelm, KM (corresponding author), Univ Tubingen Hosp, Dept Hematol Oncol Rheumatol Immunol & Pulmol, Tubingen, Germany.	kerstin.kampa-schittenhelm@med.uni-tuebingen.de		Kampa-Schittenhelm, Kerstin/0000-0003-0958-5140	Deutsche Krebshilfe Foundation; IZKF Program of the Medical Faculty Tubingen; Jose Carreras Scholarship Program	Deutsche Krebshilfe Foundation(Deutsche Krebshilfe); IZKF Program of the Medical Faculty Tubingen; Jose Carreras Scholarship Program	Grant support for this study in part by the Deutsche Krebshilfe Foundation (MMS, KKS), the IZKF Program of the Medical Faculty Tubingen (MMS) and the Jose Carreras Scholarship Program (KKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Edlund K, 2012, P NATL ACAD SCI USA, V109, P9551, DOI 10.1073/pnas.1200019109; Haferlach T., 2008, HEMATOL-AM SOC HEMAT, V2008, P400; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Joannides M, 2010, CLIN TRANSL ONCOL, V12, P8, DOI 10.1007/s12094-010-0460-5; Kampa KM, 2009, CELL CYCLE, V8, P2871, DOI 10.4161/cc.8.18.9474; Kampa KM, 2009, P NATL ACAD SCI USA, V106, P4390, DOI 10.1073/pnas.0809080106; KANEKO H, 1995, BLOOD, V85, P2189, DOI 10.1182/blood.V85.8.2189.bloodjournal8582189; KELMAN Z, 1989, BLOOD, V74, P2318; LAUMANN R, 1992, LEUKEMIA, V6, P227; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Lossos IS, 2002, LEUKEMIA LYMPHOMA, V43, P2309, DOI 10.1080/1042819021000040017; Misawa S, 1996, LEUKEMIA LYMPHOMA, V23, P417, DOI 10.3109/10428199609054848; Padua RA, 1998, LEUKEMIA, V12, P887, DOI 10.1038/sj.leu.2401044; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rollig C, 2011, J CLIN ONCOL, V29, P2758, DOI 10.1200/JCO.2010.32.8500; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schittenhelm MM, 2009, CELL CYCLE, V8, P2621, DOI 10.4161/cc.8.16.9355; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Seifert H, 2009, LEUKEMIA, V23, P656, DOI 10.1038/leu.2008.375; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XD, 2011, CELL DEATH DIFFER, V18, P304, DOI 10.1038/cdd.2010.101; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wang ZP, 2013, P NATL ACAD SCI USA, V110, P312, DOI 10.1073/pnas.1201514110; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	36	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80193	10.1371/journal.pone.0080193	http://dx.doi.org/10.1371/journal.pone.0080193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312201	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100026
J	Unterrainer, JM; Ruh, N; Loosli, SV; Heinze, K; Rahm, B; Kaller, CP				Unterrainer, Josef M.; Ruh, Nina; Loosli, Sandra V.; Heinze, Katharina; Rahm, Benjamin; Kaller, Christoph P.			Planning Steps Forward in Development: In Girls Earlier than in Boys	PLOS ONE			English	Article							HUMAN CORTICAL DEVELOPMENT; EXECUTIVE FUNCTIONS; SEX-DIFFERENCES; PREFRONTAL CORTEX; TOWER; CHILDHOOD; LONDON; TASK; PRESCHOOLERS; CHILDREN	The development of planning ability in children initially aged four and five was examined longitudinally with a retest-interval of 12 months using the Tower of London task. As expected, problems to solve straightforward without mental look-ahead were mastered by most, even the youngest children. Problems demanding look-ahead were more difficult and accuracy improved significantly with age and over time. This development was strongly moderated by sex: In contrast to coeval boys, four year old girls showed an impressive performance enhancement at age five, reaching the performance of six year olds, whereas four year old boys lagged behind and caught up with girls at the age of six, the typical age of school enrollment. This sex-specific development of planning was clearly separated from overall intelligence: young boys showed a steeper increase in raw intelligence scores than girls, whereas in the older groups scores developed similarly. The observed sex differences in planning development are evident even within a narrow time window of twelve months and may relate to differences in maturational trajectories for girls and boys in dorsolateral prefrontal cortex.	[Unterrainer, Josef M.; Rahm, Benjamin] Univ Med Ctr Mainz, Mainz, Germany; [Ruh, Nina; Loosli, Sandra V.; Heinze, Katharina; Kaller, Christoph P.] Univ Freiburg, Dept Neurol, Univ Med Ctr, D-79106 Freiburg, Germany; [Ruh, Nina; Loosli, Sandra V.; Heinze, Katharina; Kaller, Christoph P.] Univ Freiburg, Freiburg Brain Imaging Ctr, D-79106 Freiburg, Germany; [Heinze, Katharina] Univ Hosp Erlangen, Cochlear Implant Ctr Erlangen, ENT Dept, Erlangen, Germany	Johannes Gutenberg University of Mainz; University of Freiburg; University of Freiburg; University of Erlangen Nuremberg	Unterrainer, JM (corresponding author), Univ Med Ctr Mainz, Mainz, Germany.	unterrai@uni-mainz.de		Heinze-Kohler, Katharina/0000-0001-7538-8415; Kaller, Christoph/0000-0003-1206-889X	German Federal Ministry of Education and Research (BMBF) [01GW0710]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was supported by the German Federal Ministry of Education and Research (BMBF; grant number 01GW0710) (http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2011, CHILD DEV, V82, P1501, DOI 10.1111/j.1467-8624.2011.01613.x; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Bohm B, 2004, ACTA PAEDIATR, V93, P1363, DOI 10.1080/08035250410021379; Bornstein M.H., 2004, FIRST LANG, V24, P267, DOI [10.1177/0142723704045681, DOI 10.1177/0142723704045681]; Cheetham JM, 2012, BRIT J PSYCHOL, V103, P98, DOI 10.1111/j.2044-8295.2011.02049.x; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Ferrer E, 2009, FRONT NEUROSCI-SWITZ, V3, P46, DOI 10.3389/neuro.01.003.2009; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilhooly KJ., 2002, THINK REASONING, V8, P165, DOI [10.1080/13546780244000006, DOI 10.1080/13546780244000006]; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hahn N, 2010, J COGNITIVE NEUROSCI, V22, P1244, DOI 10.1162/jocn.2009.21236; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Hucker HO, 2002, COLOURED PROGR MATRI; Hughes C, 2010, DEV NEUROPSYCHOL, V35, P20, DOI 10.1080/87565640903325691; Kaller CP, 2008, BRAIN COGNITION, V67, P360, DOI 10.1016/j.bandc.2008.02.003; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Kaller CP, 2010, 2010 ANN M ORG HUM B; KIMURA D, 1992, SCI AM, V267, P119; KLAHR D, 1981, COGNITIVE PSYCHOL, V13, P113, DOI 10.1016/0010-0285(81)90006-2; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; McCormack T, 2011, DEV REV, V31, P1, DOI 10.1016/j.dr.2011.02.002; McKinlay A, 2008, NEUROPSYCHOLOGIA, V46, P384, DOI 10.1016/j.neuropsychologia.2007.08.018; Meltzer L., 2007, EXECUTIVE FUNCTION E; Moriguchi Y, 2011, DEV COGN NEUROS-NETH, V1, P153, DOI 10.1016/j.dcn.2010.12.004; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Silverman IW, 2003, DEV REV, V23, P219, DOI 10.1016/S0273-2297(03)00012-1; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Stevenson JC, 2000, HUM NATURE-INT BIOS, V11, P405, DOI 10.1007/s12110-000-1010-6; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Ward G, 2005, CURR ISS THINK REASO, P1; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483	40	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80772	10.1371/journal.pone.0080772	http://dx.doi.org/10.1371/journal.pone.0080772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312240	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100052
J	Abassi, ZA; Okun-Gurevich, M; Abu Salah, N; Awad, H; Mandel, Y; Campino, G; Mahajna, A; Feuerstein, GZ; Fitzpatrick, M; Hoffman, A; Winaver, J				Abassi, Zaid A.; Okun-Gurevich, Marina; Abu Salah, Niroz; Awad, Hoda; Mandel, Yossi; Campino, Gadi; Mahajna, Ahmad; Feuerstein, Giora Z.; Fitzpatrick, Mike; Hoffman, Aaron; Winaver, Joseph			Potential Early Predictors for Outcomes of Experimental Hemorrhagic Shock Induced by Uncontrolled Internal Bleeding in Rats	PLOS ONE			English	Article							MASSIVE SPLENIC INJURY; TRAUMA PATIENTS; SWINE MODEL; RESUSCITATION; DEATH; LACTATE; MORTALITY; SEVERITY; SALINE	Uncontrolled hemorrhage, resulting from traumatic injuries, continues to be the leading cause of death in civilian and military environments. Hemorrhagic deaths usually occur within the first 6 hours of admission to hospital; therefore, early prehospital identification of patients who are at risk for developing shock may improve survival. The aims of the current study were: 1. To establish and characterize a unique model of uncontrolled internal hemorrhage induced by massive renal injury (MRI), of different degrees (20-35% unilateral nephrectomy) in rats, 2. To identify early biomarkers those best predict the outcome of severe internal hemorrhage. For this purpose, male Sprague Dawley rats were anesthetized and cannulas were inserted into the trachea and carotid artery. After abdominal laparotomy, the lower pole of the kidney was excised. During 120 minutes, hematocrit, pO(2), pCO(2), base excess, potassium, lactate and glucose were measured from blood samples, and mean arterial pressure (MAP) was measured through arterial tracing. After 120 minutes, blood loss was determined. Statistical prediction models of mortality and amount of blood loss were performed. In this model, the lowest blood loss and mortality rate were observed in the group with 20% nephrectomy. Escalation of the extent of nephrectomy to 25% and 30% significantly increased blood loss and mortality rate. Two phases of hemodynamic and biochemical response to MRI were noticed: the primary phase, occurring during the first 15 minutes after injury, and the secondary phase, beginning 30 minutes after the induction of bleeding. A Significant correlation between early blood loss and mean arterial pressure (MAP) decrements and survival were noted. Our data also indicate that prediction of outcome was attainable in the very early stages of blood loss, over the first 15 minutes after the injury, and that blood loss and MAP were the strongest predictors of mortality.	[Abassi, Zaid A.; Okun-Gurevich, Marina; Abu Salah, Niroz; Awad, Hoda; Winaver, Joseph] Technion, Fac Med, Dept Physiol & Biophys, Haifa, Israel; [Abassi, Zaid A.] Rambam Med Ctr, Res Unit, Haifa, Israel; [Mandel, Yossi; Campino, Gadi] Israeli Med Corps, Tel Aviv, Israel; [Mandel, Yossi] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Mahajna, Ahmad] Rambam Med Ctr, Dept Gen Surg, Haifa, Israel; [Feuerstein, Giora Z.; Fitzpatrick, Mike] Cellphire Inc, Rockville, MD USA; [Hoffman, Aaron] Rambam Med Ctr, Dept Vasc Surg, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Bar Ilan University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	Abassi, ZA (corresponding author), Technion, Fac Med, Dept Physiol & Biophys, Haifa, Israel.	abassi@tx.technion.ac.il		Abassi, Zaid/0000-0002-7272-197X; Weissmann, Marina/0000-0002-6243-7748	Israeli Medical Corps-Research Unit [4440356638]	Israeli Medical Corps-Research Unit	The authors are grateful for the Israeli Medical Corps-Research Unit for the financial and logistic support and for funding this research (Grant Number 4440356638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUKHALIL B, 1994, CRIT CARE MED, V22, P633, DOI 10.1097/00003246-199404000-00020; Alam HB, 2003, J TRAUMA, V54, P1077, DOI 10.1097/01.TA.0000068258.99048.70; Alam HB, 2002, J TRAUMA, V52, P18, DOI 10.1097/00005373-200201000-00006; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Bayram B, 2012, AM J EMERG MED, V30, P1176, DOI 10.1016/j.ajem.2011.09.007; BELLAMY RF, 1984, MIL MED, V149, P55; BREIMAN L., 1984, CRC PRESS; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Coburn M, 2008, TRAUMA, P789; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Duane TM, 2008, J TRAUMA, V64, P1184, DOI 10.1097/TA.0b013e31816c5c95; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Jacoby RC, 2008, TRAUMA, P661; Kellum JA, 2002, CRIT CARE MED, V30, P259, DOI 10.1097/00003246-200201000-00046; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kerger H, 1996, AM J PHYSIOL-HEART C, V270, pH827, DOI 10.1152/ajpheart.1996.270.3.H827; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035, DOI 10.1152/ajpheart.1999.276.6.H2035; Krausz MM, 2003, SHOCK, V20, P444, DOI 10.1097/01.shk.0000094560.76615.91; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Mahajna A, 2007, EUR SURG RES, V39, P251, DOI 10.1159/000102590; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; Petratos PB, 2002, J UROLOGY, V167, P2222, DOI 10.1016/S0022-5347(05)65132-4; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SCALEA TM, 1994, CRIT CARE MED, V22, P1610; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Song H, 2010, MACROMOL BIOSCI, V10, P33, DOI 10.1002/mabi.200900129; Tuthill DD, 2001, J SURG RES, V95, P126, DOI 10.1006/jsre.2000.6027; Wahl WL, 2008, J TRAUMA, V65, P42, DOI 10.1097/TA.0b013e318176c54e; Warner RL, 2009, EXP MOL PATHOL, V87, P204, DOI 10.1016/j.yexmp.2009.09.004; Xiao N, 2004, SHOCK, V21, P276	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80862	10.1371/journal.pone.0080862	http://dx.doi.org/10.1371/journal.pone.0080862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303027	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400043
J	Bertin, D; Grimaud, JC; Lesavre, N; Benelmouloud, C; Desjeux, A; Garcia, S; Desplat-Jego, S				Bertin, Daniel; Grimaud, Jean-Charles; Lesavre, Nathalie; Benelmouloud, Chahine; Desjeux, Ariadne; Garcia, Stephane; Desplat-Jego, Sophie			Targeting Tissular Immune Response Improves Diagnostic Performance of Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SEROLOGICAL MARKERS; ULCERATIVE-COLITIS; METAANALYSIS; PROGRESSION; BIOMARKERS; PHENOTYPES; EPITOPES; BEHAVIOR; SURGERY	Antibodies against Saccharomyces cerevisiae (ASCA) and Escherichia coli outer membrane porin C (anti-OmpC) are known to be detectable in the serum of patients with Crohn's disease (CD) but display a very poor sensitivity for the disease especially in forms with isolated colonic involvement. In this study we aimed at evaluating performances of these markers in supernatant of cultured colonic biopsies. Patients with colonic CD (n = 67), ulcerative colitis (UC) (n = 35) and control individuals (n = 37) were prospectively recruited for colonoscopy pinch biopsies and blood sampling. Serum and supernatant of culture tissues were analyzed for ASCA and anti-OmpC. Direct immunofluorescence was also performed on colonic tissues for total IgA detection. We detected for the first time ASCA IgA/IgG and anti-OmpC IgA in cultured colonic tissue supernatants. For both markers, sensitivities for diagnosing CD were better in supernatants (ASCA: 53.7%, anti-OmpC: 28.4%) than in serum (ASCA: 31.3%, anti-OmpC: 22.4%). Combination of results from a panel of these tests gave the greatest sensitivity ever described for CD diagnosis in colonic forms (70.2%). In this study, we described, for the first time, ASCA in supernatant of colonic tissue cultures. This assaying approach in CD diagnosis should be taken into consideration in the future especially in CD forms with isolated colonic involvement.	[Bertin, Daniel; Benelmouloud, Chahine; Desplat-Jego, Sophie] Hop Conception, Assistance Publ Hop Marseille, Serv Immunol Biol, Marseille, France; [Grimaud, Jean-Charles; Desjeux, Ariadne] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Gastroenterol, Marseille, France; [Lesavre, Nathalie] Hop Nord Marseille, Assistance Publ Hop Marseille, Ctr Invest Clin, Marseille, France; [Garcia, Stephane] Hop Nord Marseille, Assistance Publ Hop Marseille, Lab Anat Pathol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Desplat-Jego, S (corresponding author), Hop Conception, Assistance Publ Hop Marseille, Serv Immunol Biol, Marseille, France.	sophie.jego-desplat@ap-hm.fr	Desplat-Jégo, Sophie/AGE-4465-2022		grant AORC from Assistance Publique-Hopitaux de Marseille, France (Appel d'Offre de Recherche Clinique) [UF8040]; Aix-Marseille Universite; Centre National de la Recherche Scientifique	grant AORC from Assistance Publique-Hopitaux de Marseille, France (Appel d'Offre de Recherche Clinique); Aix-Marseille Universite; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This study was supported by a grant AORC from Assistance Publique-Hopitaux de Marseille, France (Appel d'Offre de Recherche Clinique UF8040, to SDJ). This work was also supported in part by Aix-Marseille Universite and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Carroccio A, 2002, SCAND J GASTROENTERO, V37, P32, DOI 10.1080/003655202753387329; Cohavy O, 2000, INFECT IMMUN, V68, P1542, DOI 10.1128/IAI.68.3.1542-1548.2000; Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312; Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Gologan S, 2012, J GASTROINTEST LIVER, V21, P39; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Kaul A, 2012, INFLAMM BOWEL DIS, V18, P1872, DOI 10.1002/ibd.22862; Krause I, 2007, ANN NY ACAD SCI, V1108, P481, DOI 10.1196/annals.1422.051; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249; Nascimbeni R, 2005, MODERN PATHOL, V18, P681, DOI 10.1038/modpathol.3800343; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Petersen AM, 2012, SCAND J GASTROENTERO, V47, P155, DOI 10.3109/00365521.2011.639080; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Reumaux D, 2003, BEST PRACT RES CL GA, V17, P19, DOI 10.1053/bega.2002.0347; Rinaldi M, 2013, CLIN REV ALLERG IMMU, V45, P152, DOI 10.1007/s12016-012-8344-9; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Sendid B, 1996, CLIN DIAGN LAB IMMUN, V3, P219, DOI 10.1128/CDLI.3.2.219-226.1996; Sipos F, 2011, WORLD J GASTROENTERO, V17, P1666, DOI 10.3748/wjg.v17.i13.1666; Tang LY, 2012, INT J COLORECTAL DIS, V27, P1455, DOI 10.1007/s00384-012-1444-4; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487; Walker LJ, 2004, CLIN EXP IMMUNOL, V135, P490, DOI 10.1111/j.1365-2249.2003.02392.x; Zhang ZX, 2012, DIGEST DIS SCI, V57, P2944, DOI 10.1007/s10620-012-2244-y	28	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80433	10.1371/journal.pone.0080433	http://dx.doi.org/10.1371/journal.pone.0080433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303014	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400030
J	Gonzalez, R; Mandomando, I; Fumado, V; Sacoor, C; Macete, E; Alonso, PL; Menendez, C				Gonzalez, Raquel; Mandomando, Inacio; Fumado, Victoria; Sacoor, Charfudin; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara			Breast Milk and Gut Microbiota in African Mothers and Infants from an Area of High HIV Prevalence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LACTIC-ACID BACTERIA; INTESTINAL MICROBIOTA; PROBIOTIC BACTERIA; STRAINS; OLIGOSACCHARIDES; INHIBITION; LACTATION; CHILDREN; MODE	Background: Human milk and infant gut microbiota are essential for the immune system maturation and protection against infections. There is scarce information on the microbiological composition of breast milk in general, and none from developing countries. The objective of the study was to characterize the breast milk and gut microbiota from mothers and infants from southern Mozambique, where infections and breastfeeding are prevalent. Methods: A community-based study was undertaken among 121 pairs of women and infants. Breast milk and infant's faeces were analyzed by bacterial culture and molecular methods. Breast milk samples were screened for HIV RNA by RT-PCR. Results: The most frequent bacterial groups isolated by culture media in breast milk were Staphylococci (96.4%), Streptococci (92.7%) and Lactobacilli (56.4%). HIV RNA was detected in 24% of the samples. Staphylococcus hominis, S. aureus, and S.parasanguis were more frequently isolated in infants <= 14 days of life. Women on exclusive breastfeeding presented higher proportion of S.parasanguis in breast milk than those on mixed infant feeding (36.4% versus 11.1%, p = 0.035). Bacterial diversity (mean number of bacterial species isolated by sample: 10.4 versus 8.5; p = 0.004) and the frequency of Lactobacillus spp (75.9% versus 36%, p = 0.003) were higher in the specimens with HIV RNA than in those without it. The main bacterial groups found in infant's faeces were Bifidobacterium, Streptococci and Enterococci. Conclusions: Women with HIV RNA in breast milk had a different pattern of microbiological composition, suggesting specific immunopathological phenomena in HIV-infected women. Both breast milk and faecal microbiota composition varied with lactation period, which might be related to changes in the type of feeding over time and/or in the milk's biochemical characteristics. These findings provide insights into interactions between commensal bacteria and HIV infection in human milk and the role of these bacteria in mucosal protection against infections in breastfed infants.	[Gonzalez, Raquel; Fumado, Victoria; Alonso, Pedro L.; Menendez, Clara] Univ Barcelona, Barcelona Ctr Int Heath Res, CRESIB, Hosp Clin, Barcelona, Spain; [Gonzalez, Raquel; Mandomando, Inacio; Sacoor, Charfudin; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara] Manhica Hlth Res Ctr CISM, Maputo, Mozambique; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Fumado, Victoria] St Joan de Deu Paediat Hosp, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Menendez, C (corresponding author), Univ Barcelona, Barcelona Ctr Int Heath Res, CRESIB, Hosp Clin, Barcelona, Spain.	Menendez@clinic.ub.es	Barragán, Antonio Maldonado/AAC-3368-2019; Alonso, Pedro L/AAZ-3645-2020; Martin, Virginia/D-5328-2009; Menéndez, Clara/Q-3446-2016; Mandomando, Inacio/ABD-8007-2020; Rodriguez, Juan Miguel/ABB-6650-2020; Álvarez, Leónides Fernández/I-6616-2015; Gonzalez, Raquel/J-3604-2017	Barragán, Antonio Maldonado/0000-0002-4775-346X; Alonso, Pedro L/0000-0003-3292-3443; Martin, Virginia/0000-0002-0236-7936; Menéndez, Clara/0000-0002-2641-6907; Mandomando, Inacio/0000-0002-1078-2187; Rodriguez, Juan Miguel/0000-0002-1285-9686; Álvarez, Leónides Fernández/0000-0003-2380-0767; Gonzalez, Raquel/0000-0001-5487-801X	"la Caixa'' Foundation [CO04-136-0]; Spanish Agency for International Cooperation and Development (AECID)	"la Caixa'' Foundation(La Caixa Foundation); Spanish Agency for International Cooperation and Development (AECID)	This work was supported by a grant from "la Caixa'' Foundation managed by the Spanish NGO Africa Viva [grant number CO04-136-0]. The CISM receives core funding from the Spanish Agency for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesharat R, 2011, SYST APPL MICROBIOL, V34, P148, DOI 10.1016/j.syapm.2010.12.001; Alonso PL, 2002, MANHICA DEMOGRAPHIC, P189; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Cunningham-Rundles S, 2011, NUTRIENTS, V3, P1042, DOI 10.3390/nu3121042; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Fernandez L, 2012, PHARM RES; Garrett WS, 2013, NEW ENGL J MED, V368, P1746, DOI 10.1056/NEJMcibr1301297; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; Gonzalez R, 2012, HIV MED; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Grzeskowiak L, 2012, J PEDIATR GASTR NUTR, V54, P812, DOI 10.1097/MPG.0b013e318249039c; Guarner F, 2009, DIGEST DIS, V27, P412, DOI 10.1159/000228582; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Jeong K, 2012, BMB REP, V45, P433, DOI 10.5483/BMBRep.2012.45.8.168; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Joint United Nations Programme on HIV/AIDS, 2021, UNAIDS GLOB AIDS UPD; Kuhn L, 2010, CLIN INFECT DIS, V50, P770, DOI 10.1086/650536; Lara-Villoslada F, 2007, BRIT J NUTR, V98, pS96, DOI 10.1017/S0007114507832910; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Martin R, 2005, J HUM LACT, V21, P8, DOI 10.1177/0890334404272393; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin V, 2010, BREASTFEED MED, V5, P153, DOI 10.1089/bfm.2010.0001; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Olivares M, 2006, J APPL MICROBIOL, V101, P72, DOI 10.1111/j.1365-2672.2006.02981.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perez-Hoyos S, 2011, HIV MED, V12, P500, DOI 10.1111/j.1468-1293.2010.00908.x; Poggensee G, 2004, TROP MED INT HEALTH, V9, P477, DOI 10.1111/j.1365-3156.2004.01214.x; PRENTICE A, 1981, BRIT J NUTR, V45, P495, DOI 10.1079/BJN19810128; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012164; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Ssenyonga R, 2004, J TROP PEDIATRICS, V50, P348, DOI 10.1093/tropej/50.6.348; Tilg H, 2013, NAT REV GASTRO HEPAT, V10, P261, DOI 10.1038/nrgastro.2013.48; Trois L, 2008, J TROP PEDIATRICS, V54, P19, DOI 10.1093/tropej/fmm066; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; WHO, 2009, INF YOUNG CHILD FEED; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	40	59	59	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80299	10.1371/journal.pone.0080299	http://dx.doi.org/10.1371/journal.pone.0080299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303004	gold, Green Accepted, Green Published			2022-12-25	WOS:000327546400020
J	Oliveira, BRR; Slama, FA; Deslandes, AC; Furtado, ES; Santos, TM				Oliveira, Bruno R. R.; Slama, Fabian A.; Deslandes, Andrea C.; Furtado, Elen S.; Santos, Tony M.			Continuous and High-Intensity Interval Training: Which Promotes Higher Pleasure?	PLOS ONE			English	Article							AFFECTIVE RESPONSES; EXERCISE INTENSITY; DISPLEASURE; WORK; BODY	Objectives: To compare the psychological responses to continuous (CT) and high-intensity interval training (HIT) sessions. Methods: Fifteen men attended one CT session and one HIT session. During the first visit, the maximum heart rate, VO2Peak and respiratory compensation point (RCP) were determined through a maximal cardiopulmonary exercise test. The HIT stimulus intensity corresponded to 100% of VO2Peak, and the average intensity of both sessions was maintained at 15% below the RCP. The order of the sessions was randomized. Psychological and physiological variables were recorded before, during and after each session. Results: There were no significant differences between the average percentages of VO2 during the two exercise sessions (HIT: 73.3% vs. CT: 71.8%; p = 0.779). Lower responses on the feeling scale (p <= 0.01) and higher responses on the felt arousal scale (p <= 0.001) and the rating of perceived exertion were obtained during the HIT session. Despite the more negative feeling scale responses observed during HIT and a greater feeling of fatigue (measured by Profile of Mood States) afterwards (p<0.01), the physical activity enjoyment scale was not significantly different between the two conditions (p = 0.779). Conclusion: Despite the same average intensity for both conditions, similar psychological responses under HIT and CT conditions were not observed, suggesting that the higher dependence on anaerobic metabolism during HIT negatively influenced the feeling scale responses.	[Oliveira, Bruno R. R.; Deslandes, Andrea C.] Univ Gama Filho, Exercise & Sports Sci Grad Program, Rio De Janeiro, Brazil; [Oliveira, Bruno R. R.] President Antonio Carlos Univ, Dept Phys Educ, Barbacena, MG, Brazil; [Slama, Fabian A.; Furtado, Elen S.] Univ Gama Filho, Dept Phys Educ, Rio De Janeiro, Brazil; [Santos, Tony M.] Univ Fed Pernambuco, Dept Phys Educ, Recife, PE, Brazil	Universidade Gama Filho; Universidade Presidente Antonio Carlos; Universidade Gama Filho; Universidade Federal de Pernambuco	Santos, TM (corresponding author), Univ Fed Pernambuco, Dept Phys Educ, Recife, PE, Brazil.	tony.meireles@ufpe.br	Deslandes, Andrea/AAF-4525-2021; Deslandes, Andrea C/E-8594-2016; Santos, Tony M/F-2288-2011; de Oliveira, Bruno Ribeiro Ramalho/H-5298-2011; Deslandes, Andrea C/F-3545-2010; DOS SANTOS, TONY MEIRELES/V-2650-2019	Deslandes, Andrea/0000-0001-5941-9111; Santos, Tony M/0000-0002-5242-0117; de Oliveira, Bruno Ribeiro Ramalho/0000-0001-7712-0025; Deslandes, Andrea C/0000-0001-5941-9111; DOS SANTOS, TONY MEIRELES/0000-0002-5242-0117	FAPERJ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Tony M. Santos was sponsored by a grant from FAPERJ. Bruno R. R. Oliveira was sponsored by a grant from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSM, 2010, ACSMS GUID EX TEST P; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Billat VL, 2000, EUR J APPL PHYSIOL, V81, P188, DOI 10.1007/s004210050029; Blanchard CM, 2004, RES Q EXERCISE SPORT, V75, P209, DOI 10.1080/02701367.2004.10609153; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; Borg G., 1998, BORGS PERCEIVED EXER; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2002, PSYCHOL SPORT EXERC, V3, P35, DOI 10.1016/S1469-0292(01)00028-0; Ekkekakis P., 2009, INT REV SPORT EXER P, V2, P139, DOI [DOI 10.1080/17509840902829323, 10.1080/17509840902829323]; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ekkekakis P, 2010, OBESITY, V18, P79, DOI 10.1038/oby.2009.204; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Faro Viana M, 2012, ANAL PSICOL, V19, DOI [10.14417/ap.345, DOI 10.14417/AP.345]; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Hopkins W., 2006, SPORTSCIENCE, V10, P63; Hopkins W.G, 2006, SCALE MAGNITUDES EFF; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kilpatrick M, 2007, MED SCI SPORT EXER, V39, P1417, DOI 10.1249/mss.0b013e31806ad73c; Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003; Muller MD, 2011, EUR J APPL PHYSIOL, V111, P1321, DOI 10.1007/s00421-010-1759-1; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Rose EA, 2007, J SPORT EXERCISE PSY, V29, P281, DOI 10.1123/jsep.29.3.281; SALTIN B, 1976, MED SPORT, V9, P23; Santos TM, 2012, J STRENGTH COND RES, V26, P87, DOI 10.1519/JSC.0b013e318212e3fd; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; Tenenbaum G., 2007, HDB SPORT PSYCHOL; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Williams DM, 2008, J SPORT EXERCISE PSY, V30, P471, DOI 10.1123/jsep.30.5.471; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; [No title captured]	37	106	111	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e79965	10.1371/journal.pone.0079965	http://dx.doi.org/10.1371/journal.pone.0079965			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259SK	24302993	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400009
J	Pechine, S; Hennequin, C; Boursier, C; Hoys, S; Collignon, A				Pechine, Severine; Hennequin, Claire; Boursier, Celine; Hoys, Sandra; Collignon, Anne			Immunization Using GroEL Decreases Clostridium difficile Intestinal Colonization	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SURFACE-PROTEINS; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; CELL-SURFACE; INFECTION; VACCINATION; PROTECTION; HAMSTERS; HSP60	Clostridium difficile is a pathogen which is responsible for diarrhea and colitis, particularly after treatment with antibiotics. Clinical signs are mainly due to two toxins, TcdA and TcdB. However, the first step of pathogenesis is the colonization process. We evaluated C. difficile surface proteins as vaccine antigens in the hamster model to prevent intestinal colonization. This vaccination induced a partial protection of hamsters against death after a C. difficile challenge. A proteomic analysis of animal sera allowed us to identify proteins which could be responsible for the protection observed. Among these proteins, we identified the GroEL heat shock protein. To confirm the role of the specific GroEL antibodies in the delayed C. difficile colonization of hamsters, we performed an immunization assay in a mouse model. After intranasal immunization with the recombinant protein GroEL, we observed a lower C. difficile intestinal colonization in the immunized group as compared to the control group.	[Pechine, Severine; Hoys, Sandra; Collignon, Anne] Univ Paris 11, Fac Pharm, Equipe Accueil 4043, Unite Contrat Inst Natl Rech Agron, F-92290 Chatenay Malabry, France; [Hennequin, Claire] Univ Clermont Ferrand 2, Univ Auvergne, Unite Mixte Rech, Lab Microorganismes Genome Environm,CNRS, Clermont Ferrand, France; [Boursier, Celine] Univ Paris 11, Fac Pharm, Inst Paris Sud Innovat Therapeut, F-92290 Chatenay Malabry, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay	Pechine, S (corresponding author), Univ Paris 11, Fac Pharm, Equipe Accueil 4043, Unite Contrat Inst Natl Rech Agron, F-92290 Chatenay Malabry, France.	severine.pechine@u-psud.fr	PÉCHINÉ, SÉVERINE/ABD-1960-2021		French ministery of research	French ministery of research(Ministry of Research, France)	Fundings from the French ministery of research supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1990, REV INFECT DIS, V12, pS243, DOI 10.1093/clinids/12.Supplement_2.S243; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Cerquetti M, 2002, FEMS IMMUNOL MED MIC, V32, P211, DOI 10.1016/S0928-8244(01)00301-7; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Drudy D, 2001, J MED MICROBIOL, V50, P526, DOI 10.1099/0022-1317-50-6-526; Eidhin DBN, 2008, FEMS IMMUNOL MED MIC, V52, P207, DOI 10.1111/j.1574-695X.2007.00363.x; FERRERO RL, 1995, P NATL ACAD SCI USA, V92, P6499, DOI 10.1073/pnas.92.14.6499; FORREST BD, 1990, VACCINE, V8, P209, DOI 10.1016/0264-410X(90)90047-P; Frisk A, 1998, INFECT IMMUN, V66, P1252, DOI 10.1128/IAI.66.3.1252-1257.1998; Froidevaux-Klipfel L, 2011, PROTEOMICS, V11, P3877, DOI 10.1002/pmic.201000789; GOMEZ FJ, 1995, INFECT IMMUN, V63, P2587, DOI 10.1128/IAI.63.7.2587-2595.1995; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Kantele A, 1998, INFECT IMMUN, V66, P5630, DOI 10.1128/IAI.66.12.5630-5635.1998; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kelly CP, 1998, ANNU REV MED, V49, P375; Khan MN, 2009, FEMS IMMUNOL MED MIC, V56, P56, DOI 10.1111/j.1574-695X.2009.00548.x; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; O'Brien JB, 2005, FEMS MICROBIOL LETT, V246, P199, DOI 10.1016/j.femsle.2005.04.005; Pahwal PK, 2008, CLIN IMMUNOL, V126, P89, DOI 10.1016/j.clim.2007.09.004; Pechine S, 2005, J CLIN MICROBIOL, V43, P5018, DOI 10.1128/JCM.43.10.5018-5025.2005; Pechine S, 2007, VACCINE, V25, P3946, DOI 10.1016/j.vaccine.2007.02.055; Pechine S, 2011, FEMS IMMUNOL MED MIC, V63, P73, DOI 10.1111/j.1574-695X.2011.00832.x; Quintana FJ, 2003, J IMMUNOL, V171, P3533, DOI 10.4049/jimmunol.171.7.3533; Quintana FJ, 2002, J IMMUNOL, V169, P6030, DOI 10.4049/jimmunol.169.10.6030; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sandolo C, 2011, EUR J PHARM BIOPHARM, V79, P566, DOI 10.1016/j.ejpb.2011.05.011; Sinha K, 2010, MOL IMMUNOL, V48, P264, DOI 10.1016/j.molimm.2010.08.001; Sougioultzis S, 2005, GASTROENTEROLOGY, V128, P764, DOI 10.1053/j.gastro.2004.11.004; Tsuzuki T, 2002, ALIMENT PHARM THER, V16, P217, DOI 10.1046/j.1365-2036.16.s2.23.x; van Eden W, 2003, VACCINE, V21, P897, DOI 10.1016/S0264-410X(02)00538-8; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; WEXLER H, 1984, REV INFECT DIS, V6, pS229; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	37	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81112	10.1371/journal.pone.0081112	http://dx.doi.org/10.1371/journal.pone.0081112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303034	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400051
J	Schijf, MA; Lukens, MV; Kruijsen, D; van Uden, NOP; Garssen, J; Coenjaerts, FEJ; van't Land, B; van Bleek, GM				Schijf, Marcel A.; Lukens, Michael V.; Kruijsen, Debby; van Uden, Nathalie O. P.; Garssen, Johan; Coenjaerts, Frank E. J.; van't Land, Belinda; van Bleek, Grada M.			Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NF-KAPPA-B; TOLL-LIKE RECEPTOR-4; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; ANTIVIRAL RESPONSES; RIG-I; NONSTRUCTURAL PROTEINS; INDUCED ACTIVATION; ALPHA INDUCTION	Innate immune responses elicited upon virus exposure are crucial for the effective eradication of viruses, the onset of adaptive immune responses and for establishing proper immune memory. Respiratory syncytial virus (RSV) is responsible for a high disease burden in neonates and immune compromised individuals, causing severe lower respiratory tract infections. During primary infections exuberant innate immune responses may contribute to disease severity. Furthermore, immune memory is often insufficient to protect during RSV re-exposure, which results in frequent symptomatic reinfections. Therefore, identifying the cell types and pattern recognition receptors (PRRs) involved in RSV-specific innate immune responses is necessary to understand incomplete immunity against RSV. We investigated the innate cellular response triggered upon infection of epithelial cells and peripheral blood mononuclear cells. We show that CD14(+) myeloid cells and epithelial cells are the major source of IL-8 and inflammatory cytokines, IL-6 and TNF-alpha, when exposed to live RSV Three routes of RSV-induced IFN-alpha production can be distinguished that depend on the cross-talk of different cell types and the presence or absence of virus specific antibodies, whereby pDC are the ultimate source of IFN-alpha. RSV-specific antibodies facilitate direct TLR7 access into endosomal compartments, while in the absence of antibodies, infection of monocytes or epithelial cells is necessary to provide an early source of type I interferons, required to engage the IFN-alpha,beta receptor (IFNAR)-mediated pathway of IFN-alpha production by pDC. However, at high pDC density infection with RSV causes IFN-alpha production without the need for a second party cell. Our study shows that cellular context and immune status are factors affecting innate immune responses to RSV. These issues should therefore be addressed during the process of vaccine development and other interventions for RSV disease.	[Schijf, Marcel A.; Lukens, Michael V.; Kruijsen, Debby; van Uden, Nathalie O. P.; van't Land, Belinda; van Bleek, Grada M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat, Utrecht, Netherlands; [Schijf, Marcel A.; Garssen, Johan; van't Land, Belinda] Danone Res Ctr Specialised Nutr, Dept Immunol, Wageningen, Netherlands; [Coenjaerts, Frank E. J.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Garssen, Johan] UIPS, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Danone Nutricia; Utrecht University; Utrecht University Medical Center; Utrecht University	van Bleek, GM (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat, Utrecht, Netherlands.	gvanbleek@gmail.com	Land, Belinda van't/K-2986-2012; garssen, johan/I-7159-2016	Land, Belinda van't/0000-0001-8601-5032; van Uden, Nathalie/0000-0001-9952-1065	Dutch Top Institute Pharma project [D1-101-0]; Wilhelmina Research Fund [OZF-02-004, WK016]	Dutch Top Institute Pharma project; Wilhelmina Research Fund	This study was financially supported and performed within the framework of the Dutch Top Institute Pharma project: D1-101-0 (http://www.tipharma.com) and by grants OZF-02-004 and WK016 from the Wilhelmina Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; Benjamin JT, 2010, J IMMUNOL, V185, P4896, DOI 10.4049/jimmunol.1001857; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; de Jager Wilco, 2009, V514, P119, DOI 10.1007/978-1-60327-527-9_9; Demoor T, 2012, J IMMUNOL, V189, P5942, DOI 10.4049/jimmunol.1201763; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jiang ZL, 1998, J VIROL, V72, P2496, DOI 10.1128/JVI.72.3.2496-2499.1998; Jie ZJ, 2011, VIRUS RES, V156, P127, DOI 10.1016/j.virusres.2011.01.007; Johnson TR, 2012, J VIROL, V86, P1339, DOI 10.1128/JVI.06096-11; Johnson TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016458; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003233; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Liao AP, 2010, CLIN IMMUNOL, V136, P130, DOI 10.1016/j.clim.2010.02.014; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Littel-van den Hurk SV, 2012, CURR OPIN VIROL, V2, P300, DOI 10.1016/j.coviro.2012.01.008; Lizundia R, 2008, INNATE IMMUN-LONDON, V14, P223, DOI 10.1177/1753425908095957; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lukacs NW, 2008, VIRAL IMMUNOL, V21, P115, DOI 10.1089/vim.2007.0110; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Marr N, 2012, INNATE IMMUN-LONDON, V18, P856, DOI 10.1177/1753425912444479; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Mastronarde JG, 1998, J INFECT DIS, V177, P1275, DOI 10.1086/515279; Morris S, 2011, J IMMUNOL, V187, P3953, DOI 10.4049/jimmunol.1100524; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poth JM, 2010, J IMMUNOL, V185, P7367, DOI 10.4049/jimmunol.1001798; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Rudd BD, 2007, J IMMUNOL, V178, P5820, DOI 10.4049/jimmunol.178.9.5820; Schijf MA, 2012, J VIROL, V86, P11472, DOI 10.1128/JVI.06708-11; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Seng NC, 2012, INT IMMUNOL, V24, P739, DOI 10.1093/intimm/dxs099; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Szabo G, 2008, CRIT REV IMMUNOL, V28, P61, DOI 10.1615/CritRevImmunol.v28.i1.40; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; van Diepen A, 2010, J PROTEOMICS, V73, P1680, DOI 10.1016/j.jprot.2010.04.008; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263	73	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81695	10.1371/journal.pone.0081695	http://dx.doi.org/10.1371/journal.pone.0081695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303065	gold, Green Submitted, Green Published			2022-12-25	WOS:000327546400081
J	Shen, Y; Picord, G; Guyon, F; Tuffery, P				Shen, Yimin; Picord, Geraldine; Guyon, Frederic; Tuffery, Pierre			Detecting Protein Candidate Fragments Using a Structural Alphabet Profile Comparison Approach	PLOS ONE			English	Article							STRUCTURE PREDICTION; HOMOLOGOUS PROTEINS; STRUCTURE MOTIFS; LOCAL-STRUCTURE; MODEL; LIBRARY; SERVER; PEPTIDE; SCALE; LOOPS	Predicting accurate fragments from sequence has recently become a critical step for protein structure modeling, as protein fragment assembly techniques are presently among the most efficient approaches for de novo prediction. A key step in these approaches is, given the sequence of a protein to model, the identification of relevant fragments - candidate fragments - from a collection of the available 3D structures. These fragments can then be assembled to produce a model of the complete structure of the protein of interest. The search for candidate fragments is classically achieved by considering local sequence similarity using profile comparison, or threading approaches. In the present study, we introduce a new profile comparison approach that, instead of using amino acid profiles, is based on the use of predicted structural alphabet profiles, where structural alphabet profiles contain information related to the 3D local shapes associated with the sequences. We show that structural alphabet profile-profile comparison can be used efficiently to retrieve accurate structural fragments, and we introduce a fully new protocol for the detection of candidate fragments. It identifies fragments specific of each position of the sequence and of size varying between 6 and 27 amino-acids. We find it outperforms present state of the art approaches in terms (i) of the accuracy of the fragments identified, (ii) the rate of true positives identified, while having a high coverage score. We illustrate the relevance of the approach on complete target sets of the two previous Critical Assessment of Techniques for Protein Structure Prediction (CASP) rounds 9 and 10. A web server for the approach is freely available at http://bioserv.rpbs.univ-paris-diderot.fr/SAFrag.	[Shen, Yimin; Picord, Geraldine; Guyon, Frederic; Tuffery, Pierre] INSERM, MTi, U973, Paris, France; [Shen, Yimin; Picord, Geraldine; Guyon, Frederic; Tuffery, Pierre] Univ Paris Diderot, Paris, France; [Tuffery, Pierre] RPBS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tuffery, P (corresponding author), INSERM, MTi, U973, Paris, France.	pierre.tuffery@univ-paris-diderot.fr	Tuffery, Pierre/L-6953-2017	Tuffery, Pierre/0000-0003-1033-9895; Guyon, Frederic/0000-0003-3740-1839	UMR-S 973 INSERM; IA Bioinformatique BipBip grant	UMR-S 973 INSERM; IA Bioinformatique BipBip grant	UMR-S 973 INSERM recurrent funding and IA Bioinformatique BipBip grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AN, 2012, PROTEIN SCI, V21, P107, DOI 10.1002/pro.767; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Bornot A, 2011, PROTEINS, V79, P839, DOI 10.1002/prot.22922; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Bystroff C, 1996, CURR OPIN BIOTECH, V7, P417, DOI 10.1016/S0958-1669(96)80117-0; Camproux AC, 2004, J MOL BIOL, V339, P591, DOI 10.1016/j.jmb.2004.04.005; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern AG, 2005, BBA-GEN SUBJECTS, V1724, P288, DOI 10.1016/j.bbagen.2005.05.016; DEBREVERN AG, 2001, RRD PRO ENG 2, V1, P319; Deschavanne P, 2009, PROTEINS, V76, P129, DOI 10.1002/prot.22324; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Guyon F, 2004, NUCLEIC ACIDS RES, V32, pW545, DOI 10.1093/nar/gkh467; Guyon F, 2010, OPEN ACCESS BIOINFOR, V2, P67; Handl J, 2011, PROTEINS; Jallu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047304; Jones DT, 2001, PROTEINS, P127; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Karuppasamy M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r52; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Le Q, 2009, J MOL BIOL, V387, P431, DOI 10.1016/j.jmb.2008.12.044; Lee J, 2011, PROTEINS, V79, P2403, DOI 10.1002/prot.23059; Mahajan S, 2013, J BIOMOL STRUCT DYN; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Pandini A, 2007, BIOINFORMATICS, V23, P515, DOI 10.1093/bioinformatics/btl637; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Regad L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-247; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROOMAN MJ, 1990, J MOL BIOL, V213, P327, DOI 10.1016/S0022-2836(05)80194-9; Skolnick J, 2012, J PHYS CHEM B, V116, P6654, DOI 10.1021/jp211052j; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tendulkar AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009679; Tendulkar AV, 2004, J MOL BIOL, V338, P611, DOI 10.1016/j.jmb.2004.02.047; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xu D, 2012, PROTEINS; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101	42	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80493	10.1371/journal.pone.0080493	http://dx.doi.org/10.1371/journal.pone.0080493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303019	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400035
J	Typlt, M; Mirkowski, M; Azzopardi, E; Ruettiger, L; Ruth, P; Schmid, S				Typlt, Marei; Mirkowski, Magdalena; Azzopardi, Erin; Ruettiger, Lukas; Ruth, Peter; Schmid, Susanne			Mice with Deficient BK Channel Function Show Impaired Prepulse Inhibition and Spatial Learning, but Normal Working and Spatial Reference Memory	PLOS ONE			English	Article							ACOUSTIC STARTLE RESPONSE; CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; TRANSMITTER RELEASE; RAT-BRAIN; CALCIUM; HABITUATION; BEHAVIOR; SUBUNIT; IMMUNOLOCALIZATION	Genetic variations in the large-conductance, voltage-and calcium activated potassium channels (BK channels) have been recently implicated in mental retardation, autism and schizophrenia which all come along with severe cognitive impairments. In the present study we investigate the effects of functional BK channel deletion on cognition using a genetic mouse model with a knock-out of the gene for the pore forming a-subunit of the channel. We tested the F1 generation of a hybrid SV129/C57BL6 mouse line in which the slo1 gene was deleted in both parent strains. We first evaluated hearing and motor function to establish the suitability of this model for cognitive testing. Auditory brain stem responses to click stimuli showed no threshold differences between knockout mice and their wild-type littermates. Despite of muscular tremor, reduced grip force, and impaired gait, knockout mice exhibited normal locomotion. These findings allowed for testing of sensorimotor gating using the acoustic startle reflex, as well as of working memory, spatial learning and memory in the Y-maze and the Morris water maze, respectively. Prepulse inhibition on the first day of testing was normal, but the knockout mice did not improve over the days of testing as their wild-type littermates did. Spontaneous alternation in the y-maze was normal as well, suggesting that the BK channel knock-out does not impair working memory. In the Morris water maze knock-out mice showed significantly slower acquisition of the task, but normal memory once the task was learned. Thus, we propose a crucial role of the BK channels in learning, but not in memory storage or recollection.	[Typlt, Marei; Mirkowski, Magdalena; Azzopardi, Erin; Schmid, Susanne] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Ruettiger, Lukas] Univ Tubingen, Hearing Res Ctr, Tubingen, Germany; [Ruth, Peter] Univ Tubingen, Inst Pharm, Tubingen, Germany	Western University (University of Western Ontario); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schmid, S (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada.	Susanne.Schmid@schulich.uwo.ca	Schmid, Susanne/J-3201-2012	Schmid, Susanne/0000-0001-5366-8061; Typlt, Marei/0000-0002-1627-7560; Mirkowski, Magdalena/0000-0001-6263-7750	Canadian Institute for Health Research (CIHR) MOP [114870]; Deutsche Forschungsgemeinschaft (DFG)	Canadian Institute for Health Research (CIHR) MOP(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Canadian Institute for Health Research (CIHR) MOP#114870 to S. Schmid Deutsche Forschungsgemeinschaft (DFG) scholarship to M.Typlt Ontario Ministry of Training, Colleges and Universities scholarship to E. Azzopardi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Geyer MA, 2001, MEASUREMENT STARTLE; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Higgins JJ, 2008, NEUROGENETICS, V9, P219, DOI 10.1007/s10048-008-0128-2; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Knaus HG, 1996, J NEUROSCI, V16, P955; Kurt S, 2012, FASEB J, V26, P3834, DOI 10.1096/fj.11-200535; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Plappert CF, 2006, BEHAV NEUROSCI, V120, P16, DOI 10.1037/0735-7044.120.1.16; Plappert CF, 2004, BEHAV BRAIN RES, V152, P403, DOI 10.1016/j.bbr.2003.10.025; Poolos NP, 1999, J NEUROSCI, V19, P5205; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; RICHMAN C L, 1986, Current Psychological Research and Reviews, V5, P358, DOI 10.1007/BF02686603; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sailer CA, 2006, EUR J NEUROSCI, V24, P442, DOI 10.1111/j.1460-9568.2006.04936.x; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Takahashi H, 2008, NEUROSCI RES, V62, P187, DOI 10.1016/j.neures.2008.08.006; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Valsamis B, 2011, JOVE-J VIS EXP, DOI 10.3791/3446; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7; Wanner SG, 1999, BIOCHEMISTRY-US, V38, P5392, DOI 10.1021/bi983040c; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Zhang L, 2006, MED HYPOTHESES, V67, P41, DOI 10.1016/j.mehy.2005.09.055	50	69	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81270	10.1371/journal.pone.0081270	http://dx.doi.org/10.1371/journal.pone.0081270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303038	Green Published, gold			2022-12-25	WOS:000327546400055
J	Srinivasan, S; Morgan, MT; Liu, CZ; Matsen, FA; Hoffman, NG; Fiedler, TL; Agnew, KJ; Marrazzo, JM; Fredricks, DN				Srinivasan, Sujatha; Morgan, Martin T.; Liu, Congzhou; Matsen, Frederick A.; Hoffman, Noah G.; Fiedler, Tina L.; Agnew, Kathy J.; Marrazzo, Jeanne M.; Fredricks, David N.			More Than Meets the Eye: Associations of Vaginal Bacteria with Gram Stain Morphotypes Using Molecular Phylogenetic Analysis	PLOS ONE			English	Article							METRONIDAZOLE THERAPY; VAGINOSIS; BACTEROIDES; GENUS; IDENTIFICATION; MICROFLORA; MOBILUNCUS; PREVOTELLA; SEQUENCES; PROPOSAL	Bacterial vaginosis (BV) is a highly prevalent condition associated with adverse health outcomes. Gram stain analysis of vaginal fluid is the standard for confirming the diagnosis of BV, wherein abundances of key bacterial morphotypes are assessed. These Lactobacillus, Gardnerella, Bacteroides, and Mobiluncus morphotypes were originally linked to particular bacterial species through cultivation studies, but no studies have systematically investigated associations between uncultivated bacteria detected by molecular methods and Gram stain findings. In this study, 16S-rRNA PCR/pyrosequencing was used to examine associations between vaginal bacteria and bacterial morphotypes in 220 women with and without BV. Species-specific quantitative PCR (qPCR) and fluorescence in Situ hybridization (FISH) methods were used to document concentrations of two bacteria with curved rod morphologies: Mobiluncus and the fastidious BV-associated bacterium-1 (BVAB1). Rank abundance of vaginal bacteria in samples with evidence of curved gram-negative rods showed that BVAB1 was dominant (26.1%), while Mobiluncus was rare (0.2% of sequence reads). BVAB1 sequence reads were associated with Mobiluncus morphotypes (p<0.001). Among women with curved rods, mean concentration of BVAB1 DNA was 2 log units greater than Mobiluncus (p<0.001) using species-specific quantitative PCR. FISH analyses revealed that mean number of BVAB1 cells was 2 log units greater than Mobiluncus cells in women with highest Nugent score (p<0.001). Prevotella and Porphyromonas spp. were significantly associated with the "Bacteroides morphotype," whereas Bacteroides species were rare. Gram-negative rods designated Mobiluncus morphotypes on Gram stain are more likely BVAB1. These findings provide a clearer picture of the bacteria associated with morphotypes on vaginal Gram stain.	[Srinivasan, Sujatha; Liu, Congzhou; Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Morgan, Martin T.; Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Agnew, Kathy J.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Marrazzo, Jeanne M.; Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fhcrc.org; dfredric@fhcrc.org		Fredricks, David/0000-0003-2735-6800; Marrazzo, Jeanne/0000-0002-9277-7364; Morgan, Martin/0000-0002-5874-8148	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH) [R01 AI061628]; National Human Genome Research Institute (NHGRI), division of NIH [R01 HG005966-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI), division of NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded with grants R01 AI061628 to Dr. DNF from National Institute of Allergy and Infectious Diseases (NIAID) (www3.niaid.nih.gov), division of National Institutes of Health (NIH) and R01 HG005966-01 to Dr. DNF and Dr. FAM (co-PIs) from National Human Genome Research Institute (NHGRI) (www.genome.gov), division of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Holst E, 1984, Scand J Urol Nephrol Suppl, V86, P117; Hummelen R, 2010, PLOS ONE, V5; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; Morgan M, 2012, DIRICHLET MULTINOMIA; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7; PASTER BJ, 1994, J BACTERIOL, V176, P725, DOI 10.1128/jb.176.3.725-732.1994; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBERTS MC, 1985, J INFECT DIS, V152, P74, DOI 10.1093/infdis/152.1.74; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwebke JR, 2007, CLIN INFECT DIS, V44, P213, DOI 10.1086/509577; SHAH HN, 1989, INT J SYST BACTERIOL, V39, P85, DOI 10.1099/00207713-39-1-85; SHAH HN, 1988, INT J SYST BACTERIOL, V38, P128, DOI 10.1099/00207713-38-1-128; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Sobel J, 2001, Infect Dis Obstet Gynecol, V9, P9, DOI 10.1155/S1064744901000035; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; Srinivasan S, 2012, PLOS ONE, V7; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thoma ME, 2011, SEX TRANSM DIS, V38, P1040, DOI 10.1097/OLQ.0b013e3182275499; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	39	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78633	10.1371/journal.pone.0078633	http://dx.doi.org/10.1371/journal.pone.0078633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302980	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300075
J	Curtil, C; Enache, LS; Radreau, P; Dron, AG; Scholtes, C; Deloire, A; Roche, D; Lotteau, V; Andre, P; Ramiere, C				Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Roche, Didier; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe			The metabolic sensors FXR alpha, PGC-1 alpha, and SIRT1 cooperatively regulate hepatitis B virus transcription	FASEB JOURNAL			English	Article						HBV; epigenetic; metabolism; nuclear receptors	DEACETYLASE; DELETION; ELEMENTS; ENHANCER; HBV	Hepatitis B virus (HBV) genome transcription is highly dependent on liver-enriched, metabolic nuclear receptors (NRs). Among others, NR farnesoid X receptor (FXR) enhances HBV core promoter activity and pregenomic RNA synthesis. Interestingly, two food-withdrawal-induced FXR modulators, peroxisome proliferator-activated receptor- coactivator 1 (PGC-1) and deacetylase SIRT1, have been found to be associated with HBV genomes ex vivo. Whereas PGC-1 induction was shown to increase HBV replication, the effect of SIRT1 on HBV transcription remains unknown. Here, we showed that, in hepatocarcinoma-derived Huh-7 cells, combined activation of FXR by GW4064 and SIRT1 by activator 3 increased HBV core promoter-controlled luciferase expression by 25-fold, compared with a 10-fold increase with GW4064 alone. Using cell lines differentially expressing FXR in overexpression and silencing experiments, we demonstrated that SIRT1 activated the core promoter in an FXR- and PGC-1-dependent manner. Maximal activation (>150-fold) was observed in FXR- and PGC-1-overexpressing Huh-7 cells treated with FXR and SIRT1 activators. Similarly, in cells transfected with full-length HBV genomes, maximal induction (3.5-fold) of core promoter-controlled synthesis of 3.5-kb RNA was observed in the same conditions of transfection and treatments. Thus, we identified a subnetwork of metabolic factors regulating HBV replication, strengthening the hypothesis that transcription of HBV and metabolic genes is similarly controlled.Curtil, C., Enache, L. S., Radreau, P., Dron, A.-G., Scholtes, C., Deloire, A., Roche, D., Lotteau, V., Andre, P., and Ramiere, C. The metabolic sensors FXR, PGC-1, and SIRT1 cooperatively regulate hepatitis B virus transcription.	[Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe] Univ Lyon, Ctr Int Rech Infectiol CIRI, Lyon, France; [Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe] Inst Natl Sante & Rech Med INSERM, U1111, Lyon, France; [Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe] Ecole Normale Super Lyon, F-69364 Lyon, France; [Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe] Univ Lyon 1, CIRI, F-69365 Lyon, France; [Curtil, Claire; Enache, Liviu S.; Radreau, Pauline; Dron, Anne-Gaelle; Scholtes, Caroline; Deloire, Alexandre; Lotteau, Vincent; Andre, Patrice; Ramiere, Christophe] Ctr Natl Recherce Sci CNRS, Unite Mixte Rech UMR 5308, Lyon, France; [Dron, Anne-Gaelle; Scholtes, Caroline; Andre, Patrice; Ramiere, Christophe] Hosp Civils Lyon, Lyon, France; [Enache, Liviu S.] Univ Med & Pharm, Targumures, Romania; [Enache, Liviu S.] Emergency Clin Hosp, Targumures, Romania; [Roche, Didier] Edelris SAS, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon	Andre, P (corresponding author), INSERM, U1111, Ctr Int Rech Infectiol, 21 Ave Tony Garnier, F-69365 Lyon 07, France.	patrice.andre@inserm.fr	Ramière, Christophe/M-8083-2014; André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014; Scholtès, Caroline/B-9039-2011	Ramière, Christophe/0000-0002-1981-7155; André, Patrice/0000-0002-5834-7395; Scholtès, Caroline/0000-0003-0691-8480; Enache, Liviu Sorin/0000-0002-0391-9982; Lotteau, Vincent/0000-0003-0997-3282	Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS); Natheb program (French Fond Unique Interministeriel); Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian government [POSDRU 6/1.5/17]	Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Natheb program (French Fond Unique Interministeriel); Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian government(Romanian Government)	Work was supported by a grant from Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS) and by the Natheb program (French Fond Unique Interministeriel). L. S. E. was partly supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian government under contract POSDRU 6/1.5/17. The authors acknowledge the contribution of the AniRA level 3 security laboratory and genetic analysis platforms of SFR Biosciences Gerland-Lyon Sud (AMS3444/US8).	Bar-Yishay I, 2011, LIVER INT, V31, P282, DOI 10.1111/j.1478-3231.2010.02423.x; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Guise AJ, 2013, VIRUSES-BASEL, V5, P1607, DOI 10.3390/v5071607; GUNTHER S, 1995, J VIROL, V69, P5437; Herbein G, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0003-5; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li L, 2009, J VIROL, V83, P1682, DOI 10.1128/JVI.02208-08; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Ondracek CR, 2009, J VIROL, V83, P12535, DOI 10.1128/JVI.01623-09; Ondracek CR, 2009, J VIROL, V83, P12545, DOI 10.1128/JVI.01624-09; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Reese V, 2011, INT J BIOCHEM CELL B, V43, P230, DOI 10.1016/j.biocel.2009.11.016; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Sambrook J, 2001, MOL CLONING LAB MANU; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103; Srisuttee R, 2012, ONCOL REP, V28, P276, DOI 10.3892/or.2012.1798; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Wu S, 2011, CANCER LETT, V312, P33, DOI 10.1016/j.canlet.2011.07.025; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; YUH CH, 1990, J VIROL, V64, P4281, DOI 10.1128/JVI.64.9.4281-4287.1990; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	38	34	38	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1454	1463		10.1096/fj.13-236372	http://dx.doi.org/10.1096/fj.13-236372			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297698				2022-12-25	WOS:000335324800036
J	Lauridsen, HM; Pober, JS; Gonzalez, AL				Lauridsen, Holly M.; Pober, Jordan S.; Gonzalez, Anjelica L.			A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment	FASEB JOURNAL			English	Article						neutrophil migration; ICAM-1; N-cadherin; pericyte; endothelial cell; inflammation; transmigration	VASCULAR ENDOTHELIAL-CELLS; TRANSENDOTHELIAL MIGRATION; PERICYTES; CADHERIN; P120-CATENIN; DIAPEDESIS; ADHESION; CULTURE; SITE; CD99	Neutrophil extravasation occurs across postcapillary venules, structures composed of endothelial cells (ECs), pericytes (PCs), and basement membrane (BM). We constructed composite models of the human postcapillary venule, combining ECs with PCs or PC-deposited BM, to better study this process. Quiescent and tumor necrosis factor (TNF-)-activated composites demonstrated in situ-like expression of cadherins, E-selectin, intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet-endothelial cell adhesion molecule 1 (PECAM-1), CD99, and interleukin 8 (IL-8). After TNF- activation, the ECs supported greater neutrophil adhesion (66.1 vs. 23.7% of input cells) and transmigration (35.1 vs. 7.20% of input cells) than did the PCs, but the composites behaved comparably (no significant difference) to ECs in both assays. TNF--activated EC-conditioned medium (CM) increased transmigration across the PCs, whereas TNF--activated PC-CM decreased transmigration across the ECs, and culturing on PC-derived BM decreased both adhesion to and transmigration across the ECs. Anti-very late antigen 4 (VLA-4; on neutrophils) inhibited adhesion to TNF--activated composites, but not to ECs alone. Anti-CD99 (expressed on all 3 cell types) inhibited transmigration across the composites (14.5% of control) more than across the ECs (39.0% of control), and venular shear stress reduced transmigration across the ECs (17.3% of static) more than across the composites (36.7% of static). These results provide proof of concept that our composite human EC/PC/BM venular construct can reveal new interactions in the inflammatory cascade.Lauridsen, H. M., Pober, J. S., Gonzalez, A. L. A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment.	[Lauridsen, Holly M.; Gonzalez, Anjelica L.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Yale University	Gonzalez, AL (corresponding author), Yale Univ, Malone Engn Ctr 314, 55 Prospect St, New Haven, CT 06520 USA.	anjelica.gonzalez@yale.edu			U.S. National Institutes of Health [HL051014]; Dubinsky New Initiative grant; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051014] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dubinsky New Initiative grant; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Kathryn Miller-Jensen for allowing them to use the LI-COR Scanner, Dr. Thomas Manes for help with immunofluorescence, and Dr. Cheryl Maier for discussions and review of the manuscript. Facilities used were supported by the Yale Institute for Nanoscience and Quantum Engineering and National Science Foundation (NSF), Materials Research Science and Engineering Center (MRSEC), Division of Materials Research (DMR) 1119826. A.L.G. and J.S.P. were supported by U.S. National Institutes of Health grant HL051014, with additional support for A.L.G. coming from the Dubinsky New Initiative grant and The Hartwell Foundation.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bixel MG, 2010, BLOOD, V116, P1172, DOI 10.1182/blood-2009-12-256388; Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4; Burns AR, 1997, J IMMUNOL, V159, P2893; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Ding ZM, 1999, J IMMUNOL, V163, P5029; Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115; Gentil-dit-Maurin A, 2010, EXP CELL RES, V316, P2587, DOI 10.1016/j.yexcr.2010.06.015; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; MERIMEE TJ, 1970, J CLIN INVEST, V49, P2161, DOI 10.1172/JCI106434; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nelson C, 2004, STRAD, V115, P15; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Voisin M.-B., AM J PATHOL, V176, P482	30	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1166	1180		10.1096/fj.13-240986	http://dx.doi.org/10.1096/fj.13-240986			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297702	Green Published			2022-12-25	WOS:000335324800013
J	Yip, YY; Yeap, YYC; Bogoyevitch, MA; Ng, DCH				Yip, Yan Y.; Yeap, Yvonne Y. C.; Bogoyevitch, Marie A.; Ng, Dominic C. H.			cAMP-dependent Protein Kinase and c-Jun N-terminal Kinase Mediate Stathmin Phosphorylation for the Maintenance of Interphase Microtubules during Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Jun N-terminal Kinase (JNK); Protein Kinase A (PKA); Protein Phosphorylation; Signal Transduction; Osmotic Stress; Stathmin	ONCOPROTEIN 18; MULTISITE PHOSPHORYLATION; PHOSPHOPROTEIN STATHMIN; DESTABILIZING ACTIVITY; INHIBITOR SELECTIVITY; INDUCED APOPTOSIS; CYTOSOLIC TARGET; POTENTIAL TARGET; BINDING PROTEIN; T-LYMPHOCYTES	Dynamic microtubule changes after a cell stress challenge are required for cell survival and adaptation. Stathmin (STMN), a cytoplasmic microtubule-destabilizing phosphoprotein, regulates interphase microtubules during cell stress, but the signaling mechanisms involved are poorly defined. In this study ectopic expression of single alanine-substituted phospho-resistant mutants demonstrated that STMN Ser-38 and Ser-63 phosphorylation were specifically required to maintain interphase microtubules during hyperosmotic stress. STMN was phosphorylated on Ser-38 and Ser-63 in response to hyperosmolarity, heat shock, and arsenite treatment but rapidly dephosphorylated after oxidative stress treatment. Two-dimensional PAGE and Phos-tag gel analysis of stress-stimulated STMN phospho-isoforms revealed rapid STMN Ser-38 phosphorylation followed by subsequent Ser-25 and Ser-63 phosphorylation. Previously, we delineated stress-stimulated JNK targeting of STMN. Here, we identified cAMP-dependent protein kinase (PKA) signaling as responsible for stress-induced STMN Ser-63 phosphorylation. Increased cAMP levels induced by cholera toxin triggered potent STMN Ser-63 phosphorylation. Osmotic stress stimulated an increase in PKA activity and elevated STMN Ser-63 and CREB (cAMP-response element-binding protein) Ser-133 phosphorylation that was substantially attenuated by pretreatment with H-89, a PKA inhibitor. Interestingly, PKA activity and subsequent phosphorylation of STMN were augmented in the absence of JNK activation, indicating JNK and PKA pathway cross-talk during stress regulation of STMN. Taken together our study indicates that JNK- and PKA-mediated STMN Ser-38 and Ser-63 phosphorylation are required to preserve interphase microtubules in response to hyperosmotic stress.	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Ng, DCH (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Bogoyevitch, Marie/0000-0001-9745-3716	National Health and Medical Research Council of Australia [628335, 566804]; Australian Research Council [FT120100193]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was funded by National Health and Medical Research Council of Australia Grants 628335 (to D. C. H. N.) and 566804 (to M. A. B.).; Supported by an Australian Research Council Future Fellowship (FT120100193). To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, 30 Flemington Rd., Parkville, VIC, Australia 3010. Tel.: 61-3-8344-2543; Fax: 61-3-9348-1421; E-mail: ngd@unimelb.edu.au.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1995, EUR J BIOCHEM, V227, P388, DOI 10.1111/j.1432-1033.1995.tb20401.x; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Byrne F. L., 2013, ONCOGENE, DOI 10.1038/onc.2013.11; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chae HJ, 2004, IMMUNOPHARM IMMUNOT, V26, P249, DOI 10.1081/IPH-120037722; Chen PW, 2010, J BIOL CHEM, V285, P10053, DOI 10.1074/jbc.M109.044420; CHNEIWEISS H, 1989, J NEUROCHEM, V53, P856, DOI 10.1111/j.1471-4159.1989.tb11783.x; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Gavet O, 1998, J CELL SCI, V111, P3333; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Holmfeldt P, 2007, MOL BIOL CELL, V18, P1909, DOI 10.1091/mbc.E07-01-0019; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; HSUEH YP, 1995, J BIOL CHEM, V270, P18094, DOI 10.1074/jbc.270.30.18094; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita-Kikuta E, 2012, ELECTROPHORESIS, V33, P849, DOI 10.1002/elps.201100518; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; le Gouvello S, 1998, J IMMUNOL, V161, P1113; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng DCH, 2011, J BIOL CHEM, V286, P1576, DOI 10.1074/jbc.M110.128157; Ng DCH, 2010, J BIOL CHEM, V285, P29001, DOI 10.1074/jbc.M110.128454; Santamaria E, 2009, PROTEOMICS, V9, P4495, DOI 10.1002/pmic.200900110; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; SOBEL A, 1989, J BIOL CHEM, V264, P3765; Togano T, 2005, J NEUROSCI RES, V80, P475, DOI 10.1002/jnr.20462; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; Wang C, 2011, BIOCHEMISTRY-MOSCOW+, V76, P320, DOI 10.1134/S0006297911030047; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; White E, 2011, PFLUG ARCH EUR J PHY, V462, P177, DOI 10.1007/s00424-011-0963-0; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87	54	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2157	2169		10.1074/jbc.M113.470682	http://dx.doi.org/10.1074/jbc.M113.470682			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302736	hybrid, Green Published			2022-12-25	WOS:000331130200024
J	Crespillo, S; Casares, S; Mateo, PL; Conejero-Lara, F				Crespillo, Sara; Casares, Salvador; Mateo, Pedro L.; Conejero-Lara, Francisco			Thermodynamic Analysis of the Binding of 2F5 (Fab and Immunoglobulin G Forms) to Its gp41 Epitope Reveals a Strong Influence of the Immunoglobulin Fc Region on Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ISOTHERMAL TITRATION CALORIMETRY; HUMAN MONOCLONAL-ANTIBODY; CONSTANT-REGION; ANTIGEN-BINDING; CONFORMATIONAL-CHANGES; ECTODOMAIN REGION; HIV-1 VACCINE; MEMBRANE; NEUTRALIZATION	Immunotherapies and vaccines based on the induction of broadly neutralizing monoclonal antibodies (bNAbs) have become outstanding strategies against HIV-1. Diverse bNAbs recognizing different regions of the HIV-1 envelope have been identified and extensively studied. However, there is little information about the thermodynamics of binding of these bNAbs and their epitopes. We used isothermal titration calorimetry to characterize thermodynamically the interactions between bNAb 2F5 (in both the IgG and Fab forms) and its functional and core epitope peptides. We found that these interactions are enthalpically driven and opposed by a negative entropy change. The highest affinity was found for 2F5 IgG for its functional epitope, indicating that additional interactions involving residues flanking the core epitope contribute strongly to higher affinity. In addition, the strong influence of the Fc region on the binding affinity suggests long-range allosteric effects within IgG. Our results provide useful information for developing new therapeutics against HIV-1 and, in a broader scope, contribute to a better understanding of antigen-antibody recognition.	[Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	University of Granada; University of Granada	Conejero-Lara, F (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain.	conejero@ugr.es	Lara, Francisco Conejero/F-2962-2016	Lara, Francisco Conejero/0000-0002-8282-2168	European Union [201038]	European Union(European Commission)	This work was supported by European Union Seventh Framework Programme (FP7/2007-2013) Grant 201038.	Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; CAVACINI LA, 1995, J IMMUNOL, V155, P3638; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Greenspan NS, 2010, TRENDS IMMUNOL, V31, P138, DOI 10.1016/j.it.2010.01.001; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Huarte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052740; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2013, J BIOL CHEM, V288, P31888, DOI 10.1074/jbc.M113.494609; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Lu ZF, 2013, IMMUNOL LETT, V150, P152, DOI 10.1016/j.imlet.2013.01.011; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pritsch O, 1996, J CLIN INVEST, V98, P2235, DOI 10.1172/JCI119033; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sagawa T, 2005, MOL IMMUNOL, V42, P9, DOI 10.1016/j.molimm.2004.07.004; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Welfle K, 2003, J MOL RECOGNIT, V16, P54, DOI 10.1002/jmr.607; Wibbenmeyer JA, 1999, BBA-PROTEIN STRUCT M, V1430, P191, DOI 10.1016/S0167-4838(98)00285-4; Xia YM, 2013, MOL IMMUNOL, V56, P28, DOI 10.1016/j.molimm.2013.04.004	42	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					594	599		10.1074/jbc.C113.524439	http://dx.doi.org/10.1074/jbc.C113.524439			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24302742	hybrid, Green Published			2022-12-25	WOS:000330541200001
J	Basford, JE; Koch, S; Anjak, A; Singh, VP; Krause, EG; Robbins, N; Weintraub, NL; Hui, DY; Rubinstein, J				Basford, Joshua E.; Koch, Sheryl; Anjak, Ahmad; Singh, Vivek P.; Krause, Eric G.; Robbins, Nathan; Weintraub, Neal L.; Hui, David Y.; Rubinstein, Jack			Smooth Muscle LDL Receptor-Related Protein-1 Deletion Induces Aortic Insufficiency and Promotes Vascular Cardiomyopathy in Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; LEFT-VENTRICULAR FUNCTION; MARFAN-SYNDROME; CORONARY-ARTERY; TGF-BETA; NONINVASIVE MEASUREMENT; EXPRESSION; MOUSE; HEMODYNAMICS; CONTRIBUTES	Valvular disease is common in patients with Marfan syndrome and can lead to cardiomyopathy. However, some patients develop cardiomyopathy in the absence of hemodynamically significant valve dysfunction, suggesting alternative mechanisms of disease progression. Disruption of LDL receptor-related protein-1 (Lrp1) in smooth muscle cells has been shown to cause vascular pathologies similar to Marfan syndrome, with activation of smooth muscle cells, vascular dysfunction and aortic aneurysms. This study used echocardiography and blood pressure monitoring mouse models to determine whether inactivation of Lrp1 in vascular smooth muscle leads to cardiomyopathy, and if so, whether the mechanism is a consequence of valvular disease. Hemodynamic changes during treatment with captopril were also assessed. Dilation of aortic roots was observed in young Lrp1-knockout mice and progressed as hey aged, whereas no significant aortic dilation was detected in wild type littermates. Diastolic blood pressure was lower and pulse pressure higher in Lrp1-knockout mice, which was normalized by treatment with captopril. Aortic dilation was followed by development of aortic insufficiency and subsequent dilated cardiomyopathy due to valvular disease. Thus, smooth muscle cell Lrp1 deficiency results in aortic dilation and insufficiency that causes secondary cardiomyopathy that can be improved by captopril. These findings provide novel insights into mechanisms of cardiomyopathy associated with vascular activation and offer a new model of valvular cardiomyopathy,	[Basford, Joshua E.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol, Metab Dis Inst, Cincinnati, OH 45221 USA; [Koch, Sheryl; Anjak, Ahmad; Robbins, Nathan; Weintraub, Neal L.; Rubinstein, Jack] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH USA; [Singh, Vivek P.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Krause, Eric G.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol, Metab Dis Inst, Cincinnati, OH 45221 USA.	huidy@ucmail.uc.edu; rubinsjk@ucmail.uc.edu		Weintraub, Neal/0000-0002-5138-3705; Robbins, Nathan/0000-0002-9275-0778; Rubinstein, Jack/0000-0002-8811-1551; Krause, Eric/0000-0002-2718-3113	National Institutes of Health [DK074932, HL076684]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076684, R01HL112640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants DK074932 to David Hui and HL076684 to Neal Weintraub. The funders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Biros E, 2012, ATHEROSCLEROSIS, V221, P383, DOI 10.1016/j.atherosclerosis.2012.01.004; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Canadas V, 2010, NAT REV CARDIOL, V7, P256, DOI 10.1038/nrcardio.2010.30; Chatrath R, 2003, AM J CARDIOL, V91, P914, DOI 10.1016/S0002-9149(03)00039-0; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; Conlin PR, 2000, HYPERTENSION, V36, P461, DOI 10.1161/01.HYP.36.3.461; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Feintuch A, 2007, AM J PHYSIOL-HEART C, V292, pH884, DOI 10.1152/ajpheart.00796.2006; Garcia M, 2009, J APPL PHYSIOL, V106, P1338, DOI 10.1152/japplphysiol.90592.2008; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HARTLEY CJ, 1995, AM J PHYSIOL-HEART C, V268, pH499, DOI 10.1152/ajpheart.1995.268.1.H499; Heimdal A, 1998, J AM SOC ECHOCARDIOG, V11, P1013, DOI 10.1016/S0894-7317(98)70151-8; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mariko B, 2011, J PATHOL, V224, P33, DOI 10.1002/path.2840; Martin-McNulty B, 2005, ULTRASOUND MED BIOL, V31, P745, DOI 10.1016/j.ultrasmedbio.2005.02.012; Meijboom LJ, 2005, AM J CARDIOL, V95, P795, DOI 10.1016/j.amjcard.2004.11.042; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moltzer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023411; Motz W, 1996, HYPERTENSION, V27, P1031, DOI 10.1161/01.HYP.27.5.1031; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Nataatmadja M, 2006, CIRCULATION, V114, pI371, DOI 10.1161/CIRCULATIONAHA.105.000927; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Park S, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-1; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Saito M, 2008, HEART, V94, DOI 10.1136/hrt.2007.126128; SAVOLAINEN A, 1994, EUR HEART J, V15, P625, DOI 10.1093/oxfordjournals.eurheartj.a060558; Scherptong RWC, 2011, J AM SOC ECHOCARDIOG, V24, P1392, DOI 10.1016/j.echo.2011.09.004; Scherrer-Crosbie M, 2010, J MOL CELL CARDIOL, V48, P512, DOI 10.1016/j.yjmcc.2009.07.004; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; UREN NG, 1994, NEW ENGL J MED, V330, P1782, DOI 10.1056/NEJM199406233302503; Wang XW, 2006, CIRCULATION, V114, pI200, DOI 10.1161/CIRCULATIONAHA.105.000240; Wild JB, 2012, EUR J VASC ENDOVASC, V44, P127, DOI 10.1016/j.ejvs.2012.05.009; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004	49	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82026	10.1371/journal.pone.0082026	http://dx.doi.org/10.1371/journal.pone.0082026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312398	Green Submitted, gold, Green Published			2022-12-25	WOS:000327670300070
J	Nagaraju, SK; Gudasalamani, R; Barve, N; Ghazoul, J; Narayanagowda, GK; Ramanan, US				Nagaraju, Shivaprakash K.; Gudasalamani, Ravikanth; Barve, Narayani; Ghazoul, Jaboury; Narayanagowda, Ganeshaiah Kotiganahalli; Ramanan, Uma Shaanker			Do Ecological Niche Model Predictions Reflect the Adaptive Landscape of Species?: A Test Using Myristica malabarica Lam., an Endemic Tree in the Western Ghats, India	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; OVIPOSITION PREFERENCE; HABITAT SUITABILITY; POPULATION-SIZE; LEAF AGE; PLANT; FITNESS; REINTRODUCTION; DYNAMICS; DEPRESSION	Ecological niche models (ENM) have become a popular tool to define and predict the "ecological niche" of a species. An implicit assumption of the ENMs is that the predicted ecological niche of a species actually reflects the adaptive landscape of the species. Thus in sites predicted to be highly suitable, species would have maximum fitness compared to in sites predicted to be poorly suitable. As yet there are very few attempts to address this assumption. Here we evaluate this assumption. We used Bioclim (DIVA GIS version 7.3) and Maxent (version 3.3.2) to predict the habitat suitability of Myristica malabatica Lam., an economically important tree occurring in the Western Ghats, India. We located populations of the trees naturally occurring in different habitat suitability regimes (from highly suitable to poorly suitable) and evaluated them for their regeneration ability and genetic diversity. We also evaluated them for two plant functional traits, fluctuating asymmetry an index of genetic homeostasis, and specific leaf weight an index of primary productivity, often assumed to be good surrogates of fitness. We show a significant positive correlation between the predicted habitat quality and plant functional traits, regeneration index and genetic diversity of populations. Populations at sites predicted to be highly suitable had a higher regeneration and gene diversity compared to populations in sites predicted to be poor or unsuitable. Further, individuals in the highly suitable sites exhibited significantly less fluctuating asymmetry and significantly higher specific leaf weight compared to individuals in the poorly suitable habitats. These results for the first time provide an explicit test of the ENM with respect to the plant functional traits, regeneration ability and genetic diversity of populations along a habitat suitability gradient. We discuss the implication of these resultsfor designing viable species conservation and restoration programs	[Nagaraju, Shivaprakash K.; Ramanan, Uma Shaanker] Univ Agr Sci Bangalore, Dept Crop Physiol, Bangalore, Karnataka, India; [Nagaraju, Shivaprakash K.; Gudasalamani, Ravikanth; Narayanagowda, Ganeshaiah Kotiganahalli; Ramanan, Uma Shaanker] Univ Agr Sci Bangalore, Sch Ecol & Conservat, Bangalore, Karnataka, India; [Gudasalamani, Ravikanth; Narayanagowda, Ganeshaiah Kotiganahalli; Ramanan, Uma Shaanker] Ashoka Trust Res Ecol & Environm, Conservat Genet Lab, Bangalore, Karnataka, India; [Narayanagowda, Ganeshaiah Kotiganahalli] Univ Agr Sci Bangalore, Dept Forestry & Environm Sci, Bangalore, Karnataka, India; [Ghazoul, Jaboury] Inst Terr Ecosyst, Zurich, Switzerland; [Barve, Narayani] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Nagaraju, Shivaprakash K.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Nagaraju, Shivaprakash K.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Nagaraju, Shivaprakash K.] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada	University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; University of Kansas; Concordia University - Canada; Concordia University - Canada	Ramanan, US (corresponding author), Univ Agr Sci Bangalore, Dept Crop Physiol, Bangalore, Karnataka, India.	umashaanker@gmail.com	Ghazoul, Jaboury/B-2121-2018; Nagaraju, Shivaprakash/O-7654-2014; Barve, Narayani/B-8941-2017; G, Ravikanth/AAI-5668-2020	Nagaraju, Shivaprakash/0000-0002-5135-8737; Barve, Narayani/0000-0002-7893-8774; G, Ravikanth/0000-0002-9399-8580; Uma Shaanker, Ramanan/0000-0003-3100-7654	North-South Center, ETH Zurich, Switzerland; Department of Biotechnology (DBT), New Delhi	North-South Center, ETH Zurich, Switzerland; Department of Biotechnology (DBT), New Delhi(Department of Biotechnology (DBT) India)	This study was supported with grants to JG and USR from the North-South Center, ETH Zurich, Switzerland and a grant awarded to RG and USR from the Department of Biotechnology (DBT), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2008, EVOL ECOL, V22, P279, DOI 10.1007/s10682-007-9170-z; Adhikari D, 2012, ECOL ENG, V40, P37, DOI 10.1016/j.ecoleng.2011.12.004; Albert CH, 2008, ECOGRAPHY, V31, P417, DOI 10.1111/j.0906-7590.2008.05221.x; Armstrong DP, 2002, CONSERV BIOL, V16, P1074, DOI 10.1046/j.1523-1739.2002.00215.x; Barve N, 2012, REV MEX BIODIVERS, V83, P817, DOI 10.7550/rmb.26460; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bouzat JL, 1998, CONSERV BIOL, V12, P836, DOI 10.1046/j.1523-1739.1998.97164.x; BUSBY J R, 1991, Plant Protection Quarterly, V6, P8; CALVO RN, 1990, AM NAT, V136, P499, DOI 10.1086/285110; Carroll C, 2003, CONSERV BIOL, V17, P536, DOI 10.1046/j.1523-1739.2003.01552.x; Christensen R., 1996, PLANE ANSWERS COMPLE; CHRISTIANSEN FB, 1977, THEORIES POPULATIONS; Danks FS, 2002, INT J REMOTE SENS, V23, P4611, DOI 10.1080/01431160110113890; Dixon AL, 2013, MOL ECOL, V22, P1777, DOI 10.1111/mec.12207; Dostalek T, 2010, CONSERV GENET, V11, P773, DOI 10.1007/s10592-009-9879-z; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elmendorf SC, 2008, CONSERV BIOL, V22, P1523, DOI 10.1111/j.1523-1739.2008.01051.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Elton C, 1927, ANIMAL ECOLOGY, P256; Fischer M, 2003, CONSERV GENET, V4, P325, DOI 10.1023/A:1024051129024; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Ganeshaiah KN, 1998, ECON BOT, V52, P316, DOI 10.1007/BF02862150; Ganeshaiah KN, 2003, CURR SCI INDIA, V85, P1526; Ganeshaiah KN, 2003, SASYASAHYADRI DISTRI; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Gurgel-Goncalves R, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/705326; Hemmila S, 2010, CONSERV GENET RESOUR, V2, P305, DOI 10.1007/s12686-010-9212-7; Hensen I, 2005, FLORA, V200, P3, DOI 10.1016/j.flora.2004.05.001; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; Howlett BG, 2001, AGR FOREST ENTOMOL, V3, P121, DOI 10.1046/j.1461-9563.2001.00096.x; IUCN, 2013, IUCN RED LIST THREAT; Jackson CR, 2011, J NAT CONSERV, V19, P87, DOI 10.1016/j.jnc.2010.06.006; Jurik T, 1977, B ECOL SOC AM, V58, P32; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kozlov MV, 1996, J APPL ECOL, V33, P1489, DOI 10.2307/2404787; Krishnamoorthy B., 1997, PLANT GENETIC RESOUR, V3; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Li ZZ, 1997, ECOL MODEL, V104, P199, DOI 10.1016/S0304-3800(97)00127-0; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; MARKOW T.A., 1994, DEV INSTABILITY ITS; Martinez-Meyer E, 2012, BIOL LETT, V9, P1; Mittermeier R, 2005, HOTSPOTS REVISITED E; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Moller AP, 1998, ASYMMETRY DEV STABIL; Nagamitsu Teruyoshi, 2004, Plant Species Biology, V19, P13, DOI 10.1111/j.1442-1984.2004.00097.x; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polak T, 2011, CONSERV BIOL, V25, P424, DOI 10.1111/j.1523-1739.2011.01669.x; Pons T., 1992, SEEDS ECOLOGY REGENE; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saccheri IJ, 1999, GENETICS, V151, P1053; Saldanha CJ, 1996, FLORA KARNATAKA, V2, P535; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Steinbauer MJ, 1998, ECOL ENTOMOL, V23, P201, DOI 10.1046/j.1365-2311.1998.00122.x; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; THORNHILL R, 1992, ANIM BEHAV, V44, P867, DOI 10.1016/S0003-3472(05)80583-4; Thuiller W, 2010, BIOL LETTERS, V6, P120, DOI 10.1098/rsbl.2009.0669; Valkama J, 2001, J APPL ECOL, V38, P665, DOI 10.1046/j.1365-2664.2001.00628.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilsey BJ, 1998, ECOLOGY, V79, P2092, DOI 10.1890/0012-9658(1998)079[2092:LFAIWH]2.0.CO;2; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wright JW, 2006, ECOLOGY, V87, P2433, DOI 10.1890/0012-9658(2006)87[2433:EVOENM]2.0.CO;2	79	36	39	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82066	10.1371/journal.pone.0082066	http://dx.doi.org/10.1371/journal.pone.0082066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312402	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300072
J	Delgado-Sanchez, P; Yanez-Espinosa, L; Jimenez-Bremont, JF; Chapa-Vargas, L; Flores, J				Delgado-Sanchez, Pablo; Yanez-Espinosa, Laura; Jimenez-Bremont, Juan Francisco; Chapa-Vargas, Leonardo; Flores, Joel			Ecophysiological and Anatomical Mechanisms behind the Nurse Effect: Which Are More Important? A Multivariate Approach for Cactus Seedlings	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; RELATIVE GROWTH-RATE; ARABIDOPSIS-THALIANA LEAVES; OPUNTIA-FICUS-INDICA; CHLOROPLAST MOVEMENT; PHOTOSYNTHETIC METABOLISM; DROUGHT-STRESS; WATER-STRESS; LEAF-AREA; PLANT	Background: Cacti establish mostly occurs under the canopy of nurse plants which provide a less stressful micro-environment, although mechanisms underlying this process are unknown. The impact of the combination of light and watering treatments on Opuntia streptacantha (Cactaceae) seedlings was examined. Methods/Principal Findings: Ecophysiological [titratable acidity, osmotic potential ('solute potential', psi(s)), relative growth rate (RGR) and their components (NAR, SLA, and LWR)], anatomical (chloroplast density, chloroplast frequency, and cell area), and environmental [photosynthetic photon flux density (PPFD) and air temperature] sets of variables were analyzed, assessing relationships between them and measuring the intensity of the relationships. Three harvests were carried out at days 15, 30, and 45. psi(s) and acidity content were the most important responses for seedling establishment. The main anatomical and environmental variables were chloroplast density and water availability, respectively. Opuntia streptacantha seedlings establish better in the shade-watering treatment, due to higher psi(s) and acidity, unaffected chloroplasts, and lower PPFD. In addition, the chloroplasts of cells under high-light and non-watering treatment were clumped closer to the center of the cytosol than those under shade-drought, to avoid photoinhibition and/or to better distribute or utilize the penetrating light in the green plant tissue. Conclusions: Opuntia seedlings grow better under the shade, although they can tolerate drought in open spaces by increasing and moving chloroplasts and avoiding drastic decreases in their psi(s). This tolerance could have important implications for predicting the impact of climate change on natural desert regeneration, as well as for planning reforestation-afforestation practices, and rural land uses.	[Delgado-Sanchez, Pablo] Univ Autonoma San Luis Potosi, Fac Agron & Vet, Soledad De Graciano Sanc, Mexico; [Yanez-Espinosa, Laura] Univ Autonoma San Luis Potosi, Fac Ingn, Inst Invest Zonas Desert, Soledad De Graciano Sanc, Mexico; [Jimenez-Bremont, Juan Francisco] Inst Potosino Invest Cientifica & Tecnol, Div Biol Mol, San Luis Potosi, Mexico; [Chapa-Vargas, Leonardo; Flores, Joel] Inst Potosino Invest Cientif Tecnol, Div Ciencias Ambientales, San Luis Potosi, Mexico	Universidad Autonoma de San Luis Potosi; Universidad Autonoma de San Luis Potosi; Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Potosino Investigacion Cientifica y Tecnologica	Flores, J (corresponding author), Inst Potosino Invest Cientif Tecnol, Div Ciencias Ambientales, San Luis Potosi, Mexico.	joel@ipicyt.edu.mx	Flores, Joel/ABB-7877-2020; Yáñez-Espinosa, Laura/AAF-4742-2020; Yáñez-Espinosa, Laura/AAV-2337-2020; Delgado-Sánchez, Pablo/AAV-3840-2021; Jiménez Bremont, Juan Francisco/CAI-1278-2022; Jiménez Bremont, Juan Francisco/CAF-4866-2022; Jiménez Bremont, Juan Francisco/C-9256-2011	Yáñez-Espinosa, Laura/0000-0001-5211-3603; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Chapa-Vargas, Leonardo/0000-0001-5827-4328; Flores, Joel/0000-0001-8856-6022; Delgado-Sanchez, Pablo/0000-0003-2560-871X	Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Medio Ambiente y Recursos Naturales [2006-123818]; Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica [156205, 179982]; Programa de Mejoramiento [Profesorado/103.5/08/5562]; Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Agricultura, Ganaderia; Desarrollo Rural, Pesca y Alimentacion [2004-C01-216]	Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Medio Ambiente y Recursos Naturales; Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica; Programa de Mejoramiento; Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Agricultura, Ganaderia; Desarrollo Rural, Pesca y Alimentacion	This study was supported by Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Medio Ambiente y Recursos Naturales (2006-123818), Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica (156205 and 179982), Programa de Mejoramiento del Profesorado/103.5/08/5562 and Consejo Nacional de Ciencia y Tecnologia-Fondos Sectoriales-Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (2004-C01-216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTESOR A, 1992, ACTA OECOL, V13, P777; [Anonymous], 2010, DESERT WISDOM AGAVES; Bunker DE, 2005, J ECOL, V93, P794, DOI 10.1111/j.1365-2745.2005.01019.x; Cavalcante A, 2010, ECOL RES, V25, P781, DOI 10.1007/s11284-010-0708-0; Gallardo-Vasquez JC, 2007, J PROF ASSOC CACTUS, V9, P118; Cushman JC, 2002, PLANT CELL ENVIRON, V25, P295, DOI 10.1046/j.0016-8025.2001.00760.x; Cushman JC, 2001, PLANT PHYSIOL, V127, P1439, DOI 10.1104/pp.010818; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; FRANCO AC, 1988, ECOLOGY, V69, P1731, DOI 10.2307/1941151; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Galmes J, 2005, OECOLOGIA, V145, P21, DOI 10.1007/s00442-005-0106-4; GOLDSTEIN G, 1991, PLANT PHYSIOL, V95, P274, DOI 10.1104/pp.95.1.274; HANSCOM Z, 1978, PLANT PHYSIOL, V61, P327, DOI 10.1104/pp.61.3.327; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Khurana E, 2004, J TROP ECOL, V20, P385, DOI 10.1017/S026646740400135X; Koniger M, 2010, PHOTOSYNTH RES, V105, P213, DOI 10.1007/s11120-010-9580-6; Kondo A, 2004, PLANTA, V219, P500, DOI 10.1007/s00425-004-1252-3; Koniger M, 2008, J EXP BOT, V59, P2285, DOI 10.1093/jxb/ern099; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; LITTLEJOHN RO, 1983, OECOLOGIA, V59, P83, DOI 10.1007/BF00388078; Loza-Cornejo S, 2003, INTERCIENCIA, V28, P83; Martinez-Berdeja A, 2008, J ARID ENVIRON, V72, P1766, DOI 10.1016/j.jaridenv.2008.04.010; Maxwell K, 1999, PLANT PHYSIOL, V121, P89, DOI 10.1104/pp.121.1.89; McGarigal K., 2000, MULTIVARIATE STAT WI; McKenna MF, 1999, ECOSCIENCE, V6, P286, DOI 10.1080/11956860.1999.11682529; Nagy-Deri H, 2011, PHOTOSYNTHETICA, V49, P119, DOI 10.1007/s11099-011-0020-4; Naus J, 2008, J INTEGR PLANT BIOL, V50, P1292, DOI 10.1111/j.1744-7909.2008.00743.x; NOBEL PS, 1983, PLANT CELL ENVIRON, V6, P153, DOI 10.1111/j.1365-3040.1983.tb01888.x; NOBEL PS, 1987, PHYSIOL PLANTARUM, V70, P114, DOI 10.1111/j.1399-3054.1987.tb06119.x; NORTH GB, 1992, NEW PHYTOL, V120, P9, DOI 10.1111/j.1469-8137.1992.tb01053.x; Ortega-Alcala J, 1992, AGROCIENCIA SERIE MA, V3, P201; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; PEARCY RW, 1991, PLANT PHYSL ECOLOGY; Pimienta-Barrios E, 2002, ENVIRON EXP BOT, V47, P77, DOI 10.1016/S0098-8472(01)00114-9; Rizhsky L, 2003, J BIOL CHEM, V278, P38921, DOI 10.1074/jbc.M304987200; Rosas U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033936; Rundell P. W., 1991, PLANT PHYSL ECOLOGY, P29; Sato Y, 2007, STRUCTURE FUNCTION P, P527; Sharon Y, 2008, AQUAT BOT, V88, P273, DOI 10.1016/j.aquabot.2007.11.006; Shipley B, 2000, PLANT CELL ENVIRON, V23, P1207, DOI 10.1046/j.1365-3040.2000.00635.x; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Sortibran L, 2005, AM J BOT, V92, P700, DOI 10.3732/ajb.92.4.700; SZAREK SR, 1973, PLANT PHYSIOL, V52, P539, DOI 10.1104/pp.52.6.539; VARGASMENDOZA MC, 1992, SOUTHWEST NAT, V37, P379, DOI 10.2307/3671789; Winter K, 2005, FUNCT PLANT BIOL, V32, P381, DOI 10.1071/FP04123; WINTER K, 1992, OECOLOGIA, V91, P505, DOI 10.1007/BF00650323; Winter K, 2011, J EXP BOT, V62, P4037, DOI 10.1093/jxb/err106; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Yamada M, 2009, PLANT CELL PHYSIOL, V50, P1736, DOI 10.1093/pcp/pcp116; Yanez-Espinosa L, 2006, ANN BOT-LONDON, V98, P637, DOI 10.1093/aob/mcl142; YEATON RI, 1986, J ECOL, V74, P211, DOI 10.2307/2260359; Zanudo-Hernandez J, 2010, J PROF ASSOC CACTUS, V12, P20	54	15	15	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81513	10.1371/journal.pone.0081513	http://dx.doi.org/10.1371/journal.pone.0081513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312310	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900036
J	Yang, YJ; Tarabra, E; Yang, GS; Vaitheesvaran, B; Palacios, G; Kurland, IJ; Pessin, JE; Bastie, CC				Yang, Yingjuan; Tarabra, Elena; Yang, Gong-She; Vaitheesvaran, Bhavapriya; Palacios, Gustavo; Kurland, Irwin J.; Pessin, Jeffrey E.; Bastie, Claire C.			Alteration of De Novo Glucose Production Contributes to Fasting Hypoglycaemia in Fyn Deficient Mice	PLOS ONE			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; MUSCLE PHOSPHOFRUCTOKINASE; GLUCAGON; GLUCONEOGENESIS; DISPOSAL; MOUSE	Previous studies have demonstrated that glucose disposal is increased in the Fyn knockout (FynKO) mice due to increased insulin sensitivity. FynKO mice also display fasting hypoglycaemia despite decreased insulin levels, which suggested that hepatic glucose production was unable to compensate for the increased basal glucose utilization. The present study investigates the basis for the reduction in plasma glucose levels and the reduced ability for the liver to produce glucose in response to gluconeogenic substrates. FynKO mice had a 5-fold reduction in phosphoenolpyruvate carboxykinase (PEPCK) gene and protein expression and a marked reduction in pyruvate, pyruvate/lactate-stimulated glucose output. Remarkably, de novo glucose production was also blunted using gluconeogenic substrates that bypass the PEPCK step. Impaired conversion of glycerol to glucose was observed in both glycerol tolerance test and determination of the conversion of C-13-glycerol to glucose in the fasted state. alpha-glycerol phosphate levels were reduced but glycerol kinase protein expression levels were not changed. Fructose-driven glucose production was also diminished without alteration of fructokinase expression levels. The normal levels of dihydroxyacetone phosphate and glyceraldehyde-3-phosphate observed in the FynKO liver extracts suggested normal triose kinase function. Fructose-bisphosphate aldolase (aldolase) mRNA or protein levels were normal in the Fyn-deficient livers, however, there was a large reduction in liver fructose-6-phosphate (30-fold) and fructose-1,6-bisphosphate (7-fold) levels as well as a reduction in glucose-6-phosphate (2-fold) levels. These data suggest a mechanistic defect in the allosteric regulation of aldolase activity.	[Yang, Yingjuan; Yang, Gong-She] Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China; [Yang, Yingjuan; Tarabra, Elena; Vaitheesvaran, Bhavapriya; Palacios, Gustavo; Kurland, Irwin J.; Pessin, Jeffrey E.; Bastie, Claire C.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Palacios, Gustavo] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Bastie, Claire C.] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England	Northwest A&F University - China; Yeshiva University; Albert Einstein College of Medicine; St Jude Children's Research Hospital; Yeshiva University; Albert Einstein College of Medicine; University of Warwick	Yang, GS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China.	gsyang999@hotmail.com; Claire.Bastie@einstein.yu.edu	Palacios, Gustavo/I-7773-2015	Palacios, Gustavo/0000-0001-5062-1938; Bastie, Claire/0000-0001-8178-4748	National Institutes of Health [DK81412, DK020541, DK033823, DK58132]; Ellison Medical Foundation; National Basic Research Program of China [2012CB124705]; Diabetes Research and Training Center (DRTC) NIH [P60DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033823, R01DK058132, P30DK020541, R01DK033823, R01DK081412, P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Basic Research Program of China(National Basic Research Program of China); Diabetes Research and Training Center (DRTC) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by grants from the National Institutes of Health DK81412 (CCB), DK020541 and DK033823 (JEP), DK58132 (IJK), the Ellison Medical Foundation (New Scholars Award in Aging, CCB) and the National Basic Research Program of China (2012CB124705). LC-MS method development is additionally supported by Diabetes Research and Training Center (DRTC) NIH grant P60DK020541 (Albert Einstein College of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Dalby AR, 2001, ACTA CRYSTALLOGR D, V57, P1526, DOI 10.1107/S0907444901012719; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Lal A, 2005, PHYTOCHEMISTRY, V66, P968, DOI 10.1016/j.phytochem.2005.03.009; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Marcondes MC, 2011, IUBMB LIFE, V63, P435, DOI 10.1002/iub.464; Matsuda M, 2002, METABOLISM, V51, P1111, DOI 10.1053/meta.2002.34700; Neufeld DS, 1997, METHOD MOL BIOL, V75, P145; OROSZ F, 1987, BIOCHEM BIOPH RES CO, V147, P1121, DOI 10.1016/S0006-291X(87)80186-9; Rais B, 2000, BBA-PROTEIN STRUCT M, V1479, P303, DOI 10.1016/S0167-4838(00)00047-9; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shah P, 1999, AM J PHYSIOL-ENDOC M, V277, pE283, DOI 10.1152/ajpendo.1999.277.2.E283; Sygusch J, 1997, BIOCHEM J, V327, P717, DOI 10.1042/bj3270717; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Xu J, 2006, DIABETES, V55, P3372, DOI 10.2337/db06-0002; Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x	20	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81866	10.1371/journal.pone.0081866	http://dx.doi.org/10.1371/journal.pone.0081866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312371	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900057
J	Li, HH; Li, J; Wasserloos, KJ; Wallace, C; Sullivan, MG; Bauer, PM; Stolz, DB; Lee, JS; Watkins, SC; St Croix, CM; Pitt, BR; Zhang, LM				Li, Hui-Hua; Li, Jin; Wasserloos, Karla J.; Wallace, Callen; Sullivan, Mara G.; Bauer, Philip M.; Stolz, Donna B.; Lee, Janet S.; Watkins, Simon C.; St Croix, Claudette M.; Pitt, Bruce R.; Zhang, Li-Ming			Caveolae-Dependent and -Independent Uptake of Albumin in Cultured Rodent Pulmonary Endothelial Cells	PLOS ONE			English	Article							CAPILLARY-PERMEABILITY; ENDOCYTOSIS; TRANSPORT; TRANSCYTOSIS; MICE; DEFECTS; PHOSPHORYLATION; MECHANISMS; MOLECULES; CLATHRIN	Although a critical role for caveolae-mediated albumin transcytosis in pulmonary endothelium is well established, considerably less is known about caveolae-independent pathways. In this current study, we confirmed that cultured rat pulmonary microvascular (RPMEC) and pulmonary artery (RPAEC) endothelium endocytosed Alexa488-labeled albumin in a saturable, temperature-sensitive mode and internalization resulted in co-localization by fluorescence microscopy with cholera B toxin and caveolin-1. Although siRNA to caveolin-1 (cav-1) in RPAEC significantly inhibited albumin uptake, a remnant portion of albumin uptake was cav-1-independent, suggesting alternative pathways for albumin uptake. Thus, we isolated and cultured mouse lung endothelial cells (MLEC) from wild type and cav-1(-/-) mice and noted that similar to 65% of albumin uptake, as determined by confocal imaging or live cell total internal reflectance fluorescence microscopy (TIRF), persisted in total absence of cav-1. Uptake of colloidal gold labeled albumin was evaluated by electron microscopy and demonstrated that albumin uptake in MLEC from cav-1(-/-) mice was through caveolae-independent pathway(s) including clathrin-coated pits that resulted in endosomal accumulation of albumin. Finally, we noted that albumin uptake in RPMEC was in part sensitive to pharmacological agents (amiloride [sodium transport inhibitor], Go6976 [protein kinase C inhibitor], and cytochalasin D [inhibitor of actin polymerization]) consistent with a macropinocytosis-like process. The amiloride sensitivity accounting for macropinocytosis also exists in albumin uptake by both wild type and cav-1(-/-) MLEC. We conclude from these studies that in addition to the well described caveolar-dependent pulmonary endothelial cell endocytosis of albumin, a portion of overall uptake in pulmonary endothelial cells is cav-1 insensitive and appears to involve clathrin-mediated endocytosis and macropinocytosis-like process.	[Li, Hui-Hua; Zhang, Li-Ming] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Li, Hui-Hua; Li, Jin; Wasserloos, Karla J.; Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Wallace, Callen; Sullivan, Mara G.; Stolz, Donna B.; Watkins, Simon C.; St Croix, Claudette M.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Ctr Biol Imaging, Pittsburgh, PA USA; [Lee, Janet S.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pitt, BR (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	brucep@pitt.edu; ZhangL1@anes.upmc.edu	Watkins, Simon/ABG-2590-2021; St Croix, Claudette/AAA-3338-2022	Watkins, Simon/0000-0003-4092-1552; Lee, Janet/0000-0002-6812-6043	National Institutes of Health (NIH) [K08 HL79456-01A1, R37 HL65697, P50 GM53789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079456, R37HL065697, R01HL086884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789, U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) K08 HL79456-01A1 (LMZ); NIH R37 HL65697 and P50 GM53789 (BRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Bento-Abreu A, 2009, J NEUROCHEM, V111, P49, DOI 10.1111/j.1471-4159.2009.06304.x; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; GHITESCU L, 1986, J CELL BIOL, V102, P1304, DOI 10.1083/jcb.102.4.1304; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Massey Kerri A, 2009, Proc Am Thorac Soc, V6, P419, DOI 10.1513/pats.200903-011AW; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall R. D., 2006, V176, P107; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Predescu DN, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/672705; PREDESCU DN, 2006, MOL BIOL CELL S, V17, P1; Predescu SA, 2007, AM J PHYSIOL-LUNG C, V293, pL823, DOI 10.1152/ajplung.00436.2006; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Razani B, 2001, J BIOL CHEM, V276, P38121; Rosengren BI, 2006, AM J PHYSIOL-HEART C, V291, pH1371, DOI 10.1152/ajpheart.01364.2005; SCHNITZER JE, 1995, AM J PHYSIOL-HEART C, V268, pH48, DOI 10.1152/ajpheart.1995.268.1.H48; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Siddiqui SS, 2007, AM J PHYSIOL-LUNG C, V292, pL114, DOI 10.1152/ajplung.00257.2005; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; SIMIONESCU N, 1981, INT CELL BIOL 1980 1, P657; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Tang ZL, 2002, MOL CELL BIOCHEM, V234, P211, DOI 10.1023/A:1015930927407; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029624; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	51	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81903	10.1371/journal.pone.0081903	http://dx.doi.org/10.1371/journal.pone.0081903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312378	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000327652100107
J	Markakis, MN; Boron, AK; Van Loock, B; Saini, K; Cirera, S; Verbelen, JP; Vissenberg, K				Markakis, Marios Nektarios; Boron, Agnieszka Karolina; Van Loock, Bram; Saini, Kumud; Cirera, Susanna; Verbelen, Jean-Pierre; Vissenberg, Kris			Characterization of a Small Auxin-Up RNA (SAUR)-Like Gene Involved in Arabidopsis thaliana Development	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; ROOT GRAVITROPISM; CELL ELONGATION; ETHYLENE; TRANSPORT; GROWTH; BIOSYNTHESIS; INHIBITION; REGULATOR; PROMOTER	The root of Arabidopsis thaliana Is used as a model system to unravel the molecular nature of cell elongation and its arrest. From a micro-array performed on roots that were treated with aminocyclopropane-1-carboxylic acid (ACC), he precursor of ethylene, a Small auxin-up RNA (SAUR)-like gene was found to be up regulated. As it appeared as the 76th gene in the family, it was named SAUR76. Root and leaf growth of overexpression lines ectopically expressing SAUR76 indicated the possible involvement of the gene in the division process. Using promoter:GUS and GFP lines strong expression was seen in endodermal and pericycle cells at the end of the elongation zone and during several stages of lateral root primordia development. ACC and IAA/NAA were able to induce a strong up regulation of the gene and changed the expression towards cortical and even epidermal cells at the beginning of the elongation zone. Confirmation of this up regulation of expression was delivered using qPCR, which also indicated that the expression quickly returned to normal levels when the inducing IAA-stimulus was removed, a behaviour also seen in other SAUR genes. Furthermore, confocal analysis of protein-GFP fusions localized the protein in the nucleus, cytoplasm and plasma membrane. SAUR76 expression was quantified in several mutants in ethylene and auxin-related pathways, which led to the conclusion that the expression of SAUR76 is mainly regulated by the increase in auxin that results from the addition of ACC, rather than by ACC itself.	[Markakis, Marios Nektarios; Boron, Agnieszka Karolina; Van Loock, Bram; Saini, Kumud; Verbelen, Jean-Pierre; Vissenberg, Kris] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Cirera, Susanna] Univ Copenhagen, Dept Anim & Vet Basic Sci, Frederiksberg C, Denmark	University of Antwerp; University of Copenhagen	Vissenberg, K (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	kris.vissenberg@ua.ac.be	Cirera, Susanna/K-8540-2017; Vissenberg, Kris/L-2303-2017; Saini, Kumud/G-1578-2013	Vissenberg, Kris/0000-0003-0292-2095; Cirera, Susanna/0000-0001-8105-1579; Saini, Kumud/0000-0001-9129-6342; Boron, Agnieszka/0000-0001-9124-0912	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT, Vlaanderen); Interuniversity Attraction Poles Programme - Belgian State - Belgian Science Policy [IUAP VI/33]; Research Foundation-Flanders (FWO); University of Antwerp	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT, Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Poles Programme - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Research Foundation-Flanders (FWO)(FWO); University of Antwerp	This work was supported by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT, Vlaanderen), the Interuniversity Attraction Poles Programme - Belgian State - Belgian Science Policy [IUAP VI/33], the Research Foundation-Flanders (FWO) and the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Benavente LM, 2006, MOL BIOSYST, V2, P165, DOI 10.1039/b513874d; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Bishop GJ, 2001, PLANT CELL PHYSIOL, V42, P114, DOI 10.1093/pcp/pce018; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davies Peter J., 1995, P1; De Cnodder T, 2005, NEW PHYTOL, V168, P541, DOI 10.1111/j.1469-8137.2005.01540.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; GEE MA, 1991, PLANT CELL, V3, P419, DOI 10.1105/tpc.3.4.419; GIL P, 1994, PLANT PHYSIOL, V104, P777, DOI 10.1104/pp.104.2.777; Grierson Claire, 2002, Arabidopsis Book, V1, pe0060, DOI 10.1199/tab.0060; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kong YY, 2013, PLANT CELL PHYSIOL, V54, P609, DOI 10.1093/pcp/pct028; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Kuan CS, 2005, HORTSCIENCE, V40, P123, DOI 10.21273/HORTSCI.40.1.123; Le J, 2001, PLANT PHYSIOL, V125, P519, DOI 10.1104/pp.125.2.519; LIPE JA, 1973, PLANT PHYSIOL, V51, P949, DOI 10.1104/pp.51.5.949; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Markakis MN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-208; Matilla AJ, 2000, SEED SCI RES, V10, P111, DOI 10.1017/S096025850000012X; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; Mergemann H, 2000, PLANT PHYSIOL, V124, P609, DOI 10.1104/pp.124.2.609; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Park JE, 2007, PLANT SCI, V172, P150, DOI 10.1016/j.plantsci.2006.08.005; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Rymen B, 2010, METHODS MOL BIOL, V655, P203, DOI 10.1007/978-1-60761-765-5_14; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Smith Paul J, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0725s28; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Staal M, 2011, PLANT PHYSIOL, V155, P2049, DOI 10.1104/pp.110.168476; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tsuchiya Y, 2010, NAT CHEM BIOL, V6, P741, DOI [10.1038/NCHEMBIO.435, 10.1038/nchembio.435]; Ubeda-Tomas S, 2012, TRENDS PLANT SCI, V17, P326, DOI 10.1016/j.tplants.2012.02.002; Vandenbussche F, 2012, NEW PHYTOL, V194, P895, DOI 10.1111/j.1469-8137.2012.04100.x; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Weijers D, 2009, CELL, V136, P1172, DOI 10.1016/j.cell.2009.03.009; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang TF, 2008, ANN BOT-LONDON, V101, P301, DOI 10.1093/aob/mcm229; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	66	48	53	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82596	10.1371/journal.pone.0082596	http://dx.doi.org/10.1371/journal.pone.0082596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312429	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100120
J	Chakravarthy, VS				Chakravarthy, V. Srinivasa			Do Basal Ganglia Amplify Willed Action by Stochastic Resonance? A Model	PLOS ONE			English	Article							PRECEDING VOLUNTARY MOVEMENT; SUPPLEMENTARY MOTOR AREA; SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; NOISE; SYSTEM; CORTEX; CIRCUITS; MECHANORECEPTORS; OSCILLATIONS	Basal ganglia are usually attributed a role in facilitating willed action, which is found to be impaired in Parkinson's disease, a pathology of basal ganglia. We hypothesize that basal ganglia possess the machinery to amplify will signals, presumably weak, by stochastic resonance. Recently we proposed a computational model of Parkinsonian reaching, in which the contributions from basal ganglia aid the motor cortex in learning to reach. The model was cast in reinforcement learning framework. We now show that the above basal ganglia computational model has all the ingredients of stochastic resonance process. In the proposed computational model, we consider the problem of moving an arm from a rest position to a target position: the two positions correspond to two extrema of the value function. A single kick (a half-wave of sinusoid, of sufficiently low amplitude) given to the system in resting position, succeeds in taking the system to the target position, with high probability, only at a critical noise level. But for suboptimal noise levels, the model arm's movements resemble Parkinsonian movement symptoms like akinetic rigidity (low noise) and dyskinesias (high noise).	Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Chakravarthy, VS (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	schakra@iitm.ac.in		Chakravarthy, Srinivasa/0000-0002-2453-1637				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 2007, EUR J NEUROSCI, V25, P1187, DOI 10.1111/j.1460-9568.2007.05373.x; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Clark DL, 2005, BRAIN AND BEHAVIOR: AN INTRODUCTION TO BEHAVIORAL NEUROANATOMY, P1, DOI 10.1017/CBO9780511543661; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; CRITCHLEY EMR, 1981, J NEUROL NEUROSUR PS, V44, P751, DOI 10.1136/jnnp.44.9.751; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; Damasio A, 1980, NEUROLOGY, V30, P1983; Deecke L., 2003, BEREITSCHAFTSPOTENTI, P283, DOI [10.1007/978-1-4615-0189-3_17, DOI 10.1007/978-1-4615-0189-3_17]; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Frith C D, 1991, Br J Psychiatry Suppl, P26; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hikosaka O, 2002, EXP BRAIN RES, V147, P494, DOI 10.1007/s00221-002-1258-7; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Jahanshahi M, 1998, COGN NEUROPSYCHOL, V15, P483, DOI 10.1080/026432998381005; James W., 1890, PRINCIPLES PSYCHOL; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Kalva SK, 2012, NEURAL NETWORKS, V32, P65, DOI 10.1016/j.neunet.2012.02.031; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krishnan R, 2011, NEURAL NETWORKS, V24, P801, DOI 10.1016/j.neunet.2011.06.002; LANG W, 1991, EXP BRAIN RES, V87, P688; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Magdoom KN, 2011, NEURAL COMPUT, V23, P477, DOI 10.1162/NECO_a_00073; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Mejias JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017255; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pinamonti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051170; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schurger A, 2012, P NATL ACAD SCI USA, V109, pE2904, DOI 10.1073/pnas.1210467109; Sridharan D, 2006, INT J NEURAL SYST, V16, P111, DOI 10.1142/S0129065706000548; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tessone CJ, 2007, PHYSICA A, V374, P46, DOI 10.1016/j.physa.2006.06.026; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Townsend BR, 2006, J NEUROPHYSIOL, V96, P2578, DOI 10.1152/jn.01086.2005; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858, DOI 10.1152/jn.2001.85.5.1858; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	68	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e75657	10.1371/journal.pone.0075657	http://dx.doi.org/10.1371/journal.pone.0075657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302984	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400002
J	Kim, SM; Kim, H; Lee, JS; Park, KS; Jeon, GS; Shon, J; Ahn, SW; Kim, SH; Lee, KM; Sung, JJ; Lee, KW				Kim, Sung-Min; Kim, Heejaung; Lee, Jeong-Seon; Park, Kyung Seok; Jeon, Gye Sun; Shon, Jeeheun; Ahn, Suk-Won; Kim, Seung Hyun; Lee, Kyung Min; Sung, Jung-Joon; Lee, Kwang-Woo			Intermittent Hypoxia Can Aggravate Motor Neuronal Loss and Cognitive Dysfunction in ALS Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL GROWTH-FACTOR; OBSTRUCTIVE SLEEP-APNEA; TRANSGENIC MOUSE MODEL; VENTILATION; SURVIVAL; DISEASE	Background: Patients with ALS may be exposed to variable degrees of chronic intermittent hypoxia. However, all previous experimental studies on the effects of hypoxia in ALS have only used a sustained hypoxia model and it is possible that chronic intermittent hypoxia exerts effects via a different molecular mechanism from that of sustained hypoxia. No study has yet shown that hypoxia (either chronic intermittent or sustained) can affect the loss of motor neurons or cognitive function in an in vivo model of ALS. Objective: To evaluate the effects of chronic intermittent hypoxia on motor and cognitive function in ALS mice. Methods: Sixteen ALS mice and 16 wild-type mice were divided into 2 groups and subjected to either chronic intermittent hypoxia or normoxia for 2 weeks. The effects of chronic intermittent hypoxia on ALS mice were evaluated using the rotarod, Y-maze, and wire-hanging tests. In addition, numbers of motor neurons in the ventral horn of the spinal cord were counted and western blot analyses were performed for markers of oxidative stress and inflammatory pathway activation. Results: Compared to ALS mice kept in normoxic conditions, ALS mice that experienced chronic intermittent hypoxia had poorer motor learning on the rotarod test, poorer spatial memory on the Y-maze test, shorter wire hanging time, and fewer motor neurons in the ventral spinal cord. Compared to ALS-normoxic and wild-type mice, ALS mice that experienced chronic intermittent hypoxia had higher levels of oxidative stress and inflammation. Conclusions: Chronic intermittent hypoxia can aggravate motor neuronal death, neuromuscular weakness, and probably cognitive dysfunction in ALS mice. The generation of oxidative stress with activation of inflammatory pathways may be associated with this mechanism. Our study will provide insight into the association of hypoxia with disease progression, and in turn, the rationale for an early non-invasive ventilation treatment in patients with ALS.	[Kim, Sung-Min; Park, Kyung Seok; Jeon, Gye Sun; Shon, Jeeheun; Lee, Kyung Min; Sung, Jung-Joon; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Heejaung; Kim, Seung Hyun] Hanyang Univ, Dept Neurol, Coll Med, Seoul 133791, South Korea; [Lee, Jeong-Seon] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Ahn, Suk-Won] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Neurol, Seoul 156756, South Korea	Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital	Kim, SH (corresponding author), Hanyang Univ, Dept Neurol, Coll Med, Seoul 133791, South Korea.	kimsh1@hanyang.ac.kr; sueh@medimail.co.kr	Kim, Seung Hyun/T-5133-2017	Kim, Seung Hyun/0000-0001-9644-9598; Kim, Heejaung/0000-0002-0755-1740	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120182]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Korean Health Technology R&D Project (A120182) Ministry of Health and Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SW, 2012, J NEUROL SCI, V320, P1, DOI 10.1016/j.jns.2012.05.038; Almendros I, 2012, SLEEP MED, V13, P1254, DOI 10.1016/j.sleep.2012.08.012; Andersen PM, 2007, AMYOTROPH LATERAL SC, V8, P195, DOI 10.1080/17482960701262376; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Atalaia A, 2007, AMYOTROPH LATERAL SC, V8, P101, DOI 10.1080/17482960601029883; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P154, DOI 10.1080/17482960802382305; Ferguson KA, 1996, CHEST, V110, P664, DOI 10.1378/chest.110.3.664; Joo IS, 2007, J CLIN NEUROL, V3, P181, DOI 10.3988/jcn.2007.3.4.181; Jung BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033312; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Kim SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017985; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Murakami T, 2003, BRAIN RES, V989, P231, DOI 10.1016/S0006-8993(03)03374-2; Newsom-Davis IC, 2001, J NEUROL NEUROSUR PS, V71, P482, DOI 10.1136/jnnp.71.4.482; Park JH, 2007, NEUROSCI LETT, V413, P265, DOI 10.1016/j.neulet.2006.11.058; Park SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075324; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; SCHIFFMAN PL, 1993, CHEST, V103, P508, DOI 10.1378/chest.103.2.508; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; Vanacore N, 2010, AMYOTROPH LATERAL SC, V11, P430, DOI 10.3109/17482961003605796; Xu RS, 2011, BRAIN RES, V1372, P133, DOI 10.1016/j.brainres.2010.11.056	29	34	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81808	10.1371/journal.pone.0081808	http://dx.doi.org/10.1371/journal.pone.0081808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303073	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400089
J	Maiorino, L; Farke, AA; Kotsakis, T; Piras, P				Maiorino, Leonardo; Farke, Andrew A.; Kotsakis, Tassos; Piras, Paolo			Is Torosaurus Triceratops? Geometric Morphometric Evidence of Late Maastrichtian Ceratopsid Dinosaurs	PLOS ONE			English	Article							ONTOGENY; MODULARITY; ALLOMETRY; SHAPE; SIZE	Background: Recent assessments of morphological changes in the frill during ontogeny hypothesized that the late Maastrichtian horned dinosaur Torosaurus represents the "old adult" of Triceratops, although acceptance of this finding has been disputed on several lines of evidence. Methodology/Principal Findings: Examining the cranial morphology of 28 skulls in lateral view and 36 squamosals of Nedoceratops hatcheri, Triceratops spp. and Torosaurus spp. by means of landmark-based geometric morphometrics, we compared ontogenetic trajectories among these taxa. Principal Component Analysis and cluster analysis confirmed different cranial morphologies. Torosaurus shape space is well separated from Triceratops, whereas Triceratops horridus and Triceratops prorsus partially overlap within Triceratops shape space. Linear regressions between shape and size suggest different ontogenetic trajectories among these taxa. Results support the "traditional" taxonomic status of Torosaurus. We hypothesize that ontogeny drives cranial morphology with different patterns between Torosaurus and Triceratops. Conclusions/Significance: Torosaurus is a distinct and valid taxon. Whether looking at entire skulls, skulls without the frill, frills alone, or squamosals, Torosaurus has different morphologies and distinct allometric trajectories compared to Triceratops. This new approach confirms the taxonomic status of Torosaurus as well as the comparatively low diversity of ceratopsids at the end of the Maastrichtian in North America.	[Maiorino, Leonardo; Kotsakis, Tassos; Piras, Paolo] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Maiorino, Leonardo; Kotsakis, Tassos; Piras, Paolo] Ctr Evolutionary Ecol, Rome, Italy; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA	Roma Tre University	Maiorino, L (corresponding author), Univ Roma Tre, Dipartimento Sci, Rome, Italy.	leonardo.maiorino@uniroma3.it		Piras, Paolo/0000-0001-9832-2742; Farke, Andrew/0000-0002-6930-2002				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 2002, NEUROIMAGE, V15, P233, DOI 10.1006/nimg.2001.0977; BOOKSTEIN FL, 1986, STAT SCI, V1, P181, DOI [10.1214/ss/1177013696, DOI 10.1214/SS/1177013696]; Claude J, 2008, MORPHOMETRICS R; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Farke AA., 2006, HORNS BEAKS CERATOPS, P235; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; GODFREY LR, 1995, J THEOR BIOL, V172, P43, DOI 10.1006/jtbi.1995.0004; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Longrich NR, 2011, CRETACEOUS RES, V32, P264, DOI 10.1016/j.cretres.2010.12.007; Marcus Leslie F., 2000, Hystrix, V11, P27; Marquez EJ, 2008, EVOLUTION, V62, P2688, DOI 10.1111/j.1558-5646.2008.00476.x; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; MARSH OC, AM J SCI, V38, P173; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mullin SK, 2002, COMPUT BIOL MED, V32, P455, DOI 10.1016/S0010-4825(02)00037-9; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Piras P, 2011, J EVOLUTION BIOL, V24, P2705, DOI 10.1111/j.1420-9101.2011.02396.x; Piras P, 2010, EVOL DEV, V12, P568, DOI 10.1111/j.1525-142X.2010.00442.x; Reilly SM, 1997, BIOL J LINN SOC, V60, P119; Rohlf, 2010, TPSDIG2; Rohlf FJ, 2010, TPSRELW; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; SCANNELLA JB, 2009, N AM PALEONTOLOGICAL, V230, P1; Scannella JB, 2012, J VERTEBR PALEONTOL, V32, P166; Scannella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028705; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schlager S, 2013, MORPHO CALCULATIONS; Sullivan RM, 2005, J PALEONTOL, V79, P564, DOI 10.1666/0022-3360(2005)079<0564:ROTCDT>2.0.CO;2; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	42	27	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81608	10.1371/journal.pone.0081608	http://dx.doi.org/10.1371/journal.pone.0081608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303058	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400074
J	Vandewalle, J; Langen, M; Zschaetzsch, M; Nijhof, B; Kramer, JM; Brems, H; Bauters, M; Lauwers, E; Srahna, M; Marynen, P; Verstreken, P; Schenck, A; Hassan, BA; Froyen, G				Vandewalle, Joke; Langen, Marion; Zschaetzsch, Marlen; Nijhof, Bonnie; Kramer, Jamie M.; Brems, Hilde; Bauters, Marijke; Lauwers, Elsa; Srahna, Mohammed; Marynen, Peter; Verstreken, Patrik; Schenck, Annette; Hassan, Bassem A.; Froyen, Guy			Ubiquitin Ligase HUWE1 Regulates Axon Branching through the Wnt/beta-Catenin Pathway in a Drosophila Model for Intellectual Disability	PLOS ONE			English	Article							PLANAR POLARITY; GENE; ARBORIZATION; EXPRESSION	We recently reported that duplication of the E3 ubiquitin ligase HUWE1 results in intellectual disability (ID) in male patients. However, the underlying molecular mechanism remains unknown. We used Drosophila melanogaster as a model to investigate the effect of increased HUWE1 levels on the developing nervous system. Similar to the observed levels in patients we overexpressed the HUWE1 mRNA about 2-fold in the fly. The development of the mushroom body and neuromuscular junctions were not altered, and basal neurotransmission was unaffected. These data are in agreement with normal learning and memory in the courtship conditioning paradigm. However, a disturbed branching phenotype at the axon terminals of the dorsal cluster neurons (DCN) was detected. Interestingly, overexpression of HUWE1 was found to decrease the protein levels of dishevelled (dsh) by 50%. As dsh as well as Fz2 mutant flies showed the same disturbed DCN branching phenotype, and the constitutive active homolog of beta-catenin, armadillo, could partially rescue this phenotype, our data strongly suggest that increased dosage of HUWE1 compromises the Wnt/beta-catenin pathway possibly by enhancing the degradation of dsh.	[Vandewalle, Joke; Bauters, Marijke; Froyen, Guy] VIB Ctr Biol Dis, Human Genome Lab, Leuven, Belgium; [Vandewalle, Joke; Bauters, Marijke; Marynen, Peter; Froyen, Guy] Katholieke Univ Leuven, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Langen, Marion; Zschaetzsch, Marlen; Srahna, Mohammed; Hassan, Bassem A.] Katholieke Univ Leuven, VIB Ctr Biol Dis, Neurogenet Lab, Leuven, Belgium; [Nijhof, Bonnie; Kramer, Jamie M.; Schenck, Annette] Donders Inst Brain Cognit & Behav, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; [Nijhof, Bonnie; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Brems, Hilde] Katholieke Univ Leuven, Dept Human Genet, Lab Neurofibromatosis Res, Leuven, Belgium; [Lauwers, Elsa; Verstreken, Patrik] Katholieke Univ Leuven, VIB Ctr Biol Dis, Lab Neuronal Commun, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; Radboud University Nijmegen; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Hassan, BA (corresponding author), VIB Ctr Biol Dis, Human Genome Lab, Leuven, Belgium.	Bassem.Hassan@cme.vib-kuleuven.be; guy.froyen@cme.vib-kuleuven.be	Brems, Hilde/AAN-4075-2020; Verstreken, Patrik/AAC-7591-2022; Hassan, Bassem A/D-5221-2012; Schenck, Annette/E-4514-2012	Verstreken, Patrik/0000-0002-5073-5393; Hassan, Bassem A/0000-0001-9533-4908; Schenck, Annette/0000-0002-6918-3314; Lauwers, Elsa/0000-0002-0283-1911; Kramer, Jamie/0000-0002-0924-1279; Langen, Marion/0000-0001-6109-6593	University of Leuven (KU Leuven, Belgium) [GOA/12/015]; FWO [G. 0679.10, G.0680.10, G.0681.10, G.0682.10]; European Union [Gencodys HEALTH-F4-2010-241995]; Netherlands Organization for Health Research and Development [ZonMw 917-96-346]; VIB	University of Leuven (KU Leuven, Belgium); FWO(FWO); European Union(European Commission); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); VIB	This work was supported by VIB to BAH and GF, the GOA/12/015 grant of the University of Leuven (KU Leuven, Belgium) to GF, FWO grants G. 0679.10, G.0680.10, G.0681.10 and G.0682.10 to BAH, the European Union under the 7th framework program (Gencodys HEALTH-F4-2010-241995) and by a Vidi grant from the Netherlands Organization for Health Research and Development (ZonMw 917-96-346) to AS. JV is a PhD fellow from the IWT (Agentschap voor Innovatie door Wetenschap en Technologie), Belgium. MB is a post-doctoral fellow of the FWO-Vlaanderen, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bolduc FV, 2009, FLY, V3, P91, DOI 10.4161/fly.3.1.7812; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Maguschak KA, 2012, J NEUROIMMUNE PHARM, V7, P763, DOI 10.1007/s11481-012-9350-7; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Okray Z, 2013, NEUROPHARMACOLOGY, V68, P150, DOI 10.1016/j.neuropharm.2012.09.007; Ryu YK, 2013, DEV BIOL, V377, P79, DOI 10.1016/j.ydbio.2013.02.013; Singh KK, 2011, NEURON, V72, P545, DOI 10.1016/j.neuron.2011.09.030; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Tan Y, 2013, CELL REP, V4, P1082, DOI 10.1016/j.celrep.2013.08.007; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Weitzman Jonathan B, 2005, J Biol, V4, P1, DOI 10.1186/jbiol21; YANG MY, 1995, NEURON, V15, P45; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	42	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81791	10.1371/journal.pone.0081791	http://dx.doi.org/10.1371/journal.pone.0081791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303071	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400087
J	Discola, KF; Forster, A; Boulay, F; Simorre, JP; Attree, I; Dessen, A; Job, V				Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana			Membrane and Chaperone Recognition by the Major Translocator Protein PopB of the Type III Secretion System of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Host-Pathogen Interactions; Membrane Proteins; Pseudomonas aeruginosa; Type III Secretion System	PORE FORMATION; V-ANTIGEN; COMPLEX; BINDING; MODEL; DOMAINS; IPAB; ATPASE; PCRH; SIPB	Background: The type III secretion system allows bacteria to inject effectors directly into the host cytoplasm through a translocation pore. Results: Translocator proteins were characterized in lipid-bound and chaperone-associated forms. Conclusion:Pseudomonas translocators use different regions to recognize their common chaperone and the eukaryotic membrane. Significance: Mapping of key regions in translocators provides a starting point for the potential development of novel antibacterials. The type III secretion system is a widespread apparatus used by pathogenic bacteria to inject effectors directly into the cytoplasm of eukaryotic cells. A key component of this highly conserved system is the translocon, a pore formed in the host membrane that is essential for toxins to bypass this last physical barrier. In Pseudomonas aeruginosa the translocon is composed of PopB and PopD, both of which before secretion are stabilized within the bacterial cytoplasm by a common chaperone, PcrH. In this work we characterize PopB, the major translocator, in both membrane-associated and PcrH-bound forms. By combining sucrose gradient centrifugation experiments, limited proteolysis, one-dimensional NMR, and -lactamase reporter assays on eukaryotic cells, we show that PopB is stably inserted into bilayers with its flexible N-terminal domain and C-terminal tail exposed to the outside. In addition, we also report the crystal structure of the complex between PcrH and an N-terminal region of PopB (residues 51-59), which reveals that PopB lies within the concave face of PcrH, employing mostly backbone residues for contact. PcrH is thus the first chaperone whose structure has been solved in complex with both type III secretion systems translocators, revealing that both molecules employ the same surface for binding and excluding the possibility of formation of a ternary complex. The characterization of the major type III secretion system translocon component in both membrane-bound and chaperone-bound forms is a key step for the eventual development of antibacterials that block translocon assembly.	[Discola, Karen F.; Foerster, Andreas; Simorre, Jean-Pierre; Dessen, Andrea; Job, Viviana] Univ Grenoble Alpes, Inst Biol Struct, F-38000 Grenoble, France; [Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana] Commissariat Energie Atom, Grenoble, France; [Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana] CNRS, Grenoble, France; [Boulay, Francois; Attree, Ina] iRTSV, INSERM UMR1036, Grenoble, France; [Dessen, Andrea] CNPEM, Brazilian Natl Lab Biosci, BR-13083 Sao Paulo, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Job, V (corresponding author), Inst Biol Struct, 6 Rue Jules Horowitz, F-38000 Grenoble, France.	viviana.job@ibs.fr	Discola, Karen F/J-5025-2014	Forster, Andreas/0000-0003-1472-3990; Dessen, Andrea/0000-0001-6487-4020; simorre, jean-pierre/0000-0002-7943-1342; Attree, Ina/0000-0002-2580-764X; Job, Viviana/0000-0001-8421-5292	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We thank J. Marquez and the HTX Laboratory team for access to and help with high throughput crystallization, Eric Faudry and Francois Cretin for help with -Lac measurements, J.-P. Andrieu (Institut de Biologie Structurale-Grenoble Partnership for Structural Biology Platform) for N-terminal sequencing, and the European Synchrotron Radiation Facility for access to beamlines. This work used the platforms of the Grenoble Instruct center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa TRD, 2013, CELL MICROBIOL, V15, P1088, DOI 10.1111/cmi.12100; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Galle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041547; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lokareddy RK, 2010, J BIOL CHEM, V285, P39965, DOI 10.1074/jbc.M110.135616; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Tomalka AG, 2013, J BACTERIOL, V195, P4836, DOI 10.1128/JB.00335-13; Travier L, 2008, INT J PARASITOL, V38, P757, DOI 10.1016/j.ijpara.2007.10.010; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van QN, 1998, J MAGN RESON, V132, P154, DOI 10.1006/jmre.1998.1404; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Verove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030488; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	55	18	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3591	3601		10.1074/jbc.M113.517920	http://dx.doi.org/10.1074/jbc.M113.517920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24297169	Green Published, hybrid			2022-12-25	WOS:000331368700042
J	Chung, HH; Sze, SK; Tay, ASL; Lin, VCL				Chung, Hwa Hwa; Sze, Siu Kwan; Tay, Alvin Shun Long; Lin, Valerie C. -L.			Acetylation at Lysine 183 of Progesterone Receptor by p300 Accelerates DNA Binding Kinetics and Transactivation of Direct Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Acetylase; Hormone Receptors; Nuclear Receptors; Post-translational Modification; Transcription	BREAST-CANCER CELLS; NF-KAPPA-B; TRANSCRIPTIONAL COACTIVATOR; ISOFORM-B; IN-VIVO; PHOSPHORYLATION; RECRUITMENT; P53; EXPRESSION; ACTIVATION	The identification of lysine acetylation of steroid hormone receptors has previously been based on the presence of consensus motif (K/R)XKK. This study reports the discovery by mass spectrometry of a novel progesterone receptor acetylation site at Lys-183 that is not in the consensus motif. In vivo acetylation and mutagenesis experiments revealed that Lys-183 is a primary site of progesterone receptor (PR) acetylation. Lys-183 acetylation is enhanced by p300 overexpression and abrogated by p300 gene silencing, suggesting that p300 is the major acetyltransferase for Lys-183 acetylation. Furthermore, p300-mediated Lys-183 acetylation is associated with heightened PR activity. Accordingly, the acetylation-mimicking mutant PRB-K183Q exhibited accelerated DNA binding kinetics and greater activity compared with the wild-type PRB on genes containing progesterone response element. In contrast, Lys-183 acetylation had no influence on PR tethering effect on the nuclear factor -light chain enhancer of activated B cells (NFB). Additionally, increases of Lys-183 acetylation by p300 overexpression or inhibition of deacetylation resulted in increases of Ser-294 phosphorylation levels. In conclusion, PR acetylation at Lys-183 by p300 potentiates PR activity through accelerated binding of its direct target genes without affecting PR tethering on other transcription factors. The effect may be mediated by enhancing Ser-294 phosphorylation.	[Chung, Hwa Hwa; Sze, Siu Kwan; Tay, Alvin Shun Long; Lin, Valerie C. -L.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lin, VCL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	cllin@ntu.edu.sg	Sze, Siu Kwan/AAO-3342-2020; Chun Ling, Valerie Lin/A-2188-2011; Sze, Siu_kwan Newman/A-2199-2011	Sze, Siu Kwan/0000-0002-5652-1687; Sze, Siu_kwan Newman/0000-0002-5652-1687				Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bannister AJ, 1995, ONCOGENE, V11, P2509; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Davies S, 2004, GYNECOL ONCOL, V94, P463, DOI 10.1016/j.ygyno.2004.05.028; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dressing GE, 2009, STEROIDS, V74, P573, DOI 10.1016/j.steroids.2008.12.001; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Fan SJ, 2002, CANCER RES, V62, P141; Gan CS, 2008, J PROTEOME RES, V7, P4869, DOI 10.1021/pr800473j; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Grant PA, 2001, GENOME BIOL, V2; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Huang YH, 2002, ONCOGENE, V21, P6819, DOI 10.1038/sj.onc.1205854; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Li Y, 2013, MOL BIOL REP, V40, P1685, DOI 10.1007/s11033-012-2219-2; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Oh SY, 2005, AM J OBSTET GYNECOL, V193, P1156, DOI 10.1016/j.ajog.2005.05.071; ONATE SA, 1995, SCIENCE, V270, P1354; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Qiu M, 2003, J STEROID BIOCHEM, V85, P147, DOI 10.1016/S0960-0760(03)00221-8; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Telleria CM, 1998, ENDOCRINOLOGY, V139, P3597, DOI 10.1210/en.139.8.3597; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yin P, 2012, PLOS ONE, V7; Zheng ZY, 2008, BREAST CANCER RES TR, V110, P111, DOI 10.1007/s10549-007-9711-8	60	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2180	2194		10.1074/jbc.M113.517896	http://dx.doi.org/10.1074/jbc.M113.517896			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302725	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000331130200026
J	McKinlay, JB; Oda, Y; Ruhl, M; Posto, AL; Sauer, U; Harwood, CS				McKinlay, James B.; Oda, Yasuhiro; Ruehl, Martin; Posto, Amanda L.; Sauer, Uwe; Harwood, Caroline S.			Non-growing Rhodopseudomonas palustris Increases the Hydrogen Gas Yield from Acetate by Shifting from the Glyoxylate Shunt to the Tricarboxylic Acid Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Biofuel; Metabolic Engineering; Metabolic Regulation; Metabolic Tracers; Nitrogenase; Transcriptomics; Bacterial Starvation; Hydrogen Gas; Metabolic Flux Analysis	POLY-BETA-HYDROXYBUTYRATE; METABOLIC PATHWAYS; ESCHERICHIA-COLI; GENE-EXPRESSION; FLUX ANALYSIS; SEQUENCE; INSIGHTS; GROWTH; LIGHT; H-2	When starved for nitrogen, non-growing cells of the photosynthetic bacterium Rhodopseudomonas palustris continue to metabolize acetate and produce H-2, an important industrial chemical and potential biofuel. The enzyme nitrogenase catalyzes H-2 formation. The highest H-2 yields are obtained when cells are deprived of N-2 and thus use available electrons to synthesize H-2 as the exclusive product of nitrogenase. To understand how R. palustris responds metabolically to increase H-2 yields when it is starved for N-2, and thus not growing, we tracked changes in biomass composition and global transcript levels. In addition to a 3.5-fold higher H-2 yield by non-growing cells we also observed an accumulation of polyhydroxybutyrate to over 30% of the dry cell weight. The transcriptome of R. palustris showed down-regulation of biosynthetic processes and up-regulation of nitrogen scavenging mechanisms in response to N-2 starvation but gene expression changes did not point to metabolic activities that could generate the reductant necessary to explain the high H-2 yield. We therefore tracked C-13-labeled acetate through central metabolic pathways. We found that non-growing cells shifted their metabolism to use the tricarboxylic acid cycle to metabolize acetate in contrast to growing cells, which used the glyoxylate cycle exclusively. This shift enabled cells to more fully oxidize acetate, providing the necessary reducing power to explain the high H-2 yield.	[McKinlay, James B.; Posto, Amanda L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Oda, Yasuhiro; Harwood, Caroline S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ruehl, Martin; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich	McKinlay, JB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jmckinla@indiana.edu	McKinlay, James B/N-1626-2019; Sauer, Uwe/Y-3556-2019	McKinlay, James B/0000-0003-2401-6229; 	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) [DE-FG02-05ER15707]; Office of Science (BER), U.S. Department of Energy [DE-FG02-07ER64482, DE-SC0008131]; European Commission [LSHG-CT-2006-037469]; United States National Science Foundation [MCB-11457304]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); European Commission(European CommissionEuropean Commission Joint Research Centre); United States National Science Foundation(National Science Foundation (NSF))	Experimental aspects of this research were supported equally by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE), through Grant DE-FG02-05ER15707 and by the Office of Science (BER), U.S. Department of Energy, through Grant DE-FG02-07ER64482. Experimental work was also funded through the European Commission 7th Framework project BaSysBio (LSHG-CT-2006-037469). United States National Science Foundation Grant MCB-11457304 (to C. S. H.) and Office of Science (BER), U.S. Department of Energy Grant DE-SC0008131 (to J. B. M.) provided support for data analysis and manuscript preparation.	Adessi A, 2012, INT J HYDROGEN ENERG, V37, P15893, DOI 10.1016/j.ijhydene.2012.08.009; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Carlozzi P, 2001, J BIOTECHNOL, V88, P239, DOI 10.1016/S0168-1656(01)00280-2; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; DEPHILIPPIS R, 1992, FEMS MICROBIOL LETT, V103, P187; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Gosse JL, 2010, BIOTECHNOL PROGR, V26, P907, DOI 10.1002/btpr.406; Hirakawa H, 2011, J BACTERIOL, V193, P2598, DOI 10.1128/JB.01479-10; Huang JJ, 2010, APPL ENVIRON MICROB, V76, P7717, DOI 10.1128/AEM.01143-10; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; KARR DB, 1983, APPL ENVIRON MICROB, V46, P1339, DOI 10.1128/AEM.46.6.1339-1344.1983; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kranz RG, 1997, APPL ENVIRON MICROB, V63, P3003, DOI 10.1128/AEM.63.8.3003-3009.1997; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lebedeva N. V., 2002, Mikrobiologiya, V71, P762; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; McKinlay JB, 2011, MBIO, V2, DOI 10.1128/mBio.00323-10; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; McKinlay JB, 2005, APPL ENVIRON MICROB, V71, P6651, DOI 10.1128/AEM.71.11.6651-6656.2005; Melnicki MR, 2009, INT J HYDROGEN ENERG, V34, P6157, DOI 10.1016/j.ijhydene.2009.05.115; Mukhopadhyay M, 2005, WORLD J MICROB BIOT, V21, P765, DOI 10.1007/s11274-004-5565-y; Nam TW, 2013, MBIO, V4, DOI 10.1128/mBio.00541-12; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; Phattarasukol S, 2012, APPL ENVIRON MICROB, V78, P6812, DOI 10.1128/AEM.01418-12; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Rey FE, 2006, J BACTERIOL, V188, P6143, DOI 10.1128/JB.00381-06; Ruhl M, 2012, J BIOL CHEM, V287, P27959, DOI 10.1074/jbc.M112.366492; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schwender J, 2006, J BIOL CHEM, V281, P34040, DOI 10.1074/jbc.M606266200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; TAHAMA H, 1990, AGR BIOL CHEM TOKYO, V54, P3177, DOI 10.1080/00021369.1990.10870489; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P3859, DOI 10.1128/AEM.02986-06; Vincenzini M, 1997, BIOTECHNOL LETT, V19, P759, DOI 10.1023/A:1018336209252; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	43	65	66	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1960	1970		10.1074/jbc.M113.527515	http://dx.doi.org/10.1074/jbc.M113.527515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302724	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000331130200008
J	Tanaka, T; Nagashima, K; Inagaki, N; Kioka, H; Takashima, S; Fukuoka, H; Noji, H; Kakizuka, A; Imamura, H				Tanaka, Takashi; Nagashima, Kazuaki; Inagaki, Nobuya; Kioka, Hidetaka; Takashima, Seiji; Fukuoka, Hajime; Noji, Hiroyuki; Kakizuka, Akira; Imamura, Hiromi			Glucose-stimulated Single Pancreatic Islets Sustain Increased Cytosolic ATP Levels during Initial Ca2+ Influx and Subsequent Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Calcium; Energy Metabolism; Imaging; Insulin; Pancreatic Islets	BETA-CELL LINE; INSULIN-SECRETION; GLUTAMATE-DEHYDROGENASE; CYTOPLASMIC CA2+; MEMBRANE; CALCIUM; METABOLISM; EXPRESSION; CHANNELS; RELEASE	In pancreatic islets, insulin secretion occurs via synchronous elevation of Ca2+ levels throughout the islets during high glucose conditions. This Ca2+ elevation has two phases: a quick increase, observed after the glucose stimulus, followed by prolonged oscillations. In these processes, the elevation of intracellular ATP levels generated from glucose is assumed to inhibit ATP-sensitive K+ channels, leading to the depolarization of membranes, which in turn induces Ca2+ elevation in the islets. However, little is known about the dynamics of intracellular ATP levels and their correlation with Ca2+ levels in the islets in response to changing glucose levels. In this study, a genetically encoded fluorescent biosensor for ATP and a fluorescent Ca2+ dye were employed to simultaneously monitor the dynamics of intracellular ATP and Ca2+ levels, respectively, inside single isolated islets. We observed rapid increases in cytosolic and mitochondrial ATP levels after stimulation with glucose, as well as with methyl pyruvate or leucine/glutamine. High ATP levels were sustained as long as high glucose levels persisted. Inhibition of ATP production suppressed the initial Ca2+ increase, suggesting that enhanced energy metabolism triggers the initial phase of Ca2+ influx. On the other hand, cytosolic ATP levels did not fluctuate significantly with the Ca2+ level in the subsequent oscillation phases. Importantly, Ca2+ oscillations stopped immediately before ATP levels decreased significantly. These results might explain how food or glucose intake evokes insulin secretion and how the resulting decrease in plasma glucose levels leads to cessation of secretion.	[Tanaka, Takashi; Kakizuka, Akira; Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Nagashima, Kazuaki; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Kioka, Hidetaka; Takashima, Seiji] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fukuoka, Hajime] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka University; Tohoku University; University of Tokyo	Imamura, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan.	imamura@lif.kyoto-u.ac.jp	Imamura, Hiromi/AAD-5109-2019	Imamura, Hiromi/0000-0002-1896-0443; Inagaki, Nobuya/0000-0001-8261-2593; Fukuoka, Hajime/0000-0002-9060-4347	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; Precursory Research for Embryonic Science from the Japan Science and Technology Agency; Japan Diabetes Foundation;  [22590977]; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; Precursory Research for Embryonic Science from the Japan Science and Technology Agency; Japan Diabetes Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research 22590977 (to K. N.) and by funds from the Platform for Dynamic Approaches to Living System (to T. T. and H. I.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan, as well as by funds from Precursory Research for Embryonic Science (to H. I.) from the Japan Science and Technology Agency and by funds from the Japan Diabetes Foundation (to H. I.).	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223, DOI 10.1042/bj1320223; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dufer M, 2002, BIOCHEM J, V368, P817, DOI 10.1042/BJ20020657; Fahien LA, 2011, DIABETES, V60, P2450, DOI 10.2337/db10-1150; GHOSH A, 1991, J BIOL CHEM, V266, P22887; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; HELLMAN B, 1969, DIABETES, V18, P509, DOI 10.2337/diab.18.8.509; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1998, JPN J PHYSIOL, V48, P397, DOI 10.2170/jjphysiol.48.397; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Lembert N, 2001, BIOCHEM J, V354, P345, DOI 10.1042/0264-6021:3540345; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Terasawa S, 2011, BIOPHYS J, V100, P2193, DOI 10.1016/j.bpj.2011.03.030; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zawalich WS, 1997, J BIOL CHEM, V272, P3527, DOI 10.1074/jbc.272.6.3527	43	34	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2205	2216		10.1074/jbc.M113.499111	http://dx.doi.org/10.1074/jbc.M113.499111			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302735	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000331130200028
J	Bowling, DL; Herbst, CT; Fitch, WT				Bowling, Daniel L.; Herbst, Christian T.; Fitch, W. Tecumseh			Social Origins of Rhythm? Synchrony and Temporal Regularity in Human Vocalization	PLOS ONE			English	Article							EVOLUTION; SPEECH; MECHANISMS; SIGNAL; MUSIC	Humans have a capacity to perceive and synchronize with rhythms. This is unusual in that only a minority of other species exhibit similar behavior. Study of synchronizing species (particularly anurans and insects) suggests that simultaneous signal production by different individuals may play a critical role in the development of regular temporal signaling. Accordingly, we investigated the link between simultaneous signal production and temporal regularity in our own species. Specifically, we asked whether inter-individual synchronization of a behavior that is typically irregular in time, speech, could lead to evenly-paced or "isochronous'' temporal patterns. Participants read nonsense phrases aloud with and without partners, and we found that synchronous reading resulted in greater regularity of durational intervals between words. Comparison of same-gender pairings showed that males and females were able to synchronize their temporal speech patterns with equal skill. These results demonstrate that the shared goal of synchronization can lead to the development of temporal regularity in vocalizations, suggesting that the origins of musical rhythm may lie in cooperative social interaction rather than in sexual selection.	[Bowling, Daniel L.; Herbst, Christian T.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna	Bowling, DL (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	dan.bowling@univie.ac.at; tecumseh.fitch@univie.ac.at		Bowling, Daniel/0000-0002-5303-5472; Herbst, Christian/0000-0001-9095-3953	European Research Council grant SOMACCA [230604]	European Research Council grant SOMACCA	This research was partially supported by European Research Council grant SOMACCA (#230604) to WTF. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Abercrombie D., 1965, STUDIES PHONETICS LI, P16; Alexander RD, 1960, ANIMAL SOUNDS COMMUN, V1; Backwell P, 1998, NATURE, V391, P31, DOI 10.1038/34076; Brown S, 2000, ORIGINS OF MUSIC, P271; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; CLAYTON MRL, 1996, B SCH ORIENT AFR ST, V59, P323, DOI 10.1017/S0041977X00031608; Cross Ian, 2009, COMMUNICATIVE MUSICA, P61; Cummins F., 2002, Acoustics Research Letters Online, V3, P7, DOI 10.1121/1.1416672; Cummins F, 2003, J PHONETICS, V31, P139, DOI 10.1016/S0095-4470(02)00082-7; Cummins F, 2004, P 26 ANN M COGN SCI, P304; Cummins F, 2009, J PHONETICS, V37, P16, DOI 10.1016/j.wocn.2008.08.003; Darwin C, 1871, DESCENT MAN, P53; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; Fitch W. T., 2012, LANGUAGE MUSIC COGNI, P73; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Geissmann T, 2000, ORIGINS OF MUSIC, P103; Greenfield MD, 2005, ADV STUD BEHAV, V35, P1, DOI 10.1016/S0065-3454(05)35001-7; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; Greenfield MD, 2008, J COMP PSYCHOL, V122, P289, DOI 10.1037/0735-7036.122.3.289; LIVINGSTONE FB, 1973, CURR ANTHROPOL, V14, P25, DOI 10.1086/201402; MARCUS SM, 1981, PERCEPT PSYCHOPHYS, V30, P247, DOI 10.3758/BF03214280; Marler P, 2000, ORIGINS OF MUSIC, P31; McNeill W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merker BH, 1999, MUSIC SCI, V1999-2000, P59; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Mithen S, 2005, SINGING NEANDERTHALS, pXXXX; Patel A.D., 1999, P 14 INT C PHON SCI, V1, P405; Patel AD, 2008, MUSIC LANGUAGE BRAIN, P98; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; RICHMAN B, 1993, CURR ANTHROPOL, V34, P721, DOI 10.1086/204217; Roach P. J., 1982, LINGUISTIC CONTROVER, P73; SISMONDO E, 1990, SCIENCE, V249, P55, DOI 10.1126/science.249.4964.55; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X	37	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80402	10.1371/journal.pone.0080402	http://dx.doi.org/10.1371/journal.pone.0080402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261MX	24312214	Green Published, gold			2022-12-25	WOS:000327670300011
J	Perez-Shibayama, C; Gil-Cruz, C; Nussbacher, M; Allgauer, E; Cervantes-Barragan, L; Zust, R; Ludewig, B				Perez-Shibayama, Christian; Gil-Cruz, Cristina; Nussbacher, Monika; Allgaeuer, Eva; Cervantes-Barragan, Luisa; Zuest, Roland; Ludewig, Burkhard			Dendritic Cell-Specific Delivery of Flt3L by Coronavirus Vectors Secures Induction of Therapeutic Antitumor Immunity	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ANTIGEN-PRESENTING CELLS; REGULATORY T-CELLS; IMMUNOTHERAPY; INTERLEUKIN-2; ACTIVATION; VIRUS; LYMPHOCYTES; RESPONSES; SEQUENCE	Efficacy of antitumor vaccination depends to a large extent on antigen targeting to dendritic cells (DCs). Here, we assessed antitumor immunity induced by attenuated coronavirus vectors which exclusively target DCs in vivo and express either lymphocyte-or DC-activating cytokines in combination with a GFP-tagged model antigen. Tracking of in vivo transduced DCs revealed that vectors encoding for Fms-like tyrosine kinase 3 ligand (Flt3L) exhibited a higher capacity to induce DC maturation compared to vectors delivering IL-2 or IL-15. Moreover, Flt3L vectors more efficiently induced tumor-specific CD8+ T cells, expanded the epitope repertoire, and provided both prophylactic and therapeutic tumor immunity. In contrast, IL-2-or IL-15-encoding vectors showed a substantially lower efficacy in CD8+ T cell priming and failed to protect the host once tumors had been established. Thus, specific in vivo targeting of DCs with coronavirus vectors in conjunction with appropriate conditioning of the microenvironment through Flt3L represents an efficient strategy for the generation of therapeutic antitumor immunity.	[Perez-Shibayama, Christian; Gil-Cruz, Cristina; Nussbacher, Monika; Allgaeuer, Eva; Cervantes-Barragan, Luisa; Zuest, Roland; Ludewig, Burkhard] Kantonsspital, Inst Immunobiol, St Gallen, Switzerland; [Cervantes-Barragan, Luisa] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Zuest, Roland] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore	Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Washington University (WUSTL); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Ludewig, B (corresponding author), Kantonsspital, Inst Immunobiol, St Gallen, Switzerland.	burkhard.ludewig@kssg.ch		Gil Cruz, Cristina/0000-0001-5285-6503	Wilhelm Sander Foundation; European Commission; TOLERAGE project	Wilhelm Sander Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); TOLERAGE project	This study received financial support from the Wilhelm Sander Foundation (to B.L.) and through the TOLERAGE project funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Albertini MR, 2012, CANCER IMMUNOL IMMUN, V61, P2261, DOI 10.1007/s00262-012-1286-5; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Cawood R, 2012, TRENDS MOL MED, V18, P564, DOI 10.1016/j.molmed.2012.07.007; Cervantes-Barragan L, 2010, MBIO, V1, DOI 10.1128/mBio.00171-10; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Decker WK, 2011, CYTOKINE GROWTH F R, V22, P177, DOI 10.1016/j.cytogfr.2011.07.001; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eriksson KK, 2006, CLIN DEV IMMUNOL, V13, P353, DOI 10.1080/17402520600579168; Eriksson Klara Kristin, 2008, V454, P237, DOI 10.1007/978-1-59745-181-9_18; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Hermans IF, 1998, CANCER RES, V58, P3909; Jacobs JFM, 2009, NEURO-ONCOLOGY, V11, P394, DOI 10.1215/15228517-2008-104; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kuo LL, 2007, J VIROL, V81, P2249, DOI 10.1128/JVI.01577-06; Larocca C, 2011, CANCER J, V17, P359, DOI 10.1097/PPO.0b013e3182325e63; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Marabelle A, 2013, J CLIN INVEST, P64859; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; McDermott DF, 2007, CLIN CANCER RES, V13, p716S, DOI 10.1158/1078-0432.CCR-06-1872; Morse MA, 2000, J CLIN ONCOL, V18, P3883, DOI 10.1200/JCO.2000.18.23.3883; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Small EJ, 2011, J CLIN ONCOL, V29, P3595, DOI 10.1200/JCO.2011.37.8653; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; van der Burg SH, 2011, TRENDS IMMUNOL, V32, P97, DOI 10.1016/j.it.2010.12.006; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Watkins SK, 2011, J CLIN INVEST, V121, P1361, DOI 10.1172/JCI44325; Willimsky G, 2007, IMMUNOL REV, V220, P102, DOI 10.1111/j.1600-065X.2007.00578.x; WITMERPACK MD, 1987, J EXP MED, V166, P1484, DOI 10.1084/jem.166.5.1484; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	52	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81442	10.1371/journal.pone.0081442	http://dx.doi.org/10.1371/journal.pone.0081442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312302	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900032
J	Antoniak, S; Sparkenbaugh, EM; Tencati, M; Rojas, M; Mackman, N; Pawlinski, R				Antoniak, Silvio; Sparkenbaugh, Erica M.; Tencati, Michael; Rojas, Mauricio; Mackman, Nigel; Pawlinski, Rafal			Protease Activated Receptor-2 Contributes to Heart Failure	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; ISCHEMIA-REPERFUSION INJURY; INNATE IMMUNE-RESPONSE; MAST-CELL TRYPTASE; ISCHEMIA/REPERFUSION INJURY; FACTOR DEFICIENCY; CARDIAC FIBROSIS; HYPERTROPHY; PAR-1; FIBROBLASTS	Heart failure is a major clinical problem worldwide. Previous studies have demonstrated an important role or G protein coupled receptors, including protease-activated receptors (PARs), in the pathology of heart hypertrophy and failure Activation of PAR-2 on cardiomyacytes has been shown to induce hypertrophic growth in vitro. PAR-2 also contributes to myocardial infarction and heart remodeling after ischenliaireperfusion injury. In this study, we found that PAR-2 induced hypertrophic growth of cultured rat neonatal carcliomyocytes in a MEK1/2 and p38 dependent manner. In addition, PAR-2 activation on mouse cardiornyocytes increased expression of the pro-fibrotic chernakme MCP-1. Furthermore, cardiomyocyte-specific overexpression of PAR-2 in mice induced heart hypertrophy, cardiac fibrosis, inflammation and heart failure. Finally, in a mouse model of myocardial infarction induced by permanent ligation of the left anterior descending coronary artery, PAR-2 deficiency attenuated heart remodeling and improved heart function independently of its contribution to the size of the initial infarct. Taken together, our data indicate that PAR-2 signaling contributes to pathogenesis of hypertrophy and heart failure.	[Antoniak, Silvio; Sparkenbaugh, Erica M.; Rojas, Mauricio; Mackman, Nigel; Pawlinski, Rafal] Univ N Carolina, Dept Med, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Tencati, Michael] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Urbana-Champaign	Pawlinski, R (corresponding author), Univ N Carolina, Dept Med, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA.	rafal_pawlinski@med.unc.edu	PAwlinski, Rafal/AAD-6090-2022	Antoniak, Silvio/0000-0001-5523-825X; Mackman, Nigel/0000-0002-9170-7700	American Heart Association [AHA0825327E, AHA09BGIA2150078]; National Institute of Health [HL71053, HL096679]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007149, R01HL096679, R01HL071053] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the American Heart Association (S.A. - Post-doctoral fellowship AHA0825327E and R.P. - AHA09BGIA2150078) and the National Institute of Health (N.M. - HL71053 and R.P. - HL096679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami-Goli A, 2007, J IMMUNOL, V179, P5493, DOI 10.4049/jimmunol.179.8.5493; Antoniak S, 2009, J THROMB HAEMOST, V7, P871, DOI 10.1111/j.1538-7836.2009.03323.x; Antoniak S, 2008, J MOL CELL CARDIOL, V45, P118, DOI 10.1016/j.yjmcc.2008.03.013; Antoniak S, 2013, J CLIN INVEST, V123, P1310, DOI 10.1172/JCI66125; Antoniak S, 2011, IUBMB LIFE, V63, P383, DOI 10.1002/iub.441; Antoniak S, 2010, ARTERIOSCL THROM VAS, V30, P2136, DOI 10.1161/ATVBAHA.110.213280; Bhattacharya K, 2007, INT J IMMUNOPATH PH, V20, P69, DOI 10.1177/039463200702000108; Boltzen U, 2012, J MOL CELL CARDIOL, V52, P1056, DOI 10.1016/j.yjmcc.2012.01.015; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dobaczewski Marcin, 2009, Front Biosci (Schol Ed), V1, P391, DOI 10.2741/e33; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; GLEMBOTSKI CC, 1993, J BIOL CHEM, V268, P20646; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Hayashidani S, 2003, CIRCULATION, V108, P2134, DOI 10.1161/01.CIR.0000092890.29552.22; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jiang R, 2007, AM J PHYSIOL-HEART C, V293, pH2845, DOI 10.1152/ajpheart.00209.2007; Jin G, 2005, J CEREBR BLOOD F MET, V25, P302, DOI 10.1038/sj.jcbfm.9600021; Kaye DM, 2012, EUR J HEART FAIL; Kinoshita M, 2005, ARTERIOSCL THROM VAS, V25, P1858, DOI 10.1161/01.ATV.0000174797.71708.97; Levick SP, 2011, CARDIOVASC RES, V89, P12, DOI 10.1093/cvr/cvq272; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loubele STBG, 2009, J THROMB HAEMOST, V7, P290, DOI 10.1111/j.1538-7836.2008.03232.x; McLarty JL, 2011, HYPERTENSION, V58, P264, DOI 10.1161/HYPERTENSIONAHA.111.169417; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Murray DB, 2012, J CELL COMMUN SIGNAL, V6, P45, DOI 10.1007/s12079-011-0146-y; Napoli C, 2000, P NATL ACAD SCI USA, V97, P3678, DOI 10.1073/pnas.97.7.3678; Patella V, 1998, CIRCULATION, V97, P971; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Polyakova V, 2011, INT J CARDIOL, V151, P18, DOI 10.1016/j.ijcard.2010.04.053; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; Sabri A, 2000, CIRC RES, V86, P1054, DOI 10.1161/01.RES.86.10.1054; Sevastos J, 2007, BLOOD, V109, P577, DOI 10.1182/blood-2006-03-008870; Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690; Steinberg SF, 2005, MOL PHARMACOL, V67, P2, DOI 10.1124/mol.104.003103; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Szotowski B, 2005, J AM COLL CARDIOL, V45, P1081, DOI 10.1016/j.jacc.2004.12.061; TORAASON M, 1989, TOXICOLOGY, V56, P107, DOI 10.1016/0300-483X(89)90216-3; Wang HY, 2007, EUR J CELL BIOL, V86, P233, DOI 10.1016/j.ejcb.2006.12.003; Weithauser A, 2013, J AM COLL CARDIOL, V62, P1737, DOI 10.1016/j.jacc.2013.05.076; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Zeidan A, 2006, CARDIOVASC RES, V72, P101, DOI 10.1016/j.cardiores.2006.06.024	56	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81733	10.1371/journal.pone.0081733	http://dx.doi.org/10.1371/journal.pone.0081733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312345	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100094
J	Chang, HN; Leroueil, PR; Selwa, K; Gasper, CJ; Tsuchida, RE; Wang, JJ; McHugh, WM; Cornell, TT; Baker, JR; Goonewardena, SN				Chang, Huai-Ning; Leroueil, Pascale R.; Selwa, Katherine; Gasper, C. J.; Tsuchida, Ryan E.; Wang, Jason J.; McHugh, Walker M.; Cornell, Timothy T.; Baker, James R., Jr.; Goonewardena, Sascha N.			Profiling Inflammatory Responses with Microfluidic Immunoblotting	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; JAK-STAT; MICROCHANNEL; MECHANISMS; SYSTEMS; DISEASE	Rapid profiling of signaling pathways has been a long sought after goal in biological sciences and clinical medicine. To understand these signaling pathways, their protein components must be profiled. The protein components of signaling pathways are typically profiled with protein immunoblotting. Protein immunoblotting is a powerful technique but has several limitations including the large sample requirements, high amounts of antibody, and limitations in assay throughput. To overcome some of these limitations, we have designed a microfluidic protein immunoblotting device to profile multiple signaling pathways simultaneously. We show the utility of this approach by profiling inflammatory signaling pathways (NF kappa B, JAK-STAT, and MAPK) in cell models and human samples. The microfluidic immunoblotting device can profile proteins and protein modifications with 5380-fold less antibody compared to traditional protein immunoblotting. Additionally, this microfluidic device interfaces with commonly available immunoblotting equipment, has the ability to multiplex, and is compatible with several protein detection methodologies. We anticipate that this microfluidic device will complement existing techniques and is well suited for life science applications.	[Chang, Huai-Ning; Leroueil, Pascale R.; Selwa, Katherine; Gasper, C. J.; Tsuchida, Ryan E.; Wang, Jason J.; Baker, James R., Jr.; Goonewardena, Sascha N.] Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA; [Tsuchida, Ryan E.; Goonewardena, Sascha N.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [McHugh, Walker M.; Cornell, Timothy T.] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goonewardena, SN (corresponding author), Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA.	sngoonew@med.umich.edu		McHugh, Walker/0000-0003-3194-8833	Samuel and Jean Frankel Cardiovascular Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD062142] Funding Source: NIH RePORTER	Samuel and Jean Frankel Cardiovascular Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	SNG was supported by a Samuel and Jean Frankel Cardiovascular Center Inaugural Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen XF, 2011, ANAL CHEM, V83, P6573, DOI 10.1021/ac200982j; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Geng T, 2011, LAB CHIP, V11, P2842, DOI 10.1039/c1lc20253g; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; He M, 2009, ANAL CHEM, V81, P8177, DOI 10.1021/ac901392u; Ho M K C, 2009, Curr Mol Pharmacol, V2, P19; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hughes AJ, 2012, P NATL ACAD SCI USA, V109, P21450, DOI 10.1073/pnas.1207754110; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Pan WY, 2010, ANAL CHEM, V82, P3974, DOI 10.1021/ac1000493; Pimkova K, 2011, ANAL BIOANAL CHEM; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Tia SQ, 2011, ANAL CHEM, V83, P3581, DOI 10.1021/ac200322z; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wu HK, 2003, J AM CHEM SOC, V125, P554, DOI 10.1021/ja021045y; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Zubair A, 2011, BIOMED MICRODEVICES, V13, P1053, DOI 10.1007/s10544-011-9575-x	23	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81889	10.1371/journal.pone.0081889	http://dx.doi.org/10.1371/journal.pone.0081889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312374	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100105
J	Han, Z; Jin, L; Platisa, J; Cohen, LB; Baker, BJ; Pieribone, VA				Han, Zhou; Jin, Lei; Platisa, Jelena; Cohen, Lawrence B.; Baker, Bradley J.; Pieribone, Vincent A.			Fluorescent Protein Voltage Probes Derived from ArcLight that Respond to Membrane Voltage Changes with Fast Kinetics	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; ACTION-POTENTIALS; MAMMALIAN-CELLS; SENSING DOMAIN; PHOSPHATASE; NEURONS; SENSOR; CHANNEL; TPTE; GENE	We previously reported the discovery of a fluorescent protein voltage probe, ArcLight, and its derivatives that exhibit large changes in fluorescence intensity in response to changes of plasma membrane voltage. ArcLight allows the reliable detection of single action potentials and sub-threshold activities in individual neurons and dendrites. The response kinetics of ArcLight (T1-on similar to 10 ms, T2-on similar to 50 ms) are comparable with most published genetically-encoded voltage probes. However, probes using voltage-sensing domains other than that from the Ciona intestinalis voltage sensitive phosphatase exhibit faster kinetics. Here we report new versions of ArcLight, in which the Ciona voltage-sensing domain was replaced with those from chicken, zebrafish, frog, mouse or human. We found that the chicken and zebrafish-based ArcLight exhibit faster kinetics, with a time constant (T) less than 6ms for a 100 mV depolarization. Although the response amplitude of these two probes (8-9%) is not as large as the Ciona-based ArcLight (similar to 35%), they are better at reporting action potentials from cultured neurons at higher frequency. In contrast, probes based on frog, mouse and human voltage sensing domains were either slower than the Ciona-based ArcLight or had very small signals.	[Han, Zhou; Jin, Lei; Cohen, Lawrence B.; Baker, Bradley J.; Pieribone, Vincent A.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Han, Zhou; Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT USA; [Platisa, Jelena] Univ Belgrade, Fac Phys Chem, Belgrade, Serbia; [Cohen, Lawrence B.; Baker, Bradley J.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Pieribone, Vincent A.] Yale Univ, Sch Med, New Haven, CT USA	Yale University; Yale University; The John B Pierce Laboratory, Inc; University of Belgrade; Korea Institute of Science & Technology (KIST); Yale University	Pieribone, VA (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	vpieribo@jbpierce.org	Platisa, Jelena/P-4987-2019; Platisa, Jelena/R-3785-2017; Baker, Bradley/P-5047-2016	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X; Baker, Bradley/0000-0003-4652-5585; Pieribone, Vincent/0000-0002-5836-5454	National Institutes of Health [U24NS057631, DC005259-42, ARRA U24NS057631-03S1, R01NS065110, RO1NS083875, ARRA-R01NS065110]; World Class Institute program of the National Research Foundation of Korea [WCI 2009-003]; John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083875, R01NS065110, U24NS057631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005259, R56DC005259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (U24NS057631, DC005259-42, ARRA U24NS057631-03S1, R01NS065110, RO1NS083875 and ARRA-R01NS065110), the World Class Institute program of the National Research Foundation of Korea ( Grant Number: WCI 2009-003), and The John B. Pierce Laboratory, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Baker BJ, 2012, J NEUROSCI METH, V208, P190, DOI 10.1016/j.jneumeth.2012.05.016; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; FLOTTE TR, 1995, GENE THER, V2, P29; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Guipponi M, 2001, HUM GENET, V109, P569, DOI 10.1007/s004390100607; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jin L, 2011, J NEUROSCI METH, V199, P1, DOI 10.1016/j.jneumeth.2011.03.028; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LOEW LM, 1985, BIOPHYS J, V47, P71, DOI 10.1016/S0006-3495(85)83878-9; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Mishina Y, 2012, BIOPHYS J, V103, P669, DOI 10.1016/j.bpj.2012.07.031; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Ratzan WJ, 2011, J CELL PHYSIOL, V226, P2740, DOI 10.1002/jcp.22854; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sutton KA, 2012, MOL BIOL EVOL, V29, P2147, DOI 10.1093/molbev/mss083; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200	29	43	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81295	10.1371/journal.pone.0081295	http://dx.doi.org/10.1371/journal.pone.0081295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312287	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100071
J	Jiang, LJ; Wijeratnen, AJ; Wijeratne, S; Frage, M; Meulia, T; Doohan, D; Li, ZH; Qu, F				Jiang, Linjian; Wijeratne, Asela J.; Wijeratne, Saranga; Frage, Martina; Meulia, Tea; Doohan, Doug; Li, Zhaohu; Qu, Feng			Profiling mRNAs of Two Cuscuta Species Reveals Possible Candidate Transcripts Shared by Parasitic Plants	PLOS ONE			English	Article							DODDER TRANSMISSION; HOST PLANTS; MOBILE; CONVERSION; VIRUSES; PHLOEM; HYPHAE; GENES; TOOL	Dodders are among the most important parasitic plants that cause serious yield losses in crop plants. In this report, we sought to unveil the genetic basis of dodder parasitism by profiling the trancriptomes of Cuscuta pentagona and C. suaveolens, two of the most common dodder species using a next-generation RNA sequencing platform. De novo assembly of the sequence reads resulted in more than 46,000 isotigs and contigs (collectively referred to as expressed sequence tags or ESTs) for each species, with more than half of them predicted to encode proteins that share significant sequence similarities with known proteins of non-parasitic plants. Comparing our datasets with transcriptomes of 12 other fully sequenced plant species confirmed a close evolutionary relationship between dodder and tomato. Using a rigorous set of filtering parameters, we were able to identify seven pairs of ESTs that appear to be shared exclusively by parasitic plants, thus providing targets for tailored management approaches. In addition, we also discovered ESTs with sequences similarities to known plant viruses, including cryptic viruses, in the dodder sequence assemblies. Together this study represents the first comprehensive transcriptome profiling of parasitic plants in the Cuscuta genus, and is expected to contribute to our understanding of the molecular mechanisms of parasitic plant-host plant interactions.	[Jiang, Linjian; Doohan, Doug] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Jiang, Linjian; Qu, Feng] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; [Wijeratne, Asela J.; Wijeratne, Saranga; Meulia, Tea] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol & Cellular Imaging Ctr, Wooster, OH 44691 USA; [Frage, Martina] Wooster High Sch, Wooster, OH USA; [Li, Zhaohu] China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; China Agricultural University	Li, ZH (corresponding author), China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	lizhaohu@cau.edu.cn; qu.28@osu.edu	Wijeratne, Saranga/I-5341-2016; li, zh/HII-5698-2022	Wijeratne, Saranga/0000-0002-9782-4406; 	OARDC SEEDS program; Chinese Universities Scientific Fund	OARDC SEEDS program; Chinese Universities Scientific Fund	This study was supported in part by grants from OARDC SEEDS program and Chinese Universities Scientific Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Albert M, 2010, PLANT SIGNAL BEHAV, V5, P1144, DOI 10.4161/psb.5.9.12675; Alexander K, 2008, PLANT AN GEN C, V16, pP6; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birschwilks M, 2006, J EXP BOT, V57, P911, DOI 10.1093/jxb/erj076; Birschwilks M, 2007, PLANTA, V226, P1231, DOI 10.1007/s00425-007-0571-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; Hibberd JM, 2001, J EXP BOT, V52, P2043, DOI 10.1093/jexbot/52.363.2043; HILDEBRAND EM, 1958, ANNU REV MICROBIOL, V12, P441, DOI 10.1146/annurev.mi.12.100158.002301; HOSFORD RM, 1967, BOT REV, V33, P387, DOI 10.1007/BF02858742; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Lanini WT, 2005, BIOL MANAGEMENT CUSC, V32, P127; LeBlanc M, 2013, NEW PHYTOL, V200, P1225, DOI 10.1111/nph.12439; Marcone C, 1997, EUR J FOREST PATHOL, V27, P347; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Nickrent DL, 2010, INTRO PARASITIC FLOW, DOI [10.1094/PHI-I-2004-0330-01, DOI 10.1094/PHI-I-2004-0330-01.(ACCESSED]; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pennisi E, 2011, SCIENCE, V332, P1372, DOI 10.1126/science.332.6036.1372; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Qu F, 2010, WIRES RNA, V1, P22, DOI 10.1002/wrna.7; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Runyon JB, 2010, PLANT SIGNAL BEHAV, V5, P929, DOI 10.4161/psb.5.8.11772; Smith JD, 2013, CURR OPIN PLANT BIOL, V16, P464, DOI 10.1016/j.pbi.2013.06.016; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tomilov AA, 2008, PLANT J, V56, P389, DOI 10.1111/j.1365-313X.2008.03613.x; Vaughn KC, 2002, PROTOPLASMA, V219, P227, DOI 10.1007/s007090200024; Vaughn KC, 2003, PROTOPLASMA, V220, P189, DOI 10.1007/s00709-002-0038-3; Vaughn KC, 2006, INT J PLANT SCI, V167, P1099, DOI 10.1086/507872; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wickett NJ, 2011, CURR BIOL, V21, P2098, DOI 10.1016/j.cub.2011.11.011; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou LJ, 2007, PLANT DIS, V91, P227, DOI 10.1094/PDIS-91-2-0227B; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	49	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81389	10.1371/journal.pone.0081389	http://dx.doi.org/10.1371/journal.pone.0081389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312295	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100075
J	Yamanaka, K; Nozaki, D				Yamanaka, Kentaro; Nozaki, Daichi			Neural Mechanisms Underlying Stop-and-Restart Difficulties: Involvement of the Motor and Perceptual Systems	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EVENT-RELATED DESYNCHRONIZATION; MOVEMENT-RELATED POTENTIALS; REACTION-TIME PARADIGMS; SELF-PACED MOVEMENTS; CORTICOSPINAL EXCITABILITY; RESPONSE-INHIBITION; VOLUNTARY MOVEMENT; SIGNAL PARADIGM; ALPHA-RHYTHM	The ability to suddenly stop a planned movement or a movement being performed and restart it after a short interval is an important mechanism that allows appropriate behavior in response to contextual or environmental changes. However, performing such stop-and-restart movements smoothly is difficult at times. We investigated performance (response time) of stop-and-restart movements using a go/stop/re-go task and found consistent stop-and-restart difficulties after short (similar to 100 ms) stop-to-restart intervals (SRSI), and an increased probability of difficulties after longer (>200 ms) SRSIs, suggesting that two different mechanisms underlie stop-and-restart difficulties. Next, we investigated motor evoked potentials (MEPs) in a moving muscle induced by transcranial magnetic stimulation during a go/stop/re-go task. In re-go trials with a short SRSI (100 ms), the MEP amplitude continued to decrease after the re-go-signal onset, indicating that stop-and-restart difficulties with short SRSIs might be associated with a neural mechanism in the human motor system, namely, stop-related suppression of corticomotor (CM) excitability. Finally, we recorded electroencephalogram (EEG) activity during a go/stop/re-go task and performed a single-trial-based EEG power and phase time-frequency analysis. Alpha-band EEG phase locking to re-go-signal, which was only observed in re-go trials with long SRSI (250 ms), weakened in the delayed re-go response trials. These EEG phase dynamics indicate an association between stop-and-restart difficulties with long SRSIs and a neural mechanism in the human perception system, namely, decreased probability of EEG phase locking to visual stimuli. In contrast, smooth stop-and-restart human movement can be achieved in re-go trials with sufficient SRSI (150-200 ms), because release of stop-related suppression and simultaneous counter-activation of CM excitability may occur as a single task without second re-go-signal perception. These results suggest that skilled motor behavior is subject to various constraints in not only motor, but also perceptual (and attentional), systems.	[Yamanaka, Kentaro] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan; [Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan	University of Tokyo	Yamanaka, K (corresponding author), Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan.	kentaro@swu.ac.jp	Yamanaka, Kentaro/HII-3291-2022	Yamanaka, Kentaro/0000-0002-5578-440X; Nozaki, Daichi/0000-0002-1338-8337	Showa Women's University; Funding Program for Next Generation World-Leading Researchers [LS034];  [22500529];  [20670008]	Showa Women's University; Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This research was supported by Grant-in-Aid for Scientific Research (C) (#22500529) and a research grant from Showa Women's University to KY, and Grants-in-Aid for Young Scientists (S) (#20670008) and the Funding Program for Next Generation World-Leading Researchers (#LS034) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2004, EXP BRAIN RES, V159, P14, DOI 10.1007/s00221-004-1928-8; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Badry R, 2009, CLIN NEUROPHYSIOL, V120, P1717, DOI 10.1016/j.clinph.2009.06.027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Coxon JP, 2007, J NEUROPHYSIOL, V97, P2480, DOI 10.1152/jn.01284.2006; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanslmayr S, 2005, NEUROSCI LETT, V375, P64, DOI 10.1016/j.neulet.2004.10.092; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hanslmayr S, 2007, CEREB CORTEX, V17, P1, DOI 10.1093/cercor/bhj129; Hoshiyama M, 1996, NEUROSCI RES, V24, P427, DOI 10.1016/0168-0102(95)01013-0; Hoshiyama M, 1997, ELECTROMYOGR MOTOR C, V105, P255, DOI 10.1016/S0924-980X(97)00019-2; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; McGarry T, 2003, Q J EXP PSYCHOL-A, V56, P601, DOI 10.1080/02724980244000549; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; PASCUALLEONE A, 1992, BRAIN, V115, P1045, DOI 10.1093/brain/115.4.1045; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Stancak A, 2000, CLIN NEUROPHYSIOL, V111, P636, DOI 10.1016/S1388-2457(99)00310-7; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van den Wildenberg WPM, 2010, J COGNITIVE NEUROSCI, V22, P225, DOI 10.1162/jocn.2009.21248; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P1212, DOI 10.1037/0096-1523.34.5.1212; Yamanaka K, 2002, EXP BRAIN RES, V142, P301, DOI 10.1007/s00221-001-0943-2; Yamanaka K, 2010, CLIN NEUROPHYSIOL, V121, P1711, DOI 10.1016/j.clinph.2010.03.027; Yamanaka K, 2010, J COGNITIVE NEUROSCI, V22, P714, DOI 10.1162/jocn.2009.21258	46	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82272	10.1371/journal.pone.0082272	http://dx.doi.org/10.1371/journal.pone.0082272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312411	Green Published, gold			2022-12-25	WOS:000327652100110
J	Liu, XY; Zhang, L; Wu, JP; Zhou, L; Ren, YJ; Yang, WQ; Ming, ZJ; Chen, B; Wang, JR; Zhang, Y; Yang, JM				Liu, Xiao-yuan; Zhang, Li; Wu, JianPing; Zhou, Lei; Ren, Yi-Jie; Yang, Wei-Qiong; Ming, Zi-Jun; Chen, Bo; Wang, Jianrong; Zhang, Yi; Yang, Jin-Ming			Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma	PLOS ONE			English	Article							CONFERS RESISTANCE; DNA-REPAIR; PHOSPHORYLATION; AUTOPHAGY; CELLS; EXPRESSION	Background: Glioblastoma multiforme (GBM), the most common form of brain cancer with an average survival of less than 12 months, is a highly aggressive and fatal disease characterized by survival of glioma cells following initial treatment, invasion through the brain parenchyma and destruction of normal brain tissues, and ultimately resistance to current treatments. Temozolomide (TMZ) is commonly used chemotherapy for treatment of primary and recurrent high-grade gliomas. Nevertheless, the therapeutic outcome of TMZ is often unsatisfactory. In this study, we sought to determine whether eEF-2 kinase affected the sensitivity of glioma cells to treatment with TMZ. Methodology/Principal Findings: Using RNA interference approach, a small molecule inhibitor of eEF-2 kinase, and in vitro and in vivo glioma models, we observed that inhibition of eEF-2 kinase could enhance sensitivity of glioma cells to TMZ, and that this sensitizing effect was associated with blockade of autophagy and augmentation of apoptosis caused by TMZ. Conclusions/Significance: These findings demonstrated that targeting eEF-2 kinase can enhance the anti-glioma activity of TMZ, and inhibitors of this kinase may be exploited as chemo-sensitizers for TMZ in treatment of malignant glioma.	[Liu, Xiao-yuan; Zhang, Li; Wu, JianPing; Zhou, Lei; Ren, Yi-Jie; Yang, Wei-Qiong; Ming, Zi-Jun; Chen, Bo; Wang, Jianrong; Zhang, Yi; Yang, Jin-Ming] Soochow Univ, Affiliated Changshu Hosp, Coll Pharmaceut Sci, Dept Pharmacol,Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [Yang, Jin-Ming] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Yang, Jin-Ming] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Zhang, Y (corresponding author), Soochow Univ, Affiliated Changshu Hosp, Coll Pharmaceut Sci, Dept Pharmacol,Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China.	zhangyi@suda.edu.cn; juy16@psu.edu			National Natural Sciences Foundation of China [81072146, 81101913]; Natural Science Foundation of Jiangsu Province of China [BK2010224]; Natural Science Foundation of Jiangsu provincial Colleges and Universities [12KJD310005]; Science and Technology Foundation of Suzhou City [SYS201319]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu provincial Colleges and Universities; Science and Technology Foundation of Suzhou City; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was supported by the National Natural Sciences Foundation of China (81072146; 81101913), Natural Science Foundation of Jiangsu Province of China (BK2010224), Natural Science Foundation of Jiangsu provincial Colleges and Universities (12KJD310005), Science and Technology Foundation of Suzhou City (SYS201319), and by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2012, J CLIN INVEST, V122, P253, DOI 10.1172/JCI59334; Arora S, 2003, CANCER RES, V63, P6894; Chamberlain MC, 2010, EXPERT REV NEUROTHER, V10, P1537, DOI 10.1586/ERN.10.32; Chen Y, 2001, BIOCHEMISTRY-US, V40, P11565, DOI 10.1021/bi010649w; Cheng Y, 2013, AUTOPHAGY, V9, P208, DOI 10.4161/auto.22801; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; do Carmo A, 2013, CANCER BIOL THER, V14, P287, DOI 10.4161/cbt.23615; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Feng H, 2013, ONCOGENE; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Serfass L, 2007, EUR J CANCER, V43, P1494; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Warren KE, 2012, J NEURO-ONCOL, V106, P643, DOI 10.1007/s11060-011-0709-z; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yust-Katz S, 2013, CANCER, DOI [10.1002/cncr.28031, DOI 10.1002/CNCR.28031.[]; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V414, P129, DOI 10.1016/j.bbrc.2011.09.038	23	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81345	10.1371/journal.pone.0081345	http://dx.doi.org/10.1371/journal.pone.0081345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303044	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400061
J	Escrevente, C; Grammel, N; Kandzia, S; Zeiser, J; Tranfield, EM; Conradt, HS; Costa, J				Escrevente, Cristina; Grammel, Nicolas; Kandzia, Sebastian; Zeiser, Johannes; Tranfield, Erin M.; Conradt, Harald S.; Costa, Julia			Sialoglycoproteins and N-Glycans from Secreted Exosomes of Ovarian Carcinoma Cells	PLOS ONE			English	Article							TUMOR-GROWTH; GLYCOSYLATION; EXPRESSION; MIGRATION; ADHESION; L1; IDENTIFICATION; GLYCOPROTEINS; BINDING; TISSUES	Exosomes consist of vesicles that are secreted by several human cells, including tumor cells and neurons, and they are found in several biological fluids. Exosomes have characteristic protein and lipid composition, however, the results concerning glycoprotein composition and glycosylation are scarce. Here, protein glycosylation of exosomes from ovarian carcinoma SKOV3 cells has been studied by lectin blotting, NP-HPLC analysis of 2-aminobenzamide labeled glycans and mass spectrometry. An abundant sialoglycoprotein was found enriched in exosomes and it was identified by peptide mass fingerprinting and immunoblot as the galectin-3-binding protein (LGALS3BP). Exosomes were found to contain predominantly complex glycans of the di-, tri-, and tetraantennary type with or without proximal fucose and also high mannose glycans. Diantennary glycans containing bisecting N-acetylglucosamine were also detected. This work provides detailed information about glycoprotein and N-glycan composition of exosomes from ovarian cancer cells, furthermore it opens novel perspectives to further explore the functional role of glycans in the biology of exosomes.	[Escrevente, Cristina; Costa, Julia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Glycobiol, Oeiras, Portugal; [Grammel, Nicolas; Kandzia, Sebastian; Zeiser, Johannes; Conradt, Harald S.] GlycoThera GmbH, Hannover, Germany; [Tranfield, Erin M.] Inst Gulbenkian Ciencias, Electron Microscopy Facil, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Costa, J (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Glycobiol, Oeiras, Portugal.	jcosta@itqb.unl.pt	Costa, Júlia C/B-7131-2008; Tranfield, Erin M/AAU-4177-2020	Costa, Júlia C/0000-0001-7782-6319; Tranfield, Erin M/0000-0002-1542-7459; Zeiser, Johannes/0000-0001-5518-2137; Escrevente, Cristina/0000-0002-2183-3947	EU [JPND/0003/2011]; Fundacao para a Ciencia e Tecnologia, Portugal [Pest-OE/EQB/LA0004/2011];  [PTDC/SAU-NEU/100724/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/100724/2008] Funding Source: FCT	EU(European Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work was funded by projects: PTDC/SAU-NEU/100724/2008 and EU Joint Programme JPND/0003/2011 and Pest-OE/EQB/LA0004/2011, Fundacao para a Ciencia e Tecnologia, Portugal. C. E. was recipient of a PhD fellowship from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Block AS, 2011, PROSTATE, V71, P711, DOI 10.1002/pros.21287; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Escrevente C, 2006, INT J ONCOL, V29, P557; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gouveia R, 2012, BBA-GEN SUBJECTS, V1820, P2007, DOI 10.1016/j.bbagen.2012.09.004; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Hellstern S, 2002, J BIOL CHEM, V277, P15690, DOI 10.1074/jbc.M200386200; ISHIBASHI K, 1989, CLIN CHIM ACTA, V185, P325, DOI 10.1016/0009-8981(89)90223-4; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Maass K, 2007, PROTEOMICS, V7, P4435, DOI 10.1002/pmic.200700253; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Michelsen U, 2009, METHOD ENZYMOL, V463, P305, DOI 10.1016/S0076-6879(09)63019-6; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nan BC, 1998, GLYCOCONJUGATE J, V15, P1033, DOI 10.1023/A:1006950311937; OSSET M, 1989, ELECTROPHORESIS, V10, P271, DOI 10.1002/elps.1150100412; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sousa VL, 2003, J BIOL CHEM, V278, P7624, DOI 10.1074/jbc.M209325200; Staubach S, 2012, J PROTEOME RES, V11, P906, DOI 10.1021/pr200711w; Tan A, 2010, INT J NANOMED, V5, DOI 10.2147/IJN.S13402; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Ullrich KJ, 1999, J AM SOC NEPHROL, V10, P1840	38	72	75	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78631	10.1371/journal.pone.0078631	http://dx.doi.org/10.1371/journal.pone.0078631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302979	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300074
J	Caron, AZ; He, XH; Mottawea, W; Seifert, EL; Jardine, K; Dewar-Darch, D; Cron, GO; Harper, ME; Stintzi, A; McBurney, MW				Caron, Annabelle Z.; He, Xiaohong; Mottawea, Walid; Seifert, Erin L.; Jardine, Karen; Dewar-Darch, Danielle; Cron, Greg O.; Harper, Mary-Ellen; Stintzi, Alain; McBurney, Michael W.			The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome	FASEB JOURNAL			English	Article						fatty liver; gut microbiota; high-fat diet	DIET-INDUCED OBESITY; GUT MICROBIOTA; HIGH-FAT; HOMEOSTASIS; EXPRESSION; STEATOSIS; DELETION	Type 2 diabetes, hepatic steatosis, and gut dysbiosis are pathophysiological consequences of obesity. Sirtuin (SIRT)-1 is a protein deacetylase implicated in the regulation of metabolic activity. We set out to determine whether the catalytic activity of SIRT1 plays a role in the development of metabolic syndrome, hepatic steatosis, and the distribution of gut microbiota. We challenged with a high-fat diet (HFD) a strain of mice homozygous for a Sirt1 allele carrying a point mutation that ablates the deacetylase activity of SIRT1. When compared to wild-type animals, mice lacking SIRT1 catalytic activity rapidly accumulated excessive hepatic lipid while fed the HFD, an effect evident within 2 wk of HFD feeding. Both white and brown adipose depots became hypertrophic, and the animals developed insulin resistance. The ratio of the major phyla of gut microbiota (Firmicutes and Bacteroidetes) increased rapidly in the SIRT1-deficient mice after HFD challenge. We conclude that the deacetylase activity of SIRT1 plays an important role in regulating glucose and hepatic lipid homeostasis. In addition, the composition of gut microbiota is influenced by both the animals' Sirt1 genotype and diet composition.Caron, A. Z., He, X., Mottawea, W., Seifert, E. L., Jardine, K., Dewar-Darch, D., Cron, G. O., Harper, M.-E., Stintzi, A., McBurney, M. W. The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome.	[Caron, Annabelle Z.; He, Xiaohong; Jardine, Karen; Dewar-Darch, Danielle; Cron, Greg O.; McBurney, Michael W.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Mottawea, Walid; Harper, Mary-Ellen; Stintzi, Alain; McBurney, Michael W.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Seifert, Erin L.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Jefferson University	McBurney, MW (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Program Canc Therapeut,Dept Med, Box 926,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mmcburney@ohri.ca	Mottawea, Walid/K-6429-2018	Mottawea, Walid/0000-0003-1260-2140; Harper, Mary-Ellen/0000-0003-3864-5886; Cron, Greg/0000-0003-1117-9678	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Dr. Manijeh Daneshmand for help with analysis of the histology. This work was supported by grants from the Canadian Institutes for Health Research.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cron G. O., 2013, P INT SOC MAG RESON, V21, P1522; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Philp A, 2013, EXERC SPORT SCI REV, V41, P174, DOI 10.1097/JES.0b013e3182956803; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SALMON DMW, 1985, INT J OBESITY, V9, P443; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sharma A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00040; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang RH, 2010, INT J BIOL SCI, V6, P682; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Ye Q., 2012, P INT SOC MAG RESON, V20, P1368	39	56	57	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1306	1316		10.1096/fj.13-243568	http://dx.doi.org/10.1096/fj.13-243568			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297700				2022-12-25	WOS:000335324800023
J	Kurashige, C; Hosono, K; Matsuda, H; Tsujikawa, K; Okamoto, H; Majima, M				Kurashige, Chie; Hosono, Kanako; Matsuda, Hiromi; Tsujikawa, Kazutake; Okamoto, Hirotsugu; Majima, Masataka			Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice	FASEB JOURNAL			English	Article						calcitonin gene-related peptide; CD31; VEGFR-3; macrophages; vascular endothelial growth factor	GENE-RELATED PEPTIDE; COUPLED RECEPTORS; SYSTEM; GROWTH; RAMPS; FACILITATION; MACROPHAGES; MECHANISMS; EXPRESSION; BIOLOGY	Receptor activity-modifying protein 1 (RAMP1) forms a complex with calcitonin receptor-like receptor (CLR) to produce the receptor for calcitonin gene-related peptide (CGRP). CGRP, a 37-aa neuropeptide, is widely distributed in neuronal tissues and exerts its biological effects via CLR/RAMP1; however, the pathophysiological roles of CLR/RAMP1 remain to be clarified. To study the functions of CLR/RAMP1, we generated RAMP1-knockout (RAMP1(-/-)) mice. Compared with those of wild-type (WT) mice, wound healing and wound-induced angiogenesis were significantly suppressed in RAMP1(-/-) mice, with reduced expression of vascular endothelial growth factor (VEGF)-A. Formation of the lymphatic vessels that drain interstitial fluids was also suppressed in RAMP1(-/-) mice, with reduced expression of VEGF-C and VEGFR-3 in wound granulation tissues. RAMP1 was expressed in endothelial cells (ECs) in the preexisting skin blood vessels, but was not observed in ECs in newly formed blood or lymphatic vessels. Macrophages in the wound granulation tissues expressed RAMP1 and produced substantial amounts of VEGF-C in response to CGRP in vitro. RAMP1(-/-) bone marrow chimeric mice showed delayed wound healing with reduced angiogenesis/lymphangiogenesis in wound granulation tissues. These findings suggest that RAMP1 plays a crucial role in wound healing and wound-induced angiogenesis and lymphangiogenesis and that it is a promising target for controlling angiogenesis and lymphangiogenesis.Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., Majima, M. Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice.	[Kurashige, Chie; Hosono, Kanako; Matsuda, Hiromi; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Kurashige, Chie; Matsuda, Hiromi; Okamoto, Hirotsugu] Kitasato Univ, Sch Med, Dept Anesthesiol, Sagamihara, Kanagawa 2520374, Japan; [Tsujikawa, Kazutake] Osaka Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Kitasato University; Kitasato University; Osaka University	Majima, M (corresponding author), Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp	Majima, Masataka/ABH-3063-2021		Integrative Research Program of the Graduate School of Medical Science at Kitasato University	Integrative Research Program of the Graduate School of Medical Science at Kitasato University	The authors thank Michiko Ogino, Kyoko Yoshikawa, Mieko Hamano, and Yoshihiro Nara for technical assistance. This study was supported by the Integrative Research Program of the Graduate School of Medical Science at Kitasato University. The authors declare no conflicts of interest.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Amano H, 2001, JPN J PHARMACOL, V87, P181, DOI 10.1254/jjp.87.181; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Arai K, 2003, GUT, V52, P1242, DOI 10.1136/gut.52.9.1242; Archbold JK, 2011, TRENDS PHARMACOL SCI, V32, P591, DOI 10.1016/j.tips.2011.05.007; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bell D, 1996, PHARMACOL REV, V48, P253; Boku K, 2001, GASTROENTEROLOGY, V120, P134, DOI 10.1053/gast.2001.20916; Brain SD, 1996, GEN PHARMACOL, V27, P607, DOI 10.1016/0306-3623(95)00125-5; BROWN M J, 1987, Journal of Cardiovascular Pharmacology, V10, pS82, DOI 10.1097/00005344-198710012-00011; Deng PY, 2005, PEPTIDES, V26, P1676, DOI 10.1016/j.peptides.2005.02.002; DENNIS T, 1989, J PHARMACOL EXP THER, V251, P718; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Hay DL, 2008, PHARMACOL REV, V60, P143, DOI 10.1124/pr.108.00372; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Jussila L, 2002, PHYSIOL REV, V82, P673, DOI 10.1152/physrev.00005.2002; Kadmiel M, 2012, ADV EXP MED BIOL, V744, P49, DOI 10.1007/978-1-4614-2364-5_5; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller G, 2002, SCIENCE, V296, P2121; Mishima T, 2011, AM J PHYSIOL-HEART C, V300, pH431, DOI 10.1152/ajpheart.00466.2010; Morfis M, 2003, TRENDS PHARMACOL SCI, V24, P596, DOI 10.1016/j.tips.2003.09.001; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Ohno T, 2008, GASTROENTEROLOGY, V134, P215, DOI 10.1053/j.gastro.2007.10.001; PREIBISZ JJ, 1993, AM J HYPERTENS, V6, P434, DOI 10.1093/ajh/6.5.434; QUIRION R, 1992, ANN NY ACAD SCI, V657, P88, DOI 10.1111/j.1749-6632.1992.tb22759.x; Saeki T, 2000, ALIMENT PHARM THERAP, V14, P135, DOI 10.1046/j.1365-2036.2000.014s1135.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Steiner S, 2002, BIOCHEMISTRY-US, V41, P11398, DOI 10.1021/bi020279r; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Zen AA, 2009, BIOCHEM SOC T, V37, P1221, DOI 10.1042/BST0371221; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010	40	37	38	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1237	1247		10.1096/fj.13-238998	http://dx.doi.org/10.1096/fj.13-238998			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308973				2022-12-25	WOS:000335324800018
J	Liu, Z; Gunasekaran, K; Wang, W; Razinkov, V; Sekirov, L; Leng, E; Sweet, H; Foltz, I; Howard, M; Rousseau, AM; Kozlosky, C; Fanslow, W; Yan, W				Liu, Zhi; Gunasekaran, Kannan; Wang, Wei; Razinkov, Vladimir; Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian; Howard, Monique; Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William; Yan, Wei			Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cancer Therapy; Cell Death; FC Receptors; NK Cells	GAMMA RECEPTOR ENGAGEMENT; NATURAL-KILLER-CELLS; BISPECIFIC ANTIBODIES; HUMAN IGG1; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; BINDING-AFFINITY; IN-VIVO; CANCER; COMPLEX	Background: Co-crystal structure of Fc-FcRIII complex revealed that Fc binds to FcRIII asymmetrically. Results: We identified a panel of novel Fc heterodimers with enhanced ADCC activity. Conclusion: Asymmetrical Fc engineering is an efficient approach for enhancing ADCC activity and stability of engineered antibodies. Significance: The discovery could be applied in therapeutic antibodies for the treatment of cancers and infectious diseases. Antibody-dependent cellular cytotoxicity (ADCC) is mediated through the engagement of the Fc segment of antibodies with Fc receptors (FcRs) on immune cells upon binding of tumor or viral antigen. The co-crystal structure of FcRIII in complex with Fc revealed that Fc binds to FcRIII asymmetrically with two Fc chains contacting separate regions of the FcRIII by utilizing different residues. To fully explore this asymmetrical nature of the Fc-FcR interaction, we screened more than 9,000 individual clones in Fc heterodimer format in which different mutations were introduced at the same position of two Fc chains using a high throughput competition AlphaLISA (R) assay. To this end, we have identified a panel of novel Fc variants with significant binding improvement to FcRIIIA (both Phe-158 and Val-158 allotypes), increased ADCC activity in vitro, and strong tumor growth inhibition in mice xenograft human tumor models. Compared with previously identified Fc variants in conventional IgG format, Fc heterodimers with asymmetrical mutations can achieve similar or superior potency in ADCC-mediated tumor cell killing and demonstrate improved stability in the C(H)2 domain. Fc heterodimers also allow more selectivity toward activating FcRIIA than inhibitory FcRIIB. Afucosylation of Fc variants further increases the affinity of Fc to FcRIIIA, leading to much higher ADCC activity. The discovery of these Fc variants will potentially open up new opportunities of building the next generation of therapeutic antibodies with enhanced ADCC effector function for the treatment of cancers and infectious diseases.	[Liu, Zhi; Gunasekaran, Kannan; Wang, Wei; Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian; Howard, Monique; Yan, Wei] Amgen Inc, Dept Therapeut Discovery, Seattle, WA 98119 USA; [Razinkov, Vladimir] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA; [Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William] Amgen Inc, Therapeut Innovat Unit, Seattle, WA 98119 USA; [Liu, Zhi; Razinkov, Vladimir; Howard, Monique; Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William; Yan, Wei] Amgen Inc, Seattle, WA 98119 USA; [Gunasekaran, Kannan; Wang, Wei] Amgen Inc, Thousand Oaks, CA 91320 USA; [Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian] Amgen Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen; Amgen; Amgen	Liu, Z (corresponding author), Amgen Inc, Dept Therapeut Discovery, 1201 Amgen Court West, Seattle, WA 98119 USA.	liuz@amgen.com; ywei@amgen.com		Sweet, Heather/0000-0001-7478-0474				Albertsson PA, 2003, TRENDS IMMUNOL, V24, P603, DOI 10.1016/j.it.2003.09.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Esendagli G, 2008, LUNG CANCER, V59, P32, DOI 10.1016/j.lungcan.2007.07.022; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Green SK, 2002, CANCER RES, V62, P6891; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Masuda K, 2007, MOL IMMUNOL, V44, P3122, DOI 10.1016/j.molimm.2007.02.005; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Pahl JHW, 2012, CLIN CANCER RES, V18, P432, DOI 10.1158/1078-0432.CCR-11-2277; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Repp R, 2011, J IMMUNOL METHODS, V373, P67, DOI 10.1016/j.jim.2011.08.003; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	36	49	80	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3571	3590		10.1074/jbc.M113.513366	http://dx.doi.org/10.1074/jbc.M113.513366			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24311787	Green Published, hybrid			2022-12-25	WOS:000331368700041
J	Kelly, RS; Lundh, T; Porta, M; Bergdahl, IA; Palli, D; Johansson, AS; Botsivali, M; Vineis, P; Vermeulen, R; Kyrtopoulos, SA; Chadeau-Hyam, M				Kelly, Rachel S.; Lundh, Thomas; Porta, Miquel; Bergdahl, Ingvar A.; Palli, Domenico; Johansson, Ann-Sofie; Botsivali, Maria; Vineis, Paolo; Vermeulen, Roel; Kyrtopoulos, Soterios A.; Chadeau-Hyam, Marc		EnviroGenoMarkers Project Consorti	Blood Erythrocyte Concentrations of Cadmium and Lead and the Risk of B-Cell Non-Hodgkin's Lymphoma and Multiple Myeloma: A Nested Case-Control Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CANCER-MORTALITY; SEX-DIFFERENCES; IMMUNE-SYSTEM; EPIDEMIOLOGY; SUSCEPTIBILITY; ELEMENTS; METALS; HEALTH; DAMAGE	Background: Cadmium (Cd) and lead (Pb) are hypothesised to be risk factors for non-Hodgkin's lymphoma (NHL), a group of haematological malignancies with a suspected environmental aetiology. Within the EnviroGenoMarkers study we utilised pre-diagnostic erythrocyte concentrations of Cd and Pb to determine whether exposure was associated with risk of B-cell NHL and multiple myeloma. Methods: 194 incident cases of B-cell NHL and 76 cases of multiple myeloma diagnosed between 1990 and 2006 were identified from two existing cohorts; EPIC-Italy and the Northern Sweden Health and Disease Study. Cases were matched to healthy controls by centre, age, gender and date of blood collection. Cd and Pb were measured in blood samples provided at recruitment using inductively coupled plasma-mass spectrometry. Logistic regression was applied to assess the association with risk. Analyses were stratified by cohort and gender and by subtype where possible. Results: There was little evidence of an increased risk of B-cell NHL or multiple myeloma with exposure to Cd (B-cell NHL: OR 1.09 95%CI 0.61, 1.93, MM: OR 1.16 95% CI: 0.40, 3.40) or Pb (B-cell NHL: 0.93 95% CI 0.43, 2.02, multiple myeloma: OR 1.63 95% CI 0.45, 5.94) in the total population when comparing the highest to the lowest quartile of exposure. However, gender and cohort specific differences in results were observed. In females the risk of B-cell NHL was more than doubled in those with a body burden of Cd >1 mu g/L (OR 2.20 95% CI; 1.04, 4.65). Conclusions: This nested case-control study does not support a consistent positive association between Cd or Pb and NHL, but there is some indication of a gender specific effect suggesting further research is warranted.	[Kelly, Rachel S.; Vineis, Paolo; Chadeau-Hyam, Marc] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Ctr Environm & Hlth, Hlth Protect Agcy,MRC, London, England; [Lundh, Thomas] Univ Lund Hosp, Dept Occupat & Environm Med, S-22185 Lund, Sweden; [Porta, Miquel] Hosp Mar, Res Inst IMIM, CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Catalonia, Spain; [Porta, Miquel] Univ Autonoma Barcelona, E-08193 Barcelona, Catalonia, Spain; [Bergdahl, Ingvar A.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Palli, Domenico] Canc Prevent & Res Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Johansson, Ann-Sofie] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Botsivali, Maria; Kyrtopoulos, Soterios A.] Natl Hellen Res Fdn, Inst Biol Pharmaceut Chem & Biotechnol, Athens, Greece; [Vineis, Paolo] HuGeF Fdn, Turin, Italy; [Vermeulen, Roel] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands	Health Protection Agency; Imperial College London; Lund University; Skane University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Umea University; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Umea University; National Hellenic Research Foundation; Utrecht University	Chadeau-Hyam, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Ctr Environm & Hlth, Hlth Protect Agcy,MRC, London, England.	m.chadeau@imperial.ac.uk	Chadeau, Marc/AAN-7586-2021; Porta, Miquel/B-5787-2008; kelly, rachel/H-4505-2017; Vermeulen, Roel/F-8037-2011; Porta, Miquel/AAD-5371-2020; Kyrtopoulos, Soterios/AAI-6426-2020	Chadeau, Marc/0000-0001-8341-5436; Porta, Miquel/0000-0003-1684-7428; kelly, rachel/0000-0003-3023-1822; Vermeulen, Roel/0000-0003-4082-8163; Porta, Miquel/0000-0003-1684-7428; tumino, rosario/0000-0003-2666-414X; Kyrtopoulos, Soterios/0000-0002-6821-6532; PALLI, Domenico/0000-0002-5558-2437; Bergdahl, Ingvar/0000-0003-1227-6859	European Union [226756]	European Union(European Commission)	This research was supported by the European Union (Grant agreement 226756 to S. A. Kyrtopoulos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2012, OCCUP ENVIRON MED, V69, P153, DOI 10.1136/oemed-2011-100111; Akesson A, 2006, ENVIRON HEALTH PERSP, V114, P830, DOI 10.1289/ehp.8763; [Anonymous], 1993, INT AG RES CANC MON, P119; [Anonymous], 2006, IN ORG LEAD COMP; Barany E, 1997, J ANAL ATOM SPECTROM, V12, P1005, DOI 10.1039/a700904f; Bergdahl IA, 1997, PHARMACOL TOXICOL, V81, P153, DOI 10.1111/j.1600-0773.1997.tb02061.x; Brauner EV, 2012, ENVIRON HEALTH PERSP, V120, P105, DOI 10.1289/ehp.1103573; Demir C, 2011, ASIAN PAC J CANCER P, V12, P3471; Engel LS, 2007, CANCER RES, V67, P5545, DOI 10.1158/0008-5472.CAN-06-3906; FEWTRELL L, 2003, LEAD ASSESSING ENV B, P2; FISCHBEIN A, 1993, BRIT J IND MED, V50, P185; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Fritz A, 2000, INT CLASS DIS ONC IC; Garcia-Leston J, 2011, MUTAT RES-GEN TOX EN, V721, P81, DOI 10.1016/j.mrgentox.2011.01.001; Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011; Gonzalez-Estecha M, 2011, J TRACE ELEM MED BIO, V25, pS78, DOI 10.1016/j.jtemb.2010.10.015; Grover P, 2010, INT J HYG ENVIR HEAL, V213, P99, DOI 10.1016/j.ijheh.2010.01.005; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Holland NT, 2002, MUTAT RES-GEN TOX EN, V521, P165, DOI 10.1016/S1383-5718(02)00237-1; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Ilychova SA, 2012, OCCUP ENVIRON MED, V69, P87, DOI 10.1136/oem.2011.065201; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; KAYAMA F, 1995, TOXICOL APPL PHARM, V134, P26, DOI 10.1006/taap.1995.1165; Kirsch-Volders M, 2010, MUTAGENESIS, V25, P213, DOI 10.1093/mutage/geq008; Kiyohara C, 2010, GENDER MED, V7, P381, DOI 10.1016/j.genm.2010.10.002; Knox EG, 1997, J EPIDEMIOL COMMUN H, V51, P151, DOI 10.1136/jech.51.2.151; Kramer S, 2012, ENVIRON HEALTH PERSP, V120, P1067, DOI 10.1289/ehp.1104652; Laden F, 2010, CANCER EPIDEM BIOMAR, V19, P1381, DOI 10.1158/1055-9965.EPI-10-0125; Lan Q, 2010, CARCINOGENESIS, V31, P1592, DOI 10.1093/carcin/bgq121; Mendy A, 2012, INT J ENVIRON HEAL R, V22, P105, DOI 10.1080/09603123.2011.605877; Mishra KP, 2009, TOXICOL IN VITRO, V23, P969, DOI 10.1016/j.tiv.2009.06.014; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Palus J, 2003, MUTAT RES-GEN TOX EN, V540, P19, DOI 10.1016/S1383-5718(03)00167-0; Porta M, 2001, EPIDEMIOLOGY, V12, P272, DOI 10.1097/00001648-200103000-00024; Ramchandran K, 2009, SEMIN ONCOL, V36, P516, DOI 10.1053/j.seminoncol.2009.09.005; Ramis R, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-4; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Vajdic CM, 2009, CANCER RES, V69, P6482, DOI 10.1158/0008-5472.CAN-08-4372; Vlaanderen J, 2011, ENVIRON HEALTH PERSP, V119, P159, DOI 10.1289/ehp.1002318; Waalkes M P, 1992, IARC Sci Publ, P401; Weaver VM, 2011, OCCUP ENVIRON MED, V68, P250, DOI 10.1136/oem.2010.056077; Whitfield JB, 2010, ENVIRON HEALTH PERSP, V118, P776, DOI 10.1289/ehp.0901541; Zeljezic D, 2007, FOOD CHEM TOXICOL, V45, P2488, DOI 10.1016/j.fct.2007.05.025; Zheng TZ, 2001, J OCCUP ENVIRON MED, V43, P641, DOI 10.1097/00043764-200107000-00012	48	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81892	10.1371/journal.pone.0081892	http://dx.doi.org/10.1371/journal.pone.0081892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312375	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900059
J	Manczinger, M; Kemeny, L				Manczinger, Mate; Kemeny, Lajos			Novel Factors in the Pathogenesis of Psoriasis and Potential Drug Candidates Are Found with Systems Biology Approach	PLOS ONE			English	Article							POSITIVE FEEDBACK LOOPS; NF-KAPPA-B; KERATINOCYTE PROLIFERATION; INSULIN-RESISTANCE; MICROARRAY METAANALYSIS; INTERACTION NETWORKS; TRANSCRIPTION FACTOR; COMPLETE RESOLUTION; THERAPEUTIC TARGET; CYTOSCAPE PLUGIN	Psoriasis is a multifactorial inflammatory skin disease characterized by increased proliferation of keratinocytes, activation of immune cells and susceptibility to metabolic syndrome. Systems biology approach makes it possible to reveal novel important factors in the pathogenesis of the disease. Protein-protein, protein-DNA, merged (containing both protein-protein and protein-DNA interactions) and chemical-protein interaction networks were constructed consisting of differentially expressed genes (DEG) between lesional and non-lesional skin samples of psoriatic patients and/or the encoded proteins. DEGs were determined by microarray meta-analysis using MetaOMICS package. We used STRING for protein-protein, CisRED for protein-DNA and STITCH for chemical-protein interaction network construction. General network-, cluster-and motif-analysis were carried out in each network. Many DEG-coded proteins (CCNA2, FYN, PIK3R1, CTGF, F3) and transcription factors (AR, TFDP1, MEF2A, MECOM) were identified as central nodes, suggesting their potential role in psoriasis pathogenesis. CCNA2, TFDP1 and MECOM might play role in the hyperproliferation of keratinocytes, whereas FYN may be involved in the disturbed immunity in psoriasis. AR can be an important link between inflammation and insulin resistance, while MEF2A has role in insulin signaling. A controller sub-network was constructed from interlinked positive feedback loops that with the capability to maintain psoriatic lesional phenotype. Analysis of chemical-protein interaction networks detected 34 drugs with previously confirmed disease-modifying effects, 23 drugs with some experimental evidences, and 21 drugs with case reports suggesting their positive or negative effects. In addition, 99 unpublished drug candidates were also found, that might serve future treatments for psoriasis.	[Manczinger, Mate; Kemeny, Lajos] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary; [Kemeny, Lajos] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary	Szeged University; Hungarian Academy of Sciences	Manczinger, M (corresponding author), Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary.	matemanc@gmail.com	Kemeny, Lajos/ABF-1339-2021; Manczinger, Máté/AAZ-7638-2021	Kemeny, Lajos/0000-0002-2119-9501; Manczinger, Máté/0000-0003-0831-9617				Armstrong AW, 2013, J AM ACAD DERMATOL; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Brandes U, 2005, NETWORK ANAL METHODO, Vxii; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brauchli YB, 2008, J AM ACAD DERMATOL, V58, P421, DOI 10.1016/j.jaad.2007.11.023; Buerger C, 2013, BR J DERMATOL, DOI 0.1111/bjd.12271; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Cagiano R, 2008, CLIN TER, V159, P421; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Chiricozzi A, 2012, DERMATOLOGY, V225, P333, DOI 10.1159/000345762; Choi JH, 2012, J BIOL CHEM, V287, P25954, DOI 10.1074/jbc.M111.313809; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cohen AD, 2001, ACTA DERM-VENEREOL, V81, P347; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; de Jong EMGJ, 1999, DERMATOLOGY, V199, P313, DOI 10.1159/000018281; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Ehrlich A, 2004, J AM ACAD DERMATOL, V50, P533, DOI 10.1016/j.jaad.2003.09.018; Ellis CN, 2000, ARCH DERMATOL, V136, P609, DOI 10.1001/archderm.136.5.609; Faghihi T, 2011, PHARMACOTHERAPY, V31, P1045, DOI 10.1592/phco.31.11.1045; Farkas A, 2012, INT IMMUNOPHARMACOL, V13, P215, DOI 10.1016/j.intimp.2012.04.003; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Goldminz AM, 2013, J DERMATOL SCI, V69, P89, DOI 10.1016/j.jdermsci.2012.11.002; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Gulliver Wayne P, 2005, Am J Ther, V12, P398, DOI 10.1097/01.mjt.0000174350.82270.da; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Halverstam CP, 2008, CLIN DERMATOL, V26, P546, DOI 10.1016/j.clindermatol.2007.10.023; Hampton PJ, 2012, J CELL PHYSIOL, V227, P1529, DOI 10.1002/jcp.22872; Han R, 2012, BRIT J CLIN PHARMACO, V74, P424, DOI 10.1111/j.1365-2125.2012.04221.x; Hwang MK, 2009, BIOCHEM PHARMACOL, V77, P1213, DOI 10.1016/j.bcp.2008.12.021; IKAI K, 1995, J AM ACAD DERMATOL, V32, P819, DOI 10.1016/0190-9622(95)91487-0; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jackson M, 1999, FASEB J, V13, P495, DOI 10.1096/fasebj.13.3.495; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johnson-Huang LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030308; Johnston A, 2005, CLIN IMMUNOL, V114, P154, DOI 10.1016/j.clim.2004.09.001; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Kallimanis PG, 2009, CLIN EXP DERMATOL, V34, P582, DOI 10.1111/j.1365-2230.2008.03026.x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kang DD, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1071; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kim TG, 2011, EXP DERMATOL, V20, P855, DOI 10.1111/j.1600-0625.2011.01343.x; Kim WT, 2012, EMBO J, V31, P3384, DOI 10.1038/emboj.2012.181; Kippenberger S, 2001, J INVEST DERMATOL, V117, P1430, DOI 10.1046/j.0022-202x.2001.01537.x; KOHN D, 1980, ARCH DERMATOL, V116, P1101, DOI 10.1001/archderm.1980.01640340011006; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kurd SK, 2008, J AM ACAD DERMATOL, V58, P625, DOI 10.1016/j.jaad.2007.12.035; Kwon YW, 2000, BIOCHEM BIOPH RES CO, V278, P312, DOI 10.1006/bbrc.2000.3806; Lai JJ, 2012, AM J PATHOL, V181, P1504, DOI 10.1016/j.ajpath.2012.07.008; Lamba G, 2011, AM J THER, V18, pE78, DOI 10.1097/MJT.0b013e3181c6c0c2; Latini A, 2003, EUR J DERMATOL, V13, P404; Laug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045430; Lebwohl M, 1999, INT J DERMATOL, V38, P16, DOI 10.1046/j.1365-4362.1999.00500.x; Lee TW, 2013, DIABETES; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050093; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Ma'ayan A, 2008, IET SYST BIOL, V2, P103, DOI 10.1049/iet-syb:20070036; Madonna S, 2010, J IMMUNOL, V185, P2467, DOI 10.4049/jimmunol.1001426; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maioli E, 2010, CURR DRUG METAB, V11, P425, DOI 10.2174/138920010791526097; Malhotra Anita, 2012, Evid Based Med, V17, P171, DOI 10.1136/ebmed-2011-100388; McCurdy CE, 2012, DIABETES, V61, P2495, DOI 10.2337/db11-1433; Menter A, 2007, LANCET, V370, P272, DOI 10.1016/S0140-6736(07)61129-5; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; MILLER GC, 1995, INT J BIOMED COMPUT, V40, P121, DOI 10.1016/0020-7101(95)01135-2; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Morgan AA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S6; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Papakostantinou E, 2005, J DERMATOL TREAT, V16, P169, DOI 10.1080/09546630510043202; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; PASLIN D, 1990, INT J DERMATOL, V29, P37, DOI 10.1111/j.1365-4362.1990.tb03753.x; PERLMAN HH, 1972, ARCH DERMATOL, V105, P128, DOI 10.1001/archderm.1972.01620040088028; Pisano C, 2004, ARCH DERMATOL RES, V296, P141, DOI 10.1007/s00403-004-0489-9; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Roy S, 2012, BRIT J HAEMATOL, V157, P446, DOI 10.1111/j.1365-2141.2012.09078.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santamaria LF, 1999, J INVEST DERMATOL, V113, P82, DOI 10.1046/j.1523-1747.1999.00639.x; Scholzen T, 1998, EXP DERMATOL, V7, P81, DOI 10.1111/j.1600-0625.1998.tb00307.x; SCHOPF RE, 1993, DERMATOLOGY, V187, P100, DOI 10.1159/000247215; SCHWARZ W, 1981, ARCH DERMATOL RES, V270, P377, DOI 10.1007/BF00403945; SENDAGORTA E, 1987, DERMATOLOGICA, V175, P300, DOI 10.1159/000248839; Senturk N, 2008, EUR J DERMATOL, V18, P343, DOI 10.1684/ejd.2008.0403; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Shirinsky IV, 2007, J AM ACAD DERMATOL, V57, P529, DOI 10.1016/j.jaad.2007.05.040; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth D, 2011, LAB INVEST, V91, P764, DOI 10.1038/labinvest.2010.208; Soler DC, 2011, J INVEST DERMATOL, V131, P1785, DOI 10.1038/jid.2011.200; Staples J, 2012, CAN FAM PHYSICIAN, V58, P404; Sticozzi C, 2013, EUR J PHARM SCI, V49, P133, DOI 10.1016/j.ejps.2013.02.009; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan Pei Lin L, 2010, GEN HOSP PSYCHIAT, V32; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tsankov N, 2011, J DERMATOL TREAT, V22, P62, DOI 10.3109/09546630903496975; Tse WP, 2008, J PHARMACOL EXP THER, V326, P388, DOI 10.1124/jpet.107.134080; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vali A, 2005, J DERMATOL TREAT, V16, P234, DOI 10.1080/09546630510011801; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang TS, 2012, J DERMATOLOG TREAT; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Woo SM, 2007, J DERMATOL, V34, P724, DOI 10.1111/j.1346-8138.2007.00369.x; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zorzou MP, 2004, ACTA DERM-VENEREOL, V84, P308, DOI 10.1080/00015550410024634	114	22	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80751	10.1371/journal.pone.0080751	http://dx.doi.org/10.1371/journal.pone.0080751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303025	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400041
J	Xi, D; Wang, M; Ye, HL; Luo, XP; Ning, Q				Xi, Dong; Wang, Ming; Ye, Huali; Luo, Xiaoping; Ning, Qin			Combined Adenovirus-Mediated Artificial microRNAs Targeting mfgl2, mFas, and mTNFR1 Protect against Fulminant Hepatic Failure in Mice	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; VIRAL-HEPATITIS; IN-VIVO; GENE-EXPRESSION; BALB/CJ MICE; FAS LIGAND; TNF-ALPHA; RAT-LIVER; B-VIRUS; APOPTOSIS	Hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) has a poor prognosis with high in-hospital mortality. Hepatic and circulating inflammatory cytokines, such as fibrinogen like protein 2 (fgl2), FasL/Fas, and TNF alpha/TNFR1, play a significant role in the pathophysiology of ACLF. This study aimed to investigate the therapeutic effect of recombinant adenoviral vectors carrying constructed DNA code for non-native microRNA (miRNA) targeting mouse fgl2 (mfgl2) or both mFas and mTNFR1 on murine hepatitis virus (MHV)-3-induced fulminant hepatitis in BALB/cJ mice. Artificial miRNA eukaryotic expression plasmids against mfgl2, mFas, and mTNFR1 were constructed, and their inhibitory effects on the target genes were confirmed in vitro. pcDNA6.2-mFas-mTNFR1-miRNA, which expresses miRNA against both mFas and mTNFR1 simultaneously, was constructed. To construct a miRNA adenovirus expression vector against mfgl2, pcDNA6.2-mfgl2-miRNA was cloned using Gateway technology. Ad-mFas-mTNFR1-miRNA was also constructed by the same procedure. Adenovirus vectors were delivered by tail-vein injection into MHV-3-infected BALB/cJ mice to evaluate the therapeutic effect. 8 of 18 (44.4%) mice recovered from fulminant viral hepatitis in the combined interference group treated with Ad-mfgl2-miRNA and Ad-mFas-mTNFR1-miRNA. But only 4 of 18 (22.2%) mice receiving Ad-mfgl2-miRNA and 3 of 18 (16.7%) mice receiving Ad-mFas-mTNFR1- miRNA survived. These adenovirus vectors significantly ameliorated inflammatory infiltration, fibrin deposition, hepatocyte necrosis and apoptosis, and prolonged survival time. Our data illustrated that combined interference using adenovirus-mediated artificial miRNAs targeting mfgl2, mFas, and mTNFR1 might have significant therapeutic potential for the treatment of fulminant hepatitis.	[Xi, Dong; Wang, Ming; Ye, Huali; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan 430074, Peoples R China; [Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ning, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan 430074, Peoples R China.	qning@vip.sina.com			Ministry of Education of China [IRT1131]; National High Technology Program of China [2012AA020801]; National Science Youth Fund of China [NSFC30700702]	Ministry of Education of China(Ministry of Education, China); National High Technology Program of China; National Science Youth Fund of China	This study was supported by the Innovation Team Development Plan of the Ministry of Education of China (IRT1131), National High Technology Program of China (2012AA020801) and the National Science Youth Fund of China (NSFC30700702). DX was supported by the National Science Youth Fund of China and National High Technology Program of China. QN was supported by the Innovation Team Development Plan of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust T, 2004, J HEPATOL, V40, P638, DOI 10.1016/j.jhep.2003.12.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng VCC, 2003, SEMIN LIVER DIS, V23, P239; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Gao S, 2010, HUM GENE THER, V21, P969, DOI 10.1089/hum.2009.177; Guo ZS, 1996, GENE THER, V3, P802; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044138; Ke WM, 2003, J GASTROENTEROL, V38, P861, DOI 10.1007/s00535-003-1162-3; Kuriyama S, 1999, GENE THER, V6, P749, DOI 10.1038/sj.gt.3300894; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LEIST M, 1994, J IMMUNOL, V153, P1778; Levy GA, 2000, AM J PATHOL, V156, P1217, DOI 10.1016/S0002-9440(10)64992-9; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Liu XR, 2012, J CELL MOL MED, V16, P1298, DOI 10.1111/j.1582-4934.2011.01396.x; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Mita A, 2005, AM J GASTROENTEROL, V100, P2551, DOI 10.1111/j.1572-0241.2005.00265.x; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nakamoto Y, 2003, CURR MOL MED, V3, P537, DOI 10.2174/1566524033479591; Nakayama Y, 2005, HEPATOLOGY, V42, P915, DOI 10.1002/hep.20872; Ning Q, 1998, J IMMUNOL, V160, P3487; O'Donnell JM, 2012, CURR GENE THER, V12, P454; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pawlotsky JM, 2002, GASTROENTEROLOGY, V122, P1554, DOI 10.1053/gast.2002.33428; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Rivero M, 2002, J VIRAL HEPATITIS, V9, P107, DOI 10.1046/j.1365-2893.2002.00338.x; Ryo K, 2000, AM J GASTROENTEROL, V95, P2047; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; SCHWARTZ BS, 1982, J EXP MED, V155, P1464, DOI 10.1084/jem.155.5.1464; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Stravitz RT, 2009, NAT REV GASTRO HEPAT, V6, P542, DOI 10.1038/nrgastro.2009.127; Tokushige K, 2000, AM J GASTROENTEROL, V95, P2040; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785; Yoon S, 2010, LIVER INT, V30, P376, DOI 10.1111/j.1478-3231.2009.02181.x; Zhu CL, 2005, WORLD J GASTROENTERO, V11, P6936, DOI 10.3748/wjg.v11.i44.6936; Zhu CL, 2006, HUM GENE THER, V17, P589, DOI 10.1089/hum.2006.17.589; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	46	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82330	10.1371/journal.pone.0082330	http://dx.doi.org/10.1371/journal.pone.0082330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303082	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400099
J	Xu, MF; Qin, YF; Qu, JH; Lu, CC; Wang, Y; Wu, W; Song, L; Wang, SL; Chen, F; Shen, HB; Sha, JH; Hu, ZB; Xia, YK; Wang, X				Xu, Miaofei; Qin, Yufeng; Qu, Jianhua; Lu, Chuncheng; Wang, Ying; Wu, Wei; Song, Ling; Wang, Shoulin; Chen, Feng; Shen, Hongbing; Sha, Jiahao; Hu, Zhibin; Xia, Yankai; Wang, Xinru			Evaluation of Five Candidate Genes from GWAS for Association with Oligozoospermia in a Han Chinese Population	PLOS ONE			English	Article							SIGNAL-REGULATORY PROTEIN; MALE-INFERTILITY; NEGATIVE REGULATION; GENOME-WIDE; ALPHA; AZOOSPERMIA; CELLS; POLYMORPHISMS; SUBDELETION; INHIBITION	Background: Oligozoospermia is one of the severe forms of idiopathic male infertility. However, its pathology is largely unknown, and few genetic factors have been defined. Our previous genome-wide association study (GWAS) has identified four risk loci for non-obstructive azoospermia (NOA). Objective: To investigate the potentially functional genetic variants (including not only common variants, but also less-common and rare variants) of these loci on spermatogenic impairment, especially oligozoospermia. Design, Setting, and Participants: A total of 784 individuals with oligozoospermia and 592 healthy controls were recruited to this study from March 2004 and January 2011. Measurements: We conducted a two-stage study to explore the association between oligozoospermia and new makers near NOA risk loci. In the first stage, we used next generation sequencing (NGS) in 96 oligozoospermia cases and 96 healthy controls to screen oligozoospermia-susceptible genetic variants. Next, we validated these variants in a large cohort containing 688 cases and 496 controls by SNPscan for high-throughput Single Nucleotide Polymorphism (SNP) genotyping. Results and Limitations: Totally, we observed seven oligozoospermia associated variants (rs3791185 and rs2232015 in PRMT6, rs146039840 and rs11046992 in Sox5, rs1129332 in PEX10, rs3197744 in SIRPA, rs1048055 in SIRPG) in the first stage. In the validation stage, rs3197744 in SIRPA and rs11046992 in Sox5 were associated with increased risk of oligozoospermia with an odds ratio (OR) of 4.62 (P = 0.005, 95% CI 1.58-13.4) and 1.82 (P = 0.005, 95% CI 1.01-1.64), respectively. Further investigation in larger populations and functional characterizations are needed to validate our findings. Conclusions: Our study provides evidence of independent oligozoospermia risk alleles driven by variants in the potentially functional regions of genes discovered by GWAS. Our findings suggest that integrating sequence data with large-scale genotyping will serve as an effective strategy for discovering risk alleles in the future.	[Xu, Miaofei; Qin, Yufeng; Qu, Jianhua; Lu, Chuncheng; Wang, Ying; Wu, Wei; Song, Ling; Wang, Shoulin; Shen, Hongbing; Sha, Jiahao; Hu, Zhibin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Miaofei; Qin, Yufeng; Qu, Jianhua; Lu, Chuncheng; Wang, Ying; Wu, Wei; Song, Ling; Wang, Shoulin; Chen, Feng; Shen, Hongbing; Hu, Zhibin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Qu, Jianhua] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China; [Chen, Feng; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nantong University; Nanjing Medical University	Lu, CC (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	chunchenglu@gmail.com; yankaixia@njmu.edu.cn; xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012	Wu, Wei/0000-0002-0267-1284	National Natural Science Foundation of China [81100461, 30930079]; National Basic Research Program of China (973 Program) [2009CB941703]; Jiangsu Natural Science Foundation [BK2011774]; Postdoctoral Science Foundation [2012T50513, 1101025C]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	Funding was provided by grants from National Natural Science Foundation of China (81100461 and30930079), the National Basic Research Program of China (973 Program) (2009CB941703), the Jiangsu Natural Science Foundation (BK2011774), Postdoctoral Science Foundation (2012T50513 and 1101025C) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bhasin S, 1997, ANN MED, V29, P261, DOI 10.3109/07853899708999344; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Hu ZB, 2012, NAT GENET, V44, P183, DOI 10.1038/ng.1040; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kiselak EA, 2010, J BIOL CHEM, V285, P30496, DOI 10.1074/jbc.M110.121590; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; van den Berg TK, 2005, J IMMUNOL, V175, P7788, DOI 10.4049/jimmunol.175.12.7788; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Xu WM, 2009, MOL BIOL REP, V36, P1187, DOI 10.1007/s11033-008-9296-2	30	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80374	10.1371/journal.pone.0080374	http://dx.doi.org/10.1371/journal.pone.0080374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303009	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400025
J	Villarejo, A; Cortes-Cabrera, A; Molina-Ortiz, P; Portillo, F; Cano, A				Villarejo, Ana; Cortes-Cabrera, Alvaro; Molina-Ortiz, Patricia; Portillo, Francisco; Cano, Amparo			Differential Role of Snail1 and Snail2 Zinc Fingers in E-cadherin Repression and Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; TUMOR-GROWTH; SLUG; EXPRESSION; GENE; PHOSPHORYLATION; FAMILY; SUPERFAMILY; METASTASIS; REGULATORS	Snail1 (Snail) and Snail2 (Slug) are transcription factors that share a similar DNA binding structure of four and five C2H2 zinc finger motifs (ZF), respectively. Both factors bind specifically to a subset of E-box motifs (E2-box: CAGGTG/CACCTG) in target promoters like the E-cadherin promoter and are key mediators of epithelial-to-mesenchymal transition (EMT). However, there are differences in the biological actions, in binding affinities to E-cadherin promoter, and in the target genes of Snail1 and Snail2, although the molecular bases are presently unknown. In particular, the role of each Snail1 and Snail2 ZF in the binding to E-boxes and in EMT induction has not been previously explored. We have approached this question by modeling Snail1 and Snail2 protein-DNA interactions and through mutational and functional assays of different ZFs. Results show that Snail1 efficient repression and binding to human and mouse E-cadherin promoter as well as EMT-inducing ability require intact ZF1 and ZF2, while for Snail2, either ZF3 or ZF4 is essential for those functions. Furthermore, the differential distribution of E2-boxes in mouse and human E-cadherin promoters also contributes to the differential Snail factor activity. These data indicate a non-equivalent role of Snail1 and Snail2 ZFs in gene repression, contributing to the elucidation of the molecular differences between these important EMT regulators.	[Villarejo, Ana; Molina-Ortiz, Patricia; Portillo, Francisco; Cano, Amparo] Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM, IdiPAZ, Madrid 28029, Spain; [Cortes-Cabrera, Alvaro] Ctr Biol Mol Severo Ochoa CSIC UAM, Unidad Bioinformat, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Portillo, F (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM, IdiPAZ, Arzobispo Morcillo 2, Madrid 28029, Spain.	fportillo@iib.uam.es; acano@iib.uam.es	; Cortes Cabrera, Alvaro/B-3748-2016	Portillo Perez, Francisco/0000-0003-4922-346X; Cortes Cabrera, Alvaro/0000-0003-4635-6267	Spanish Ministry of Economy and Competitiveness [SAF2010-21143, CSD2007-00017]; Comunidad de Madrid [S2010/BMD-2303]; Instituto de Salud Carlos III [RETIC-RD12/0036/0007]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Economy and Competitiveness (formerly Innovation and Sciences) [SAF2010-21143; Consolider-Ingenio CSD2007-00017]; Comunidad de Madrid [S2010/BMD-2303]; and the Instituto de Salud Carlos III [RETIC-RD12/0036/0007].	Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hajra KM, 2002, CANCER RES, V62, P1613; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Martinez-Alvarez C, 2004, DEV BIOL, V265, P207, DOI 10.1016/j.ydbio.2003.09.022; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Molina-Ortiz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036132; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Sefton M, 1998, DEVELOPMENT, V125, P3111; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	106	113	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					930	941		10.1074/jbc.M113.528026	http://dx.doi.org/10.1074/jbc.M113.528026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24297167	Green Published, hybrid			2022-12-25	WOS:000330541200028
J	Fecchio, C; De Franceschi, G; Relini, A; Greggio, E; Serra, MD; Bubacco, L; de Laureto, PP				Fecchio, Chiara; De Franceschi, Giorgia; Relini, Annalisa; Greggio, Elisa; Serra, Mauro Dalla; Bubacco, Luigi; de Laureto, Patrizia Polverino			alpha-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity	PLOS ONE			English	Article							PARKINSONS-DISEASE; VESICLE PERMEABILIZATION; OXIDATIVE STRESS; FATTY-ACIDS; BINDING; AGGREGATION; NEUROPATHOLOGY; PATHOGENESIS; MUTATIONS; RELEASE	A key feature of Parkinson disease is the aggregation of alpha-synuclein and its intracellular deposition in fibrillar form. Increasing evidence suggests that the pathogenicity of alpha-synuclein is correlated with the activity of oligomers formed in the early stages of its aggregation process. Oligomers toxicity seems to be associated with both their ability to bind and affect the integrity of lipid membranes. Previously, we demonstrated that alpha-synuclein forms oligomeric species in the presence of docosahexaenoic acid and that these species are toxic to cells. Here we studied how interaction of these oligomers with membranes results in cell toxicity, using cellular membrane-mimetic and cell model systems. We found that alpha-synuclein oligomers are able to interact with large and small unilamellar negatively charged vesicles acquiring an increased amount of alpha-helical structure, which induces small molecules release. We explored the possibility that oligomers effects on membranes could be due to pore formation, to a detergent-like effect or to fibril growth on the membrane. Our biophysical and cellular findings are consistent with a model where alpha-synuclein oligomers are embedded into the lipid bilayer causing transient alteration of membrane permeability.	[Fecchio, Chiara; De Franceschi, Giorgia; de Laureto, Patrizia Polverino] Univ Padua, Dept Pharmaceut Sci, Ctr Biotechnol, CRIBI, Padua, Italy; [Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy; [Greggio, Elisa; Bubacco, Luigi] Univ Padua, Dept Biol, Padua, Italy; [Serra, Mauro Dalla] Natl Res Council Italy, Inst Biophys, Trento, Italy; [Serra, Mauro Dalla] Bruno Kessler Fdn, Trento, Italy	University of Padua; University of Genoa; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Bruno Kessler	de Laureto, PP (corresponding author), Univ Padua, Dept Pharmaceut Sci, Ctr Biotechnol, CRIBI, Padua, Italy.	patrizia.polverinodelaureto@unipd.it	Greggio, Elisa/H-6119-2013; Relini, Annalisa/AHC-3105-2022; Bubacco, Luigi/B-5602-2012; Serra, Mauro Dalla/AAK-9299-2021; Serra, Mauro Dalla/A-6218-2010	Greggio, Elisa/0000-0002-8172-3598; Bubacco, Luigi/0000-0001-7927-9208; Serra, Mauro Dalla/0000-0003-1048-2739; Serra, Mauro Dalla/0000-0003-1048-2739; RELINI, ANNALISA/0000-0002-4040-9279	University of Padova [CPDA125928]; University of Genova (Fondi di Ateneo); Italian Ministry of Education; University and Research	University of Padova; University of Genova (Fondi di Ateneo); Italian Ministry of Education; University and Research	This work was supported by a Research Project of University of Padova (CPDA125928, 2012), by University of Genova (Fondi di Ateneo) and by the Rientro dei Cervelli Program (Incentivazione alla mobilita' di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bae EJ, 2013, ANTIOXID REDOX SIGN, V18, P770, DOI 10.1089/ars.2011.4429; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Bodles AM, 2001, J NEUROCHEM, V78, P384, DOI 10.1046/j.1471-4159.2001.00408.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.03247.x; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dalfo E, 2005, NEUROSCI LETT, V380, P170, DOI 10.1016/j.neulet.2005.01.034; Dalla Serra M, 2000, METHODS MOL BIOL, V145, P171; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Mazzuca C, 2010, BIOPHYS J, V99, P1791, DOI 10.1016/j.bpj.2010.07.010; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Xiang W, 2013, MOL CELL NEUROSCI, V54, P71, DOI 10.1016/j.mcn.2013.01.004; Yakunin E, 2012, BRAIN PATHOL, V22, P280, DOI 10.1111/j.1750-3639.2011.00530.x	51	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82732	10.1371/journal.pone.0082732	http://dx.doi.org/10.1371/journal.pone.0082732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312431	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300084
J	Sunagar, K; Fry, BG; Jackson, TNW; Casewell, NR; Undheim, EAB; Vidal, N; Ali, SA; King, GF; Vasudevan, K; Vasconcelos, V; Antunes, A				Sunagar, Kartik; Fry, Bryan Grieg; Jackson, Timothy N. W.; Casewell, Nicholas R.; Undheim, Eivind A. B.; Vidal, Nicolas; Ali, Syed A.; King, Glenn F.; Vasudevan, Karthikeyan; Vasconcelos, Vitor; Antunes, Agostinho			Molecular Evolution of Vertebrate Neurotrophins: Co-Option of the Highly Conserved Nerve Growth Factor Gene into the Advanced Snake Venom Arsenalf	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; DETECTING POSITIVE SELECTION; PHYLOGENETIC ANALYSIS; CELL-DEATH; ACCELERATED EVOLUTION; LIKELIHOOD METHOD; INDIVIDUAL SITES; NUCLEAR LOCI; MAST-CELLS; DIVERSIFICATION	Neurotrophins are a diverse class of structurally related proteins, essential for neuronal development, survival, plasticity and regeneration. They are characterized by major family members, such as the nerve growth factors (NGF), brain-derived neurotrophic factors (BDNF) and neurotrophin-3 (NT-3), which have been demonstrated here to lack coding sequence variations and follow the regime of negative selection, highlighting their extremely important conserved role in vertebrate homeostasis. However, in stark contrast, venom NGF secreted as part of the chemical arsenal of the venomous advanced snake family Elapidae (and to a lesser extent Viperidae) have characteristics consistent with the typical accelerated molecular evolution of venom components. This includes a rapid rate of diversification under the significant influence of positive-selection, with the majority of positively-selected sites found in the secreted beta-polypeptide chain (74%) and on the molecular surface of the protein (92%), while the core structural and functional residues remain highly constrained. Such focal mutagenesis generates active residues on the toxin molecular surface, which are capable of interacting with novel biological targets in prey to induce a myriad of pharmacological effects. We propose that caenophidian NGFs could participate in prey-envenoming by causing a massive release of chemical mediators from mast cells to mount inflammatory reactions and increase vascular permeability, thereby aiding the spread of other toxins and/or by acting as proapoptotic factors. Despite their presence in reptilian venom having been known for over 60 years, this is the first evidence that venom-secreted NGF follows the molecular evolutionary pattern of other venom components, and thus likely participates in preyenvenomation.	[Sunagar, Kartik; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Sunagar, Kartik; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Fry, Bryan Grieg; Jackson, Timothy N. W.; Undheim, Eivind A. B.; Ali, Syed A.] Univ Queensland, Sch Biol Sci, Venom Evolut Lab, St Lucia, Qld, Australia; [Fry, Bryan Grieg; Jackson, Timothy N. W.; Undheim, Eivind A. B.; King, Glenn F.] Univ Queenland, Inst Mol Biosci, St Lucia, Qld, Australia; [Casewell, Nicholas R.] Bangor Univ, Sch Biol Sci, Mol Ecol & Evolut Grp, Bangor, Gwynedd, Wales; [Casewell, Nicholas R.] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England; [Vidal, Nicolas] Museum Natl Hist Nat, UMR 7138, Dept Systemat & Evolut, Serv Systemat Mol, F-75231 Paris, France; [Ali, Syed A.] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 32, Pakistan; [Vasudevan, Karthikeyan] Wildlife Inst India, Dehra Dun, Uttar Pradesh, India	Universidade do Porto; Universidade do Porto; University of Queensland; University of Queensland; Bangor University; Liverpool School of Tropical Medicine; University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Karachi; Wildlife Institute of India	Antunes, A (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	King, Glenn F/J-5059-2012; Vasconcelos, Vitor/A-8933-2008; Casewell, Nicholas/C-3187-2014; Sunagar, Kartik/F-9241-2013	King, Glenn F/0000-0002-2308-2200; Vasconcelos, Vitor/0000-0003-3585-2417; Antunes, Agostinho/0000-0002-1328-1732; Sunagar, Kartik/0000-0003-0998-1581; Jackson, Timothy/0000-0001-6277-7745; Casewell, Nicholas/0000-0002-8035-4719; Vasudevan, Karthikeyan/0000-0003-2316-3382; Undheim, Eivind/0000-0002-8667-3999	F.C.T (Fundacao para a Ciencia e a Tecnologia) [SFRH/BD/61959/2009, PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; Australian Research Council [DP130103813]; University of Queensland; Australian Postgraduate Award; Natural Environment Research Council, UK [NE/J018678/1]; Norwegian State Education Loans Fund; 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle [UMS 2700 (OMSI)]; Higher Education Commission (HEC Islamabad) Pakistan; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; NERC [NE/J018678/1] Funding Source: UKRI; Natural Environment Research Council [NE/J018678/1] Funding Source: researchfish	F.C.T (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); Australian Postgraduate Award(Australian Government); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Norwegian State Education Loans Fund; 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS)); Higher Education Commission (HEC Islamabad) Pakistan(Higher Education Commission of Pakistan); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KS was funded by PhD grant (SFRH/BD/61959/2009) from F.C.T (Fundacao para a Ciencia e a Tecnologia). BGF was funded by an Australian Research Council Future Fellowship and by the University of Queensland. TNWJ was funded by an Australian Postgraduate Award. NRC was funded by fellowship award (NE/J018678/1) from the Natural Environment Research Council, UK. EABU acknowledges funding from the University of Queensland (International Postgraduate Research Scholarship, UQ Centennial Scholarship, and UQ Advantage Top-Up Scholarship) and the Norwegian State Education Loans Fund. NV was funded by the 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle [UMS 2700 (OMSI)]. GFK was funded by Australian Research Council Discovery Grant DP130103813. SAA was the recipient of postdoctoral fellowship (PDRF Phase II Batch-V) from Higher Education Commission (HEC Islamabad) Pakistan. AA was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through F. C. T under the projects PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Boldrini-Franca J, 2010, J PROTEOMICS, V73, P1758, DOI 10.1016/j.jprot.2010.06.001; Brust A, 2013, MOL CELL PROTEOMICS, V12, P1488, DOI [10.1074/mcp.A112.023135, 10.1074/mcp.M112.023135]; Bush SP, 2002, ANN EMERG MED, V40, P619, DOI 10.1067/mem.2002.129939; Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Casewell NR, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2065; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Casewell NR, 2011, MOL BIOL EVOL, V28, P1157, DOI 10.1093/molbev/msq302; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Chang D, 2012, MOL BIOL EVOL, V29, P2019, DOI 10.1093/molbev/mss068; Ching ATC, 2006, FEBS LETT, V580, P4417, DOI 10.1016/j.febslet.2006.07.010; Ching ATC, 2012, J PROTEOME RES, V11, P1152, DOI 10.1021/pr200876c; COHEN S, 1959, J BIOL CHEM, V234, P1129; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Earl STH, 2006, PROTEOMICS, V6, P6554, DOI 10.1002/pmic.200600263; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1996, NATURE, V383, P166; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Fry BG, 2013, MOL CELL PROTEOMICS, V12, P1881, DOI 10.1074/mcp.M112.023143; Fry BG, 2012, TOXICON, V60, P434, DOI 10.1016/j.toxicon.2012.02.013; Fry BG, 2012, TOXICON, V59, P696, DOI 10.1016/j.toxicon.2012.03.005; Fry BG, 2010, MOL CELL PROTEOMICS, V9, P2369, DOI 10.1074/mcp.M110.001370; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Girish KS, 2002, MOL CELL BIOCHEM, V240, P105, DOI 10.1023/A:1020651607164; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008; Hallbook F, 1998, J NEUROSCI, V18, P8700; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Heatwole H, 1998, TOXICON, V36, P619, DOI 10.1016/S0041-0101(97)00081-0; HOGUEANGELETTI RA, 1976, BIOCHEMISTRY-US, V15, P26, DOI 10.1021/bi00646a005; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jaaro H, 2001, TRENDS NEUROSCI, V24, P79, DOI 10.1016/S0166-2236(00)01690-8; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Katzir I, 2003, TOXICON, V42, P481, DOI 10.1016/S0041-0101(03)00225-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koh DCI, 2004, BIOCHEM J, V383, P149, DOI 10.1042/BJ20040569; Koludarov I, 2012, J MOL EVOL, V75, P168, DOI 10.1007/s00239-012-9529-9; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; KOYAMA J, 1992, BIOCHIM BIOPHYS ACTA, V1160, P287, DOI 10.1016/0167-4838(92)90090-Z; Kozminsky-Atias A, 2012, FASEB J, V26, P576, DOI 10.1096/fj.11-187179; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Low DHW, 2013, J PROTEOMICS, V89, P95, DOI 10.1016/j.jprot.2013.05.034; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022; MORRISON JJ, 1982, TOXICON, V20, P739, DOI 10.1016/0041-0101(82)90121-0; MORRISON JJ, 1984, TOXICON, V22, P759, DOI 10.1016/0041-0101(84)90158-2; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nielsen R, 1998, GENETICS, V148, P929; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Nisani Z, 2012, TOXICON, V60, P315, DOI 10.1016/j.toxicon.2012.04.343; ODA T, 1989, BIOCHEM INT, V19, P909; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; PEARCE FL, 1972, EUR J BIOCHEM, V29, P417, DOI 10.1111/j.1432-1033.1972.tb02004.x; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; Pond SLK, 2010, MOL BIOL EVOL, V27, P520, DOI 10.1093/molbev/msp260; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruder T, 2013, J MOL EVOL, V76, P192, DOI 10.1007/s00239-013-9552-5; Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500; SIIGUR E, 1985, COMP BIOCHEM PHYS B, V81, P211, DOI 10.1016/0305-0491(85)90185-3; SIIGUR J, 1987, COMP BIOCHEM PHYS B, V87, P329, DOI 10.1016/0305-0491(87)90147-7; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sunagar K, 2012, MOL BIOL EVOL, V29, P1807, DOI 10.1093/molbev/mss058; Terrat Y, 2013, TOXINS, V5, P1948, DOI 10.3390/toxins5111948; THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wijeyewickrema LC, 2007, TOXICON, V50, P1064, DOI 10.1016/j.toxicon.2007.07.006; WIJEYEWICKREMA LC, 2010, 6 J BIOL CHEM, V285, P11793, DOI DOI 10.1074/JBC.M110.100479; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhu SY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012054	110	44	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81827	10.1371/journal.pone.0081827	http://dx.doi.org/10.1371/journal.pone.0081827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312363	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327670300052
J	Szabo, JA; Szilagyi, A; Doleschall, Z; Patocs, A; Farkas, H; Prohaszka, Z; Racz, K; Fust, G; Doleschall, M				Szabo, Julianna Anna; Szilagyi, Agnes; Doleschall, Zoltan; Patocs, Attila; Farkas, Henriette; Prohaszka, Zoltan; Racz, Karioly; Fuest, George; Doleschall, Marton			Both Positive and Negative Selection Pressures Contribute to the Polymorphism Pattern of the Duplicated Human CYP21A2 Gene	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; HUMAN-COMPLEMENT C4A; STATISTICAL TESTS; HAPLOTYPE RECONSTRUCTION; ADAPTIVE EVOLUTION; NATURAL-SELECTION; MOSAIC STRUCTURE; RCCX MODULES; CONVERSION; POPULATION	The human steroid 21-hydroxylase gene (CYP21A2) participates in cortisol and aldosterone biosynthesis, and resides together with its paralogous (duplicated) pseudogene in a multiallelic copy number variation (CNV), called RCCX CNV. Concerted evolution caused by non-allelic gene conversion has been described in great ape CYP21 genes, and the same conversion activity is responsible for a serious genetic disorder of CYP21A2, congenital adrenal hyperplasia (CAH). In the current study, 33 CYP21A2 haplotype variants encoding 6 protein variants were determined from a European population. CYP21A2 was shown to be one of the most diverse human genes (HHe=0.949), but the diversity of intron 2 was greater still. Contrary to previous findings, the evolution of intron 2 did not follow concerted evolution, although the remaining part of the gene did. Fixed sites (different fixed alleles of sites in human CYP21 paralogues) significantly accumulated in intron 2, indicating that the excess of fixed sites was connected to the lack of effective non-allelic conversion and concerted evolution. Furthermore, positive selection was presumably focused on intron 2, and possibly associated with the previous genetic features. However, the positive selection detected by several neutrality tests was discerned along the whole gene. In addition, the clear signature of negative selection was observed in the coding sequence. The maintenance of the CYP21 enzyme function is critical, and could lead to negative selection, whereas the presumed gene regulation altering steroid hormone levels via intron 2 might help fast adaptation, which broadly characterizes the genes of human CNVs responding to the environment.	[Szabo, Julianna Anna; Szilagyi, Agnes; Farkas, Henriette; Prohaszka, Zoltan; Fuest, George; Doleschall, Marton] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary; [Doleschall, Zoltan] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary; [Patocs, Attila; Racz, Karioly; Doleschall, Marton] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Patocs, Attila; Racz, Karioly; Doleschall, Marton] Semmelweis Univ, H-1085 Budapest, Hungary; [Patocs, Attila] Hungarian Acad Sci, Lendulet Hereditary Endocrine Tumours Res Grp, Budapest, Hungary; [Racz, Karioly] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary	Semmelweis University; National Institute of Oncology Hungary; Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Doleschall, M (corresponding author), Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary.	doleschall@med.semmelweis-univ.hu	Prohászka, Zoltán/F-2191-2010; Doleschall, Marton/F-5386-2011; Szilagyi, Agnes/F-2337-2010; Doleschall, Marton/AAF-7742-2020	Prohászka, Zoltán/0000-0003-1761-7982; Doleschall, Marton/0000-0002-0909-5232; Szilagyi, Agnes/0000-0002-9769-3215; Doleschall, Marton/0000-0002-0909-5232; Patocs, Attila/0000-0001-7506-674X; Farkas, Henriette/0000-0003-2929-1721	Hungarian Scientific Research Fund (OTKA) [PD100648]; Foundation for the Prevention and Treatment of Fatal Angioedematous Disease and Research; Technology Innovation Fund, National Developmental Agency [KTIA-AIK-2012-12-1-0010]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Foundation for the Prevention and Treatment of Fatal Angioedematous Disease and Research; Technology Innovation Fund, National Developmental Agency	The authors acknowledge the financial support from Hungarian Scientific Research Fund (OTKA, PD100648 (AP)), Foundation for the Prevention and Treatment of Fatal Angioedematous Disease and Research, and Technology Innovation Fund, National Developmental Agency (KTIA-AIK-2012-12-1-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Araki H, 2001, GENETICS, V157, P667; Banlaki Z, 2012, GENES IMMUN, V13, P530, DOI 10.1038/gene.2012.29; Banlaki Z, 2013, GENOME BIOL EVOL, V5, P98, DOI 10.1093/gbe/evs121; Banlaki Z, 2012, CLIN ENDOCRINOL, V76, P478, DOI 10.1111/j.1365-2265.2011.04247.x; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Canturk C, 2011, CLIN CHEM, V57, P511, DOI 10.1373/clinchem.2010.156893; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fay JC, 2001, GENETICS, V158, P1227; Fay JC, 2000, GENETICS, V155, P1405; Fu YX, 1997, GENETICS, V147, P915; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Innan H, 2004, GENES GENET SYST, V79, P65, DOI 10.1266/ggs.79.65; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Innan H, 2003, GENETICS, V163, P803; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jin P, 2004, GENOMICS, V83, P566, DOI 10.1016/j.ygeno.2003.09.023; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; KAWAGUCHI H, 1992, AM J HUM GENET, V50, P766; Khurana E, 2010, NUCLEIC ACIDS RES, V38, P6997, DOI 10.1093/nar/gkq587; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazzaro BP, 2001, GENETICS, V159, P659; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; NAGYLAKI T, 1982, GENETICS, V100, P315; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; New MI, 2013, P NATL ACAD SCI USA, V110, P2611, DOI 10.1073/pnas.1300057110; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nikolaidis N, 2004, MOL BIOL EVOL, V21, P498, DOI 10.1093/molbev/msh041; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ohno S., 1970, P1; Ohta T., 1980, EVOLUTION VARIATION, V37, DOI [10.1007/978-3-642-93138-3, DOI 10.1007/978-3-642-93138-3]; OTA T, 1994, MOL BIOL EVOL, V11, P469; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Proulx SR, 2012, GENETICS, V190, P737, DOI 10.1534/genetics.111.135590; Przeworski M, 2002, GENETICS, V160, P1179; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Ramos-Onsins SE, 2007, EVOL BIOINFORM, V3, P41; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Slatkin M, 1996, GENET RES, V68, P259, DOI 10.1017/S0016672300034236; SMITH JM, 1992, J MOL EVOL, V34, P126; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storz JF, 2007, GENETICS, V177, P481, DOI 10.1534/genetics.107.078550; Szilagyi A, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-1; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teshima KM, 2012, GENETICS, V190, P1077, DOI 10.1534/genetics.111.135343; Thornton KR, 2007, GENETICS, V177, P987, DOI 10.1534/genetics.107.074948; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Tsai LP, 2012, GENE, V506, P261, DOI 10.1016/j.gene.2012.06.045; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; Wilming LG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat011; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	98	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81977	10.1371/journal.pone.0081977	http://dx.doi.org/10.1371/journal.pone.0081977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312389	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327670300061
J	Xue, J; Bosch, M; Knox, JP				Xue, Jie; Bosch, Maurice; Knox, J. Paul			Heterogeneity and Glycan Masking of Cell Wall Microstructures in the Stems of Miscanthus x giganteus, and Its Parents M. sinensis and M. sacchariflorus	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; ENERGY CROP; POLYSACCHARIDES; LOCALIZATION; CHEMISTRY; PROTEINS; BIOFUELS; GRASSES; XYLANS; PLANTS	Plant cell walls, being repositories of fixed carbon, are important sources of biomass and renewable energy. Miscanthus species are fast growing grasses with a high biomass yield and they have been identified as potential bioenergy crops. Miscanthus x giganteus is the sterile hybrid between M. sinensis and M. sacchariflorus, with a faster and taller growth than its parents. In this study, the occurrence of cell wall polysaccharides in stems of Miscanthus species has been determined using fluorescence imaging with sets of cell wall directed monoclonal antibodies. Heteroxylan and mixed linkage-glucan (MLG) epitopes are abundant in stem cell walls of Miseanthus species but their distributions are different in relation to the interfascicular parenchyma and these epitopes also display different developmental dynamics. Detection of pectic homogalacturonan (HG) epitopes was often restricted to intercellular spaces of parenchyma regions and, notably, the high methyl ester LM20 HG epitope was specifically abundant in the pith parenchyma cell walls of M. x giganteus. Some cell wall probes cannot access their target glycan epitopes because of masking by other polysaccharides. In the case of Miscanthus stems, masking of xyloglucan by heteroxylan and masking of pectic galactan by heteroxylan and MLG was detected in certain cell wall regions. Knowledge of tissue level heterogeneity of polysaccharide distributions and molecular architectures in Miscanthus cell wall structures will be important for both understanding growth mechanisms and also for the development of potential strategies for the efficient deconstruction of Miscanthus biomass.	[Xue, Jie; Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Bosch, Maurice] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Leeds; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Knox, JP (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England.	j.p.knox@leeds.ac.uk	Bosch, Maurice/C-6400-2008; Knox, Paul/H-4577-2012	Bosch, Maurice/0000-0003-1990-589X; Knox, Paul/0000-0002-9231-6891	China Scholarship Council/University of Leeds; Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant [BBS/E/W/00003134]; BBSRC [BBS/E/W/10963A01D, BBS/E/W/10963A01C] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10963A01C, BBS/E/W/10963A01D] Funding Source: researchfish	China Scholarship Council/University of Leeds(China Scholarship Council); Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the China Scholarship Council/University of Leeds to JX. MB was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant BBS/E/W/00003134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GG, 2011, BIOMASS BIOENERG, V35, P4740, DOI 10.1016/j.biombioe.2011.10.008; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Christiaens S, 2011, FOOD RES INT, V44, P225, DOI 10.1016/j.foodres.2010.10.031; Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x; Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204; Davies LJ, 2012, NEW PHYTOL, V196, P238, DOI 10.1111/j.1469-8137.2012.04238.x; Derbyshire P, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-31; Domon JM, 2013, PHYTOCHEMISTRY, V85, P51, DOI 10.1016/j.phytochem.2012.09.001; Gibeaut DM, 2005, PLANTA, V221, P729, DOI 10.1007/s00425-005-1481-0; Glowacka K, 2011, BIOMASS BIOENERG, V35, P2445, DOI 10.1016/j.biombioe.2011.01.041; Harris PJ, 2010, PHYTOCHEM REV, V9, P19, DOI 10.1007/s11101-009-9146-4; Herve C, 2009, PLANT J, V58, P413, DOI 10.1111/j.1365-313X.2009.03785.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hodgson EM, 2010, BIOMASS BIOENERG, V34, P652, DOI 10.1016/j.biombioe.2010.01.008; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Huyen TLN, 2010, BIORESOURCE TECHNOL, V101, P8224, DOI 10.1016/j.biortech.2010.05.087; JARVIS MC, 1988, PLANT PHYSIOL, V88, P309, DOI 10.1104/pp.88.2.309; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Kaack K, 2003, IND CROP PROD, V17, P131, DOI 10.1016/S0926-6690(02)00093-6; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Kulkarni AR, 2012, IND BIOTECHNOL, V8, P222, DOI DOI 10.1089/IND.2012.0014; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Naidu SL, 2003, PLANT PHYSIOL, V132, P1688, DOI 10.1104/pp.103.021790; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Suzuki K, 2000, PLANT CELL PHYSIOL, V41, P948, DOI 10.1093/pcp/pcd019; van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107; Vega-Sanchez ME, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23143; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wolf S, 2012, PROTOPLASMA, V249, P169, DOI 10.1007/s00709-011-0371-5; Zhang SJ, 2012, MOL PLANT, V5, P162, DOI 10.1093/mp/ssr076	46	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82114	10.1371/journal.pone.0082114	http://dx.doi.org/10.1371/journal.pone.0082114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312403	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300073
J	Nakamori, M; Takahashi, T; Nishikawa, T; Yamazaki, Y; Kurashige, T; Maruyama, H; Arihiro, K; Matsumoto, M				Nakamori, Masahiro; Takahashi, Tetsuya; Nishikawa, Tomokazu; Yamazaki, Yu; Kurashige, Takashi; Maruyama, Hirofumi; Arihiro, Koji; Matsumoto, Masayasu			Molecular Markers for Granulovacuolar Degeneration Are Present in Rimmed Vacuoles	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; CYCLIN-DEPENDENT KINASE-5; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; LIPID RAFTS; EXPRESSION; ACCUMULATION; MYOPATHY; NEURONS; TDP-43	Background: Rimmed vacuoles (RVs) are round-oval cytoplasmic inclusions, detected in muscle cells of patients with myopathies, such as inclusion body myositis (IBM) and distal myopathy with RVs (DMRV). Granulovacuolar degeneration (GVD) bodies are spherical vacuoles containing argentophilic and hematoxyphilic granules, and are one of the pathological hallmarks commonly found in hippocampal pyramidal neurons of patients with aging-related neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These diseases are common in the elderly and share some pathological features. Therefore, we hypothesized that mechanisms of vacuolar formation in RVs and GVD bodies are common despite their role in two differing pathologies. We explored the components of RVs by immunohistochemistry, using antibodies for GVD markers. Methods: Subjects included one AD case, eight cases of sporadic IBM, and three cases of DMRV. We compared immunoreactivity and staining patterns for GVD markers. These markers included: (1) tau-modifying proteins (caspase 3, cyclin-dependent kinase 5 [CDK5], casein kinase 1 delta [CK1 delta], and c-jun N-terminal kinase [JNK]), (2) lipid raft-associated materials (annexin 2, leucine-rich repeat kinase 2 [LRRK2], and flotillin-1), and (3) other markers (charged multi-vesicular body protein 2B [CHMP2B] and phosphorylated transactive response DNA binding protein-43 [pTDP43]) in both GVD bodies and RVs. Furthermore, we performed double staining of each GVD marker with pTDP43 to verify the co-localization. Results: GVD markers, including lipid raft-associated proteins and tau kinases, were detected in RVs. CHMP2B, pTDP43, caspase 3, LRRK2, annexin 2 and flotillin-1 were detected on the rim and were diffusely distributed in the cytoplasm of RV-positive fibers. CDK5, CK1 delta and JNK were detected only on the rim. In double staining experiments, all GVD markers colocalized with pTDP43 in RVs. Conclusions: These results suggest that RVs of muscle cells and GVD bodies of neurons share a number of molecules, such as raft-related proteins and tau-modifying proteins.	[Nakamori, Masahiro; Takahashi, Tetsuya; Nishikawa, Tomokazu; Yamazaki, Yu; Kurashige, Takashi; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Anat Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University	Takahashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	tetakaha@mac.com	Kurashige, Takashi/N-1767-2014; Takahashi, Tetsuya/ABG-8566-2021; Maruyama, Hirofumi/B-9333-2011	Kurashige, Takashi/0000-0002-5206-5979; Takahashi, Tetsuya/0000-0001-6891-0842; Maruyama, Hirofumi/0000-0001-7613-8717; Yamazaki, Yu/0000-0002-0806-4960	Ministry of Education, Culture, Sports, Science and Technology [21591085]; Smoking Research Foundation, Tokyo, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation, Tokyo, Japan	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/) Grant-in-Aid for Scientific Research (C) (#21591085; Principle Investigator, Tetsuya Takahashi) and in part by a grant from the Smoking Research Foundation, Tokyo, Japan (http://www.srf.or.jp) to Tetsuya Takahashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1; Askanas V, 1998, SCAND J RHEUMATOL, V27, P389; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; BOSCH EP, 1979, MUSCLE NERVE, V2, P73, DOI 10.1002/mus.880020111; FUKUHARA N, 1980, ACTA NEUROPATHOL, V51, P229, DOI 10.1007/BF00687390; Funk KE, 2011, NEUROPATH APPL NEURO, V37, P295, DOI 10.1111/j.1365-2990.2010.01135.x; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; GOTO Y, 1990, ACTA NEUROPATHOL, V80, P123, DOI 10.1007/BF00308914; Hoshi A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-22; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2; Kusters B, 2009, ACTA NEUROPATHOL, V117, P209, DOI 10.1007/s00401-008-0471-2; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lagalwar S, 2007, ACTA NEUROPATHOL, V113, P63, DOI 10.1007/s00401-006-0159-4; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Momma K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052002; Murakami N, 1998, J NEUROPATH EXP NEUR, V57, P664, DOI 10.1097/00005072-199807000-00003; Nakamori M, 2012, NEUROREPORT, V23, P867, DOI 10.1097/WNR.0b013e328358720b; Nakamura S, 2012, MED MOL MORPHOL, V45, P86, DOI 10.1007/s00795-011-0542-7; Nakano S, 1999, NEUROLOGY, V53, P1671, DOI 10.1212/WNL.53.8.1671; Nakano S, 2008, NEUROMUSCULAR DISORD, V18, P27, DOI 10.1016/j.nmd.2007.08.005; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Nishikawa T, 2013, NEUROPATHOL APPL NEU; OKAMOTO K, 1991, ACTA NEUROPATHOL, V82, P340, DOI 10.1007/BF00296544; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Su JH, 2002, ACTA NEUROPATHOL, V104, P1, DOI 10.1007/s00401-002-0548-2; Suzuki T, 2002, J BIOCHEM, V131, P647, DOI 10.1093/oxfordjournals.jbchem.a003147; Taylor DR, 2007, SEMIN CELL DEV BIOL, V18, P638, DOI 10.1016/j.semcdb.2007.07.008; Thal DR, 2011, ACTA NEUROPATHOL, V122, P577, DOI 10.1007/s00401-011-0871-6; Wilczynski GM, 2000, NEUROSCI LETT, V293, P33, DOI 10.1016/S0304-3940(00)01485-3; WOODARD JS, 1962, J NEUROPATH EXP NEUR, V21, P85, DOI 10.1097/00005072-196201000-00007; Yamashita S, 2013, NEUROPATH APPL NEURO, V39, P406, DOI 10.1111/j.1365-2990.2012.01297.x; Yamazaki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026996; Yamazaki Y, 2010, NEUROSCI LETT, V477, P86, DOI 10.1016/j.neulet.2010.04.038; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com	47	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80995	10.1371/journal.pone.0080995	http://dx.doi.org/10.1371/journal.pone.0080995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312256	Green Submitted, Green Published, gold			2022-12-25	WOS:000327657900019
J	Tao, AZ; Chen, Z; Shao, YL; Wang, JH; Zhao, YN; Lu, P; Lu, F				Tao, Aizhu; Chen, Zhao; Shao, Yilei; Wang, Jianhua; Zhao, Yune; Lu, Ping; Lu, Fan			Phacoemulsification Induced Transient Swelling of Corneal Descemet's Endothelium Complex Imaged with Ultra-High Resolution Optical Coherence Tomography	PLOS ONE			English	Article							THICKNESS PROFILES; STROMAL THICKNESS; BOWMANS LAYER; CELL LOSS; EPITHELIUM; DENSITY; SURGERY	Purpose: Thickness changes of corneal sub-layers after phacoemulsification were investigated by spectral domain ultra-high resolution optical coherence tomography (UHR-OCT). Methods: The corneas (n = 26) of 26 age-related cataract surgery patients were studied. UHR-OCT was used to evaluate the thickness of Descemet's Endothelium Complex (DEC), stroma, Bowman's layer, epithelium, and full cornea at the center (CCT) before, one day after, and one week after surgery. Non-contact specular microscopy measured CCT, endothelial cell density, and morphology. Results: The DEC, stroma, Bowman's layer, and epithelium were visualized by UHR-OCT. Before surgery, the DEC in all cases appeared as a translucent space between two smooth opaque lines. One day after surgery, the posterior corneal surfaces in half of the eyes were wavy and irregular. Compared to the baseline, one day after surgery the thickness increases of the DEC, stroma, and CCT were 4.3 +/- 2.6 mu m, 25.5 +/- 24.9 mu m, and 32.1 +/- 26.6 mu m, respectively (P < 0.001). The morphology of the DEC and the CCT recovered to baseline one week after surgery (P > 0.05), but endothelial cell density was 8.7% less than at baseline. There were no significant changes in Bowman's layer and epithelium after the operation. The pre-operative DEC thickness was positively correlated with the decreased endothelial cell density at 1 day after surgery (r = 0.55, P = 0.003). Conclusions: The DEC showed edematous thickening and different degrees of morphological changes after phacoemulsification. The DEC deformation and corneal edema recovered by one week after surgery, which indicated recovery of endothelial function. UHR-OCT is a useful tool to evaluate function of the DEC after phacoemulsification. Pre-operative DEC thickness may indicate the integrity of the endothelium and could be used for predicting endothelial cell loss after phacoemulsification.	[Tao, Aizhu; Chen, Zhao; Shao, Yilei; Zhao, Yune; Lu, Ping; Lu, Fan] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Wang, Jianhua] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Wenzhou Medical University; Bascom Palmer Eye Institute; University of Miami	Lu, F (corresponding author), Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	lufan62@mail.eye.ac.cn		Chen, Zhao/0000-0002-3970-5249	National Natural Science Foundation of China [81170869]; Development Program Project Grant from Wenzhou, China [Y20100192, Y20100296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Program Project Grant from Wenzhou, China	This study was supported by research grants from the National Natural Science Foundation of China (81170869 to Lu) and the Development Program Project Grant from Wenzhou, China (Y20100192 and Y20100296 to Tao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Shousha M, 2010, OPHTHALMOLOGY, V117, P1220, DOI 10.1016/j.ophtha.2009.10.027; ARNER RS, 1972, AMER J OPT ARCH AM A, V49, P862; Behndig A, 2002, J CATARACT REFR SURG, V28, P1551, DOI 10.1016/S0886-3350(01)01219-6; Bizheva K, 2011, BIOMED OPT EXPRESS, V2, P1794, DOI 10.1364/BOE.2.001794; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolz M, 2006, J CATARACT REFR SURG, V32, P1667, DOI 10.1016/j.jcrs.2006.05.018; Bourne RRA, 2004, OPHTHALMOLOGY, V111, P679, DOI 10.1016/j.ophtha.2003.07.015; Dawson DG, 2008, J REFRACT SURG, V24, P90, DOI 10.3928/1081597X-20080101-16; Doughty MJ, 2000, CORNEA, V19, P148, DOI 10.1097/00003226-200003000-00006; Du CX, 2012, CORNEA, V31, P1036, DOI 10.1097/ICO.0b013e31823f8d56; Emery JM, 1979, PHACOEMULSIFICATION, P45; Fakhry MA, 2011, CLIN OPHTHALMOL, V5, P973, DOI 10.2147/OPTH.S22879; Ge LL, 2012, EYE CONTACT LENS, V38, P150, DOI 10.1097/ICL.0b013e3182499b64; Hutchings N, 2010, INVEST OPHTH VIS SCI, V51, P4579, DOI 10.1167/iovs.09-4676; Ivarsen A, 2009, INVEST OPHTH VIS SCI, V50, P2061, DOI 10.1167/iovs.08-2853; Jalbert I, 2003, BRIT J OPHTHALMOL, V87, P225, DOI 10.1136/bjo.87.2.225; Kieval JZ, 2012, OPHTHALMOLOGY, V119, P481, DOI 10.1016/j.ophtha.2011.08.028; Leung EW, 2000, MOL VIS, V6, P15; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Lin RC, 2004, OPT LETT, V29, P83, DOI 10.1364/OL.29.000083; Lundberg B, 2005, AM J OPHTHALMOL, V139, P1035, DOI 10.1016/j.ajo.2004.12.080; Lundstrom M, 2002, ACTA OPHTHALMOL SCAN, V80, P248, DOI 10.1034/j.1600-0420.2002.800304.x; Mahdy MAES, 2012, CLIN OPHTHALMOL, V6, P503, DOI 10.2147/OPTH.S29865; MISHIMA S, 1982, AM J OPHTHALMOL, V93, P1; MISHIMA S, 1967, EXP EYE RES, V6, P10, DOI 10.1016/S0014-4835(67)80049-6; Miyata K, 2002, J CATARACT REFR SURG, V28, P1557, DOI 10.1016/S0886-3350(02)01540-7; Reinstein DZ, 2009, J REFRACT SURG, V25, P776, DOI 10.3928/1081597X-20090813-04; Rosa N, 2010, OPHTHALMOLOGY, V117, P223, DOI 10.1016/j.ophtha.2009.07.003; SAWA M, 1984, AM J OPHTHALMOL, V97, P197, DOI 10.1016/S0002-9394(14)76090-8; Sheng H, 2007, CORNEA, V26, P520, DOI 10.1097/ICO.0b013e318033a6da; Tao AZ, 2011, INVEST OPHTH VIS SCI, V52, P3901, DOI 10.1167/iovs.09-4748; Ventura ACS, 2001, BRIT J OPHTHALMOL, V85, P18, DOI 10.1136/bjo.85.1.18; Wang Jianhua, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS15, DOI 10.3928/15428877-20110627-02	33	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80986	10.1371/journal.pone.0080986	http://dx.doi.org/10.1371/journal.pone.0080986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312254	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900017
J	Dolan, J; Mitchell, KJ				Dolan, Jackie; Mitchell, Kevin J.			Mutation of Elfn1 in Mice Causes Seizures and Hyperactivity	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EXCITATORY SYNAPSE FORMATION; STATIONARY NIGHT BLINDNESS; INDUCED DOPAMINE RELEASE; CELL-ADHESION MOLECULE; RICH REPEAT PROTEINS; TRANSMEMBRANE PROTEINS; HABENULAR NUCLEI; MEDIAL HABENULA; GROWTH CONE	A growing number of proteins with extracellular leucine-rich repeats (eLRRs) have been implicated in directing neuronal connectivity. We previously identified a novel family of eLRR proteins in mammals: the Elfns are transmembrane proteins with 6 LRRs, a fibronectin type-3 domain and a long cytoplasmic tail. The recent discovery that Elfn1 protein, expressed postsynaptically, can direct the elaboration of specific electrochemical properties of synapses between particular cell types in the hippocampus strongly reinforces this hypothesis. Here, we present analyses of an Elfn1 mutant mouse line and demonstrate a functional requirement for this gene in vivo. We first carried out detailed expression analysis of Elfn1 using a beta-galactosidase reporter gene in the knockout line. Elfn1 is expressed in distinct subsets of interneurons of the hippocampus and cortex, and also in discrete subsets of cells in the habenula, septum, globus pallidus, dorsal subiculum, amygdala and several other regions. Elfn1 is expressed in diverse cell types, including local GABAergic interneurons as well as long-range projecting GABAergic and glutamatergic neurons. Elfn1 protein localises to axons of excitatory neurons in the habenula, and long-range GABAergic neurons of the globus pallidus, suggesting the possibility of additional roles for Elfn1 in axons or presynaptically. While gross anatomical analyses did not reveal any obvious neuroanatomical abnormalities, behavioural analyses clearly illustrate functional effects of Elfn1 mutation. Elfn1 mutant mice exhibit seizures, subtle motor abnormalities, reduced thigmotaxis and hyperactivity. The hyperactivity is paradoxically reversible by treatment with the stimulant amphetamine, consistent with phenotypes observed in animals with habenular lesions. These analyses reveal a requirement for Elfn1 in brain function and are suggestive of possible relevance to the etiology and pathophysiology of epilepsy and attention-deficit hyperactivity disorder.	[Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Mitchell, KJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	Kevin.Mitchell@tcd.ie		Mitchell, Kevin/0000-0002-3433-4530	Science Foundation Ireland [07/IN.1/B969, 09/IN.1/B2614]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants (07/IN.1/B969 and 09/IN.1/B2614) from Science Foundation Ireland to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Aizawa H, 2013, ANAT SCI INT, V88, P1, DOI 10.1007/s12565-012-0158-6; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Batten TFC, 2002, AUTON NEUROSCI-BASIC, V98, P28, DOI 10.1016/S1566-0702(02)00026-7; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Berghuis B, 2013, EPILEPSY BEHAV, V28, P41, DOI 10.1016/j.yebeh.2013.03.032; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Butte NF, 1999, J PEDIATR-US, V135, P203, DOI 10.1016/S0022-3476(99)70023-5; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Chou IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057926; Clarke VRJ, 2012, J NEUROSCI, V32, P18215, DOI 10.1523/JNEUROSCI.2327-12.2012; Cohen R, 2013, J CHILD NEUROL, V28, P120, DOI 10.1177/0883073812440327; COSTALL B, 1984, PSYCHOPHARMACOLOGY, V82, P174, DOI 10.1007/BF00427768; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; DeNardo LA, 2012, NEURON, V76, P762, DOI 10.1016/j.neuron.2012.10.013; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; FALLON JH, 1978, J COMP NEUROL, V181, P375, DOI 10.1002/cne.901810209; Flapper BCT, 2006, DEV MED CHILD NEUROL, V48, P165, DOI 10.1017/S0012162206000375; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gainetdinov RR, 2010, ADHD-ATTEND DEFICIT, V2, P21, DOI 10.1007/s12402-010-0021-3; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; He DF, 2010, BRAIN PATHOL, V20, P80, DOI 10.1111/j.1750-3639.2009.00243.x; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kaufmann R, 2009, J CHILD NEUROL, V24, P727, DOI 10.1177/0883073808330165; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Kim U, 2009, J COMP NEUROL, V513, P173, DOI 10.1002/cne.21951; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Kolodkin AL, 2011, COLD SPRING HARBOR P, V3; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Lammel S., 2013, GENES BRAIN BEHAV; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lee YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019450; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lincoln S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064164; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipska BK, 2002, NEUROTOX RES, V4, P469, DOI 10.1080/1029842021000022089; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Mathuru Ajay S, 2013, Front Neural Circuits, V7, P99, DOI 10.3389/fncir.2013.00099; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Milton JG, 2012, EUR J NEUROSCI, V36, P2156, DOI 10.1111/j.1460-9568.2012.08102.x; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Muller JF, 2007, J COMP NEUROL, V500, P513, DOI 10.1002/cne.21185; NISHIKAWA T, 1986, BRAIN RES, V373, P324, DOI 10.1016/0006-8993(86)90347-1; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Nose A, 1997, DEVELOPMENT, V124, P1433; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Panuccio G, 2012, EPILEPSIA, V53, P459, DOI 10.1111/j.1528-1167.2012.03408.x; Papaleo F, 2011, LEARN MEMORY, V18, P534, DOI 10.1101/lm.2213711; PARK MR, 1987, BRAIN RES BULL, V19, P581, DOI 10.1016/0361-9230(87)90075-X; PITON A, 2010, MOL PSYCHIAT; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Quina LA, 2009, J NEUROSCI, V29, P14309, DOI 10.1523/JNEUROSCI.2430-09.2009; Racine RJ, 1972, CLIN NEUROPHYSIOL, V32, P281, DOI DOI 10.1016/0013-4694(72)90177-0; Reilly CJ, 2011, RES DEV DISABIL, V32, P883, DOI 10.1016/j.ridd.2011.01.019; Reitz C, 2012, ARCH NEUROL-CHICAGO, V69, P894, DOI 10.1001/archneurol.2011.2463; Rose D, 1997, DEVELOPMENT, V124, P1561; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Runker AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026488; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Stuart HM, 2013, AM J HUM GENET, V92, P259, DOI 10.1016/j.ajhg.2012.12.002; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tekin M, 2013, J CLIN INVEST, V123, P2094, DOI 10.1172/JCI65853; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; van der Kooij MA, 2007, NEUROSCI BIOBEHAV R, V31, P597, DOI 10.1016/j.neubiorev.2006.12.002; VANDENBUUSE M, 1989, J PHARMACOL EXP THER, V248, P1189; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	98	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80491	10.1371/journal.pone.0080491	http://dx.doi.org/10.1371/journal.pone.0080491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312227	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100043
J	Dubois, M; Delannoy, E; Duluc, L; Closs, E; Li, HG; Toussaint, C; Gadeau, AP; Godecke, A; Freund-Michel, V; Courtois, A; Marthan, R; Savineau, JP; Muller, B				Dubois, Mathilde; Delannoy, Estelle; Duluc, Lucie; Closs, Ellen; Li, Huige; Toussaint, Christian; Gadeau, Alain-Pierre; Goedecke, Axel; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Savineau, Jean-Pierre; Muller, Bernard			Biopterin Metabolism and eNOS Expression during Hypoxic Pulmonary Hypertension in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SOLUBLE GUANYLATE-CYCLASE; ENDOTHELIAL-CELLS; UP-REGULATION; OXIDATIVE STRESS; NADPH OXIDASE; L-ARGININE; TETRAHYDROBIOPTERIN; SUPEROXIDE; DISEASE	Tetrahydrobiopterin (BH4), which fosters the formation of and stabilizes endothelial NO synthase (eNOS) as an active dimer, tightly regulates eNOS coupling / uncoupling. Moreover, studies conducted in genetically-modified models demonstrate that BH4 pulmonary deficiency is a key determinant in the pathogenesis of pulmonary hypertension. The present study thus investigates biopterin metabolism and eNOS expression, as well as the effect of sepiapterin (a precursor of BH4) and eNOS gene deletion, in a mice model of hypoxic pulmonary hypertension. In lungs, chronic hypoxia increased BH4 levels and eNOS expression, without modifying dihydrobiopterin (BH2, the oxidation product of BH4) levels, GTP cyclohydrolase-1 or dihydrofolate reductase expression (two key enzymes regulating BH4 availability). In intrapulmonary arteries, chronic hypoxia also increased expression of eNOS, but did not induce destabilisation of eNOS dimers into monomers. In hypoxic mice, sepiapterin prevented increase in right ventricular systolic pressure and right ventricular hypertrophy, whereas it modified neither remodelling nor alteration in vasomotor responses (hyper-responsiveness to phenylephrine, decrease in endothelium-dependent relaxation to acetylcholine) in intrapulmonary arteries. Finally, deletion of eNOS gene partially prevented hypoxia-induced increase in right ventricular systolic pressure, right ventricular hypertrophy and remodelling of intrapulmonary arteries. Collectively, these data demonstrate the absence of BH4/BH2 changes and eNOS dimer destabilisation, which may induce eNOS uncoupling during hypoxia-induced pulmonary hypertension. Thus, even though eNOS gene deletion and sepiapterin treatment exert protective effects on hypoxia-induced pulmonary vascular remodelling, increase on right ventricular pressure and / or right ventricular hypertrophy, these effects appear unrelated to biopterin-dependent eNOS uncoupling within pulmonary vasculature of hypoxic wild-type mice.	[Dubois, Mathilde; Delannoy, Estelle; Duluc, Lucie; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Savineau, Jean-Pierre; Muller, Bernard] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [Dubois, Mathilde; Delannoy, Estelle; Duluc, Lucie; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Savineau, Jean-Pierre; Muller, Bernard] INSERM, U1045, Ctr Rech Cardiothorac Bordeaux, Bordeaux, France; [Delannoy, Estelle; Marthan, Roger] CHU, Bordeaux, France; [Closs, Ellen; Li, Huige] Johannes Gutenberg Univ Med Ctr, Dept Pharmacol, Mainz, Germany; [Toussaint, Christian] Univ Bordeaux, Bordeaux, France; [Gadeau, Alain-Pierre] INSERM, U1034, Pessac, France; [Goedecke, Axel] Univ Dusseldorf, Inst Cardiovasc Physiol, Dusseldorf, Germany	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Johannes Gutenberg University of Mainz; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Heinrich Heine University Dusseldorf	Dubois, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France.	mathilde.dubois@u-bordeaux2.fr	FREUND-MICHEL, Véronique/M-2827-2014; Gadeau, Alain-Pierre/H-7889-2016; Li, Huige/M-2662-2013; Dubois, Mathilde/M-2971-2014; Closs, Ellen/ABD-5217-2020	Gadeau, Alain-Pierre/0000-0003-1312-6481; Li, Huige/0000-0003-3458-7391; Closs, Ellen/0000-0002-9505-2289; FREUND-MICHEL, Veronique/0000-0001-8912-6117; Duluc, Lucie/0000-0002-5952-8008; Marthan, Roger/0000-0001-5412-5712; courtois, arnaud/0000-0002-0996-7133	INSERM; ANR in COPD [ANR06 Physio 01501: HPV-PAH]; "Fondation de France" [2008002719]; "Groupe de Reflexion sur la Recherche Cardiovasculaire GRRC."	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR in COPD(French National Research Agency (ANR)); "Fondation de France"(Fondation de France); "Groupe de Reflexion sur la Recherche Cardiovasculaire GRRC."	This work was supported by INSERM, ANR (ANR06 Physio 01501: HPV-PAH in COPD) and "Fondation de France" (grant 2008002719). Estelle Delannoy was recipient of a fellowship from "Groupe de Reflexion sur la Recherche Cardiovasculaire GRRC." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Billon A, 2008, AM J PATHOL, V172, P830, DOI 10.2353/ajpath.2008.070439; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; Chen CA, 2011, J BIOL CHEM, V286, P29098, DOI 10.1074/jbc.M111.240127; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Cho YR, 2011, ONCOL REP, V26, P861, DOI 10.3892/or.2011.1335; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2011, NITRIC OXIDE-BIOL CH, V25, P81, DOI 10.1016/j.niox.2011.04.004; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fresquet F, 2006, BRIT J PHARMACOL, V148, P714, DOI 10.1038/sj.bjp.0706779; Godecke A, 1998, CIRC RES, V82, P186; Gorenflo M, 2001, J CARDIOVASC PHARM, V37, P489, DOI 10.1097/00005344-200104000-00016; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Ishii M, 1999, J CARDIOVASC PHARM, V33, P295, DOI 10.1097/00005344-199902000-00018; Jo H, 2011, CLIN EXP PHARMACOL P, V38, P485, DOI 10.1111/j.1440-1681.2011.05535.x; Katusic ZS, 2009, TRENDS PHARMACOL SCI, V30, P48, DOI 10.1016/j.tips.2008.10.003; Khoo JP, 2005, CIRCULATION, V111, P2126, DOI 10.1161/01.CIR.0000162470.26840.89; Konduri GG, 2007, AM J PHYSIOL-HEART C, V292, pH1812, DOI 10.1152/ajpheart.00425.2006; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164; Li DC, 2001, AM J PHYSIOL-LUNG C, V281, pL369, DOI 10.1152/ajplung.2001.281.2.L369; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masano T, 2008, CIRC J, V72, P1512, DOI 10.1253/circj.CJ-08-0072; Mayahi L, 2007, ARTERIOSCL THROM VAS, V27, P1334, DOI 10.1161/ATVBAHA.107.142257; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Nandi M, 2005, CIRCULATION, V111, P2086, DOI 10.1161/01.CIR.0000163268.32638.F4; Noguchi K, 2011, AM J PHYSIOL-HEART C, V301, pH721, DOI 10.1152/ajpheart.01089.2010; Orr R, 2012, CURR OPIN PULM MED, V18, P138, DOI 10.1097/MCP.0b013e32834f2093; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Quinlan TR, 2000, AM J PHYSIOL-LUNG C, V279, pL641, DOI 10.1152/ajplung.2000.279.4.L641; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Sasaki A, 2007, AM J PHYSIOL-LUNG C, V292, pL1480, DOI 10.1152/ajplung.00360.2006; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schmidt K, 2012, MOL PHARMACOL, V82, P420, DOI 10.1124/mol.112.079855; Steudel W, 1998, J CLIN INVEST, V101, P2468, DOI 10.1172/JCI2356; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Xia N, 2010, J PHARMACOL EXP THER, V335, P149, DOI 10.1124/jpet.110.168724; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yu LY, 2011, J VASC RES, V48, P465, DOI 10.1159/000327005; Yu LY, 2005, CIRC RES, V97, P937, DOI 10.1161/01.RES.0000188211.83193.1a; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	48	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82594	10.1371/journal.pone.0082594	http://dx.doi.org/10.1371/journal.pone.0082594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312428	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100119
J	Qiu, JZ; Wang, DC; Zhang, Y; Dong, J; Wang, JF; Niu, XD				Qiu, Jiazhang; Wang, Dacheng; Zhang, Yu; Dong, Jing; Wang, Jianfenq; Niu, Xiaodi			Molecular Modeling Reveals the Novel Inhibition Mechanism and Binding Mode of Three Natural Compounds to Staphylococcal alpha-Hemolysin	PLOS ONE			English	Article							BETA-BARREL; CRYSTAL-STRUCTURE; AUREUS; DYNAMICS; PROTECTION; VIRULENCE; EFFICIENT; COMPONENT; INSIGHT; TOXIN	alpha-Hemolysin (alpha-HL) is a self-assembling, channel-forming toxin that is produced as a soluble monomer by Staphylococcus aureus strains. Until now, alpha-HL has been a significant virulence target for the treatment of S. aureus infection. In our previous report, we demonstrated that some natural compounds could bind to alpha-HL. Due to the binding of those compounds, the conformational transition of alpha-HL from the monomer to the oligomer was blocked, which resulted in inhibition of the hemolytic activity of alpha-HL. However, these results have not indicated how the binding of the alpha-HL inhibitors influence the conformational transition of the whole protein during the oligomerization process. In this study, we found that three natural compounds, Oroxylin A 7-O-glucuronide (OLG), Oroxin A (ORA), and Oroxin B (ORB), when inhibiting the hemolytic activity of alpha-HL, could bind to the "stem" region of alpha-HL. This was completed using conventional Molecular Dynamics (MD) simulations. By interacting with the novel binding sites of alpha-HL, the ligands could form strong interactions with both sides of the binding cavity. The results of the principal component analysis (PCA) indicated that because of the inhibitors that bind to the "stem" region of alpha-HL, the conformational transition of alpha-HL from the monomer to the oligomer was restricted. This caused the inhibition of the hemolytic activity of alpha-HL. This novel inhibition mechanism has been confirmed by both the steered MD simulations and the experimental data obtained from a deoxycholate-induced oligomerization assay. This study can facilitate the design of new antibacterial drugs against S. aureus.	[Niu, Xiaodi] Jilin Univ, Dept Food Qual & Safety, Changchun 130023, Peoples R China; [Qiu, Jiazhang; Wang, Dacheng; Zhang, Yu; Dong, Jing; Wang, Jianfenq] Jilin Univ, Colleg Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China	Jilin University; Jilin University	Niu, XD (corresponding author), Jilin Univ, Dept Food Qual & Safety, Changchun 130023, Peoples R China.	niuxd@jlu.edu.cn			National Nature Science Foundation of China [311300535]; National 863 programme [2012AA020303]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 programme(National High Technology Research and Development Program of China)	This work was supported by the National Nature Science Foundation of China (No. 311300535 and the National 863 programme (No. 2012AA020303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bandyopadhyay S, 2002, BIOCHEMISTRY-US, V41, P14421, DOI 10.1021/bi026243g; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Dong J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002869; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu Y, 2012, J CHEM INF MODEL, V52, P2550, DOI [10.1021/ci3003304, 10.1021/ci30033041]; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurasekova Z, 2009, BIOPOLYMERS, V91, P917, DOI 10.1002/bip.21278; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Niu XD, 2013, EUR J MED CHEM, V62, P320, DOI 10.1016/j.ejmech.2013.01.008; Olausson BES, 2012, J AM CHEM SOC, V134, P4324, DOI 10.1021/ja2108382; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Qiu JZ, 2012, J INFECT DIS, V206, P292, DOI 10.1093/infdis/jis336; Ragle BE, 2010, ANTIMICROB AGENTS CH, V54, P298, DOI 10.1128/AAC.00973-09; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Roblin P, 2008, PROTEINS, V71, P485, DOI 10.1002/prot.21900; RYCKAERT JP, 1986, J CHEM PHYS, V85, P1613, DOI 10.1063/1.451203; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vargiu AV, 2011, J AM CHEM SOC, V133, P10704, DOI 10.1021/ja202666x; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0	33	33	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80197	10.1371/journal.pone.0080197	http://dx.doi.org/10.1371/journal.pone.0080197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312202	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100027
J	Rajasekaran, D; Palombo, EA; Yeo, TC; Ley, DLS; Tu, CL; Malherbe, F; Grollo, L				Rajasekaran, Dhivya; Palombo, Enzo A.; Yeo, Tiong Chia; Ley, Diana Lim Siok; Tu, Chu Lee; Malherbe, Francois; Grollo, Lara			Identification of Traditional Medicinal Plant Extracts with Novel Anti-Influenza Activity	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; ANTIVIRAL ACTIVITY; HERBAL MEDICINE; NEURAMINIDASE; AGENTS; HEMAGGLUTINATION; INACTIVATION; INHIBITORS; CAPSULE; FUSION	The emergence of drug resistant variants of the influenza virus has led to a need to identify novel and effective antiviral agents. As an alternative to synthetic drugs, the consolidation of empirical knowledge with ethnopharmacological evidence of medicinal plants offers a novel platform for the development of antiviral drugs. The aim of this study was to identify plant extracts with proven activity against the influenza virus. Extracts of fifty medicinal plants, originating from the tropical rainforests of Borneo used as herbal medicines by traditional healers to treat flu-like symptoms, were tested against the H1N1 and H3N1 subtypes of the virus. In the initial phase, in vitro micro-inhibition assays along with cytotoxicity screening were performed on MDCK cells. Most plant extracts were found to be minimally cytotoxic, indicating that the compounds linked to an ethnomedical framework were relatively innocuous, and eleven crude extracts exhibited viral inhibition against both the strains. All extracts inhibited the enzymatic activity of viral neuraminidase and four extracts were also shown to act through the hemagglutination inhibition (HI) pathway. Moreover, the samples that acted through both HI and neuraminidase inhibition (NI) evidenced more than 90% reduction in virus adsorption and penetration, thereby indicating potent action in the early stages of viral replication. Concurrent studies involving Receptor Destroying Enzyme treatments of HI extracts indicated the presence of sialic acid-like component(s) that could be responsible for hemagglutination inhibition. The manifestation of both modes of viral inhibition in a single extract suggests that there may be a synergistic effect implicating more than one active component. Overall, our results provide substantive support for the use of Borneo traditional plants as promising sources of novel anti-influenza drug candidates. Furthermore, the pathways involving inhibition of hemagglutination could be a solution to the global occurrence of viral strains resistant to neuraminidase drugs.	[Rajasekaran, Dhivya; Palombo, Enzo A.; Malherbe, Francois; Grollo, Lara] Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Hawthorn, Vic 3122, Australia; [Yeo, Tiong Chia; Ley, Diana Lim Siok; Tu, Chu Lee] Sarawak Biodivers Ctr, Kuching, Sarawak, Malaysia	Swinburne University of Technology	Grollo, L (corresponding author), Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Hawthorn, Vic 3122, Australia.	lgrollo@swin.edu.au	Palombo, Enzo/AAV-8632-2021; Malherbe, François Clément/ABG-8109-2020	Palombo, Enzo/0000-0001-5889-1393; Malherbe, François Clément/0000-0001-6127-4169; Rajasekaran, Dhivya/0000-0003-4369-9985	Grollo Ruzzene Foundation	Grollo Ruzzene Foundation	This project was supported by funds from the Grollo Ruzzene Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin R, 1997, ANTIVIR RES, V35, P139, DOI 10.1016/S0166-3542(97)00023-5; Ali NAA, 2001, J ETHNOPHARMACOL, V74, P173, DOI 10.1016/S0378-8741(00)00364-0; Basavaraja B. M., 2011, Journal of Global Pharma Technology, V3, P14; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Chai PPK, 2006, MED PLANTS SARAWAK; Chang TT, 2011, J TAIWAN INST CHEM E, V42, P563, DOI 10.1016/j.jtice.2010.11.001; Chang TT, 2011, MOL SIMULAT, V37, P361, DOI 10.1080/08927022.2010.543973; Chattopadhyay D, 2007, MINI-REV MED CHEM, V7, P275, DOI 10.2174/138955707780059844; Chen DY, 2010, FOOD CHEM, V119, P1346, DOI 10.1016/j.foodchem.2009.09.011; Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4; Dan K, 2013, PHARMACOLOGY, V91, P314, DOI 10.1159/000350188; De Logu A, 2000, ANTIVIR RES, V48, P177, DOI 10.1016/S0166-3542(00)00127-3; Duan ZP, 2011, CHINESE MED J-PEKING, V124, P2925, DOI 10.3760/cma.j.issn.0366-6999.2011.18.024; Focho DA, 2010, J MED PLANTS RES, V4, P2148; Grienke U, 2012, NAT PROD REP, V29, P11, DOI 10.1039/c1np00053e; Grienke U, 2010, J MED CHEM, V53, P778, DOI 10.1021/jm901440f; Hokari R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/794970; Hsieh CF, 2012, J ETHNOPHARMACOL, V143, P57, DOI 10.1016/j.jep.2012.05.061; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Kaur R, 2011, INT J PHARM BIOSCIEN, V2, P387; Kinoshita E, 2012, BIOSCI BIOTECH BIOCH, V76, P1633, DOI 10.1271/bbb.120112; Kiyohara H, 2012, PHYTOMEDICINE, V19, P111, DOI 10.1016/j.phymed.2011.07.004; Kiyohara H, 2012, J NAT MED-TOKYO, V66, P55, DOI 10.1007/s11418-011-0550-x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lee JB, 2012, FOOD CHEM, V134, P2164, DOI 10.1016/j.foodchem.2012.04.016; Luo C, 1999, J GEN VIROL, V80, P2969, DOI 10.1099/0022-1317-80-11-2969; Maji S., 2010, Journal of Phytology, V2, P57; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McCaughey Conall, 2010, Ulster Med J, V79, P46; Nabeshima S, 2012, J INFECT CHEMOTHER, V18, P534, DOI 10.1007/s10156-012-0378-7; Nguyen TNA, 2011, FOOD CHEM, V124, P437, DOI 10.1016/j.foodchem.2010.06.049; Oh DY, 2008, J CLIN MICROBIOLOGY; Pleschka S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-197; Pourianfar HR, 2012, INDIAN J VIROL, V23, P303, DOI 10.1007/s13337-012-0105-0; Pourianfar HR, 2012, VIRUS RES, V169, P22, DOI 10.1016/j.virusres.2012.06.025; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roberts NA, 2001, PROG DRUG RES, V56, P195; Salleh KM, 2002, KEMENTERIAN SAINS TD; Shin WJ, 2010, MICROBIOL IMMUNOL, V54, P11, DOI 10.1111/j.1348-0421.2009.00173.x; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013; STEGMANN T, 1987, J BIOL CHEM, V262, P17744; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Tayal S, 2012, INT BRAZ J UROL, V38, P204, DOI 10.1590/S1677-55382012000200008; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Uchide N, 2008, MINI-REV MED CHEM, V8, P491, DOI 10.2174/138955708784223530; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wang XY, 2006, PHYTOTHER RES, V20, P335, DOI 10.1002/ptr.1892; Wirotesangthong M, 2009, MICROBIOL IMMUNOL, V53, P66, DOI 10.1111/j.1348-0421.2008.00095.x; Won JN, 2013, J MICROBIOL BIOTECHN, V23, P125, DOI 10.4014/jmb.1210.10074; World Health Organization [WHO], 2002, WHO AN INFL MAN; Yaacob M., 2009, TUMBUHAN UBATAN POPU; Zhong JY, 2013, J TRADIT CHIN MED, V33, P200, DOI 10.1016/S0254-6272(13)60125-9	54	56	58	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79293	10.1371/journal.pone.0079293	http://dx.doi.org/10.1371/journal.pone.0079293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312177	Green Published, gold			2022-12-25	WOS:000327652100008
J	Vilotti, S; Marchenkove, A; Ntamati, N; Nistri, A				Vilotti, Sandra; Marchenkove, Anna; Ntamati, Niels; Nistri, Andrea			B-Type Natriuretic Peptide-Induced Delayed Modulation of TRPV1 and P2X3 Receptors of Mouse Trigeminal Sensory Neurons	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; P2X(3) RECEPTOR; BRAIN-STEM; MOLECULAR-MECHANISMS; VANILLOID RECEPTOR-1; INFLAMMATORY PAIN; UP-REGULATION; SPINAL-CORD; RAT; RESPONSES	Important pain transducers of noxious stimuli are small- and medium-diameter sensory neurons that express transient receptor vanilloid-1 (TRPV1) channels and/or adenosine triphosphate (ATP)-gated P2X3 receptors whose activity is upregulated by endogenous neuropeptides in acute and chronic pain models. Little is known about the role of endogenous modulators in restraining the expression and function of TRPV1 and P2X3 receptors. In dorsal root ganglia, evidence supports the involvement of the natriuretic peptide system in the modulation of nociceptive transmission especially via the B-type natriuretic peptide (BNP) that activates the natriuretic peptide receptor-A (NPR-A) to downregulate sensory neuron excitability. Since the role of BNP in trigeminal ganglia (TG) is unclear, we investigated the expression of BNP in mouse TG in situ or in primary cultures and its effect on P2X3 and TRPV1 receptors of patch-clamped cultured neurons. Against scant expression of BNP, almost all neurons expressed NPRA at membrane level. While BNP rapidly increased cGMP production and Akt kinase phosphorylation, there was no early change in passive neuronal properties or responses to capsaicin, alpha,beta-meATP or GABA. Nonetheless, 24 h application of BNP depressed TRPV1 mediated currents (an effect blocked by the NPR-A antagonist anantin) without changing responses to alpha,beta-meATP or GABA. Anantin alone decreased basal cGMP production and enhanced control alpha,beta-meATP-evoked responses, implying constitutive regulation of P2X3 receptors by ambient BNP. These data suggest a slow modulatory action by BNP on TRPV1 and P2X3 receptors outlining the role of this peptide as a negative regulator of trigeminal sensory neuron excitability to nociceptive stimuli.	[Vilotti, Sandra; Marchenkove, Anna; Ntamati, Niels; Nistri, Andrea] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy	International School for Advanced Studies (SISSA)	Nistri, A (corresponding author), Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy.	nistri@sissa.it		Marchenkova, Anna/0000-0002-8477-2969; Ntamati, Niels/0000-0001-6573-0467	Telethon-Italy [GGP10082]; TransReg grant (MINA) from the Friuli Venezia Giulia Region; Cariplo Foundation [2011-0505]	Telethon-Italy(Fondazione Telethon); TransReg grant (MINA) from the Friuli Venezia Giulia Region; Cariplo Foundation(Fondazione Cariplo)	The financial support of Telethon-Italy (Grant no. GGP10082) is gratefully acknowledged. This work was also supported by the TransReg grant (MINA) from the Friuli Venezia Giulia Region and by the Cariplo Foundation Grant no. 2011-0505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2008, NEUROSCIENCE, V155, P192, DOI 10.1016/j.neuroscience.2008.05.020; Abdelalim EM, 2007, NEUROSCIENCE, V145, P1087, DOI 10.1016/j.neuroscience.2006.12.062; Abdelalim EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.10; Abdelalim EM, 2011, BRAIN STRUCT FUNCT, V216, P387, DOI 10.1007/s00429-011-0313-1; AZAROV AV, 1992, PHARMACOL BIOCHEM BE, V43, P193, DOI 10.1016/0091-3057(92)90657-2; Benemei S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-71; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Burnstock G, 2013, EUR J PHARM; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Christoffersen C, 2006, EUR J CLIN INVEST, V36, P69, DOI 10.1111/j.1365-2362.2006.01596.x; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Ciobanu C, 2009, BRAIN RES, V1284, P54, DOI 10.1016/j.brainres.2009.06.014; D'Arco M, 2007, J NEUROSCI, V27, P8190, DOI 10.1523/JNEUROSCI.0713-07.2007; D'Arco M, 2009, J BIOL CHEM, V284, P21393, DOI 10.1074/jbc.M109.023051; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; El-Ayoubi R, 2005, BRIT J PHARMACOL, V145, P50, DOI 10.1038/sj.bjp.0706146; Endlich K, 1997, KIDNEY INT, V52, P202, DOI 10.1038/ki.1997.320; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Fabbretti E, 2012, CNS NEUROL DISORD-DR, V11, P687, DOI 10.2174/187152712803581029; Fabbro A, 2004, BRIT J PHARMACOL, V142, P425, DOI 10.1038/sj.bjp.0705813; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Franceschini A, 2013, PURINERG SIGNAL, V9, P7, DOI 10.1007/s11302-012-9328-1; Franceschini A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-143; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; Heine S, 2011, J NEUROSCI, V31, P11184, DOI 10.1523/JNEUROSCI.6159-10.2011; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Hullugundi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060677; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Katoli P, 2010, MOL VIS, V16, P1241; Llewellyn-Smith IJ, 1998, NEUROREPORT, V9, P2545, DOI 10.1097/00001756-199808030-00022; Lonardo G, 2004, CARDIOVASC RES, V63, P528, DOI 10.1016/j.cardiores.2004.03.004; Loo L, 2012, J NEUROSCI, V32, P11942, DOI 10.1523/JNEUROSCI.1330-12.2012; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; Medvedev A, 2005, BRAIN RES, V1042, P119, DOI 10.1016/j.brainres.2005.02.051; Messlinger Karl, 2011, Keio Journal of Medicine, V60, P82; Misono KS, 2002, MOL CELL BIOCHEM, V230, P49, DOI 10.1023/A:1014257621362; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; NACHSHON S, 1995, AM J PHYSIOL-ENDOC M, V268, pE428, DOI 10.1152/ajpendo.1995.268.3.E428; Nair A, 2010, CELL MOL NEUROBIOL, V30, P505, DOI 10.1007/s10571-009-9483-2; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; NISTRI A, 1979, PROG NEUROBIOL, V13, P117, DOI 10.1016/0301-0082(79)90016-9; NOHR D, 1989, CELL TISSUE RES, V258, P387; North R Alan, 2003, Curr Opin Investig Drugs, V4, P833; Oliveira MCG, 2005, EUR J PAIN, V9, P87, DOI 10.1016/j.ejpain.2004.04.006; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Park CK, 2010, J DENT RES, V89, P1154, DOI 10.1177/0022034510377094; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Puri V, 2005, NEUROPEPTIDES, V39, P409, DOI 10.1016/j.npep.2005.04.002; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Shimizu T, 2012, NEUROBIOL DIS, V48, P367, DOI 10.1016/j.nbd.2012.07.010; Simonetti M, 2008, J BIOL CHEM, V283, P18743, DOI 10.1074/jbc.M800296200; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; SPENCER SE, 1991, NEUROSCI LETT, V128, P217, DOI 10.1016/0304-3940(91)90264-T; Spicarova D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-49; Sundukova Mayya, 2012, J Neurochem, V122, P557, DOI 10.1111/j.1471-4159.2012.07810.x; Tang HB, 2008, NEUROPHARMACOLOGY, V55, P1405, DOI 10.1016/j.neuropharm.2008.08.037; Uzar E, 2011, EUR REV MED PHARMACO, V15, P1111; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Vulchanova L, 1997, NEUROPHARMACOLOGY, V36, P1229, DOI 10.1016/S0028-3908(97)00126-3; WEBER W, 1991, J ANTIBIOT, V44, P164, DOI 10.7164/antibiotics.44.164; Yang Z, 2009, ARCH ORAL BIOL, V54, P63, DOI 10.1016/j.archoralbio.2008.09.003; Yu YC, 2006, J NEUROSCI, V26, P696, DOI 10.1523/JNEUROSCI.3653-05.2006; Zhang FX, 2010, J NEUROSCI, V30, P10927, DOI 10.1523/JNEUROSCI.0657-10.2010; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	73	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81138	10.1371/journal.pone.0081138	http://dx.doi.org/10.1371/journal.pone.0081138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312267	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100061
J	Chaurasia, SS; Perera, PR; Poh, R; Lim, RR; Wong, TT; Mehta, JS				Chaurasia, Shyam S.; Perera, Promoda R.; Poh, Rebekah; Lim, Rayne R.; Wong, Tina T.; Mehta, Jodhbir S.			Hevin Plays a Pivotal Role in Corneal Wound Healing	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX GLYCOPROTEIN; MESSENGER-RNA; TISSUE-REPAIR; MATRICELLULAR GLYCOPROTEIN; MYOFIBROBLAST GENERATION; BIOLOGICAL FUNCTIONS; REFRACTIVE SURGERY; TUMOR-SUPPRESSOR; RAT CEREBELLUM; EXCIMER-LASER	Background: Hevin is a matricellular protein involved in tissue repair and remodeling via interaction with the surrounding extracellular matrix (ECM) proteins. In this study, we examined the functional role of hevin using a corneal stromal wound healing model achieved by an excimer laser-induced irregular phototherapeutic keratectomy (IrrPTK) in hevin-null (hevin(-/-)) mice. We also investigated the effects of exogenous supplementation of recombinant human hevin (rhHevin) to rescue the stromal cellular components damaged by the excimer laser. Methodology/Principal Findings: Wild type (WT) and hevin(-/-) mice were divided into three groups at 4 time points-1, 2, 3 and 4 weeks. Group I served as naive without any treatment. Group II received epithelial debridement and underwent IrrPTK using excimer laser. Group III received topical application of rhHevin after IrrPTK surgery for 3 days. Eyes were analyzed for corneal haze and matrix remodeling components using slit lamp biomicroscopy, in vivo confocal microscopy, light microscopy (LM), transmission electron microscopy (TEM), immunohistochemistry (IHC) and western blotting (WB). IHC showed upregulation of hevin in IrrPTK-injured WT mice. Hevin(-/-) mice developed corneal haze as early as 1-2 weeks post IrrPTK-treatment compared to the WT group, which peaked at 3-4 weeks. They also exhibited accumulation of inflammatory cells, fibrotic components of ECM proteins and vascularized corneas as seen by IHC and WB. LM and TEM showed activated keratocytes (myofibroblasts), inflammatory debris and vascular tissues in the stroma. Exogenous application of rhHevin for 3 days reinstated inflammatory index of the corneal stroma similar to WT mice. Conclusions/Significance: Hevin is transiently expressed in the IrrPTK-injured corneas and loss of hevin predisposes them to aberrant wound healing. Hevin(-/-) mice develop early corneal haze characterized by severe chronic inflammation and stromal fibrosis that can be rescued with exogenous administration of rhHevin. Thus, hevin plays a pivotal role in the corneal wound healing.	[Chaurasia, Shyam S.; Perera, Promoda R.; Poh, Rebekah; Lim, Rayne R.; Wong, Tina T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Chaurasia, Shyam S.] Duke NUS Grad Med Sch, Signature Res Program Neurosci & Behav Disorders, Singapore, Singapore; [Chaurasia, Shyam S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Wong, Tina T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tina T.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Chaurasia, SS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	shyamsunderc@yahoo.com	Chaurasia, Shyam/AAB-4709-2019; Mehta, Jodhbir/O-6192-2015; Perera, Promoda P/G-7163-2015	Chaurasia, Shyam/0000-0001-8725-676X; Perera, Promoda P/0000-0002-3674-9940	SingHealth Foundation [R756/40/2010 SHF, R729/13/2010 SHF]; National medical Research Council [R751/35/2010 NMRC]; Biomedical Research Council [R826C]; NMRC-Funded Translational & Clinical Research (TCR) Programme Grant [NMRC/TCR/002-SERI/2008-TCR 620/41/2008]	SingHealth Foundation(SingHealth); National medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NMRC-Funded Translational & Clinical Research (TCR) Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from SingHealth Foundation [R756/40/2010 SHF; R729/13/2010 SHF] to SSC, National medical Research Council funded NIG award [R751/35/2010 NMRC] to SSC, Biomedical Research Council funded TCRP grant [R826C] to SSC and NMRC-Funded Translational & Clinical Research (TCR) Programme Grant [NMRC/TCR/002-SERI/2008-TCR 620/41/2008] to JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angunawela RI, 2011, MOL VIS, V17, P3005; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Chaurasia SS, 2009, EXP EYE RES, V89, P590, DOI 10.1016/S0014-4835(09)00247-4; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001; Gambato C, 2005, OPHTHALMOLOGY, V112, P208, DOI 10.1016/j.ophtha.2004.07.035; Girard JP, 1996, J BIOL CHEM, V271, P4511; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Han SB, 2013, MOL VIS, V19, P1222; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hisatomi T, 2012, AM J PATHOL, V181, P53, DOI 10.1016/j.ajpath.2012.03.022; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1999, J CELL SCI, V112, P613; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Kang MH, 2011, INVEST OPHTH VIS SCI, V52, P2187, DOI 10.1167/iovs.10-5428; Kaur H, 2009, EXP EYE RES, V89, P152, DOI 10.1016/j.exer.2009.03.001; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Li Q, 2000, GRAEF ARCH CLIN EXP, V238, P853, DOI 10.1007/s004170000182; Li YX, 2006, BIOCHEM BIOPH RES CO, V339, P797, DOI 10.1016/j.bbrc.2005.11.082; Maak S, 2001, ANIM GENET, V32, P303, DOI 10.1046/j.1365-2052.2001.00778.x; MENDIS DB, 1994, BRAIN RES, V633, P197, DOI 10.1016/0006-8993(94)91540-7; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mohan RR, 2008, EXP EYE RES, V86, P235, DOI 10.1016/j.exer.2007.10.014; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Mothe AJ, 2000, MOL BRAIN RES, V76, P73, DOI 10.1016/S0169-328X(99)00336-8; Mothe AJ, 2002, BRAIN RES, V931, P146, DOI 10.1016/S0006-8993(02)02270-9; Mothe AJ, 2001, BRAIN RES, V892, P27, DOI 10.1016/S0006-8993(00)03141-3; NAKAYASU K, 1986, OPHTHALMIC RES, V18, P1, DOI 10.1159/000265406; Nelson PS, 1998, CANCER RES, V58, P232; Nishida T, 1996, Curr Opin Ophthalmol, V7, P2, DOI 10.1097/00055735-199608000-00002; Okanobo A, 2012, AM J OPHTHALMOL, V154, P63, DOI 10.1016/j.ajo.2012.01.034; REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406; Saika S, 2007, CORNEA, V26, pS70, DOI 10.1097/ICO.0b013e31812f6d14; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; St Croix B, 2000, SCIENCE, V289, P1197; Stapleton WM, 2008, EXP EYE RES, V86, P753, DOI 10.1016/j.exer.2008.02.001; Sullivan MM, 2008, WOUND REPAIR REGEN, V16, P310, DOI 10.1111/j.1524-475X.2008.00370.x; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Sullivan MM, 2004, INT J BIOCHEM CELL B, V36, P991, DOI 10.1016/j.biocel.2004.01.017; Tervo T, 2003, PROG RETIN EYE RES, V22, P339, DOI 10.1016/S1350-9462(02)00064-2; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	51	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81544	10.1371/journal.pone.0081544	http://dx.doi.org/10.1371/journal.pone.0081544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303054	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400070
J	Jeong, IS; Fukudome, A; Aksoy, E; Bang, WY; Kim, S; Guan, QM; Bahk, JD; May, KA; Russell, WK; Zhu, JH; Koiwa, H				Jeong, In Sil; Fukudome, Akihito; Aksoy, Emre; Bang, Woo Young; Kim, Sewon; Guan, Qingmei; Bahk, Jeong Dong; May, Kimberly A.; Russell, William K.; Zhu, Jianhua; Koiwa, Hisashi			Regulation of Abiotic Stress Signalling by Arabidopsis C-Terminal Domain Phosphatase-Like 1 Requires Interaction with a K-Homology Domain-Containing Protein	PLOS ONE			English	Article							IRON-DEFICIENCY RESPONSES; RNA-BINDING PROTEINS; MESSENGER-RNA; TRANSCRIPTIONAL ADAPTER; FLOWERING TIME; GENES; IDENTIFICATION; EXPRESSION; RECOGNITION; PROMOTER	Arabidopsis thaliana CARBOXYL-TERMINAL DOMAIN (CTD) PHOSPHATASE-LIKE 1 (CPL1) regulates plant transcriptional responses to diverse stress signals. Unlike typical CTD phosphatases, CPL1 contains two double-stranded (ds) RNA binding motifs (dsRBMs) at its C-terminus. Some dsRBMs can bind to dsRNA and/or other proteins, but the function of the CPL1 dsRBMs has remained obscure. Here, we report identification of REGULATOR OF CBF GENE EXPRESSION 3 (RCF3) as a CPL1-interacting protein. RCF3 co-purified with tandem-affinity-tagged CPL1 from cultured Arabidopsis cells and contains multiple K-homology (KH) domains, which were predicted to be important for binding to single-stranded DNA/RNA. Yeast two-hybrid, luciferase complementation imaging, and bimolecular fluorescence complementation analyses established that CPL1 and RCF3 strongly associate in vivo, an interaction mediated by the dsRBM1 of CPL1 and the KH3/KH4 domains of RCF3. Mapping of functional regions of CPL1 indicated that CPL1 in vivo function requires the dsRBM1, catalytic activity, and nuclear targeting of CPL1. Gene expression profiles of rcf3 and cpl1 mutants were similar during iron deficiency, but were distinct during the cold response. These results suggest that tethering CPL1 to RCF3 via dsRBM1 is part of the mechanism that confers specificity to CPL1-mediated transcriptional regulation.	[Jeong, In Sil; Fukudome, Akihito; Aksoy, Emre; Bang, Woo Young; Kim, Sewon; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Jeong, In Sil; Bang, Woo Young; Kim, Sewon; Bahk, Jeong Dong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, BK21 Program, Jinju, Gyeongsangnam D, South Korea; [Guan, Qingmei; Zhu, Jianhua] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [May, Kimberly A.; Russell, William K.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Gyeongsang National University; University System of Maryland; University of Maryland College Park; Texas A&M University System; Texas A&M University College Station	Koiwa, H (corresponding author), Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA.	koiwa@neo.tamu.edu	Koiwa, Hisashi/AAA-8182-2019; Fukudome, Akihito/X-5091-2019; Aksoy, Emre/ABB-6969-2020; Zhu, Jianhua/F-7127-2013; Koiwa, Hisashi/AAO-6512-2020; Guan, Qingmei/B-7389-2014; Guan, Qingmei/B-7389-2014	Fukudome, Akihito/0000-0001-8924-1035; Koiwa, Hisashi/0000-0002-7421-340X; Guan, Qingmei/0000-0002-3153-3147; Guan, Qingmei/0000-0001-6967-9240	National Science Foundation [MCB0950459]; USDA-CSREES "Designing Food for Health'' [2008-34402-19195, 2009-34402-19831]; National Center for Research Resources [1 S10 RR022378-01]; Office of Vice-President for Research, Texas AM University; BK21 program of the Ministry of Education and Science Technology of Korea; Direct For Biological Sciences [0950459] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0950242] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022378] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); USDA-CSREES "Designing Food for Health''(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Vice-President for Research, Texas AM University; BK21 program of the Ministry of Education and Science Technology of Korea(Ministry of Education (MOE), Republic of Korea); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Science Foundation (MCB0950459), USDA-CSREES (2008-34402-19195 and 2009-34402-19831) "Designing Food for Health'', National Center for Research Resources (1 S10 RR022378-01) and the Office of Vice-President for Research, Texas A&M University. This work was also supported by grants from the BK21 program of the Ministry of Education and Science Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24120; Aksoy E, 2013, PLANT PHYSIOL, V161, P330, DOI 10.1104/pp.112.207043; Bang WY, 2008, BIOCHEM BIOPH RES CO, V372, P907, DOI 10.1016/j.bbrc.2008.05.161; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DIETRICH MA, 1990, PLANT MOL BIOL, V15, P207, DOI 10.1007/BF00036908; DOELLING JH, 1993, PLANT CELL REP, V12, P241, DOI 10.1007/BF00237127; Du ZH, 2004, J BIOL CHEM, V279, P48126, DOI 10.1074/jbc.M405371200; Du Z, 2007, RNA, V13, P1043, DOI 10.1261/rna.410107; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gamarnik AV, 1997, RNA, V3, P882; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Guan QM, 2013, MOL PLANT, V6, P386, DOI 10.1093/mp/sss119; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; James P, 1996, GENETICS, V144, P1425; Jeong IS, 2013, PLOS ONE IN PRESS; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kuhn JM, 2003, CURR OPIN PLANT BIOL, V6, P463, DOI 10.1016/S1369-5266(03)00084-0; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lorkovic ZJ, 2008, EXP CELL RES, V314, P3175, DOI 10.1016/j.yexcr.2008.06.020; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Milla MAR, 2006, FEBS LETT, V580, P904, DOI 10.1016/j.febslet.2006.01.013; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Park ZY, 2001, ANAL CHEM, V73, P2558, DOI 10.1021/ac001488p; Reddy ASN, 2012, PLANT PHYSIOL, V158, P67, DOI 10.1104/pp.111.186700; Schmidt W, 2011, PLANT PHYSIOL BIOCH, V49, P462, DOI 10.1016/j.plaphy.2010.12.001; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Sivitz AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044843; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599	63	17	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80509	10.1371/journal.pone.0080509	http://dx.doi.org/10.1371/journal.pone.0080509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303021	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400037
J	Kang, SC; Lim, SY; Song, YJ				Kang, Se Chan; Lim, Sue Yeon; Song, Yoon-Jae			Lupeol Is One of Active Components in the Extract of Chrysanthemum indicum Linne That Inhibits LMP1-Induced NF-kappa B Activation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; DIETARY TRITERPENE LUPEOL; PROSTATE-CANCER CELLS; SIGNALING PATHWAYS; LYMPHOCYTE TRANSFORMATION; ANTICANCER DRUGS; APOPTOTIC DEATH; TRANSCRIPTION; EXPRESSION	We have previously reported that seventy percent ethanol extract of Chrysanthemum indicum Linne (CIE) strongly reduces Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line (LCL) survival by inhibiting virus-encoded latent infection membrane protein 1 (LMP1)-induced NF-kappa B activation. To identify an active compound(s) in CIE that inhibits LMP1-induced NF-kappa B activation, activity-guided fractionation was employed. The CH2Cl2 fraction of CIE strongly reduced LMP1-induced NF-kappa B activation and LCL viability with relatively low cytotoxic effects on primary human foreskin fibroblast (HFF), HeLa or Burkitt's lymphoma (BL41) cells. Furthermore, lupeol, a pentacyclic triterpene, was identified in the CH2Cl2 fraction of CIE to attenuate LMP1-induced NF-kappa B activation and LCL viability. This study demonstrates that lupeol is one of active compounds in the CH2Cl2 fraction of CIE that inhibits LMP1-induced NF-kappa B activation and reduces NF-kappa B-dependent LCL viability.	[Kang, Se Chan; Lim, Sue Yeon; Song, Yoon-Jae] Gachon Univ, Dept Life Sci, Songnam, Kyeonggi Do, South Korea	Gachon University	Song, YJ (corresponding author), Gachon Univ, Dept Life Sci, Songnam, Kyeonggi Do, South Korea.	songyj@gachon.ac.kr			Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs [311063-5]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2010-0003301]	Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (No. 311063-5) and by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 2010-0003301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bari W, 2011, INFECT IMMUN, V79, P3149, DOI 10.1128/IAI.01237-10; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Chen LC, 2011, INT J ONCOL, V39, P883, DOI 10.3892/ijo.2011.1104; Cheng WM, 2005, J ETHNOPHARMACOL, V101, P334, DOI 10.1016/j.jep.2005.04.035; Cheon MS, 2009, J ETHNOPHARMACOL, V122, P473, DOI 10.1016/j.jep.2009.01.034; Chun HS, 2008, J MED FOOD, V11, P246, DOI 10.1089/jmf.2007.542; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HUEN DS, 1995, ONCOGENE, V10, P549; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Izumi KM, 1999, J VIROL, V73, P9908, DOI 10.1128/JVI.73.12.9908-9916.1999; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; KATO T, 1987, ARCH INT PHARMACOD T, V285, P288; KAYE KM, 1995, J VIROL, V69, P675, DOI 10.1128/JVI.69.2.675-683.1995; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kim IS, 2011, FOOD CHEM TOXICOL, V49, P963, DOI 10.1016/j.fct.2011.01.002; Kim JE, 2012, FOOD CHEM TOXICOL, V50, P1524, DOI 10.1016/j.fct.2012.02.034; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Lee DY, 2009, J ETHNOPHARMACOL, V123, P149, DOI 10.1016/j.jep.2009.02.009; Lee TK, 2007, CANCER RES, V67, P8800, DOI 10.1158/0008-5472.CAN-07-0801; Li W, 2013, ARCH PHARM RES; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pongjit K, 2011, HUM EXP TOXICOL, V30, P1931, DOI 10.1177/0960327111402242; Prasad S, 2009, CANCER BIOL THER, V8, P1639, DOI 10.4161/cbt.8.17.9204; Rickinson AB, 2007, FIELDS VIROLOGY, V2, P2655; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Saleem M, 2005, CANCER RES, V65, P11203, DOI 10.1158/0008-5472.CAN-05-1965; Saleem M, 2005, CARCINOGENESIS, V26, P1956, DOI 10.1093/carcin/bgi157; Saleem M, 2004, ONCOGENE, V23, P5203, DOI 10.1038/sj.onc.1207641; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Su JY, 2011, J ETHNOPHARMACOL; Tarapore RS, 2010, CARCINOGENESIS, V31, P1844, DOI 10.1093/carcin/bgq169; Tarapore RS, 2013, MOL NUTR FOOD RES; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; Wang ZD, 2010, ONCOL REP, V23, P413, DOI 10.3892/or_00000650	58	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82688	10.1371/journal.pone.0082688	http://dx.doi.org/10.1371/journal.pone.0082688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303085	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400103
J	Monyarch, G; Reis, FD; Zock, JP; Giraldo, J; Pozo-Rodriguez, F; Espinosa, A; Rodriguez-Trigo, G; Verea, H; Castano-Vinyals, G; Gomez, FP; Anto, JM; Coll, MD; Barbera, JA; Fuster, C				Monyarch, Gemma; de Castro Reis, Fernanda; Zock, Jan-Paul; Giraldo, Jesus; Pozo-Rodriguez, Francisco; Espinosa, Ana; Rodriguez-Trigo, Gema; Verea, Hector; Castano-Vinyals, Gemma; Gomez, Federico P.; Anto, Josep M.; Dolors Coll, Maria; Albert Barbera, Joan; Fuster, Carme			Chromosomal Bands Affected by Acute Oil Exposure and DNA Repair Errors	PLOS ONE			English	Article							PRESTIGE OIL; FRAGILE SITES; MYELOID-LEUKEMIA; WORKERS; BENZENE; LYMPHOCYTES; BIOMARKERS; DELETION; HEALTH; DAMAGE	Background: In a previous study, we showed that individuals who had participated in oil clean-up tasks after the wreckage of the Prestige presented an increase of structural chromosomal alterations two years after the acute exposure had occurred. Other studies have also reported the presence of DNA damage during acute oil exposure, but little is known about the long term persistence of chromosomal alterations, which can be considered as a marker of cancer risk. Objectives: We analyzed whether the breakpoints involved in chromosomal damage can help to assess the risk of cancer as well as to investigate their possible association with DNA repair efficiency. Methods: Cytogenetic analyses were carried out on the same individuals of our previous study and DNA repair errors were assessed in cultures with aphidicolin. Results: Three chromosomal bands, 2q21, 3q27 and 5q31, were most affected by acute oil exposure. The dysfunction in DNA repair mechanisms, expressed as chromosomal damage, was significantly higher in exposed-oil participants than in those not exposed (p=0.016). Conclusion: The present study shows that breaks in 2q21, 3q27 and 5q31 chromosomal bands, which are commonly involved in hematological cancer, could be considered useful genotoxic oil biomarkers. Moreover, breakages in these bands could induce chromosomal instability, which can explain the increased risk of cancer (leukemia and lymphomas) reported in chronically benzene-exposed individuals. In addition, it has been determined that the individuals who participated in clean-up of the oil spill presented an alteration of their DNA repair mechanisms two years after exposure.	[Monyarch, Gemma; de Castro Reis, Fernanda; Fuster, Carme] Univ Autonoma Barcelona, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain; [Zock, Jan-Paul; Espinosa, Ana; Castano-Vinyals, Gemma; Anto, Josep M.] Ctr Recerca Epidemiol Ambiental CREAL, Barcelona, Spain; [Zock, Jan-Paul; Espinosa, Ana; Castano-Vinyals, Gemma; Anto, Josep M.] Inst Recerca Hosp Mar IMIM, Barcelona, Spain; [Zock, Jan-Paul; Espinosa, Ana; Castano-Vinyals, Gemma; Anto, Josep M.] CIBER Epidemiol & Salut Publ CIBERESP, Barcelona, Spain; [Giraldo, Jesus] UAB, Fac Med, Unitat Bioestadist, Bellaterra, Spain; [Giraldo, Jesus] UAB, Fac Med, Inst Neurociencies, Bellaterra, Spain; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Dept Resp Med, Unidad Epidemiol Clin, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco; Rodriguez-Trigo, Gema; Gomez, Federico P.; Albert Barbera, Joan] CIBER Enfermedades Resp CIBERES, Bunyola, Mallorca, Spain; [Rodriguez-Trigo, Gema] Hosp Clin San Carlos, Dept Resp Med, Madrid, Spain; [Verea, Hector] Complexo Hosp Univ A Coruna, Dept Resp Med, La Coruna, Spain; [Gomez, Federico P.; Albert Barbera, Joan] Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Anto, Josep M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Dolors Coll, Maria] UAB, Fac Ciencias, Unitat Biol Cellular, Bellaterra, Spain	Autonomous University of Barcelona; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Clinico San Carlos; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University; Autonomous University of Barcelona	Fuster, C (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain.	carme.fuster@uab.es	Zock, Jan-Paul/P-5034-2018; Anto, J M/H-2676-2014; Castaño-Vinyals, Gemma/N-3885-2019; Castaño-Vinyals, Gemma/H-7021-2017; Giraldo, Jesus/F-9881-2011	Zock, Jan-Paul/0000-0002-2941-6259; Anto, J M/0000-0002-4736-8529; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Giraldo, Jesus/0000-0001-7082-4695; Barbera, Joan Albert/0000-0003-1469-4990; Espinosa, Ana/0000-0001-7399-3267	Health Institute Carlos III FEDER/ERDF [PI03/1685]; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya [SGR09-1107]; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona [PS-456-01/08]	Health Institute Carlos III FEDER/ERDF; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona	For this study was provided by grants from the Health Institute Carlos III FEDER/ERDF (PI03/1685), Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), Comissionat per a Universitats i Recerca from Generalitat de Catalunya (SGR09-1107), Centro de Investigacion en Red de Enfermedades Respiratorias and Universidad Autonoma de Barcelona (PS-456-01/08). The different sponsors were not involved in the design of the study, sample collection, cytogenetic analysis, and interpretation of the data, and preparation/revision of the manuscript.	Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Au WW, 2007, INT J HYG ENVIR HEAL, V210, P239, DOI 10.1016/j.ijheh.2006.11.001; Baron BW, 2007, P NATL ACAD SCI USA, V104, P7449, DOI 10.1073/pnas.0701770104; Barregard L, 2009, ENVIRON RES, V109, P985, DOI 10.1016/j.envres.2009.09.001; Suarez MPB, 2011, EUR J PEDIATR, V170, P531, DOI 10.1007/s00431-010-1339-8; BOHM U, 1995, HUM GENET, V95, P249, DOI 10.1007/BF00225189; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Borkhardt A, 2000, P NATL ACAD SCI USA, V97, P9168, DOI 10.1073/pnas.150079597; Chanvaivit S, 2007, MUTAT RES-GEN TOX EN, V626, P79, DOI 10.1016/j.mrgentox.2006.09.007; CLARE MG, 1984, BRIT J IND MED, V41, P249; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; de la Chica RA, 2005, JAMA-J AM MED ASSOC, V293, P1212, DOI 10.1001/jama.293.10.1212; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Escobar PA, 2007, MUTAGENESIS, V22, P321, DOI 10.1093/mutage/gem020; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hallberg LM, 1997, MUTAT RES-DNA REPAIR, V383, P213, DOI 10.1016/S0921-8777(97)00004-9; *IARC, 1998, MON OV EV CARC UP S7, V1; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; LEVINE EG, 1986, CANCER RES, V46, P6481; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Navasumrit P, 2008, CHEM-BIOL INTERACT, V173, P19, DOI 10.1016/j.cbi.2008.02.004; Nimer SD, 2006, J CLIN ONCOL, V24, P2576, DOI 10.1200/JCO.2005.03.6715; Norppa H, 2006, MUTAT RES-FUND MOL M, V600, P37, DOI 10.1016/j.mrfmmm.2006.05.030; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2008, CHEMOSPHERE, V71, P447, DOI 10.1016/j.chemosphere.2007.10.053; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Perez-Cadahia B, 2006, THESCIENTIFICWORLDJO, V6, P1221, DOI 10.1100/tsw.2006.206; Perez-Cadahia B, 2008, ENVIRON HEALTH INSIG, V2, P83; Pinheiro RF, 2008, BRAZ J MED BIOL RES, V41, P610, DOI 10.1590/S0100-879X2008000700010; Rodriguez-Trigo G, 2010, ANN INTERN MED, V153, P489, DOI 10.7326/0003-4819-153-8-201010190-00279; Rowley JD, 1999, SEMIN HEMATOL, V36, P59; Ruchirawat M, 2013, INT J HYG ENVIR HEAL, V216, P566, DOI 10.1016/j.ijheh.2013.03.003; SASIADEK M, 1992, ENVIRON HEALTH PERSP, V97, P255, DOI 10.2307/3431361; Shaffer L.G., 2013, INT SYSTEM HUMAN CYT; Smith MT, 1998, ENVIRON HEALTH PERSP, V106, P937, DOI 10.2307/3434135; Speit G, 2013, MUTAGENESIS, V28, P145, DOI 10.1093/mutage/ges063; Stallings RL, 2007, TRENDS GENET, V23, P278, DOI 10.1016/j.tig.2007.03.009; Stillman WS, 2000, EXP HEMATOL, V28, P169, DOI 10.1016/S0301-472X(99)00144-7; Tedeschi B, 2004, MUTAT RES-FUND MOL M, V546, P55, DOI 10.1016/j.mrfmmm.2003.10.006; Wang Y, 2010, CANCER GENET CYTOGEN, V199, P9, DOI 10.1016/j.cancergencyto.2010.01.008; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zhang LP, 1998, LEUKEMIA RES, V22, P105, DOI 10.1016/S0145-2126(97)00157-4; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC	47	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81276	10.1371/journal.pone.0081276	http://dx.doi.org/10.1371/journal.pone.0081276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303039	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400056
J	Senin, LL; Al-Massadi, O; Folgueira, C; Castelao, C; Pardo, M; Barja-Fernandez, S; Roca-Rivada, A; Amil, M; Crujeiras, AB; Garcia-Caballero, T; Gabellieri, E; Leis, R; Dieguez, C; Pagotto, U; Casanueva, FF; Seoane, LM				Senin, Lucia L.; Al-Massadi, Omar; Folgueira, Cintia; Castelao, Cecilia; Pardo, Maria; Barja-Fernandez, Silvia; Roca-Rivada, Arturo; Amil, Maria; Crujeiras, Ana B.; Garcia-Caballero, Tomas; Gabellieri, Enrico; Leis, Rosaura; Dieguez, Carlos; Pagotto, Uberto; Casanueva, Felipe F.; Seoane, Luisa M.			The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; ANTAGONIST SR141716; CANNABINOIDS; RIMONABANT; VAGAL; ENDOCANNABINOIDS; HEALTH; CELLS	Over the years, the knowledge regarding the relevance of the cannabinoid system to the regulation of metabolism has grown steadily. A central interaction between the cannabinoid system and ghrelin has been suggested to regulate food intake. Although the stomach is the main source of ghrelin and CB1 receptor expression in the stomach has been described, little information is available regarding the possible interaction between the gastric cannabinoid and ghrelin systems in the integrated control of energy homeostasis. The main objective of the present work was to assess the functional interaction between these two systems in terms of food intake using a combination of in vivo and in vitro approaches. The present work demonstrates that the peripheral blockade of the CB1 receptor by rimonabant treatment decreased food intake but only in food-deprived animals. This anorexigenic effect is likely a consequence of decreases in gastric ghrelin secretion induced by the activation of the mTOR/S6K1 intracellular pathway in the stomach following treatment with rimonabant. In support of this supposition, animals in which the mTOR/S6K1 intracellular pathway was blocked by chronic rapamycin treatment, rimonabant had no effect on ghrelin secretion. Vagal communication may also be involved because rimonabant treatment was no longer effective when administered to animals that had undergone surgical vagotomy. In conclusion, to the best of our knowledge, the present work is the first to describe a CB1 receptor-mediated mechanism that influences gastric ghrelin secretion and food intake through the mTOR pathway.	[Senin, Lucia L.; Folgueira, Cintia; Castelao, Cecilia; Barja-Fernandez, Silvia; Seoane, Luisa M.] Complexo Hosp Univ Santiago CHUS SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Grp Fisiopatol Endocrina, Santiago De Compostela, Spain; [Senin, Lucia L.; Al-Massadi, Omar; Castelao, Cecilia; Pardo, Maria; Roca-Rivada, Arturo; Amil, Maria; Crujeiras, Ana B.; Dieguez, Carlos; Casanueva, Felipe F.; Seoane, Luisa M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Al-Massadi, Omar; Dieguez, Carlos] Inst Invest Sanitaria Santiago de Compostela IDIS, Res Ctr Mol Med & Chron Dis CIMUS, Dept Physiol, Santiago De Compostela, Spain; [Castelao, Cecilia; Pardo, Maria; Roca-Rivada, Arturo] Complexo Hosp Univ Santiago CHUS SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Grp Obesid, Santiago De Compostela, Spain; [Amil, Maria; Crujeiras, Ana B.; Casanueva, Felipe F.] Complejo Hosp Santiago CHUS SERGAS, Inst Invest Sanitaria Santiago IDIS, Grp Fisiopatol Endocrina, Lab Endocrinol Mol & Celular, Santiago De Compostela, Spain; [Garcia-Caballero, Tomas] Complejo Hosp Santiago CHUS SERGAS, USC, Fac Med, Dept Ciencias Morfol, Santiago De Compostela, Spain; [Gabellieri, Enrico] Amedeo Avogadro Univ, Dept Translat Med, Novara, Italy; [Barja-Fernandez, Silvia; Leis, Rosaura] Complexo Hosp Univ Santiago, Inst Invest Sanitaria Santiago de Compostela IDIS, Unit Invest Nutr Growth & Human Dev Galicia, Pediat Dept USC, Santiago De Compostela, Spain; [Pagotto, Uberto] Alma Mater Univ Bologna, Endocrinol Unit, Hosp S Orsola Malpighi, Bologna, Italy; [Pagotto, Uberto] Alma Mater Univ Bologna, Ctr Appl Biomed Res, Hosp S Orsola Malpighi, Dept Med & Surg Sci, Bologna, Italy	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; University of Eastern Piedmont Amedeo Avogadro; Complexo Hospitalario Universitario de Santiago de Compostela; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Seoane, LM (corresponding author), Complexo Hosp Univ Santiago CHUS SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Grp Fisiopatol Endocrina, Santiago De Compostela, Spain.	luisamaria.seoane@usc.es	Pardo, María/C-5124-2012; Leis, Rosaura/Z-3186-2019; Garcia-Caballero, Tomas/H-7213-2015; Folgueira, Cintia/AAB-6964-2019; Al-Massadi, Omar/C-1526-2017; Crujeiras, Ana/ABA-8866-2021	Pardo, María/0000-0002-9967-1650; Leis, Rosaura/0000-0002-0540-4210; Folgueira, Cintia/0000-0003-3803-9149; Al-Massadi, Omar/0000-0003-0645-6159; Crujeiras, Ana/0000-0003-4392-0301; dieguez, carlos/0000-0002-0919-4337; Roca-Rivada, Arturo/0000-0002-0048-3589; Garcia-Caballero, Tomas/0000-0002-7938-1437	Instituto de Salud Carlos III [PS09/02075, PI1202021]; Xunta de Galicia [10 PXIB 918 273PR]; Fundacion Mutua Madrilena; Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion is an ISCIII iniciative [CB06/03]; CIBER Fisiopatologia Obesidad y Nutricion [CB06/03]; Spanish Ministry of Education	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion is an ISCIII iniciative; CIBER Fisiopatologia Obesidad y Nutricion; Spanish Ministry of Education(Spanish Government)	This research has been funded by Instituto de Salud Carlos III (PS09/02075 and PI1202021); Xunta de Galicia (10 PXIB 918 273PR) Fundacion Mutua Madrilena. Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion is an ISCIII iniciative (CB06/03). CC is funded by CIBER Fisiopatologia Obesidad y Nutricion (CB06/03), LLS is funded by the University Professional Development Program (FPU) of the Spanish Ministry of Education, SB-F by Xunta de Galicia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; Al Massadi OP, 2010, METABOLIC IMMNUNE DR, V4, P75; Al-Massadi O, 2011, REGUL PEPTIDES, V166, P3, DOI 10.1016/j.regpep.2010.10.008; Al-Massadi O, 2010, J NEUROENDOCRINOL, V22, P1127, DOI 10.1111/j.1365-2826.2010.02065.x; Al-Massadi O, 2010, AM J PHYSIOL-ENDOC M, V299, pE341, DOI 10.1152/ajpendo.00057.2010; Alen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060918; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Cani PD, 2004, BRIT J NUTR, V92, P757, DOI 10.1079/BJN20041256; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; de la Cour CD, 2001, REGUL PEPTIDES, V99, P141, DOI 10.1016/S0167-0115(01)00243-9; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Gomez R, 2002, J NEUROSCI, V22, P9612; HOLLISTER LE, 1986, PHARMACOL REV, V38, P1; Kirkham TC, 2001, NUTR RES REV, V14, P65, DOI 10.1079/NRR200118; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lim CT, 2013, MOL CELL ENDOCRINOL, V365, P303, DOI 10.1016/j.mce.2012.11.007; Lopez M, 2004, EUR J NEUROSCI, V19, P2080, DOI 10.1111/j.0953-816X.2004.03318.x; Madsen AN, 2009, NEUROSCI LETT, V449, P20, DOI 10.1016/j.neulet.2008.10.001; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Rigamonti AE, 2006, EUR J PHARMACOL, V542, P116, DOI 10.1016/j.ejphar.2006.05.028; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Seoane LM, 2007, J ENDOCRINOL INVEST, V30, pRC22, DOI 10.1007/BF03350806; Seoane LM, 2007, ENDOCRINOLOGY, V148, P3998, DOI 10.1210/en.2007-0226; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; van Thuijl H, 2008, VITAM HORM, V77, P121, DOI 10.1016/S0083-6729(06)77006-6; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu GY, 2009, ENDOCRINOLOGY, V150, P3637, DOI 10.1210/en.2009-0372; Zbucki RL, 2008, FOLIA HISTOCHEM CYTO, V46, P219, DOI 10.2478/v10042-008-0033-4	30	51	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80339	10.1371/journal.pone.0080339	http://dx.doi.org/10.1371/journal.pone.0080339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303008	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400024
J	Park, M; Ohana, E; Choi, SY; Lee, MS; Park, JH; Muallem, S				Park, Meeyoung; Ohana, Ehud; Choi, Soo Young; Lee, Myeong-Sok; Park, Jong Hoon; Muallem, Shmuel			Multiple Roles of the SO42-/Cl-/OH- Exchanger Protein Slc26a2 in Chondrocyte Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Cellular Regulation; Chondrocytes; Insulin-like Growth Factor (IGF); Transporters	DYSPLASIA SULFATE TRANSPORTER; GROWTH-FACTOR-I; BONE-GROWTH; PROTEOGLYCAN SULFATION; SIGNALING PATHWAYS; CARTILAGE; FAMILY; DIFFERENTIATION; MUTATIONS; KINASE	Mutations in the SO42-/Cl-/OH- exchanger Slc26a2 cause the disease diastrophic dysplasia (DTD), resulting in aberrant bone development and, therefore, skeletal deformities. DTD is commonly attributed to a lack of chondrocyte SO42- uptake and proteoglycan sulfation. However, the skeletal phenotype of patients with DTD is typified by reduction in cartilage and osteoporosis of the long bones. Chondrocytes of patients with DTD are irregular in size and have a reduced capacity for proliferation and terminal differentiation. This raises the possibility of additional roles for Slc26a2 in chondrocyte function. Here, we examined the roles of Slc26a2 in chondrocyte biology using two distinct systems: mouse progenitor mesenchymal cells differentiated to chondrocytes and freshly isolated mouse articular chondrocytes differentiated into hypertrophic chondrocytes. Slc26a2 expression was manipulated acutely by delivery of Slc26a2 or shSlc26a2 with lentiviral vectors. We demonstrate that slc26a2 is essential for chondrocyte proliferation and differentiation and for proteoglycan synthesis. Slc26a2 also regulates the terminal stage of chondrocyte cell size expansion. These findings reveal multiple roles for Slc26a2 in chondrocyte biology and emphasize the importance of Slc26a2-mediated protein sulfation in cell signaling, which may account for the complex phenotype of DTD.	[Park, Meeyoung; Lee, Myeong-Sok; Park, Jong Hoon] Sookmyung Womens Univ, Res Ctr Womens Dis, Dept Biol Sci, Seoul 140742, South Korea; [Ohana, Ehud; Muallem, Shmuel] Natl Inst Dent & Craniofacial Res, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Choi, Soo Young] Hallym Univ, Inst Biosci & Biotechnol, Dept Biomed Sci & Res, Chunchon 200702, South Korea	Sookmyung Women's University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Hallym University	Park, JH (corresponding author), Sookmyung Womens Univ, Res Ctr Womens Dis, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr; shmuel.muallem@nih.gov	Ohana, Ehud/ABB-3060-2020	Ohana, Ehud/0000-0001-8598-4042	National Institutes of Health [ZIA DE000735]; National Research Foundation [NRF-2008-359-C00029, NRF-2009-0071060]; MSIP [2013R1A2A1A01011908]; Korean government; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation; MSIP; Korean government(Korean Government); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Grant ZIA DE000735. This work was also supported by National Research Foundation Grants NRF-2008-359-C00029 and NRF-2009-0071060] and MSIP Grant 2013R1A2A1A01011908 funded by the Korean government.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Chapman JM, 2010, HISTOCHEM CELL BIOL, V133, P541, DOI 10.1007/s00418-010-0694-x; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Cornaglia AI, 2009, CONNECT TISSUE RES, V50, P232, DOI 10.1080/03008200802684623; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; de Andrea CE, 2012, J PATHOL, V226, P219, DOI 10.1002/path.3003; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dwyer E, 2010, AM J MED GENET A, V152A, P3043, DOI 10.1002/ajmg.a.33736; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Gualeni B, 2013, BONE, V54, P83, DOI 10.1016/j.bone.2013.01.036; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haila S, 2001, J HISTOCHEM CYTOCHEM, V49, P973, DOI 10.1177/002215540104900805; Harrington EK, 2010, ANAT REC, V293, P225, DOI 10.1002/ar.21072; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MacRae VE, 2007, GROWTH HORM IGF RES, V17, P435, DOI 10.1016/j.ghir.2007.05.002; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Markovich D, 2007, ANNU REV PHYSIOL, V69, P361, DOI 10.1146/annurev.physiol.69.040705.141319; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; Mohan S, 2012, CURR OSTEOPOROS REP, V10, P178, DOI 10.1007/s11914-012-0100-9; Ohana E, 2012, J BIOL CHEM, V287, P5122, DOI 10.1074/jbc.M111.297192; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Patil AS, 2012, J CELL PHYSIOL, V227, P1796, DOI 10.1002/jcp.22905; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Rossi A, 1998, MATRIX BIOL, V17, P361, DOI 10.1016/S0945-053X(98)90088-9; Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wang F, 2011, J BIOCHEM, V150, P83, DOI 10.1093/jb/mvr037; Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; ZAPF J, 1986, HORM RES, V24, P160, DOI 10.1159/000180555; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026	41	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1993	2001		10.1074/jbc.M113.503466	http://dx.doi.org/10.1074/jbc.M113.503466			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302720	Green Published, hybrid			2022-12-25	WOS:000331130200011
J	Maalcke, WJ; Dietl, A; Marritt, SJ; Butt, JN; Jetten, MSM; Keltjens, JT; Barends, TRM; Kartal, B				Maalcke, Wouter J.; Dietl, Andreas; Marritt, Sophie J.; Butt, Julea N.; Jetten, Mike S. M.; Keltjens, Jan T.; Barends, Thomas R. M.; Kartal, Boran			Structural Basis of Biological NO Generation by Octaheme Oxidoreductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Purification; Nitric Oxide; Nitrogen Metabolism; Protein Structure; Reactive Nitrogen Species; X-ray Crystallography; Anaerobic Ammonium Oxidation; Hydroxylamine; Octaheme Proteins	C NITRITE REDUCTASE; HYDROXYLAMINE OXIDOREDUCTASE; CYTOCHROME-C; OXIDE; AMMONIA; PROTEIN; MECHANISM; BACTERIUM; OXIDATION; QUANTITATION	Background: Multiheme proteins have crucial roles in diverse nitrogen cycle processes. Results: The kustc1061 octaheme protein from anaerobic ammonium-oxidizing (anammox) bacteria specifically oxidizes hydroxylamine to NO. Conclusion: Enzyme specificity derives from subtle amino acid changes near the P-460 catalytic heme. Significance: The presence of kustc1061 homologs in anammox and other bacteria enables the detoxification of hydroxylamine, thereby generating NO for respiratory purposes. Nitric oxide is an important molecule in all domains of life with significant biological functions in both pro- and eukaryotes. Anaerobic ammonium-oxidizing (anammox) bacteria that contribute substantially to the release of fixed nitrogen into the atmosphere use the oxidizing power of NO to activate inert ammonium into hydrazine (N2H4). Here, we describe an enzyme from the anammox bacterium Kuenenia stuttgartiensis that uses a novel pathway to make NO from hydroxylamine. This new enzyme is related to octaheme hydroxylamine oxidoreductase, a key protein in aerobic ammonium-oxidizing bacteria. By a multiphasic approach including the determination of the crystal structure of the K. stuttgartiensis enzyme at 1.8 resolution and refinement and reassessment of the hydroxylamine oxidoreductase structure from Nitrosomonas europaea, both in the presence and absence of their substrates, we propose a model for NO formation by the K. stuttgartiensis enzyme. Our results expand the understanding of the functions that the widespread family of octaheme proteins have.	[Maalcke, Wouter J.; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Dietl, Andreas; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mechanisms, D-69120 Heidelberg, Germany; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; Max Planck Society; University of East Anglia; University of East Anglia; Delft University of Technology	Barends, TRM (corresponding author), Max Planck Inst Med Res, Dept Biomol Mechanisms, Jahnstr 29, D-69120 Heidelberg, Germany.	Thomas.Barends@mpimf-heidelberg.mpg.de; kartal@science.ru.nl	Jetten, Mike/B-8834-2011; Kartal, Boran/ABD-5400-2021; Kartal, Boran/D-2488-2014; Butt, Julea/E-2133-2011; Keltjens, Jan/M-3002-2013	Jetten, Mike/0000-0002-4691-7039; Butt, Julea/0000-0002-9624-5226; Kartal, Boran/0000-0003-4199-952X	Netherlands Organization for Scientific Research [142.16.1201, VENI 863.11.003]; European Research Council [232937]; Max-Planck Society; UK Biotechnology and Biological Sciences Research Council [BB/G009228]; BBSRC [BB/G009228/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009228/1] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Netherlands Organization for Scientific Research Darwin Grants 142.16.1201 (to W. J. M.) and VENI 863.11.003 (to B. K.), by European Research Council Advanced Grant 232937 (to M. S. M. J), by the Max-Planck Society, and by UK Biotechnology and Biological Sciences Research Council Grant BB/G009228 (to S. J. M.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Atkinson SJ, 2007, FEBS LETT, V581, P3805, DOI 10.1016/j.febslet.2007.07.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Campbell MA, 2011, FEMS MICROBIOL LETT, V322, P82, DOI 10.1111/j.1574-6968.2011.02340.x; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; Cedervall PE, 2009, ACTA CRYSTALLOGR F, V65, P1296, DOI 10.1107/S1744309109046119; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clarke TA, 2008, METHOD ENZYMOL, V437, P63, DOI 10.1016/S0076-6879(07)37004-3; COLLINS MJ, 1993, J BIOL CHEM, V268, P14655; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Fernandez ML, 2008, J INORG BIOCHEM, V102, P1523, DOI 10.1016/j.jinorgbio.2008.01.032; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Harp JM, 1999, ACTA CRYSTALLOGR D, V55, P1329, DOI 10.1107/S0907444999005442; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; Hirst DG, 2011, METHODS MOL BIOL, V704, P1, DOI 10.1007/978-1-61737-964-2_1; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1979, BIOCHIM BIOPHYS ACTA, V571, P12, DOI 10.1016/0005-2744(79)90220-1; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Kartal B, 2010, APPL ENVIRON MICROB, V76, P6304, DOI 10.1128/AEM.00991-10; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Kostera J, 2010, BIOCHEMISTRY-US, V49, P8546, DOI 10.1021/bi1006783; Kurnikov IV, 2005, BIOCHEMISTRY-US, V44, P1856, DOI 10.1021/bi048060v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McQuade LE, 2010, INORG CHEM, V49, P7464, DOI 10.1021/ic100802q; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G; Pacheco AA, 2011, METHOD ENZYMOL, V486, P447, DOI [10.1016/S0076-6879(11)86020-9, 10.1016/B978-0-12-381294-0.00020-1]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Poret-Peterson AT, 2008, ISME J, V2, P1213, DOI 10.1038/ismej.2008.71; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00372; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; TERRY KR, 1981, BIOCHEMISTRY-US, V20, P7026, DOI 10.1021/bi00527a039; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YL, 2011, CELL MICROBIOL, V13, P518, DOI 10.1111/j.1462-5822.2011.01576.x; WATANABE T, 1982, J PHYS CHEM-US, V86, P2617, DOI 10.1021/j100211a014; YONETANI T, 1965, J BIOL CHEM, V240, P4509	62	68	71	4	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1228	1242		10.1074/jbc.M113.525147	http://dx.doi.org/10.1074/jbc.M113.525147			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302732	Green Published, hybrid			2022-12-25	WOS:000332401700004
J	Bersch, B; Bougault, C; Roux, L; Favier, A; Vernet, T; Durmort, C				Bersch, Beate; Bougault, Catherine; Roux, Laure; Favier, Adrien; Vernet, Thierry; Durmort, Claire			New Insights into Histidine Triad Proteins: Solution Structure of a Streptococcus pneumoniae PhtD Domain and Zinc Transfer to AdcAII	PLOS ONE			English	Article							NMR STRUCTURE DETERMINATION; GROUP-A STREPTOCOCCUS; ESCHERICHIA-COLI; BINDING PROTEIN; PATHOGENIC STREPTOCOCCI; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; METAL-BINDING; UPTAKE SYSTEM	Zinc (Zn2+) homeostasis is critical for pathogen host colonization and invasion. Polyhistidine triad (Pht) proteins, located at the surface of various streptococci, have been proposed to be involved in Zn2+ homeostasis. The phtD gene, coding for a Zn2+-binding protein, is organized in an operon with adcAII coding for the extracellular part of a Zn2+ transporter. In the present work, we investigate the relationship between PhtD and AdcAII using biochemical and structural biology approaches. Immuno-precipitation experiments on purified membranes of Streptococcus pneumoniae (S. pneumoniae) demonstrate that native PhtD and AdcAII interact in vivo confirming our previous in vitro observations. NMR was used to demonstrate Zn2+ transfer from the Zn2+-bound form of a 137 amino acid N-terminal domain of PhtD (t-PhtD) to AdcAII. The high resolution NMR structure of t-PhtD shows that Zn2+ is bound in a tetrahedral site by histidines 83, 86, and 88 as well as by glutamate 63. Comparison of the NMR parameters measured for apo- and Zn2+-t-PhtD shows that the loss of Zn2+ leads to a diminished helical propensity at the C-terminus and increases the local dynamics and overall molecular volume. Structural comparison with the crystal structure of a 55-long fragment of PhtA suggests that Pht proteins are built from short repetitive units formed by three beta-strands containing the conserved HxxHxH motif. Taken together, these results support a role for S. pneumoniae PhtD as a Zn2+ scavenger for later release to the surface transporter AdcAII, leading to Zn2+ uptake.	[Bersch, Beate; Bougault, Catherine; Roux, Laure; Favier, Adrien; Vernet, Thierry; Durmort, Claire] Univ Grenoble Alpes, Inst Biol, Grenoble, France; [Bersch, Beate; Bougault, Catherine; Roux, Laure; Favier, Adrien; Vernet, Thierry; Durmort, Claire] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Struct, Grenoble, France; [Bersch, Beate; Bougault, Catherine; Roux, Laure; Favier, Adrien; Vernet, Thierry; Durmort, Claire] CNRS, Inst Biol Struct, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Vernet, T (corresponding author), Univ Grenoble Alpes, Inst Biol, Grenoble, France.	thierry.vernet@ibs.fr; claire.durmort@ibs.fr	Bersch, Beate/A-7011-2013	Bersch, Beate/0000-0003-1138-4911; Bougault, Catherine/0000-0003-3358-5255	"coopol innovation France-Chinese" program	"coopol innovation France-Chinese" program	This work was partly funded by the "coopol innovation France-Chinese" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Aranda J, 2012, CAN J VET RES, V76, P72; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bersch C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.093903; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Castelli S, 2013, BIOCHEM BIOPH RES CO, V430, P769, DOI 10.1016/j.bbrc.2012.11.073; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Guerry P, 2012, METHODS MOL BIOL, V831, P429, DOI 10.1007/978-1-61779-480-3_22; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Lim J, 2011, INT J FOOD MICROBIOL, V149, P159, DOI 10.1016/j.ijfoodmicro.2011.06.017; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Llull D, 2011, J BACTERIOL, V193, P1919, DOI 10.1128/JB.01109-10; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Mulder FAA, 1998, J MAGN RESON, V131, P351, DOI 10.1006/jmre.1998.1380; Niemiec MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036102; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; PELTON JG, 1993, PROTEIN SCI, V2, P543; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Ragunathan P, 2009, ACTA CRYSTALLOGR D, V65, P1262, DOI 10.1107/S0907444909038359; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Reid SD, 2001, P NATL ACAD SCI USA, V98, P7552, DOI 10.1073/pnas.121188598; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Riboldi-Tunnicliffe A, 2005, FEBS LETT, V579, P5353, DOI 10.1016/j.febslet.2005.08.066; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Sabri M, 2009, INFECT IMMUN, V77, P1155, DOI 10.1128/IAI.01082-08; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Shafeeq S, 2013, MOL MICROBIOL, V88, P1047, DOI 10.1111/mmi.12256; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Shao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060116; Shao ZQ, 2011, FEMS MICROBIOL LETT, V314, P174, DOI 10.1111/j.1574-6968.2010.02162.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Van Melckebeke N, 2004, J AM CHEM SOC, V126, P9584, DOI 10.1021/ja0489644; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Zhang Y, 2001, INFECT IMMUN, V69, P3827, DOI 10.1128/IAI.69.6.3827-3836.2001	82	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81168	10.1371/journal.pone.0081168	http://dx.doi.org/10.1371/journal.pone.0081168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312273	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900024
J	Rachmany, L; Tweedie, D; Rubovitch, V; Yu, QS; Li, YZ; Wang, JY; Pick, CG; Greig, NH				Rachmany, Lital; Tweedie, David; Rubovitch, Vardit; Yu, Qian-Sheng; Li, Yazhou; Wang, Jia-Yi; Pick, Chaim G.; Greig, Nigel H.			Cognitive Impairments Accompanying Rodent Mild Traumatic Brain Injury Involve p53-Dependent Neuronal Cell Death and Are Ameliorated by the Tetrahydrobenzothiazole PFT-alpha	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; OBJECT RECOGNITION MEMORY; FLUORO-JADE-B; CEREBRAL-ISCHEMIA; P53-INDUCED APOPTOSIS; FUNCTIONAL OUTCOMES; GENE-EXPRESSION; HEAD-INJURY; P53; MECHANISMS	With parallels to concussive mild traumatic brain injury (mTBI) occurring in humans, anesthetized mice subjected to a single 30 g weight drop mTBI event to the right parietal cortex exhibited significant diffuse neuronal degeneration that was accompanied by delayed impairments in recognition and spatial memory. To elucidate the involvement of reversible p53-dependent apoptosis in this neuronal loss and associated cognitive deficits, mice were subjected to experimental mTBI followed by the systemic administration of the tetrahydrobenzothiazole p53 inactivator, PFT-alpha, or vehicle. Neuronal loss was quantified immunohistochemically at 72 hr. post-injury by the use of fluoro-Jade B and NeuN within the dentate gyrus on both sides of the brain, and recognition and spatial memory were assessed by novel object recognition and Y-maze paradigms at 7 and 30 days post injury. Systemic administration of a single dose of PFT-alpha 1 hr. post-injury significantly ameliorated both neuronal cell death and cognitive impairments, which were no different from sham control animals. Cellular studies on human SH-SY5Y cells and rat primary neurons challenged with glutamate excitotoxicity and H2O2 induced oxidative stress, confirmed the ability of PFT-alpha and a close analog to protect against these TBI associated mechanisms mediating neuronal loss. These studies suggest that p53-dependent apoptotic mechanisms underpin the neuronal and cognitive losses accompanying mTBI, and that these are potentially reversible by p53 inactivation.	[Rachmany, Lital; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Rachmany, Lital; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Tweedie, David; Yu, Qian-Sheng; Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Taipei Medical University	Pick, CG (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	pickc@post.tau.ac.il; Greign@grc.nia.nih.gov	Rachmany, Lital/GSN-9569-2022	Wang, Jia-Yi/0000-0002-9106-3351	Intramural Research Program of the National Institute on Aging, National Institutes of Health; National Science Council, Taiwan [NSC 101-2321-B-038-003, NSC 102-2321-B-038-003]; Sackler School of Medicine, Tel-Aviv University; Israeli Science Foundation [108/09]; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Sackler School of Medicine, Tel-Aviv University; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health (DT,QSY,NHG); (ii) grants from the National Science Council (NSC 101-2321-B-038-003 and NSC 102-2321-B-038-003), Taiwan (JYW); (iii) by the Sackler School of Medicine, Tel-Aviv University, and, in part, by a grant from the Israeli Science Foundation (grant no. 108/09) (LR,VR,CGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; CHOI DW, 1987, J NEUROSCI, V7, P357; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Culmsee C, 2003, J NEUROSCI, V23, P8586; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Davenport CM, 2010, J NEUROCHEM, V112, P552, DOI 10.1111/j.1471-4159.2009.06485.x; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Eve DJ, 2007, BRAIN RES, V1150, P174, DOI 10.1016/j.brainres.2007.02.088; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gudkov AV, 2007, HUM MOL GENET, V16, pR67, DOI 10.1093/hmg/ddm052; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hong MY, 2012, CHINESE MED J-PEKING, V125, P2019, DOI 10.3760/cma.j.issn.0366-6999.2012.11.032; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Nayak SK, 2009, CURR MED CHEM, V16, P2627, DOI 10.2174/092986709788681976; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Watanabe H, 1999, BRAIN RES, V837, P38, DOI 10.1016/S0006-8993(99)01652-2; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhu XX, 2002, J MED CHEM, V45, P5090, DOI 10.1021/jm020044d; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	87	57	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e79837	10.1371/journal.pone.0079837	http://dx.doi.org/10.1371/journal.pone.0079837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312187	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900003
J	Weide, B; Richter, S; Buttner, P; Leiter, U; Forschner, A; Bauer, J; Held, L; Eigentler, TK; Meier, F; Garbe, C				Weide, Benjamin; Richter, Sabina; Buettner, Petra; Leiter, Ulrike; Forschner, Andrea; Bauer, Juergen; Held, Laura; Eigentler, Thomas Kurt; Meier, Friedegund; Garbe, Claus			Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy	PLOS ONE			English	Article							STAGE-IV MELANOMA; AMERICAN JOINT COMMITTEE; MALIGNANT-MELANOMA; IMPROVED SURVIVAL; MARKER; LDH; S100-BETA; PROTEIN; S-100B; TRIALS	Background: Prognostic factors of melanoma with distant metastasis and systemic treatment are only poorly established. This study aimed to analyse the impact of S100B, lactate dehydrogenase (LDH) and the type of treatment on survival in advanced patients receiving systemic treatment. Patients and Methods: We analysed overall survival of 499 patients from the university department of dermatology in Tuebingen, Germany, with unresectable melanoma at the time point of initiation of first-line systemic therapy. Only patients who started treatment between the years 2000 and 2010 were included. Disease-specific survival was calculated by bivariate Kaplan Meier survival probabilities and multivariate Cox hazard regression analysis. Results: In univariate analysis LDH, S100B, the site of distant metastasis (soft tissue vs. lung vs. other visceral), the presence of brain metastases and the type of treatment (monochemotherapy, polychemotherapy, immunotherapy or biochemotherapy) were associated with overall survival (all p<0.001). In multivariate analysis LDH (Hazard ratio [HR] 1.6 [1.3-2.1]; p<0.001), S100B (HR 1.6 [1.2-2.1]; p<0.001) and the presence of brain metastases (HR 1.5 [1.1-1.9]; p = 0.009), but not the type of treatment had significant independent impact. Among those factors normal S100B was the best indicator of long-term survival, which was 12.3% after 5 years for this subgroup. Conclusion: Serum S100B is a prognostic marker predicting survival at the time of initiation of first-line treatment in unresectable melanoma patients. Compared to the other independent factors LDH and the presence of brain metastases it is most appropriate to predict long-term survival and requires further prospective investigation in patients treated with new and more potent drugs in metastatic melanoma.	[Weide, Benjamin; Richter, Sabina; Leiter, Ulrike; Forschner, Andrea; Bauer, Juergen; Held, Laura; Eigentler, Thomas Kurt; Meier, Friedegund; Garbe, Claus] Univ Med Ctr, Dept Dermatol, Tubingen, Germany; [Weide, Benjamin] German Canc Res Ctr, DKFZ, Heidelberg, Germany; [Weide, Benjamin] German Canc Consortium DKTK, Heidelberg, Germany; [Buettner, Petra; Garbe, Claus] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Skin Canc Res Grp, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); James Cook University	Weide, B (corresponding author), Univ Med Ctr, Dept Dermatol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	Eigentler, Thomas/K-8570-2015; Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Bauer, Jurgen/B-4656-2008	Eigentler, Thomas/0000-0003-0019-2770; Garbe, Claus/0000-0001-8530-780X; Leiter, Ulrike/0000-0002-8019-1577; Bauer, Jurgen/0000-0001-8789-1536				Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Balch CM, 2009, AJCC CANC STAGING MA, P325; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Egberts F, 2008, ONKOLOGIE, V31, P380, DOI 10.1159/000135492; Egberts F, 2012, EUR J CANCER, V48, P695, DOI 10.1016/j.ejca.2011.08.007; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; Eton O, 1998, J CLIN ONCOL, V16, P1103, DOI 10.1200/JCO.1998.16.3.1103; FINCK SJ, 1983, CANCER-AM CANCER SOC, V51, P840, DOI 10.1002/1097-0142(19830301)51:5<840::AID-CNCR2820510516>3.0.CO;2-7; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Hauschild A, 1999, MELANOMA RES, V9, P155, DOI 10.1097/00008390-199904000-00008; HEIMDAL K, 1989, EUR J CANCER CLIN ON, V25, P1219, DOI 10.1016/0277-5379(89)90418-5; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Lasithiotakis KG, 2007, CANCER-AM CANCER SOC, V109, P1174, DOI 10.1002/cncr.22511; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; Mohammed MQ, 2001, MED ONCOL, V18, P109; Ollila DW, 1996, ARCH SURG-CHICAGO, V131, P975; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schmidt H, 2005, MELANOMA RES, V15, P409, DOI 10.1097/00008390-200510000-00009; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; SIROTT MN, 1993, CANCER-AM CANCER SOC, V72, P3091, DOI 10.1002/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V; Smit LHM, 2005, EUR J CANCER, V41, P386, DOI 10.1016/j.ejca.2004.10.019; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Wasif N, 2011, J SURG ONCOL, V104, P111, DOI 10.1002/jso.21903; Weide B, 2012, BRIT J CANCER, V107, P422, DOI 10.1038/bjc.2012.306	28	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81624	10.1371/journal.pone.0081624	http://dx.doi.org/10.1371/journal.pone.0081624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312329	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327657900042
J	Li, NN; Tan, EK; Chang, XL; Mao, XY; Zhang, JH; Zhao, DM; Liao, Q; Yu, WJ; Peng, R				Li, Nan-Nan; Tan, Eng-King; Chang, Xue-Li; Mao, Xue-Ye; Zhang, Jin-Hong; Zhao, Dong-Mei; Liao, Qiao; Yu, Wen-Juan; Peng, Rong			Genetic Association Study between STK39 and CCDC62/HIP1R and Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK-FACTORS; IDENTIFICATION; SPAK; LOCI; METAANALYSIS; VARIANTS; KINASES; FAMILY; REGION	Background: The first large-scale meta-analysis of published genome-wide association studies (GWAS) in Parkinson's disease (PD) identified 5 new genetic loci (ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R). Very recently, a large-scale replication and heterogeneity study also reported that STK39 and CCDC62/HIP1R increased risk of PD in Asian and Caucasian populations. However, their roles still remain unclear in a Han Chinese population from mainland China. Methods: We examined genetic associations of STK39 rs2102808 and CCDC62/HIP1R rs12817488 with PD susceptibility in a Han Chinese population of 783 PD patients and 725 controls. We also performed further stratified analyses by the age of onset and accomplished in-depth clinical characteristics analyses between the different genotypes for each locus. Results: No significant differences were observed in the minor allele frequency (MAF) among cases and controls at the two loci (STK39 rs2102808: OR = 1.06, 95% CI = 0.91, 1.23, P = 0.467; CCDC62/HIP1R rs12817488: OR = 0.88, 95% CI = 0.76, 1.01, P = 0.072). Subgroup analyses by the age of onset also showed no significant differences among different subgroups of the two loci. In addition, minor allele carriers cannot be distinguished from non-carriers based on their clinical features at the two loci. Conclusions: We are unable to demonstrate the association between STK39 and CCDC62/HIP1R and PD susceptibility in a Han Chinese population from mainland China. Additional replication studies in other populations and functional studies are warranted to better validate the role of the two new loci in PD risk.	[Li, Nan-Nan; Chang, Xue-Li; Mao, Xue-Ye; Zhang, Jin-Hong; Zhao, Dong-Mei; Liao, Qiao; Yu, Wen-Juan; Peng, Rong] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China; [Tan, Eng-King] Singapore Gen Hosp, Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Tan, Eng-King] Duke NUS Grad Med Sch, Singapore, Singapore; [Zhang, Jin-Hong] Sichuan Univ, Wangjiang Hosp, Dept Internal Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; National Neuroscience Institute (NNI); Singapore General Hospital; National University of Singapore; Sichuan University	Peng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China.	qrpeng@hotmail.com			West China Hospital of Sichuan University; Duke-NUS Graduate Medical School; Singapore Millennium Foundation; National Medical Research Council	West China Hospital of Sichuan University(Sichuan University); Duke-NUS Graduate Medical School; Singapore Millennium Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by West China Hospital of Sichuan University, Duke-NUS Graduate Medical School, Singapore Millennium Foundation, and National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady RJ, 2010, J CELL SCI, V123, P3652, DOI 10.1242/jcs.066852; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Domae S, 2009, INT J CANCER, V124, P2347, DOI 10.1002/ijc.24220; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fritsch T, 2012, SOUTH MED J, V105, P650, DOI 10.1097/SMJ.0b013e318273a60d; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gottfried I, 2010, BIOCHEM SOC T, V38, P187, DOI 10.1042/BST0380187; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Kim JH, 2009, CELL PHYSIOL BIOCHEM, V23, P43, DOI 10.1159/000204088; Lauterbach EC, 2012, PARKINSONS DIS, V2012; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Pankratz N, 2007, GENET MED, V9, P801, DOI 10.1097/GIM.0b013e31815bf97c; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Park SJ, 2010, BMB REP, V43, P795, DOI 10.5483/BMBRep.2010.43.12.795; Parker JA, 2007, J NEUROSCI, V27, P11056, DOI 10.1523/JNEUROSCI.1941-07.2007; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Yan YT, 2011, J IMMUNOL, V187, P1496, DOI 10.4049/jimmunol.1002910	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79211	10.1371/journal.pone.0079211	http://dx.doi.org/10.1371/journal.pone.0079211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312176	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100007
J	Van Leeuwen, EJC; Cronin, KA; Schutte, S; Call, J; Haun, DBM				Van Leeuwen, Edwin J. C.; Cronin, Katherine A.; Schutte, Sebastian; Call, Josep; Haun, Daniel B. M.			Chimpanzees (Pan troglodytes) Flexibly Adjust Their Behaviour in Order to Maximize Payoffs, Not to Conform to Majorities	PLOS ONE			English	Article							TRANSMISSION; CHILDREN; CULTURE	Chimpanzees have been shown to be adept learners, both individually and socially. Yet, sometimes their conservative nature seems to hamper the flexible adoption of superior alternatives, even to the extent that they persist in using entirely ineffective strategies. In this study, we investigated chimpanzees' behavioural flexibility in two different conditions under which social animals have been predicted to abandon personal preferences and adopt alternative strategies: i) under influence of majority demonstrations (i.e. conformity), and ii) in the presence of superior reward contingencies (i.e. maximizing payoffs). Unlike previous nonhuman primate studies, this study disentangled the concept of conformity from the tendency to maintain one's first-learned strategy. Studying captive (n=16) and semi-wild (n=12) chimpanzees in two complementary exchange paradigms, we found that chimpanzees did not abandon their behaviour in order to match the majority, but instead remained faithful to their first-learned strategy (Study 1a and 1b). However, the chimpanzees' fidelity to their first-learned strategy was overridden by an experimental upgrade of the profitability of the alternative strategy (Study 2). We interpret our observations in terms of chimpanzees' relative weighing of behavioural options as a function of situation-specific trade-offs. More specifically, contrary to previous findings, chimpanzees in our study abandoned their familiar behaviour to maximize payoffs, but not to conform to a majority.	[Van Leeuwen, Edwin J. C.; Cronin, Katherine A.] Max Planck Inst Psycholinguist, Max Planck Res Grp Comparat Cognit Anthropol, Nijmegen, Netherlands; [Schutte, Sebastian; Call, Josep] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Max Planck Res Grp Comparat Cognit Anthropol, Leipzig, Germany; [Haun, Daniel B. M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Haun, Daniel B. M.] Univ Portsmouth, Portsmouth, Hants, England	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; University of Portsmouth	Van Leeuwen, EJC (corresponding author), Max Planck Inst Psycholinguist, Max Planck Res Grp Comparat Cognit Anthropol, Nijmegen, Netherlands.	Edwin.vanleeuwen@mpi.nl		Call Balaguer, Josep/0000-0002-8597-8336	Max Planck Institute for Psycholinguistics; Max Planck Institute for Evolutionary Psychology; Netherlands Organization for Scientific Research	Max Planck Institute for Psycholinguistics(Max Planck Society); Max Planck Institute for Evolutionary Psychology(Max Planck Society); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The present study was financially supported by the Max Planck Institute for Psycholinguistics, the Max Planck Institute for Evolutionary Psychology and the Netherlands Organization for Scientific Research (KAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Bonnie KE, 2012, AM J PRIMATOL, V74, P661, DOI 10.1002/ajp.22020; Boyd R., 1985, CULTURE EVOLUTIONARY; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Hanus D, 2011, ANIM COGN, V14, P871, DOI 10.1007/s10071-011-0421-6; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Haun DBM, 2013, DEV COGN NEUROS-NETH, V3, P61, DOI 10.1016/j.dcn.2012.09.003; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; Kendal Rachel L., 2009, P249; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Laland KN, 2004, LEARN BEHAV, V32, P4; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; MCFARLAND DJ, 1977, NATURE, V269, P15, DOI 10.1038/269015a0; Mesoudi A, 2011, CULTURAL EVOLUTION D; Pesendorfer MB, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004472, DOI 10.1371/J0URNAL.P0NE.0004472]; Price EE, 2009, P ROY SOC B-BIOL SCI, V276, P3377, DOI 10.1098/rspb.2009.0640; Ron T., 1988, Primate Conservation, P37; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Schrauf C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041044; van Leeuwen EJC, 2013, EVOL HUM BEHAV, V34, P1, DOI 10.1016/j.evolhumbehav.2012.07.005; van Leeuwen EJC, 2012, P ROY SOC B-BIOL SCI, V279, P4362, DOI 10.1098/rspb.2012.1543; Volter CJ, 2012, ANIM COGN, V15, P923, DOI 10.1007/s10071-012-0519-5; Weatherall D., 2006, USE NONHUMAN PRIMATE; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Yamamoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055768	36	48	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80945	10.1371/journal.pone.0080945	http://dx.doi.org/10.1371/journal.pone.0080945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312252	Green Published, gold			2022-12-25	WOS:000327652100056
J	Hung, PS; Liu, CJ; Chou, CS; Kao, SY; Yang, CC; Chang, KW; Chiu, TH; Lin, SC				Hung, Pei-Shi; Liu, Chung-Ji; Chou, Chung-Shan; Kao, Shou-Yen; Yang, Cheng-Chieh; Chang, Kuo-Wei; Chiu, Ting-Hui; Lin, Shu-Chun			miR-146a Enhances the Oncogenicity of Oral Carcinoma by Concomitant Targeting of the IRAK1, TRAF6 and NUMB Genes	PLOS ONE			English	Article							NF-KAPPA-B; CELL-PROLIFERATION; HUMAN HEAD; TGF-BETA; MICRORNAS; CANCER; SUPPRESSES; EXPRESSION; TUMOR; DIFFERENTIATION	MicroRNAs are short non-coding RNAs that regulate gene expression and are crucial to tumorigenesis. Oral squamous cell carcinoma (OSCC) is a prevalent malignancy worldwide. Up-regulation of miR-146 has been identified in OSCC tissues. However, the roles of miR-146 in carcinogenesis are controversial as it is suppressive in many other malignancies. The present study investigated the pathogenic implications of miR-146a in oral carcinogenesis. Microdissected OSCC exhibits higher levels of miR-146a expression than matched adjacent mucosal cells. The plasma miR-146a levels of patients are significantly higher than those of control subjects; these levels decrease drastically after tumor resection. miR-146a levels in tumors and in patients' plasma can be used to classify OSCC and non-disease status (sensitivity: >0.72). Exogenous miR-146a expression is significantly increased in vitro oncogenic phenotypes as well as during xenograft tumorigenesis and OSCC metastasis. The plasma miR-146a levels of these mice parallel the xenograft tumor burdens of the mice. A miR-146a blocker abrogates the growth of xenograft tumors. miR-146a oncogenic activity is associated with down-regulation of IRAK1, TRAF6 and NUMB expression. Furthermore, miR-146a directly targets the 3'UTR of NUMB and a region within the NUMB coding sequence when suppressing NUMB expression. Exogenous NUMB expression attenuates OSCC oncogenicity. Double knockdown of IRAK1 and TRAF6, and of TRAF6 and NUMB, enhance the oncogenic phenotypes of OSCC cells. Oncogenic enhancement modulated by miR-146a expression is attenuated by exogenous IRAK1 or NUMB expression. This study shows that miR-146a expression contributes to oral carcinogenesis by targeting the IRAK1, TRAF6 and NUMB genes.	[Hung, Pei-Shi] Natl Yang Ming Univ Hosp, Dept Surg, Yi Lan, Taiwan; [Hung, Pei-Shi] Natl Yang Ming Univ Hosp, Dept Med Res, Yi Lan, Taiwan; [Hung, Pei-Shi; Liu, Chung-Ji; Chou, Chung-Shan; Kao, Shou-Yen; Yang, Cheng-Chieh; Chang, Kuo-Wei; Chiu, Ting-Hui; Lin, Shu-Chun] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Liu, Chung-Ji; Kao, Shou-Yen; Yang, Cheng-Chieh; Chang, Kuo-Wei; Lin, Shu-Chun] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Liu, Chung-Ji] Taipei Mackay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Kao, Shou-Yen; Yang, Cheng-Chieh; Chang, Kuo-Wei; Lin, Shu-Chun] Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taipei Veterans General Hospital	Lin, SC (corresponding author), Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan.	sclin@ym.edu.tw			National Science Council [NSC99-2628-B-010-012-MY3, NSC99-2628-B-010-013-MY3]; Taipei Veterans General Hospital [V99C1-083]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants NSC99-2628-B-010-012-MY3 and NSC99-2628-B-010-013-MY3 from National Science Council and Taipei Veterans General Hospital Grant V99C1-083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2008, ONCOGENE; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen HZ, 2009, PATHOBIOLOGY, V76, P149, DOI 10.1159/000209393; Chen YT, 2008, MODERN PATHOL, V21, P1139, DOI 10.1038/modpathol.2008.105; Chung CH, 2011, J CLIN ONCOL, V29, P1326, DOI 10.1200/JCO.2010.32.3295; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; He Y, 2012, CELL SIGNAL, V24, P1923, DOI 10.1016/j.cellsig.2012.06.003; Hou ZB, 2012, MOL MED REP, V6, P501, DOI 10.3892/mmr.2012.946; Hung PS, 2010, J DENT RES, V89, P252, DOI 10.1177/0022034509357411; Hung PS, 2008, J PATHOL, V214, P368, DOI 10.1002/path.2280; Hung PS, 2012, ORAL ONCOL, V48, P404, DOI 10.1016/j.oraloncology.2011.11.019; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jiang XL, 2012, STEM CELLS, V30, P1313, DOI 10.1002/stem.1120; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin SC, 2005, INT J CANCER, V116, P526, DOI 10.1002/ijc.21104; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Lu HH, 2008, J DENT RES, V87, P1069, DOI 10.1177/154405910808701111; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195	56	88	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e79926	10.1371/journal.pone.0079926	http://dx.doi.org/10.1371/journal.pone.0079926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302991	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400007
J	Hou, Y; Gao, J; Xu, H; Xu, Y; Zhang, Z; Xu, Q; Zhang, C				Hou, Y.; Gao, J.; Xu, H.; Xu, Y.; Zhang, Z.; Xu, Q.; Zhang, C.			PPAR gamma E3 ubiquitin ligase regulates MUC1-C oncoprotein stability	ONCOGENE			English	Article						PPAR gamma; MUC1-C; ubiquitin; degradation; ubiquitination; cancer	NF-KAPPA-B; RECEPTOR-GAMMA; COLON-CANCER; CELLS; TRANSCRIPTION; EXPRESSION; DEGRADATION; ACTIVATION; LIGANDS; DOMAIN	MUC1-C oncoprotein is associated with colon, breast, ovarian, lung and pancreatic cancers. MUC1-C interacts with intracellular proteins to elicit signaling cascades that induce cell proliferation and tumor growth. Here we report that peroxisome proliferator-activated receptor gamma (PPAR gamma), an E3 ubiquitin ligase, is an inhibitor of MUC1-C-mediated cell proliferation. PPAR gamma does so by binding to and inducing MUC1-C proteasome-dependent degradation that was independent of PPAR gamma transcriptional activity. Lys134 residue was found to be critically important for PPAR gamma-mediated MUC1-C degradation, as it terminated MUC1-C-mediated cell proliferation. These findings demonstrate PPAR gamma induces MUC1-C ubiquitination and degradation that is critical to terminate MUC1-C signaling pathway-elicited cancer.	[Hou, Y.; Gao, J.; Xu, H.; Xu, Y.; Zhang, Z.; Xu, Q.; Zhang, C.] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China	Jiangsu University	Hou, Y (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China.	houyz@mail.ujs.edu.cn	hou, YONGZHONG/K-7771-2013	xu, qinggang/0000-0002-8659-7041; Hou, Yongzhong/0000-0003-2019-8686	Jiangsu Province Natural Science Foundation [SBK201320232]; Start Fund of University of JiangSu [12JDG071]	Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Start Fund of University of JiangSu	This work was supported by Jiangsu Province Natural Science Foundation (SBK201320232) and Start Fund of University of JiangSu (12JDG071).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2012, J BIOL CHEM, V287, P20866, DOI 10.1074/jbc.M112.357293; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Heaney AP, 2003, J CLIN INVEST, V111, P1381, DOI 10.1172/JCI200316575; Hou Y, 2014, ONCOGENE, V33, P1997, DOI 10.1038/onc.2013.135; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kufe DW, 2008, CANCER BIOL THER, V7, P81, DOI 10.4161/cbt.7.1.5631; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Ogino S, 2009, GASTROENTEROLOGY, V136, P1242, DOI 10.1053/j.gastro.2008.12.048; Park YS, 2012, AM J PHYSIOL-GASTR L, V303, pG765, DOI 10.1152/ajpgi.00023.2012; Park YS, 2012, AM J PHYSIOL-LUNG C, V302, P1679, DOI 10.1152/ajplung.00360.2011; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Uchida Y, 2013, CANCER BIOL THER, V14, P127, DOI 10.4161/cbt.22634; Wang P, 2010, MOL ENDOCRINOL, V24, P1368, DOI 10.1210/me.2009-0221; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008	33	31	32	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5619	5625		10.1038/onc.2013.504	http://dx.doi.org/10.1038/onc.2013.504			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24292674				2022-12-25	WOS:000346088700006
J	Zhong, J; Cao, RX; Liu, JH; Liu, YB; Wang, J; Liu, LP; Chen, YJ; Yang, J; Zhang, QH; Wu, Y; Ding, WJ; Hong, T; Xiao, XH; Zu, XY; Wen, GB				Zhong, J.; Cao, R-X; Liu, J-H; Liu, Y-B; Wang, J.; Liu, L-P; Chen, Y-J; Yang, J.; Zhang, Q-H; Wu, Y.; Ding, W-J; Hong, T.; Xiao, X-H; Zu, X-Y; Wen, G-B			Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein	ONCOGENE			English	Article						nuclear loss; PRMT2; cyclin D1; breast cancer	ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; KAPPA-B; IN-VIVO; CANCER; IDENTIFICATION; METHYLATION; PROMOTER; PRMT2; CELL	Human protein arginine N-methyltransferase 2 (PRMT2, HRMT1L1) is a protein that belongs to the arginine methyltransferase family, and it has diverse roles in transcriptional regulation through different mechanisms depending on its binding partners. In this study, we provide evidences for the negative effect of PRMT2 on breast cancer cell proliferation in vitro and in vivo. Morever, cyclin D1, one of the key modulators of cell cycle, was found to be downregulated by PRMT2, and PRMT2 was further shown to suppress the estrogen receptor alpha-binding affinity to the activator protein-1 (AP-1) site in cyclin D1 promoter through indirect binding with AP-1 site, resulting in the inhibition of cyclin D1 promoter activity in MCF-7 cells. Furthermore, a positive correlation between the expression of PRMT2 and cyclin D1 was confirmed in the breast cancer tissues by using tissue microarray assay. In addition, PRMT2 was found to show a high absent percentage in breast caner cell nuclei and the nuclear loss ratio of PRMT2 was demonstrated to positively correlate with cyclin D1 expression and the increasing tumor grade of invasive ductal carcinoma. Those results offer an essential insight into the effect of PRMT2 on breast carcinogenesis, and PRMT2 nuclear loss might be an important biological marker for the diagnosis of breast cancer.	[Zhong, J.; Cao, R-X; Liu, J-H; Liu, Y-B; Wang, J.; Liu, L-P; Chen, Y-J; Yang, J.; Zhang, Q-H; Wu, Y.; Ding, W-J; Hong, T.; Xiao, X-H; Zu, X-Y; Wen, G-B] Univ South China, Affiliated Hosp 1, Inst Clin Med, 69 Chuanshan Rd, Hengyang 421001, Peoples R China; [Cao, R-X; Liu, J-H; Yang, J.; Hong, T.; Xiao, X-H] Univ South China, Affiliated Hosp 1, Dept Metab & Endocrinol, Hengyang 421001, Peoples R China	University of South China; University of South China	Zu, XY (corresponding author), Univ South China, Affiliated Hosp 1, Inst Clin Med, 69 Chuanshan Rd, Hengyang 421001, Peoples R China.	zuxuyu0108@hotmail.com; wen_gb@hotmail.com	Zhong, Jing/M-1057-2018	Zhong, Jing/0000-0003-4593-4897	National Natural Science Foundation of P.R.China [31200573, 81272906, 81272355, 81172542]; Hunan Provincial Natural Science Foundation of China [12JJ3116]; Education Department of Hunan Province Youth Fund [12B108]	National Natural Science Foundation of P.R.China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Education Department of Hunan Province Youth Fund	This work is supported by projects from the National Natural Science Foundation of P.R.China (Grant No. 31200573, 81272906, 81272355 and 81172542), Hunan Provincial Natural Science Foundation of China (12JJ3116) and The Education Department of Hunan Province Youth Fund (12B108).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartusel T, 2005, GENE, V351, P171, DOI 10.1016/j.gene.2005.03.035; Besson V, 2007, HUM MOL GENET, V16, P2040, DOI 10.1093/hmg/ddm152; Blythe SA, 2010, DEV CELL, V19, P220, DOI 10.1016/j.devcel.2010.07.007; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Ferguson AT, 1997, CRIT REV ONCOGENESIS, V8, P29, DOI 10.1615/CritRevOncog.v8.i1.20; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Ganesh L, 2006, MOL CELL BIOL, V26, P3864, DOI 10.1128/MCB.26.10.3864-3874.2006; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Iwasaki H, 2010, CIRC RES, V107, P992, DOI 10.1161/CIRCRESAHA.110.225326; Katsanis N, 1997, MAMM GENOME, V8, P526, DOI 10.1007/s003359900491; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P194; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lukong KE, 2004, NAT STRUCT MOL BIOL, V11, P914, DOI 10.1038/nsmb1004-914; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Steeg PS, 1998, BREAST CANCER RES TR, V52, P17, DOI 10.1023/A:1006102916060; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Ye XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055615; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Yildirim AO, 2006, AM J RESP CELL MOL, V35, P436, DOI 10.1165/rcmb.2006-0097OC; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Zhong J, 2012, FEBS J, V279, P316, DOI 10.1111/j.1742-4658.2011.08426.x; Zhong J, 2011, GENE, V487, P1, DOI 10.1016/j.gene.2011.06.022; Zu XY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2843	57	25	28	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5546	5558		10.1038/onc.2013.500	http://dx.doi.org/10.1038/onc.2013.500			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24292672				2022-12-25	WOS:000346087900007
J	Wolf, J; Muller-Decker, K; Flechtenmacher, C; Zhang, F; Shahmoradgoli, M; Mills, GB; Hoheisel, JD; Boettcher, M				Wolf, J.; Mueller-Decker, K.; Flechtenmacher, C.; Zhang, F.; Shahmoradgoli, M.; Mills, G. B.; Hoheisel, J. D.; Boettcher, M.			An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation	ONCOGENE			English	Article						In vivo RNAi screening; shRNA screen; tumor suppressor; SALL1; CDH1; EMT	EPITHELIAL-MESENCHYMAL TRANSITION; TOWNES-BROCKS-SYNDROME; EXPRESSION; CELLS; CARCINOMAS; MUTATIONS; MOESIN; GENES	The gold standard for determining the tumorigenic potential of human cancer cells is a xenotransplantation into immunodeficient mice. Higher tumorigenicity of cells is associated with earlier tumor onset. Here, we used xenotransplantation to assess the tumorigenic potential of human breast cancer cells following RNA interference-mediated inhibition of over 5000 genes. We identify 16 candidate tumor suppressors, one of which is the zinc-finger transcription factor SALL1. Analyzing this particular molecule in more detail, we show that inhibition of SALL1 correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. Also, SALL1 expression correlates with the survival of breast cancer patients. These findings cast new light on a gene that has previously been described to be relevant during embryogenesis, but not carcinogenesis.	[Wolf, J.; Hoheisel, J. D.; Boettcher, M.] Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-69120 Heidelberg, Germany; [Mueller-Decker, K.] Deutsch Krebsforschungszentrum, Core Facil Tumor Models, D-69120 Heidelberg, Germany; [Flechtenmacher, C.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Zhang, F.; Shahmoradgoli, M.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Texas System; UTMD Anderson Cancer Center	Hoheisel, JD (corresponding author), Deutsch Krebsforschungszentrum, Div Funct Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	j.hoheisel@dkfz.de		Boettcher, Michael/0000-0003-0986-4465	DKFZ; DKFZ PhD scholarship; NIH [44RR024095, 44HG003355]	DKFZ(Helmholtz Association); DKFZ PhD scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the DKFZ intramural funding program awarded to MB, and a DKFZ PhD scholarship awarded to JW. Lentiviral shRNA libraries were kindly provided and developed by Cellecta based on NIH-funded research grant support 44RR024095, 44HG003355.	Argos M, 2008, CANCER GENET CYTOGEN, V182, P69, DOI 10.1016/j.cancergencyto.2008.01.001; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fredebohm J, 2013, J CELL SCI, V126, P3380, DOI 10.1242/jcs.124768; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Hsu TH, 2012, FEBS LETT, V586, P1287, DOI 10.1016/j.febslet.2012.03.020; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Kiefer SM, 2010, DEVELOPMENT, V137, P3099, DOI 10.1242/dev.037812; Kohlhase J, 2000, HUM MUTAT, V16, P460, DOI 10.1002/1098-1004(200012)16:6<460::AID-HUMU2>3.0.CO;2-4; Krelin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062124; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	34	28	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4273	4278		10.1038/onc.2013.515	http://dx.doi.org/10.1038/onc.2013.515			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24292671	Green Accepted, hybrid			2022-12-25	WOS:000341155800009
J	Murase, T; Eugenio, L; Schorr, M; Hussack, G; Tanha, J; Kitova, EN; Klassen, JS; Ng, KKS				Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Hussack, Greg; Tanha, Jamshid; Kitova, Elena N.; Klassen, John S.; Ng, Kenneth K. S.			Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Bacterial Toxins; Mass Spectrometry (MS); Protein-Protein Interactions; X-ray Crystallography	MONOCLONAL-ANTIBODIES; MAXIMUM-LIKELIHOOD; INFECTION; MODEL; TCDA; REPEATS; DISEASE	Clostridium difficile infection is a serious and highly prevalent nosocomial disease in which the two large, Rho-glucosylating toxins TcdA and TcdB are the main virulence factors. We report for the first time crystal structures revealing how neutralizing and non-neutralizing single-domain antibodies (sdAbs) recognize the receptor-binding domains (RBDs) of TcdA and TcdB. Surprisingly, the complexes formed by two neutralizing antibodies recognizing TcdA do not show direct interference with the previously identified carbohydrate-binding sites, suggesting that neutralization of toxin activity may be mediated by mechanisms distinct from steric blockage of receptor binding. A camelid sdAb complex also reveals the molecular structure of the TcdB RBD for the first time, facilitating the crystallization of a strongly negatively charged protein fragment that has resisted previous attempts at crystallization and structure determination. Electrospray ionization mass spectrometry measurements confirm the stoichiometries of sdAbs observed in the crystal structures. These studies indicate how key epitopes in the RBDs from TcdA and TcdB are recognized by sdAbs, providing molecular insights into toxin structure and function and providing for the first time a basis for the design of highly specific toxin-specific therapeutic and diagnostic agents.	[Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Ng, Kenneth K. S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada; [Hussack, Greg; Tanha, Jamshid] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Calgary; University of Calgary; National Research Council Canada; University of Ottawa; University of Alberta; University of Alberta	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Klassen, John/0000-0002-3389-7112; Ng, Kenneth K.S./0000-0001-7280-8445	National Institutes of Health [P41GM103393, P41RR001209]; Department of Energy Office of Biological and Environmental Research; Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103393 and P41RR001209 (to the Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program). This work was also supported by funds from Department of Energy Office of Biological and Environmental Research (to the Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program), the Alberta Glycomics Centre and Discovery grants from the Natural Sciences and Engineering Research Council of Canada (to K. K. S. N. and J. S. K.), and the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan (to Beamline 08-ID-1).	Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Ballard JD, 2010, NATURE, V467, P665, DOI 10.1038/467665a; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; El-Hawiet A, 2011, GLYCOBIOLOGY, V21, P1217, DOI 10.1093/glycob/cwr055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerding DN, 2012, DISCOV MED, V13, P75; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hussack Greg, 2012, Methods Mol Biol, V911, P211, DOI 10.1007/978-1-61779-968-6_14; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; Lin H, 2012, J AM SOC MASS SPECTR, V23, P2122, DOI 10.1007/s13361-012-0483-y; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	39	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2331	2343		10.1074/jbc.M113.505917	http://dx.doi.org/10.1074/jbc.M113.505917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311789	Green Published, hybrid			2022-12-25	WOS:000331130200037
J	Lee, P; Bax, DV; Bilek, MMM; Weiss, AS				Lee, Pearl; Bax, Daniel V.; Bilek, Marcela M. M.; Weiss, Anthony S.			A Novel Cell Adhesion Region in Tropoelastin Mediates Attachment to Integrin alpha(V)beta(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Elastin; Extracellular Matrix; Fibroblast; Integrin; Dermal Fibroblast; Multiple Integrins; Tropoelastin	INCREASED EXPRESSION; ELASTIN; BINDING; PROTEIN; ALPHA-V-BETA-5; FIBROBLASTS; INHIBITION; MIGRATION	Background: Cellular integrin (V3) binds to RKRK at the C-terminal tail of tropoelastin. Results: Inhibition of integrin (V5) hinders cell adhesion to tropoelastin constructs comprising domains 17 and 18. Conclusion: Integrin (V5) mediates cell adhesion to tropoelastin through a central region. Significance: Understanding the cell adhesion activity of tropoelastin gives improved insight into the physiological and pathological cell responses to this protein. Tropoelastin protein monomers assemble to form elastin. Cellular integrin (V3) binds RKRK at the C-terminal tail of tropoelastin. We probed cell interactions with tropoelastin by deleting the RKRK sequence to identify other cell-binding interactions within tropoelastin. We found a novel human dermal fibroblast attachment and spreading site on tropoelastin that is located centrally in the molecule. Inhibition studies demonstrated that this cell adhesion was not mediated by either elastin-binding protein or glycosaminoglycans. Cell interactions were divalent cation-dependent, indicating integrin dependence. Function-blocking monoclonal antibodies revealed that (V) integrin(s) and integrin (V5) specifically were critical for cell adhesion to this part of tropoelastin. These data reveal a common (V) integrin-binding theme for tropoelastin: (V3) at the C terminus and (V5) at the central region of tropoelastin. Each (V) region contributes to fibroblast attachment and spreading, but they differ in their effects on cytoskeletal assembly.	[Lee, Pearl; Bax, Daniel V.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Darlington, NSW 2006, Australia; [Bax, Daniel V.; Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Darlington, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Darlington, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Darlington, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Weiss, AS (corresponding author), Univ Sydney, Sch Mol Biosci, Darlington, NSW 2006, Australia.	tony.weiss@sydney.edu.au	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; Bilek, Marcela/0000-0003-3363-2664	National Institutes of Health [EB014283]; Australian Research Council; Australian Defense Health Foundation; National Health and Medical Research Council; Australian Postgraduate Research Award Ph.D. scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian Defense Health Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Research Award Ph.D. scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB014283 (to A. S. W.). This work was also supported by the Australian Research Council, the Australian Defense Health Foundation, and the National Health and Medical Research Council (to A. S. W.) and by an Australian Postgraduate Research Award Ph.D. scholarship (to P. L.). A. S. W. is the scientific founder of Elastagen Pty. Ltd.	Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p; AOTA S, 1994, J BIOL CHEM, V269, P24756; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2004, AM J PATHOL, V164, P1275, DOI 10.1016/S0002-9440(10)63215-4; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Humphries MJ, 2001, SCIENCE, V294, P316, DOI 10.1126/science.1066240; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Sinanan ACM, 2008, BIOL CELL, V100, P465, DOI 10.1042/BC20070115; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Trikha M, 2004, INT J CANCER, V110, P326, DOI 10.1002/ijc.20116; von Ballmoos MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014107; Wachi H, 2007, BIOCHEM J, V402, P63, DOI 10.1042/BJ20061145; Wang L., 2012, PLOS ONE, V7; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	35	54	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1467	1477		10.1074/jbc.M113.518381	http://dx.doi.org/10.1074/jbc.M113.518381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293364	Green Published, hybrid			2022-12-25	WOS:000332401700023
J	Arbing, MA; Chan, S; Harris, L; Kuo, E; Zhou, TNT; Ahn, CJ; Nguyen, L; He, QX; Lu, JM; Menchavez, PT; Shin, A; Holton, T; Sawaya, MR; Cascio, D; Eisenberg, D				Arbing, Mark A.; Chan, Sum; Harris, Liam; Kuo, Emmeline; Zhou, Tina T.; Ahn, Christine J.; Lin Nguyen; He, Qixin; Lu, Jamie; Menchavez, Phuong T.; Shin, Annie; Holton, Thomas; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David			Heterologous Expression of Mycobacterial Esx Complexes in Escherichia coli for Structural Studies Is Facilitated by the Use of Maltose Binding Protein Fusions	PLOS ONE			English	Article							RECOMBINANT PROTEINS; CRYSTAL-STRUCTURE; DNA TRANSFER; TUBERCULOSIS; SOLUBILITY; SIGNAL; SECRETION; SEQUENCE; GENOMICS; RD1	The expression of heteroligomeric protein complexes for structural studies often requires a special coexpression strategy. The reason is that the solubility and proper folding of each subunit of the complex requires physical association with other subunits of the complex. The genomes of pathogenic mycobacteria encode many small protein complexes, implicated in bacterial fitness and pathogenicity, whose characterization may be further complicated by insolubility upon expression in Escherichia coli, the most common heterologous protein expression host. As protein fusions have been shown to dramatically affect the solubility of the proteins to which they are fused, we evaluated the ability of maltose binding protein fusions to produce mycobacterial Esx protein complexes. A single plasmid expression strategy using an N-terminal maltose binding protein fusion to the CFP-10 homolog proved effective in producing soluble Esx protein complexes, as determined by a small-scale expression and affinity purification screen, and coupled with intracellular proteolytic cleavage of the maltose binding protein moiety produced protein complexes of sufficient purity for structural studies. In comparison, the expression of complexes with hexahistidine affinity tags alone on the CFP-10 subunits failed to express in amounts sufficient for biochemical characterization. Using this strategy, six mycobacterial Esx complexes were expressed, purified to homogeneity, and subjected to crystallization screening and the crystal structures of the Mycobacterium abscessus EsxEF, M. smegmatis EsxGH, and M. tuberculosis EsxOP complexes were determined. Maltose binding protein fusions are thus an effective method for production of Esx complexes and this strategy may be applicable for production of other protein complexes.	[Arbing, Mark A.; Chan, Sum; Harris, Liam; Kuo, Emmeline; Zhou, Tina T.; Ahn, Christine J.; Lin Nguyen; He, Qixin; Lu, Jamie; Menchavez, Phuong T.; Shin, Annie; Holton, Thomas; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Eisenberg, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Eisenberg, David] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043; He, Cyndi/0000-0002-3143-6435	Howard Hughes Medical Institute; National Institutes of Health [23616-002-06 F3:02, TBSGC R01 (A1068135), TBSGC P01 (AI095208)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute (www.hhmi.org) and National Institutes of Health (www.nih.gov) grants 23616-002-06 F3:02, TBSGC R01 (A1068135), and TBSGC P01 (AI095208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Arbing MA, 2010, PROTEIN SCI, V19, P1692, DOI 10.1002/pro.451; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Austin Brian R., 2009, V498, P157, DOI 10.1007/978-1-59745-196-3_11; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chim N, 2011, TUBERCULOSIS, V91, P155, DOI 10.1016/j.tube.2010.11.009; Chou YT, 2005, J BIOL CHEM, V280, P32753, DOI 10.1074/jbc.M507532200; Christendat D, 2000, PROG BIOPHYS MOL BIO, V73, P339, DOI 10.1016/S0079-6107(00)00010-9; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ergin A, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-18; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kataeva I, 2005, J PROTEOME RES, V4, P1942, DOI 10.1021/pr050108j; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Nallamsetty S, 2007, BIOCHEM BIOPH RES CO, V364, P639, DOI 10.1016/j.bbrc.2007.10.060; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Poulsen C, 2010, FEBS LETT, V584, P669, DOI 10.1016/j.febslet.2009.12.057; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	64	17	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81753	10.1371/journal.pone.0081753	http://dx.doi.org/10.1371/journal.pone.0081753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312350	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300048
J	Guerriero, G; Silvestrini, L; Obersriebnig, M; Salerno, M; Pum, D; Strauss, J				Guerriero, Gea; Silvestrini, Lucia; Obersriebnig, Michael; Salerno, Marco; Pum, Dietmar; Strauss, Joseph			Sensitivity of Aspergillus nidulans to the Cellulose Synthase Inhibitor Dichlobenil: Insights from Wall-Related Genes' Expression and Ultrastructural Hyphal Morphologies	PLOS ONE			English	Article							MOTOR-LIKE DOMAIN; V CHITIN SYNTHASE; ATOMIC-FORCE MICROSCOPY; FUNGAL CELL-WALL; BETA-GLUCAN; CLASS-I; CANDIDA-ALBICANS; CHSB EXPRESSION; PLASMA-MEMBRANE; STRESS SENSORS	The fungal cell wall constitutes an important target for the development of antifungal drugs, because of its central role in morphogenesis, development and determination of fungal-specific molecular features. Fungal walls are characterized by a network of interconnected glycoproteins and polysaccharides, namely alpha-, beta-glucans and chitin. Cell walls promptly and dynamically respond to environmental stimuli by a signaling mechanism, which triggers, among other responses, modulations in wall biosynthetic genes' expression. Despite the absence of cellulose in the wall of the model filamentous fungus Aspergillus nidulans, we found in this study that fungal growth, spore germination and morphology are affected by the addition of the cellulose synthase inhibitor dichlobenil. Expression analysis of selected genes putatively involved in cell wall biosynthesis, carried out at different time points of drug exposure (i.e. 0, 1, 3, 6 and 24 h), revealed increased expression for the putative mixed linkage beta-1,3; 1,4 glucan synthase celA together with the beta-1,3-glucan synthase fksA and the Rho-related GTPase rhoA. We also compared these data with the response to Congo Red, a known plant/fungal drug affecting both chitin and cellulose biosynthesis. The two drugs exerted different effects at the cell wall level, as shown by gene expression analysis and the ultrastructural features observed through atomic force microscopy and scanning electron microscopy. Although the concentration of dichlobenil required to affect growth of A. nidulans is approximately 10-fold higher than that required to inhibit plant cellulose biosynthesis, our work for the first time demonstrates that a cellulose biosynthesis inhibitor affects fungal growth, changes fungal morphology and expression of genes connected to fungal cell wall biosynthesis.	[Guerriero, Gea; Silvestrini, Lucia; Strauss, Joseph] Univ Nat Resources & Life Sci Vienna BOKU, Fungal Genet & Genom Unit, Dept Appl Genet & Cell Biol, Tulln Donau, Austria; [Obersriebnig, Michael] Univ Nat Resources & Life Sci Vienna BOKU, Inst Wood Sci & Technol, Tulln Donau, Austria; [Salerno, Marco] Ist Italiano Tecnol, Nanophys Dept, Genoa, Italy; [Pum, Dietmar] Univ Nat Resources & Life Sci Vienna BOKU, Inst Biophys, Dept Nanobiotechnol, Vienna, Austria; [Strauss, Joseph] Austrian Inst Technol GmbH AIT, Hlth & Environm Dept, Belvaux, Luxembourg	Istituto Italiano di Tecnologia - IIT; University of Natural Resources & Life Sciences, Vienna	Guerriero, G (corresponding author), Ctr Rech Publ Gabriel Lippmann, Dept Environm & Agrobiotechnol EVA, Belvaux, Luxembourg.	guerrier@lippmann.lu; joseph.strauss@boku.ac.at	Salerno, Marco/E-8309-2011; Guerriero, Gea/B-4883-2013; Silvestrini, Lucia/GZG-9705-2022	Salerno, Marco/0000-0003-4522-828X; Guerriero, Gea/0000-0001-6586-6997; Silvestrini, Lucia/0000-0002-0476-2358; Strauss, Joseph/0000-0003-0474-6267	Austrian Science Fund (FWF) [M1315]; FFG-COMET Project [825339/PVM]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FFG-COMET Project	GG was supported by the Austrian Science Fund (FWF; http://www.fwf.ac.at/en/), grant number M1315. Work in the Fungal Genetics and Genomics Unit was supported by the FFG-COMET Project "825339/PVM'' to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; ARAD SM, 1993, J PHYCOL, V29, P309, DOI 10.1111/j.0022-3646.1993.00309.x; ARAD SM, 1994, PHYCOLOGIA, V33, P158, DOI 10.2216/i0031-8884-33-3-158.1; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; Bischoff V, 2009, J EXP BOT, V60, P955, DOI 10.1093/jxb/ern344; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; BORGIA PT, 1992, J BACTERIOL, V174, P377, DOI 10.1128/jb.174.2.377-383.1992; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; Brochu V, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-272; BULL A T, 1970, Journal of General Microbiology, V63, P75; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; Chang HT, 2012, BIOCHEM J, V441, P963, DOI 10.1042/BJ20111454; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Coronado JE, 2007, EUKARYOT CELL, V6, P2269, DOI 10.1128/EC.00044-07; Culp DW, 2000, FEMS MICROBIOL LETT, V182, P349, DOI 10.1016/S0378-1097(99)00581-9; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Dobrescu G, 1999, FRACTALS THEORY APPL, P277; Duarte AA, 2013, MICROSC MICROANAL, V7, P1; Dufrene YF, 2010, YEAST, V27, P465, DOI 10.1002/yea.1773; Duval I, 2009, PLANT CELL REP, V28, P811, DOI 10.1007/s00299-009-0670-x; Edgar L.A., 1984, PROGR PHYCOLOGICAL R, P47; Encina AE, 2001, PLANT SCI, V160, P331, DOI 10.1016/S0168-9452(00)00397-6; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fugelstad J, 2009, FUNGAL GENET BIOL, V46, P759, DOI 10.1016/j.fgb.2009.07.001; Fujiwara M, 2000, J BIOCHEM-TOKYO, V127, P359, DOI 10.1093/oxfordjournals.jbchem.a022616; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Fukuda K, 2009, EUKARYOT CELL, V8, P945, DOI 10.1128/EC.00326-08; Futagami Taiki, 2012, Commun Integr Biol, V5, P206, DOI 10.4161/cib.18993; Futagami T, 2011, EUKARYOT CELL, V10, P1504, DOI 10.1128/EC.05080-11; GORDON R, 1970, P NATL ACAD SCI USA, V67, P338, DOI 10.1073/pnas.67.1.338; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; Guerriero G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001070; Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Holder DJ, 2007, MICROBIOL-SGM, V153, P3448, DOI 10.1099/mic.0.2007/008524-0; Horiuchi H, 1999, J BACTERIOL, V181, P3721, DOI 10.1128/JB.181.12.3721-3729.1999; Horiuchi H, 2009, MED MYCOL, V47, pS47, DOI 10.1080/13693780802213332; Ichinomiya M, 2005, EUKARYOT CELL, V4, P1125, DOI 10.1128/EC.4.6.1125-1136.2005; Ichinomiya M, 2002, CURR GENET, V42, P51, DOI 10.1007/s00294-002-0329-4; Ichinomiya M, 2002, MICROBIOL-SGM, V148, P1335, DOI 10.1099/00221287-148-5-1335; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Kelly R, 1996, J BACTERIOL, V178, P4381, DOI 10.1128/jb.178.15.4381-4391.1996; Kiedaisch BM, 2003, PLANTA, V217, P922, DOI 10.1007/s00425-003-1071-y; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Koukaki M, 2003, J MICROBIOL METH, V55, P687, DOI 10.1016/S0167-7012(03)00208-2; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Li L, 2008, PLANT SIGNAL BEHAV, V3, P1126, DOI 10.4161/psb.3.12.7041; Mandelbrot B.B, 1975, OBJETS FRACTALS FORM; Motoyama T, 1996, MOL GEN GENET, V251, P442, DOI 10.1007/BF02172373; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Munro CA, 2013, ADV APPL MICROBIOL, V83, P145, DOI 10.1016/B978-0-12-407678-5.00004-0; Nam JS, 1998, FEMS MICROBIOL LETT, V159, P77, DOI 10.1111/j.1574-6968.1998.tb12844.x; NODET P, 1990, FEMS MICROBIOL LETT, V69, P225; NODET P, 1990, J GEN MICROBIOL, V136, P303, DOI 10.1099/00221287-136-2-303; Orologas N, 2005, PHYCOLOGIA, V44, P465, DOI 10.2216/0031-8884(2005)44[465:EODOPM]2.0.CO;2; Paul BC, 2011, EUKARYOT CELL, V10, P646, DOI 10.1128/EC.00304-10; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Perlin DS, 2007, MED MYCOL S1, V43, pS299; POLACHECK I, 1977, J BACTERIOL, V132, P650, DOI 10.1128/JB.132.2.650-656.1977; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rajangam AS, 2008, PLANT PHYSIOL, V148, P1283, DOI 10.1104/pp.108.121913; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Ruiz-Herrera J, 2010, FEMS YEAST RES, V10, P225, DOI 10.1111/j.1567-1364.2009.00589.x; Sabba RP, 1999, INT J PLANT SCI, V160, P275, DOI 10.1086/314135; Salerno M, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-59; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; SHEDLETZKY E, 1990, PLANT PHYSIOL, V94, P980, DOI 10.1104/pp.94.3.980; Shishkovsky I, 2009, APPL SURF SCI, V255, P5565, DOI 10.1016/j.apsusc.2008.09.090; Smyth PA, 2012, SCANNING, V34, P418, DOI 10.1002/sca.21026; Specht CA, 1996, FUNGAL GENET BIOL, V20, P153, DOI 10.1006/fgbi.1996.0030; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Tsuizaki M, 2013, BIOSCI BIOTECH BIOCH, V77, P369, DOI 10.1271/bbb.120822; Tsuizaki M, 2009, BIOSCI BIOTECH BIOCH, V73, P1163, DOI 10.1271/bbb.90074; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang Y, 1997, PLANT PHYSIOL, V113, P1071, DOI 10.1104/pp.113.4.1071; WITT JG, 1966, BIOCHEM J, V101, P698; Wormit A, 2012, PLANT PHYSIOL, V159, P105, DOI 10.1104/pp.112.195198; Yamada E, 2005, BIOSCI BIOTECH BIOCH, V69, P87, DOI 10.1271/bbb.69.87; Yoneda A, 2007, PLANT CELL PHYSIOL, V48, P1393, DOI 10.1093/pcp/pcm120; Yoshimi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054893; ZONNEVELD BJ, 1971, BIOCHIM BIOPHYS ACTA, V249, P506, DOI 10.1016/0005-2736(71)90126-X	97	4	4	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80038	10.1371/journal.pone.0080038	http://dx.doi.org/10.1371/journal.pone.0080038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312197	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300008
J	Kihara, T; Ito, J; Miyake, J				Kihara, Takanori; Ito, Junri; Miyake, Jun			Measurement of Biomolecular Diffusion in Extracellular Matrix Condensed by Fibroblasts Using Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							COLLAGEN GEL CONTRACTION; CONCENTRATION GRADIENT; ANOMALOUS DIFFUSION; TRANSPORT; PROTEIN; FIBRILS; ACTIVIN; CELLS	The extracellular matrix (ECM) comprises the heterogeneous environment outside of cells in a biological system. The ECM is dynamically organized and regulated, and many biomolecules secreted from cells diffuse throughout the ECM, regulating a variety of cellular processes. Therefore, investigation of the diffusive behaviors of biomolecules in the extracellular environment is critical. In this study, we investigated the diffusion coefficients of biomolecules of various sizes, measuring from 1 to 10 nm in radius, by fluorescence correlation spectroscopy in contracted collagen gel caused by fibroblasts, a traditional culture model of dynamic rearrangement of collagen fibers. The diffusion coefficients of the biomolecules in control collagen gel without cells decreased slightly as compared to those in solution, while the diffusion coefficients of biomolecules in the contracted gel at the cell vicinity decreased dramatically. Additionally, the diffusion coefficients of biomolecules were inversely correlated with molecular radius. In collagen gels populated with fibroblasts, the diffusion coefficient at the cell vicinity clearly decreased in the first 24 h of culture. Furthermore, molecular diffusion was greatly restricted, with a central focus on the populated cells. By using the obtained diffusion coefficients of biomolecules, we calculated the collagen fiber condensation ratio by fibroblasts in the cell vicinity at 3 days of culture to represent a 52-fold concentration. Thus, biomolecular diffusion is restricted in the vicinity of the cells where collagen fibers are highly condensed.	[Kihara, Takanori] Univ Kitakyushu, Fac Environm Engn, Dept Life & Environm Engn, Kitakyushu, Fukuoka, Japan; [Kihara, Takanori; Ito, Junri; Miyake, Jun] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 560, Japan	University of Kitakyushu; Osaka University	Kihara, T (corresponding author), Univ Kitakyushu, Fac Environm Engn, Dept Life & Environm Engn, 1-1 Hibikino, Kitakyushu, Fukuoka, Japan.	takanori.kihara@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24106507, 24700454, 23107006]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24106507, 24700454, and 23107006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Fatin-Rouge N, 2004, BIOPHYS J, V86, P2710, DOI 10.1016/S0006-3495(04)74325-8; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; Hofer AM, 2004, CELL CALCIUM, V35, P297, DOI 10.1016/j.ceca.2003.10.021; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Kihara T, 2008, J BIOCHEM, V144, P625, DOI 10.1093/jb/mvn109; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Marrocco M, 2004, APPL OPTICS, V43, P5251, DOI 10.1364/AO.43.005251; Masuda A, 2005, BIOPHYS J, V88, P3584, DOI 10.1529/biophysj.104.048009; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; NETZ PA, 1995, J CHEM PHYS, V103, P9074, DOI 10.1063/1.470018; NISHIYAMA T, 1988, COLLAGEN REL RES, V8, P259; NISHIYAMA T, 1989, MATRIX, V9, P193, DOI 10.1016/S0934-8832(89)80050-2; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; OGSTON AG, 1973, P ROY SOC LOND A MAT, V333, P297, DOI 10.1098/rspa.1973.0064; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Reitan NK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982530; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; TERRY BR, 1995, BIOCHEM BIOPH RES CO, V217, P21, DOI 10.1006/bbrc.1995.2740; TOMASEK JJ, 1984, J CELL BIOL, V99, P536, DOI 10.1083/jcb.99.2.536; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940, DOI 10.1093/oxfordjournals.jbchem.a124824; YAMATO M, 1993, MECH AGEING DEV, V67, P149, DOI 10.1016/0047-6374(93)90119-C; Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10	37	75	75	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82382	10.1371/journal.pone.0082382	http://dx.doi.org/10.1371/journal.pone.0082382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312418	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900071
J	Goh, J; Tsai, J; Bammler, TK; Farin, FM; Endicott, E; Ladiges, WC				Goh, Jorming; Tsai, Jesse; Bammler, Theo K.; Farin, Frederico M.; Endicott, Emma; Ladiges, Warren C.			Exercise Training in Transgenic Mice Is Associated with Attenuation of Early Breast Cancer Growth in a Dose-Dependent Manner	PLOS ONE			English	Article							REGULATORY T-CELLS; PHYSICAL-ACTIVITY; TUMOR-CELLS; MOUSE MODEL; PROGRESSION; INFLAMMATION; RECRUITMENT; TUMORIGENESIS; INVOLVEMENT; EXPRESSION	Epidemiological research suggests that regular physical activity confers beneficial effects that mediate an anti-tumor response and may reduce cancer recurrence. It is unclear what amount of physical activity is necessary to exert such a protective effect and what mechanisms are involved. We investigated the effects of voluntary wheel running on tumor progression and cytokine gene expression in the transgenic polyoma middle T oncoprotein (PyMT) mouse model of invasive breast cancer. Runners showed significantly reduced tumor sizes compared with non-runners after 3 weeks of running (p <= 0.01), and the greater the running distance the smaller the tumor size (Pearson's r = -0.61, p <= 0.04, R-2 = 0.38). Mice running greater than 150 km per week had a significantly attenuated tumor size compared with non-runners (p <= 0.05). Adipose tissue mass was inversely correlated with tumor size in runners (Pearson's r = -0.77, p = 0.014) but not non-runners. Gene expression of CCL22, a cytokine associated with recruitment of immunosuppressive T regulatory cells, was decreased in tumors of runners compared to non-runners (p <= 0.005). No differences in tumor burden or metastatic burden were observed between runners and non-runners after ten weeks of running when the study was completed. We conclude that voluntary wheel running in PyMT mice correlates with an attenuation in tumor progression early during the course of invasive breast cancer. This effect is absent in the later stages of overwhelming tumor burden even though cytokine signaling for immunosuppressive regulatory T cells was down regulated. These observations suggest that the initiation of moderate exercise training for adjunctive therapeutic benefit early in the course of invasive breast cancer should be considered for further investigation.	[Goh, Jorming] Univ Washington, Interdisciplinary Program Nutr Sci, Seattle, WA 98195 USA; [Goh, Jorming; Endicott, Emma; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Tsai, Jesse; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ladiges, WC (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	wladiges@u.washington.edu	Goh, Jorming/Q-4565-2019	Goh, Jorming/0000-0002-6250-8251	NIH [R21 CA140916, P30 AG13280]; NATIONAL CANCER INSTITUTE [R21CA140916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751, P30AG013280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported in part by NIH grants R21 CA140916 and P30 AG13280, url: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the document.	Abdalla DR, 2013, EUR J CANCER PREV, V22, P251, DOI 10.1097/CEJ.0b013e3283592cbb; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bing Chen, 2011, Curr Opin Support Palliat Care, V5, P356, DOI 10.1097/SPC.0b013e32834bde0e; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Boimel PJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3108; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chen XL, 2011, CANCER PREV RES, V4, P1409, DOI 10.1158/1940-6207.CAPR-10-0355; Colbert LH, 2009, MED SCI SPORT EXER, V41, P1597, DOI 10.1249/MSS.0b013e31819f1f05; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Goh Jorming, 2013, BMC Res Notes, V6, P66, DOI 10.1186/1756-0500-6-66; Goh J, 2012, EXERC IMMUNOL REV, V18, P158; Goh J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-191; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hampras SS, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/191090; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Hoffman-Goetz L, 2003, MED SCI SPORT EXER, V35, P1828, DOI 10.1249/01.MSs.0000093621.09328.70; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Irwin ML, 2011, CANCER PREV RES, V4, P522, DOI 10.1158/1940-6207.CAPR-10-0295; Jones LW, 2010, J APPL PHYSIOL, V108, P343, DOI 10.1152/japplphysiol.00424.2009; Jones LW, 2005, CLIN CANCER RES, V11, P6695, DOI 10.1158/1078-0432.CCR-05-0844; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Menetrier-Caux C, 2012, ONCOIMMUNOLOGY, V1, P759, DOI 10.4161/onci.19680; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy EA, 2011, CYTOKINE, V55, P274, DOI 10.1016/j.cyto.2011.04.007; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Pulaski B. A., 2000, CURR PROTOC IMMUNOL, V39, P1, DOI 10.1002/; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Steiner JL, 2013, INT J ONCOL, DOI [10.3892/ijo.2013.1827, DOI 10.3892/IJ0.2013.1827]; THOMPSON HJ, 1995, CARCINOGENESIS, V16, P1783, DOI 10.1093/carcin/16.8.1783; THOMPSON HJ, 1988, CANCER RES, V48, P2720; THOMPSON HJ, 1989, CANCER RES, V49, P1904; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869	39	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80123	10.1371/journal.pone.0080123	http://dx.doi.org/10.1371/journal.pone.0080123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312199	Green Submitted, Green Published			2022-12-25	WOS:000327652100024
J	Gombash, SE; Manfredsson, FP; Kemp, CJ; Kuhn, NC; Fleming, SM; Egan, AE; Grant, LM; Ciucci, MR; MacKeigan, JP; Sortwell, CE				Gombash, Sara E.; Manfredsson, Fredric P.; Kemp, Christopher J.; Kuhn, Nathan C.; Fleming, Sheila M.; Egan, Ann E.; Grant, Laura M.; Ciucci, Michelle R.; MacKeigan, Jeffrey P.; Sortwell, Caryl E.			Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System	PLOS ONE			English	Article							PARKINSONS-DISEASE; ULTRASONIC VOCALIZATIONS; DOPAMINE TRANSPORTER; LEWY BODIES; MODEL; NEURONS; SENSORIMOTOR; NEURODEGENERATION; PHOSPHORYLATION; NEUROPROTECTION	The discovery of the involvement of alpha-synuclein (alpha-syn) in Parkinson's disease (PD) pathogenesis has resulted in the development and use of viral vector-mediated alpha-syn overexpression rodent models. The goal of these series of experiments was to characterize the neurodegeneration and functional deficits resulting from injection of recombinant adeno-associated virus (rAAV) serotype 2/5-expressing human wildtype alpha-syn in the rat substantia nigra (SN). Rats were unilaterally injected into two sites in the SN with either rAAV2/5-expressing green fluorescent protein (GFP, 1.2 x 10(13)) or varying titers (2.2 x 10(12), 1.0 x 10(13), 5.9 x 10(13), or 1.0 x 10(14)) of rAAV2/5-alpha-syn. Cohorts of rats were euthanized 4, 8, or 12 weeks following vector injection. The severity of tyrosine hydroxylase immunoreactive (THir) neuron death in the SN pars compacta (SNpc) was dependent on vector titer. An identical magnitude of nigrostriatal degeneration (60-70% SNpc THir neuron degeneration and 40-50% loss of striatal TH expression) was observed four weeks following 1.0 x 1014 titer rAAV2/5-alpha-syn injection and 8 weeks following 1.0 x 1013 titer rAAV2/5-alpha-syn injection. THir neuron degeneration was relatively uniform throughout the rostral-caudal axis of the SNpc. Despite equivalent nigrostriatal degeneration between the 1.0 x 10(13) and 1.0 x 10(14) rAAV2/5-alpha-syn groups, functional impairment in the cylinder test and the adjusting steps task was only observed in rats with the longer 8 week duration of alpha-syn expression. Motor impairment in the cylinder task was highly correlated to striatal TH loss. Further, 8 weeks following 5.9 x 10(13) rAAV2/5-alpha-syn injection deficits in ultrasonic vocalizations were observed. In conclusion, our rAAV2/5-alpha-syn overexpression model demonstrates robust nigrostriatal alpha-syn overexpression, induces significant nigrostriatal degeneration that is both vector and duration dependent and under specific parameters can result in motor impairment that directly relates to the level of striatal TH denervation.	[Gombash, Sara E.; Egan, Ann E.] Univ Cincinnati, Grad Program Neurosci, Cincinnati, OH USA; [Gombash, Sara E.; Manfredsson, Fredric P.; Kemp, Christopher J.; Kuhn, Nathan C.; Sortwell, Caryl E.] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA; [Fleming, Sheila M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Fleming, Sheila M.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Grant, Laura M.; Ciucci, Michelle R.] Univ Wisconsin, Dept Surg, Madison, WI USA; [Grant, Laura M.; Ciucci, Michelle R.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA	University System of Ohio; University of Cincinnati; Michigan State University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Van Andel Institute	Sortwell, CE (corresponding author), Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA.	caryl.sortwell@hc.msu.edu	Ciucci, Michelle R/O-9144-2016; Manfredsson, Fredric/GMI-5876-2022	Ciucci, Michelle R/0000-0002-9913-8784; Manfredsson, Fredric/0000-0001-5802-5487; MacKeigan, Jeffrey/0000-0002-0198-5679	National Institute for Neurological Disorders and Stroke (NINDS) [NS058682, NS076158]; Morris K. Udall Center of Excellence for Parksinson's Disease Research at Michigan State University [NS058830]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058682, P50NS058830, F31NS076158] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris K. Udall Center of Excellence for Parksinson's Disease Research at Michigan State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the National Institute for Neurological Disorders and Stroke (NINDS), NS058682 (CES) and NS076158 (SEG), and the Morris K. Udall Center of Excellence for Parksinson's Disease Research at Michigan State University NS058830 (TJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basken JN, 2012, EXP BRAIN RES, V219, P351, DOI 10.1007/s00221-012-3096-6; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; Bjorklund A, 2010, PROG BRAIN RES, V184, P89, DOI 10.1016/S0079-6123(10)84005-1; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Ciucci MR, 2007, BEHAV BRAIN RES, V182, P284, DOI 10.1016/j.bbr.2007.02.020; Clucci MR, 2009, BEHAV NEUROSCI, V123, P328, DOI 10.1037/a0014593; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Ibanez P, 2009, ARCH NEUROL-CHICAGO, V66, P102, DOI 10.1001/archneurol.2008.555; Johnson AM, 2010, J ACOUST SOC AM, V128, pEL75, DOI 10.1121/1.3462234; Kanaan NM, 2012, J PARKINSON DIS, V2, P249, DOI 10.3233/JPD-012138; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lauwers E, 2003, BRAIN PATHOL, V13, P364; Lee HJ, 2011, BIOCHEM BIOPH RES CO, V412, P526, DOI 10.1016/j.bbrc.2011.07.028; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Mulcahy P, 2012, NEUROSCIENCE, V203, P170, DOI 10.1016/j.neuroscience.2011.12.011; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nikolaus S, 2003, EUR J NUCL MED MOL I, V30, P390, DOI 10.1007/s00259-002-1056-2; OLSSON M, 1995, J NEUROSCI, V15, P3863; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Plowman-Prine EK, 2009, NEUROREHABILITATION, V24, P131, DOI 10.3233/NRE-2009-0462; Polymeropoulos MH, 1998, ANN NEUROL, V44, pS63, DOI 10.1002/ana.410440710; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; Ringel LE, 2013, BEHAV BRAIN RES, V252, P252, DOI 10.1016/j.bbr.2013.06.006; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; SCHALLERT T, 1979, EXP NEUROL, V64, P33, DOI 10.1016/0014-4886(79)90003-7; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yamada M, 2005, HUM GENE THER, V16, P262, DOI 10.1089/hum.2005.16.262; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	57	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81426	10.1371/journal.pone.0081426	http://dx.doi.org/10.1371/journal.pone.0081426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312298	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100078
J	Xu, Y; Guo, WJ; Wang, Q; Lanzi, GG; Luobu, OZ; Ma, XH; Wang, YC; Zhen, P; Deng, W; Liu, X; Zhuoma, BS; Liu, XH; Li, T; Hu, X				Xu, Yan; Guo, Wan-jun; Wang, Qiang; Lanzi, Gongga; Luobu, Ouzhu; Ma, Xiao-hong; Wang, Ying-cheng; Zhen, Puo; Deng, Wei; Liu, Xiang; Zhuoma, Basang; Liu, Xie-he; Li, Tao; Hu, Xun			Polymorphisms of Genes in Neurotransmitter Systems Were Associated with Alcohol Use Disorders in a Tibetan Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SEROTONIN TRANSPORTER GENE; O-METHYLTRANSFERASE GENE; GABA(A) RECEPTOR GENES; BIPOLAR DISORDER; DOPAMINE-D-2 RECEPTOR; ALLELIC ASSOCIATION; MOLECULAR-GENETICS; CHROMOSOME 5Q33-34	Studies of linkage and association in various ethnic populations have revealed many predisposing genes of multiple neurotransmitter systems for alcohol use disorders (AUD). However, evidence often is contradictory regarding the contribution of most candidate genes to the susceptibility of AUD. We, therefore, performed a case-control study to investigate the possible associations of genes selected from multiple neurotransmitter systems with AUD in a homogeneous Tibetan community population in China. AUD cases (N = 281) with an alcohol use disorder identification test (AUDIT) score >= 10, as well as healthy controls (N = 277) with an AUDIT score <= 5, were recruited. All participants were genotyped for 366 single nucleotide polymorphisms (SNPs) of 34 genes selected from those involved in neurotransmitter systems. Association analyses were performed using PLINK version 1.07 software. Allelic analyses before adjustment for multiple tests showed that 15 polymorphisms within seven genes were associated with AUD (p<0.05). After adjustment for the number of SNPs genotyped within each gene, only the association of a single marker (rs10044881) in HTR4 remained statistically significant. Haplotype analysis for two SNPs in HTR4 (rs17777298 and rs10044881) showed that the haplotype AG was significantly associated with the protective effect for AUD. In conclusion, the present study discovered that the HTR4 gene may play a marked role in the pathogenesis of AUD. In addition, this Tibetan population sample marginally replicated previous evidence regarding the associations of six genes in AUD.	[Xu, Yan; Hu, Xun] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Guo, Wan-jun; Wang, Qiang; Ma, Xiao-hong; Wang, Ying-cheng; Deng, Wei; Liu, Xiang; Liu, Xie-he; Li, Tao] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Guo, Wan-jun; Wang, Qiang; Ma, Xiao-hong; Wang, Ying-cheng; Deng, Wei; Liu, Xiang; Liu, Xie-he; Li, Tao] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Psychiat Lab, Chengdu 610064, Peoples R China; [Lanzi, Gongga; Luobu, Ouzhu; Zhen, Puo; Zhuoma, Basang] Tibet Univ, Coll Med, Lasha, Tibet, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Tibet University	Li, T (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mental Hlth Ctr, Chengdu 610064, Peoples R China.	xuntao26@hotmail.com; hxxhu99@163.com	Deng, Wei/GWC-9207-2022; Deng, Wei/AAU-9945-2020; Xiaoheng, LIU/GNP-3359-2022	Ma, Xiaohong/0000-0003-2627-9946	National Nature Science Foundation of China [30870889]; Department of Science and Technology, Sichuan, China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology, Sichuan, China(Department of Science & Technology (India))	Funded by a grant from the National Nature Science Foundation of China (grant No. 30870889) and a grant from the Department of Science and Technology, Sichuan, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, DRUG ALCOHOL DEPEN, V93, P12, DOI 10.1016/j.drugalcdep.2007.08.015; Agrawal A, 2006, BEHAV GENET, V36, P640, DOI 10.1007/s10519-006-9069-4; August GJ, 2006, J AM ACAD CHILD PSY, V45, P824, DOI 10.1097/01.chi.0000219831.16226.f8; Babor TF., 2001, ALCOHOL USE DISORDER; Baik I, 2011, AM J CLIN NUTR, V93, P809, DOI 10.3945/ajcn.110.001776; Baumberg B, 2008, ADDICTION, V103, P1952, DOI 10.1111/j.1360-0443.2008.02322.x; Bianchi C, 2002, NEUROREPORT, V13, P2177, DOI 10.1097/00001756-200212030-00003; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Cao JX, 2011, BRAIN RES, V1376, P1, DOI 10.1016/j.brainres.2010.12.039; Chen WJ, 2001, PSYCHIATR GENET, V11, P187, DOI 10.1097/00041444-200112000-00002; Claeysen S, 1997, NEUROREPORT, V8, P3189, DOI 10.1097/00001756-199710200-00002; Dick DM, 2007, PSYCHIAT GENET, V17, P35, DOI 10.1097/YPG.0b013e328011188b; Dick DM, 2005, AM J MED GENET B, V132B, P24, DOI 10.1002/ajmg.b.30058; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Ehringer MA, 2007, AM J MED GENET B, V144B, P596, DOI 10.1002/ajmg.b.30464; Enoch MA, 2009, NEUROPSYCHOPHARMACOL, V34, P1245, DOI 10.1038/npp.2008.171; Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Foley PF, 2004, ANN NY ACAD SCI, V1025, P39, DOI 10.1196/annals.1316.005; Garwood P, 2004, M S-MED SCI, V20, P1132, DOI 10.1051/medsci/200420121132; Gelernter J, 2009, BIOL PSYCHIAT, V65, P111, DOI 10.1016/j.biopsych.2008.08.036; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Guo WJ, 2011, NEUROSCI LETT, V495, P22, DOI 10.1016/j.neulet.2011.03.020; Guo WJ, 2008, PSYCHIAT RES, V159, P56, DOI 10.1016/j.psychres.2007.09.012; Guo WJ, 2010, AM J MED GENET B, V153B, P561, DOI 10.1002/ajmg.b.31020; Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x; Heinz A, 1996, ALCOHOL CLIN EXP RES, V20, P1109, DOI 10.1111/j.1530-0277.1996.tb01954.x; Higuchi S, 2006, CURR OPIN PSYCHIATR, V19, P253, DOI 10.1097/01.yco.0000218595.54054.7a; Hill SY, 2004, AM J MED GENET B, V128B, P102, DOI 10.1002/ajmg.b.30013; Hu J, 2010, BIOL PSYCHIAT, V67, P800, DOI 10.1016/j.biopsych.2009.12.028; Huang C, 2012, J MED SCI YANBIAN U, V35, P199; Huang SY, 2007, J PSYCHIATR NEUROSCI, V32, P185; Jacob T, 2003, ARCH GEN PSYCHIAT, V60, P1265, DOI 10.1001/archpsyc.60.12.1265; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kerner B, 2007, AM J MED GENET B, V144B, P74, DOI 10.1002/ajmg.b.30402; Kibitov AO, 2010, ZH NEVROL PSIKHIATR, V110, P84; Kimura M, 2011, PSYCHIAT CLIN NEUROS, V65, P213, DOI 10.1111/j.1440-1819.2011.02190.x; King MV, 2008, TRENDS PHARMACOL SCI, V29, P482, DOI 10.1016/j.tips.2008.07.001; Koehnke MD, 2002, J NEURAL TRANSM, V109, P1423, DOI 10.1007/s00702-002-0752-1; Koehnke MD, 2008, BIOCHEM PHARMACOL, V75, P160, DOI 10.1016/j.bcp.2007.06.021; Kohnke MD, 2003, NEUROPSYCHOPHARMACOL, V28, P1004, DOI 10.1038/sj.npp.1300107; Konishi T, 2004, ALCOHOL, V32, P45, DOI 10.1016/j.alcohol.2003.11.002; Kuo PH, 2006, ALCOHOL CLIN EXP RES, V30, P1807, DOI 10.1111/j.1530-0277.2006.00217.x; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Lappalainen J, 2002, ARCH GEN PSYCHIAT, V59, P825, DOI 10.1001/archpsyc.59.9.825; Lee JF, 1999, ALCOHOL CLIN EXP RES, V23, P592, DOI 10.1111/j.1530-0277.1999.tb04159.x; Lee SY, 2010, ALCOHOL CLIN EXP RES, V34, P1212, DOI 10.1111/j.1530-0277.2010.01198.x; Lee SY, 2009, ALCOHOL CLIN EXP RES, V33, P1589, DOI 10.1111/j.1530-0277.2009.00990.x; Li J, 2006, NEUROSCI LETT, V401, P6, DOI 10.1016/j.neulet.2006.02.053; Loh EW, 2006, ALCOHOL CLIN EXP RES, V30, P1817, DOI 10.1111/j.1530-0277.2006.00218.x; Loh EW, 2000, MOL PSYCHIATR, V5, P301, DOI 10.1038/sj.mp.4000719; Loh EW, 1999, MOL PSYCHIATR, V4, P539, DOI 10.1038/sj.mp.4000554; Loh EW, 2004, ALCOHOL CLIN EXP RES, V28, P15, DOI 10.1097/01.ALC.0000106303.41755.B8; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Martinez D, 2009, BIOL PSYCHIAT, V65, P175, DOI 10.1016/j.biopsych.2008.08.034; Molina BSG, 2007, ALCOHOL CLIN EXP RES, V31, P643, DOI 10.1111/j.1530-0277.2007.00349.x; Noble EP, 2000, AM J MED GENET, V96, P622, DOI 10.1002/1096-8628(20001009)96:5<622::AID-AJMG7>3.0.CO;2-5; Nurnberger JI, 2007, SCI AM, V296, P46, DOI 10.1038/scientificamerican0407-46; Ohtsuki T, 2002, MOL PSYCHIATR, V7, P954, DOI 10.1038/sj.mp.4001133; Park CS, 2006, J KOREAN MED SCI, V21, P533, DOI 10.3346/jkms.2006.21.3.533; Perlis RH, 2013, PHARMACOGENOMICS J, V13, P280, DOI 10.1038/tpj.2011.62; Polina ER, 2009, DRUG ALCOHOL DEPEN, V101, P128, DOI 10.1016/j.drugalcdep.2008.11.001; Radel M, 2005, ARCH GEN PSYCHIAT, V62, P47, DOI 10.1001/archpsyc.62.1.47; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; Testino G, 2008, HEPATO-GASTROENTEROL, V55, P371; Timberlake DS, 2007, ALCOHOL CLIN EXP RES, V31, P1020, DOI 10.1111/j.1530-0277.2007.00383.x; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Wang Xue-Jing, 2011, Yichuan, V33, P48, DOI 10.3724/SP.J.1005.2011.00048; Yoshimoto K, 1996, ALCOHOL CLIN EXP RES, V20, pA311; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	74	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80206	10.1371/journal.pone.0080206	http://dx.doi.org/10.1371/journal.pone.0080206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312204	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100029
J	Hasegawa, K; Takahashi, S				Hasegawa, Kunihiro; Takahashi, Shin'ya			Functional Difference between Sustained and Transient Modulations of Cognitive Control in the Simon Task: Evidence from False Alarm Responses on No-Go Trials	PLOS ONE			English	Article							SEQUENTIAL MODULATIONS; PROPORTION CONGRUENT; ANTERIOR CINGULATE; CONTROL MECHANISMS; CONFLICT; INFORMATION; ACTIVATION; INTERFERENCE; OVERLAP; CORTEX	Cognitive control in response compatibility tasks is modulated by the task context. Two types of contextual modulations have been demonstrated; sustained (block-wise) and transient (trial-by-trial). Recent research suggests that these modulations have different underlying mechanisms. This study presents new evidence supporting this claim by comparing false alarm (FA) responses on no-go trials of the Simon task between the sustained and transient contexts. In Experiment 1, the sustained context was manipulated so that a block included a larger number of incongruent trials. Results showed that participants made more FA responses by the hand opposite to the stimulus location. This suggests a generation of response bias in which the task-irrelevant location information is utilized in a reversed manner (i.e., to respond with the right hand to a stimulus presented on the left side and vice versa). Next, Experiment 2 examined the effect of the transient context and found that overall FA rate was lower when a no-go trial was preceded by an incongruent trial than by a congruent trial, whereas such response bias as that shown in Experiment 1 was not demonstrated. This suggests that the transient conflict context enhances inhibition of the task-irrelevant process but does not make the task-irrelevant information actively usable. Based on these results, we propound two types of cognitive control modulations as adaptive behaviors: response biasing based on utilization of the task-irrelevant information under the sustained conflict context and transient enhancement of inhibition of the task-irrelevant process based on the online conflict monitoring.	[Hasegawa, Kunihiro; Takahashi, Shin'ya] Nagoya Univ, Dept Psychol, Nagoya, Aichi 4648601, Japan	Nagoya University	Hasegawa, K (corresponding author), Nagoya Univ, Dept Psychol, Nagoya, Aichi 4648601, Japan.	hasegawa.kunihiro@f.nagoya-u.jp	Hasegawa, Kunihiro/D-1204-2015	Hasegawa, Kunihiro/0000-0002-9236-5693	Grants-in-Aid for Scientific Research [24653164] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hasegawa K, 2013, JPN PSYCHOL RES, V55, P84, DOI 10.1111/j.1468-5884.2012.00535.x; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Kleiner M., 2007, WHATS NEW PSYCHTOO S; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Notebaert W, 2008, COGNITION, V106, P1071, DOI 10.1016/j.cognition.2007.04.011; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644	23	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81804	10.1371/journal.pone.0081804	http://dx.doi.org/10.1371/journal.pone.0081804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259SK	24303072	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400088
J	Khedoe, PPSJ; Wong, MC; Wagenaar, GTM; Plomp, JJ; van Eck, M; Havekes, LM; Rensen, PCN; Hiemstra, PS; Berbee, JFP				Khedoe, P. Padmini S. J.; Wong, Man C.; Wagenaar, Gerry T. M.; Plomp, Jaap J.; van Eck, Miranda; Havekes, Louis M.; Rensen, Patrick C. N.; Hiemstra, Pieter S.; Berbee, Jimmy F. P.			The Effect of PPE-Induced Emphysema and Chronic LPS-Induced Pulmonary Inflammation on Atherosclerosis Development in APOE*3-LEIDEN Mice	PLOS ONE			English	Article							RIGHT-VENTRICULAR HYPERTROPHY; NECROSIS-FACTOR-ALPHA; SYSTEMIC INFLAMMATION; COLLAGEN; PROGRESSION; DISEASE; INTERLEUKIN-6; EXPRESSION; MORTALITY; LUNGS	Background: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation, airways obstruction and emphysema, and is a risk factor for cardiovascular disease (CVD). However, the contribution of these individual COPD components to this increased risk is unknown. Therefore, the aim of this study was to determine the contribution of emphysema in the presence or absence of pulmonary inflammation to the increased risk of CVD, using a mouse model for atherosclerosis. Because smoke is a known risk factor for both COPD and CVD, emphysema was induced by intratracheal instillation of porcine pancreatic elastase (PPE). Methods: Hyperlipidemic APOE*3-Leiden mice were intratracheally instilled with vehicle, 15 or 30 mg PPE and after 4 weeks, mice received a Western-type diet (WTD). To study the effect of emphysema combined with pulmonary inflammation on atherosclerosis, mice received 30 mu g PPE and during WTD feeding, mice were intranasally instilled with vehicle or low-dose lipopolysaccharide (LPS; 1 mu g/mouse, twice weekly). After 20 weeks WTD, mice were sacrificed and emphysema, pulmonary inflammation and atherosclerosis were analysed. Results: Intratracheal PPE administration resulted in a dose-dependent increase in emphysema, whereas atherosclerotic lesion area was not affected by PPE treatment. Additional low-dose intranasal LPS administration induced a low-grade systemic IL-6 response, as compared to vehicle. Combining intratracheal PPE with intranasal LPS instillation significantly increased the number of pulmonary macrophages and neutrophils. Plasma lipids during the study were not different. LPS instillation caused a limited, but significant increase in the atherosclerotic lesion area. This increase was not further enhanced by PPE. Conclusion: This study shows for the first time that PPE-induced emphysema both in the presence and absence of pulmonary inflammation does not affect atherosclerotic lesion development.	[Khedoe, P. Padmini S. J.; Wong, Man C.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Wong, Man C.; Havekes, Louis M.; Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Wagenaar, Gerry T. M.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van Eck, Miranda] Gorlaeus Labs, Leiden Acad Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Havekes, Louis M.] TNO, IVVO, Gaubius Lab, Netherlands Org Appl Sci Res,Metab Hlth Res, NL-2300 AK Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Khedoe, PPSJ (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.	p.p.s.j.khedoe@lumc.nl	/V-8478-2019; Hiemstra, Pieter S/K-8587-2018; Wagenaar, Gerry/GRS-3567-2022; Rensen, Patrick C.N./D-7176-2018	Hiemstra, Pieter S/0000-0002-0238-5982; Rensen, Patrick C.N./0000-0002-8455-4988; Khedoe, Padmini/0000-0002-0798-014X; Wagenaar, Gerry/0000-0001-5716-6018	F.R. Nieuwenkamp Stichting (LUMC); Netherlands Lung Foundation [3.2.10.048]	F.R. Nieuwenkamp Stichting (LUMC); Netherlands Lung Foundation	This projects was funded by the F.R. Nieuwenkamp Stichting (LUMC) and the Netherlands Lung Foundation (grant 3.2.10.048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; Andrus MR, 2008, DRUG AGING, V25, P131, DOI 10.2165/00002512-200825020-00005; Arunachalam G, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-34; Barnes MJ, 1999, EXP GERONTOL, V34, P513, DOI 10.1016/S0531-5565(99)00038-8; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; BUCCINO RA, 1969, AM J PHYSIOL, V216, P425, DOI 10.1152/ajplegacy.1969.216.2.425; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; de Visser YP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-30; Fu Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002526; Gairola CG, 2001, ATHEROSCLEROSIS, V156, P49, DOI 10.1016/S0021-9150(00)00621-3; Garcia M, 2009, J APPL PHYSIOL, V106, P1338, DOI 10.1152/japplphysiol.90592.2008; Han SG, 2012, TOXICOLOGY, V299, P133, DOI 10.1016/j.tox.2012.05.015; HAYES JA, 1975, J PATHOL, V117, P1, DOI 10.1002/path.1711170102; Hulten LM, 2009, CURR OPIN LIPIDOL, V20, P409, DOI 10.1097/MOL.0b013e3283307be8; Hurst JR, 2005, CHEST, V127, P1219, DOI 10.1378/chest.127.4.1219; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Lamberts RR, 2007, BASIC RES CARDIOL, V102, P19, DOI 10.1007/s00395-006-0620-5; Loke YK, 2010, EUR RESPIR J, V35, P1003, DOI 10.1183/09031936.00095909; Lopes J, 2013, AM J PATHOL, V182, P2241, DOI 10.1016/j.ajpath.2013.02.011; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; Luthje L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-7; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; REKHTER MD, 1993, AM J PATHOL, V143, P1634; Rutten EPA, 2011, PULM MED, V2011, DOI 10.1155/2011/419328; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Tamagawa E, 2009, INNATE IMMUN-LONDON, V15, P251, DOI 10.1177/1753425909104782; Tkacova R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/585989; van der Hoorn JWA, 2009, BRIT J PHARMACOL, V156, P1067, DOI 10.1111/j.1476-5381.2008.00109.x; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Vernooy JH, 2002, AM J RESP CRIT CARE, V166, P1218, DOI 10.1164/rccm.2202023; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; von Holt K, 2009, ATHEROSCLEROSIS, V205, P135, DOI 10.1016/j.atherosclerosis.2008.11.031; Westerterp M, 2007, CIRCULATION, V116, P2173, DOI 10.1161/CIRCULATIONAHA.107.693382; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66; Zitman FMP, 2008, NEUROSCIENCE, V156, P885, DOI 10.1016/j.neuroscience.2008.08.034	43	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80196	10.1371/journal.pone.0080196	http://dx.doi.org/10.1371/journal.pone.0080196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303000	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400016
J	Weber, A; Hochmann, S; Cimalla, P; Gartner, M; Kuscha, V; Hans, S; Geffarth, M; Kaslin, J; Koch, E; Brand, M				Weber, Anke; Hochmann, Sarah; Cimalla, Peter; Gaertner, Maria; Kuscha, Veronika; Hans, Stefan; Geffarth, Michaela; Kaslin, Jan; Koch, Edmund; Brand, Michael			Characterization of Light Lesion Paradigms and Optical Coherence Tomography as Tools to Study Adult Retina Regeneration in Zebrafish	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; SPECTRAL-DOMAIN; MULLER GLIA; STEM-CELLS; NEURONAL PROGENITORS; REGIONAL DIFFERENCES; CRYSTALLINE LENS; GENE-EXPRESSION; TELEOST RETINA; TIME-COURSE	Light-induced lesions are a powerful tool to study the amazing ability of photoreceptors to regenerate in the adult zebrafish retina. However, the specificity of the lesion towards photoreceptors or regional differences within the retina are still incompletely understood. We therefore characterized the process of degeneration and regeneration in an established paradigm, using intense white light from a fluorescence lamp on swimming fish (diffuse light lesion). We also designed a new light lesion paradigm where light is focused through a microscope onto the retina of an immobilized fish (focused light lesion). Focused light lesion has the advantage of creating a locally restricted area of damage, with the additional benefit of an untreated control eye in the same animal. In both paradigms, cell death is observed as an immediate early response, and proliferation is initiated around 2 days post lesion (dpl), peaking at 3 dpl. We furthermore find that two photoreceptor subtypes (UV and blue sensitive cones) are more susceptible towards intense white light than red/green double cones and rods. We also observed specific differences within light lesioned areas with respect to the process of photoreceptor degeneration: UV cone debris is removed later than any other type of photoreceptor in light lesions. Unspecific damage to retinal neurons occurs at the center of a focused light lesion territory, but not in the diffuse light lesion areas. We simulated the fish eye optical properties using software simulation, and show that the optical properties may explain the light lesion patterns that we observe. Furthermore, as a new tool to study retinal degeneration and regeneration in individual fish in vivo, we use spectral domain optical coherence tomography. Collectively, the light lesion and imaging assays described here represent powerful tools for studying degeneration and regeneration processes in the adult zebrafish retina.	[Weber, Anke; Hochmann, Sarah; Kuscha, Veronika; Hans, Stefan; Geffarth, Michaela; Kaslin, Jan; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, DFG Res Ctr Regenerat Therapies Dresden Cluster E, D-01062 Dresden, Germany; [Cimalla, Peter; Gaertner, Maria] Tech Univ Dresden, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Brand, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, DFG Res Ctr Regenerat Therapies Dresden Cluster E, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010; Gaertner, Maria/ABD-1596-2020	Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889; Koch, Edmund/0000-0003-0554-2178; Weber, Anke/0000-0003-2220-658X; Hochmann, Sarah/0000-0002-6766-4093	Deutsche Forschungsgemeinschaft [SFB 655 A3]; European Union (ZF-Health); Center for Regenerative Therapies Dresden (CRTD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF-Health); Center for Regenerative Therapies Dresden (CRTD)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 655 A3), European Union (ZF-Health) and by a seed grant of the Center for Regenerative Therapies Dresden (CRTD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; Bailey TJ, 2012, INVEST OPHTH VIS SCI, V53, P3126, DOI 10.1167/iovs.11-8895; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Bantseev V, 2004, CAN J ZOOL, V82, P86, DOI 10.1139/Z03-223; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Brand Michael, 2002, P7; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Brockerhoff SE, 2010, CELL MOL LIFE SCI; Cameron DA, 2000, VISUAL NEUROSCI, V17, P789, DOI 10.1017/S0952523800175121; Cimalla P, 2011, NONINVASIVE IMAGING; Cimalla P, 2009, OPT EXPRESS, V17, P19486, DOI 10.1364/OE.17.019486; Connaughton VP, 2004, J COMP NEUROL, V477, P371, DOI 10.1002/cne.20261; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Eichenbaum Joseph W., 2009, Journal of Pharmacological and Toxicological Methods, V59, P121, DOI 10.1016/j.vascn.2009.02.006; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Glickman RD, 2002, INT J TOXICOL, V21, P473, DOI 10.1080/10915810290169909; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; Hodel C, 2006, ANAT REC PART A, V288A, P653, DOI 10.1002/ar.a.20329; Horio N, 2001, ARCH OPHTHALMOL-CHIC, V119, P1329; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; JAGGER WS, 1992, VISION RES, V32, P1271, DOI 10.1016/0042-6989(92)90222-5; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kroger RHH, 1996, J OPT SOC AM A, V13, P2341, DOI 10.1364/JOSAA.13.002341; LAWWILL T, 1977, DOC OPHTHALMOL, V44, P379; Li SH, 1996, CURR EYE RES, V15, P914, DOI 10.3109/02713689609017635; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Mensinger AF, 1999, VISUAL NEUROSCI, V16, P241, DOI 10.1017/S0952523899162059; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Nagata A, 2009, INVEST OPHTH VIS SCI, V50, P2809, DOI 10.1167/iovs.08-2764; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Noell W K, 1966, Invest Ophthalmol, V5, P450; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1994, PROG RETIN EYE RES, V13, P1, DOI 10.1016/1350-9462(94)90003-5; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; PARVER LM, 1980, AM J OPHTHALMOL, V89, P641, DOI 10.1016/0002-9394(80)90280-9; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reifers F, 1998, DEVELOPMENT, V125, P2381; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrijvers DM, 2006, BIOMARK INSIGHTS, V1, P193; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; Shaw SL, 1997, CURR BIOL, V7, P701, DOI 10.1016/S0960-9822(06)00299-5; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Thomas JL, 2012, EXP EYE RES, V97, P105, DOI 10.1016/j.exer.2012.02.004; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Verma Y, 2007, APPL PHYS B-LASERS O, V87, P607, DOI 10.1007/s00340-007-2689-4; Vihtelic TS, 2006, EXP EYE RES, V82, P558, DOI 10.1016/j.exer.2005.08.015; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Walther J, 2011, ANAL BIOANAL CHEM, V400, P2721, DOI 10.1007/s00216-011-5052-x; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yazulla S, 2001, J NEUROCYTOL, V30, P551, DOI 10.1023/A:1016512617484	66	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80483	10.1371/journal.pone.0080483	http://dx.doi.org/10.1371/journal.pone.0080483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303018	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400034
J	Glenn, ST; Jones, CA; Sexton, S; Levea, CM; Caraker, SM; Hajduczok, G; Gross, KW				Glenn, S. T.; Jones, C. A.; Sexton, S.; Levea, C. M.; Caraker, S. M.; Hajduczok, G.; Gross, K. W.			Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma	ONCOGENE			English	Article						glucagonoma; renin; pancreas; PanNET	MULTIPLE ENDOCRINE NEOPLASIA; ANGIOTENSIN SYSTEM; TRANSGENIC MICE; MOUSE MODEL; MUTANT MICE; ALPHA-CELLS; TUMORS; TYPE-1; INHIBITORS; MEN1	Efforts to model human pancreatic neuroendocrine tumors (PanNETs) in animals have been moderately successful, with minimal evidence for glucagonomas or metastatic spread. The renin gene, although classically associated with expression in the kidney, is also expressed in many other extrarenal tissues including the pancreas. To induce tumorigenesis within renin-specific tissues, floxed alleles of p53 and Rb were selectively abrogated using Cre-recombinase driven by the renin promoter. The primary neoplasm generated is a highly metastatic islet cell carcinoma of the pancreas. Lineage tracing identifies descendants of renin-expressing cells as pancreatic alpha cells despite a lack of active renin expression in the mature pancreas. Both primary and metastatic tumors express high levels of glucagon; furthermore, an increased level of glucagon is found in the serum, identifying the pancreatic cancer as a functional glucagonoma. This new model is highly penetrant and exhibits robust frequency of metastases to the lymph nodes and the liver, mimicking human disease, and provides a useful platform for better understanding pancreatic endocrine differentiation and development, as well as islet cell carcinogenesis. The use of fluorescent reporters for lineage tracing of the cells contributing to disease initiation and progression provides an unique opportunity to dissect the timeline of disease, examining mechanisms of the metastatic process, as well as recovering primary and metastatic cells for identifying cooperating mutations that are necessary for progression of disease.	[Glenn, S. T.; Jones, C. A.; Gross, K. W.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Sexton, S.] Roswell Pk Canc Inst, Dept Lab Anim Resources, Buffalo, NY 14263 USA; [Levea, C. M.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Caraker, S. M.] IDEXX RADIL, Columbia, MO USA; [Hajduczok, G.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gross, KW (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton Str, Buffalo, NY 14263 USA.	Kenneth.Gross@roswellpark.org			NIH [5R01HL048459, R21CA164795, R21CA169717]; CCSG [CA016056]; Genomics Shared Resource (GSR); National Science Foundation Major Research Instrumentation [DBI 0923133]; NATIONAL CANCER INSTITUTE [P30CA016056, R21CA164795, R21CA169717] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG; Genomics Shared Resource (GSR); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NIH grants 5R01HL048459, R21CA164795 and R21CA169717. We would like to thank the CCSG funded (CA016056) Roswell Park Gene Targeting and Transgenic Resource and the Genomics Shared Resource (GSR). Confocal Microscopy was performed at the University at Buffalo North Campus Imaging Facility using a Zeiss LSM 710 purchased through National Science Foundation Major Research Instrumentation grant DBI 0923133. We would also like to thank MK Ellsworth and Caretta Reese for maintenance of the mouse colonies, as well as Dominic Smiraglia and Elizabeth Repasky for critical reading and discussion of work. A special thank you to Dr George Deeb for his insightful observations on anatomy.	Benson C, 2005, BRIT J CANCER, V92, P7, DOI 10.1038/sj.bjc.6602229; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Carlsson P O, 2001, JOP, V2, P26; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Ehehalt F, 2009, ONCOLOGIST, V14, P456, DOI 10.1634/theoncologist.2008-0259; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Glenn ST, 2008, PHYSIOL GENOMICS, V35, P243, DOI 10.1152/physiolgenomics.00017.2008; Gomez RA, 1998, KIDNEY INT, V54, pS12, DOI 10.1046/j.1523-1755.1998.06703.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARVEY M, 1995, CANCER RES, V55, P1146; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Hu Wenwei, 2010, Genes Cancer, V1, P360; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jones CA, 2000, PHYSIOL GENOMICS, V4, P75, DOI 10.1152/physiolgenomics.2000.4.1.75; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lam K Y, 2001, JOP, V2, P40; Lam KY, 2002, EUR J ENDOCRINOL, V146, P567, DOI 10.1530/eje.0.1460567; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; Leung KK, 2012, STEM CELLS, V30, P525, DOI 10.1002/stem.1008; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; Leung PS, 2005, PANCREAS, V30, P293, DOI 10.1097/01.mpa.0000158028.76666.76; Leung PS, 2003, INT J BIOCHEM CELL B, V35, P838, DOI 10.1016/S1357-2725(02)00179-6; Leung PS, 2001, J MOL ENDOCRINOL, V26, P155, DOI 10.1677/jme.0.0260155; Liu LX, 2005, MODERN PATHOL, V18, P1632, DOI 10.1038/modpathol.3800490; Loffler KA, 2007, INT J CANCER, V120, P259, DOI 10.1002/ijc.22288; Lopez MLSS, 2004, DEV CELL, V6, P719; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Marino S, 2000, GENE DEV, V14, P994; Nishimura H, 1999, INTERNAL MED, V38, P315, DOI 10.2169/internalmedicine.38.315; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RINDI G, 1991, VIRCHOWS ARCH A, V419, P115, DOI 10.1007/BF01600225; RUTTMAN E, 1980, VIRCHOWS ARCH A, V388, P51, DOI 10.1007/BF00430676; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004897; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Tahmasebi M, 1999, J ENDOCRINOL, V161, P317, DOI 10.1677/joe.0.1610317; Tang LH, 2012, CLIN CANCER RES, V18, P4612, DOI 10.1158/1078-0432.CCR-11-3264; Tikellis C, 2006, INT J BIOCHEM CELL B, V38, P737, DOI 10.1016/j.biocel.2005.08.007; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480	51	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5706	5715		10.1038/onc.2013.514	http://dx.doi.org/10.1038/onc.2013.514			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24292676	Green Accepted			2022-12-25	WOS:000346089300006
J	You, ZP; Al Kindi, H; Abdul-Karim, A; Barrette, PO; Schwertani, A				You, Zhipeng; Al Kindi, Hamood; Abdul-Karim, Ahmad; Barrette, Piere-Olivier; Schwertani, Adel			Blocking the urotensin II receptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice	FASEB JOURNAL			English	Article						UT; heart; ob; ob	SMOOTH-MUSCLE-CELLS; PERFUSED RAT PANCREAS; MILDLY OXIDIZED LDL; CONFOCAL MICROSCOPY; DIABETES-MELLITUS; NUCLEAR-MEMBRANES; INSULIN-RELEASE; MOUSE HEART; HYPERTENSION; ATHEROSCLEROSIS	The metabolic syndrome is defined by the presence of hyperlipidemia, obesity, hypertension, and diabetes. The syndrome is associated with significant cardiovascular morbidity and mortality. The aim of the present study was to determine the role of the vasoactive peptide urotensin II (UII) in the pathogenesis of the metabolic syndrome. We used obese mice (ob/ob) to determine the effect of UII receptor (UT) blockage on the different facets of the metabolic syndrome with special emphasis on cardiac function. Our data demonstrate a significant increase in UII and UT expression in the myocardium of obese mice accompanied by a significant decrease in sarco/endoplasmic reticulum Ca2+-ATPase 2a (SERCA2a) expression, as well as intracellular Na+ and Ca2+ compared with wild-type mice (P<0.05). Treatment of ob/ob mice with the UII receptor antagonist SB657510 significantly improved glucose levels, blood pressure, hyperlipidemia, expression of myocardial SERCA2a, intracellular Na+ and Ca2+ and cardiac function in association with a decrease in weight gain, and mammalian target of rapamycin (mTOR) and sodium/hydrogen exchanger 1 (NHE-1) protein expression compared with vehicle (P<0.05). These findings demonstrate an important role for UII in the pathogenesis of the metabolic syndrome and suggest that the use of UT receptor antagonists may provide a new therapeutic tool for the treatment of this syndrome.You, Z., Al Kindi, H., Abdul-Karim, A., Barrette, P.-O., Schwertani, A. Blocking the urotensin II receptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice.	[You, Zhipeng; Abdul-Karim, Ahmad; Barrette, Piere-Olivier; Schwertani, Adel] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ H3G 1A4, Canada; [Al Kindi, Hamood] McGill Univ, Ctr Hlth, Div Cardiac Surg, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Schwertani, A (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Ste C9-166,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	adel.schwertani@mcgill.ca			Canadian Institute of Health Research; Heart and Stroke Foundation of Quebec	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec	This work was supported by the Canadian Institute of Health Research and the Heart and Stroke Foundation of Quebec. The authors thank GlaxoSmithKline for providing SB657510. The authors declare no conflicts of interest.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Ban Y, 2009, J ATHEROSCLER THROMB, V16, P179, DOI 10.5551/jat.E608; Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533; Bkaily G, 2004, CAN J PHYSIOL PHARM, V82, P805, DOI 10.1139/Y04-119; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; Bkaily G, 1999, METHOD ENZYMOL, V307, P119; Bkaily G, 2006, CAN J PHYSIOL PHARM, V84, P431, DOI 10.1139/Y06-002; Bkaily G, 2009, CAN J PHYSIOL PHARM, V87, P108, DOI 10.1139/Y08-115; Bouchentouf M, 2011, CYTOKINE, V56, P732, DOI 10.1016/j.cyto.2011.09.023; Bouchentouf M, 2010, CELL TRANSPLANT, V19, P369, DOI 10.3727/096368909X484266; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.3.CO;2-Y; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Gruson D, 2010, J CLIN HYPERTENS, V12, P653, DOI 10.1111/j.1751-7176.2010.00336.x; Harris GS, 2007, PEPTIDES, V28, P1483, DOI 10.1016/j.peptides.2007.04.018; Hileeto D, 2002, DIABETES-METAB RES, V18, P386, DOI 10.1002/dmrr.322; Hillier C, 2001, CIRCULATION, V103, P1378, DOI 10.1161/01.CIR.103.10.1378; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hirose T, 2009, PEPTIDES, V30, P1124, DOI 10.1016/j.peptides.2009.02.009; Iglarz M, 2003, HYPERTENSION, V42, P737, DOI 10.1161/01.HYP.0000083511.91817.B1; Karmazyn M, 2013, J MOL CELL CARDIOL, V61, P77, DOI 10.1016/j.yjmcc.2013.02.006; Kato K, 2010, J CARDIOVASC PHARM, V55, P191, DOI 10.1097/FJC.0b013e3181cf0074; Kiss RS, 2011, PEPTIDES, V32, P956, DOI 10.1016/j.peptides.2011.02.016; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, P478, DOI 10.1161/01.ATV.0000153088.15433.8f; Kylin E., 1923, ZENTRALBLATT INNERE, V44, P105, DOI DOI 10.1002/(SICI)1096-9136(199807)15:7<539::; Lim M, 2004, CIRCULATION, V109, P1212, DOI 10.1161/01.CIR.0000121326.69153.98; Maddaford TG, 2010, AM J PHYSIOL-HEART C, V298, pH360, DOI 10.1152/ajpheart.00932.2009; Matsushita M, 2001, J HYPERTENS, V19, P2185, DOI 10.1097/00004872-200112000-00011; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Ong KL, 2006, PEPTIDES, V27, P1659, DOI 10.1016/j.peptides.2006.02.008; Pakala R, 2008, CARDIOVASC REVASCULA, V9, P166, DOI 10.1016/j.carrev.2008.02.001; Papadopoulos P, 2009, ATHEROSCLEROSIS, V204, P395, DOI 10.1016/j.atherosclerosis.2008.10.044; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Russell FD, 2004, J PHARMACOL EXP THER, V310, P209, DOI 10.1124/jpet.104.065425; Saez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030968; Silvestre R, 2004, EUR J ENDOCRINOL, V151, P803, DOI 10.1530/eje.0.1510803; Silvestre RA, 2001, HORM METAB RES, V33, P379, DOI 10.1055/s-2001-15414; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Sun Hong-xia, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P223; Totsune K, 2003, CLIN SCI, V104, P1, DOI 10.1042/CS20020271; VAGUE J, 1947, PRESSE MED, V55, P339; Wang HX, 2009, REGUL PEPTIDES, V154, P85, DOI 10.1016/j.regpep.2009.01.004; Watanabe T, 2001, CIRCULATION, V103, P1440, DOI 10.1161/01.CIR.103.10.1440; Watanabe T, 2001, CIRCULATION, V104, P16, DOI 10.1161/hc2601.092848; Watanabe T, 2006, HYPERTENS RES, V29, P375, DOI 10.1291/hypres.29.375; Watanabe T, 2006, HYPERTENS RES, V29, P821, DOI 10.1291/hypres.29.821; Wenyi Z, 2003, DIABETOLOGIA, V46, P972, DOI 10.1007/s00125-003-1145-1; Wold LE, 2006, FREE RADICAL BIO MED, V40, P1419, DOI 10.1016/j.freeradbiomed.2005.12.009; You ZP, 2012, ARTERIOSCL THROM VAS, V32, P1809, DOI 10.1161/ATVBAHA.112.252973; Zhu Fang, 2002, Zhonghua Yi Xue Za Zhi, V82, P1473	56	13	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1210	1220		10.1096/fj.13-236471	http://dx.doi.org/10.1096/fj.13-236471			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297699				2022-12-25	WOS:000335324800016
J	Premkumar, L; Kurth, F; Neyer, S; Schembri, MA; Martin, JL				Premkumar, Lakshmanane; Kurth, Fabian; Neyer, Simon; Schembri, Mark A.; Martin, Jennifer L.			The Multidrug Resistance IncA/C Transferable Plasmid Encodes a Novel Domain-swapped Dimeric Protein-disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Bacterial Conjugation; Crystal Structure; Disulfide; Enzyme Structure; DsbC; DsbG; Disulfide Isomerase; Domain Swapping; Horizontal Gene Transfer; Multidrug Resistance	ENTERICA SEROVAR TYPHIMURIUM; ACTIVE-SITE; IN-VIVO; CRYSTAL-STRUCTURE; BOND ISOMERASE; FUNCTIONAL-CHARACTERIZATION; DSBC; DIMERIZATION; MECHANISMS; EVOLUTION	Background: Bacterial IncA/C plasmids distribute antibiotic resistance genes and encode a conserved thioredoxin-fold protein (DsbP). Results: DsbP shuffles incorrect disulfide bonds in misfolded proteins, and its structure diverges from previously characterized disulfide isomerases. Conclusion: Plasmid-encoded DsbP is a novel domain-swapped protein-disulfide isomerase. Significance: IncA/C plasmids may encode this protein proofreading machinery to ensure horizontal gene transfer of antibiotic resistance genes. The multidrug resistance-encoding IncA/C conjugative plasmids disseminate antibiotic resistance genes among clinically relevant enteric bacteria. A plasmid-encoded disulfide isomerase is associated with conjugation. Sequence analysis of several IncA/C plasmids and IncA/C-related integrative and conjugative elements (ICE) from commensal and pathogenic bacteria identified a conserved DsbC/DsbG homolog (DsbP). The crystal structure of DsbP reveals an N-terminal domain, a linker region, and a C-terminal catalytic domain. A DsbP homodimer is formed through domain swapping of two DsbP N-terminal domains. The catalytic domain incorporates a thioredoxin-fold with characteristic CXXC and cis-Pro motifs. Overall, the structure and redox properties of DsbP diverge from the Escherichia coli DsbC and DsbG disulfide isomerases. Specifically, the V-shaped dimer of DsbP is inverted compared with EcDsbC and EcDsbG. In addition, the redox potential of DsbP (-161 mV) is more reducing than EcDsbC (-130 mV) and EcDsbG (-126 mV). Other catalytic properties of DsbP more closely resemble those of EcDsbG than EcDsbC. These catalytic differences are in part a consequence of the unusual active site motif of DsbP (CAVC); substitution to the EcDsbC-like (CGYC) motif converts the catalytic properties to those of EcDsbC. Structural comparison of the 12 independent subunit structures of DsbP that we determined revealed that conformational changes in the linker region contribute to mobility of the catalytic domain, providing mechanistic insight into DsbP function. In summary, our data reveal that the conserved plasmid-encoded DsbP protein is a bona fide disulfide isomerase and suggest that a dedicated oxidative folding enzyme is important for conjugative plasmid transfer.	[Premkumar, Lakshmanane; Kurth, Fabian; Neyer, Simon; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia; [Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4067, Australia	University of Queensland; University of Queensland	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia.	j.martin@imb.uq.edu.au	Schembri, Mark A/C-7262-2009; Martin, Jennifer L./A-6039-2010	Schembri, Mark A/0000-0003-4863-9260; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council (ARC) [FL0992138]; Australian Research Council [FT100100662]	Australian Research Council (ARC)(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) Australian Laureate Fellowship FL0992138 (to J. L. M.).; Supported by Australian Research Council Future Fellow Grant FT100100662.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Arredondo SA, 2009, J BIOL CHEM, V284, P23972, DOI 10.1074/jbc.M109.010199; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; del Castillo CS, 2013, ANTIMICROB AGENTS CH, V57, P120, DOI 10.1128/AAC.01239-12; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Drieux L, 2013, J ANTIMICROB CHEMOTH, V68, P97, DOI 10.1093/jac/dks367; Elton TC, 2005, J BACTERIOL, V187, P8267, DOI 10.1128/JB.187.24.8267-8277.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Garriss G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000775; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Hemmis CW, 2013, PLASMID, V70, P168, DOI 10.1016/j.plasmid.2013.05.004; Hemmis CW, 2011, J BACTERIOL, V193, P4588, DOI 10.1128/JB.00351-11; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jiao L, 2013, J STRUCT BIOL, V183, P1, DOI 10.1016/j.jsb.2013.05.013; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Johnson Timothy J, 2012, Mob Genet Elements, V2, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levin BR, 2000, P NATL ACAD SCI USA, V97, P6981, DOI 10.1073/pnas.97.13.6981; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mossner E, 1998, PROTEIN SCI, V7, P1233; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sykes R, 2010, J ANTIMICROB CHEMOTH, V65, P1842, DOI 10.1093/jac/dkq217; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482; WOZNIAK R, 2009, PLOS GENET, V5; WU JH, 1987, PLASMID, V18, P54, DOI 10.1016/0147-619X(87)90078-3; WUNDERLICH M, 1993, J BIOL CHEM, V268, P24547; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zhang M, 2004, ACTA CRYSTALLOGR D, V60, P1512, DOI 10.1107/S0907444904014S93; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	79	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2563	2576		10.1074/jbc.M113.516898	http://dx.doi.org/10.1074/jbc.M113.516898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24311786	Green Published, hybrid			2022-12-25	WOS:000333403000008
J	Jacobs, JL; Zhu, JZ; Sarkar, SN; Coyne, CB				Jacobs, Jana L.; Zhu, Jianzhong; Sarkar, Saumendra N.; Coyne, Carolyn B.			Regulation of Mitochondrial Antiviral Signaling (MAVS) Expression and Signaling by the Mitochondria-associated Endoplasmic Reticulum Membrane (MAM) Protein Gp78	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERad; Interferon; Mitochondria; Rig-like receptors (RLR); RNA Viruses; Gp78; MAM; MAVS; Antiviral Signaling	MOTILITY FACTOR-RECEPTOR; RIG-I; UBIQUITIN LIGASE; KAPPA-B; DEPENDENT PHOSPHORYLATION; ADAPTER PROTEIN; DEGRADATION; ACTIVATION; E3; ER	Background: Negative regulation of innate antiviral singling is crucial for preventing cell damage elicited by hyperinflammation. Results: Gp78 was identified as a negative regulator of innate antiviral signaling. Conclusion: Gp78 regulates MAVS by both decreasing protein levels and by inhibiting signaling via physical interactions. Significance: Gp78 regulation of innate antiviral signaling points to a novel and unexpected role for this protein. In a previous study, we identified the E3 ubiquitin ligase Gp78 by RNAi high-throughput screening as a gene whose depletion restricted enterovirus infection. In the current study, we show that Gp78, which localizes to the ER-mitochondria interface, is a regulator of RIG-I-like receptor (RLR) antiviral signaling. We show that depletion of Gp78 results in a robust decrease of vesicular stomatitis virus (VSV) infection and a corresponding enhancement of type I interferon (IFN) signaling. Mechanistically, we show that Gp78 modulates type I IFN induction by altering both the expression and signaling of the mitochondria-localized RLR adaptor mitochondrial antiviral signaling (MAVS). Expression of mutants of Gp78 that abolish its E3 ubiquitin ligase and its participation in ER-associated degradation (ERAD) lost their ability to degrade MAVS, but surprisingly maintained their ability to repress RLR signaling. In contrast, Gp78 lacking its entire C terminus lost both its ability to degrade MAVS and repress RLR signaling. We show that Gp78 interacts with both the N- and C-terminal domains of MAVS via its C-terminal RING domain, and that this interaction is required to abrogate Gp78-mediated attenuation of MAVS signaling. Our data thus implicate two parallel pathways by which Gp78 regulates MAVS signaling; one pathway requires its E3 ubiquitin ligase and ERAD activity to directly degrade MAVS, whereas the other pathway occurs independently of these activities, but requires the Gp78 RING domain and occurs via a direct association between this region and MAVS.	[Jacobs, Jana L.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Grad Sch Publ Hlth, Pittsburgh, PA 15219 USA; [Zhu, Jianzhong; Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15219 USA; [Sarkar, Saumendra N.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), 427 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.	coynec2@pitt.edu	Sarkar, Saumendra N/B-5038-2011	Sarkar, Saumendra N/0000-0002-2850-6121	National Institutes of Health [R01-AI081759]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI081759 (to C. B. C.).	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Castanier C, 2011, BBA-MOL CELL RES, V1813, P575, DOI 10.1016/j.bbamcr.2010.08.009; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; DENNIS EA, 1972, J LIPID RES, V13, P263; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Lawlor K. E., 2013, BIOCH BIOPH IN PRESS; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; NABI IR, 1990, CANCER RES, V50, P409; Nakhaei P, 2012, J VIROL, V86, P726, DOI 10.1128/JVI.05989-11; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Pottekat A, 2004, J BIOL CHEM, V279, P15743, DOI 10.1074/jbc.M313537200; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; St-Pierre P, 2012, J CELL SCI, V125, P1727, DOI 10.1242/jcs.096396; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wang HJ, 1997, J CELL SCI, V110, P3043; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	70	29	32	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1604	1616		10.1074/jbc.M113.520254	http://dx.doi.org/10.1074/jbc.M113.520254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285545	Green Published, hybrid			2022-12-25	WOS:000332401700034
J	Kawai, M; Kinoshita, S; Shimba, S; Ozono, K; Michigami, T				Kawai, Masanobu; Kinoshita, Saori; Shimba, Shigeki; Ozono, Keiichi; Michigami, Toshimi			Sympathetic Activation Induces Skeletal Fgf23 Expression in a Circadian Rhythm-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Circadian Rhythms; Fibroblast Growth Factor (FGF); Nerve; Parathyroid Hormone; FGF23; Cryptochrome1; Phosphate Metabolism; Sympathetic Activity	GROWTH-FACTOR 23; GENE-EXPRESSION; NERVOUS-SYSTEM; PHOSPHATE; BONE; KLOTHO; METABOLISM; CLOCK; FIBROBLAST-GROWTH-FACTOR-23; HYPOPHOSPHATEMIA	Background: The mechanism whereby the circadian clock regulates phosphate metabolism remains elusive. Results:Fgf23 expression is regulated by the time of food intake which involves the alteration in circadian profile of sympathetic activity. Conclusion: The circadian network plays important roles in phosphate metabolism. Significance: The sympathetic regulation of Fgf23 expression may shed light on new regulatory networks that could be important for phosphate homeostasis. The circadian clock network is well known to link food intake and metabolic outputs. Phosphorus is a pivotal nutritional factor involved in energy and skeletal metabolisms and possesses a circadian profile in the circulation; however, the precise mechanisms whereby phosphate metabolism is regulated by the circadian clock network remain largely unknown. Because sympathetic tone, which displays a circadian profile, is activated by food intake, we tested the hypothesis that phosphate metabolism was regulated by the circadian clock network through the modification of food intake-associated sympathetic activation. Skeletal Fgf23 expression showed higher expression during the dark phase (DP) associated with elevated circulating FGF23 levels and enhanced phosphate excretion in the urine. The peaks in skeletal Fgf23 expression and urine epinephrine levels, a marker for sympathetic tone, shifted from DP to the light phase (LP) when mice were fed during LP. Interestingly, -adrenergic agonist, isoproterenol (ISO), induced skeletal Fgf23 expression when administered at ZT12, but this was not observed in Bmal1-deficient mice. In vitro reporter assays revealed that ISO trans-activated Fgf23 promoter through a cAMP responsive element in osteoblastic UMR-106 cells. The mechanism of circadian regulation of Fgf23 induction by ISO in vivo was partly explained by the suppressive effect of Cryptochrome1 (Cry1) on ISO signaling. These results indicate that the regulation of skeletal Fgf23 expression by sympathetic activity is dependent on the circadian clock system and may shed light on new regulatory networks of FGF23 that could be important for understanding the physiology of phosphate metabolism.	[Kawai, Masanobu; Kinoshita, Saori; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, Osaka 5941101, Japan; [Kawai, Masanobu; Kinoshita, Saori; Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan; [Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Nihon University; Osaka University	Kawai, M (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	kawaim@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021		Sukoyaka Grant for Maternal and Child Health; Grants-in-Aid for Scientific Research [23591227] Funding Source: KAKEN	Sukoyaka Grant for Maternal and Child Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Sukoyaka Grant for Maternal and Child Health (to M. K.).	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Beret-Pages A, 2004, BONE, V35, P455, DOI 10.1016/j.bone.2004.04.002; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; FAGIUS J, 1994, CLIN SCI, V86, P159, DOI 10.1042/cs0860159; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; NELSON W, 1964, AM J PHYSIOL, V206, P589, DOI 10.1152/ajplegacy.1964.206.3.589; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Razzaque MS, 2012, NAT REV ENDOCRINOL, V8, P579, DOI 10.1038/nrendo.2012.75; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; SAKAGUCHI T, 1988, AM J PHYSIOL, V255, pR284, DOI 10.1152/ajpregu.1988.255.2.R284; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Smith B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S15; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang LY, 2012, P NATL ACAD SCI USA, V109, P20679, DOI 10.1073/pnas.1218699110	47	55	55	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1457	1466		10.1074/jbc.M113.500850	http://dx.doi.org/10.1074/jbc.M113.500850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302726	hybrid, Green Published			2022-12-25	WOS:000332401700022
J	Okajima, K; Aihara, Y; Takayama, Y; Nakajima, M; Kashojiya, S; Hikima, T; Oroguchi, T; Kobayashi, A; Sekiguchi, Y; Yamamoto, M; Suzuki, T; Nagatani, A; Nakasako, M; Tokutomi, S				Okajima, Koji; Aihara, Yusuke; Takayama, Yuki; Nakajima, Mihoko; Kashojiya, Sachiko; Hikima, Takaaki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Yamamoto, Masaki; Suzuki, Tomomi; Nagatani, Akira; Nakasako, Masayoshi; Tokutomi, Satoru			Light-induced Conformational Changes of LOV1 (Light Oxygen Voltage-sensing Domain 1) and LOV2 Relative to the Kinase Domain and Regulation of Kinase Activity in Chlamydomonas Phototropin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphorylation; Photoreceptors; Plant Biochemistry; Serine Threonine Protein Kinase; Spectroscopy; X-ray Scattering	BLUE-LIGHT; ARABIDOPSIS PHOTOTROPIN-1; FLAVIN MONONUCLEOTIDE; MUTATIONAL ANALYSIS; STRUCTURAL BASIS; BINDING DOMAINS; PHOTORECEPTOR; RECEPTOR; PHOT; NPH1	Phototropin (phot), a blue light (BL) receptor in plants, has two photoreceptive domains named LOV1 and LOV2 as well as a Ser/Thr kinase domain (KD) and acts as a BL-regulated protein kinase. A LOV domain harbors a flavin mononucleotide that undergoes a cyclic photoreaction upon BL excitation via a signaling state in which the inhibition of the kinase activity by LOV2 is negated. To understand the molecular mechanism underlying the BL-dependent activation of the kinase, the photochemistry, kinase activity, and molecular structure were studied with the phot of Chlamydomonas reinhardtii. Full-length and LOV2-KD samples of C. reinhardtii phot showed cyclic photoreaction characteristics with the activation of LOV- and BL-dependent kinase. Truncation of LOV1 decreased the photosensitivity of the kinase activation, which was well explained by the fact that the signaling state lasted for a shorter period of time compared with that of the phot. Small angle x-ray scattering revealed monomeric forms of the proteins in solution and detected BL-dependent conformational changes, suggesting an extension of the global molecular shapes of both samples. Constructed molecular model of full-length phot based on the small angle x-ray scattering data proved the arrangement of LOV1, LOV2, and KD for the first time that showed a tandem arrangement both in the dark and under BL irradiation. The models suggest that LOV1 alters its position relative to LOV2-KD under BL irradiation. This finding demonstrates that LOV1 may interact with LOV2 and modify the photosensitivity of the kinase activation through alteration of the duration of the signaling state in LOV2.	[Okajima, Koji; Nakajima, Mihoko; Kashojiya, Sachiko; Tokutomi, Satoru] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Okajima, Koji; Takayama, Yuki; Kashojiya, Sachiko; Hikima, Takaaki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Yamamoto, Masaki; Nakasako, Masayoshi] RIKEN, Harima Inst, Sayo, Hyogo 6795148, Japan; [Aihara, Yusuke; Suzuki, Tomomi; Nagatani, Akira] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Takayama, Yuki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Fujisawa, Kanagawa 2238522, Japan	Osaka Metropolitan University; RIKEN; Kyoto University; Keio University	Nakasako, M (corresponding author), RIKEN, Harima Inst, SPring 8,1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	nakasako@phys.keio.ac.jp; toxan@b.s.osakafu-u.ac.jp	Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768; Suzuki, Tomomi/0000-0003-0935-5505	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22120002, 23120525, 22120005, 17084002, 17084008, 23657105, A06]; Grants-in-Aid for Scientific Research [22244054, 22120005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas 22120002 (to A. N.), 23120525 (to M. Nakasako), and 22120005 (to S. T.), Grants-in-aid for Scientific Research on Priority Areas 17084002 (to A. N.) and 17084008 (to S. T.), Grant-in-aid for Exploratory Research 23657105 (to S. T.), and a Grant-in-aid for the Global COE Program "Formation of a strategic base for biodiversity and evolutionary research: from genome to ecosystem" (A06; to A. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo HM, 2005, BIOPHYS J, V89, P402, DOI 10.1529/biophysj.104.058230; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Holzer W, 2004, CHEM PHYS, V302, P105, DOI 10.1016/j.chemphys.2004.03.017; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Huang KY, 2002, PHYSIOL PLANTARUM, V115, P613, DOI 10.1034/j.1399-3054.2002.1150416.x; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Koyama T, 2009, BIOCHEMISTRY-US, V48, P7621, DOI 10.1021/bi9009192; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Liu HY, 2011, NUCL ENG INT, V56, P16; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Song SH, 2007, J PHOTOCH PHOTOBIO B, V87, P37, DOI 10.1016/j.jphotobiol.2006.12.007; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Swartz TE, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P305, DOI 10.1002/352760510X.ch14; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Trippens J, 2012, PLANT CELL, V24, P4687, DOI 10.1105/tpc.112.103523; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569	53	35	36	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					413	422		10.1074/jbc.M113.515403	http://dx.doi.org/10.1074/jbc.M113.515403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24285544	Green Published, hybrid			2022-12-25	WOS:000329370900036
J	Andernach, IE; Hunewald, OE; Muller, CP				Andernach, Iris E.; Hunewald, Oliver E.; Muller, Claude P.			Bayesian Inference of the Evolution of HBV/E	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENETIC DIVERSITY; GENOTYPE-E; SUBGENOTYPE A1; C VIRUS; TRANSMISSION; EPIDEMIOLOGY; VARIABILITY; INJECTIONS; EMERGENCE	Despite its wide spread and high prevalence in sub-Saharan Africa, hepatitis B virus genotype E (HBV/E) has a surprisingly low genetic diversity, indicating an only recent emergence of this genotype in the general African population. Here, we performed extensive phylogeographic analyses, including Bayesian MCMC modeling. Our results indicate a mutation rate of 1.9x10(-4) substitutions per site and year (s/s/y) and confirm a recent emergence of HBV/E, most likely within the last 130 years, and only after the transatlantic slave-trade had come to an end. Our analyses suggest that HBV/E originated from the area of Nigeria, before rapidly spreading throughout sub-Saharan Africa. Interestingly, viral strains found in Haiti seem to be the result of multiple introductions only in the second half of the 20th century, corroborating an absence of a significant number of HBV/E strains in West Africa several centuries ago. Our results confirm that the hyperendemicity of HBV(E) in today's Africa is a recent phenomenon and likely the result of dramatic changes in the routes of viral transmission in a relatively recent past.	[Andernach, Iris E.; Hunewald, Oliver E.; Muller, Claude P.] Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg	Luxembourg Institute of Health	Muller, CP (corresponding author), Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg.	Claude.Muller@CRP-SANTE.LU		Hunewald, Oliver/0000-0001-5402-5084	National Research Fund, Luxembourg [TR-PHD-BFR07-129 TR]	National Research Fund, Luxembourg(Luxembourg National Research Fund)	National Research Fund, Luxembourg (TR-PHD-BFR07-129 TR) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brichler S, 2013, J GEN VIROL; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, P88, DOI 10.1111/j.1469-0691.2010.03205.x; Hubschen JM, 2009, J MED VIROL, V81, P435, DOI 10.1002/jmv.21412; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2007, HEPATOL RES, V37, pS27, DOI 10.1111/j.1872-034X.2007.00100.x; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Njouom R, 2007, INFECT GENET EVOL, V7, P361, DOI 10.1016/j.meegid.2006.10.003; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Pepin J, 2008, TROP MED INT HEALTH, V13, P744, DOI 10.1111/j.1365-3156.2008.02060.x; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SMITH JM, 1992, J MOL EVOL, V34, P126; Tatematsu K, 2009, J VIROL; WHO (World Health Organization), 2002, WHOCDSCSRLYO20022; Zaaijer HL, 2008, J VIRAL HEPATITIS, V15, P239, DOI 10.1111/j.1365-2893.2007.00938.x; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	42	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81690	10.1371/journal.pone.0081690	http://dx.doi.org/10.1371/journal.pone.0081690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312336	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300042
J	Dasgupta, S; Kong, JN; Bieberich, E				Dasgupta, Somsankar; Kong, Jina; Bieberich, Erhard			Phytoceramide in Vertebrate Tissues: One Step Chromatography Separation for Molecular Characterization of Ceramide Species	PLOS ONE			English	Article							2-HYDROXY FATTY-ACIDS; LONG-CHAIN BASES; GAS-CHROMATOGRAPHY; QUANTITATIVE-DETERMINATION; SUBSTRATE-SPECIFICITY; MASS-SPECTROMETRY; SPHINGOLIPIDS; PHYTOSPHINGOSINE; DESATURASE; GLYCOSPHINGOLIPIDS	Ceramide is a precursor for complex sphingolipids in vertebrates, while plants contain phytoceramide. By using a novel chromatography purification method we show that phytoceramide comprises a significant proportion of animal sphingolipids. Total ceramide including phytoceramide from mouse tissue (brain, heart, liver) lipid extracts and cell culture (mouse primary astrocytes, human oligodendroglioma cells) was eluted as a single homogenous fraction, and then analyzed by thin layer chromatography, and further characterized by gas chromatography-mass spectrometry (GC-MS). We detected a unique band that migrated between non-hydroxy fatty acyl ceramide and hydroxy fatty acyl ceramide, and identified it as phytoceramide. Using RT-PCR, we confirmed that mouse tissues expressed desaturase 2, an enzyme that has been reported to generate phytoceramide from dihydroceramide. Previously, only trace amounts of phytoceramide were reported in vertebrate intestine, kidney, and skin. While its function is still elusive, this is the first report of phytoceramide characterization in glial cells and vertebrate brain, heart, and liver.	[Dasgupta, Somsankar; Kong, Jina; Bieberich, Erhard] Georgia Regents Univ, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30904 USA	University System of Georgia; Augusta University	Bieberich, E (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30904 USA.	ebieberich@gru.edu			National Institutes of Health [R01AG034389]; NSF [NSF1121579]; NATIONAL INSTITUTE ON AGING [R01AG034389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant R01AG034389 and an NSF grant NSF1121579 to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; CARTER HE, 1963, BIOCHEMISTRY-US, V2, P389, DOI 10.1021/bi00902a036; Dasgupta S, 2001, J LIPID RES, V42, P301; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GAVER RC, 1965, J AM OIL CHEM SOC, V42, P294, DOI 10.1007/BF02540132; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He Q, 2012, MOL BIOL CELL, V23, P3156, DOI 10.1091/mbc.E12-02-0079; Hwang O, 2001, MOL PHARMACOL, V59, P1249, DOI 10.1124/mol.59.5.1249; IWAMORI M, 1979, J LIPID RES, V20, P86; Jung JC, 2011, MOLECULES, V16, P9090, DOI 10.3390/molecules16119090; KARLSSON KA, 1973, BIOCHIM BIOPHYS ACTA, V316, P336, DOI 10.1016/0005-2760(73)90073-8; KAWAMURA N, 1977, J BIOCHEM-TOKYO, V81, P1217; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; LAINE RA, 1974, BIOMED MASS SPECTROM, V1, P10, DOI 10.1002/bms.1200010105; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee JS, 2001, FEBS LETT, V499, P82, DOI 10.1016/S0014-5793(01)02527-3; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Masood MA, 2010, ANAL BIOCHEM, V400, P259, DOI 10.1016/j.ab.2010.01.033; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; MONONEN I, 1975, FEBS LETT, V59, P190, DOI 10.1016/0014-5793(75)80372-3; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; PRITCHARD DG, 1977, J CHROMATOGR, V133, P133, DOI 10.1016/S0021-9673(00)89212-2; RAUVALA H, 1977, CARBOHYD RES, V56, P1, DOI 10.1016/S0008-6215(00)84231-7; Sekiya M, 2011, INT IMMUNOPHARMACOL, V11, P1497, DOI 10.1016/j.intimp.2011.05.001; SIDDIQUI B, 1978, J BIOL CHEM, V253, P2168; VANCE DE, 1967, J LIPID RES, V8, P621; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; YU RK, 1970, J LIPID RES, V11, P506	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80841	10.1371/journal.pone.0080841	http://dx.doi.org/10.1371/journal.pone.0080841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312247	Green Submitted, gold, Green Published			2022-12-25	WOS:000327670300018
J	Odman-Naresh, J; Duevel, M; Muthukrishnan, S; Merzendorfer, H				Odman-Naresh, Jothini; Duevel, Margret; Muthukrishnan, Subbaratnam; Merzendorfer, Hans			A Lepidopteran-Specific Gene Family Encoding Valine-Rich Midgut Proteins	PLOS ONE			English	Article							PERITROPHIC MATRIX; TOBACCO HORNWORM; MANDUCA-SEXTA; CHITIN SYNTHASE; CUTICULAR PROTEINS; INTESTINAL MUCIN; PLASMA-MEMBRANE; K+/H+ ANTIPORT; BOMBYX-MORI; EXPRESSION	Many lepidopteran larvae are serious agricultural pests due to their feeding activity. Digestion of the plant diet occurs mainly in the midgut and is facilitated by the peritrophic matrix (PM), an extracellular sac-like structure, which lines the midgut epithelium and creates different digestive compartments. The PM is attracting increasing attention to control lepidopteran pests by interfering with this vital function. To identify novel PM components and thus potential targets for insecticides, we performed an immunoscreening with anti-PM antibodies using an expression library representing the larval midgut transcriptome of the tobacco hornworm, Manduca sexta. We identified three cDNAs encoding valine-rich midgut proteins of M. sexta (MsVmps), which appear to be loosely associated with the PM. They are members of a lepidopteran-specific family of nine VMP genes, which are exclusively expressed in larval stages in M. sexta. Most of the MsVMP transcripts are detected in the posterior midgut, with the highest levels observed for MsVMP1. To obtain further insight into Vmp function, we expressed MsVMP1 in insect cells and purified the recombinant protein. Lectin staining and glycosidase treatment indicated that MsVmp1 is highly O-glycosylated. In line with results from qPCR, immunoblots revealed that MsVmpl amounts are highest in feeding larvae, while MsVmpl is undetectable in starving and molting larvae. Finally using immunocytochemistry, we demonstrated that MsVmpl localizes to the cytosol of columnar cells, which secrete MsVmpl into the ectoperitrophic space in feeding larvae. In starving and molting larvae, MsVmpl is found in the gut lumen, suggesting that the PM has increased its permeability. The present study demonstrates that lepidopteran species including many agricultural pests have evolved a set of unique proteins that are not found in any other taxon and thus may reflect an important adaptation in the highly specialized lepidopteran digestive tract facing particular immune challenges.	[Odman-Naresh, Jothini; Duevel, Margret; Merzendorfer, Hans] Univ Osnabruck, Dept Biol, Osnabruck, Germany; [Muthukrishnan, Subbaratnam] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	University Osnabruck; Kansas State University	Merzendorfer, H (corresponding author), Univ Osnabruck, Dept Biol, Osnabruck, Germany.	merzendorfer@biologie.uni-osnabrueck.de			NSF [IOS-1022227]; DFG [Me2210/2-2]; Government of the State of Lower Saxonia, Germany; Lichtenberg fellowship; Division Of Integrative Organismal Systems [1022227] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Government of the State of Lower Saxonia, Germany; Lichtenberg fellowship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF Grant IOS-1022227 to S.Muthukrishnan and DFG Grant Me2210/2-2 to H.Merzendorfer. J. Odman-Naresh was supported by a Lichtenberg fellowship awarded by the Government of the State of Lower Saxonia, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA M, 1995, FEBS LETT, V361, P153, DOI 10.1016/0014-5793(95)00146-Z; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BEREBAUM M, 1980, AM NAT, V115, P138, DOI 10.1086/283551; Broehan G, 2008, J INSECT PHYSIOL, V54, P1243, DOI 10.1016/j.jinsphys.2008.06.007; Broehan G, 2007, J EXP BIOL, V210, P3636, DOI 10.1242/jeb.008334; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; BULLA LA, 1980, CRC CR REV MICROBIOL, V8, P147, DOI 10.3109/10408418009081124; Dow JA, 1984, AM J PHYSIOL R, V246, P633; DOW JAT, 1992, J EXP BIOL, V172, P355; Dyson HJ, 2005, METHOD ENZYMOL, V394, P299, DOI 10.1016/S0076-6879(05)94011-1; Gan L, 2013, PEST MANAG SCI; GRAF R, 1992, FEBS LETT, V300, P119, DOI 10.1016/0014-5793(92)80177-I; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hogenkamp DG, 2005, INSECT BIOCHEM MOLEC, V35, P529, DOI 10.1016/j.ibmb.2005.01.016; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KLEIN U, 1991, J EXP BIOL, V161, P61; Korayem AM, 2004, INSECT BIOCHEM MOLEC, V34, P1297, DOI 10.1016/j.ibmb.2004.09.001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Sarauer BL, 2003, INSECT MOL BIOL, V12, P333, DOI 10.1046/j.1365-2583.2003.00420.x; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Tellam R. L., 1996, P86; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Toprak U, 2010, INSECT MOL BIOL, V19, P163, DOI 10.1111/j.1365-2583.2009.00966.x; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008; Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7	45	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82015	10.1371/journal.pone.0082015	http://dx.doi.org/10.1371/journal.pone.0082015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312395	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300066
J	Li, WT; Jiang, ZW; Yang, ZH; Zhao, N; Yuan, WZ				Li, Wenting; Jiang, Zhengwu; Yang, Zhenghong; Zhao, Nan; Yuan, Weizhong			Self-Healing Efficiency of Cementitious Materials Containing Microcapsules Filled with Healing Adhesive: Mechanical Restoration and Healing Process Monitored by Water Absorption	PLOS ONE			English	Article							TOUGHENED EPOXY COMPOSITE; FATIGUE CRACKS; CONCRETE; REPAIR; PERMEABILITY; RETARDATION; PERFORMANCE; FRACTURE; DAMAGE	Autonomous crack healing of cementitious composite, a construction material that is susceptible to cracking, is of great significance to improve the serviceability and to prolong the longevity of concrete structures. In this study, the St-DVB microcapsules enclosing epoxy resins as the adhesive agent were embedded in cement paste to achieve self-healing capability. The self-healing efficiency was firstly assessed by mechanical restoration of the damaging specimens after being matured. The flexural and compressive configurations were both used to stimulate the localized and distributed cracks respectively. The effects of some factors, including the content of microcapsules, the curing conditions and the degree of damage on the healing efficiency were investigated. Water absorption was innovatively proposed to monitor and characterize the evolution of crack networks during the healing process. The healing cracks were observed by SEM-EDS following. The results demonstrated that the capsule-containing cement paste can achieve the various mechanical restorations depending on the curing condition and the degree of damage. But the voids generated by the surfactants compromised the strength. Though no noticeable improved stiffness obtained, the increasing fracture energy was seen particularly for the specimen acquiring 60% pre-damage. The sorptivity and amount of water decreased with cracks healing by the adhesive, which contributed to cut off and block ingress of water. The micrographs by SEM-EDS also validated that the cracks were bridged by the hardened epoxy as the dominated elements of C and O accounted for 95% by mass in the nearby cracks.	[Li, Wenting; Jiang, Zhengwu; Yang, Zhenghong; Zhao, Nan] Tongji Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai 200092, Peoples R China; [Yuan, Weizhong] Tongji Univ, Dept Mat Sci & Engn, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Jiang, ZW (corresponding author), Tongji Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai 200092, Peoples R China.	jzhw@tongji.edu.cn	yang, zheng/HGC-7753-2022		National Basic Research Program of China (973 Program) [2011CB013805]; National Natural Science Foundation of China [51278360, 51078269, 51308407]; National Key Project of Scientific and Technical Supporting Programs of China [2011BAE14B06]; Fundamental Research Funds for the Central Universities; State Key Laboratory of High Performance Civil Engineering Materials and Kwang-Hua Fund for College of Civil Engineering; open funding of Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education [201303]; Tongji University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Scientific and Technical Supporting Programs of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of High Performance Civil Engineering Materials and Kwang-Hua Fund for College of Civil Engineering; open funding of Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education; Tongji University	The authors gratefully acknowledge the financial support provided by National Basic Research Program of China (973 Program: 2011CB013805), National Natural Science Foundation of China (51278360, 51078269, 51308407), National Key Project of Scientific and Technical Supporting Programs of China (No. 2011BAE14B06), the Fundamental Research Funds for the Central Universities, State Key Laboratory of High Performance Civil Engineering Materials and Kwang-Hua Fund for College of Civil Engineering, open funding of Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education (201303), Tongji University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T.H., 2010, 4 INT C CONSTR MAT P, P1339; Ahn TH, 2010, J ADV CONCR TECHNOL, V8, P171, DOI 10.3151/jact.8.171; [Anonymous], 2008, C34808 ASTM INT; [Anonymous], 1993, CAUS EV REP CRACKS C; ASTM, 2004, STANDARD TEST METHOD; Breugel K. van, 2007, 1 INT C SELF HEAL MA; Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc; Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2474, DOI 10.1016/j.compscitech.2005.04.053; Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2466, DOI 10.1016/j.compscitech.2005.04.020; Brown EN, 2002, EXP MECH, V42, P372, DOI 10.1007/BF02412141; Dry C., 1994, SMART MATER STRUCT, V3, P118; Edvardsen C, 1999, ACI MATER J, V96, P448; Gerard B., 1997, 16 RILEM, P265; Ghosh S.K., 2009, SELF HEALING MAT FUN, DOI 10.1002/9783527625376.ch1; Granger S, 2007, CEMENT CONCRETE RES, V37, P519, DOI 10.1016/j.cemconres.2006.12.005; Guo ZH, 2011, REINFORCED CONCRETE, P10; Hall C., 2002, WATER TRANSPORT BRIC, P29; Hanzic L, 2010, CEMENT CONCRETE COMP, V32, P84, DOI 10.1016/j.cemconcomp.2009.10.005; Hayes SA, 2007, J R SOC INTERFACE, V4, P381, DOI 10.1098/rsif.2006.0209; Hearn N, 1997, MATER STRUCT, V30, P404, DOI 10.1007/BF02498563; Hearn N, 1998, MATER STRUCT, V31, P563, DOI 10.1007/BF02481539; [胡婷 Hu Ting], 2012, [高分子材料科学与工程, Polymer Materials Science & Engineering], V28, P148; Igarashi S, 2009, JCITC075B; Jin H, 2011, POLYMER, V52, P1628, DOI 10.1016/j.polymer.2011.02.011; Jones AS, 2007, J R SOC INTERFACE, V4, P395, DOI 10.1098/rsif.2006.0199; Joseph C, 2010, MAG CONCRETE RES, V62, P831, DOI 10.1680/macr.2010.62.11.831; Joseph C, 2011, PROC INST CIV ENG-CO, V164, P29, DOI 10.1680/coma.900051; Kanematsu M, 2009, NUCL INSTRUM METH A, V605, P154, DOI 10.1016/j.nima.2009.01.206; Kanninen MF, 1985, ADV FRACTURE MECH, P131; Keller MW, 2007, P 1 INT C SELF HEAL, P18; Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6; Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4; Kishi T., 2007, P 1 INT C SELF HEAL; Li WT, 2011, CONSTR BUILD MATER, V25, P2604, DOI 10.1016/j.conbuildmat.2010.12.007; Mehta P K, 1997, CONCRETE INT, V19, P1; Mehta P. K., 1999, CONCRETE INT, V21, P47; Mihashi H., 2000, T JAPAN CONCRETE I, V11, P21, DOI [10.3151/crt1990.11.2_21, DOI 10.3151/CRT1990.11.2_21, DOI 10.3151/CRT1990.11.2_]; Monteiro P, 2006, CONCRETE MICROSTRUCT, DOI DOI 10.1036/0071462899; Na SH, 2012, J ADV CONCR TECHNOL, V10, P240, DOI 10.3151/jact.10.240; Neville A., 2002, CONCR INT, V24, P76; Neville A. M., 2012, PROPERTIES CONCRETE, Vfifth; Nishiwaki T, 1997, THESIS TOHOKU U; Nishiwaki T., 2006, J ADV CONCR TECHNOL, V4, P267, DOI DOI 10.3151/JACT.4.267; [欧进萍 Ou Jinping], 2004, [固体力学学报, Acta Mechanica Solida Sinica], V25, P320; Panjehpour M, 2011, INT J SUSTAIN CONSTR, V2, P54; Patel AJ, 2007, P 1 INT C SELF HEAL, P18; Pelletier M.M., 2011, CEMENT CONCRETE RES, V8, P1055; Picandet V, 2009, CEMENT CONCRETE RES, V39, P537, DOI 10.1016/j.cemconres.2009.03.009; Rattner E., 2010, COST EFFECTIVE SELF; Rfalcon Warner, 1998, CONCRETE STRUCTURES; Rilem T, 1985, MATER STRUCT, V18, P285, DOI DOI 10.1007/BF02472918; Rule JD, 2007, POLYMER, V48, P3520, DOI 10.1016/j.polymer.2007.04.008; Sahmaran M, 2013, CEMENT CONCRETE COMP, V35, P89, DOI 10.1016/j.cemconcomp.2012.08.013; Sain T, 2008, ENG FRACT MECH, V75, P4036, DOI 10.1016/j.engfracmech.2008.04.007; Sisomphon K, 2012, CEMENT CONCRETE COMP, V34, P566, DOI 10.1016/j.cemconcomp.2012.01.005; Sun MQ, 2000, CEMENT CONCRETE RES, V30, P1251, DOI 10.1016/S0008-8846(00)00284-2; Wang KJ, 1997, CEMENT CONCRETE RES, V27, P381, DOI 10.1016/S0008-8846(97)00031-8; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g; Wu M, 2012, CONSTR BUILD MATER, V28, P571, DOI 10.1016/j.conbuildmat.2011.08.086; Xing F, 2008, Patent No. [200810067312.9, 2008100673129]; Xing F, 2008, Patent No. [200810067313.3, 2008100673133]; Xing F, 2008, Patent No. [200810067314.8, 2008100673148]; Yang ZX, 2010, TRANSPORT RES REC, P9, DOI 10.3141/2142-02	64	170	177	4	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81616	10.1371/journal.pone.0081616	http://dx.doi.org/10.1371/journal.pone.0081616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312328	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900041
J	Potschke, C; Kessler, W; Maier, S; Heidecke, CD; Broker, BM				Poetschke, Christian; Kessler, Wolfram; Maier, Stefan; Heidecke, Claus-Dieter; Broeker, Barbara M.			Experimental Sepsis Impairs Humoral Memory in Mice	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; ASCENDENS STENT PERITONITIS; REGULATORY T-CELLS; BONE-MARROW; IMMUNOLOGICAL MEMORY; IMMUNITY; ANTIGEN; ACTIVATION; MECHANISMS; DURATION	Patients with sepsis are often immune suppressed, and experimental mouse models of sepsis also display this feature. However, acute sepsis in mice is also characterized by a generalized B cell activation and plasma cell differentiation, resulting in a marked increase in serum antibody concentration. Its effects on humoral memory are not clearly defined. We measured the effects of experimental sepsis on long-term immunological memory for a defined antigen: we induced colon ascendens stent peritonitis (CASP) 8 weeks after 2 rounds of immunization with ovalbumin. Four weeks later, the antigen-specific bone marrow plasma cell count had doubled in immunized non-septic animals, but remained unchanged in immunized septic animals. Sepsis also caused a decrease in antigen-specific serum antibody concentration. We conclude that sepsis weakens humoral memory by impeding the antigen-specific plasma cell pool's development, which is not complete 8 weeks after secondary immunization.	[Poetschke, Christian; Broeker, Barbara M.] Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Kessler, Wolfram; Maier, Stefan; Heidecke, Claus-Dieter] Univ Med Greifswald, Dept Surg, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School	Broker, BM (corresponding author), Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany.	broeker@uni-greifswald.de	Bröker, Barbara M/O-4850-2015; Maier, Stefan/V-2883-2019	Bröker, Barbara M/0000-0002-5020-8542; Maier, Stefan/0000-0001-9704-7902	DFG [GRK840]	DFG(German Research Foundation (DFG))	The study was financed in part by the DFG (GRK840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Amanna IJ, 2012, HUM IMMUNOL, V73, P1082, DOI 10.1016/j.humimm.2012.07.328; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Benjamim CF, 2005, BLOOD, V105, P3588, DOI 10.1182/blood-2004-08-3251; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Boontham P, 2003, SURG-J R COLL SURG E, V1, P187, DOI 10.1016/S1479-666X(03)80018-5; Bortnick A, 2012, J IMMUNOL, V188, P5389, DOI 10.4049/jimmunol.1102808; CasamayorPalleja M, 1996, INT IMMUNOL, V8, P737, DOI 10.1093/intimm/8.5.737; Chu VT, 2012, EUR J IMMUNOL, V42, P130, DOI 10.1002/eji.201141953; COICO RF, 1983, J IMMUNOL, V131, P2254; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Meyer-Bahlburg A, 2012, FRONT BIOSCI-LANDMRK, V17, P1499, DOI 10.2741/4000; Mohr A, 2012, EUR J IMMUNOL, V42, P341, DOI 10.1002/eji.201141692; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Persson T, 2001, INFECT IMMUN, V69, P3591, DOI 10.1128/IAI.69.6.3591-3596.2001; Pick M, 2006, BLOOD, V107, P3397, DOI 10.1182/blood-2005-08-3240; Pinheiro-da-Silva F, 2006, SHOCK, V25, P61, DOI 10.1097/01.shk.0000196496.72553.78; Potschke C, 2012, BLOOD, V120, P4238, DOI 10.1182/blood-2012-04-419424; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Slade E, 2003, CRIT CARE, V7, P1, DOI 10.1186/cc1876; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Svensson L, 2005, MICROBES INFECT, V7, P720, DOI 10.1016/j.micinf.2005.01.010; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Trampuza A, 2003, SCHWEIZ MED FORUM, V35, P811; Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Wolber EM, 2001, THROMB HAEMOSTASIS, V86, P1421; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Wraith DC, 2004, CURR OPIN IMMUNOL, V16, P695, DOI 10.1016/j.coi.2004.09.015; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	64	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81752	10.1371/journal.pone.0081752	http://dx.doi.org/10.1371/journal.pone.0081752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312349	gold, Green Submitted, Green Published			2022-12-25	WOS:000327657900049
J	Sedes, L; Leclerc, A; Moindjie, H; Cate, RL; Picard, JY; di Clemente, N; Jamin, SP				Sedes, Lauriane; Leclerc, Arnaud; Moindjie, Hadia; Cate, Richard L.; Picard, Jean-Yves; di Clemente, Nathalie; Jamin, Soazik P.			Anti-Mullerian Hormone Recruits BMPR-IA in Immature Granulosa Cells	PLOS ONE			English	Article							REPULSIVE GUIDANCE MOLECULE; INHIBITING SUBSTANCE; BREAST-CANCER; DUCT REGRESSION; RECEPTOR ALK2; LEYDIG-CELLS; II RECEPTOR; ID PROTEINS; EXPRESSION; GROWTH	Anti-Mullerian hormone (AMH) is a member of the TGF-beta superfamily secreted by the gonads of both sexes. This hormone is primarily known for its role in the regression of the Mullerian ducts in male fetuses. In females, AMH is expressed in granulosa cells of developing follicles. Like other members of the TGF-b superfamily, AMH transduces its signal through two transmembrane serine/threonine kinase receptors including a well characterized type II receptor, AMHR-II. The complete signalling pathway of AMH involving Smads proteins and the type I receptor is well known in the Mullerian duct and in Sertoli and Leydig cells but not in granulosa cells. In addition, few AMH target genes have been identified in these cells. Finally, while several co-receptors have been reported for members of the TGF-beta superfamily, none have been described for AMH. Here, we have shown that none of the Bone Morphogenetic Proteins (BMPs) co-receptors, Repulsive guidance molecules (RGMs), were essential for AMH signalling. We also demonstrated that the main Smad proteins used by AMH in granulosa cells were Smad 1 and Smad 5. Like for the other AMH target cells, the most important type I receptor for AMH in these cells was BMPR-IA. Finally, we have identified a new AMH target gene, Id3, which could be involved in the effects of AMH on the differentiation of granulosa cells and its other target cells.	[Sedes, Lauriane; Leclerc, Arnaud; Moindjie, Hadia; Cate, Richard L.; Picard, Jean-Yves; di Clemente, Nathalie; Jamin, Soazik P.] INSERM, U782, Clamart, France; [Sedes, Lauriane; Leclerc, Arnaud; Moindjie, Hadia; Cate, Richard L.; Picard, Jean-Yves; di Clemente, Nathalie; Jamin, Soazik P.] Univ Paris 11, UMR S0782, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Jamin, SP (corresponding author), Univ Rennes 1, INSERM, IRSET, U1085, Rennes, France.	soazik.jamin@inserm.fr	Jamin, Soazik/F-6796-2015; Jamin, Soazik P./K-1507-2019	Jamin, Soazik P./0000-0002-1688-0167; Moindjie, Hadia/0000-0001-6763-214X; di Clemente, Nathalie/0000-0001-9087-3486	INSERM, Universite Paris-Sud XI; French Agence Nationale de la Recherche (ANR) [ANR-08-JCJC-0059]; Universite Paris-Sud XI	INSERM, Universite Paris-Sud XI; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Universite Paris-Sud XI	This work was supported by INSERM, Universite Paris-Sud XI and the French Agence Nationale de la Recherche (ANR) (grant under reference [ANR-08-JCJC-0059] to Soazik P. Jamin). Lauriane Sedes holds a PhD studentship from Universite Paris-Sud XI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Belville C, 2005, ONCOGENE, V24, P4984, DOI 10.1038/sj.onc.1208686; Belville C, 1999, AM J MED GENET, V89, P218, DOI 10.1002/(SICI)1096-8628(19991229)89:4<218::AID-AJMG6>3.0.CO;2-E; CAMPBELL KL, 1979, BIOL REPROD, V21, P773, DOI 10.1095/biolreprod21.4.773; Chang H, 1999, DEVELOPMENT, V126, P1631; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; Clement JH, 2000, J CANCER RES CLIN, V126, P271, DOI 10.1007/s004320050342; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; DICLEMENTE N, 1994, ENDOCRINE, V2, P553; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; Edson MA, 2010, MOL ENDOCRINOL, V24, P1251, DOI 10.1210/me.2009-0461; Fynn-Thompson E, 2003, MOL CELL ENDOCRINOL, V211, P99, DOI 10.1016/j.mce.2003.09.015; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Haugen MJ, 2010, REPRODUCTION, V140, P551, DOI 10.1530/REP-10-0211; Hogg K, 2010, ENDOCRINOLOGY, V151, P1247, DOI 10.1210/en.2009-0914; Huang Z, 2009, HUM MOL GENET, V18, P2791, DOI 10.1093/hmg/ddp214; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Johnson AL, 2008, ENDOCRINOLOGY, V149, P3187, DOI 10.1210/en.2007-1659; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; Kubler NR, 1998, INT J ORAL MAX SURG, V27, P305, DOI 10.1016/S0901-5027(05)80621-6; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lebeurrier N, 2008, J CELL SCI, V121, P3357, DOI 10.1242/jcs.031872; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Li J, 2012, J CELL BIOCHEM, V113, P2523, DOI 10.1002/jcb.24128; Li J, 2012, INT J ONCOL, V40, P544, DOI 10.3892/ijo.2011.1251; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Masiakos PT, 1999, CLIN CANCER RES, V5, P3488; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MATZUK MM, 1995, MOL ENDOCRINOL, V9, P1337, DOI 10.1210/me.9.10.1337; Messika-Zeitoun L, 2001, J CLIN ENDOCR METAB, V86, P4390, DOI 10.1210/jc.86.9.4390; Mishina Y, 1999, ENDOCRINOLOGY, V140, P2084, DOI 10.1210/en.140.5.2084; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mishina Y, 1996, GENE DEV, V10, P2577, DOI 10.1101/gad.10.20.2577; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Orvis GD, 2008, BIOL REPROD, V78, P994, DOI 10.1095/biolreprod.107.066605; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Pellatt L, 2011, FERTIL STERIL, V96, P1246, DOI 10.1016/j.fertnstert.2011.08.015; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; Renaud EJ, 2005, P NATL ACAD SCI USA, V102, P111, DOI 10.1073/pnas.0407772101; Rey R, 2000, HUM PATHOL, V31, P1202, DOI 10.1053/hupa.2000.18498; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Segev DL, 2000, J BIOL CHEM, V275, P28371, DOI 10.1074/jbc.M004554200; VASHEE S, 1995, P NATL ACAD SCI USA, V92, P10683, DOI 10.1073/pnas.92.23.10683; Verbraak EJC, 2011, THERIOGENOLOGY, V75, P362, DOI 10.1016/j.theriogenology.2010.09.008; VIGIER B, 1984, ENDOCRINOLOGY, V114, P1315, DOI 10.1210/endo-114-4-1315; Visser JA, 2001, MOL ENDOCRINOL, V15, P936, DOI 10.1210/me.15.6.936; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Wu XF, 2012, ENDOCRINOLOGY, V153, P4929, DOI 10.1210/en.2012-1168; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Yi SE, 2001, P NATL ACAD SCI USA, V98, P7994, DOI 10.1073/pnas.141002798	62	30	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81551	10.1371/journal.pone.0081551	http://dx.doi.org/10.1371/journal.pone.0081551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312319	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900040
J	Tomiyasu, M; Aida, N; Endo, M; Shibasaki, J; Nozawa, K; Shimizu, E; Tsuji, H; Obata, T				Tomiyasu, Moyoko; Aida, Noriko; Endo, Mamiko; Shibasaki, Jun; Nozawa, Kumiko; Shimizu, Eiji; Tsuji, Hiroshi; Obata, Takayuki			Neonatal Brain Metabolite Concentrations: An In Vivo Magnetic Resonance Spectroscopy Study with a Clinical MR System at 3 Tesla	PLOS ONE			English	Article							N-ACETYLASPARTATE; LOCALIZED PROTON; PRETERM; TERM; AGE; LACTATE; RELAXATION; CHILDREN; INFANTS; CHOLINE	Brain metabolite concentrations change dynamically throughout development, especially during early childhood. The purpose of this study was to investigate the brain metabolite concentrations of neonates (postconceptional age (PCA): 30 to 43 weeks) using single-voxel magnetic resonance spectroscopy (MRS) and to discuss the relationships between the changes in the concentrations of such metabolites and brain development during the neonatal period. A total of 83 neonatal subjects were included using the following criteria: the neonates had to be free of radiological abnormalities, organic illness, and neurological symptoms; the MR spectra had to have signal-to-noise ratios >= 4; and the estimated metabolite concentrations had to display Cramer-Rao lower bounds of <= 30%. MRS data (echo time/repetition time, 30/5000 ms; 3T) were acquired from the basal ganglia (BG), centrum semiovale (CS), and the cerebellum. The concentrations of five metabolites were measured: creatine, choline, N-acetylaspartate, myo-inositol, and glutamate/glutamine complex (Glx). One hundred and eighty-four MR spectra were obtained (83 BG, 77 CS, and 24 cerebellum spectra). Creatine, N-acetylaspartate, and Glx displayed increases in their concentrations with PCA. Choline was not correlated with PCA in any region. As for myo-inositol, its concentration decreased with PCA in the BG, whereas it increased with PCA in the cerebellum. Quantitative brain metabolite concentrations and their changes during the neonatal period were assessed. Although the observed changes were partly similar to those detected in previous reports, our results are with more subjects (n = 83), and higher magnetic field (3T). The metabolite concentrations examined in this study and their changes are clinically useful indices of neonatal brain development.	[Tomiyasu, Moyoko; Aida, Noriko; Nozawa, Kumiko; Tsuji, Hiroshi; Obata, Takayuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Tomiyasu, Moyoko; Aida, Noriko; Nozawa, Kumiko; Obata, Takayuki] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa, Japan; [Tomiyasu, Moyoko; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Res Ctr Child Mental Dev, Chiba, Japan; [Endo, Mamiko; Shibasaki, Jun] Kanagawa Childrens Med Ctr, Dept Neonatol, Yokohama, Kanagawa, Japan	National Institutes for Quantum Science & Technology; Chiba University	Obata, T (corresponding author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan.	t_obata@nirs.go.jp	Obata, Takayuki/AAR-9820-2020; Shimizu, Eiji/K-4637-2017	Obata, Takayuki/0000-0001-7678-5033; Shimizu, Eiji/0000-0002-6741-9338; Tomiyasu, Moyoko/0000-0002-0360-9175; Shibasaki, Jun/0000-0003-4986-4697	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kanagawa Municipal Hospital Pediatric Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanagawa Municipal Hospital Pediatric Research	The present study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from Kanagawa Municipal Hospital Pediatric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J CEREBR BLOOD F MET, V26, P153, DOI 10.1038/sj.jcbfm.9600175; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Brighina E, 2009, PEDIATR NEUROL, V40, P327, DOI 10.1016/j.pediatrneurol.2008.11.001; Cady EB, 1996, MAGN RESON MED, V36, P878, DOI 10.1002/mrm.1910360610; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Huppi PS, 1996, PEDIATR RES, V39, P895; HUPPI PS, 1991, PEDIATR RES, V30, P574; HUPPI PS, 1995, PEDIATR RES, V37, P145; Inder TE, 2000, MENT RETARD DEV D R, V6, P59, DOI 10.1002/(SICI)1098-2779(2000)6:1<59::AID-MRDD8>3.0.CO;2-E; Katz-Brull R, 2002, BRAIN RES, V951, P158, DOI 10.1016/S0006-8993(02)03155-4; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; LETH H, 1995, ACTA PAEDIATR, V84, P495, DOI 10.1111/j.1651-2227.1995.tb13681.x; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; PEDEN CJ, 1990, J COMPUT ASSIST TOMO, V14, P886, DOI 10.1097/00004728-199011000-00004; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Penrice J, 1996, PEDIATR RES, V40, P6, DOI 10.1203/00006450-199607000-00002; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Provencher S., 2012, LCMODEL LCMGUI USERS; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Roelants-Van Rijn AM, 2004, PEDIATR RES, V56, P285, DOI 10.1203/01.PDR.0000132751.09067.3F; Srinivasan L, 2006, AM J NEURORADIOL, V27, P573; Tomiyasu M, 2012, MAGN RESON IMAGING, V30, P1527, DOI 10.1016/j.mri.2012.05.007; Tomiyasu M, 2012, ACTA RADIOL, V53, P223, DOI 10.1258/ar.2011.110339; Tsuji M, 2010, J INHERIT METAB DIS, V33, P85, DOI 10.1007/s10545-009-9022-9; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Vannucci RC, 2011, NEUROIMAGE, V56, P1855, DOI 10.1016/j.neuroimage.2011.03.044; Verkhratsky A., 2007, GLIAL NEUROBIOLOGY T; Watanabe H, 2012, MAGN RESON MED SCI, V11, P235, DOI 10.2463/mrms.11.235; Williams LA, 2005, RADIOLOGY, V235, P595, DOI 10.1148/radiol.2352031769; Xu DA, 2011, J MAGN RESON IMAGING, V33, P306, DOI 10.1002/jmri.22460	37	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82746	10.1371/journal.pone.0082746	http://dx.doi.org/10.1371/journal.pone.0082746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312433	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900073
J	Fierro-Monti, I; Racle, J; Hernandez, C; Waridel, P; Hatzimanikatis, V; Quadroni, M				Fierro-Monti, Ivo; Racle, Julien; Hernandez, Celine; Waridel, Patrice; Hatzimanikatis, Vassily; Quadroni, Manfredo			A Novel Pulse-Chase SILAC Strategy Measures Changes in Protein Decay and Synthesis Rates Induced by Perturbation of Proteostasis with an Hsp90 Inhibitor	PLOS ONE			English	Article							QUANTITATIVE MASS-SPECTROMETRY; CANCER-CELLS; TURNOVER; DYNAMICS; PROTEOMICS; QUANTIFICATION; DEGRADATION; PRINCIPLES; NUCLEAR; SUPERANTIGEN	Standard proteomics methods allow the relative quantitation of levels of thousands of proteins in two or more samples. While such methods are invaluable for defining the variations in protein concentrations which follow the perturbation of a biological system, they do not offer information on the mechanisms underlying such changes. Expanding on previous work ['I], we developed a pulse-chase (pc) variant of SILAC (stable isotope labeling by amino acids in cell culture). pcSILAC can quantitate in one experiment and for two conditions the relative levels of proteins newly synthesized in a given time as well as the relative levels of remaining preexisting proteins. We validated the method studying the drug-mediated inhibition of the Hsp90 molecular chaperone, which is known to lead to increased synthesis of stress response proteins as well as the increased decay of Hsp90 "clients". We showed that pcSILAC can give information on changes in global cellular proteostasis induced by treatment with the inhibitor, which are normally not captured by standard relative quantitation techniques. Furthermore, we have developed a mathematical model and computational framework that uses pcSILAC data to determine degradation constants k(d) and synthesis rates V, for proteins in both control and drug-treated cells. The results show that Hsp90 inhibition induced a generalized slowdown of protein synthesis and an increase in protein decay. Treatment with the inhibitor also resulted in widespread protein-specific changes in relative synthesis rates, together with variations in protein decay rates. The latter were more restricted to individual proteins or protein families than the variations in synthesis. Our results establish pcSILAC as a viable workflow for the mechanistic dissection of changes in the proteome which follow perturbations. Data are available via ProteomeXchange with identifier PXD000538.	[Fierro-Monti, Ivo; Hernandez, Celine; Waridel, Patrice; Quadroni, Manfredo] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Racle, Julien; Hatzimanikatis, Vassily] Ecole Polytech Fed Lausanne, Lab Computat Syst Biotechnol, Lausanne, Switzerland; [Racle, Julien; Hatzimanikatis, Vassily] SIB, Lausanne, Switzerland; [Hernandez, Celine] SIB, Vital IT Grp, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics	Quadroni, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	manfredo.quadroni@unil.ch	Hernandez, Céline/F-1164-2016; Fierro-Monti, Ivo/AAH-3595-2020; Racle, Julien/F-3215-2010; Hatzimanikatis, Vassily/G-6505-2010	Hernandez, Céline/0000-0001-8664-1340; Racle, Julien/0000-0002-0100-0323; Hatzimanikatis, Vassily/0000-0001-6432-4694; /0000-0002-5460-2117; Quadroni, Manfredo/0000-0002-2720-4084	Swiss National Science Foundation [31003A_127256]; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	This work was supported by grant number 31003A_127256 from the Swiss National Science Foundation (www.snf.ch) as well as internal funding from the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y., 2012, MOL CELL PROTEOMICS, V11, P1, DOI [10.1074/mcp.M111.013680, DOI 10.1074/mcp.M111.013680]; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beynon Robert J., 2005, Briefings in Functional Genomics & Proteomics, V3, P382, DOI 10.1093/bfgp/3.4.382; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Geiser L, 2011, METHODS MOL BIOL, V681, P459, DOI 10.1007/978-1-60761-913-0_27; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Haegler K, 2009, J PROTEOMICS, V71, P601, DOI 10.1016/j.jprot.2008.10.004; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jayapal KP, 2010, J PROTEOME RES, V9, P2087, DOI 10.1021/pr9007738; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lam YW, 2010, CURR BIOL, V20, pR1049, DOI [10.1016/j.cub.2010.09.068, DOI 10.1016/J.CUB.2010.09.068]; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Mandal AK, MOL BIOL, V787, P75, DOI [10.1007/978-1-61779-295-3, DOI 10.1007/978-1-61779-295-3]; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Niedergang F, 1997, J IMMUNOL, V159, P1703; Niedergang F, 1997, RES IMMUNOL, V148, P231, DOI 10.1016/S0923-2494(97)80865-6; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PENN EJ, 1987, J CELL BIOL, V105, P2327, DOI 10.1083/jcb.105.5.2327; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rao PK, 2008, ANAL CHEM, V80, P6860, DOI 10.1021/ac800288t; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; ROBERTS S, 1988, J BIOL CHEM, V263, P19181; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; STOSCHECK CM, 1984, J CELL PHYSIOL, V120, P296, DOI 10.1002/jcp.1041200306; Tabuchi Y, 2008, INT J HYPERTHER, V24, P613, DOI 10.1080/02656730802140777; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Trotschel C, 2012, MOL CELL PROTEOMICS, V11, P512, DOI 10.1074/mcp.M111.014134; Turnbull EL, 2006, J CELL SCI, V119, P292, DOI 10.1242/jcs.02729; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yorgin PD, 2000, J IMMUNOL, V164, P2915, DOI 10.4049/jimmunol.164.6.2915; Zhang YY, 2011, ANAL CHEM, V83, P1665, DOI 10.1021/ac102755n	62	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80423	10.1371/journal.pone.0080423	http://dx.doi.org/10.1371/journal.pone.0080423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312217	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100037
J	Cafardi, V; Biagini, M; Martinelli, M; Leuzzi, R; Rubino, JT; Cantini, F; Norais, N; Scarselli, M; Serruto, D; Unnikrishnan, M				Cafardi, Valeria; Biagini, Massimiliano; Martinelli, Manuele; Leuzzi, Rosanna; Rubino, Jeffrey T.; Cantini, Francesca; Norais, Nathalie; Scarselli, Maria; Serruto, Davide; Unnikrishnan, Meera			Identification of a Novel Zinc Metalloprotease through a Global Analysis of Clostridium difficile Extracellular Proteins	PLOS ONE			English	Article							SURFACE-LAYER PROTEINS; CELL-WALL; MOLECULAR CHARACTERIZATION; FLAGELLAR PROTEINS; PROTEOMIC ANALYSIS; TOXIN PRODUCTION; FIBRONECTIN; VIRULENCE; SEQUENCE; BINDING	Clostridium difficile is a major cause of infectious diarrhea worldwide. Although the cell surface proteins are recognized to be important in clostridial pathogenesis, biological functions of only a few are known. Also, apart from the toxins, proteins exported by C. difficile into the extracellular milieu have been poorly studied. In order to identify novel extracellular factors of C. difficile, we analyzed bacterial culture supernatants prepared from clinical isolates, 630 and R20291, using liquid chromatography-tandem mass spectrometry. The majority of the proteins identified were non-canonical extracellular proteins. These could be largely classified into proteins associated to the cell wall (including CWPs and extracellular hydrolases), transporters and flagellar proteins. Seven unknown hypothetical proteins were also identified. One of these proteins, CD630_28300, shared sequence similarity with the anthrax lethal factor, a known zinc metallopeptidase. We demonstrated that CD630_28300 (named Zmp1) binds zinc and is able to cleave fibronectin and fibrinogen in vitro in a zinc-dependent manner. Using site-directed mutagenesis, we identified residues important in zinc binding and enzymatic activity. Furthermore, we demonstrated that Zmp1 destabilizes the fibronectin network produced by human fibroblasts. Thus, by analyzing the exoproteome of C. difficile, we identified a novel extracellular metalloprotease that may be important in key steps of clostridial pathogenesis.	[Cafardi, Valeria; Biagini, Massimiliano; Martinelli, Manuele; Leuzzi, Rosanna; Norais, Nathalie; Scarselli, Maria; Serruto, Davide; Unnikrishnan, Meera] Novartis Vaccines & Diagnost, Siena, Italy; [Rubino, Jeffrey T.; Cantini, Francesca] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Cantini, Francesca] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	Novartis; University of Florence; University of Florence	Unnikrishnan, M (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	m.unnikrishnan@warwick.ac.uk	Cantini, Francesca/O-1220-2015	Cantini, Francesca/0000-0003-0526-6732; martinelli, manuele/0000-0002-9371-076X; Unnikrishnan, Meera/0000-0001-5417-9331	Novartis Vaccines and Regione Toscana [POR CREO FESR 2007-20013]; MIUR (Italian Ministry of University and Research)	Novartis Vaccines and Regione Toscana; MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR))	The research was supported by Novartis Vaccines and Regione Toscana(BIOVAX project-POR CREO FESR 2007-20013) and MIUR (Italian Ministry of University and Research)[PON01_00117]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Boetzkes A, 2012, ARCH MICROBIOL, V194, P675, DOI 10.1007/s00203-012-0802-5; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cerquetti M, 2002, FEMS IMMUNOL MED MIC, V32, P211, DOI 10.1016/S0928-8244(01)00301-7; Dalkas GA, 2010, BIOCHEMISTRY-US, V49, P10767, DOI 10.1021/bi1017792; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Desvaux M, 2010, J PROTEOME RES, V9, P5076, DOI 10.1021/pr1003642; Dhalluin A, 2005, MICROBIOL-SGM, V151, P2343, DOI 10.1099/mic.0.27878-0; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; HASE CC, 1993, MICROBIOL REV, V57, P823; Hoffmann BR, 2011, J BIOL CHEM, V286, P32220, DOI 10.1074/jbc.M111.255562; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karjalainen T, 2001, INFECT IMMUN, V69, P3442, DOI 10.1128/IAI.69.5.3442-3446.2001; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuipers EJ, 2008, LANCET, V371, P1486, DOI 10.1016/S0140-6736(08)60635-2; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Maeda H, 1996, BIOL CHEM H-S, V377, P217; Miura M, 2011, INFECT IMMUN, V79, P3810, DOI 10.1128/IAI.00051-11; MOLLA A, 1988, BIOCHIM BIOPHYS ACTA, V955, P77; Monot M, 2011, J MED MICROBIOL, V60, P1193, DOI 10.1099/jmm.0.030452-0; Mukherjee K, 2002, MICROBIOL-SGM, V148, P2245, DOI 10.1099/00221287-148-7-2245; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Connor J, 2009, GEOJOURNAL LIB, V98, P1, DOI 10.1007/978-1-4020-9949-6_1; Pacheco LGC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-12; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Pechine S, 2007, VACCINE, V25, P3946, DOI 10.1016/j.vaccine.2007.02.055; Poilane I, 1998, CAN J MICROBIOL, V44, P157, DOI 10.1139/cjm-44-2-157; Ravipaty S, 2010, MOL CELL PROTEOMICS, V9, P1898, DOI 10.1074/mcp.M900494-MCP200; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Rigden DJ, 2008, BIOINFORMATICS, V24, P1793, DOI 10.1093/bioinformatics/btn314; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sengupta N, 2010, INFECT IMMUN, V78, P3957, DOI 10.1128/IAI.00374-10; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; SLYNN GM, 1994, FEMS MICROBIOL LETT, V121, P315, DOI 10.1016/0378-1097(94)90310-7; Surawicz CM, 2011, NAT REV GASTRO HEPAT, V8, P330, DOI 10.1038/nrgastro.2011.59; Tasteyre A, 2000, MICROBIOL-SGM, V146, P957, DOI 10.1099/00221287-146-4-957; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Teo JWP, 2003, GENE, V303, P147, DOI 10.1016/S0378-1119(02)01151-4; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5; Zhang DL, 2003, INFECT IMMUN, V71, P510, DOI 10.1128/IAI.71.1.510-515.2003	63	50	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81306	10.1371/journal.pone.0081306	http://dx.doi.org/10.1371/journal.pone.0081306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303041	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400058
J	Gouarne, C; Tardif, G; Tracz, J; Latyszenok, V; Michaud, M; Clemens, LE; Yu-Taeger, L; Nguyen, HP; Bordet, T; Pruss, RM				Gouarne, Caroline; Tardif, Gwenaelle; Tracz, Jennifer; Latyszenok, Virginie; Michaud, Magali; Clemens, Laura Emily; Yu-Taeger, Libo; Nguyen, Huu Phuc; Bordet, Thierry; Pruss, Rebecca M.			Early Deficits in Glycolysis Are Specific to Striatal Neurons from a Rat Model of Huntington Disease	PLOS ONE			English	Article							EXPRESSING MUTANT HUNTINGTIN; ENERGY-METABOLISM; TRANSGENIC MICE; IN-VIVO; MITOCHONDRIAL RESPIRATION; GLUCOSE-METABOLISM; BRAIN; DYSFUNCTION; CELLS; DEHYDROGENASE	In Huntington disease (HD), there is increasing evidence for a link between mutant huntingtin expression, mitochondrial dysfunction, energetic deficits and neurodegeneration but the precise nature, causes and order of these events remain to be determined. In this work, our objective was to evaluate mitochondrial respiratory function in intact, non-permeabilized, neurons derived from a transgenic rat model for HD compared to their wild type littermates by measuring oxygen consumption rates and extracellular acidification rates. Although HD striatal neurons had similar respiratory capacity as those from their wild-type littermates when they were incubated in rich medium containing a supra-physiological glucose concentration (25 mM), pyruvate and amino acids, respiratory defects emerged when cells were incubated in media containing only a physiological cerebral level of glucose (2.5 mM). According to the concept that glucose is not the sole substrate used by the brain for neuronal energy production, we provide evidence that primary neurons can use lactate as well as pyruvate to fuel the mitochondrial respiratory chain. In contrast to glucose, we found no major deficits in HD striatal neurons' capacity to use pyruvate as a respiratory substrate compared to wild type littermates. Additionally, we used extracellular acidification rates to confirm a reduction in anaerobic glycolysis in the same cells. Interestingly, the metabolic disturbances observed in striatal neurons were not seen in primary cortical neurons, a brain region affected in later stages of HD. In conclusion, our results argue for a dysfunction in glycolysis, which might precede any defects in the respiratory chain itself, and these are early events in the onset of disease.	[Gouarne, Caroline; Tardif, Gwenaelle; Tracz, Jennifer; Latyszenok, Virginie; Michaud, Magali; Bordet, Thierry; Pruss, Rebecca M.] Luminy Biotech Entreprises, Trophos, Marseille, France; [Clemens, Laura Emily; Yu-Taeger, Libo; Nguyen, Huu Phuc] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Clemens, Laura Emily; Yu-Taeger, Libo; Nguyen, Huu Phuc] Univ Tubingen, Ctr Rare Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Pruss, RM (corresponding author), Luminy Biotech Entreprises, Trophos, Parc Sci Luminy, Marseille, France.	rpruss@trophos.com	Nguyen, Huu Phuc/HDO-3462-2022; BORDET, THIERRY/AIA-7041-2022; Nguyen, Huu Phuc/F-5390-2015	Nguyen, Huu Phuc/0000-0001-6139-788X; BORDET, THIERRY/0000-0002-3648-2270; Nguyen, Huu Phuc/0000-0001-6139-788X; Gourdou-Latyszenok, Virginie/0000-0002-1595-2528; Yu-Taeger, Libo/0000-0003-4091-5531	Trophos; European Union [HEALTH-F2-2008-223388]	Trophos; European Union(European Commission)	Funding was provided by Trophos and by the European Union under the 7th Framework Program for RTD - Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Bruyn G W, 1979, Tijdschr Ziekenverpl, V32, P101; Cheng A, 2010, NEW EUR, V2; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; HAYDEN MR, 1986, NEUROLOGY, V36, P888, DOI 10.1212/WNL.36.7.888; Jagust WJ, 2012, J NEUROSCI, V32, P18227, DOI 10.1523/JNEUROSCI.3266-12.2012; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Jin YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030406; Koroshetz WJ, 1997, ANN NEUROL, V41, P160, DOI 10.1002/ana.410410206; KUHL DE, 1982, ANN NEUROL, V12, P425, DOI 10.1002/ana.410120504; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Li XJ, 2010, BBA-MOL BASIS DIS, V1802, P62, DOI 10.1016/j.bbadis.2009.06.008; Ferreira IL, 2011, EXP NEUROL, V231, P127, DOI 10.1016/j.expneurol.2011.05.024; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAGISTRETTI PJ, 1994, RENAL PHYSIOL BIOCH, V17, P168; Martin WRW, 2007, J NEUROL SCI, V263, P70, DOI 10.1016/j.jns.2007.05.035; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; O'Brien J, 2007, NEUROCHEM RES, V32, P597, DOI 10.1007/s11064-006-9132-9; Olah J, 2008, FEBS J, V275, P4740, DOI 10.1111/j.1742-4658.2008.06612.x; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reynolds NC, 2005, BRAIN RES, V1031, P82, DOI 10.1016/j.brainres.2004.10.030; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Sanchez-Pernaute R, 1999, NEUROLOGY, V53, P806, DOI 10.1212/WNL.53.4.806; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P1478, DOI 10.1016/j.freeradbiomed.2012.06.008; SILVER IA, 1994, J NEUROSCI, V14, P5068; Unschuld PG, 2012, MOVEMENT DISORD, V27, P895, DOI 10.1002/mds.25010; van den Bogaard SJA, 2011, J NEUROL, V258, P2230, DOI 10.1007/s00415-011-6099-5; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029	51	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81528	10.1371/journal.pone.0081528	http://dx.doi.org/10.1371/journal.pone.0081528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303051	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400067
J	Xie, Q; Wu, J; Tang, Y; Dou, YF; Hao, SJ; Xu, FJ; Feng, XY; Liang, ZH				Xie, Qian; Wu, Juan; Tang, Ying; Dou, Yafang; Hao, Sijie; Xu, Feijia; Feng, Xiaoyuan; Liang, Zonghui			Whole-Organ CT Perfusion of the Pancreas: Impact of Iterative Reconstruction on Image Quality, Perfusion Parameters and Radiation Dose in 256-Slice CT-Preliminary Findings	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; DYNAMIC COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; ROW CT; MULTIDETECTOR CT; ABDOMINAL CT; ALGORITHM; ADENOCARCINOMA; STROKE; ANGIOGRAPHY	Background: This study was performed to assess whether iterative reconstruction can reduce radiation dose while maintaining acceptable image quality, and to investigate whether perfusion parameters vary from conventional filtered back projection (FBP) at the low-tube-voltage (80-kVp) during whole-pancreas perfusion examination using a 256-slice CT. Methods: 76 patients with known or suspected pancreatic mass underwent whole-pancreas perfusion by a 256-slice CT. High-and low-tube-voltage CT images were acquired. 120-kVp image data (protocol A) and 80-kVp image data (protocol B) were reconstructed with conventional FBP, and 80-kVp image data were reconstructed with iDose(4) (protocol C) iterative reconstruction. The image noise; contrast-to-noise ratio (CNR) relative to muscle for the pancreas, liver, and aorta; and radiation dose of each protocol were assessed quantitatively. Overall image quality was assessed qualitatively. Among 76 patients, 23 were eventually proven to have a normal pancreas. Perfusion parameters of normal pancreas in each protocol including blood volume, blood flow, and permeability-surface area product were measured. Results: In the quantitative study, protocol C reduced image noise by 36.8% compared to protocol B (P<0.001). Protocol C yielded significantly higher CNR relative to muscle for the aorta, pancreas and liver compared to protocol B (P<0.001), and offered no significant difference compared to protocol A. In the qualitative study, protocols C and A gained similar scores and protocol B gained the lowest score for overall image quality (P<0.001). Mean effective doses were 23.37 mSv for protocol A and 10.81 mSv for protocols B and C. There were no significant differences in the normal pancreas perfusion values among three different protocols. Conclusion: Low-tube-voltage and iDose(4) iterative reconstruction can dramatically decrease the radiation dose with acceptable image quality during whole-pancreas CT perfusion and have no significant impact on the perfusion parameters of normal pancreas compared to the conventional FBP reconstruction using a 256-slice CT scanner.	[Xie, Qian; Tang, Ying; Dou, Yafang; Xu, Feijia; Feng, Xiaoyuan] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Liang, Zonghui] Fudan Univ, Huashan Hosp, Jingan Dist Cent Hosp Shanghai, Dept Radiol,Jingan Branch, Shanghai 200433, Peoples R China; [Wu, Juan] Nantong Univ, Affiliated Hosp, Dept Radiol, Nantong, Peoples R China; [Hao, Sijie] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nantong University; Fudan University	Liang, ZH (corresponding author), Fudan Univ, Huashan Hosp, Jingan Dist Cent Hosp Shanghai, Dept Radiol,Jingan Branch, Shanghai 200433, Peoples R China.	liangzh@vip.163.com		Liang, Zong Hui/0000-0002-3501-8505	Shanghai Municipal Health Bureau, China [20114187]	Shanghai Municipal Health Bureau, China	This work was supported by a grant from Shanghai Municipal Health Bureau, China (Grant No. 20114187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.smhb.gov.cn/website/b/65167.shtml	Abels B, 2012, EUR RADIOL, V22, P2559, DOI 10.1007/s00330-012-2529-8; Abo H, 2005, RADIAT MED, V23, P364; Aviv RI, 2009, RADIOLOGY, V250, P867, DOI 10.1148/radiol.2503080257; Badea CT, 2010, MED PHYS, V37, P54, DOI 10.1118/1.3264619; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Deak Z, 2013, RADIOLOGY, V266, P197, DOI 10.1148/radiol.12112707; Delrue L, 2011, J COMPUT ASSIST TOMO, V35, P434, DOI 10.1097/RCT.0b013e318223f0c5; Desai GS, 2012, EUR RADIOL, V22, P1631, DOI 10.1007/s00330-012-2424-3; Goshima S, 2006, RADIOLOGY, V241, P167, DOI 10.1148/radiol.2411051338; Hamberg LM, 2002, AM J NEURORADIOL, V23, P1013; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Leipsic J, 2012, INT J CARDIOVAS IMAG, V28, P613, DOI 10.1007/s10554-011-9832-3; Leipsic J, 2010, AM J ROENTGENOL, V195, P655, DOI 10.2214/AJR.10.4288; Lu N, 2011, ACAD RADIOL, V18, P81, DOI 10.1016/j.acra.2010.07.012; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; McNulty NJ, 2001, RADIOLOGY, V220, P97, DOI 10.1148/radiology.220.1.r01jl1897; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MILES KA, 1991, LANCET, V337, P643, DOI 10.1016/0140-6736(91)92455-B; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Nelson RC, 2011, J CARDIOVASC COMPUT, V5, P286, DOI 10.1016/j.jcct.2011.07.001; Oda S, 2012, AM J ROENTGENOL, V198, P1126, DOI 10.2214/AJR.11.7117; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Rigby AS, 2000, DISABIL REHABIL, V22, P339, DOI 10.1080/096382800296575; Schindera ST, 2011, RADIOLOGY, V260, P454, DOI 10.1148/radiol.11102217; Singh S, 2012, RADIOLOGY, V263, P537, DOI 10.1148/radiol.12110268; Spielmann AL, 2002, RADIOLOGY, V222, P278, DOI 10.1148/radiol.2221010190; Tsuji Y, 2007, CLIN GASTROENTEROL H, V5, P1484, DOI 10.1016/j.cgh.2007.07.014; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Xu J, 2009, ABDOM IMAGING, V34, P759, DOI 10.1007/s00261-009-9564-1	35	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80468	10.1371/journal.pone.0080468	http://dx.doi.org/10.1371/journal.pone.0080468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303017	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400033
J	Greenwald, EC; Redden, JM; Dodge-Kafka, KL; Saucerman, JJ				Greenwald, Eric C.; Redden, John M.; Dodge-Kafka, Kimberly L.; Saucerman, Jeffrey J.			Scaffold State Switching Amplifies, Accelerates, and Insulates Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKAP; Cell Signaling; Enzyme Kinetics; Mathematical Modeling; Protein Kinase C (PKC); Scaffold Proteins; Anchoring	MAP KINASE; ANCHORING PROTEINS; AKAP79; ACTIVATION; PATHWAYS; CASCADES; MODELS; PKC	Scaffold proteins localize two or more signaling enzymes in close proximity to their downstream effectors. A-kinase-anchoring proteins (AKAPs) are a canonical family of scaffold proteins known to bind protein kinase A (PKA) and other enzymes. Several AKAPs have been shown to accelerate, amplify, and specify signal transduction to dynamically regulate numerous cellular processes. However, there is little theory available to mechanistically explain how signaling on protein scaffolds differs from solution biochemistry. In our present study, we propose a novel kinetic mechanism for enzymatic reactions on protein scaffolds to explain these phenomena, wherein the enzyme-substrate-scaffold complex undergoes stochastic state switching to reach an active state. This model predicted anchored enzymatic reactions to be accelerated, amplified, and insulated from inhibition compared with those occurring in solution. We exploited a direct interaction between protein kinase C (PKC) and AKAP7 as a model to validate these predictions experimentally. Using a genetically encoded PKC activity reporter, we found that both the strength and speed of substrate phosphorylation were enhanced by AKAP7. PKC tethered to AKAP7 was less susceptible to inhibition from the ATP-competitive inhibitor Go6976 and the substrate-competitive inhibitor PKC 20-28, but not the activation-competitive inhibitor calphostin C. Model predictions and experimental validation demonstrated that insulation is a general property of scaffold tethering. Sensitivity analysis indicated that these findings may be applicable to many other scaffolds as well. Collectively, our findings provide theoretical and experimental evidence that scaffold proteins can amplify, accelerate, and insulate signal transduction.	[Greenwald, Eric C.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Redden, John M.; Dodge-Kafka, Kimberly L.] Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA	University of Virginia; University of Connecticut	Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA.	dodge@uchc.edu; jsaucerman@virginia.edu	Greenwald, Eric/B-9539-2011	Greenwald, Eric/0000-0003-3600-0750; Redden, John/0000-0003-4797-3267	National Institutes of Health [HL82705, HL094476]; State of Connecticut Department of Public Health [2011-0142]; American Heart Association [11PRE7830027]; National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia [T32 GM007055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082705, R01HL094476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Department of Public Health; American Heart Association(American Heart Association); National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL82705 (to K. L. D.-K.), and HL094476 (to J. J. S.). This work was also supported by State of Connecticut Department of Public Health Grant 2011-0142 (to K. L. D.-K.), American Heart Association Predoctoral Fellowship 11PRE7830027 (to J. M. R.), and National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia T32 GM007055 (to E. C. G.).	Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Malbon CC, 2004, BIOCHEM SOC T, V32, P861, DOI 10.1042/BST0320861; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Redden JM, 2012, BIOCHEM J, V446, P301, DOI 10.1042/BJ20120366; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	27	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2353	2360		10.1074/jbc.M113.497941	http://dx.doi.org/10.1074/jbc.M113.497941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302730	Green Published, hybrid			2022-12-25	WOS:000331130200039
J	Oger, F; Dubois-Chevalier, J; Gheeraert, C; Avner, S; Durand, E; Froguel, P; Salbert, G; Staels, B; Lefebvre, P; Eeckhoute, J				Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Avner, Stephane; Durand, Emmanuelle; Froguel, Philippe; Salbert, Gilles; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome			Peroxisome Proliferator-activated Receptor gamma Regulates Genes Involved in Insulin/Insulin-like Growth Factor Signaling and Lipid Metabolism during Adipogenesis through Functionally Distinct Enhancer Classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; DNA METHYLATION; ADIPOSE-TISSUE; CHROMATIN STATE; CELL; ADIPOCYTES; BINDING; FAT; DIFFERENTIATION; EXPLORATION	The nuclear receptor peroxisome proliferator-activated receptor (PPAR) gamma is a transcription factor whose expression is induced during adipogenesis and that is required for the acquisition and control of mature adipocyte functions. Indeed, PPAR gamma induces the expression of genes involved in lipid synthesis and storage through enhancers activated during adipocyte differentiation. Here, we show that PPAR gamma also binds to enhancers already active in preadipocytes as evidenced by an active chromatin state including lower DNA methylation levels despite higher CpG content. These constitutive enhancers are linked to genes involved in the insulin/insulin-like growth factor signaling pathway that are transcriptionally induced during adipogenesis but to a lower extent than lipid metabolism genes, because of stronger basal expression levels in preadipocytes. This is consistent with the sequential involvement of hormonal sensitivity and lipid handling during adipocyte maturation and correlates with the chromatin structure dynamics at constitutive and activated enhancers. Interestingly, constitutive enhancers are evolutionary conserved and can be activated in other tissues, in contrast to enhancers controlling lipid handling genes whose activation is more restricted to adipocytes. Thus, PPAR gamma utilizes both broadly active and cell type-specific enhancers to modulate the dynamic range of activation of genes involved in the adipogenic process.	[Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] INSERM, UMR U1011, F-59000 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Durand, Emmanuelle; Froguel, Philippe; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] Univ Lille 2, F-59000 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] Inst Pasteur, F-59019 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Durand, Emmanuelle; Froguel, Philippe; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] European Genom Inst Diabet, F-59000 Lille, France; [Avner, Stephane; Salbert, Gilles] Univ Rennes 1, F-35042 Rennes, France; [Avner, Stephane; Salbert, Gilles] CNRS, UMR6290, Team SP RTE, F-35042 Rennes, France; [Durand, Emmanuelle; Froguel, Philippe] CNRS, UMR 8199, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Lefebvre, P (corresponding author), Univ Lille Nord France, Fac Med Lille Pole Rech, INSERM, UMR 1011, Batiment J&K,Blvd Prof Leclerc, F-59045 Lille, France.	philippe-claude.lefebvre@inserm.fr; jerome.eeckhoute@inserm.fr	Staels, Bart/N-9497-2016; Salbert, Gilles/W-9196-2019; Lefebvre, Philippe/F-2685-2010; Eeckhoute, Jerome/AAN-8219-2021; FROGUEL, Philippe/O-6799-2017	Staels, Bart/0000-0002-3784-1503; Salbert, Gilles/0000-0001-6115-4140; Lefebvre, Philippe/0000-0002-9366-5129; Eeckhoute, Jerome/0000-0002-7222-9264; FROGUEL, Philippe/0000-0003-2972-0784; Oger, Frederik/0000-0003-0006-5835; Dubois-Chevalier, Julie/0000-0003-0471-752X; Avner, Stephane/0000-0001-7413-1327	OSEO-ANVAR IT-DIAB; European Genomic Institute for Diabetes [ANR-10-LABX-46]; Medical Research Council [G1002084] Funding Source: researchfish; MRC [G1002084] Funding Source: UKRI	OSEO-ANVAR IT-DIAB; European Genomic Institute for Diabetes; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from OSEO-ANVAR IT-DIAB and European Genomic Institute for Diabetes Grant ANR-10-LABX-46.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Eeckhoute J, 2012, PPAR RES, V2012, DOI 10.1155/2012/164140; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henry SL, 2012, INT J BIOCHEM CELL B, V44, P435, DOI 10.1016/j.biocel.2011.12.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang YW, 2012, CELL, V150, P234, DOI 10.1016/j.cell.2012.06.022; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Matsusue K, 2004, FASEB J, V18, P1477, DOI 10.1096/fj.04-1944fje; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu DY, 2011, TRENDS ENDOCRIN MET, V22, P474, DOI 10.1016/j.tem.2011.07.006; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang ZZ, 2013, J COMPUT BIOL, V20, P237, DOI 10.1089/cmb.2012.0233; Zhou HY, 2013, ELIFE, V2, DOI 10.7554/eLife.00170	57	35	38	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					708	722		10.1074/jbc.M113.526996	http://dx.doi.org/10.1074/jbc.M113.526996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24288131	Green Published, hybrid			2022-12-25	WOS:000330541200011
J	Buri, MV; Domingues, TM; Paredes-Gamero, EJ; Casaes-Rodrigues, RL; Rodrigues, EG; Miranda, A				Buri, Marcus V.; Domingues, Tatiana M.; Paredes-Gamero, Edgar J.; Casaes-Rodrigues, Rafael L.; Rodrigues, Elaine Guadelupe; Miranda, Antonio			Resistance to Degradation and Cellular Distribution Are Important Features for the Antitumor Activity of Gomesin	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GOMESIN; TUMOR-CELLS; ANALOGS; DEATH; MECHANISM; APOPTOSIS; MELANOMA	Many reports have shown that antimicrobial peptides exhibit anticancer abilities. Gomesin (Gm) exhibits potent cytotoxic activity against cancer cells by a membrane pore formation induced after well-orchestrated intracellular mechanisms. In this report, the replacements of the Cys by Ser or Thr, and the use D-amino acids in the Gm structure were done to investigate the importance of the resistance to degradation of the molecule with its cytotoxicity. [Thr(2,6,11,15)]-Gm, and [Ser(2,6,11,15)]-Gm exhibits low cytotoxicity, and low resistance to degradation, and after 24 h are present in localized area near to the membrane. Conversely, the use of D-amino acids in the analogue [D-Thr(2,6,11,15)]-D-Gm confers resistance to degradation, increases its potency, and maintained this peptide spread in the cytosol similarly to what happens with Gm. Replacements of Cys by Thr and Gln by L- or D-Pro ([D-Thr(2,6,11,15), Pro(9)]-D-Gm, and [Thr(2,6,11,15), D-Pro(9)]-Gm), which induced a similar beta-hairpin conformation, also increase their resistance to degradation, and cytotoxicity, but after 24 h they are not present spread in the cytosol, exhibiting lower cytotoxicity in comparison to Gm. Additionally, chloroquine, a lysosomal enzyme inhibitor potentiated the effect of the peptides. Furthermore, the binding and internalization of peptides was determined, but a direct correlation among these factors was not observed. However, cholesterol ablation, which increase fluidity of cellular membrane, also increase cytotoxicity and internalization of peptides. beta-hairpin spatial conformation, and intracellular localization/target, and the capability of entry are important properties of gomesin cytotoxicity.	[Buri, Marcus V.; Domingues, Tatiana M.; Paredes-Gamero, Edgar J.; Miranda, Antonio] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Paredes-Gamero, Edgar J.; Casaes-Rodrigues, Rafael L.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Rodrigues, Elaine Guadelupe] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Paredes-Gamero, EJ (corresponding author), Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.	edgar.gamero@unifesp.br; admiranda@unifesp.br	Rodrigues, Elaine G/H-3688-2014; Paredes-Gamero, Edgar J/C-4791-2012; Miranda, Antonio/C-8855-2012; Rodrigues, Elaine Guadelupe/ABB-6632-2021; Buri, Marcus Vinicius/L-4333-2017	Paredes-Gamero, Edgar J/0000-0003-3686-8402; Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; Buri, Marcus Vinicius/0000-0002-8925-1206	FAPESP [2011/17584-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP, Grant number 2011/17584-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calgarotto AK, 2012, EUR J PHARMACOL, V678, P6, DOI 10.1016/j.ejphar.2011.12.031; Chen JG, 2005, CANCER RES, V65, P4614, DOI 10.1158/0008-5472.CAN-04-2253; Chen YX, 2001, CANCER RES, V61, P2434; Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huang TC, 2011, MAR DRUGS, V9, P1995, DOI 10.3390/md9101995; Jarczak J, 2013, HUM IMMUNOL; Mandard N, 1998, EUR J BIOCHEM, V256, P404, DOI 10.1046/j.1432-1327.1998.2560404.x; Moraes LGM, 2007, BBA-BIOMEMBRANES, V1768, P52, DOI 10.1016/j.bbamem.2006.08.016; Paredes-Gamero Edgar J, 2013, Front Biosci (Elite Ed), V5, P130; Paredes-Gamero EJ, 2012, MOL PHARMACEUT, V9, P2686, DOI 10.1021/mp300251j; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; RAZ A, 1980, NATURE, V284, P363, DOI 10.1038/284363a0; RIGAUT JP, 1991, ANAL QUANT CYTOL, V13, P223; Rodrigues EG, 2008, NEOPLASIA, V10, P61, DOI 10.1593/neo.07885; Rodrigues EG, 2009, AN ACAD BRAS CIENC, V81, P503, DOI 10.1590/S0001-37652009000300015; Sacramento RS, 2009, PARASITOLOGY, V136, P813, DOI 10.1017/S0031182009006283; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Slaninova J, 2012, PEPTIDES, V33, P18, DOI 10.1016/j.peptides.2011.11.002; Soletti RC, 2010, CHEM-BIOL INTERACT, V186, P135, DOI 10.1016/j.cbi.2010.04.012; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Yan JX, 2012, BIOCHIMIE, V94, P184, DOI 10.1016/j.biochi.2011.10.005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	29	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80924	10.1371/journal.pone.0080924	http://dx.doi.org/10.1371/journal.pone.0080924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312251	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300020
J	Shimokawa, C; Culleton, R; Imai, T; Suzue, K; Hirai, M; Taniguchi, T; Kobayashi, S; Hisaeda, H; Hamano, S				Shimokawa, Chikako; Culleton, Richard; Imai, Takashi; Suzue, Kazutomo; Hirai, Makoto; Taniguchi, Tomoyo; Kobayashi, Seiki; Hisaeda, Hajime; Hamano, Shinjiro			Species-Specific Immunity Induced by Infection with Entamoeba histolytica and Entamoeba moshkovskii in Mice	PLOS ONE			English	Article							ADHERENCE LECTIN; INTESTINAL AMEBIASIS; BANGLADESHI CHILDREN; MALARIA PARASITES; COLONIC MUCINS; RESISTANCE; COLITIS; CELLS; DIARRHEA; DISEASE	Entamaeba histolytica, he parasitic amoeba responsible for amoebiasi, causes approximately 100,000 death every year. There is currently no vaccine against this parasite. We have previously shown that intracecal inoculation of E. histolytica trophozoites leads to chronic and non-healing cecitis in mice. Entamoeba moshkovskii, a closely related amoeba, also causes diarrhea and other intestinal disorders in this model. Here, we investigated the effect of infection followed by of these species on the induction of immunity against homologous or heterologous species challenge. Mice were infected with E. histolytica or E. moshkovskii and treated with metronidazole 14 days later. Re-challenge with E. histolytica or E. moshkovskii was conducted seven or 28 days following confirmation of the clearance of amoebae, and the degree of protection compared to non-exposed control mice was evaluated. We how that primary infection with these amoebae induces a species-specific immune response which protects against challenge with the homologous, but not a heterologous species. These findings pave the way, therefore, for the identification of novel amoebae antigens that may become the targets of vaccines and provide a useful platform to investigate host protective immunity to Entamoeba infections	[Shimokawa, Chikako; Hamano, Shinjiro] Nagasaki Univ, Dept Parasitol, Nagasaki 852, Japan; [Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Malaria Unit, Nagasaki 852, Japan; [Imai, Takashi; Suzue, Kazutomo; Hirai, Makoto; Taniguchi, Tomoyo; Hisaeda, Hajime] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma, Japan; [Kobayashi, Seiki] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo, Japan; [Hamano, Shinjiro] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Gunma University; Keio University; Nagasaki University	Hamano, S (corresponding author), Nagasaki Univ, Dept Parasitol, Nagasaki 852, Japan.	shinjiro@nagasaki-u.ac.jp	Hamano, Shinjiro/A-7932-2011; Culleton, Richard/H-8327-2014	Hamano, Shinjiro/0000-0003-3881-8337; Imai, Takashi/0000-0001-9049-8102; Suzue, Kazutomo/0000-0002-8959-5746; Culleton, Richard/0000-0001-8808-5771	MEXT [21022037]; JSPS [20406008, 23406009]; Health Labour Sciences Research Grant [H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014]; Takeda Foundation; Uehara Foundation; Global COE Program, Nagasaki University; MEXT; Sasakawa Foundation (Japan Science Society); Grants-in-Aid for Scientific Research [23406009] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Takeda Foundation(Takeda Science Foundation (TSF)); Uehara Foundation(Uehara Memorial Foundation); Global COE Program, Nagasaki University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Foundation (Japan Science Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from MEXT (21022037 to S.H.), http://vvww.mext.go.jp/english/, Grants-in-Aid for International Scientific Research (B) from JSPS (20406008, 23406009 to S.H.), http://vvww.jsps.go.jp/english/index.html, a Health Labour Sciences Research Grant (H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014 to S.H.), http://vvww.mhlw.go.jp/english/, the Takeda Foundation http://vvww.takeda-sci.or.jp/, the Uehara Foundation, (to S. H.) http://vvww.ueharazaidan.or.jp/, the Global COE Program, Nagasaki University, supported by MEXT (to S. H.) http://vvww.jsps.go.jp/j-globalcoe/ and the Sasakawa Foundation (Scientific Research Grant from The Japan Science Society) (to CS.), http://vvww.jss.or.jp/ikusei/sasakawa/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Alla MD, 2012, VACCINE, V30, P3068, DOI 10.1016/j.vaccine.2012.02.066; Asgharpour A, 2005, INFECT IMMUN, V73, P4522, DOI 10.1128/IAI.73.8.4522-4529.2005; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CHADEE K, 1987, J CLIN INVEST, V80, P1245, DOI 10.1172/JCI113199; CHADEE K, 1988, J INFECT DIS, V158, P398, DOI 10.1093/infdis/158.2.398; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Fotedar R, 2008, EUR J CLIN MICROBIOL, V27, P133, DOI 10.1007/s10096-007-0399-9; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Guo X, 2008, MUCOSAL IMMUNOL, V1, P139, DOI 10.1038/mi.2007.18; Hamano S, 2008, GENES IMMUN, V9, P452, DOI 10.1038/gene.2008.37; Hamano S, 2006, J IMMUNOL, V177, P1208, DOI 10.4049/jimmunol.177.2.1208; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Haque R, 2002, J INFECT DIS, V186, P547, DOI 10.1086/341566; Haque R, 2001, J INFECT DIS, V183, P1787, DOI 10.1086/320740; Haque R, 2006, INFECT IMMUN, V74, P904, DOI 10.1128/IAI.74.2.904-909.2006; Houpt E, 2004, VACCINE, V22, P611, DOI 10.1016/j.vaccine.2003.09.003; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Inoue M, 2012, INT J PARASITOL, V42, P859, DOI 10.1016/j.ijpara.2012.07.001; IRUSEN EM, 1992, CLIN INFECT DIS, V14, P889, DOI 10.1093/clinids/14.4.889; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Shimokawa C, 2012, J INFECT DIS, V206, P744, DOI 10.1093/infdis/jis414	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82025	10.1371/journal.pone.0082025	http://dx.doi.org/10.1371/journal.pone.0082025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312397	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300069
J	Ding, J; Guo, JY; Yuan, Q; Yuan, F; Chen, H; Tian, H				Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli			Inhibition of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Decreases Rat Cortical Neuron Injury and Blood-Brain Barrier Permeability, and Improves Neurological Functional Recovery in Traumatic Brain Injury Model	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PTEN; PATHWAY; SURVIVAL; AKT; PHOSPHORYLATION; STROKE; MICE; ANGIOGENESIS; OUTGROWTH	Background and Purpose: Recent evidence has supported the neuroprotective effect of bpV (pic), an inhibitor of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), in models of ischemic stroke. However, whether PTEN inhibitors improve long-term functional recovery after traumatic brain injury (TBI) and whether PTEN affects blood brain barrier (BBB) permeability need further elucidation. The present study was performed to address these issues. Methods: Adult Sprague-Dawley rats were subjected to fluid percussion injury (FPI) after treatment with a well-established PTEN inhibitor bpV (pic) or saline starting 24 h before FPI. Western blotting, real-time quantitative PCR, or immunostaining was used to measure PTEN, p-Akt, or MMP-9 expression. We determined the presence of neuron apoptosis by TUNEL assay. Evans Blue dye extravasation was measured to evaluate the extent of BBB disruption. Functional recovery was assessed by the neurological severity score (NSS), and Kaplan-Meier analysis was used for survival analysis. Results: PTEN expression was up-regulated after TBI. After bpV (pic) treatment, p-Akt was also up-regulated. We found that bpV (pic) significantly decreased BBB permeability and reduced the number of TUNEL-positive cells. We further demonstrated that PTEN inhibition improved neurological function recovery in the early stage after TBI. Conclusion: These data suggest that treatment with the PTEN inhibitor bpV (pic) has a neuroprotective effect in TBI rats.	[Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tian, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China.	tianhlsh@126.com			National Nature and Science Foundation of China [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technique Committee	Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai QY, 2009, ANAT REC, V292, P498, DOI 10.1002/ar.20834; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Guo JY, 2013, INT J MOL SCI; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li PP, 2012, MOL BIOL CELL, V23, P4109, DOI 10.1091/mbc.E12-05-0367; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Marin D, 2005, LEUKEMIA, V19, P507, DOI 10.1038/sj.leu.2403664; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sedding DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055445; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Walker CL, 2013, FRONT BIOL; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	44	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80429	10.1371/journal.pone.0080429	http://dx.doi.org/10.1371/journal.pone.0080429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312220	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900007
J	Huang, YX; Wu, ZJ; Huang, BT; Luo, M				Huang, Yao-Xiong; Wu, Zheng-Jie; Huang, Bao-Tian; Luo, Man			Pathway and Mechanism of pH Dependent Human Hemoglobin Tetramer-Dimer-Monomer Dissociations	PLOS ONE			English	Article							MICRO-RAMAN CHARACTERIZATION; LIGHT-SCATTERING; RED-CELLS; BLOOD; PROTEINS; STORAGE; HEME; MODEL	Hemoglobin dissociation is of great interest in protein process and clinical medicine as well as in artificial blood research. However, the pathway and mechanisms of pH-dependent human Hb dissociation are not clear, whether Hb would really dissociate into monomers is still a question. Therefore, we have conducted a multi-technique investigation on the structure and function of human Hb versus pH. Here we demonstrate that tetramer hemoglobin can easily dissociate into dimer in abnormal pH and the tetramer -> dimer dissociation is reversible if pH returns to normal physiological value. When the environmental pH becomes more acidic (<6.5) or alkaline (>8.0), Hb can further dissociate from dimer to monomer. The proportion of monomers increases while the fraction of dimers decreases as pH declines from 6.2 to 5.4. The dimer -> monomer dissociation is accompanied with series changes of protein structure thus it is an irreversible process. The structural changes in the dissociated Hbs result in some loss of their functions. Both the Hb dimer and monomer cannot adequately carry and release oxygen to the tissues in circulation. These findings provide a comprehensive understanding on the pH-dependent protein transitions of human Hb, give guideline to explain complex protein processes and the means to control protein dissociation or re-association reaction. They are also of practical value in clinical medicine, blood preservation and blood substitute development.	[Huang, Yao-Xiong; Wu, Zheng-Jie; Huang, Bao-Tian; Luo, Man] Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Jinan University	Huang, YX (corresponding author), Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	tyxhuang@jnu.edu.cn	luo, man/HGC-7868-2022		Chinese National Natural Science Foundation [30940019, 60377043]; Guang Dong Provincial Science and Technology Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guang Dong Provincial Science and Technology Foundation	This work was supported partly by the Chinese National Natural Science Foundation (Nos. 30940019 and 60377043) and Guang Dong Provincial Science and Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1981, J BIOL CHEM, V256, P1824; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P110; ATHA DH, 1976, J BIOL CHEM, V251, P5537; BANDEKAR J, 1980, BIOPOLYMERS, V19, P31, DOI 10.1002/bip.1980.360190103; BUNN HF, 1968, J BIOL CHEM, V243, P465; Carey P. R., 1982, BIOCH APPL RAMAN RES; CHIANCONE E, 1968, J BIOL CHEM, V243, P1212; FLANAGAN MA, 1981, BIOCHEMISTRY-US, V20, P7439, DOI 10.1021/bi00529a018; GERACI G, 1969, J BIOL CHEM, V244, P4664; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Hogman CF, 1999, TRANSFUSION, V39, P492, DOI 10.1046/j.1537-2995.1999.39050492.x; Huang YX, 2005, CURR APPL PHYS, V5, P553, DOI 10.1016/j.cap.2005.01.030; Huang YX, 1997, J CHEM PHYS, V107, P9141, DOI 10.1063/1.475206; Kang LL, 2008, BIOPOLYMERS, V89, P951, DOI 10.1002/bip.21042; KAWAHARA K, 1965, BIOCHEMISTRY-US, V4, P1203, DOI 10.1021/bi00883a001; KIRSHNER AG, 1964, BIOCHEMISTRY-US, V3, P291, DOI 10.1021/bi00891a002; Llohn AH, 2005, TRANSFUS APHER SCI, V33, P113, DOI 10.1016/j.transci.2004.12.002; LUNELLI L, 1994, BIOPOLYMERS, V34, P747, DOI 10.1002/bip.360340607; LUNELLI L, 1993, PHYS REV LETT, V70, P513, DOI 10.1103/PhysRevLett.70.513; MAZOR D, 1994, VOX SANG, V66, P264, DOI 10.1111/j.1423-0410.1994.tb00327.x; MRABET NT, 1986, J BIOL CHEM, V261, P1111; Narayanan P, 2000, ESSENTIALS BIOPHYSIC; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; SHAEFFER JR, 1984, J BIOL CHEM, V259, P4544; SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014; Sinha S, 2005, BIOPHYS J, V88, P1300, DOI 10.1529/biophysj.104.051052; SPIRO TG, 1998, BIOL APPL RAMAN SPEC, P1; Squires JE, 2002, SCIENCE, V295, P1002, DOI 10.1126/science.1068443; THOMAS JO, 1972, J BIOL CHEM, V247, P7870; Tu A.T., 1982, RAMAN SPECTROSCOPY B, P65; Wood BR, 2005, VIB SPECTROSC, V38, P71, DOI 10.1016/j.vibspec.2005.02.016; Wood BR, 2002, BIOPOLYMERS, V67, P259, DOI 10.1002/bip.10120; Wood BR, 2002, J RAMAN SPECTROSC, V33, P517, DOI 10.1002/jrs.870; Wood BR, 2001, BBA-MOL CELL RES, V1539, P58, DOI 10.1016/S0167-4889(01)00089-1; Wu Y, 2010, BIOPOLYMERS, V93, P348, DOI 10.1002/bip.21348; Zwart A, 1996, J CLIN PATHOL, V49, P271, DOI 10.1136/jcp.49.4.271	38	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81708	10.1371/journal.pone.0081708	http://dx.doi.org/10.1371/journal.pone.0081708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312337	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900045
J	Pita, L; Erwin, PM; Turon, X; Lopez-Legentil, S				Pita, Lucia; Erwin, Patrick M.; Turon, Xavier; Lopez-Legentil, Susanna			Till Death Do Us Part: Stable Sponge-Bacteria Associations under Thermal and Food Shortage Stresses	PLOS ONE			English	Article							MICROBIAL COMMUNITY; MASS MORTALITY; MARINE SPONGES; IRCINIA SPP.; TEMPERATURE; DIVERSITY; STABILITY; SYMBIONTS	Sporadic mass mortality events of Mediterranean sponges following periods of anomalously high temperatures or longer than usual stratification of the seawater column (i.e. low food availability) suggest that these animals are sensitive to environmental stresses. The Mediterranean sponges Ircinia fasciculata and I. oros harbor distinct, species-specific bacterial communities that are highly stable over time and space but little is known about how anomalous environmental conditions affect the structure of the resident bacterial communities. Here, we monitored the bacterial communities in I. fasciculata (largely affected by mass mortalities) and I. oros (overall unaffected) maintained in aquaria during 3 weeks under 4 treatments that mimicked realistic stress pressures: control conditions (13 degrees C, unfiltered seawater), low food availability (13 degrees C, 0.1 mu m-filtered seawater), elevated temperatures (25 degrees C, unfiltered seawater), and a combination of the 2 stressors (25 degrees C, 0.1 mu m-filtered seawater). Bacterial community structure was assessed using terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA gene sequences and transmission electron microscopy (TEM). As I. fasciculata harbors cyanobacteria, we also measured chlorophyll a (chl a) levels in this species. Multivariate analysis revealed no significant differences in bacterial T-RFLP profiles among treatments for either host sponge species, indicating no effect of high temperatures and food shortage on symbiont community structure. In I. fasciculata, chl a content did not significantly differ among treatments although TEM micrographs revealed some cyanobacteria cells undergoing degradation when exposed to both elevated temperature and food shortage conditions. Arguably, longer-term treatments (months) could have eventually affected bacterial community structure. However, we evidenced no appreciable decay of the symbiotic community in response to medium-term (3 weeks) environmental anomalies purported to cause the recurrent sponge mortality episodes. Thus, changes in symbiont structure are not likely the proximate cause for these reported mortality events.	[Pita, Lucia; Lopez-Legentil, Susanna] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Pita, Lucia; Lopez-Legentil, Susanna] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Erwin, Patrick M.; Lopez-Legentil, Susanna] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Turon, Xavier] Ctr Adv Studies Blanes CEAB CSIC, Blanes, Spain	University of Barcelona; University of Barcelona; University of North Carolina; University of North Carolina Wilmington; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Lopez-Legentil, S (corresponding author), Univ Barcelona, Dept Biol Anim, Barcelona, Spain.	lopezlegentils@uncw.edu	Pita, Lucia/AAC-3012-2020; Turon, Xavier/J-9211-2012; Erwin, Patrick/E-9926-2016; Lopez-Legentil, Susanna/B-8194-2008	Turon, Xavier/0000-0002-9229-5541; Erwin, Patrick/0000-0001-9276-0020; Lopez-Legentil, Susanna/0000-0001-8737-6729; Pita Galan, Lucia/0000-0003-0163-1587	Marie Curie International Reintegration Grant (within the 7th European Community Framework Program) [FP7-PEOPLE-2010-RG 277038]; Spanish Government [CTM2010-17755, CTM2010-22218]; Catalan Government [2009SGR-484]; FI-DGR fellowship	Marie Curie International Reintegration Grant (within the 7th European Community Framework Program); Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; FI-DGR fellowship	This study was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), the Spanish Government projects CTM2010-17755 and CTM2010-22218, the Catalan Government grant 2009SGR-484 for Consolidated Research Groups, and a FI-DGR fellowship to L.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2001, ITAL J ZOOL, V68, P131, DOI 10.1080/11250000109356397; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Erwin PM, 2012, APPL ENVIRON MICROB, V78, P7358, DOI 10.1128/AEM.02035-12; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Fan L, 2013, ISME J, V7, P991, DOI 10.1038/ismej.2012.165; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lemoine Nathan, 2007, V28, P419; Lopez-Legentil S, 2013, INVERTEBR BIOL, V132, P69, DOI 10.1111/ivb.12013; Lopez-Legentil S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023938; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Pita L, 2013, FEMS MICROBIOL ECOL, V86, P268, DOI 10.1111/1574-6941.12159; Pita L, 2013, MICROB ECOL, V66, P437, DOI 10.1007/s00248-013-0215-2; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Simister R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052220; Simister R, 2012, ENVIRON MICROBIOL, V14, P3232, DOI 10.1111/1462-2920.12010; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turon X, 2013, MAR BIOL, V160, P2743, DOI 10.1007/s00227-013-2267-8; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x; Weisz JB, 2010, BIOL BULL-US, V219, P189, DOI 10.1086/BBLv219n3p189; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204	39	34	34	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80307	10.1371/journal.pone.0080307	http://dx.doi.org/10.1371/journal.pone.0080307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312210	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900006
J	Leng, XY; Wong, KS; Soo, Y; Leung, T; Zou, XY; Wang, YJ; Feldmann, E; Liu, LP; Liebeskind, DS				Leng, Xinyi; Wong, Ka Sing; Soo, Yannie; Leung, Thomas; Zou, Xinying; Wang, Yongjun; Feldmann, Edward; Liu, Liping; Liebeskind, David S.			Magnetic Resonance Angiography Signal Intensity as a Marker of Hemodynamic Impairment in Intracranial Arterial Stenosis	PLOS ONE			English	Article							CHINESE PATIENTS; DISEASE; STROKE	Background: Intracranial arterial stenosis (ICAS) is the predominant cause of ischemic stroke and transient ischemic attack in Asia. Change of signal intensities (SI) across an ICAS on magnetic resonance angiography (MRA) may reflect its hemodynamic severity. Methods: In-patients with a symptomatic single ICAS detected on 3D time-of-flight MRA were recruited from 2 hospitals. Baseline and 1-year follow-up data were collected. Signal intensity ratio (SIR) [= (mean post-stenotic SI -mean background SI)/(mean pre-stenotic SI -mean background SI)] was evaluated on baseline MRA to represent change of SIs across an ICAS. Acute infarct volume was measured on baseline diffusion-weighted images (DWI). Relationships between SIR and baseline characteristics as well as 1y outcomes were evaluated. Results: Thirty-six subjects (86.1% males, mean age 55.0) were recruited. Overall, mean SIR was 0.84 +/- 0.23. Mean SIRs were not significantly different between the 23 (63.9%) anatomically severe stenoses and the 13 (36.1%) anatomically moderate stenoses (0.80 +/- 0.23 versus 0.92 +/- 0.21, p = 0.126). SIR was significantly, linearly and negatively correlated to acute infarct volume on DWI (Spearman correlation coefficient 20.471, p = 0.011). Two patients (5.6%) had recurrent ischemic strokes at 1y, not related to SIR values. Conclusions: Change of signal intensities across an ICAS on MRA may reflect its hemodynamic and functional severity. Future studies are warranted to further verify the relationships between this index and prognosis of patients with symptomatic ICAS.	[Leng, Xinyi; Wong, Ka Sing; Soo, Yannie; Leung, Thomas; Zou, Xinying] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Wang, Yongjun; Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Feldmann, Edward] Tufts Med Ctr, Dept Neurol, Boston, MA USA; [Liebeskind, David S.] Univ Calif Los Angeles, UCLA Stroke Ctr, Los Angeles, CA USA	Chinese University of Hong Kong; Prince of Wales Hospital; Capital Medical University; Tufts Medical Center; University of California System; University of California Los Angeles	Wong, KS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ks-wong@cuhk.edu.hk	Leung, Thomas W/AAU-6475-2021; LENG, Xinyi/N-4082-2015; liu, li/HGC-0900-2022; Leung, Thomas W. H./O-8567-2015; Wong, Ka Sing Lawrence/N-3434-2015	Leung, Thomas W/0000-0001-8193-0709; LENG, Xinyi/0000-0001-7300-6647; Wong, Ka Sing Lawrence/0000-0002-2031-9866	National Science and Technology Major Project of China [2008ZX09312-008]; State Key Development Program for Basic Research of China [2009CB521905]; Ministry of Science and Technology; Ministry of Health of the People's Republic of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS072272] Funding Source: NIH RePORTER	National Science and Technology Major Project of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science and Technology Major Project of China (2008ZX09312-008) and State Key Development Program for Basic Research of China (2009CB521905), Ministry of Science and Technology and Ministry of Health of the People's Republic of China, as well as the S. H. Ho Cardiovascular Disease and Stroke Centre, Institute of Vascular Medicine, the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY WG, 1984, AM J ROENTGENOL, V143, P1167, DOI 10.2214/ajr.143.6.1167; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Leng X, 2013, J STROKE CEREBROVASC; Leng XY, 2013, INT J STROKE, V8, pE46, DOI 10.1111/ijs.12080; Liebeskind DS, 2013, STROKE, V44; Liu HM, 1996, STROKE, V27, P650, DOI 10.1161/01.STR.27.4.650; Mustert BR, 1998, MAGN RESON IMAGING, V16, P301, DOI 10.1016/S0730-725X(97)00304-4; Qian YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064395; Qureshi AI, 2009, ANN NEUROL, V66, P730, DOI 10.1002/ana.21768; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trail Investigators, 2004, Neuroepidemiology, V23, P23; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x	18	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80124	10.1371/journal.pone.0080124	http://dx.doi.org/10.1371/journal.pone.0080124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302997	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400013
J	Probst, FJ; Corrigan, RR; del Gaudio, D; Salinger, AP; Lorenzo, I; Gao, SS; Chiu, I; Xia, A; Oghalai, JS; Justice, MJ				Probst, Frank J.; Corrigan, Rebecca R.; del Gaudio, Daniela; Salinger, Andrew P.; Lorenzo, Isabel; Gao, Simon S.; Chiu, Ilene; Xia, Anping; Oghalai, John S.; Justice, Monica J.			A Point Mutation in the Gene for Asparagine-Linked Glycosylation 10B (Alg10b) Causes Nonsyndromic Hearing Impairment in Mice (Mus musculus)	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CHARGE-SYNDROME; MOUSE MODELS; IN-VIVO; DEAFNESS; GENOME; THERAPY; ENCODES	The study of mouse hearing impairment mutants has led to the identification of a number of human hearing impairment genes and has greatly furthered our understanding of the physiology of hearing. The novel mouse mutant neurological/sensory 5 (nse5) demonstrates a significantly reduced or absent startle response to sound and is therefore a potential murine model of human hearing impairment. Genetic analysis of 500 intercross progeny localized the mutant locus to a 524 kilobase (kb) interval on mouse chromosome 15. A missense mutation in a highly-conserved amino acid was found in the asparagine-linked glycosylation 10B gene (Alg10b), which is within the critical interval for the nse5 mutation. A 20.4 kb transgene containing a wildtype copy of the Alg10b gene rescued the mutant phenotype in nse5/nse5 homozygous animals, confirming that the mutation in Alg10b is responsible for the nse5/nse5 mutant phenotype. Homozygous nse5/nse5 mutants had abnormal auditory brainstem responses (ABRs), distortion product otoacoustic emissions (DPOAEs), and cochlear microphonics (CMs). Endocochlear potentials (EPs), on the other hand, were normal. ABRs and DPOAEs also confirmed the rescue of the mutant nse5/nse5 phenotype by the wildtype Alg10b transgene. These results suggested a defect in the outer hair cells of mutant animals, which was confirmed by histologic analysis. This is the first report of mutation in a gene involved in the asparagine (N)-linked glycosylation pathway causing nonsyndromic hearing impairment, and it suggests that the hearing apparatus, and the outer hair cells in particular, are exquisitely sensitive to perturbations of the N-linked glycosylation pathway.	[Probst, Frank J.; Corrigan, Rebecca R.; del Gaudio, Daniela; Salinger, Andrew P.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lorenzo, Isabel] Baylor Coll Med, Houston, TX 77030 USA; [Gao, Simon S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Chiu, Ilene] Baylor Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Xia, Anping; Oghalai, John S.] Stanford Univ, Dept Otorhinolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Baylor College of Medicine; Stanford University	Justice, MJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu		Gao, Simon/0000-0002-7020-037X	Burroughs Wellcome Fund; American Academy of Pediatrics (AAP) Section on Genetics and Birth Defects (SOGBD); Baylor College of Medicine; Naman Family Fund for Basic Research; NIDCD [K08DC006671, P30DC010363]; DoD [W81XWH-11-2-0004]; NIH [U01 HD039372, R01 CA115503]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD039372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA115503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC006671, P30DC010363] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Academy of Pediatrics (AAP) Section on Genetics and Birth Defects (SOGBD); Baylor College of Medicine; Naman Family Fund for Basic Research; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Frank J. Probst, M. D., Ph.D., holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund (http://www.bwfund.org). This work was supported by a Young Investigator Research Grant (YIRG) from the American Academy of Pediatrics (AAP) Section on Genetics and Birth Defects (SOGBD) (https://www2.aap.org/sections/genetics/default.cfm), by a Junior Faculty Seed Grant from Baylor College of Medicine, and by the Naman Family Fund for Basic Research. The work by John S. Oghalai was supported by NIDCD grants K08DC006671 and P30DC010363, and by DoD grant W81XWH-11-2-0004. The work by Monica J. Justice was supported by NIH grants U01 HD039372 and R01 CA115503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; Farid A, 2011, PLANT J, V68, P314, DOI 10.1111/j.1365-313X.2011.04688.x; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Gaffney M., 2010, Morbidity and Mortality Weekly Report, V59, P220; Gregg RB, 2004, PEDIATR REV, V25, P224, DOI 10.1542/pir.25-7-224; Hardisty RE, 1999, BRIT J AUDIOL, V33, P279, DOI 10.3109/03005369909090110; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiernan AE, 1999, J NEUROCYTOL, V28, P969, DOI 10.1023/A:1007090626294; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Lenz DR, 2011, HEARING RES, V281, P3, DOI 10.1016/j.heares.2011.05.021; Liu CC, 2011, JARO-J ASSOC RES OTO, V12, P577, DOI 10.1007/s10162-011-0269-0; Nagy A., 2003, MANIPULATING MOUSE E; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Oghalai JS, 2004, HEARING RES, V198, P59, DOI 10.1016/j.heares.2004.03.013; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Probst FJ, 1999, HEARING RES, V130, P1, DOI 10.1016/S0378-5955(98)00231-7; Raphael Y, 1996, NEUROSCI LETT, V207, P137, DOI 10.1016/0304-3940(96)12499-X; Raviv D, 2010, ANN NY ACAD SCI, V1214, P168, DOI 10.1111/j.1749-6632.2010.05868.x; Romero PA, 1997, GLYCOBIOLOGY, V7, P997, DOI 10.1093/glycob/7.7.997; Ross SA, 2007, PEDIATR RES, V61, P687, DOI 10.1203/pdr.0b013e3180536609; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; STEEL KP, 1996, SOC NEUROSCI SHORT C, P26; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vrijens K, 2008, HUM GENET, V124, P325, DOI 10.1007/s00439-008-0556-y; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wenzel GI, 2007, OTOL NEUROTOL, V28, P1100, DOI 10.1097/MAO.0b013e318158973f; Wenzel GI, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714286; Xia AP, 2007, JARO-J ASSOC RES OTO, V8, P447, DOI 10.1007/s10162-007-0092-9; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Yuan T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290799; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	47	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80408	10.1371/journal.pone.0080408	http://dx.doi.org/10.1371/journal.pone.0080408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303013	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400029
J	Jiang, JX; Aitken, KJ; Sotiropolous, C; Kirwan, T; Panchal, T; Zhang, N; Pu, SY; Wodak, S; Tolg, C; Bagli, DJ				Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Panchal, Trupti; Zhang, Nicole; Pu, Shuye; Wodak, Shoshana; Tolg, Cornelia; Baegli, Darius J.			Phenotypic Switching Induced by Damaged Matrix Is Associated with DNA Methyltransferase 3A (DNMT3A) Activity and Nuclear Localization in Smooth Muscle Cells (SMC)	PLOS ONE			English	Article							BLADDER OUTLET OBSTRUCTION; NERVE GROWTH-FACTOR; CONTRACTILE PROTEIN-CHANGES; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; TENASCIN-C; IN-VITRO; METHYLATION; ACETYLATION; INTEGRIN	Extracellular matrix changes are often crucial inciting events for fibroproliferative disease. Epigenetic changes, specifically DNA methylation, are critical factors underlying differentiated phenotypes. We examined the dependency of matrix-induced fibroproliferation and SMC phenotype on DNA methyltransferases. The cooperativity of matrix with growth factors, cell density and hypoxia was also examined. Primary rat visceral SMC of early passage (0-2) were plated on native collagen or damaged/heat-denatured collagen. Hypoxia was induced with 3% O-2 (balanced 5% CO2 and 95% N-2) over 48 hours. Inhibitors were applied 2-3 hours after cells were plated on matrix, or immediately before hypoxia. Cells were fixed and stained for DNMT3A and smooth muscle actin (SMA) or smooth muscle myosin heavy chain. Illumina 450 K array of CpG sites was performed on bisulfite-converted DNA from smooth muscle cells on damaged matrix vs native collagen. Matrix exquisitely regulates DNMT3A localization and expression, and influences differentiation in SMCs exposed to denatured matrix +/- hypoxia. Analysis of DNA methylation signatures showed that Matrix caused significant DNA methylation alterations in a discrete number of CpG sites proximal to genes related to SMC differentiation. Matrix has a profound effect on the regulation of SMC phenotype, which is associated with altered expression, localization of DNMTs and discrete changes DNA methylation.	[Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Tolg, Cornelia; Baegli, Darius J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Tolg, Cornelia; Baegli, Darius J.] Hosp Sick Children, Div Urol, Toronto, ON M5G 1X8, Canada; [Jiang, Jia-Xin; Sotiropolous, Chris; Zhang, Nicole; Baegli, Darius J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Panchal, Trupti; Baegli, Darius J.] Univ Toronto, Toronto, ON, Canada; [Pu, Shuye; Wodak, Shoshana] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada; [Baegli, Darius J.] Univ Toronto, Dept Surg, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Aitken, KJ (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	kjglennie@rogers.com	Aitken, KJ/AAC-5383-2019	wodak, shoshana/0000-0002-0701-6545	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken K, 2009, NATURE REV UROLOGY; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Aprelikova O, 2012, ONCOGENE; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Barendrecht MM, 2009, NEUROUROL URODYNAM, V28, P349, DOI 10.1002/nau.20642; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bissell M J, 1987, Prog Clin Biol Res, V249, P251; BISSELL MJ, 1987, J CELL SCI, P327; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Burkhard FC, 2001, J UROLOGY, V165, P963, DOI 10.1016/S0022-5347(05)66585-8; Chacko S, 1999, ADV EXP MED BIOL, V462, P137; CHACKO S, 1994, WORLD J UROL, V12, P292; Chacko S, 1997, SCAND J UROL NEPHROL, V31, P67; Chaqour B, 2002, AM J PHYSIOL-ENDOC M, V283, pE765, DOI 10.1152/ajpendo.00131.2002; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cowan DB, 2003, ARTERIOSCL THROM VAS, V23, P1754, DOI 10.1161/01.ATV.0000093546.10162.B2; Dakhlallah D, 2013, AM J RESP CRITICAL C; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; DiSanto ME, 2003, AM J PHYSIOL-CELL PH, V285, pC1397, DOI 10.1152/ajpcell.00513.2002; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Ghafar MA, 2002, J UROLOGY, V167, P1508, DOI 10.1016/S0022-5347(05)65354-2; Ghafar MA, 2002, LAB INVEST, V82, P903, DOI 10.1097/01.LAB.0000021135.87203.92; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Glass TF, 2002, NEUROSCI LETT, V328, P133, DOI 10.1016/S0304-3940(02)00510-4; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Halachmi S, 2006, CELL TISSUE RES, V326, P149, DOI 10.1007/s00441-006-0204-6; Herz DB, 2003, J UROLOGY, V170, P2072, DOI 10.1097/01.ju.0000091810.33953.13; Ho B, 2009, CELL ADHES MIGR, V3, P174, DOI 10.4161/cam.3.2.7374; Hodges SJ, 2010, UROLOGY, V75, P868, DOI 10.1016/j.urology.2009.11.022; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Huang SK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.146; Imamura M, 2009, AM J PHYSIOL-RENAL, V297, pF46, DOI 10.1152/ajprenal.90207.2008; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; Jones PL, 1999, J CELL SCI, V112, P435; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kim JC, 2004, BJU INT, V94, P915, DOI 10.1111/j.1464-4096.2003.05059.x; Kim JY, 2010, CELL CYCLE, V9, P3680, DOI 10.4161/cc.9.18.12716; Koontongkaew S, 2011, MED ONCOL; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Kuo Hann-Chorng, 2010, Rev Urol, V12, pe69; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b; Lu P, 2011, COLD SPRING HARB PER, V3; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malloy BJ, 1998, J UROLOGY, V160, P937, DOI 10.1016/S0022-5347(01)62836-2; MALMQVIST U, 1991, AM J PHYSIOL, V260, pC1085, DOI 10.1152/ajpcell.1991.260.5.C1085; MALMQVIST U, 1991, SCAND J UROL NEPHROL, V25, P261, DOI 10.3109/00365599109024556; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mann J, 2013, CURR OPIN RHEUMATOL, V25, P101, DOI 10.1097/BOR.0b013e32835b13e1; Matsumoto S, 2003, INT J UROL, V10, P339, DOI 10.1046/j.1442-2042.2003.00637.x; Metcalfe PD, 2010, BJU INT; Michelotti Gregory A, 2004, Curr Urol Rep, V5, P258, DOI 10.1007/s11934-004-0048-0; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Ning YY, 2013, ARCH TOXICOL, V87, P871, DOI 10.1007/s00204-012-1008-y; Oh BK, 2007, INT J MOL MED, V20, P65; Orlandi A, 2005, EXP CELL RES, V311, P317, DOI 10.1016/j.yexcr.2005.10.008; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114; PERSSON K, 1995, AM J PHYSIOL-CELL PH, V269, pC1018, DOI 10.1152/ajpcell.1995.269.4.C1018; Pickard A, 2010, J CELL SCI, V123, P3718, DOI 10.1242/jcs.068924; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Sabha N, 2006, IN VITRO CELL DEV-AN, V42, P124; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Schumacher A, 2006, CURR TOP MICROBIOL, V310, P81; Singh N, 2011, CIRC RES, V109, P1240, DOI 10.1161/CIRCRESAHA.111.255067; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Spin JM, 2012, CARDIOVASC RES; Spin JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014301; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Stein R, 2001, J UROLOGY, V166, P651, DOI 10.1016/S0022-5347(05)66037-5; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Sun X, 2013, CELLULAR SIGNALLING; Thieszen SL, 1996, EXP CELL RES, V227, P135, DOI 10.1006/excr.1996.0258; Tolg C, 2011, LAB INVEST; Wang L, 2009, CIRC RES; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Yang L, 2008, ACTA PHARMACOL SIN, V29, P600, DOI 10.1111/j.1745-7254.2008.00784.x; Zeisberg EM, 2012, J PATHOLOGY; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang N, 2012, J UNDERGRADUATE LIFE, V6, P70; Zhang Xu, 2012, Frontiers in Genetics, V3, P73, DOI 10.3389/fgene.2012.00073; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	107	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69089	10.1371/journal.pone.0069089	http://dx.doi.org/10.1371/journal.pone.0069089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	24282625	Green Submitted, Green Published, gold			2022-12-25	WOS:000323109700013
J	Esser, D; Mars, M; Oosterink, E; Stalmach, A; Muller, M; Afman, LA				Esser, Diederik; Mars, Monica; Oosterink, Els; Stalmach, Angelique; Muller, Michael; Afman, Lydia A.			Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men	FASEB JOURNAL			English	Article						flow mediated dilation; augmentation index; high-fat challenge; cardiovascular disease	FLAVANOL-RICH COCOA; ENDOTHELIAL FUNCTION; MEDIATED VASODILATATION; CARDIOVASCULAR HEALTH; POSTPRANDIAL LIPEMIA; REPEATED EXPOSURE; PREDICTION; MORTALITY; EVENTS; ARTERY	Flavanol-enriched chocolate consumption increases endothelium-dependent vasodilation. Most research so far has focused on flow-mediated dilation (FMD) only; the effects on other factors relevant to endothelial health, such as inflammation and leukocyte adhesion, have hardly been addressed. We investigated whether consumption of regular dark chocolate also affects other markers of endothelial health, and whether chocolate enrichment with flavanols has additional benefits. In a randomized double-blind crossover study, the effects of acute and of 4 wk daily consumption of high flavanol chocolate (HFC) and normal flavanol chocolate (NFC) on FMD, augmentation index (AIX), leukocyte count, plasma cytokines, and leukocyte cell surface molecules in overweight men (age 45-70 yr) were investigated. Sensory profiles and motivation scores to eat chocolate were also collected. Findings showed that a 4 wk chocolate intake increased FMD by 1%, which was paralleled by a decreased AIX of 1%, decreased leukocyte cell count, decreased plasma sICAM1 and sICAM3, and decreased leukocyte adhesion marker expression (P<0.05 for time effect), with no difference between HFC and NFC consumption. Flavanol enrichment did affect taste and negatively affected motivation to consume chocolate. This study provides new insights on how chocolate affects endothelial health by demonstrating that chocolate consumption, besides improving vascular function, also lowers the adherence capacity of leukocytes in the circulation.Esser, D., Mars, M., Oosterink, E., Stalmach, A., Muller, M., Afman, L.A. Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men.	[Esser, Diederik; Mars, Monica; Oosterink, Els; Muller, Michael; Afman, Lydia A.] Top Inst Food & Nutr, Wageningen, Netherlands; [Esser, Diederik; Mars, Monica; Oosterink, Els; Muller, Michael; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, NL-6703 HD Wageningen, Netherlands; [Stalmach, Angelique] Univ Glasgow, Ctr Populat & Hlth Sci, Glasgow, Lanark, Scotland	Top Institute Food & Nutrition; Wageningen University & Research; University of Glasgow	Afman, LA (corresponding author), Wageningen Univ, Div Human Nutr, Bomenweg 2, NL-6703 HD Wageningen, Netherlands.	lydia.afman@wur.nl	Mars, Monica/O-4423-2014; Muller, Michael/B-5795-2008; Stalmach, Angelique/B-3250-2009; Muller, Michael/M-5724-2019	Mars, Monica/0000-0003-2010-1039; Muller, Michael/0000-0002-5930-9905; Stalmach, Angelique/0000-0003-4491-654X; Muller, Michael/0000-0002-5930-9905	Top Institute Food and Nutrition [A-1004]	Top Institute Food and Nutrition	The authors thank Casper Schalkwijk, Jos op't Roodt, Iris Smaardijk, Jeske Hageman, Tessa Romijn, Anneke Flipse and Edith van den Bergh for their help and technical assistance. This study was funded by Top Institute Food and Nutrition (A-1004). The chocolate used in this study was donated by Barry Callebaut (Lebbeke, Belgium). The authors declare no conflicts of interest.	Alipour A, 2008, ATHEROSCLEROSIS SUPP, V9, P39, DOI 10.1016/j.atherosclerosissup.2008.05.007; Alipour A, 2007, BIOCHEM SOC T, V35, P466, DOI 10.1042/BST0350466; Arts ICW, 2002, METHODS IN POLYPHENOL ANALYSIS, P214; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Esser D, 2013, J NUTR, V143, P843, DOI 10.3945/jn.113.174540; Esser D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053474; Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58; Farouque HMO, 2006, CLIN SCI, V111, P71, DOI 10.1042/CS20060048; Grassi D, 2012, HYPERTENSION, V60, P827, DOI 10.1161/HYPERTENSIONAHA.112.193995; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001; Hetherington MM, 2002, APPETITE, V38, P19, DOI 10.1006/appe.2001.0442; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Jalil AMM, 2008, MOLECULES, V13, P2190, DOI 10.3390/molecules13092190; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Langer S, 2011, J AGR FOOD CHEM, V59, P8435, DOI 10.1021/jf201398t; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lesschaeve I, 2005, AM J CLIN NUTR, V81, p330S, DOI 10.1093/ajcn/81.1.330S; Li CR, 2010, ATHEROSCLEROSIS, V209, P545, DOI 10.1016/j.atherosclerosis.2009.09.029; Monagas M, 2009, AM J CLIN NUTR, V90, P1144, DOI 10.3945/ajcn.2009.27716; Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457; Robbins RJ, 2009, J CHROMATOGR A, V1216, P4831, DOI 10.1016/j.chroma.2009.04.006; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Steffen Y, 2005, BIOCHEM BIOPH RES CO, V331, P1277, DOI 10.1016/j.bbrc.2005.04.035; Steffen Y, 2007, BIOCHEM BIOPH RES CO, V359, P828, DOI 10.1016/j.bbrc.2007.05.200; Stein LJ, 2003, APPETITE, V40, P119, DOI 10.1016/S0195-6663(02)00173-3; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; Torres-Moreno M, 2012, J SCI FOOD AGR, V92, P404, DOI 10.1002/jsfa.4592; van Bussel BCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058576; van Oostrom AJHHM, 2004, ATHEROSCLEROSIS, V177, P175, DOI 10.1016/j.atherosclerosis.2004.07.004; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wang-Polagruto JF, 2006, J CARDIOVASC PHARM, V47, pS177, DOI 10.1097/00005344-200606001-00013	34	42	42	3	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1464	1473		10.1096/fj.13-239384	http://dx.doi.org/10.1096/fj.13-239384			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24302679				2022-12-25	WOS:000335324800037
J	Levit, A; Nowak, S; Peters, M; Wiener, A; Meyerhof, W; Behrens, M; Niv, MY				Levit, Anat; Nowak, Stefanie; Peters, Maximilian; Wiener, Ayana; Meyerhof, Wolfgang; Behrens, Maik; Niv, Masha Y.			The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14	FASEB JOURNAL			English	Article						GPCRs; cross-reactivity; drug repositioning; multispecificity	AIRWAY SMOOTH-MUSCLE; POTASSIUM CHANNELS; IDENTIFICATION; MEDICATIONS; GLIMEPIRIDE; DISCOVERY; COMPONENT; DOCKING; TARGETS; T2R38	Bitter taste receptors (TAS2Rs) mediate aversive response to toxic food, which is often bitter. These G-protein-coupled receptors are also expressed in extraoral tissues, and emerge as novel targets for therapeutic indications such as asthma and infection. Our goal was to identify ligands of the broadly tuned TAS2R14 among clinical drugs. Molecular properties of known human bitter taste receptor TAS2R14 agonists were incorporated into pharmacophore- and shape-based models and used to computationally predict additional ligands. Predictions were tested by calcium imaging of TAS2R14-transfected HEK293 cells. In vitro testing of the virtual screening predictions resulted in 30-80% success rates, and 15 clinical drugs were found to activate the TAS2R14. hERG potassium channel, which is predominantly expressed in the heart, emerged as a common off-target of bitter drugs. Despite immense chemical diversity of known TAS2R14 ligands, novel ligands and previously unknown polypharmacology of drugs were unraveled by in vitro screening of computational predictions. This enables rational repurposing of traditional and standard drugs for bitter taste signaling modulation for therapeutic indications.Levit, A., Nowak, S., Peters, M., Wiener, A., Meyerhof, W., Behrens, M., Niv, M. Y. The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14.	[Levit, Anat; Wiener, Ayana; Niv, Masha Y.] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Levit, Anat; Wiener, Ayana; Niv, Masha Y.] Hebrew Univ Jerusalem, Fritz Haber Ctr Mol Dynam, Jerusalem, Israel; [Peters, Maximilian] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Jerusalem, Israel; [Nowak, Stefanie; Meyerhof, Wolfgang; Behrens, Maik] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Niv, MY (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, POB 12, IL-76100 Rehovot, Israel.	masha.niv@mail.huji.ac.il	Niv, Masha/AAL-1123-2020; Behrens, Maik/B-6753-2016; Peters, Maximilian/AAA-3509-2020	Behrens, Maik/0000-0003-2082-8860; Niv, Masha/0000-0001-8275-8795	Deutsche Forschungsgemeinschaft grant [ME 1024/8-1]; Israel Science Foundation	Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by a Deutsche Forschungsgemeinschaft grant (ME 1024/8-1) to W.M., M.B., M.Y.N. and an Israel Science Foundation grant to M.Y.N. The authors thank Dr. Elite Levin for helpful discussions and OpenEye Scientific Software for free academic license of their software.	An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; Ayenew Zelalem, 2009, Recent Pat Drug Deliv Formul, V3, P26; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Barra J, 1999, Pharm Acta Helv, V74, P37, DOI 10.1016/S0031-6865(99)00013-8; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Behrens M, 2010, RESULTS PROBL CELL D, V52, P87, DOI 10.1007/978-3-642-14426-4_8; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Bolton E., 2008, ANN REPORTS COMPUTAT, V4; Bordon Y, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3332; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Briscoe VJ, 2010, EXPERT OPIN DRUG MET, V6, P225, DOI 10.1517/17425250903512955; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cho MJ, 2004, J AGR FOOD CHEM, V52, P5895, DOI 10.1021/jf0495035; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dorkhan M, 2007, VASC HEALTH RISK MAN, V3, P721; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Drew MGB, 1998, J AGR FOOD CHEM, V46, P3016, DOI 10.1021/jf980095c; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Gerthoffer WT, 2013, CURR OPIN PHARMACOL, V13, P324, DOI 10.1016/j.coph.2013.04.002; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Intelmann D, 2009, CHEMOSENS PERCEPT, V2, P118, DOI 10.1007/s12078-009-9049-1; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Jonsson MKB, 2012, J MOL CELL CARDIOL, V53, P369, DOI 10.1016/j.yjmcc.2012.06.011; Karaman R, 2013, J MOL MODEL, V19, P2399, DOI 10.1007/s00894-013-1780-5; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kim HO, 2006, J AGR FOOD CHEM, V54, P10102, DOI 10.1021/jf062422j; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kruger DM, 2010, CHEMMEDCHEM, V5, P148, DOI 10.1002/cmdc.200900314; Kubinyi H., 2006, COMPUTER APPL PHARM, P377, DOI DOI 10.1002/0470037237; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Levit Anat, 2012, Methods Mol Biol, V914, P179, DOI 10.1007/978-1-62703-023-6_11; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Ley JP, 2012, J AGR FOOD CHEM, V60, P6303, DOI 10.1021/jf301335z; Li F, 2013, MOL HUM REPROD, V19, P349, DOI 10.1093/molehr/gat009; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lin XY, 2012, J MED CHEM, V55, P5749, DOI 10.1021/jm300338m; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lombardino JG, 2004, NAT REV DRUG DISCOV, V3, P853, DOI 10.1038/nrd1523; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Maniruzzaman M, 2014, DRUG DEV IND PHARM, V40, P145, DOI 10.3109/03639045.2013.804833; Mattes RD, 2011, PHYSIOL BEHAV, V104, P624, DOI 10.1016/j.physbeh.2011.05.002; Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; Murgueitio Manuela S, 2012, Drug Discov Today Technol, V9, pe219, DOI 10.1016/j.ddtec.2012.07.009; Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004; Ohmoto M, 2006, CHEM SENSES, V31, P739, DOI 10.1093/chemse/bjl016; Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z; Rodgers S, 2006, J CHEM INF MODEL, V46, P569, DOI 10.1021/ci0504418; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Schiffman SS, 2000, PHYSIOL BEHAV, V69, P413, DOI 10.1016/S0031-9384(99)00262-0; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Stumpfe D, 2012, J MED CHEM, V55, P2932, DOI 10.1021/jm201706b; Tizzano M, 2013, PHYSIOLOGY, V28, P51, DOI 10.1152/physiol.00035.2012; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Ueda T, 2003, J NEUROSCI, V23, P7376; Urban J, 2013, ANGEW CHEM INT EDIT, V52, P1553, DOI 10.1002/anie.201208450; Viswanathan VK, 2013, GUT MICROBES, V4, P91, DOI 10.4161/gmic.23776; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Wu KK, 2000, CIRCULATION, V102, P2022, DOI 10.1161/01.CIR.102.17.2022; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Xu J, 2013, MOL HUM REPROD, V19, P17, DOI 10.1093/molehr/gas040; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhou PZ, 2011, ACTA PHARMACOL SIN, V32, P781, DOI 10.1038/aps.2011.70	79	73	75	7	46	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1181	1197		10.1096/fj.13-242594	http://dx.doi.org/10.1096/fj.13-242594			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24285091				2022-12-25	WOS:000335324800014
J	Abendroth, J; Ollodart, A; Andrews, ESV; Myler, PJ; Staker, BL; Edwards, TE; Arcus, VL; Grundner, C				Abendroth, Jan; Ollodart, Anja; Andrews, Emma S. V.; Myler, Peter J.; Staker, Bart L.; Edwards, Thomas E.; Arcus, Vickery L.; Grundner, Christoph			Mycobacterium tuberculosis Rv2179c Protein Establishes a New Exoribonuclease Family with Broad Phylogenetic Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Microbiology; Mycobacterium tuberculosis; Pseudomonas; Ribonuclease; Annotation	ADENOSINE NUCLEOTIDE-BINDING; RNASE-T; MATURATION; SEQUENCE	Ribonucleases (RNases) maintain the cellular RNA pool by RNA processing and degradation. In many bacteria, including the human pathogen Mycobacterium tuberculosis (Mtb), the enzymes mediating several central RNA processing functions are still unknown. Here, we identify the hypothetical Mtb protein Rv2179c as a highly divergent exoribonuclease. Although the primary sequence of Rv2179c has no detectable similarity to any known RNase, the Rv2179c crystal structure reveals an RNase fold. Active site residues are equivalent to those in the DEDD family of RNases, and Rv2179c has close structural homology to Escherichia coli RNase T. Consistent with the DEDD fold, Rv2179c has exoribonuclease activity, cleaving the 3 single-strand overhangs of duplex RNA. Functional orthologs of Rv2179c are prevalent in actinobacteria and found in bacteria as phylogenetically distant as proteobacteria. Thus, Rv2179c is the founding member of a new, large RNase family with hundreds of members across the bacterial kingdom.	[Abendroth, Jan; Staker, Bart L.; Edwards, Thomas E.] Emerald Bio, Bainbridge Isl, WA 98110 USA; [Ollodart, Anja; Myler, Peter J.; Grundner, Christoph] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Andrews, Emma S. V.; Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand; [Myler, Peter J.; Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Waikato; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N, Seattle, WA 98109 USA.	christoph.grundner@seattlebiomed.org	Myler, Peter John/AAR-9535-2021; Andrews, Emma/P-9877-2016	Andrews, Emma/0000-0003-2153-4346; Staker, Bart/0000-0001-9570-5086; Edwards, Thomas/0000-0002-0474-8003; Ollodart, Anja/0000-0002-6329-9463	National Institutes of Health from the NIAID [HHSN272200700057C, HHSN272201200025C]; Paul G. Allen Family Foundation [8999]; American Lung Association	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul G. Allen Family Foundation; American Lung Association	This work was supported, in whole or in part, by National Institutes of Health Federal Contracts HHSN272200700057C and HHSN272201200025C from the NIAID.; Supported by the Paul G. Allen Family Foundation Grant 8999 and the American Lung Association. To whom correspondence should be addressed: Seattle Biomedical Research Institute, 307 Westlake Ave. N., Seattle, WA 98109. Tel.: 206-256-7295; Fax: 206-256-7229; E-mail: christoph.grundner@seattlebiomed.org.	Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ansong C, 2013, CHEM BIOL, V20, P123, DOI 10.1016/j.chembiol.2012.11.008; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Qiu HB, 2007, ANAL CHEM, V79, P5547, DOI 10.1021/ac0622375; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	24	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2139	2147		10.1074/jbc.M113.525683	http://dx.doi.org/10.1074/jbc.M113.525683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311791	hybrid, Green Published			2022-12-25	WOS:000331130200022
J	Stachel, I; Geismann, C; Aden, K; Deisinger, F; Rosenstiel, P; Schreiber, S; Sebens, S; Arlt, A; Schafer, H				Stachel, Imke; Geismann, Claudia; Aden, Konrad; Deisinger, Florian; Rosenstiel, Philip; Schreiber, Stefan; Sebens, Susanne; Arlt, Alexander; Schaefer, Heiner			Modulation of Nuclear Factor E2-related Factor-2 (Nrf2) Activation by the Stress Response Gene Immediate Early Response-3 (IER3) in Colonic Epithelial Cells A NOVEL MECHANISM OF CELLULAR ADAPTION TO INFLAMMATORY STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Colon Cancer; Nrf2; Oxidative Stress; Transcription Factors	NF-KAPPA-B; PANCREATIC-CANCER CELLS; PROTEASOME ACTIVITY; SIGNALING PATHWAY; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; IEX-1 EXPRESSION; DRUG-RESISTANCE; KEAP1 GENE	Although nuclear factor E2-related factor-2 (Nrf2) protects from carcinogen-induced tumorigenesis, underlying the rationale for using Nrf2 inducers in chemoprevention, this antioxidative transcription factor may also act as a proto-oncogene. Thus, an enhanced Nrf2 activity promotes formation and chemoresistance of colon cancer. One mechanism causing persistent Nrf2 activation is the adaptation of epithelial cells to oxidative stress during chronic inflammation, e.g. colonocytes in inflammatory bowel diseases, and the multifunctional stress response gene immediate early response-3 (IER3) has a crucial role under these conditions. We now demonstrate that colonic tissue from Ier3(-/-) mice subject of dextran sodium sulfate colitis exhibit greater Nrf2 activity than Ier3(+/+) mice, manifesting as increased nuclear Nrf2 protein level and Nrf2 target gene expression. Likewise, human NCM460 colonocytes subjected to shRNA-mediated IER3 knockdown exhibit greater Nrf2 activity compared with control cells, whereas IER3 overexpression attenuated Nrf2 activation. IER3-deficient NCM460 cells exhibited reduced reactive oxygen species levels, indicating increased antioxidative protection, as well as lower sensitivity to TRAIL or anticancer drug-induced apoptosis and greater clonogenicity. Knockdown of Nrf2 expression reversed these IER3-dependent effects. Further, the enhancing effect of IER3 deficiency on Nrf2 activity relates to the control of the inhibitory tyrosine kinase Fyn by the PI3K/Akt pathway. Thus, the PI3K inhibitor LY294002 or knockdown of Akt or Fyn expression abrogated the impact of IER3 deficiency on Nrf2 activity. In conclusion, the interference of IER3 with the PI3K/Akt-Fyn pathway represents a novel mechanism of Nrf2 regulation that may get lost in tumors and by which IER3 exerts its stress-adaptive and tumor-suppressive activity.	[Stachel, Imke; Geismann, Claudia; Aden, Konrad; Deisinger, Florian; Schreiber, Stefan; Arlt, Alexander; Schaefer, Heiner] Dept Internal Med 1, Lab Mol Gastroenterol & Hepatol, D-24105 Kiel, Germany; [Sebens, Susanne] Inst Expt Med, D-24105 Kiel, Germany; [Rosenstiel, Philip] Inst Clin Mol Biol, D-24105 Kiel, Germany		Schafer, H (corresponding author), Dept Internal Med 1, UKSH Campus Kiel,Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Aden, Konrad/H-1477-2014; Sebens, Susanne/C-1222-2010; Schäfer, Heiner/C-1055-2011; Geismann, Claudia/AAX-8158-2021; Aden, Konrad/AAG-3290-2020; Rosenstiel, Philip/A-5137-2009; Arlt, Alexander/G-7308-2019	Aden, Konrad/0000-0003-3482-7316; Geismann, Claudia/0000-0003-0640-9256; Rosenstiel, Philip/0000-0002-9692-8828; Arlt, Alexander/0000-0002-6160-1059; Schafer, Heiner/0000-0001-6936-9090	Medical Faculty of the University of Kiel; German Research Society Deutsche Forschungsgemeinschaft (DFG); DFG Cluster of Excellence Inflammation at Interfaces	Medical Faculty of the University of Kiel; German Research Society Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG))	This work was supported by the Medical Faculty of the University of Kiel (to C. G., A. A., and H. S.), the German Research Society Deutsche Forschungsgemeinschaft (DFG) (to H. S. and A. A.), and the DFG Cluster of Excellence Inflammation at Interfaces.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Arlt A, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.35; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt A, 2003, ONCOGENE, V22, P3343, DOI 10.1038/sj.onc.1206524; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arlt A, 2008, BBA-MOL CELL RES, V1783, P941, DOI 10.1016/j.bbamcr.2007.12.010; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Billmann-Born S, 2011, J IMMUNOL, V186, P4027, DOI 10.4049/jimmunol.1000085; Chang LC, 2013, APPL IMMUNOHISTO M M, V21, P511, DOI 10.1097/PAI.0b013e318282ac20; Chang WCL, 2007, CARCINOGENESIS, V28, P2375, DOI 10.1093/carcin/bgm134; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Deng C, 2012, MOL MED REP, V5, P847, DOI 10.3892/mmr.2011.731; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Han LP, 2011, ULTRASTRUCT PATHOL, V35, P260, DOI 10.3109/01913123.2011.608916; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Kapoor S, 2012, ULTRASTRUCT PATHOL, V36, P285, DOI 10.3109/01913123.2012.697981; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kinch L, 2011, CANCER CELL, V20, P418, DOI 10.1016/j.ccr.2011.10.005; Kondratyev AD, 1996, CANCER RES, V56, P1498; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Leoncini E, 2011, J FOOD SCI, V76, pH175, DOI 10.1111/j.1750-3841.2011.02311.x; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Nambiar PR, 2004, CANCER RES, V64, P6394, DOI 10.1158/0008-5472.CAN-04-0933; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Osawa Y, 2003, J IMMUNOL, V170, P4053, DOI 10.4049/jimmunol.170.8.4053; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Sasada T, 2008, ANN SURG ONCOL, V15, P609, DOI 10.1245/s10434-007-9669-0; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Sina C, 2010, INFLAMM BOWEL DIS, V16, P320, DOI 10.1002/ibd.21066; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Ustyugova IV, 2012, INFLAMM BOWEL DIS, V18, P333, DOI 10.1002/ibd.21772; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Wu MX, 2013, EXPERT OPIN THER TAR, V17, P593, DOI 10.1517/14728222.2013.768234; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528	59	34	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1917	1929		10.1074/jbc.M113.490920	http://dx.doi.org/10.1074/jbc.M113.490920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311782	Green Published, hybrid			2022-12-25	WOS:000331130200004
J	Nguyen, A; Tao, H; Metrione, M; Hajri, T				Andrew Nguyen; Tao, Huan; Metrione, Michael; Hajri, Tahar			Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue; Inflammation; Macrophages; Obesity; VLDLR	FATTY-ACID UPTAKE; NECROSIS-FACTOR-ALPHA; APOLIPOPROTEIN-E; ENDOPLASMIC-RETICULUM; OBESITY; MICE; APOE; METABOLISM; LIPASE; JNK	Background: Very low density lipoprotein receptor (VLDLR) is highly expressed in adipose tissue. Results: VLDLR deficiency attenuates inflammation in adipose tissue of mice fed a high fat diet and reduces adipocyte hypertrophy and inflammation in response to VLDL. Conclusion: VLDLR is a prominent player in adipose tissue inflammation in obesity. Significance: These studies provide a possible mechanism thorough which VLDL induces inflammation. Obesity is associated with adipose tissue remodeling, characterized by adipocyte hypertrophy and macrophage infiltration. Previously, we have shown that very low density lipoprotein receptor (VLDLR) is virtually absent in preadipocytes but is strongly induced during adipogenesis and actively participates in adipocyte hypertrophy. In this study, we investigated the role of VLDLR in adipose tissue inflammation and adipocyte-macrophage interactions in wild type and VLDLR-deficient mice fed a high fat diet. The results show that VLDLR deficiency reduced high fat diet-induced inflammation and endoplasmic reticulum (ER) stress in adipose tissue in conjunction with reduced macrophage infiltration, especially those expressing pro-inflammatory markers. In adipocyte culture, VLDLR deficiency prevented adipocyte hypertrophy and strongly reduced VLDL-induced ER stress and inflammation. Likewise, cultures of primary peritoneal macrophages show that VLDLR deficiency reduced lipid accumulation and inflammation but did not alter chemotactic response of macrophages to adipocyte signals. Moreover, VLDLR deficiency tempered the synergistic inflammatory interactions between adipocytes and macrophages in a co-culture system. Collectively, these results show that VLDLR contributes to adipose tissue inflammation and mediates VLDL-induced lipid accumulation and induction of inflammation and ER stress in adipocytes and macrophages.	[Andrew Nguyen; Metrione, Michael; Hajri, Tahar] Hackensack Univ, Dept Surg, Med Ctr, Hackensack, NJ 07601 USA; [Tao, Huan] Vanderbilt Univ, Atherosclerosis Res Unit, Div Cardiovasc Med, Nashville, TN 37212 USA	Hackensack University Medical Center; Vanderbilt University	Hajri, T (corresponding author), Dept Surg, Jurist Res Bldg,Rm 432,40 Prospect Ave, Hackensack, NJ 07601 USA.	thajri@hackensackumc.org	Hajri, Tahar/AAQ-6499-2020	Hajri, Tahar/0000-0003-3805-3717	Hackensack University Medical Center; American Heart Association [AHA0730356N]	Hackensack University Medical Center; American Heart Association(American Heart Association)	This work was supported by development grants from Hackensack University Medical Center and American Heart Association Award AHA0730356N.	Ahlin S, 2013, OBESITY, V21, pE571, DOI 10.1002/oby.20443; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Cai L., 2012, PLOS ONE, V7; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Crawford DC, 2008, J LIPID RES, V49, P588, DOI 10.1194/jlr.M700409-JLR200; Du Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2011; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hajri T, 1998, J NUTR, V128, P477, DOI 10.1093/jn/128.3.477; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2001, J BIOL CHEM, V276, P23661, DOI 10.1074/jbc.M100942200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Hajri T, 2011, AM J PHYSIOL-ENDOC M, V300, pE350, DOI 10.1152/ajpendo.00307.2010; He JY, 2011, ATHEROSCLEROSIS, V215, P243, DOI 10.1016/j.atherosclerosis.2010.12.018; Huang ZH, 2009, J BIOL CHEM, V284, P31512, DOI 10.1074/jbc.M109.004754; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shapiro H, 2013, J CLIN ENDOCR METAB, V98, P1173, DOI 10.1210/jc.2012-2745; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Tao H, 2011, BIOCHEM PHARMACOL, V82, P1950, DOI 10.1016/j.bcp.2011.09.003; Tao H, 2010, AM J PHYSIOL-ENDOC M, V298, pE68, DOI 10.1152/ajpendo.00367.2009; Ueda Y, 2011, OBESITY, V19, P1663, DOI 10.1038/oby.2011.58; Wang JL, 2012, ATHEROSCLEROSIS, V223, P342, DOI 10.1016/j.atherosclerosis.2012.06.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200	50	41	41	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1688	1703		10.1074/jbc.M113.515320	http://dx.doi.org/10.1074/jbc.M113.515320			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293365	Green Published, hybrid			2022-12-25	WOS:000332401700041
J	Zandawala, M; Li, SZ; Hauser, F; Grimmelikhuijzen, CJP; Orchard, I				Zandawala, Meet; Li, Shizhong; Hauser, Frank; Grimmelikhuijzen, Cornelis J. P.; Orchard, Ian			Isolation and Functional Characterization of Calcitonin-Like Diuretic Hormone Receptors in Rhodnius prolixus	PLOS ONE			English	Article							DROSOPHILA; PEPTIDE; CGRP; SEQUENCE; RAMPS; DH31; BUG	Several families of diuretic hormones exist in insects, one of which is the calcitonin-like diuretic hormone (CT/DH) family. CT/DH mediates its effects by binding to family B G-protein coupled receptors (GPCRs). Here we isolate and functionally characterize two R. prolixus CT/DH receptor paralogs (Rhopr-CT/DH-R1 and Rhopr-CT/DH-R2) using a novel heterologous assay utilizing a modified human embryonic kidney 293 (HEK293) cell line. Rhopr-CT/DH-R1 is orthologous to the previously characterized D. melanogaster CT/DH receptor (CG17415) while Rhopr-CT/DH-R2 is orthologous to the D. melanogaster receptor (CG4395), an orphan receptor whose ligand was unknown until now. We determine the cDNA sequences of three splice variants encoding Rhopr-CT/DH-R1 (Rhopr-CT/DH-R1-A, Rhopr-CT/DH-R1-B and Rhopr-CT/DH-R1-C) and two splice variants encoding Rhopr-CT/DH-R2 (Rhopr-CT/DH-R2-A and Rhopr-CT/DH-R2-B). Rhopr-CT/DH-R1-A and Rhopr-CT/DH-R2-A encode truncated receptors that lack six and seven of the characteristic seven transmembrane domains, respectively. Rhopr-CT/DH-R1-B and Rhopr-CT/DH-R1-C, which only differ by 2 amino acids in their C-terminal domain, can both be activated by Rhopr-CT/DH at equal sensitivities (EC50 = 200-300nM). Interestingly, Rhopr-CT/DH-R2-B is much more sensitive to Rhopr-CT/DH (EC50 = 15nM) compared to Rhopr-CT/DH-R1-B/C and also yields a much greater response (amplitude) in our heterologous assay. This is the first study to reveal that insects possess at least two CT/DH receptors, which may be functionally different. Quantitative PCR demonstrates that Rhopr-CT/DH-R1 and Rhopr-CT/DH-R2 have distinct expression patterns, with both receptors expressed centrally and peripherally. Moreover, the expression analysis also identified novel target tissues for this neuropeptide, including testes, ovaries and prothoracic glands, suggesting a possible role for Rhopr-CT/DH in reproductive physiology and development.	[Zandawala, Meet; Orchard, Ian] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Zandawala, Meet; Li, Shizhong; Hauser, Frank; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Ctr Funct & Comparat Insect Genom, Copenhagen, Denmark	University of Toronto; University Toronto Mississauga; University of Copenhagen	Zandawala, M (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	meet.zandawala@utoronto.ca	Hauser, Frank/M-2952-2014; Zandawala, Meet/I-7019-2018	Hauser, Frank/0000-0001-5563-2345; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Zandawala, Meet/0000-0001-6498-2208	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Canadian Graduate Scholarship; NSERC Michael Smith Foreign Study Supplement; Danish Research Agency; Carlsberg Foundation; Lundbeck Foundation; Lundbeck Foundation [R83-2011-7610] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Michael Smith Foreign Study Supplement; Danish Research Agency; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to I.O., an NSERC Canadian Graduate Scholarship and NSERC Michael Smith Foreign Study Supplement to M.Z., and by grants from the Danish Research Agency, Carlsberg Foundation, and Lundbeck Foundation to C.J.P.G. and F.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brugge VAT, 2008, J EXP BIOL, V211, P382, DOI 10.1242/jeb.013771; Brugge VT, 2009, GEN COMP ENDOCR, V162, P105, DOI 10.1016/j.ygcen.2009.01.025; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coast GM, 2011, PEPTIDES, V32, P493, DOI 10.1016/j.peptides.2010.11.009; Coast GM, 2005, J EXP BIOL, V208, P3281, DOI 10.1242/jeb.01760; Coast GM, 2001, J EXP BIOL, V204, P1795; Collin C, 2013, CELL MOL LIFE SCI, V70, P3231, DOI 10.1007/s00018-013-1334-0; Conner AC, 2004, BIOCHEM SOC T, V32, P843, DOI 10.1042/BST0320843; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kaskani C, 2012, PEPTIDES, V34, P258, DOI 10.1016/j.peptides.2011.04.009; Kwon H, 2013, INSECT BIOCHEM MOLEC, V43, P588, DOI 10.1016/j.ibmb.2013.03.005; Kwon H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050374; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028269; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mikhailova MV, 2007, MOL ENDOCRINOL, V21, P2178, DOI 10.1210/me.2007-0160; Nag K, 2007, BIOCHEM BIOPH RES CO, V362, P1037, DOI 10.1016/j.bbrc.2007.08.107; ORCHARD I, 1989, J INSECT PHYSIOL, V35, P943, DOI 10.1016/0022-1910(89)90017-6; Orchard Ian, 2009, Front Biosci (Elite Ed), V1, P250; Park Y, 2012, CAN J ZOOL, V90, P507, DOI 10.1139/Z2012-013; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Te Brugge VA, 2005, PEPTIDES, V26, P29, DOI 10.1016/j.peptides.2004.08.025; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Visegrady A, 2007, J BIOMOL SCREEN, V12, P1068, DOI 10.1177/1087057107309035; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P10, DOI 10.1016/j.ibmb.2011.10.002	34	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82466	10.1371/journal.pone.0082466	http://dx.doi.org/10.1371/journal.pone.0082466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312424	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300081
J	Rodil, IF; Lohrer, AM; Thrush, SF				Rodil, Ivan F.; Lohrer, Andrew M.; Thrush, Simon F.			Sensitivity of Heterogeneous Marine Benthic Habitats to Subtle Stressors	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; CALCIUM-CARBONATE; BIODIVERSITY; NITROGEN; IMPACT; CO2; PATTERNS; MATTER; FUTURE	It is important to understand the consequences of low level disturbances on the functioning of ecological communities because of the pervasiveness and frequency of this type of environmental change. In this study we investigated the response of a heterogeneous, subtidal, soft-sediment habitat to small experimental additions of organic matter and calcium carbonate to examine the sensitivity of benthic ecosystem functioning to changes in sediment characteristics that relate to the environmental threats of coastal eutrophication and ocean acidification. Our results documented significant changes between key biogeochemical and sedimentary variables such as gross primary production, ammonium uptake and dissolved reactive phosphorus flux following treatment additions. Moreover, the application of treatments affected relationships between macrofauna communities, sediment characteristics (e.g., chlorophyll a content) and biogeochemical processes (oxygen and nutrient fluxes). In this experiment organic matter and calcium carbonate showed persistent opposing effects on sedimentary processes, and we demonstrated that highly heterogeneous sediment habitats can be surprisingly sensitive to subtle perturbations. Our results have important biological implications in a world with relentless anthropogenic inputs of atmospheric CO2 and nutrients in coastal waters.	[Rodil, Ivan F.] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Rodil, Ivan F.; Lohrer, Andrew M.; Thrush, Simon F.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	Universidade de Vigo; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Rodil, IF (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ibantxorodil@gmail.com	Rodil, Iván F./I-5305-2013	Rodil, Iván F./0000-0001-6375-1598; Thrush, Simon/0000-0002-4005-3882; Lohrer, Andrew Martin/0000-0002-3893-6539	Angeles Alvarino (XUGA, Spain); Ministry of Business, Innovation and Employment (MoBIE) [NIWA COMS1320, COER1201]	Angeles Alvarino (XUGA, Spain); Ministry of Business, Innovation and Employment (MoBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE))	IFR acknowledges the financial support from the postdoctoral program Angeles Alvarino (XUGA, Spain). This work was supported by funding from Ministry of Business, Innovation and Employment (MoBIE) (NIWA COMS1320 and COER1201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2006, CORAL REEFS, V25, P123, DOI 10.1007/s00338-005-0069-2; Blake RE, 2010, OIKOS, V119, P1625, DOI 10.1111/j.1600-0706.2010.18419.x; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Cebrian J, 2002, LIMNOL OCEANOGR, V47, P11, DOI 10.4319/lo.2002.47.1.0011; Clavier J, 2005, J EXP MAR BIOL ECOL, V316, P231, DOI 10.1016/j.jembe.2004.11.004; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Egleston ES, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003407; Engelsen A, 2008, ESTUAR COAST SHELF S, V78, P783, DOI 10.1016/j.ecss.2008.02.018; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Grashoff K., 1983, METHODS SEAWATER ANA; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; Hicks Natalie, 2011, BMC Ecology, V11, P7, DOI 10.1186/1472-6785-11-7; Huesemann MH, 2002, MAR POLLUT BULL, V44, P142, DOI 10.1016/S0025-326X(01)00194-1; Hulth S, 2005, MAR CHEM, V94, P125, DOI 10.1016/j.marchem.2004.07.013; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Lerman A, 2005, AQUAT GEOCHEM, V11, P345, DOI 10.1007/s10498-005-8620-x; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2012, MAR POLLUT BULL, V64, P2761, DOI 10.1016/j.marpolbul.2012.09.012; Lohrer AM, 2011, AUSTRAL ECOL, V36, P378, DOI 10.1111/j.1442-9993.2010.02148.x; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; NELSON CS, 1988, SEDIMENT GEOL, V60, P3, DOI 10.1016/0037-0738(88)90108-X; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao AMF, 2012, LIMNOL OCEANOGR, V57, P809, DOI 10.4319/lo.2012.57.3.0809; Rodil IF, 2011, ECOL APPL, V21, P416, DOI 10.1890/09-1845.1; Sartory D.P., 1982, SPECTROPHOTOMETRIC A; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; Sundback K, 2000, MAR ECOL PROG SER, V200, P59, DOI 10.3354/meps200059; Sundby B, 1992, LIMNOLOGY OCEANOGRAP, V49, P1095; Tang QS, 2011, MAR ECOL PROG SER, V424, P97, DOI 10.3354/meps08979; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Thrush SF, 2013, ECOL APPL, V23, P226, DOI 10.1890/12-0793.1; Tynan S, 2011, SCI TOTAL ENVIRON, V409, P1082, DOI 10.1016/j.scitotenv.2010.12.007; Welsh DT, 2003, CHEM ECOL, V19, P321, DOI 10.1080/0275754031000155474; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894	50	4	4	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81646	10.1371/journal.pone.0081646	http://dx.doi.org/10.1371/journal.pone.0081646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312332	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900043
J	Silva, J; Barrote, I; Costa, MM; Albano, S; Santos, R				Silva, Joao; Barrote, Isabel; Costa, Monya M.; Albano, Silvia; Santos, Rui			Physiological Responses of Zostera marina and Cymodocea nodosa to Light-Limitation Stress	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; CARBOHYDRATE RESERVES; OXIDATIVE STRESS; ANTENNA COMPLEX; LUTEIN-EPOXIDE; CARBON BALANCE; PLANT-TISSUES; METABOLISM; EELGRASS; CYCLE	The effects of light-limitation stress were investigated in natural stands of the seagrasses Zostera marina and Cymodocea nodosa in Ria Formosa coastal lagoon, southern Portugal. Three levels of light attenuation were imposed for 3 weeks in two adjacent meadows (2-3 m depth), each dominated by one species. The response of photosynthesis to light was determined with oxygen electrodes. Chlorophylls and carotenoids were determined by high-pressure liquid chromatography (HPLC). Soluble protein, carbohydrates, malondialdehyde and phenol contents were also analysed. Both species showed evident signs of photoacclimation. Their maximum photosynthetic rates were significantly reduced with shading. Ratios between specific light harvesting carotenoids and the epoxidation state of xanthophyll cycle carotenoids revealed significantly higher light harvesting efficiency of C. nodosa, a competitive advantage in a low light environment. The contents of both soluble sugars and starch were considerably lower in Z. marina plants, particularly in the rhizomes, decreasing even further with shading. The different carbohydrate energy storage strategies found between the two species clearly favour C. nodosa's resilience to light deprivation, a condition enhanced by its intrinsic arrangement of the pigment pool. On the other hand, Z. marina revealed a lower tolerance to light reduction, mostly due to a less plastic arrangement of the pigment pool and lower carbohydrate storage. Our findings indicate that Z. marina is close to a light-mediated ecophysiological threshold in Ria Formosa.	[Silva, Joao; Costa, Monya M.; Albano, Silvia; Santos, Rui] CCMAR, Faro, Portugal; [Barrote, Isabel] Univ Algarve, CECTA, Faro, Portugal	Universidade do Algarve	Silva, J (corresponding author), CCMAR, Faro, Portugal.	jmsilva@ualg.pt	Barrote, Isabel/AAK-4887-2021; Santos, Rui O P/B-4168-2008; Silva, João/J-7874-2013	Barrote, Isabel/0000-0002-0922-0259; Santos, Rui O P/0000-0002-7861-4366; Silva, João/0000-0002-7211-1661	FCT [PTCD/MAR-EST/3687/2012, PTDC/AAC-CLI/103348/2008, SFRH/BD/64590/2009]; COST action "Seagrass Productivity" [ES0906]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-CLI/103348/2008] Funding Source: FCT	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); COST action "Seagrass Productivity"; Fundação para a Ciência e a Tecnologia	This study was supported by the FCT-funded projects "HighGrass" (PTCD/MAR-EST/3687/2012) and "Metabolism" (PTDC/AAC-CLI/103348/2008) and by the COST action "Seagrass Productivity" (ES0906). Monya Costa is supported by the FCT grant SFRH/BD/64590/2009. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abadia Javier, 1993, P327; Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bjork M., 2008, MANAGING SEAGRASSES; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Booker FL, 1998, J EXP BOT, V49, P1191, DOI 10.1093/jexbot/49.324.1191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke MK, 1996, MAR ECOL PROG SER, V137, P195, DOI 10.3354/meps137195; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Casazza G, 2000, BIOL MAR MEDIT, V7, P31; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Collier CJ, 2008, MAR ECOL PROG SER, V353, P65, DOI 10.3354/meps07171; Collier CJ, 2009, J EXP MAR BIOL ECOL, V370, P89, DOI 10.1016/j.jembe.2008.12.003; Curiel Daniele, 2005, Bollettino del Museo Civico di Storia Naturale di Venezia, V56, P25; Davey MW, 2005, ANAL BIOCHEM, V347, P201, DOI 10.1016/j.ab.2005.09.041; DELASRIVAS J, 1989, PLANT PHYSIOL, V91, P190, DOI 10.1104/pp.91.1.190; DENNISON WC, 1985, MAR ECOL PROG SER, V25, P51, DOI 10.3354/meps025051; Desikan R, 2005, BIOL SCI SER, P169, DOI 10.1002/9780470988565.ch7; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; Gruszecki WI, 2010, BIOCHEM SOC T, V38, P702, DOI 10.1042/BST0380702; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Janhs P, 2009, BIOCHIM BIOPHYS ACTA, V1787, P3; Kraemer BP, 1995, J EXP MAR BIOL ECOL, V185, P191; Larbi A, 2004, PHOTOSYNTH RES, V79, P59, DOI 10.1023/B:PRES.0000011919.35309.5e; Lichtenthaler HK, 2004, ADV PHOTO RESPIRAT, V19, P713; Lichtenthaler HK., 2001, CURRENT PROTOCOLS FO, P431, DOI DOI 10.1002/0471142913.FAF0403S01; Longstaff BJ, 1999, J EXP MAR BIOL ECOL, V234, P1, DOI 10.1016/S0022-0981(98)00137-3; Malta EJ, 2006, SCI MAR, V70, P413, DOI 10.3989/scimar.2006.70n3413; MARBA N, 1994, MAR ECOL PROG SER, V107, P307, DOI 10.3354/meps107307; Matsubara S, 2005, J EXP BOT, V56, P461, DOI 10.1093/jxb/eri012; Matsubara S, 2009, FUNCT PLANT BIOL, V36, P20, DOI 10.1071/FP08214; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; Migliore Luciana, 2007, BMC Ecology, V7, P6, DOI 10.1186/1472-6785-7-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nixon PJ, 2000, PHILOS T R SOC B, V355, P1541, DOI 10.1098/rstb.2000.0714; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Ralph PJ, 2002, J EXP MAR BIOL ECOL, V271, P189, DOI 10.1016/S0022-0981(02)00047-3; Ruban AV, 2011, ENERG ENVIRON SCI, V4, P1643, DOI 10.1039/c0ee00578a; Silva J, 2004, J EXP MAR BIOL ECOL, V307, P207, DOI 10.1016/j.jembe.2004.02.009; Smith EL, 1936, P NATL ACAD SCI USA, V22, P504, DOI 10.1073/pnas.22.8.504; Sokal R. R., 1981, BIOMETRY; TALLING J. F., 1957, NEW PHYTOL, V56, P29, DOI 10.1111/j.1469-8137.1957.tb07447.x; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Zhang M, 2010, ENVIRON EXP BOT, V68, P44, DOI 10.1016/j.envexpbot.2009.09.003; ZIMMERMAN RC, 1989, J EXP MAR BIOL ECOL, V130, P93, DOI 10.1016/0022-0981(89)90197-4; ZIMMERMAN RC, 1995, AQUAT BOT, V51, P67, DOI 10.1016/0304-3770(95)00472-C	53	56	57	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81058	10.1371/journal.pone.0081058	http://dx.doi.org/10.1371/journal.pone.0081058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312260	gold, Green Published			2022-12-25	WOS:000327657900020
J	Azai, C; Harada, J; Oh-oka, H				Azai, Chihiro; Harada, Jiro; Oh-oka, Hirozo			Gene Expression System in Green Sulfur Bacteria by Conjugative Plasmid Transfer	PLOS ONE			English	Article							CHLOROBIUM-TEPIDUM; EVOLUTION; PROTEIN; TRANSFORMATION; MUTAGENESIS; METABOLISM; MATURATION; TAXONOMY; CLONING; RNA	Gene transfer and expression systems in green sulfur bacteria were established by bacterial conjugation with Escherichia coli. Conjugative plasmid transfer from E. coli S17-1 to a thermophilic green sulfur bacterium, Chlorobaculum tepidum (formerly Chlorobium tepidum) WT2321, was executed with RSF 1010-derivative broad-host-range plasmids, named pDSK5191 and pDSK5192, that confer erythromycin and streptomycin/spectinomycin resistance, respectively. The transconjugants harboring these plasmids were reproducibly obtained at a frequency of approximately 10(-5) by selection with erythromycin and a combination of streptomycin and spectinomycin, respectively. These plasmids were stably maintained in C. tepidum cells in the presence of these antibiotics. The plasmid transfer to another mesophilic green sulfur bacterium, C. limnaeum (formerly Chlorobium phaeobacteroides) RK-j-1, was also achieved with pDSK5192. The expression plasmid based on pDSK5191 was constructed by incorporating the upstream and downstream regions of the pscAB gene cluster on the C. tepidum genome, since these regions were considered to include a constitutive promoter and rho-independent terminator, respectively. Growth defections of the Delta cycA and Delta soxB mutants were completely rescued after introduction of pDSK5191-cycA and -soxB that were designed to express their complementary genes. On the other hand, pDSK5191-6xhis-pscAB, which incorporated the gene cluster of 6xhis-pscA and pscB, produced approximately four times more of the photosynthetic reaction center complex with His-tagged PscA as compared with that expressed in the genome by the conventional natural transformation method. This expression system, based on conjugative plasmid, would be applicable to general molecular biological studies of green sulfur bacteria.	[Azai, Chihiro; Oh-oka, Hirozo] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Harada, Jiro] Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 830, Japan	Osaka University; Kurume University	Oh-oka, H (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Bioinformat, Kusatsu, Shiga, Japan.	ohoka@bio.sci.osaka-u.ac.jp	Azai, Chihiro/N-9151-2013		Japan Society for the Promotion of Science [24570183, 24750169, 21001578, 23006665]; Grants-in-Aid for Scientific Research [25650092, 24550201] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grants-in-Aid for Scientific Research (C) (No. 24570183 to HO), Young Scientists (B) (No. 24750169 to JH), and postdoctoral fellowships (No. 21001578 and 23006665, to CA) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azai C, 2011, BBA-BIOENERGETICS, V1807, P803, DOI 10.1016/j.bbabio.2011.03.007; Azai C, 2010, PHOTOSYNTH RES, V104, P189, DOI 10.1007/s11120-009-9521-4; Azai C, 2009, PHOTOSYNTH RES, V100, P57, DOI 10.1007/s11120-009-9426-2; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Chan LK, 2009, J BACTERIOL, V191, P1026, DOI 10.1128/JB.01154-08; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Falkenby LG, 2011, FEMS MICROBIOL LETT, V323, P142, DOI 10.1111/j.1574-6968.2011.02370.x; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; Habicht KS, 2011, ENVIRON MICROBIOL, V13, P203, DOI 10.1111/j.1462-2920.2010.02321.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Holkenbrink C, 2011, MICROBIOL-SGM, V157, P1229, DOI 10.1099/mic.0.044669-0; HORINOUCHI S, 1980, P NATL ACAD SCI-BIOL, V77, P7079, DOI 10.1073/pnas.77.12.7079; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; Imhoff JF, 2010, PHOTOSYNTH RES, V104, P123, DOI 10.1007/s11120-009-9510-7; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Li H, 2009, ARCH MICROBIOL, V191, P853, DOI 10.1007/s00203-009-0514-7; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; MENDEZALVAREZ S, 1994, J BACTERIOL, V176, P7395; Olson JM, 2004, PHOTOSYNTH RES, V80, P373, DOI 10.1023/B:PRES.0000030457.06495.83; OLSON JM, 1973, BIOCHIM BIOPHYS ACTA, V292, P206, DOI 10.1016/0005-2728(73)90265-X; OVERMANN J, 2000, PROKARYOTES EVOLVING, P359; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rawlings DE, 2001, MICROBIOL MOL BIOL R, V65, P481, DOI 10.1128/MMBR.65.4.481-496.2001; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tsukatani Y, 2006, FEBS LETT, V580, P2191, DOI 10.1016/j.febslet.2006.03.016; Tsukatani Y, 2008, BBA-BIOENERGETICS, V1777, P1211, DOI 10.1016/j.bbabio.2008.05.002; Verte F, 2002, BIOCHEMISTRY-US, V41, P2932, DOI 10.1021/bi011404m; Vogl K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00298; WAHLUND TM, 1995, J BACTERIOL, V177, P2583, DOI 10.1128/jb.177.9.2583-2588.1995; WAHLUND TM, 1991, ARCH MICROBIOL, V156, P81, DOI 10.1007/BF00290978; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82345	10.1371/journal.pone.0082345	http://dx.doi.org/10.1371/journal.pone.0082345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312414	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100112
J	Fierro-Monti, I; Echeverria, P; Racle, J; Hernandez, C; Picard, D; Quadroni, M				Fierro-Monti, Ivo; Echeverria, Pablo; Racle, Julien; Hernandez, Celine; Picard, Didier; Quadroni, Manfredo			Dynamic Impacts of the Inhibition of the Molecular Chaperone Hsp90 on T-Cell Proteome Have Implications for Anti-Cancer Therapy	PLOS ONE			English	Article							GENE-EXPRESSION; CLINICAL DEVELOPMENT; STRESS; GELDANAMYCIN; SUPERANTIGEN; TRANSLATION; DEGRADATION; HOMEOSTASIS; ACTIVATION; PRINCIPLES	The molecular chaperone Hsp90-dependent proteome represents a complex protein network of critical biological and medical relevance. Known to associate with proteins with a broad variety of functions termed clients, Hsp90 maintains key essential and oncogenic signalling pathways. Consequently, Hsp90 inhibitors are being tested as anti-cancer drugs. Using an integrated systematic approach to analyse the effects of Hsp90 inhibition in T-cells, we quantified differential changes in the Hsp90-dependent proteome, Hsp90 interactome, and a selection of the transcriptome. Kinetic behaviours in the Hsp90-dependent proteome were assessed using a novel pulse-chase strategy (Fierro-Monti et al., accompanying article), detecting effects on both protein stability and synthesis. Global and specific dynamic impacts, including proteostatic responses, are due to direct inhibition of Hsp90 as well as indirect effects. As a result, a decrease was detected in most proteins that changed their levels, including known Hsp90 clients. Most likely, consequences of the role of Hsp90 in gene expression determined a global reduction in net de novo protein synthesis. This decrease appeared to be greater in magnitude than a concomitantly observed global increase in protein decay rates. Several novel putative Hsp90 clients were validated, and interestingly, protein families with critical functions, particularly the Hsp90 family and cofactors themselves as well as protein kinases, displayed strongly increased decay rates due to Hsp90 inhibitor treatment. Remarkably, an upsurge in survival pathways, involving molecular chaperones and several oncoproteins, and decreased levels of some tumour suppressors, have implications for anti-cancer therapy with Hsp90 inhibitors. The diversity of global effects may represent a paradigm of mechanisms that are operating to shield cells from proteotoxic stress, by promoting pro-survival and anti-proliferative functions. Data are available via ProteomeXchange with identifier PXD000537.	[Fierro-Monti, Ivo; Hernandez, Celine; Quadroni, Manfredo] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Echeverria, Pablo; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland; [Racle, Julien] Ecole Polytech Fed Lausanne, Lab Computat Syst Biotechnol, Lausanne, Switzerland; [Racle, Julien; Hernandez, Celine] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland	University of Lausanne; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Fierro-Monti, I (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	ivfimo@gmail.com; manfredo.quadroni@unil.ch	Echeverria, Pablo Christian/A-9098-2010; Fierro-Monti, Ivo/AAH-3595-2020; Hernandez, Céline/F-1164-2016; Racle, Julien/F-3215-2010	Echeverria, Pablo Christian/0000-0003-1367-9692; Hernandez, Céline/0000-0001-8664-1340; Racle, Julien/0000-0002-0100-0323; /0000-0002-5460-2117; Quadroni, Manfredo/0000-0002-2720-4084	Swiss National Science Foundation [31003A_127256]; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	This work was supported by grant number 31003A_127256 from the Swiss National Science Foundation (www.snf.ch) as well as internal funding from the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boulon Severine, 2012, RNA Biol, V9, P148, DOI 10.4161/rna.18494; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Echeverria PC, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-15; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Geiser L, 2011, METHODS MOL BIOL, V681, P459, DOI 10.1007/978-1-60761-913-0_27; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; Haupt A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-38; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Manni S, 2012, CLIN CANCER RES, V18, P1888, DOI 10.1158/1078-0432.CCR-11-1789; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Matsuda S, 1999, J BIOL CHEM, V274, P34515, DOI 10.1074/jbc.274.49.34515; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Nahleh Z, 2012, FUTURE MED CHEM, V4, P927, DOI [10.4155/FMC.12.50, 10.4155/fmc.12.50]; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Niedergang F, 1997, J IMMUNOL, V159, P1703; Niedergang F, 1997, RES IMMUNOL, V148, P231, DOI 10.1016/S0923-2494(97)80865-6; Ouchi Mutsuko, 2010, Genes Cancer, V1, P1211, DOI 10.1177/1947601911404222; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; Sangster TA, 2003, CELL CYCLE, V2, P166; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Schnaider T, 2000, CELL STRESS CHAPERON, V5, P52, DOI 10.1379/1466-1268(2000)005<0052:THSIGS>2.0.CO;2; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Schwanhausser B, 2013, BIOESSAYS, V35, P597, DOI 10.1002/bies.201300017; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Suzuki Y, 2009, J BIOL CHEM, V284, P35597, DOI 10.1074/jbc.M109.036285; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532; Yorgin PD, 2000, J IMMUNOL, V164, P2915, DOI 10.4049/jimmunol.164.6.2915; Zhang FX, 2012, AM J PHYSIOL-CELL PH, V302, pC1786, DOI 10.1152/ajpcell.00004.2012; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	72	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80425	10.1371/journal.pone.0080425	http://dx.doi.org/10.1371/journal.pone.0080425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312219	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100039
J	Gaston, DC; Odom, CI; Li, L; Markert, JM; Roth, JC; Cassady, KA; Whitley, RJ; Parker, JN				Gaston, David C.; Odom, Carl I.; Li, Li; Markert, James M.; Roth, Justin C.; Cassady, Kevin A.; Whitley, Richard J.; Parker, Jacqueline N.			Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; T-CELL PROLIFERATION; NATURAL-KILLER-CELLS; IMMUNE-RESPONSE; MALIGNANT GLIOMA; SECRETABLE FORM; SIGNAL PEPTIDE; PHASE-I; IL-15; TUMOR	Oncolytic type-1 herpes simplex viruses (oHSVs) lacking the Y(1)34.5 neurovirulence gene are being evaluated for treatment of a variety of malignancies. oHSVs replicate within and directly kill permissive cancer cells. To augment their anti-tumor activity, oHSVs have been engineered to express immunostimulatory molecules, including cytokines, to elicit tumor-specific immune responses. Interleukin-15 (IL-15) holds potential as an immunotherapeutic cytokine because it has been demonstrated to promote both natural killer (NK) cell-mediated and CD8(+) T cell-mediated cytotoxicity against cancer cells. The purpose of these studies was to engineer an oHSV producing bioactive IL-15. Two oHSVs were constructed encoding murine (m)IL-15 alone (J100) or with the mIL-15 receptor alpha (mIL-15R alpha, J100D) to determine whether co-expression of these proteins is required for production of bioactive mIL-15 from oHSV. The following were demonstrated: i) both oHSVs retain replication competence and cytotoxicity in permissive tumor cell lines. ii) Enhanced production of mIL-15 was detected in cell lysates of neuro-2a cells following J100D infection as compared to J100 infection, suggesting that mIL-15Ra improved mIL-15 production. iii) Soluble mIL-15 in complex with mIL-15Ra was detected in supernates from J100D-infected, but not J100-infected, neuro-2a, GL261, and CT-2A cells. These cell lines vary in permissiveness to oHSV replication and cytotoxicity, demonstrating soluble mIL-15/IL-15R alpha complex production from J100D was independent of direct oHSV effects. iv) The soluble mIL-15/IL-15R alpha complex produced by J100D was bioactive, stimulating NK cells to proliferate and reduce the viability of syngeneic GL261 and CT-2A cells. v) J100 and J100D were aneurovirulent inasmuch as no neuropathologic effects were documented following direct inoculation into brains of CBA/J mice at up to 1x10(7) plaque forming units. The production of mIL-15/mIL-15R alpha from multiple tumor lines, as well as the lack of neurovirulence, renders J100D suitable for investigating the combined effects of oHSV and mIL-15/IL-15R alpha in various cancer models.	[Gaston, David C.; Markert, James M.; Cassady, Kevin A.; Parker, Jacqueline N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Roth, Justin C.; Cassady, Kevin A.; Whitley, Richard J.; Parker, Jacqueline N.] Univ Alabama Birmingham, Dept Pediat, Div Infect Dis, Birmingham, AL 35294 USA; [Li, Li; Markert, James M.] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Whitley, Richard J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gaston, David C.; Odom, Carl I.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Whitley, RJ (corresponding author), Univ Alabama Birmingham, Dept Pediat, Div Infect Dis, Birmingham, AL 35294 USA.	RWhitley@peds.uab.edu			NIH NCI [P01-CA-071933]; NIH NIGMS [5-T32-GM008361-16]; NIH NINDS [5-T32-N5048039-04]; NATIONAL CANCER INSTITUTE [P01CA071933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an NIH NCI grant (P01-CA-071933). DCG was supported in part by the NIH NIGMS funded University of Alabama at Birmingham Medical Scientist Training Program (5-T32-GM008361-16), as well as an NIH NINDS awarded institutional predoctoral fellowship (5-T32-N5048039-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2000, J VIROL, V74, P7196, DOI 10.1128/JVI.74.16.7196-7203.2000; Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Alvarez-Breckenridge CA, 2012, INTERFERON J VIROLOG, V86, P4566, DOI [10.1128/JVI.05545-11, DOI 10.1128/JVI.05545-11]; Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Andreansky S, 1997, CANCER RES, V57, P1502; Bamford RN, 1998, J IMMUNOL, V160, P4418; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Carson WE, 1995, J CLIN INVEST, V96, P2578, DOI 10.1172/JCI118321; Cassady KA, 2005, J VIROL, V79, P8707, DOI 10.1128/JVI.79.14.8707-8715.2005; CHAMBERS R, 1995, P NATL ACAD SCI USA, V92, P1411, DOI 10.1073/pnas.92.5.1411; Chang CM, 2010, HUM GENE THER, V21, P611, DOI 10.1089/hum.2009.187; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chertova E, 2013, J BIOL CHEM, V288, P18093, DOI 10.1074/jbc.M113.461756; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; DYER CA, 1995, J NEUROPATH EXP NEUR, V54, P852, DOI 10.1097/00005072-199511000-00012; Fawaz LM, 1999, J IMMUNOL, V163, P4473; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; Harrow S, 2004, GENE THER, V11, P1648, DOI 10.1038/sj.gt.3302289; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Liu J, 2009, J VIROL, V83, P5933, DOI 10.1128/JVI.00204-09; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Liu RB, 2013, P NATL ACAD SCI USA, V110, P8158, DOI 10.1073/pnas.1301022110; Liu Y, 2011, CANCER GENE THER, V18, P407, DOI 10.1038/cgt.2011.8; Mace ATM, 2008, HEAD NECK-J SCI SPEC, V30, P1045, DOI 10.1002/hed.20840; MacKie RM, 2001, LANCET, V357, P525, DOI 10.1016/S0140-6736(00)04048-4; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Martinez-Murillo R, 2007, HISTOL HISTOPATHOL, V22, P1309, DOI 10.14670/HH-22.1309; Meazza R, 2000, INT J CANCER, V87, P574, DOI 10.1002/1097-0215(20000815)87:4<574::AID-IJC18>3.3.CO;2-K; Miller CG, 2003, MOL THER, V7, P741, DOI 10.1016/S1525-0016(03)00120-5; Onu A, 1997, J IMMUNOL, V158, P255; Papanastassiou V, 2002, GENE THER, V9, P398, DOI 10.1038/sj.gt.3301664; Parker JN, 2011, MOL PHARMACEUT, V8, P44, DOI 10.1021/mp100230y; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Parker JN, 2006, VACCINE, V24, P1644, DOI 10.1016/j.vaccine.2005.09.051; Parker JN, 2005, CANCER GENE THER, V12, P359, DOI 10.1038/sj.cgt.7700784; Rampling R, 2000, GENE THER, V7, P859, DOI 10.1038/sj.gt.3301184; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; SEYFRIED TN, 1992, MOL CHEM NEUROPATHOL, V17, P147, DOI 10.1007/BF03159989; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Suzuki K, 2001, J LEUKOCYTE BIOL, V69, P531; Tamang DL, 2006, CYTOKINE, V36, P148, DOI 10.1016/j.cyto.2006.11.008; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Todo T, 1999, HUM GENE THER, V10, P2741, DOI 10.1089/10430349950016483; Ugen KE, 2006, CANCER GENE THER, V13, P969, DOI 10.1038/sj.cgt.7700973; van Rikxoort M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036506; Wakimoto H, 2004, GENE THER, V11, P214, DOI 10.1038/sj.gt.3302143; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Waldmann TA, 2011, BLOOD, V117, P4787, DOI 10.1182/blood-2010-10-311456; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Yiang GT, 2012, INT J MOL MED, V29, P809, DOI 10.3892/ijmm.2012.921; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47	76	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81768	10.1371/journal.pone.0081768	http://dx.doi.org/10.1371/journal.pone.0081768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312353	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100096
J	LaPointe, VLS; Verpoorte, A; Stevens, MM				LaPointe, Vanessa L. S.; Verpoorte, Amanda; Stevens, Molly M.			The Changing Integrin Expression and a Role for Integrin beta 8 in the Chondrogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; IN-VITRO; CHONDROCYTES; SCAFFOLD; REPAIR; DEDIFFERENTIATION; FIBRONECTIN; INHIBITION; INDUCTION; DEFECTS	Many cartilage tissue engineering approaches aim to differentiate human mesenchymal stem cells (hMSCs) into chondrocytes and develop cartilage in vitro by targeting cell-matrix interactions. We sought to better inform the design of cartilage tissue engineering scaffolds by understanding how integrin expression changes during chondrogenic differentiation. In three models of in vitro chondrogenesis, we studied the temporal change of cartilage phenotype markers and integrin subunits during the differentiation of hMSCs. We found that transcript expression of most subunits was conserved across the chondrogenesis models, but was significantly affected by the time-course of differentiation. In particular, ITGB8 was up-regulated and its importance in chondrogenesis was further established by a knockdown of integrin beta 8, which resulted in a non-hyaline cartilage phenotype, with no COL2A1 expression detected. In conclusion, we performed a systematic study of the temporal changes of integrin expression during chondrogenic differentiation in multiple chondrogenesis models, and revealed a role for integrin beta 8 in chondrogenesis. This work enhances our understanding of the changing adhesion requirements of hMSCs during chondrogenic differentiation and underlines the importance of integrins in establishing a cartilage phenotype.	[Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England	Imperial College London; Imperial College London; Imperial College London	Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.	m.stevens@imperial.ac.uk	LaPointe, Vanessa/G-9787-2012	LaPointe, Vanessa/0000-0002-0887-7443	Wellcome Trust; Engineering and Physical Sciences Research Council; Rosetrees Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Rosetrees Trust(Rosetrees Trust)	MMS thanks the Medical Engineering Solutions in Osteoarthritis Centre of Excellence funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council, and MMS and VL thank the Rosetrees Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Brodkin KR, 2004, BIOMATERIALS, V25, P5929, DOI 10.1016/j.biomaterials.2004.01.044; Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006; Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; Fukui N, 2011, ARTHRITIS RHEUM-US, V63, P1938, DOI 10.1002/art.30351; Goessler UR, 2006, INT J MOL MED, V17, P301; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001; LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811; Mahmoudifar N, 2012, TRENDS BIOTECHNOL, V30, P166, DOI 10.1016/j.tibtech.2011.09.002; McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]; Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Ostergaard K, 1998, ANN RHEUM DIS, V57, P303, DOI 10.1136/ard.57.5.303; Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023; Pabbruwe MB, 2009, BIOMATERIALS, V30, P4277, DOI 10.1016/j.biomaterials.2009.02.052; Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; SHAKIBAEI M, 1995, J HISTOCHEM CYTOCHEM, V43, P1061, DOI 10.1177/43.10.7560884; Singh P, 2012, J CELL SCI, V125, P3703, DOI 10.1242/jcs.095786; Tavella S, 1997, J CELL SCI, V110, P2261; Varas L, 2007, STEM CELLS DEV, V16, P965, DOI 10.1089/scd.2007.0049; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]	35	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82035	10.1371/journal.pone.0082035	http://dx.doi.org/10.1371/journal.pone.0082035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312400	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100108
J	Mikol, BA; Cohenz, B; Haxa, K; Conway', L; Kelly, N; Stare, D; Tropiano, C; Gilmans, A; Seward, SL; Larson, E				Mikol, Benjamin A.; Cohenz, Bevin; Haxa, Katharine; Conway', Laurie; Kelly, Nicole; Stare, Dianne; Tropiano, Christina; Gilmans, Allan; Seward, Samuel L., Jr.; Larson, Elaine			Personal and Household Hygiene, Environmental Contamination, and Health in Undergraduate Residence Halls in New York City, 2011	PLOS ONE			English	Article							HAND HYGIENE; COLLEGE; DISINFECTION; STUDENTS; DISEASE; HOME; SALMONELLA; SYMPTOMS; SURFACES; ILLNESS	Background: While several studies have documented the importance of hand washing in the university setting, the added role of environmental hygiene remains poorly understood. The purpose of this study was to characterize the personal and environmental hygiene habits of college students, define the determinants of hygiene in this population, and assess the relationship between reported hygiene behaviors, environmental contamination, and health status. Methods: 501 undergraduate students completed a previously validated survey assessing baseline demographics, hygiene habits, determinants of hygiene, and health status. Sixty survey respondents had microbiological samples taken from eight standardized surfaces in their dormitory environment. Bacterial contamination was assessed using standard quantitative bacterial culture techniques. Additional culturing for coagulase-positive Staphylococcus and coliforms was performed using selective agar. Results: While the vast majority of study participants (n = 461, 92%) believed that hand washing was important for infection prevention, there was a large amount of variation in reported personal hygiene practices. More women than men reported consistent hand washing before preparing food (p = .002) and after using the toilet (p = .001). Environmental hygiene showed similar variability although 73.3% (n = 367) of subjects reported dormitory cleaning at least once per month. Contamination of certain surfaces was common, with at least one third of all bookshelves, desks, refrigerator handles, toilet handles, and bathroom door handles positive for >10 CFU of bacteria per 4 cm(2) area. Coagulase-positive Staphylococcus was detected in three participants' rooms (5%) and coliforms were present in six students' rooms (10%). Surface contamination with any bacteria did not vary by frequency of cleaning or frequency of illness (p>.05). Conclusions: Our results suggest that surface contamination, while prevalent, is unrelated to reported hygiene or health in the university setting. Further research into environmental reservoirs of infectious diseases may delineate whether surface decontamination is an effective target of hygiene interventions in this population.	[Mikol, Benjamin A.] Columbia Univ, Coll Phys & Surg, Div Infect Dis, New York, NY 10027 USA; [Mikol, Benjamin A.; Cohenz, Bevin; Conway', Laurie; Larson, Elaine] Columbia Univ, Ctr Interdisciplinary Res Reduce Antimicrobial Re, New York, NY USA; [Cohenz, Bevin; Larson, Elaine] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Haxa, Katharine; Conway', Laurie; Kelly, Nicole; Stare, Dianne; Tropiano, Christina; Larson, Elaine] Columbia Univ, Sch Nursing, New York, NY USA; [Gilmans, Allan] CUNY Bronx Community Coll, Dept Biol & Med Lab Technol, Bronx, NY USA; [Seward, Samuel L., Jr.] Columbia Univ, Hlth Serv, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; City University of New York (CUNY) System; Columbia University	Mikol, BA (corresponding author), Columbia Univ, Coll Phys & Surg, Div Infect Dis, New York, NY 10027 USA.	bm2266@columbia.edu		Kelly, Nicole/0000-0003-4476-5462; Conway, Laurie/0000-0001-8657-7633	"Training in Interdisciplinary Research to Reduce Antimicrobial Resistance," NIH at Columbia University [T90 NR010824]; The Clorox Company; NATIONAL INSTITUTE OF NURSING RESEARCH [T90NR010824] Funding Source: NIH RePORTER	"Training in Interdisciplinary Research to Reduce Antimicrobial Resistance," NIH at Columbia University; The Clorox Company; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by "Training in Interdisciplinary Research to Reduce Antimicrobial Resistance," NIH T90 NR010824 at Columbia University and by the The Clorox Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Barker J, 2003, J APPL MICROBIOL, V95, P1351, DOI 10.1046/j.1365-2672.2003.02127.x; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Bruce MG, 2001, JAMA-J AM MED ASSOC, V286, P688, DOI 10.1001/jama.286.6.688; Cogan TA, 2002, J APPL MICROBIOL, V92, P885, DOI 10.1046/j.1365-2672.2002.01598.x; Cozad A, 2003, AM J INFECT CONTROL, V31, P243, DOI 10.1067/mic.2003.49; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 2003, SOC SCI MED, V57, P657, DOI 10.1016/S0277-9536(02)00409-4; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; HERSH BS, 1991, AM J PUBLIC HEALTH, V81, P360, DOI 10.2105/AJPH.81.3.360; Judah G, 2010, EPIDEMIOL INFECT, V138, P409, DOI 10.1017/S0950268809990641; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Kak V, 2007, INFECT DIS CLIN N AM, V21, P773, DOI 10.1016/j.idc.2007.06.004; Kniehl E, 2005, J HOSP INFECT, V59, P180, DOI 10.1016/j.jhin.2004.06.016; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; MASTERTON RG, 1995, J HOSP INFECT, V29, P318, DOI 10.1016/0195-6701(95)90284-8; Miko BA, 2012, AM J INFECT CONTROL, V40, P940, DOI [10.1016/j.ajic.2011.12.015, 10.1016/j.ajic]; Roberts MC, 2011, J APPL MICROBIOL, V110, P1531, DOI 10.1111/j.1365-2672.2011.05017.x; Roberts MC, 2011, AM J INFECT CONTROL, V39, P382, DOI 10.1016/j.ajic.2010.09.008; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; SOSIN DM, 1989, PEDIATRICS, V84, P779; Tsuang WM, 2004, J ENVIRON HEALTH, V66, P39; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5	25	3	3	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81460	10.1371/journal.pone.0081460	http://dx.doi.org/10.1371/journal.pone.0081460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312303	Green Published, gold			2022-12-25	WOS:000327652100081
J	Goh, PA; Caxaria, S; Casper, C; Rosales, C; Warner, TT; Coffey, PJ; Nathwani, AC				Goh, Pollyanna A.; Caxaria, Sara; Casper, Catharina; Rosales, Cecilia; Warner, Thomas T.; Coffey, Pete J.; Nathwani, Amit C.			A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells	PLOS ONE			English	Article							MOUSE SOMATIC-CELLS; HUMAN FIBROBLASTS; GENERATION; DIFFERENTIATION; DERIVATION; INDUCTION	A systematic evaluation of three different methods for generating induced pluripotent stem (iPS) cells was performed using the same set of parental cells in our quest to develop a feeder independent and xeno-free method for somatic cell reprogramming that could be transferred into a GMP environment. When using the BJ fibroblast cell line, the highest reprogramming efficiency (1.89% of starting cells) was observed with the mRNA based method which was almost 20 fold higher than that observed with the retrovirus (0.2%) and episomal plasmid (0.10%) methods. Standard characterisation tests did not reveal any differences in an array of pluripotency markers between the iPS lines derived using the various methods. However, when the same methods were used to reprogram three different primary fibroblasts lines, two derived from patients with rapid onset parkinsonism dystonia and one from an elderly healthy volunteer, we consistently observed higher reprogramming efficiencies with the episomal plasmid method, which was 4 fold higher when compared to the retroviral method and over 50 fold higher than the mRNA method. Additionally, with the plasmid reprogramming protocol, recombinant vitronectin and synthemax (R) could be used together with commercially available, fully defined, xeno-free essential 8 medium without significantly impacting the reprogramming efficiency. To demonstrate the robustness of this protocol, we reprogrammed a further 2 primary patient cell lines, one with retinosa pigmentosa and the other with Parkinsons disease. We believe that we have optimised a simple and reproducible method which could be used as a starting point for developing GMP protocols, a prerequisite for generating clinically relevant patient specific iPS cells.	[Goh, Pollyanna A.; Caxaria, Sara; Rosales, Cecilia; Nathwani, Amit C.] UCL, Dept Res Haematol, Inst Canc, London, England; [Goh, Pollyanna A.; Caxaria, Sara; Rosales, Cecilia; Nathwani, Amit C.] Natl Hlth Serv, Blood & Transplant Unit, London, England; [Casper, Catharina; Warner, Thomas T.] UCL, Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England; [Coffey, Pete J.] UCL, Inst Ophthalmol, London, England; [Nathwani, Amit C.] Royal Free Hosp, Katharine Dormandy Haemophilia Ctr, London NW3 2QG, England; [Nathwani, Amit C.] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England	University of London; University College London; NHS Blood & Transplant (NHSBT); University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Nathwani, AC (corresponding author), UCL, Dept Res Haematol, Inst Canc, London, England.	amit.nathwani@ucl.ac.uk	Warner, Thomas T/A-1454-2013	Warner, Thomas T/0000-0001-6195-6995; Coffey, Peter/0000-0002-5427-2939; Caxaria, Sara/0000-0002-8434-8332; Goh, Pollyanna/0000-0002-6244-7428	National Institute of Health Research (NIHR) UK Programme Grant [RP-PG-0310-1001]; National Health Service Blood and Transplant (NHSBT); Brain Research Trust	National Institute of Health Research (NIHR) UK Programme Grant(National Institute for Health Research (NIHR)); National Health Service Blood and Transplant (NHSBT); Brain Research Trust	This work was supported by the National Institute of Health Research (NIHR) UK Programme Grant (RP-PG-0310-1001) and grants from the National Health Service Blood and Transplant (NHSBT). Catharina Casper was supported by a grant from the Brain Research Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Karumbayaram S, 2012, STEM CELL TRANSL MED, V1, P36, DOI 10.5966/sctm.2011-0001; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; MacArthur CC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/564612; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Plews JR, 2010, APPROACH PLOS ONE, V5, DOI [10.1371/journal.pone. 0014397, DOI 10.1371/J0URNAL.P0NE.0014397]; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rajala K, 2010, STEM CELLS PLOS ONE, V5, DOI [10.1371/journal.pone.0010246, DOI 10.1371/J0URNAL.P0NE.0010246]; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ross PJ, 2010, STEM CELLS DEV, V19, P1221, DOI 10.1089/scd.2009.0459; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tucker BA, 2013, STEM CELL TRANSL MED, V2, P16, DOI 10.5966/sctm.2012-0040; Wang B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1274; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wen Y, 2013, STEM CELL TRANSL MED, V2, P118, DOI 10.5966/sctm.2012-0092; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yu J, 2011, MOL PLOS ONE, V6, DOI [10.1371/journal.pone.0017557, DOI 10.1371/J0URNAL.P0NE.0017557]; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	30	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81622	10.1371/journal.pone.0081622	http://dx.doi.org/10.1371/journal.pone.0081622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303062	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400078
J	Azzi, S; Smith, SS; Dwyer, J; Leclair, HM; Alexia, C; Hebda, JK; Dupin, N; Bidere, N; Gavard, J				Azzi, S.; Smith, S. S.; Dwyer, J.; Leclair, H. M.; Alexia, C.; Hebda, J. K.; Dupin, N.; Bidere, N.; Gavard, J.			YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-kappa B activation and paracrine actions	ONCOGENE			English	Article						KSHV; vGPCR; NF-kappa B; trafficking; B-lymphocytes; HIV malignancies	PRIMARY EFFUSION LYMPHOMA; ENDOTHELIAL-CELLS; IN-VIVO; MULTIPLE PATHWAYS; KSHV VFLIP; VGPCR; CONTRIBUTES; PROGRESSION; EXPRESSION; NEOPLASIA	Kaposi sarcoma (KS) and primary effusion lymphoma (PEL) are two pathologies associated with KS herpes virus (KSHV/HHV-8) infection. KSHV genome contains several oncogenes, among which, the viral G-protein-coupled receptor (vGPCR open reading frame 74) has emerged as a major factor in KS pathogenicity. Indeed, vGPCR is a constitutively active receptor, whose expression is sufficient to drive cell transformation in vitro and tumour development in mice. However, neither the role of vGPCR in KSHV-infected B-lymphocytes nor the molecular basis for its constitutive activation is well understood. Here, we show that vGPCR expression contributes to nuclear factor-kappa B (NF-kappa B)-dependent cellular survival in both PEL cells and primary B cells from HIV-negative KS patients. We further identified within vGPCR an AP2 consensus binding motif, Y(326)GLF, that directs its localization between the plasma membrane and clathrin-coated vesicles. The introduction of a mutation in this site (Y(326)A) increased NF-kappa B activity and proinflammatory cytokines production. This correlated with exacerbated morphological rearrangement, migration and proliferation of non-infected monocytes. Collectively, our work raises the possibility that KSHV-infected B-lymphocytes use vGPCR to impact ultimately the immune response and communication within the tumour microenvironment in KSHV-associated pathologies.	[Azzi, S.; Smith, S. S.; Dwyer, J.; Leclair, H. M.; Hebda, J. K.; Gavard, J.] CNRS, UMR8104, Paris, France; [Azzi, S.; Smith, S. S.; Dwyer, J.; Leclair, H. M.; Hebda, J. K.; Gavard, J.] INSERM, U1016, Paris, France; [Azzi, S.; Smith, S. S.; Dwyer, J.; Leclair, H. M.; Hebda, J. K.; Dupin, N.; Gavard, J.] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Alexia, C.; Bidere, N.] Hop Paul Brousse, INSERM, U1014, Villejuif, France; [Alexia, C.] Univ Paris 11, Orsay, France; [Alexia, C.] Equipe Labellisee Ligue Contre Canc, Villejuif, France; [Dupin, N.] Hop Cochin Tarnier, AP HP, Serv Dermatol, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gavard, J (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR8104,INSERM U1016, 22 Rue Mech,Room 306, F-75014 Paris, France.	julie.gavard@inserm.fr	Gavard, Julie/I-5487-2012; Bidère, Nicolas/K-8887-2015; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Bidère, Nicolas/0000-0001-9177-0008; Leclair, Heloise/0000-0002-9517-9079; Dupin, Nicolas/0000-0002-6237-4951; Gavard, Julie/0000-0003-3107-2026	ANR JCJC; Fondation ARC; Fondation pour la Recherche Medicale; Ligue nationale contre le cancer comite de Paris; Marie Curie International Reintegration Grant within The Seventh Framework Program; Canceropole Ile-de-France; ANRS; Universite Paris Descartes;  [INCA_6508]	ANR JCJC(French National Research Agency (ANR)); Fondation ARC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue nationale contre le cancer comite de Paris; Marie Curie International Reintegration Grant within The Seventh Framework Program; Canceropole Ile-de-France(Region Ile-de-France); ANRS(ANRSFrench National Research Agency (ANR)); Universite Paris Descartes; 	We thank the members of JG laboratory for comments on the manuscript. We are grateful to Dr A Benmerah (Institut Necker, Paris, France) for the EPS15 constructs and helpful discussion and to C Catherinet (INSA, Rennes, France) for technical support. This research was funded by: ANR JCJC, Fondation ARC, Fondation pour la Recherche Medicale, INCA_6508, Ligue nationale contre le cancer comite de Paris and a Marie Curie International Reintegration Grant within The Seventh Framework Program. SA, SSS and JD are supported by postdoctoral fellowships from Fondation ARC, Canceropole Ile-de-France and ANRS, respectively. JKH is supported by a doctoral fellowship from Universite Paris Descartes.	An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Benmerah A, 1999, J CELL SCI, V112, P1303; BOSHOFF C, 1995, LANCET, V345, P1043; Boshoff C, 2011, J CLIN INVEST, V121, P838, DOI 10.1172/JCI46499; Cannon M, 2003, J VIROL, V77, P57, DOI 10.1128/JVI.77.1.57-67.2003; Cannon ML, 2004, ONCOGENE, V23, P514, DOI 10.1038/sj.onc.1207021; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Cesarman E, 1996, AM J PATHOL, V149, P53; Chang HH, 2013, CELL HOST MICROBE, V13, P429, DOI 10.1016/j.chom.2013.03.009; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen YB, 2007, ONCOLOGIST, V12, P569, DOI 10.1634/theoncologist.12-5-569; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Couty JP, 2001, J BIOL CHEM, V276, P33805, DOI 10.1074/jbc.M104631200; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Dwyer J, 2011, ONCOGENE, V30, P190, DOI 10.1038/onc.2010.411; Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hassman LM, 2011, J CLIN INVEST, V121, P752, DOI 10.1172/JCI44185; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lanternier F, 2008, AIDS, V22, P1163, DOI 10.1097/QAD.0b013e3283031a8a; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lodi S, 2010, JNCI-J NATL CANCER I, V102, P784, DOI 10.1093/jnci/djq134; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Mesri EA, 1996, J EXP MED, V183, P2385, DOI 10.1084/jem.183.5.2385; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Montaner S, 2013, ANNU REV PHARMACOL, V53, P331, DOI 10.1146/annurev-pharmtox-010510-100608; Myoung J, 2011, J CLIN INVEST, V121, P1130, DOI 10.1172/JCI43755; Rosenkilde MM, 2000, J BIOL CHEM, V275, P26309, DOI 10.1074/jbc.M003800200; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sin SH, 2013, BLOOD, V121, P2952, DOI 10.1182/blood-2012-03-415620; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445	48	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5609	5618		10.1038/onc.2013.503	http://dx.doi.org/10.1038/onc.2013.503			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24292677	Green Published			2022-12-25	WOS:000346088700005
J	Fortin, J; Boehm, U; Weinstein, MB; Graff, JM; Bernard, DJ				Fortin, Jerome; Boehm, Ulrich; Weinstein, Michael B.; Graff, Jonathan M.; Bernard, Daniel J.			Follicle-stimulating hormone synthesis and fertility are intact in mice lacking SMAD3 DNA binding activity and SMAD2 in gonadotrope cells	FASEB JOURNAL			English	Article						pituitary; reproduction; activin; knockout	BETA-SUBUNIT TRANSCRIPTION; BONE MORPHOGENETIC PROTEIN-2; MESSENGER-RIBONUCLEIC-ACID; REGULATES EXPRESSION; TARGETED DISRUPTION; LUTEINIZING-HORMONE; SECONDARY SURGE; GENE-EXPRESSION; RU486 BLOCKS; A INDUCTION	The activin/inhibin system regulates follicle-stimulating hormone (FSH) synthesis and release by pituitary gonadotrope cells in mammals. In vitro cell line data suggest that activins stimulate FSH -subunit (Fshb) transcription via complexes containing the receptor-regulated SMAD proteins SMAD2 and SMAD3. Here, we used a Cre-loxP approach to determine the necessity for SMAD2 and/or SMAD3 in FSH synthesis in vivo. Surprisingly, mice with conditional mutations in both Smad2 and Smad3 specifically in gonadotrope cells are fertile and produce FSH at quantitatively normal levels. Notably, however, we discovered that the recombined Smad3 allele produces a transcript that encodes the entirety of the SMAD3 C-terminal Mad homology 2 (MH2) domain. This protein behaves similarly to full-length SMAD3 in Fshb transcriptional assays. As the truncated protein lacks the N-terminal Mad homology 1 (MH1) domain, these results show that SMAD3 DNA-binding activity as well as SMAD2 are dispensable for normal FSH synthesis in vivo. Furthermore, the observation that deletion of proximal exons does not remove all SMAD3 function may facilitate interpretation of divergent phenotypes previously described in different Smad3 knockout mouse lines.Fortin, J., Boehm, U., Weinstein, M. B., Graff, J. M., Bernard, D. J. Follicle-stimulating hormone synthesis and fertility are intact in mice lacking SMAD3 DNA binding activity and SMAD2 in gonadotrope cells.	[Fortin, Jerome; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Boehm, Ulrich] Univ Saarland, Dept Pharmacol & Toxicol, Sch Med, Homburg, Germany; [Weinstein, Michael B.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Graff, Jonathan M.] Univ Texas Southwestern, Dept Dev Biol, Dallas, TX USA	McGill University; Saarland University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fortin, J (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler,Rm 1315, Montreal, PQ H3G 1Y6, Canada.	jerome.fortin@mail.mcgill.ca; daniel.bernard@mcgill.ca		Bernard, Daniel/0000-0001-5365-5586	Canadian Institutes of Health Research (CIHR); CIHR [MOP-89991]; DFG [BO1743/2]; U.S. National Institutes of Health National Institute of Child Health and Human Development [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); DFG(German Research Foundation (DFG)); U.S. National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge Xiang Zhou for help with the ovariectomy procedures and Ken McDonald for assistance with FACS. J.F. was supported by a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR). This work was funded by CIHR operating grant MOP-89991 (to D.J.B). D.J.B. is a Senior Research Scholar of the Fonds de la Recherche en Sante de Quebec. U. B. is funded by DFG BO1743/2. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the U.S. National Institutes of Health National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant U54-HD28934.	Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Caligioni CS, 2009, CURR PROTOC NEUROSCI; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; CORRIGAN AZ, 1991, ENDOCRINOLOGY, V128, P1682, DOI 10.1210/endo-128-3-1682; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; DALKIN AC, 1993, ENDOCRINOLOGY, V132, P1297, DOI 10.1210/en.132.3.1297; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Fortin J., 2013, ENDOCR REV, V34, pOR04; Fortin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059058; Ho CC, 2010, ENDOCRINOLOGY, V151, P3445, DOI 10.1210/en.2010-0071; Ho CC, 2009, BIOL REPROD, V81, P133, DOI 10.1095/biolreprod.108.074211; HOAK DC, 1980, P NATL ACAD SCI-BIOL, V77, P4953, DOI 10.1073/pnas.77.8.4953; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; Itman C, 2011, ENDOCRINOLOGY, V152, P2076, DOI 10.1210/en.2010-1453; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kim S, 2011, N KOREAN REV, V7, P3; KIRK SE, 1994, ENDOCRINOLOGY, V135, P876, DOI 10.1210/en.135.3.876; KNOX KL, 1992, BIOL REPROD, V46, P220, DOI 10.1095/biolreprod46.2.220; Knox KL, 1996, ENDOCRINOLOGY, V137, P1226, DOI 10.1210/en.137.4.1226; KNOX KL, 1993, ENDOCRINOLOGY, V133, P277, DOI 10.1210/en.133.1.277; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2008, ENDOCRINOLOGY, V149, P3095, DOI 10.1210/en.2007-0425; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; Liu Y, 2004, GENESIS, V40, P118, DOI 10.1002/gene.20072; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Marshall J C, 1993, Trans Am Clin Climatol Assoc, V104, P31; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Rejon CA, 2013, CELL SIGNAL, V25, P1403, DOI 10.1016/j.cellsig.2013.03.002; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suszko MI, 2008, MOL CELL ENDOCRINOL, V281, P27, DOI 10.1016/j.mce.2007.10.003; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Szabo M, 1996, ENDOCRINOLOGY, V137, P85, DOI 10.1210/en.137.1.85; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Tomic D, 2002, BIOL REPROD, V66, P917, DOI 10.1095/biolreprod66.4.917; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wang Y, 2012, CELL SIGNAL, V24, P1632, DOI 10.1016/j.cellsig.2012.04.006; Wang Y, 2010, J MOL ENDOCRINOL, V44, P349, DOI 10.1677/JME-09-0142; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107; Woodruff TK, 1996, ENDOCRINOLOGY, V137, P5463, DOI 10.1210/en.137.12.5463; Wu S, 2010, ENDOCRINOLOGY, V151, P1142, DOI 10.1210/en.2009-0598; Xu R, 2003, J ANDROL, V24, P192; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Ye P, 2013, J CLIN INVEST, V123, P2317, DOI 10.1172/JCI67356; YING SY, 1988, ENDOCR REV, V9, P267, DOI 10.1210/edrv-9-2-267; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	73	23	23	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1474	1485		10.1096/fj.13-237818	http://dx.doi.org/10.1096/fj.13-237818			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308975	Green Published			2022-12-25	WOS:000335324800038
J	Nguyen, T; Chen, CJ; Shively, JE				Tung Nguyen; Chen, Charng-Jui; Shively, John E.			Phosphorylation of CEACAM1 Molecule by Calmodulin Kinase IID in a Three-dimensional Model of Mammary Gland Lumen Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Breast Cancer; Calmodulin; CaMKII; Cell Adhesion; RNA Interference (RNAi)	DEPENDENT PROTEIN-KINASE; SHORT CYTOPLASMIC DOMAIN; BILIARY GLYCOPROTEIN CD66A; CELL ADHESION MOLECULE; APOPTOSIS; ACTIN; IDENTIFICATION; MORPHOGENESIS; SEQUENCES; ISOFORMS	Background: CEACAM1, a cell-cell adhesion molecule that induces lumen formation, requires phosphorylation on Thr-457 for its function. Results: Biochemical and RNAi approaches identified that CaMKIID was responsible for phosphorylation of Thr-457 and lumen formation. Conclusion: CaMKIID, up-regulated during lumen formation, is associated with CEACAM1-mediated apoptosis, a key feature of lumen formation. Significance: Lumen formation, a hallmark of epithelial cells, is lost upon malignant transformation. Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), a transmembrane protein, expressed on normal breast epithelial cells is down-regulated in breast cancer. Phosphorylation of Thr-457 on the short cytoplasmic domain isoform (CEACAM1-SF) that is predominant in normal epithelial cells is required for lumen formation in a three-dimensional model that involves apoptosis of the central acinar cells. Calmodulin kinase IID (CaMKIID) was selected as a candidate for the kinase required for Thr-457 phosphorylation from a gene chip analysis comparing genes up-regulated in MCF7 cells expressing wild type CEACAM1-SF compared with the T457A-mutated gene (Chen, C. J., Kirshner, J., Sherman, M. A., Hu, W., Nguyen, T., and Shively, J. E. (2007) J. Biol. Chem. 282, 5749-5760). Up-regulation of CaMKIID during lumen formation was confirmed by analysis of mRNA and protein levels. CaMKIID was able to phosphorylate a synthetic peptide corresponding to the cytoplasmic domain of CEACAM1-SF and was covalently bound to biotinylated and T457C-modified peptide in the presence of a kinase trap previously described by Shokat and co-workers (Maly, D. J., Allen, J. A., and Shokat, K. M. (2004) J. Am. Chem. Soc. 126, 9160-9161). When cell lysates from wild type-transfected MCF7 cells undergoing lumen formation were incubated with the peptide and kinase trap, a cross-linked band corresponding to CaMKIID was observed. When these cells were treated with an RNAi that inhibits CaMKIID expression, lumen formation was blocked by over 90%. We conclude that CaMKIID specifically phosphorylates Thr-457 on CEACAM1-SF, which in turn regulates the process of lumen formation via apoptosis of the central acinar cells.	[Tung Nguyen; Chen, Charng-Jui; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, 1450 East Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202.	BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Edlund M, 1998, FEBS LETT, V425, P166, DOI 10.1016/S0014-5793(98)00222-1; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Lu RZ, 2011, J BIOL CHEM, V286, P27528, DOI 10.1074/jbc.M111.235762; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Maly DJ, 2004, J AM CHEM SOC, V126, P9160, DOI 10.1021/ja048659i; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Tombes RM, 1999, BBA-MOL CELL RES, V1452, P1, DOI 10.1016/S0167-4889(99)00113-5; TURBIDE C, 1991, J BIOL CHEM, V266, P309; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	31	12	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2934	2945		10.1074/jbc.M113.496992	http://dx.doi.org/10.1074/jbc.M113.496992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24302721	Green Published, hybrid			2022-12-25	WOS:000333403000041
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			The Replication Initiation Protein Sld2 Regulates Helicase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Cell Cycle; DNA-binding Protein; DNA Helicase; DNA Replication	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; MCM2-7 HELICASE; BUDDING YEAST; ORIGIN DNA; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; COMPLEX; GINS; CDC45	Assembly of the Cdc45-Mcm2-7-GINS (CMG) replicative helicase complex must be regulated to ensure that DNA unwinding is coupled with DNA synthesis. Sld2 is required for the initiation of DNA replication in budding yeast. We identified a mutant of Sld2, Sld2-m1,4, that is specifically defective in Mcm2-7 binding. When this sld2-m1,4 mutant is expressed, cells exhibit severe inhibition of DNA replication. Furthermore, the CMG complex assembles prematurely in G(1) in mutant cells, but not wild-type cells. These data suggest that Sld2 binding to Mcm2-7 is essential to block the inappropriate formation of a CMG helicase complex in G(1). We also study a mutant of Sld2 that is defective in binding DNA, sld2-DNA, and find that sld2-DNA cells exhibit no GINS-Mcm2-7 interaction. These data suggest that Sld2 association with DNA is required for CMG assembly in S phase.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA.	Daniel.Kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1265431]; Div Of Molecular and Cellular Bioscience [1265431] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1265431 (to D. L. K.).	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Ohlenschlager O, 2012, NUCLEIC ACIDS RES, V40, P8309, DOI 10.1093/nar/gks591; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1948	1959		10.1074/jbc.M113.532085	http://dx.doi.org/10.1074/jbc.M113.532085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24307213	hybrid, Green Published			2022-12-25	WOS:000331130200007
J	Antony, ML; Lee, J; Hahm, ER; Kim, SH; Marcus, AI; Kumari, V; Ji, XH; Yang, Z; Vowell, CL; Wipf, P; Uechi, GT; Yates, NA; Romero, G; Sarkar, SN; Singh, SV				Antony, Marie L.; Lee, Joomin; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Marcus, Adam I.; Kumari, Vandana; Ji, Xinhua; Yang, Zhen; Vowell, Courtney L.; Wipf, Peter; Uechi, Guy T.; Yates, Nathan A.; Romero, Guillermo; Sarkar, Saumendra N.; Singh, Shivendra V.			Growth Arrest by the Antitumor Steroidal Lactone Withaferin A in Human Breast Cancer Cells Is Associated with Down-regulation and Covalent Binding at Cysteine 303 of beta-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Chemoprevention; Cell Cycle; Natural Products; Tubulin; Withaferin A	ALLYL ISOTHIOCYANATE; COMPOUND WITHAFERIN; AYURVEDIC MEDICINE; MICHAEL ACCEPTORS; INDUCED APOPTOSIS; MITOTIC ARREST; ACTIVATION; PREVENTION; TARGET; PHOSPHORYLATION	Background: The tubulin microtubule network remains an attractive anticancer target. Results: The antitumor steroidal lactone withaferin A (WA) down-regulates tubulin and binds to Cys(303) of -tubulin. Conclusion: Tubulin is a novel target of WA-mediated growth arrest in human breast cancer cells. Significance: Favorable safety and pharmacokinetic profiles merit clinical investigation of WA for prevention and/or treatment of breast cancer. Withaferin A (WA), a C-5,C-6-epoxy steroidal lactone derived from a medicinal plant (Withania somnifera), inhibits growth of human breast cancer cells in vitro and in vivo and prevents mammary cancer development in a transgenic mouse model. However, the mechanisms underlying the anticancer effect of WA are not fully understood. Herein, we report that tubulin is a novel target of WA-mediated growth arrest in human breast cancer cells. The G(2) and mitotic arrest resulting from WA exposure in MCF-7, SUM159, and SK-BR-3 cells was associated with a marked decrease in protein levels of -tubulin. These effects were not observed with the naturally occurring C-6,C-7-epoxy analogs of WA (withanone and withanolide A). A non-tumorigenic normal mammary epithelial cell line (MCF-10A) was markedly more resistant to mitotic arrest by WA compared with breast cancer cells. Vehicle-treated control cells exhibited a normal bipolar spindle with chromosomes aligned along the metaphase plate. In contrast, WA treatment led to a severe disruption of normal spindle morphology. NMR analyses revealed that the A-ring enone in WA, but not in withanone or withanolide A, was highly reactive with cysteamine and rapidly succumbed to irreversible nucleophilic addition. Mass spectrometry demonstrated direct covalent binding of WA to Cys(303) of -tubulin in MCF-7 cells. Molecular docking indicated that the WA-binding pocket is located on the surface of -tubulin and characterized by a hydrophobic floor, a hydrophobic wall, and a charge-balanced hydrophilic entrance. These results provide novel insights into the mechanism of growth arrest by WA in breast cancer cells.	[Antony, Marie L.; Lee, Joomin; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Romero, Guillermo; Singh, Shivendra V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA; [Sarkar, Saumendra N.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA; [Vowell, Courtney L.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Marcus, Adam I.; Yang, Zhen] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kumari, Vandana; Ji, Xinhua] NCI, Biomol Struct Sect, Ctr Canc Res, Frederick, MD 21702 USA; [Uechi, Guy T.; Yates, Nathan A.] Univ Pittsburgh, Sch Med, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15213 USA; [Uechi, Guy T.; Yates, Nathan A.; Sarkar, Saumendra N.; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), Univ Pittsburgh, Hillman Canc Ctr 2 32A, Inst Canc, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu	Antony, Marie Lue/AAB-3952-2019; Sarkar, Saumendra N/B-5038-2011; Wipf, Peter/AAG-1771-2021; Ji, Xinhua/C-9664-2012	Sarkar, Saumendra N/0000-0002-2850-6121; Wipf, Peter/0000-0001-7693-5863; Ji, Xinhua/0000-0001-6942-1514	National Institutes of Health from NCI [R01 CA142604-04, R01 CA129347-07]; Center for Cancer Research, NCI, National Institutes of Health; National Institutes of Health Cancer Center from NCI [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA129347, R01CA142604, ZIABC010326, P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Cancer Center from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA142604-04 and R01 CA129347-07 from NCI (to S. V. S.) and by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to X. J.). The work performed in the University of Pittsburgh Cancer Institute Flow Cytometry Facility and Cancer Biomarkers Facility was supported in part by National Institutes of Health Cancer Center Support Grant P30CA047904 from NCI.	Aggarwal BB, 2011, CURR DRUG TARGETS, V12, P1595; Amslinger S, 2010, CHEMMEDCHEM, V5, P351, DOI 10.1002/cmdc.200900499; Avonto C, 2011, ANGEW CHEM INT EDIT, V50, P467, DOI 10.1002/anie.201005959; Bayraktar S, 2013, BREAST CANCER RES TR, V138, P21, DOI 10.1007/s10549-013-2421-5; Castelli VV, 1999, J ORG CHEM, V64, P8122; Chen JG, 2002, CANCER RES, V62, P1935; Devi PU, 1996, INT J RADIAT BIOL, V69, P193, DOI 10.1080/095530096146020; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Geng F, 2011, J BIOL CHEM, V286, P32259, DOI 10.1074/jbc.M111.278127; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hahm ER, 2011, MOL CARCINOGEN, V50, P614, DOI 10.1002/mc.20760; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krenske EH, 2011, J ORG CHEM, V76, P5074, DOI 10.1021/jo200761w; Lee J, 2012, BREAST CANCER RES TR, V136, P45, DOI 10.1007/s10549-012-2239-6; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Manoharan S, 2009, INDIAN J EXP BIOL, V47, P16; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Rosenker CJ, 2013, ORG LETT, V15, P1076, DOI 10.1021/ol400094k; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHOHAT B, 1971, INT J CANCER, V8, P487, DOI 10.1002/ijc.2910080317; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vyas A. R., 2013, AAPS J, DOI 10.1208/s12248-013-9531-1; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zheng SQ, 2012, J MED CHEM, V55, P4837, DOI 10.1021/jm3003922	50	76	77	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1852	1865		10.1074/jbc.M113.496844	http://dx.doi.org/10.1074/jbc.M113.496844			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297176	Green Published, hybrid			2022-12-25	WOS:000332401700054
J	Le, HT; Sin, WC; Lozinsky, S; Bechberger, J; Vega, JL; Guo, XQ; Saez, JC; Naus, CC				Le, Hoa T.; Sin, Wun Chey; Lozinsky, Shannon; Bechberger, John; Luis Vega, Jose; Guo, Xu Qiu; Saez, Juan C.; Naus, Christian C.			Gap Junction Intercellular Communication Mediated by Connexin43 in Astrocytes Is Essential for Their Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; Connexin; Gap Junctions; Hydrogen Peroxide; Hypoxia; Hemichannels; Hypoxia; Reoxygenation	CULTURED ASTROCYTES; LIFE-CYCLE; CELL-DEATH; FUNCTIONAL HEMICHANNELS; METABOLIC INHIBITION; CORTICAL ASTROCYTES; PROTEIN CONNEXIN43; PLASMA-MEMBRANE; CHANNELS; PHOSPHORYLATION	Background: The gap junction protein Cx43 is implicated in maintaining anti-oxidative defense in astrocytes. Results: In contrast to hypoxia/reoxygenation, oxidative stress induced by H2O2 triggers more astrocytic death in the absence of Cx43 channels. Conclusion: Gap junction intercellular communication is required for Cx43-mediated resistance to H2O2. Significance: An altered Cx43 phosphorylation state in response to cellular stress may be critical for Cx43-mediated cell death or recovery. Oxidative stress induced by reactive oxygen species (ROS) is associated with various neurological disorders including aging, neurodegenerative diseases, as well as traumatic and ischemic insults. Astrocytes have an important role in the anti-oxidative defense in the brain. The gap junction protein connexin43 (Cx43) forms intercellular channels as well as hemichannels in astrocytes. In the present study, we investigated the contribution of Cx43 to astrocytic death induced by the ROS hydrogen peroxide (H2O2) and the mechanism by which Cx43 exerts its effects. Lack of Cx43 expression or blockage of Cx43 channels resulted in increased ROS-induced astrocytic death, supporting a cell protective effect of functional Cx43 channels. H2O2 transiently increased hemichannel activity, but reduced gap junction intercellular communication (GJIC). GJIC in wild-type astrocytes recovered after 7 h, but was absent in Cx43 knock-out astrocytes. Blockage of Cx43 hemichannels incompletely inhibited H2O2-induced hemichannel activity, indicating the presence of other hemichannel proteins. Panx1, which is predicted to be a major hemichannel contributor in astrocytes, did not appear to have any cell protective effect from H2O2 insults. Our data suggest that GJIC is important for Cx43-mediated ROS resistance. In contrast to hypoxia/reoxygenation, H2O2 treatment decreased the ratio of the hypophosphorylated isoform to total Cx43 level. Cx43 has been reported to promote astrocytic death induced by hypoxia/reoxygenation. We therefore speculate the increase in Cx43 dephosphorylation may account for the facilitation of astrocytic death. Our findings suggest that the role of Cx43 in response to cellular stress is dependent on the activation of signaling pathways leading to alteration of Cx43 phosphorylation states.	[Le, Hoa T.; Sin, Wun Chey; Lozinsky, Shannon; Bechberger, John; Luis Vega, Jose; Guo, Xu Qiu; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Luis Vega, Jose; Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago 8330025, Chile; [Luis Vega, Jose] Univ Antofagasta, Lab Fisiol Expt, Inst Antofagasta, Antofagasta 1270300, Chile; [Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2340000, Chile	University of British Columbia; Pontificia Universidad Catolica de Chile; Universidad de Antofagasta	Naus, CC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	christian.naus@ubc.ca	Vega, Jose Luis/AAE-3131-2019; Vega, José Luis/AAT-4119-2021	Vega, Jose Luis/0000-0001-9333-8729; 	Heart and Stroke Foundation of Canada; Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [FONDECYT 3120006]; CIHR	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of Canada (to C. C. N.) and the Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant FONDECYT 3120006 (to J. L. V.) of Chile. Funding was partly provided through the CIHR Team Grant on "Vascular Cognitive Impairment: Animal Models of Co-morbidity."	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401, DOI 10.1152/ajpheart.1988.255.2.H401; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone S, 2001, FASEB J, V15, P10; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Danilov CA, 2008, GLIA, V56, P801, DOI 10.1002/glia.20655; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Giardina SF, 2007, BIOCHEM BIOPH RES CO, V362, P747, DOI 10.1016/j.bbrc.2007.08.066; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; HU J, 1995, CHEM-BIOL INTERACT, V95, P291, DOI 10.1016/0009-2797(94)03568-S; Hutnik CML, 2008, INVEST OPHTH VIS SCI, V49, P800, DOI 10.1167/iovs.07-0717; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kang KS, 2000, CANCER LETT, V152, P97, DOI 10.1016/S0304-3835(99)00438-3; Kar R, 2013, J BONE MINER RES, V28, P1611, DOI 10.1002/jbmr.1917; Kozoriz MG, 2013, NEUROPHARMACOLOGY, V75, P549, DOI 10.1016/j.neuropharm.2013.05.003; Kuo ML, 1998, MUTAT RES-GEN TOX EN, V413, P143, DOI 10.1016/S1383-5718(98)00020-5; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lee DE, 2010, J NUTR BIOCHEM, V21, P680, DOI 10.1016/j.jnutbio.2009.03.014; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Li WEI, 2000, EUR J NEUROSCI, V12, P2644, DOI 10.1046/j.1460-9568.2000.00162.x; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu SS, 2006, DEVELOPMENT, V133, P2063, DOI 10.1242/dev.02374; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Martinez AD, 2000, BRAIN RES REV, V32, P250, DOI 10.1016/S0165-0173(99)00086-7; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Ozog MA, 2002, CANCER RES, V62, P3544; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Rouach N, 2004, GLIA, V45, P28, DOI 10.1002/glia.10300; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2006, ADV CARDIOL, V42, P57, DOI 10.1159/000092562; Scemes E, 2012, BBA-BIOMEMBRANES, V1818, P1880, DOI 10.1016/j.bbamem.2011.06.005; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Todt I, 2001, J MEMBRANE BIOL, V181, P107, DOI 10.1007/s00232001-0014-4; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	66	79	83	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1345	1354		10.1074/jbc.M113.508390	http://dx.doi.org/10.1074/jbc.M113.508390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302722	hybrid, Green Published			2022-12-25	WOS:000332401700013
J	Okon, IS; Coughlan, KA; Zou, MH				Okon, Imoh S.; Coughlan, Kathleen A.; Zou, Ming-Hui			Liver Kinase B1 Expression Promotes Phosphatase Activity and Abrogation of Receptor Tyrosine Kinase Phosphorylation in Human Cancer Cells (Publication with Expression of Concern. See vol. 294, pg. 10022, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern						Epidermal Growth Factor Receptor (EGFR); Growth Factors; LKB; Lung Cancer; Receptor Tyrosine Kinase; LKB1	ACTIVATED PROTEIN-KINASE; LUNG-CANCER; MOLECULAR-MECHANISMS; IGF-I; LKB1; MUTATIONS; GENE; AMPK; PREVALENCE; SURVIVAL	Background: Frequent loss of liver kinase B1 (LKB1) has been reported in human neoplasm. Results: LKB1 depletion correlated with enhanced RTK phosphorylation in human lung cancer cell line. Ectopic LKB1 expression in deficient lung and cervical cancer cell lines abrogated a repertoire of phospho-RTKs associated with tumor development and progression. Conclusion: LKB1 promotes protein tyrosine phosphatase activity and inhibition of RTK-activated pathways. Significance: LKB1 protects against RTK-driven tumors. Aberrant receptor tyrosine kinase phosphorylation (pRTK) has been associated with diverse pathological conditions, including human neoplasms. In lung cancer, frequent liver kinase B1 (LKB1) mutations correlate with tumor progression, but potential links with pRTK remain unknown. Heightened and sustained receptor activation was demonstrated by LKB1-deficient A549 (lung) and HeLaS3 (cervical) cancer cell lines. Depletion (siRNA) of endogenous LKB1 expression in H1792 lung cancer cells also correlated with increased pRTK. However, ectopic LKB1 expression in A549 and HeLaS3 cell lines, as well as H1975 activating-EGF receptor mutant lung cancer cell resulted in dephosphorylation of several tumor-enhancing RTKs, including EGF receptor, ErbB2, hepatocyte growth factor receptor (c-Met), EphA2, rearranged during transfection (RET), and insulin-like growth factor I receptor. Receptor abrogation correlated with attenuation of phospho-Akt and increased apoptosis. Global phosphatase inhibition by orthovanadate or depletion of protein tyrosine phosphatases (PTPs) resulted in the recovery of receptor phosphorylation. Specifically, the activity of SHP-2, PTP-1, and PTP-PEST was enhanced by LKB1-expressing cells. Our findings provide novel insight on how LKB1 loss of expression or function promotes aberrant RTK signaling and rapid growth of cancer cells.	[Okon, Imoh S.; Coughlan, Kathleen A.; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu			National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL096032, R01HL080499, R01HL105157, R01HL110488, R01HL074399, R01HL079584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, and HL110488 (to M.-H.Z.).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fan DH, 2009, ACTA BIOCH BIOPH SIN, V41, P97, DOI 10.1093/abbs/gmn011; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meng T.- C., 2006, J CANC MOL, V2, P9; Nitert MD, 2005, MOL CELL ENDOCRINOL, V229, P31, DOI 10.1016/j.mce.2004.10.003; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P712, DOI 10.1016/j.bbagen.2011.03.008; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Puri Neelu, 2008, J Carcinog, V7, P9; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V282, pF442, DOI 10.1152/ajprenal.00184.2001; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tiganis T, 2002, IUBMB LIFE, V53, P3, DOI 10.1080/15216540210811; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Varewijck AJ, 2013, DIABETES, V62, P2539, DOI 10.2337/db12-1773; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	45	8	8	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1639	1648		10.1074/jbc.M113.500934	http://dx.doi.org/10.1074/jbc.M113.500934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285539	hybrid, Green Published			2022-12-25	WOS:000332401700037
J	Van Acker, T; Eyckerman, S; Vande Walle, L; Gerlo, S; Goethals, M; Lamkanfi, M; Bovijn, C; Tavernier, J; Peelman, F				Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank			The Small GTPase Arf6 Is Essential for the Tram/Trif Pathway in TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokines; Interferon; Endocytosis; Innate Immunity; Lipopolysaccharide (LPS); Mal TIRAP; MyD88; Toll-like Receptors (TLR); TRIF; Arf6	INTERFERON REGULATORY FACTOR-3; RECEPTOR-MEDIATED PHAGOCYTOSIS; RIBOSYLATION FACTOR 6; MYD88 ADAPTER-LIKE; NF-KAPPA-B; PLASMA-MEMBRANE; ACTIVATING PROTEIN; IKK-EPSILON; MOLECULE; REQUIREMENT	Background: The small GTPase Arf6 affects LPS-induced cytokine secretion. Results: Arf6 regulates transport of the TLR4 adaptor protein Tram and internalization of LPS. Conclusion: Arf6 plays an essential role in regulating the Tram/Trif-dependent TLR4 pathway. Significance: Knowing how TLR4 is modulated is crucial for understanding innate immunity. Recognition of lipopolysaccharides (LPS) by Toll-like receptor 4 (TLR4) at the plasma membrane triggers NF-B activation through recruitment of the adaptor proteins Mal and MyD88. Endocytosis of the activated TLR4 allows recruitment of the adaptors Tram and Trif, leading to activation of the transcription factor IRF3 and interferon production. The small GTPase ADP-ribosylation factor 6 (Arf6) was shown to regulate the plasma membrane association of Mal. Here we demonstrate that inhibition of Arf6 also markedly reduced LPS-induced cytokine production in Mal(-/-) mouse macrophages. In this article, we focus on a novel role for Arf6 in the MyD88-independent TLR4 pathway. MyD88-independent IRF3 activation and IRF3-dependent gene transcription were strictly dependent on Arf6. Arf6 was involved in transport of Tram to the endocytic recycling compartment and internalization of LPS, possibly explaining its requirement for LPS-induced IRF3 activation. Together, these results show a critical role for Arf6 in regulating Tram/Trif-dependent TLR4 signaling.	[Van Acker, Tim; Eyckerman, Sven; Gerlo, Sarah; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Cytokine Receptor Lab, Dept Med Prot Res, B-9000 Ghent, Belgium; [Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, Cytokine Receptor Lab, Dept Biochem, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Ghent University; Belgian Government [P7/13]; Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders)	Ghent University(Ghent University); Belgian Government; Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported using grants from Ghent University (Group-ID Multidisciplinary Research Partnerships) and the Belgian Government (Interuniversitary Attraction Poles P7/13).; Supported by the Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders).	Balana ME, 2005, J CELL SCI, V118, P2201, DOI 10.1242/jcs.02351; Bovijn C, 2013, J BIOL CHEM, V288, P12054, DOI 10.1074/jbc.M112.415810; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gould GW, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002186; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Icardi L, 2012, FASEB J, V26, P240, DOI 10.1096/fj.11-191122; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jia T, 2012, MOL MED REP, V6, P167, DOI 10.3892/mmr.2012.877; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Otani T, 2011, DEV CELL, V20, P219, DOI 10.1016/j.devcel.2011.02.001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rizzo A, 2013, INT IMMUNOPHARMACOL, V17, P453, DOI 10.1016/j.intimp.2013.07.005; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Uchida H, 2001, J EXP MED, V193, P955, DOI 10.1084/jem.193.8.955; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Wan T, 2010, J BIOL CHEM, V285, P3750, DOI 10.1074/jbc.M109.069385; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Wu Jing-Yiing, 2012, Commun Integr Biol, V5, P316, DOI 10.4161/cib.20182; Wu JY, 2012, J BIOL CHEM, V287, P4323, DOI 10.1074/jbc.M111.295113; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	62	21	21	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1364	1376		10.1074/jbc.M113.499194	http://dx.doi.org/10.1074/jbc.M113.499194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297182	hybrid, Green Published			2022-12-25	WOS:000332401700015
J	Wang, YG; Wang, ZY; Li, Y				Wang, Yugang; Wang, Zhongyuan; Li, Yan			Storage/Turnover Rate of Inorganic Carbon and Its Dissolvable Part in the Profile of Saline/Alkaline Soils	PLOS ONE			English	Article							DESERT; STORAGE; SEQUESTRATION; GEOCHEMISTRY; HORIZONS; FLUXES; SCALE; DEEP	Soil inorganic carbon is the most common form of carbon in and and semiarid regions, and has a very long turnover time. However, little is known about dissolved inorganic carbon storage and its turnover time in these soils. With 81 soil samples taken from 6 profiles in the southern Gurbantongute Desert, China, we investigated the soil inorganic carbon (SIC) and the soil dissolved inorganic carbon (SDIC) in whole profiles of saline and alkaline soils by analyzing their contents and ages with radiocarbon dating. The results showed that there is considerable SDIC content in SIC, and the variations of SDIC and SIC contents in the saline soil profile were much larger than that in the alkaline profile. SDIC storage accounted for more than 20% of SIC storage, indicating that more than 1/5 of the inorganic carbon in both saline and alkaline soil is not in non-leachable forms. Deep layer soil contains considerable inorganic carbon, with more than 80% of the soil carbon stored below 1 m, whether for SDIC or SIC. More importantly, SDIC ages were much younger than SIC in both saline soil and alkaline soil. The input rate of SDIC and SIC ranged from 7.58 to 29.54 g C m(-2) yr(-1) and 1.34 to 5.33 g C m(-2) yr(-1) respectively for saline soil, and from 1.43 to 4,9 g C m(-2) yr(-1) and 0.79 to 1.27 g C m(-2) yr(-1) respectively for alkaline soil. The comparison of SDIC and SIC residence time showed that using soil inorganic carbon to estimate soil carbon turnover would obscure an important fraction that contributes to the modern carbon cycle: namely the shorter residence and higher input rate of SDIC. This is especially true for SDIC in deep layers of the soil profile.	[Wang, Yugang; Wang, Zhongyuan; Li, Yan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Wang, Zhongyuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Y (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	liyan@ms.xjb.ac.cn		wang, zhongyuan/0000-0001-6018-4647	National Natural Science Foundation of China [41371200]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-QN-316]; "Strategic Priority Research Program" of China [XDA05030500]; International Science & Technology Cooperation Program of China [2010DFA92720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); "Strategic Priority Research Program" of China; International Science & Technology Cooperation Program of China	This study was financed by National Natural Science Foundation of China (No.41371200), the Knowledge Innovation Program of the Chinese Academy of Sciences (No.KZCX2-EW-QN-316), "Strategic Priority Research Program" of China (No.XDA05030500) and International Science & Technology Cooperation Program of China (2010DFA92720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol I.P., 1988, SALT AFFECTED SOILS; Afzal M, 2002, PAK J AGR RES, V17, P379; Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Batjes NH, 1997, GLOBAL CHANGE BIOL, V3, P161, DOI 10.1046/j.1365-2486.1997.00062.x; BRIMHALL GH, 1992, SCIENCE, V255, P695, DOI 10.1126/science.255.5045.695; Cai WJ, 2003, GEOCHIM COSMOCHIM AC, V67, P631, DOI 10.1016/S0016-7037(02)01167-5; CHADWICK OA, 1994, BIOGEOCHEMISTRY, V24, P115, DOI 10.1007/BF00003268; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dawson JJC, 2007, SCI TOTAL ENVIRON, V382, P165, DOI 10.1016/j.scitotenv.2007.03.023; Diaz-Hernandez JL, 2008, CATENA, V74, P80, DOI 10.1016/j.catena.2008.03.008; Eshel G, 2007, SOIL SCI SOC AM J, V71, P397, DOI 10.2136/sssaj2006.0061; Harrison RB, 2011, FOREST SCI, V57, P67; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; IPCC (Intergovernmental Panel on Climate Change), 2000, SPECIAL REPORT EMISS; Khademi H, 1999, EUR J SOIL SCI, V50, P207, DOI 10.1046/j.1365-2389.1999.t01-1-00237.x; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P1; Lal R., 1998, POTENTIAL US CROPLAN, P128; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Landi A, 2003, GEODERMA, V117, P143, DOI 10.1016/S0016-7061(03)00161-7; Li ZP, 2007, GEODERMA, V138, P119, DOI 10.1016/j.geoderma.2006.11.007; Lindsay W. L., 1979, CHEM EQUILIBRIA SOIL, P78; Liu R, 2012, AGR FOREST METEOROL, V162, P127, DOI 10.1016/j.agrformet.2012.04.015; Diaz-Hernandez JL, 2010, CHEMOSPHERE, V80, P346, DOI 10.1016/j.chemosphere.2010.04.038; Ma J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02025; Ma J, 2012, HYDROL PROCESS, V26, P4029, DOI 10.1002/hyp.9204; MARION GM, 1985, SOIL SCI, V139, P468, DOI 10.1097/00010694-198505000-00014; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; Monger HC, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P273; Neill C, 2006, HYDROL PROCESS, V20, P2467, DOI 10.1002/hyp.6210; Nordt LC, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P43; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; RICHTER DD, 1995, BIOSCIENCE, V45, P600, DOI 10.2307/1312764; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sahrawat KL, 2003, CURR SCI INDIA, V84, P864; SCHLESINGER WH, 1985, GEOCHIM COSMOCHIM AC, V49, P57, DOI 10.1016/0016-7037(85)90191-7; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Shi Y, 2012, BIOGEOSCIENCES, V9, P2287, DOI 10.5194/bg-9-2287-2012; Smith P, 2008, ADV AGRON, V97, P1, DOI 10.1016/S0065-2113(07)00001-6; Smith P, 2010, NATURE, V464, P499, DOI 10.1038/464499a; Stevenson BA, 2006, SOIL BIOL BIOCHEM, V38, P1727, DOI 10.1016/j.soilbio.2005.11.028; Stone R, 2008, SCIENCE, V320, P1409, DOI 10.1126/science.320.5882.1409; Strahm BD, 2009, FOREST ECOL MANAG, V258, P2347, DOI 10.1016/j.foreco.2009.03.014; Tobias C, 2011, CHEM GEOL, V283, P18, DOI 10.1016/j.chemgeo.2010.12.012; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; Wang YG, 2013, ENVIRON EARTH SCI, V70, P3217, DOI 10.1007/s12665-013-2386-z; Wang YG, 2013, CATENA, V100, P50, DOI 10.1016/j.catena.2012.08.005; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Xie JX, 2009, ENVIRON GEOL, V56, P953, DOI 10.1007/s00254-008-1197-0; Xu GQ, 2010, J ARID LAND, V2, P98, DOI 10.3724/SP.J.1227.2010.00098; Zhang HC, 2006, RADIOCARBON, V48, P109, DOI 10.1017/S0033822200035438	55	11	18	16	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82029	10.1371/journal.pone.0082029	http://dx.doi.org/10.1371/journal.pone.0082029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312399	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300071
J	Konieczna, J; Garcia, AP; Sanchez, J; Palou, M; Palou, A; Pico, C				Konieczna, Jadwiga; Paula Garcia, Ana; Sanchez, Juana; Palou, Mariona; Palou, Andreu; Pico, Catalina			Oral Leptin Treatment in Suckling Rats Ameliorates Detrimental Effects in Hypothalamic Structure and Function Caused by Maternal Caloric Restriction during Gestation	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENERGY HOMEOSTASIS; PREVENTS OBESITY; FOOD PREFERENCES; ADIPOSE-TISSUE; INSULIN; LACTATION; NEURONS; UNDERNUTRITION; SUSCEPTIBILITY	A poor prenatal environment brings about perturbations in leptin surge and hypothalamic circuitry that program impaired ability to regulate energy homeostasis in adulthood. Here, using a rat model of moderate maternal caloric restriction during gestation, we aimed to investigate whether leptin supplementation with physiological doses throughout lactation is able to ameliorate the adverse developmental malprogramming effects exerted in offspring hypothalamus structure and function. Three groups of male and female rats were studied: the offspring of ad libitum fed dams (controls), the offspring of 20% calorie restricted dams during the first part of pregnancy (CR), and CR rats supplemented with physiological doses of leptin throughout lactation (CR-Leptin). Animals were sacrificed on postnatal day 25. Morphometric and immunohistochemical studies on arcuate (ARC) and paraventicular (PVN) nucleus were performed and hypothalamic expression levels of selected genes were determined. In CR males, leptin treatment restored, at least in part, the number of immunoreactive neuropeptide Y (NPY+) cells in ARC, the total number of cells in PVN, hypothalamic NPY, cocaine-and amphetamine-regulated transcript (CART) and suppressor of cytokine signalling-3 (SOCS-3) mRNA levels, and plasma leptin levels, which were decreased in CR animals. CR-Leptin males showed higher hypothalamic long-form leptin receptor (ObRb) mRNA levels, compared to control and CR animals. In CR females, leptin treatment reverted the increased number of cells in ARC and cell density in ARC and PVN, and reduced hypothalamic SOCS-3 mRNA expression to levels similar to controls. Leptin treatment also reverted the increased relative area of NPY+ fibers in the PVN occurring in CR animals. In conclusion, leptin supplementation throughout lactation is able to revert, at least partly, most of the developmental effects on hypothalamic structure and function caused by moderate maternal caloric restriction during gestation, and hence making this metabolic malprogramming reversible to some extent.	[Palou, Andreu] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma de Mallorca, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma de Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Palou, A (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma de Mallorca, Spain.	andreu.palou@uib.es; cati.pico@uib.es	Palou, Andreu/K-9881-2014; Palou, Mariona/H-9208-2015; Palou, Mariona/S-2098-2018; Sanchez, Juana/K-9675-2014; Pico, Catalina/H-7115-2015	Palou, Andreu/0000-0002-0295-4452; Palou, Mariona/0000-0001-9918-3764; Palou, Mariona/0000-0001-9918-3764; Sanchez, Juana/0000-0002-9176-8060; Pico, Catalina/0000-0001-6759-5844	Spanish Government [AGL2009-11277]; European Union [244995]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU) [FP6-506360]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU)(European Commission)	The research leading to these results was supported by the Spanish Government (grant AGL2009-11277), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n. 244995 (BIOCLAIMS Project), and the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn. The Laboratory belongs to the Nutrigenomics-group, awarded as "Group of Excellence" of CAIB and supported by "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB) and FEDER funds (EU Contract: n. FP6-506360). Jadwiga Konieczna is granted with a PhD fellowship entitled "beca para la formacion de personal investigador, en el marco de un programa operativo cofinanciado por el Fondo Social Europeo". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Minana-Solis MD, 2011, NUTR NEUROSCI, V14, P72, DOI 10.1179/1476830511Y.0000000003; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Djiane J, 2008, J PHYSIOL PHARMACOL, V59, P55; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Grino M, 2005, AM J PHYSIOL-REG I, V289, pR1233, DOI 10.1152/ajpregu.00542.2005; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; JONES AP, 1984, J NUTR, V114, P1484; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Palou M, 2010, ENDOCRINOLOGY, V151, P1030, DOI 10.1210/en.2009-0934; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Pico C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00436; Pico C, 2011, AM J CLIN NUTR, V94, p1830S, DOI 10.3945/ajcn.110.000752; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Priego T, 2010, INT J OBESITY, V34, P809, DOI 10.1038/ijo.2010.18; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spencer SJ, 2012, CURR DIABETES REV, V8, P55, DOI 10.2174/157339912798829214; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Vickers Mark H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P17, DOI 10.1097/MED.0b013e328013da48; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Yang ZY, 2013, MATERN CHILD NUTR, V9, P105, DOI 10.1111/mcn.12010	45	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81906	10.1371/journal.pone.0081906	http://dx.doi.org/10.1371/journal.pone.0081906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312379	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900061
J	Lopez-Miras, MD; Martin-Sanchez, I; Yebra-Rodriguez, A; Romero-Noguera, J; Bolivar-Galiano, F; Ettenauer, J; Sterflinger, K; Pinar, G				del Mar Lopez-Miras, Maria; Martin-Sanchez, Ines; Yebra-Rodriguez, Africa; Romero-Noguera, Julio; Bolivar-Galiano, Fernando; Ettenauer, Joerg; Sterflinger, Katja; Pinar, Guadalupe			Contribution of the Microbial Communities Detected on an Oil Painting on Canvas to Its Biodeterioration	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ANCIENT WALL PAINTINGS; FUNGAL COMMUNITIES; HETEROTROPHIC BACTERIA; BUILDING-MATERIALS; FTIR SPECTROSCOPY; MURAL PAINTINGS; DNA EXTRACTION; IDENTIFICATION; MICROORGANISMS	In this study, we investigated the microbial community (bacteria and fungi) colonising an oil painting on canvas, which showed visible signs of biodeterioration. A combined strategy, comprising culture-dependent and -independent techniques, was selected. The results derived from the two techniques were disparate. Most of the isolated bacterial strains belonged to related species of the phylum Firmicutes, as Bacillus sp. and Paenisporosarcina sp., whereas the majority of the non-cultivable members of the bacterial community were shown to be related to species of the phylum Proteobacteria, as Stenotrophomonas sp. Fungal communities also showed discrepancies: the isolated fungal strains belonged to different genera of the order Eurotiales, as Penicillium and Eurotium, and the non-cultivable belonged to species of the order Pleosporales and Saccharomycetales. The cultivable microorganisms, which exhibited enzymatic activities related to the deterioration processes, were selected to evaluate their biodeteriorative potential on canvas paintings; namely Arthrobacter sp. as the representative bacterium and Penicillium sp. as the representative fungus. With this aim, a sample taken from the painting studied in this work was examined to determine the stratigraphic sequence of its cross-section. From this information, "mock paintings," simulating the structure of the original painting, were prepared, inoculated with the selected bacterial and fungal strains, and subsequently examined by micro-Fourier Transform Infrared spectroscopy, in order to determine their potential susceptibility to microbial degradation. The FTIR-spectra revealed that neither Arthrobacter sp. nor Penicillium sp. alone, were able to induce chemical changes on the various materials used to prepare "mock paintings." Only when inoculated together, could a synergistic effect on the FTIR-spectra be observed, in the form of a variation in band position on the spectrum.	[del Mar Lopez-Miras, Maria; Martin-Sanchez, Ines] Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain; [Yebra-Rodriguez, Africa] Univ Jaen, Fac Expt Sci, Dept Geol, Jaen, Spain; [Yebra-Rodriguez, Africa] Univ Jaen, Ctr Estudios Avanzados Ciencias Tierra, Fac Expt Sci, Jaen, Spain; [Romero-Noguera, Julio; Bolivar-Galiano, Fernando] Univ Granada, Fac Fine Arts, Dept Painting, Granada, Spain; [Ettenauer, Joerg; Sterflinger, Katja; Pinar, Guadalupe] Univ Nat Resources & Life Sci, Vienna Inst Bio Technol, Dept Biotechnol, Inst Appl Microbiol, Vienna, Austria	University of Granada; Universidad de Jaen; Universidad de Jaen; University of Granada; University of Natural Resources & Life Sciences, Vienna	Lopez-Miras, MD (corresponding author), Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain.	marlopezmiras@ugr.es	Pinar, Guadalupe/I-8959-2016; Yebra-Rodriguez, Africa/K-4662-2013; NOGUERA, JULIO ROMERO/L-1359-2014; Galiano, Fernando C. Bolivar/C-4332-2018	Pinar, Guadalupe/0000-0001-7881-8572; Yebra-Rodriguez, Africa/0000-0002-1452-1136; NOGUERA, JULIO ROMERO/0000-0002-7590-232X; Sterflinger, Katja/0000-0002-0296-6728; Bolivar-Galiano, Fernando/0000-0001-8456-9613	Junta de Andalucia [RNM-325]; Austrian Science Fund (FWF) [Hertha-Firnberg T137]; Spanish Ministry of Science and Innovation [CTQ2008-06727-C03-03]	Junta de Andalucia(Junta de Andalucia); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The FTIR analyses performed in this study were financed by the Junta de Andalucia (RNM-325 group). The molecular analyses performed in this study were financed by the Austrian Science Fund (FWF) project 'Hertha-Firnberg T137' and the Spanish Ministry of Science and Innovation (Project CTQ2008-06727-C03-03). G. Pinar also thanks the "Elise-Richter V194-B20" projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Bersani D, 2008, ANAL CHIM ACTA, V610, P74, DOI 10.1016/j.aca.2008.01.041; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Cappitelli F, 2005, MACROMOL BIOSCI, V5, P49, DOI 10.1002/mabi.200400134; Centeno SA, 2004, J AM INST CONSERV, V43, P139, DOI 10.2307/4129649; Chahinian H, 2002, LIPIDS, V37, P653, DOI 10.1007/s11745-002-0946-7; Ciferri O, 1999, APPL ENVIRON MICROB, V65, P879; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Derrick M., 1989, J AM INT CONSERV, V28, P43, DOI DOI 10.2307/3179466; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Ettenauer J, 2011, SCI TOTAL ENVIRON, V409, P5337, DOI 10.1016/j.scitotenv.2011.08.063; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Ettenauer JD, 2012, SCI TOTAL ENVIRON, V439, P44, DOI 10.1016/j.scitotenv.2012.09.005; Flemming HC, 1998, POLYM DEGRAD STABIL, V59, P309, DOI 10.1016/S0141-3910(97)00189-4; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Gonzalez JM, 2005, INT MICROBIOL, V8, P189; GUGLIELMINETTI M, 1994, INT BIODETER BIODEGR, V33, P269, DOI 10.1016/0964-8305(94)90066-3; Gurtner C, 2000, INT BIODETER BIODEGR, V46, P229, DOI 10.1016/S0964-8305(00)00079-2; Heyrman J, 1999, FEMS MICROBIOL LETT, V181, P55, DOI 10.1016/S0378-1097(99)00514-5; Hyvarinen A, 2002, CHARACTERIZING MOIST; Karamanos Y, 1997, RES MICROBIOL, V148, P661, DOI 10.1016/S0923-2508(99)80065-5; Kavkler K, 2011, POLYM DEGRAD STABIL, V96, P1081, DOI 10.1016/j.polymdegradstab.2011.03.011; Laiz L, 2003, ENVIRON MICROBIOL, V5, P72, DOI 10.1046/j.1462-2920.2003.00381.x; Laiz L, 2002, PROTECTION CONSERVAT, P173; Lazzari M, 1999, POLYM DEGRAD STABIL, V65, P303, DOI 10.1016/S0141-3910(99)00020-8; Lopez-Miras M, 2013, AEROBIOLOGIA, V29, P301, DOI 10.1007/s10453-012-9281-z; Manso M, 2009, SPECTROCHIM ACTA B, V64, P482, DOI 10.1016/j.sab.2009.01.009; Mastalerz M, 2001, ICCP NEW METH TECHN; Meilunas RJ, 1990, STUD CONSERV, V35, P33, DOI [10.1179/sic.1990.35.1.33, DOI 10.1179/SIC.1990.35.1.33, DOI 10.2307/]; Meng GT, 2001, INT J BIOL MACROMOL, V29, P287, DOI 10.1016/S0141-8130(01)00178-7; Michaelsen A, 2006, INT BIODETER BIODEGR, V58, P133, DOI 10.1016/j.ibiod.2006.06.019; Mohlenhoff P, 2001, FEMS MICROBIOL LETT, V195, P169; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Naumann A, 2005, FUNGAL GENET BIOL, V42, P829, DOI 10.1016/j.fgb.2005.06.003; Navas N, 2008, ANAL CHIM ACTA, V630, P141, DOI 10.1016/j.aca.2008.10.008; Ortega-Aviles M, 2005, ANAL CHIM ACTA, V550, P164, DOI 10.1016/j.aca.2005.06.059; Pepe O, 2010, MICROBIOL RES, V165, P21, DOI 10.1016/j.micres.2008.03.005; Pepe O, 2011, J ENVIRON BIOL, V32, P241; Pinar G, 2001, FEMS MICROBIOL ECOL, V37, P45, DOI 10.1016/S0168-6496(01)00144-1; Pinar G, 2001, APPL ENVIRON MICROB, V67, P4891, DOI 10.1128/AEM.67.10.4891-4895.2001; Pinar G., 2009, BUILDING MAT PROPERT, P163; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; Pinzari F, 2009, COALITION, V19, P6; Prati S, 2011, ANAL BIOANAL CHEM, V399, P3081, DOI 10.1007/s00216-010-4388-y; PRIEST FG, 1977, BACTERIOL REV, V41, P711, DOI 10.1128/MMBR.41.3.711-753.1977; Radaelli A, 2004, LETT APPL MICROBIOL, V38, P447, DOI 10.1111/j.1472-765X.2004.01514.x; Rheims H, 1999, J MICROBIOL METH, V36, P65, DOI 10.1016/S0167-7012(99)00012-3; Rheims H, 1996, MICROBIOL-SGM, V142, P2863, DOI 10.1099/13500872-142-10-2863; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Saad DS, 2004, INT BIODETER BIODEGR, V54, P99, DOI 10.1016/j.ibiod.2004.05.003; SAIZJIMENEZ C, 1993, ATMOS ENVIRON B-URB, V27, P77, DOI 10.1016/0957-1272(93)90047-A; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V47, P345, DOI 10.1016/S0167-7012(01)00344-X; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Sert HB, 2010, MYCOL PROG, V9, P353, DOI 10.1007/s11557-009-0643-z; Simionescu B, 2011, EUR J SCI THEOL, V7, P85; Spring M, 2008, ANAL BIOANAL CHEM, V392, P37, DOI 10.1007/s00216-008-2092-y; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; WAINWRIGHT M, 1993, INT BIODETER BIODEGR, V31, P1, DOI 10.1016/0964-8305(93)90010-Y; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Warscheid T, 2000, OF MICROBES AND ART: THE ROLE OF MICROBIAL COMMUNITIES IN THE DEGRADATION AND PROTECTION OF CULTURAL HERITAGE, P185; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	63	37	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80198	10.1371/journal.pone.0080198	http://dx.doi.org/10.1371/journal.pone.0080198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312203	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100028
J	Wolff, DG; Castiblanco-Valencia, MM; Abe, CM; Monaris, D; Morais, ZM; Souza, GO; Vasconcellos, SA; Isaac, L; Abreu, PAE; Barbosa, AS				Wolff, Danielly G.; Castiblanco-Valencia, Monica M.; Abe, Cecilia M.; Monaris, Denize; Morais, Zenaide M.; Souza, Gisele O.; Vasconcellos, Silvio A.; Isaac, Lourdes; Abreu, Patricia A. E.; Barbosa, Angela S.			Interaction of Leptospira Elongation Factor Tu with Plasminogen and Complement Factor H: A Metabolic Leptospiral Protein with Moonlighting Activities	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; IMMUNE EVASION; SURFACE; FIBRONECTIN; BINDING; ACTIVATION; LIGB; ACQUISITION; ATTACHMENT; REGULATORS	The elongation factor Tu (EF-Tu), an abundant bacterial protein involved in protein synthesis, has been shown to display moonlighting activities. Known to perform more than one function at different times or in different places, it IS found in several subcellular locations in a single organism, and may serve as a virulence factor in a range of important human pathogens. Here we demonstrate that Leptospira EF-Tu is surface-exposed and performs additional roles as a cell-surface receptor for host plasma proteins. It binds plasminogen in a dose-dependent manner, and lysine residues are critical for this interaction. Bound plasminogen is converted to active plasm in, which in turn, is able to cleave the natural substrates C3b and fibrinogen. Leptospira EF-Tu also acquires the complement regulator Factor H (FH). FH bound to immobilized EF-Tu displays cofactor activity, mediating C3b degradation by Factor I (FI). In this manner, EF-Tu may contribute to leptospiral tissue invasion and complement inactivation. To our knowledge this is the first description of a leptospiral protein exhibiting moonlighting activities.	[Wolff, Danielly G.; Monaris, Denize; Abreu, Patricia A. E.; Barbosa, Angela S.] Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil; [Castiblanco-Valencia, Monica M.; Isaac, Lourdes] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Abe, Cecilia M.] Inst Butantan, Lab Biol Celular, Sao Paulo, Brazil; [Morais, Zenaide M.; Souza, Gisele O.; Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo	Barbosa, AS (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil.	angelabarbosa@butantan.gov.br	Monaris, Denize/J-3041-2015; Abe, Cecilia/F-1518-2013; Barbosa, Angela S/I-3518-2013; Abreu, Patricia/C-4682-2012; Abe, Cecilia/AAM-6374-2021; Isaac, Lourdes/I-7186-2012	Monaris, Denize/0000-0003-1427-0530; Abe, Cecilia/0000-0003-0218-9372; Barbosa, Angela S/0000-0002-6458-9489; Abreu, Patricia/0000-0002-7541-0341; Isaac, Lourdes/0000-0002-7746-8942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/07297-3, 2010/50043-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grants 2011/07297-3 and 2010/50043-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Sharma J, 2011, CELL IMMUNOL, V269, P69, DOI 10.1016/j.cellimm.2011.03.023; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/758513; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147	42	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81818	10.1371/journal.pone.0081818	http://dx.doi.org/10.1371/journal.pone.0081818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312361	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100100
J	Geiser, J; De Lisle, RC; Andrews, GK				Geiser, Jim; De Lisle, Robert C.; Andrews, Glen K.			The Zinc Transporter Zip5 (Slc39a5) Regulates Intestinal Zinc Excretion and Protects the Pancreas against Zinc Toxicity	PLOS ONE			English	Article							DIETARY ZINC; ACRODERMATITIS-ENTEROPATHICA; FUNCTIONAL GENOMICS; METALLOTHIONEIN-I; OXIDATIVE STRESS; TRANSGENIC MICE; MAMMARY-GLAND; MOUSE; HOMEOSTASIS; DEFICIENCY	Background: ZIP5 localizes to the baso-lateral membranes of intestinal enterocytes and pancreatic acinar cells and is internalized and degraded coordinately in these cell-types during periods of dietary zinc deficiency. These cell-types are thought to control zinc excretion from the body. The baso-lateral localization and zinc-regulation of ZIP5 in these cells are unique among the 14 members of the Slc39a family and suggest that ZIP5 plays a role in zinc excretion. Methods/Principal Findings: We created mice with floxed Zip5 genes and deleted this gene in the entire mouse or specifically in enterocytes or acinar cells and then examined the effects on zinc homeostasis. We found that ZIP5 is not essential for growth and viability but total knockout of ZIP5 led to increased zinc in the liver in mice fed a zinc-adequate (ZnA) diet but impaired accumulation of pancreatic zinc in mice fed a zinc-excess (ZnE) diet. Loss-of-function of enterocyte ZIP5, in contrast, led to increased pancreatic zinc in mice fed a ZnA diet and increased abundance of intestinal Zip4 mRNA. Finally, loss-of-function of acinar cell ZIP5 modestly reduced pancreatic zinc in mice fed a ZnA diet but did not impair zinc uptake as measured by the rapid accumulation of 67 zinc. Retention of pancreatic 67 zinc was impaired in these mice but the absence of pancreatic ZIP5 sensitized them to zinc-induced pancreatitis and exacerbated the formation of large cytoplasmic vacuoles containing secretory protein in acinar cells. Conclusions: These studies demonstrate that ZIP5 participates in the control of zinc excretion in mice. Specifically, they reveal a paramount function of intestinal ZIP5 in zinc excretion but suggest a role for pancreatic ZIP5 in zinc accumulation/retention in acinar cells. ZIP5 functions in acinar cells to protect against zinc-induced acute pancreatitis and attenuate the process of zymophagy. This suggests that it may play a role in autophagy.	[Geiser, Jim; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [De Lisle, Robert C.; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Andrews, GK (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	gandrews@kumc.edu			NIH [R01 DK 63975]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R01 DK 63975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 1999, J NUTR, V129, P1643, DOI 10.1093/jn/129.9.1643; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dalton T, 1996, J NUTR, V126, P825, DOI 10.1093/jn/126.4.825; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; DeLisle RC, 1996, AM J PHYSIOL-CELL PH, V271, pC1103, DOI 10.1152/ajpcell.1996.271.4.C1103; Dempski RE, 2012, CURR TOP MEMBR, V69, P221, DOI 10.1016/B978-0-12-394390-3.00009-4; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Dufner-Beattie J, 2006, GENESIS, V44, P239, DOI 10.1002/dvg.20211; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fu K, 1997, AM J PHYSIOL-GASTR L, V273, pG696, DOI 10.1152/ajpgi.1997.273.3.G696; Fu K, 1998, PANCREAS, V17, P238, DOI 10.1097/00006676-199810000-00003; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Girish BN, 2012, INDIAN J BIOCHEM BIO, V49, P386; Girish BN, 2011, INDIAN J GASTROENTER, V30, P84, DOI 10.1007/s12664-011-0094-8; Gukovskaya AS, 2012, AM J PHYSIOL-GASTR L, V303, pG993, DOI 10.1152/ajpgi.00122.2012; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Hambidge M, 2001, ANNU REV NUTR, V21, P429, DOI 10.1146/annurev.nutr.21.1.429; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; ISHIHARA N, 1987, ARCH ENVIRON HEALTH, V42, P356, DOI 10.1080/00039896.1987.9934359; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Ji BA, 2008, GENESIS, V46, P390, DOI 10.1002/dvg.20411; Kambe T, 2008, AM J PHYSIOL-REG I, V294, pR1474, DOI 10.1152/ajpregu.00130.2008; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2009, AM J PHYSIOL-REG I, V297, pR194, DOI 10.1152/ajpregu.00162.2009; Kelly P, 2004, CLIN EXP IMMUNOL, V135, P303, DOI 10.1111/j.1365-2249.2004.02374.x; Krebs NF, 2001, BIOMETALS, V14, P397, DOI 10.1023/A:1012942409274; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lee DK, 2003, J NUTR, V133, P45, DOI 10.1093/jn/133.1.45; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Maret W, 2013, METAL IONS LIFE SCI, V12, P479, DOI 10.1007/978-94-007-5561-1_14; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; METHFESSEL AH, 1973, J APPL PHYSIOL, V34, P63, DOI 10.1152/jappl.1973.34.1.63; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Oberleas D, 1996, J INORG BIOCHEM, V62, P231, DOI 10.1016/0162-0134(95)00157-3; Onosaka B, 2002, TOHOKU J EXP MED, V196, P1, DOI 10.1620/tjem.196.1; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Seok SH, 2013, J APPL TOXICOL, V33, P1089, DOI 10.1002/jat.2862; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vaccaro M.I., 2012, INT J CELL BIOL, V2012; VANWOUWE JP, 1994, BIOL TRACE ELEM RES, V42, P143, DOI 10.1007/BF02785385; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wastney ME, 2008, J NUTR, V138, P2148, DOI 10.3945/jn.108.091504; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Weaver BP, 2012, BIOMETALS, V25, P319, DOI 10.1007/s10534-011-9508-4; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502	61	42	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82149	10.1371/journal.pone.0082149	http://dx.doi.org/10.1371/journal.pone.0082149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303081	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400098
J	Williams, JH; Madsen, J				Williams, James H.; Madsen, Jesper			Stakeholder Perspectives and Values when Setting Waterbird Population Targets: Implications for Flyway Management Planning in a European Context	PLOS ONE			English	Article							WILDLIFE; ENOUGH	Managing and controlling wildlife species within Europe is an acknowledged part of conservation management, yet deciding and setting a population target in order to control a population is perceived to be conceptually very challenging. We interviewed stakeholders, within a variety of governmental and non-governmental organizations, to evaluate their perspectives about setting population targets as part of waterbird management for controlling population sizes. We conclude that the setting of a quantifiable population target is beneficial as a measurable objective for monitoring and evaluating management actions. However, it must be recognised as just one possible measurable objective and there may well be multiple supporting objectives that encapsulate the management aims of different stakeholders. When considering wide-scale control of waterbirds species, where it is likely that population size matters, any population target should be coupled to the issues being addressed. We highlight that it is important to actively engage with stakeholders as part of the decision-making process, not only to gain consensus but to share knowledge. A clear understanding of the context and the rationale for controlling a waterbird species is needed to align the interests of diverse stakeholders. The provision of scientific data and the continuous monitoring of management actions is viewed as beneficial and demanded by stakeholders, as part of any decision-making process when setting population targets. This facilitates effective evaluation of management actions, helping managers make wise decisions as well as enabling the continued development of management plans.	[Williams, James H.; Madsen, Jesper] Aarhus Univ, Dept Biosci, Arctic Res Ctr, Aarhus, Denmark; [Williams, James H.] Open Univ, Commun & Syst Dept, Nottingham, England	Aarhus University; Open University - UK	Williams, JH (corresponding author), Aarhus Univ, Dept Biosci, Arctic Res Ctr, Aarhus, Denmark.	jhw@dmu.dk	; Madsen, Jesper/J-7853-2013	Williams, James/0000-0003-4143-2128; Madsen, Jesper/0000-0003-3246-0215	Aarhus University; Norwegian Directorate for Nature Management	Aarhus University; Norwegian Directorate for Nature Management	The authors gratefully acknowledge funding support from Aarhus University and the Norwegian Directorate for Nature Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African-Eurasian Waterbird Agreement, 2008, ACT PLAN 2009 2012 A; Behrens V, 2008, ENVIRON CONSERV, V35, P55, DOI 10.1017/S037689290800444X; Belanger L., 2006, PLAN SUSTAINABLE INT; Cope DR, 2003, BIOL CONSERV, V110, P113, DOI 10.1016/S0006-3207(02)00182-9; Cundill G, 2012, CONSERV BIOL, V26, P13, DOI 10.1111/j.1523-1739.2011.01755.x; Delli Priscoli J., 2003, PARTICIPATION CONSEN; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Glaser B, 1978, DISCOV GROUNDED THEO; Jupp V., 2006, SAGE DICT SOCIAL RES; Madsen J., 2012, AEWA TECHNICAL SERIE; McNie EC, 2007, ENVIRON SCI POLICY, V10, P17, DOI 10.1016/j.envsci.2006.10.004; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Newig J., 2009, Environmental Policy and Governance, V19, P197, DOI 10.1002/eet.509; Nichols JD, 2007, J ORNITHOL, V148, pS343, DOI 10.1007/s10336-007-0256-8; Rodenhoff V., 2003, REV EUROPEAN COMMUNI, V11, P343; Salafsky N., 2001, ADAPTIVE MANAGEMENT; Sanderson EW, 2006, BIOSCIENCE, V56, P911, DOI 10.1641/0006-3568(2006)56[911:HMADWW]2.0.CO;2; Sijtsma MTJ, 2012, SOC NATUR RESOUR, V25, P1308, DOI 10.1080/08941920.2012.684850; Snow Goose Swan and Brant Committee, 2009, MAN PLAN GREAT SNOW; Stringer LC, 2006, ECOL SOC, V11; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Trinder M.N., 2008, VOGELWELT, V129, P158; Van Roomen M, 1992, IWRB SPECIAL PUBLICA, V21, P21; Wilhere GF, 2008, CONSERV BIOL, V22, P514, DOI 10.1111/j.1523-1739.2008.00926.x; Williams B.K., 2009, ADAPTIVE MANAGEMENT; Young JC, 2010, BIODIVERS CONSERV, V19, P3973, DOI 10.1007/s10531-010-9941-7	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81836	10.1371/journal.pone.0081836	http://dx.doi.org/10.1371/journal.pone.0081836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303076	Green Published, gold			2022-12-25	WOS:000327546400092
J	Deng, YZ; Qu, ZW; Naqvi, NI				Deng, Yizhen; Qu, Ziwei; Naqvi, Naweed I.			The Role of Snx41-Based Pexophagy in Magnaporthe Development	PLOS ONE			English	Article							PEROXISOMAL METABOLIC FUNCTION; ATG26-MEDIATED PEXOPHAGY; HOST INVASION; AUTOPHAGY; YEAST; DEGRADATION; INFECTION; CYTOPLASM; PROTEIN; GENE	Pexophagy, the degradation of peroxisomes via selective autophagy, depends on Atg20/Snx42 function in Saccharomyces cerevisiae. Besides its role in selective autophagy, Atg20/Snx42 is also involved in an autophagy-independent endosomal retrieval trafficking, in cooperation with two other sorting nexins, Snx41 and Snx4. Recently, we reported that the sorting nexin MoSnx41, which showed high sequence similarity to yeast Snx41 and Snx42/Atg20 proteins, regulates the gamma-glutamyl cycle and GSH production and is essential for conidiation and pathogenicity in Magnaporthe oryzae. Pexophagy was also found to be defective in Mosnx41 Delta mutant. These findings indicate that MoSnx41 likely serves combined functions of Snx42/Atg20 and Snx41 in M. oryzae.. In this study, we performed complementation analyses and demonstrate that MoSnx41 alone serves the dual function of protein sorting (ScSnx41) and pexophagy (ScSnx42/Atg20). To study the potential biological function of pexophagy in fungal pathogenic life cycle, we created deletion mutants of potential pexophagy-specific genes, and characterized them in terms of pexophagy, conidiation and pathogenesis. We identified Pex14 as an essential protein for pexophagy in M. oryzae. Overall, our results show that pexophagy per se is not essential for asexual development or virulence in M. oryzae.	[Deng, Yizhen; Qu, Ziwei; Naqvi, Naweed I.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Deng, Yizhen; Qu, Ziwei; Naqvi, Naweed I.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Naqvi, Naweed I.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Deng, YZ (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	yizhen@tll.org.sg; naweed@tll.org.sg	Deng, Yizhen/AGQ-0430-2022; Naqvi, Naweed/CAG-5662-2022	Naqvi, Naweed/0000-0002-3619-4906	Temasek Life Sciences Laboratory, Singapore	Temasek Life Sciences Laboratory, Singapore(National University of Singapore)	This work was funded by intramural grants from the Temasek Life Sciences Laboratory, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2005, MOL BIOL CELL, V16, P446, DOI 10.1091/mbc.E04-09-0842; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; Asakura M, 2009, PLANT CELL, V21, P1291, DOI 10.1105/tpc.108.060996; Bellu AR, 2001, J BIOL CHEM, V276, P44570, DOI 10.1074/jbc.M107599200; Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; BREZINA R, 1975, ACTA VIROL, V19, P496; Deng YZ, 2012, AUTOPHAGY, V8, P1058, DOI 10.4161/auto.20217; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Gunkel K, 1999, FEBS LETT, V451, P1, DOI 10.1016/S0014-5793(99)00513-X; Hajra A K, 1988, Prog Clin Biol Res, V282, P99; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033270; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; IGUAL JC, 1992, MOL MICROBIOL, V6, P1867, DOI 10.1111/j.1365-2958.1992.tb01359.x; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; LIU H, 1995, J BIOL CHEM, V270, P10940, DOI 10.1074/jbc.270.18.10940; MCGROARTY E, 1973, J HISTOCHEM CYTOCHEM, V21, P949, DOI 10.1177/21.11.949; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Nazarko TY, 2007, MOL BIOL CELL, V18, P106, DOI 10.1091/mbc.E06-06-0554; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Takano Y, 2009, AUTOPHAGY, V5, P1041, DOI 10.4161/auto.5.7.9316; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; van Zutphen T, 2008, AUTOPHAGY, V4, P63, DOI 10.4161/auto.5076; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Vizeacoumar FJ, 2006, J BIOL CHEM, V281, P14805, DOI 10.1074/jbc.M601808200	38	24	26	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79128	10.1371/journal.pone.0079128	http://dx.doi.org/10.1371/journal.pone.0079128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24302988	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300061
J	Buffa, P; Romano, C; Pandini, A; Massimino, M; Tirro, E; Di Raimondo, F; Manzella, L; Fraternali, F; Vigneri, PG				Buffa, Pietro; Romano, Chiara; Pandini, Alessandro; Massimino, Michele; Tirro, Elena; Di Raimondo, Francesco; Manzella, Livia; Fraternali, Franca; Vigneri, Paolo G.			BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein	FASEB JOURNAL			English	Article						CML; molecular dynamics; mutations; resistance; TKIs	CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; IMATINIB RESISTANCE; PHILADELPHIA-CHROMOSOME; DASATINIB BMS-354825; T315I MUTANT; C-ABL; MUTATION; AP24534; DOMAIN	Patients with chronic myeloid leukemia in whom tyrosine kinase inhibitors (TKIs) fail often present mutations in the BCR-ABL catalytic domain. We noticed a lack of substitutions involving 4 amino acids (E286, M318, I360, and D381) that form hydrogen bonds with ponatinib. We therefore introduced mutations in each of these residues, either preserving or altering their physicochemical properties. We found that E286, M318, I360, and D381 are dispensable for ABL and BCR-ABL protein stability but are critical for preserving catalytic activity. Indeed, only a conservative I360T substitution retained kinase proficiency and transforming potential. Molecular dynamics simulations of BCR-ABL(I360T) revealed differences in both helix C dynamics and protein-correlated motions, consistent with a modified ATP-binding pocket. Nevertheless, this mutant remained sensitive to ponatinib, imatinib, and dasatinib. These results suggest that changes in the 4 BCR-ABL residues described here would be selected against by a lack of kinase activity or by maintained responsiveness to TKIs. Notably, amino acids equivalent to those identified in BCR-ABL are conserved in 51% of human tyrosine kinases. Hence, these residues may represent an appealing target for the design of pharmacological compounds that would inhibit additional oncogenic tyrosine kinases while avoiding the emergence of resistance due to point mutations.Buffa, P., Romano, C., Pandini. A., Massimino, M., Tirr, E., Di Raimondo, F., Manzella, L., Fraternali. F., Vigneri, P. G. BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein.	[Buffa, Pietro; Pandini, Alessandro; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Romano, Chiara; Massimino, Michele; Tirro, Elena; Di Raimondo, Francesco; Manzella, Livia; Vigneri, Paolo G.] Univ Catania, Dept Clin & Mol Biomed, I-95124 Catania, Italy; [Vigneri, Paolo G.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy	University of London; King's College London; University of Catania; Istituto Superiore di Sanita (ISS)	Vigneri, PG (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Via Androne 85, I-95124 Catania, Italy.	franca.fraternali@kcl.ac.uk; pvigneri@libero.it	Fraternali, Franca/D-4410-2011; Tirrò, Elena/AAQ-8085-2020; VIGNERI, Paolo/K-8504-2016; Di Raimondo, Francesco/K-7965-2016; Pandini, Alessandro/F-9854-2012; Fraternali, Franca/C-8912-2009	Tirrò, Elena/0000-0001-8012-5134; VIGNERI, Paolo/0000-0002-5943-6066; Massimino, Michele/0000-0001-5896-8573; Romano, Chiara/0000-0002-2586-8266; Di Raimondo, Francesco/0000-0002-7749-0293; Pandini, Alessandro/0000-0002-4158-233X; MANZELLA, Livia/0000-0002-9908-6443; Fraternali, Franca/0000-0002-3143-6574	Associazione Italiana per la Ricerca sul Cancro (AIRC); Biotechnology and Biological Sciences Research Council [BB/I023291/1, BB/H018409/1]; AIRC-Marie Curie fellowship; BBSRC [BB/H018409/1, BB/I023291/1] Funding Source: UKRI	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AIRC-Marie Curie fellowship(Fondazione AIRC per la ricerca sul cancro); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Maria Stella Pennisi, Stefania Stella, and Silvia Rita Vitale for critical reading of the manuscript. This work was supported by an investigator grant to P.G.V. from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and by funding from the Biotechnology and Biological Sciences Research Council (BB/I023291/1 and BB/H018409/1 to A.P. and F.F.). P.B. is the recipient of an AIRC-Marie Curie fellowship.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660; Aloisi A, 2006, BLOOD, V107, P1591, DOI 10.1182/blood-2005-05-2123; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cortes J, 2009, BLOOD, V114, P267; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; De Falco V, 2013, J CLIN ENDOCR METAB, V98, pE811, DOI 10.1210/jc.2012-2672; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Ernst T, 2012, SEMIN ONCOL, V39, P58, DOI 10.1053/j.seminoncol.2011.11.002; Gibbons DL, 2012, CANCER-AM CANCER SOC, V118, P293, DOI 10.1002/cncr.26225; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang WS, 2010, J MED CHEM, V53, P4701, DOI 10.1021/jm100395q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jabbour E, 2012, AM J HEMATOL, V87, P1038, DOI 10.1002/ajh.23282; Jabbour E, 2011, CANCER-AM CANCER SOC, V117, P1800, DOI 10.1002/cncr.25717; Jabbour E, 2009, BLOOD, V114, P2037, DOI 10.1182/blood-2009-01-197715; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Lee TS, 2009, RECENT PAT ANTI-CANC, V4, P164, DOI 10.2174/157489209788452867; Lee TS, 2008, MOL CANCER THER, V7, P3834, DOI 10.1158/1535-7163.MCT-08-0482; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Lovera S, 2012, J AM CHEM SOC, V134, P2496, DOI 10.1021/ja210751t; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nagar B, 2002, CANCER RES, V62, P4236; Nicolini FE, 2013, HAEMATOLOGICA, V98, P1510, DOI 10.3324/haematol.2012.080234; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Preyer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017020; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Quintas-Cardama A, 2008, CLIN CANCER RES, V14, P4392, DOI 10.1158/1078-0432.CCR-08-0117; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah Neil P, 2011, Clin Adv Hematol Oncol, V9, P925; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	67	26	26	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1221	1236		10.1096/fj.13-236992	http://dx.doi.org/10.1096/fj.13-236992			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24297701	Green Submitted			2022-12-25	WOS:000335324800017
J	Shrive, AK; Moeller, JB; Burns, I; Paterson, JM; Shaw, AJ; Schlosser, A; Sorensen, GL; Greenhough, TJ; Holmskov, U				Shrive, Annette K.; Moeller, Jesper B.; Burns, Ian; Paterson, Jenny M.; Shaw, Amy J.; Schlosser, Anders; Sorensen, Grith L.; Greenhough, Trevor J.; Holmskov, Uffe			Crystal Structure of the Tetrameric Fibrinogen-like Recognition Domain of Fibrinogen C Domain Containing 1 (FIBCD1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ligand-binding Protein; Pattern Recognition Receptor; Receptor Structure-Function; Structural Biology; FIBCD1; Acetyl Binding; Chitin Receptor; Fibrinogen-like Domain	MOLECULAR REPLACEMENT; L-FICOLIN; GEOMETRY; LECTIN	Background: FIBCD1 is a tetrameric plasma membrane protein that uses a fibrinogen-like recognition domain (FReD) for pattern recognition of acetyl groups on chitin. Results: The x-ray structure of the FIBCD1 FReD reveals how FIBCD1 binds acetylated and sulfated molecules. Conclusion: FReD domains combine versatility with conservation to recognize their targets. Significance: The structure suggests how FIBCD1 binds acetylated pathogen-associated molecular patterns (PAMPS) and endogenous glycosaminoglycans. The high resolution crystal structures of a recombinant fragment of the C-terminal fibrinogen-like recognition domain of FIBCD1, a vertebrate receptor that binds chitin, have been determined. The overall tetrameric structure shows similarity in structure and aggregation to the horseshoe crab innate immune protein tachylectin 5A. The high affinity ligand N-acetylmannosamine (ManNAc) binds in the S1 site, predominantly via the acetyl group with the oxygen and acetamide nitrogen hydrogen-bonded to the protein and the methyl group inserted into a hydrophobic pocket. The binding of the ManNAc pyranose ring differs markedly between the two independent subunits, but in all structures the binding of the N-acetyl group is conserved. In the native structure, a crystal contact results in one of the independent protomers binding the first GlcNAc of the Asn(340)N-linked glycan on the other independent protomer. In the ligand-bound structure this GlcNAc is replaced by the higher affinity ligand ManNAc. In addition, a sulfate ion has been modeled into the electron density at a location similar to the S3 binding site in L-ficolin, whereas in the native structure an acetate ion has been placed in the S1 N-acetyl binding site, and a sulfate ion has been placed adjacent to this site. These ion binding sites are ideally placed to receive the N-acetyl and sulfate groups of sulfated GalNAc residues of glycosaminoglycans such as chondroitin and dermatan sulfate. Together, these structures give insight into important determinants of ligand selectivity, demonstrating versatility in recognition and binding while maintaining conservation in N-acetyl and calcium binding.	[Shrive, Annette K.; Burns, Ian; Paterson, Jenny M.; Shaw, Amy J.; Greenhough, Trevor J.] Keele Univ, Sch Life Sci, Res Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Moeller, Jesper B.; Schlosser, Anders; Sorensen, Grith L.; Holmskov, Uffe] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, DK-5000 Odense, Denmark	Keele University; University of Southern Denmark	Shrive, AK (corresponding author), Keele Univ, Sch Life Sci, Res Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.	a.k.shrive@keele.ac.uk	Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015	Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097	Medical Research Council; Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory; Diamond Light Source [Midlands BAG MX310]; Danish Medical Research Council; NOVO Nordic Foundation; Lundbeck Foundation; Fonden til Laegevidenskabens Fremme; Medical Research Council [G0400743] Funding Source: researchfish; MRC [G0400743] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory; Diamond Light Source; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NOVO Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to A. K. S., T. J. G., and I. B.), Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory, the Diamond Light Source (Midlands BAG MX310), the Danish Medical Research Council (to U. H.), the NOVO Nordic Foundation (to U. H.), the Lundbeck Foundation (U. H.), and Fonden til Laegevidenskabens Fremme (to U. H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garlatti V, 2010, J INNATE IMMUN, V2, P17, DOI 10.1159/000233475; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Shrive AK, 1996, ACTA CRYSTALLOGR D, V52, P1049, DOI 10.1107/S0907444996008311; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523	22	19	19	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2880	2887		10.1074/jbc.M113.520577	http://dx.doi.org/10.1074/jbc.M113.520577			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24293368	Green Published, hybrid			2022-12-25	WOS:000333403000036
J	Huang, L; Huang, QY; Huang, HQ				Huang, Lin; Huang, Qing-Yu; Huang, He-Qing			The Evidence of HeLa Cell Apoptosis Induced with Tetraethylammonium Using Proteomics and Various Analytical Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bioinformatics; Flow Cytometry; Pharmacology; Proteomics; Western Blotting; HeLa Cell Line; Patch Clamp Technology; RT-qPCR; Tetraethylammonium	PROTEIN-DISULFIDE ISOMERASE; ENOYL-COA HYDRATASE; POTASSIUM CHANNEL; UP-REGULATION; CANCER-CELLS; K+ CHANNEL; EXPRESSION; SORCIN; CISPLATIN; 4-AMINOPYRIDINE	Tetraethylammonium (TEA) is a potassium channel (KCh) blocker applied in the functional and pharmacological studies of the KChs. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, a colorimetric assay to quantitatively measure living cells, demonstrated that TEA reduced the HeLa cell viability dose-dependently. Flow cytometry analysis indicated an increased apoptosis rate of the HeLa cell after exposing to TEA. The patch clamp technique revealed that the K+ current of the HeLa cell was inhibited up to 80% when exposed to TEA. In addition, quantitative real-time PCR approach set up cross-talk among the cytotoxicity of TEA, 4-aminopyridine, and anti-cancer drug such as cisplatin. Using comparative proteomics combined with MALDI-TOF MS/MS, 33 significantly changed proteins were found from TEA treatment group; among these proteins, 12 were up-regulated, and 21 were down-regulated. Here we indicated that these proteins were closely connected with many biological functions such as oxidative stress response, signal transduction, metabolism, protein synthesis, and degradation. Both Western blotting and quantitative real-time PCR approaches further verified these differential proteins. Ingenuity Pathways Analysis software, a tool to analyze omics data and model biological system, was applied to analyze the interaction pathways of these proteins. The subcellular locations of the differential proteins are also predicted from Uniprot. All results above can help in our understanding of the mechanism of TEA-induced cytotoxicity and provide potential cancer biomarkers. Various experimental results in this study (like those for cisplatin) indicated that TEA is not only a KCh blocker but also a potential anti-cancer drug.	[Huang, Lin; Huang, Qing-Yu; Huang, He-Qing] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Huang, Lin] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Xiamen University; Oregon State University	Huang, HQ (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	hqhuang@xmu.edu.cn	Huang, Qingyu/O-1662-2014	Huang, Qingyu/0000-0002-5076-2084	State Natural Science Fund [30870515]; PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University), China [IRT0941]	State Natural Science Fund(National Natural Science Foundation of China (NSFC)); PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University), China	This work was supported by State Natural Science Fund 30870515 and by PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University) Project IRT0941, China.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capozzi F, 2007, J PROTEOME RES, V6, P4245, DOI 10.1021/pr070314m; Chavez JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019892; Checinska A, 2009, J PROTEOMICS, V72, P575, DOI 10.1016/j.jprot.2008.11.016; Chen DS, 2009, AQUAT TOXICOL, V94, P163, DOI 10.1016/j.aquatox.2009.06.014; CHEN L, 2011, PLOS ONE, V6; Chin LS, 1997, J NEUROSCI RES, V48, P122, DOI 10.1002/(SICI)1097-4547(19970415)48:2<122::AID-JNR4>3.0.CO;2-E; Cho YE, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010884; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; Dilly S, 2013, BIOCHEM PHARMACOL, V85, P560, DOI 10.1016/j.bcp.2012.12.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fanarraga Monica Lopez, 2010, Commun Integr Biol, V3, P306; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Guidoni L, 2002, J RECEPT SIGNAL TR R, V22, P315, DOI 10.1081/RRS-120014604; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Huang QY, 2011, PROTEOMICS, V11, P3743, DOI 10.1002/pmic.201100084; Huang QY, 2011, COMP BIOCHEM PHYS C, V153, P67, DOI 10.1016/j.cbpc.2010.08.009; Ji XT, 2012, J PROTEOMICS, V75, P3145, DOI 10.1016/j.jprot.2012.03.013; Kawakami M, 2007, BIOL PHARM BULL, V30, P1065, DOI 10.1248/bpb.30.1065; Kim JA, 2000, PHARMACOLOGY, V60, P74, DOI 10.1159/000028350; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Liu XA, 2010, FEBS LETT, V584, P3185, DOI 10.1016/j.febslet.2010.06.002; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luo LZ, 2012, J PROTEOMICS, V77, P237, DOI 10.1016/j.jprot.2012.08.023; Matsumoto T, 2005, BASIC RES CARDIOL, V100, P250, DOI 10.1007/s00395-005-0518-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nonn L, 2003, MOL CANCER RES, V1, P682; Park KS, 2008, PHYSIOLOGY, V23, P49, DOI 10.1152/physiol.00031.2007; Patel SK, 2013, J CELL MOL MED, V17, P134, DOI 10.1111/j.1582-4934.2012.01656.x; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qi J, 2006, BIOCHEM BIOPH RES CO, V349, P303, DOI 10.1016/j.bbrc.2006.08.042; Salerno DM, 2012, J CELL PHYSIOL, V227, P3613, DOI 10.1002/jcp.24067; Saraste A, 1997, CIRCULATION, V95, P320; Satou M, 2010, ENDOCRINOLOGY, V151, P4765, DOI 10.1210/en.2010-0412; Shen QJ, 2009, J NEUROSCI RES, V87, P3153, DOI 10.1002/jnr.22136; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; Sun H, 2008, TOXICOL APPL PHARM, V232, P25, DOI 10.1016/j.taap.2008.05.024; Tan QL, 2012, J GEN PHYSIOL, V139, P295, DOI 10.1085/jgp.201110725; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Thevenin AF, 2011, BIOCHEMISTRY-US, V50, P8417, DOI 10.1021/bi200802w; Valencia-Cruz G, 2009, AM J PHYSIOL-CELL PH, V297, pC1544, DOI 10.1152/ajpcell.00064.2009; Wallace JL, 2011, J MEMBRANE BIOL, V242, P53, DOI 10.1007/s00232-011-9376-4; Wang G, 2008, BIOCHEM BIOPH RES CO, V374, P204, DOI 10.1016/j.bbrc.2008.07.003; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wible BA, 2002, J BIOL CHEM, V277, P17852, DOI 10.1074/jbc.M201689200; Xu Y, 2010, MICROBES INFECT, V12, P683, DOI 10.1016/j.micinf.2010.04.002; Yang KB, 2009, CHEMOTHERAPY, V55, P372, DOI 10.1159/000235730; Zeng HZ, 2011, INT J MOL SCI, V12, P3489, DOI 10.3390/ijms12063489; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang J, 2011, BIOMED PHARMACOTHER, V65, P157, DOI 10.1016/j.biopha.2011.02.010; Zhang Y, 2008, J BIOL CHEM, V283, P10632, DOI 10.1074/jbc.M800253200	63	7	8	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2217	2229		10.1074/jbc.M113.515932	http://dx.doi.org/10.1074/jbc.M113.515932			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297172	hybrid, Green Published			2022-12-25	WOS:000331130200029
J	Jiang, WR; Cady, G; Hossain, MM; Huang, QQ; Wang, X; Jin, JP				Jiang, Wen-rui; Cady, Geoffrey; Hossain, M. Moazzem; Huang, Qi-Quan; Wang, Xin; Jin, J. -P.			Mechanoregulation of h2-Calponin Gene Expression and the Role of Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Gene Transcription; Mechanotransduction; Transcription Promoter	VASCULAR SMOOTH-MUSCLE; CELLS IN-VITRO; EXTRACELLULAR-MATRIX; SENSORY TRANSDUCTION; MOLECULAR-CLONING; CULTURED-CELLS; CALPONIN; MYOSIN; ACTIN; CYTOSKELETAL	Background: Mechanical forces regulate gene expression. The mechanisms are not well understood. Results: A HES-1 site in the promoter of h2-calponin gene is a tension-regulated repressor responsive to Notch signaling. Conclusion: Notch regulation plays a role in the mechanoregulation of h2-calponin. Significance: The findings demonstrated a novel mechanism in the mechanoregulation of h2-calponin gene expression. The essential role of mechanical signals in regulating the function of living cells is universally observed. However, how mechanical signals are transduced in cells to regulate gene expression is largely unknown. We previously demonstrated that the gene encoding h2-calponin (Cnn2) is sensitively regulated by mechanical tension. In the present study, mouse genomic DNA containing the Cnn2 promoter was cloned, and a nested set of 5 truncations was studied. Transcriptional activity of the Cnn2 promoter-reporter constructs was examined in transfected NIH/3T3, HEK293, and C2C12 cells for their responses to the stiffness of culture substrate. The results showed significant transcriptional activities of the -1.00- and -1.24-kb promoter constructs, whereas the -0.61-kb construct was inactive. The -1.38-, -1.57-, and -2.12-kb constructs showed higher transcriptional activity, whereas only the -1.57- and -2.12-kb constructs exhibited repression of expression when the host cells were cultured on low stiffness substrate. Internal deletion of the segment between -1.57 and -1.38 kb in the -2.12-kb promoter construct abolished the low substrate stiffness-induced repression. Site-specific deletion or mutation of an HES-1 transcription factor binding site in this region also abolished this repression effect. The level of HES-1 increased in cells cultured under a low tension condition, corresponding to the down-regulation of h2-calponin. h2-Calponin gene expression is further affected by the treatment of cells with Notch inhibitor and activator, suggesting an upstream signaling mechanism.	[Jiang, Wen-rui; Cady, Geoffrey; Hossain, M. Moazzem; Huang, Qi-Quan; Wang, Xin; Jin, J. -P.] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL-086720]; China Scholarship Council [2008659010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-086720 ( to J. P. J.).; Recipient of a scholarship from the China Scholarship Council under File 2008659010. Ph.D. candidate at Tangdu Hospital, Fourth Military Medical University, China.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen J., 2011, ULTR S, V1, P1; Chow EK, 2006, J EXP MED, V203, P2589, DOI 10.1084/jem.20060929; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; de Cavanagh EMV, 2009, AM J PHYSIOL-HEART C, V296, pH550, DOI 10.1152/ajpheart.01176.2008; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; HAEBERLE JR, 1994, J BIOL CHEM, V269, P12424; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; HORIUCHI KY, 1991, BIOCHEM BIOPH RES CO, V176, P1487, DOI 10.1016/0006-291X(91)90455-G; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Hossain MM, 2003, AM J PHYSIOL-CELL PH, V284, pC156, DOI 10.1152/ajpcell.00233.2002; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Huang QQ, 1999, J MOL EVOL, V49, P780, DOI 10.1007/PL00006600; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kang J, 2011, J THEOR BIOL, V274, P109, DOI 10.1016/j.jtbi.2011.01.011; Kuromitsu J, 1997, MOL CELL BIOL, V17, P707, DOI 10.1128/MCB.17.2.707; Li J, 2008, MOL CELL BIOCHEM, V309, P41, DOI 10.1007/s11010-007-9641-0; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Masuda H, 1996, J BIOCHEM-TOKYO, V120, P415; Mikhailenko SV, 2010, J R SOC INTERFACE, V7, pS295, DOI 10.1098/rsif.2010.0107.focus; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2007, AM J PHYSIOL-CELL PH, V292, pC488, DOI 10.1152/ajpcell.00337.2005; NISHIDA W, 1993, GENE, V130, P297, DOI 10.1016/0378-1119(93)90435-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rayment I, 1996, STRUCTURE, V4, P501, DOI 10.1016/S0969-2126(96)00055-X; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; SHIRINSKY VP, 1992, J BIOL CHEM, V267, P15886; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; WINDER SJ, 1991, ADV EXP MED BIOL, V304, P37; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	51	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1617	1628		10.1074/jbc.M113.498147	http://dx.doi.org/10.1074/jbc.M113.498147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285540	Green Published, hybrid			2022-12-25	WOS:000332401700035
J	Field, DJ; Lynner, C; Brown, C; Darroch, SAF				Field, Daniel J.; Lynner, Colton; Brown, Christian; Darroch, Simon A. F.			Skeletal Correlates for Body Mass Estimation in Modern and Fossil Flying Birds	PLOS ONE			English	Article							PRIMARY FEATHER RACHISES; SIZE EVOLUTION; BONE STRENGTH; AMBOSELI PARK; MAMMALS; CONFUCIUSORNIS; ALLOMETRY; PATTERNS; ECOLOGY; GROWTH	Scaling relationships between skeletal dimensions and body mass in extant birds are often used to estimate body mass in fossil crown-group birds, as well as in stem-group avialans. However, useful statistical measurements for constraining the precision and accuracy of fossil mass estimates are rarely provided, which prevents the quantification of robust upper and lower bound body mass estimates for fossils. Here, we generate thirteen body mass correlations and associated measures of statistical robustness using a sample of 863 extant flying birds. By providing robust body mass regressions with upper- and lower-bound prediction intervals for individual skeletal elements, we address the longstanding problem of body mass estimation for highly fragmentary fossil birds. We demonstrate that the most precise proxy for estimating body mass in the overall dataset, measured both as coefficient determination of ordinary least squares regression and percent prediction error, is the maximum diameter of the coracoid's humeral articulation facet (the glenoid). We further demonstrate that this result is consistent among the majority of investigated avian orders (10 out of 18). As a result, we suggest that, in the majority of cases, this proxy may provide the most accurate estimates of body mass for volant fossil birds. Additionally, by presenting statistical measurements of body mass prediction error for thirteen different body mass regressions, this study provides a much-needed quantitative framework for the accurate estimation of body mass and associated ecological correlates in fossil birds. The application of these regressions will enhance the precision and robustness of many mass-based inferences in future paleornithological studies.	[Field, Daniel J.; Lynner, Colton; Brown, Christian; Darroch, Simon A. F.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Field, DJ (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	daniel.field@yale.edu	/AAD-1732-2020	Darroch, Simon/0000-0003-1922-7136; Field, Daniel/0000-0002-1786-0352	Sir James Lougheed Award of Distinction (masters and doctoral levels); Jurassic Foundation; Alexander Graham Bell Canada Graduate Scholarship; Yale Peabody Museum	Sir James Lougheed Award of Distinction (masters and doctoral levels); Jurassic Foundation; Alexander Graham Bell Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Yale Peabody Museum	DJF was supported by the Sir James Lougheed Award of Distinction (masters and doctoral levels), the Jurassic Foundation, and an Alexander Graham Bell Canada Graduate Scholarship. DJF and SAFD acknowledge the Yale Peabody Museum for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad'a Bellairs, 1960, SKELETON BIRDS BIOL, V1, P241; Ahlborn BK, 2000, J NON-EQUIL THERMODY, V25, P87, DOI 10.1515/JNETDY.2000.006; ALEXANDER RM, 1983, J ZOOL, V200, P215; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Alroy J, 2012, J VERTEBR PALEONTOL, V32, P55; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], 2012, BIOMETRY PRINCIPLES; [Anonymous], 2007, CRC HDB AVIAN BODY M, DOI [DOI 10.1201/9781420064452, DOI 10.1080/10888705.2011.527604]; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Behrensmeyer AK, 2003, PALEOBIOLOGY, V29, P52, DOI 10.1666/0094-8373(2003)029<0052:TAEOMA>2.0.CO;2; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; BIEWENER AA, 1982, J EXP BIOL, V98, P289; Blob RW, 1999, J EXP BIOL, V202, P1023; Brown J. H., 1995, MACROECOLOGY; Butler RJ, 2008, J EVOLUTION BIOL, V21, P1673, DOI 10.1111/j.1420-9101.2008.01594.x; Campbell Kenneth E. Jr, 1992, Natural History Museum of Los Angeles County Science Series, V36, P395; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chinsamy Anusuya, 2002, P421; Close RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036664; Cubo J, 1998, ANN SCI NAT ZOOL, V19, P51, DOI 10.1016/S0003-4339(98)80134-2; Elzanowski A, 2012, PALAEONTOLOGY, V55, P1199, DOI 10.1111/j.1475-4983.2012.01187.x; Elzanowski Andrzej, 2002, P129; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; Field DJ, 2013, J VERT PAL PROGR ABS, P126; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hinic-Frlog S, 2008, THESIS U CALIFORNIA; Hone DWE, 2008, J EVOLUTION BIOL, V21, P618, DOI 10.1111/j.1420-9101.2007.01483.x; Hope Sylvia, 2002, P339; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jones W, 2013, J PALEONTOL, V87, P151, DOI 10.1666/12-026R.1; KIRKWOOD JK, 1989, J ZOOL, V217, P403, DOI 10.1111/j.1469-7998.1989.tb02498.x; Koppelhus, 2005, DINOSAUR PROVINCIAL; Livezey Bradley C., 1993, Journal of Vertebrate Paleontology, V13, P185; LIVINGSTON SD, 1989, J ARCHAEOL SCI, V16, P537, DOI 10.1016/0305-4403(89)90072-1; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Longrich N, 2009, CRETACEOUS RES, V30, P161, DOI 10.1016/j.cretres.2008.06.007; Louchart A, 2011, NATURWISSENSCHAFTEN, V98, P357, DOI 10.1007/s00114-011-0771-6; Makovicky P. J., 2011, LIVING DINOSAURS EVO, P9, DOI DOI 10.1002/9781119990475.CH1; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Millien V, 2010, J MAMMAL, V91, P11, DOI 10.1644/08-MAMM-A-347R1.1; Mitchell JS, 2012, J VERT PAL PROGR ABS, P59; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Olmos M, 1996, ANN SCI NAT ZOOL, V17, P39; Paul GS, 2010, SCIENCE, V330, DOI 10.1126/science.1192963; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; R Development Core Team, 2011, R LANG ENV STAT COMP; RAYNER JMV, 1988, BIOL J LINN SOC, V34, P269, DOI 10.1111/j.1095-8312.1988.tb01963.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Whitlock M. C., 2009, ANAL BIOL DATA; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Zeffer A, 2003, BIOL J LINN SOC, V79, P461, DOI 10.1046/j.1095-8312.2003.00200.x; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x	64	79	82	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82000	10.1371/journal.pone.0082000	http://dx.doi.org/10.1371/journal.pone.0082000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312392	gold, Green Submitted, Green Published			2022-12-25	WOS:000327670300064
J	Jantzen, C; Schmidt, GM; Wild, C; Roder, C; Khokiattiwong, S; Richter, C				Jantzen, Carin; Schmidt, Gertraud M.; Wild, Christian; Roder, Cornelia; Khokiattiwong, Somkiat; Richter, Claudio			Benthic Reef Primary Production in Response to Large Amplitude Internal Waves at the Similan Islands (Andaman Sea, Thailand)	PLOS ONE			English	Article							PARTICULATE ORGANIC-MATTER; GREAT-BARRIER-REEF; EXTERNAL NUTRIENT RESOURCES; CORAL-REEF; PHASE-SHIFTS; SPATIAL HETEROGENEITY; PERMEABLE CARBONATE; COMMUNITY STRUCTURE; OXYGEN-CONSUMPTION; FLORIDA-KEYS	Coral reefs are facing rapidly changing environments, but implications for reef ecosystem functioning and important services, such as productivity, are difficult to predict. Comparative investigations on coral reefs that are naturally exposed to differing environmental settings can provide essential information in this context. One prevalent phenomenon regularly introducing alterations in water chemistry into coral reefs are internal waves. This study therefore investigates the effect of large amplitude internal waves (LAIW) on primary productivity in coral reefs at the Similan Islands (Andaman Sea, Thailand). The LAIW-exposed west sides of the islands are subjected to sudden drops in water temperature accompanied by enhanced inorganic nutrient concentrations compared to the sheltered east. At the central island, Ko Miang, east and west reefs are only few hundred meters apart, but feature pronounced differences. On the west lower live coral cover (-38 %) coincides with higher turf algae cover (+64 %) and growth (+54 %) compared to the east side. Turf algae and the reef sand-associated microphytobenthos displayed similar chlorophyll a contents on both island sides, but under LAIW exposure, turf algae exhibited higher net photosynthesis (+23 %), whereas the microphytobenthos displayed reduced net and gross photosynthesis (-19 % and -26 %, respectively) accompanied by lower respiration (-42 %). In contrast, the predominant coral Porites lutea showed higher chlorophyll a tissues contents (+42 %) on the LAIW-exposed west in response to lower light availability and higher inorganic nutrient concentrations, but net photosynthesis was comparable for both sides. Turf algae were the major primary producers on the west side, whereas microphytobenthos dominated on the east. The overall primary production rate (comprising all main benthic primary producers) was similar on both island sides, which indicates high primary production variability under different environmental conditions.	[Jantzen, Carin; Schmidt, Gertraud M.; Roder, Cornelia; Richter, Claudio] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Jantzen, Carin; Wild, Christian; Roder, Cornelia] Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Khokiattiwong, Somkiat] Phuket Marine Biol Ctr, Phuket 83000, Thailand	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Jantzen, C (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	carin.jantzen@awi.de	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896; Roder, Cornelia/0000-0003-1074-2473	German Research Foundation (DFG) [RI 1074/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Research was carried out as part of the Thai-German bilateral ORCAS (Ocean-Reef Coupling in the Andaman Sea) project and funded by the German Research Foundation (DFG, RI 1074/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala MLR, 1997, 8 INT COR REEF S, V2, P1452; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Apel JR, 2006, WHOI00604 OC I; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; BOROWITZKA MA, 1978, AQUAT BOT, V5, P365, DOI 10.1016/0304-3770(78)90077-3; BUNT JS, 1972, MAR BIOL, V16, P28, DOI 10.1007/BF00347844; CARPENTER RC, 1991, LIMNOL OCEANOGR, V36, P40, DOI 10.4319/lo.1991.36.1.0040; CARPENTER RC, 1985, LIMNOL OCEANOGR, V30, P784, DOI 10.4319/lo.1985.30.4.0784; CHANSANG H, 1999, MAPS CORAL REEFS THA, V2, P198; Clavier J, 1999, MAR ECOL PROG SER, V191, P79, DOI 10.3354/meps191079; Cook PLM, 2006, LIMNOL OCEANOGR, V51, P1594, DOI 10.4319/lo.2006.51.4.1594; CORTES J, 1984, REV BIOL TROP, V32, P109; Darwin CJ, 1842, CORAL REEFS; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; EDMUNDS PJ, 1988, CORAL REEFS, V7, P7, DOI 10.1007/BF00301975; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; GERKEMA T, 1995, J PHYS OCEANOGR, V25, P1081, DOI 10.1175/1520-0485(1995)025<1081:GONITA>2.0.CO;2; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; GORDON DC, 1971, PAC SCI, V25, P222; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; Grasshoff K, 1999, METHODS SEAWATER ANA; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; HANSEN JA, 1992, MAR BIOL, V113, P363, DOI 10.1007/BF00349160; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hatcher BG, 1997, CORAL REEFS, V16, pS77, DOI 10.1007/s003380050244; Hatcher BG, 1990, TREE, P149; Hearn CJ, 2001, CORAL REEFS, V20, P347, DOI 10.1007/s00338-001-0185-6; Helmuth BST, 1997, J EXP MAR BIOL ECOL, V209, P233, DOI 10.1016/S0022-0981(96)02687-1; Hodgson G., 2004, REEF CHECK INSTRUCTI; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUTHNANCE JM, 1989, GEOPHYS ASTRO FLUID, V48, P81, DOI 10.1080/03091928908219527; Hutter K, 2001, NUMERICAL EXPT BREAK, P1781; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jackson C R, 2004, ATLAS OCEANIC INTERN, P485; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kattner G, 1999, MAR CHEM, V67, P61, DOI 10.1016/S0304-4203(99)00049-3; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; KUHL M, 1994, MAR ECOL PROG SER, V105, P139, DOI 10.3354/meps105139; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Leletkin V. A., 2000, RUSSIAN, V26, P231, DOI DOI 10.1007/BF02759502; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McManus J., 1988, TECHNIQUES SEDIMENTO, P63; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Milne-Edwards H., 1851, ARCH MUSEUM HIST NAT, V5, P1; Miyajima T, 2001, MAR ECOL PROG SER, V217, P273, DOI 10.3354/meps217273; MORELOCK J, 1983, J SEDIMENT PETROL, V53, P371; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; ODUM EP, 1968, AM ZOOL, V8, P11; OSBORNE AR, 1980, SCIENCE, V208, P451, DOI 10.1126/science.208.4443.451; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PERRY RB, 1965, J GEOPHYS RES, V70, P2319, DOI 10.1029/JZ070i010p02319; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Phongsuwan N, 2008, 10 YEARS BLEACHING F; PINEDA J, 1991, SCIENCE, V253, P548, DOI 10.1126/science.253.5019.548; Ralph PJ, 2002, MAR BIOL, V141, P639, DOI 10.1007/s00227-002-0866-x; Rasheed M, 2006, CHEM ECOL, V22, P13, DOI 10.1080/02757540500456823; Rasheed M, 2004, ESTUAR COAST SHELF S, V59, P139, DOI 10.1016/j.ecss.2003.08.013; Rasheed M, 2003, CORAL REEFS, V22, P167, DOI 10.1007/s00338-003-0300-y; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Roder C, 2010, MAR ECOL PROG SER, V412, P113, DOI 10.3354/meps08707; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1981, J EXP MAR BIOL ECOL, V49, P179, DOI 10.1016/0022-0981(81)90069-1; Rusch A, 2000, ESTUAR COAST SHELF S, V51, P399, DOI 10.1006/ecss.2000.0687; Rusch A, 2006, AQUAT GEOCHEM, V12, P1, DOI 10.1007/s10498-005-0784-x; Schlacher TA, 1998, MAR ECOL PROG SER, V174, P159, DOI 10.3354/meps174159; Schlichting E., 1995, BODENKUNDLICHES PRAK; Schmidt GM, 2012, MAR ECOL PROG SER, V456, P113, DOI 10.3354/meps09682; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Smith JE, 2004, LIMNOL OCEANOGR, V49, P1923, DOI 10.4319/lo.2004.49.6.1923; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; SOURNIA A, 1976, HELGOLAND WISS MEER, V28, P401, DOI 10.1007/BF01610589; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; TITLYANOV EA, 1991, HYDROBIOLOGIA, V216, P383, DOI 10.1007/BF00026490; Vlasenko V, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004107; Webster I. T., 2001, BENTHIC BOUNDARY LAY; Wild C, 2006, MAR FRESHWATER RES, V57, P415, DOI 10.1071/MF05205; Wild C, 2005, MAR ECOL PROG SER, V298, P69, DOI 10.3354/meps298069; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; WILLIAMS SL, 1988, MAR ECOL PROG SER, V47, P145, DOI 10.3354/meps047145	92	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81834	10.1371/journal.pone.0081834	http://dx.doi.org/10.1371/journal.pone.0081834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312365	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300053
J	Ralph, AP; Kenangalem, E; Waramori, G; Pontororing, GJ; Sandjaja; Tjitra, E; Maguire, GP; Kelly, PM; Anstey, NM				Ralph, Anna P.; Kenangalem, Enny; Waramori, Govert; Pontororing, Gysje J.; Sandjaja; Tjitra, Emiliana; Maguire, Graeme P.; Kelly, Paul M.; Anstey, Nicholas M.			High Morbidity during Treatment and Residual Pulmonary Disability in Pulmonary Tuberculosis: Under-Recognised Phenomena	PLOS ONE			English	Article							GEORGES RESPIRATORY QUESTIONNAIRE; 6-MINUTE WALK TEST; QUALITY-OF-LIFE; ANTITUBERCULOSIS DRUGS; PAPUA PROVINCE; LUNG-FUNCTION; HEALTH-STATUS; INDONESIA; BURDEN; IMPAIRMENT	Background: In pulmonary tuberculosis (PTB), morbidity during treatment and residual pulmonary disability can be under-estimated. Methods: Among adults with smear-positive PTB at an outpatient clinic in Papua, Indonesia, we assessed morbidity at baseline and during treatment, and 6-month residual disability, by measuring functional capacity (six-minute walk test [6MWT] and pulmonary function), quality of life (St George's Respiratory Questionnaire [SGRQ]) and Adverse Events ([AE]: new symptoms not present at outset). Results were compared with findings in locally-recruited volunteers. Results: 200 PTB patients and 40 volunteers were enrolled. 6WMT was 497m (interquartile range 460-529) in controls versus 408m (IQR 346-450) in PTB patients at baseline (p<0.0001) and 470m (IQR 418-515) in PTB patients after 6 months (p=0.02 versus controls). SGRQ total score was 0 units (IQR 0-2.9) in controls, versus 36.9 (27.4-52.8) in PTB patients at baseline (p<0.0001) and 4.3 (1.7-8.8) by 6 months (p<0.0001). Mean percentage of predicted FEV1 was 92% (standard deviation 19.9) in controls, versus 63% (19.4) in PTB patients at baseline (p<0.0001) and 71% (17.5) by 6 months (p<0.0001). After 6 months, 27% of TB patients still had at least moderate-severe pulmonary function impairment, and 57% still had respiratory symptoms, despite most achieving 'successful' treatment outcomes, and reporting good quality of life. More-advanced disease at baseline (longer illness duration, worse baseline X-ray) and HIV positivity predicted residual disability. AE at any time during treatment were common: itch 59%, arthralgia 58%, headache 40%, nausea 33%, vomiting 16%. Conclusion: We found high 6-month residual pulmonary disability and high AE rates. Although PTB treatment is highly successful, the extent of morbidity during treatment and residual impairment could be overlooked if not specifically sought. Calculations of PTB-related burden of disease should acknowledge that TB-related morbidity does not stop at 6 months. Early case detection and treatment are key in minimising residual impairment.	[Ralph, Anna P.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia; [Ralph, Anna P.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Ralph, Anna P.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Dept Infect Dis, Darwin, NT, Australia; [Kenangalem, Enny; Pontororing, Gysje J.] NIH, Menzies Sch Hlth Res, Res & Dev Res Program, Timika, Papua Province, Indonesia; [Kenangalem, Enny] Dist Hlth Author, Timika, Papua Province, Indonesia; [Waramori, Govert] PT Freeport Indonesia, Publ Hlth & Malaria Control Dept, Timika, Papua Province, Indonesia; [Sandjaja; Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Maguire, Graeme P.] Baker IDI Heart & Diabet Inst, Alice Springs, NT, Australia; [Maguire, Graeme P.] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Kelly, Paul M.] ACT Govt Hlth Directorate, Populat Hlth Div, Canberra, ACT, Australia; [Kelly, Paul M.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Freeport Indonesia; National Institute of Health Research & Development - Indonesia; Baker Heart and Diabetes Institute; James Cook University; Australian National University	Ralph, AP (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia.	anna.ralph@menzies.edu.au	Ralph, Anna/AAB-6103-2021		Australian Respiratory Council; Royal Australasian College of Physicians; National Health and Medical Research Council (NHMRC) of Australia [605806, 496600]; NHMRC Practitioner Fellowship; Margaret Ross Chair in Indigenous Health	Australian Respiratory Council; Royal Australasian College of Physicians(General Electric); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Margaret Ross Chair in Indigenous Health	The study received funding from the Australian Respiratory Council, Royal Australasian College of Physicians (Covance Award to APR), National Health and Medical Research Council (NHMRC) of Australia (Grants 605806 and 496600, a scholarship to APR, and fellowships to APR, TWY, PMK, NMA). Graeme Maguire is supported by an NHMRC Practitioner Fellowship and the Margaret Ross Chair in Indigenous Health. Views expressed in this publication are those of the authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2013, ST GEORG RESP QUEST; Ardian M, 2007, INT J TUBERC LUNG D, V11, P1101; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Erhabor GE, 2008, CHEST, V134; Ferrer M, 2002, EUR RESPIR J, V19, P405, DOI 10.1183/09031936.02.00213202; Forde Y., 2009, ST GEORGES RESP QUES; Global Initiative for Chronic Obstructive Lung Disease, 2013, POCK GUID COPD DIAGN; Gulbay BE, 2006, RESP MED, V100, P1834, DOI 10.1016/j.rmed.2006.01.014; Handojo Tjandra, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P571; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kenangalem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076077; Kesehatan Departemen Republik Indonesia, 2007, NAS PED PEND TUB; Kunst H, 2010, INT J TUBERC LUNG D, V14, P1374; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pasipanodya JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-259; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Pontororing GJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-362; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070032; Ralph AP, 2013, J INFECT DIS, V208, P616, DOI 10.1093/infdis/jit248; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Ruslami R, 2007, ANTIMICROB AGENTS CH, V51, P2546, DOI 10.1128/AAC.01550-06; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026; Statistics Indonesia and the Ministry of Health, 2006, RISK BEH HIV PREV TA; Stevens D, 1999, AM J RESP CRIT CARE, V160, P1540, DOI 10.1164/ajrccm.160.5.9808139; Therapeutic Goods Administration, 2000, NOT GUID GOOD CLIN P; World Health Organisation, 2002, WHOCDSTB2002308; World Health Organisation, 2011, METH US EST BURD DIS; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	46	51	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80302	10.1371/journal.pone.0080302	http://dx.doi.org/10.1371/journal.pone.0080302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312209	Green Published, Green Accepted, gold			2022-12-25	WOS:000327670300009
J	Vieira, MC; Cianciaruso, MV; Almeida-Neto, M				Vieira, Marcos Costa; Cianciaruso, Marcus Vinicius; Almeida-Neto, Mario			Plant-Pollinator Coextinctions and the Loss of Plant Functional and Phylogenetic Diversity	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; ECOSYSTEM-FUNCTION; COMMUNITY ECOLOGY; BIODIVERSITY LOSS; STRATEGY SCHEME; EXTINCTION; RESTORATION; ROBUSTNESS; SPECIALIZATION; PATTERNS	Plant-pollinator coextinctions are likely to become more frequent as habitat alteration and climate change continue to threaten pollinators. The consequences of the resulting collapse of plant communities will depend partly on how quickly plant functional and phylogenetic diversity decline following pollinator extinctions. We investigated the functional and phylogenetic consequences of pollinator extinctions by simulating coextinctions in seven plant-pollinator networks coupled with independent data on plant phylogeny and functional traits. Declines in plant functional diversity were slower than expected under a scenario of random extinctions, while phylogenetic diversity often decreased faster than expected by chance. Our results show that plant functional diversity was relatively robust to plant-pollinator coextinctions, despite the underlying rapid loss of evolutionary history. Thus, our study suggests the possibility of uncoupled responses of functional and phylogenetic diversity to species coextinctions, highlighting the importance of considering both dimensions of biodiversity explicitly in ecological studies and when planning for the conservation of species and interactions.	[Vieira, Marcos Costa] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Cianciaruso, Marcus Vinicius; Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Vieira, MC (corresponding author), Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	markoz.vieira@gmail.com	Cianciaruso, Marcus V/B-9509-2012; Almeida-Neto, M./A-6389-2009	Cianciaruso, Marcus V/0000-0001-5866-5345; Almeida-Neto, M./0000-0002-2161-2968	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq [306843/2012-9, 306870/2012-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MCV is supported by a graduate scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br). MVC and MAN received research fellowships (306843/2012-9 and 306870/2012-6, respectively) from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cianciaruso MV, 2012, PERSPECT PLANT ECOL, V14, P205, DOI 10.1016/j.ppees.2011.11.004; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Diniz JAF, 2012, GENET MOL BIOL, V35, P673, DOI 10.1590/S1415-47572012005000053; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Durka W., 2012, Ecology, V93, P2297, DOI 10.1890/12-0743.1; Duru M, 2010, ANN BOT-LONDON, V106, P823, DOI 10.1093/aob/mcq178; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Golodets C, 2009, J VEG SCI, V20, P392, DOI 10.1111/j.1654-1103.2009.01071.x; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Junker RR, 2010, J ANIM ECOL, V79, P818, DOI 10.1111/j.1365-2656.2010.01698.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Laughlin DC, 2010, FUNCT ECOL, V24, P493, DOI 10.1111/j.1365-2435.2009.01672.x; Lavergne S, 2003, ECOL LETT, V6, P398, DOI 10.1046/j.1461-0248.2003.00456.x; Liancourt P, 2009, BASIC APPL ECOL, V10, P707, DOI 10.1016/j.baae.2009.05.003; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya D, 2012, TRENDS ECOL EVOL, V27, P666, DOI 10.1016/j.tree.2012.07.004; O'Gorman EJ, 2011, P ROY SOC B-BIOL SCI, V278, P1886, DOI 10.1098/rspb.2010.2036; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Quijas S, 2010, BASIC APPL ECOL, V11, P582, DOI 10.1016/j.baae.2010.06.009; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rangel TFLVB, 2013, PAM PHYLOGENETIC ANA; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Trindade J, 2012, BIOL CONSERV, V146, P155, DOI 10.1016/j.biocon.2011.12.004; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Weiner CN, 2011, BASIC APPL ECOL, V12, P292, DOI 10.1016/j.baae.2010.08.006; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	64	18	18	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81242	10.1371/journal.pone.0081242	http://dx.doi.org/10.1371/journal.pone.0081242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312281	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300030
J	Winandy, L; Denoel, M				Winandy, Laurane; Denoel, Mathieu			Introduced Goldfish Affect Amphibians through Inhibition of Sexual Behaviour in Risky Habitats: an Experimental Approach	PLOS ONE			English	Article							ALTERNATIVE MATING TACTICS; NEWT TRITURUS-ALPESTRIS; PREDATION RISK; ALPINE NEWT; ANTIPREDATOR BEHAVIOR; TEMPORAL VARIATION; CARASSIUS-AURATUS; FORAGING BEHAVIOR; ALIEN PREDATORS; MOUNTAIN LAKES	The introduction of alien species is one of the major causes of current and global biodiversity loss. The introduction of fish can be a particular threat to native amphibian populations, which are declining worldwide. One way for amphibians to persist in such altered environments is to adopt anti-predator strategies especially at the behavioural level. However, although it has been shown that avoidance behaviour may decrease the probability of being detected by a potential predator, little is known on the consequences on sexual behaviour. In this study, we tested the hypothesis that adult Alpine newts (Ichthyosaura alpestris) use shelters more often and exhibit less sexual activity in the presence of goldfish (Carassius auratus) and that they reduce sexual activity more in risky micro-habitats than in safe environments. To this end, we assessed behavioural patterns of adult newts in a replicated laboratory design. Goldfish were present in direct contact with newts in half of the tanks. Consistently throughout the study period, significantly more newts used shelter in the presence of fish than in their absence. Newts also significantly decreased their sexual activity level overall, but specially outside the shelter when they were in direct contact with fish. These results show that fish presence can affect newts in complex ways, such as through inhibition of their reproduction. Our work highlights that integrating behaviour in conservation studies is essential to understanding the patterns of coexistence and exclusion between introduced fish and amphibians.	[Winandy, Laurane; Denoel, Mathieu] Univ Liege, Dept Biol Ecol & Evolut, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium	University of Liege	Winandy, L (corresponding author), Univ Liege, Dept Biol Ecol & Evolut, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium.	laurane.winandy@ulg.ac.be; Mathieu.Denoel@ulg.ac.be		Winandy, Laurane/0000-0001-6255-2503; Denoel, Mathieu/0000-0002-3586-8323	Fonds de la Recherche Scientifique - FNRS [1.5.040.10, J.0008.13]; University of Liege under Fonds Speciaux pour la Recherche [C11/23]; "non-fria" grants	Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege under Fonds Speciaux pour la Recherche; "non-fria" grants	Laurane Winandy and Mathieu Denoel are a Research Fellow and a Research Associate, respectively, of the Fonds de la Recherche Scientifique-FNRS. This work was supported by the Fonds de la Recherche Scientifique - FNRS under grants 1.5.040.10 and J.0008.13 and by the University of Liege under Fonds Speciaux pour la Recherche C11/23 and "non-fria" grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060916; Beisel JN, 2001, ETHOL ECOL EVOL, V13, P193; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Brana F, 1996, HERPETOL J, V6, P145; Brown Grant E., 2005, P34; Brzezinski M, 2012, BIOL CONSERV, V147, P68, DOI 10.1016/j.biocon.2011.11.012; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Davis DR, 2012, ETHOLOGY, V118, P1191, DOI 10.1111/eth.12025; de Queiroz A, 2006, AM NAT, V167, P684, DOI 10.1086/503118; Denoel M, 2001, J HERPETOL, V35, P62, DOI 10.2307/1566024; Denoel M, 2005, CONSERV BIOL, V19, P162, DOI 10.1111/j.1523-1739.2005.00001.x; Denoel M, 2002, BEHAV ECOL SOCIOBIOL, V52, P394, DOI 10.1007/s00265-002-0526-7; Denoel M, 2001, ARCH HYDROBIOL, V152, P661; Denoel M, 2001, ANIM BEHAV, V62, P559, DOI 10.1006/anbe.2001.1793; Denoel M, 2001, FRESHWATER BIOL, V46, P1387, DOI 10.1046/j.1365-2427.2001.00762.x; Denoel M, 2009, BIOL CONSERV, V142, P509, DOI 10.1016/j.biocon.2008.11.008; Denoel M, 2008, AQUAT CONSERV, V18, P714, DOI 10.1002/aqc.853; Denoel M, 2006, BIOL CONSERV, V130, P495, DOI 10.1016/j.biocon.2006.01.009; Denoel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062727; Denoel M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1171, DOI 10.1007/s00265-010-0933-0; Dill LM, 1999, BEHAV ECOL, V10, P452, DOI 10.1093/beheco/10.4.452; Eccard JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003438; Epp KJ, 2008, ETHOLOGY, V114, P607, DOI 10.1111/j.1439-0310.2008.01494.x; Ficetola GF, 2011, DIVERS DISTRIB, V17, P1141, DOI 10.1111/j.1472-4642.2011.00797.x; Figueira WF, 2007, ANIM BEHAV, V74, P329, DOI 10.1016/j.anbehav.2006.12.010; Francis RA, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P1; Gall BG, 2010, ETHOLOGY, V116, P47, DOI 10.1111/j.1439-0310.2009.01718.x; Gamradt SC, 1996, CONSERV BIOL, V10, P1155, DOI 10.1046/j.1523-1739.1996.10041155.x; Gamradt SC, 1997, CONSERV BIOL, V11, P793, DOI 10.1046/j.1523-1739.1997.96230.x; Gherardi F, 2010, REV SCI TECH OIE, V29, P241, DOI 10.20506/rst.29.2.1973; Grayson KL, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-24; Hecnar SJ, 1997, BIOL CONSERV, V79, P123, DOI 10.1016/S0006-3207(96)00113-9; HORAT P, 1994, BEHAV ECOL SOCIOBIOL, V34, P393, DOI 10.1007/BF00167330; Indermaur L, 2010, ECOGRAPHY, V33, P887, DOI 10.1111/j.1600-0587.2010.06150.x; JEFFRIES M, 1994, FRESHWATER BIOL, V32, P603, DOI 10.1111/j.1365-2427.1994.tb01151.x; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Leahy SM, 2011, BIOL LETTERS, V7, P811, DOI 10.1098/rsbl.2011.0645; Leu T, 2009, AMPHIBIA-REPTILIA, V30, P290, DOI 10.1163/156853809788201153; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1992, BEHAV ECOL SOCIOBIOL, V30, P283, DOI 10.1007/BF00166714; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Martin Bateson, 2007, MEASURING BEHAV INTR; Mathis A, 2003, ETHOLOGY, V109, P159, DOI 10.1046/j.1439-0310.2003.00849.x; Mathis A, 2012, ETHOLOGY, V118, P57, DOI 10.1111/j.1439-0310.2011.01987.x; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Mirza RS, 2006, ETHOLOGY, V112, P44, DOI 10.1111/j.1439-0310.2006.01111.x; Monello RJ, 2001, J HERPETOL, V35, P350, DOI 10.2307/1566132; Monello RJ, 1999, J HERPETOL, V33, P298, DOI 10.2307/1565727; Orizaola G, 2006, ANIM CONSERV, V9, P171, DOI 10.1111/j.1469-1795.2006.00023.x; Orizaola G, 2003, HERPETOL J, V13, P189; Orizaola G, 2003, CAN J ZOOL, V81, P1845, DOI 10.1139/Z03-160; Pearson KJ, 2009, CAN J ZOOL, V87, P948, DOI 10.1139/Z09-084; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; RICHARDSON MJ, 1995, J FISH BIOL, V47, P576, DOI 10.1111/j.1095-8649.1995.tb01924.x; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; Rohr JR, 2001, ANIM BEHAV, V62, P863, DOI 10.1006/anbe.2001.1816; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Savini D, 2010, J APPL ICHTHYOL, V26, P1, DOI 10.1111/j.1439-0426.2010.01503.x; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sih A, 2010, INTEGR COMP BIOL, V50, P934, DOI 10.1093/icb/icq148; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Smith GR, 2008, BIOL INVASIONS, V10, P743, DOI 10.1007/s10530-007-9166-1; Smith GR, 2008, ETHOLOGY, V114, P701, DOI 10.1111/j.1439-0310.2008.01505.x; Sorato E, 2012, ANIM BEHAV, V84, P823, DOI 10.1016/j.anbehav.2012.07.003; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuart-Smith RD, 2008, ENVIRON BIOL FISH, V82, P93, DOI 10.1007/s10641-007-9256-z; Takahara T, 2003, ECOL RES, V18, P793, DOI 10.1111/j.1440-1703.2003.00598.x; Teplitsky C, 2003, OECOLOGIA, V134, P270, DOI 10.1007/s00442-002-1106-2; Tiberti R, 2012, AMPHIBIA-REPTILIA, V33, P303, DOI 10.1163/156853812X634044; UZENDOSKI K, 1993, BEHAV ECOL SOCIOBIOL, V32, P421, DOI 10.1007/BF00168826; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Watson RT, 2004, BEHAV PROCESS, V65, P201, DOI 10.1016/j.beproc.2003.09.007; Winandy L, 2013, ETHOLOGY, V119, P121, DOI 10.1111/eth.12043; Winandy L, 2011, BEHAV RES METHODS, V43, P568, DOI 10.3758/s13428-011-0058-z; Wissinger SA, 2010, ECOLOGY, V91, P549, DOI 10.1890/08-1366.1; Woody DR, 1997, J HERPETOL, V31, P316, DOI 10.2307/1565407	87	20	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82736	10.1371/journal.pone.0082736	http://dx.doi.org/10.1371/journal.pone.0082736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312432	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300085
J	Bargsten, JW; Folta, A; Mlynarova, L; Nap, JP				Bargsten, Joachim W.; Folta, Adam; Mlynarova, Ludmila; Nap, Jan-Peter			Snf2 Family Gene Distribution in Higher Plant Genomes Reveals DRD1 Expansion and Diversification in the Tomato Genome	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; POL-IVB; SEQUENCE; CHROMATIN; PROTEINS; DATABASE; SUBFAMILIES; TRANSCRIPTS; EXPRESSION; GENERATION	As part of large protein complexes, Snf2 family ATPases are responsible for energy supply during chromatin remodeling, but the precise mechanism of action of many of these proteins is largely unknown. They influence many processes in plants, such as the response to environmental stress. This analysis is the first comprehensive study of Snf2 family ATPases in plants. We here present a comparative analysis of 1159 candidate plant Snf2 genes in 33 complete and annotated plant genomes, including two green algae. The number of Snf2 ATPases shows considerable variation across plant genomes (17-63 genes). The DRD1, Rad5/16 and Snf2 subfamily members occur most often. Detailed analysis of the plant-specific DRD1 subfamily in related plant genomes shows the occurrence of a complex series of evolutionary events. Notably tomato carries unexpected gene expansions of DRD1 gene members. Most of these genes are expressed in tomato, although at low levels and with distinct tissue or organ specificity. In contrast, the Snf2 subfamily genes tend to be expressed constitutively in tomato. The results underpin and extend the Snf2 subfamily classification, which could help to determine the various functional roles of Snf2 ATPases and to target environmental stress tolerance and yield in future breeding.	[Bargsten, Joachim W.; Nap, Jan-Peter] Univ Wageningen & Res Ctr, Plant Res Int, Wageningen, Netherlands; [Bargsten, Joachim W.] NBIC, Nijmegen, Netherlands; [Bargsten, Joachim W.] Univ Wageningen & Res Ctr, Lab Plant Breeding, Wageningen, Netherlands; [Folta, Adam; Mlynarova, Ludmila] Univ Wageningen & Res Ctr, Mol Biol Lab, Wageningen, Netherlands; [Mlynarova, Ludmila; Nap, Jan-Peter] CBSG2012, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Nap, JP (corresponding author), Univ Wageningen & Res Ctr, Plant Res Int, Wageningen, Netherlands.	janpeter.nap@wur.nl		Folta, Adam/0000-0001-6509-6902	BioRange program of the Netherlands Bioinformatics Centre (NBIC); BSIK grant through the Netherlands Genomics Initiative (NGI); bioinformatics and biostatistics program of the Centre for BioSystems Genomics [CBSG2012]	BioRange program of the Netherlands Bioinformatics Centre (NBIC); BSIK grant through the Netherlands Genomics Initiative (NGI); bioinformatics and biostatistics program of the Centre for BioSystems Genomics	This work was supported by the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI), and by the bioinformatics and biostatistics program of the Centre for BioSystems Genomics (CBSG2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ba ANN, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002515; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bezhani S, 2007, PLANT CELL, V19, P403, DOI 10.1105/tpc.106.048272; Bolanos-Garcia VM, 2012, PHILOS T R SOC A, V370, P3023, DOI 10.1098/rsta.2011.0268; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Knizewski L, 2008, TRENDS PLANT SCI, V13, P557, DOI 10.1016/j.tplants.2008.08.004; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lall S, 2011, NAT STRUCT MOL BIOL, V18, P865, DOI 10.1038/nsmb0811-865; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XY, 2011, BIOL PLANTARUM, V55, P625, DOI 10.1007/s10535-011-0160-1; Lopez A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002434; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mahfouz MM, 2010, PLANT SIGNAL BEHAV, V5, P806, DOI 10.4161/psb.5.7.11695; Matzke M, 2006, COLD SPRING HARB SYM, V71, P449, DOI 10.1101/sqb.2006.71.028; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Sang Y, 2012, PLANT J, DOI [10.1111/tpj.12009, DOI 10.1111/TPJ.12009.PUBMED:23062007]; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vos RA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-63; Walley JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000237; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	61	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81147	10.1371/journal.pone.0081147	http://dx.doi.org/10.1371/journal.pone.0081147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312269	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900022
J	Nakanishi, K; Narimatsu, S; Ichikawa, S; Tobisawa, Y; Kurohane, K; Niwa, Y; Kobayashi, H; Imai, Y				Nakanishi, Katsuhiro; Narimatsu, Sanshiro; Ichikawa, Shiori; Tobisawa, Yuki; Kurohane, Kohta; Niwa, Yasuo; Kobayashi, Hirokazu; Imai, Yasuyuki			Production of Hybrid-IgG/IgA Plantibodies with Neutralizing Activity against Shiga Toxin 1	PLOS ONE			English	Article							ESCHERICHIA-COLI; MONOCLONAL-ANTIBODY; IMMUNOGLOBULIN-A; BINDING; VACCINE; CHAIN; ARABIDOPSIS; INFECTIONS; APOPTOSIS; PROTECTS	Shiga toxin 1 (Stx1) is a virulence factor of enterohemorrhagic Escherichia coli, such as the O157:H7 strain. In the intestines, secretory IgA (SIgA) is a major component of the immune defense against pathogens and toxins. To form SIgA, the production of dimeric IgA that retains biological activity is an important step. We previously established hybrid-IgG/IgA having variable regions of the IgG specific for the binding subunit of Stx1 (Stx1B) and the heavy chain constant region of IgA. If hybrid-IgG/IgA cDNAs can be expressed in plants, therapeutic or preventive effects may be expected in people eating those plants containing a "plantibody". Here, we established transgenic Arabidopsis thaliana expressing dimeric hybrid-IgG/IgA. The heavy and light chain genes were placed under the control of a bidirectional promoter and terminator of the chlorophyll a/b-binding protein of Arabidopsis thaliana (expression cassette). This expression cassette and the J chain gene were subcloned into a single binary vector, which was then introduced into A. thaliana by means of the Agrobacterium method. Expression and assembly of the dimeric hybrid-IgG/IgA in plants were revealed by ELISA and immunoblotting. The hybrid-IgG/IgA bound to Stx1B and inhibited Stx1B binding to Gb(3), as demonstrated by ELISA. When Stx1 holotoxin was pre-treated with the resulting plantibody, the cytotoxicity of Stx1 was inhibited. The toxin neutralization was also demonstrated by means of several assays including Stx1-induced phosphatidylserine translocation on the plasma membrane, caspase-3 activation and 180 base-pair DNA ladder formation due to inter-nucleosomal cleavage. These results indicate that edible plants containing hybrid-IgG/IgA against Stx1B have the potential to be used for immunotherapy against Stx1-caused food poisoning.	[Nakanishi, Katsuhiro; Narimatsu, Sanshiro; Ichikawa, Shiori; Tobisawa, Yuki; Kurohane, Kohta; Imai, Yasuyuki] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka, Shizuoka, Japan; [Niwa, Yasuo; Kobayashi, Hirokazu] Univ Shizuoka, Grad Div Nutrit & Environm Sci, Lab Plant Mol Improvement, Shizuoka, Shizuoka, Japan; [Kurohane, Kohta; Niwa, Yasuo; Kobayashi, Hirokazu; Imai, Yasuyuki] Univ Shizuoka, Grad Program Pharmaceut & Nutrit Sci, Shizuoka, Shizuoka, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka	Imai, Y (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka, Shizuoka, Japan.	imai@u-shizuoka-ken.ac.jp	Imai, Yasuyuki/E-8701-2010; Kobayashi, Hirokazu/E-7903-2010; Tobisawa, Yuki/G-3802-2014	Imai, Yasuyuki/0000-0002-8937-0221; Kobayashi, Hirokazu/0000-0002-8040-0826; Tobisawa, Yuki/0000-0001-8026-9541	Japan Society for the Promotion of Science [16590055, 23659067, 25670063]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by a grant-in-aid (16590055, 23659067, 25670063) and by research funding for the Global COE Program from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, BIOSCI BIOTECH BIOCH, V73, P936, DOI 10.1271/bbb.80725; Batard Y, 2000, ARCH BIOCHEM BIOPHYS, V379, P161, DOI 10.1006/abbi.2000.1867; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; Daniell H, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-33; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Duc M, 2010, J BIOL CHEM, V285, P953, DOI 10.1074/jbc.M109.059220; Farid SS, 2007, J CHROMATOGR B, V848, P8, DOI 10.1016/j.jchromb.2006.07.037; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hadlington JL, 2003, MOL BIOL CELL, V14, P2592, DOI 10.1091/mbc.E02-11-0771; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; Hood EE, 2002, CURR OPIN BIOTECH, V13, P630, DOI 10.1016/S0958-1669(02)00351-8; HOVDE CJ, 1988, P NATL ACAD SCI USA, V85, P2568, DOI 10.1073/pnas.85.8.2568; Imai Y, 2005, J IMMUNOL METHODS, V302, P125, DOI 10.1016/j.jim.2005.05.007; Imai Y, 2002, IMMUNOLOGY, V105, P509, DOI 10.1046/j.1365-2567.2002.01373.x; Ito Y, 2001, GENESIS, V30, P231, DOI 10.1002/gene.1069; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Juarez P, 2012, PLANT BIOTECHNOL J, V10, P341, DOI 10.1111/j.1467-7652.2011.00666.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; Lim S, 2011, PLANT MOL BIOL, V76, P335, DOI 10.1007/s11103-011-9745-5; LINDH E, 1975, J IMMUNOL, V114, P284; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; MANGENEY M, 1993, CANCER RES, V53, P5314; McCloskey N, 1999, EUR J IMMUNOL, V29, P3236, DOI 10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mitra A, 2009, PLANTA, V229, P1015, DOI 10.1007/s00425-008-0859-1; Miyashita S, 1999, GLYCOCONJUGATE J, V16, P697, DOI 10.1023/A:1007107425891; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Oliveira M, 2012, INT J FOOD MICROBIOL, V156, P133, DOI 10.1016/j.ijfoodmicro.2012.03.014; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; Sekino T, 2004, MICROBIOL IMMUNOL, V48, P377, DOI 10.1111/j.1348-0421.2004.tb03527.x; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Taguchi T, 1998, KIDNEY INT, V53, P1681, DOI 10.1046/j.1523-1755.1998.00939.x; Tanikawa T, 2008, SCAND J IMMUNOL, V68, P414, DOI 10.1111/j.1365-3083.2008.02153.x; Tobisawa Y, 2011, SCAND J IMMUNOL, V74, P574, DOI 10.1111/j.1365-3083.2011.02617.x; Travis J, 2008, SCIENCE, V320, P473, DOI 10.1126/science.320.5875.473; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877	47	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80712	10.1371/journal.pone.0080712	http://dx.doi.org/10.1371/journal.pone.0080712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312238	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900014
J	Tanksley, JP; Chen, X; Coffey, RJ				Tanksley, Jarred P.; Chen, Xi; Coffey, Robert J.			NEDD4L Is Downregulated in Colorectal Cancer and Inhibits Canonical WNT Signaling	PLOS ONE			English	Article							UBIQUITIN LIGASE; TGF-BETA; COLON-CANCER; EXPRESSION; DEGRADATION; MUTATIONS; PROGNOSIS; CATENIN; DEATH	The NEDD4 family of E3 ubiquitin ligases includes nine members. Each is a modular protein, containing an N-terminal C2 domain for cell localization, two-to-four central WW domains for substrate recognition, and a C-terminal, catalytic HECT domain, which is responsible for catalyzing the ubiquitylation reaction. Members of this family are known to affect pathways central to the pathogenesis of colorectal cancer, including the WNT, TGF beta, EGFR, and p53 pathways. Recently, NEDD4 mRNA was reported to be overexpressed in colorectal cancer, but tumor stage was not considered in the analysis. Expression of the other family members has not been studied in colorectal cancer. Herein, we determined the expression patterns of all nine NEDD4 family members in 256 patients who presented with disease ranging from premalignant adenoma to stage IV colorectal cancer. NEDD4 mRNA was significantly increased in all stages of colorectal cancer. In contrast, NEDD4L mRNA, the closest homolog to NEDD4, was the most highly downregulated family member, and was significantly downregulated in all tumor stages. We also found NEDD4L protein was significantly decreased by western blotting in colorectal cancer samples compared to adjacent normal mucosa. In addition, NEDD4L, but not catalytically inactive NEDD4L, inhibited canonical WNT signaling at or below the level of beta-catenin in vitro. These findings suggest that NEDD4L may play a tumor suppressive role in colorectal cancer, possibly through inhibition of canonical WNT signaling.	[Tanksley, Jarred P.; Coffey, Robert J.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Chen, Xi] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Coffey, Robert J.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Coffey, Robert J.] Vanderbilt Univ, Dept Vet Affairs Med Ctr, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Coffey, RJ (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	robert.coffey@vanderbilt.edu			 [NCIP5095103];  [RO1CA46413];  [GM007347];  [RO1CA158472]; NATIONAL CANCER INSTITUTE [R01CA158472, R01CA046413, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Jarred Tanksley was supported by NCIP5095103, RO1CA46413, and GM007347. Xi Chen was supported by RO1CA158472. Robert J. Coffey was supported by NCIP5095103 and RO1CA46413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; Fukasawa H, 2010, INT J CANCER, V127, P1517, DOI 10.1002/ijc.25164; Fukuchi M, 2002, CANCER RES, V62, P7162; Gao CC, 2012, MED ONCOL, V29, P1733, DOI 10.1007/s12032-011-0061-3; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007982; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; He SM, 2012, JPN J CLIN ONCOL, V42, P196, DOI 10.1093/jjco/hyr195; Hellwinkel OJC, 2011, PROSTATE CANCER P D, V14, P38, DOI 10.1038/pcan.2010.48; Hu XY, 2009, EJSO-EUR J SURG ONC, V35, P527, DOI 10.1016/j.ejso.2008.09.015; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim BG, 2011, J BONE MINER RES, V26, P1411, DOI 10.1002/jbmr.348; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Takeuchi T, 2011, INT J EXP PATHOL, V92, P79, DOI 10.1111/j.1365-2613.2010.00740.x; Wang C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-166; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	35	45	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81514	10.1371/journal.pone.0081514	http://dx.doi.org/10.1371/journal.pone.0081514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312311	gold, Green Submitted, Green Published			2022-12-25	WOS:000327657900037
J	Ruiz, A; Pesini, P; Espinosa, A; Perez-Grijalba, V; Valero, S; Sotolongo-Grau, O; Alegret, M; Monleon, I; Lafuentel, A; Buendia, M; Ibarria, M; Ruizl, S; Hernandez, I; San Jose, I; Tarraga, L; Boada, M; Sarasa, M				Ruiz, Agustin; Pesini, Pedro; Espinosa, Ana; Perez-Grijalba, Virginia; Valero, Sergi; Sotolongo-Grau, Oscar; Alegret, Montserrat; Monleon, Inmaculada; Lafuentel, Asuncion; Buendia, Mar; Ibarria, Marta; Ruizl, Susana; Hernandez, Isabel; San Jose, Itziar; Tarraga, Lluis; Boada, Merce; Sarasa, Manuel			Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates	PLOS ONE			English	Article							RISK-FACTORS; DIAGNOSIS; BIOMARKERS; PROTEIN; IDENTIFICATION; VASOACTIVITY; HOMOCYSTEINE; ASSOCIATION; CREATININE; A-BETA-42	Plasma amyloid beta (A beta) levels are being investigated as potential biomarkers for Alzheimer's disease. In AB128 cross-sectional study, a number of medical relevant correlates of blood A beta 40 or A beta 42 were analyzed in 140 subjects (51 Alzheimer's disease patients, 53 healthy controls and 36 individuals diagnosed with mild cognitive impairment). We determined the association between multiple variables with A beta 40 and A beta 42 levels measured in three different blood compartments called i) A beta directly accessible (DA) in the plasma, ii) A beta recovered from the plasma matrix (RP) after diluting the plasma sample in a formulated buffer, and iii) associated with the remaining cellular pellet (CP). We confirmed that diastolic blood pressure (DBP) is consistently correlated with blood DA A beta 40 levels (r=-0.19, P=0.032). These results were consistent in the three phenotypic groups studied. Importantly, the observation resisted covariation with age, gender or creatinine levels. Observed effect size and direction of A beta 40 levels/DBP correlation are in accordance with previous reports. Of note, DA A beta 40 and the RP A beta 40 were also strongly associated with creatinine levels (r=0.599, P << 0.001) and to a lesser extent to urea, age, hematocrit, uric acid and homocysteine (p<0.001). DBP and the rest of statistical significant correlates identified should be considered as potential confounder factors in studies investigating blood A beta levels as potential AD biomarker. Remarkably, the factors affecting A beta levels in plasma (DA, RP) and blood cell compartments (CP) seem completely different.	[Ruiz, Agustin; Espinosa, Ana; Valero, Sergi; Sotolongo-Grau, Oscar; Alegret, Montserrat; Lafuentel, Asuncion; Buendia, Mar; Ibarria, Marta; Ruizl, Susana; Hernandez, Isabel; Tarraga, Lluis; Boada, Merce] Fundacio ACE, Alzheimer Res Ctr, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Ruiz, Agustin; Espinosa, Ana; Valero, Sergi; Sotolongo-Grau, Oscar; Alegret, Montserrat; Lafuentel, Asuncion; Buendia, Mar; Ibarria, Marta; Ruizl, Susana; Hernandez, Isabel; Tarraga, Lluis; Boada, Merce] Fundacio ACE, Memory Clin, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Pesini, Pedro; Perez-Grijalba, Virginia; Monleon, Inmaculada; San Jose, Itziar; Sarasa, Manuel] Araclon Biotech Ltd, Zaragoza, Spain; [Valero, Sergi] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Psychiat, Ctr Invest Biomed Red,Area Salud Mental, E-08193 Barcelona, Spain; [Boada, Merce] Univ Autonoma Barcelona, Inst Recerca, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Ruiz, A (corresponding author), Fundacio ACE, Alzheimer Res Ctr, Inst Catala Neurociencies Aplicades, Barcelona, Spain.	aruiz@fundacioace.com	Valero, Sergi/AAB-7596-2019; Sotolongo-Grau, Oscar/AAB-7908-2019; Pérez-Grijalba, Virginia/T-4320-2017; Alegret, Montserrat/AAB-8239-2019; Ruiz, Agustin/G-5677-2012	Sotolongo-Grau, Oscar/0000-0002-9679-0670; Pérez-Grijalba, Virginia/0000-0002-7062-827X; Alegret, Montserrat/0000-0002-8164-9500; Valero, Sergi/0000-0002-6599-948X; Espinosa, Ana/0000-0001-8414-6522; Ruiz Laza, Agustin/0000-0003-2633-2495	Araclon Biotech Ltd.; Fundacio ACE; Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid) [FISS PI10/00954]; Agencia d'Avaluacio de Tecnologia i Recerca Mediques; Departament de Salut de la Generalitat de Catalunya [390]	Araclon Biotech Ltd.; Fundacio ACE; Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid); Agencia d'Avaluacio de Tecnologia i Recerca Mediques; Departament de Salut de la Generalitat de Catalunya(Generalitat de Catalunya)	This work has been funded by Araclon Biotech Ltd., Fundacio ACE, and is also supported by the Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid) (FISS PI10/00954) and by Agencia d'Avaluacio de Tecnologia i Recerca Mediques. Departament de Salut de la Generalitat de Catalunya (grant num. 390). The funder, Araclon Biotech Ltd., had a role in study design and data collection, but had no role on analysis, decision to publish, or preparation of the manuscript. The rest of funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah L, 2007, NEUROSCI LETT, V428, P53, DOI 10.1016/j.neulet.2007.09.058; Ajmani RS, 2000, NEUROBIOL AGING, V21, P257, DOI 10.1016/S0197-4580(00)00118-4; Alegret M, 2012, J CLIN EXP NEUROPSYC, V34, P209, DOI 10.1080/13803395.2011.630652; Arvanitakis Z, 2002, ALZ DIS ASSOC DIS, V16, P187, DOI 10.1097/00002093-200207000-00009; Balakrishnan K, 2005, J ALZHEIMERS DIS, V8, P269; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Blesa R, 2001, NEUROPSYCHOLOGIA, V39, P1150, DOI 10.1016/S0028-3932(01)00055-0; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; Crawford F, 1998, FEBS LETT, V436, P445, DOI 10.1016/S0014-5793(98)01170-3; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fletcher L.C.B., 2013, GMS HLTH TECHNOL ASS, V9, DOI [10.3205/HTA000107, DOI 10.3205/HTA000107]; Fujiwara Y, 2003, GERONTOLOGY, V49, P374, DOI 10.1159/000073765; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Irizarry MC, 2005, NEUROLOGY, V65, P1402, DOI 10.1212/01.wnl.0000183063.99107.5c; ISHII T, 1975, ACTA NEUROPATHOL, V32, P157, DOI 10.1007/BF00689569; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lambert JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018536; Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Luchsinger JA, 2007, NEUROCHEM RES, V32, P775, DOI 10.1007/s11064-006-9207-7; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; METTI AL, 2012, ALZHEIMER DIS ASS DI; Nagasaka Y, 2005, P NATL ACAD SCI USA, V102, P14854, DOI 10.1073/pnas.0504178102; Niranjan R, 2013, MOL NEUROBIOL, V48, P412, DOI 10.1007/s12035-013-8428-4; Perez-Grijalba V, 2013, J ALZHEIMERS DIS, V36, P211, DOI 10.3233/JAD-121744; Pesini Pedro, 2012, Int J Alzheimers Dis, V2012, P604141, DOI 10.1155/2012/604141; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; R Core Team, 2021, R LANG ENV STAT COMP; Rajagopalan P, 2013, NEUROBIOL AGING, V34, P1221, DOI 10.1016/j.neurobiolaging.2012.10.022; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20; Sawmiller DR, 2012, J NEUROCHEM, V123, P525, DOI 10.1111/j.1471-4159.2012.07923.x; Shah NS, 2012, HYPERTENSION, V59, P780, DOI 10.1161/HYPERTENSIONAHA.111.178962; Soininen HS, 1998, ANN MED, V30, P553, DOI 10.3109/07853899809002604; Toledo JB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt162; Toledo JB, 2012, ALZHEIMERS DEMENT, V8, P483, DOI 10.1016/j.jalz.2011.08.008; Townsend MK, 2012, ALZ DIS ASSOC DIS, V26, P50, DOI 10.1097/WAD.0b013e31821764ce; Vidoni ED, 2011, NEUROLOGY, V77, P1913, DOI 10.1212/WNL.0b013e318238eec1	42	28	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81334	10.1371/journal.pone.0081334	http://dx.doi.org/10.1371/journal.pone.0081334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312290	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100074
J	Swamy-Mruthinti, S; Srinivas, V; Hansen, JE; Rao, CM				Swamy-Mruthinti, Satyanarayana; Srinivas, Volety; Hansen, John E.; Rao, Ch Mohan			Thermal Stress Induced Aggregation of Aquaporin 0 (AQPO) and Protection by alpha-Crystallin via Its Chaperone Function	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; PLASMA-MEMBRANE; NEISSERIA-MENINGITIDIS; GAMMA-CRYSTALLIN; HUMAN LENSES; MIP; BINDING; IDENTIFICATION; ASSOCIATION; CALMODULIN	Aquaporin 0 (AQPO) formerly known as membrane intrinsic protein (MIP), is expressed exclusively in the lens during terminal differentiation of fiber cells. AQPO plays an important role not only in the regulation of water content but also in cell-to-cell adhesion of the lens fiber cells. We have investigated the thermal stress-induced structural alterations of detergent (octyl glucoside)-solubilized calf lens AQPO. The results show an increase in the amount of AQPO that aggregated as the temperature increased from 40 degrees C to 65 degrees C. alpha-Crystallin, molecular chaperone abundantly present in the eye lens, completely prevented the AQPO aggregation at a 1:1 (weight/weight) ratio. Since alpha-crystallin consists of two gene products namely alpha A- and alpha B-crystallins, we have tested the recombinant proteins on their ability to prevent thermal-stress induced AQPO aggregation. In contrast to the general observation made with other target proteins, alpha A-crystallin exhibited better chaperone-like activity towards AQPO compared to alpha B-crystallin. Neither post-translational modifications (glycation) nor C-terminus truncation of AQPO have any appreciable effect on its thermal aggregation properties. alpha-Crystallin offers similar protection against thermal aggregation as in the case of the unmodified AQPO, suggesting that alpha crystallin may bind to either intracellular loops or other residues of AQPO that become exposed during thermal stress. Far-UV circular dichroism studies indicated a loss of alpha helical structures when AQPO was subjected to temperatures above 45 degrees C, and the presence of alpha-crystallin stabilized these secondary structures. We report here, for the first time, that alpha-crystallin protects AQPO from thermal aggregation. Since stress-induced structural perturbations of AQPO may affect the integrity of the lens, presence of the molecular chaperone, alpha-crystallin (particularly alpha A-crystallin) in dose proximity to the lens membrane is physiologically relevant.	[Swamy-Mruthinti, Satyanarayana; Hansen, John E.] Univ West Georgia, Carrollton, GA USA; [Hansen, John E.; Rao, Ch Mohan] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	University System of Georgia; University of West Georgia; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Swamy-Mruthinti, S (corresponding author), Univ West Georgia, Carrollton, GA USA.	smruthin@westga.edu			NSF [DBI0521238, DUE9751530]	NSF(National Science Foundation (NSF))	This work is supported by NSF grants # DBI0521238, DUE9751530, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; BENEDETTI EL, 1974, P NATL ACAD SCI USA, V71, P5073, DOI 10.1073/pnas.71.12.5073; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Bhat SP, 2003, PROG DRUG RES, V60, P205; Boyle DL, 1996, CURR EYE RES, V15, P577, DOI 10.3109/02713689609000769; CENEDELLA RJ, 1992, CURR EYE RES, V11, P801, DOI 10.3109/02713689209000753; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; DUNIA I, 1987, J CELL BIOL, V105, P1679, DOI 10.1083/jcb.105.4.1679; Engel A, 2002, INT REV CYTOL, V215, P75; FLESCHNER CR, 1992, CURR EYE RES, V11, P739, DOI 10.3109/02713689209000748; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; FRASCH CE, 1986, CLIN INVEST MED, V9, P101; Friedrich MG, 2010, INVEST OPHTH VIS SCI, V51, P5145, DOI 10.1167/iovs.10-5261; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Gupta R, 2011, J BIOL CHEM, V286, P11579, DOI 10.1074/jbc.M110.148627; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; IFEANYI F, 1990, CURR EYE RES, V9, P259, DOI 10.3109/02713689009044521; Kozono D, 2003, J BIOL CHEM, V278, P10649, DOI 10.1074/jbc.M212418200; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; LIANG JJN, 1992, EXP EYE RES, V54, P719, DOI 10.1016/0014-4835(92)90026-O; Liu BF, 2008, J CELL BIOCHEM, V104, P51, DOI 10.1002/jcb.21598; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Minetti CASA, 1997, J BIOL CHEM, V272, P10710; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; MULDERS JWM, 1985, EUR J BIOCHEM, V152, P721, DOI 10.1111/j.1432-1033.1985.tb09253.x; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PERACCHIA C, 1985, BIOCHEM BIOPH RES CO, V133, P688, DOI 10.1016/0006-291X(85)90959-3; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Plasencia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014674; RAMAN B, 1994, J BIOL CHEM, V269, P27264; RAMAN B, 1995, J BIOL CHEM, V270, P19888, DOI 10.1074/jbc.270.34.19888; RAO CM, 1993, INVEST OPHTH VIS SCI, V34, P988; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Schey KL, 1997, INVEST OPHTH VIS SCI, V38, P2508; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Su Shih-Ping, 2011, Mol Vis, V17, P2798; SWAMY MS, 1992, BIOCHEM BIOPH RES CO, V186, P632, DOI 10.1016/0006-291X(92)90793-K; Swamy-Mruthinti S, 2001, BBA-MOL BASIS DIS, V1536, P64, DOI 10.1016/S0925-4439(01)00031-X; SwamyMruthinti S, 1997, CURR EYE RES, V16, P936, DOI 10.1076/ceyr.16.9.936.5037; Varadaraj K, 1999, J MEMBRANE BIOL, V170, P191, DOI 10.1007/s002329900549; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325	48	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80404	10.1371/journal.pone.0080404	http://dx.doi.org/10.1371/journal.pone.0080404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312215	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100036
J	Chu, D; Pan, HP; Li, XC; Guo, D; Tao, YL; Liu, BM; Zhang, YJ				Chu, Dong; Pan, Hui-Peng; Li, Xian-Chun; Guo, Dong; Tao, Yun-Li; Liu, Bai-Ming; Zhang, You-Jun			Spatial Genetic Heterogeneity in Populations of a Newly Invasive Whitefly in China Revealed by a Nation-Wide Field Survey	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; ALEYRODIDAE BIOTYPES; MITOCHONDRIAL; EVOLUTION; DIFFERENTIATION; DIVERSITY; REGION; LOCI; DNA	Background: Even though introductions of exotic species provide ready-made experiments of rapid evolution, few studies have examined the genetic structure of an exotic species shortly after its initial introduction and subsequent spread. To determine the genetic structure of its populations during the initial introduction, we investigated the invasive sweet potato whitefly (Bemisia tabaci Q, commonly known as B. tabaci biotype Q) in China, which was introduced in approximately 2003. A total of 619 B. tabaci Q individuals in 20 provinces throughout China were collected and analyzed using five microsatellite loci. Results: The introduced populations of B. tabaci Q in China represent eight genetic clusters with different geographic distributions. The populations in Yunnan Province, where B. tabaci Q was first detected, are genetically different from the other populations in China. Conclusion: The introduced populations of B. tabaci Q in China have high spatial genetic heterogeneity. Additional research is required to determine whether the heterogeneity results from multiple introductions, rapid evolution following one or few introductions, or some combination of multiple introductions and rapid evolution. The heterogeneity, however, is inconsistent with a single introduction at Yunnan Province, where B. tabaci Q was first detected, followed by spread.	[Chu, Dong; Guo, Dong; Tao, Yun-Li] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China; [Pan, Hui-Peng; Liu, Bai-Ming; Zhang, You-Jun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Li, Xian-Chun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xian-Chun] Univ Arizona, Inst BIO5, Tucson, AZ USA	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Arizona; University of Arizona	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Chu, Dong/AAS-3914-2020; CHU, DONG/AAI-1892-2020; Zhang, Youjun/AAY-7948-2020	Chu, Dong/0000-0001-5716-4979; Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars of China [31025020]; High-Level Talents Fund of Qingdao Agricultural University [631212]; National Natural Science Foundation of China [31071747, 31272105]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong [17]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); High-Level Talents Fund of Qingdao Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	This research was supported by the National Science Fund for Distinguished Young Scholars of China (31025020) to Y. Zhang, the High-Level Talents Fund of Qingdao Agricultural University (631212), the National Natural Science Foundation of China (31071747; 31272105), and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong 17 to D. Chu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Bjorklund M, 2010, BIOL INVASIONS, V12, P2609, DOI 10.1007/s10530-009-9669-z; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Chu Dong, 2008, Acta Entomologica Sinica, V51, P150; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 1996, GENETICS, V144, P2001; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Dennehy T. J., 2005, NEW CHALLENGES MANAG, P31; Dinsdale A, 2012, B ENTOMOL RES, V102, P539, DOI 10.1017/S0007485312000077; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elton C. S., 1958, ECOLOGY INVASIONS AN; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Franklin MT, 2010, MOL ECOL, V19, P1122, DOI 10.1111/j.1365-294X.2010.04548.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lockwood JL, 2007, INVASION ECOLOGY; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Miura O, 2007, ECOL RES, V22, P876, DOI 10.1007/s11284-007-0389-5; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034567	42	8	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e79997	10.1371/journal.pone.0079997	http://dx.doi.org/10.1371/journal.pone.0079997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302995	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400011
J	Wilson, NG; Maschek, JA; Baker, BJ				Wilson, Nerida G.; Maschek, J. Alan; Baker, Bill J.			A Species Flock Driven by Predation? Secondary Metabolites Support Diversification of Slugs in Antarctica	PLOS ONE			English	Article							NUDIBRANCH AUSTRODORIS-KERGUELENENSIS; ADAPTIVE RADIATION; CHEMICAL DEFENSE; 1ST INSIGHTS; GASTROPODA; MOLLUSCA; OPISTHOBRANCHIA; INVERTEBRATES; DIVERSITY; ECOLOGY	Antarctica's rich marine animal biodiversity has been substantially influenced by a complex glacial history, but it is unclear why some taxa responded with diversification while others did not. Despite being considered a single endemic sea slug species in the Southern Ocean, mitochondrial DNA sequencing of Doris kerguelenensis (Bergh, 1884) revealed a multitude of highly divergent lineages. But because of the uniparental inheritance of mitochondria, it was unclear whether those lineages represented a radiation of cryptic species or simply stochastic sorting patterns of populations that rarely reach equilibrium. Here we demonstrate that the mitochondrial groups in D. kerguelenensis also correlate with nuclear DNA. Additionally, by extracting secondary metabolites from the same individuals we sequenced, we were also able to directly link the secondary metabolome to a mitochondrial lineage. These metabolites are not derived from the diet, but instead are synthesized de novo and implicated in an anti-predatory role. The strong linkage between these metabolites and the mitochondrial lineages strongly suggests that these lineages represent cryptic species in an adaptive radiation. Over millions of years, episodic glacial cycles reduced the distribution of a formerly widespread slug into a series of small vicariant refuges, vulnerable to genetic drift and predation pressure. The recognition of this marine invertebrate species flock implicates a strongly synergistic role for selection and allopatry driving speciation in this system.	[Wilson, Nerida G.] Australian Museum, Australian Museum Res Inst, Sydney, NSW 2000, Australia; [Wilson, Nerida G.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Maschek, J. Alan; Baker, Bill J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Baker, Bill J.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA	Australian Museum; University of California System; University of California San Diego; Scripps Institution of Oceanography; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wilson, NG (corresponding author), Australian Museum, Australian Museum Res Inst, 6-8 Coll St, Sydney, NSW 2000, Australia.	ngwilson@ucsd.edu	Wilson, Nerida G./AAC-1456-2019; Wilson, Nerida/G-8433-2011; Baker, Bill/N-4312-2019	Wilson, Nerida/0000-0002-0784-0200; 	US National Science Foundation Office of Polar Programs Antarctic Organisms and Ecosystems Program [ANT-1043749, OPP-0442857, ANT-0838776]; Antarctic Science Bursary; Australian Museum; Scripps Institution of Oceanography; University of South Florida; Directorate For Geosciences [1043749] Funding Source: National Science Foundation	US National Science Foundation Office of Polar Programs Antarctic Organisms and Ecosystems Program; Antarctic Science Bursary; Australian Museum; Scripps Institution of Oceanography(University of California System); University of South Florida; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the US National Science Foundation Office of Polar Programs Antarctic Organisms and Ecosystems Program (ANT-1043749 to NGW; OPP-0442857 and ANT-0838776 to BJB), an Antarctic Science Bursary (to NGW), The Australian Museum, Scripps Institution of Oceanography and the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audzijonyte A, 2010, MOL ECOL RESOUR, V10, P200, DOI 10.1111/j.1755-0998.2009.02737.x; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CIMINO G, 1983, SCIENCE, V219, P1237, DOI 10.1126/science.219.4589.1237; Cimino G, 1999, CHEMOECOLOGY, V9, P187, DOI 10.1007/s000490050052; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Cutignano A, 2011, EUR J ORG CHEM, V2011, P5383, DOI 10.1002/ejoc.201100552; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diyabalanage T, 2010, J NAT PROD, V73, P416, DOI 10.1021/np900617m; Ellison CK, 2010, J EVOLUTION BIOL, V23, P528, DOI 10.1111/j.1420-9101.2009.01917.x; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; Firn RD, 2009, J EXP BOT, V60, P719, DOI 10.1093/jxb/erp002; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; HAIN S, 1989, BEITRAGE BIOL BESCHA; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iken K, 2002, MAR BIOL, V141, P101, DOI 10.1007/s00227-002-0816-7; JABLONSKI D, 1986, B MAR SCI, V39, P565; Johnson RF, 2010, ZOOL SCRIPTA, V136, P137; Jones C, 1991, PHILOS T R SOC B, V333, P272; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kettlewell B, 1973, EVOLUTION MELANISM S; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; Lecointre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068787; Macel M, 2010, MOL ECOL RESOUR, V10, P583, DOI 10.1111/j.1755-0998.2010.02854.x; Maschek JA, 2012, TETRAHEDRON, V68, P9095, DOI 10.1016/j.tet.2012.08.045; NAKASHIMA Y, 1995, J ETHOL, V13, P125, DOI 10.1007/BF02352571; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; Poulin E, 1996, EVOLUTION, V50, P820, DOI 10.1111/j.1558-5646.1996.tb03891.x; Rogers AD, 2012, ANTARCTIC ECOSYSTEMS, P417; Ronsted N, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-182; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwabe E, 2007, DEEP-SEA RES PT II, V54, P1831, DOI 10.1016/j.dsr2.2007.07.010; SILVESTRO D., 2011, ORG DIVERS EVOL, V12, P335; Smith JA, 2010, EARTH PLANET SC LETT, V296, P287, DOI 10.1016/j.epsl.2010.05.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Valdes A, 2002, ZOOL J LINN SOC-LOND, V136, P535, DOI 10.1046/j.1096-3642.2002.00039.x; WAGELE H, 1990, J MOLLUS STUD, V56, P163, DOI 10.1093/mollus/56.2.163; Wagele Heike, 1996, Malacological Review Supplement, V6, P21; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x	50	66	67	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80277	10.1371/journal.pone.0080277	http://dx.doi.org/10.1371/journal.pone.0080277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303002	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400018
J	Kikuchi, R; Ohata, H; Ohoka, N; Kawabata, A; Naito, M				Kikuchi, Ryo; Ohata, Hirokazu; Ohoka, Nobumichi; Kawabata, Atsushi; Naito, Mikihiko			APOLLON Protein Promotes Early Mitotic CYCLIN A Degradation Independent of the Spindle Assembly Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclins; Mitosis; Protein Degradation; Ubiquitin; APC; C; APPOLON; Cyclin A; Spindle Assembly Checkpoint	E2/E3 UBIQUITIN LIGASE; CELL-CYCLE; DESTRUCTION BOX; EARLY MITOSIS; COMPLEX; APC/C; ANAPHASE; CDC20; BINDING; INHIBITION	Background: CYCLIN A is degraded in early mitosis independent of spindle assembly checkpoint. Results: APOLLON interacts with CYCLIN A and promotes its degradation in mitosis. Conclusion: APOLLON is a novel regulator of CYCLIN A degradation in early mitosis. Significance: This study expands our knowledge on the huge APOLLON protein known to regulate apoptosis and cytokinesis. In the mammalian cell cycle, both CYCLIN A and CYCLIN B are required for entry into mitosis, and their elimination is also essential to complete the process. During mitosis, CYCLIN A and CYCLIN B are ubiquitylated by the anaphase-promoting complex/cyclosome (APC/C) and then subjected to proteasomal degradation. However, CYCLIN A, but not CYCLIN B, begins to be degraded in the prometaphase when APC/C is inactivated by the spindle assembly checkpoint (SAC). Here, we show that APOLLON (also known as BRUCE or BIRC6) plays a role in SAC-independent degradation of CYCLIN A in early mitosis. APPOLON interacts with CYCLIN A that is not associated with cyclin-dependent kinases. APPOLON also interacts with APC/C, and it facilitates CYCLIN A ubiquitylation. In APPOLON-deficient cells, mitotic degradation of CYCLIN A is delayed, and the total, but not the cyclin-dependent kinase-bound, CYCLIN A level was increased. We propose APPOLON to be a novel regulator of mitotic CYCLIN A degradation independent of SAC.	[Kikuchi, Ryo; Ohata, Hirokazu; Kawabata, Atsushi; Naito, Mikihiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kikuchi, Ryo; Kawabata, Atsushi; Naito, Mikihiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohata, Hirokazu; Naito, Mikihiko] Univ Tokyo, Grad Sch Frontier Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohoka, Nobumichi; Naito, Mikihiko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan	Naito, M (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp			Ministry of Education, Science, Sports and Culture, Japan; NOVARTIS Foundation (Japan) for the Promotion of Science; Cosmetology Research Foundation; Grants-in-Aid for Scientific Research [23790117] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Cosmetology Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Science, Sports and Culture, Japan (grants-in-aid for cancer research and scientific research), the NOVARTIS Foundation (Japan) for the Promotion of Science, and the Cosmetology Research Foundation.	Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hitz C, 2005, GENESIS, V42, P91, DOI 10.1002/gene.20128; Ishioka T, 2007, GENES CELLS, V12, P735, DOI 10.1111/j.1365-2443.2007.01087.x; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kaspar M, 2001, CURR BIOL, V11, P685, DOI 10.1016/S0960-9822(01)00205-6; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merrick KA, 2008, MOL CELL, V32, P662, DOI 10.1016/j.molcel.2008.10.022; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Ramachandran V, 2007, CELL CYCLE, V6, P171, DOI 10.4161/cc.6.2.3716; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Sczaniecka Matylda M, 2008, SEB Exp Biol Ser, V59, P243; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Vanoosthuyse V, 2005, TRENDS CELL BIOL, V15, P231, DOI 10.1016/j.tcb.2005.03.003; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	64	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3457	3467		10.1074/jbc.M113.514430	http://dx.doi.org/10.1074/jbc.M113.514430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24302728	hybrid, Green Published			2022-12-25	WOS:000331368700030
J	Li, XM; Xu, M; Wang, F; Kohan, AB; Haas, MK; Yang, Q; Lou, DW; Obici, S; Davidson, WS; Tso, P				Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Haas, Michael K.; Yang, Qing; Lou, Danwen; Obici, Silvana; Davidson, W. Sean; Tso, Patrick			Apolipoprotein A-IV Reduces Hepatic Gluconeogenesis through Nuclear Receptor NR1D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Diabetes; Gluconeogenesis; Nuclear Receptors; Phosphoenolpyruvate Carboxykinase; Apolipoprotein A-IV; NR1D1	REV-ERB-ALPHA; FREE HORMONE HYPOTHESIS; PLASMA APOLIPOPROTEINS; BINDING PROTEINS; CELLULAR UPTAKE; AIV; METABOLISM; SECRETION; INTESTINE; CELLS	We showed recently that apoA-IV improves glucose homeostasis by enhancing pancreatic insulin secretion in the presence of elevated levels of glucose. Therefore, examined whether apolipoprotein A-IV (apoA-IV) also regulates glucose metabolism through the suppression of hepatic gluconeogenesis. The ability of apoA-IV to lower gluconeogenic gene expression and glucose production was measured in apoA-IV-/- and wild-type mice and primary mouse hepatocytes. The transcriptional regulation of Glc-6-Pase and phosphoenolpyruvate carboxykinase (PEPCK) by apoA-IV was determined by luciferase activity assay. Using bacterial two-hybrid library screening, NR1D1 was identified as a putative apoA-IV-binding protein. The colocalization and interaction between apoA-IV and NR1D1 were confirmed by immunofluorescence, in situ proximity ligation assay, and coimmunoprecipitation. Enhanced recruitment of NR1D1 and activity by apoA-IV to Glc-6-Pase promoter was verified with ChIP and a luciferase assay. Down-regulation of apoA-IV on gluconeogenic genes is mediated through NR1D1, as illustrated in cells with NR1D1 knockdown by siRNA. We found that apoA-IV suppresses the expression of PEPCK and Glc-6-Pase in hepatocytes; decreases hepatic glucose production; binds and activates nuclear receptor NR1D1 and stimulates NR1D1 expression; in cells lacking NR1D1, fails to inhibit PEPCK and Glc-6-Pase gene expression; and stimulates higher hepatic glucose production and higher gluconeogenic gene expression in apoA-IV-/- mice. We conclude that apoA-IV inhibits hepatic gluconeogenesis by decreasing Glc-6-Pase and PEPCK gene expression through NR1D1. This novel regulatory pathway connects an influx of energy as fat from the gut (and subsequent apoA-IV secretion) with inhibition of hepatic glucose production.	[Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Haas, Michael K.; Yang, Qing; Lou, Danwen; Obici, Silvana; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Cincinnati Obes Res Ctr, Cincinnati, OH 45237 USA; [Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Yang, Qing; Lou, Danwen; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Tso, P (corresponding author), Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	tsopp@ucmail.uc.edu		Davidson, William/0000-0003-2756-2989; Kohan, Alison/0000-0003-3127-7283	National Institutes of Health [DK 59630, DK 92138, DK 76928, F32-091173-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, U24DK059630, R01DK092138, R01DK076928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 59630, DK 92138, and DK 76928 (to P. T.) and F32-091173-01 (to A. B. K.).	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Andreassen TK, 2006, HORM METAB RES, V38, P279, DOI 10.1055/s-2006-925348; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; BISGAIER CL, 1985, J LIPID RES, V26, P11; Bottermann K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066045; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; De Wolf FA, 2000, PHARMACOL REV, V52, P207; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; EMMANUEL F, 1994, J BIOL CHEM, V269, P29883; Ferretti G, 2002, CHEM PHYS LIPIDS, V114, P45, DOI 10.1016/S0009-3084(01)00201-8; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; KALOGERIS TJ, 1994, J LIPID RES, V35, P1141; Kalogeris TJ, 2001, AM J PHYSIOL-REG I, V280, pR1155, DOI 10.1152/ajpregu.2001.280.4.R1155; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; Liu M, 2001, AM J PHYSIOL-REG I, V280, pR1382, DOI 10.1152/ajpregu.2001.280.5.R1382; Lo CM, 2011, DIABETES, V60, P2000, DOI 10.2337/db10-0789; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Main LA, 1996, BBA-LIPID LIPID MET, V1300, P17, DOI 10.1016/0005-2760(95)00228-6; MENDEL CM, 1989, ENDOCRINOLOGY, V124, P468, DOI 10.1210/endo-124-1-468; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Pan XY, 2013, J BIOL CHEM, V288, P20464, DOI 10.1074/jbc.M113.473454; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Watson CS, 2003, EXP BIOL MED, V228, P1272, DOI 10.1177/153537020322801106; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; WINDMUELLER HG, 1981, J BIOL CHEM, V256, P3012; WU AL, 1979, J BIOL CHEM, V254, P7316; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	43	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2396	2404		10.1074/jbc.M113.511766	http://dx.doi.org/10.1074/jbc.M113.511766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311788	Green Published, hybrid			2022-12-25	WOS:000331130200043
J	El Hachmane, MF; Rees, KA; Veale, EL; Sumbayev, VV; Mathie, A				El Hachmane, Mickael-F; Rees, Kathryn A.; Veale, Emma L.; Sumbayev, Vadim V.; Mathie, Alistair			Enhancement of TWIK-related Acid-sensitive Potassium Channel 3 (TASK3) Two-pore Domain Potassium Channel Activity by Tumor Necrosis Factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Ion Channels; Jun N-terminal Kinase (JNK); p38; Patch Clamp Electrophysiology; Potassium Channels; Tumor Necrosis Factor (TNF)	CEREBELLAR GRANULE NEURONS; K+ CHANNELS; CELL-DEATH; TNF-ALPHA; VOLUME REGULATION; APOPTOTIC SURGE; UP-REGULATION; K2P CHANNELS; NITRIC-OXIDE; ACTIVATION	Background: TASK3 potassium channels regulate cellular excitability and intracellular potassium homeostasis. Results: TNF enhances current through TASK3 channels by modulating channel gating. Conclusion: TNF treatment, together with an increase of potassium efflux through TASK3 channels, promotes apoptosis. Significance: A novel mechanism for TNF-mediated changes in cellular homeostasis is described. TASK3 two-pore domain potassium (K2P) channels are responsible for native leak K channels in many cell types which regulate cell resting membrane potential and excitability. In addition, TASK3 channels contribute to the regulation of cellular potassium homeostasis. Because TASK3 channels are important for cell viability, having putative roles in both neuronal apoptosis and oncogenesis, we sought to determine their behavior under inflammatory conditions by investigating the effect of TNF on TASK3 channel current. TASK3 channels were expressed in tsA-201 cells, and the current through them was measured using whole cell voltage clamp recordings. We show that THP-1 human myeloid leukemia monocytes, co-cultured with hTASK3-transfected tsA-201 cells, can be activated by the specific Toll-like receptor 7/8 activator, R848, to release TNF that subsequently enhances hTASK3 current. Both hTASK3 and mTASK3 channel activity is increased by incubation with recombinant TNF (10 ng/ml for 2-15 h), but other K2P channels (hTASK1, hTASK2, hTREK1, and hTRESK) are unaffected. This enhancement by TNF is not due to alterations in levels of channel expression at the membrane but rather to an alteration in channel gating. The enhancement by TNF can be blocked by extracellular acidification but persists for mutated TASK3 (H98A) channels that are no longer acid-sensitive even in an acidic extracellular environment. TNF action on TASK3 channels is mediated through the intracellular C terminus of the channel. Furthermore, it occurs through the ASK1 pathway and is JNK- and p38-dependent. In combination, TNF activation and TASK3 channel activity can promote cellular apoptosis.	[El Hachmane, Mickael-F; Rees, Kathryn A.; Veale, Emma L.; Sumbayev, Vadim V.; Mathie, Alistair] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England	University of Greenwich; University of Kent	Mathie, A (corresponding author), Univ Kent, Medway Sch Pharm, Cent Ave, Chatham ME4 4TB, Kent, England.	a.a.mathie@kent.ac.uk	Mathie, Alistair/K-7198-2019; Veale, Emma/AAA-5022-2022; Sumbayev, Vadim/HCH-7696-2022	Mathie, Alistair/0000-0001-6094-2890; Veale, Emma/0000-0002-6778-9929; 	BBSRC; BBSRC [BB/J000930/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000930/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Royal Society Industry Fellow, supported by the BBSRC. To whom correspondence should be addressed. Tel.: 01634-202955; Fax: 01634-883927; E-mail: a.a.mathie@kent.ac.uk.	Aimond F, 2000, J BIOL CHEM, V275, P39110, DOI 10.1074/jbc.M008192200; Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Aras MA, 2005, NEUROSCI LETT, V387, P136, DOI 10.1016/j.neulet.2005.06.024; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Goetz FW, 2004, DEV COMP IMMUNOL, V28, P487, DOI 10.1016/j.dci.2003.09.008; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Houzen H, 1997, J NEUROSCI RES, V50, P990, DOI 10.1002/(SICI)1097-4547(19971215)50:6<990::AID-JNR9>3.3.CO;2-8; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Kapiszewska M, 2007, TOXICOL IN VITRO, V21, P1020, DOI 10.1016/j.tiv.2007.03.005; Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Meuth SG, 2008, J NEURO-ONCOL, V87, P263, DOI 10.1007/s11060-008-9517-5; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Montague JW, 1999, STEROIDS, V64, P563, DOI 10.1016/S0039-128X(99)00034-3; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nam JH, 2011, AM J PHYSIOL-CELL PH, V300, pC1013, DOI 10.1152/ajpcell.00475.2010; Nicholas SA, 2009, CELL RES, V19, P973, DOI 10.1038/cr.2009.44; Niemeyer MI, 2000, J PHYSIOL-LONDON, V524, P757, DOI 10.1111/j.1469-7793.2000.00757.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Seguin DG, 1997, AM J PHYSIOL-CELL PH, V272, pC1854, DOI 10.1152/ajpcell.1997.272.6.C1854; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Trimarchi JR, 2000, BIOL REPROD, V63, P851, DOI 10.1095/biolreprod63.3.851; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	60	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1388	1401		10.1074/jbc.M113.500033	http://dx.doi.org/10.1074/jbc.M113.500033			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307172	hybrid, Green Published			2022-12-25	WOS:000332401700017
J	Civan, P; Ivanicova, Z; Brown, TA				Civan, Peter; Ivanicova, Zuzana; Brown, Terence A.			Reticulated Origin of Domesticated Emmer Wheat Supports a Dynamic Model for the Emergence of Agriculture in the Fertile Crescent	PLOS ONE			English	Article							RNA MULTIGENE FAMILY; TRITICUM-DICOCCOIDES; PHYLOGENETIC NETWORKS; TETRAPLOID WHEATS; AFLP ANALYSIS; COMMON WHEAT; WILD WHEATS; NEAR-EAST; GENE FLOW; EVOLUTION	We used supernetworks with datasets of nuclear gene sequences and novel markers detecting retrotransposon insertions in ribosomal DNA loci to reassess the evolutionary relationships among tetraploid wheats. We show that domesticated emmer has a reticulated genetic ancestry, sharing phylogenetic signals with wild populations from all parts of the wild range. The extent of the genetic reticulation cannot be explained by post-domestication gene flow between cultivated emmer and wild plants, and the phylogenetic relationships among tetraploid wheats are incompatible with simple linear descent of the domesticates from a single wild population. A more parsimonious explanation of the data is that domesticated emmer originates from a hybridized population of different wild lineages. The observed diversity and reticulation patterns indicate that wild emmer evolved in the southern Levant, and that the wild emmer populations in south-eastern Turkey and the Zagros Mountains are relatively recent reticulate descendants of a subset of the Levantine wild populations. Based on our results we propose a new model for the emergence of domesticated emmer. During a pre-domestication period, diverse wild populations were collected from a large area west of the Euphrates and cultivated in mixed stands. Within these cultivated stands, hybridization gave rise to lineages displaying reticulated genealogical relationships with their ancestral populations. Gradual movement of early farmers out of the Levant introduced the pre-domesticated reticulated lineages to the northern and eastern parts of the Fertile Crescent, giving rise to the local wild populations but also facilitating fixation of domestication traits. Our model is consistent with the protracted and dispersed transition to agriculture indicated by the archaeobotanical evidence, and also with previous genetic data affiliating domesticated emmer with the wild populations in southeast Turkey. Unlike other protracted models, we assume that humans played an intuitive role throughout the process.	[Civan, Peter; Brown, Terence A.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England; [Civan, Peter; Ivanicova, Zuzana] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 81806, Slovakia; [Civan, Peter] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Ivanicova, Zuzana] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic	University of Manchester; Comenius University Bratislava; Universidade do Algarve; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Brown, TA (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England.	terry.brown@manchester.ac.uk	Civan, Peter/AAL-9909-2021; Ivaničová, Zuzana/F-7304-2014	Civan, Peter/0000-0002-0273-3801; 	Natural Environment Research Council [NE/E015948/1]; Slovak Research and Development Agency [APVV-0661-10, APVV-0197-10]; NERC [NE/E015948/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Slovak Research and Development Agency(Slovak Research and Development Agency); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the following: Natural Environment Research Council NE/E015948/1 www.nerc.ac.uk>; and Slovak Research and Development Agency APVV-0661-10, APVV-0197-10 http://www.apvv.sk/agentura?lang=sk>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2011, GENET RESOUR CROP EV, V58, P175, DOI 10.1007/s10722-010-9630-0; Allaby RG, 2003, GENOME, V46, P448, DOI [10.1139/g03-025, 10.1139/G03-025]; Allaby RG, 2001, GENETICS, V157, P1331; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bettinger R, 2009, CURR ANTHROPOL, V50, P627, DOI 10.1086/605359; Bowles S, 2012, P NATL ACAD SCI USA, V22, P4760; BROWN TA, 2006, DARWINS HARVEST NEW, P197; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Cauvin J., 2000, BEGINNINGS AGR NEAR; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Diamond J, 1997, SCIENCE, V278, P1243, DOI 10.1126/science.278.5341.1243; Drummond A.J, 2010, GENEIOUS, V5, P3; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fuller DQ, 2012, VEG HIST ARCHAEOBOT, V21, P131, DOI 10.1007/s00334-011-0329-8; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; FULLER DQ, 2007, WORLD ANN BOT, V100, P903, DOI DOI 10.1093/A0B/MCM048; GOLENBERG EM, 1988, THEOR APPL GENET, V75, P937, DOI 10.1007/BF00258057; Haldorsen S, 2011, VEG HIST ARCHAEOBOT, V20, P305, DOI 10.1007/s00334-011-0291-5; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Heun M, 2012, J EXP BOT, V63, P4333, DOI 10.1093/jxb/ers162; HILLMAN GC, 1990, J WORLD PREHIST, V4, P157, DOI 10.1007/BF00974763; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huson DH, 2006, LECT NOTES COMPUT SC, V4175, P150; Huson DH, 2004, IEEE ACM T COMPUT BI, V1, P151, DOI 10.1109/TCBB.2004.44; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, SYST BIOL IN PRESS; Jones M., 2007, RETHINKING AGR ARCHA, P36; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; KALENDAR R, 2008, RNA P NATL SCI US, V105, P5833, DOI DOI 10.1073/PNAS.0709698105; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mithen, 2003, ICE GLOBAL HUMAN HIS; Mori N., 2003, P 10 INT WHEAT GEN S, P25; MUKAI Y, 1990, J HERED, V81, P290, DOI 10.1093/oxfordjournals.jhered.a110991; MUKAI Y, 1991, CHROMOSOMA, V100, P71, DOI 10.1007/BF00418239; NEVO E, 1982, THEOR APPL GENET, V62, P241, DOI 10.1007/BF00276247; Ozbek O, 2007, GENET RESOUR CROP EV, V54, P1587, DOI 10.1007/s10722-006-9171-8; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Rindos D., 1984, ORIGINS AGR EVOLUTIO; RODER MS, 1992, MOL GEN GENET, V232, P215; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sherratt A, 2005, OBSIDIAN TRADE NEAR; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tanno K-I, 2011, VEG HIST ARCHAEOBOT, V27, P107; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Wicker T, 2002, TRENDS PLANT SCI, V7, P561, DOI 10.1016/S1360-1385(02)02372-5; Yahiaoui N, 2009, PLANT J, V57, P846, DOI 10.1111/j.1365-313X.2008.03731.x; Zohary D., 1996, ORIGINS SPREAD AGR P, P142	60	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81955	10.1371/journal.pone.0081955	http://dx.doi.org/10.1371/journal.pone.0081955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312385	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300058
J	Mao, P; Hever-Jardine, MP; Rahme, GJ; Yang, E; Tam, J; Kodali, A; Biswal, B; Fadul, CE; Gaur, A; Israel, MA; Spinella, MJ				Mao, Pingping; Hever-Jardine, Mary P.; Rahme, Gilbert J.; Yang, Eric; Tam, Janice; Kodali, Anita; Biswal, Bijesh; Fadul, Camilo E.; Gaur, Arti; Israel, Mark A.; Spinella, Michael J.			Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; GROWTH-FACTOR RECEPTOR; DAP-KINASE; PROTEIN-KINASE; GENE; CHEMOTHERAPY; SUBTYPES; MARKERS; GLIOMA; ROLES	STK17A is a relatively uncharacterized member of the death-associated protein family of serine/threonine kinases which have previously been associated with cell death and apoptosis. Our prior work established that STK17A is a novel p53 target gene that is induced by a variety of DNA damaging agents in a p53-dependent manner. In this study we have uncovered an additional, unanticipated role for STK17A as a candidate promoter of cell proliferation and survival in glioblastoma (GBM). Unexpectedly, it was found that STK17A is highly overexpressed in a grade-dependent manner in gliomas compared to normal brain and other cancer cell types with the highest level of expression in GBM. Knockdown of STK17A in GBM cells results in a dramatic alteration in cell shape that is associated with decreased proliferation, clonogenicity, migration, invasion and anchorage independent colony formation. STK17A knockdown also sensitizes GBM cells to genotoxic stress. STK17A overexpression is associated with a significant survival disadvantage among patients with glioma which is independent of age, molecular phenotype, IDH1 mutation, PTEN loss, and alterations in the p53 pathway and partially independent of grade. In summary, we demonstrate that STK17A provides a proliferative and survival advantage to GBM cells and is a potential target to be exploited therapeutically in patients with glioma.	[Mao, Pingping; Hever-Jardine, Mary P.; Yang, Eric; Tam, Janice; Kodali, Anita; Biswal, Bijesh; Spinella, Michael J.] Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA; [Rahme, Gilbert J.; Fadul, Camilo E.; Gaur, Arti; Israel, Mark A.] Geisel Sch Med, Hanover, NH USA; [Fadul, Camilo E.; Gaur, Arti; Israel, Mark A.] Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Spinella, MJ (corresponding author), Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA.	michael.spinella@dartmouth.edu	Spinella, Michael/B-7210-2014	Biswal, Bijesh Kumar/0000-0002-5609-7660; Rahme, Gilbert/0000-0001-6060-1279	United States Department of Defense Investigator-Initiated Research Award [PR093629]; Prouty Developmental Award from Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [R21CA177781] Funding Source: NIH RePORTER	United States Department of Defense Investigator-Initiated Research Award(United States Department of Defense); Prouty Developmental Award from Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Department of Defense Investigator-Initiated Research Award PR093629 (MJS) and a Prouty Developmental Award from the Norris Cotton Cancer Center (MJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton K, 2012, HEMATOL ONCOL CLIN N, V26, P825, DOI 10.1016/j.hoc.2012.04.006; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; ENGLAND B, 2013, TUMOR BIOL IN PRESS; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Giuliano CJ, 2005, BBA-GENE STRUCT EXPR, V1731, P48, DOI 10.1016/j.bbaexp.2005.08.006; GOODENGERGER ML, 2005, CANC GENET, V205, P613; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Hegi ME, 2012, CURR OPIN NEUROL, V25, P774, DOI 10.1097/WCO.0b013e328359b0bc; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kuo JC, 2003, J CELL SCI, V116, P4777, DOI 10.1242/jcs.00794; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin Y, 2010, FEBS J, V277, P48, DOI 10.1111/j.1742-4658.2009.07411.x; Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Neubueser D, 2010, MOL BIOL CELL, V21, P2869, DOI 10.1091/mbc.E10-04-0328; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peller S, 1998, SEMIN CANCER BIOL, V8, P379, DOI 10.1006/scbi.1998.0100; Polivka J, 2012, ANTICANCER RES, V32, P2935; Robertson F, 2012, DEVELOPMENT, V139, P3432, DOI 10.1242/dev.080762; Robertson T, 2011, PATHOLOGY, V43, P88, DOI 10.1097/PAT.0b013e3283426e86; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TEMMERMAN K, 2013, FEBS J IN PRESS; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Weller M, 1998, CELL TISSUE RES, V292, P435, DOI 10.1007/s004410051072; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625	35	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81803	10.1371/journal.pone.0081803	http://dx.doi.org/10.1371/journal.pone.0081803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312360	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900052
J	Yuan, L; Chu, HY; Wang, ML; Gu, XJ; Shi, D; Ma, L; Zhong, DY; Du, ML; Li, P; Tong, N; Fu, GB; Qin, C; Yin, CJ; Zhang, ZD				Yuan, Lin; Chu, Haiyan; Wang, Meilin; Gu, Xiaojian; Shi, Danni; Ma, Lan; Zhong, Dongyan; Du, Mulong; Li, Pu; Tong, Na; Fu, Guangbo; Qin, Chao; Yin, Changjun; Zhang, Zhengdong			Genetic Variation in DROSHA 3'UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk	PLOS ONE			English	Article							UROTHELIAL CELL-CARCINOMA; GENOME-WIDE ASSOCIATION; MICRORNA-RELATED GENES; CONFERS SUSCEPTIBILITY; SEQUENCE VARIANT; DOWN-REGULATION; BINDING-SITE; DICER; PROLIFERATION; FGFR3	Purpose: miRNAs can regulate the biological processes, including differentiation, proliferation and apoptosis. DICER and DROSHA are two members of RNase III family, playing pivotal roles in the pathway of miRNAs biogenesis. In this study, we hypothesized that genetic variations of the DICER and DROSHA genes were associated with the bladder cancer risk. Experimental Design: We performed a case-control study of 685 bladder cancer cases and 730 controls to investigate the association between the seven functional SNPs of DICER and DROSHA genes and bladder cancer risk. We then evaluated the functionality of the important SNPs. Results: We found that rs10719T>C polymorphism located in 3' untranslated region (UTR) of DROSHA gene was associated with the increased risk of bladder cancer. Stratified analysis suggested that rs10719TC/CC genotype can increase risk of bladder cancer among male patients (Adjusted OR = 1.34, 95% CI = 1.05-1.70, P = 0.018), and ever smokers (1.56, 1.14-2.14, 0.006), compared with TT genotype. Furthermore, DROSHA rs10719T>C polymorphism was predicted to regulate the binding activity of hsa-miR-27a/b. Luciferase reported gene assay confirmed that rs10719 T to G substitution disrupted the binding site for hsa-miR-27b, resulting the increased levels of DROSHA protein. Conclusions: Taken together, these findings suggested that DROSHA rs10719T>C polymorphism may be associated with bladder cancer risk in a Chinese population, and hsa-miR-27b can influence the expression of DROSHA protein by binding with 3' UTR.	[Yuan, Lin; Gu, Xiaojian] Jiangsu Prov Hosp TCM, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Yuan, Lin; Chu, Haiyan; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chu, Haiyan; Wang, Meilin; Shi, Danni; Ma, Lan; Zhong, Dongyan; Du, Mulong; Zhang, Zhengdong] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China; [Chu, Haiyan; Wang, Meilin; Tong, Na; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol,Dept Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Li, Pu; Qin, Chao; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Li, Pu; Fu, Guangbo; Yin, Changjun] Nanjing Med Univ, Huai An Affiliated Hosp 1, Dept Urol, Huaian, Peoples R China	Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZD (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81230068, 30901166, 81202268, 81102089]; Natural Science Foundation of Jiangsu Province [BK2011773, BK2011775]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002, 12KJA330002]; Jiangsu Provincial Six Talent Peaks Project [2012-SWYY-028]; Specialized Research Fund for the Doctoral Program of Higher Education [20123234110001]; Jiangsu Provincial Graduates Innovative Project [CXZZ12_0594]; Qing-Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Jiangsu Provincial Six Talent Peaks Project; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jiangsu Provincial Graduates Innovative Project; Qing-Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (81230068, 30901166, 81202268 and 81102089), Natural Science Foundation of Jiangsu Province (BK2011773 and BK2011775), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002, and 12KJA330002), Jiangsu Provincial Six Talent Peaks Project (2012-SWYY-028), Specialized Research Fund for the Doctoral Program of Higher Education (20123234110001), Jiangsu Provincial Graduates Innovative Project (CXZZ12_0594), the Qing-Lan Project of Jiangsu Provincial Department of Education, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkar AA, 2003, CANCER RES, V63, P8108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chu HY, 2013, J BIOMED RES, V27, P170, DOI 10.7555/JBR.27.20130026; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Garcia-Closas M, 2011, HUM MOL GENET, V20, P4282, DOI 10.1093/hmg/ddr342; Han S, 2013, ONCOLOGY PROCESS, V11, P89; Han YH, 2013, J SURG ONCOL, V107, P201, DOI 10.1002/jso.23214; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kiriluk KJ, 2012, UROL ONCOL-SEMIN ORI, V30, P199, DOI 10.1016/j.urolonc.2011.10.010; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; Lee J. M., 2012, ONCOGENE, DOI 10.1038/onc.2012.551; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qin Y, 2012, REPROD BIOMED ONLINE; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Weng Y, 2013, CANC EPIDEMIOL; Wu DY, 2012, MOL MED REP, V5, P695, DOI 10.3892/mmr.2011.711; Wu XF, 2008, BJU INT, V102, P1207, DOI 10.1111/j.1464-410X.2008.07961.x; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060687	41	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81524	10.1371/journal.pone.0081524	http://dx.doi.org/10.1371/journal.pone.0081524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312312	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900038
J	Gandon, E; Bootsma, RJ; Endler, JA; Grosman, L				Gandon, Enora; Bootsma, Reinoud J.; Endler, John A.; Grosman, Leore			How Can Ten Fingers Shape a Pot? Evidence for Equivalent Function in Culturally Distinct Motor Skills	PLOS ONE			English	Article							ACQUISITION; EVOLUTION; PERCEPTION; NICHE	Behavioural variability is likely to emerge when a particular task is performed in different cultural settings, assuming that part of human motor behaviour is influenced by culture. In analysing motor behaviour it is useful to distinguish how the action is performed from the result achieved. Does cultural environment lead to specific cultural motor skills? Are there differences between cultures both in the skills themselves and in the corresponding outcomes? Here we analyse the skill of pottery wheel-throwing in French and Indian cultural environments. Our specific goal was to examine the ability of expert potters from distinct cultural settings to reproduce a common model shape (a sphere). The operational aspects of motor performance were captured through the analysis of the hand positions used by the potters during the fashioning process. In parallel, the outcomes were captured by the geometrical characteristics of the vessels produced. As expected, results revealed a cultural influence on the operational aspects of the potters' motor skill. Yet, the marked cultural differences in hand positions used did not give rise to noticeable differences in the shapes of the vessels produced. Hence, for the simple model form studied, the culturally-specific motor traditions of the French and Indian potters gave rise to an equivalent outcome, that is shape uniformity. Further work is needed to test whether such equivalence is also observed in more complex ceramic shapes.	[Gandon, Enora; Grosman, Leore] Hebrew Univ Jerusalem, Inst Archaeol, Computerized Archaeol Lab, Jerusalem, Israel; [Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Endler, John A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia	Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Deakin University	Gandon, E (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Computerized Archaeol Lab, Jerusalem, Israel.	gandon.enora@gmail.com	Bootsma, Reinoud/B-1254-2008; Grosman, Leore/C-7010-2014; Grosman, Leore/GRJ-0792-2022; Endler, John A/B-6659-2009	Bootsma, Reinoud/0000-0002-3719-7586; Grosman, Leore/0000-0002-6976-6202; Grosman, Leore/0000-0002-6976-6202; Endler, John A/0000-0002-7557-7627	Aix-Marseille University; Fyssen foundation	Aix-Marseille University; Fyssen foundation	This study was funded by Aix-Marseille University http://www.univ-amu.fr/) and the Fyssen foundation (http://www.fondationfyssen.fr/), who provided EG's salary for PhD and post-doc positions, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abood SA, 2001, J MOTOR BEHAV, V33, P295, DOI 10.1080/00222890109601915; Bateson G, 1977, ACTES RECH SCI SOC, V14, P3; Bernstein N.A., 1967, COORDINATION REGULAT; Bosch, 1998, MODELS HUMAN MOVEMEN, P51; Boyer I, 2001, P INT C MOT DEV LEAR, P55; Bril B, 2002, GESTE TECHNIQUE REFL, P113; Bril B., 2002, INTELLECTIA, V2, P251, DOI DOI 10.3406/INTEL.2002.1669; Bril B., 1986, THEMES MOTOR DEV, P315; Bril B., 2009, INTELLECTICA, V51, P273; Bril B, 2012, PHILOS T R SOC B, V367, P59, DOI 10.1098/rstb.2011.0147; Gandon E, 2011, J ARCHAEOL SCI, V38, P1080, DOI 10.1016/j.jas.2010.12.003; Gibson JJ, 1979, ECOLOGICAL APPROACH; Handford C, 1997, J SPORT SCI, V15, P621, DOI 10.1080/026404197367056; Haudricourt A., 1948, REV GEOGRAPHIE HUMAI, V1, P58; Haudricourt AG, 1987, TECHNOLOGIE SCI HUMA; Hewes GW, 1955, AM ANTHROPOL, V57, P231, DOI 10.1525/aa.1955.57.2.02a00040; Hirschfeld N, 2008, NEAR EAST ARCHAEOL, V71, P120, DOI 10.1086/NEA20361356; Jacobs DM, 2007, ECOL PSYCHOL, V19, P321, DOI 10.1080/10407410701432337; Janelle CM, 2003, J SPORT SCI, V21, P825, DOI 10.1080/0264041031000140310; Karasik A, 2011, J ARCHAEOL SCI, V38, P2644, DOI 10.1016/j.jas.2011.05.023; Knappett C., 2005, ANATOL STUD, V55, P25, DOI DOI 10.1017/S0066154600000648; Kramer Carol, 1997, POTTERY RAJASTHAN ET; Kugler PN, 1987, INFORM NATURAL LAW S; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Mauss M, 1936, J PSYCHOL, V32; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; Neuman B, 2013, MOVEMENT SPORT SCI, V1, P11; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; ODLINGSMEE FJ, 1996, BEHAV PROCESS, V35, P195; Orton C., 1993, POTTERY ARCHAEOLOGY; Pierret A., 1995, ANAL TECHNOLOGIQUE C; Quinn P.S., 2009, INTERPRETING SILENT; Read D, 2009, ARTIFACT CLASSIFICAT; REED ES, 1996, RES ECOL PS, P431; Rice P.M., 1987, POTTERY ANAL SOURCEB; Roux V., 1990, TOUR POTIER SPECIALI; Roux V, 2013, J ARCHAEOL METHOD TH, V20, P312, DOI 10.1007/s10816-012-9153-4; Rye O.S., 1981, MANUALS ARCHAEOLOGY, V4; Saraswati B, 1966, POTTERY TECHNIQUES P, V13; SCULLY DM, 1985, J HUM MOVEMENT STUD, V11, P169; Shepard Anna O., 1956, CERAMICS ARCHAEOLOGI, V609; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; WADDINGTON CH, 1959, NATURE, V183, P1634, DOI 10.1038/1831634a0; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Whitehouse H., 2001, DEBATED MIND EVOLUTI, P113	47	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81614	10.1371/journal.pone.0081614	http://dx.doi.org/10.1371/journal.pone.0081614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261GG	24312327	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100089
J	Hu, XS				Hu, Xin-Sheng			Evolution of Zygotic Linkage Disequilibrium in a Finite Local Population	PLOS ONE			English	Article							COMPLEX ALLOZYME POLYMORPHISMS; INBREEDING COEFFICIENTS; PROGENY VIGOR; GENE FLOW; SELECTION; POLLEN; SEED; HOMOZYGOSITY; PREDICTION; MIGRATION	One crucial feature of zygotic linkage disequilibrium D) analysis use of plaid genotyping data, irrespective he type of mating Previous theories from an evolutionary perspective mainly focus on gametic LD, but the equivalent development for zygotic is not available. Here I study the evolution of zygotic LD and the covariances between gametic and zygotic LDs or between distinct zygotic LDs in a finite local population under constant immigration from a continent population. I derive the analytical theory under genetic hitchhiking effects or in a neutral process. Result indicate that zygotic LDs (diploid level) are more informative than gametic LD (haploid level) in indicating the effects of different evolutionary forces. Zygotic LDs may be greater than or comparable to gametic LD under the epistatic selection process, but smaller than gametic LD under the non epistatic selection process. The covariances between gametic and zygotic LDs are strongly affected by the mating system, linkage distance, and genetic drift effects, but weakly affected by seed and pollen flow and natural selection. The covariances between different zygotic LDs are generally robust to the effects of gene flow, selection, and linkage distance, but sensitive to the effects of genetic drift and mating system Consistent patterns exist for he covariances between the zygotic LDs for the two-locus genotypes with one common genotype at one locus or without any common genotype at each locus. The results highlight hat zygotic LDs can be applied to detecting natural population history.	Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Hu, XS (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	xin-sheng.hu@plants.ox.ac.uk						Adams WT, 1997, CAN J FOREST RES, V27, P131, DOI 10.1139/cjfr-27-1-131; AVERY PJ, 1979, GENETICS, V91, P817; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; BENNETT J. H., 1956, HEREDITY, V10, P51, DOI 10.1038/hdy.1956.3; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; CHARLESWORTH D, 1989, NATURE, V338, P21, DOI 10.1038/338021a0; CHARLESWORTH D, 1992, EVOLUTION, V46, P703, DOI [10.2307/2409639, 10.1111/j.1558-5646.1992.tb02077.x]; CLARK AG, 1984, GENETICS, V107, P679; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1937; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Gavrilets S, 1997, EVOLUTION, V51, P1027, DOI 10.2307/2411031; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Haldane JBS, 1932, AM NAT, V66, P5, DOI 10.1086/280406; Hernandez-Sanchez J, 2004, GENET RES, V83, P113, DOI 10.1017/S0016672303006633; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hill WG, 2007, THEOR POPUL BIOL, V72, P179, DOI 10.1016/j.tpb.2006.05.006; Hu XS, 2008, EVOLUTION, V62, P2260, DOI 10.1111/j.1558-5646.2008.00439.x; Hu XS, 2011, GENET RES, V93, P233, DOI 10.1017/S0016672311000127; Hu XS, 2011, CURR GENOMICS, V12, P55, DOI 10.2174/138920211794520141; Hu XS, 2005, THEOR POPUL BIOL, V68, P119, DOI 10.1016/j.tpb.2005.02.003; Hu XS, 2005, J THEOR BIOL, V235, P207, DOI 10.1016/j.jtbi.2005.01.004; Hu XS, 2004, THEOR APPL GENET, V109, P996, DOI 10.1007/s00122-004-1705-x; Hu XS, 1999, GENETICS, V152, P441; Hudson RR, 1998, MOL ECOL, V7, P413, DOI 10.1046/j.1365-294x.1998.00344.x; Jiang Q, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-65; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; LEVIN DA, 1988, AM NAT, V132, P643, DOI 10.1086/284879; LEWONTIN RC, 1964, GENETICS, V49, P49; Liu T, 2006, GENETICS, V174, P439, DOI 10.1534/genetics.106.060137; MALLET J, 1990, GENETICS, V124, P921; Mitchell RJ, 1997, EVOLUTION, V51, P1679, DOI 10.1111/j.1558-5646.1997.tb01490.x; Mitton J. B., 1992, New Forests, V6, P197, DOI 10.1007/BF00120645; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Mulcahy DL, 1996, SEX PLANT REPROD, V9, P353, DOI 10.1007/BF02441955; Muller HJ, 1942, BIOL S, V6, P71; Niesenbaum RA, 1999, AM J BOT, V86, P261, DOI 10.2307/2656941; Nordborg M, 1996, GENET RES, V67, P159, DOI 10.1017/S0016672300033619; OHTA T, 1970, GENET RES, V16, P165, DOI 10.1017/S0016672300002391; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; PRESS WH, 1991, NUMERICAL RECIPES C; Robbins RB, 1918, GENETICS, V3, P375; ROBERTSON A, 1952, GENETICS, V37, P188; Rosenberg NA, 2007, MATH BIOSCI, V208, P33, DOI 10.1016/j.mbs.2006.07.001; Sabatti C, 2002, GENETICS, V160, P1707; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Snow AA, 1996, EVOLUTION, V50, P1866, DOI [10.2307/2410744, 10.1111/j.1558-5646.1996.tb03573.x]; SORENSEN FC, 1982, EVOLUTION, V36, P725, DOI 10.1111/j.1558-5646.1982.tb05438.x; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7; Sved JA, 1968, THEORETICAL POPULATI, V2, P125; TANKSLEY SD, 1981, SCIENCE, V213, P453, DOI 10.1126/science.213.4506.453; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1974, GENETICS, V78, P911; WEIR BS, 1972, GENETICS, V72, P505; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Wolfram Research Inc., 2008, MATH VERS 7 0; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wu S, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1578; Yang RC, 2003, GENETICS, V165, P447; Yang RC, 2002, GENETICS, V161, P435; Zollner S, 2008, ENCY LIFE SCI	73	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80538	10.1371/journal.pone.0080538	http://dx.doi.org/10.1371/journal.pone.0080538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312231	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100046
J	Luef, EM; Pike, S				Luef, Eva Maria; Pike, Simone			Gorilla Mothers Also Matter! New Insights on Social Transmission in Gorillas (Gorilla gorilla gorilla) in Captivity	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; TOOL USE; GESTURAL COMMUNICATION; FEEDING-BEHAVIOR; INFORMATION; REPERTOIRE; IMITATION; EVOLUTION; PANISCUS; CULTURE	The present paper describes two distinct behaviors relating to food processing and communication that were observed in a community of five separately housed groups of lowland gorillas (Gorilla gorilla gorilla) in captivity during two study periods one decade apart: (1) a food processing technique to separate wheat from chaff, the so-called PUFF-BLOWING technique; and (2) a male display used to attract the attention of visitors, the so-called THROW-KISS-DISPLAY. We investigated (a) whether the behaviors were transmitted within the respective groups; and if yes, (b) their possible mode of transmission. Our results showed that only the food processing technique spread from three to twenty-one individuals during the ten-year period, whereas the communicative display died out completely. The main transmission mode of the PUFF-BLOWING technique was the mother-offspring dyad: offspring of PUFF-BLOWING mothers showed the behavior, while the offspring of non- PUFF-BLOWING mothers did not. These results strongly support the role mothers play in the acquisition of novel skills and vertical social transmission. Furthermore, they suggest that behaviors, which provide a direct benefit to individuals, have a high chance of social transmission while the loss of benefits can result in the extinction of behaviors.	[Luef, Eva Maria; Pike, Simone] Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Seewiesen, Germany	Max Planck Society	Pike, S (corresponding author), Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Seewiesen, Germany.	spika@orn.mpg.de	Luef, Eva/AAN-6158-2020	Pika, Simone/0000-0002-4398-2337	Fritz-Thyssen Foundation, Germany [Az. 40.12.0.005]; Sofja Kovalevskaja Award, Alexander-von-Humboldt Foundation, Germany	Fritz-Thyssen Foundation, Germany; Sofja Kovalevskaja Award, Alexander-von-Humboldt Foundation, Germany	Funding for EML: Fritz-Thyssen Foundation, Germany, www.fritz-thyssen-stiftung.de, grant number: Az. 40.12.0.005. Funding for SP: Sofja Kovalevskaja Award, Alexander-von-Humboldt Foundation, Germany (humboldt-foundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allritz M, 2013, PRIMATES; Altmann D, 1991, PRACTICAL STAT MED R; Aspinall J, 1976, BEST FRIENDS; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Boesch C, 1998, CURR ANTHROPOL, V39, P591, DOI 10.1086/204785; Boyd R., 1988, P29; Boyd R., 1985, CULTURE EVOLUTIONARY; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Byrne RW, 2003, PHILOS T R SOC B, V358, P529, DOI 10.1098/rstb.2002.1219; Byrne RW, 2002, INT J PRIMATOL, V23, P539, DOI 10.1023/A:1014917600198; Byrne RW, 2011, ANIMAL COGNITION, V14, P5; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; Cronin KA, 2012, P ROYAL SOC B; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dindo M, 2011, BIOL LETTERS, V7, P181, DOI 10.1098/rsbl.2010.0637; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Field A., 2009, DISCOVERING STAT USI; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Galef B.G. Jr, 1990, P74; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Heyes CM, 2000, LEARN MOTIV, V31, P83, DOI 10.1006/lmot.1999.1041; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huffman MA, 2010, ANIM COGN, V13, P871, DOI 10.1007/s10071-010-0335-8; Huffman MA, 2008, CURR DIR PSYCHOL SCI, V17, P410, DOI 10.1111/j.1467-8721.2008.00616.x; INGMANSON EJ, 1987, AM J PHYS ANTHROPOL, V72, P214; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; King Barbara J, 1994, INFORM CONTINUUM EVO; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Leadbeater E, 2006, CURR BIOL, V16, pR323, DOI 10.1016/j.cub.2006.03.078; Luef EM, 2012, J PRIMATOLO IN PRESS; Maestripieri D, 2002, J COMP PSYCHOL, V116, P219, DOI 10.1037//0735-7036.116.3.219; Martin P., 1994, MEASURING BEHAV INTR, V3rd; Masi S, 2011, ANIM COGN, V14, P921, DOI 10.1007/s10071-011-0457-7; McGrew W.C., 2010, P168; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; MCGREW WC, 1978, MAN, V13, P234, DOI 10.2307/2800247; Mentz I, 1998, ZOOL GARTEN N E, V69, P49; MORI A, 1983, Primates, V24, P486, DOI 10.1007/BF02381682; NAGELL K, 1993, J COMP PSYCHOL, V107, P174, DOI 10.1037/0735-7036.107.2.174; Nahallage CAD, 2007, BEHAVIOUR, V144, P1193, DOI 10.1163/156853907781890959; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; Nishida T., 1987, P462; Nowell AA, 2008, BEHAVIOUR, V145, P171, DOI 10.1163/156853907783244747; Parnell RJ, 2001, NATURE, V412, P294, DOI 10.1038/35085631; PEACOCK MM, 1988, BEHAV ECOL SOCIOBIOL, V22, P393, DOI 10.1007/BF00294976; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pika S, 2003, AM J PRIMATOL, V60, P95, DOI 10.1002/ajp.10097; Pika S, 2001, PRIMATES, V42, P167, DOI 10.1007/BF02558144; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Stoinski TS, 2001, J COMP PSYCHOL, V115, P272, DOI 10.1037//0735-7036.115.3.272; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Tanner J.E., 1998, THESIS U ST ANDREWS; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Tennie C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041548; Tomasello M, 1998, BEHAV BRAIN SCI, V21, P703, DOI 10.1017/S0140525X98441748; Tomasello M, 1997, PRIMATE COGNITION; van Schaik CP, 2012, CURR BIOL, V22, pR402, DOI 10.1016/j.cub.2012.04.001; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; Visalberghi E, 2000, ANIM BEHAV, V60, P69, DOI 10.1006/anbe.2000.1425; WATTS DP, 1985, AM J PRIMATOL, V8, P1, DOI 10.1002/ajp.1350080102; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Wittiger L, 2007, AM J PRIMATOL, V69, P1307, DOI 10.1002/ajp.20436; Wrangham R. W., 1994, CHIMPANZEE CULTURES	79	3	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79600	10.1371/journal.pone.0079600	http://dx.doi.org/10.1371/journal.pone.0079600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312184	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100013
J	Morais, LLCD; Garza, DR; Loureiro, ECB; Vale, ER; Santos, DSAD; Correa, VC; Sousa, NR; Gurjao, TCM; Santos, ECD; Vieira, VV; da Fonseca, EL; Vicente, ACP				Canto de Sa Morais, Lena Lillian; Garza, Daniel Rios; Brito Loureiro, Edvaldo Carlos; Vale, Elivam Rodrigues; Amorim de Sousa Santos, Denise Suellem; Correa, Vanessa Cavaleiro; Sousa, Nayara Rufino; Monteiro Gurjao, Tereza Cristina; de Oliveira Santos, Elisabeth Conceicao; Vieira, Veronica Viana; da Fonseca, Erica Lourenco; Paulo Vicente, Ana Carolina			Population and Genetic Study of Vibrio cholerae from the Amazon Environment Confirms that the WASA-1 Prophage Is the Main Marker of the Epidemic Strain that Circulated in the Region	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; NON-O1/NON-O139 STRAINS; GENOMIC DIVERSITY; O1; VIRULENCE; BRAZIL; WATER; IDENTIFICATION; TEMPERATURE; PATTERNS	Vibrio cholerae is a natural inhabitant of many aquatic environments in the world. Biotypes harboring similar virulence-related gene clusters are the causative agents of epidemic cholera, but the majority of strains are harmless to humans. Since 1971, environmental surveillance for potentially pathogenic V. cholerae has resulted in the isolation of many strains from the Brazilian Amazon aquatic ecosystem. Most of these strains are from the non-O1/non-O139 serogroups (NAGs), but toxigenic O1 strains were isolated during the Latin America cholera epidemic in the region (1991-1996). A collection of environmental V. cholerae strains from the Brazilian Amazon belonging to pre-epidemic (1977-1990), epidemic (1991-1996), and post-epidemic (1996-2007) periods in the region, was analyzed. The presence of genes related to virulence within the species and the genetic relationship among the strains were studied. These variables and the information available concerning the strains were used to build a Bayesian multivariate dependency model to distinguish the importance of each variable in determining the others. Some genes related to the epidemic strains were found in environmental NAGs during and after the epidemic. Significant diversity among the virulence-related gene content was observed among O1 strains isolated from the environment during the epidemic period, but not from clinical isolates, which were analyzed as controls. Despite this diversity, these strains exhibited similar PFGE profiles. PFGE profiles were significant while separating potentially epidemic clones from indigenous strains. No significant correlation with isolation source, place or period was observed. The presence of the WASA-1 prophage significantly correlated with serogroups, PFGE profiles, and the presence of virulence-related genes. This study provides a broad characterization of the environmental V. cholerae population from the Amazon, and also highlights the importance of identifying precisely defined genetic markers such as the WASA-1 prophage for the surveillance of cholera.	[Canto de Sa Morais, Lena Lillian; Garza, Daniel Rios; Vale, Elivam Rodrigues; Amorim de Sousa Santos, Denise Suellem; Correa, Vanessa Cavaleiro; Sousa, Nayara Rufino; Monteiro Gurjao, Tereza Cristina; de Oliveira Santos, Elisabeth Conceicao] Evandro Chagas Inst, Environm Sect, Ananindeua, Para, Brazil; [Brito Loureiro, Edvaldo Carlos] Evandro Chagas Inst, Bacteriol Sect, Ananindeua, Para, Brazil; [Vieira, Veronica Viana; da Fonseca, Erica Lourenco; Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Lab Mol Genet Microorganisms, Rio De Janeiro, Brazil	Instituto Evandro Chagas; Instituto Evandro Chagas; Fundacao Oswaldo Cruz	Morais, LLCD (corresponding author), Evandro Chagas Inst, Environm Sect, Ananindeua, Para, Brazil.	lenasa@iec.pa.gov.br	Garza, Daniel/AAN-8016-2021; Garza, Daniel Rios/A-1716-2016; Garza, Daniel/AAF-6237-2019	Garza, Daniel/0000-0003-3865-2146; Garza, Daniel Rios/0000-0001-5956-6832; 	Evandro Chagas Institute; CNPq; CAPES	Evandro Chagas Institute; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by the Evandro Chagas Institute, CNPq, and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, APPL ENVIRON MICROB, V72, P4096, DOI 10.1128/AEM.00066-06; Borroto RJ, 2000, INT J EPIDEMIOL, V29, P764, DOI 10.1093/ije/29.4.764; Brazil JMV, 2002, FEMS MICROBIOL LETT, V215, P15; Morais LLCD, 2012, J BACTERIOL, V194, P2772, DOI 10.1128/JB.00300-12; Chakraborty S, 2000, APPL ENVIRON MICROB, V66, P4022, DOI 10.1128/AEM.66.9.4022-4028.2000; Cho YJ, 2010, CURR OPIN MICROBIOL, V13, P646, DOI 10.1016/j.mib.2010.08.007; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COELHO A, 1995, RES MICROBIOL, V146, P671, DOI 10.1016/0923-2508(96)81064-3; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; Colombara DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054395; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; COOPER DB, 1975, B NEW YORK ACAD MED, V51, P672; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Theophilo Grace Nazareth Diogo, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P65, DOI 10.1590/S0036-46652006000200002; FARUQUE SM, 1995, J CLIN MICROBIOL, V33, P2833, DOI 10.1128/JCM.33.11.2833-2838.1995; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Garza DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037283; GOODGAME RW, 1975, ANN INTERN MED, V82, P101, DOI 10.7326/0003-4819-82-1-101; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; HASAN NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI DOI 10.1073/pnas.1207359109; Hassan F, 2010, NATURE, V467, P982, DOI 10.1038/nature09469; HUQ A, 1984, APPL ENVIRON MICROB, V48, P420, DOI 10.1128/AEM.48.2.420-424.1984; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Jensen FV, 2007, BAYESIAN NETWORKS DE; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Kirschner AKT, 2008, APPL ENVIRON MICROB, V74, P2004, DOI 10.1128/AEM.01739-07; Leal NC, 2008, T ROY SOC TROP MED H, V102, P272, DOI 10.1016/j.trstmh.2007.12.008; LEVINE MM, 1982, J INFECT DIS, V145, P296, DOI 10.1093/infdis/145.3.296; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Myllymaki P., 2002, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V11, P369, DOI 10.1142/S0218213002000940; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; POPOVIC T, 1993, J CLIN MICROBIOL, V31, P2474, DOI 10.1128/JCM.31.9.2474-2482.1993; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Rosewell A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-287; Ruiz-Moreno D, 2007, ECOHEALTH, V4, P52, DOI 10.1007/s10393-006-0079-8; Sa LLC, 2012, BRAZ J MICROBIOL, V43, P635, DOI 10.1590/S1517-83822012000200027; SALLES CA, 1991, T ROY SOC TROP MED H, V85, P544, DOI 10.1016/0035-9203(91)90251-S; Sambrook J, 2001, MOL CLONING LAB MANU; Sidley P, 2008, BRIT MED J, V336, P471, DOI 10.1136/bmj.39503.700903.DB; Silander T, 2012, ARXIV PREPRINT ARXIV; Speelmon EC, 2000, JAMA-J AM MED ASSOC, V283, P3072, DOI 10.1001/jama.283.23.3072-a; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson FL, 2003, J CLIN MICROBIOL, V41, P1946, DOI 10.1128/JCM.41.5.1946-1950.2003; Trucksis M, 2000, AM J PHYSIOL-CELL PH, V279, pC567, DOI 10.1152/ajpcell.2000.279.3.C567; Vicente ACR, 2005, EMERG INFECT DIS, V11, P171; WACHSMUTH IK, 1991, LANCET, V337, P1097; Waldman EA, 2002, J HEALTH POPUL NUTR, V20, P85; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Worden AZ, 2006, ENVIRON MICROBIOL, V8, P21, DOI 10.1111/j.1462-2920.2005.00863.x	58	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81372	10.1371/journal.pone.0081372	http://dx.doi.org/10.1371/journal.pone.0081372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303045	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400062
J	Centanni, M; Turron, S; Consolandi, C; Rampelli, S; Peano, C; Severgnini, M; Biagi, E; Caredda, G; De Bellis, G; Brigidi, P; Candela, M				Centanni, Manuela; Turron, Silvia; Consolandi, Clarissa; Rampelli, Simone; Peano, Clelia; Severgnini, Marco; Biagi, Elena; Caredda, Giada; De Bellis, Gianluca; Brigidi, Patrizia; Candela, Marco			The Enterocyte-Associated Intestinal Microbiota of Breast-Fed Infants and Adults Responds Differently to a TNF-alpha-Mediated Pro-Inflammatory Stimulus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; POLYMERIC IG RECEPTOR; REAL-TIME PCR; GUT MICROBIOTA; GENE-EXPRESSION; BACTERIAL ADHESION; EARLY-LIFE; DIVERSITY; MODULATION; CELLS	Co-evolved as an integral component of our immune system, the gut microbiota provides specific immunological services at different ages, supporting the immune education during our infancy and sustaining a well-balanced immunological homeostasis during the course of our life. In order to figure out whether this involves differences in the microbial groups primarily interacting with the host immune system, we developed a non-invasive HT29 cell-based minimal model to fingerprint the enterocyte-associated microbiota fraction in infants and adults. After depicting the fecal microbial community of 12 breast-fed infants and 6 adults by 16S rDNA amplicon pools 454 pyrosequencing, their respective HT29 cell-associated gut microbiota fractions were characterized by the universal phylogenetic array platform HTF-Microbi. Array, both in the presence and absence of a tumor necrosis factor-alpha (TNF-alpha)-mediated pro-inflammatory stimulus. Our data revealed remarkable differences between the enterocyte-associated microbiota fractions in breast-fed infants and adults, being dominated by Bifidobacterium and Enterobacteriaceae the first and Bacteroides-Prevotella and Clostridium clusters IV and XIVa the second. While in adults TNF-alpha resulted in a profound impairment of the structure of the enterocyte-associated microbiota fraction, in infants it remained unaffected. Differently from the adult-type gut microbial community, the infant-type microbiota is structured to cope with inflammation, being co-evolved to prime the early immune response by means of transient inflammatory signals from gut microorganisms.	[Centanni, Manuela; Turron, Silvia; Rampelli, Simone; Biagi, Elena; Brigidi, Patrizia; Candela, Marco] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Consolandi, Clarissa; Peano, Clelia; Severgnini, Marco; Caredda, Giada; De Bellis, Gianluca] Italian Natl Res Council, Inst Biomed Technol, Milan, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Candela, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	marco.candela@unibo.it	Severgnini, Marco/F-5832-2013; Rampelli, Simone/K-5675-2016; De Bellis, Gianluca/H-9725-2013; Peano, Clelia/C-4015-2018	Severgnini, Marco/0000-0001-8655-1206; Rampelli, Simone/0000-0002-5655-6695; De Bellis, Gianluca/0000-0002-1622-4477; Peano, Clelia/0000-0001-7055-3629; Brigidi, Patrizia/0000-0001-8375-6150				Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Battersby AJ, 2013, PEDIAT ALLERG IMM-UK, V24, P414, DOI 10.1111/pai.12079; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Candela M, 2005, RES MICROBIOL, V156, P887, DOI 10.1016/j.resmic.2005.04.006; Candela M, 2015, CRIT REV MICROBIOL, V41, P165, DOI 10.3109/1040841X.2013.813900; Candela M, 2012, TRENDS MICROBIOL, V20, P385, DOI 10.1016/j.tim.2012.05.003; Candela M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-95; Candela M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-116; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centanni M, 2013, FEMS MICROBIOL LETT, V343, P121, DOI 10.1111/1574-6968.12138; Centanni M, 2012, APPL ENVIRON MICROB, V78, P2465, DOI 10.1128/AEM.07883-11; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dolan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047300; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hess DJ, 2002, J SURG RES, V104, P88, DOI 10.1006/jsre.2002.6417; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Kavanaugh DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067224; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; KVALE D, 1988, J IMMUNOL, V140, P3086; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Neutra M, 1989, FUNCTIONAL EPITHELIA, P363; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ouwehand AC, 2004, MICROBIOL IMMUNOL, V48, P497, DOI 10.1111/j.1348-0421.2004.tb03544.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Porath D, 2005, J PHARMACOL EXP THER, V315, P1172, DOI 10.1124/jpet.105.090167; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2008, CURR OPIN GASTROEN, V24, P435, DOI 10.1097/MOG.0b013e32830007f7; Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	61	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81762	10.1371/journal.pone.0081762	http://dx.doi.org/10.1371/journal.pone.0081762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303069	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400085
J	Miller, E; Huppert, A				Miller, Ezer; Huppert, Amit			The Effects of Host Diversity on Vector-Borne Disease: The Conditions under Which Diversity Will Amplify or Dilute the Disease Risk	PLOS ONE			English	Article							WEST-NILE-VIRUS; POPULATION-DYNAMICS; FEEDING PREFERENCES; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; BIODIVERSITY LOSS; TRANSMISSION; ECOLOGY; PATHOGENS; MODEL	Multihost vector-borne infectious diseases form a significant fraction of the global infectious disease burden. In this study we explore the relationship between host diversity, vector behavior, and disease risk. To this end, we have developed a new dynamic model which includes two distinct host species and one vector species with variable preferences. With the aid of the model we were able to compute the basic reproductive rate, R-0, a well-established measure of disease risk that serves as a threshold parameter for disease outbreak. The model analysis reveals that the system has two different qualitative behaviors: (i) the well-known dilution effect, where the maximal R-0 is obtained in a community which consists a single host (ii) a new amplification effect, denoted by us as diversity amplification, where the maximal R-0 is attained in a community which consists both hosts. The model analysis extends on previous results by underlining the mechanism of both, diversity amplification and the dilution, and specifies the exact conditions for their occurrence. We have found that diversity amplification occurs where the vector prefers the host with the highest transmission ability, and dilution is obtained when the vector does not show any preference, or it prefers to bite the host with the lower transmission ability. The mechanisms of dilution and diversity amplification are able to account for the different and contradictory patterns often observed in nature (i.e., in some cases disease risk is increased while in other is decreased when the diversity is increased). Implication of the diversity amplification mechanism also challenges current premises about the interaction between biodiversity, climate change, and disease risk and calls for retrospective thinking in planning intervention policies aimed at protecting the preferred host species.	[Miller, Ezer] Hebrew Univ Jerusalem, Fac Med, Microbiol & Mol Genet Dept, Jerusalem, Israel; [Miller, Ezer; Huppert, Amit] Gertner Inst Epidemiol & Hlth Policy Res, Biostat Unit, Ramat Gan, Israel	Hebrew University of Jerusalem	Miller, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Microbiol & Mol Genet Dept, Jerusalem, Israel.	ezermiller@gmail.com			Bill and Melinda Gates Foundation [OPPGH5336]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill and Melinda Gates Foundation Global Health Program [grant number OPPGH5336; http://www.gatesfoundation.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Brooks CP, 2010, J THEOR BIOL, V264, P866, DOI 10.1016/j.jtbi.2010.03.016; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Campbell-Lendrum D, 2005, ECOSYSTEMS HUMAN WEL, P353; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dobson A., 1992, GLOBAL WARMING POTEN; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Hall SR, 2009, ECOLOGY, V90, P791, DOI 10.1890/08-0838.1; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loss SR, 2009, OECOLOGIA, V159, P415, DOI 10.1007/s00442-008-1224-6; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Muriu SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-43; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2009, CLIN MICROBIOL INFEC, V15, P40, DOI 10.1111/j.1469-0691.2008.02691.x; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; ROGERS DJ, 1988, PHILOS T R SOC B, V321, P513, DOI 10.1098/rstb.1988.0106; Ross R., 1910, PREVENTION MALARIA; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Slowik TJ, 2009, J MED ENTOMOL, V46, P115, DOI 10.1603/033.046.0115; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO, 2004, WHOCDSCPEPVC200410; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	48	40	43	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80279	10.1371/journal.pone.0080279	http://dx.doi.org/10.1371/journal.pone.0080279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303003	Green Published, gold			2022-12-25	WOS:000327546400019
J	Noel, PB; Renger, B; Fiebich, M; Munzel, D; Fingerle, AA; Rummeny, EJ; Dobritz, M				Noel, Peter B.; Renger, Bernhard; Fiebich, Martin; Muenzel, Daniela; Fingerle, Alexander A.; Rummeny, Ernst J.; Dobritz, Martin			Does Iterative Reconstruction Lower CT Radiation Dose: Evaluation of 15,000 Examinations	PLOS ONE			English	Article							IMAGE QUALITY; ALGORITHM; ROUTINE	Purpose: Evaluation of 15,000 computed tomography (CT) examinations to investigate if iterative reconstruction (IR) reduces sustainably radiation exposure. Method and Materials: Information from 15,000 CT examinations was collected, including all aspects of the exams such as scan parameter, patient information, and reconstruction instructions. The examinations were acquired between January 2010 and December 2012, while after 15 months a first generation IR algorithm was installed. To collect the necessary information from PACS, RIS, MPPS and structured reports a Dose Monitoring System was developed. To harvest all possible information an optical character recognition system was integrated, for example to collect information from the screenshot CT-dose report. The tool transfers all data to a database for further processing such as the calculation of effective dose and organ doses. To evaluate if IR provides a sustainable dose reduction, the effective dose values were statistically analyzed with respect to protocol type, diagnostic indication, and patient population. Results: IR has the potential to reduce radiation dose significantly. Before clinical introduction of IR the average effective dose was 10.1 +/- 7.8mSv and with IR 8.9 +/- 7.1mSv (p*=0.01). Especially in CTA, with the possibility to use kV reduction protocols, such as in aortic CTAs (before IR: average14.2 +/- 7.8mSv; median11.4mSv /with IR: average9.9 +/- 7.4mSv; median7.4mSv), or pulmonary CTAs (before IR: average9.7 +/- 6.2mSV; median7.7mSv /with IR: average6.4 +/- 4.7mSv; median4.8mSv) the dose reduction effect is significant(p*=0.01). On the contrary for unenhanced low-dose scans of the cranial (for example sinuses) the reduction is not significant (before IR: average6.6 +/- 5.8mSv; median3.9mSv/with IR: average6.0 +/- 3.1mSV; median3.2mSv). Conclusion: The dose aspect remains a priority in CT research. Iterative reconstruction algorithms reduce sustainably and significantly radiation dose in the clinical routine. Our results illustrate that not only in studies with a limited number of patients but also in the clinical routine, IRs provide long-term dose saving.	[Noel, Peter B.; Renger, Bernhard; Muenzel, Daniela; Fingerle, Alexander A.; Rummeny, Ernst J.; Dobritz, Martin] Tech Univ Munich, Dept Diagnost Intervent Radiol, D-80290 Munich, Germany; [Fiebich, Martin] Univ Appl Sci, Inst Med Phys & Radiat Protect, Giessen, Germany	Technical University of Munich	Noel, PB (corresponding author), Tech Univ Munich, Dept Diagnost Intervent Radiol, D-80290 Munich, Germany.	peter.noel@tum.de		Noel, Peter/0000-0002-9671-6171	German Federal Ministry of Education and Research (BMBF) [02NUK088C]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) under grant 02NUK088C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongartz G, 2012, CT QUALITY CRITERIA; Chen GH, 2009, MED PHYS, V36, P2130, DOI 10.1118/1.3130018; Cody DD, 2013, J APPL CLIN MED PHYS, V14, P3, DOI 10.1120/jacmp.v14i5.4462; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Gramer BM, 2012, EUR RADIOL, V22, P2654, DOI 10.1007/s00330-012-2525-z; Grant K, 2013, ITERATIVE RECONSTRUC; Grant K, 2013, SAFIRE SINOGRAM AFFI; Hsieh J, 2010, ASIR DEMONSTRATES AD; Irwan R, 2011, AIDR 3D REDUCES DOSE; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Leipsic J, 2010, AM J ROENTGENOL, V195, P655, DOI 10.2214/AJR.10.4288; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Nagel HD, 1999, STRAHLENEXPOSITION C; Noel PB, 2012, RSNA 98 SCI ASS ANN; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Schauer DA, 2009, HEALTH PHYS, V97, P1, DOI 10.1097/01.HP.0000356672.44380.b7; Scibelli A., 2011, IDOSE4 ITERATIVE REC; Stamm G, 2013, CT EXPO EXCEL PROGRA; Thibault J.B., 2010, GE HEALTHCARE CHALFO, P1; von Falck C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056875	24	61	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81141	10.1371/journal.pone.0081141	http://dx.doi.org/10.1371/journal.pone.0081141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303035	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400052
J	Wang, JC; Spiegel, N; Bertelsen, S; Le, N; McKenna, N; Budde, JP; Harari, O; Kapoor, M; Brooks, A; Hancock, D; Tischfield, J; Foroud, T; Bierut, LJ; Steinbach, JH; Edenberg, HJ; Traynor, BJ; Goate, AM				Wang, Jen-Chyong; Spiegel, Noah; Bertelsen, Sarah; Nhung Le; McKenna, Nicholas; Budde, John P.; Harari, Oscar; Kapoor, Manav; Brooks, Andrew; Hancock, Dana; Tischfield, Jay; Foroud, Tatiana; Bierut, Laura J.; Steinbach, Joe Henry; Edenberg, Howard J.; Traynor, Bryan J.; Goate, Alison M.			Cis-Regulatory Variants Affect CHRNA5 mRNA Expression in Populations of African and European Ancestry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; RECEPTOR GENES; RISK; TISSUE; ALCOHOL; SNPS	Variants within the gene cluster encoding alpha 3, alpha 5, and beta 4 nicotinic receptor subunits are major risk factors for substance dependence. The strongest impact on risk is associated with variation in the CHRNA5 gene, where at least two mechanisms are at work: amino acid variation and altered mRNA expression levels. The risk allele of the non-synonymous variant (rs16969968; D398N) primarily occurs on the haplotype containing the low mRNA expression allele. In populations of European ancestry, there are approximately 50 highly correlated variants in the CHRNA5-CHRNA3-CHRNB4 gene cluster and the adjacent PSMA4 gene region that are associated with CHRNA5 mRNA levels. It is not clear which of these variants contribute to the changes in CHRNA5 transcript level. Because populations of African ancestry have reduced linkage disequilibrium among variants spanning this gene cluster, eQTL mapping in subjects of African ancestry could potentially aid in defining the functional variants that affect CHRNA5 mRNA levels. We performed quantitative allele specific gene expression using frontal cortices derived from 49 subjects of African ancestry and 111 subjects of European ancestry. This method measures allele-specific transcript levels in the same individual, which eliminates other biological variation that occurs when comparing expression levels between different samples. This analysis confirmed that substance dependence associated variants have a direct cis-regulatory effect on CHRNA5 transcript levels in human frontal cortices of African and European ancestry and identified 10 highly correlated variants, located in a 9 kb region, that are potential functional variants modifying CHRNA5 mRNA expression levels.	[Wang, Jen-Chyong; Spiegel, Noah; Bertelsen, Sarah; Nhung Le; McKenna, Nicholas; Budde, John P.; Harari, Oscar; Kapoor, Manav; Bierut, Laura J.; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Brooks, Andrew; Tischfield, Jay] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Hancock, Dana] Res Triangle Inst, Dept Behav Hlth Epidemiol, Res Triangle Pk, NC 27709 USA; [Foroud, Tatiana; Edenberg, Howard J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Edenberg, Howard J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Traynor, Bryan J.] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Rutgers State University New Brunswick; Research Triangle Institute; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington University (WUSTL); Washington University (WUSTL)	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goate@wustl.edu	Bierut, Laura Jean/W-6806-2019; Traynor, Bryan J/G-5690-2010	Bierut, Laura Jean/0000-0002-9952-4810; Hancock, Dana/0000-0003-2240-3604; Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472; Tischfield, Jay/0000-0003-3217-8287; Budde, John/0000-0001-7778-7276	National Institute on Aging [P50 AG05681]; University of Sydney; National Health and Medical Research Council of Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism; National Institute on Aging, National Institutes of Health; Collaborative Study on the Genetics of Alcoholism (COGA); National Institute on Alcohol Abuse and Alcoholism (NIH) [U10AA008401]; Collaborative Study on the Genetics of Nicotine Dependence; NCI (NIH) [P01 CA89392]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Collaborative Study on the Genetics of Alcoholism (COGA); National Institute on Alcohol Abuse and Alcoholism (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Collaborative Study on the Genetics of Nicotine Dependence; NCI (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	ADRC is supported by grants from the National Institute on Aging P50 AG05681. ABDP is supported by the University of Sydney, National Health and Medical Research Council of Australia, Schizophrenia Research Institute, and the National Institute of Alcohol Abuse and Alcoholism. NICHD is supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. This study was supported in part by the Collaborative Study on the Genetics of Alcoholism (COGA) funded by the National Institute on Alcohol Abuse and Alcoholism (NIH Grant U10AA008401) and the Collaborative Study on the Genetics of Nicotine Dependence funded by NCI (NIH grant P01 CA89392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Doyle GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023373; Falvella FS, 2013, CARCINOGENESIS, V34, P1281, DOI 10.1093/carcin/bgt062; Falvella FS, 2010, J NATL CANCER I, V102, P1366, DOI 10.1093/jnci/djq264; Falvella FS, 2009, CLIN CANCER RES, V15, P1837, DOI 10.1158/1078-0432.CCR-08-2107; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Liu Y, 2009, CANCER RES, V69, P7844, DOI 10.1158/0008-5472.CAN-09-1833; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Wang JC, 2012, ANNU REV GENOM HUM G, V13, P241, DOI 10.1146/annurev-genom-090711-163844; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80204	10.1371/journal.pone.0080204	http://dx.doi.org/10.1371/journal.pone.0080204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303001	gold, Green Published			2022-12-25	WOS:000327546400017
J	Zhang, ZC; Dai, W; Dai, DZ				Zhang, Zhicheng; Dai, Wei; Dai, Dingzhen			Synonymous Codon Usage in TTSuV2: Analysis and Comparison with TTSuV1	PLOS ONE			English	Article							TORQUE-TENO-VIRUS; MULTISYSTEMIC WASTING SYNDROME; SPECIES-SPECIFIC TTVS; GC-RICH GENOME; MOUTH-DISEASE; SYNDROME PMWS; RECOMBINATION; SELECTION; BIAS; MUTATION	Two species of the DNA virus Torque teno sus virus (TTSuV), TTSuV1 and TTSuV2, have become widely distributed in pig-farming countries in recent years. In this study, we performed a comprehensive analysis of synonymous codon usage bias in 41 available TTSuV2 coding sequences (CDS), and compared the codon usage patterns of TTSuV2 and TTSuV1. TTSuV codon usage patterns were found to be phylogenetically conserved. Values for the effective number of codons (ENC) indicated that the overall extent of codon usage bias in both TTSuV2 and TTSuV1 was not significant, the most frequently occurring codons had an A or C at the third codon position. Correspondence analysis (COA) was performed and TTSuV2 and TTSuV1 sequences were located in different quadrants of the first two major axes. A plot of the ENC revealed that compositional constraint was the major factor determining the codon usage bias for TTSuV2. In addition, hierarchical cluster analysis of 41 TTSuV2 isolates based on relative synonymous codon usage (RSCU) values suggested that there was no association between geographic distribution and codon bias of TTSuV2 sequences. Finally, the comparison of RSCU for TTSuV2, TTSuV1 and the corresponding host sequence indicated that the codon usage pattern of TTSuV2 was similar to that of TTSuV1. However the similarity was low for each virus and its host. These conclusions provide important insight into the synonymous codon usage pattern of TTSuV2, as well as better understangding of the molecular evolution of TTSuV2 genomes.	[Zhang, Zhicheng; Dai, Dingzhen] Jinling Inst Technol, Dept Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Dai, Wei] Anhui Agr Univ, Key Lab Zoonoses Anhui Prov, Hefei, Peoples R China	Jinling Institute of Technology; Anhui Agricultural University	Zhang, ZC (corresponding author), Jinling Inst Technol, Dept Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	andzzc@126.com			Natural Science Foundation of Jiangsu Province [BK2012083]; Major project of Nanjing Science and Technology Committee [201201026]; Cooperative innovation fund of production-college-research of Jiangsu Province [BY2011114]; Research Foundation of Jinling Institute of Technology [40610047]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Major project of Nanjing Science and Technology Committee; Cooperative innovation fund of production-college-research of Jiangsu Province; Research Foundation of Jinling Institute of Technology	This study was supported by the Natural Science Foundation of Jiangsu Province (BK2012083), Major project of Nanjing Science and Technology Committee (201201026), Cooperative innovation fund of production-college-research of Jiangsu Province (BY2011114), and Research Foundation of Jinling Institute of Technology (40610047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2008, ARCH VIROL, V153, P329, DOI 10.1007/s00705-007-1084-0; Aramouni M, 2011, VET MICROBIOL, V153, P377, DOI 10.1016/j.vetmic.2011.05.046; Biagini P, 2009, CURR TOP MICROBIOL, V331, P21; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Chiusano ML, 2000, GENE, V261, P63, DOI 10.1016/S0378-1119(00)00521-7; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Ellis JA, 2008, AM J VET RES, V69, P1608, DOI 10.2460/ajvr.69.12.1608; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Gupta SK, 2004, J BIOMOL STRUCT DYN, V21, P527, DOI 10.1080/07391102.2004.10506946; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kakkola L, 2008, VIROLOGY, V382, P182, DOI 10.1016/j.virol.2008.09.012; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; KRAKOWKA JE, 2008, P INT PIG VET SOC DU, V1, P99; Krakowka S, 2008, AM J VET RES, V69, P1623, DOI 10.2460/ajvr.69.12.1623; Levin DB, 2000, J GEN VIROL, V81, P2313, DOI 10.1099/0022-1317-81-9-2313; Li J, 2012, VIRUS RES, V169, P195, DOI 10.1016/j.virusres.2012.07.028; LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289; Ma ESK, 2002, HAEMATOLOGICA, V87, P553; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; McInerney JO, 1998, P NATL ACAD SCI USA, V95, P10698, DOI 10.1073/pnas.95.18.10698; McKeown NE, 2004, VET MICROBIOL, V104, P113, DOI 10.1016/j.vetmic.2004.08.013; Mushahwar IK, 1999, P NATL ACAD SCI USA, V96, P3177, DOI 10.1073/pnas.96.6.3177; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Naya H, 2001, FEBS LETT, V501, P127, DOI 10.1016/S0014-5793(01)02644-8; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Nieto D, 2011, VET MICROBIOL, V152, P284, DOI 10.1016/j.vetmic.2011.05.020; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2002, J GEN VIROL, V83, P1291, DOI 10.1099/0022-1317-83-6-1291; Okamoto H, 2001, J GEN VIROL, V82, P2041, DOI 10.1099/0022-1317-82-9-2041; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Ramos N, 2013, INFECT GENET EVOL, V19, P23, DOI 10.1016/j.meegid.2013.06.017; Sau K, 2005, ACTA BIOCH BIOPH SIN, V37, P625, DOI 10.1111/j.1745-7270.2005.00089.x; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; Shi M, 2013, J VIROL, V87, P10904, DOI 10.1128/JVI.01270-13; Taira O, 2009, VET MICROBIOL, V139, P347, DOI 10.1016/j.vetmic.2009.06.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang M, 2011, BIOSYSTEMS, V106, P45, DOI 10.1016/j.biosystems.2011.06.005; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Zhang ZC, 2013, ARCH VIROL, V158, P145, DOI 10.1007/s00705-012-1480-y; Zhang ZC, 2012, ARCH VIROL, V157, P927, DOI 10.1007/s00705-012-1249-3; Zhao S, 2008, BIOSYSTEMS, V92, P207, DOI 10.1016/j.biosystems.2008.01.006; Zhong J, 2007, VIRUS GENES, V35, P767, DOI 10.1007/s11262-007-0159-z; Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	50	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81469	10.1371/journal.pone.0081469	http://dx.doi.org/10.1371/journal.pone.0081469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303050	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400066
J	Yang, Y; Liu, R; Qiu, R; Zheng, Y; Huang, W; Hu, H; Ji, Q; He, H; Shang, Y; Gong, Y; Wang, Y				Yang, Y.; Liu, R.; Qiu, R.; Zheng, Y.; Huang, W.; Hu, H.; Ji, Q.; He, H.; Shang, Y.; Gong, Y.; Wang, Y.			CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3 A in DNA methylation-based epigenetic silencing	ONCOGENE			English	Article						CRL4B; SUV39H1; DNMT3A; HP1; transcriptional repression	FACTOR-BINDING PROTEIN-3; HISTONE H2A UBIQUITINATION; METHYLTRANSFERASES DNMT3A; CHROMATIN MODIFICATIONS; HUMAN HOMOLOG; LYSINE 9; GENE; LIGASE; GROWTH; H3	Cullin 4B (CUL4B) is a component of the Cullin4B-Ring E3 ligase complex (CRL4B) that functions in proteolysis and is implicated in tumorigenesis. Here, we report that CRL4B is associated with histone methyltransferase SUV39H1, heterochromatin protein 1 (HP1) and DNA methyltransferases 3A (DNMT3A). We showed that CRL4B, through catalyzing H2AK119 nnonoubiquitination, facilitates H3K9 tri-methylation and DNA methylation, two key epigenetic modifications involved in DNA methylation-based gene silencing. Depletion of CUL4B resulted in loss of not only H2AK119 monoubiquitination but also H3K9 trimethylation and DNA methylation, leading to derepression of a collection of genes, including the tumor suppressor IGFBP3. We demonstrated that CUL4B promotes cell proliferation and invasion, which are consistent with a tumorigenic phenotype, at least partially by repressing IGFBP3. We found that the expression of CUL4B is markedly upregulated in samples of human cervical carcinoma and is negatively correlated with the expression of IGFBP3. Our experiments unveiled a coordinated action between histone ubiquitination/methylation and DNA methylation in transcription repression, providing a mechanism for CUL4B in tunnorigenesis.	[Yang, Y.; Liu, R.; Hu, H.; Ji, Q.; Gong, Y.; Wang, Y.] Shandong Univ, Sch Med, Inst Mol Med & Genet, Key Lab Expt Teratol,Minist Educ, Jinan 250100, Shandong, Peoples R China; [Qiu, R.; Zheng, Y.; Huang, W.; Shang, Y.; Wang, Y.] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China; [He, H.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada	Shandong University; Tianjin Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wang, Y (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	yanwang@tmu.edu.cn			National Natural Science Foundation of China [81322032, 31171240, 90919053]; Ministry of Education of China [NECT-12-1067]; National Basic Research Program of China [2013CB910900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants (81322032,31171240 and 90919053 to YW) from the National Natural Science Foundation of China, grant (NECT-12-1067 to YW) from the Ministry of Education of China, and grant (2013CB910900 to YG) from the National Basic Research Program of China.	Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Chen CY, 2012, HUM MOL GENET, V21, P4270, DOI 10.1093/hmg/dds261; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dumbliauskas E, 2011, EMBO J, V30, P731, DOI 10.1038/emboj.2010.359; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Grimberg A, 2000, MOL GENET METAB, V70, P85, DOI 10.1006/mgme.2000.3008; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; Hanafusa T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-9; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jason LJM, 2002, BIOESSAYS, V24, P166, DOI 10.1002/bies.10038; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Liu HC, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-112; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Schindl M, 2007, ANTICANCER RES, V27, P949; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Thon G, 2000, GENETICS, V155, P551; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Williams AC, 2000, CANCER RES, V60, P22; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	86	62	64	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					104	118		10.1038/onc.2013.522	http://dx.doi.org/10.1038/onc.2013.522			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24292684				2022-12-25	WOS:000349740100010
J	Pan, C; Fang, D; Xu, GR; Liang, J; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Pan, Cong; Fang, Dong; Xu, Guangrui; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			A Novel Acidic Matrix Protein, PfN44, Stabilizes Magnesium Calcite to Inhibit the Crystallization of Aragonite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomaterials; Biomineralization; Cloning; Extracellular Matrix Proteins; Protein Chemistry	NACREOUS LAYER FORMATION; SOLUBLE ORGANIC MATRIX; PEARL OYSTER; PINCTADA-MAXIMA; FRAMEWORK FORMATION; CARBONIC-ANHYDRASE; EXTRAPALLIAL FLUID; KEY MACROMOLECULE; PRISMATIC LAYER; SHELL MATRIX	Background: Thermodynamically unstable magnesium calcite is deposited in the shell of pearl oysters at ambient pressure. Results: The novel acidic matrix protein PfN44 interacts with magnesium to inhibit the deposition of aragonite. Conclusion: PfN44 participates in shell formation by inhibiting aragonite formation. Significance: Results of this study suggest a connection between the matrix protein and magnesium. Magnesium is widely used to control calcium carbonate deposition in the shell of pearl oysters. Matrix proteins in the shell are responsible for nucleation and growth of calcium carbonate crystals. However, there is no direct evidence supporting a connection between matrix proteins and magnesium. Here, we identified a novel acidic matrix protein named PfN44 that affected aragonite formation in the shell of the pearl oyster Pinctada fucata. Using immunogold labeling assays, we found PfN44 in both the nacreous and prismatic layers. In shell repair, PfN44 was repressed, whereas other matrix proteins were up-regulated. Disturbing the function of PfN44 by RNAi led to the deposition of porous nacreous tablets with overgrowth of crystals in the nacreous layer. By in vitro circular dichroism spectra and fluorescence quenching, we found that PfN44 bound to both calcium and magnesium with a stronger affinity for magnesium. During in vitro calcium carbonate crystallization and calcification of amorphous calcium carbonate, PfN44 regulated the magnesium content of crystalline carbonate polymorphs and stabilized magnesium calcite to inhibit aragonite deposition. Taken together, our results suggested that by stabilizing magnesium calcite to inhibit aragonite deposition, PfN44 participated in P. fucata shell formation. These observations extend our understanding of the connections between matrix proteins and magnesium.	[Pan, Cong; Fang, Dong; Xu, Guangrui; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Rm 206,Old Bldg Sch Life Sci, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Independent Research Projects of Tsinghua University [20111080964]; Ministry of Agriculture [2011ZX08011-006]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China Grant 2010AA09Z405, National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong), and Independent Research Projects of Tsinghua University Grant 20111080964. Grant 2011ZX08011-006 is a Major Project of Ministry of Agriculture.	Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; BISCHOFF WD, 1987, GEOCHIM COSMOCHIM AC, V51, P1413, DOI 10.1016/0016-7037(87)90325-5; Bonucci E, 2009, J BONE MINER METAB, V27, P255, DOI 10.1007/s00774-009-0061-y; BORBAS JE, 1991, J EXP ZOOL, V258, P1, DOI 10.1002/jez.1402580102; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Long X, 2011, CRYST GROWTH DES, V11, P2866, DOI 10.1021/cg200028x; LOWENSTAM HA, 1975, SCIENCE, V188, P363, DOI 10.1126/science.1118730; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin F, 2007, BIOMATERIALS, V28, P2368, DOI 10.1016/j.biomaterials.2007.01.029; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; MURAMOTO K, 1994, COMP BIOCHEM PHYS B, V107, P401, DOI 10.1016/0305-0491(94)90204-6; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; SIMKISS K, 1977, CALC TISS RES, V24, P199, DOI 10.1007/BF02223316; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; WEINER S, 1979, CALCIFIED TISSUE INT, V29, P163, DOI 10.1007/BF02408072; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Weiner S, 2003, CONNECT TISSUE RES, V44, P214, DOI 10.1080/713713619; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WILBUR KM, 1984, BIOL BULL, V166, P251, DOI 10.2307/1541446; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6; Zhou YJ, 2010, COMP BIOCHEM PHYS B, V156, P158, DOI 10.1016/j.cbpb.2010.02.012	58	52	52	2	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2776	2787		10.1074/jbc.M113.504027	http://dx.doi.org/10.1074/jbc.M113.504027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24302723	Green Published, hybrid			2022-12-25	WOS:000333403000027
J	Christensen, CE; Karlsson, M; Winther, JR; Jensen, PR; Lerche, MH				Christensen, Caspar Elo; Karlsson, Magnus; Winther, Jakob R.; Jensen, Pernille Rose; Lerche, Mathilde H.			Non-invasive In-cell Determination of Free Cytosolic [NAD(+)]/[NADH] Ratios Using Hyperpolarized Glucose Show Large Variations in Metabolic Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Glucose; NAD; NADH; Prostate Cancer; Hyperpolarization; Metabolic Phenotype	NICOTINAMIDE-ADENINE DINUCLEOTIDE; POSITRON-EMISSION-TOMOGRAPHY; REDOX STATE; NAD(+) METABOLISM; PROSTATE-CANCER; BLOOD-FLOW; NADH; PATHWAY; DISEASE; INHIBITION	Accumulating evidence suggest that the pyridine nucleotide NAD has far wider biological functions than its classical role in energy metabolism. NAD is used by hundreds of enzymes that catalyze substrate oxidation and, as such, it plays a key role in various biological processes such as aging, cell death, and oxidative stress. It has been suggested that changes in the ratio of free cytosolic [NAD(+)]/[NADH] reflects metabolic alterations leading to, or correlating with, pathological states. We have designed an isotopically labeled metabolic bioprobe of free cytosolic [NAD(+)]/[NADH] by combining a magnetic enhancement technique (hyperpolarization) with cellular glycolytic activity. The bioprobe reports free cytosolic [NAD(+)]/[NADH] ratios based on dynamically measured in-cell [pyruvate]/[lactate] ratios. We demonstrate its utility in breast and prostate cancer cells. The free cytosolic [NAD(+)]/[NADH] ratio determined in prostate cancer cells was 4 times higher than in breast cancer cells. This higher ratio reflects a distinct metabolic phenotype of prostate cancer cells consistent with previously reported alterations in the energy metabolism of these cells. As a reporter on free cytosolic [NAD(+)]/[NADH] ratio, the bioprobe will enable better understanding of the origin of diverse pathological states of the cell as well as monitor cellular consequences of diseases and/or treatments.	[Karlsson, Magnus; Jensen, Pernille Rose; Lerche, Mathilde H.] Albeda Res Aps, DK-1799 Copenhagen, Denmark; [Christensen, Caspar Elo] Albeda Innovat Aps, DK-1799 Copenhagen, Denmark; [Christensen, Caspar Elo; Winther, Jakob R.] Univ Copenhagen, Dept Biol, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Lerche, MH (corresponding author), Albeda Res Aps, Gamle Carlsberg Vej 10, DK-1799 Copenhagen, Denmark.	Mathilde.lerche@albeda.dk	Winther, Jakob R./K-4451-2014; Jensen, Pernille Rose/GQQ-6261-2022; Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/J-8648-2016; Karlsson, Magnus/AAZ-1768-2021; Christensen, Caspar Elo/K-2753-2014; Lerche, Mathilde Hauge/J-5487-2017	Winther, Jakob R./0000-0001-6995-9154; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Christensen, Caspar Elo/0000-0002-0214-8477; Karlsson, Magnus/0000-0001-7738-1700; Lerche, Mathilde Hauge/0000-0002-5899-2781	Danish National Advanced Technology Foundation (Hojteknologifonden)	Danish National Advanced Technology Foundation (Hojteknologifonden)	This work was supported by the Danish National Advanced Technology Foundation (Hojteknologifonden).	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Costello LC, 1997, J BIOL CHEM, V272, P28875, DOI 10.1074/jbc.272.46.28875; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Effert PJ, 1996, J UROLOGY, V155, P994, DOI 10.1016/S0022-5347(01)66366-3; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Hochachka PW, 2002, BIOESSAYS, V24, P749, DOI 10.1002/bies.10131; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Ma YX, 2012, CURR DRUG TARGETS, V13, P222, DOI 10.2174/138945012799201711; Medina-Cleghorn D, 2013, PFLUG ARCH EUR J PHY, V465, P427, DOI 10.1007/s00424-012-1201-0; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Sanni LA, 2001, AM J PATHOL, V159, P1105, DOI 10.1016/S0002-9440(10)61786-5; Schwab M., 2011, ENCY CANC, V2; Teodoro JS, 2013, TOXICOL MECH METHOD, V23, P297, DOI 10.3109/15376516.2012.759305; Veech RL, 2006, BIOCHEM MOL BIOL EDU, V34, P168, DOI 10.1002/bmb.2006.49403403168; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	42	88	88	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2344	2352		10.1074/jbc.M113.498626	http://dx.doi.org/10.1074/jbc.M113.498626			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302737	Green Published, hybrid			2022-12-25	WOS:000331130200038
J	Shulman, E; Belakhov, V; Wei, G; Kendall, A; Meyron-Holtz, EG; Ben-Shachar, D; Schacht, J; Baasov, T				Shulman, Eli; Belakhov, Valery; Wei, Gao; Kendall, Ann; Meyron-Holtz, Esther G.; Ben-Shachar, Dorit; Schacht, Jochen; Baasov, Timor			Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity A STRATEGY FOR THE TREATMENT OF GENETIC DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics Action; Genetic Diseases; Mitochondrial Apoptosis; Oxidative Stress; Ribosome Function; Aminoglycosides; Cytoplasmic Protein Synthesis Inhibition; Mitochondrial Protein Synthesis Inhibition; Ototoxicity	PREMATURE TERMINATION CODONS; SUPEROXIDE-PRODUCTION; PROTEIN-SYNTHESIS; SYNTHETIC AMINOGLYCOSIDES; NONSENSE MUTATION; FENTON REACTION; READ-THROUGH; ANTIBIOTICS; IRON; SUPPRESSION	There is compelling evidence that aminoglycoside (AG) antibiotics can induce the mammalian ribosome to suppress disease-causing nonsense mutations and partially restore the expression of functional proteins. However, prolonged AG treatment can cause detrimental side effects in patients, including most prominently, ototoxicity. Recent mechanistic discussions have considered the relative contributions of mitochondrial and cytoplasmic protein synthesis inhibition to AG-induced ototoxicity. We show that AGs inhibit mitochondrial protein synthesis in mammalian cells and perturb cell respiration, leading to a time- and dose-dependent increase in superoxide overproduction and accumulation of free ferrous iron in mitochondria caused by oxidative damage of mitochondrial aconitase, ultimately leading to cell apoptosis via the Fenton reaction. These deleterious effects increase with the increased potency of AG to inhibit the mitochondrial rather than cytoplasmic protein synthesis, which in turn correlates with their ototoxic potential in both murine cochlear explants and the guinea pig in vivo. The deleterious effects of AGs were alleviated in synthetic derivatives specially designed for the treatment of genetic diseases caused by nonsense mutations and possessing low affinity toward mitochondrial ribosomes. This work highlights the benefit of a mechanism-based drug redesign strategy that can maximize the translational value of readthrough therapy while mitigating drug-induced side effects. This approach holds promise for patients suffering from genetic diseases caused by nonsense mutations.	[Shulman, Eli; Belakhov, Valery; Baasov, Timor] Technion IIT, Schulich Fac Chem, Edith & Joseph Fischer Enzyme Inhibitors Lab, IL-32000 Haifa, Israel; [Meyron-Holtz, Esther G.] Technion IIT, Fac Biotechnol & Food Engn, Lab Mol Nutr, IL-32000 Haifa, Israel; [Wei, Gao; Kendall, Ann; Schacht, Jochen] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; [Ben-Shachar, Dorit] Technion IIT, Dept Psychiat, Rambam Med Ctr, Psychobiol Lab, IL-31096 Haifa, Israel; [Ben-Shachar, Dorit] Technion IIT, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Michigan System; University of Michigan; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Baasov, T (corresponding author), Technion IIT, Schulich Fac Chem, IL-32000 Haifa, Israel.	chtimor@techunix.technion.ac.il	Baasov, Timor/L-5173-2019; Ben-Shachar, Dorit/D-4703-2015	Baasov, Timor/0000-0002-1427-2619; Ben-Shachar, Dorit/0000-0003-2317-1489; Belakhov, Valery/0000-0003-1918-974X	National Institutes of Health [1 R01 GM094792-01 A1]; German-Israeli Foundation [G-1048-95.5/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R01 GM094792-01 A1 (to T. B. and J. S.). This work was also supported by German-Israeli Foundation Grant G-1048-95.5/2009 (to T. B.).	Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brendel C, 2011, J MOL MED, V89, P389, DOI 10.1007/s00109-010-0704-4; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chernikov VG, 2003, B EXP BIOL MED+, V135, P103, DOI 10.1023/A:1023474719042; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; Clerici WJ, 1996, HEARING RES, V101, P14, DOI 10.1016/S0378-5955(96)00126-8; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; EUSTICE DC, 1984, BIOCHEMISTRY-US, V23, P1462, DOI 10.1021/bi00302a019; Feldman L, 2007, KIDNEY INT, V72, P359, DOI 10.1038/sj.ki.5002295; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Francis SP, 2013, J NEUROSCI, V33, P3079, DOI 10.1523/JNEUROSCI.3430-12.2013; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Goldmann T, 2010, INVEST OPHTH VIS SCI, V51, P6671, DOI 10.1167/iovs.10-5741; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; Huth M, 2011, INT J OTOLARYNGOL, V2011; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kandasamy J, 2012, J MED CHEM, V55, P10630, DOI 10.1021/jm3012992; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kondo J, 2007, CHEMBIOCHEM, V8, P1700, DOI 10.1002/cbic.200700271; KURTZ DI, 1974, BIOCHEMISTRY-US, V13, P572, DOI 10.1021/bi00700a026; LAUTERMANN J, 1995, HEARING RES, V86, P15, DOI 10.1016/0378-5955(95)00049-A; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Matt T, 2012, P NATL ACAD SCI USA, V109, P10984, DOI 10.1073/pnas.1204073109; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rowe SM, 2011, J MOL MED, V89, P1149, DOI 10.1007/s00109-011-0787-6; Sha SH, 2006, NEW ENGL J MED, V354, P1856, DOI 10.1056/NEJMc053428; Shalev M, 2013, J PHARMACEUT BIOMED, V75, P33, DOI 10.1016/j.jpba.2012.11.014; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vecsler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020733; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008	53	78	83	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2318	2330		10.1074/jbc.M113.533588	http://dx.doi.org/10.1074/jbc.M113.533588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302717	hybrid, Green Published			2022-12-25	WOS:000331130200036
J	Chen, BX; Siderovski, DP; Neubig, RR; Lawson, MA; Trejo, J				Chen, Buxin; Siderovski, David P.; Neubig, Richard R.; Lawson, Mark A.; Trejo, JoAnn			Regulation of Protease-activated Receptor 1 Signaling by the Adaptor Protein Complex 2 and R4 Subfamily of Regulator of G Protein Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; G Protein-coupled Receptors (GPCR); G Proteins; Intracellular Trafficking; Thrombin	THROMBIN RECEPTOR; BETA-ARRESTINS; PLATELET ACTIVATION; INTERNALIZATION; CLATHRIN; TRAFFICKING; KINASE; ALPHA; TRANSACTIVATION; DEGRADATION	Background: The function of the clathrin adaptor AP-2 in the regulation of GPCR coupling to G protein signaling is not known. Results: AP-2 controls GPCR signaling by modulating receptor surface expression and, unexpectedly, through RGS protein recruitment to G proteins. Conclusion: AP-2 has diverse functions in the regulation of GPCR signaling. Significance: AP-2 provides a new mode of GPCR signal regulation. The G protein-coupled protease-activated receptor 1 (PAR1) is irreversibly proteolytically activated by thrombin. Hence, the precise regulation of PAR1 signaling is important for proper cellular responses. In addition to desensitization, internalization and lysosomal sorting of activated PAR1 are critical for the termination of signaling. Unlike most G protein-coupled receptors, PAR1 internalization is mediated by the clathrin adaptor protein complex 2 (AP-2) and epsin-1, rather than -arrestins. However, the function of AP-2 and epsin-1 in the regulation of PAR1 signaling is not known. Here, we report that AP-2, and not epsin-1, regulates activated PAR1-stimulated phosphoinositide hydrolysis via two different mechanisms that involve, in part, a subset of R4 subfamily of regulator of G protein signaling (RGS) proteins. A significantly greater increase in activated PAR1 signaling was observed in cells depleted of AP-2 using siRNA or in cells expressing a PAR1 (420)AKKAA(424) mutant with defective AP-2 binding. This effect was attributed to AP-2 modulation of PAR1 surface expression and efficiency of G protein coupling. We further found that ectopic expression of R4 subfamily members RGS2, RGS3, RGS4, and RGS5 reduced activated PAR1 wild-type signaling, whereas signaling by the PAR1 AKKAA mutant was minimally affected. Intriguingly, siRNA-mediated depletion analysis revealed a function for RGS5 in the regulation of signaling by the PAR1 wild type but not the AKKAA mutant. Moreover, activation of the PAR1 wild type, and not the AKKAA mutant, induced G(q) association with RGS3 via an AP-2-dependent mechanism. Thus, AP-2 regulates activated PAR1 signaling by altering receptor surface expression and through recruitment of RGS proteins.	[Chen, Buxin; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Lawson, Mark A.] Univ Calif San Diego, Dept Reprod Med, Sch Med, La Jolla, CA 92093 USA; [Siderovski, David P.] W Virginia Univ, Dept Physiol & Pharmacol, Sch Med, Morgantown, WV 26506 USA; [Neubig, Richard R.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; West Virginia University; Michigan State University	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,BSB Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Lawson, Mark/ABH-2007-2020; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Neubig, Richard/0000-0003-0501-0008; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [R01 GM090689]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037568, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (to J. T.).	Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; BENKA ML, 1995, FEBS LETT, V363, P49, DOI 10.1016/0014-5793(95)00278-H; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Hains MD, 2004, METHOD ENZYMOL, V389, P71; ISHII K, 1994, J BIOL CHEM, V269, P1125; Kim I, 2013, J CELL BIOL, V200, P419, DOI 10.1083/jcb.201206096; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laroche G, 2010, AM J PHYSIOL-CELL PH, V299, pC654, DOI 10.1152/ajpcell.00441.2009; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	39	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1580	1591		10.1074/jbc.M113.528273	http://dx.doi.org/10.1074/jbc.M113.528273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297163	hybrid, Green Published			2022-12-25	WOS:000332401700032
J	Boari, S; Josens, R; Parisi, DR				Boari, Santiago; Josens, Roxana; Parisi, Daniel R.			Efficient Egress of Escaping Ants Stressed with Temperature	PLOS ONE			English	Article							EVACUATION	In the present work we investigate the egress times of a group of Argentine ants (Linepithema humile) stressed with different heating speeds. We found that the higher the temperature ramp is, the faster ants evacuate showing, in this sense, a group-efficient evacuation strategy. It is important to note that even when the life of ants was in danger, jamming and clogging was not observed near the exit, in accordance with other experiments reported in the literature using citronella as aversive stimuli. Because of this clear difference between ants and humans, we recommend the use of some other animal models for studying competitive egress dynamics as a more accurate approach to understanding competitive egress in human systems.	[Boari, Santiago] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Boari, Santiago; Josens, Roxana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Estudio Insectos Sociales, RA-1428 Buenos Aires, DF, Argentina; [Josens, Roxana; Parisi, Daniel R.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Parisi, Daniel R.] Inst Tecnol Buenos Aires, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Parisi, DR (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	dparisi@itba.edu.ar	Parisi, Daniel/L-7218-2014; Boari, Santiago/AAX-1597-2020	Parisi, Daniel/0000-0001-6228-5652; Boari, Santiago/0000-0003-2315-5411	CONICET-Argentina [PIP 2010-0304]; ANPCyT, Argentina [PICT 2011-1238]	CONICET-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT)	This work was supported by grants PIP 2010-0304 (CONICET-Argentina) and PICT 2011-1238 (ANPCyT, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Fahy RF, 2012, FIRE MATER, V36, P328, DOI 10.1002/fam.1083; Fourcassie V, 2010, J EXP BIOL, V213, P2357, DOI 10.1242/jeb.031237; Gago PA, 2013, TRAFFIC GRA IN PRESS; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Helbing D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168001; Heliovaara S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012802; John A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.108001; Kirchner A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056122; Liendro JI, 2013, ANT SWARM; MORI M, 1987, TRANSPORT RES A-POL, V21, P223, DOI 10.1016/0191-2607(87)90016-1; Nelson H. B., 2002, SFPE HDB FIRE PROTEC, V3rd, P3; Parisi DR, 2007, PHYSICA A, V385, P343, DOI 10.1016/j.physa.2007.06.033; Saloma C, 2003, P NATL ACAD SCI USA, V100, P11947, DOI 10.1073/pnas.2031912100; Seyfried A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10002; Shiwakoti N, 2013, TRANSPORT C IN PRESS; Shiwakoti N, 2011, TRANSPORT RES B-METH, V45, P1433, DOI 10.1016/j.trb.2011.05.016; Soria SA, 2012, SAFETY SCI, V50, P1584, DOI 10.1016/j.ssci.2012.03.010; WEIDMANN U, 1993, SCHRIFTENREIHE IVT, V90; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105	24	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81082	10.1371/journal.pone.0081082	http://dx.doi.org/10.1371/journal.pone.0081082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312264	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300023
J	Boschert, V; van Dinther, M; Weidauer, S; van Pee, K; Muth, EM; ten Dijke, P; Mueller, TD				Boschert, Verena; van Dinther, Maarten; Weidauer, Stella; van Pee, Katharina; Muth, Eva-Maria; ten Dijke, Peter; Mueller, Thomas D.			Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; SOST GENE; PARATHYROID-HORMONE; RECEPTOR; BINDING; LIGAND; LRP6; DENSITY; BETA; ANTIBODY	The cystine-knot containing protein Sclerostin is an important negative regulator of bone growth and therefore represents a promising therapeutic target. It exerts its biological task by inhibiting the Wnt (wingless and int1) signaling pathway, which participates in bone formation by promoting the differentiation of mesenchymal stem cells to osteoblasts. The core structure of Sclerostin consists of three loops with the first and third loop (Finger 1 and Finger 2) forming a structured beta-sheet and the second loop being unstructured and highly flexible. Biochemical data showed that the flexible loop is important for binding of Sclerostin to Wnt co-receptors of the low-density lipoprotein related-protein family (LRP), by interacting with the Wnt co-receptors LRP5 or -6 it inhibits Wnt signaling. To further examine the structural requirements for Wnt inhibition, we performed an extensive mutational study within all three loops of the Sclerostin core domain involving single and multiple mutations as well as truncation of important regions. By this approach we could confirm the importance of the second loop and especially of amino acids Asn92 and Ile94 for binding to LRP6. Based on a Sclerostin variant found in a Turkish family suffering from Sclerosteosis we generated a Sclerostin mutant with cysteines 84 and 142 exchanged thereby removing the third disulfide bond of the cystine-knot. This mutant binds to LRP6 with reduced binding affinity and also exhibits a strongly reduced inhibitory activity against Wnt1 thereby showing that also elements outside the flexible loop are important for inhibition of Wnt by Sclerostin. Additionally, we examined the effect of the mutations on the inhibition of two different Wnt proteins, Wnt3a and Wnt1. We could detect clear differences in the inhibition of these proteins, suggesting that the mechanism by which Sclerostin antagonizes Wnt1 and Wnt3a is fundamentally different.	[Boschert, Verena; Weidauer, Stella; van Pee, Katharina; Muth, Eva-Maria; Mueller, Thomas D.] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97070 Wurzburg, Germany; [van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Dept Mol Cell Biol, NL-2300 RA Leiden, Netherlands; [van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RA Leiden, Netherlands	University of Wurzburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mueller, TD (corresponding author), Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97070 Wurzburg, Germany.	mueller@biozentrum.uni-wuerzburg.de	Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; van Dinther, Maarten/0000-0002-9451-8884; Mueller, Thomas/0000-0003-1862-7357	EU FP7 HEALTH program (TALOS) [HEALTH-F2-2008-201099]; Netherlands Research Council, Cancer Genomics Centre Netherlands; Centre for Biomedical Genetics; Deutsche Forschungsgemeinschaft (DFG) [MU1095/5-1]	EU FP7 HEALTH program (TALOS); Netherlands Research Council, Cancer Genomics Centre Netherlands; Centre for Biomedical Genetics; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by funds of the EU FP7 HEALTH program (TALOS, http://www.talosproject.nl, grant number HEALTH-F2-2008-201099 to PtD and TDM), the Netherlands Research Council, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics (to PtD) and the Deutsche Forschungsgemeinschaft (DFG) MU1095/5-1 (to TDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Back JW, 2012, PROTEIN ENG DES SEL, V25, P251, DOI 10.1093/protein/gzs012; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; CHANG MK, 2013, J BONE MINERAL RES O; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Cui L, 2013, J MUSCULOSKEL NEURON, V13, P178; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Eddleston A, 2009, J BONE MINER RES, V24, P1662, DOI [10.1359/JBMR.090403, 10.1359/jbmr.090403]; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Fox J, 2002, CURR OPIN PHARMACOL, V2, P338, DOI 10.1016/S1471-4892(02)00154-6; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HAMANN C, 2012, J BONE MINERAL RES O; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Huang QY, 2009, BONE, V45, P289, DOI 10.1016/j.bone.2009.03.676; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; MCCOLM J, 2013, J BONE MINERAL RES O; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Piters E, 2010, HUM MUTAT, V31, pE1526, DOI 10.1002/humu.21274; Poole KE, 2005, FASEB J; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Raisz LG, 1999, CLIN CHEM, V45, P1353; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; SPATZ J, 2012, J BONE MINERAL RES O; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; van Dinther M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062295; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Virk MS, 2013, J BONE JOINT SURG AM, V95A, P694, DOI 10.2106/JBJS.L.00285; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; WEINER MP, 1994, PCR METH APPL, V4, pS131; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81710	10.1371/journal.pone.0081710	http://dx.doi.org/10.1371/journal.pone.0081710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312339	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300044
J	Ou, W; Li, PJ; Reiser, J				Ou, Wu; Li, Pingjuan; Reiser, Jakob			Targeting of Herpes Simplex Virus 1 Thymidine Kinase Gene Sequences into the OCT4 Locus of Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							GANCICLOVIR RESISTANCE; REGULATORY CIRCUITRY; SELECTIVE ABLATION; TUMOR-FORMATION; SUICIDE GENE; IN-VITRO; EXPRESSION; DIFFERENTIATION; SURVIVAL; OCT3/4	The in vitro differentiation of human induced pluripotent stem cells (hiPSC) to generate specific types of cells is inefficient, and the remaining undifferentiated cells may form teratomas. This raises safety concerns for clinical applications of hiPSC-derived cellular products. To improve the safety of hiPSC, we attempted to site-specifically insert a herpes simplex virus 1 thymidine kinase (HSV1-TK) suicide gene at the endogenous OCT4 (POU5F1) locus of hiPSC. Since the endogenous OCT4 promoter is active in undifferentiated cells only, we speculated that the HSV1-TK suicide gene will be transcribed in undifferentiated cells only and that the remaining undifferentiated cells can be depleted by treating them with the prodrug ganciclovir (GCV) prior to transplantation. To insert the HSV1-TK gene at the OCT4 locus, we cotransfected hiPSC with a pair of plasmids encoding an OCT4-specific zinc finger nuclease (ZFN) and a donor plasmid harboring a promoter-less transgene cassette consisting of HSV1-TK and puromycin resistance gene sequences, flanked by OCT4 gene sequences. Puromycin resistant clones were established and characterized regarding their sensitivity to GCV and the site of integration of the HSV1-TK/puromycin resistance gene cassette. Of the nine puromycin-resistant iPSC clones analyzed, three contained the HSV1-TK transgene at the OCT4 locus, but they were not sensitive to GCV. The other six clones were GCV-sensitive, but the TK gene was located at off-target sites. These TK-expressing hiPSC clones remained GCV sensitive for up to 90 days, indicating that TK transgene expression was stable. Possible reasons for our failed attempt to selectively target the OCT4 locus are discussed.	[Ou, Wu; Li, Pingjuan; Reiser, Jakob] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Reiser, J (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA.	Jakob.Reiser@fda.hhs.gov			FDA Medical Countermeasures Initiative (MCMi) grant; U.S. Department of Energy; U.S. Food and Drug Administration	FDA Medical Countermeasures Initiative (MCMi) grant; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Food and Drug Administration	This study was supported by an FDA Medical Countermeasures Initiative (MCMi) grant. This project was supported in part by an appointment of PL to the Research Participation Program at the Center for Biologics Evaluation and Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Black ME, 2001, CANCER RES, V61, P3022; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Brundin P, 1988, Brain Res, V467, P233; Chen F, 2013, BIOMATERIALS, V34, P1701, DOI 10.1016/j.biomaterials.2012.11.018; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Garin MI, 2001, BLOOD, V97, P122, DOI 10.1182/blood.V97.1.122; Hara A, 2008, STEM CELLS DEV, V17, P619, DOI 10.1089/scd.2007.0235; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Hong SG, 2013, MOL THER, V21, P272, DOI 10.1038/mt.2012.255; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Jung J, 2007, HUM GENE THER, V18, P1182, DOI 10.1089/hum.2007.078; Kiuru M, 2009, CELL STEM CELL, V4, P289, DOI 10.1016/j.stem.2009.03.010; Kurdow R, 2004, ANTICANCER RES, V24, P827; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Naujok O, 2010, STEM CELL REV REP, V6, P450, DOI 10.1007/s12015-010-9148-z; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ono M, 2010, HUM REPROD, V25, P2059, DOI 10.1093/humrep/deq163; Palumbo C, 2002, J PATHOL, V196, P467, DOI 10.1002/path.1064; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Rizzino A, 2010, REGEN MED, V5, P799, DOI 10.2217/RME.10.45; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Terstegge S, 2010, STEM CELL REV REP, V6, P260, DOI 10.1007/s12015-010-9114-9; Wang H, 2009, HISTOCHEM CELL BIOL, V131, P553, DOI 10.1007/s00418-009-0560-x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034778; Yang L, 1998, CLIN CANCER RES, V4, P731; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang LQ, 1997, HUM GENE THER, V8, P563, DOI 10.1089/hum.1997.8.5-563; Zhong BN, 2011, MOL THER, V19, P1667, DOI 10.1038/mt.2011.51	47	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81131	10.1371/journal.pone.0081131	http://dx.doi.org/10.1371/journal.pone.0081131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312266	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300024
J	Khing, PP; Swanson, BA; Ambikairajah, E				Khing, Phyu P.; Swanson, Brett A.; Ambikairajah, Eliathamby			The Effect of Automatic Gain Control Structure and Release Time on Cochlear Implant Speech Intelligibility	PLOS ONE			English	Article							DYNAMIC-RANGE; NOISE; COMPRESSION; RECOGNITION; PERFORMANCE; ENVELOPE; PHONEME; SYSTEMS; INPUT	Nucleus cochlear implant systems incorporate a fast-acting front-end automatic gain control (AGC), sometimes called a compression limiter. The objective of the present study was to determine the effect of replacing the front-end compression limiter with a newly proposed envelope profile limiter. A secondary objective was to investigate the effect of AGC speed on cochlear implant speech intelligibility. The envelope profile limiter was located after the filter bank and reduced the gain when the largest of the filter bank envelopes exceeded the compression threshold. The compression threshold was set equal to the saturation level of the loudness growth function (i.e. the envelope level that mapped to the maximum comfortable current level), ensuring that no envelope clipping occurred. To preserve the spectral profile, the same gain was applied to all channels. Experiment 1 compared sentence recognition with the front-end limiter and with the envelope profile limiter, each with two release times (75 and 625 ms). Six implant recipients were tested in quiet and in four-talker babble noise, at a high presentation level of 89 dB SPL. Overall, release time had a larger effect than the AGC type. With both AGC types, speech intelligibility was lower for the 75 ms release time than for the 625 ms release time. With the shorter release time, the envelope profile limiter provided higher group mean scores than the front-end limiter in quiet, but there was no significant difference in noise. Experiment 2 measured sentence recognition in noise as a function of presentation level, from 55 to 89 dB SPL. The envelope profile limiter with 625 ms release time yielded better scores than the front-end limiter with 75 ms release time. A take-home study showed no clear pattern of preferences. It is concluded that the envelope profile limiter is a feasible alternative to a front-end compression limiter.	[Khing, Phyu P.; Ambikairajah, Eliathamby] Univ New S Wales, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia; [Khing, Phyu P.; Swanson, Brett A.] Cochlear Ltd, Sydney, NSW, Australia	University of New South Wales Sydney; Cochlear	Swanson, BA (corresponding author), Cochlear Ltd, Sydney, NSW, Australia.	bswanson@cochlear.com		Ambikairajah, Eliathamby/0000-0003-4673-6534; Swanson, Brett/0000-0003-1732-2332	Australian Postgraduate Award from Australian government	Australian Postgraduate Award from Australian government	PK was funded by an Australian Postgraduate Award from the Australian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOTHROYD A, 1988, J ACOUST SOC AM, V84, P101, DOI 10.1121/1.396976; BOOTHROYD A, 1994, EAR HEARING, V15, P432, DOI 10.1097/00003446-199412000-00004; Boyle PJ, 2009, INT J AUDIOL, V48, P211, DOI 10.1080/14992020802581982; Dawson PW, 2013, EAR HEARING, V34, P592, DOI 10.1097/AUD.0b013e31828576fb; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Dawson PW, 2004, EAR HEARING, V25, P230, DOI 10.1097/01.AUD.0000130795.66185.28; Dillon H., 2001, HEARING AIDS; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Fullgrabe C, 2009, J ACOUST SOC AM, V125, P1277, DOI 10.1121/1.3075591; Gatehouse S, 2006, INT J AUDIOL, V45, P130, DOI 10.1080/14992020500429518; Hersbach AA, 2013, J ACOUST SOC AM, V133, P2412, DOI 10.1121/1.4794391; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; HESTERBERG T, 2005, INTRO PRACTICE STAT; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; Khing PP, 2011, INT CONF ACOUST SPEE, P285; Khing PP, 2013, 2013 IEEE INT C AC S; McDermott Hugh J, 2002, J Am Acad Audiol, V13, P14; MOORE B C J, 1988, British Journal of Audiology, V22, P93, DOI 10.3109/03005368809077803; Moore Brian C J, 2008, Trends Amplif, V12, P103, DOI 10.1177/1084713808317819; Muller-Deile J, 2008, Cochlear Implants Int, V9, P8, DOI 10.1179/cim.2008.9.1.8; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; Pearsons K., 1977, SPEECH LEVELS VARIOU; PLOMP R, 1994, EAR HEARING, V15, P2, DOI 10.1097/00003446-199402000-00002; Plomp R., 1983, P 10 INT C PHON SCI, P29; Seligman P, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P172; Simon J., 1997, RESAMPLING NEW STAT; Souza Pamela E, 2002, Trends Amplif, V6, P131, DOI 10.1177/108471380200600402; Spahr AJ, 2007, EAR HEARING, V28, P260, DOI 10.1097/AUD.0b013e3180312607; Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; Stobich B, 1999, EAR HEARING, V20, P104, DOI 10.1097/00003446-199904000-00002; Stone MA, 2003, J ACOUST SOC AM, V114, P1023, DOI 10.1121/1.1592160; Stone MA, 2004, J ACOUST SOC AM, V116, P2311, DOI 10.1121/1.1784447; Stone MA, 1999, J ACOUST SOC AM, V106, P3603, DOI 10.1121/1.428213; Stone MA, 2008, J ACOUST SOC AM, V123, P1063, DOI 10.1121/1.2821969; Stone MA, 2007, J ACOUST SOC AM, V121, P1654, DOI 10.1121/1.2434754; Swanson B, 2007, IEEE CUST INTEGR CIR, P437; White M W, 1986, J Rehabil Res Dev, V23, P25; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Wolfe J, 2011, OTOL NEUROTOL, V32, P533, DOI 10.1097/MAO.0b013e318210b6ec; Wolfe J, 2009, J AM ACAD AUDIOL, V20, P409, DOI 10.3766/jaaa.20.7.3; Zeng FG, 2002, J ACOUST SOC AM, V111, P377, DOI 10.1121/1.1423926; Zeng FG, 1999, EAR HEARING, V20, P60, DOI 10.1097/00003446-199902000-00006	43	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82263	10.1371/journal.pone.0082263	http://dx.doi.org/10.1371/journal.pone.0082263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312408	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900069
J	Xu, P; Wang, J; Yang, ZW; Lou, XL; Chen, C				Xu, Ping; Wang, Jing; Yang, Zhi-wen; Lou, Xiao-li; Chen, Cheng			Regulatory Roles of the PI3K/Akt Signaling Pathway in Rats with Severe Acute Pancreatitis	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE INHIBITOR; MEDIATED CYTOKINE PRODUCTION; ACINAR-CELLS; ACTIVATION; WORTMANNIN; APOPTOSIS; RESPONSES; KINASE; AKT	The phosphatidylinositol 3-kinase(PI3K)/protein kinase B (Akt) pathway plays a key role in inflammation. However, the regulatory roles of PI3K/Akt in severe acute pancreatitis (SAP) have not been elucidated. The aim of this study was to investigate the impact of wortmannin, a PI3K/Akt inhibitor, on SAP rats through exposure to sodium taurocholate (STC) after 3 h and 6 h. The SAP group was found to have a significant increase in pancreas Akt expression, along with the activation of serum amylase, TNF-alpha, IL-1 beta, and IL-6, and pancreas histological aggravation. The administration of wortmannin in SAP rats reduced Akt expression, attenuated the level of serum amylase and inflammation factor, and alleviated the damage of pancreatic tissue. Furthermore, the administration of wortmannin led to an obvious reduction in NF-kappa B and p38MAPK expression in SAP rats. These findings showed that the PI3K/Akt inhibitor wortmannin decreases inflammatory cytokines in SAP rats and suggests its regulatory mechanisms may occur through the suppression on NF-kappa B and p38MAPK activity.	[Xu, Ping; Wang, Jing; Lou, Xiao-li; Chen, Cheng] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp Affiliated, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Yang, Zhi-wen] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp Affiliated, Dept Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, P (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp Affiliated, Dept Gastroenterol, Shanghai 200030, Peoples R China.	yfyxp@yahoo.com.cn			Shanghai Songjiang District Health Board leading cooperative project	Shanghai Songjiang District Health Board leading cooperative project	The study was supported by a grant from Shanghai Songjiang District Health Board leading cooperative project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; Feng Z, 2012, IMMUNOTHERAPY-UK, V4, P1817, DOI [10.2217/IMT.12.131, 10.2217/imt.12.131]; Fetaud-Lapierre V, 2013, J PROTEOMICS, V85, P12, DOI 10.1016/j.jprot.2013.04.022; Fischer L, 2004, AM J PHYSIOL-GASTR L, V287, pG1200, DOI 10.1152/ajpgi.00212.2004; Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Howard TJ, 2013, SURG CLIN N AM, V93, P585, DOI 10.1016/j.suc.2013.02.006; Jung HJ, 2013, LIFE SCI, V92, P42, DOI 10.1016/j.lfs.2012.10.018; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim SH, 2012, EXP MOL MED, V44, P45, DOI 10.3858/emm.2012.44.1.004; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Morrow LE, 2012, CURR OPIN CRIT CARE, V18, P186, DOI 10.1097/MCC.0b013e3283514b17; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Ronnelid J, 2008, ADV EXP MED BIOL, V632, P187, DOI 10.1007/978-0-387-78952-1_14; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; Talukdar Rupjyoti, 2011, Curr Gastroenterol Rep, V13, P123, DOI 10.1007/s11894-010-0174-4; Xu P, 2011, DIGEST DIS SCI, V56, P1082, DOI 10.1007/s10620-010-1393-0; Yadav UCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057442; Yaman A, 2013, PEDIATR EMERG CARE, V29, P659, DOI 10.1097/PEC.0b013e31828ec2d5; Yu J, 2012, PANCREAS, V41, P1299, DOI 10.1097/MPA.0b013e318252dbc3; Zhu JX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-1	25	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81767	10.1371/journal.pone.0081767	http://dx.doi.org/10.1371/journal.pone.0081767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312352	gold, Green Submitted, Green Published			2022-12-25	WOS:000327657900050
J	Audia, JP; Lindsey, AS; Housley, NA; Ochoa, CR; Zhou, C; Toba, M; Oka, M; Annamdevula, NS; Fitzgerald, MS; Frank, DW; Alvarez, DF				Audia, Jonathon P.; Lindsey, Ashley S.; Housley, Nicole A.; Ochoa, Courtney R.; Zhou, Chun; Toba, Michie; Oka, Masahiko; Annamdevula, Naga S.; Fitzgerald, Meshann S.; Frank, Dara W.; Alvarez, Diego F.			In the Absence of Effector Proteins, the Pseudomonas aeruginosa Type Three Secretion System Needle Tip Complex Contributes to Lung Injury and Systemic Inflammatory Responses	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; EPITHELIAL-CELLS; V-ANTIGEN; MICROVASCULAR ENDOTHELIUM; VASCULAR-PERMEABILITY; TRANSLOCATION PORE; CLINICAL-OUTCOMES; PNEUMONIA; EXOU; CYTOTOXIN	Herein we describe a pathogenic role for the Pseudomonas aeruginosa type three secretion system (T3SS) needle tip complex protein, PcrV, in causing lung endothelial injury. We first established a model in which P. aeruginosa wild type strain PA103 caused pneumonia-induced sepsis and distal organ dysfunction. Interestingly, a PA103 derivative strain lacking its two known secreted effectors, ExoU and ExoT [denoted PA103 (Delta U/Delta T)], also caused sepsis and modest distal organ injury whereas an isogenic PA103 strain lacking the T3SS needle tip complex assembly protein [denoted PA103 (Delta PcrV)] did not. PA103 (Delta U/Delta T) infection caused neutrophil influx into the lung parenchyma, lung endothelial injury, and distal organ injury (reminiscent of sepsis). In contrast, PA103 (Delta PcrV) infection caused nominal neutrophil infiltration and lung endothelial injury, but no distal organ injury. We further examined pathogenic mechanisms of the T3SS needle tip complex using cultured rat pulmonary microvascular endothelial cells (PMVECs) and revealed a two-phase, temporal nature of infection. At 5-hours post-inoculation (early phase infection), PA103 (Delta U/Delta T) elicited PMVEC barrier disruption via perturbation of the actin cytoskeleton and did so in a cell death-independent manner. Conversely, PA103 (Delta PcrV) infection did not elicit early phase PMVEC barrier disruption. At 24-hours post-inoculation (late phase infection), PA103 (Delta U/Delta T) induced PMVEC damage and death that displayed an apoptotic component. Although PA103 (Delta PcrV) infection induced late phase PMVEC damage and death, it did so to an attenuated extent. The PA103 (Delta U/Delta T) and PA103 (Delta PcrV) mutants grew at similar rates and were able to adhere equally to PMVECs post-inoculation indicating that the observed differences in damage and barrier disruption are likely attributable to T3SS needle tip complex-mediated pathogenic differences post host cell attachment. Together, these infection data suggest that the T3SS needle tip complex and/or another undefined secreted effector(s) are important determinants of P. aeruginosa pneumonia-induced lung endothelial barrier disruption.	[Audia, Jonathon P.; Housley, Nicole A.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA; [Fitzgerald, Meshann S.; Alvarez, Diego F.] Univ S Alabama, Dept Internal Med, Mobile, AL 36688 USA; [Lindsey, Ashley S.; Ochoa, Courtney R.; Toba, Michie; Oka, Masahiko; Fitzgerald, Meshann S.; Alvarez, Diego F.] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; [Audia, Jonathon P.; Lindsey, Ashley S.; Housley, Nicole A.; Ochoa, Courtney R.; Zhou, Chun; Toba, Michie; Oka, Masahiko; Fitzgerald, Meshann S.; Alvarez, Diego F.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Annamdevula, Naga S.] Univ S Alabama, Dept Chem & Biomol Engn, Mobile, AL 36688 USA; [Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; Medical College of Wisconsin	Audia, JP (corresponding author), Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	jaudia@southalabama.edu; dalvarez@southalabama.edu	Alvarez, Diego/AAT-3897-2020	Alvarez, Diego/0000-0001-8244-629X	National Institutes of Health/National Heart, Lung, and Blood Institute [HL066299]; American Heart Association [0835134N]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI085002]; National Institutes of Health [10RR027535]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299, T32HL076125] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant # HL066299 from National Institutes of Health/National Heart, Lung, and Blood Institute, by grant # 0835134N from American Heart Association, by grant # AI085002 from National Institutes of Health/National Institute of Allergy and Infectious Diseases, and by equipment grant # 10RR027535 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2005, INFECT IMMUN, V73, P4263, DOI 10.1128/IAI.73.7.4263-4271.2005; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Allmond LR, 2004, J CLIN MICROBIOL, V42, P3857, DOI 10.1128/JCM.42.8.3857-3860.2004; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Anderson DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002823; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Auvin S, 2005, PEDIATR RES, V58, P211, DOI 10.1203/01.PDR.0000169979.27641.40; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Boyer S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-17; BRIGHAM KL, 1974, J CLIN INVEST, V54, P792, DOI 10.1172/JCI107819; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Bucior I, 2010, INFECT IMMUN, V78, P939, DOI 10.1128/IAI.01215-09; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Cines DB, 1998, BLOOD, V91, P3527; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Diaz MH, 2008, INFECT IMMUN, V76, P4414, DOI 10.1128/IAI.00012-08; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704; Faure K, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-1; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041547; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Garcia AN, 2011, METHODS MOL BIOL, V763, P333, DOI 10.1007/978-1-61779-191-8_23; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Housley NA, 2011, J BACTERIOL, V193, P4634, DOI 10.1128/JB.00141-11; Hritonenko V, 2011, MICROB PATHOGENESIS, V51, P305, DOI 10.1016/j.micpath.2011.08.001; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Lange M, 2008, CRIT CARE MED, V36, P1284, DOI 10.1097/CCM.0b013e318169ef74; Le Berre R, 2011, CRIT CARE MED, V39, P2113, DOI 10.1097/CCM.0b013e31821e899f; Leavesley SJ, 2012, J BIOPHOTONICS, V5, P67, DOI 10.1002/jbio.201100066; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lowe K, 2007, J SURG RES, V143, P70, DOI 10.1016/j.jss.2007.03.047; Lynch JP, 2001, CHEST, V119, p373S, DOI 10.1378/chest.119.2_suppl.373S; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Neely AN, 2005, BURNS, V31, P153, DOI 10.1016/j.burns.2004.09.002; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Parker JC, 2006, AM J PHYSIOL-LUNG C, V291, pL30, DOI 10.1152/ajplung.00317.2005; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; Saleh M, 2007, CELL DEATH DIFFER, V14, P1559, DOI 10.1038/sj.cdd.4402203; Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Sato H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00142; Sato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018356; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; SUTTORP N, 1988, AM J PHYSIOL, V255, pC368, DOI 10.1152/ajpcell.1988.255.3.C368; Troyanovsky B, 2008, AM J PHYSIOL-LUNG C, V294, pL266, DOI 10.1152/ajplung.00107.2007; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	78	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81792	10.1371/journal.pone.0081792	http://dx.doi.org/10.1371/journal.pone.0081792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312357	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100098
J	Nishimura, H; Sakata, S; Kaga, A				Nishimura, Hidekazu; Sakata, Soichiro; Kaga, Akikazu			A New Methodology for Studying Dynamics of Aerosol Particles in Sneeze and Cough Using a Digital High-Vision, High-Speed Video System and Vector Analyses	PLOS ONE			English	Article								Microbial pathogens of respiratory infectious diseases are often transmitted through particles in sneeze and cough. Therefore, understanding the particle movement is important for infection control. Images of a sneeze induced by nasal cavity stimulation by healthy adult volunteers, were taken by a digital high-vision, high-speed video system equipped with a computer system and treated as a research model. The obtained images were enhanced electronically, converted to digital images every 1/300 s, and subjected to vector analysis of the bioparticles contained in the whole sneeze cloud using automatic image processing software. The initial velocity of the particles or their clusters in the sneeze was greater than 6 m/s, but decreased as the particles moved forward; the momentums of the particles seemed to be lost by 0.15-0.20 s and started a diffusion movement. An approximate equation of a function of elapsed time for their velocity was obtained from the vector analysis to represent the dynamics of the front-line particles. This methodology was also applied for a cough. Microclouds contained in a smoke exhaled with a voluntary cough by a volunteer after smoking one breath of cigarette, were traced as the visible, aerodynamic surrogates for invisible bioparticles of cough. The smoke cough microclouds had an initial velocity greater than 5 m/s. The fastest microclouds were located at the forefront of cloud mass that moving forward; however, their velocity clearly decreased after 0.05 s and they began to diffuse in the environmental airflow. The maximum direct reaches of the particles and microclouds driven by sneezing and coughing unaffected by environmental airflows were estimated by calculations using the obtained equations to be about 84 cm and 30 cm from the mouth, respectively, both achieved in about 0.2 s, suggesting that data relating to the dynamics of sneeze and cough became available by calculation.	[Nishimura, Hidekazu] Sendai Med Ctr, Virus Res Ctr, Div Clin Res, Sendai, Miyagi, Japan; [Sakata, Soichiro] Takasago Thermal Engn Co Ltd, Tokyo, Japan; [Kaga, Akikazu] Osaka Univ, Grad Sch Engn, Osaka, Japan	Osaka University	Nishimura, H (corresponding author), Sendai Med Ctr, Virus Res Ctr, Div Clin Res, Sendai, Miyagi, Japan.	hide-nishimura@mte.biglobe.ne.jp			Clinical Research Fund of the Sendai Medical Center	Clinical Research Fund of the Sendai Medical Center	This work was financially supported by the Clinical Research Fund of the Sendai Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Heating Refrigerating and Air-Conditioning Engineers, 1985, ASHRAE HDB FUND; Broday DM, 2003, AEROSOL SCI TECH, V37, P510, DOI 10.1080/02786820300969; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; GERONE PJ, 1966, BACTERIOL REV, V30, P576, DOI 10.1128/MMBR.30.3.576-588.1966; Hinds W. C., 1999, AEROSOL TECHNOLOGY P, P111; Ishimine Y, 2009, ANN DISAS PREV RES B, V52B, P319; JENNISON MW, 1942, AEROBIOLOGY, P106; Kaga A., 1993, J FLOW VISUAL IMAGE, V1, P283; Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032; McGrath B, 2009, J PHYS C SERIES, V151; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Phalen RF, 2002, ANN OCCUP HYG     S1, V46, P343, DOI DOI 10.1093/ANNHYG/MEF670; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Udrea DD, 1996, OPT LASER TECHNOL, V28, P389, DOI 10.1016/0030-3992(95)00112-3; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	18	49	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80244	10.1371/journal.pone.0080244	http://dx.doi.org/10.1371/journal.pone.0080244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312206	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100031
J	Yin, CH; Qin, LT; Sun, MY; Gao, YL; Qi, XL; Gao, HL; Wang, YQ; Wang, XM				Yin, Chun-hong; Qin, Li-ting; Sun, Mei-yu; Gao, Yu-long; Qi, Xiao-le; Gao, Hong-lei; Wang, Yong-qiang; Wang, Xiao-mei			Antigenic Analysis of Monoclonal Antibodies against Different Epitopes of sigma B Protein of Avian Reovirus	PLOS ONE			English	Article							MUSCOVY DUCK REOVIRUS; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; S3 GENE; VIRUS; NEUTRALIZATION; SEQUENCE; STRAIN; NS	Background: Avian reovirus (ARV) causes arthritis, tenosynovitis, runting-stunting syndrome (RSS), malabsorption syndrome (MAS) and immunosuppression in chickens. GB is one of the major structural proteins of ARV, which is able to induce group-specific antibodies against the virus. Methods and Results: The present study described the identification of two linear B-cell epitopes in ARV sigma B through expressing a set of partially overlapping and consecutive truncated peptides spanning sigma B screened with two monoclonal antibodies (mAbs) 1F4 and 1H3-1. The data indicated that (21)KTPACW(26) (epitope A) and (WDTVTFH38)-W-32 (epitope B) were minimal determinants of the linear B cell epitopes. Antibodies present in the serum of ARV-positive chickens recognized the minimal linear epitopes in Western blot analyses. By sequence alignment analysis, we determined that the epitopes A and B were not conserved among ARV, duck reovirus (DRV) and turkey reovirus (TRV) strains. Western blot assays, confirmed that epitopes A and B were ARV-specific epitopes, and they could not react with the corresponding peptides of DRV and TRV. Conclusions and Significance: We identified (21)KTPACW(26) and (WDTVTFH38)-W-32 as sigma B -specific epitopes recognized by mAbs 1F4 and 1H3-1, respectively. The results in this study may have potential applications in development of diagnostic techniques and epitope-based marker vaccines against ARV groups.	[Yin, Chun-hong; Qin, Li-ting; Sun, Mei-yu; Gao, Yu-long; Qi, Xiao-le; Gao, Hong-lei; Wang, Yong-qiang; Wang, Xiao-mei] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	xmw@hvri.ac.cn			modern agro-industry technology research system [CARS-42]	modern agro-industry technology research system	This study was supported by the modern agro-industry technology research system (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; CRAWFORDMIKSZA LK, 1994, J CLIN MICROBIOL, V32, P2331, DOI 10.1128/JCM.32.9.2331-2334.1994; Dandar E, 2013, ARCH VIROL, V158, P2583, DOI 10.1007/s00705-013-1739-y; Day JM, 2007, VIRUS GENES, V35, P235, DOI 10.1007/s11262-006-0044-1; Denisova GF, 2008, MOL IMMUNOL, V46, P125, DOI 10.1016/j.molimm.2008.07.020; Duncan Roy, 1996, Virology, V219, P179; FAHEY J. E., 1954, CANADIAN JOUR COMP MED AND VET SCI, V18, P13; Goldenberg D, 2010, AVIAN PATHOL, V39, P189, DOI 10.1080/03079457.2010.480969; Hou HS, 2001, VIROLOGY, V282, P168, DOI 10.1006/viro.2001.0814; Hsu CJ, 2006, AVIAN PATHOL, V35, P320, DOI 10.1080/03079450600823386; Huang PH, 2005, VIROLOGY, V332, P584, DOI 10.1016/j.virol.2004.12.005; Jindal N, 2010, AVIAN PATHOL, V39, P53, DOI 10.1080/03079450903490289; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Kapczynski DR, 2002, VIRUS GENES, V25, P95, DOI 10.1023/A:1020130410601; Kort YH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-12; Kuntz-Simon G, 2002, J GEN VIROL, V83, P1189, DOI 10.1099/0022-1317-83-5-1189; Le Gall-Recule G, 1999, J GEN VIROL, V80, P195, DOI 10.1099/0022-1317-80-1-195; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li Y, 2013, VET IMMUNOL IMMUNOP, V151, P331, DOI 10.1016/j.vetimm.2012.11.011; Lin XA, 2010, CLIN VACCINE IMMUNOL, V17, P778, DOI 10.1128/CVI.00405-09; NI YW, 1993, VIROLOGY, V194, P705, DOI 10.1006/viro.1993.1311; Peng WP, 2008, VIRUS RES, V135, P267, DOI 10.1016/j.virusres.2008.04.003; Rosenberger J, 2011, CEV WORKSH IT; ROSENBERGER JK, 1989, AVIAN DIS, V33, P535, DOI 10.2307/1591118; SCHNITZER TJ, 1985, VIROLOGY, V141, P167, DOI 10.1016/0042-6822(85)90194-1; SCHNITZER TJ, 1982, J VIROL, V43, P1006, DOI 10.1128/JVI.43.3.1006-1014.1982; Sellers HS, 2004, AVIAN DIS, V48, P651, DOI 10.1637/7181-032304R; Sellers HS, 2013, POULTRY INFORM PROFE, V127; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; van der Heide L, 2000, AVIAN DIS, V44, P638, DOI 10.2307/1593104; VANDERHEIDE L, 1983, AVIAN DIS, V27, P698, DOI 10.2307/1590312; WICKRAMASINGHE R, 1993, VIROLOGY, V194, P688, DOI 10.1006/viro.1993.1309; WILCOX GE, 1985, AVIAN PATHOL, V14, P321, DOI 10.1080/03079458508436234; Xu HY, 2011, CLIN VACCINE IMMUNOL, V18, P893, DOI 10.1128/CVI.00066-11; Zhang Y, 2007, VET MICROBIOL, V121, P231, DOI 10.1016/j.vetmic.2006.12.008; Zhang Y, 2007, VIRUS RES, V125, P42, DOI 10.1016/j.virusres.2006.12.004	38	4	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81533	10.1371/journal.pone.0081533	http://dx.doi.org/10.1371/journal.pone.0081533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312314	Green Published, gold, Green Submitted			2022-12-25	WOS:000327652100084
J	Chantratita, N; Tandhavanant, S; Myers, ND; Seal, S; Arayawichanont, A; Kliangsa-Ad, A; Hittle, LE; Ernst, RK; Emond, MJ; Wurfel, MM; Day, NPJ; Peacock, SJ; West, TE				Chantratita, Narisara; Tandhavanant, Sarunporn; Myers, Nicolle D.; Seal, Sudeshna; Arayawichanont, Arkhom; Kliangsa-ad, Aroonsri; Hittle, Lauren E.; Ernst, Robert K.; Emond, Mary J.; Wurfel, Mark M.; Day, Nicholas P. J.; Peacock, Sharon J.; West, T. Eoin			Survey of Innate Immune Responses to Burkholderia pseudomallei in Human Blood Identifies a Central Role for Lipopolysaccharide	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; SEVERE MELIOIDOSIS; PSEUDOMONAS-PSEUDOMALLEI; NORTHEAST THAILAND; ANIMAL-MODELS; IFN-GAMMA; SEPSIS; INTERLEUKIN-6; EPIDEMIOLOGY	B. pseudomallei is a gram-negative bacterium that causes the tropical infection melioidosis. In northeast Thailand, mortality from melioidosis approaches 40%. As exemplified by the lipopolysaccharide-Toll-like receptor 4 interaction, innate immune responses to invading bacteria are precipitated by activation of host pathogen recognition receptors by pathogen associated molecular patterns. Human melioidosis is characterized by up-regulation of pathogen recognition receptors and pro-inflammatory cytokine release. In contrast to many gram-negative pathogens, however, the lipopolysaccharide of B. pseudomallei is considered only weakly inflammatory. We conducted a study in 300 healthy Thai subjects to investigate the ex vivo human blood response to various bacterial pathogen associated molecular patterns, including lipopolysaccharide from several bacteria, and to two heat-killed B. pseudomallei isolates. We measured cytokine levels after stimulation of fresh whole blood with a panel of stimuli. We found that age, sex, and white blood cell count modulate the innate immune response to B. pseudomallei. We further observed that, in comparison to other stimuli, the innate immune response to B. pseudomallei is most highly correlated with the response to lipopolysaccharide. The magnitude of cytokine responses induced by B. pseudomallei lipopolysaccharide was significantly greater than those induced by lipopolysaccharide from Escherichia coli and comparable to many responses induced by lipopolysaccharide from Salmonella minnesota despite lower amounts of lipid A in the B. pseudomallei lipopolysaccharide preparation. In human monocytes stimulated with B. pseudomallei, addition of polymyxin B or a TLR4/MD-2 neutralizing antibody inhibited the majority of TNF-alpha production. Challenging existing views, our data indicate that the innate immune response to B. pseudomallei in human blood is largely driven by lipopolysaccharide, and that the response to B. pseudomallei lipopolysaccharide in blood is greater than the response to other lipopolysaccharide expressing isolates. Our findings suggest that B. pseudomallei lipopolysaccharide may play a central role in stimulating the host response in melioidosis.	[Chantratita, Narisara; Tandhavanant, Sarunporn; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Chantratita, Narisara; Tandhavanant, Sarunporn; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Myers, Nicolle D.; Seal, Sudeshna; West, T. Eoin] Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA USA; [Arayawichanont, Arkhom] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Kliangsa-ad, Aroonsri] Sappasithiprasong Hosp, Dept Clin Pathol, Ubon Ratchathani, Thailand; [Hittle, Lauren E.; Ernst, Robert K.] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Emond, Mary J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [West, T. Eoin] Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Washington; University of Washington Seattle	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	narisara@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Tandhavanant, Sarunporn/R-7620-2019; Tandhavanant, Sarunporn/Q-7376-2019; Chantratita, Narisara/P-2169-2019	Tandhavanant, Sarunporn/0000-0003-0261-3233; Tandhavanant, Sarunporn/0000-0003-0261-3233; West, T Eoin/0000-0001-5503-7204; Peacock, Sharon/0000-0002-1718-2782; Ernst, Robert/0000-0001-5016-8694	Wellcome Trust; Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; NIH [K08HL094759, R01HL113382]; Doris Duke Charitable Foundation; NIHR Cambridge Biomedical Research Centre;  [R01HL089807];  [U54AI057141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089807, K08HL094759, R01HL113382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Wellcome Trust. NC is supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z). TEW is supported by NIH awards K08HL094759 and R01HL113382 and by the Doris Duke Charitable Foundation. MMW is supported by R01HL089807. RKE was supported by U54AI057141. SJP is supported by the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2018, CELL MOL IMMUNOL, V9; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Butler D, 2012, NATURE, V490, P456, DOI 10.1038/490456a; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DARVEAU RP, 1995, INFECT IMMUN, V63, P1311, DOI 10.1128/IAI.63.4.1311-1317.1995; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDLAND JS, 1992, INFECT IMMUN, V60, P2402, DOI 10.1128/IAI.60.6.2402-2408.1992; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lauw FN, 2000, INFECT IMMUN, V68, P3888, DOI 10.1128/IAI.68.7.3888-3893.2000; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642; Limmathurotsakul D, 2005, J CLIN MICROBIOL, V43, P2274, DOI 10.1128/JCM.43.5.2274-2276.2005; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Novem V, 2009, CLIN VACCINE IMMUNOL, V16, P1420, DOI 10.1128/CVI.00472-08; Simpson AJH, 2000, J INFECT DIS, V181, P1014, DOI 10.1086/315306; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2009, INFECT IMMUN, V77, P5612, DOI 10.1128/IAI.00618-09; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3074, DOI 10.1128/IAI.01733-06; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Wurfel MM, 2008, PEDIAT PULMONOLOGY, V43; Wuthiekanun V, 2006, AM J TROP MED HYG, V74, P1074, DOI 10.4269/ajtmh.2006.74.1074; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	47	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81617	10.1371/journal.pone.0081617	http://dx.doi.org/10.1371/journal.pone.0081617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303060	gold, Green Published, Green Submitted			2022-12-25	WOS:000327546400076
J	Ding, HL; Gong, SQ; Tian, YX; Yang, ZS; Brunham, R; Zhong, GM				Ding, Honglei; Gong, Siqi; Tian, Yingxin; Yang, Zhangsheng; Brunham, Robert; Zhong, Guangming			Transformation of Sexually Transmitted Infection-Causing Serovars of Chlamydia trachomatis Using Blasticidin for Selection	PLOS ONE			English	Article							ELEMENTARY BODIES; CELLS; PURIFICATION; PATHOGENESIS; PREGNANCY; APOPTOSIS	Plasmid-free Chlamydia trachomatis serovar L2 organisms have been transformed with chlamydial plasmid-based shuttle vectors pGFP:: SW2 and pBRCT using beta-lactamase as a selectable marker. However, the recommendation of amoxicillin, a beta-lactam antibiotics, as one of the choices for treating pregnant women with cervicitis due to C. trachomatis infection has made the existing shuttle vectors unsuitable for transforming sexually transmitted infection (STI)-causing serovars of C. trachomatis. Thus, in the current study, we modified the pGFP:: SW2 plasmid by fusing a blasticidin S deaminase gene to the GFP gene to establish blasticidin resistance as a selectable marker and replacing the beta-lactamase gene with the Sh ble gene to eliminate the penicillin resistance. The new vector termed pGFPBSD/Z:: SW2 was used for transforming plasmid-free C. trachomatis serovar D organisms. Using blasticidin for selection, stable transformants were obtained. The GFP-BSD fusion protein was detected in cultures infected with the pGFPBSD/Z:: SW2-trasnformed serovar D organisms. The transformation restored the plasmid property to the plasmid-free serovar D organisms. Thus, we have successfully modified the pGFP:: SW2 transformation system for studying the biology and pathogenesis of other STI-causing serovars of C. trachomatis.	[Ding, Honglei; Gong, Siqi; Tian, Yingxin; Yang, Zhangsheng; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Brunham, Robert] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada	University of Texas System; University of Texas Health San Antonio; University of British Columbia	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.EDU	Gong, Siqi/AAM-1568-2021; Gong, Siqi/ABD-9207-2020	Gong, Siqi/0000-0002-1111-6039	US NIH [R01AI64537, R01AI47997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US NIH grant# R01AI64537 & R01AI47997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneke A, 2012, TRAVEL MED INFECT DI, V10, P92, DOI 10.1016/j.tmaid.2012.01.005; BANKS J, 1970, Infection and Immunity, V1, P259; BOSE SK, 1982, J GEN MICROBIOL, V128, P1371; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Gong SQ, 2011, MICROBIOL-SGM, V157, P1134, DOI 10.1099/mic.0.047746-0; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Hu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035542; Karthikeyan V, 2010, BENEF MICROBES, V1, P155, DOI 10.3920/BM2009.0038; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064529; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; Mukhopadhyay S, 2004, J CLIN MICROBIOL, V42, P3288, DOI 10.1128/JCM.42.7.3288-3290.2004; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Vargas-Leguas H, 2012, EUROSURVEILLANCE, P17; Wang YB, 2013, PATHOG DIS, V67, P100, DOI 10.1111/2049-632X.12024; Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059195; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wong YC, 2011, J VIROL METHODS, V171, P295, DOI 10.1016/j.jviromet.2010.11.003; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	27	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80534	10.1371/journal.pone.0080534	http://dx.doi.org/10.1371/journal.pone.0080534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303023	Green Submitted, gold, Green Published			2022-12-25	WOS:000327546400039
J	Zhang, FL; Wang, P; Liu, YH; Liu, LB; Liu, XB; Li, Z; Xue, YX				Zhang, Feng-Lei; Wang, Ping; Liu, Yun-Hui; Liu, Li-Bo; Liu, Xiao-Bai; Li, Zhen; Xue, Yi-Xue			Topoisomerase I Inhibitors, Shikonin and Topotecan, Inhibit Growth and Induce Apoptosis of Glioma Cells and Glioma Stem Cells	PLOS ONE			English	Article							SIDE POPULATION; CANCER-CELLS; EXPRESSION; EFFICACY; PATHWAY; BCL-2	Gliomas, the most malignant form of brain tumors, contain a small subpopulation of glioma stem cells (GSCs) that are implicated in therapeutic resistance and tumor recurrence. Topoisomerase I inhibitors, shikonin and topotecan, play a crucial role in anti-cancer therapies. After isolated and identified the GSCs from glioma cells successfully, U251, U87, GSCs-U251 and GSCs-U87 cells were administrated with various concentrations of shikonin or topotecan at different time points to seek for the optimal administration concentration and time point. The cell viability, cell cycle and apoptosis were detected using cell counting kit-8 and flow cytometer to observe the inhibitory effects on glioma cells and GSCs. We demonstrated that shikonin and topotecan obviously inhibited proliferation of not only human glioma cells but also GSCs in a dose-and time-dependent manner. According to the IC50 values at 24 h, 2 mu mol/L of shikonin and 3 mu mol/L of topotecan were selected as the optimal administration concentration. In addition, shikonin and topotecan induced cell cycle arrest in G0/G1 and S phases and promoted apoptosis. The down-regulation of Bcl-2 expression with the activation of caspase 9/3-dependent pathway was involved in the apoptosis process. Therefore, the above results showed that topoisomerase I inhibitors, shikonin and topotecan, inhibited growth and induced apoptosis of GSCs as well as glioma cells, which suggested that they might be the potential anticancer agents targeting gliomas to provide a novel therapeutic strategy.	[Zhang, Feng-Lei; Wang, Ping; Liu, Li-Bo; Xue, Yi-Xue] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Feng-Lei; Wang, Ping; Liu, Li-Bo; Xue, Yi-Xue] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning Provin, Peoples R China; [Liu, Yun-Hui; Li, Zhen] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China; [Liu, Xiao-Bai] China Med Univ, Year Program 7, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Xue, YX (corresponding author), China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning Provin, Peoples R China.	xueyixue888@163.com			Natural Science Foundation of China [81172197, 81072056, 81171131, 81272564, 81272795]; special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities [20102104110009]; Natural Science Foundation of Liaoning Province in China [201102300]; Liaoning Science and Technology Plan Projects [2011225020]; Shenyang Science and Technology Plan Projects [F11-264-1-15, F12-277-1-05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities; Natural Science Foundation of Liaoning Province in China(Natural Science Foundation of Liaoning Province); Liaoning Science and Technology Plan Projects; Shenyang Science and Technology Plan Projects	This work is supported by grants from the Natural Science Foundation of China (81172197, 81072056, 81171131, 81272564, 81272795), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities (20102104110009), the Natural Science Foundation of Liaoning Province in China (No. 201102300), Liaoning Science and Technology Plan Projects (No. 2011225020), and Shenyang Science and Technology Plan Projects (nos. F11-264-1-15 and F12-277-1-05). The funders of YXX and YHL played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Bruzzese F, 2009, MOL CANCER THER, V8, P3075, DOI 10.1158/1535-7163.MCT-09-0254; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Chang IC, 2010, BIOL PHARM BULL, V33, P816, DOI 10.1248/bpb.33.816; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Christensen K, 2010, NEUROSURGERY, V66, P933, DOI 10.1227/01.NEU.0000368393.45935.46; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; FRIEDMAN HS, 1994, CANCER CHEMOTH PHARM, V34, P171; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Heywood RM, 2012, ACTA NEUROCHIR, V154, P951, DOI 10.1007/s00701-012-1338-9; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; HOUGHTON PJ, 1995, CANCER CHEMOTH PHARM, V36, P393; Huinink WTB, 1997, J CLIN ONCOL, V15, P2183, DOI 10.1200/JCO.1997.15.6.2183; IKEGAKI N, 1994, CANCER RES, V54, P6; Inoue A, 2010, INT J ONCOL, V37, P1121, DOI 10.3892/ijo_00000764; Kushner BH, 2010, CANCER-AM CANCER SOC, V116, P3054, DOI 10.1002/cncr.25232; Malla RR, 2012, NEURO-ONCOLOGY, V14, P745, DOI 10.1093/neuonc/nos088; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Min R, 2011, ORAL DIS, V17, P362, DOI 10.1111/j.1601-0825.2010.01758.x; Nie YK, 2010, CAN J PHYSIOL PHARM, V88, P1138, DOI 10.1139/Y10-085; O'Brien M, 2007, ONCOLOGIST, V12, P1194, DOI 10.1634/theoncologist.12-10-1194; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Rapisarda A, 2004, CANCER RES, V64, P6845, DOI 10.1158/0008-5472.CAN-04-2116; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Tomicic MT, 2010, J PHARMACOL EXP THER, V332, P316, DOI 10.1124/jpet.109.159962; Tsavaris N, 2009, CANCER CHEMOTH PHARM, V64, P391, DOI 10.1007/s00280-008-0886-4; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yang F, 2006, INT J CANCER, V119, P1184, DOI 10.1002/ijc.21943; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Yao Y, 2010, BREAST CANCER RES TR, V121, P233, DOI 10.1007/s10549-009-0547-2; Yeh CC, 2007, IN VIVO, V21, P1011; Yoon Y, 1999, PLANTA MED, V65, P532, DOI 10.1055/s-1999-14010; Zhang F, 2012, ONCOTARGET, V3, P998	41	49	53	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81815	10.1371/journal.pone.0081815	http://dx.doi.org/10.1371/journal.pone.0081815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303074	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400090
J	Nguyen, HN; Afkari, Y; Senoo, H; Sesaki, H; Devreotes, PN; Iijima, M				Nguyen, H. N.; Afkari, Y.; Senoo, H.; Sesaki, H.; Devreotes, P. N.; Iijima, M.			Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium	ONCOGENE			English	Article						PTEN; membrane localization; mutational analysis; Dictyostelium	TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; BINDING; PHOSPHORYLATION	Phosphatase and tensin homolog (PTEN) is one of the most frequently mutated tumor suppressor genes in cancers. PTEN has a central role in phosphatidylinositol (3,4,5)-trisphosphate (PIP3) signaling and converts PIP3 to phosphatidylinositol (4,5)bisphosphate at the plasma membrane. Despite its importance, the mechanism that mediates membrane localization of PTEN is poorly understood. Here, we generated a library that contains green fluorescent protein fused to randomly mutated human PTEN and expressed the library in Dictyostelium cells. Using live cell imaging, we identified mutations that enhance the association of PTEN with the plasma membrane. These mutations were located in four separate regions, including the phosphatase catalytic site, the calcium-binding region 3 (CBR3) loop, the C alpha 2 loop and the C-terminal tail phosphorylation site. The phosphatase catalytic site, the CBR3 loop and the C alpha 2 loop formed the membrane-binding regulatory interface and interacted with the inhibitory phosphorylated C-terminal tail. Furthermore, we showed that membrane recruitment of PTEN is required for PTEN function in cells. Thus, heterologous expression system in Dictyostelium cells provides mechanistic and functional insight into membrane localization of PTEN.	[Nguyen, H. N.; Afkari, Y.; Senoo, H.; Sesaki, H.; Devreotes, P. N.; Iijima, M.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Devreotes, PN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	pnd@jhmi.edu; miijima@jhmi.edu			NIH [GM084015, GM28007, GM34933, GM089853, NS084154]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM034933, R01GM084015, R01GM028007, R01GM089853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants to MI (GM084015), PND (GM28007 and GM34933) and HS (GM089853 and NS084154). We thank M Rahdar and KF Swaney for providing plasmids.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Cai HQ, 2011, METHODS MOL BIOL, V757, P451, DOI 10.1007/978-1-61779-166-6_26; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie Nick R, 2012, Adv Biol Regul, V52, P205; Lumb CN, 2013, BIOPHYS J, V104, P613, DOI 10.1016/j.bpj.2012.12.002; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Shenoy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032591; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang Y, 2011, MOL BIOL CELL, V22, P2270, DOI 10.1091/mbc.E10-11-0926; Zhang PB, 2010, P NATL ACAD SCI USA, V107, P11829, DOI 10.1073/pnas.1006153107	26	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5688	5696		10.1038/onc.2013.507	http://dx.doi.org/10.1038/onc.2013.507			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24292679	Green Accepted			2022-12-25	WOS:000346089300004
J	Holtzhausen, A; Golzio, C; How, T; Lee, YH; Schiemann, WP; Katsanis, N; Blobe, GC				Holtzhausen, Alisha; Golzio, Christelle; How, Tam; Lee, Yong-Hun; Schiemann, William P.; Katsanis, Nicholas; Blobe, Gerard C.			Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development	FASEB JOURNAL			English	Article						TGF-; tumorigenesis; invasion; dorsoventral axis	GROWTH-FACTOR-BETA; TGF-BETA; II RECEPTOR; ENDOTHELIAL-CELLS; ZEBRAFISH EMBRYO; UP-REGULATION; TUMOR; TRANSDUCTION; MECHANISM; ACTIVIN	The bone morphogenetic protein (BMP) signaling pathways have important roles in embryonic development and cellular homeostasis, with aberrant BMP signaling resulting in a broad spectrum of human disease. We report that BMPs unexpectedly signal through the canonical transforming growth factor (TGF-)-responsive Smad2 and Smad3. BMP-induced Smad2/3 signaling occurs preferentially in embryonic cells and transformed cells. BMPs signal to Smad2/3 by stimulating complex formation between the BMP-binding TGF- superfamily receptors, activin receptor-like kinase (ALK)3/6, and the Smad2/3 phosphorylating receptors ALK5/7. BMP signaling through Smad2 mediates, in part, dorsoventral axis patterning in zebrafish embryos, whereas BMP signaling through Smad3 facilitates cancer cell invasion. Consistent with increased BMP-mediated Smad2/3 signaling during cancer progression, Smad1/5 and Smad 2/3 signaling converge in human cancer specimens. Thus, the signaling mechanisms used by BMPs and TGF- superfamily receptors are broader than previously appreciated.Holtzhausen, A., Golzio, C., How, T., Lee, Y.-H., Schiemann, W. P., Katsanis, N., Blobe, G. C. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.	[Holtzhausen, Alisha; Blobe, Gerard C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27708 USA; [How, Tam; Blobe, Gerard C.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Lee, Yong-Hun; Schiemann, William P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Duke University; Duke University; Duke University; Case Western Reserve University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, 450 Res Dr,LSRC B354,Box 91004, Durham, NC 27708 USA.	gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020; Holtzhausen, Alisha/AAR-3606-2021	Blobe, Gerard/0000-0002-4274-8901; Holtzhausen, Alisha/0000-0003-3604-7401; Katsanis, Nicholas/0000-0002-2480-0171; Golzio, Christelle/0000-0002-4420-3921	U.S. National Institutes of Health [R01-CA136786]; Komen for the Cure grant [SAC100002]; American Heart Association [AHA-11POST7160006]; Center of Human Disease Modeling; NATIONAL CANCER INSTITUTE [R01CA129359, R01CA136786, P30CA014236] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen for the Cure grant; American Heart Association(American Heart Association); Center of Human Disease Modeling; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Drs. Paul Yu (Massachusetts General Hospital, Boston, MA, USA), Fred Miller (Wayne State University, Detroit, MI, USA), and Harold Moses (Vanderbilt University, Nashville, TN, USA) for reagents, Kyu Seo Kim (Duke University) for help with cloning and in vitro transcription, and Brad Gersh and Alok Tewari (Duke University) for data processing and analysis. This work was supported in part by U.S. National Institutes of Health grant R01-CA136786 (to G.C.B.), Komen for the Cure grant SAC100002 (to G.C.B.), American Heart Association grant AHA-11POST7160006 (to C.G.) and seed funding from the Center of Human Disease Modeling. N.K. is a Distinguished Brumley Professor. The authors declare no conflicts of interest.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Deng HY, 2009, CANCER LETT, V281, P220, DOI 10.1016/j.canlet.2009.02.046; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dick A, 2000, DEVELOPMENT, V127, P343; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Gordon KJ, 2009, CARCINOGENESIS, V30, P238, DOI 10.1093/carcin/bgn274; GRAINGER DJ, 1995, CLIN CHIM ACTA, V235, P11, DOI 10.1016/0009-8981(94)05995-4; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hild M, 1999, DEVELOPMENT, V126, P2149; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Imai Y, 2001, GENESIS, V30, P160, DOI 10.1002/gene.1055; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Kropf J, 1997, CLIN CHEM, V43, P1965; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Schmid B, 2000, DEVELOPMENT, V127, P957; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Star GP, 2010, MICROVASC RES, V80, P349, DOI 10.1016/j.mvr.2010.05.010; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	55	70	70	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1248	1267		10.1096/fj.13-239178	http://dx.doi.org/10.1096/fj.13-239178			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308972	Green Published			2022-12-25	WOS:000335324800019
J	Cattaneo, M; Baronchelli, S; Schiffer, D; Mellai, M; Caldera, V; Saccani, GJ; Dalpra, L; Daga, A; Orlandi, R; DeBlasio, P; Biunno, I				Cattaneo, Monica; Baronchelli, Simona; Schiffer, Davide; Mellai, Marta; Caldera, Valentina; Saccani, Gloria Jotti; Dalpra, Leda; Daga, Antonio; Orlandi, Rosaria; DeBlasio, Pasquale; Biunno, Ida			Down-modulation of SEL1L, an Unfolded Protein Response and Endoplasmic Reticulum-associated Degradation Protein, Sensitizes Glioma Stem Cells to the Cytotoxic Effect of Valproic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Tumors; Cancer Stem Cells; Cell Proliferation; Drug Resistance; Histone Deacetylase	HISTONE DEACETYLASE INHIBITORS; IN-VITRO; EXPRESSION PROFILES; CANCER; GENE; GROWTH; PATHWAY; LINES; VIVO; DIFFERENTIATION	Background: Valproic acid is considered as a promising anti-cancer therapeutic agent acting on unfolded protein response. SEL1L is an UPR-responsive gene. Results: SEL1L interference synergy enhances VPA cytotoxic effects on glioma stem cells. Conclusion: VPA treatment combined with SEL1L depletion may influence GSC pharmacological response. Significance: Targeting SEL1L in association with valproic acid treatment may improve glioma treatment. Valproic acid (VPA), an histone deacetylase inhibitor, is emerging as a promising therapeutic agent for the treatments of gliomas by virtue of its ability to reactivate the expression of epigenetically silenced genes. VPA induces the unfolded protein response (UPR), an adaptive pathway displaying a dichotomic yin yang characteristic; it initially contributes in safeguarding the malignant cell survival, whereas long-lasting activation favors a proapoptotic response. By triggering UPR, VPA might tip the balance between cellular adaptation and programmed cell death via the deregulation of protein homeostasis and induction of proteotoxicity. Here we aimed to investigate the impact of proteostasis on glioma stem cells (GSC) using VPA treatment combined with subversion of SEL1L, a crucial protein involved in homeostatic pathways, cancer aggressiveness, and stem cell state maintenance. We investigated the global expression of GSC lines untreated and treated with VPA, SEL1L interference, and GSC line response to VPA treatment by analyzing cell viability via MTT assay, neurosphere formation, and endoplasmic reticulum stress/UPR-responsive proteins. Moreover, SEL1L immunohistochemistry was performed on primary glial tumors. The results show that (i) VPA affects GSC lines viability and anchorage-dependent growth by inducing differentiative programs and cell cycle progression, (ii) SEL1L down-modulation synergy enhances VPA cytotoxic effects by influencing GSCs proliferation and self-renewal properties, and (iii) SEL1L expression is indicative of glioma proliferation rate, malignancy, and endoplasmic reticulum stress statuses. Targeting the proteostasis network in association to VPA treatment may provide an alternative approach to deplete GSC and improve glioma treatments.	[Cattaneo, Monica; Baronchelli, Simona; Biunno, Ida] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, I-20138 Milan, Italy; [Schiffer, Davide; Mellai, Marta; Caldera, Valentina] Policlin Monza Fdn, Neurobiooncol Ctr, I-13100 Vercelli, Italy; [Saccani, Gloria Jotti] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-19138 Parma, Italy; [Dalpra, Leda] Univ Milano Bicocca, Dept Surg & Translat Med, I-20900 Monza, Italy; [Dalpra, Leda] S Gerardo Hosp, Dept Surg Pathol, I-20900 Monza, Italy; [Daga, Antonio] IRCCS Azienda Osped Univ San Martino, Ist Sci Tumori, Ist Nazl Ric Canc, Dept Hematol Oncol, I-16132 Genoa, Italy; [Orlandi, Rosaria] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, I-20133 Milan, Italy; [DeBlasio, Pasquale] ISENET, I-20138 Milan, Italy; [Cattaneo, Monica; Baronchelli, Simona; Biunno, Ida] CNR, Inst Genet & Biomed Res, I-20138 Milan, Italy	University of Parma; University of Milano-Bicocca; University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Biunno, I (corresponding author), CNR, Inst Genet & Biomed Res, Via Fantoli 16-15, I-20138 Milan, Italy.	ida.biunno@irgb.cnr.it	Baronchelli, Simona/G-6771-2016; Orlandi, Rosaria/C-1182-2017; Daga, Antonio/Z-2417-2019	Baronchelli, Simona/0000-0002-1857-1472; Orlandi, Rosaria/0000-0002-0533-9041; Daga, Antonio/0000-0001-5845-8530; De Blasio, Pasquale/0000-0003-1698-1221; /0000-0002-1866-5866; , IDA_2/0000-0002-1068-4763	Ministero della Salute [RF-MUL-2008-1248034]; Compagnia di San Paolo, Turin [2011.0438]	Ministero della Salute(Ministry of Health, Italy); Compagnia di San Paolo, Turin(Compagnia di San Paolo)	This work was supported by grants from Ministero della Salute (RF-MUL-2008-1248034) and Compagnia di San Paolo, Turin (2011.0438).	Adler JT, 2008, SURGERY, V144, P956, DOI 10.1016/j.surg.2008.08.027; Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y; Barberis MCP, 2006, HISTOPATHOLOGY, V48, P614, DOI 10.1111/j.1365-2559.2005.02274.x; Baronchelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057462; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P918, DOI 10.1001/jama.271.12.918; Cardano M, 2011, J BIOL CHEM, V286, P18708, DOI 10.1074/jbc.M110.210740; Cattaneo M, 2003, ONCOGENE, V22, P6359, DOI 10.1038/sj.onc.1206665; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen Y, 2012, J NEURO-ONCOL, V109, P23, DOI 10.1007/s11060-012-0871-y; Choi MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011885; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Ferrero S, 2006, HUM PATHOL, V37, P505, DOI 10.1016/j.humpath.2005.12.012; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Granelli P, 2004, CLIN CANCER RES, V10, P5857, DOI 10.1158/1078-0432.CCR-04-0075; Grant B, 1996, GENETICS, V143, P237; Griffero F, 2009, J BIOL CHEM, V284, P7138, DOI 10.1074/jbc.M807111200; Kahali S, 2010, NEOPLASIA, V12, P80, DOI 10.1593/neo.91422; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu Q., 2013, MOL CARCINOG, DOI 10.1002/mc.22023; Lu Y, 2009, TOHOKU J EXP MED, V219, P17, DOI 10.1620/tjem.219.17; Machado Marcel Cerqueira Cesar, 2011, J Exp Ther Oncol, V9, P85; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masoudi A, 2008, ANTICANCER RES, V28, P2437; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Natsume A, 2011, BRAIN TUMOR PATHOL, V28, P1, DOI 10.1007/s10014-010-0011-3; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Olzmann J. A, 2013, COLD SPRING HARB PER, V5; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Osuka S, 2012, NEUROL MED-CHIR, V52, P186, DOI 10.2176/nmc.52.186; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ryu CH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/987495; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Shankar S, 2008, ADV EXP MED BIOL, V615, P261, DOI 10.1007/978-1-4020-6554-5_13; Shao CJ, 2012, CHINESE MED J-PEKING, V125, P4338, DOI 10.3760/cma.j.issn.0366-6999.2012.24.004; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Su JM, 2011, CLIN CANCER RES, V17, P589, DOI 10.1158/1078-0432.CCR-10-0738; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; The WHO, 2020, CLASSIFICATION TUMOU; Thomas RP, 2013, CLIN PHARMACOL-ADV A, V5, P1, DOI 10.2147/CPAA.S26586; Walkinshaw DR, 2008, CURR ONCOL, V15, P237	52	20	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2826	2838		10.1074/jbc.M113.527754	http://dx.doi.org/10.1074/jbc.M113.527754			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24311781	Green Published, hybrid			2022-12-25	WOS:000333403000031
J	He, HQ; Troksa, EL; Caltabiano, G; Pardo, L; Ye, RD				He, Hui-Qiong; Troksa, Erica L.; Caltabiano, Gianluigi; Pardo, Leonardo; Ye, Richard D.			Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Computer Modeling; G Protein-coupled Receptors (GPCR); Peptides; Receptor Structure-Function	PROTEIN-COUPLED RECEPTORS; N-FORMYLPEPTIDE RECEPTOR; LISTERIA-MONOCYTOGENES; HUMAN-NEUTROPHILS; SMALL-MOLECULE; BINDING-SITE; IDENTIFICATION; CHEMOATTRACTANTS; ACTIVATION; RESPONSES	Unlike formyl peptide receptor 1 (FPR1), FPR2/ALX (FPR2) interacts with peptides of diverse sequences but has low affinity for the Escherichia coli-derived chemotactic peptide fMet-Leu-Phe (fMLF). Using computer modeling and site-directed mutagenesis, we investigated the structural requirements for FPR2 to interact with formyl peptides of different length and composition. In calcium flux assay, the N-formyl group of these peptides is necessary for activation of both FPR2 and FPR1, whereas the composition of the C-terminal amino acids appears more important for FPR2 than FPR1. FPR2 interacts better with pentapeptides (fMLFII, fMLFIK) than tetrapeptides (fMLFK, fMLFW) and tripeptide (fMLF) but only weakly with peptides carrying negative charges at the C terminus (e.g. fMLFE). In contrast, FPR1 is less sensitive to negative charges at the C terminus. A CXCR4-based homology model of FPR1 and FPR2 suggested that Asp-281(7.32) is crucial for the interaction of FPR2 with certain formyl peptides as its negative charge may be repulsive with the terminal COO- group of fMLF and negatively charged Glu in fMLFE. Asp-281(7.32) might also form a stable interaction with the positively charged Lys in fMLFK. Site-directed mutagenesis was performed to remove the negative charge at position 281 in FPR2. The D281(7.32)G mutant showed improved affinity for fMLFE and fMLF and reduced affinity for fMLFK compared with wild type FPR2. These results indicate that different structural determinants are used by FPR1 and FPR2 to interact with formyl peptides.	[He, Hui-Qiong; Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Troksa, Erica L.; Ye, Richard D.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Caltabiano, Gianluigi; Pardo, Leonardo] Univ Autonoma Madrid, Fac Med, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Autonomous University of Madrid	Ye, RD (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.	ye.richard@outlook.com	Ye, Richard/O-5223-2016; Caltabiano, Gianluigi/F-4654-2010; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Caltabiano, Gianluigi/0000-0002-2929-7069; Ye, Richard/0000-0002-2164-5620; Pardo, Leonardo/0000-0003-1778-7420	National Basic Research Program of China (973 Program) [2012CB518000]; National Natural Science Foundation of China [31270941]; National Institutes of Health [R01 AI033503, P01 HL077806]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120073110069]; Ministerio de Ciencia e Innovacion [SAF2010-22198-C02-02]; Instituto de Salud Carlos III of Spain [RD07/0067/0008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033503] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Basic Research Program of China (973 Program Grant 2012CB518000) and National Natural Science Foundation of China (Grant 31270941). This work was also supported by National Institutes of Health Grants R01 AI033503 and P01 HL077806, and by Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant 20120073110069), the Ministerio de Ciencia e Innovacion (SAF2010-22198-C02-02) and the Instituto de Salud Carlos III (RD07/0067/0008) of Spain.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; Case D. A., 2006, AMBER9; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Kirpotina LN, 2010, MOL PHARMACOL, V77, P159, DOI 10.1124/mol.109.060673; Lala A, 1999, EUR J BIOCHEM, V264, P495, DOI 10.1046/j.1432-1327.1999.00647.x; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; NIEDEL JE, 1979, SCIENCE, V205, P1412, DOI 10.1126/science.472759; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Quehenberger O, 1997, BIOCHEM BIOPH RES CO, V238, P377, DOI 10.1006/bbrc.1997.7298; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	37	47	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2295	2306		10.1074/jbc.M113.509216	http://dx.doi.org/10.1074/jbc.M113.509216			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24285541	Green Published, hybrid			2022-12-25	WOS:000331130200034
J	Heckmann, BL; Zhang, XD; Xie, XT; Saarinen, A; Lu, X; Yang, XY; Liu, J				Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Lu, Xin; Yang, Xingyuan; Liu, Jun			Defective Adipose Lipolysis and Altered Global Energy Metabolism in Mice with Adipose Overexpression of the Lipolytic Inhibitor G(0)/G(1) Switch Gene 2 (G0S2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Adipose Tissue Metabolism; Adipose Triglyceride Lipase; Energy Metabolism; Fatty Acid; Fatty Acid Metabolism; Fatty Acid Oxidation; Lipolysis; Metabolism; G0S2	HORMONE-SENSITIVE LIPASE; TRIGLYCERIDE LIPASE; PROTEIN; TISSUE; OBESITY; CGI-58	Biochemical and cell-based studies have identified the G0S2 (G(0)/G(1) switch gene 2) as a selective inhibitor of the key intracellular triacylglycerol hydrolase, adipose triglyceride lipase. To better understand the physiological role of G0S2, we constructed an adipose tissue-specific G0S2 transgenic mouse model. In comparison with wild type animals, the transgenic mice exhibited a significant increase in overall fat mass and a decrease in peripheral triglyceride accumulation. Basal and adrenergically stimulated lipolysis was attenuated in adipose explants isolated from the transgenic mice. Following fasting or injection of a 3-adrenergic agonist, in vivo lipolysis and ketogenesis were decreased in G0S2 transgenic mice when compared with wild type animals. Consequently, adipose overexpression of G0S2 prevented the switch of energy substrate from carbohydrates to fatty acids during fasting. Moreover, G0S2 overexpression promoted accumulation of more and larger lipid droplets in brown adipocytes without impacting either mitochondrial morphology or expression of oxidative genes. This phenotypic change was accompanied by defective cold adaptation. Furthermore, feeding with a high fat diet caused a greater gain of both body weight and adiposity in the transgenic mice. The transgenic mice also displayed a decrease in fasting plasma levels of free fatty acid, triglyceride, and insulin as well as improved glucose and insulin tolerance. Cumulatively, these results indicate that fat-specific G0S2 overexpression uncouples adiposity from insulin sensitivity and overall metabolic health through inhibiting adipose lipolysis and decreasing circulating fatty acids.	[Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Liu, Jun] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Liu, Jun] Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85259 USA; [Heckmann, Bradlee L.] Mayo Grad Sch, Rochester, MN 55905 USA; [Lu, Xin] Univ Kentucky, Transgen Anim Facil, Lexington, KY 40508 USA; [Yang, Xingyuan] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; University of Kentucky; University System of Ohio; University of Cincinnati	Liu, J (corresponding author), Mayo Clin Arizona, Dept Biochem & Mol Biol, Hlth Program, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; American Diabetes Association [1-10-JF-30]; Mayo Foundation for Medical Research and Education; Mayo Clinic College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089178, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Mayo Foundation for Medical Research and Education; Mayo Clinic College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK089178) and The American Diabetes Association (1-10-JF-30) (to J. L.).; Supported by predoctoral funding from The Mayo Foundation for Medical Research and Education and the Mayo Clinic College of Medicine.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Bachner D, 1998, DEV DYNAM, V213, P398; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Mi J, 2010, J OBES, V2010, DOI 10.1155/2010/892081; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Perkins GA, 1998, J BIOENERG BIOMEMBR, V30, P431, DOI 10.1023/A:1020586012561; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Schrammel A, 2013, BBA-MOL CELL BIOL L, V1831, P1600, DOI 10.1016/j.bbalip.2013.07.004; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; VATNICK I, 1987, AM J PHYSIOL, V252, pE391, DOI 10.1152/ajpendo.1987.252.3.E391; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	37	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1905	1916		10.1074/jbc.M113.522011	http://dx.doi.org/10.1074/jbc.M113.522011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302733	hybrid, Green Published			2022-12-25	WOS:000331130200003
J	Gooneratne, CP; Kurnicki, A; Yamada, S; Mukhopadhyay, SC; Kosel, J				Gooneratne, Chinthaka P.; Kurnicki, Adam; Yamada, Sotoshi; Mukhopadhyay, Subhas C.; Kosel, Juergen			Analysis of the Distribution of Magnetic Fluid inside Tumors by a Giant Magnetoresistance Probe	PLOS ONE			English	Article							THERMAL THERAPY; BLOOD-FLOW; SUPERPARAMAGNETIC NANOPARTICLES; TEMPERATURE DISTRIBUTION; PARTICLE HYPERTHERMIA; DIELECTRIC-PROPERTIES; BIOLOGICAL TISSUES; LOCAL HYPERTHERMIA; SPHERICAL TISSUE; CANCER	Magnetic fluid hyperthermia (MFH) therapy uses the magnetic component of electromagnetic fields in the radiofrequency spectrum to couple energy to magnetic nanoparticles inside tumors. In MFH therapy, magnetic fluid is injected into tumors and an alternating current (AC) magnetic flux is applied to heat the magnetic fluid-filled tumor. If the temperature can be maintained at the therapeutic threshold of 42 degrees C for 30 minutes or more, the tumor cells can be destroyed. Analyzing the distribution of the magnetic fluid injected into tumors prior to the heating step in MFH therapy is an essential criterion for homogenous heating of tumors, since a decision can then be taken on the strength and localization of the applied external AC magnetic flux density needed to destroy the tumor without affecting healthy cells. This paper proposes a methodology for analyzing the distribution of magnetic fluid in a tumor by a specifically designed giant magnetoresistance (GMR) probe prior to MFH heat treatment. Experimental results analyzing the distribution of magnetic fluid suggest that different magnetic fluid weight densities could be estimated inside a single tumor by the GMR probe.	[Gooneratne, Chinthaka P.; Kosel, Juergen] King Abdullah Univ Sci & Technol, Thuwal, Makkah, Saudi Arabia; [Kurnicki, Adam] Lublin Univ Technol, Automat & Metrol Dept, Lublin, Poland; [Yamada, Sotoshi] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa, Japan; [Mukhopadhyay, Subhas C.] Massey Univ, Sch Engn & Adv Technol, Palmerston North, Manawatu, New Zealand	King Abdullah University of Science & Technology; Lublin University of Technology; Kanazawa University; Massey University	Gooneratne, CP (corresponding author), King Abdullah Univ Sci & Technol, Thuwal, Makkah, Saudi Arabia.	chinthaka.gooneratne@gmail.com	Kosel, Jürgen/H-1837-2014; Kurnicki, Adam/B-6906-2013; Mukhopadhyay, Subhas/AAJ-5336-2020	Kosel, Jürgen/0000-0002-8998-8275; Kurnicki, Adam/0000-0002-4988-7322; Mukhopadhyay, Subhas/0000-0002-8600-5907				Alam J, 2007, J MAGN MAGN MATER, V314, P93, DOI 10.1016/j.jmmm.2007.02.195; ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372; Bekovic M, 2010, IEEE T MAGN, V46, P552, DOI 10.1109/TMAG.2009.2033944; Bozorth RM, 1951, FERROMAGNETISM, P845; BREZOVICH IA, 1984, CANCER RES, V44, P4752; Bubnovskaya L., 2012, Experimental Oncology, V34, P336; Cervadoro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057332; CHEN DX, 1991, IEEE T MAGN, V27, P3601, DOI 10.1109/20.102932; Chieh JJ, 2011, IEEE T BIO-MED ENG, V58, P2719, DOI 10.1109/TBME.2010.2090042; Di Barba P, 2012, IEEE T MAGN, V48, P263, DOI 10.1109/TMAG.2011.2174340; Di Barba P, 2011, IEEE T MAGN, V47, P914, DOI 10.1109/TMAG.2010.2073453; Falk MH, 2001, INT J HYPERTHER, V17, P1, DOI 10.1080/02656730150201552; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gneveckow U, 2004, MED PHYS, V31, P1444, DOI 10.1118/1.1748629; Golneshan AA, 2011, INT J HYPERTHER, V27, P266, DOI 10.3109/02656736.2010.519370; Golneshan AA, 2011, MECH RES COMMUN, V38, P425, DOI 10.1016/j.mechrescom.2011.05.012; Gooneratne CP, 2012, J APPL PHYS, V111, DOI 10.1063/1.3678303; Gooneratne CP, 2013, ADV SENSING TECHNOLO, P121; Habash Riadh W. Y., 2006, Critical Reviews in Biomedical Engineering, V34, P459, DOI 10.1615/CritRevBiomedEng.v34.i6.20; Habash Riadh W. Y., 2006, Critical Reviews in Biomedical Engineering, V34, P491, DOI 10.1615/CritRevBiomedEng.v34.i6.30; Hergt R., 2007, MAGNETISM MED HDB, P550, DOI DOI 10.1002/9783527610174.CH4F; Hergt R, 2007, J MAGN MAGN MATER, V311, P187, DOI 10.1016/j.jmmm.2006.10.1156; Hergt R, 2006, J PHYS-CONDENS MAT, V18, pS2919, DOI 10.1088/0953-8984/18/38/S26; Horsman MR, 2006, INT J HYPERTHER, V22, P197, DOI 10.1080/02656730600689066; Hu RL, 2012, THORAC CANCER, V3, P34, DOI 10.1111/j.1759-7714.2011.00075.x; Johannsen M, 2005, PROSTATE, V64, P283, DOI 10.1002/pros.20213; Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360; Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7; Kappiyoor R, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500337; Khandhar AP, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556948; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kobayashi T, 2011, BIOTECHNOL J, V6, P1342, DOI 10.1002/biot.201100045; Kong G, 2001, CANCER RES, V61, P3027; Krishnan S, 2010, INT J HYPERTHER, V26, P775, DOI 10.3109/02656736.2010.485593; Lacroix LM, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2972172; Lahonian M, 2011, IEEE T NANOBIOSCI, V10, P262, DOI 10.1109/TNB.2011.2177100; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lenz J, 2006, IEEE SENS J, V6, P631, DOI 10.1109/JSEN.2006.874493; Li GX, 2006, SENSOR ACTUAT A-PHYS, V126, P98, DOI 10.1016/j.sna.2005.10.001; Lv YG, 2005, IEEE T NANOBIOSCI, V4, P284, DOI 10.1109/TNB.2005.859549; Mamiya H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00157; Miaskowski A, 2013, IEEE T BIO-MED ENG, V60, P1806, DOI 10.1109/TBME.2013.2242071; Miklavcic D., 2006, WILEY ENCY BIOMEDICA; Millen RL, 2005, ANAL CHEM, V77, P6581, DOI 10.1021/ac0509049; Nagae H, 2011, 30 GEN ASS SCI S, DOI [10.1109/URSIGASS.2011.6051352, DOI 10.1109/URSIGASS.2011.6051352]; Nedelcu G, 2008, DIG J NANOMATER BIOS, V3, P103; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; Ortega D, 2013, NANOSCI-SPEC PER REP, V1, P60, DOI 10.1039/9781849734844-00060; OSBORN JA, 1945, PHYS REV, V67, P351, DOI 10.1103/PhysRev.67.351; Rast L, 2010, PIERS ONLINE, V6, P5, DOI [10.2529/PIERS091218133748, DOI 10.2529/PIERS091218133748]; Silva AC, 2011, INT J NANOMED, V6, P591, DOI 10.2147/IJN.S14737; Smith C. H., 1999, Sensors, V16, P76; Song CW, 2005, INT J HYPERTHER, V21, P761, DOI 10.1080/02656730500204487; Srinivasan B, 2009, ANGEW CHEM, V121, P2802; Tasci TO, 2009, MED PHYS, V36, P1906, DOI 10.1118/1.3106343; THRALL DE, 1980, RADIAT ENVIRON BIOPH, V17, P229, DOI 10.1007/BF01323649; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; VAUPEL P, 1983, J CANCER RES CLIN, V105, P303, DOI 10.1007/BF00395763; Wang Q, 2011, J NANOTECHNOL ENG ME, V2; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Xu RZ, 2007, IEEE T MAGN, V43, P1078, DOI 10.1109/TMAG.2006.888737; Yamada S., 2007, Journal of the Magnetics Society of Japan, V31, P44, DOI 10.3379/jmsjmag.31.44; Zhong J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075703	68	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81227	10.1371/journal.pone.0081227	http://dx.doi.org/10.1371/journal.pone.0081227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312280	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300029
J	Luo, YQ; Battistuzzi, F; Lin, K				Luo, Yingqin; Battistuzzi, Fabia; Lin, Kui			Evolutionary Dynamics of Overlapped Genes in Salmonella	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI K-12; ANCESTRAL CHARACTER STATES; MICROBIAL GENOMES; BACTERIOPHAGE-LAMBDA; MAXIMUM-LIKELIHOOD; SELFISH OPERONS; DNA-SEQUENCE; PROKARYOTES; EXPRESSION	Presence of overlapping genes (OGs) is a common phenomenon in bacterial genomes. Most frequently, overlapping genes share coding regions with as few as one nucleotide to as many as thousands of nucleotides. Overlapping genes are often co-regulated, transcriptionally and translationally. Overlapping genes are also subject to the whims of evolution, as the gene overlap is known to be disrupted in some species/strains and participating genes are sometimes lost in independent lineages. Therefore, a better understanding of evolutionary patterns and rates of the disruption of overlapping genes is an important component of genome structure and evolution of gene function. In this study, we investigate the fate of ancestrally overlapping genes in complete genomes from 15 contemporary strains of Salmonella species. We find that the fates of overlapping genes inside and outside operons are distinctly different. A larger fraction of overlapping genes inside operons conserves their overlap as compared to gene pairs outside of the operons (average 0.89 vs. 0.83 per genome). However, when overlapping genes in the operons separate, one partner is lost more frequently than in those separated genes outside of operons (average 0.02 vs. 0.01 per genome). We also investigate the fate of a pan set of overlapping genes at the present and ancestral nodes over a phylogenetic tree based on genome sequence data, respectively. We propose that co-regulation plays important roles on the fates of genes. Furthermore, a vast majority of disruptions occurred prior to the common ancestor of all 15 Salmonella strains, which enables us to obtain an estimate of disruptions between Salmonella and E. coli.	[Luo, Yingqin] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA; [Luo, Yingqin] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Battistuzzi, Fabia] Oakland Univ, Dept Biol Sci, Rochester, MI USA; [Lin, Kui] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Oakland University; Beijing Normal University	Luo, YQ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA.	luoyq.cmb@gmail.com	Lin, Kui/P-4492-2015	Lin, Kui/0000-0002-5993-1972				[Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cheng CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-102; Chirico N, 2010, P BIOL SCI; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; DAVIES RW, 1980, NUCLEIC ACIDS RES, V8, P1765, DOI 10.1093/nar/8.8.1765; DEMEREC M, 1959, ANNU REV MICROBIOL, V13, P377, DOI 10.1146/annurev.mi.13.100159.002113; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Francetic O, 1996, J BACTERIOL, V178, P3544, DOI 10.1128/jb.178.12.3544-3549.1996; Fukuda Y, 1999, NUCLEIC ACIDS RES, V27, P1847, DOI 10.1093/nar/27.8.1847; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; HOESS RH, 1980, P NATL ACAD SCI-BIOL, V77, P2482, DOI 10.1073/pnas.77.5.2482; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jiang LW, 2008, NUCLEIC ACIDS RES, V36, pW475, DOI 10.1093/nar/gkn240; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1996, GENETICS, V143, P1843; LILJESTROM P, 1988, J MOL BIOL, V201, P663, DOI 10.1016/0022-2836(88)90465-2; Lillo F, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-22; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lucena B, 2005, SYST BIOL, V54, P693, DOI 10.1080/10635150590950344; Luo YQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-266; Luo YQ, 2006, TRENDS GENET, V22, P593, DOI 10.1016/j.tig.2006.08.011; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OPPENHEIM DS, 1980, GENETICS, V95, P785; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Romling Ute, 2007, P107, DOI 10.1007/978-1-4020-5380-1_7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shcherbakov D. V., 2000, Molekulyarnaya Biologiya (Moscow), V34, P572; Shendure J, 2002, GENOME BIOL, V3; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin YB, 2010, P NATL ACAD SCI USA, V107, P6310, DOI 10.1073/pnas.0911237107; Zheng Y, 2002, GENOME RES, V12, P1221, DOI 10.1101/gr.200602; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	69	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81016	10.1371/journal.pone.0081016	http://dx.doi.org/10.1371/journal.pone.0081016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312259	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300022
J	Mariotti, LG; Pirovano, G; Savage, KI; Ghita, M; Ottolenghi, A; Prise, KM; Schettino, G				Mariotti, Luca G.; Pirovano, Giacomo; Savage, Kienan I.; Ghita, Mihaela; Ottolenghi, Andrea; Prise, Kevin M.; Schettino, Giuseppe			Use of the gamma-H2AX Assay to Investigate DNA Repair Dynamics Following Multiple Radiation Exposures	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DSB REPAIR; HETEROCHROMATIN; KINETICS; INDUCTION; DAMAGE; 53BP1; CELLS; FOCI	Radiation therapy is one of the most common and effective strategies used to treat cancer. The irradiation is usually performed with a fractionated scheme, where the dose required to kill tumour cells is given in several sessions, spaced by specific time intervals, to allow healthy tissue recovery. In this work, we examined the DNA repair dynamics of cells exposed to radiation delivered in fractions, by assessing the response of histone-2AX (H2AX) phosphorylation (gamma-H2AX), a marker of DNA double strand breaks. gamma-H2AX foci induction and disappearance were monitored following split dose irradiation experiments in which time interval between exposure and dose were varied. Experimental data have been coupled to an analytical theoretical model, in order to quantify key parameters involved in the foci induction process. Induction of gamma-H2AX foci was found to be affected by the initial radiation exposure with a smaller number of foci induced by subsequent exposures. This was compared to chromatin relaxation and cell survival. The time needed for full recovery of gamma-H2AX foci induction was quantified (12 hours) and the 1:1 relationship between radiation induced DNA double strand breaks and foci numbers was critically assessed in the multiple irradiation scenarios.	[Mariotti, Luca G.; Pirovano, Giacomo; Ottolenghi, Andrea] Univ Pavia, Dipartimento Fis, I-27100 Pavia, Italy; [Pirovano, Giacomo; Savage, Kienan I.; Ghita, Mihaela; Prise, Kevin M.; Schettino, Giuseppe] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Mariotti, Luca G.; Ottolenghi, Andrea] Ist Nazl Fis Nucl, Sez Pavia, I-27100 Pavia, Italy	University of Pavia; Queens University Belfast; Istituto Nazionale di Fisica Nucleare (INFN)	Mariotti, LG (corresponding author), Univ Oxford, Gray Inst Radiat Oncol & Biol, Dept Oncol, Oxford OX1 2JD, England.	luca.mariotti@pv.infn.it	Schettino, Giuseppe/X-1983-2018; Ghita, Mihaela/J-3797-2019; Prise, Kevin/N-7872-2015; Pirovano, Giacomo/AAQ-9437-2020	Schettino, Giuseppe/0000-0003-3284-3953; Prise, Kevin/0000-0001-6134-7946; Pirovano, Giacomo/0000-0001-8862-3613; Savage, Kienan/0000-0002-4898-899X; Ottolenghi, Andrea/0000-0002-4923-257X	EURATOM DOREMI - INITIUM [249689]; Cancer Research United Kingdom [C1513/A7047]; Medical Research Council [G1100014/1]	EURATOM DOREMI - INITIUM; Cancer Research United Kingdom(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by EURATOM DOREMI - INITIUM (249689), Cancer Research United Kingdom (C1513/A7047) and Medical Research Council (G1100014/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloni D, 2013, RADIAT RES, V179, P690, DOI 10.1667/R3043.1; Alloni D, 2011, RADIAT PROT DOSIM, V143, P226, DOI 10.1093/rpd/ncq384; Alloni D, 2012, INT J RADIAT BIOL, V88, P77, DOI 10.3109/09553002.2011.627976; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Belli M, 2000, INT J RADIAT BIOL, V76, P1095; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Costes SV, 2007, PLOS COMPUT BIOL, V3, P1477, DOI 10.1371/journal.pcbi.0030155; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; HU LL, 2009, INT J RADIAT BIOL, V85, P532, DOI DOI 10.1080/09553000902883828.PUBMED:19401904; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; KAVANAGH J, 2013, ANTIOXID REDOX SIGNA; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mariotti L, 2010, RADIAT RES, V174, P280, DOI 10.1667/RR1889.1; Mariotti LG, 2012, INT J RADIAT BIOL, V88, P751, DOI 10.3109/09553002.2012.703365; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; NIKJOO H, 2004, PHYS MED BIOL, V55, P143; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Staaf Elina, 2012, Genome Integr, V3, P8, DOI 10.1186/2041-9414-3-8; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	43	123	126	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e79541	10.1371/journal.pone.0079541	http://dx.doi.org/10.1371/journal.pone.0079541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312182	Green Submitted, gold, Green Published			2022-12-25	WOS:000327670300007
J	Yan, JH; Zhang, H; Li, YP				Yan, Jianhua; Zhang, Hao; Li, Yongping			Establishment of the Relationship between Tumor Size and Range of Histological Involvement to Evaluate the Rationality of Current Retinoblastoma Management	PLOS ONE			English	Article							CLINICAL RISK-FACTORS; INTRAOCULAR RETINOBLASTOMA; OPTIC-NERVE; CHEMOREDUCTION; CHEMOTHERAPY; INVASION; RADIOTHERAPY; ENUCLEATION; METASTASES; RADIATION	Purpose: To determine whether tumor size correlates with histopathological involvement and hence evaluate the rationality of conservative treatment for retinoblastoma. Methods: We retrospectively studied 221 patients (221 eyes) treated for retinoblastoma with enucleation in the Zhongshan Ophthalmic Center of Sun Yat-sen University, China, from October 1995 to December 2004. Histopathological data included involvement of the anterior chamber, sclera, choroids, and optic nerve. Tumor size was measured by B-ultrasound examination. Results: Tumor invasion of the optic nerve correlated with the Reese-Ellsworth (R-E) staging system and the International Classification for Retinoblastoma (ICRB): optic nerve involvement was significantly more frequent in R-E stage V (P = 0.009) and ICRB Group E (P = 0.002) cases. However, 19.1% of patients with R-E stage I, II and III, and 16.7% of patients with ICRB Group B and C disease showed histopathological involvement of the postlaminar optic nerve. Extraocular involvement was observed in 17.7% of tumors <= 15 mm in diameter. Tumors >15 mm in diameter showed greater extraocular involvement, including the optic nerve (P = 0.000) and sclera (P = 0.032), than tumors <= 15 mm in diameter. Postlaminar optic nerve invasion was observed in 19.6% of tumors <= 10 mm in thickness. Tumors >10 mm in thickness had sclera involvement more frequently than tumors <= 10 mm in thickness (P = 0.029). Postlaminar optic nerve invasion was noted in 17.1% of patients with tumors <= 15 mm in diameter and <= 10 mm in thickness. Conclusions: Medium-sized retinoblastomas frequently invade outside the globe. Thus, indications for conservative treatment need improvement.	[Yan, Jianhua; Zhang, Hao; Li, Yongping] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yan, JH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yanjh2011@126.com		yan, jian hua/0000-0001-7564-8491	Research Foundation of Science and Technology Plan Project, Guangdong, China [2012B061700088]	Research Foundation of Science and Technology Plan Project, Guangdong, China	This work was supported by the Research Foundation of Science and Technology Plan Project, Guangdong, China (Grant Number: 2012B061700088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034120; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; Chantada G L, 1999, Ophthalmic Genet, V20, P133, DOI 10.1076/opge.20.3.133.2277; Chantada GL, 2004, BRIT J OPHTHALMOL, V88, P1069, DOI 10.1136/bjo.2003.037044; De Potter Patrick, 2002, Curr Opin Ophthalmol, V13, P331; Finger PT, 2002, SURV OPHTHALMOL, V47, P1, DOI 10.1016/S0039-6257(01)00279-X; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Hernandez JC, 1996, INT J RADIAT ONCOL, V35, P125, DOI 10.1016/S0360-3016(96)85020-6; Khelfaoui F, 1996, CANCER-AM CANCER SOC, V77, P1206, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.3.CO;2-Q; Kim Jeong Hun, 2003, Korean J Ophthalmol, V17, P35; MAGRAMM I, 1989, OPHTHALMOLOGY, V96, P217; MESSMER EP, 1991, OPHTHALMOLOGY, V98, P136; Shields Carol L, 2004, Cancer Control, V11, P317; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; SHIELDS CL, 1993, BRIT J OPHTHALMOL, V77, P544, DOI 10.1136/bjo.77.9.544; SHIELDS CL, 1994, CANCER, V73, P692, DOI 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8; Shields CL, 2003, J PEDIAT OPHTH STRAB, V40, P6; Shields CL, 2004, AM J OPHTHALMOL, V138, P329, DOI 10.1016/j.ajo.2004.04.032; Shields CL, 1997, OPHTHALMOLOGY, V104, P2101, DOI 10.1016/S0161-6420(97)30053-0; Shields CL, 2001, OPHTHALMOLOGY, V108, P2116, DOI 10.1016/S0161-6420(01)00797-7; STANNARD C, 1979, BRIT J OPHTHALMOL, V63, P560, DOI 10.1136/bjo.63.8.560; Wilson MW, 2001, OPHTHALMOLOGY, V108, P2106, DOI 10.1016/S0161-6420(01)00805-3; WOLTER JR, 1987, OPHTHALMIC PAED GEN, V8, P151, DOI 10.3109/13816818709031461; Zhao JY, 2011, J CLIN ONCOL, V29, P845, DOI 10.1200/JCO.2010.32.5332	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80484	10.1371/journal.pone.0080484	http://dx.doi.org/10.1371/journal.pone.0080484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312226	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900010
J	Angst, D; Buffetaut, E; Lecuyer, C; Amiot, R				Angst, Delphine; Buffetaut, Eric; Lecuyer, Christophe; Amiot, Romain			"Terror Birds" (Phorusrhacidae) from the Eocene of Europe Imply Trans-Tethys Dispersal	PLOS ONE			English	Article							FOSSIL RECORD; SOUTH-AMERICA; TERTIARY; AFRICA	Background: Phorusrhacidae was a clade including middle-sized to giant terrestrial carnivorous birds, known mainly from the Cenozoic of South America, but also occurring in the Plio-Pleistocene of North America and the Eocene of Africa. Previous reports of small phorusrhacids in the Paleogene of Europe have been dismissed as based on non-phorusrhacid material. Methodology: we have re-examined specimens of large terrestrial birds from the Eocene (late Lutetian) of France and Switzerland previously referred to gastornithids and ratites and have identified them as belonging to a phorusrhacid for which the name Eleutherornis cotei should be used. Conclusions/Significance: The occurrence of a phorusrhacid in the late Lutetian of Europe indicates that these flightless birds had a wider geographical distribution than previously recognized. The likeliest interpretation is that they dispersed from Africa, where the group is known in the Eocene, which implies crossing the Tethys Sea. The Early Tertiary distribution of phorusrhacids can be best explained by transoceanic dispersal, across both the South Atlantic and the Tethys.	[Angst, Delphine; Amiot, Romain] Univ Lyon 1, Lab Geol Lyon Terre Planetes Environm UMR CNRS, ENS Lyon 5276, Dept Sci,Fac Sci, F-69622 Villeurbanne, France	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Angst, D (corresponding author), Univ Lyon 1, Lab Geol Lyon Terre Planetes Environm UMR CNRS, ENS Lyon 5276, Dept Sci,Fac Sci, Campus Doua, F-69622 Villeurbanne, France.	angst.delphine@gmail.com	Amiot, Romain/C-8132-2012; Lecuyer, Christophe/AAO-8154-2021	Angst, Delphine/0000-0002-1050-518X; Lecuyer, Christophe/0000-0001-9513-2492	INTERRVIE programme of the Centre National de la Recherche Scientifique, Paris	INTERRVIE programme of the Centre National de la Recherche Scientifique, Paris	This research was partly supported by a grant from the INTERRVIE programme of the Centre National de la Recherche Scientifique, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agnolin F.L, 2009, SISTEMATICA FILOGENI; Agnolin Federico L., 2013, Revista del Museo Argentino de Ciencias Naturales, V15, P39; ALVARENGA H., 1985, NME DNPM SERIE GEOLO, V27, P17; Alvarenga H.M.F., 2011, LIVING DINOSAURS EVO, P187; Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Andors Allison Victor, 1992, Natural History Museum of Los Angeles County Science Series, V36, P109; Andrews C.W., 1901, T ZOOLOGICAL SOC LON, V15, P55; Biochro M, 1997, MEMOIRES TRAVAUX EPH, V21, P769; Buffetaut E, P 1 INT C S IN PRESS; Buffetaut E., 2000, VERTEBRATA PALASIA S, V38, P3; Cenizo MM, 2012, ALCHERINGA, V36, P47, DOI 10.1080/03115518.2011.582806; Chantre E., 1897, CR HEBD ACAD SCI, V125, P986; Deperet C, 1894, COMPTES RENDUS LACAD, V118, P822; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Feduccia A, 1999, ORIGINE EVOLUTION BI; Fleagle JG, 2006, DEV PRIMATOL, P375; Gaillard C., 1937, Annales de la Societe Linneenne de Lyon, V80, P111; GAILLARD CLAUDE, 1936, COMPT REND ACAD SCI [PARIS], V202, P965; GEORGE W, 1993, AFRICA S AM CONNECTI, P119; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gould Gina C., 2005, Bulletin of the Florida Museum of Natural History, V45, P201; MARSHALL LG, 1994, SCI AM, V270, P90, DOI 10.1038/scientificamerican0294-90; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr Gerald, 2005, Paleobios, V25, P11; Mlikovsky J., 2002, CENOZOIC BIRDS WOR 1; Mourer-Chauvire C, 1999, B SOC GEOL FR, V170, P85; MOURER-CHAUVIRE C, 1981, Geobios (Villeurbanne), V14, P637, DOI 10.1016/S0016-6995(81)80140-4; Mourer-Chauvire C, 2011, NATURWISSENSCHAFTEN, V98, P815, DOI 10.1007/s00114-011-0829-5; Oliveira FB, 2009, PALEOGEOGRAPHY S ATL, P55; Patterson B, 1960, PUB MUS MUN CIENC NA, V1, P3; Peters D.S., 1987, DOCUMENTS LAB GEOLOG, V99, P71; PROTHERO DR, 2006, DINOSAURS AGE MAMMAL; Roman F, 1926, GEOLOGIE LYONNAISE; Rutimeyer L., 1891, ABHANDLUNGEN SCHWEIZ, V18, P1, DOI 10.5962/bhl.title.158813; SCHAUB S., 1929, VERHANDL NATURFORSCH GES BASEL, V40, P588; Schaub S, 1940, ECLOGAE GEOL HELV, V32, P274; SINCLAIR WILLIAM J., 1932, REPT PRINCETON UNIV EXPED PATAGONIA 1896 1899, V7, P157; Tambussi CP, 2011, BIOL J LINN SOC, V103, P458, DOI 10.1111/j.1095-8312.2011.01658.x; Tambussi CP, 2013, PALEOBIOGEOGRAPHIC A; Tonni Eduardo P., 1986, P131; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531	43	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80357	10.1371/journal.pone.0080357	http://dx.doi.org/10.1371/journal.pone.0080357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312212	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100034
J	He, HY; Han, D; Feng, HL; Qu, H; Song, SJ; Bai, BJ; Zhang, ZT				He, Huiying; Han, Dong; Feng, Hailan; Qu, Hong; Song, Shujuan; Bai, Baojing; Zhang, Zhenting			Involvement of and Interaction between WNT10A and EDA Mutations in Tooth Agenesis Cases in the Chinese Population	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; NON-SYNDROMIC HYPODONTIA; ECTODYSPLASIN-A; GENETIC-BASIS; INHERITED ANOMALIES; HAIR-FOLLICLES; KAPPA-B; IDENTIFICATION; MORPHOGENESIS; EXPRESSION	Background: Dental agenesis is the most common, often heritable, developmental anomaly in humans. Although WNT10A gene mutations are known to cause rare syndromes associated with tooth agenesis, including onycho-odontodermal dysplasia (OODD), Schopf-Schulz-Passarge syndrome (SSPS), hypohidrotic ectodermal dysplasia (HED), and more than half of the cases of isolated oligodontia recently, the genotype-phenotype correlations and the mode of inheritance of WNT10A mutations remain unclear. The phenotypic expression with WNT10A mutations shows a high degree of variability, suggesting that other genes might function with WNT10A in regulating ectodermal organ development. Moreover, the involvement of mutations in other genes, such as EDA, which is also associated with HED and isolated tooth agenesis, is not clear. Therefore, we hypothesized that EDA mutations interact with WNT10A mutations to play a role in tooth agenesis. Additionally, EDA, EDAR, and EDARADD encode signaling molecules in the Eda/Edar/NF-kappa B signaling pathways, we also checked EDAR and EDARADD in this study. Methods: WNT10A, EDA, EDAR and EDARADD were sequenced in 88 patients with isolated oligodontia and 26 patients with syndromic tooth agenesis. The structure of two mutated WNT10A and two mutated EDA proteins was analyzed. Results: Digenic mutations of both WNT10A and EDA were identified in 2 of 88 (2.27%) isolated oligodontia cases and 4 of 26 (15.38%) syndromic tooth agenesis cases. No mutation in EDAR or EDARADD gene was found. Conclusions: WNT10A and EDA digenic mutations could result in oligodontia and syndromic tooth agenesis in the Chinese population. Moreover, our results will greatly expand the genotypic spectrum of tooth agenesis.	[He, Huiying; Han, Dong; Feng, Hailan] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Qu, Hong] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Song, Shujuan] Peking Univ, Hlth Sci Ctr, Dept Genet, Beijing 100871, Peoples R China; [Bai, Baojing; Zhang, Zhenting] Capital Med Univ, Sch Stomatol, Dept Prosthodont, Beijing, Peoples R China	Peking University; Peking University; Peking University; Capital Medical University	Feng, HL (corresponding author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqfenghl@bjmu.edu.cn	Han, Dong/V-2128-2018	Han, Dong/0000-0001-9625-3384	National Natural Science Foundation of China [81271121, 81100725]; Major Clinical Specialty Project of Chinese Ministry of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Clinical Specialty Project of Chinese Ministry of Health	This work was supported by the National Natural Science Foundation of China(Grant No. 81271121 and 81100725), and the Major Clinical Specialty Project of Chinese Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P383, DOI 10.1016/j.ejmg.2008.05.003; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P273, DOI 10.1016/j.ejmg.2008.02.009; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bhuiyan ZA, 2009, CIRC-CARDIOVASC GENE, V2, P418, DOI 10.1161/CIRCGENETICS.108.839829; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Castori M, 2008, ACTA DERM-VENEREOL, V88, P607, DOI 10.2340/00015555-0547; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; El Hokayem J, 2012, J MED GENET, V49, P227, DOI 10.1136/jmedgenet-2011-100717; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurikkala J, 2001, DEV BIOL, V229, P443, DOI 10.1006/dbio.2000.9955; Lexner MO, 2008, CLIN GENET, V74, P252, DOI 10.1111/j.1399-0004.2008.01037.x; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Morak M, 2011, EUR J CANCER, V47, P1046, DOI 10.1016/j.ejca.2010.11.016; NAKATA M, 1980, AM J HUM GENET, V32, P908; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Orange JS, 2005, IMMUNOL REV, V203, P21, DOI 10.1111/j.0105-2896.2005.00221.x; Paakkonen K, 2001, Hum Mutat, V17, P349, DOI 10.1002/humu.33; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vincent MC, 2001, EUR J HUM GENET, V9, P355, DOI 10.1038/sj.ejhg.5200635; Wang SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051533; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Zhang J, 2011, EUR J MED GENET, V54, pE377, DOI 10.1016/j.ejmg.2011.03.005; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; Zhao R, 2013, IADR AADR CADR GEN S	40	38	42	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80393	10.1371/journal.pone.0080393	http://dx.doi.org/10.1371/journal.pone.0080393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312213	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100035
J	Ren, Z				Ren, Zhong			Reverse Engineering the Cooperative Machinery of Human Hemoglobin	PLOS ONE			English	Article							DEER MOUSE HEMOGLOBIN; R-STATE HEMOGLOBIN; STRUCTURAL-CHANGES; OXYGEN-BINDING; ALLOSTERIC TRANSITIONS; QUATERNARY STRUCTURE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; MOLECULAR CODE; MODEL	Hemoglobin transports molecular oxygen from the lungs to all human tissues for cellular respiration. Its alpha(2)beta(2) tetrameric assembly undergoes cooperative binding and releasing of oxygen for superior efficiency and responsiveness. Over past decades, hundreds of hemoglobin structures were determined under a wide range of conditions for investigation of molecular mechanism of cooperativity. Based on a joint analysis of hemoglobin structures in the Protein Data Bank (Ren, companion article), here I present a reverse engineering approach to elucidate how two subunits within each dimer reciprocate identical motions that achieves intradimer cooperativity, how ligand-induced structural signals from two subunits are integrated to drive quaternary rotation, and how the structural environment at the oxygen binding sites alter their binding affinity. This mechanical model reveals the intricate design that achieves the cooperative mechanism and has previously been masked by inconsistent structural fluctuations. A number of competing theories on hemoglobin cooperativity and broader protein allostery are reconciled and unified.	[Ren, Zhong] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL USA; [Ren, Zhong] Renz Research Inc, Westmont, IL USA	University of Chicago	Ren, Z (corresponding author), Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL USA.	renzresearch@gmail.com			National Institutes of Health, National Center for Research Resources [RR007707]; National Institute of General Medical Sciences [8P41GM103543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103543] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research funding is provided by the National Institutes of Health, National Center for Research Resources (ncrr.nih.gov), under grant number RR007707, and by the National Institute of General Medical Sciences (nigms.nih.gov), under grant number 8P41GM103543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author declares no competing financial interests.	Ackers GK, 2000, PROTEINS, P23; ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; Adachi S, 2003, P NATL ACAD SCI USA, V100, P7039, DOI 10.1073/pnas.1230629100; ARNONE A, 1972, NATURE, V237, P146, DOI 10.1038/237146a0; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Baldwin J.M., 1975, Progress Biophys Molec Biol, V29, P225; Barrick D, 1997, NAT STRUCT BIOL, V4, P78, DOI 10.1038/nsb0197-78; BRUNORI M, 1966, J BIOL CHEM, V241, P5238; Cammarata M, 2008, NAT METHODS, V5, P881, DOI [10.1038/nmeth.1255, 10.1038/NMETH.1255]; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Crowley MA, 2011, NEW ENGL J MED, V364, P1837, DOI 10.1056/NEJMoa1013579; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; Edelstein SJ, 1996, J MOL BIOL, V257, P737, DOI 10.1006/jmbi.1996.0198; GELIN BR, 1977, P NATL ACAD SCI USA, V74, P801, DOI 10.1073/pnas.74.3.801; GODZIK A, 1993, PROTEIN ENG, V6, P801, DOI 10.1093/protein/6.8.801; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; HOLT JM, 1995, FASEB J, V9, P210, DOI 10.1096/fasebj.9.2.7781923; JANIN J, 1985, BIOPOLYMERS, V24, P509, DOI 10.1002/bip.360240307; Kano G, 2004, INT J HEMATOL, V80, P410, DOI 10.1532/IJH97.04048; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; KILMARTIN JV, 1971, COLD SPRING HARB SYM, V36, P311; Kloczkowski Andrzej, 2009, Journal of Structural and Functional Genomics, V10, P67, DOI 10.1007/s10969-009-9062-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEE AWM, 1983, P NATL ACAD SCI-BIOL, V80, P7055, DOI 10.1073/pnas.80.23.7055; LIDDINGTON R, 1988, NATURE, V331, P725, DOI 10.1038/331725a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PERUTZ MF, 1987, COLD SPRING HARB SYM, V52, P555, DOI 10.1101/SQB.1987.052.01.063; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; Ren Z, 2013, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0077141, DOI 10.1371/J0URNAL.P0NE.0077141]; Ren Z, 2012, P NATL ACAD SCI USA, V109, P107, DOI 10.1073/pnas.1109213108; RICHARD V, 1993, J MOL BIOL, V233, P270, DOI 10.1006/jmbi.1993.1505; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Royer WE, 2005, J BIOL CHEM, V280, P27477, DOI 10.1074/jbc.R500006200; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; Safo MK, 2002, ACTA CRYSTALLOGR D, V58, P634, DOI 10.1107/S0907444902002627; Safo MK, 2001, PROTEIN SCI, V10, P951, DOI 10.1110/ps.50601; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Shibayama N, 2002, J BIOL CHEM, V277, P38791, DOI 10.1074/jbc.M205461200; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SMITH FR, 1985, P NATL ACAD SCI USA, V82, P5347, DOI 10.1073/pnas.82.16.5347; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Ye JP, 2004, J COMPUT BIOL, V11, P986, DOI 10.1089/cmb.2004.11.986; Yokoyama T, 2006, J MOL BIOL, V356, P790, DOI 10.1016/j.jmb.2005.12.018; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200; Yun KM, 2002, J BIOL CHEM, V277, P1878, DOI 10.1074/jbc.M108494200	54	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e77363	10.1371/journal.pone.0077363	http://dx.doi.org/10.1371/journal.pone.0077363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312167	gold, Green Published, Green Submitted			2022-12-25	WOS:000327652100003
J	Huang, YC; Su, LH; Lin, TY				Huang, Yhu-Chering; Su, Lin-Hui; Lin, Tzou-Yien			Nasal Carriage of Methicillin-Resistant Staphylococcus aureus among Pediatricians in Taiwan	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; RAPID IDENTIFICATION; MOLECULAR ANALYSIS; NORTHERN TAIWAN; RISK-FACTORS; COLONIZATION; EPIDEMIOLOGY; CHILDREN; MRSA; MEC	Background: Health care workers (HCWs) are at the interface between hospitals and communities. The survey for methicillin-resistant Staphylococcus aureus (MRSA) carriage among HCWs has mostly been conducted to investigate outbreaks or endemics. Community-associated MRSA are prevalent among children in Taiwan. We conducted this study to better understand the carriage rate of MRSA among pediatricians in non-outbreak situations in Taiwan,. Methods: A total of 220 pediatricians from Taiwan who attended the annual meeting of Taiwan Pediatric Association in April, 2010 were recruited to participate in this study and were sampled from the nares for the detection of MRSA by polymerase chain reaction (PCR) and further by culture. The following molecular analyses were performed, including pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), typing of staphylococcal cassette chromosome mec (SCCmec) and the presence of Panton-Valentine leukocidin (PVL) genes. Results: MRSA was detected from 15 attendees (6.8%) by PCR. MRSA-colonized attendees had a significantly lower rate (0.041) of working in the medical center, while borderline significantly higher rate of working in the Regional Hospital (p=0.056), than those without MRSA colonization. From those 15 samples, 12 MRSA isolates were identified by culture and molecularly characterized. Three PFGE patterns, two sequence types (ST 59, ST 508), and two SCCmec types (IV and V-T) were identified, respectively. Five isolates, including three carrying SCCmec types VT, were PVL-positive. All 12 isolates were susceptible to vancomycin, teicoplanin, linezolid, fusidic acid, trimethoprim/sulfamethoxazole, and doxycyclin, and resistant to penicillin. Conclusion/significance: Around seven percent of pediatricians in Taiwan harbored CA-MRSA in their nares.	[Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Su, Lin-Hui; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp Linkou, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 460113]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant from Chang Gung Memorial Hospital (CMRPG 460113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Bartels MD, 2009, J CLIN MICROBIOL, V47, P1524, DOI 10.1128/JCM.02153-08; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho TH, 2011, J MICROBIOL IMMUNOL, V44, P310, DOI 10.1016/j.jmii.2010.08.008; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2004, PEDIATR INFECT DIS J, V23, P919, DOI 10.1097/01.inf.0000141745.12941.ef; Huang YC, 2007, PEDIATR INFECT DIS J, V26, P1066, DOI 10.1097/INF.0b013e31813429e8; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Huang YC, 2009, PEDIATR INFECT DIS J, V28, P742, DOI 10.1097/INF.0b013e31819c132a; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lu PL, 2005, J CLIN MICROBIOL, V43, P132, DOI 10.1128/JCM.43.1.132-139.2005; Lu SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018620; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto M, 2012, VIRULENCE, V3, P521, DOI 10.4161/viru.21523; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82472	10.1371/journal.pone.0082472	http://dx.doi.org/10.1371/journal.pone.0082472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303083	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400101
J	Zhao, ZY; Wu, GQ; Wang, J; Liu, CL; Qiu, LH				Zhao, Zengyang; Wu, Gongqing; Wang, Jia; Liu, Chunlin; Qiu, Lihong			Next-Generation Sequencing-Based Transcriptome Analysis of Helicoverpa armigera Larvae Immune-Primed with Photorhabdus luminescens TT01	PLOS ONE			English	Article							RED FLOUR BEETLE; RNA-SEQ; FUNCTIONAL GENOMICS; GENE-EXPRESSION; INNATE; SYSTEM; MEMORY; TOOL; SPECIFICITY; PARASITE	Although invertebrates are incapable of adaptive immunity, immunal reactions which are functionally similar to the adaptive immunity of vertebrates have been described in many studies of invertebrates including insects. The phenomenon was termed immune priming. In order to understand the molecular mechanism of immune priming, we employed Illumina/Solexa platform to investigate the transcriptional changes of the hemocytes and fat body of Helicoverpa armigera larvae immune-primed with the pathogenic bacteria Photorhabdus luminescens TT01. A total of 43.6 and 65.1 million clean reads with 4.4 and 6.5 gigabase sequence data were obtained from the TT01 (the immune-primed) and PBS (non-primed) cDNA libraries and assembled into 35,707 all-unigenes (non-redundant transcripts), which has a length varied from 201 to 16,947 bp and a N50 length of 1,997 bp. For 35,707 all-unigenes, 20,438 were functionally annotated and 2,494 were differentially expressed after immune priming. The differentially expressed genes (DEGs) are mainly related to immunity, detoxification, development and metabolism of the host insect. Analysis on the annotated immune related DEGs supported a hypothesis that we proposed previously: the immune priming phenomenon observed in H. armigera larvae was achieved by regulation of key innate immune elements. The transcriptome profiling data sets (especially the sequences of 1,022 unannotated DEGs) and the clues (such as those on immune-related signal and regulatory pathways) obtained from this study will facilitate immune-related novel gene discovery and provide valuable information for further exploring the molecular mechanism of immune priming of invertebrates. All these will increase our understanding of invertebrate immunity which may provide new approaches to control insect pests or prevent epidemic of infectious diseases in economic invertebrates in the future.	[Zhao, Zengyang; Wu, Gongqing; Wang, Jia; Liu, Chunlin; Qiu, Lihong] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Qiu, LH (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	qiulh@mail.sysu.edu.cn			National Natural Science Foundation of China [30771457]; Ministry of Education [20100171110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	This work was supported partly by the National Natural Science Foundation of China (Grant No. 30771457) and the Doctoral Program of the Ministry of Education (Grant No. 20100171110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Brown MJF, 2003, PARASITOLOGY, V126, P253, DOI 10.1017/S0031182002002755; Cadeddu A, 2000, HIST PHIL LIFE SCI, V22, P3; Camp JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037104; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Desai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060204; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fleche C, 1997, REV SCI TECH OIE, V16, P177, DOI 10.20506/rst.16.1.1007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hernandez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050533; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Kang SM, 2009, MOL CELLS, V27, P5, DOI 10.1007/s10059-009-0015-1; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; le Roex N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048792; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mironidis GK, 2013, INSECT SCI, V20, P505, DOI 10.1111/j.1744-7917.2012.01528.x; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Onmus-Leone F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061762; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; Powell A, 2011, J INVERTEBR PATHOL, V107, P95, DOI 10.1016/j.jip.2011.02.006; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Somboonna Naraporn, 2010, BMC Res Notes, V3, P315, DOI 10.1186/1756-0500-3-315; Subhadra B, 2010, J APPL MICROBIOL, V108, P831, DOI 10.1111/j.1365-2672.2009.04479.x; Sun Jianyu, 2012, Weishengwu Xuebao, V52, P532; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035142; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Y, 2012, GENOMICS; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	61	23	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80146	10.1371/journal.pone.0080146	http://dx.doi.org/10.1371/journal.pone.0080146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302999	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400015
J	Gong, C; Qu, S; Liu, B; Pan, S; Jiao, Y; Nie, Y; Su, F; Liu, Q; Song, E				Gong, C.; Qu, S.; Liu, B.; Pan, S.; Jiao, Y.; Nie, Y.; Su, F.; Liu, Q.; Song, E.			MiR-106b expression determines the proliferation paradox of TGF-beta in breast cancer cells	ONCOGENE			English	Article						TGF-beta; microRNA; breast cancer; cell proliferation	GROWTH-FACTOR-BETA; MICRORNA CLUSTER; GENE-PRODUCT; PHOSPHORYLATION; INHIBITION; AP-1; PRB	TGF-beta has paradoxical effects on cancer cell proliferation, as it suppresses proliferation of normal epithelial and low-invasive cancer cells, but enhances that of high-invasive cancer cells. However, how cancer cells acquire the ability to evade the tumor-suppressing effects of TGF-beta, yet still take advantage of its tumor-promoting effects, remains elusive. Here, we identified miR-106b as a molecular switch to determine TGF-beta effects on cell proliferation. TGF-beta 1 enhances the transcription of miR-106b via a promoter independent of its host gene MCM7 by activating c-jun. In high-invasive breast cancer cells, miR-106b is upregulated by TGF-beta 1 at a much higher level than that in normal or low-invasive cancer cells. Accumulation of miR-106b counterbalances TGF-beta growth-inhibiting effects by eliminating activated retinoblastoma (RB) and results in enhanced proliferation. Furthermore, miR-106b mediates TGF-beta effects on tumor growth and metastasis in breast cancer xenografts. In addition, miR-106b expression is elevated in higher stage tumors and correlated with tumor progression in breast cancer patients. These findings suggest that high level of miR-106b induced by TGF-beta determines the tumor-promoting effects of TGF-beta in breast cancer.	[Gong, C.; Qu, S.; Pan, S.; Jiao, Y.; Nie, Y.; Su, F.; Liu, Q.; Song, E.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Gong, C.; Qu, S.; Liu, B.; Pan, S.; Jiao, Y.; Nie, Y.; Su, F.; Liu, Q.; Song, E.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Liu, B.; Song, E.] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn Minist, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Liu, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	victorlq@hotmail.com; songew@mail.sysu.edu.cn	Liu, Bodu/AAR-9402-2021; Liu, Bodu/G-5222-2016	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Liu, Qiang/0000-0002-5451-4862	973 Projects from Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; Natural Science Foundation of China [81230060, 81261140373, 81272893, 81172524, 81372817, 81272894, 81072178]; National S&T Major Special Project on New Drug Innovation of China [2011ZX09102-010-02]; Program for New Century Excellent Talents in University [NCET-12-0565]; Science Foundation of Guangdong Province [S2012030006287, 2012J2200092]; Sun Yat-sen University Training Project [11ykpy28, 11ykzd12]; Translational medicine public platform of Guangdong Province [4202037]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University [KLB09001]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]	973 Projects from Ministry of Science and Technology of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on New Drug Innovation of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Sun Yat-sen University Training Project; Translational medicine public platform of Guangdong Province; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	This work was supported by grants from 973 (2010CB912800, 2011CB504203) Projects from Ministry of Science and Technology of China, the Natural Science Foundation of China (81230060, 81261140373, 81272893, 81172524, 81372817, 81272894, 81072178), National S&T Major Special Project on New Drug Innovation of China (No. 2011ZX09102-010-02), Program for New Century Excellent Talents in University(NCET-12-0565), Science Foundation of Guangdong Province (S2012030006287, 2012J2200092), Sun Yat-sen University Training Project (11ykpy28, 11ykzd12) and Translational medicine public platform of Guangdong Province(4202037), Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University,Grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.	Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Fang YJ, 2012, AM J PATHOL, V180, P650, DOI 10.1016/j.ajpath.2011.10.009; Francis SM, 2009, MOL CELL BIOL, V29, P4455, DOI 10.1128/MCB.00473-09; FURUKAWA Y, 1992, J BIOL CHEM, V267, P17121; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; KIM TA, 1994, J CELL PHYSIOL, V160, P1, DOI 10.1002/jcp.1041600102; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhu F, 2006, CANCER RES, V66, P5729, DOI 10.1158/0008-5472.CAN-05-4466	26	46	49	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					84	93		10.1038/onc.2013.525	http://dx.doi.org/10.1038/onc.2013.525			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24292682				2022-12-25	WOS:000349740100008
J	D'Lima, NG; Teschke, CM				D'Lima, Nadia G.; Teschke, Carolyn M.			ADP-dependent Conformational Changes Distinguish Mycobacterium tuberculosis SecA2 from SecA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; FRET; Protein Export; Secretion; Tuberculosis	ATP-BINDING-SITE; NUCLEOTIDE EXCHANGE; TRANSLOCATION; SECRETION; PROTEINS; COMPLEX; SYSTEM; EXPORT; CYCLE	In bacteria, most secreted proteins are exported through the SecYEG translocon by the SecA ATPase motor via the general secretion or Sec pathway. The identification of an additional SecA protein, particularly in Gram-positive pathogens, has raised important questions about the role of SecA2 in both protein export and establishment of virulence. We previously showed in Mycobacterium tuberculosis, the causative agent of tuberculosis, the accessory SecA2 protein possesses ATPase activity that is required for bacterial survival in host macrophages, highlighting its importance in virulence. Here, we show that SecA2 binds ADP with much higher affinity than SecA1 and releases the nucleotide more slowly. Nucleotide binding also regulates movement of the precursor-binding domain in SecA2, unlike in SecA1 or conventional SecA proteins. This conformational change involving closure of the clamp in SecA2 may provide a mechanism for the cell to direct protein export through the conventional SecA1 pathway under normal growth conditions while preventing ordinary precursor proteins from interacting with the specialized SecA2 ATPase.	[D'Lima, Nadia G.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	teschke@uconn.edu			University of Connecticut Research Foundation Large Faculty grant program	University of Connecticut Research Foundation Large Faculty grant program	This work was supported by University of Connecticut Research Foundation Large Faculty grant program.	Bates PA, 2001, PROTEINS, P39; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fak JJ, 2004, BIOCHEMISTRY-US, V43, P7307, DOI 10.1021/BI0357208; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gold VAM, 2013, BIOCHEM J, V449, P695, DOI 10.1042/BJ20121314; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lingappa V R, 1980, Recent Prog Horm Res, V36, P451; Natale P, 2004, J BIOL CHEM, V279, P13769, DOI 10.1074/jbc.M312892200; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Owens MU, 2002, FEMS MICROBIOL LETT, V211, P133, DOI 10.1016/S0378-1097(02)00708-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Scopes R. K., 1993, PROTEIN PURIFICATION, P210; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wowor AJ, 2011, J MOL BIOL, V408, P87, DOI 10.1016/j.jmb.2011.02.006; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	43	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2307	2317		10.1074/jbc.M113.533323	http://dx.doi.org/10.1074/jbc.M113.533323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297168	Green Published, hybrid			2022-12-25	WOS:000331130200035
J	Schneider, N; Cordeiro, S; Machtens, JP; Braams, S; Rauen, T; Fahlke, C				Schneider, Nicole; Cordeiro, Soenke; Machtens, Jan-Philipp; Braams, Simona; Rauen, Thomas; Fahlke, Christoph			Functional Properties of the Retinal Glutamate Transporters GLT-1c and EAAT5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate; Ion Channels; Neurotransmitter Transport; Patch Clamp; Retina; Excitatory Amino Acid Transporter	AMINO-ACID TRANSPORTER; RAT RETINA; TRANSMITTER CLEARANCE; TIGER SALAMANDER; CHLORIDE CHANNEL; ANION CHANNELS; BIPOLAR CELLS; LOCALIZATION; EXPRESSION; CURRENTS	Background: GLT-1c and EAAT5 are two excitatory amino acid transporters co-expressed in retinal neurons. Results: GLT-1c and EAAT5 differ in glutamate and Na+ affinity, individual transport rates as well as in unitary anion current amplitudes. Conclusion: GLT-1c and EAAT5 are optimized to fulfill different physiological tasks. Significance: Identification of unitary channel properties underlying separate anion conductances associated with GLT-1c and EAAT5. In the mammalian retina, glutamate uptake is mediated by members of a family of glutamate transporters known as excitatory amino acid transporters (EAATs). Here we cloned and functionally characterized two retinal EAATs from mouse, the GLT-1/EAAT2 splice variant GLT-1c, and EAAT5. EAATs are glutamate transporters and anion-selective ion channels, and we used heterologous expression in mammalian cells, patch-clamp recordings and noise analysis to study and compare glutamate transport and anion channel properties of both EAAT isoforms. We found GLT-1c to be an effective glutamate transporter with high affinity for Na+ and glutamate that resembles original GLT-1/EAAT2 in all tested functional aspects. EAAT5 exhibits glutamate transport rates too low to be accurately measured in our experimental system, with significantly lower affinities for Na+ and glutamate than GLT-1c. Non-stationary noise analysis demonstrated that GLT-1c and EAAT5 also differ in single-channel current amplitudes of associated anion channels. Unitary current amplitudes of EAAT5 anion channels turned out to be approximately twice as high as single-channel amplitudes of GLT-1c. Moreover, at negative potentials open probabilities of EAAT5 anion channels were much larger than for GLT-1c. Our data illustrate unique functional properties of EAAT5, being a low-affinity and low-capacity glutamate transport system, with an anion channel optimized for anion conduction in the negative voltage range.	[Schneider, Nicole; Machtens, Jan-Philipp; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, D-52428 Julich, Germany; [Schneider, Nicole; Cordeiro, Soenke; Machtens, Jan-Philipp; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Schneider, Nicole; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany; [Cordeiro, Soenke] Inst Physiol, D-24118 Kiel, Germany; [Braams, Simona; Rauen, Thomas] Univ Osnabruck, FB Biol Chem, D-49076 Osnabruck, Germany	Helmholtz Association; Research Center Julich; Hannover Medical School; University Osnabruck	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Leo Brandt Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013; Cordeiro, Soenke/A-1782-2012; Machtens, Jan-Philipp/M-8659-2013	Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571; Rauen, Thomas/0000-0001-9699-182X	Deutsche Forschungs-gemeinschaft [FA301/9]	Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG))	These studies were supported by the Deutsche Forschungs-gemeinschaft FA301/9 (to Ch. F.).	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; DACHEUX RF, 1976, SCIENCE, V191, P963, DOI 10.1126/science.175443; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Efron B., 1994, INTRO BOOTSTRAP; Eliasof S, 1998, J NEUROSCI, V18, P698; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fyk-Kolodziej B, 2004, VISUAL NEUROSCI, V21, P551, DOI 10.1017/S0952523804214067; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; HILLE B, 2002, IONIC CHANNELS EXCIT; Hotzy J, 2013, J BIOL CHEM, V288, P36492, DOI 10.1074/jbc.M113.489385; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Kugler P, 2003, HISTOCHEM CELL BIOL, V120, P199, DOI 10.1007/s00418-003-0555-y; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; LASANSKY A, 1981, J PHYSIOL-LONDON, V310, P205, DOI 10.1113/jphysiol.1981.sp013544; Lehre KP, 1997, BRAIN RES, V744, P129, DOI 10.1016/S0006-8993(96)01022-0; Leinenweber A, 2011, J BIOL CHEM, V286, P1927, DOI 10.1074/jbc.M110.153486; Maenpaa H, 2004, CURR EYE RES, V28, P159, DOI 10.1076/ceyr.28.3.159.26244; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Pow DV, 1999, CELL TISSUE RES, V297, P57, DOI 10.1007/s004410051333; Pow DV, 2000, NEUROCHEM INT, V37, P191, DOI 10.1016/S0197-0186(00)00022-X; Rabl K, 2003, VISUAL NEUROSCI, V20, P557, DOI 10.1017/S0952523803205095; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rauen T, 1998, CELL TISSUE RES, V291, P19; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Schulz K, 1996, NEUROSCI LETT, V211, P191, DOI 10.1016/0304-3940(96)12762-2; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Wiessner M, 2002, CELL TISSUE RES, V310, P31, DOI 10.1007/s00441-002-0612-1; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255	45	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1815	1824		10.1074/jbc.M113.517177	http://dx.doi.org/10.1074/jbc.M113.517177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307171	Green Published, hybrid			2022-12-25	WOS:000332401700051
J	Yates, CJ; Masuyer, G; Schwager, SLU; Akif, M; Sturrock, ED; Acharya, KR				Yates, Christopher J.; Masuyer, Geoffrey; Schwager, Sylva L. U.; Akif, Mohd; Sturrock, Edward D.; Acharya, K. Ravi			Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Crystallography; Hypertension; Protein Structure; Thermodynamics; Angiotensin-1-converting Enzyme; Chloride Ion Activation; Enzymology	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; N-DOMAIN; IDENTIFICATION; RESIDUES; SPECIFICITY; ACTIVATION; REACTIVITY; BINDING	Background: The angiotensin-1-converting enzyme (ACE) is a zinc protease unique in its chloride ion dependence. Results: Key substrate interactions with the catalytic site affect the structure and thermodynamics of ACE, which modulate chloride ion-dependent hydrolysis. Conclusion: Substrate composition influences chloride affinity in ACE. Significance: The interdependence of ACE substrate composition, structure, and thermodynamics influence its chloride ion activation in biology. Somatic angiotensin-converting enzyme (sACE), a key regulator of blood pressure and electrolyte fluid homeostasis, cleaves the vasoactive angiotensin-I, bradykinin, and a number of other physiologically relevant peptides. sACE consists of two homologous and catalytically active N- and C-domains, which display marked differences in substrate specificities and chloride activation. A series of single substitution mutants were generated and evaluated under varying chloride concentrations using isothermal titration calorimetry. The x-ray crystal structures of the mutants provided details on the chloride-dependent interactions with ACE. Chloride binding in the chloride 1 pocket of C-domain ACE was found to affect positioning of residues from the active site. Analysis of the chloride 2 pocket R522Q and R522K mutations revealed the key interactions with the catalytic site that are stabilized via chloride coordination of Arg(522). Substrate interactions in the S2 subsite were shown to affect chloride affinity in the chloride 2 pocket. The Glu(403)-Lys(118) salt bridge in C-domain ACE was shown to stabilize the hinge-bending region and reduce chloride affinity by constraining the chloride 2 pocket. This work demonstrated that substrate composition to the C-terminal side of the scissile bond as well as interactions of larger substrates in the S2 subsite moderate chloride affinity in the chloride 2 pocket of the ACE C-domain, providing a rationale for the substrate-selective nature of chloride dependence in ACE and how this varies between the N- and C-domains.	[Yates, Christopher J.; Schwager, Sylva L. U.; Sturrock, Edward D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa; [Yates, Christopher J.; Schwager, Sylva L. U.; Sturrock, Edward D.] Univ Cape Town, Div Med Biochem, ZA-7935 Observatory, South Africa; [Masuyer, Geoffrey; Akif, Mohd; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Cape Town; University of Cape Town; University of Bath	Sturrock, ED (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa.	Edward.Sturrock@uct.ac.za; K.R.Acharya@bath.ac.uk	Masuyer, Geoffrey/AAO-5977-2021	Masuyer, Geoffrey/0000-0002-9527-2310; Acharya, K. Ravi/0000-0002-3009-4058	Medical Research Council [G1001685]; Wellcome Trust [088464]; University of Cape Town; South African National Research Foundation; MRC [G1001685] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cape Town; South African National Research Foundation(National Research Foundation - South Africa); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Project Grant G1001685 and Wellcome Trust Equipment Grant 088464 (to K. R. A.). This work was also supported by the University of Cape Town and the South African National Research Foundation (to E. D. S. and C. J. Y.).	Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108; Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Anthony CS, 2012, CURR MED CHEM, V19, P845; Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHEN YNP, 1990, BIOCHEMISTRY-US, V29, P10493, DOI 10.1021/bi00498a011; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez M, 2001, J BIOL CHEM, V276, P4998, DOI 10.1074/jbc.M009009200; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Golicnik M, 2010, ANAL BIOCHEM, V406, P94, DOI 10.1016/j.ab.2010.06.041; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Lodish H., 1999, MOL CELL BIOL; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moiseeva NA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1167, DOI 10.1007/s10541-005-0242-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Rushworth CA, 2008, FEBS J, V275, P6033, DOI 10.1111/j.1742-4658.2008.06733.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEN I, 1993, J BIOL CHEM, V268, P25748; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Tzakos AG, 2003, PROTEIN ENG, V16, P993, DOI 10.1093/protein/gzg122; Watermeyer J. M., 2009, CURRENT ENZYME INHIB, V5, P134, DOI DOI 10.2174/157340809789071155; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1992, J BIOL CHEM, V267, P13398; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	42	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1798	1814		10.1074/jbc.M113.512335	http://dx.doi.org/10.1074/jbc.M113.512335			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297181	Green Published, hybrid			2022-12-25	WOS:000332401700050
J	Akinci, E; Banga, A; Tungatt, K; Segal, J; Eberhard, D; Dutton, JR; Slack, JMW				Akinci, Ersin; Banga, Anannya; Tungatt, Katie; Segal, Joanna; Eberhard, Daniel; Dutton, James R.; Slack, Jonathan M. W.			Reprogramming of Various Cell Types to a Beta-Like State by Pdx1, Ngn3 and MafA	PLOS ONE			English	Article							PANCREATIC EXOCRINE CELLS; IN-VIVO; DIFFERENTIATION; PROGENITORS; LIVER	The three transcription factors, PDX1, NGN3 and MAFA, are very important in pancreatic development. Overexpression of these three factors can reprogram both pancreatic exocrine cells and SOX9-positive cells of the liver into cells resembling pancreatic beta cells. In this study we investigate whether other cell types can be reprogrammed. Eight cell types are compared and the results are consistent with the idea that reprogramming occurs to a greater degree for developmentally related cells (pancreas, liver) than for other types, such as fibroblasts. Using a line of mouse hepatocyte-derived cells we screened 13 compounds for the ability to increase the yield of reprogrammed cells. Three are active and when used in combination they can increase the yield of insulin-immunopositive cells by a factor of six. These results should contribute to the eventual ability to develop a new cure for diabetes based on the ability to reprogram other cells in the body to a beta cell phenotype.	[Akinci, Ersin; Banga, Anannya; Tungatt, Katie; Segal, Joanna; Dutton, James R.; Slack, Jonathan M. W.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Tungatt, Katie; Segal, Joanna; Eberhard, Daniel] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Minnesota System; University of Minnesota Twin Cities; University of Bath	Slack, JMW (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	slack017@umn.edu	Akıncı, Ersin/K-8370-2012	Akıncı, Ersin/0000-0003-1463-2255; Tungatt, Katie/0000-0002-4088-3501; Slack, Jonathan/0000-0002-7154-6778	National Institutes of Health (NIH) (NIDDK) [R01DK080747]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080747] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) (NIDDK) Grant R01DK080747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Andersson O, 2012, CELL METAB, V15, P885, DOI 10.1016/j.cmet.2012.04.018; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Percival AC, 1999, EXP CELL RES, V247, P123, DOI 10.1006/excr.1998.4322; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Weir GC, 2011, GENOME MED, V3, DOI 10.1186/gm277; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	18	24	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82424	10.1371/journal.pone.0082424	http://dx.doi.org/10.1371/journal.pone.0082424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312421	Green Published, gold, Green Accepted			2022-12-25	WOS:000327670300079
J	Ocon, S; Murphy, C; Dang, AT; Sankaran-Walters, S; Li, CS; Tarara, R; Borujerdpur, N; Dandekar, S; Paster, BJ; George, MD				Ocon, Susan; Murphy, Christina; Dang, Angeline T.; Sankaran-Walters, Sumathi; Li, Chin-Shang; Tarara, Ross; Borujerdpur, Niku; Dandekar, Satya; Paster, Bruce J.; George, Michael D.			Transcription Profiling Reveals Potential Mechanisms of Dysbiosis in the Oral Microbiome of Rhesus Macaques with Chronic Untreated SIV Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; T-CELL DEPLETION; GEMELLA-MORBILLORUM; PROINFLAMMATORY CYTOKINES; ANTIMICROBIAL PEPTIDES; COMMENSAL BACTERIA; VALVE ENDOCARDITIS; PLAQUE MICROBIOTA; BARRIER FUNCTION; MUCOSA	A majority of individuals infected with human immunodeficiency virus (HIV) have inadequate access to antiretroviral therapy and ultimately develop debilitating oral infections that often correlate with disease progression. Due to the impracticalities of conducting host-microbe systems-based studies in HIV infected patients, we have evaluated the potential of simian immunodeficiency virus (SIV) infected rhesus macaques to serve as a non-human primate model for oral manifestations of HIV disease. We present the first description of the rhesus macaque oral microbiota and show that a mixture of human commensal bacteria and "macaque versions'' of human commensals colonize the tongue dorsum and dental plaque. Our findings indicate that SIV infection results in chronic activation of antiviral and inflammatory responses in the tongue mucosa that may collectively lead to repression of epithelial development and impact the microbiome. In addition, we show that dysbiosis of the lingual microbiome in SIV infection is characterized by outgrowth of Gemella morbillorum that may result from impaired macrophage function. Finally, we provide evidence that the increased capacity of opportunistic pathogens (e.g. E. coli) to colonize the microbiome is associated with reduced production of antimicrobial peptides.	[Ocon, Susan; Sankaran-Walters, Sumathi; Dandekar, Satya; George, Michael D.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Murphy, Christina; Paster, Bruce J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Dang, Angeline T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Li, Chin-Shang] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Tarara, Ross] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Forsyth Institute; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard School of Dental Medicine	George, MD (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	mdgeorge@ucdavis.edu	Paster, Bruce J/AAP-8559-2021		National Institutes of Health [1R21DE020025]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) [UL1 TR000002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE020025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The studies were funded by National Institutes of Health grant #1R21DE020025 and supported by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through grant #UL1 TR000002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/j.1600-051X.2006.01034.x; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Arotiba J T, 2006, Afr J Med Med Sci, V35 Suppl, P13; Bando M, 2007, IMMUNOL CELL BIOL, V85, P532, DOI 10.1038/sj.icb.7100078; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Benes J, 2002, FOLIA MICROBIOL, V47, P737, DOI 10.1007/BF02818681; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chotai S, 2012, TURK NEUROSURG, V22, P374, DOI 10.5137/1019-5149.JTN.3634-10.0; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; Delgado AJE, 2004, MED ORAL PATOL ORAL, V9, P410; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diamond G, 2011, ORAL DIS, V17, P628, DOI 10.1111/j.1601-0825.2011.01799.x; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Dixon DR, 2004, J PERIODONTOL, V75, P1486, DOI 10.1902/jop.2004.75.11.1486; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Exposito-Delgado Antonio Javier, 2004, Med Oral Patol Oral Cir Bucal, V9, P415; Feller Liviu, 2008, J Int Acad Periodontol, V10, P10; Garcia-Lechuz Juan M., 2002, International Journal of Infectious Diseases, V6, P78, DOI 10.1016/S1201-9712(02)90142-6; Gennaro S, 2008, MCN-AM J MATERN-CHIL, V33, P50, DOI 10.1097/01.NMC.0000305658.32237.7d; George MD, 2008, J MED PRIMATOL, V37, P55, DOI 10.1111/j.1600-0684.2008.00322.x; George MP, 2011, AIDS RES HUM RETROV, V27, P103, DOI 10.1089/aid.2009.0297; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; George MD, 2009, CLIN VACCINE IMMUNOL, V16, P277, DOI 10.1128/CVI.00265-08; Gervasoni Cristina, 1996, Clin Microbiol Infect, V2, P65, DOI 10.1111/j.1469-0691.1996.tb00204.x; Gomes BPFA, 2008, ORAL SURG ORAL MED O, V105, P519, DOI 10.1016/j.tripleo.2007.10.005; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Hartzell W, 1999, CHEST, V116, p31S, DOI 10.1378/chest.116.suppl_1.31S-a; HEISE C, 1994, J INFECT DIS, V169, P1116, DOI 10.1093/infdis/169.5.1116; Hull JE, 2010, MIL MED, V175, P923, DOI 10.7205/MILMED-D-10-00121; Leao JC, 2009, CLINICS, V64, P459, DOI 10.1590/S1807-59322009000500014; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Meyer JE, 2008, MUCOSAL IMMUNOL, V1, P239, DOI 10.1038/mi.2008.3; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Mittal M, 2011, J CLIN PEDIATR DENT, V36, P85, DOI 10.17796/jcpd.36.1.h858tw2488v17164; Pollanen MT, 2012, INT J DENT, V2012, DOI 10.1155/2012/821383; Preza D, 2009, EUR J CLIN MICROBIOL, V28, P509, DOI 10.1007/s10096-008-0662-8; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reznik David A, 2005, Top HIV Med, V13, P143; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Saini Rajiv, 2011, J Nat Sci Biol Med, V2, P145, DOI 10.4103/0976-9668.92316; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shrihari T. G., 2012, General Dentistry, V60, P20; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Sugawara S, 2002, J ENDOTOXIN RES, V8, P465, DOI 10.1179/096805102125001082; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Viard-Leveugle I, 2013, J INVEST DERMATOL, V133, P489, DOI 10.1038/jid.2012.330; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Ye P, 2012, MICROB PATHOG; Zakir RM, 2004, J CLIN MICROBIOL, V42, P4893, DOI 10.1128/JCM.42.10.4893-4896.2004; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	55	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e80863	10.1371/journal.pone.0080863	http://dx.doi.org/10.1371/journal.pone.0080863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312248	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300019
J	Walker, AK; Soo, KY; Sundaramoorthy, V; Parakh, S; Ma, Y; Farg, MA; Wallace, RH; Crouch, PJ; Turner, BJ; Horne, MK; Atkin, JD				Walker, Adam K.; Soo, Kai Y.; Sundaramoorthy, Vinod; Parakh, Sonam; Ma, Yi; Farg, Manal A.; Wallace, Robyn H.; Crouch, Peter J.; Turner, Bradley J.; Horne, Malcolm K.; Atkin, Julie D.			ALS-Associated TDP-43 Induces Endoplasmic Reticulum Stress, Which Drives Cytoplasmic TDP-43 Accumulation and Stress Granule Formation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-DISULFIDE-ISOMERASE; FRONTOTEMPORAL LOBAR DEGENERATION; ER STRESS; TRANSMEMBRANE PROTEIN; IN-VIVO; AGGREGATION; MUTATIONS; MICE; SUPEROXIDE-DISMUTASE-1	In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA binding protein 4 3 (TDP-43) accumulates in the cytoplasm of affected neurons and glia, where it associates with stress granules (SGs) and forms large inclusions. SGs form in response to cellular stress, including endoplasmic reticulum (ER) stress, which is induced in both familial and sporadic forms of ALS. Here we demonstrate that pharmacological induction of ER stress causes TDP-43 to accumulate in the cytoplasm, where TDP-43 also associates with SGs. Furthermore, treatment with salubrinal, an inhibitor of dephosphoryation of eukaryotic initiation factor 2-alpha key modulator of ER stress, potentiates ER stress-mediated SG formation. Inclusions of C-terminal fragment TDP-43 reminiscent of disease-pathology, form in close association with and Golgi compartments, further indicating the involvement of ER dysfunction in TDP-43-associated disease. Consistent with this notion, over-expression of ALS-linked mutant TDP-43, and to a lesser extent wildtype TDP-43, triggers several ER pathways in neuroblastoma cells. Similarly, we found an interaction between the ER chaperone protein disulphide isomerase and TDP-43 in transfected cell lysates and in the spinal cords of mutant A315T TDP-43 transgenic mice. This study provides evidence for ER stress as a pathogenic pathway in TDP-43-mediated disease.	[Walker, Adam K.; Soo, Kai Y.; Sundaramoorthy, Vinod; Parakh, Sonam; Farg, Manal A.; Atkin, Julie D.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Walker, Adam K.; Ma, Yi; Crouch, Peter J.; Turner, Bradley J.; Horne, Malcolm K.; Atkin, Julie D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Wallace, Robyn H.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Wallace, Robyn H.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Crouch, Peter J.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] Univ Melbourne, Fac Med Dent & Hlth Sci, Florey Dept Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] St Vincents Hosp, Fitzroy, Vic 3065, Australia	La Trobe University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Queensland; University of Queensland; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Atkin, JD (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia.	j.atkin@latrobe.edu.au	Horne, Malcolm/AAL-5214-2020; Sundaramoorthy, Vinod/M-6133-2018; Sundaramoorthy, Vinod/AAE-4302-2020; Ma, Yi/AAF-4532-2021; Walker, Adam Keith/B-7418-2009	Horne, Malcolm/0000-0001-9427-2100; Sundaramoorthy, Vinod/0000-0001-6309-8031; Ma, Yi/0000-0003-2351-9537; Walker, Adam Keith/0000-0001-7954-5801; Turner, Bradley/0000-0001-6580-7655; Parakh, Sonam/0000-0002-7048-9695; Atkin, Julie/0000-0003-2427-499X; Wallace, Robyn/0000-0001-6141-3317; Crouch, Peter/0000-0002-7777-4747	National Health and Medical Research Council of Australia (NHMRC) [454749, 1005651, 1006141, 1030513]; Amyotrophic Lateral Sclerosis Association; Bethlehem Griffiths Research Council; Henry H Roth Charitable Foundation Grant from the MND Research Institute of Australia; Australian Rotary Health; Brain Foundation; NHMRC [1036835]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Amyotrophic Lateral Sclerosis Association; Bethlehem Griffiths Research Council; Henry H Roth Charitable Foundation Grant from the MND Research Institute of Australia; Australian Rotary Health; Brain Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC, grants 454749, 1005651, 1006141, 1030513), www.nhmrc.gov.au, Amyotrophic Lateral Sclerosis Association, www.alsa.org, Bethlehem Griffiths Research Council, www.bethlehemgrf.com.au, a Henry H Roth Charitable Foundation Grant from the MND Research Institute of Australia, www.mndaust.asn.au/mndria, Australian Rotary Health, www.australianrotaryhealth.org.au, and the Brain Foundation, www.brainfoundation.org.au. AKW holds an NHMRC CJ Martin Biomedical Early Career Fellowship (1036835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Balague O, 2009, AM J PATHOL, V174, P2337, DOI 10.2353/ajpath.2009.080848; Bernardoni P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Farg MA, 2013, HUM MOL GENET, V22, P717, DOI 10.1093/hmg/dds479; Farg MA, 2012, NEUROBIOL AGING, V33, P2855, DOI 10.1016/j.neurobiolaging.2012.02.009; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Honjo Y, 2011, AMYOTROPH LATERAL SC, V12, P444, DOI 10.3109/17482968.2011.594055; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kwok CT, 2013, FREE RADICAL BIO MED, V58, P81, DOI 10.1016/j.freeradbiomed.2013.01.001; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Soo KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035413; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suzuki H, 2012, J NEUROSCI RES, V90, P641, DOI 10.1002/jnr.22777; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tabata Y, 2007, AM J PHYSIOL-CELL PH, V293, pC411, DOI 10.1152/ajpcell.00095.2007; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tong JB, 2012, J NEUROCHEM, V123, P406, DOI 10.1111/jnc.12014; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vaccaro A, 2013, NEUROBIOL DIS, V55, P64, DOI 10.1016/j.nbd.2013.03.015; Walker AK, 2011, IUBMB LIFE, V63, P754, DOI 10.1002/iub.520; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang YS, 2009, J NEUROSCI, V29, P13850, DOI 10.1523/JNEUROSCI.2312-09.2009; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	69	105	105	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81170	10.1371/journal.pone.0081170	http://dx.doi.org/10.1371/journal.pone.0081170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312274	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300026
J	Ngo, AD; Ha, TH; Rule, J; Dang, CV				Ngo, Anh D.; Ha, Toan H.; Rule, John; Dang, Chinh V.			Peer-based Education and the Integration of HIV and Sexual and Reproductive Health Services for Young People in Vietnam: Evidence from a Project Evaluation	PLOS ONE			English	Article							TESTING SERVICES; INTERVENTIONS; HIV/AIDS; YOUTH; WOMEN	Introduction: This paper reports changes in behavioral outcomes related to the use of HIV testing service of a project that employed peer-based education strategies and integration of HIV voluntary counseling and testing (VCT) and Sexual and Reproductive Health (SRH) services targeting young people aged 15-24 across 5 provinces in Vietnam. Methods: A pre-test/post-test, non-experimental evaluation design was used. Data were collected from cross-sectional surveys of youth and client exit interviews at project supported SRH clinics conducted at baseline and again at 24 months following implementation. The baseline samples consisted of 813 youth and 399 exit clients. The end line samples included 501 youths and 399 exit clients. Z test was used to assess changes in behavioral outcomes. Results: Results show that there was a significant increase (p < 0.05) in the percentage of youth who wanted to obtain a HIV test (from 33% to 51%), who had ever had a test (from 7.5% to 15%), and who had a repeat test in the last 12 months (from 54.5% to 67.5%). Exit client interviews found a nearly five-fold increase in the percentage of clients seeking HIV VCT in their current visit (5.0% vs. 24.5%) and almost two-fold increase in the percentage of those having their last test at a project supported clinic (9.3% vs. 17.8%). There were also positive changes in some aspects of youth HIV/AIDS knowledge, attitudes, and risk perceptions. Conclusions: This study provides preliminary evidence regarding the benefits of the integration of HIV VCT-SRH services in terms of increased access to HIV services and testing in Vietnam. Benefits of peer-based education regarding increased HIV knowledge were also identified. Further investigations, including experimental studies with assessment of health outcomes and the uptake of HIV testing services, are required to better elucidate the effectiveness and challenges of this intervention model in Vietnam.	[Ngo, Anh D.] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Ngo, Anh D.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ha, Toan H.] Independent Consultant, Hanoi, Vietnam; [Rule, John] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Dang, Chinh V.] Ho Chi Minh Inst Hyg & Publ Hlth, Ho Chi Minh City, Vietnam; [Ngo, Anh D.] CPAS, Hanoi, Vietnam	University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of New South Wales Sydney	Ngo, AD (corresponding author), Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia.	anh.ngo@sydney.edu.au	Ha, Toan/AAD-3554-2020	Ha, Toan/0000-0002-0574-0804	MSIV (Marie Stopes International Vietnam)	MSIV (Marie Stopes International Vietnam)	Funding for this study came from MSIV (Marie Stopes International Vietnam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew I, 2003, REPROD HEALTH MATTER, V11, P51, DOI 10.1016/S0968-8080(03)22101-7; Baggaley R., 2002, VOLUNTARY COUNSELING; Bateganya M, 2010, COCHRANE DATABASE SY; Burke HM, 2012, HEALTH EDUC RES, V27, P359, DOI 10.1093/her/cyr103; Coovadia HM, 2000, ANN NY ACAD SCI, V918, P57; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; General Statistics Office, 2009, NAT SURV AD YOUTH VI; Kabbash I. A., 2010, Eastern Mediterranean Health Journal, V16, P491; Kennedy CE, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-26; Liechty Cheryl A, 2004, Curr HIV/AIDS Rep, V1, P181, DOI 10.1007/s11904-004-0028-5; National Committee for AIDS D and Prostitution Prevention and Control, 2012, VIETN AIDS RESP PROG; Nguyen HT, 2004, INT AIDS C BANGK THA; Nguyen TH, 2007, ANTIVIR THER, V13, P116; OHara P, 1996, J SCHOOL HEALTH, V66, P176, DOI 10.1111/j.1746-1561.1996.tb06271.x; Okonofua Friday E., 2003, International Journal of Infectious Diseases, V7, P61, DOI 10.1016/S1201-9712(03)90044-0; Rosner B, 2011, FUNBDERMENTALS BIOST, P353; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Spaulding AB, 2009, AIDS, V23, pS79, DOI 10.1097/01.aids.0000363780.42956.ff; Trung NQ, 2004, INT AIDS C BANGK THA; UNAIDS, 2010, 26 M UNAIDS PROGR CO; United Nation, 2010, MILL DEV GOALS; Vietnam Administration of HIV/AIDS Control, 2007, NAT STRAT HIV AIDS P; Wyss S, 2007, AJAR-AFR J AIDS RES, V6, P121, DOI 10.2989/16085900709490406; Xu FJ, 2002, J ACQ IMMUN DEF SYND, V29, P284, DOI 10.1097/00042560-200203010-00009	24	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80951	10.1371/journal.pone.0080951	http://dx.doi.org/10.1371/journal.pone.0080951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261IJ	24312253	Green Submitted, gold, Green Published			2022-12-25	WOS:000327657900016
J	Orsini, LGS; Pinheiro, MM; Castro, CHM; Silva, AEB; Szejnfeld, VL				Orsini, Luciana G. S.; Pinheiro, Marcelo M.; Castro, Charlles H. M.; Silva, Antonio E. B.; Szejnfeld, Vera L.			Bone Mineral Density Measurements, Bone Markers and Serum Vitamin D Concentrations in Men with Chronic Non-Cirrhotic Untreated Hepatitis C	PLOS ONE			English	Article							RISK-FACTORS; QUANTITATIVE ULTRASOUND; OSTEOPOROTIC FRACTURE; RIBAVIRIN THERAPY; INTERFERON-ALPHA; LIVER-CIRRHOSIS; WOMEN; OSTEOSCLEROSIS; POPULATION; DENSITOMETRY	Introduction: The high prevalence of chronic hepatitis C (CHC) and its consequent cirrhosis has been associated with bone fragility. Whether CHC may cause bone and mineral abnormalities in the absence of hepatocellular dysfunction is still unknown. In this study we aimed to determine the prevalence of osteoporotic vertebral fractures and low BMD measurements in men with non-cirrhotic CHC. Risk factors for low BMD and fractures were also investigated. Methods: Morphometric vertebral fractures and BMD measurements were performed in 60 non-cirrhotic untreated men with CHC and 59 healthy controls, matched for age and gender, weight and current smoking. Serum CTx, calcium, phosphate, intact PTH, alkaline phosphatase and vitamin D (25OHD) concentrations were measured in all participants. Clinical risk factors for low BMD and fractures were evaluated by a structured questionnaire as well as details regarding HCV infection. Results: Trochanter and total femur BMD were significantly lower in CHC patients as compared to healthy men (p = 0.04). In men 50 years and older, the prevalence of osteoporosis was significantly higher among CHC patients (p = 0.01). Lower levels of physical activities and more often report of prolonged immobilization were observed among CHC patients (p<0.05). Liver inflammation and fibrosis, viral load and genotype did not correlate with BMD measurements. Bone markers and 25OHD concentrations were similar in both groups. Only a few vertebral fractures were observed. Conclusions: Our results demonstrate that non-cirrhotic untreated CHC patients have lower BMD at the femur as compared to healthy men in spite of the absence of significant bone and mineral abnormalities.	[Orsini, Luciana G. S.; Pinheiro, Marcelo M.; Castro, Charlles H. M.; Szejnfeld, Vera L.] Univ Fed Sao Paulo, Escola Paulista Med, Div Rheumatol, Sao Paulo, Brazil; [Silva, Antonio E. B.] Univ Fed Sao Paulo, Escola Paulista Med, Div Gastroenterol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Castro, CHM (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Div Rheumatol, Sao Paulo, Brazil.	cheldan@uol.com.br	Silva, Antonio Eduardo Benedito/N-7911-2013; Castro, Charlles HM/C-1594-2012	Silva, Antonio Eduardo Benedito/0000-0002-5579-5416; Castro, Charlles HM/0000-0001-9144-996X	Rheumatology Division at the Universidade Federal de Sao Paulo/Escola Paulista de Medicina (Unifesp/EPM)	Rheumatology Division at the Universidade Federal de Sao Paulo/Escola Paulista de Medicina (Unifesp/EPM)	This study was funded by a grant from the Rheumatology Division at the Universidade Federal de Sao Paulo/Escola Paulista de Medicina (Unifesp/EPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Collier JD, 2002, GUT, V50, P1; COOPER C, 1993, BONE, V14, pS89; Corazza GR, 2000, DIGEST DIS SCI, V45, P1392, DOI 10.1023/A:1005568406664; Damrongrungruang T, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000137293.33127.1b; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P902, DOI 10.1097/01.ALC.0000164544.45746.A7; Duarte MPC, 2001, J GASTROEN HEPATOL, V16, P1022, DOI 10.1046/j.1440-1746.2001.02561.x; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gonzalez-Calvin JL, 2004, J CLIN ENDOCR METAB, V89, P4325, DOI 10.1210/jc.2004-0077; Hofmann WP, 2008, J VIRAL HEPATITIS, V15, P790, DOI 10.1111/j.1365-2893.2008.01038.x; Hoiberg M, 2007, OSTEOPOROSIS INT, V18, P1507, DOI 10.1007/s00198-007-0399-8; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Khosla S, 1998, J CLIN INVEST, V101, P2165, DOI 10.1172/JCI1111; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Manganelli P, 2005, CLIN RHEUMATOL, V24, P296, DOI 10.1007/s10067-004-1031-3; Nishida N, 2006, HEPATOL RES, V34, P222, DOI 10.1016/j.hepres.2006.01.004; ONEILL TW, 1994, INT J EPIDEMIOL, V23, P559, DOI 10.1093/ije/23.3.559; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P507, DOI 10.1007/s00198-008-0720-1; Pedreira PG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3240; Pinheiro MM, 2006, J GERONTOL A-BIOL, V61, P196, DOI 10.1093/gerona/61.2.196; Pinheiro MM, 2003, CALCIFIED TISSUE INT, V73, P555, DOI 10.1007/s00223-002-1096-4; Schiefke I, 2005, WORLD J GASTROENTERO, V11, P1843, DOI 10.3748/wjg.v11.i12.1843; Schwartz KM, 2008, SKELETAL RADIOL, V37, P679, DOI 10.1007/s00256-008-0471-2; Solis-Herruzo JA, 2000, J HEPATOL, V33, P812, DOI 10.1016/S0168-8278(00)80314-1; Tanaka T, 2001, OSTEOPOROSIS INT, V12, P942, DOI 10.1007/s001980170023; Tsuneoka K, 1996, J GASTROENTEROL, V31, P669, DOI 10.1007/BF02347615; Urganci N, 2005, J PEDIATR GASTR NUTR, V41, P650, DOI 10.1097/01.mpg.0000182800.07794.01; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Yenice Necati, 2006, Turk J Gastroenterol, V17, P260	33	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81652	10.1371/journal.pone.0081652	http://dx.doi.org/10.1371/journal.pone.0081652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312334	gold, Green Published, Green Submitted			2022-12-25	WOS:000327657900044
J	Pirttimaki, TM; Codadu, NK; Awni, A; Pratik, P; Nagel, DA; Hill, EJ; Dineley, KT; Parri, HR				Pirttimaki, Tiina Maria; Codadu, Neela Krushna; Awni, Alia; Pratik, Pandey; Nagel, David Andrew; Hill, Eric James; Dineley, Kelly Tennyson; Parri, H. Rheinallt			alpha 7 Nicotinic Receptor-Mediated Astrocytic Gliotransmitter Release: A beta Effects in a Preclinical Alzheimer's Mouse Model	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; AMYLOID PRECURSOR PROTEINS; RAT HIPPOCAMPUS; IN-SITU; ACETYLCHOLINE-RECEPTORS; TRANSGENIC MICE; CALCIUM OSCILLATIONS; PYRAMIDAL NEURONS; NMDA RECEPTORS; GLIAL-CELLS	It is now recognized that astrocytes participate in synaptic communication through intimate interactions with neurons. A principal mechanism is through the release of gliotransmitters (GTs) such as ATP, D-serine and most notably, glutamate, in response to astrocytic calcium elevations. We and others have shown that amyloid-beta (A beta), the toxic trigger for Alzheimer's disease (AD), interacts with hippocampal alpha 7 nicotinic acetylcholine receptors (nAChRs). Since alpha 7nAChRs are highly permeable to calcium and are expressed on hippocampal astrocytes, we investigated whether A beta could activate astrocytic alpha 7nAChRs in hippocampal slices and induce GT glutamate release. We found that biologically-relevant concentrations of A beta(1-42) elicited alpha 7nAChR-dependent calcium elevations in hippocampal CA1 astrocytes and induced NMDAR-mediated slow inward currents (SICs) in CA1 neurons. In the Tg2576 AD mouse model for A beta over-production and accumulation, we found that spontaneous astrocytic calcium elevations were of higher frequency compared to wildtype (WT). The frequency and kinetic parameters of AD mice SICs indicated enhanced gliotransmission, possibly due to increased endogenous A beta observed in this model. Activation of alpha 7nAChRs on WT astrocytes increased spontaneous inward currents on pyramidal neurons while alpha 7nAChRs on astrocytes of AD mice were abrogated. These findings suggest that, at an age that far precedes the emergence of cognitive deficits and plaque deposition, this mouse model for AD-like amyloidosis exhibits augmented astrocytic activity and glutamate GT release suggesting possible repercussions for preclinical AD hippocampal neural networks that contribute to subsequent cognitive decline.	[Pirttimaki, Tiina Maria; Codadu, Neela Krushna; Awni, Alia; Pratik, Pandey; Nagel, David Andrew; Parri, H. Rheinallt] Aston Univ, Sch Life & Hlth Sci, Birmingham, England; [Hill, Eric James] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham, W Midlands, England; [Dineley, Kelly Tennyson] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA	Aston University; Aston University; University of Texas System; University of Texas Medical Branch Galveston	Dineley, KT (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	ktdinele@utmb.edu; Parrihr@aston.ac.uk		Hill, Eric/0000-0002-9419-1500; Parri, Rheinallt/0000-0002-1412-2688	Alzheimer's Research UK; Alzheimers Research UK [ART-PPG2007B-6] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The work was supported by "Alzheimer's Research UK", http://www.alzheimersresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Gu ZL, 2012, J NEUROSCI, V32, P12337, DOI 10.1523/JNEUROSCI.2129-12.2012; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hamann S, 2002, NEUROPSYCHOLOGIA, V40, P1187, DOI 10.1016/S0028-3932(01)00223-8; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hoefer M, 2008, BRAIN, V131, P1646, DOI 10.1093/brain/awn082; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jones IW, 2006, J MOL NEUROSCI, V30, P83, DOI 10.1385/JMN:30:1:83; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lalo U, 2011, SEMIN CELL DEV BIOL, V22, P220, DOI 10.1016/j.semcdb.2011.02.012; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Pirttimaki T, 2013, J PHYSIOL-LONDON, V591, P823, DOI 10.1113/jphysiol.2012.242016; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Placzek AN, 2009, ACTA PHARMACOL SIN, V30, P752, DOI 10.1038/aps.2009.39; Ponomarev I, 2010, NEUROPSYCHOPHARMACOL, V35, P1402, DOI 10.1038/npp.2010.10; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; SEGUELA P, 1993, J NEUROSCI, V13, P596; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Talantova M, 2013, P NATL ACAD SCI US; Tapiola T, 2000, NEUROSCI LETT, V280, P119, DOI 10.1016/S0304-3940(00)00767-9; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Wang H, 2000, ADV IND CON; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yakel JL, 2012, NICOTINE TOB RES, V14, P1249, DOI 10.1093/ntr/nts091; Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025	64	68	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81828	10.1371/journal.pone.0081828	http://dx.doi.org/10.1371/journal.pone.0081828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312364	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327657900053
J	Hirose, N; Nishimura, K; Inoue-Sakamoto, M; Masudar, M				Hirose, Noriyuki; Nishimura, Kazuko; Inoue-Sakamoto, Maki; Masudar, Michiaki			Ribosomal Internal Transcribed Spacer of Prototheca wickerhamii Has Characteristic Structure Useful for Identification and Genotyping	PLOS ONE			English	Article							GENUS PROTOTHECA; ZOPFII GENOTYPES; CANINE; BOVINE; PARASITES; ALGAE	Prototheca species are achlorophyllous algae ubiquitous in nature and known to cause localized and systemic infection both in humans and animals. Although identification of the Prototheca species in clinical specimens is a challenge, there are an increasing number of cases in which molecular techniques have successfully been used for diagnosis of protothecosis. In this study, we characterized nuclear ribosomal DNA (rDNA) of a strain of Prototheca (FL11-0001) isolated from a dermatitis patient in Japan for its species identification. When nuclear rDNA of FL11-0001 and that of various other Prototheca strains were compared by polymerase chain reaction (PCR), the results indicated that the sizes of ribosomal internal transcribed spacer (ITS) were different in a species-dependent manner, suggesting that the variation might be useful for differentiation of Prototheca spp. Especially, ITS of P. wickerhamii, the most common cause of human protothecosis, was distinctively larger than that of other Prototheca spp. FL11-0001, whose ITS was comparably large, could easily be identified as P. wickerhamii. The usefulness of the PCR analysis of ITS was also demonstrated by the discovery that one of the clinical isolates that had previously been designated as P. wickerhamii was likely a novel species. Furthermore, our data demonstrated that nucleotide sequences of P. wickerhamii ITS are heterogenous between different rDNA copies in each strain and also polymorphic between strains. Phylogenetic analysis suggested that the ITS sequences could be classified to four clades, based on which P. wickerhamii strains might be grouped into at least two genotypes. Comprehensive characterization of Prototheca rDNA may provide valuable insights into diagnosis and epidemiology of protothecosis, as well as evolution and taxonomy of Prototheca and related organisms.	[Hirose, Noriyuki; Nishimura, Kazuko; Masudar, Michiaki] Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan; [Hirose, Noriyuki] BD Japan Co Ltd, Fukushima Plant, Fukushima, Japan; [Nishimura, Kazuko] First Labs Co Ltd, Kanagawa, Japan; [Inoue-Sakamoto, Maki] Amakusa Chuo Gen Hosp, Div Dermatol, Kumamoto, Japan; [Inoue-Sakamoto, Maki] Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan	Dokkyo Medical University; Kumamoto University	Masudar, M (corresponding author), Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan.	m-masuda@dokkyomed.ac.jp			Department of Microbiology; First Laboratories, Co. Ltd.	Department of Microbiology; First Laboratories, Co. Ltd.	This study was supported by the research budget of the Department of Microbiology allocated by Dokkyo Medical University. The study was also supported partly by the research fund donated by First Laboratories, Co. Ltd. While some authors work for the funders, the funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrholdt J, 2012, MED MYCOL, V50, P234, DOI 10.3109/13693786.2011.597445; Casal M, 1997, MYCOPATHOLOGIA, V137, P79, DOI 10.1023/A:1006818606851; Ebihara M, 2009, BRIT J DERMATOL, V161, P1038, DOI 10.1111/j.1365-2133.2009.09249.x; FRANK N, 1969, AM J VET RES, V30, P1785; GUEHO E, 1990, INT J SYST BACTERIOL, V40, P60, DOI 10.1099/00207713-40-1-60; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hollingsworth SR, 2000, VET CLIN N AM-SMALL, V30, P1091, DOI 10.1016/S0195-5616(00)05008-7; Janosi S, 2001, VET QUART, V23, P58, DOI 10.1080/01652176.2001.9695082; Lass-Florl C, 2007, CLIN MICROBIOL REV, V20, P230, DOI 10.1128/CMR.00032-06; MATSUDA T, 1992, EUR J EPIDEMIOL, V8, P397, DOI 10.1007/BF00158575; McMullan B, 2011, J CLIN MICROBIOL, V49, P3078, DOI 10.1128/JCM.00487-11; Mercereau-Puijalon O, 2002, INT J PARASITOL, V32, P1323, DOI 10.1016/S0020-7519(02)00111-X; Miura K., 2005, J HIROSHIMA SOC MED, V95, P35; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; Ricchi M, 2011, J APPL MICROBIOL, V110, P27, DOI 10.1111/j.1365-2672.2010.04861.x; Roesler U, 2006, INT J SYST EVOL MICR, V56, P1419, DOI 10.1099/ijs.0.63892-0; Roesler UH, 2011, MOLECULAR DETECTION OF HUMAN FUNGAL PATHOGENS, P865; Satoh K, 2010, INT J SYST EVOL MICR, V60, P1236, DOI 10.1099/ijs.0.016402-0; Sobukawa H, 2011, MED MYCOL, V49, P222, DOI 10.3109/13693786.2010.511285; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Stenner VJ, 2007, MED MYCOL, V45, P249, DOI 10.1080/13693780601187158; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todd JR, 2012, MED MYCOL, V50, P673, DOI 10.3109/13693786.2012.677862; Tsuji H, 2006, VET MICROBIOL, V118, P305, DOI 10.1016/j.vetmic.2006.08.003; TUBAKI K., 1959, Nagaoa = Mycol. J. Nagao Inst., V6, P25; Ueno R, 2007, MICROBIOL-SGM, V153, P3879, DOI 10.1099/mic.0.2007/009365-0; von Bergen M, 2009, PROTEOM CLIN APPL, V3, P774, DOI 10.1002/prca.200780138; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wirth H, 2012, J MICROBIOL METH, V88, P83, DOI 10.1016/j.mimet.2011.10.013; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Zak I, 2012, DIAGN MICR INFEC DIS, V74, P186, DOI 10.1016/j.diagmicrobio.2012.06.015	32	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81223	10.1371/journal.pone.0081223	http://dx.doi.org/10.1371/journal.pone.0081223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312279	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100066
J	Painting, CJ; Holwell, GI				Painting, Christina. J.; Holwell, Gregory I.			Exaggerated Trait Allometry, Compensation and Trade-Offs in the New Zealand Giraffe Weevil (Lasiorhynchus barbicornis)	PLOS ONE			English	Article							SPERM COMPETITION GAMES; ALTERNATIVE REPRODUCTIVE TACTICS; STALK-EYED FLIES; SEXUAL SELECTION; HORN DIMORPHISM; BEETLE; EVOLUTION; SIZE; WEAPONS; STRATEGIES	Sexual selection has driven the evolution of exaggerated traits among diverse animal taxa. The production of exaggerated traits can come at a cost to other traits through trade-offs when resources allocated to trait development are limited. Alternatively some traits can be selected for in parallel to support or compensate for the cost of bearing the exaggerated trait. Male giraffe weevils (Lasiorhynchus barbicornis) display an extremely elongated rostrum used as a weapon during contests for mates. Here we characterise the scaling relationship between rostrum and body size and show that males have a steep positive allometry, but that the slope is non-linear due to a relative reduction in rostrum length for the largest males, suggesting a limitation in resource allocation or a diminishing requirement for large males to invest increasingly into larger rostra. We also measured testes, wings, antennae, fore-and hind-tibia size and found no evidence of a trade-off between these traits and rostrum length when comparing phenotypic correlations. However, the relative length of wings, antennae, fore-and hind-tibia all increased with relative rostrum length suggesting these traits may be under correlational selection. Increased investment in wing and leg length is therefore likely to compensate for the costs of flying with, and wielding the exaggerated rostrum of larger male giraffe weevils. These results provide a first step in identifying the potential for trait compensation and trades-offs, but are phenotypic correlations only and should be interpreted with care in the absence of breeding experiments.	[Painting, Christina. J.; Holwell, Gregory I.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Painting, CJ (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	cpai015@aucklanduni.ac.nz		Holwell, Gregory/0000-0002-6059-6032; Painting, Christina/0000-0003-0701-2648	University of Auckland; Forest and Bird Waitakare Branch	University of Auckland; Forest and Bird Waitakare Branch	This study was financially supported by a University of Auckland Doctoral Scholarship awarded to CJ Painting, and by the Forest and Bird Waitakare Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR; Andersson Malte, 1994; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Darwin G., 1871, P423; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.1111/j.1558-5646.1991.tb05262.x; EBERHARD WG, 1982, AM NAT, V119, P420, DOI 10.1086/283920; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Emlen DJ, 2005, EVOLUTION, V59, P1060; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; GAGE MJG, 1995, PHILOS T R SOC B, V350, P391; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hardersen S, 2011, EUR J ENTOMOL, V108, P461, DOI 10.14411/eje.2011.059; Hardersen S, 2010, ETHOL ECOL EVOL, V22, P365, DOI 10.1080/03949370.2010.510042; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Huxley J., 1932, PROBLEMS RELATIVE GR; Kelly CD, 2008, BEHAV ECOL, V19, P1018, DOI 10.1093/beheco/arn058; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Klingenberg CP, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P213; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1135, DOI 10.1098/rspb.1998.0409; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, P523, DOI 10.1098/rspb.2003.2641; Knell RJ, 2009, ECOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-2311.2008.01022.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kuschel G, 2003, FAUNA NZ 45 NEMONYCH; McCullough EL, 2012, BEHAV ECOL, V23, P1042, DOI 10.1093/beheco/ars069; Meads M.J., 1976, New Zealand Entomologist, V6, P171; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Muggeo V, 2008, R NEWS, V8, P20, DOI DOI 10.1159/000323281; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munguia-Steyer R, 2012, BEHAV ECOL, V23, P827, DOI 10.1093/beheco/ars037; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; Okada K, 2009, ANIM BEHAV, V77, P1057, DOI 10.1016/j.anbehav.2009.01.008; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; Packard GC, 2012, BIOL J LINN SOC, V107, P764, DOI 10.1111/j.1095-8312.2012.01995.x; Packard GC, 2011, J COMP PHYSIOL B, V181, P841, DOI 10.1007/s00360-011-0565-3; Packard GC, 2009, J THEOR BIOL, V257, P515, DOI 10.1016/j.jtbi.2008.10.016; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; Pizzo A, 2012, ZOOMORPHOLOGY, V131, P57, DOI 10.1007/s00435-012-0148-1; R Core Team, 2021, R LANG ENV STAT COMP; Ribak G, 2007, J COMP PHYSIOL A, V193, P1065, DOI 10.1007/s00359-007-0259-1; Robinson MR, 2013, ECOL LETT, V16, P281, DOI 10.1111/ele.12047; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simmons LW, 2007, EVOLUTION, V61, P2684, DOI 10.1111/j.1558-5646.2007.00243.x; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 1999, P ROY SOC B-BIOL SCI, V266, P145, DOI 10.1098/rspb.1999.0614; Simmons LW, 2000, BEHAV ECOL, V11, P319, DOI 10.1093/beheco/11.3.319; STOCKLEY P, 1993, FUNCT ECOL, V7, P560, DOI 10.2307/2390132; Swallow JG, 2000, J COMP PHYSIOL B, V170, P481, DOI 10.1007/s003600000124; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Tomkins JL, 2005, P ROY SOC B-BIOL SCI, V272, P543, DOI 10.1098/rspb.2004.2950; Tomkins JL, 2005, AM NAT, V165, P389, DOI 10.1086/427732; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Whitlock M. C., 2009, ANAL BIOL DATA; Wilson E.O., 1975, P1; Wong-Munoz J, 2011, EVOL ECOL, V25, P59, DOI [10.1007/s10682-010-9379-0, 10.1002/ece3.65]; Yamane T, 2010, P ROY SOC B-BIOL SCI, V277, P1705, DOI 10.1098/rspb.2009.2017	65	47	49	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e82467	10.1371/journal.pone.0082467	http://dx.doi.org/10.1371/journal.pone.0082467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312425	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100118
J	Umeano, O; Phillips-Bute, B; Hailey, CE; Sun, W; Gray, MC; Roulhac-Wilson, B; McDonagh, DL; Kranz, PG; Laskowitz, DT; James, ML				Umeano, Odera; Phillips-Bute, Barbara; Hailey, Claire E.; Sun, Wei; Gray, Marisa C.; Roulhac-Wilson, Briana; McDonagh, David L.; Kranz, Peter G.; Laskowitz, Daniel T.; James, Michael L.			Gender and Age Interact to Affect Early Outcome after Intracerebral Hemorrhage	PLOS ONE			English	Article							SEX-DIFFERENCES; CLINICAL-TRIAL; BRAIN-INJURY; STROKE; ESTROGEN; MORTALITY; PROGESTERONE; COMORBIDITY; POPULATION; THERAPY	Background: Intracerebral hemorrhage (ICH) is a common and devastating form of cerebrovascular disease. In ICH, gender differences in outcomes remain relatively understudied but have been examined in other neurological emergencies. Further, a potential effect of age and gender on outcomes after ICH has not been explored. This study was designed to test the hypothesis that age and gender interact to modify neurological outcomes after ICH. Methods: Adult patients admitted with spontaneous primary supratentorial ICH from July 2007 through April 2010 were assessed via retrospective analysis of an existing stroke database at Duke University. Univariate analysis of collected variables was used to compare gender and outcome. Unfavorable outcome was defined as discharge to hospice or death. Using multivariate regression, the combined effect of age and gender on outcome after ICH was analyzed. Results: In this study population, women were younger (61.1 +/- 14.5 versus 65.8 +/- 17.3 years, p=0.03) and more likely to have a history of substance abuse (35% versus 8.9%, p<0.0001) compared to men. Multivariable models demonstrated that advancing age had a greater effect on predicting discharge outcome in women compared to men (p=0.02). For younger patients, female sex was protective; however, at ages greater than 60 years, female sex was a risk factor for discharge to hospice or death. Conclusion: While independently associated with discharge to hospice or death after ICH, the interaction effect between gender and age demonstrated significantly stronger correlation with early outcome after ICH in a single center cohort. Prospective study is required to verify these findings.	[Umeano, Odera] Duke Univ, Sch Med, Durham, NC USA; [Phillips-Bute, Barbara; McDonagh, David L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Hailey, Claire E.; Gray, Marisa C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Sun, Wei] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China; [Roulhac-Wilson, Briana] Duke Univ, Durham, NC USA; [Kranz, Peter G.] Duke Univ, Dept Radiol, Durham, NC 27710 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Brain Injury Translat Res Ctr, Dept Neurol, Durham, NC 27710 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Peking University; Duke University; Duke University; Duke University	James, ML (corresponding author), Duke Univ, Brain Injury Translat Res Ctr, Dept Neurol, Durham, NC 27710 USA.	michael.james@duke.edu	Kranz, Peter G/B-2471-2016; James, Michael L./AAJ-5592-2020	Kranz, Peter G/0000-0001-5410-7135; James, Michael L./0000-0002-8715-5210	American Heart Association - Scientist Development Grant; FOGARTY INTERNATIONAL CENTER [D43TW008303] Funding Source: NIH RePORTER	American Heart Association - Scientist Development Grant(American Heart Association); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by an American Heart Association - Scientist Development Grant (MLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brouwers HB, 2013, CEREBROVASC DIS, V35, P195, DOI 10.1159/000346599; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; de los Rios F, 2012, STROKE, V43, P3179, DOI 10.1161/STROKEAHA.112.667808; Elkind MSV, 2007, NEUROLOGY, V68, P842, DOI 10.1212/01.wnl.0000256748.28281.ad; Engman J, 2012, EUR NEUROPSYCHOPHARM, V22, P562, DOI 10.1016/j.euroneuro.2011.12.005; Gong Y, 2011, ACTA NEUROCHIR SUPPL, V111, P113, DOI 10.1007/978-3-7091-0693-8_18; Gu Y, 2010, ACTA NEUROCHIR SUPPL, V106, P159, DOI 10.1007/978-3-211-98811-4_29; Guevara R, 2011, CELL PHYSIOL BIOCHEM, V27, P201, DOI 10.1159/000327945; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; James ML, 2009, BIOMARKERS, V14, P388, DOI 10.1080/13547500903015784; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; Kiphuth IC, 2012, CEREBROVASC DIS, V34, P297, DOI 10.1159/000343224; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuramatsu JB, 2011, J NEUROL NEUROSUR PS, V82, P144, DOI 10.1136/jnnp.2010.208439; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Lee WC, 2007, ADV THER, V24, P258, DOI 10.1007/BF02849893; Lei BL, 2012, TRANSL STROKE RES, V3, pS94, DOI 10.1007/s12975-012-0176-7; Li H, 2005, ANN NEUROL, V58, P317, DOI 10.1002/ana.20538; LI W, 2012, HUM BRAIN MAPP, P96803; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mendelow AD, 2005, LANCET, V365, P387; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; MULLIE A, 1988, LANCET, V1, P137; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P218; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Rincon F, 2011, J CRIT CARE, V26, P620, DOI 10.1016/j.jcrc.2011.02.009; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Steiner T, 2011, CEREBROVASC DIS, V32, P409, DOI 10.1159/000330653; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; TEASDALE G, 1974, LANCET, V2, P81; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; Vasileyko V, 2010, ANN NY ACAD SCI, V1207, P58, DOI 10.1111/j.1749-6632.2010.05786.x; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Weimar C, 2011, CEREBROVASC DIS, V32, P283, DOI 10.1159/000330643; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Zahuranec DB, 2012, CEREBROVASC DIS, V34, P86, DOI 10.1159/000339684; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	47	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81664	10.1371/journal.pone.0081664	http://dx.doi.org/10.1371/journal.pone.0081664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312335	Green Published, Green Submitted, gold			2022-12-25	WOS:000327652100092
J	Merritt, MA; Bentink, S; Schwede, M; Iwanicki, MP; Quackenbush, J; Woo, T; Agoston, ES; Reinhardt, F; Crum, CP; Berkowitz, RS; Mok, SC; Witt, AE; Jones, MA; Wang, B; Ince, TA				Merritt, Melissa A.; Bentink, Stefan; Schwede, Matthew; Iwanicki, Marcin P.; Quackenbush, John; Woo, Terri; Agoston, Elin S.; Reinhardt, Ferenc; Crum, Christopher P.; Berkowitz, Ross S.; Mok, Samuel C.; Witt, Abigail E.; Jones, Michelle A.; Wang, Bin; Ince, Tan A.			Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; FALLOPIAN-TUBE EPITHELIUM; SEROUS CARCINOMA; CANCER; MODEL; BREAST; IDENTIFICATION; PATHWAYS; MUTATION; BIOLOGY	The potential role of the cell-of-origin in determining the tumor phenotype has been raised, but not adequately examined. We hypothesized that distinct cells-of-origin may play a role in determining ovarian tumor phenotype and outcome. Here we describe a new cell culture medium for in vitro culture of paired normal human ovarian (OV) and fallopian tube (FT) epithelial cells from donors without cancer. While these cells have been cultured individually for short periods of time, to our knowledge this is the first long-term culture of both cell types from the same donors. Through analysis of the gene expression profiles of the cultured OV/FT cells we identified a normal cell-of-origin gene signature that classified primary ovarian cancers into OV-like and FT-like subgroups; this classification correlated with significant differences in clinical outcomes. The identification of a prognostically significant gene expression signature derived solely from normal untransformed cells is consistent with the hypothesis that the normal cell-of-origin may be a source of ovarian tumor heterogeneity and the associated differences in tumor outcome.	[Merritt, Melissa A.; Bentink, Stefan; Schwede, Matthew; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Merritt, Melissa A.; Berkowitz, Ross S.; Mok, Samuel C.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Boston, MA 02115 USA; [Merritt, Melissa A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Iwanicki, Marcin P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Woo, Terri; Agoston, Elin S.; Reinhardt, Ferenc; Crum, Christopher P.; Ince, Tan A.] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, Boston, MA 02115 USA; [Mok, Samuel C.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Witt, Abigail E.; Jones, Michelle A.; Wang, Bin; Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Witt, Abigail E.; Jones, Michelle A.; Wang, Bin; Ince, Tan A.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Miami, FL 33136 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Miami; University of Miami	Ince, TA (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, 75 Francis St, Boston, MA 02115 USA.	TInce@med.miami.edu		Ince, Tan/0000-0003-0315-6425; Quackenbush, John/0000-0002-2702-5879	National Cancer Institute (NCI) [R01-CA146445-01]; Breast Cancer Research Foundation; NCI SPORE in Ovarian Cancer [5P50 CA105009-05]; Women's Cancer Program at Dana-Farber/Harvard Cancer Center; Ovarian Cancer Research Fund; Gynecologic Cancer Foundation; NCI Nutritional Epidemiology of Cancer training program [R25CA098566]; NCI [R21 CA124688-01A1, NCI R01-CA133057-01]; NATIONAL CANCER INSTITUTE [R25CA098566, P50CA105009, R21CA124688, R01CA146445] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; NCI SPORE in Ovarian Cancer; Women's Cancer Program at Dana-Farber/Harvard Cancer Center; Ovarian Cancer Research Fund; Gynecologic Cancer Foundation; NCI Nutritional Epidemiology of Cancer training program; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this research was provided by grants from the National Cancer Institute (NCI) (http://www.cancer.gov/) (R01-CA146445-01), Breast Cancer Research Foundation (http://www.bcrfcure.org/), and Pilot Project Awards from the NCI SPORE in Ovarian Cancer (5P50 CA105009-05) and Women's Cancer Program at Dana-Farber/Harvard Cancer Center to T. A. Ince; grants from the Ovarian Cancer Research Fund (http://www.ocrf.org/), the Gynecologic Cancer Foundation (http://www. foundationforwomenscancer.org/) and the NCI Nutritional Epidemiology of Cancer training program (R25CA098566) to M. A. Merritt, an NCI R21 CA124688-01A1 to C. P. Crum, and an NCI R01-CA133057-01 to S. C. Mok. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2013, INT J GYNECOL PATHOL, V32, P444, DOI 10.1097/PGP.0b013e3182800ad5; Baker SG, 2012, JNCI-J NATL CANCER I, V104, P262, DOI 10.1093/jnci/djr557; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bellacosa A, 2010, CANCER PREV RES, V3, P48, DOI 10.1158/1940-6207.CAPR-09-0078; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Briton-Jones C, 2002, FERTIL STERIL, V77, P576, DOI 10.1016/S0015-0282(01)03216-2; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chang ACM, 1998, MOL CELL ENDOCRINOL, V141, P95, DOI 10.1016/S0303-7207(98)00097-5; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Comer MT, 1998, HUM REPROD, V13, P3114, DOI 10.1093/humrep/13.11.3114; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; ELLIOTT WM, 1993, IN VITRO CELL DEV-AN, V29A, P9; Fraley C, 2006, MCLUST VERSION 3 R N; George SHL, 2011, J PATHOL, V225, P106, DOI 10.1002/path.2927; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hand DJ, 2006, STAT SCI, V21, P1, DOI 10.1214/088342306000000060; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Jazaeri AA, 2011, NEOPLASIA, V13, P899, DOI 10.1593/neo.11138; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; KRUK PA, 1990, LAB INVEST, V63, P132; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Li J, 2011, MODERN PATHOL, V24, P1488, DOI 10.1038/modpathol.2011.106; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Shan WW, 2012, CELL CYCLE, V11, P2107, DOI 10.4161/cc.20544; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yamamoto S, 2011, J PATHOL, V225, P189, DOI 10.1002/path.2940	60	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80314	10.1371/journal.pone.0080314	http://dx.doi.org/10.1371/journal.pone.0080314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303006	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400022
J	Wood, NT; Fadda, E; Davis, R; Grant, OC; Martin, JC; Woods, RJ; Travers, SA				Wood, Natasha T.; Fadda, Elisa; Davis, Robert; Grant, Oliver C.; Martin, Joanne C.; Woods, Robert J.; Travers, Simon A.			The Influence of N-Linked Glycans on the Molecular Dynamics of the HIV-1 gp120 V3 Loop	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN GP120; AMINO-ACID SUBSTITUTION; HAMSTER OVARY CELLS; CORECEPTOR USAGE; ANTIBODY NEUTRALIZATION; MONOCLONAL-ANTIBODIES; SOLUBLE CD4; CONFORMATIONAL DYNAMICS; PHENOTYPE PREDICTION	N-linked glycans attached to specific amino acids of the gp120 envelope trimer of a HIV virion can modulate the binding affinity of gp120 to CD4, influence coreceptor tropism, and play an important role in neutralising antibody responses. Because of the challenges associated with crystallising fully glycosylated proteins, most structural investigations have focused on describing the features of a non-glycosylated HIV-1 gp120 protein. Here, we use a computational approach to determine the influence of N-linked glycans on the dynamics of the HIV-1 gp120 protein and, in particular, the V3 loop. We compare the conformational dynamics of a non-glycosylated gp120 structure to that of two glycosylated gp120 structures, one with a single, and a second with five, covalently linked high-mannose glycans. Our findings provide a clear illustration of the significant effect that N-linked glycosylation has on the temporal and spatial properties of the underlying protein structure. We find that glycans surrounding the V3 loop modulate its dynamics, conferring to the loop a marked propensity towards a more narrow conformation relative to its non-glycosylated counterpart. The conformational effect on the V3 loop provides further support for the suggestion that N-linked glycosylation plays a role in determining HIV-1 coreceptor tropism.	[Wood, Natasha T.; Travers, Simon A.] Univ Western Cape, Bioinformat Unit, South African Med Res Council, South African Natl Bioinformat Inst, Cape Town, South Africa; [Fadda, Elisa] Natl Univ Ireland, Dept Chem, Maynooth, Kildare, Ireland; [Davis, Robert; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Grant, Oliver C.; Martin, Joanne C.; Woods, Robert J.] Natl Univ Ireland Univ Coll Galway, Sch Chem, Galway, Ireland	South African Medical Research Council; University of the Western Cape; Maynooth University; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway	Travers, SA (corresponding author), Univ Western Cape, Bioinformat Unit, South African Med Res Council, South African Natl Bioinformat Inst, Cape Town, South Africa.	simon@sanbi.ac.za		Grant, Oliver/0000-0003-4835-5161; Woods, Robert/0000-0002-2400-6293; Fadda, Elisa/0000-0002-2898-7770	South African National Research Foundation Blue Skies [BSC20100827000017262]; South African National Research Foundation [SFP20110919000027165]; Science Foundation of Ireland [08/IN.1/B2070]; European Research Development Fund; National Institute of Health [GM094919]	South African National Research Foundation Blue Skies; South African National Research Foundation(National Research Foundation - South Africa); Science Foundation of Ireland(Science Foundation Ireland); European Research Development Fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding from the South African National Research Foundation Blue Skies (grant number: BSC20100827000017262), the South African National Research Foundation Innovation Scholarship Fund (SFP20110919000027165), as well as the Science Foundation of Ireland (08/IN.1/B2070), the European Research Development Fund, and the National Institute of Health (GM094919 (EUREKA)), is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Benson NC, 2008, PROTEIN SCI, V17, P2038, DOI 10.1110/ps.037473.108; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bolmstedt A, 2001, VACCINE, V20, P397, DOI 10.1016/S0264-410X(01)00358-9; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Briggs D, 2000, SURF INTERFACE ANAL, V29, P1; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cheng-Mayer C, 1999, J VIROL, V73, P5294, DOI 10.1128/JVI.73.7.5294-5300.1999; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; DePaul AJ, 2010, NUCLEIC ACIDS RES, V38, P4856, DOI 10.1093/nar/gkq134; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; DEWOLF F, 1994, AIDS RES HUM RETROV, V10, P1387, DOI 10.1089/aid.1994.10.1387; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Ji X, 2006, CURR PROTEIN PEPT SC, V7, P317, DOI 10.2174/138920306778017990; JOAO HC, 1993, EUR J BIOCHEM, V218, P239, DOI 10.1111/j.1432-1033.1993.tb18370.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang SM, 2005, VIROLOGY, V331, P20, DOI 10.1016/j.virol.2004.10.005; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KEET IPM, 1993, AIDS, V7, P51, DOI 10.1097/00002030-199301000-00008; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lopez de Victoria A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049925; Losman B, 1999, FEBS LETT, V454, P47, DOI 10.1016/S0014-5793(99)00740-1; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Moore PL, 2012, NAT MED; MYERS G, 1992, AIDS RES HUM RETROV, V8, P373, DOI 10.1089/aid.1992.8.373; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Ohgimoto S, 1998, J VIROL, V72, P8365, DOI 10.1128/JVI.72.10.8365-8370.1998; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pikora C, 2005, J VIROL, V79, P12575, DOI 10.1128/JVI.79.19.12575-12583.2005; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; R Core Team, 2012, R LANG ENV STAT COMP; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Schonning K, 1996, J GEN VIROL, V77, P753, DOI 10.1099/0022-1317-77-4-753; Sing T, 2007, ANTIVIR THER, V12, P1097; Smyth RJ, 1998, J VIROL, V72, P4478, DOI 10.1128/JVI.72.5.4478-4484.1998; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang XL, 2013, PROTEINS, V81, P443, DOI 10.1002/prot.24202; Wehle M, 2012, J AM CHEM SOC, V134, P18964, DOI 10.1021/ja302803r; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Westby Mike, 2010, Antiviral Chemistry & Chemotherapy, V20, P179, DOI 10.3851/IMP1507; Wilhelm D, 2012, CHEMBIOCHEM, V13, P524, DOI 10.1002/cbic.201100740; Woods RJ, 2010, CURR OPIN STRUC BIOL, V20, P575, DOI 10.1016/j.sbi.2010.07.005; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu SG, 2007, J MICROBIOL, V45, P441; Yang Q, 2010, BIOCONJUGATE CHEM, V21, P875, DOI 10.1021/bc9004238; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530; Zhang LQ, 1996, NATURE, V383, P768, DOI 10.1038/383768a0; Zheng K, 2011, MABS-AUSTIN, V3, P568, DOI 10.4161/mabs.3.6.17922; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	97	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80301	10.1371/journal.pone.0080301	http://dx.doi.org/10.1371/journal.pone.0080301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303005	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400021
J	Yang, F; Li, WS; Jorgensen, HJL				Yang, Fen; Li, Wanshun; Jorgensen, Hans J. L.			Transcriptional Reprogramming of Wheat and the Hemibiotrophic Pathogen Septoria tritici during Two Phases of the Compatible Interaction	PLOS ONE			English	Article							FUNGUS MYCOSPHAERELLA-GRAMINICOLA; CELL-DEATH; RNA-SEQ; PHYTOPHTHORA-INFESTANS; FUSARIUM-GRAMINEARUM; HYDROGEN-PEROXIDE; PROTEIN; EXPRESSION; ADAPTATION; METABOLISM	The disease septoria leaf blotch of wheat, caused by fungal pathogen Septoria tritici, is of worldwide concern. The fungus exhibits a hemibiotrophic lifestyle, with a long symptomless, biotrophic phase followed by a sudden transition to necrotrophy associated with host necrosis. Little is known about the systematic interaction between fungal pathogenicity and host responses at specific growth stages and the factors triggering the transition. In order to gain some insights into global transcriptome alterations in both host and pathogen during the two phases of the compatible interaction, disease transition was monitored using pathogenesis-related gene markers and H2O2 signature prior to RNA-Seq. Transcriptome analysis revealed that the slow symptomless growth was accompanied by minor metabolic responses and slightly suppressed defences in the host, whereas necrotrophic growth was associated with enhanced host responses involving energy metabolism, transport, signalling, defence and oxidative stress as well as a decrease in photosynthesis. The fungus expresses distinct classes of stage-specific genes encoding potential effectors, probably first suppressing plant defence responses/facilitating the symptomless growth and later triggering life style transition and inducing host necrosis/facilitating the necrotrophic growth. Transport, signalling, anti-oxidative stress mechanisms and apoplastic nutrient acquisition play important roles in the entire infection process of S. tritici. Our findings uncover systematic S. tritici-induced expression profiles of wheat related to specific fungal infection strategies and provide a transcriptome resource for studying both hosts and pathogens in plant-Dothideomycete interactions.	[Yang, Fen; Jorgensen, Hans J. L.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Li, Wanshun] BGI Tech BGI, Shenzhen, Peoples R China	University of Copenhagen; Beijing Genomics Institute (BGI)	Yang, F (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Frederiksberg, Denmark.	yangf@plen.ku.dk	Jørgensen, Hans Jørgen Lyngs/G-4946-2011	Jørgensen, Hans Jørgen Lyngs/0000-0002-5902-6550	Danish Research Council for Technology and Production [11-105997]	Danish Research Council for Technology and Production	This work was supported by a postdoctoral grant from the Danish Research Council for Technology and Production (11-105997) to Dr. Fen Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe T, 2012, MYCORRHIZA, V22, P471, DOI 10.1007/s00572-011-0424-9; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; do Amaral AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049904; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Kelley BS, 2010, PLANT J, V62, P357, DOI 10.1111/j.1365-313X.2010.04160.x; Kema GHJ, 2008, MOL PLANT MICROBE IN, V21, P1249, DOI 10.1094/MPMI-21-9-1249; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P777, DOI 10.1094/Phyto-86-777; Keon J, 2005, MOL PLANT PATHOL, V6, P527, DOI 10.1111/J.1364-3703.2005.00304.X; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; Kirsten S, 2012, MOL PLANT MICROBE IN, V25, P1314, DOI 10.1094/MPMI-03-12-0065-R; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kulye MS, 2012, J INTEGR AGR, V11, P1305; Lee SJ, 2010, PLANT SIGNAL BEHAV, V5, P769, DOI 10.4161/psb.5.6.11778; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Mehrabi R., 2006, THESIS WAGENINGEN U; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Ray S, 2003, PLANT MOL BIOL, V53, P741, DOI 10.1023/B:PLAN.0000019120.74610.52; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rohel EA, 2001, MOL PLANT MICROBE IN, V14, P156, DOI 10.1094/MPMI.2001.14.2.156; Rudd JJ, 2008, PLANT PHYSIOL, V147, P802, DOI 10.1104/pp.108.119511; Rudd JJ, 2010, FUNGAL GENET BIOL, V47, P19, DOI 10.1016/j.fgb.2009.10.009; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shetty NP, 2007, NEW PHYTOL, V174, P637, DOI 10.1111/j.1469-8137.2007.02026.x; Shetty NP, 2009, J EXP BOT, V60, P4287, DOI 10.1093/jxb/erp269; Shetty NP, 2003, PHYSIOL MOL PLANT P, V62, P333, DOI 10.1016/S0885-5765(03)00079-1; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yang F, 2013, MOL CELL PROTEOMICS, V12, P2497, DOI 10.1074/mcp.M113.027532; Yang F, 2012, MOL PLANT PATHOL, V13, P445, DOI 10.1111/j.1364-3703.2011.00759.x; Yang F, 2010, PROTEOMICS, V10, P3748, DOI 10.1002/pmic.201000243; Yang F, 2010, J PROTEOMICS, V73, P743, DOI 10.1016/j.jprot.2009.10.010	47	69	70	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81606	10.1371/journal.pone.0081606	http://dx.doi.org/10.1371/journal.pone.0081606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303057	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400073
J	Williams, LM; Timme-Laragy, AR; Goldstone, JV; McArthur, AG; Stegeman, JJ; Smolowitz, RM; Hahn, ME				Williams, Larissa M.; Timme-Laragy, Alicia R.; Goldstone, Jared V.; McArthur, Andrew G.; Stegeman, John J.; Smolowitz, Roxanna M.; Hahn, Mark E.			Developmental Expression of the Nfe2-Related Factor (Nrf) Transcription Factor Family in the Zebrafish, Danio rerio	PLOS ONE			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; GLOBIN GENE-EXPRESSION; IN-SITU HYBRIDIZATION; LIFE-STAGE TOXICITY; FACTOR NF-E2; OXIDATIVE-STRESS; FUNCTIONAL-CHARACTERIZATION; SWIMBLADDER DEVELOPMENT; OXIDIZED PHOSPHOLIPIDS; EMBRYONIC LETHALITY	Transcription factors in the CNC-bZIP family (NFE2, NRF1, NRF2 and NRF3) regulate genes with a wide range of functions in response to both physiological and exogenous signals, including those indicating changes in cellular redox status. Given their role in helping to maintain cellular homeostasis, it is imperative to understand the expression, regulation, and function of CNC-bZIP genes during embryonic development. We explored the expression and function of six nrf genes (nfe2, nrf1a, nrf1b, nrf2a, nrf2b, and nrf3) using zebrafish embryos as a model system. Analysis by microarray and quantitative RT-PCR showed that genes in the nrf family were expressed throughout development from oocytes to larvae. The spatial expression of nrf3 suggested a role in regulating the development of the brain, brachia and pectoral fins. Knock-down by morpholino anti-sense oligonucleotides suggested that none of the genes were necessary for embryonic viability, but nfe2 was required for proper cellular organization in the pneumatic duct and subsequent swim bladder function, as well as for proper formation of the otic vesicles. nrf genes were induced by the oxidant tert-butylhydroperoxide, and some of this response was regulated through family members Nrf2a and Nrf2b. Our results provide a foundation for understanding the role of nrf genes in normal development and in regulating the response to oxidative stress in vertebrate embryos.	[Williams, Larissa M.; Timme-Laragy, Alicia R.; Goldstone, Jared V.; Stegeman, John J.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Williams, Larissa M.] Bates Coll, Dept Biol, Lewiston, ME 04240 USA; [McArthur, Andrew G.] Andrew McArthur Consulting, Hamilton, ON, Canada; [Smolowitz, Roxanna M.] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA	Woods Hole Oceanographic Institution	Hahn, ME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mhahn@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; Williams, Larissa/0000-0001-8972-9735; McArthur, Andrew/0000-0002-1142-3063; Timme-Laragy, Alicia/0000-0002-8835-5038; Goldstone, Jared/0000-0002-9618-4961; Stegeman, John/0000-0001-8204-5357	National Institutes of Health [F32ES019832, F32ES017585, R01ES015912, R01ES016366]; J. Seward Johnson Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016366, F32ES017585, P42ES007381, R01ES015912, F32ES019832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Seward Johnson Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health grants F32ES019832 (to L. M. W.), F32ES017585 (to A. R. T.-L.), R01ES015912 (to J.J.S.), and R01ES016366 (to M. E. H.). This work was also supported by Walter A. and Hope Noyes Smith and the J. Seward Johnson Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Balasubramanian S, 2012, J BIOL CHEM; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 2001, BLOOD, V97, P2151, DOI 10.1182/blood.V97.7.2151; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chevillard G, 2011, BLOOD, V117, P2005, DOI 10.1182/blood-2010-02-271460; Chevillard G, 2010, FEBS LETT, V584, P923, DOI 10.1016/j.febslet.2010.01.028; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Han WN, 2012, J BIOL CHEM, V287, P18788, DOI 10.1074/jbc.M112.363614; Heideman W, 2005, CARDIOVASC TOXICOL, V5, P203, DOI 10.1385/CT:5:2:203; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jenny MJ, 2009, TOXICOL SCI, V110, P426, DOI 10.1093/toxsci/kfp116; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Jonsson ME, 2012, TOXICOL APPL PHARM, V265, P166, DOI 10.1016/j.taap.2012.09.023; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Korzh S, 2011, DEV BIOL, V359, P262, DOI 10.1016/j.ydbio.2011.08.024; Kubota A, 2011, TOXICOL APPL PHARM, V253, P244, DOI 10.1016/j.taap.2011.03.025; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Lassiter CS, 2007, ZEBRAFISH, V4, P49, DOI 10.1089/zeb.2006.9995; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Liao W, 1997, ZEBRAFISH GENE CLOCH, P381; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2010, BLOOD, V115, P677, DOI 10.1182/blood-2009-05-223107; Nakajima H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026884; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Pettazzoni P, 2011, FREE RADICAL BIO MED, V51, P1610, DOI 10.1016/j.freeradbiomed.2011.07.009; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pratt SJ, 2002, PHYSIOL GENOMICS, V11, P91, DOI 10.1152/physiolgenomics.00112.2001; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Sapede D, 2010, J NEUROSCI, V30, P3612, DOI 10.1523/JNEUROSCI.5109-09.2010; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Shen-Orr SS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r58; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; Sisman T, 2007, TOXICOL IND HEALTH, V23, P529, DOI 10.1177/0748233708089042; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Van de Peer Y, 2002, NUCLEIC ACIDS RES, V30, P109, DOI 10.1093/nar/30.1.109; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ward AC, 2002, FRONT BIOSCI, V7, pD827, DOI 10.2741/ward; Winata CL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-3; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; ZeRuth G, 2007, CHEM-BIOL INTERACT, V170, P100, DOI 10.1016/j.cbi.2007.07.003	87	19	20	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79574	10.1371/journal.pone.0079574	http://dx.doi.org/10.1371/journal.pone.0079574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24298298	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300096
J	Graindorge, M; Giustini, C; Kraut, A; Moyet, L; Curien, G; Matringe, M				Graindorge, Matthieu; Giustini, Cecile; Kraut, Alexandra; Moyet, Lucas; Curien, Gilles; Matringe, Michel			Three Different Classes of Aminotransferases Evolved Prephenate Aminotransferase Functionality in Arogenate-competent Microorganisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amination; Amino Acid; Bacterial Metabolism; Enzymes; Tyrosine	L-TYROSINE BIOSYNTHESIS; AROMATIC-AMINO-ACIDS; L-PHENYLALANINE; ARABIDOPSIS-THALIANA; LYSINE BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; REGULATORY PROPERTIES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; DEHYDROGENASE	Background: The genes encoding prephenate aminotransferase in arogenate-competent microorganisms for tyrosine synthesis are still unknown. Results: Three different classes of aminotransferase use prephenate as an amino acceptor. Conclusion: Prephenate aminotransferase functionality has arisen more than once during evolution. Significance: This first identification of prephenate aminotransferases in arogenate competent microorganisms affords a better understanding of the origin and fixation of the arogenate route during evolution. The aromatic amino acids phenylalanine and tyrosine represent essential sources of high value natural aromatic compounds for human health and industry. Depending on the organism, alternative routes exist for their synthesis. Phenylalanine and tyrosine are synthesized either via phenylpyruvate/4-hydroxyphenylpyruvate or via arogenate. In arogenate-competent microorganisms, an aminotransferase is required for the transamination of prephenate into arogenate, but the identity of the genes is still unknown. We present here the first identification of prephenate aminotransferases (PATs) in seven arogenate-competent microorganisms and the discovery that PAT activity is provided by three different classes of aminotransferase, which belong to two different fold types of pyridoxal phosphate enzymes: an aspartate aminotransferase subgroup 1 in tested - and -proteobacteria, a branched-chain aminotransferase in tested cyanobacteria, and an N-succinyldiaminopimelate aminotransferase in tested actinobacteria and in the -proteobacterium Nitrosomonas europaea. Recombinant PAT enzymes exhibit high activity toward prephenate, indicating that the corresponding genes encode bona fide PAT. PAT functionality was acquired without other modification of substrate specificity and is not a general catalytic property of the three classes of aminotransferases.	[Graindorge, Matthieu; Giustini, Cecile; Moyet, Lucas; Curien, Gilles; Matringe, Michel] CEA, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Graindorge, Matthieu] Univ Grenoble Alpes, F-38054 Grenoble, France; [Giustini, Cecile; Matringe, Michel] INRA, USC1359, F-38054 Grenoble, France; [Kraut, Alexandra] INSERM, Lab Etud Dynam Proteomes, U880, F-38054 Grenoble, France; [Moyet, Lucas; Curien, Gilles] CNRS, UMR 5168, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Curien, G (corresponding author), CNRS, CEA iRTSV, Lab Physiol Cellulaire & Vegetale, UMR 5168, 17 Rue Martyrs, F-38054 Grenoble, France.	gilles.curien@cea.fr; michel.matringe@cea.fr			French National Institute for Agricultural Research (INRA); CNRS; Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); University of Grenoble Alpes; GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology) [ANR-10-LABEX-04]	French National Institute for Agricultural Research (INRA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); University of Grenoble Alpes; GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology)	This work was supported in part by the French National Institute for Agricultural Research (INRA), CNRS, and the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA).; Supported by a Ph.D. fellowship from the University of Grenoble Alpes.; Supported by a grant from the GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology: ANR-10-LABEX-04).	ABOUZEID A, 1995, APPL ENVIRON MICROB, V61, P1298, DOI 10.1128/AEM.61.4.1298-1302.1995; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Berger BJ, 2003, J BACTERIOL, V185, P2418, DOI 10.1128/JB.185.8.2418-2431.2003; Bernay B, 2009, MOL CELL PROTEOMICS, V8, P946, DOI 10.1074/mcp.M800501-MCP200; Bonner CA, 2008, MICROBIOL MOL BIOL R, V72, P13, DOI 10.1128/MMBR.00026-07; BYNG G, 1981, PHYTOCHEMISTRY, V20, P1289, DOI 10.1016/0031-9422(81)80023-4; CHAMPNEY WS, 1970, J BIOL CHEM, V245, P3763; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; Christendat D, 1999, BIOCHEMISTRY-US, V38, P4782, DOI 10.1021/bi982673o; CONNELLY JA, 1986, Z NATURFORSCH C, V41, P69; Dewick PM, 1998, NAT PROD REP, V15, P17; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; Fuchs TM, 2000, J BACTERIOL, V182, P3626, DOI 10.1128/JB.182.13.3626-3631.2000; Garcia I, 1997, BIOCHEM J, V325, P761, DOI 10.1042/bj3250761; Graindorge M, 2010, FEBS LETT, V584, P4357, DOI 10.1016/j.febslet.2010.09.037; HALL GC, 1982, J BACTERIOL, V149, P65, DOI 10.1128/JB.149.1.65-78.1982; Hartmann M, 2003, J BIOTECHNOL, V104, P199, DOI 10.1016/S0168-1656(03)00156-1; Haslam E., 1993, SHIKIMIC ACID METABO; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; JENSEN RA, 1975, NATURE, V254, P667, DOI 10.1038/254667a0; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; KOCH GLE, 1971, BIOCHIM BIOPHYS ACTA, V229, P795, DOI 10.1016/0005-2795(71)90298-4; Kraut A, 2009, J PROTEOME RES, V8, P3778, DOI 10.1021/pr900095u; Large P. J., 1986, YEAST, V2, P1; Legrand P, 2006, STRUCTURE, V14, P767, DOI 10.1016/j.str.2006.01.006; LINDSTEDT S, 1977, BIOCHEMISTRY-US, V16, P3369, DOI 10.1021/bi00634a013; Maeda H, 2011, NAT CHEM BIOL, V7, P19, DOI [10.1038/nchembio.485, 10.1038/NCHEMBIO.485]; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; PATEL N, 1977, J BIOL CHEM, V252, P5839; Razal RA, 1996, PHYTOCHEMISTRY, V41, P31, DOI 10.1016/0031-9422(95)00628-1; Rippert P, 2002, PLANT MOL BIOL, V48, P361, DOI 10.1023/A:1014018926676; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; STENMARK SL, 1974, NATURE, V247, P290, DOI 10.1038/247290a0; SUBRAMANIAM P, 1994, MICROBIOL-SGM, V140, P3431, DOI 10.1099/13500872-140-12-3431; TURNBULL J, 1990, BIOCHEMISTRY-US, V29, P10255, DOI 10.1021/bi00496a015; ZHAO G, 1993, EUR J BIOCHEM, V212, P157, DOI 10.1111/j.1432-1033.1993.tb17646.x	43	13	16	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3198	3208		10.1074/jbc.M113.486480	http://dx.doi.org/10.1074/jbc.M113.486480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24302739	Green Published, hybrid			2022-12-25	WOS:000331368700009
J	Valderrama, JA; Shingler, V; Carmona, M; Diaz, E				Andres Valderrama, J.; Shingler, Victoria; Carmona, Manuel; Diaz, Eduardo			AccR Is a Master Regulator Involved in Carbon Catabolite Repression of the Anaerobic Catabolism of Aromatic Compounds in Azoarcus sp CIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Gene Regulation; Microbiology; Protein-DNA Interaction; Signal Transduction; Transcription Regulation; Anaerobic Degradation; Azoarcus; Carbon Catabolite Repression	CRC GLOBAL REGULATOR; GRAM-NEGATIVE BACTERIA; SP STRAIN CIB; PSEUDOMONAS-PUTIDA; RESPONSE REGULATOR; ESCHERICHIA-COLI; CENTRAL PATHWAY; SUICIDE VECTOR; EXPRESSION; BENZOATE	Here we characterized the first known transcriptional regulator that accounts for carbon catabolite repression (CCR) control of the anaerobic catabolism of aromatic compounds in bacteria. The AccR response regulator of Azoarcus sp. CIB controls succinate-responsive CCR of the central pathways for the anaerobic catabolism of aromatics by this strain. Phosphorylation of AccR to AccR-P triggers a monomer-to-dimer transition as well as the ability to bind to the target promoter and causes repression both in vivo and in vitro. Substitution of the Asp(60) phosphorylation target residue of the N-terminal receiver motif of AccR to a phosphomimic Glu residue generates a constitutively active derivative that behaves as a superrepressor of the target genes. AccR-P binds in vitro to a conserved inverted repeat (ATGCA-N-6-TGCAT) present at two different locations within the P-N promoter of the bzd genes for anaerobic benzoate degradation. Because the DNA binding-proficient C-terminal domain of AccR is monomeric, we propose an activation mechanism in which phosphorylation of Asp(60) of AccR alleviates interdomain repression mediated by the N-terminal domain. The presence of AccR-like proteins encoded in the genomes of other -proteobacteria of the Azoarcus/Thauera group further suggests that AccR constitutes a master regulator that controls anaerobic CCR in these bacteria.	[Andres Valderrama, J.; Carmona, Manuel; Diaz, Eduardo] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Shingler, Victoria] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Umea University	Diaz, E (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Valderrama, Jonathan Andres/AAC-1098-2021; Diaz, Eduardo/F-8605-2016	Diaz, Eduardo/0000-0002-9731-6524; Shingler, Victoria/0000-0002-7349-1678; Valderrama Traslavina, J. Andres/0000-0001-7440-4225; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2012-39501]; European Union [311815]; Swedish Research Council [621-2011-4791]; Ministry of Economy and Competitiveness of Spain	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, CSD2007-00005, and BIO2012-39501), European Union FP7 Grant 311815, and Swedish Research Council Grant 621-2011-4791.	Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Felsenstein J., 1993, PHYLYP PHYLOGENETIC; Fonseca P, 2013, ENVIRON MICROBIOL, V15, P24, DOI 10.1111/j.1462-2920.2012.02708.x; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Heider J, 1998, ARCH MICROBIOL, V170, P120, DOI 10.1007/s002030050623; Hernandez-Arranz S, 2013, ENVIRON MICROBIOL, V15, P227, DOI 10.1111/j.1462-2920.2012.02863.x; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurashima-Ito K, 2005, BIOCHEMISTRY-US, V44, P14835, DOI 10.1021/bi0509043; Lan CY, 1998, J BACTERIOL, V180, P171, DOI 10.1128/JB.180.1.171-174.1998; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; MACGREGOR CH, 1991, J BACTERIOL, V173, P7204, DOI 10.1128/jb.173.22.7204-7212.1991; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Marques S, 2006, CURR OPIN BIOTECH, V17, P50, DOI 10.1016/j.copbio.2005.12.001; Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200; Maxam A M, 1980, Methods Enzymol, V65, P499; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milojevic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064609; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Moreno R, 2012, MOL MICROBIOL, V83, P24, DOI 10.1111/j.1365-2958.2011.07912.x; Moreno R, 2010, J BIOL CHEM, V285, P24412, DOI 10.1074/jbc.M110.126615; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Ohtsubo Y, 2006, MOL MICROBIOL, V60, P1563, DOI 10.1111/j.1365-2958.2006.05197.x; Petruschka L, 2001, MOL GENET GENOMICS, V266, P199, DOI 10.1007/s004380100539; Pfluger K, 2008, J BACTERIOL, V190, P3374, DOI 10.1128/JB.02002-07; Prieto MA, 2004, FEMS MICROBIOL REV, V28, P503, DOI 10.1016/j.femsre.2004.04.004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trautwein K, 2012, J BACTERIOL, V194, P518, DOI 10.1128/JB.05072-11; Valentini M, 2013, ENVIRON MICROBIOL, V15, P1707, DOI 10.1111/1462-2920.12056	57	14	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1892	1904		10.1074/jbc.M113.517714	http://dx.doi.org/10.1074/jbc.M113.517714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302740	Green Published, hybrid			2022-12-25	WOS:000331130200002
J	Choi, YH; Jin, GY; Li, LC; Yan, GH				Choi, Yun Ho; Jin, Guang Yu; Li, Liang Chang; Yan, Guang Hai			Inhibition of Protein Kinase C Delta Attenuates Allergic Airway Inflammation through Suppression of PI3K/Akt/mTOR/HIF-1 Alpha/VEGF Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; ADHESION MOLECULE-1 ICAM-1; INDUCIBLE FACTOR-I; EPITHELIAL-CELLS; MAMMALIAN TARGET; RAPAMYCIN MTOR; E-SELECTIN; ASTHMA; EXPRESSION	Vascular endothelial growth factor (VEGF) is supposed to contribute to the pathogenesis of allergic airway disease. VEGF expression is regulated by a variety of stimuli such as nitric oxide, growth factors, and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models. Based on these observations, we have investigated whether mTOR is associated with HIF-1 alpha-mediated VEGF expression in allergic asthma. In studies with the mTOR inhibitor rapamycin, we have elucidated the stimulatory role of a mTOR-HIF-1 alpha-VEGF axis in allergic response. Next, the mechanisms by which mTOR is activated to modulate this response have been evaluated. mTOR is known to be regulated by phosphoinositide 3-kinase (PI3K)/Akt or protein kinase C-delta (PKC delta) in various cell types. Consistent with these, our results have revealed that suppression of PKC d by rottlerin leads to the inhibition of PI3K/Akt activity and the subsequent blockade of a mTOR-HIF-1a-VEGF module, thereby attenuating typical asthmatic attack in a murine model. Thus, the present data indicate that PKC d is necessary for the modulation of the PI3K/Akt/mTOR signaling cascade, resulting in a tight regulation of HIF-1a activity and VEGF expression. In conclusion, PKC d may represent a valuable target for innovative therapeutic treatment of allergic airway disease.	[Choi, Yun Ho] Chonbuk Natl Univ, Inst Med Sci, Sch Med, Dept Anat, Jeonju, Jeonbuk, South Korea; [Jin, Guang Yu] Yanbian Univ Hosp, Yanji, Peoples R China; [Li, Liang Chang; Yan, Guang Hai] Yanbian Univ, Sch Basic Med Sci, Dept Anat & Histol & Embryol, Yanji, Jilin, Peoples R China	Jeonbuk National University; Yanbian University; Yanbian University	Yan, GH (corresponding author), Yanbian Univ, Sch Basic Med Sci, Dept Anat & Histol & Embryol, Yanji, Jilin, Peoples R China.	ghyan@ybu.edu.cn			National Natural Science Foundation of China [81060003, 81260665, 81160176]; Chonbuk National University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chonbuk National University	This paper was supported by the National Natural Science Foundation of China (81060003, 81260665, and 81160176; http://www.nsfc.gov.cn/Portal0/default152.htm) and by research funds of Chonbuk National University in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert SE, 1999, AM J PHYSIOL-LUNG C, V277, pL457, DOI 10.1152/ajplung.1999.277.3.L457; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bove PF, 2007, AM J RESP CELL MOL, V36, P138, DOI 10.1165/rcmb.2006-0253SM; Boyce JA, 2009, J ALLERGY CLIN IMMUN, V123, P569, DOI 10.1016/j.jaci.2009.01.041; Brannan JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00460; Cho SH, 2004, J IMMUNOL, V173, P624, DOI 10.4049/jimmunol.173.1.624; Choi IW, 2004, INT IMMUNOPHARMACOL, V4, P1817, DOI 10.1016/j.intimp.2004.07.030; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dempsey EC, 2007, PHARMACOL RES, V55, P545, DOI 10.1016/j.phrs.2007.04.010; Dey D, 2006, MOL CELL ENDOCRINOL, V246, P60, DOI 10.1016/j.mce.2005.12.014; Eynott PR, 2003, IMMUNOLOGY, V109, P461, DOI 10.1046/j.1365-2567.2003.01672.x; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gibbs BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022502; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Hamzaoui A, 2001, MEDIAT INFLAMM, V10, P339, DOI 10.1080/09629350120102361; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jiang H, 2010, AM J PHYSIOL-LUNG C, V298, pL660, DOI 10.1152/ajplung.00394.2009; Kanazawa H, 2007, RECENT PATENTS INFLA, V1, P1, DOI 10.2174/187221307779815066; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Korfhagen TR, 2009, AM J RESP CELL MOL, V41, P562, DOI 10.1165/rcmb.2008-0377OC; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Langlois A, 2009, J LEUKOCYTE BIOL, V85, P656, DOI 10.1189/jlb.0808492; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee Chun Geun, 2011, Proc Am Thorac Soc, V8, P512, DOI 10.1513/pats.201102-018MW; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P403, DOI 10.1016/j.jaci.2006.04.041; Lee YC, 2001, J ALLERGY CLIN IMMUN, V107, P1106, DOI 10.1067/mai.2001.115628; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Luque A, 2008, FRONT BIOSCI, V13, P6483, DOI 10.2741/3168; McCullagh A, 2010, PEDIATR PULM, V45, P1, DOI 10.1002/ppul.21135; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200; Miyazawa M, 2009, PATHOL INT, V59, P19, DOI 10.1111/j.1440-1827.2008.02320.x; Mizokami K, 2006, J SURG ONCOL, V94, P149, DOI 10.1002/jso.20568; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Mushaben EM, 2011, J IMMUNOL, V187, P5756, DOI 10.4049/jimmunol.1102133; Nagai H, 1997, CLIN EXP ALLERGY, V27, P218; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Tamaoki J, 1999, AM J PHYSIOL-LUNG C, V276, pL351, DOI 10.1152/ajplung.1999.276.2.L351; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Walters EH, 2008, CURR OPIN ALLERGY CL, V8, P39, DOI 10.1097/ACI.0b013e3282f42696; Wan XL, 2006, NEOPLASIA, V8, P394, DOI 10.1593/neo.05820; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; Zhai YX, 2008, MOL CELL BIOL, V28, P7414, DOI 10.1128/MCB.01237-08; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	60	70	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81773	10.1371/journal.pone.0081773	http://dx.doi.org/10.1371/journal.pone.0081773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312355	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300050
J	Koval, P; Ogrinz, B; Kuppens, P; Van den Bergh, O; Tuerlinckx, F; Sutterlin, S				Koval, Peter; Ogrinz, Barbara; Kuppens, Peter; Van den Bergh, Omer; Tuerlinckx, Francis; Suetterlin, Stefan			Affective Instability in Daily Life Is Predicted by Resting Heart Rate Variability	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; ECOLOGICAL MOMENTARY ASSESSMENT; INDIVIDUAL-DIFFERENCES; EMOTION REGULATION; INTRAINDIVIDUAL VARIABILITY; NEUROVISCERAL INTEGRATION; EXPRESSIVE SUPPRESSION; COGNITIVE REAPPRAISAL; SUCCESSIVE DIFFERENCE; NEGATIVE AFFECT	Previous research has shown that being affectively unstable is an indicator of several forms of psychological maladjustment. However, little is known about the mechanisms underlying affective instability. Our research aims to examine the possibility that being prone to extreme fluctuations in one's feelings is related to maladaptive emotion regulation. We investigated this hypothesis by relating affective instability, assessed in daily life using the experience sampling method, to self-reported emotion regulation strategies and to parasympathetically mediated heart rate variability (HRV), a physiological indicator of emotion regulation capacity. Results showed that HRV was negatively related to instability of positive affect (as measured by mean square successive differences), indicating that individuals with lower parasympathetic tone are emotionally less stable, particularly for positive affect.	[Koval, Peter; Ogrinz, Barbara; Kuppens, Peter; Van den Bergh, Omer; Tuerlinckx, Francis; Suetterlin, Stefan] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Suetterlin, Stefan] Lillehammer Univ Coll, Dept Psychol, Lillehammer, Norway; [Suetterlin, Stefan] Oslo Univ Hosp, Rikshosp, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway	KU Leuven; Inland Norway University of Applied Sciences; University of Oslo; National Hospital Norway	Sutterlin, S (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium.	stefan.sutterlin@hil.no	Koval, Peter/ABB-9116-2020; kuppens, peter/DHG-5268-2022	Koval, Peter/0000-0003-2460-0943; kuppens, peter/0000-0002-2363-2356; Van den Bergh, Omer/0000-0001-6394-7363; Sutterlin, Stefan/0000-0002-4337-1296; tuerlinckx, francis/0000-0002-1775-7654	KU Leuven Research Council [GOA/10/02, OT/11/31]; ESA-PRODEX grant	KU Leuven Research Council(KU Leuven); ESA-PRODEX grant	This research was supported by KU Leuven Research Council Grant GOA/10/02 and OT/11/31 and ESA-PRODEX grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; APA, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; ASENDORPF JB, 1983, J PERS SOC PSYCHOL, V45, P1334, DOI 10.1037/0022-3514.45.6.1334; Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Barrett D. J., 2000, EXPERIENCE SAMPLING; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Berntson GG, 2005, PSYCHOPHYSIOLOGY, V42, P246, DOI 10.1111/j.1469-8986.2005.00277.x; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Berntson GG, 1998, PSYCHOPHYSIOLOGY, V35, P127, DOI 10.1111/1469-8986.3510127; Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen H, 2003, BIPOLAR DISORD, V5, P138, DOI 10.1034/j.1399-5618.2003.00027.x; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Demaree HA, 2004, BRAIN COGNITION, V56, P14, DOI 10.1016/j.bandc.2004.05.001; Ebner-Priemer UW, 2007, PSYCHIAT RES, V150, P265, DOI 10.1016/j.psychres.2006.04.014; Ebner-Priemer UW, 2009, PSYCHOL ASSESSMENT, V21, P463, DOI 10.1037/a0017075; Ebner-Priemer UW, 2009, J ABNORM PSYCHOL, V118, P195, DOI 10.1037/a0014868; Eid M, 1999, J PERS SOC PSYCHOL, V76, P662, DOI 10.1037/0022-3514.76.4.662; Fabes RA, 1997, J PERS SOC PSYCHOL, V73, P1107, DOI 10.1037/0022-3514.73.5.1107; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; Geisler FCM, 2010, PERS INDIV DIFFER, V49, P723, DOI 10.1016/j.paid.2010.06.015; Goedhart AD, 2007, PSYCHOPHYSIOLOGY, V44, P203, DOI 10.1111/j.1469-8986.2006.00490.x; GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gruber J, 2008, EMOTION, V8, P23, DOI 10.1037/1528-3542.8.1.23; Haga SM, 2009, J HAPPINESS STUD, V10, P271, DOI 10.1007/s10902-007-9080-3; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hemenover SH, 2008, EMOTION, V8, P468, DOI 10.1037/1528-3542.8.4.468; Henry BL, 2010, J PSYCHIATR RES, V44, P168, DOI 10.1016/j.jpsychires.2009.07.011; Hollenstein T, 2013, EMOT REV, V5, P397, DOI 10.1177/1754073913484181; Ingjaldsson JT, 2003, BIOL PSYCHIAT, V54, P1427, DOI 10.1016/S0006-3223(02)01926-1; Ingram R. E., 2009, HDB DEPRESSION, P69; Irina E, 2009, CURR PSYCHIAT REP, V11, P74, DOI 10.1007/s11920-009-0012-2; Jahng S, 2008, PSYCHOL METHODS, V13, P354, DOI 10.1037/a0014173; JONES CJ, 2006, OXFORD HDB METHODS P, P3; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Kok BE, 2010, BIOL PSYCHOL, V85, P432, DOI 10.1016/j.biopsycho.2010.09.005; KOVAL P, 2013, EMOTION; Kuo JR, 2009, J ABNORM PSYCHOL, V118, P531, DOI 10.1037/a0016392; Kuppens P, 2007, EMOTION, V7, P262, DOI 10.1037/1528-3542.7.2.262; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; Kuppens P, 2010, PSYCHOL SCI, V21, P984, DOI 10.1177/0956797610372634; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; McConville C, 1999, PERS INDIV DIFFER, V26, P65; McConville C, 1996, CURR PSYCHOL, V14, P329, DOI 10.1007/BF02686921; McRae K, 2013, SOC PERSONAL PSYCHOL, V7, P289, DOI 10.1111/spc3.12027; Miller JD, 2006, AM J PSYCHIAT, V163, P839, DOI 10.1176/appi.ajp.163.5.839; Moore SA, 2008, BEHAV RES THER, V46, P993, DOI 10.1016/j.brat.2008.05.001; Neumann A, 2011, J ABNORM CHILD PSYCH, V39, P657, DOI 10.1007/s10802-011-9509-3; Nezlek J.B., 2012, HDB RES METHODS STUD, P357, DOI DOI 10.1080/10705511.2011.557329; Nezlek JB, 2008, J PERS, V76, P561, DOI 10.1111/j.1467-6494.2008.00496.x; Nunan D, 2008, EUR J APPL PHYSIOL, V103, P529, DOI 10.1007/s00421-008-0742-6; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Oveis C, 2009, EMOTION, V9, P265, DOI 10.1037/a0015383; Park G, 2012, EMOTION, V12, P1292, DOI 10.1037/a0028528; Peeters F, 2006, EMOTION, V6, P383, DOI 10.1037/1528-3542.6.3.383; Porges S W, 1994, Monogr Soc Res Child Dev, V59, P167, DOI 10.2307/1166144; Pu J, 2010, BIOL PSYCHOL, V84, P531, DOI 10.1016/j.biopsycho.2009.07.006; Putnam KM, 2005, DEV PSYCHOPATHOL, V17, P899, DOI 10.1017/S0954579405050431; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rhodewalt F, 1998, PERS SOC PSYCHOL B, V24, P75, DOI 10.1177/0146167298241006; Rocke C, 2009, PSYCHOL AGING, V24, P863, DOI 10.1037/a0016276; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JJ, 2007, J ABNORM PSYCHOL, V116, P578, DOI 10.1037/0021-843X.116.3.578; Singh JP, 1999, CIRCULATION, V99, P2251, DOI 10.1161/01.CIR.99.17.2251; Sinnreich R, 1998, HEART, V80, P156, DOI 10.1136/hrt.80.2.156; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thompson R.A., 2007, HDB EMOTION REGULATI, P249, DOI DOI 10.1080/00140130600971135; Trull TJ, 2008, J ABNORM PSYCHOL, V117, P647, DOI 10.1037/a0012532; Vasilev CA, 2009, J CHILD PSYCHOL PSYC, V50, P1357, DOI 10.1111/j.1469-7610.2009.02172.x; Verduyn P, 2011, EMOTION, V11, P20, DOI 10.1037/a0021239; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Zeigler-Hill V, 2006, J SOC CLIN PSYCHOL, V25, P668, DOI 10.1521/jscp.2006.25.6.668	84	90	91	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81536	10.1371/journal.pone.0081536	http://dx.doi.org/10.1371/journal.pone.0081536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261MX	24312315	gold, Green Published			2022-12-25	WOS:000327670300035
J	Mishra, D; Vishnupriya, MR; Anil, MG; Konda, K; Raj, Y; Sonti, RV				Mishra, Deo; Vishnupriya, Manne Ramachander; Anil, Madhusoodana Girija; Konda, Kotilingam; Raj, Yog; Sonti, Ramesh V.			Pathotype and Genetic Diversity amongst Indian Isolates of Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							BACTERIAL-BLIGHT RESISTANCE; MARKER-ASSISTED SELECTION; DISEASE-SUSCEPTIBILITY GENE; RICE VARIETY; POPULATION; INDUCTION; PATHOGEN; TREES; RFLP; XA13	A number of rice resistance genes, called Xa genes, have been identified that confer resistance against various strains of Xanthomonas oryzae pv. oryzae (Xoo), the causal agent of bacterial blight. An understanding of pathotype diversity within the target pathogen population is required for identifying the Xa genes that are to be deployed for development of resistant rice cultivars. Among 1024 isolates of Xoo collected from 20 different states of India, 11 major pathotypes were distinguished based on their reaction towards ten Xa genes (Xa1, Xa3, Xa4, xa5, Xa7, xa8, Xa10, Xa11, xa13, Xa21). Isolates belonging to pathotype III showing incompatible interaction towards xa8, xa13 and Xa21 and compatible interaction towards the rest of Xa genes formed the most frequent (41%) and widely distributed pathotype. The vast majority of the assayed Xoo isolates were incompatible with one or more Xa genes. Exceptionally, the isolates of pathotype XI were virulent on all Xa genes, but have restricted distribution. Considering the individual R-genes, Xa21 appeared as the most broadly effective, conferring resistance against 88 % of the isolates, followed in decreasing order by xa13 (84 %), xa8 (64 %), xa5 (30 %), Xa7 (17 %) and Xa4 (14 %). Fifty isolates representing all the eleven pathotypes were analyzed by southern hybridization to determine their genetic relatedness using the IS1112 repeat element of Xoo. Isolates belonging to pathotype XI were the most divergent. The results suggest that one RFLP haplotype that is widely distributed all over India and is represented in strains from five different pathotypes might be an ancestral hapfotype. A rice line with xa5, xa13 and Xa21 resistance genes is resistant to all strains, including those belonging to pathotype XI. This three gene combination appears to be the most suitable Xa gene combination to be deployed in Indian rice cultivars.	[Mishra, Deo; Konda, Kotilingam; Raj, Yog] Bayer BioSci, Hyderabad, Andhra Pradesh, India; [Vishnupriya, Manne Ramachander; Anil, Madhusoodana Girija; Sonti, Ramesh V.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Bayer AG; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sonti, RV (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	sonti@ccmb.res.in		Girija, Anil Madhusoodana/0000-0003-0809-506X	AMAAS project of the Indian Council of Agricultural Research, Department of Biotechnology; Plant-Microbe and Soil Interactions (PMSI) project of the Council of Scientific and Industrial Research (CSIR); CSIR	AMAAS project of the Indian Council of Agricultural Research, Department of Biotechnology; Plant-Microbe and Soil Interactions (PMSI) project of the Council of Scientific and Industrial Research (CSIR); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants to RVS from the AMAAS project of the Indian Council of Agricultural Research, Department of Biotechnology and the Plant-Microbe and Soil Interactions (PMSI) project of the Council of Scientific and Industrial Research (CSIR). MGA was supported by a doctoral fellowship from the CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIKARI TB, 1995, APPL ENVIRON MICROB, V61, P966, DOI 10.1128/AEM.61.3.966-971.1995; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Ellson J, 2004, MATH VIS, P127; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Huang N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/s001220050565; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Jeung JU, 2006, PHYTOPATHOLOGY, V96, P867, DOI 10.1094/PHYTO-96-0867; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; LEACH JE, 1992, APPL ENVIRON MICROB, V58, P2188, DOI 10.1128/AEM.58.7.2188-2195.1992; LEACH JE, 1995, CURR OPIN BIOTECH, V6, P298, DOI 10.1016/0958-1669(95)80051-4; Li ZK, 2001, GENETICS, V159, P757; Liu-Nino DO, 2006, MOL PLANT PATHOL, V7, P303, DOI [10.1111/j.1364-3703.2006.00344.x.PubMed:20507449, DOI 10.1111/J.1364-3703.2006.00344.X.PUBMED:20507449]; Lore JS, 2011, J PHYTOPATHOL, V159, P479, DOI 10.1111/j.1439-0434.2011.01789.x; NELSON RJ, 1994, APPL ENVIRON MICROB, V60, P3275, DOI 10.1128/AEM.60.9.3275-3283.1994; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rajeshwari R, 2000, J BACTERIOL, V182, P4797, DOI 10.1128/JB.182.17.4797-4802.2000; Reddy A, 1980, BREEDING BACTERIAL L, P5; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Sambrook J., 2002, MOL CLONING LAB MANU; Seshu DV, 1989, SALIENT FINDINGS MUL, P167; Shanti ML, 2001, PLANT DIS, V85, P506, DOI 10.1094/PDIS.2001.85.5.506; SINGH RA, 1980, TROP PEST MANAGE, V26, P21, DOI 10.1080/09670878009414278; Singh S, 2001, THEOR APPL GENET, V102, P1011, DOI 10.1007/s001220000495; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Sundaram Raman M., 2009, Biotechnology Journal, V4, P400, DOI 10.1002/biot.200800310; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yashitola J, 1997, PHYTOPATHOLOGY, V87, P760, DOI 10.1094/PHYTO.1997.87.7.760; Yashitola J, 2000, PLANT DIS, V84, P465, DOI 10.1094/PDIS.2000.84.4.465; YOSHIMURA S, 1995, MOL BREEDING, V1, P375, DOI 10.1007/BF01248415	34	40	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81996	10.1371/journal.pone.0081996	http://dx.doi.org/10.1371/journal.pone.0081996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312391	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300063
J	Tsurumura, T; Qiu, H; Yoshida, T; Tsumori, Y; Hatakeyama, D; Kuzuhara, T; Tsuge, H				Tsurumura, Toshiharu; Qiu, Hao; Yoshida, Toru; Tsumori, Yayoi; Hatakeyama, Dai; Kuzuhara, Takashi; Tsuge, Hideaki			Conformational Polymorphism of m(7)GTP in Crystal Structure of the PB2 Middle Domain from Human Influenza A Virus	PLOS ONE			English	Article							CAP-BINDING; POLYMERASE; SUBUNIT; ENDONUCLEASE; MODEL; REPLICATION; SITE	Influenza pandemics with human-to-human transmission of the virus are of great public concern, It is now recognized that a number of factors are necessary for human transmission and virulence, including several key mutations within the PI:32 subunit of RNA-dependent RNA polymerase, The structure of the middle domain in PB2 has been revealed with or without m(7)GTP, thus the middle domain is considered to be novel target for structure-based drug design. Here we report the crystal structure of the middle domain of H1N1 PB2 with or without m7GTP at 1.9 angstrom and 2.0 angstrom resolution, respectively, which has two mutations (P453H, I471T) to increase electrostatic potential and solubility. Here we report the m7GTP has unique conformation differ from the reported structure. 7-methyl-guanine is fixed in the pocket, but particularly significant change is seen in ribose and triphosphate region: the buried 7-methyl-guanine indeed binds in the pocket forming by H357, F404, E361 and K376 but the triphosphate continues directly to the outer domain. The presented conformation of m(7)GTP may be a clue for the anti-influenza drug-design.	[Tsurumura, Toshiharu; Qiu, Hao; Yoshida, Toru; Tsumori, Yayoi; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Hatakeyama, Dai; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 770, Japan	Kyoto Sangyo University; Tokushima Bunri University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021; Qiu, Hao/HGU-4490-2022; ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Tsuge, Hideaki/0000-0003-0166-9163; Kuzuhara, Takashi/0000-0003-0565-6060	Strategic Research Foundation; MEXT/JSPS KAKENHI of Japan [25121733]	Strategic Research Foundation; MEXT/JSPS KAKENHI of Japan	This work supported in part by a Strategic Research Foundation Grant-aided Project for Private Universities and Grant-in-Aid for Scientific Research on Innovative Areas, MEXT/JSPS KAKENHI grant number 25121733 of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; DeLano L, 2002, PYMOL USERS MANUAL; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Elton D, 2005, CURRENT TOPICS INFLU; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z., 1997, PROCESSING XRAY DIFF; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82020	10.1371/journal.pone.0082020	http://dx.doi.org/10.1371/journal.pone.0082020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312396	Green Submitted, Green Published, gold			2022-12-25	WOS:000327670300068
J	Guo, SY; Lucas, RM; Ponsonby, AL				Guo, Shuyu; Lucas, Robyn M.; Ponsonby, Anne-Louise		Ausimmune Investigator Grp	A Novel Approach for Prediction of Vitamin D Status Using Support Vector Regression	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; CANCER INCIDENCE; MACHINES; MULTICENTER; MORTALITY; TUTORIAL; SCORE; RISK	Background: Epidemiological evidence suggests that vitamin D deficiency is linked to various chronic diseases. However direct measurement of serum 25-hydroxyvitamin D (25(OH) D) concentration, the accepted biomarker of vitamin D status, may not be feasible in large epidemiological studies. An alternative approach is to estimate vitamin D status using a predictive model based on parameters derived from questionnaire data. In previous studies, models developed using Multiple Linear Regression (MLR) have explained a limited proportion of the variance and predicted values have correlated only modestly with measured values. Here, a new modelling approach, nonlinear radial basis function support vector regression (RBF SVR), was used in prediction of serum 25(OH) D concentration. Predicted scores were compared with those from a MLR model. Methods: Determinants of serum 25(OH) D in Caucasian adults (n = 494) that had been previously identified were modelled using MLR and RBF SVR to develop a 25(OH) D prediction score and then validated in an independent dataset. The correlation between actual and predicted serum 25(OH) D concentrations was analysed with a Pearson correlation coefficient. Results: Better correlation was observed between predicted scores and measured 25(OH) D concentrations using the RBF SVR model in comparison with MLR (Pearson correlation coefficient: 0.74 for RBF SVR; 0.51 for MLR). The RBF SVR model was more accurately able to identify individuals with lower 25(OH) D levels (< 75 nmol/L). Conclusion: Using identical determinants, the RBF SVR model provided improved prediction of serum 25(OH) D concentrations and vitamin D deficiency compared with a MLR model, in this dataset.	[Guo, Shuyu; Lucas, Robyn M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Ponsonby, Anne-Louise] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Australian National University; Murdoch Children's Research Institute	Guo, SY (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Shuyu.guo@anu.edu.au	Ponsonby, Anne-Louise/AAE-4351-2019; Valery, Patricia/AAV-5448-2020; van der Mei, Ingrid/J-7457-2014	Valery, Patricia/0000-0002-8823-3006; Lucas, Robyn/0000-0003-2736-3541; Pender, Michael/0000-0003-3792-3768; Ponsonby, Anne-Louise/0000-0002-6581-3657; Dear, Keith/0000-0002-0788-7404; van der Mei, Ingrid/0000-0001-9009-7472; Kilpatrick, Trevor/0000-0003-3999-085X	Australian Postgraduate Award; National Health and Medical Research (NHMRC) Career Development Fellowship; Cancer Australia; NHMRC; MS Research Australia; US National Multiple Sclerosis Society	Australian Postgraduate Award(Australian Government); National Health and Medical Research (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MS Research Australia; US National Multiple Sclerosis Society(National Multiple Sclerosis Society)	Dr. Guo is funded by an Australian Postgraduate Award. Prof. Lucas is funded by a National Health and Medical Research (NHMRC) Career Development Fellowship and receives research funding from Cancer Australia, NHMRC, and MS Research Australia. Prof. Ponsonby is funded by a NHMRC Research Fellowship and receives research funding from NHMRC and MS Research Australia. The Ausimmune Study was funded by the US National Multiple Sclerosis Society, NHMRC, and MS Research Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizerman M, 1964, AUTOMAT REM CONTR, V25, P82; Anguita D, 2005, IEEE IJCNN, P681; Bertrand KA, 2012, BR J NUTR, P1; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chan J, 2010, CANCER CAUSE CONTROL, V21, P501, DOI 10.1007/s10552-009-9481-1; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crooke Philip S, 2012, J Clin Bioinforma, V2, P20, DOI 10.1186/2043-9113-2-20; Drucker H, 1999, IEEE T NEURAL NETWOR, V10, P1048, DOI 10.1109/72.788645; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Lai JKC, 2012, INTERN MED J, V42, P43, DOI 10.1111/j.1445-5994.2011.02471.x; Lin HC, 2011, J MED SYST, V35, P283, DOI 10.1007/s10916-009-9364-8; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Lucas R, 2013, J STEROID B IN PRESS; Lucas RM, 2007, MULT SCLER J, V13, P827, DOI 10.1177/1352458507077174; Lucas RM, 2009, CANCER EPIDEM BIOMAR, V18, P2887, DOI 10.1158/1055-9965.EPI-09-0191; MAXWELL AE, 1975, BRIT J MATH STAT PSY, V28, P51, DOI 10.1111/j.2044-8317.1975.tb00547.x; Millen AE, 2010, AM J CLIN NUTR, V91, P1324, DOI 10.3945/ajcn.2009.28908; Mohr SB, 2011, ANTICANCER RES, V31, P2939; Peiris AN, 2011, SOUTH MED J, V104, P636, DOI 10.1097/SMJ.0b013e3182297169; Reid IR, 2012, HEART, V98, P609, DOI 10.1136/heartjnl-2011-301356; Schottker B, 2013, EUR J EPIDEMIOL; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Song DS, 2012, ANAL QUANT CYTOL, V34, P180; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16	34	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e79970	10.1371/journal.pone.0079970	http://dx.doi.org/10.1371/journal.pone.0079970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302994	Green Published, Green Submitted, gold			2022-12-25	WOS:000327546400010
J	Schuman, CD; Birdwell, JD				Schuman, Catherine D.; Birdwell, J. Douglas			Dynamic Artificial Neural Networks with Affective Systems	PLOS ONE			English	Article							CREATIVITY; MODEL	Artificial neural networks (ANNs) are processors that are trained to perform particular tasks. We couple a computational ANN with a simulated affective system in order to explore the interaction between the two. In particular, we design a simple affective system that adjusts the threshold values in the neurons of our ANN. The aim of this paper is to demonstrate that this simple affective system can control the firing rate of the ensemble of neurons in the ANN, as well as to explore the coupling between the affective system and the processes of long term potentiation (LTP) and long term depression (LTD), and the effect of the parameters of the affective system on its performance. We apply our networks with affective systems to a simple pole balancing example and briefly discuss the effect of affective systems on network performance.	[Schuman, Catherine D.; Birdwell, J. Douglas] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Schuman, CD (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA.	cschuman@lit.net		Schuman, Catherine/0000-0002-4264-8097	National Science Foundation Graduate Research Fellowship Program [DGE-0929298]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-0929298 (http://www.nsfgrfp.org/). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn H, 2005, LECT NOTES COMPUT SC, V3784, P866; Anderson C. W., 1989, IEEE Control Systems Magazine, V9, P31, DOI 10.1109/37.24809; [Anonymous], 2010, FUNDAMENTALS COMPUTA; Banik SC, 2008, LECT NOTES ELECTR EN, V21, P355; Chentanez N., 2004, P 3 INT C DEV LEARN, P112; Damasio A.R., 1994, DESCARTES ERROR EMOT; Dayan P., 2001, THEORETICAL NEUROSCI; Dorf R.C., 2001, MODERN CONTROL SYSTE; Gomez F, 2006, LECT NOTES COMPUT SC, V4212, P654; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Izumi K, 2009, PROC IEEE INT SYMP, P455, DOI 10.1109/ISIE.2009.5214718; Kandel E., 2000, PRINCIPLES NEURAL SC; Kaplan F, 2007, LECT NOTES ARTIF INT, V4850, P303; Lau C., 1992, NEURAL NETWORKS THEO; Malfaz M, 2011, IEEE T AUTON MENT DE, V3, P232, DOI 10.1109/TAMD.2011.2112766; Michaud F, 2001, EM INT 2 TANGL KNOT, P85; MITCHELL M, 1997, INTRO GENETIC ALGORI; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Reilly WS., 1992, CMUCS92143 SCH COMP; Schembri M., 2007, P 6 IEEE INT C DEV L, P282; SCHMIDHUBER J, 1991, IEEE IJCNN, P1458, DOI 10.1109/IJCNN.1991.170605; Schmidhuber J, 2010, IEEE T AUTON MENT DE, V2, P230, DOI 10.1109/TAMD.2010.2056368; Schuman CD, 2013, BIOL INSPIR COGN ARC, V6, P126, DOI 10.1016/j.bica.2013.05.001; Sequeira P, 2011, LECT NOTES COMPUT SC, V6974, P326, DOI 10.1007/978-3-642-24600-5_36; Shastri L, 2002, NEUROCOMPUTING, V44, P33, DOI 10.1016/S0925-2312(02)00403-4; Simsek O., 2006, P 23 INT C MACHINE L, P833; Singh S., 2004, 18 ANN C NEUR INF PR; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takeuchi J, 2007, IEEE IJCNN, P1151, DOI 10.1109/IJCNN.2007.4371120; Vogel D, 2001, BRAIN COGNITION, V45, P212, DOI 10.1006/brcg.2000.1238	32	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e80455	10.1371/journal.pone.0080455	http://dx.doi.org/10.1371/journal.pone.0080455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303015	Green Published, gold, Green Submitted			2022-12-25	WOS:000327546400031
J	Bruzzone, A; Sauliere, A; Finana, F; Senard, JM; Luthy, I; Gales, C				Bruzzone, Ariana; Sauliere, Aude; Finana, Frederic; Senard, Jean-Michel; Luethy, Isabel; Gales, Celine			Dosage-dependent regulation of cell proliferation and adhesion through dual beta(2)-adrenergic receptor/cAMP signals	FASEB JOURNAL			English	Article						MCF-10A human breast cell line; Epac; PKA; signaling compartmentalization	BETA-ADRENERGIC-RECEPTORS; BREAST-CANCER CELLS; CYCLIC-AMP ANALOGS; BETA-2-ADRENERGIC RECEPTOR; CHOLESTEROL DEPLETION; ADENYLATE-CYCLASE; CARDIAC MYOCYTES; MAMMARY-GLAND; LIPID RAFTS; CAMP	The role of -adrenergic receptors (-ARs) remains controversial in normal and tumor breast. Herein we explore the cAMP signaling involved in -AR-dependent control of proliferation and adhesion of nontumor human breast cell line MCF-10A. Low concentrations of a -agonist, isoproterenol (ISO), promote cell adhesion (87.5% cells remaining adherent to the plastic dishes following specific detachment vs. 35.0% in control, P<0.001), while increasing concentrations further engages an additional 36% inhibition of Erk1/2 phosphorylation (p-Erk1/2)-dependent cell proliferation (P<0.01). Isoproterenol dose response on cell adhesion was fitted to a 2-site curve (EC50(1): 16.5 +/- 11.5 fM, EC50(2): 4.08 +/- 3.09 nM), while ISO significantly inhibited p-Erk1/2 according to a 1-site model (EC50: 0.25 +/- 0.13 nM). Using -AR-selective agonist/antagonists and cAMP analogs/inhibitors, we identified a dosage-dependent signaling in which low ISO concentrations target a (2)-AR population localized in raft microdomains and stimulate a G(s)/cAMP/Epac/adhesion-signaling module, while higher concentrations engage a concomitant activation of another (2)-AR population outside rafts and inhibit the proliferation by a G(s)/cAMP/PKA-dependent signaling module. Our data provide a new molecular basis for the dose-dependent switch of -AR signaling. This study also sheds light on a new cAMP pathway core mechanism with a single receptor triggering dual cAMP signaling controlled by PKA or Epac but with different cellular outputs.Bruzzone, A., Sauliere, A., Finana, F., Senard, J.-M., Luthy, I., Gales, C. Dosage-dependent regulation of cell proliferation and adhesion through dual (2)-adrenergic receptor/cAMP signals.	[Bruzzone, Ariana; Luethy, Isabel] Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Sauliere, Aude; Senard, Jean-Michel; Gales, Celine] Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc, F-31062 Toulouse, France; [Finana, Frederic] Inst Rech Pierre Fabre, Dept Cellular & Mol Biol, Castres, France; [Senard, Jean-Michel] Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Gales, C (corresponding author), Inst Malad Metab & Cardiovasc, INSERM, U1048, I2MC, 1 Ave Jean Poulhes,BP84225, F-31432 Toulouse 4, France.	celine.gales@inserm.fr		Senard, Jean-Michel/0000-0001-7679-1281; GALES, Celine/0000-0002-4938-1583	Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT)/EcosSud Argentina/Francia; Proyecto de Investigacion en Ciencia y Tecnologia (PICT) Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Proyecto de Investigacion Plurianual (692-Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fundacion Roemmers; Fundacion Bunge y Born Argentina	Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT)/EcosSud Argentina/Francia; Proyecto de Investigacion en Ciencia y Tecnologia (PICT) Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Proyecto de Investigacion Plurianual (692-Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fundacion Roemmers; Fundacion Bunge y Born Argentina	This paper is dedicated to the memory of the authors' friend and colleague Dr. Herve Paris, who was the mentor of this work and passed away suddenly during its completion. This work was supported by a grant from the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT)/EcosSud Argentina/Francia, Proyecto de Investigacion en Ciencia y Tecnologia (PICT) 2011#103 Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Proyecto de Investigacion Plurianual (PIP 2010-2012#692-Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and Fundacion Roemmers. A. B. was a recipient of an Oster fellowship from Fundacion Bunge y Born Argentina. The authors especially thank Sabrina Copsel, Lucia Gargiulo, Carlos Davio, Lauriane Onfroy, Colette Denis, and Marie-Helene Seguelas for their invaluable technical help, Silvio Gutkind (U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research, Bethesda, MD, USA) and Omar Coso [Facultad de Ciencias Exactas y Naturales (FCEN)-Instituto de Fisiologica, Biologia Molecular y Neurociencias (IFIBYNE), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina] for generously providing PKI and N-Epac encoding vectors, and Lucrecia Calvo for critical reading of the manuscript.	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; Barron TI, 2012, THER ADV MED ONCOL, V4, P113, DOI 10.1177/1758834012439738; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brock M, 2007, BRAIN RES, V1145, P1, DOI 10.1016/j.brainres.2007.01.119; Carie AE, 2007, ONCOGENE, V26, P3777, DOI 10.1038/sj.onc.1210172; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Daly CJ, 2011, TRENDS PHARMACOL SCI, V32, P219, DOI 10.1016/j.tips.2011.02.008; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; DRAOUI A, 1991, ANTICANCER RES, V11, P677; Eid AH, 2012, CELL PHYSIOL BIOCHEM, V30, P247, DOI 10.1159/000339061; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Grandoch M, 2009, BRIT J CANCER, V101, P2038, DOI 10.1038/sj.bjc.6605439; Guzzi F, 2002, ONCOGENE, V21, P1658, DOI 10.1038/sj.onc.1205219; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Inderwies T, 2003, DOMEST ANIM ENDOCRIN, V24, P123, DOI 10.1016/S0739-7240(02)00211-4; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim MO, 2012, BBA-GEN SUBJECTS, V1820, P1636, DOI 10.1016/j.bbagen.2012.05.008; Leitinger B, 2002, J CELL SCI, V115, P963; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Mantovani G, 2008, EXP CELL RES, V314, P123, DOI 10.1016/j.yexcr.2007.08.024; MARCHETTI B, 1990, ENDOCRINOLOGY, V126, P565, DOI 10.1210/endo-126-1-565; Mouat MF, 2003, J NUTR BIOCHEM, V14, P74, DOI 10.1016/S0955-2863(02)00250-4; Nedvetsky PI, 2012, MOL BIOL CELL, V23, P2973, DOI 10.1091/mbc.E12-02-0078; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pinero CP, 2012, BRIT J PHARMACOL, V166, P721, DOI 10.1111/j.1476-5381.2011.01791.x; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Powe DG, 2011, BREAST CANCER RES TR, V130, P457, DOI 10.1007/s10549-011-1371-z; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Re G, 1996, PHARMACOL RES, V33, P255, DOI 10.1006/phrs.1996.0036; Rivas M, 2003, MOL CELL ENDOCRINOL, V213, P31, DOI 10.1016/j.mce.2003.10.029; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Spina A, 2012, BIORESEARCH OPEN ACC, V1, P324, DOI 10.1089/biores.2012.0270; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; TAGLIAFERRI P, 1988, CANCER RES, V48, P1642; TAGLIAFERRI P, 1988, J BIOL CHEM, V263, P409; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Toll L, 2011, J PHARMACOL EXP THER, V336, P524, DOI 10.1124/jpet.110.173971; TORTORA G, 1988, BLOOD, V71, P230; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; WELLNER RB, 1988, BIOCHEM PHARMACOL, V37, P3035, DOI 10.1016/0006-2952(88)90293-6; Wu CY, 2010, AM J PHYSIOL-CELL PH, V298, pC1151, DOI 10.1152/ajpcell.00382.2009; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zaccolo M, 2005, BIOCHEM SOC T, V33, P1323, DOI 10.1042/BST0331323; Zocher M, 2012, P NATL ACAD SCI USA, V109, pE3463, DOI 10.1073/pnas.1210373109	63	28	28	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1342	1354		10.1096/fj.13-239285	http://dx.doi.org/10.1096/fj.13-239285			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24308976				2022-12-25	WOS:000335324800026
J	Guijarro-Munoz, I; Compte, M; Alvarez-Cienfuegos, A; Alvarez-Vallina, L; Sanz, L				Guijarro-Munoz, Irene; Compte, Marta; Alvarez-Cienfuegos, Ana; Alvarez-Vallina, Luis; Sanz, Laura			Lipopolysaccharide Activates Toll-like Receptor 4 (TLR4)-mediated NF-kappa B Signaling Pathway and Proinflammatory Response in Human Pericytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Chemokines; Cytokine; Inflammation; Lipopolysaccharide (LPS); HMGB1; NF-B; TLR4; Pericyte	MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; GENE-EXPRESSION; CYTOKINE; ARRAY; RECOGNITION; PROTEIN; INNATE; HMGB1	Pericytes and mesenchymal stem cells (MSCs) are ontogenically related, and in fact, no significant phenotypic differences could be observed by flow cytometry. Transcriptome analysis of human pericytes and MSCs revealed that 43 genes were up-regulated more than 10-fold in pericytes compared with MSCs. Identification of Toll-like receptor 4 (TLR4) as one of the most abundant RNA species in pericytes with respect to MSCs and confirmation of TLR4 expression on the cell surface led us to obtain a comprehensive overview of the expression program of lipopolysaccharide (LPS)-stimulated pericytes. Transcriptional profiling of LPS-treated cells revealed that 22 genes were up-regulated more than 5-fold. Of them, 10 genes encoded chemokines and cytokines (CXCL10, CCL20, IL8, CXCL1, IL6, CCL2, IL1B, CXCL2, IL1A, and CXCL6), and three genes encoded adhesion molecules (ICAM1, VCAM1, and SELE). LPS induced nuclear translocation of the transcription factor NF-B in stimulated pericytes. Moreover, inhibition of NF-B activation by SC-514 blocked LPS-induced up-regulation of a subset of chemokine genes, confirming the key role of NF-B in LPS signaling in pericytes. At the protein level, we assessed the secretion of the proinflammatory cytokines and chemokines IL-6, IL-8, CXCL1, CXCL2, CXCL3, and CCL2 not only after LPS treatment but also in HMGB1-stimulated pericytes. Up-regulation of the adhesion molecules ICAM-1 and VCAM-1 resulted in an increased adhesion of peripheral blood leukocytes to an LPS-treated pericyte monolayer. The role of pericytes in the inflammatory context has been scarcely addressed; according to these results, pericytes should be considered as active players in the inflammatory cascade with potential physiopathological implications.	[Guijarro-Munoz, Irene; Compte, Marta; Alvarez-Cienfuegos, Ana; Alvarez-Vallina, Luis; Sanz, Laura] Hosp Univ Puerta Hierro Majadahonda, Mol Immunol Unit, Madrid 28222, Spain	Hospital Puerta de Hierro-Majadahonda	Sanz, L (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Mol Immunol Unit, Madrid 28222, Spain.	lsalcober@salud.madrid.org	Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/ABD-2431-2020	Sanz, Laura/0000-0002-3119-3218; Alvarez-Vallina, Luis/0000-0003-3053-6757; Compte Grau, Marta/0000-0002-7138-9266	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III [PI08/90856, PS09/00227]; Fundacion Investigacion Biomedica Hospital Puerta de Hierro; Ministerio de Economia y Competitividad [BIO2011-22738]; Comunidad de Madrid [S2010/BMD-2312]	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Investigacion Biomedica Hospital Puerta de Hierro; Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III Grants PI08/90856 and PS09/00227 and Fundacion Investigacion Biomedica Hospital Puerta de Hierro (to L. S.) and by Ministerio de Economia y Competitividad Grant BIO2011-22738 and Comunidad de Madrid Grant S2010/BMD-2312 (to L. A.-V.).	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barlow KD, 2013, CANCER MICROENVIRON, V6, P1, DOI 10.1007/s12307-012-0102-2; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bose A, 2013, J IMMUNOL, V191, P971, DOI 10.4049/jimmunol.1300280; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2003, BRAZ J MED BIOL RES, V36, P1179, DOI 10.1590/S0100-879X2003000900006; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Edelman DA, 2007, AM J SURG, V193, P730, DOI 10.1016/j.amjsurg.2006.08.086; Edelman DA, 2006, J SURG RES, V134, P22, DOI 10.1016/j.jss.2006.03.007; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guijarro-Munoz I, 2012, EXP CELL RES, V318, P371, DOI 10.1016/j.yexcr.2011.12.005; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Keeley EC, 2011, EXP CELL RES, V317, P685, DOI 10.1016/j.yexcr.2010.10.020; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Li AH, 2002, MICROVASC RES, V64, P476, DOI 10.1006/mvre.2002.2442; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Maier CL, 2011, ARTERIOSCL THROM VAS, V31, P183, DOI 10.1161/ATVBAHA.110.217117; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2010, J MOL MED, V88, P5, DOI 10.1007/s00109-009-0523-7; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Samaniego R, 2013, J INVEST DERMATOL, V133, P2255, DOI 10.1038/jid.2013.88; Sanz L, 2008, MICROVASC RES, V75, P308, DOI 10.1016/j.mvr.2007.11.007; Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Starkie RL, 2001, J PHYSIOL-LONDON, V533, P585, DOI 10.1111/j.1469-7793.2001.0585a.x; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; Tu ZD, 2011, INVEST OPHTH VIS SCI, V52, P9005, DOI 10.1167/iovs.11-8008; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	60	179	188	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2457	2468		10.1074/jbc.M113.521161	http://dx.doi.org/10.1074/jbc.M113.521161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24307174	hybrid, Green Published			2022-12-25	WOS:000331130200049
J	Felts, B; Pramod, AB; Sandtner, W; Burbach, N; Bulling, S; Sitte, HH; Henry, LK				Felts, Bruce; Pramod, Akula Bala; Sandtner, Walter; Burbach, Nathan; Bulling, Simon; Sitte, Harald H.; Henry, L. Keith			The Two Na+ Sites in the Human Serotonin Transporter Play Distinct Roles in the Ion Coupling and Electrogenicity of Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Homology Modeling; Monoamine Transporters; Serotonin Transporters; Transporters; SLC6; Ion Dependence; Structure-Function	TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITES; PLATELET 5-HYDROXYTRYPTAMINE; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; CONDUCTING STATES; SODIUM SYMPORTERS; CRYSTAL-STRUCTURE; COCAINE BINDING	Background: The Na+/Cl--dependent serotonin transporter contains two putative Na+-binding sites (Na1 and Na2). Results: Mutations at Na1, but not Na2, allow Ca2+ to replace Na+ and alter the conducting properties of the transporter. Conclusion: Ca2+ binds at Na1, but in the Na1 mutant, it does not appear to be transported. Significance: This work uncovers distinct roles of the Na+-binding sites for serotonin transporter function. Neurotransmitter transporters of the SLC6 family of proteins, including the human serotonin transporter (hSERT), utilize Na+, Cl-, and K+ gradients to induce conformational changes necessary for substrate translocation. Dysregulation of ion movement through monoamine transporters has been shown to impact neuronal firing potentials and could play a role in pathophysiologies, such as depression and anxiety. Despite multiple crystal structures of prokaryotic and eukaryotic SLC transporters indicating the location of both (or one) conserved Na+-binding sites (termed Na1 and Na2), much remains uncertain in regard to the movements and contributions of these cation-binding sites in the transport process. In this study, we utilize the unique properties of a mutation of hSERT at a single, highly conserved asparagine on TM1 (Asn-101) to provide several lines of evidence demonstrating mechanistically distinct roles for Na1 and Na2. Mutations at Asn-101 alter the cation dependence of the transporter, allowing Ca2+ (but not other cations) to functionally replace Na+ for driving transport and promoting 5-hydroxytryptamine (5-HT)-dependent conformational changes. Furthermore, in two-electrode voltage clamp studies in Xenopus oocytes, both Ca2+ and Na+ illicit 5-HT-induced currents in the Asn-101 mutants and reveal that, although Ca2+ promotes substrate-induced current, it does not appear to be the charge carrier during 5-HT transport. These findings, in addition to functional evaluation of Na1 and Na2 site mutants, reveal separate roles for Na1 and Na2 and provide insight into initiation of the translocation process as well as a mechanism whereby the reported SERT stoichiometry can be obtained despite the presence of two putative Na+-binding sites.	[Felts, Bruce; Pramod, Akula Bala; Burbach, Nathan; Henry, L. Keith] Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA; [Sandtner, Walter; Bulling, Simon; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of North Dakota Grand Forks; Medical University of Vienna	Henry, LK (corresponding author), 501 N Columbia Rd,Rm 3700, Grand Forks, ND 58201 USA.	keith.henry@med.und.edu	Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444	National Institutes of Health K01 Career Development Award [DA022378]; National Institutes of Health, NIGMS, Institutional Development Award (IDeA) [P20GM12345]; National Science Foundation-EPSCoR Faculty Startup Award; Austrian Science Foundation/FWF Grant [F3506]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA022378] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	National Institutes of Health K01 Career Development Award; National Institutes of Health, NIGMS, Institutional Development Award (IDeA); National Science Foundation-EPSCoR Faculty Startup Award; Austrian Science Foundation/FWF Grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health K01 Career Development Award DA022378 (to L. K. H.) and by National Institutes of Health, NIGMS, Institutional Development Award (IDeA) P20GM12345. This work was also supported by a National Science Foundation-EPSCoR Faculty Startup Award (to L. K. H.) and Austrian Science Foundation/FWF Grant F3506 (to H.H.S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Androutsellis-Theotokis A, 2001, J BIOL CHEM, V276, P45933, DOI 10.1074/jbc.M107462200; Barker EL, 1999, J NEUROSCI, V19, P4705; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Boehm S, 1999, J NEUROSCI, V19, P737; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chang AS, 1998, J PHYSIOL-LONDON, V510, P903, DOI 10.1111/j.1469-7793.1998.903bj.x; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Kolds O. H., 2011, PLOS COMPUT BIOL, V7; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Partridge L. D., 1991, CALCIUM CHANNELS THE, P121; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Reith M. E., 2002, NEUROTRANSMITTER TRA; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SNEDDON JM, 1969, BRIT J PHARMACOL, V37, P680, DOI 10.1111/j.1476-5381.1969.tb08506.x; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	74	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1825	1840		10.1074/jbc.M113.504654	http://dx.doi.org/10.1074/jbc.M113.504654			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293367	Green Published, hybrid			2022-12-25	WOS:000332401700052
J	Huang, WY; Jou, MJ; Tsung, IP				Huang, Wen-Yi; Jou, Mei-Jie; Tsung, I. Peng			mtDNA T8993G Mutation-Induced F1F0-ATP Synthase Defect Augments Mitochondrial Dysfunction Associated with hypoxia/reoxygenation: The Protective Role of Melatonin	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION INJURY; OXYGEN-FREE RADICALS; REACTIVE OXYGEN; RAT-HEART; OXIDATIVE STRESS; MYOCARDIAL REPERFUSION; CARDIAC ISCHEMIA; COMMON DELETION; NARP MUTATION	Background: F1F0-ATP synthase (F1F0-ATPase) plays important roles in regulating mitochondrial function during hypoxia, but the effect of F1F0-ATPase defect on hypoxia/reoxygenation (H/RO) is unknown. The aim of this study was to investigate how mtDNA T8993G mutation (NARP)-induced inhibition of F1F0-ATPase modulates the H/RO-induced mitochondrial dysfunction. In addition, the potential for melatonin, a potent antioxidant with multiple mitochondrial protective properties, to protect NARP cells exposed to H/RO was assessed. Methods And Findings: NARP cybrids harboring 98% of mtDNA T8993G genes were established as an in vitro model for cells with F1F0-ATPase defect; their parental osteosarcoma 143B cells were studied for comparison. Treating the cells with H/RO using a hypoxic chamber resembles ischemia/reperfusion in vivo. NARP significantly enhanced apoptotic death upon H/RO detected by MTT assay and the trypan blue exclusion test of cell viability. Based on fluorescence probe-coupled laser scanning imaging microscopy, NARP significantly enhanced mitochondrial reactive oxygen species (mROS) formation and mitochondrial Ca2+ (mCa(2+)) accumulation in response to H/RO, which augmented the depletion of cardiolipin, resulting in the retardation of mitochondrial movement. With stronger H/RO stress (either with longer reoxygenation duration, longer hypoxia duration, or administrating secondary oxidative stress following H/RO), NARP augmented H/RO-induced mROS formation to significantly depolarize mitochondrial membrane potential (Delta psi m), and enhance mCa(2+) accumulation and nitric oxide formation. Also, NARP augmented H/RO-induced mROS oxidized and depleted cardiolipin, thereby promoting permanent mitochondrial permeability transition, retarded mitochondrial movement, and enhanced apoptosis. Melatonin markedly reduced NARP-augmented H/RO-induced mROS formation and therefore significantly reduced mROS-mediated depolarization of Delta psi m and accumulation of mCa(2+), stabilized cardiolipin, and then improved mitochondrial movement and cell survival. Conclusion: NARP-induced inhibition of F1F0-ATPase enhances mROS formation upon H/RO, which augments the depletion of cardiolipin and retardation of mitochondrial movement. Melatonin may have the potential to rescue patients with ischemia/reperfusion insults, even those associated with NARP symptoms.	[Huang, Wen-Yi] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Wen-Yi; Tsung, I. Peng] Chang Gung Mem Hosp, Dept Neurol, Keelung Branch, Kaohsiung, Taiwan; [Jou, Mei-Jie] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Tsung, I. Peng] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Tsung, IP (corresponding author), Chang Gung Mem Hosp, Dept Neurol, Keelung Branch, Kaohsiung, Taiwan.	tipeng@cgmh.org.tw			Chang Gung Memorial Hospital and Chang Gung Medical Research Foundation, Taiwan [CMRPG 270331-3, CMRPG 270341-2, CMRPD 180491-3, CMRPD 170411-3]	Chang Gung Memorial Hospital and Chang Gung Medical Research Foundation, Taiwan	This work was supported by the grants CMRPG 270331-3 (to Huang), CMRPG 270341-2 (to Peng), and CMRPD 180491-3 and CMRPD 170411-3 (to Jou) from the Chang Gung Memorial Hospital and Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Di Lisa F, 2011, ANTIOXID REDOX SIGN, V14, P881, DOI 10.1089/ars.2010.3375; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Finsterer J, 2012, ADV EXP MED BIOL, V942, P187, DOI 10.1007/978-94-007-2869-1_8; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Heusch G, 2010, BASIC RES CARDIOL, V105, P151, DOI 10.1007/s00395-009-0080-9; Huang WY, 2012, CEREBROVASC DIS, V34, P55, DOI 10.1159/000338906; Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x; Kaneko S, 2000, LIFE SCI, V67, P101, DOI 10.1016/S0024-3205(00)00607-X; KATSURA K, 1993, J NEUROCHEM, V61, P1677, DOI 10.1111/j.1471-4159.1993.tb09803.x; Kilic E, 2005, J PINEAL RES, V39, P151, DOI 10.1111/j.1600-079X.2005.00228.x; Kilic E, 2004, J PINEAL RES, V36, P171, DOI 10.1046/j.1600-079X.2003.00115.x; Lebiedzinska M, 2013, INT J BIOCHEM CELL B, V45, P141, DOI 10.1016/j.biocel.2012.07.020; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Liu RR, 2009, J BIOL CHEM, V284, P36109, DOI 10.1074/jbc.M109.055301; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Paradies G, 1999, FREE RADICAL BIO MED, V27, P42, DOI 10.1016/S0891-5849(99)00032-5; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008; Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; Petrosillo G, 2009, FREE RADICAL BIO MED, V47, P969, DOI 10.1016/j.freeradbiomed.2009.06.032; Petrosillo G, 2009, AM J PHYSIOL-HEART C, V297, pH1487, DOI 10.1152/ajpheart.00163.2009; Peyrot F, 2008, J PINEAL RES, V45, P235, DOI 10.1111/j.1600-079X.2008.00580.x; Reiter RJ, 2003, CARDIOVASC RES, V58, P10, DOI 10.1016/S0008-6363(02)00827-1; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rosen J, 2006, J PINEAL RES, V41, P374, DOI 10.1111/j.1600-079X.2006.00379.x; Ruiz-Meana M, 2007, BASIC RES CARDIOL, V102, P542, DOI 10.1007/s00395-007-0675-y; Salie R, 2001, J MOL CELL CARDIOL, V33, P343, DOI 10.1006/jmcc.2000.1306; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Tan DX, 1998, J PINEAL RES, V25, P184, DOI 10.1111/j.1600-079X.1998.tb00558.x; Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137; Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980; Tengattini S, 2008, J PINEAL RES, V44, P16, DOI 10.1111/j.1600-079X.2007.00518.x; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4	63	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81546	10.1371/journal.pone.0081546	http://dx.doi.org/10.1371/journal.pone.0081546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312318	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300036
J	Iwasaki, M; Poulsen, TM; Oka, K; Hessler, NA				Iwasaki, Mai; Poulsen, Thomas M.; Oka, Kotaro; Hessler, Neal A.			Singing-Related Activity in Anterior Forebrain of Male Zebra Finches Reflects Courtship Motivation for Target Females	PLOS ONE			English	Article							BASAL GANGLIA CIRCUIT; CONTEXT-DEPENDENT CHANGES; NEURAL ACTIVITY; SOCIAL MODULATION; SONG; VARIABILITY; DOPAMINE; SEQUENCE; INSIGHTS; BEHAVIOR	A critical function of singing by male songbirds is to attract a female mate. Previous studies have suggested that the anterior forebrain system is involved in this courtship behavior. Neural activity in this system, including the striatal Area X, is strikingly dependent on the function of male singing. When males sing to attract a female bird rather than while alone, less variable neural activity results in less variable song spectral features, which may be attractive to the female. These characteristics of neural activity and singing thus may reflect a male's motivation for courtship. Here, we compared the variability of neural activity and song features between courtship singing directed to a female with whom a male had previously formed a pair-bond or to other females. Surprisingly, across all units, there was no clear tendency for a difference in variability of neural activity or song features between courtship of paired females, nonpaired females, or dummy females. However, across the population of recordings, there was a significant relationship between the relative variability of syllable frequency and neural activity: when syllable frequency was less variable to paired than nonpaired females, neural activity was also less variable (and vice-versa). These results show that the lower variability of neural activity and syllable frequency during directed singing is not a binary distinction from undirected singing, but can vary in intensity, possibly related to the relative preference of a male for his singing target.	[Iwasaki, Mai; Poulsen, Thomas M.; Hessler, Neal A.] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Iwasaki, Mai; Oka, Kotaro] Keio Univ, Yokohama, Kanagawa 223, Japan	RIKEN; Keio University	Hessler, NA (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	hessler@brain.riken	Oka, Kotaro/C-4918-2014	Iwasaki, Mai/0000-0002-4332-4203	RIKEN Brain Science Institut	RIKEN Brain Science Institut	Funding was provided by RIKEN Brain Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BISCHOF HJ, 1981, Z TIERPSYCHOL, V57, P261; BUTTERFIELD PA, 1970, SOCIAL BEHAV BIRDS M; CARYL PG, 1981, Z TIERPSYCHOL, V57, P37; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; CLAYTON NS, 1990, ANIM BEHAV, V39, P474, DOI 10.1016/S0003-3472(05)80411-7; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Freeman SM, 2013, OXYTOCIN, VASOPRESSIN AND RELATED PEPTIDES IN THE REGULATION OF BEHAVIOR, P128; GARSON PJ, 1980, ANIM BEHAV, V28, P1184, DOI 10.1016/S0003-3472(80)80106-0; George I, 2006, J NEUROBIOL, V66, P1164, DOI 10.1002/neu.20273; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goldberg JH, 2010, J NEUROSCI, V30, P7088, DOI 10.1523/JNEUROSCI.0168-10.2010; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kao MH, 2008, J NEUROSCI, V28, P13232, DOI 10.1523/JNEUROSCI.2250-08.2008; Kelley AE, 2002, J NEUROSCI, V22, P3306; Lack D., 1968, pvii; Leblois A, 2012, EUR J NEUROSCI, V35, P1771, DOI 10.1111/j.1460-9568.2012.08095.x; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Leblois A, 2009, J NEUROSCI, V29, P15420, DOI 10.1523/JNEUROSCI.3060-09.2009; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Stepanek L, 2010, J NEUROPHYSIOL, V104, P2474, DOI 10.1152/jn.00977.2009; Stoesz BM, 2013, NEUROSCI BIOBEHAV R, V37, P123, DOI 10.1016/j.neubiorev.2012.11.007; Svec LA, 2009, NEUROSCIENCE, V160, P275, DOI 10.1016/j.neuroscience.2009.02.003; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; Yanagihara S, 2012, J NEUROPHYSIOL, V107, P424, DOI 10.1152/jn.00790.2011; Zann RA., 1996, ZEBRA FINCH SYNTHESI	42	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							0081725	10.1371/journal.pone.0081725	http://dx.doi.org/10.1371/journal.pone.0081725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312344	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300047
J	Tao, L; Fan, FT; Liu, YP; Li, WD; Zhang, L; Ruan, JS; Shen, CS; Sheng, XB; Zhu, ZJ; Wang, AY; Chen, WX; Huang, SL; Lu, Y				Tao, Li; Fan, Fangtian; Liu, Yuping; Li, Weidong; Zhang, Lei; Ruan, Junshan; Shen, Cunsi; Sheng, Xiaobo; Zhu, Zhijie; Wang, Aiyun; Chen, Wenxing; Huang, Shile; Lu, Yin			Concerted Suppression of STAT3 and GSK3 beta Is Involved in Growth Inhibition of Non-Small Cell Lung Cancer by Xanthatin	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; NUCLEAR ACCUMULATION; CYCLE ARREST; INACTIVATION; PHOSPHORYLATION; GSK-3-BETA; APOPTOSIS; PATHWAY; ACTIVATION	Xanthatin, a sesquiterpene lactone purified from Xanthium strumarium L., possesses prominent anticancer activity. We found that disruption of GSK3 beta activity was essential for xanthatin to exert its anticancer properties in non-small cell lung cancer (NSCLC), concurrent with preferable suppression of constitutive activation of STAT3. Interestingly, inactivation of the two signals are two mutually exclusive events in xanthatin-induced cell death. Moreover, we surprisingly found that exposure of xanthatin failed to trigger the presumable side effect of canonical Wnt/beta-Catenin followed by GSK3 beta inactivation. We further observed that the downregulation of STAT3 was required for xanthatin to fine-tune the risk. Thus, the discovery of xanthatin, which has ability to simultaneously orchestrate two independent signaling cascades, may have important implications for screening promising drugs in cancer therapies.	[Tao, Li; Fan, Fangtian; Liu, Yuping; Zhang, Lei; Ruan, Junshan; Shen, Cunsi; Sheng, Xiaobo; Zhu, Zhijie; Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Coll Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Li, Weidong] Nanjing Univ Chinese Med, Ctr Engn, State Minist Educ Standardizat, Nanjing, Jiangsu, Peoples R China; [Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Lu, Y (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.	profyinlu@163.com	Tao, Li/AAF-4654-2021; Huang, Shile/I-1632-2019; Chen, Wenxing/GSI-9910-2022	Huang, Shile/0000-0002-3239-1072; Chen, Wenxing/0000-0003-4571-7622	National Natural Science Foundation of China [81173174, 81202655]; National Key Technology Research & Development Program [2008BAI51B02]; Ph.D. Programs Foundation of Ministry of Education of China [20113237110008]; Jiangsu College graduate research and innovation projects [CXZZ13_0627]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Jiangsu College graduate research and innovation projects	This work was supported by the National Natural Science Foundation of China (No. 81173174 and 81202655); The National Key Technology Research & Development Program (No. 2008BAI51B02); Ph.D. Programs Foundation of Ministry of Education of China (No. 20113237110008). Jiangsu College graduate research and innovation projects (No. CXZZ13_0627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JT, 2009, MOL CANCER THER, V8, P914, DOI 10.1158/1535-7163.MCT-08-0712; Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; Chiara F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00016; Dickey A, 2011, J NEURO-ONCOL, V104, P145, DOI 10.1007/s11060-010-0491-3; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gao Y, 2013, CANCER LETT, V336, P231, DOI 10.1016/j.canlet.2013.05.005; Garcea G, 2007, CURR CANCER DRUG TAR, V7, P209, DOI 10.2174/156800907780618266; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Kawada M, 2006, CANCER RES, V66, P2913, DOI 10.1158/0008-5472.CAN-05-3460; Kumeta Masahiro, 2012, Int J Cell Biol, V2012, P494902, DOI 10.1155/2012/494902; Lan Y, 2013, BIOMETALS, V26, P241, DOI 10.1007/s10534-012-9607-x; Li H, 2012, BIOSCI BIOTECH BIOCH, V76, P767, DOI 10.1271/bbb.110894; Li WD, 2013, PHYTOMEDICINE, V20, P865, DOI 10.1016/j.phymed.2013.03.006; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; ROUSSAKIS C, 1994, PLANTA MED, V60, P473, DOI 10.1055/s-2006-959537; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Watanabe M, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.21; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P279, DOI 10.1093/neuonc/nos306; Zhang L, 2012, PLANTA MED, V78, P890, DOI 10.1055/s-0031-1298481; Zhang L, 2012, MOLECULES, V17, P3736, DOI 10.3390/molecules17043736; Zheng HC, 2007, ANTICANCER RES, V27, P3561; Zhou W, 2012, CANCER LETT, V316, P178, DOI 10.1016/j.canlet.2011.10.033	44	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e81945	10.1371/journal.pone.0081945	http://dx.doi.org/10.1371/journal.pone.0081945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312384	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900064
J	Busch-Dienstfertig, M; Roth, CA; Stein, C				Busch-Dienstfertig, Melanie; Roth, Clarisse A.; Stein, Christoph			Functional Characteristics of the Naked Mole Rat mu-Opioid Receptor	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MORPHINE CONSUMPTION; A118G POLYMORPHISM; FORMALIN TEST; ENDOCYTOSIS; ANALGESIA; BINDING; DELTA; PAIN; ANTINOCICEPTION	While humans and most animals respond to mu-opioid receptor (MOR) agonists with analgesia and decreased aggression, in the naked mole rat (NMR) opioids induce hyperalgesia and severe aggression. Single nucleotide polymorphisms in the human mu-opioid receptor gene (OPRM1) can underlie altered behavioral responses to opioids. Therefore, we hypothesized that the primary structure of the NMR MOR may differ from other species. Sequencing of the NMR oprm1 revealed strong homology to other mammals, but exposed three unique amino acids that might affect receptor-ligand interactions. The NMR and rat oprm1 sequences were cloned into mammalian expression vectors and transfected into HEK293 cells. Radioligand binding and 3'-5'-cyclic adenosine monophosphate (cAMP) enzyme immunoassays were used to compare opioid binding and opioid-mediated cAMP inhibition. At normalized opioid receptor protein levels we detected significantly lower [3H]DAMGO binding to NMR compared to rat MOR, but no significant difference in DAMGO-induced cAMP inhibition. Strong DAMGO-induced MOR internalization was detectable using radioligand binding and confocal imaging in HEK293 cells expressing rat or NMR receptor, while morphine showed weak or no effects. In summary, we found minor functional differences between rat and NMR MOR suggesting that other differences e. g. in anatomical distribution of MOR underlie the NMR's extreme reaction to opioids.	[Busch-Dienstfertig, Melanie; Roth, Clarisse A.; Stein, Christoph] Free Univ Berlin, Dept Anesthesiol & Intens Care Med, Charite Campus Benjamin Franklin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Busch-Dienstfertig, M (corresponding author), Free Univ Berlin, Dept Anesthesiol & Intens Care Med, Charite Campus Benjamin Franklin, Berlin, Germany.	melanie.busch@charite.de		Stein, Christoph/0000-0001-5240-6836	Bundesministerium fur Bildung und Forschung (BMBF)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by the Bundesministerium fur Bildung und Forschung (BMBF) and institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Beyer A, 2004, J NEUROCHEM, V89, P553, DOI 10.1111/j.1471-4159.2004.02340.x; Chou WY, 2006, ACTA ANAESTH SCAND, V50, P787, DOI 10.1111/j.1399-6576.2006.01058.x; Chou WY, 2006, ANESTHESIOLOGY, V105, P334, DOI 10.1097/00000542-200608000-00016; Copeland WE, 2011, NEUROPSYCHOPHARMACOL, V36, P1165, DOI 10.1038/npp.2010.251; EVANS N, 2004, CURR PROTOC PHARM; Gharagozlou Parham, 2003, BMC Pharmacol, V3, P1, DOI 10.1186/1471-2210-3-1; Hayashida M, 2008, PHARMACOGENOMICS, V9, P1605, DOI 10.2217/14622416.9.11.1605; Huang P, 2012, BIOCHEM J, V441, P379, DOI 10.1042/BJ20111050; KANUI TI, 1990, COMP BIOCHEM PHYS C, V96, P131, DOI 10.1016/0742-8413(90)90057-G; KANUI TI, 1993, BRAIN RES, V600, P123, DOI 10.1016/0006-8993(93)90409-G; KARIM F, 1993, NEUROREPORT, V4, P25, DOI 10.1097/00001756-199301000-00006; Kato S, 1998, EUR J PHARMACOL, V345, P221, DOI 10.1016/S0014-2999(98)00023-5; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kroslak T, 2007, J NEUROCHEM, V103, P77, DOI 10.1111/j.1471-4159.2007.04738.x; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Li X, 1996, J MOL EVOL, V43, P179, DOI 10.1007/BF02338825; Mague SD, 2010, DRUG ALCOHOL DEPEN, V108, P172, DOI 10.1016/j.drugalcdep.2009.12.016; Miller GM, 2004, MOL PSYCHIATR, V9, P99, DOI 10.1038/sj.mp.4001378; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Patierno S, 2011, GASTROENTEROLOGY, V140, P618, DOI 10.1053/j.gastro.2010.11.005; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; Sia AT, 2008, ANESTHESIOLOGY, V109, P520, DOI 10.1097/ALN.0b013e318182af21; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; Tordjman S, 2003, BEHAV GENET, V33, P529, DOI 10.1023/A:1025774716976; Towett PK, 2006, BRAIN RES BULL, V71, P60, DOI 10.1016/j.brainresbull.2006.08.001; Towett PK, 2009, PHARMACOL BIOCHEM BE, V91, P566, DOI 10.1016/j.pbb.2008.09.011; TOWETT PK, 1993, PHARMACOL BIOCHEM BE, V45, P153, DOI 10.1016/0091-3057(93)90099-F; TROISI A, 2011, SOC COGN AFFECT NEUR; Vallender EJ, 2008, BEHAV GENET, V38, P390, DOI 10.1007/s10519-008-9207-2; Vukojevic V, 2008, FASEB J, V22, P3537, DOI 10.1096/fj.08-108894; Wang YJ, 2012, NEUROSCIENCE, V205, P178, DOI 10.1016/j.neuroscience.2011.12.033; Way BM, 2010, SOC COGN AFFECT NEUR, V5, P203, DOI 10.1093/scan/nsq059; WEERTS EM, 2012, INT J NEUROPSYCHOPH, P1; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Zollner C., 2007, HDB EXP PHARM, V177, P31, DOI DOI 10.1007/978-3-540-33823-9_2	43	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79121	10.1371/journal.pone.0079121	http://dx.doi.org/10.1371/journal.pone.0079121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24312175	Green Submitted, Green Published, gold			2022-12-25	WOS:000327652100006
J	Alant, JDD; Senjaya, F; Ivanovic, A; Forden, J; Shakhbazau, A; Midha, R				Alant, Jacob Daniel de Villiers; Senjaya, Ferry; Ivanovic, Aleksandra; Forden, Joanne; Shakhbazau, Antos; Midha, Rajiv			The Impact of Motor Axon Misdirection and Attrition on Behavioral Deficit Following Experimental Nerve Injuries	PLOS ONE			English	Article							RAT SCIATIC-NERVE; POOR FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; PREFERENTIAL REINNERVATION; CONTRIBUTING FACTORS; FEMORAL NERVE; REPAIR; REGENERATION; SPECIFICITY; COORDINATION	Peripheral nerve transection and neuroma-in-continuity injuries are associated with permanent functional deficits, often despite successful end-organ reinnervation. Axonal misdirection with non-specific reinnervation, frustrated regeneration and axonal attrition are believed to be among the anatomical substrates that underlie the poor functional recovery associated with these devastating injuries. Yet, functional deficits associated with axonal misdirection in experimental neuroma-in-continuity injuries have not yet been studied. We hypothesized that experimental neuroma-in-continuity injuries would result in motor axon misdirection and attrition with proportional persistent functional deficits. The femoral nerve misdirection model was exploited to assess major motor pathway misdirection and axonal attrition over a spectrum of experimental nerve injuries, with neuroma-in-continuity injuries simulated by the combination of compression and traction forces in 42 male rats. Sciatic nerve injuries were employed in an additional 42 rats, to evaluate the contribution of axonal misdirection to locomotor deficits by a ladder rung task up to 12 weeks. Retrograde motor neuron labeling techniques were utilized to determine the degree of axonal misdirection and attrition. Characteristic histological neuroma-in-continuity features were demonstrated in the neuroma-in-continuity groups and poor functional recovery was seen despite successful nerve regeneration and muscle reinnervation. Good positive and negative correlations were observed respectively between axonal misdirection (p<.0001, r(2)=.67), motor neuron counts (attrition) (p<.0001, r(2)=.69) and final functional deficits. We demonstrate prominent motor axon misdirection and attrition in neuroma-in-continuity and transection injuries of mixed motor nerves that contribute to the long-term functional deficits. Although widely accepted in theory, to our knowledge, this is the first experimental evidence to convincingly demonstrate these correlations with data inclusive of the neuroma-in-continuity spectrum. This work emphasizes the need to focus on strategies that promote both robust and accurate nerve regeneration to optimize functional recovery. It also demonstrates that clinically relevant neuroma-in-continuity injuries can now also be subjected to experimental investigation.	[Alant, Jacob Daniel de Villiers; Senjaya, Ferry; Midha, Rajiv] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Ivanovic, Aleksandra; Forden, Joanne; Shakhbazau, Antos] Univ Calgary, Hotchkiss Brain Inst, Dept Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Alant, JDD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.	japiealant@hotmail.com			AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award; Plastic Surgery Foundation; American Association for Peripheral Nerve	AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award; Plastic Surgery Foundation; American Association for Peripheral Nerve	The authors thank the AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award (http://www.spinesection.org/fellowships_awards.php?id=3) and the Plastic Surgery Foundation/(http://www.thepsf.org/x365.xml?keyword=&investigator=alant&year=&institution=&location=&fundingmechanism=&focusarea=) American Association for Peripheral Nerve (http://www.peripheralnerve.org/fellowships/fellowships.html) for funding provided in partial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alant JD, 2002, J NEUROTRAUM, V29, P1691; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; BRUSHART TM, 1983, J HAND SURG-AM, V8, P248, DOI 10.1016/S0363-5023(83)80152-X; Brushart TM, 2011, NERVE REPAIR, P135; Brushart TM., 2011, NERVE REPAIR, P353; Brushart TM, 2011, NERVE REPAIR, P159; BRUSHART TME, 1988, J NEUROSCI, V8, P1026; de Ruiter GCW, 2008, EXP NEUROL, V211, P339, DOI 10.1016/j.expneurol.2007.12.023; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Hamilton SK, 2011, J COMP NEUROL, V519, P21, DOI 10.1002/cne.22446; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; Kemp SWP, 2010, EUR J NEUROSCI, V31, P1074, DOI 10.1111/j.1460-9568.2010.07130.x; MACKINNON SE, 1989, ANN PLAS SURG, V22, P257, DOI 10.1097/00000637-198903000-00013; Madison RD, 2007, ACTA PHYSIOL, V189, P201, DOI 10.1111/j.1748-1716.2006.01657.x; Madison RD, 1996, J NEUROSCI, V16, P5698; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Sabatier MJ, 2011, CELLS TISSUES ORGANS, V193, P298, DOI 10.1159/000323677; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Spencer P S, 1974, Bull Hosp Joint Dis, V35, P85; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; SWETT JE, 1986, EXP NEUROL, V93, P227, DOI 10.1016/0014-4886(86)90161-5; TADA K, 1979, EXP NEUROL, V65, P301, DOI 10.1016/0014-4886(79)90100-6; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Valero-Cabre A, 2002, J NEUROTRAUM, V19, P1475, DOI 10.1089/089771502320914705; Valls-Sole J, 2011, CLIN NEUROPHYSIOL, V122, P219, DOI 10.1016/j.clinph.2010.06.024; WASSERSCHAFF M, 1990, BRAIN RES, V515, P241, DOI 10.1016/0006-8993(90)90602-8; WIKHOLM RP, 1988, OTOLARYNG HEAD NECK, V99, P353, DOI 10.1177/019459988809900401; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	32	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82546	10.1371/journal.pone.0082546	http://dx.doi.org/10.1371/journal.pone.0082546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282624	Green Published, Green Submitted, gold			2022-12-25	WOS:000327543500128
J	Chen, S; Xiang, Y; Deng, J; Liu, YL; Li, SH				Chen, Sha; Xiang, Yue; Deng, Jiao; Liu, Yanling; Li, Shaohua			Simultaneous Analysis of Anthocyanin and Non-Anthocyanin Flavonoid in Various Tissues of Different Lotus (Nelumbo) Cultivars by HPLC-DAD-ESI-MSn	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; NUCIFERA GAERTN.; BIOSYNTHESIS; CHROMATOGRAPHY; LEAVES; POLYPHENOLS; FRUITS; PETALS; PARTS; ACID	A validated HPLC-DAD-ESI-MSn method for the analysis of non-anthocyanin flavonoids was applied to nine different tissues of twelve lotus genotypes of Nelumbo nucifera and N. lutea, together with an optimized anthocyanin extraction and separation protocol for lotus petals. A total of five anthocyanins and twenty non-anthocyanin flavonoids was identified and quantified. Flavonoid contents and compositions varied with cultivar and tissue and were used as a basis to divide tissues into three groups characterized by kaempferol and quercetin derivatives. Influences on flower petal coloration were investigated by principal components analyses. High contents of kaempferol glycosides were detected in the petals of N. nucifera while high quercetin glycoside concentrations occurred in N. lutea. Based on these results, biosynthetic pathways leading to specific compounds in lotus tissues are deduced through metabolomic analysis of different genotypes and tissues and correlations among flavonoid compounds.	[Chen, Sha; Xiang, Yue; Deng, Jiao; Liu, Yanling; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Chen, Sha; Li, Shaohua] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Chen, Sha; Li, Shaohua] Chinese Acad Sci, Inst Bot, Lab Plant Resource, Beijing, Peoples R China; [Chen, Sha; Xiang, Yue; Deng, Jiao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	shhli@wbgcas.cn	liu, yan/HCI-5542-2022	Chao, Yin Kai/0000-0001-8649-8783; Chen, Sha/0000-0003-1387-9133	Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-20]	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was financially supported by The Knowledge Innovation Project of the Chinese Academy of Sciences, No. KSCX2-EW-J-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2012, J AGR FOOD CHEM, V60, P3635, DOI 10.1021/jf300022u; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Chen S, 2012, ANAL CHIM ACTA, V724, P127, DOI 10.1016/j.aca.2012.02.051; Chen S, 2012, J CHROMATOGR A, V1227, P145, DOI 10.1016/j.chroma.2011.12.098; Gouveia S, 2011, FOOD CHEM, V129, P333, DOI 10.1016/j.foodchem.2011.04.078; Guo HB, 2009, GENET RESOUR CROP EV, V56, P323, DOI 10.1007/s10722-008-9366-2; Guo XF, 2010, PHYTOCHEM ANALYSIS, V21, P268, DOI 10.1002/pca.1196; Imsabai W, 2010, POSTHARVEST BIOL TEC, V58, P57, DOI 10.1016/j.postharvbio.2010.04.007; Jung HA, 2003, ARCH PHARM RES, V26, P279, DOI 10.1007/BF02976956; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Kredy HM, 2010, EUR FOOD RES TECHNOL, V231, P387, DOI 10.1007/s00217-010-1287-6; Lee HK, 2005, INT J FOOD SCI TECH, V40, P709, DOI 10.1111/j.1365-2621.2005.00990.x; Liang ZC, 2012, FOOD CHEM, V132, P730, DOI 10.1016/j.foodchem.2011.11.009; Martin Bueno J, 2012, CRIT REV ANAL CHEM, V42, P126; Masuda J, 2012, J JPN SOC HORTIC SCI, V81, P67, DOI 10.2503/jjshs1.81.67; MATEK Vladimir, 1987, DANAS; Mattivi F, 2006, J AGR FOOD CHEM, V54, P7692, DOI 10.1021/jf061538c; MERVOYER C, 2012, PLANTA MED, V78, P1257; Mukherjee D, 2010, J ETHNOPHARMACOL, V128, P490, DOI 10.1016/j.jep.2010.01.015; Pfeiffer P, 2011, ACTA ALIMENT HUNG, V40, P150, DOI 10.1556/AAlim.40.2011.Suppl.15; Rai S, 2006, J ETHNOPHARMACOL, V104, P322, DOI 10.1016/j.jep.2005.09.025; Ryan KG, 2002, PHYTOCHEMISTRY, V59, P23, DOI 10.1016/S0031-9422(01)00404-6; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Steffensen SK, 2011, J AGR FOOD CHEM, V59, P12073, DOI 10.1021/jf202969e; Sun JH, 2012, RAPID COMMUN MASS SP, V26, P1123, DOI 10.1002/rcm.6209; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Valls J, 2009, J CHROMATOGR A, V1216, P7143, DOI 10.1016/j.chroma.2009.07.030; Wang Q., 2005, COLORED ILLUSTRATION; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu JZ, 2007, FOOD CHEM, V105, P540, DOI 10.1016/j.foodchem.2007.04.011; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046	31	37	37	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62291	10.1371/journal.pone.0062291	http://dx.doi.org/10.1371/journal.pone.0062291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646125	Green Published, gold, Green Submitted			2022-12-25	WOS:000319077300038
J	Xu, HY; Yang, NW; Wan, FH				Xu, Hai-Yun; Yang, Nian-Wan; Wan, Fang-Hao			Competitive Interactions between Parasitoids Provide New Insight into Host Suppression	PLOS ONE			English	Article							TABACI BIOTYPE-B; BEMISIA-TABACI; INTRINSIC COMPETITION; ENCARSIA-FORMOSA; LETHAL INTERFERENCE; LARVAL PARASITOIDS; 2 ENDOPARASITOIDS; ERETMOCERUS; DISCRIMINATION; HYMENOPTERA	Understanding the dynamics of potential inter- and intraspecific competition in parasitoid communities is crucial in the screening of efficient parasitoid species and for utilization of the best parasitoid species combinations. In this respect, the host-parasitoid systems, Bemisia tabaci and two parasitoids, Eretmocerus hayati (exotic) and Encarsia sophia (existing) were studied under laboratory conditions to investigate whether interference competition between the exotic and existing species occurs as well as the influence of potential interference competition on the suppression of the host B. tabaci. Studies on interspecific-, intraspecific- and self-interference competition in two parasitoid species were conducted under both rich and limited host resource conditions. Results showed that (1) both parasitoid species negatively affect the progeny production of the other under both rich and limited host resource conditions; (2) both parasitoid species interfered intraspecifically on conspecific parasitized hosts when the available hosts are scarce and; 3) the mortality of B. tabaci induced by parasitoids via parasitism, host-feeding or both parasitism and host-feeding together varied among treatments under different host resource conditions, but showed promise for optimizing control strategies. As a result of our current findings, we suggest a need to investigate the interactions between the two parasitoids on continuous generations.	[Xu, Hai-Yun; Yang, Nian-Wan; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wanfanghao@caas.cn	Yang, Nianwan/AAH-7371-2019	Yang, Nianwan/0000-0002-6014-3383; Tang, Shihuan/0000-0003-0589-4499	National Natural Science Foundation [30930062]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	The research was financially supported by the National Natural Science Foundation (30930062) and the National Basic Research and Development Program of China (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeh MJ, 2005, BIOL CONTROL, V33, P74, DOI 10.1016/j.biocontrol.2005.01.006; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Collier T, 2002, BIOL CONTROL, V23, P254, DOI 10.1006/bcon.2001.1007; Collier TR, 2007, ECOL ENTOMOL, V32, P70, DOI 10.1111/j.1365-2311.2006.00844.x; Collier TR, 2001, OECOLOGIA, V129, P147, DOI 10.1007/s004420100706; COLLIER TR, 1995, ANN ENTOMOL SOC AM, V88, P206, DOI 10.1093/aesa/88.2.206; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; De Vis RMJ, 2003, J INSECT BEHAV, V16, P117, DOI 10.1023/A:1022805529942; FORCE DC, 1985, AM NAT, V126, P440, DOI 10.1086/284430; FORCE DC, 1974, SCIENCE, V184, P624, DOI 10.1126/science.184.4137.624; Giron D, 2002, FUNCT ECOL, V16, P750, DOI 10.1046/j.1365-2435.2002.00679.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goolsby J, 2005, 2 INT S BIOL CONTR A; Goolsby JA, 2005, BIOL CONTROL, V32, P70, DOI 10.1016/j.biocontrol.2004.07.012; Goolsby John A., 2008, V4, P179; Gould Juli, 2008, V4, P191, DOI 10.1007/978-1-4020-6740-2_12; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2009, ENTOMOL EXP APPL, V132, P155, DOI 10.1111/j.1570-7458.2009.00882.x; Huang Jian, 2000, Entomological Journal of East China, V9, P29; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Hunter MS, 1998, ENTOMOL EXP APPL, V89, P249, DOI 10.1023/A:1003555607725; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; [冀禄禄 Ji Lulu], 2012, [中国生物防治学报, Chinese Journal of Biological Control], V28, P303; Khafagi WE, 2008, BIOCONTROL, V53, P427, DOI 10.1007/s10526-007-9078-0; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; MACKAUER M, 1990, CRITICAL ISSUES IN BIOLOGICAL CONTROL, P41; Moretti R, 2008, ENTOMOL EXP APPL, V129, P44, DOI 10.1111/j.1570-7458.2008.00745.x; Mucheru OM, 2009, ENTOMOL EXP APPL, V130, P10, DOI 10.1111/j.1570-7458.2008.00788.x; Murdoch WW, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P167; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pedata PA, 2002, B ENTOMOL RES, V92, P521, DOI 10.1079/BER2002203; Perring Thomas M., 1996, P3; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; PRICE PW, 1972, ECOLOGY, V53, P190, DOI 10.2307/1935729; PRICE PW, 1988, AM NAT, V131, P544, DOI 10.1086/284805; Qio Bao-Li, 2004, Entomological Knowledge, V41, P333; TILLMAN PG, 1992, ENTOMOPHAGA, V37, P439, DOI 10.1007/BF02373117; WALTER GH, 1983, BIOL J LINN SOC, V19, P63, DOI 10.1111/j.1095-8312.1983.tb00777.x; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Yang NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041189; Yang NW, 2011, BIOL CONTROL, V59, P313, DOI 10.1016/j.biocontrol.2011.07.019; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zolnerowich G, 1998, P ENTOMOL SOC WASH, V100, P310	47	43	50	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82003	10.1371/journal.pone.0082003	http://dx.doi.org/10.1371/journal.pone.0082003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24339904	Green Published, Green Submitted, gold			2022-12-25	WOS:000327657900066
J	Hou, TT; Zhang, X; Xu, JJ; Jian, CS; Huang, ZL; Ye, T; Hu, KP; Zheng, M; Gao, F; Wang, XH; Cheng, HP				Hou, Tingting; Zhang, Xing; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Ye, Tao; Hu, Keping; Zheng, Ming; Gao, Feng; Wang, Xianhua; Cheng, Heping			Synergistic Triggering of Superoxide Flashes by Mitochondrial Ca2+ Uniport and Basal Reactive Oxygen Species Elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CA-2&-INDUCED MEMBRANE TRANSITION; OXIDATIVE-STRESS; CYCLOPHILIN-D; CA-2+-DEPENDENT PORE; ISOLATED HEPATOCYTES; CELL-DEATH; TRANSIENT; METABOLISM; COMPONENT	Mitochondrial superoxide flashes reflect a quantal, bursting mode of reactive oxygen species (ROS) production that arises from stochastic, transient opening of the mitochondrial permeability transition pore (mPTP) in many types of cells and in living animals. However, the regulatory mechanisms and the exact nature of the flash-coupled mPTP remain poorly understood. Here we demonstrate a profound synergistic effect between mitochondrial Ca2+ uniport and elevated basal ROS production in triggering superoxide flashes in intact cells. Hyperosmotic stress potently augmented the flash activity while simultaneously elevating mitochondrial Ca2+ and ROS. Blocking mitochondrial Ca2+ transport by knockdown of MICU1 or MCU, newly identified components of the mitochondrial Ca2+ uniporter, or scavenging mitochondrial basal ROS markedly diminished the flash response. More importantly, whereas elevating Ca2+ or ROS production alone was inefficacious in triggering the flashes, concurrent physiological Ca2+ and ROS elevation served as the most powerful flash activator, increasing the flash incidence by an order of magnitude. Functionally, superoxide flashes in response to hyperosmotic stress participated in the activation of JNK and p38. Thus, physiological levels of mitochondrial Ca2+ and ROS synergistically regulate stochastic mPTP opening and quantal ROS production in intact cells, marking the flash as a coincidence detector of mitochondrial Ca2+ and ROS signals.	[Hou, Tingting; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Zheng, Ming; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xing; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710023, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Hu, Keping] Chinese Acad Med Sci, Inst Med Plant Dev, Res Ctr Pharmacol & Toxicol, Beijing 100094, Peoples R China; [Hu, Keping] Peking Union Med Coll, Beijing 100094, Peoples R China	Peking University; Air Force Military Medical University; Hong Kong Polytechnic University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, XH (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Gao, Feng/X-4385-2019; Zhang, Xing/ACQ-5035-2022; cheng, heping/A-7299-2011; Ye，PhD，FRSC, Tao/ABB-8698-2020; Heping, Cheng/AAE-2680-2019	Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Heping, Cheng/0000-0002-9604-6702; Xu, Jiejia/0000-0003-3885-3546; Hahn, Michael/0000-0003-2136-5191; Knox, John Paul/0000-0002-9231-6891	National Basic Research Program of China [2011CB809102]; National Science Foundation of China [31221002, 31130067, 31123004, 30900264]; BBSRC [BB/E015190/1] Funding Source: UKRI	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Basic Research Program of China Grant 2011CB809102 and National Science Foundation of China Grants 31221002, 31130067, 31123004, and 30900264.	ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 2007, NOVART FDN SYMP, V287, P164; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, BIOCHEM J, V255, P357; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2011, J BIOL CHEM, V286, P34851, DOI 10.1074/jbc.M111.239921; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; POWIS G, 1981, MOL PHARMACOL, V20, P387; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; THOR H, 1982, J BIOL CHEM, V257, P2419; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	54	80	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4602	4612		10.1074/jbc.M112.398297	http://dx.doi.org/10.1074/jbc.M112.398297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283965	Green Published, hybrid			2022-12-25	WOS:000315340400010
J	Kim, J; Yoon, JH; Kim, YC				Kim, Jiyoung; Yoon, Jee-Hyun; Kim, Yeon-Soo			HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICROTUBULE-ASSOCIATED PROTEIN-2; LIPID RAFTS; A-BETA; TRANSACTIVATOR PROTEIN; MODULATION; RECEPTOR; EXPRESSION; SECRETASE; CELLS	HIV-1 Tat protein plays various roles in virus proliferation and in the regulation of numerous host cell functions. Accumulating evidence suggests that HIV-1 Tat also plays an important role in HIV-associated neurocognitive disorders (HAND) by disrupting intracellular communication. Amyloid beta (A beta) is generated from amyloid precursor protein (APP) and accumulates in the senile plaques of Alzheimer's disease patients. This study demonstrates that Tat interacts with APP both in vitro and in vivo, and increases the level of A beta 42 by recruiting APP into lipid rafts. Co-localization of Tat with APP in the cytosol was observed in U-87 MG cells that expressed high levels of Tat, and redistribution of APP into lipid rafts, a site of increased beta- and gamma-secretase activity, was demonstrated by discontinuous sucrose density gradient ultracentrifugation in the presence of Tat. Furthermore, Tat enhanced the cleavage of APP by beta-secretase in vitro, resulting in 5.5-fold higher levels of A beta 42. This was consistent with increased levels of beta-C-terminal fragment (beta-CTF) and reduced levels of alpha-CTF. Moreover, stereotaxic injection of a lentiviral Tat expression construct into the hippocampus of APP/presenilin-1 (PS1) transgenic mice resulted in increased Tat-mediated production and processing of A beta in vivo. Increased levels of A beta 42, as well as an increase in the number and size of A beta plaques, were observed in the hippocampus following injection of Tat virus compared with mock virus. These results suggest that HIV-1 Tat may contribute to HAND by interacting with and modifying APP processing, thereby increasing A beta production.	[Kim, Jiyoung; Kim, Yeon-Soo] Inje Univ, Lndang Inst Mol Biol, Seoul, South Korea; [Yoon, Jee-Hyun; Kim, Yeon-Soo] Inje Univ, Dept Smart Foods & Drugs, Seoul, South Korea	Inje University; Inje University	Kim, YC (corresponding author), Inje Univ, Lndang Inst Mol Biol, Seoul, South Korea.	kimys@inje.ac.kr			National Research Foundation of Korea [2005-2001152]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (2005-2001152) (www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aksenov MY, 2010, NEUROSCI LETT, V475, P174, DOI 10.1016/j.neulet.2010.03.073; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Andersen OS, 2005, J GEN PHYSIOL, V125, P1, DOI 10.1085/jgp.200409233; Andersson LM, 1999, J NEUROL SCI, V171, P92, DOI 10.1016/S0022-510X(99)00253-1; Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; BRADDOCK M, 1990, CELL, V62, P1123, DOI 10.1016/0092-8674(90)90389-V; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chen L, 2012, NEUROBIOL AGING, V33, P1579, DOI 10.1016/j.neurobiolaging.2011.06.004; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; CRAS P, 1991, ANN NEUROL, V30, P853, DOI 10.1002/ana.410300621; Crozet C, 2004, J CELL SCI, V117, P5591, DOI 10.1242/jcs.01484; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Giometto B, 1997, ANN NEUROL, V42, P34, DOI 10.1002/ana.410420108; Giunta B, 2009, INT J CLIN EXP PATHO, V2, P433; Giunta B, 2008, INT J CLIN EXP PATHO, V1, P260; Green AJE, 2000, SEX TRANSM INFECT, V76, P443, DOI 10.1136/sti.76.6.443; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaniowska D, 2006, J VIROL, V80, P9288, DOI 10.1128/JVI.02138-05; Kim SY, 2002, J BIOTECHNOL, V93, P183, DOI 10.1016/S0168-1656(01)00388-1; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Kittiworakarn J, 2006, J BIOL CHEM, V281, P3105, DOI 10.1074/jbc.M509899200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Levy-Dweck S, 2005, J GERONTOL SOC WORK, V46, P37, DOI 10.1300/J083v46n02_04; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; LOTZ M, 1994, J CELL BIOL, V124, P365, DOI 10.1083/jcb.124.3.365; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Milani D, 1996, J BIOL CHEM, V271, P22961, DOI 10.1074/jbc.271.38.22961; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parkin ET, 1999, BIOCHEM J, V344, P23, DOI 10.1042/0264-6021:3440023; Raja F, 1997, ACTA NEUROPATHOL, V93, P184, DOI 10.1007/s004010050601; REFOLO LM, 1991, J NEUROSCI, V11, P3888; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saunders M, 2005, APOPTOSIS, V10, P1419, DOI 10.1007/s10495-005-2467-x; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SHIOMURA Y, 1987, J CELL BIOL, V104, P1575, DOI 10.1083/jcb.104.6.1575; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Ulich C, 1999, J VIROL, V73, P2499, DOI 10.1128/JVI.73.3.2499-2508.1999; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang Can, 2009, Discov Med, V8, P18	70	94	99	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e77972	10.1371/journal.pone.0077972	http://dx.doi.org/10.1371/journal.pone.0077972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	23637966	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300003
J	Song, Y; Garg, S; Girotra, M; Maddox, C; von Rosenvinge, EC; Dutta, A; Dutta, S; Fricke, WF				Song, Yang; Garg, Shashank; Girotra, Mohit; Maddox, Cynthia; von Rosenvinge, Erik C.; Dutta, Anand; Dutta, Sudhir; Fricke, W. Florian			Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; SEQUENCE-ANALYSIS; DISEASE; THERAPY; VANCOMYCIN; COLITIS; DIARRHEA; COMBINATION; SENSITIVITY	Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refractory to antibiotic therapy. It has recently been discussed favorably in the clinical and scientific communities and is receiving increasing public attention. However, short-and long-term health consequences of FMT remain a concern, as the effects of the transplanted microbiota on the patient remain unknown. To shed light on microbial events associated with RCDI and treatment by FMT, we performed fecal microbiota analysis by 16S rRNA gene amplicon pyrosequencing of 14 pairs of healthy donors and RCDI patients treated successfully by FMT. Post-FMT patient and healthy donor samples collected up to one year after FMT were studied longitudinally, including one post-FMT patient with antibiotic-associated relapse three months after FMT. This analysis allowed us not only to confirm prior reports that RCDI is associated with reduced diversity and compositional changes in the fecal microbiota, but also to characterize previously undocumented post-FMT microbiota dynamics. Members of the Streptococcaceae, Enterococcaceae, or Enterobacteriaceae were significantly increased and putative butyrate producers, such as Lachnospiraceae and Ruminococcaceae were significantly reduced in samples from RCDI patients before FMT as compared to post-FMT patient and healthy donor samples. RCDI patient samples showed more case-specific variations than post-FMT patient and healthy donor samples. However, none of the bacterial groups were invariably associated with RCDI or successful treatment by FMT. Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after FMT.	[Song, Yang; Maddox, Cynthia; Fricke, W. Florian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Garg, Shashank; Girotra, Mohit; Dutta, Anand; Dutta, Sudhir] Sinai Hosp, Div Gastroenterol, Baltimore, MD 21215 USA; [von Rosenvinge, Erik C.] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA; [Dutta, Sudhir] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Sinai Hospital of Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fricke, WF (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	wffricke@som.umaryland.edu	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	This study or parts thereof were funded by the Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD and Gastroenterology Research Funds from the Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2013, GRID EN STOR; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Berman AL, 2007, J CLIN GASTROENTEROL, V41, P932, DOI 10.1097/01.mcg.0000225685.37465.e7; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; BUGGY BP, 1987, J CLIN GASTROENTEROL, V9, P155, DOI 10.1097/00004836-198704000-00009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daneman N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001268; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dutta SK, 2013, GASTROENTEROLO UNPUB; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Garey KW, 2009, J CLIN GASTROENTEROL, V43, P91, DOI 10.1097/MCG.0b013e31814a4e97; Gorkiewicz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055817; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; James White WFF, 2011, NATURE PRECEDINGS; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Johnson S, 2007, CLIN INFECT DIS, V44, P846, DOI 10.1086/511870; Johnson S, 2009, ANAEROBE, V15, P290, DOI 10.1016/j.anaerobe.2009.08.004; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; KORUDA MJ, 1990, AM J CLIN NUTR, V51, P685, DOI 10.1093/ajcn/51.4.685; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Lawley B, 2012, GASTROENTEROL CLIN N, V41, P855, DOI 10.1016/j.gtc.2012.08.010; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Musa S, 2010, SCAND J GASTROENTERO, V45, P261, DOI 10.3109/00365520903497098; Musher DM, 2007, J ANTIMICROB CHEMOTH, V59, P705, DOI 10.1093/jac/dkl553; Navaneethan U, 2010, WORLD J GASTROENTERO, V16, P4892, DOI 10.3748/wjg.v16.i39.4892; O'Keefe SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/wjg.v16.i2.139; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pohl JF, 2012, CURR OPIN PEDIATR, V24, P627, DOI 10.1097/MOP.0b013e328355a3e1; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Skraban J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058005; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Vrieze A, 2013, BEST PRACT RES CL GA, V27, P127, DOI 10.1016/j.bpg.2013.03.003; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wettstein A, 2007, 15 GUT UN EUR GAS S1, V39, pA303; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	70	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81330	10.1371/journal.pone.0081330	http://dx.doi.org/10.1371/journal.pone.0081330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303043	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400060
J	Richter, L; Neumann, G; Oung, S; Schweikard, A; Trillenberg, P				Richter, Lars; Neumann, Gunnar; Oung, Stephen; Schweikard, Achim; Trillenberg, Peter			Optimal Coil Orientation for Transcranial Magnetic Stimulation	PLOS ONE			English	Article							MOTOR CORTEX; BRAIN-STIMULATION; ACTIVATION; AREA; LOCALIZATION; THRESHOLD; COLUMN; PULSE; TMS	We study the impact of coil orientation on the motor threshold (MT) and present an optimal coil orientation for stimulation of the foot. The result can be compared to results of models that predict this orientation from electrodynamic properties of the media in the skull and from orientations of cells, respectively. We used a robotized TMS system for precise coil placement and recorded motor-evoked potentials with surface electrodes on the abductor hallucis muscle of the right foot in 8 healthy control subjects. First, we performed a hot-spot search in standard (lateral) orientation and then rotated the coil in steps of 10 degrees or 20 degrees. At each step we estimated the MT. For navigated stimulation and for correlation with the underlying anatomy a structural MRI scan was obtained. Optimal coil orientation was 33.1 +/- 18.3 degrees anteriorly in relation to the standard lateral orientation. In this orientation the threshold was 54 +/- 18% in units of maximum stimulator output. There was a significant difference of 8.0 +/- 5.9% between the MTs at optimal and at standard orientation. The optimal coil orientations were significantly correlated with the direction perpendicular to the postcentral gyrus (r=0.78). Robotized TMS facilitates sufficiently precise coil positioning and orientation to study even small variations of the MT with coil orientation. The deviations from standard orientation are more closely matched by models based on field propagation in media than by models based on orientations of pyramidal cells.	[Richter, Lars] Med Univ Lubeck, Inst Robot & Cognit Syst, D-23538 Lubeck, Germany; [Richter, Lars; Oung, Stephen; Schweikard, Achim] Med Univ Lubeck, Grad Sch Comp Med & Life Sci, D-23538 Lubeck, Germany; [Neumann, Gunnar; Trillenberg, Peter] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital	Richter, L (corresponding author), Med Univ Lubeck, Inst Robot & Cognit Syst, D-23538 Lubeck, Germany.	richter@rob.uni-luebeck.de		Arif, Mohammad/0000-0002-5887-2050; Ochoa-Corona, Francisco/0000-0002-4112-8209	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative [DFG GSC 235/1]	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative	This work was partially supported by the Graduate School for Computing in Medicine and Life Sciences funded by Germany's Excellence Initiative [DFG GSC 235/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allison T, 1996, EVOKED POTENTIAL, V100, P126, DOI 10.1016/0013-4694(95)00226-X; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, 2011, BRAIN STIMUL, V4, P58, DOI 10.1016/j.brs.2010.09.004; Balslev D, 2007, J NEUROSCI METH, V162, P309, DOI 10.1016/j.jneumeth.2007.01.021; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brockhardt, 2011, TMS MOTOR THRESHOLD; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kocak M, 2009, RADIOLOGY, V251, P485, DOI 10.1148/radiol.2512080231; Langguth B, 2010, NEUROPHYSIOL CLIN, V40, P45, DOI 10.1016/j.neucli.2009.03.001; Matthaus L, 2006, STUD HEALTH TECHNOL, V119, P373; Matthaus L, 2008, THESIS U LUBECK; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Niyazov DM, 2005, CLIN NEUROPHYSIOL, V116, P1601, DOI 10.1016/j.clinph.2005.02.028; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6; Qazi AA, 2009, NEUROIMAGE, V47, pT98, DOI 10.1016/j.neuroimage.2008.06.034; Richter L, 2012, BRAIN STIMUL, P1; Richter L, 2011, INT J MED ROBOT COMP, V7, P414, DOI 10.1002/rcs.411; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Ruohonen J, 1999, EEG CL N SU, P30; Ruohonen J, 1998, THESIS HELSINKI U TE; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; TERAO Y, 1994, ACTA NEUROL SCAND, V89, P378; Terao Y, 1998, EXP BRAIN RES, V121, P145, DOI 10.1007/s002210050446; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Trillenberg P, 2011, KLIN NEUROPHYSIOL, V42, pP280, DOI [10.1055/s-0031-1272727, DOI 10.1055/S-0031-1272727]; Wagner T, 2012, ANNU REV BIOMED ENG, V9, P527; WERHAHN KJ, 1994, ELECTROEN CLIN NEURO, V93, P138, DOI 10.1016/0168-5597(94)90077-9; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	43	59	59	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2013	8	4							e60358	10.1371/journal.pone.0060358	http://dx.doi.org/10.1371/journal.pone.0060358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123JA	23593200	Green Submitted, gold, Green Published			2022-12-25	WOS:000317383200006
J	Shin, H; Song, H; Suh, CS; Lim, HJ				Shin, Hyejin; Song, Haengseok; Suh, Chang Suk; Lim, Hyunjung Jade			The Formin Protein mDia2 Serves as a Marker of Spindle Pole Dynamics in Vitrified-Warmed Mouse Oocytes	PLOS ONE			English	Article							POLARIZED-LIGHT MICROSCOPY; LIVING HUMAN OOCYTES; MEIOTIC SPINDLE; DEVELOPMENTAL COMPETENCE; THAWED OOCYTES; GAMMA-TUBULIN; CRYOPRESERVATION; VITRIFICATION; MICROTUBULES; ORGANIZATION	The mouse diaphanous 2 (mDia2) protein belongs to the formin family and has been shown to nucleate actin filaments and stabilize microtubules, thus indicating a role in cytoskeleton organization. Our previous study, which showed that mDia2 specifically localizes to spindle poles of metaphase I mouse oocytes and NIH3T3 cells, provided the first evidence of its spindle pole-associated cellular function. In the present study, we aim to determine whether spindle pole proteins, such as mDia2 and pericentrin, can be used to monitor the status of spindle poles in cryopreserved mouse oocytes. We show herein that mDia2 exhibits an overlapping distribution with pericentrin, which is a crucial component of centrosomes and microtubule organizing centers (MTOCs). In vitrified-warmed oocytes, the overlapping distribution of mDia2 and pericentrin was immediately detected after thawing, thereby suggesting that mDia2 maintains a tight association with the spindle pole machinery. Interestingly, we observed that microtubules extend from mDia2 clusters in cytoplasmic MTOCs after thawing. This result suggests that mDia2 is a major MTOC component that is closely associated with pericentrin and that it plays a role in microtubule growth from MTOCs. Collectively, our results provide evidence that mDia2 is a novel marker of spindle pole dynamics before and after cryopreservation.	[Shin, Hyejin; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Song, Haengseok] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Songnam, South Korea	Konkuk University; Pochon Cha University; Seoul National University (SNU)	Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.	hlim@konkuk.ac.kr	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055) (https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bromfield JJ, 2009, HUM REPROD, V24, P2114, DOI 10.1093/humrep/dep182; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Chen CK, 2004, FERTIL STERIL, V82, P666, DOI 10.1016/j.fertnstert.2003.12.053; Ciotti PM, 2009, FERTIL STERIL, V91, P2399, DOI 10.1016/j.fertnstert.2008.03.013; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; DIDION BA, 1990, J ANIM SCI, V68, P2803; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; George MA, 1996, MOL HUM REPROD, V2, P445, DOI 10.1093/molehr/2.6.445; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Kwon Sojung, 2011, Clin Exp Reprod Med, V38, P1, DOI 10.5653/cerm.2011.38.1.1; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; LANZENDORF SE, 1990, BIOL REPROD, V42, P703, DOI 10.1095/biolreprod42.4.703; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; MANDELBAUM J, 1988, HUM REPROD, V3, P117, DOI 10.1093/oxfordjournals.humrep.a136642; Moon JH, 2005, HUM REPROD, V20, P2207, DOI 10.1093/humrep/dei044; Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165; Otoi T, 1997, CRYOBIOLOGY, V34, P36, DOI 10.1006/cryo.1996.1988; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Sereni E, 2009, REPROD BIOMED ONLINE, V19, P191, DOI 10.1016/S1472-6483(10)60071-5; Wang WH, 2001, HUM REPROD, V16, P2374, DOI 10.1093/humrep/16.11.2374; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	39	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75729	10.1371/journal.pone.0075729	http://dx.doi.org/10.1371/journal.pone.0075729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24303043	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300094
J	Kim, J; Dotson, B; Rey, C; Lindsey, J; Bleecker, AB; Binder, BM; Patterson, SE				Kim, Joonyup; Dotson, Bradley; Rey, Camila; Lindsey, Joshua; Bleecker, Anthony B.; Binder, Brad M.; Patterson, Sara E.			New Clothes for the Jasmonic Acid Receptor COI1: Delayed Abscission, Meristem Arrest and Apical Dominance	PLOS ONE			English	Article							FLORAL ORGAN ABSCISSION; SIGNAL-TRANSDUCTION; GROWTH-RESPONSE; GENE-EXPRESSION; CROSS-TALK; ARABIDOPSIS; ETHYLENE; PATHWAYS; SEPARATION; ENCODES	In a screen for delayed floral organ abscission in Arabidopsis, we have identified a novel mutant of CORONATINE INSENSITIVE 1 (COI1), the F-box protein that has been shown to be the jasmonic acid (JA) co-receptor. While JA has been shown to have an important role in senescence, root development, pollen dehiscence and defense responses, there has been little focus on its critical role in floral organ abscission. Abscission, or the detachment of organs from the main body of a plant, is an essential process during plant development and a unique type of cell separation regulated by endogenous and exogenous signals. Previous studies have indicated that auxin and ethylene are major plant hormones regulating abscission; and here we show that regulation of floral organ abscission is also controlled by jasmonic acid in Arabidopsis thaliana. Our characterization of coi1-1 and a novel allele (coi1-37) has also revealed an essential role in apical dominance and floral meristem arrest. In this study we provide genetic evidence indicating that delayed abscission 4 (dab4-1) is allelic to coi1-1 and that meristem arrest and apical dominance appear to be evolutionarily divergent functions for COI1 that are governed in an ecotype-dependent manner. Further characterizations of ethylene and JA responses of dab4-1/coi1-37 also provide new information suggesting separate pathways for ethylene and JA that control both floral organ abscission and hypocotyl growth in young seedlings. Our study opens the door revealing new roles for JA and its interaction with other hormones during plant development.	[Kim, Joonyup; Dotson, Bradley; Rey, Camila; Lindsey, Joshua; Patterson, Sara E.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Kim, Joonyup; Binder, Brad M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Dotson, Bradley] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Rey, Camila] Pontificia Univ Catolica Chile, Dept Ecosistemas & Medio Ambiente, Santiago, Chile; [Lindsey, Joshua] Univ Washington, Seattle, WA 98195 USA; [Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Berkeley; Pontificia Universidad Catolica de Chile; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Patterson, SE (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	spatters@wisc.edu			USDA HATCH WISO [4409]; NSF [DBI-0077719, MCB-0918430]	USDA HATCH WISO; NSF(National Science Foundation (NSF))	Funding was provided by USDA HATCH WISO 4409 and NSF DBI-0077719 to SEP and NSF MCB-0918430 to BMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; Acosta Ivan F, 2010, Arabidopsis Book, V8, pe0129, DOI 10.1199/tab.0129; Addicott F.T, 1982, ABSCISSION; Agusti J, 2008, J EXP BOT, V59, P2717, DOI 10.1093/jxb/ern138; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], 1901, BOT CENTRALBL BEIH; Beno-Moualem D, 2004, PLANT SCI, V167, P499, DOI 10.1016/j.plantsci.2004.04.016; Binder B, 2009, STEWART POSTHARVEST; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; CURTIS RW, 1984, J PLANT GROWTH REGUL, V3, P157, DOI 10.1007/BF02042000; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Fernandez DE, 2000, PLANT CELL, V12, P183, DOI 10.1105/tpc.12.2.183; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Gonzalez-Carranza ZH, 2007, PLANT PHYSIOL, V144, P1370, DOI 10.1104/pp.106.092288; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hartmond U, 2000, J AM SOC HORTIC SCI, V125, P547, DOI 10.21273/JASHS.125.5.547; HENSEL LL, 1994, PLANT PHYSIOL, V106, P863, DOI 10.1104/pp.106.3.863; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jinn TL, 2000, GENE DEV, V14, P108; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim J, 2013, FEBS LETT, V587, P226, DOI 10.1016/j.febslet.2012.11.030; Kim J, 2012, PLANT PHYSIOL, V160, P1567, DOI 10.1104/pp.112.205799; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kou XH, 2012, J EXP BOT, V63, P6139, DOI 10.1093/jxb/ers266; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Laux T, 1996, DEVELOPMENT, V122, P87; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Lewis MW, 2006, CURR OPIN PLANT BIOL, V9, P59, DOI 10.1016/j.pbi.2005.11.009; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Liljegren SJ, 2012, CURR OPIN PLANT BIOL, V15, P670, DOI 10.1016/j.pbi.2012.09.012; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Patterson S, 2007, ADVANCES IN PLANT ETHYLENE RESEARCH, P271, DOI 10.1007/978-1-4020-6014-4_60; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; ROBERTS JA, 1984, PLANTA, V160, P159, DOI 10.1007/BF00392864; Rohwer CL, 2008, J HORTIC SCI BIOTECH, V83, P283, DOI 10.1080/14620316.2008.11512381; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; vanDoorn WG, 1997, J EXP BOT, V48, P821, DOI 10.1093/jxb/48.4.821; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; WOLTERING EJ, 1988, J EXP BOT, V39, P1605, DOI 10.1093/jxb/39.11.1605; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XU Y, 1994, PLANT CELL, V6, P1077, DOI 10.1105/tpc.6.8.1077; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	67	94	99	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60505	10.1371/journal.pone.0060505	http://dx.doi.org/10.1371/journal.pone.0060505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23637966	Green Submitted, Green Published, gold			2022-12-25	WOS:000316930900070
J	Cho, YA; Kim, J; Woo, HD; Kang, M				Cho, Young Ae; Kim, Jeongseon; Woo, Hae Dong; Kang, Moonsu			Dietary Cadmium Intake and the Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							POSTMENOPAUSAL BREAST-CANCER; BODY IRON STORES; PROSTATE-CANCER; PROSPECTIVE COHORT; TOENAIL CADMIUM; EXPOSURE; POPULATION; WOMEN; HEALTH; ZINC	Background: Diet is a major source of cadmium intake among the non-smoking general population. Recent studies have determined that cadmium exposure may produce adverse health effects at lower exposure levels than previously predicted. We conducted a meta-analysis to combine and analyze the results of previous studies that have investigated the association of dietary cadmium intake and cancer risk. Methods: We searched PubMed, EMBASE, and MEDLINE database for case-control and cohort studies that assessed the association of dietary cadmium intake and cancer risk. We performed a meta-analysis using eight eligible studies to summarize the data and summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using a random effects model. Results: Overall, dietary cadmium intake showed no statistically significant association with cancer risk (RR = 1.10; 95% CI: 0.99-1.22, for highest vs. lowest dietary cadmium group). However, there was strong evidence of heterogeneity, and subgroup analyses were conducted using the study design, geographical location, and cancer type. In subgroup analyses, the positive associations between dietary cadmium intake and cancer risk were observed among studies with Western populations (RR = 1.15; 95% CI: 1.08-1.23) and studies investigating some hormone-related cancers (prostate, breast, and endometrial cancers). Conclusion: Our analysis found a positive association between dietary cadmium intake and cancer risk among studies conducted in Western countries, particularly with hormone-related cancers. Additional experimental and epidemiological studies are required to verify our findings.	[Cho, Young Ae; Kim, Jeongseon; Woo, Hae Dong] Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea; [Kang, Moonsu] Gangneung Wonju Natl Univ, Dept Informat Stat, Kangnung, South Korea	National Cancer Center - Korea (NCC); Kangnung Wonju National University	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Chun, Jongsik/R-8458-2017	Chun, Jongsik/0000-0003-3385-5171; Shin, Sung Jae/0000-0003-0854-4582; Cho, Yong-Joon/0000-0003-3191-2670; Cho, Young Ae/0000-0001-6076-916X	Korea Food and Drug Administration [10162KFDA994]	Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea)	This research was supported by a grant from Korea Food and Drug Administration (10162KFDA994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2012, CANCER CAUSE CONTROL, V23, P845, DOI 10.1007/s10552-012-9953-6; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGLUND M, 1994, ENVIRON HEALTH PERSP, V102, P1058, DOI 10.2307/3431993; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Chen YC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-429; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gallagher CM, 2010, AGING-US, V2, P804, DOI 10.18632/aging.100226; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22; International Agency for Research on Cancer, 1993, IARC MON EV CARC RIS, P58; Itoh H, 2013, INT J HYG ENVIR HEAL, DOI [10.1016/j.ijheh.2013.1003.1010, DOI 10.1016/J.IJHEH.2013.1003.1010.PUBMED:23608001]; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Julin B, 2012, BRIT J CANCER, V107, P895, DOI 10.1038/bjc.2012.311; Julin B, 2011, BRIT J CANCER, V105, P441, DOI 10.1038/bjc.2011.238; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; Julin B, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-105; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1; Martin MB, 2002, ENDOCRINOLOGY, V143, P263, DOI 10.1210/en.143.1.263; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Nagata C, 2013, BREAST CANCER RES TR, V138, P235, DOI 10.1007/s10549-013-2414-4; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nimptsch K, 2011, CANCER CAUSE CONTROL, V22, P51, DOI 10.1007/s10552-010-9671-x; OGUNLEWE JO, 1989, CANCER, V63, P1388, DOI 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Platz EA, 2002, PROSTATE, V52, P288, DOI 10.1002/pros.10115; Reeves PG, 2008, SCI TOTAL ENVIRON, V398, P13, DOI 10.1016/j.scitotenv.2008.03.009; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; van Wijngaarden E, 2008, PROSTATE, V68, P122, DOI 10.1002/pros.20668; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; Watanabe T, 2000, INT ARCH OCC ENV HEA, V73, P26, DOI 10.1007/PL00007934; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; Zhang ZW, 1997, INT ARCH OCC ENV HEA, V69, P273	41	89	91	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75087	10.1371/journal.pone.0075087	http://dx.doi.org/10.1371/journal.pone.0075087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24312320	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300070
J	Zhang, HD; Song, J; Ren, H; Xu, ZR; Wang, XN; Shan, LF; Fang, J				Zhang, Huidan; Song, Jin; Ren, Hui; Xu, Zhangrun; Wang, Xiaonan; Shan, Lianfeng; Fang, Jin			Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; CONTEMPORARY SAMPLE STACKING; REAL-TIME PCR; MICROCHIP ELECTROPHORESIS; FLUORESCENCE DETECTION; 1ST-LINE TREATMENT; ANTIBODY THERAPY; ENERGY-TRANSFER; DNA	Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (mu CE-based RFLP) platform for low-abundance KRAS genotyping with the combination of mu CE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of mu CE for Phi 174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by mu CE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by mu CE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the mu CE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.	[Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China; [Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Ren, Hui] Shenyang Anal Rectum Hosp, Dept Colon Surg, Shenyang, Peoples R China; [Xu, Zhangrun] Northeastern Univ, Res Ctr Analyt Sci, Shenyang, Peoples R China; [Shan, Lianfeng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China	China Medical University; China Medical University; Northeastern University - China; China Medical University	Fang, J (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China.	jfang61@gmail.com	Zhang, Huidan/K-8399-2015; Zhang, Hai-Lin/H-2715-2017	Chen, Guifen/0000-0002-5459-660X; Zhang, Hai-Lin/0000-0002-7426-2885	National Natural Science Foundation of China [30901727, 20975019, 20875103, 20375047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 30901727, 20975019, 20875103, 20375047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2009, J PHARMACEUT BIOMED, V50, P947, DOI 10.1016/j.jpba.2009.06.034; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Assenat E, 2011, ONCOLOGIST, V16, P1557, DOI 10.1634/theoncologist.2011-0141; Beard NR, 2003, ELECTROPHORESIS, V24, P732, DOI 10.1002/elps.200390088; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5727, DOI 10.1093/nar/21.24.5727; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chowdhury J, 2007, J MOL DIAGN, V9, P521, DOI 10.2353/jmoldx.2007.070014; DELATTRE O, 1989, LANCET, V2, P353; Evenhuis CJ, 2009, ELECTROPHORESIS, V30, P897, DOI 10.1002/elps.200800643; Fang Q, 2002, ANAL CHEM, V74, P1223, DOI 10.1021/ac010925c; Gebauer P, 2009, ELECTROPHORESIS, V30, pS27, DOI 10.1002/elps.200900053; Gotz S, 2007, ANAL BIOANAL CHEM, V387, P183, DOI 10.1007/s00216-006-0820-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477; Jiang GF, 2000, BIOSENS BIOELECTRON, V14, P861, DOI 10.1016/S0956-5663(99)00056-1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kleparnik K, 2007, CHEM REV, V107, P5279, DOI 10.1021/cr0101860; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; Lanthaler AJ, 2011, DIAGN MOL PATHOL, V20, P90, DOI 10.1097/PDM.0b013e31820e5f9a; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; LODA M, 1994, HUM PATHOL, V25, P564, DOI 10.1016/0046-8177(94)90220-8; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mala Z, 2009, J CHROMATOGR A, V1051, P147; Mala Z, 2007, ELECTROPHORESIS, V28, P243, DOI 10.1002/elps.200600397; Mala Z, 2009, ELECTROPHORESIS, V30, P215, DOI 10.1002/elps.200800433; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Milano G, 2008, ANN ONCOL, V19, P2033, DOI 10.1093/annonc/mdn416; Minucci A, 2008, J SEP SCI, V31, P2694, DOI 10.1002/jssc.200800216; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nachamkin I, 2001, J CLIN MICROBIOL, V39, P754, DOI 10.1128/JCM.39.2.754-757.2001; Nishikawa T, 2002, CLIN CHIM ACTA, V318, P107, DOI 10.1016/S0009-8981(01)00806-3; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Petersen NJ, 2004, ELECTROPHORESIS, V25, P253, DOI 10.1002/elps.200305747; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Schimanski CC, 1999, CANCER RES, V59, P5169; Scholtka B, 2009, CANCER EPIDEMIOL, V33, P123, DOI 10.1016/j.canep.2009.05.001; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Wu CM, 2005, CANCER GENET CYTOGEN, V158, P55, DOI 10.1016/j.cancergencyto.2004.08.030; Xiao SX, 1997, PROG BIOCHEM BIOPHYS, V24, P375; Xu F, 2004, J CHROMATOGR A, V1051, P147, DOI 10.1016/j.chroma.2004.05.019; Yang YZ, 2006, ANAL CHEM, V78, P4752, DOI 10.1021/ac051735v; Zhang HD, 2011, LAB INVEST, V91, P788, DOI 10.1038/labinvest.2010.200; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	61	203	206	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54510	10.1371/journal.pone.0054510	http://dx.doi.org/10.1371/journal.pone.0054510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23750250	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500082
